Citrus Sinensis ID: 002214

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950--
Protein Sequence
MINDNPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSRKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIEMV
Secondary Structure (PSIPRED)
cccccccccccccccccccccccEEEEEcccccEEEEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHHccccccEEEccccccEEcccccHHcccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccccccccccEEccccccccccccccEEccccccEEcccHHHHcccccccEEccccccEEEccccccccccccccEEEccccccEEcccccccccccccEEcccccccccEEEccccccccccHHHccccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHccccccEEEccccEEEEccccccccccccccEEcccccccccccHHHHccccccEEEcccccccccccHHHHcccccccEEcccccccccccHHHHccccccEEcccccccccccHHHHHccccccccccccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHcccccccccEEEEEEccccEEEEEcccccccccHHcccccccccHHHHHHHHHHHHHHHHccccccccccEEccccccccccccccEEEEcccccccccccccccccEEccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccEEccccccccHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHccccc
Secondary Structure Prediction (SSPRO)
cccccccccHHcccccccccccEEEEEEcccccEEEEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHHccHHHHcEEEcccccccccccHHHcccccccEEEccccccEEcccHHHHHcccccEEEcEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHccHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHccccccccEEEEccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEcccccccccccHHHccccccccEEEccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEEccccccHHHccHHHcccccEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHHcccHccEEEccccEEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHcHHHHHHHHHHEccccccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEcccccHHHHHHccHHEEEcccccccccHEccccccccccccEEEEEcccccHEHHHHHHHHHHcccccccccccccccHHHHHHHHHccHHHHccHHHccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccccccc
Coil and Loop (DISEMBL)
mindnpnnilaqnwtsnasVCSWMGITcdvygnrvtsltisdlglagtipshlgnlssLQTLVlsrnwfsgtipkeignltKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNnlltgtipasiFNLSFISTaldfsdnsltgsfpydmcpglprlkglYVSYnqfkgpipnnlwhckelsSVSLSYnqftgrlprdlgnstklksldlgfnnlngeipqeignlrnleilgidqsnlvgfvpdtiFNISTLKILSLFNntlsgnlpssknliglpnleglnlglnnlsgsipsfffNASKLYALELGynsnlkrlglernyltFSTSELMSLFSALVNckslkignlinlttlslgdnnlsgslpitLGRLKklqgldlqnnkfegpipqefchFSRLYVVYLNRnklsgsipsclgdlnslrilslssneltsvipstfwnledilgfdfssnslngslpleIENLKAVVDIYLSrnnlsgnipstiiGLKNLQHLSLehnklqgpipesfgeLVSLEfldlsnndlsgvipASLEKLLYLKSLNLSFNKlvgeiprggafanfsaesfigndllcgspylhvplckssphkksrkQVILLGVVLPLSTVFIVTVILVLTFGLITRCckrrstevshikagmspqvmwrrYSHDELLRAtdqfseenligigsygsvykgrfpdgIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLeympkgsledcmyasnfnlDIFQRLGIMIDVASALEylhfghsnpivhcdikpsnvllddsmvAHLSDFGIAKLLSEEDSMKQTQTLATIgyiapeygregqvsikgdVYNYGIMLMEVFtgmkptnefftgeMSIKRWINDSLPAVmnimdtnllsedeeHANVAKQSCASSVLSLAMectsespenrvnTKEIISRLIKIRDLLFANIEMV
Flexible Loop (DISEMBL)
MINDNPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSRKQVILLGVVLPLSTVFIVTVILVLTFGLITRCckrrstevshikagmspqvmWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGyiapeygregqvSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMectsespenrvntkeIISRLIKIRDLLFANIEMV
Low Complexity Region (SEG)
MINDNPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGnlaelemlvlnnnllTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKnliglpnleglnlglnnlsgsipSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTlslgdnnlsgslPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDlnslrilslssnelTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPAslekllylkslnlsfnklVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSRKQVILLGVVLPLStvfivtvilvltfGLITRCCKRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIEMV
Disordered region (IsUnstruct)
********ILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKS******RKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE*****QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL***********************************TKEIISRLIKIRDLLFANI***
Disordered Region (DISOPRED)
MINDNPNNILA*NWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSP**********************GVVLPLSTVFIVTVILVLTFGLI**********************MWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE*ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS*KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIEMV
Disordered Region (DISEMBL)
MINDNPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSRKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE**********ASSVLSL************VNTKEIISRLIKIRDLLFANIEMV
Disordered Region (DISPRO)
*INDNPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPL*********RKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRR*******KAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MINDNPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSRKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIEMV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	952	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.953	0.899	0.364	1e-153
C0LGT6	1031	LRR receptor-like serine/	no	no	0.967	0.893	0.355	1e-151
Q9SD62	1025	Putative receptor-like pr	no	no	0.959	0.890	0.353	1e-138
Q9FL28	1173	LRR receptor-like serine/	no	no	0.972	0.789	0.323	1e-135
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.932	0.710	0.344	1e-132
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.927	0.705	0.341	1e-130
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.961	0.830	0.324	1e-127
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.970	0.839	0.334	1e-125
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.924	0.878	0.334	1e-120
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.898	0.872	0.331	1e-119

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  542 bits (1396), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 361/991 (36%), Positives = 527/991 (53%), Gaps = 83/991 (8%)

Query: 9    ILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNW 68
            ++  +W  +  +C+W G+TC     RVT L +  L L G I   +GNLS L +L L  N+
Sbjct: 42   VVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVISPSIGNLSFLVSLDLYENF 101

Query: 69   FSGTIPKEIGNLTKLK------------------------ELHLDYNKLQGEIPEELGNL 104
            F GTIP+E+G L++L+                         L LD N+L G +P ELG+L
Sbjct: 102  FGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSL 161

Query: 105  AELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSY 164
              L  L L  N + G +P S+ NL+ +   L  S N+L G  P D+   L ++  L +  
Sbjct: 162  TNLVQLNLYGNNMRGKLPTSLGNLTLLE-QLALSHNNLEGEIPSDVAQ-LTQIWSLQLVA 219

Query: 165  NQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGN-STKLKSLDLGFNNLNGEIPQEI 223
            N F G  P  L++   L  + + YN F+GRL  DLG     L S ++G N   G IP  +
Sbjct: 220  NNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTL 279

Query: 224  GNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTL----SGNLPSSKNLIGLPNL 279
             N+  LE LG++++NL G +P T  N+  LK+L L  N+L    S +L    +L     L
Sbjct: 280  SNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQL 338

Query: 280  EGLNLGLNNLSGSIPSFFFN-ASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSAL 338
            E L +G N L G +P    N ++KL  L+LG                       +L S  
Sbjct: 339  ETLGIGRNRLGGDLPISIANLSAKLVTLDLGG----------------------TLISGS 376

Query: 339  VNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFS 398
            +      IGNLINL  L L  N LSG LP +LG+L  L+ L L +N+  G IP    + +
Sbjct: 377  I---PYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMT 433

Query: 399  RLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSL 458
             L  + L+ N   G +P+ LG+ + L  L +  N+L   IP     ++ +L  D S NSL
Sbjct: 434  MLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSL 493

Query: 459  NGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELV 518
             GSLP +I  L+ +  + L  N LSG +P T+     ++ L LE N   G IP+  G LV
Sbjct: 494  IGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LV 552

Query: 519  SLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLL 578
             ++ +DLSNNDLSG IP        L+ LNLSFN L G++P  G F N +  S +GN+ L
Sbjct: 553  GVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDL 612

Query: 579  CGS--PYLHVPLCKSSPHKKSRKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRST 636
            CG    +   P    +P    +    L  VV+ +S    + ++L +    +    KR+  
Sbjct: 613  CGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKN 672

Query: 637  EVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKV 695
            + ++     + +V+  + S+ +L  AT+ FS  N++G GS+G+VYK     +   VA+KV
Sbjct: 673  KETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKV 732

Query: 696  FHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN-----HNFKALVLEYMPKGSLEDC 750
             ++QR GA+ SF AECE LK IRHRNLVK++++C++     + F+AL+ E+MP GSL+  
Sbjct: 733  LNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMW 792

Query: 751  MYASNF--------NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV 802
            ++             L + +RL I IDVAS L+YLH     PI HCD+KPSNVLLDD + 
Sbjct: 793  LHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLT 852

Query: 803  AHLSDFGIAKLL---SEEDSMKQTQTL---ATIGYIAPEYGREGQVSIKGDVYNYGIMLM 856
            AH+SDFG+A+LL    EE    Q  +     TIGY APEYG  GQ SI GDVY++GI+L+
Sbjct: 853  AHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLL 912

Query: 857  EVFTGMKPTNEFFTGEMSIKRWINDSLPA-VMNIMDTNLLSEDEEHANVAKQSCASSVLS 915
            E+FTG +PTNE F G  ++  +   +LP  +++I+D ++L             C + V  
Sbjct: 913  EMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESIL-HIGLRVGFPVVECLTMVFE 971

Query: 916  LAMECTSESPENRVNTKEIISRLIKIRDLLF 946
            + + C  ESP NR+ T  ++  LI IR+  F
Sbjct: 972  VGLRCCEESPMNRLATSIVVKELISIRERFF 1002

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  537 bits (1383), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 349/983 (35%), Positives = 540/983 (54%), Gaps = 62/983 (6%)

Query: 4    DNPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLV 63
            +N   +LA +W  ++  C+W+G+TC     RV SL +    L G I   +GNLS L+ L 
Sbjct: 45   NNKREVLA-SWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGVISPSIGNLSFLRLLN 103

Query: 64   LSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPA 123
            L+ N F  TIP+++G L +L+ L++ YN L+G IP  L N + L  + L++N L   +P+
Sbjct: 104  LADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPS 163

Query: 124  SIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSS 183
             + +LS ++  LD S N+LTG+FP  +   L  L+ L  +YNQ +G IP+ +    ++  
Sbjct: 164  ELGSLSKLAI-LDLSKNNLTGNFPASL-GNLTSLQKLDFAYNQMRGEIPDEVARLTQMVF 221

Query: 184  VSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSN-LVGF 242
              ++ N F+G  P  L N + L+SL L  N+ +G +  + G L       +  +N   G 
Sbjct: 222  FQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGA 281

Query: 243  VPDTIFNISTLKILSLFNNTLSGNLPSS----KNLIGLPNLEGLNLGLNNLSGSIPSFFF 298
            +P T+ NIS+L+   + +N LSG++P S    +NL  L          ++          
Sbjct: 282  IPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVA 341

Query: 299  NASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSL-------KIGNLIN 351
            N ++L  L++GYN    RLG E   L  S + L +  ++L   ++L        IGNL++
Sbjct: 342  NCTQLEYLDVGYN----RLGGE---LPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVS 394

Query: 352  LTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLS 411
            L  LSL  N LSG LP++ G+L  LQ +DL +N   G IP  F + +RL  ++LN N   
Sbjct: 395  LQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFH 454

Query: 412  GSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKA 471
            G IP  LG    L  L + +N L   IP     +  +   D S+N L G  P E+  L+ 
Sbjct: 455  GRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLEL 514

Query: 472  VVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLS 531
            +V +  S N LSG +P  I G  +++ L ++ N   G IP+    LVSL+ +D SNN+LS
Sbjct: 515  LVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLS 573

Query: 532  GVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSP---YLHVPL 588
            G IP  L  L  L++LNLS NK  G +P  G F N +A S  GN  +CG      L   +
Sbjct: 574  GRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCI 633

Query: 589  CKSSPHKK---SRKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRSTEVSHIKAGM 645
             ++SP K+   S ++ ++ G+ + ++++ ++ ++  L + +  +  K+ +    +     
Sbjct: 634  VQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRK--KKNNASDGNPSDST 691

Query: 646  SPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGAL 704
            +  +   + S++EL  AT +FS  NLIG G++G+V+KG   P+   VA+KV +L + GA 
Sbjct: 692  TLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGAT 751

Query: 705  NSFDAECEILKTIRHRNLVKIISSCTN-----HNFKALVLEYMPKGSLEDCMYASNF--- 756
             SF AECE  K IRHRNLVK+I+ C++     ++F+ALV E+MPKGSL+  +   +    
Sbjct: 752  KSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERV 811

Query: 757  -----NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA 811
                 +L   ++L I IDVASALEYLH    +P+ HCDIKPSN+LLDD + AH+SDFG+A
Sbjct: 812  NDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLA 871

Query: 812  KLLSEED------SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPT 865
            +LL + D               TIGY APEYG  GQ SI+GDVY++GI+L+E+F+G KPT
Sbjct: 872  QLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPT 931

Query: 866  NEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESP 925
            +E F G+ ++  +    L    +   +N + E               VL + ++C+ E P
Sbjct: 932  DESFAGDYNLHSYTKSILSGCTSSGGSNAIDEG-----------LRLVLQVGIKCSEEYP 980

Query: 926  ENRVNTKEIISRLIKIRDLLFAN 948
             +R+ T E +  LI IR   F++
Sbjct: 981  RDRMRTDEAVRELISIRSKFFSS 1003

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  491 bits (1265), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 352/997 (35%), Positives = 523/997 (52%), Gaps = 84/997 (8%)

Query: 9    ILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNW 68
            ++  +W  +  +CSW G+ C +   RVT + +  L L G +   +GNLS L++L L+ N+
Sbjct: 57   VVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNF 116

Query: 69   FSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNL 128
            F G IP E+GNL +L+ L++  N   G IP  L N + L  L L++N L   +P   F  
Sbjct: 117  FHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLE-FGS 175

Query: 129  SFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSY 188
                  L    N+LTG FP  +   L  L+ L   YNQ +G IP ++   K++    ++ 
Sbjct: 176  LSKLVLLSLGRNNLTGKFPASL-GNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIAL 234

Query: 189  NQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGN-LRNLEILGIDQSNLVGFVPDTI 247
            N+F G  P  + N + L  L +  N+ +G +  + G+ L NL+IL +  ++  G +P+T+
Sbjct: 235  NKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETL 294

Query: 248  FNISTLKILSLFNNTLSGNLPSS----------------------------KNLIGLPNL 279
             NIS+L+ L + +N L+G +P S                              L     L
Sbjct: 295  SNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQL 354

Query: 280  EGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALV 339
            + LN+G N L G +P F  N S          + L  L L  N ++ S            
Sbjct: 355  QYLNVGFNKLGGQLPVFIANLS----------TQLTELSLGGNLISGSIPH--------- 395

Query: 340  NCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSR 399
                  IGNL++L TL LG+N L+G LP +LG L +L+ + L +N   G IP    + S 
Sbjct: 396  -----GIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISG 450

Query: 400  LYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLN 459
            L  +YL  N   GSIPS LG  + L  L+L +N+L   IP     L  ++  + S N L 
Sbjct: 451  LTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLV 510

Query: 460  GSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVS 519
            G L  +I  LK ++ + +S N LSG IP T+    +L+ L L+ N   GPIP+  G L  
Sbjct: 511  GPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTG 569

Query: 520  LEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLC 579
            L FLDLS N+LSG IP  +     L++LNLS N   G +P  G F N SA S  GN  LC
Sbjct: 570  LRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLC 629

Query: 580  GS-PYLHVPLCKSS-PHKKSR-KQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRST 636
            G  P L +  C    P + S  +++I + V   ++ + ++ + +V       R    R+ 
Sbjct: 630  GGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRAN 689

Query: 637  EVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKV 695
               + ++    +  + + S+DEL + T  FS  NLIG G++G+V+KG        VAIKV
Sbjct: 690  NNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKV 749

Query: 696  FHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN-----HNFKALVLEYMPKGSLEDC 750
             +L + GA  SF AECE L  IRHRNLVK+++ C++     ++F+ALV E+MP G+L+  
Sbjct: 750  LNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMW 809

Query: 751  MYASNF--------NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV 802
            ++             L +F RL I IDVASAL YLH    NPI HCDIKPSN+LLD  + 
Sbjct: 810  LHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLT 869

Query: 803  AHLSDFGIAKLLSEED------SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLM 856
            AH+SDFG+A+LL + D               TIGY APEYG  G  SI GDVY++GI+L+
Sbjct: 870  AHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLL 929

Query: 857  EVFTGMKPTNEFFTGEMSIKRWINDSLPA--VMNIMDTNLL-SEDEEHANVAKQSCASSV 913
            E+FTG +PTN+ F   +++  +   +L     ++I D  +L     +H N+ +  C + V
Sbjct: 930  EIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVE--CLTLV 987

Query: 914  LSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIE 950
              + + C+ ESP NR++  E IS+L+ IR+  F + E
Sbjct: 988  FRVGVSCSEESPVNRISMAEAISKLVSIRESFFRDEE 1024

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  484 bits (1245), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 366/1132 (32%), Positives = 556/1132 (49%), Gaps = 206/1132 (18%)

Query: 2    INDNPNNILAQNWTSNASV--CSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSL 59
            I+++P  +L+ +WT   S+  C+W GITCD  G+ V S+++ +  L G +   + NL+ L
Sbjct: 41   ISNDPLGVLS-DWTIIGSLRHCNWTGITCDSTGH-VVSVSLLEKQLEGVLSPAIANLTYL 98

Query: 60   QTLVLSRNWFSGTIPKEIGNLTKLKELHL------------------------------- 88
            Q L L+ N F+G IP EIG LT+L +L L                               
Sbjct: 99   QVLDLTSNSFTGKIPAEIGKLTELNQLILYLNYFSGSIPSGIWELKNIFYLDLRNNLLSG 158

Query: 89   -----------------DYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFI 131
                             DYN L G+IPE LG+L  L+M V   N LTG+IP SI  L+ +
Sbjct: 159  DVPEEICKTSSLVLIGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSIPVSIGTLANL 218

Query: 132  STALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQF 191
             T LD S N LTG  P D    L  L+ L ++ N  +G IP  + +C  L  + L  NQ 
Sbjct: 219  -TDLDLSGNQLTGKIPRDFG-NLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQL 276

Query: 192  TGRLPRDLGNS------------------------TKLKSLDLGFNNLNGEIPQEIGNLR 227
            TG++P +LGN                         T+L  L L  N+L G I +EIG L 
Sbjct: 277  TGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGFLE 336

Query: 228  NLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLN 287
            +LE+L +  +N  G  P +I N+  L +L++  N +SG LP+   L  L NL  L+   N
Sbjct: 337  SLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL--LTNLRNLSAHDN 394

Query: 288  NLSGSIPSFFFNASKLYALELGYNS------------NLKRLGLERNYLT-------FST 328
             L+G IPS   N + L  L+L +N             NL  + + RN+ T       F+ 
Sbjct: 395  LLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFISIGRNHFTGEIPDDIFNC 454

Query: 329  SELMSL---------------------------FSALVNCKSLKIGNLINLTTLSLGDNN 361
            S L +L                           +++L      +IGNL +L  L L  N 
Sbjct: 455  SNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNLKDLNILYLHSNG 514

Query: 362  LSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDL 421
             +G +P  +  L  LQGL + +N  EGPIP+E      L V+ L+ NK SG IP+    L
Sbjct: 515  FTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKL 574

Query: 422  NSLRILSLSSNE------------------------------------------------ 433
             SL  LSL  N+                                                
Sbjct: 575  ESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSN 634

Query: 434  --LTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTII 491
              LT  IP     LE +   D S+N  +GS+P  ++  K V  +  S+NNLSG+IP  + 
Sbjct: 635  NLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVF 694

Query: 492  -GLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLS 550
             G+  +  L+L  N   G IP+SFG +  L  LDLS+N+L+G IP SL  L  LK L L+
Sbjct: 695  QGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLA 754

Query: 551  FNKLVGEIPRGGAFANFSAESFIGNDLLCGS--PYLHVPLCKSSPHKKSRKQVILLGVVL 608
             N L G +P  G F N +A   +GN  LCGS  P     + + S H   R +VIL+ +  
Sbjct: 755  SNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGS 814

Query: 609  PLSTVFIVTVILVLTFGLITRCCKRRSTEVSHIKAGMSPQ----VMWRRYSHDELLRATD 664
              + + ++ ++L+LT      CCK++  ++ +      P     +  +R+   EL +ATD
Sbjct: 815  AAALLLVLLLVLILT------CCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATD 868

Query: 665  QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRNL 722
             F+  N+IG  S  +VYKG+  DG  +A+KV +L+   A +   F  E + L  ++HRNL
Sbjct: 869  SFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNL 928

Query: 723  VKIIS-SCTNHNFKALVLEYMPKGSLEDCMYASNFNL-DIFQRLGIMIDVASALEYLHFG 780
            VKI+  +  +   KALVL +M  G+LED ++ S   +  + +++ + + +AS ++YLH G
Sbjct: 929  VKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSG 988

Query: 781  HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS-EEDSMKQTQTLA---TIGYIAPEY 836
            +  PIVHCD+KP+N+LLD   VAH+SDFG A++L   ED      T A   TIGY+APE+
Sbjct: 989  YGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEF 1048

Query: 837  GREGQVSIKGDVYNYGIMLMEVFTGMKPT--NEFFTGEMSIKRWINDSL----PAVMNIM 890
                +V+ K DV+++GI++ME+ T  +PT  N+  + +M++++ +  S+      ++ ++
Sbjct: 1049 AYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVL 1108

Query: 891  DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR 942
            D  L    +   ++ ++      L L + CTS  PE+R +  EI++ L+K+R
Sbjct: 1109 DMEL---GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  474 bits (1220), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 334/969 (34%), Positives = 506/969 (52%), Gaps = 81/969 (8%)

Query: 35   VTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYNKL 93
            + +L +S   L G IP    N+S L  LVL+ N  SG++PK I  N T L++L L   +L
Sbjct: 289  LQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQL 348

Query: 94   QGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPG 153
             GEIP EL     L+ L L+NN L G+IP ++F L  + T L   +N+L G+    +   
Sbjct: 349  SGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVEL-TDLYLHNNTLEGTLSPSIS-N 406

Query: 154  LPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFN 213
            L  L+ L + +N  +G +P  +   ++L  + L  N+F+G +P+++GN T LK +D+  N
Sbjct: 407  LTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGN 466

Query: 214  NLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNL 273
            +  GEIP  IG L+ L +L + Q+ LVG +P ++ N   L IL L +N LSG++PSS   
Sbjct: 467  HFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGF 526

Query: 274  IGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN---SNLKRLGLERNYLTFSTSE 330
              L  LE L L  N+L G++P    +   L  + L +N     +  L    +YL+F  + 
Sbjct: 527  --LKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTN 584

Query: 331  LMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPI 390
                 +   +   L++GN  NL  L LG N L+G +P TLG++++L  LD+ +N   G I
Sbjct: 585  -----NGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTI 639

Query: 391  PQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILG 450
            P +     +L  + LN N LSG IP  LG L+ L  L LSSN+    +P+  +N   +L 
Sbjct: 640  PLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLV 699

Query: 451  FDFSSNSLNGSLPLEIENLKA------------------------VVDIYLSRNNLSGNI 486
                 NSLNGS+P EI NL A                        + ++ LSRN+L+G I
Sbjct: 700  LSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEI 759

Query: 487  PSTIIGLKNLQH-LSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLK 545
            P  I  L++LQ  L L +N   G IP + G L  LE LDLS+N L+G +P S+  +  L 
Sbjct: 760  PVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLG 819

Query: 546  SLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKK--SRKQVIL 603
             LN+SFN L G++ +   F+ + A+SF+GN  LCGSP       +S+  ++  S + V++
Sbjct: 820  YLNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVI 877

Query: 604  LGVVLPLSTVFIVTVILVLTFGLITRCCKRRS---TEVSHIKAGMSPQVMWRRYSHDELL 660
            +  +  L+ + ++ +++ L F       K+R     +V H     +      + +H  L 
Sbjct: 878  ISAISALTAIGLMILVIALFF-------KQRHDFFKKVGHGSTAYTSSSSSSQATHKPLF 930

Query: 661  R---------------ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN 705
            R               AT   SEE +IG G  G VYK    +G  VA+K    + +   N
Sbjct: 931  RNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSN 990

Query: 706  -SFDAECEILKTIRHRNLVKIISSCTNHN--FKALVLEYMPKGSLEDCMY-------ASN 755
             SF  E + L  IRHR+LVK++  C++ +     L+ EYM  GS+ D ++          
Sbjct: 991  KSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKK 1050

Query: 756  FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS 815
              LD   RL I + +A  +EYLH     PIVH DIK SNVLLD +M AHL DFG+AK+L+
Sbjct: 1051 KLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLT 1110

Query: 816  EE---DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
            E    ++   T    + GYIAPEY    + + K DVY+ GI+LME+ TG  PT+  F  E
Sbjct: 1111 ENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAE 1170

Query: 873  MSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTK 932
            M + RW+   L    +  D  L+    +     ++  A  VL +A++CT  SP+ R +++
Sbjct: 1171 MDMVRWVETHLEVAGSARD-KLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSR 1229

Query: 933  EIISRLIKI 941
            +    L+ +
Sbjct: 1230 QACDSLLHV 1238

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  466 bits (1198), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 331/970 (34%), Positives = 505/970 (52%), Gaps = 87/970 (8%)

Query: 35   VTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYNKL 93
            + +L +S   L G I      ++ L+ LVL++N  SG++PK I  N T LK+L L   +L
Sbjct: 290  LQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQL 349

Query: 94   QGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPG 153
             GEIP E+ N   L++L L+NN LTG IP S+F L  + T L  ++NSL G+    +   
Sbjct: 350  SGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVEL-TNLYLNNNSLEGTLSSSIS-N 407

Query: 154  LPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFN 213
            L  L+   + +N  +G +P  +    +L  + L  N+F+G +P ++GN T+L+ +D   N
Sbjct: 408  LTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGN 467

Query: 214  NLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNL 273
             L+GEIP  IG L++L  L + ++ LVG +P ++ N   + ++ L +N LSG++PSS   
Sbjct: 468  RLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGF 527

Query: 274  IGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELG---YNSNLKRLGLERNYLTFSTSE 330
              L  LE   +  N+L G++P    N   L  +      +N ++  L    +YL+F  +E
Sbjct: 528  --LTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTE 585

Query: 331  LMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPI 390
                 +       L++G   NL  L LG N  +G +P T G++ +L  LD+  N   G I
Sbjct: 586  -----NGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGII 640

Query: 391  PQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILG 450
            P E     +L  + LN N LSG IP+ LG L  L  L LSSN+    +P+  ++L +IL 
Sbjct: 641  PVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILT 700

Query: 451  FDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPI 510
                 NSLNGS+P EI NL+A+  + L  N LSG +PSTI  L  L  L L  N L G I
Sbjct: 701  LFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEI 760

Query: 511  PESFGELVSLE-FLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR--------- 560
            P   G+L  L+  LDLS N+ +G IP+++  L  L+SL+LS N+LVGE+P          
Sbjct: 761  PVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLG 820

Query: 561  -------------GGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSR----KQVIL 603
                            F+ + A++F+GN  LCGSP  H   C  +  K  R    K V++
Sbjct: 821  YLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPLSH---CNRAGSKNQRSLSPKTVVI 877

Query: 604  LGVVLPLSTVFIVTVILVLTFGLITRCCKRRSTEVSHI-------------KAGMSPQVM 650
            +  +  L+ + ++ ++++L F       K+     S                 G    + 
Sbjct: 878  ISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIK 937

Query: 651  WRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN-SFDA 709
            W     D+++ AT   +EE +IG G  G VYK    +G  +A+K    + +   N SF+ 
Sbjct: 938  W-----DDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNR 992

Query: 710  ECEILKTIRHRNLVKIISSCTNH--NFKALVLEYMPKGSLEDCMYASNFN-----LDIFQ 762
            E + L TIRHR+LVK++  C++       L+ EYM  GS+ D ++A+        L    
Sbjct: 993  EVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWET 1052

Query: 763  RLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS---EEDS 819
            RL I + +A  +EYLH+    PIVH DIK SNVLLD ++ AHL DFG+AK+L+   + ++
Sbjct: 1053 RLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNT 1112

Query: 820  MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI 879
               T    + GYIAPEY    + + K DVY+ GI+LME+ TG  PT   F  E  + RW+
Sbjct: 1113 ESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWV 1172

Query: 880  N---DSLP---AVMNIMDTNLLS--EDEEHANVAKQSCASSVLSLAMECTSESPENRVNT 931
                D+ P   A   ++D+ L S    EE A       A  VL +A++CT   P+ R ++
Sbjct: 1173 ETVLDTPPGSEAREKLIDSELKSLLPCEEEA-------AYQVLEIALQCTKSYPQERPSS 1225

Query: 932  KEIISRLIKI 941
            ++    L+ +
Sbjct: 1226 RQASEYLLNV 1235

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  456 bits (1174), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 339/1046 (32%), Positives = 515/1046 (49%), Gaps = 131/1046 (12%)

Query: 12   QNWTSNASV-CSWMGITCDVYGN--RVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNW 68
            +NW SN SV C W G+ C  Y +   V SL +S + L+G +   +G L  L+ L LS N 
Sbjct: 49   RNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNG 108

Query: 69   FSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNL 128
             SG IPKEIGN + L+ L L+ N+  GEIP E+G L  LE L++ NN ++G++P  I NL
Sbjct: 109  LSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNL 168

Query: 129  SFISTALDFSDN-----------------------SLTGSFPYDMCPGLPRLKGLYVSYN 165
              +S  + +S+N                        ++GS P ++  G   L  L ++ N
Sbjct: 169  LSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIG-GCESLVMLGLAQN 227

Query: 166  QFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGN 225
            Q  G +P  +   K+LS V L  N+F+G +PR++ N T L++L L  N L G IP+E+G+
Sbjct: 228  QLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGD 287

Query: 226  LRNLEILGIDQSNLVGFVPDTIFNIS------------------------TLKILSLFNN 261
            L++LE L + ++ L G +P  I N+S                         L++L LF N
Sbjct: 288  LQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFEN 347

Query: 262  TLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALEL------------- 308
             L+G +P    L  L NL  L+L +N L+G IP  F     L+ L+L             
Sbjct: 348  QLTGTIPVE--LSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKL 405

Query: 309  GYNSNLKRLGLERNYLTFSTSELMSLFSALV------------------NCKSL------ 344
            G+ S+L  L +  N+L+      + L S ++                   CK+L      
Sbjct: 406  GWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLA 465

Query: 345  ----------KIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEF 394
                       +   +N+T + LG N   GS+P  +G    LQ L L +N F G +P+E 
Sbjct: 466  RNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREI 525

Query: 395  CHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFS 454
               S+L  + ++ NKL+G +PS + +   L+ L +  N  +  +PS   +L  +     S
Sbjct: 526  GMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLS 585

Query: 455  SNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ-HLSLEHNKLQGPIPES 513
            +N+L+G++P+ + NL  + ++ +  N  +G+IP  +  L  LQ  L+L +NKL G IP  
Sbjct: 586  NNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPE 645

Query: 514  FGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFI 573
               LV LEFL L+NN+LSG IP+S   L  L   N S+N L G IP      N S  SFI
Sbjct: 646  LSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFI 702

Query: 574  GNDLLCGSPYLHVPLCKS-SPHKKSRKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCK 632
            GN+ LCG P       +  +P + + K   +    +   T  ++  + ++   LI    +
Sbjct: 703  GNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMR 762

Query: 633  RRSTEVSHIKAGMSPQVM--------WRRYSHDELLRATDQFSEENLIGIGSYGSVYKGR 684
            R    V+       P  M           ++  +L+ ATD F E  ++G G+ G+VYK  
Sbjct: 763  RPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAV 822

Query: 685  FPDGIEVAIKVFHLQREGA-----LNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL 739
             P G  +A+K      EG       NSF AE   L  IRHRN+VK+   C +     L+ 
Sbjct: 823  LPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLY 882

Query: 740  EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD 799
            EYMPKGSL + ++  + NLD  +R  I +  A  L YLH      I H DIK +N+LLDD
Sbjct: 883  EYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDD 942

Query: 800  SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
               AH+ DFG+AK++    S   +    + GYIAPEY    +V+ K D+Y+YG++L+E+ 
Sbjct: 943  KFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELL 1002

Query: 860  TGMKPTNEFFTGEMSIKRWI-----NDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVL 914
            TG  P      G   +  W+      D+L +   ++D  L  EDE        S   +VL
Sbjct: 1003 TGKAPVQPIDQGG-DVVNWVRSYIRRDALSS--GVLDARLTLEDERIV-----SHMLTVL 1054

Query: 915  SLAMECTSESPENRVNTKEIISRLIK 940
             +A+ CTS SP  R + ++++  LI+
Sbjct: 1055 KIALLCTSVSPVARPSMRQVVLMLIE 1080

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  448 bits (1153), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 352/1052 (33%), Positives = 516/1052 (49%), Gaps = 128/1052 (12%)

Query: 5    NPNNILAQNWTS-NASVCSWMGITCDVYGNRVTSLTISDLGLAGT--------------- 48
            N +N    +W   +++ C+W GI C  +   VTS+ ++ + L+GT               
Sbjct: 39   NDSNGYLASWNQLDSNPCNWTGIAC-THLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLN 97

Query: 49   ---------IPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPE 99
                     IP  L    SL+ L L  N F G IP ++  +  LK+L+L  N L G IP 
Sbjct: 98   VSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPR 157

Query: 100  ELGNLAELEMLVLNNNLLTGTIPASIFNL------------------SFIS-----TALD 136
            ++GNL+ L+ LV+ +N LTG IP S+  L                  S IS       L 
Sbjct: 158  QIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLG 217

Query: 137  FSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLP 196
             ++N L GS P  +   L  L  L +  N+  G IP ++ +   L  ++L  N FTG +P
Sbjct: 218  LAENLLEGSLPKQL-EKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIP 276

Query: 197  RDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKIL 256
            R++G  TK+K L L  N L GEIP+EIGNL +   +   ++ L GF+P    +I  LK+L
Sbjct: 277  REIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLL 336

Query: 257  SLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALEL-------- 308
             LF N L G +P  + L  L  LE L+L +N L+G+IP        L  L+L        
Sbjct: 337  HLFENILLGPIP--RELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGK 394

Query: 309  -----GYNSNLKRLGLERNYLT---------FSTSELMSLFS---------ALVNCKSL- 344
                 G+ SN   L +  N L+         F T  L+SL S          L  CKSL 
Sbjct: 395  IPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLT 454

Query: 345  ---------------KIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGP 389
                           ++ NL NLT L L  N LSG++   LG+LK L+ L L NN F G 
Sbjct: 455  KLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGE 514

Query: 390  IPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDIL 449
            IP E  + +++    ++ N+L+G IP  LG   +++ L LS N+ +  I      L  + 
Sbjct: 515  IPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLE 574

Query: 450  GFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ-HLSLEHNKLQG 508
                S N L G +P    +L  ++++ L  N LS NIP  +  L +LQ  L++ HN L G
Sbjct: 575  ILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSG 634

Query: 509  PIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFS 568
             IP+S G L  LE L L++N LSG IPAS+  L+ L   N+S N LVG +P    F    
Sbjct: 635  TIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMD 694

Query: 569  AESFIGNDLLCGSPYLHV-PLCKSSPHKKSRKQVILLGV----VLPLSTVFIVTVILVLT 623
            + +F GN  LC S   H  PL    PH  S+   ++ G     +L ++ + I +V L+  
Sbjct: 695  SSNFAGNHGLCNSQRSHCQPLV---PHSDSKLNWLINGSQRQKILTITCIVIGSVFLITF 751

Query: 624  FGLITRCCKRRSTEVSHIKAGMSPQVM------WRRYSHDELLRATDQFSEENLIGIGSY 677
             GL     KRR      ++    P VM       + +++  L+ AT  FSE+ ++G G+ 
Sbjct: 752  LGL-CWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGAC 810

Query: 678  GSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSCTNHNFK 735
            G+VYK     G  +A+K  + + EGA   NSF AE   L  IRHRN+VK+   C + N  
Sbjct: 811  GTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSN 870

Query: 736  ALVLEYMPKGSLEDCMYASNFN--LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPS 793
             L+ EYM KGSL + +     N  LD   R  I +  A  L YLH      IVH DIK +
Sbjct: 871  LLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSN 930

Query: 794  NVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGI 853
            N+LLD+   AH+ DFG+AKL+    S   +    + GYIAPEY    +V+ K D+Y++G+
Sbjct: 931  NILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGV 990

Query: 854  MLMEVFTGMKPTNEFFTGE---MSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCA 910
            +L+E+ TG  P      G      ++R I + +P +  + D  L + D+   +       
Sbjct: 991  VLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTI-EMFDARLDTNDKRTVHE-----M 1044

Query: 911  SSVLSLAMECTSESPENRVNTKEIISRLIKIR 942
            S VL +A+ CTS SP +R   +E+++ + + R
Sbjct: 1045 SLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  434 bits (1115), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 325/971 (33%), Positives = 483/971 (49%), Gaps = 91/971 (9%)

Query: 10  LAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWF 69
           L  +W  + + CSW G+TCDV    VTSL +S L L+GT+ S + +L  LQ L L+ N  
Sbjct: 46  LLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQI 105

Query: 70  SGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGN-LAELEMLVLNNNLLTGTIPASIFNL 128
           SG IP +I NL +L+ L+L  N   G  P+EL + L  L +L L NN LTG +P S+ NL
Sbjct: 106 SGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNL 165

Query: 129 SFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSY 188
           + +   L    N  +G  P       P L+ L VS N+  G IP  + +   L  + + Y
Sbjct: 166 TQLR-HLHLGGNYFSGKIPATYGT-WPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGY 223

Query: 189 -NQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTI 247
            N F   LP ++GN ++L   D     L GEIP EIG L+ L+ L +  +   G +   +
Sbjct: 224 YNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQEL 283

Query: 248 FNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALE 307
             IS+LK + L NN  +G +P+S     L NL  LNL  N L G+IP F     +L  L+
Sbjct: 284 GLISSLKSMDLSNNMFTGEIPTS--FSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQ 341

Query: 308 L-------------GYNSNLKRLGLERNYLT-------FSTSELMSLFSA---LVNCKSL 344
           L             G N  L  L L  N LT        S + LM+L +    L      
Sbjct: 342 LWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPD 401

Query: 345 KIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFS-RLYVV 403
            +G   +LT + +G+N L+GS+P  L  L KL  ++LQ+N   G +P      S  L  +
Sbjct: 402 SLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQI 461

Query: 404 YLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLP 463
            L+ N+LSGS+P+ +G+L+ ++ L L  N+ +  IP     L+ +   DFS N  +G + 
Sbjct: 462 SLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIA 521

Query: 464 LEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFL 523
            EI   K +  + LSRN LSG+IP+ + G+K L +L+L  N L G IP +   + SL  +
Sbjct: 522 PEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSV 581

Query: 524 DLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPY 583
           D S N+LSG++P++                        G F+ F+  SF+GN  LCG PY
Sbjct: 582 DFSYNNLSGLVPST------------------------GQFSYFNYTSFVGNSHLCG-PY 616

Query: 584 LHVPLCKSSPHKKSRKQVILLGVVLPLSTV-----FIVTVILVLTFGLITRCCKRRSTEV 638
           L    C    H+   K         PLS        +  +   + F ++     R     
Sbjct: 617 LGP--CGKGTHQSHVK---------PLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNA 665

Query: 639 SHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHL 698
           S  KA          ++ D++L   D   E+N+IG G  G VYKG  P G  VA+K    
Sbjct: 666 SEAKAWRLTAFQRLDFTCDDVL---DSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLAT 722

Query: 699 QREGAL--NSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN- 755
              G+   + F+AE + L  IRHR++V+++  C+NH    LV EYMP GSL + ++    
Sbjct: 723 MSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG 782

Query: 756 FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS 815
            +L    R  I ++ A  L YLH   S  IVH D+K +N+LLD +  AH++DFG+AK L 
Sbjct: 783 GHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQ 842

Query: 816 EEDSMKQTQTLA-TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS 874
           +  + +    +A + GYIAPEY    +V  K DVY++G++L+E+ TG KP  EF  G + 
Sbjct: 843 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDG-VD 901

Query: 875 IKRWI----NDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN 930
           I +W+    + +   V+ ++D  L S              + V  +A+ C  E    R  
Sbjct: 902 IVQWVRSMTDSNKDCVLKVIDLRLSSVPVHE--------VTHVFYVALLCVEEQAVERPT 953

Query: 931 TKEIISRLIKI 941
            +E++  L +I
Sbjct: 954 MREVVQILTEI 964

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  429 bits (1102), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 326/983 (33%), Positives = 488/983 (49%), Gaps = 128/983 (13%)

Query: 20  VCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGN 79
           VC+W G+ C+    +V  L IS   L G I   + NL+ L  L LSRN+F G IP EIG+
Sbjct: 53  VCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGS 112

Query: 80  LTK-LKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIF------NLSFIS 132
           L + LK+L L  N L G IP+ELG L  L  L L +N L G+IP  +F      +L +I 
Sbjct: 113 LHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYI- 171

Query: 133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHC--KELSSVSLSYNQ 190
              D S+NSLTG  P +                          +HC  KEL  + L  N+
Sbjct: 172 ---DLSNNSLTGEIPLN--------------------------YHCHLKELRFLLLWSNK 202

Query: 191 FTGRLPRDLGNSTKLKSLDLGFNNLNGEIP-QEIGNLRNLEILGIDQSNLVGFVPDT--- 246
            TG +P  L NST LK +DL  N L+GE+P Q I  +  L+ L +  ++ V    +T   
Sbjct: 203 LTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLE 262

Query: 247 -----IFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNAS 301
                + N S L+ L L  N+L G + SS   + + NL  ++L  N + GSIP    N  
Sbjct: 263 PFFASLANSSDLQELELAGNSLGGEITSSVRHLSV-NLVQIHLDQNRIHGSIPPEISNLL 321

Query: 302 KLYAL-------------ELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGN 348
            L  L             EL   S L+R+ L  N+LT                  +++G+
Sbjct: 322 NLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEI--------------PMELGD 367

Query: 349 LINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRN 408
           +  L  L +  NNLSGS+P + G L +L+ L L  N   G +PQ       L ++ L+ N
Sbjct: 368 IPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHN 427

Query: 409 KLSGSIP-SCLGDLNSLRI-LSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEI 466
            L+G+IP   + +L +L++ L+LSSN L+  IP     ++ +L  D SSN L+G +P ++
Sbjct: 428 NLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQL 487

Query: 467 ENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLS 526
            +  A+  + LSRN  S  +PS++  L  L+ L +  N+L G IP SF +  +       
Sbjct: 488 GSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSST------- 540

Query: 527 NNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHV 586
                            LK LN SFN L G +   G+F+  + ESF+G+ LLCGS     
Sbjct: 541 -----------------LKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ 583

Query: 587 PLCKSSPHKKSRKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRSTEVSHIKAGMS 646
              K   +      V+L  +  P+  VF   ++    FG       +   E    +    
Sbjct: 584 ACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQND 643

Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN- 705
           P+  + R S+ +L+ AT  F+  +LIG G +G VYKG   +  +VA+KV  L  + AL  
Sbjct: 644 PK--YPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKV--LDPKTALEF 699

Query: 706 --SFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---NLDI 760
             SF  EC+ILK  RHRNL++II++C+   F ALVL  MP GSLE  +Y   +   NLD+
Sbjct: 700 SGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDL 759

Query: 761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL------- 813
            Q + I  DVA  + YLH      +VHCD+KPSN+LLDD M A ++DFGI++L       
Sbjct: 760 IQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEET 819

Query: 814 LSEEDSMKQTQT----LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFF 869
           +S +DS+    T      ++GYIAPEYG   + S  GDVY++G++L+E+ +G +PT+   
Sbjct: 820 VSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLV 879

Query: 870 TGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAK-----QSCASSVLSLAMECTSES 924
               S+  ++    P  +  +    LS  +      K     +     ++ L + CT  +
Sbjct: 880 NEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYN 939

Query: 925 PENRVNTKEIISRLIKIRDLLFA 947
           P  R +  ++   + ++++ LFA
Sbjct: 940 PSTRPDMLDVAHEMGRLKEYLFA 962

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	952
255572272	1089	serine-threonine protein kinase, plant-t	0.986	0.862	0.462	0.0
359483198	1087	PREDICTED: probable LRR receptor-like se	0.978	0.857	0.459	0.0
224139658	1019	predicted protein [Populus trichocarpa]	0.954	0.892	0.469	0.0
147853795	1420	hypothetical protein VITISV_005816 [Viti	0.950	0.637	0.490	0.0
359483685	1046	PREDICTED: LRR receptor-like serine/thre	0.954	0.869	0.453	0.0
359485453	1202	PREDICTED: probable LRR receptor-like se	0.941	0.745	0.485	0.0
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.924	0.716	0.479	0.0
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.926	0.606	0.473	0.0
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.931	0.736	0.476	0.0
255578886	1043	serine-threonine protein kinase, plant-t	0.971	0.886	0.461	0.0

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  850 bits (2195), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 490/1059 (46%), Positives = 659/1059 (62%), Gaps = 120/1059 (11%)

Query: 3    NDNPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTL 62
            + N +  +++NW+S  S C W G+TC    NRV +LT+S++G+ G +P H+GNLS L  +
Sbjct: 41   HSNFDPFMSKNWSSATSFCHWYGVTCSERHNRVVALTLSNMGIKGIVPPHIGNLSFLVHI 100

Query: 63   VLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIP 122
             +S N +SG +P E+GNL +LK ++   N   GEIP  L  L +L+ L+L NN LT    
Sbjct: 101  DMSNNSYSGHLPNELGNLHRLKFMNFSNNSFVGEIPSSLAMLPKLQHLLLANNSLTAG-R 159

Query: 123  ASIFNLSFISTALDFSDN-------------------------SLTGSFPYDMCPGLPRL 157
            +SIFN++ ++T LD +DN                          L+GSFP  +   LP L
Sbjct: 160  SSIFNITTLNT-LDLNDNLLGGNILDNIGGNLSNLQVLNMGLNQLSGSFPPKIL-DLPSL 217

Query: 158  KGLYVSYN-------------------------QFKGPIPNNLWHCKELSSVSLSYNQFT 192
            K +Y+  N                         Q  G IP++L+ CKEL S++L  N+FT
Sbjct: 218  KFIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYGQIPSDLYKCKELRSLALHANKFT 277

Query: 193  GRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNIST 252
            G +PR +GN TKLK L LG NNL G IP EIGNL+NL+I+ +  +NL G +P  +FNIST
Sbjct: 278  GSIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNGSIPHALFNIST 337

Query: 253  LKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNS 312
            +K +++ +N L GNLP+S  L  LPNL  L LG+N LSG IPS+  NASKL  LEL  NS
Sbjct: 338  MKWIAMTSNNLLGNLPTSLGL-HLPNLIWLYLGINKLSGPIPSYISNASKLTILELPSNS 396

Query: 313  -------------NLKRLGLERNYLTFS-TSELMSLFSALVNCKSLK------------- 345
                         NL+ L L  N L+   TS+ +++FS+L NC++LK             
Sbjct: 397  FTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFSSLKNCQNLKYLWLSYNPLDGYL 456

Query: 346  ----------------------------IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQ 377
                                        IGNL +LT L+LG+N+L+G +P T+G LK LQ
Sbjct: 457  PHSVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRIPTTIGTLKHLQ 516

Query: 378  GLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSV 437
            GL L  N  +G IP E C    LY + L  NKLSGSIP+C  +L SLR L L+SN   S 
Sbjct: 517  GLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNLFLASNRFVST 576

Query: 438  IPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ 497
            I ST W L+DIL  + +SN L GSLP EIENL+AV  I +S+N LSG IP +I GL++L 
Sbjct: 577  ISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIPISIGGLQDLA 636

Query: 498  HLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGE 557
             L L  NKLQGPIP+S G++ SLEFLDLS+N+LSG+IP SL+ LLYLK  N+SFN L GE
Sbjct: 637  QLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGE 696

Query: 558  IPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSRK--QVILLGVVLPLSTVFI 615
            IP GG+F+NFSA+SFIGN+ LCGS  L V  CK    + +      I+L  VLP     I
Sbjct: 697  IPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIVLRYVLPA----I 752

Query: 616  VTVILVLTFG-LITRCCKRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGI 674
            V  + VL F  ++ R C+R++     I+         RR S+ EL  AT+ F E N +G+
Sbjct: 753  VFAVFVLAFVIMLKRYCERKAK--FSIEDDFLALTTIRRISYHELQLATNGFQESNFLGM 810

Query: 675  GSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNF 734
            GS+GSVYKG   DG  +A KVF+LQ E A  SFD ECE+L+ +RHRNLVKII+SC+  NF
Sbjct: 811  GSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCSGPNF 870

Query: 735  KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSN 794
            KALVLE+MP  SLE  +Y+ ++ L+  QRL IM+DVAS LEYLH G++ P+ HCDIKPSN
Sbjct: 871  KALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPSN 930

Query: 795  VLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIM 854
            VLL++ MVA L+DFGI+KLL EE S+ QT TLATIGY+APEYG EG VS++GDVY+YG++
Sbjct: 931  VLLNEDMVAFLADFGISKLLGEEGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYGVL 990

Query: 855  LMEVFTGMKPTNEFFTGEMSIKRWINDSLPA-VMNIMDTNLLSEDEEHANVAKQSCASSV 913
            LME FT  KPT++ FT ++S+K W+  SL   V  ++D NLL  +E+H   AK+ C  S+
Sbjct: 991  LMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHL-AAKKDCIVSI 1049

Query: 914  LSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIEMV 952
            L LA++C+++ P +R++ K +++ L KI+     +I  +
Sbjct: 1050 LKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLRDIRQL 1088

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  833 bits (2152), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 482/1049 (45%), Positives = 645/1049 (61%), Gaps = 117/1049 (11%)

Query: 2    INDNPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQT 61
            I  +P+++LA NW++  S C W+G++C+    RV +L +S+LGL GTIP  LGNLS L +
Sbjct: 43   ITLDPHHVLAGNWSTKTSFCEWIGVSCNAQQQRVIALDLSNLGLRGTIPPDLGNLSFLVS 102

Query: 62   LVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTI 121
            L LS N F G +P E+G LT L  ++L YN L G+IP   GNL  L+ L L NN  TGTI
Sbjct: 103  LDLSSNNFHGPVPVEVGQLTSLLSMNLQYNLLSGQIPPSFGNLNRLQSLFLGNNSFTGTI 162

Query: 122  PASIFNLSFIST-----------------------------------------------A 134
            P SI N+S + T                                                
Sbjct: 163  PPSIGNMSMLETLGLGGNHLQGNIPEEIGKLSTMKILDIQSNQLVGAIPSAIFNISSLQE 222

Query: 135  LDFSDNSLTGSFPYDMC-PGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTG 193
            +  + NSL+G  P  MC   L  L+G+ +S N+F GPIP+NL  C EL ++ LS+N+FTG
Sbjct: 223  IALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTGPIPSNLSKCGELQTLYLSFNKFTG 282

Query: 194  RLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTL 253
             +PR + + TKL  L L  N+L+GE+P EIG+L  L +L I+ ++L G +P  IFNIS++
Sbjct: 283  GIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQIFNISSM 342

Query: 254  KILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN-- 311
               SL  N LSGNLP +     LPNLE L L +N LSG IPS   NASKL +L+ GYN  
Sbjct: 343  VSGSLTRNNLSGNLPPNFGSY-LPNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNML 401

Query: 312  -----------SNLKRLGLERNYLTF-STSELMSLFSALVNCKSLKI-----GNLINLTT 354
                         L+RL L  N L   S  + +S  ++L NCK L+I       LI +  
Sbjct: 402  TGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNCKRLRILYLSFNPLIGILP 461

Query: 355  LSLGD------------------------------------NNLSGSLPITLGRLKKLQG 378
            +S+G+                                    N+L+G++P ++G+L+KLQG
Sbjct: 462  ISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQG 521

Query: 379  LDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVI 438
            L L +NK +G IP + C    L  ++L  N+LSGSIP+CLG+L  LR L L SN+L S I
Sbjct: 522  LYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTI 581

Query: 439  PSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQH 498
            PST W+L  IL  D SSN L G LP ++ NLK +V I LSRN LSG IPS I GL++L  
Sbjct: 582  PSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTS 641

Query: 499  LSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEI 558
            LSL HN+ +GPI  SF  L SLEF+DLS+N L G IP SLE L+YLK L++SFN L GEI
Sbjct: 642  LSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEI 701

Query: 559  PRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSRKQVILLGVVLP--LSTVFIV 616
            P  G FANFSAESF+ N  LCGSP L +P C++     +    +LL  +LP  LST+  +
Sbjct: 702  PPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTRWSTTISWLLLKYILPAILSTLLFL 761

Query: 617  TVILVLTFGLITRCCKRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGS 676
             +I V      TRC KR +   +  ++ ++    WRR S+ E+ +AT+ FS  NL+G GS
Sbjct: 762  ALIFVW-----TRCRKRNAVLPTQSESLLT--ATWRRISYQEIFQATNGFSAGNLLGRGS 814

Query: 677  YGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNH--NF 734
             GSVY+G   DG   AIKVF+LQ E A  SFDAECE++  IRHRNL+KI+SSC+N   +F
Sbjct: 815  LGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDF 874

Query: 735  KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSN 794
            KALVLEY+P GSLE  +Y+ N+ LDI QRL IMIDVA A+EYLH G S P+VHCD+KPSN
Sbjct: 875  KALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSN 934

Query: 795  VLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIM 854
            +LLD+    H+ DFGIAKLL EE+S+++TQTLATIGY+AP+Y   G V+  GDVY+YGI+
Sbjct: 935  ILLDEDFGGHVGDFGIAKLLREEESIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIV 994

Query: 855  LMEVFTGMKPTNEFFTGEMSIKRWINDSL-PAVMNIMDTNLLSEDEEHANVAKQSCASSV 913
            LME FT  +PT+E F+ EMS+K W+ D L  ++  ++D NLL  ++E   +AK+ C S +
Sbjct: 995  LMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQF-MAKKQCISLI 1053

Query: 914  LSLAMECTSESPENRVNTKEIISRLIKIR 942
            L LAM+C ++SPE R+  K++++ L KI+
Sbjct: 1054 LGLAMDCVADSPEERIKMKDVVTTLKKIK 1082

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  829 bits (2141), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 469/998 (46%), Positives = 626/998 (62%), Gaps = 89/998 (8%)

Query: 2    INDNPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQT 61
            I  +P N+L  +W+S  S C+WMG++C +   RVT+L +S +GL GTIP  LGNLS LQ 
Sbjct: 42   ITFDPQNMLTHSWSSKTSFCNWMGVSCSLRRQRVTALDLSSMGLLGTIPPQLGNLSFLQY 101

Query: 62   LVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEI-PEELGNLAELEMLVLNNNLLTGT 120
            L+L  N F G +P EIGNL +L+ + +  NKL   I PE  GNL  LE L  + N LTGT
Sbjct: 102  LILYNNSFHGDLPSEIGNLRRLQVMDIGSNKLSLVIVPESFGNLHRLEELRFDGNNLTGT 161

Query: 121  IPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKE 180
            IP++IFN+S +   LD   N L GS P +MC  LPRL+ L                    
Sbjct: 162  IPSTIFNISSLK-VLDLMFNGLFGSLPKNMCDHLPRLEMLL------------------- 201

Query: 181  LSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLV 240
                 LS NQ +G++P DL    +L+ L L +NN  G IP+E+G L  LE+L +  + L 
Sbjct: 202  -----LSSNQLSGQIPSDLFKCRELQLLWLPYNNFTGVIPEELGFLPMLEVLNLGVNMLS 256

Query: 241  GFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNA 300
            G +P +IFN+++L+ + +  N LSG++P  +N I LPNLE L L LN ++GS+P F  N 
Sbjct: 257  GDLPRSIFNMTSLRTMQICCNNLSGSIPQ-ENSIDLPNLEELQLNLNGITGSMPRFLGNM 315

Query: 301  SKLYALELGYNS-------------NLKRLGLERNYLT-FSTSELMSLFSALVNCKSLK- 345
            S+L  L+L YN               L+ L L+ N  T   +S+ ++  ++L N + LK 
Sbjct: 316  SRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPSSQTLNFITSLTNSRQLKE 375

Query: 346  ----------------------------------------IGNLINLTTLSLGDNNLSGS 365
                                                    IGNL NL  LSL +N+L G 
Sbjct: 376  LHIGDNPLDGMLPNSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIVLSLEENSLMGP 435

Query: 366  LPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR 425
            +P T+G L+K+Q L L  N   G IP + C   RL  + LN N LSG IPSC+G+L SLR
Sbjct: 436  IPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIPSCIGNLTSLR 495

Query: 426  ILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGN 485
             L L  N L+S IP   W+L+D+L  +  SN L GSLP ++  ++A + I LS N LSGN
Sbjct: 496  NLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGN 555

Query: 486  IPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLK 545
            IPSTI  L+NL   SL  N  QG IPE+FG LVSLE LDLS N+LSG IP SLE L YL+
Sbjct: 556  IPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLE 615

Query: 546  SLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSRKQVILLG 605
              ++SFN L GEIPRGG FANF+A SFI N  LCG   L VP C     K S+ +  LL 
Sbjct: 616  FFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKDSKTKSRLLR 675

Query: 606  VVLPLSTVFIVTVILVLTFGLITRCCKRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQ 665
              LP     + +++LV+ F  +   C+RR  +   I   +    + RR S+ ELL AT++
Sbjct: 676  FSLPT----VASILLVVAFIFLVMGCRRRYRK-DPIPEALPVTAIQRRISYLELLHATNE 730

Query: 666  FSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI 725
            F E NL+GIGS+GSVY+GR  DG+ VA+K+F+LQ + A  SFD ECEI++ IRHRNLVKI
Sbjct: 731  FHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKI 790

Query: 726  ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
            I SC+N +FKALVLEYMPKGSLE  +Y+ N+ LDI QR+ IMIDVASALEYLH G+ +P+
Sbjct: 791  ICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPV 850

Query: 786  VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIK 845
            VHCD+KPSNVLLD+ MVAH+ DFGIAKLL E +S  QT+TLATIGY+APEYG +G VS K
Sbjct: 851  VHCDLKPSNVLLDEDMVAHVCDFGIAKLLGENESFAQTRTLATIGYMAPEYGLDGLVSTK 910

Query: 846  GDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP-AVMNIMDTNLLSEDEEHANV 904
             DVY++GIMLME+ T  +PT+E F GEMS+KR + +SLP +V++I+D+N+L+  + ++ V
Sbjct: 911  IDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYS-V 969

Query: 905  AKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR 942
             K+ C +S++ LA++C +ESP  R+   EI++RL  I+
Sbjct: 970  KKEHCVTSIMELALQCVNESPGERMAMVEILARLKNIK 1007

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera]

 Score =  827 bits (2135), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 481/980 (49%), Positives = 624/980 (63%), Gaps = 75/980 (7%)

Query: 24   MGITCDVYGNRVTSLTISDLGL---AGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNL 80
            +GI     G  +  L + DL +    G IPS L +   L+ L LS N F+G IP+ IG+L
Sbjct: 227  VGILPTGMGYDLPKLEMIDLSINQFKGEIPSSLSHCRQLRGLSLSLNQFTGGIPQAIGSL 286

Query: 81   TKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDN 140
            + L+E++L YN L G IP E+GNL+ L  L L +  ++G IP  IFN+S +   +D +DN
Sbjct: 287  SNLEEVYLAYNNLAGGIPREIGNLSNLNSLQLGSCGISGPIPPEIFNISSLQM-IDLTDN 345

Query: 141  SLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLG 200
            SL GS P D+C  L  L+GLY+S+NQ  G +P  L  C +L S+SL  N+FTG +P   G
Sbjct: 346  SLHGSLPMDICKHLHNLQGLYLSFNQLSGQLPTTLSLCGQLLSLSLWGNRFTGNIPPSFG 405

Query: 201  NSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFN 260
            N T L+ L+L  NN+ G IP E+GNL NL+ L +  +NL G +P+ IFNIS L+ L L  
Sbjct: 406  NLTVLQDLELXENNIQGNIPNELGNLINLQNLKLSVNNLTGIIPEAIFNISKLQTLXLAQ 465

Query: 261  NTLSGNLPSSKNLIG--LPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN------- 311
            N  SG+LPSS   IG  LP+LEGL +G N  SG IP    N S+L  L++  N       
Sbjct: 466  NHFSGSLPSS---IGTQLPDLEGLAIGXNEFSGIIPMSISNMSELTVLDIWANFFTGDVP 522

Query: 312  ---SNLKRL---GLERNYLT--FSTSELMSLFSALVNCKSLK------------------ 345
                NL+RL    L  N LT   STSE +   ++L NCK L+                  
Sbjct: 523  KDLGNLRRLEFLNLGFNQLTDEHSTSE-VGFLTSLTNCKFLRRLWIEDNPLKGILPNSLG 581

Query: 346  -----------------------IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQ 382
                                   IGNLINL  L L DN+L+G +PI+ G L+KLQ   + 
Sbjct: 582  NLSISLESFDASACQFKGTIPTGIGNLINLIDLRLNDNDLTGLIPISFGHLQKLQWFAIS 641

Query: 383  NNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTF 442
             N+  G IP   CH   L  + L+ NKLSG+IP C G+L +LR +SL SN L S IPS+ 
Sbjct: 642  GNRIHGSIPSVLCHLRNLGYLDLSSNKLSGTIPGCFGNLTALRNISLHSNGLASEIPSSL 701

Query: 443  WNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLE 502
            W L D+L  + SSN LN  LPLE+ N+K+++ + LS+N  SGNIPSTI  L+NL  L L 
Sbjct: 702  WTLRDLLVLNLSSNFLNCQLPLEVGNMKSLLVLDLSKNQFSGNIPSTISLLQNLLQLYLS 761

Query: 503  HNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGG 562
            HNKLQG +P +FG LVSLE+LDLS N+ SG IP SLE L YLK LN+SFNKL GEIP  G
Sbjct: 762  HNKLQGHMPPNFGALVSLEYLDLSGNNFSGTIPTSLEALKYLKYLNVSFNKLQGEIPNRG 821

Query: 563  AFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSRKQVILLGVVLPLSTVFIVTVILVL 622
             FANF+AESFI N  LCG+P   V  C+    + ++   +LL  ++PLS V + T+ILV+
Sbjct: 822  PFANFTAESFISNLALCGAPRFQVMACEKDARRNTKS--LLLKCIVPLS-VSLSTMILVV 878

Query: 623  TFGLITRCCKRRSTEV-SHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVY 681
             F L     KRR TE  S ++  +    M R  SH ELL AT  F EENLIG GS G VY
Sbjct: 879  LFTL----WKRRQTESESPVQVDLLLPRMHRLISHQELLYATSYFGEENLIGKGSLGMVY 934

Query: 682  KGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY 741
            KG   DG+ VA+KVF+L+  GA  SF+ ECE+++ IRHRNL KIISSC+N +FKALVLEY
Sbjct: 935  KGVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEY 994

Query: 742  MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM 801
            MP  SLE  +Y+ N+ LD  QRL IMIDVAS LEYLH  +SNP+VHCD+KPSNVLLDD M
Sbjct: 995  MPNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYSNPVVHCDLKPSNVLLDDDM 1054

Query: 802  VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTG 861
            VAH+SDFGIAKLL   + MK+T+TL TIGY+APEYG EG VS K D Y+YGI+LME+F  
Sbjct: 1055 VAHISDFGIAKLLMGSEFMKRTKTLGTIGYMAPEYGSEGIVSTKCDTYSYGIILMEIFVR 1114

Query: 862  MKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECT 921
             KPT+E F  E+++K W+  S   +M ++D NLL+E++E +   KQ+C SS+++LA++CT
Sbjct: 1115 KKPTDEMFVEELTLKSWVESSANNIMEVIDANLLTEEDE-SFALKQACFSSIMTLALDCT 1173

Query: 922  SESPENRVNTKEIISRLIKI 941
             E PE R+N K++++RL KI
Sbjct: 1174 IEPPEKRINMKDVVARLKKI 1193

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera]

 Score =  824 bits (2129), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 478/1054 (45%), Positives = 645/1054 (61%), Gaps = 145/1054 (13%)

Query: 2    INDNPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLS---- 57
            I  +   ILA NW++ +S C+W GI+C+    RV+++ +S++GL GTI   +GNLS    
Sbjct: 20   ITYDSQGILATNWSTKSSYCNWYGISCNAPQQRVSAINLSNMGLEGTIAPQVGNLSFLVS 79

Query: 58   --------------------------------------------SLQTLVLSRNWFSGTI 73
                                                         L+ L LS N F+G I
Sbjct: 80   LDLTYNDFTGSIPNGIGNLVELQRLSLRNNSLTGEIPSNLSHCRELRGLSLSINQFTGGI 139

Query: 74   PKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIST 133
            P+ IG+L+ L+EL+L+YNKL G IP E+GNL+ L +L L +N ++G IPA IF +S +  
Sbjct: 140  PQAIGSLSNLEELYLNYNKLTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFTVSSLQR 199

Query: 134  ALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTG 193
             + F++NSL+GS P D+C  LP L+GLY+S N   G +P  L  C+EL S++L  N+FTG
Sbjct: 200  II-FANNSLSGSLPMDICKHLPNLQGLYLSQNHLSGQLPTTLSLCRELLSLALPMNKFTG 258

Query: 194  RLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTL 253
             +PR++GN +KL+ +DL  N+L G IP   GNL  L+ L               FNIS L
Sbjct: 259  SIPREIGNLSKLEEIDLSENSLIGSIPTSFGNLMTLKFLS--------------FNISKL 304

Query: 254  KILSLFNNTLSGNLPSSKNLIG--LPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN 311
            + L L  N LSG+LPSS   IG  LP+LEGL +G+N  SG+IP    N SKL  L L  N
Sbjct: 305  QTLGLVQNHLSGSLPSS---IGTWLPDLEGLYIGINEFSGTIPMSISNMSKLTVLSLSDN 361

Query: 312  S----------NLKRLG-LERNYLTFSTSELMS---LFSALVNCKSLK------------ 345
            S          NL +L  L+  Y   +   L S     ++L NCK L+            
Sbjct: 362  SFTGNVPKDLCNLTKLQFLDLAYNQLTDEHLASGVGFLTSLTNCKFLRNLWIGYNPLTGT 421

Query: 346  -----------------------------IGNLINLTTLSLGDNNLSGSLPITLGRLKKL 376
                                         IGNL NL  L LG N+L+GS+P TLG+L+KL
Sbjct: 422  LPNSLGNLPIALEIFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKL 481

Query: 377  QGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTS 436
            Q L +  N+  G IP + CH   L  + L+ NKLSGSIPSC GDL +LR LSL SN L  
Sbjct: 482  QALSIVGNRIRGSIPNDLCHLKNLGYLRLSYNKLSGSIPSCFGDLPALRELSLDSNVLAF 541

Query: 437  VIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNL 496
             IP +FW+L D+L  + SSN L G+LP E+ N+K++  + LS+N +SG IPS +  L+NL
Sbjct: 542  NIPMSFWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQNL 601

Query: 497  QHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVG 556
              LSL  NKLQGPIP  FG+LVSLE LDLS N+LSG IP +LE L+YLK LN+SFNKL G
Sbjct: 602  ITLSLSQNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKTLEALIYLKYLNVSFNKLQG 661

Query: 557  EIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKS--RKQVILLGVVLPLSTVF 614
            EIP GG F  F+AESF+ N+ LCG+P+  V  C  +   +S   K  IL  ++LP+ +  
Sbjct: 662  EIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTV 721

Query: 615  IVTVILVLTFGLITRCCKRRSTEVSHIKAGMSPQVMW-----RRYSHDELLRATDQFSEE 669
             + V +VL         +R + E+       +P   W      + SH +LL AT+ F E+
Sbjct: 722  TLVVFIVLWIR------RRDNMEIP------TPIDSWLPGTHEKISHQQLLYATNDFGED 769

Query: 670  NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSC 729
            NLIG GS G VYKG   +G+ VAIKVF+L+ +GAL SF++ECE+++ IRHRNLV+II+ C
Sbjct: 770  NLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHRNLVRIITCC 829

Query: 730  TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
            +N +FKALVL+YMP GSLE  +Y+  + LD+ QRL IMIDVASALEYLH   S+ +VHCD
Sbjct: 830  SNLDFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCD 889

Query: 790  IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
            +KPSNVLLDD MVAH++DFGIAKLL+E +SM+QT+TL+TIGY+APE+G  G VS K DVY
Sbjct: 890  LKPSNVLLDDDMVAHVADFGIAKLLTETESMQQTKTLSTIGYMAPEHGSAGIVSTKSDVY 949

Query: 850  NYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL-SEDEEHANVAKQS 908
            +YGI+LMEVF   KP +E FTG++++K W+     +V+ ++D NLL  EDE+ A   K S
Sbjct: 950  SYGILLMEVFARKKPMDEMFTGDLTLKTWVESLSNSVIQVVDVNLLRREDEDLA--TKLS 1007

Query: 909  CASSVLSLAMECTSESPENRVNTKEIISRLIKIR 942
            C SS+++LA+ CT++SPE R++ K+ +  L K R
Sbjct: 1008 CLSSIMALALACTTDSPEERIDMKDAVVELKKSR 1041

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  813 bits (2101), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 469/966 (48%), Positives = 628/966 (65%), Gaps = 70/966 (7%)

Query: 34   RVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKL 93
            R+  L+++   L G IPS L +   L+ L LS N F+G IP+ IG+L+ L+ L+L +N+L
Sbjct: 239  RLKFLSLAANNLKGEIPSSLLHCRELRLLDLSINQFTGFIPQAIGSLSNLETLYLGFNQL 298

Query: 94   QGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPG 153
             G IP E+GNL+ L +L   ++ L+G IPA IFN+S +   + F++NSL+GS P D+C  
Sbjct: 299  AGGIPGEIGNLSNLNLLNSASSGLSGPIPAEIFNISSLQ-EIGFANNSLSGSLPMDICKH 357

Query: 154  LPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFN 213
            LP L+ L +S NQ  G +P  L  C EL +++L+YN FTG +PR++GN +KL+ +    +
Sbjct: 358  LPNLQWLLLSLNQLSGQLPTTLSLCGELLTLTLAYNNFTGSIPREIGNLSKLEQIYFRRS 417

Query: 214  NLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNL 273
            +  G IP+E+GNL NL+ L ++ +NL G VP+ IFNIS L++LSL  N LSG+LPSS   
Sbjct: 418  SFTGNIPKELGNLVNLQFLSLNVNNLTGIVPEAIFNISKLQVLSLAGNHLSGSLPSS--- 474

Query: 274  IG--LPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN-------------SNLKRLG 318
            IG  LPNLE L +G N  SG IP    N S L +L++  N               L+ LG
Sbjct: 475  IGSWLPNLEQLLIGGNEFSGIIPMSISNMSNLISLDISDNFFIGNVPKDLGNLRQLQLLG 534

Query: 319  LERNYLT--FSTSELMSLFSALVNCKSLK------------------------------- 345
            L  N LT   S SEL +  ++L NC  L+                               
Sbjct: 535  LSHNQLTNEHSASEL-AFLTSLTNCIFLRTLSISDNPLKGMIPNSLGNLSISLEIIYASD 593

Query: 346  ----------IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFC 395
                      I NL NL  L L DN+L+G +P   GRL+KLQ L +  N+  G IP   C
Sbjct: 594  CQLRGTIPTGISNLTNLIGLRLDDNDLTGLIPTPFGRLQKLQMLSISQNRIHGSIPSGLC 653

Query: 396  HFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSS 455
            H + L  + L+ NKLSG+IPSC G+L  LR + L SN L S IPS+  NL  +L  + SS
Sbjct: 654  HLTNLAFLDLSSNKLSGTIPSCSGNLTGLRNVYLHSNGLASEIPSSLCNLRGLLVLNLSS 713

Query: 456  NSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFG 515
            N LN  LPL++ N+K++V + LS+N  SGNIPSTI  L+NL  L L HNKLQG IP +FG
Sbjct: 714  NFLNSQLPLQVGNMKSLVALDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHIPPNFG 773

Query: 516  ELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGN 575
            +LVSLE LDLS N+LSG IP SLE L YL+ LN+SFNKL GEIP GG FANF+AESFI N
Sbjct: 774  DLVSLESLDLSGNNLSGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFANFTAESFISN 833

Query: 576  DLLCGSPYLHVPLCKSSPHKKSRKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRS 635
              LCG+P   V  C+    K ++   +LL  ++PLS V + T+ILV+ F    +  +R++
Sbjct: 834  LALCGAPRFQVMACEKDSRKNTKS--LLLKCIVPLS-VSLSTIILVVLF---VQWKRRQT 887

Query: 636  TEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKV 695
               + I+  +S   M R   H ELL AT+ F E+NLIG GS G VYKG   DG+ VA+KV
Sbjct: 888  KSETPIQVDLSLPRMHRMIPHQELLYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKV 947

Query: 696  FHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN 755
            F+L+ +GA  SF+ ECE+++ IRHRNL KIISSC+N +FKALVLEYMP GSLE  +Y+ N
Sbjct: 948  FNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHN 1007

Query: 756  FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS 815
            + LD  QRL IMIDVAS LEYLH  +SNP+VHCD+KPSNVLLDD MVAH+SDFGIAKLL 
Sbjct: 1008 YYLDFVQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLM 1067

Query: 816  EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI 875
              + MK+T+TL T+GY+APEYG EG VS KGD+Y+YGI+LME F   KPT+E F  E+++
Sbjct: 1068 GSEFMKRTKTLGTVGYMAPEYGSEGIVSTKGDIYSYGILLMETFVRKKPTDEMFVEELTL 1127

Query: 876  KRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII 935
            K W+  S   +M ++D NLL+E++E +   K++C SS+++LA++CT E PE R+NTK+++
Sbjct: 1128 KSWVESSTNNIMEVIDANLLTEEDE-SFALKRACFSSIMTLALDCTVEPPEKRINTKDVV 1186

Query: 936  SRLIKI 941
             RL K+
Sbjct: 1187 VRLKKL 1192

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  812 bits (2098), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 462/963 (47%), Positives = 621/963 (64%), Gaps = 83/963 (8%)

Query: 45   LAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNL 104
            L G IPS+L +   L+ L LS N F+G IP+ IG+L+ L+EL+L +NKL G IP E+GNL
Sbjct: 280  LEGEIPSNLSHCRELRVLSLSFNQFTGGIPQAIGSLSNLEELYLSHNKLTGGIPREIGNL 339

Query: 105  AELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSY 164
            + L +L L++N ++G IPA IFN+S +   + F+DNSL+GS P D+C  LP L+GL +S 
Sbjct: 340  SNLNILQLSSNGISGPIPAEIFNVSSLQ-VIAFTDNSLSGSLPKDICKHLPNLQGLSLSQ 398

Query: 165  NQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIG 224
            N   G +P  L  C EL  +SLS+N+F G +P+++GN +KL+ + LG N+L G IP   G
Sbjct: 399  NHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPKEIGNLSKLEKIYLGTNSLIGSIPTSFG 458

Query: 225  NLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIG--LPNLEGL 282
            NL+ L+ L +  +NL G VP+ IFNIS L+ L++  N LSG+LPSS   IG  L +LEGL
Sbjct: 459  NLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSS---IGTWLSDLEGL 515

Query: 283  NLGLNNLSGSIPSFFFNASKLYALELGYNS-------------NLKRLGLERNYLTFS-T 328
             +  N  SG IP    N SKL  L L  NS              LK L L  N LT    
Sbjct: 516  FIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHV 575

Query: 329  SELMSLFSALVNCKSLK-----------------------------------------IG 347
            +  +   ++L NCK LK                                         IG
Sbjct: 576  ASEVGFLTSLTNCKFLKNLWIGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTRIG 635

Query: 348  NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNR 407
            NL NL  L LG N+L+GS+P TLGRLKKLQ L +  N+  G IP + CH   L  ++L+ 
Sbjct: 636  NLTNLIWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSS 695

Query: 408  NKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIE 467
            NKLSGSIPSC GDL +L+ L L SN L   IP++ W+L D+L  + SSN L G+LP E+ 
Sbjct: 696  NKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVG 755

Query: 468  NLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSN 527
            N+K++  + LS+N +SG+IP  +   +NL  LSL  NKLQGPIP  FG+LVSLE LDLS 
Sbjct: 756  NMKSITTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQ 815

Query: 528  NDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVP 587
            N+LSG IP SLE L+YLK LN+S NKL GEIP GG F NF+AESF+ N+ LCG+P+  V 
Sbjct: 816  NNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVM 875

Query: 588  LCKSSPHKKS--RKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRSTEVSHIKAGM 645
             C  +   +S   K  IL  ++LP+ ++  + V +VL         +R + E+       
Sbjct: 876  ACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIR------RRDNMEIP------ 923

Query: 646  SPQVMW-----RRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR 700
            +P   W      + SH +LL AT+ F E+NLIG GS G VYKG   +G+ VAIKVF+L+ 
Sbjct: 924  TPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEF 983

Query: 701  EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDI 760
            +GAL SFD+ECE+++ IRHRNLV+II+ C+N +FKALVLEYMP GSLE  +Y+ N+ LD+
Sbjct: 984  QGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDL 1043

Query: 761  FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM 820
             QRL IMIDVASALEYLH   S+ +VHCD+KP+NVLLDD MVAH++DFGI KLL++ +SM
Sbjct: 1044 IQRLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTESM 1103

Query: 821  KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN 880
            +QT+TL TIGY+APE+G +G VS K DVY+YGI+LMEVF+  KP +E FTG++++K W+ 
Sbjct: 1104 QQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWVE 1163

Query: 881  DSLPAVMNIMDTNLL-SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI 939
                +V+ ++D NLL  EDE+ A   K SC SS+++LA+ CT++SPE R+N K+ +  L 
Sbjct: 1164 SLSNSVIQVVDANLLRREDEDLA--TKLSCLSSIMALALACTTDSPEERLNMKDAVVELK 1221

Query: 940  KIR 942
            K R
Sbjct: 1222 KSR 1224

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  810 bits (2091), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 455/961 (47%), Positives = 623/961 (64%), Gaps = 79/961 (8%)

Query: 45   LAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNL 104
            L G IPS L +   L+ L LS N F+G IP+ IG+L+ L+EL+L YN L G IP E+GNL
Sbjct: 505  LKGEIPSSLSHCPHLRGLSLSLNQFTGGIPQAIGSLSNLEELYLAYNNLVGGIPREIGNL 564

Query: 105  AELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSY 164
            + L +L   ++ ++G IP  IFN+S +    D +DNSL GS P D+   LP L+ LY+S+
Sbjct: 565  SNLNILDFGSSGISGPIPPEIFNISSLQI-FDLTDNSLLGSLPMDIYKHLPNLQELYLSW 623

Query: 165  NQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIG 224
            N+  G +P+ L  C +L S+SL  N+FTG +P   GN T L+ L+LG NN+ G IP E+G
Sbjct: 624  NKLSGQLPSTLSLCGQLQSLSLWGNRFTGNIPPSFGNLTALQDLELGDNNIQGNIPNELG 683

Query: 225  NLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNL 284
            NL NL+ L + ++NL G +P+ IFNIS L+ LSL  N  SG+LPSS     LP+LEGL +
Sbjct: 684  NLINLQNLKLSENNLTGIIPEAIFNISKLQSLSLAQNHFSGSLPSSLG-TQLPDLEGLAI 742

Query: 285  GLNNLSGSIPSFFFNASKLYALELGYN----------SNLKRL---GLERNYLT--FSTS 329
            G N  SG IP    N S+L  L++  N           NL+RL    L  N LT   S S
Sbjct: 743  GRNEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLEFLNLGSNQLTDEHSAS 802

Query: 330  ELMSLFSALVNCKSLK-----------------------------------------IGN 348
            E +   ++L NC  L+                                         IGN
Sbjct: 803  E-VGFLTSLTNCNFLRTLWIEDNPLKGILPNSLGNLSISLESFDASACQFRGTIPTGIGN 861

Query: 349  LINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRN 408
            L +L +L LGDN+L+G +P TLG+LKKLQ L +  N+  G IP + C    L  ++L+ N
Sbjct: 862  LTSLISLELGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPNDLCRLKNLGYLFLSSN 921

Query: 409  KLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIEN 468
            +L+GSIPSCLG L  LR L L SN L S IP + W L  +L  + SSN L G LP E+ N
Sbjct: 922  QLTGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSNFLTGHLPPEVGN 981

Query: 469  LKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN 528
            +K++  + LS+N +SG+IP T+  L+NL+ LSL  N+LQGPIP  FG+L+SL+FLDLS N
Sbjct: 982  IKSIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFLDLSQN 1041

Query: 529  DLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPL 588
            +LSGVIP SL+ L YLK LN+SFNKL GEIP GG F NF+AESFI N+ LCG+P+  V  
Sbjct: 1042 NLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPHFQVIA 1101

Query: 589  CKSSPHKKS-RKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRSTEVSHIKAGMSP 647
            C  S   +S R ++ +L  +LP     ++++I ++ F L+    +R++ EV       +P
Sbjct: 1102 CDKSTRSRSWRTKLFILKYILPP----VISIITLVVF-LVLWIRRRKNLEVP------TP 1150

Query: 648  QVMW-----RRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREG 702
               W      + SH +LL AT+ F E+NLIG GS   VYKG   +G+ VA+KVF+L+ +G
Sbjct: 1151 IDSWLPGSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQG 1210

Query: 703  ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQ 762
            A  SFD+ECE++++IRHRNLVKII+ C+N +FKALVLEYMPKGSL+  +Y+ N+ LD+ Q
Sbjct: 1211 AFRSFDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQ 1270

Query: 763  RLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ 822
            RL IMIDVASALEYLH    + +VHCD+KP+N+LLDD MVAH+ DFGIA+LL+E +SM+Q
Sbjct: 1271 RLNIMIDVASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDFGIARLLTETESMQQ 1330

Query: 823  TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS 882
            T+TL TIGY+APEYG +G VS KGDV++YGIMLMEVF   KP +E F G++++K W+   
Sbjct: 1331 TKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWVESL 1390

Query: 883  LPAVMNIMDTNLL-SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
              +++ ++D NLL  EDE+ A   K SC SS+++LA+ CT++SPE R++ K+++  L KI
Sbjct: 1391 ADSMIEVVDANLLRREDEDFA--TKLSCLSSIMALALACTTDSPEERIDMKDVVVGLKKI 1448

Query: 942  R 942
            +
Sbjct: 1449 K 1449

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  809 bits (2090), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 462/970 (47%), Positives = 621/970 (64%), Gaps = 83/970 (8%)

Query: 38   LTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEI 97
            L++ +  L G IPS+L +   L+ L  S N F+G IP+ IG+L  L+EL+L +NKL G I
Sbjct: 249  LSLRNNSLTGEIPSNLSHCRELRVLSSSFNQFTGGIPQAIGSLCNLEELYLAFNKLTGGI 308

Query: 98   PEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRL 157
            P E+GNL+ L +L L +N ++G IPA IFN+S +   +DF++NSL+GS P  +C  LP L
Sbjct: 309  PREIGNLSNLNILQLGSNGISGPIPAEIFNISSLQ-VIDFTNNSLSGSLPMGICKHLPNL 367

Query: 158  KGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNG 217
            +GLY++ N   G +P  L  C EL  +SLS+N+F G +PR++GN +KL+ +DL  N+L G
Sbjct: 368  QGLYLAQNHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPREIGNLSKLEHIDLRSNSLVG 427

Query: 218  EIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIG-- 275
             IP   GNL+ L+ L +  + L G VP+ IFNIS L+ L+L  N LSG+LPSS   IG  
Sbjct: 428  SIPTSFGNLKALKFLNLGINFLTGTVPEAIFNISELQNLALVQNHLSGSLPSS---IGTW 484

Query: 276  LPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNS-------------NLKRLGLERN 322
            LP+LEGL +G N  SG+IP    N SKL  L L  NS              LK L L  N
Sbjct: 485  LPDLEGLYIGANEFSGTIPMSISNMSKLTVLSLSDNSFTGNVPKDLCNLTKLKFLNLAHN 544

Query: 323  YLTFS-TSELMSLFSALVNCKSLK------------------------------------ 345
             LT    +  +   ++L NCK L+                                    
Sbjct: 545  QLTDEHLASGVGFLTSLTNCKFLRYLWIGYNPLKGTLPNSLGNLPIALESFTAYACQFRG 604

Query: 346  -----IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRL 400
                 IGNL NL  L LG N+L+GS+P TLGRL+KLQ L +  N+  G IP + CH   L
Sbjct: 605  TIPTGIGNLTNLIWLDLGANDLTGSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNL 664

Query: 401  YVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNG 460
              + L+ NKLSGS PSC GDL +LR L L SN L   IP++ W+L D+L  + SSN L G
Sbjct: 665  GYLGLSSNKLSGSTPSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTG 724

Query: 461  SLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSL 520
            +LP E+ N+K++  + LS+N +SG IPS +  L+ L  LSL  N+LQGPI   FG+LVSL
Sbjct: 725  NLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQYLITLSLSQNRLQGPIXVEFGDLVSL 784

Query: 521  EFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCG 580
            E LDLS+N+LSG IP SLE L+YLK LN+SFNKL GEIP GG F  F+AESF+ N+ LCG
Sbjct: 785  ESLDLSHNNLSGTIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCG 844

Query: 581  SPYLHVPLCKSSPHKKS--RKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRSTEV 638
            +P+  V  C  +   +S   K  IL  ++LP+ +   + V +VL         +R + E+
Sbjct: 845  APHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWIR------RRDNMEI 898

Query: 639  SHIKAGMSPQVMW-----RRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAI 693
                   +P   W      + SH +LL AT+ F E+NLIG GS G VYKG   +G+ VAI
Sbjct: 899  P------TPIDSWLLGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLNVAI 952

Query: 694  KVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA 753
            KVF+L+ +GAL SFD+ECE+++ IRHRNLV+II+ C+N +FKALVLEYMP GSLE  +Y+
Sbjct: 953  KVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYS 1012

Query: 754  SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL 813
             N+ LD+ QRL IMIDVASALEYLH   S+ +VHCD+KPSNVLLDD MVAH++DFGIAKL
Sbjct: 1013 HNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAKL 1072

Query: 814  LSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM 873
            L+E +SM+QT+TL TIGY+APE+G  G VS K DVY+YGI+LMEVF   KP +E FTG++
Sbjct: 1073 LTETESMQQTKTLGTIGYMAPEHGSAGIVSTKSDVYSYGILLMEVFARKKPMDEMFTGDL 1132

Query: 874  SIKRWINDSLPAVMNIMDTNLL-SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTK 932
            ++K W+     +V+ ++D NLL  EDE+ A   K SC SS+++LA+ CT++SP+ R++ K
Sbjct: 1133 TLKTWVESLSNSVIQVVDVNLLRREDEDLA--TKLSCLSSIMALALACTTDSPKERIDMK 1190

Query: 933  EIISRLIKIR 942
            + +  L K R
Sbjct: 1191 DAVVELKKSR 1200

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  805 bits (2078), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 458/993 (46%), Positives = 627/993 (63%), Gaps = 68/993 (6%)

Query: 5    NPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVL 64
            +PNN+LA NW+   SVC+W+G+TC     RVT+L +SD+GL GTIP HLGNLS L  +  
Sbjct: 48   DPNNLLAANWSITTSVCTWVGVTCGARHGRVTALDLSDMGLTGTIPPHLGNLSFLAFISF 107

Query: 65   SRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPAS 124
              N F G++P E+  L ++K   +  N   GEIP  +G+  +L+ L L++N  TG +PA 
Sbjct: 108  YNNRFHGSLPDELSKLRRIKAFGMSTNYFSGEIPSWIGSFTQLQRLSLSSNKFTGLLPAI 167

Query: 125  IFNLSFIST-ALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSS 183
            + N +  S   LDF  N+LTG  P ++   L  L+ LY++ N F GPIP+ L  C++L  
Sbjct: 168  LANNTISSLWLLDFGTNNLTGRLPPNIFTHLANLRALYLNSNLFNGPIPSTLMACQQLKL 227

Query: 184  VSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFV 243
            ++LS+N F G + +D+GN T L+ L LG NN +G IP EIG+L +LE + ++ + L G V
Sbjct: 228  LALSFNHFEGSIHKDIGNLTMLQELYLGGNNFSGTIPDEIGDLAHLEEIILNVNGLSGLV 287

Query: 244  PDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKL 303
            P  I+N S +  + L  N LSG LPSS NL   PNLE   +  NN +G IP   FNASKL
Sbjct: 288  PSGIYNASKMTAIGLALNQLSGYLPSSSNL---PNLEFFIIEDNNFTGPIPVSLFNASKL 344

Query: 304  YALELGYNS--------------------------------------------NLKRLGL 319
              ++LG+NS                                            +L+R  L
Sbjct: 345  GNIDLGWNSFYGPIPDELGNLKSLEVFSFWVNHLTVKSSSSGLSLFSSLTKCKHLRRFDL 404

Query: 320  ERNYLT----------FSTSELMSLFS-ALVNCKSLKIGNLINLTTLSLGDNNLSGSLPI 368
              N L            S+ E++ +F   +      +IGNL +L+ L LG N+L G++P 
Sbjct: 405  SNNPLNGNLPISVGNLSSSLEVVEIFDCGITGTIPKEIGNLSSLSWLDLGANDLRGTIPT 464

Query: 369  TLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILS 428
            T+ +L KLQ L L  N+ EG  P E C    L  +YL  N LSG IPSCLG++NSLR LS
Sbjct: 465  TIRKLGKLQELKLHYNRLEGSFPYELCDLQSLAYLYLEVNALSGQIPSCLGNVNSLRTLS 524

Query: 429  LSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPS 488
            +  N+ +S IPST W L DIL  + SSNSL+GSL ++I NLKAV  I LS N LSG+IPS
Sbjct: 525  MGMNKFSSTIPSTLWRLADILELNLSSNSLSGSLAVDIGNLKAVTLIDLSGNQLSGHIPS 584

Query: 489  TIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLN 548
            +I GLK L +LSL  N+L+G IP+ FG+ +SL+ LDLSNN+LSG IP SLE+L YL   N
Sbjct: 585  SIGGLKTLLNLSLAVNRLEGSIPQLFGDAISLQLLDLSNNNLSGEIPKSLEELRYLTYFN 644

Query: 549  LSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSRKQVILLGVVL 608
            +SFN+L GEIP G AF N SA+SF+GN  LCG+  L V  C++S H+ S+         L
Sbjct: 645  VSFNELQGEIPNGRAFINLSAKSFMGNKGLCGAAKLQVQPCETSTHQGSKA-----ASKL 699

Query: 609  PLSTVFIVTVILVLTFGLITRCCKRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSE 668
             L    + T + +L    +     R       I  G+ P    +R S+ EL +ATD+F+E
Sbjct: 700  ALRYGLMATGLTILAVAAVAIIFIRSRKRNMRITEGLLPLATLKRISYRELEQATDKFNE 759

Query: 669  ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISS 728
             NL+G GS+GSVYKG F DG  VA+KVF+LQ EGA  SFD ECE+L+ IRHRNLVKII+S
Sbjct: 760  MNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEGAFKSFDVECEVLRMIRHRNLVKIITS 819

Query: 729  CT--NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
            C+  N +FKALVLE+MP  SLE  + +    L++ +RL IM+DVASA+EYLH G++ PIV
Sbjct: 820  CSDINIDFKALVLEFMPNYSLEKWLCSPKHFLELLERLNIMLDVASAVEYLHHGYAMPIV 879

Query: 787  HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
            HCD+KPSN+LLD++MVAH++DFGIAKLL +E S  QT TLAT+GY+APEYG EG VS  G
Sbjct: 880  HCDLKPSNILLDENMVAHVTDFGIAKLLGDEHSFIQTITLATVGYMAPEYGSEGVVSTGG 939

Query: 847  DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP-AVMNIMDTNLLSEDEEHANVA 905
            D+Y++GI+LME FT  KPT++ F  E+S+K+W+ +S+P  V  I D +LL  +E+H + A
Sbjct: 940  DIYSFGILLMETFTRKKPTDDMFNEEISMKQWVQESVPGGVTQITDPDLLRIEEQHFS-A 998

Query: 906  KQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
            K+ C  SV+ +A++C+++ PE R N +++++ L
Sbjct: 999  KKDCILSVMQVALQCSADLPEERPNIRDVLNTL 1031

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	952
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.970	0.901	0.335	3.6e-128
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.941	0.887	0.335	1e-123
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.943	0.888	0.313	2.2e-114
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.736	0.561	0.279	2.4e-110
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.536	0.521	0.351	1.7e-105
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.860	0.811	0.320	2.2e-105
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.847	0.787	0.331	1.1e-103
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.933	0.807	0.315	1.4e-101
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.929	0.803	0.307	5.9e-101
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.564	0.450	0.274	7.8e-79

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1258 (447.9 bits), Expect = 3.6e-128, P = 3.6e-128
 Identities = 327/976 (33%), Positives = 493/976 (50%)

Query:     8 NILAQNWTSNASVCSWMGITCDV----YGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLV 63
             ++ + N + +   C+W+G+ C      + +RV  L +    L+G I   LGNLS L+ L 
Sbjct:    50 SLASWNTSGHGQHCTWVGVVCGRRRRRHPHRVVKLLLRSSNLSGIISPSLGNLSFLRELD 109

Query:    64 LSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGXXXXXXXXXXXXXXXTGTIPA 123
             L  N+ SG IP E+  L++L+ L L  N +QG IP  +G                G IP 
Sbjct:   110 LGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMIPR 169

Query:   124 SI-FNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELS 182
              I  +L  +S  L    N L+G  P  +   L  L+   +S+N+  G IP++L     L 
Sbjct:   170 EIGASLKHLSN-LYLYKNGLSGEIPSAL-GNLTSLQEFDLSFNRLSGAIPSSLGQLSSLL 227

Query:   183 SVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQE-IGNLRNLEILGIDQSNLVG 241
             +++L  N  +G +P  + N + L++  +  N L G IP      L  LE++ +  +   G
Sbjct:   228 TMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHG 287

Query:   242 FVPDTIFNISTLKILSLFNNTLSGNLPSS----KXXXXXXXXXXXXXXXXXXXXXXXSFF 297
              +P ++ N S L ++ ++ N  SG + S     +                       S  
Sbjct:   288 KIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDL 347

Query:   298 FNASKLYALELGYNSNLKRLGLERNYLTFSTS-ELMSL-FSALVNCKSLKIGNLINLTTX 355
              N SKL  L LG N NL  + L  ++   STS   ++L  + +       IGNLI L   
Sbjct:   348 TNCSKLQTLNLGEN-NLGGV-LPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHL 405

Query:   356 XXXXXXXXXXXPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIP 415
                        P +LGRLK L  L    N   G IP    + + L ++ L  NK SG IP
Sbjct:   406 YLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIP 465

Query:   416 SCLGDXXXXXXXXXXXXXXTSVIPSTFWNLEDI-LGFDFSSNSLNGSLPLEIENLKAVVD 474
               L +              +  IPS  +N++ + +  + S N+L GS+P EI +LK +V+
Sbjct:   466 YTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVE 525

Query:   475 IYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVI 534
              +   N LSG IP+T+   + L++L L++N L G IP + G+L  LE LDLS+N+LSG I
Sbjct:   526 FHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQI 585

Query:   535 PAXXXXXXXXXXXXXXXXXXVGEIPRGGAFANFSAESFIGNDLLCGS-PYLHVPLCKSSP 593
             P                   VGE+P  GAFA  S  S  GN  LCG  P LH+P C   P
Sbjct:   586 PTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRC--CP 643

Query:   594 HKKSRKQVILLGVVLPLSXXXXXXXXXXXXXGLITRCCKRRSTEVSHIKAGMSPQVMWRR 653
               ++RK       VLP+S              L+    KR + + +  +  M    +   
Sbjct:   644 LLENRKHF----PVLPISVSLAAALAILSSLYLLITWHKR-TKKGAPSRTSMKGHPL--- 695

Query:   654 YSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEI 713
              S+ +L++ATD F+  NL+G GS+GSVYKG+      VA+KV  L+   AL SF AECE 
Sbjct:   696 VSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEA 755

Query:   714 LKTIRHRNLVKIISSCTN-----HNFKALVLEYMPKGSLEDCMY------ASNFNLDIFQ 762
             L+ +RHRNLVKI++ C++     ++FKA+V ++MP GSLED ++      A   +L++ +
Sbjct:   756 LRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHR 815

Query:   763 RLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ 822
             R+ I++DVA AL+YLH     P+VHCDIK SNVLLD  MVAH+ DFG+A++L +  S+ Q
Sbjct:   816 RVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQ 875

Query:   823 TQT-----LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
               T     + TIGY APEYG     S  GD+Y+YGI+++E+ TG +PT+  F  ++ +++
Sbjct:   876 QSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQ 935

Query:   878 WINDSLPA-VMNIMDTNLLSEDEEHANVAKQS-------CASSVLSLAMECTSESPENRV 929
             ++   L   V +++DT L+ + E   N    S       C   +L L + C+ E P +R 
Sbjct:   936 YVELGLHGRVTDVVDTKLILDSENWLNSTNNSPCRRITECIVWLLRLGLSCSQELPSSRT 995

Query:   930 NTKEIISRLIKIRDLL 945
              T +II  L  I+  L
Sbjct:   996 PTGDIIDELNAIKQNL 1011

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1216 (433.1 bits), Expect = 1.0e-123, P = 1.0e-123
 Identities = 318/949 (33%), Positives = 469/949 (49%)

Query:    25 GITCDVYGNR--VTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTK 82
             G+     GN   + SL + +    GTIP  +G LS L+ L +  N+  G IP  + N ++
Sbjct:    80 GVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSR 139

Query:    83 LKELHLDYNKLQGEIPEELGXXXXXXXXXXXXXXXTGTIPASIFNLSFISTALDFSDNSL 142
             L  L LD N+L G +P ELG                G +P S+ NL+ +   L  S N+L
Sbjct:   140 LLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQ-LALSHNNL 198

Query:   143 TGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNS 202
              G  P D+   L ++  L +  N F G  P  L++   L  + + YN F+GRL  DLG  
Sbjct:   199 EGEIPSDVAQ-LTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGIL 257

Query:   203 T-KLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNN 261
                L S ++G N   G IP  + N+  LE LG++++NL G +P T  N+  LK+L L  N
Sbjct:   258 LPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTN 316

Query:   262 TLSGNLPSSKXXXXXXXXXXXXXXXXXXXXXXXSFFFNASKLYALELGYNSNLKRLGLER 321
             +L  +  SS+                           N ++L  L +G N     L +  
Sbjct:   317 SLGSD--SSRDLEFLTSLT------------------NCTQLETLGIGRNRLGGDLPISI 356

Query:   322 NYLTFSTSELMSLFSALVNCK-SLKIGNLINLTTXXXXXXXXXXXXPITLGRLKKLQGLD 380
               L+     L  L   L++      IGNLINL              P +LG+L  L+ L 
Sbjct:   357 ANLSAKLVTL-DLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLS 415

Query:   381 LQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDXXXXXXXXXXXXXXTSVIPS 440
             L +N+  G IP    + + L  + L+ N   G +P+ LG+                 IP 
Sbjct:   416 LFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPL 475

Query:   441 TFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLS 500
                 ++ +L  D S NSL GSLP +I  L+ +  + L  N LSG +P T+     ++ L 
Sbjct:   476 EIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLF 535

Query:   501 LEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPAXXXXXXXXXXXXXXXXXXVGEIPR 560
             LE N   G IP+  G LV ++ +DLSNNDLSG IP                    G++P 
Sbjct:   536 LEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPV 594

Query:   561 GGAFANFSAESFIGNDLLCGS--PYLHVPLCKSSPHKKSRKQVILLGVVLPLSXXXXXXX 618
              G F N +  S +GN+ LCG    +   P    +P    +    L  VV+ +S       
Sbjct:   595 KGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLL 654

Query:   619 XXXXXXGLITRCCKRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYG 678
                     +    KR+  + ++     + +V+  + S+ +L  AT+ FS  N++G GS+G
Sbjct:   655 LLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFG 714

Query:   679 SVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN-----H 732
             +VYK     +   VA+KV ++QR GA+ SF AECE LK IRHRNLVK++++C++     +
Sbjct:   715 TVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGN 774

Query:   733 NFKALVLEYMPKGSLEDCMYASNFN--------LDIFQRLGIMIDVASALEYLHFGHSNP 784
              F+AL+ E+MP GSL+  ++             L + +RL I IDVAS L+YLH     P
Sbjct:   775 EFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEP 834

Query:   785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLL---SEEDSMKQTQTLA---TIGYIAPEYGR 838
             I HCD+KPSNVLLDD + AH+SDFG+A+LL    EE    Q  +     TIGY APEYG 
Sbjct:   835 IAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGV 894

Query:   839 EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA-VMNIMDTNLLSE 897
              GQ SI GDVY++GI+L+E+FTG +PTNE F G  ++  +   +LP  +++I+D ++L  
Sbjct:   895 GGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHI 954

Query:   898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF 946
                        C + V  + + C  ESP NR+ T  ++  LI IR+  F
Sbjct:   955 GLR-VGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFF 1002

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1128 (402.1 bits), Expect = 2.2e-114, P = 2.2e-114
 Identities = 297/948 (31%), Positives = 455/948 (47%)

Query:    25 GITCDVYGNR--VTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTK 82
             GI     GN   + SL +SD    G IP  +GNL  L+ L ++ N   G IP  + N ++
Sbjct:    80 GIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSR 139

Query:    83 LKELHLDYNKLQGEIPEELGXXXXXXXXXXXXXXXTGTIPASIFNLSFISTALDFSDNSL 142
             L  L L  N L+  +P ELG                G +P S+ NL+ + + L F+DN++
Sbjct:   140 LLNLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKS-LGFTDNNI 198

Query:   143 TGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNS 202
              G  P D    L ++ GL +S N+F G  P  +++   L  + L  + F+G L  D GN 
Sbjct:   199 EGEVP-DELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNL 257

Query:   203 T-KLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNN 261
                ++ L+LG N+L G IP  + N+  L+  GI+++ + G +      + +L+ L L  N
Sbjct:   258 LPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSEN 317

Query:   262 TLSGNLPSSKXXXXXXXXXXXXXXXXXXXXXXXSFFFNASKLYALELGYNSNLKRLGLER 321
              L G+                                N + L  L +GY      L    
Sbjct:   318 PL-GSYTFGDLEFIDSLT-------------------NCTHLQLLSVGYTRLGGALPTSI 357

Query:   322 NYLTFSTSELMSLFSALVNCKSLKIGNLINLTTXXXXXXXXXXXXPITLGRLKKLQGLDL 381
               ++     L  + +         IGNLI L              P +LG+L +L  L L
Sbjct:   358 ANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSL 417

Query:   382 QNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDXXXXXXXXXXXXXXTSVIPST 441
              +N+  G IP    + ++L ++YL+ N   G +P  LG                  IP  
Sbjct:   418 YSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKE 477

Query:   442 FWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSL 501
                +  ++      NSL+GSLP +I +L+ +V + L  N  SG++P T+     ++ L L
Sbjct:   478 IMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFL 537

Query:   502 EHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPAXXXXXXXXXXXXXXXXXXVGEIPRG 561
             + N   G IP   G L+ +  +DLSNNDLSG IP                    G++P  
Sbjct:   538 QGNSFDGAIPNIRG-LMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSK 596

Query:   562 GAFANFSAESFIGNDLLCGS-PYLHVPLCKSS-PHKKSRKQVILLGVVLPLSXXXXXXXX 619
             G F N +     GN  LCG    L +  C +  P  +++    L  V + +S        
Sbjct:   597 GNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLL 656

Query:   620 XXXXXGLITRCCKRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGS 679
                   ++    KRR  + ++       ++   + S+ +L  AT+ FS  N++G GS+G+
Sbjct:   657 LVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGT 716

Query:   680 VYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN-----HN 733
             V+K   P   + VA+KV ++QR GA+ SF AECE LK  RHRNLVK++++C +     + 
Sbjct:   717 VFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNE 776

Query:   734 FKALVLEYMPKGSLEDCMYASNFN--------LDIFQRLGIMIDVASALEYLHFGHSNPI 785
             F+AL+ EY+P GS++  ++             L + +RL I+IDVAS L+YLH     PI
Sbjct:   777 FRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPI 836

Query:   786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLL---SEEDSMKQTQTLA---TIGYIAPEYGRE 839
              HCD+KPSNVLL+D + AH+SDFG+A+LL    +E  + Q  +     TIGY APEYG  
Sbjct:   837 AHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMG 896

Query:   840 GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA-VMNIMDTNLLSED 898
             GQ SI GDVY++G++L+E+FTG +PT+E F G +++  +   +LP  V  I D  +L   
Sbjct:   897 GQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIG 956

Query:   899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF 946
                       C + VL + + C  E P NR+ T E+   LI IR+  F
Sbjct:   957 LR-VGFRTAECLTLVLEVGLRCCEEYPTNRLATSEVAKELISIRERFF 1003

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 670 (240.9 bits), Expect = 2.4e-110, Sum P(2) = 2.4e-110
 Identities = 209/749 (27%), Positives = 334/749 (44%)

Query:    33 NRVTSLTISDLGLAGTIPSHL-GNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYN 91
             +++  L +++  L+G++P  +  N ++L+ LVLS    SG IP E+     LK+L L  N
Sbjct:   311 SQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNN 370

Query:    92 KLQGEIPEELGXXXXXXXXXXXXXXXTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMC 151
              L G IPE L                 GT+  SI NL+ +   + + +N L G  P ++ 
Sbjct:   371 SLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNN-LEGKLPKEIS 429

Query:   152 PGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLG 211
               L +L+ L++  N+F G IP  + +C  L  + +  N F G +P  +G   +L  L L 
Sbjct:   430 -ALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLR 488

Query:   212 FNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSS- 270
              N L G +P  +GN   L IL +  + L G +P +   +  L+ L L+NN+L GNLP S 
Sbjct:   489 QNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSL 548

Query:   271 ---KXXXXXXXXXXXXXXXXXXXXXXXSFF-FNASKL-----YALELGYNSNLKRLGLER 321
                +                       S+  F+ +         LELG + NL RL L +
Sbjct:   549 ISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGK 608

Query:   322 NYLTFSTSELMSLFSALVNCKSLKIGNLINLTTXXXXXXXXXXXXPITLGRLKKLQGLDL 381
             N LT                    +G +  L+             P+ L   KKL  +DL
Sbjct:   609 NQLTGKIP--------------WTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDL 654

Query:   382 QNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDXXXXXXXXXXXXXXTSVIPST 441
              NN   GPIP      S+L  + L+ N+   S+P+ L +                 IP  
Sbjct:   655 NNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQE 714

Query:   442 FWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQH-LS 500
               NL  +   +   N  +GSLP  +  L  + ++ LSRN+L+G IP  I  L++LQ  L 
Sbjct:   715 IGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALD 774

Query:   501 LEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPAXXXXXXXXXXXXXXXXXXVGEIPR 560
             L +N   G IP + G L  LE LDLS+N L+G +P                    G++ +
Sbjct:   775 LSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK 834

Query:   561 GGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKK--SRKQVILLGVVLPLSXXXXXXX 618
                F+ + A+SF+GN  LCGSP       +S+  ++  S + V+++  +  L+       
Sbjct:   835 --QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMIL 892

Query:   619 XXXXXXGLITRCCKRRST-EVSHIKAGMSPQV----MWRRYSH------DELLRATDQFS 667
                          K+      ++  +  S Q     ++R  +       ++++ AT   S
Sbjct:   893 VIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLS 952

Query:   668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKI 725
             EE +IG G  G VYK    +G  VA+K   L ++  ++  SF  E + L  IRHR+LVK+
Sbjct:   953 EEFMIGSGGSGKVYKAELENGETVAVKKI-LWKDDLMSNKSFSREVKTLGRIRHRHLVKL 1011

Query:   726 ISSCTNHN--FKALVLEYMPKGSLEDCMY 752
             +  C++ +     L+ EYM  GS+ D ++
Sbjct:  1012 MGYCSSKSEGLNLLIYEYMKNGSIWDWLH 1040

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 755 (270.8 bits), Expect = 1.7e-105, Sum P(2) = 1.7e-105
 Identities = 190/540 (35%), Positives = 278/540 (51%)

Query:   367 PITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDXXXXXX 426
             P+ LG + +L  LD+  N   G IP  F + S+L  + L  N LSG++P  LG       
Sbjct:   362 PMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEI 421

Query:   427 XXXXXXXXTSVIP-STFWNLEDI-LGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSG 484
                     T  IP     NL ++ L  + SSN L+G +PLE+  +  V+ + LS N LSG
Sbjct:   422 LDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSG 481

Query:   485 NIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPAXXXXXXXX 544
              IP  +     L+HL+L  N     +P S G+L  L+ LD+S N L+G IP         
Sbjct:   482 KIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTL 541

Query:   545 XXXXXXXXXXVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSRKQVILL 604
                        G +   G+F+  + ESF+G+ LLCGS    +  CK      S    +LL
Sbjct:   542 KHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGS-IKGMQACKKKHKYPSVLLPVLL 600

Query:   605 GVVL-PLSXXXXXXXXXXXXXGLITRCCKRRSTEVSHIKAGMSPQVMWRRYSHDELLRAT 663
              ++  P+              G       +   E    +    P+  + R S+ +L+ AT
Sbjct:   601 SLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPK--YPRISYQQLIAAT 658

Query:   664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN---SFDAECEILKTIRHR 720
               F+  +LIG G +G VYKG   +  +VA+KV  L  + AL    SF  EC+ILK  RHR
Sbjct:   659 GGFNASSLIGSGRFGHVYKGVLRNNTKVAVKV--LDPKTALEFSGSFKRECQILKRTRHR 716

Query:   721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---NLDIFQRLGIMIDVASALEYL 777
             NL++II++C+   F ALVL  MP GSLE  +Y   +   NLD+ Q + I  DVA  + YL
Sbjct:   717 NLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYL 776

Query:   778 HFGHSNPI--VHCDIKPSNVLLDDSMVAHLSDFGIAKLL-------SEEDSMK--QTQTL 826
             H  H +P+  VHCD+KPSN+LLDD M A ++DFGI++L+       S +DS+    T  L
Sbjct:   777 H--HYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGL 834

Query:   827 --ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP 884
                ++GYIAPEYG   + S  GDVY++G++L+E+ +G +PT+       S+  ++    P
Sbjct:   835 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYP 894

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1043 (372.2 bits), Expect = 2.2e-105, P = 2.2e-105
 Identities = 274/854 (32%), Positives = 425/854 (49%)

Query:     2 INDNPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQT 61
             ++++  + L+  W ++  +CSW  + C     RVT L +  L L G I   +GNLS L  
Sbjct:    36 VSESKRDALSA-WNNSFPLCSWKWVRCGRKHKRVTRLDLGGLQLGGVISPSIGNLSFLIY 94

Query:    62 LVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGXXXXXXXXXXXXXXXTGTI 121
             L LS N F GTIP+E+GNL +LK L + +N L+GEIP  L                   +
Sbjct:    95 LDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLLYLDLFSNNLGDGV 154

Query:   122 PASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKEL 181
             P+ + +L  +   L    N L G FP      L  L  L + YN  +G IP+++    ++
Sbjct:   155 PSELGSLRKL-LYLYLGLNDLKGKFPV-FIRNLTSLIVLNLGYNHLEGEIPDDIAMLSQM 212

Query:   182 SSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLR-NLEILGIDQSNLV 240
              S++L+ N F+G  P    N + L++L L  N  +G +  + GNL  N+  L +  + L 
Sbjct:   213 VSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNIHELSLHGNFLT 272

Query:   241 GFVPDTIFNISTLKILSLFNNTLSGNL-PSSKXXXXXXXXXXXXXXXXXXXXXXXSFF-- 297
             G +P T+ NISTL++  +  N ++G++ P+                         +F   
Sbjct:   273 GAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGSYSFGDLAFLDA 332

Query:   298 -FNASKLYALELGYNSNLKRLG--LERNYLTFSTS-ELMSLFSALV-NCKSLKIGNLINL 352
               N S L+ L + YN    RLG  L  + +  ST   +++L   L+       IGNLI L
Sbjct:   333 LTNCSHLHGLSVSYN----RLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGL 388

Query:   353 TTXXXXXXXXXXXXPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSG 412
              +            P +LG L  L  L L +N+F G IP    + ++L  +YL+ N   G
Sbjct:   389 QSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEG 448

Query:   413 SIPSCLGDXXXXXXXXXXXXXXTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAV 472
              +P  LGD                 IP     +  ++  +  SNSL+GSLP +I  L+ +
Sbjct:   449 IVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPNDIGRLQNL 508

Query:   473 VDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSG 532
             V++ L  NNLSG++P T+    +++ + L+ N   G IP+  G L+ ++ +DLSNN+LSG
Sbjct:   509 VELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMGVKNVDLSNNNLSG 567

Query:   533 VIPAXXXXXXXXXXXXXXXXXXVGEIPRGGAFANFSAESFIGNDLLCGS-PYLHVPLC-K 590
              I                     G +P  G F N +  S  GN  LCGS   L +  C  
Sbjct:   568 SISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIA 627

Query:   591 SSPHKKSRKQVILLGVVLPLSXXXXXXXXXXXXXGLITRCCKRRSTEVSHIKAGMSPQVM 650
              +P  ++R   +L  V + +S               ++   KR++ +  +  A  + ++ 
Sbjct:   628 QAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVS--LSWFKKRKNNQKINNSAPFTLEIF 685

Query:   651 WRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDA 709
               + S+ +L  ATD FS  N++G GS+G+V+K     +   VA+KV ++QR GA+ SF A
Sbjct:   686 HEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMA 745

Query:   710 ECEILKTIRHRNLVKIISSCTN-----HNFKALVLEYMPKGSLEDCMYASNFN------- 757
             ECE LK IRHRNLVK++++C +     + F+AL+ E+MP GSL+  ++            
Sbjct:   746 ECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSR 805

Query:   758 -LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE 816
              L + +RL I IDVAS L+YLH     PI HCD+KPSN+LLDD + AH+SDFG+A+LL +
Sbjct:   806 TLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLK 865

Query:   817 EDSMKQTQTLATIG 830
              D       L++ G
Sbjct:   866 FDQESFFNQLSSAG 879

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1027 (366.6 bits), Expect = 1.1e-103, P = 1.1e-103
 Identities = 277/836 (33%), Positives = 411/836 (49%)

Query:     7 NNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSR 66
             + ++  +W  +  +CSW G+ C +   RVT + +  L L G +   +GNLS L++L L+ 
Sbjct:    55 SRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLAD 114

Query:    67 NWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGXXXXXXXXXXXXXXXTGTIPASIF 126
             N+F G IP E+GNL +L+ L++  N   G IP  L                   +P    
Sbjct:   115 NFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFG 174

Query:   127 NLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSL 186
             +LS +   L    N+LTG FP  +   L  L+ L   YNQ +G IP ++   K++    +
Sbjct:   175 SLSKL-VLLSLGRNNLTGKFPASL-GNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRI 232

Query:   187 SYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLR-NLEILGIDQSNLVGFVPD 245
             + N+F G  P  + N + L  L +  N+ +G +  + G+L  NL+IL +  ++  G +P+
Sbjct:   233 ALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPE 292

Query:   246 TIFNISTLKILSLFNNTLSGNLPSSKXXXXXXXXXXXXXXXXXXXXXXXSFFF----NAS 301
             T+ NIS+L+ L + +N L+G +P S                          F     N S
Sbjct:   293 TLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCS 352

Query:   302 KLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLK--IGNLINLTTXXXXX 359
             +L  L +G+N    +L +    L+   +EL SL   L++  S+   IGNL++L T     
Sbjct:   353 QLQYLNVGFNKLGGQLPVFIANLSTQLTEL-SLGGNLIS-GSIPHGIGNLVSLQTLDLGE 410

Query:   360 XXXXXXXPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLG 419
                    P +LG L +L+ + L +N   G IP    + S L  +YL  N   GSIPS LG
Sbjct:   411 NLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLG 470

Query:   420 DXXXXXXXXXXXXXXTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSR 479
                               IP     L  ++  + S N L G L  +I  LK ++ + +S 
Sbjct:   471 SCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSY 530

Query:   480 NNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPAXXX 539
             N LSG IP T+    +L+ L L+ N   GPIP+  G L  L FLDLS N+LSG IP    
Sbjct:   531 NKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMA 589

Query:   540 XXXXXXXXXXXXXXXVGEIPRGGAFANFSAESFIGNDLLCGS-PYLHVPLCKSS-PHKKS 597
                             G +P  G F N SA S  GN  LCG  P L +  C    P + S
Sbjct:   590 NFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHS 649

Query:   598 R-KQVILLGVVLPLSXXXXXXXXXXXXXGLITRCCKRRSTEVSHIKAGMSPQVMWRRYSH 656
               +++I + V   ++                 R    R+    + ++    +  + + S+
Sbjct:   650 SVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISY 709

Query:   657 DELLRATDQFSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILK 715
             DEL + T  FS  NLIG G++G+V+KG      + VAIKV +L + GA  SF AECE L 
Sbjct:   710 DELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALG 769

Query:   716 TIRHRNLVKIISSCTN-----HNFKALVLEYMPKGSLEDCMYASNFN--------LDIFQ 762
              IRHRNLVK+++ C++     ++F+ALV E+MP G+L+  ++             L +F 
Sbjct:   770 GIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFA 829

Query:   763 RLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
             RL I IDVASAL YLH    NPI HCDIKPSN+LLD  + AH+SDFG+A+LL + D
Sbjct:   830 RLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFD 885

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 1007 (359.5 bits), Expect = 1.4e-101, P = 1.4e-101
 Identities = 292/925 (31%), Positives = 428/925 (46%)

Query:    38 LTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEI 97
             L I    L G IP  +  L  L+ +   RN FSG IP EI     LK L L  N L+G +
Sbjct:   168 LVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSL 227

Query:    98 PEELGXXXXXXXXXXXXXXXTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRL 157
             P++L                +G IP S+ N+S +   L   +N  TGS P ++   L ++
Sbjct:   228 PKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEV-LALHENYFTGSIPREIGK-LTKM 285

Query:   158 KGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNG 217
             K LY+  NQ  G IP  + +  + + +  S NQ TG +P++ G+   LK L L  N L G
Sbjct:   286 KRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLG 345

Query:   218 EIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKXXXXXX 277
              IP+E+G L  LE L +  + L G +P  +  +  L  L LF+N L G +P         
Sbjct:   346 PIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPP--LIGFYS 403

Query:   278 XXXXXXXXXXXXXXXXXSFFFNASKLYALELGYNSNLKRLGLERNYLTF-STSELMSLFS 336
                              + F     L  L LG  SN     + R+  T  S ++LM   +
Sbjct:   404 NFSVLDMSANSLSGPIPAHFCRFQTLILLSLG--SNKLSGNIPRDLKTCKSLTKLMLGDN 461

Query:   337 ALVNCKSLKIGNLINLTTXXXXXXXXXXXXPITLGRLKKLQGLDLQNNKFEGPIPQEFCH 396
              L     +++ NL NLT                LG+LK L+ L L NN F G IP E  +
Sbjct:   462 QLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGN 521

Query:   397 FSRLYVVYLNRNKLSGSIPSCLGDXXXXXXXXXXXXXXTSVIPSTFWNLEDILGFDFSSN 456
              +++    ++ N+L+G IP  LG               +  I      L  +     S N
Sbjct:   522 LTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDN 581

Query:   457 SLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ-HLSLEHNKLQGPIPESFG 515
              L G +P    +L  ++++ L  N LS NIP  +  L +LQ  L++ HN L G IP+S G
Sbjct:   582 RLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLG 641

Query:   516 ELVSLEFLDLSNNDLSGVIPAXXXXXXXXXXXXXXXXXXVGEIPRGGAFANFSAESFIGN 575
              L  LE L L++N LSG IPA                  VG +P    F    + +F GN
Sbjct:   642 NLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGN 701

Query:   576 DLLCGSPYLHV-PLCKSSPHKKSRKQVILLGV----VLPLSXXXXXXXXXXXXXGLITRC 630
               LC S   H  PL    PH  S+   ++ G     +L ++             GL    
Sbjct:   702 HGLCNSQRSHCQPLV---PHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTI 758

Query:   631 CKRRSTEVSHIKAGMSPQVMWRRY------SHDELLRATDQFSEENLIGIGSYGSVYKGR 684
              KRR      ++    P VM   Y      ++  L+ AT  FSE+ ++G G+ G+VYK  
Sbjct:   759 -KRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAE 817

Query:   685 FPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM 742
                G  +A+K  + + EGA   NSF AE   L  IRHRN+VK+   C + N   L+ EYM
Sbjct:   818 MSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYM 877

Query:   743 PKGSLEDCMYASNFN--LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS 800
              KGSL + +     N  LD   R  I +  A  L YLH      IVH DIK +N+LLD+ 
Sbjct:   878 SKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDER 937

Query:   801 MVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
               AH+ DFG+AKL+    S   +    + GYIAPEY    +V+ K D+Y++G++L+E+ T
Sbjct:   938 FQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELIT 997

Query:   861 GMKPTNEFFTG-EMS--IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLA 917
             G  P      G ++   ++R I + +P +  + D  L + D+    V + S    VL +A
Sbjct:   998 GKPPVQPLEQGGDLVNWVRRSIRNMIPTI-EMFDARLDTNDKR--TVHEMSL---VLKIA 1051

Query:   918 MECTSESPENRVNTKEIISRLIKIR 942
             + CTS SP +R   +E+++ + + R
Sbjct:  1052 LFCTSNSPASRPTMREVVAMITEAR 1076

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 984 (351.4 bits), Expect = 5.9e-101, Sum P(2) = 5.9e-101
 Identities = 284/924 (30%), Positives = 424/924 (45%)

Query:    38 LTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEI 97
             +T S+  ++G +P  +GNL  L +    +N  SG++P EIG    L  L L  N+L GE+
Sbjct:   175 VTYSN-NISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGEL 233

Query:    98 PEELGXXXXXXXXXXXXXXXTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRL 157
             P+E+G               +G IP  I N + + T L    N L G  P ++   L  L
Sbjct:   234 PKEIGMLKKLSQVILWENEFSGFIPREISNCTSLET-LALYKNQLVGPIPKEL-GDLQSL 291

Query:   158 KGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNG 217
             + LY+  N   G IP  + +      +  S N  TG +P +LGN   L+ L L  N L G
Sbjct:   292 EFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTG 351

Query:   218 EIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKXXXXXX 277
              IP E+  L+NL  L +  + L G +P     +  L +L LF N+LSG +P         
Sbjct:   352 TIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPK--LGWYS 409

Query:   278 XXXXXXXXXXXXXXXXXSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSA 337
                              S+    S +  L LG N NL    +     T  T  L+ L  A
Sbjct:   410 DLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTN-NLSG-NIPTGITTCKT--LVQLRLA 465

Query:   338 LVNCKSLKIGNL---INLTTXXXXXXXXXXXXPITLGRLKKLQGLDLQNNKFEGPIPQEF 394
               N       NL   +N+T             P  +G    LQ L L +N F G +P+E 
Sbjct:   466 RNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREI 525

Query:   395 CHFSRLYVVYLNRNKLSGSIPSCLGDXXXXXXXXXXXXXXTSVIPSTFWNLEDILGFDFS 454
                S+L  + ++ NKL+G +PS + +              +  +PS   +L  +     S
Sbjct:   526 GMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLS 585

Query:   455 SNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ-HLSLEHNKLQGPIPES 513
             +N+L+G++P+ + NL  + ++ +  N  +G+IP  +  L  LQ  L+L +NKL G IP  
Sbjct:   586 NNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPE 645

Query:   514 FGELVSLEFLDLSNNDLSGVIPAXXXXXXXXXXXXXXXXXXVGEIPRGGAFANFSAESFI 573
                LV LEFL L+NN+LSG IP+                   G IP      N S  SFI
Sbjct:   646 LSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFI 702

Query:   574 GNDLLCGSPYLH-VPLCKSSPHKKSRKQVILLGVVLPLSXXXXXXXXXXXXXGLITRCCK 632
             GN+ LCG P    +     +P + + K   +    +                 LI    +
Sbjct:   703 GNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMR 762

Query:   633 RR-STEVSHIKAG----MSPQVMW---RRYSHDELLRATDQFSEENLIGIGSYGSVYKGR 684
             R   T  S  + G    MS  + +     ++  +L+ ATD F E  ++G G+ G+VYK  
Sbjct:   763 RPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAV 822

Query:   685 FPDGIEVAIKVFHLQREGALN-----SFDAECEILKTIRHRNLVKIISSCTNHNFKALVL 739
              P G  +A+K      EG  N     SF AE   L  IRHRN+VK+   C +     L+ 
Sbjct:   823 LPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLY 882

Query:   740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD 799
             EYMPKGSL + ++  + NLD  +R  I +  A  L YLH      I H DIK +N+LLDD
Sbjct:   883 EYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDD 942

Query:   800 SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
                AH+ DFG+AK++    S   +    + GYIAPEY    +V+ K D+Y+YG++L+E+ 
Sbjct:   943 KFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELL 1002

Query:   860 TGMKPTNEFFTGEMSIKRWINDSL--PAVMN-IMDTNLLSEDEEHANVAKQSCASSVLSL 916
             TG  P      G   +  W+   +   A+ + ++D  L  EDE        S   +VL +
Sbjct:  1003 TGKAPVQPIDQGG-DVVNWVRSYIRRDALSSGVLDARLTLEDERIV-----SHMLTVLKI 1056

Query:   917 AMECTSESPENRVNTKEIISRLIK 940
             A+ CTS SP  R + ++++  LI+
Sbjct:  1057 ALLCTSVSPVARPSMRQVVLMLIE 1080

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 448 (162.8 bits), Expect = 7.8e-79, Sum P(2) = 7.8e-79
 Identities = 156/569 (27%), Positives = 252/569 (44%)

Query:    47 GTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGXXXX 106
             G +P  +  L  L  L LS N    +IPK  G L  L  L+L   +L G IP ELG    
Sbjct:   224 GPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGELHNLSILNLVSAELIGLIPPELGNCKS 283

Query:   107 XXXXXXXXXXXTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPR-LKGLYVSYN 165
                        +G +P  +  +  ++ + +   N L+GS P  M  G  + L  L ++ N
Sbjct:   284 LKSLMLSFNSLSGPLPLELSEIPLLTFSAE--RNQLSGSLPSWM--GKWKVLDSLLLANN 339

Query:   166 QFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGN 225
             +F G IP+ +  C  L  +SL+ N  +G +PR+L  S  L+++DL  N L+G I +    
Sbjct:   340 RFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDG 399

Query:   226 LRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKXXXXXXXXXXXXXX 285
               +L  L +  + + G +P+ ++ +  L  L L +N  +G +P  K              
Sbjct:   400 CSSLGELLLTNNQINGSIPEDLWKLP-LMALDLDSNNFTGEIP--KSLWKSTNLMEFTAS 456

Query:   286 XXXXXXXXXSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCK-SL 344
                      +   NA+ L  L L  N     +  E   LT S S +++L + +   K  +
Sbjct:   457 YNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLT-SLS-VLNLNANMFQGKIPV 514

Query:   345 KIGNLINLTTXXXXXXXXXXXXPITLGRLKKLQGLDLQNNKFEGPIPQE---FCH----- 396
             ++G+  +LTT            P  +  L +LQ L L  N   G IP +   + H     
Sbjct:   515 ELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMP 574

Query:   397 ---FSRLYVVY-LNRNKLSGSIPSCLGDXXXXXXXXXXXXXXTSVIPSTFWNLEDILGFD 452
                F + + ++ L+ N+LSG IP  LG+              +  IP++   L ++   D
Sbjct:   575 DLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILD 634

Query:   453 FSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPE 512
              S N+L GS+P E+ N   +  + L+ N L+G+IP +   L +L  L+L  NKL GP+P 
Sbjct:   635 LSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPA 694

Query:   513 SFGELVSLEFLDLSNNDLSGVIPAXXXXXXXXXXXXXXXXXXVGEIPRG-GAFANFS--- 568
             S G L  L  +DLS N+LSG + +                   GEIP   G         
Sbjct:   695 SLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLD 754

Query:   569 -AESFIGNDL---LCGSPYLH-VPLCKSS 592
              +E+ +  ++   +CG P L  + L K++
Sbjct:   755 VSENLLSGEIPTKICGLPNLEFLNLAKNN 783

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGP4	Y3475_ARATH	2, ., 7, ., 1, 1, ., 1	0.3642	0.9537	0.8990	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	952
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-112
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-45
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-41
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-39
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-38
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-37
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-24
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-23
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-20
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-19
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-18
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-13
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	4e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	5e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	3e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-04
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.001
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.001
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.002
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.002
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	0.003
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.003
pfam03109	117	pfam03109, ABC1, ABC1 family	0.004
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.004
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  368 bits (945), Expect = e-112
 Identities = 294/964 (30%), Positives = 459/964 (47%), Gaps = 103/964 (10%)

Query: 13  NWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNL---------------- 56
           NW S+A VC W GITC+   +RV S+ +S   ++G I S +  L                
Sbjct: 50  NWNSSADVCLWQGITCNNS-SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGP 108

Query: 57  ---------SSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAEL 107
                    SSL+ L LS N F+G+IP+  G++  L+ L L  N L GEIP ++G+ + L
Sbjct: 109 IPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSL 166

Query: 108 EMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQF 167
           ++L L  N+L G IP S+ NL+ +   L  + N L G  P ++   +  LK +Y+ YN  
Sbjct: 167 KVLDLGGNVLVGKIPNSLTNLTSLEF-LTLASNQLVGQIPRELGQ-MKSLKWIYLGYNNL 224

Query: 168 KGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLR 227
            G IP  +     L+ + L YN  TG +P  LGN   L+ L L  N L+G IP  I +L+
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQ 284

Query: 228 NLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLN 287
            L  L +  ++L G +P+ +  +  L+IL LF+N  +G +P +  L  LP L+ L L  N
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA--LTSLPRLQVLQLWSN 342

Query: 288 NLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIG 347
             SG IP             LG ++NL  L L  N LT    E +        C S   G
Sbjct: 343 KFSGEIPK-----------NLGKHNNLTVLDLSTNNLTGEIPEGL--------CSS---G 380

Query: 348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNR 407
           NL  L   S   N+L G +P +LG  + L+ + LQ+N F G +P EF     +Y + ++ 
Sbjct: 381 NLFKLILFS---NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437

Query: 408 NKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIE 467
           N L G I S   D+ SL++LSL+ N+    +P +F + + +   D S N  +G++P ++ 
Sbjct: 438 NNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLG 496

Query: 468 NLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSN 527
           +L  ++ + LS N LSG IP  +   K L  L L HN+L G IP SF E+  L  LDLS 
Sbjct: 497 SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQ 556

Query: 528 NDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLH-V 586
           N LSG IP +L  +  L  +N+S N L G +P  GAF   +A +  GN  LCG      +
Sbjct: 557 NQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL 616

Query: 587 PLCKSSPHKKSRKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRSTEVSHIKAGMS 646
           P CK      S    I         T+    V+ ++ FG +      R      +K   +
Sbjct: 617 PPCKRVRKTPSWWFYI-------TCTLGAFLVLALVAFGFVF----IRGRNNLELKRVEN 665

Query: 647 PQVMW----------RRYSHDELLRATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKV 695
               W          +  + +++L +     EEN+I  G  G+ YKG+   +G++     
Sbjct: 666 EDGTWELQFFDSKVSKSITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQ----- 717

Query: 696 FHLQREGALNSF-DAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYAS 754
           F ++    +NS   +E   +  ++H N+VK+I  C +     L+ EY+   +L + +   
Sbjct: 718 FVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-- 775

Query: 755 NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL 814
             NL   +R  I I +A AL +LH   S  +V  ++ P  +++D     HL    +  LL
Sbjct: 776 --NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832

Query: 815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS 874
             +     T+   +  Y+APE      ++ K D+Y +G++L+E+ TG  P +  F    S
Sbjct: 833 CTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS 887

Query: 875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
           I  W           +D  +        +V +      V++LA+ CT+  P  R    ++
Sbjct: 888 IVEWARYCYSDCH--LDMWIDPSIRGDVSVNQNEIV-EVMNLALHCTATDPTARPCANDV 944

Query: 935 ISRL 938
           +  L
Sbjct: 945 LKTL 948

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  161 bits (409), Expect = 5e-45
 Identities = 71/190 (37%), Positives = 108/190 (56%), Gaps = 8/190 (4%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSC 729
           +G G +G+VY  R    G +VAIK+   +     L     E EILK + H N+VK+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
            + N   LV+EY   GSL+D +  +   L   + L I++ +   LEYL   HSN I+H D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRD 117

Query: 790 IKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR-EGQVSIKGD 847
           +KP N+LLD D+    L+DFG++KLL+ + S+ +T  + T  Y+APE    +G  S K D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKSD 176

Query: 848 VYNYGIMLME 857
           +++ G++L E
Sbjct: 177 IWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  158 bits (402), Expect = 1e-43
 Identities = 83/267 (31%), Positives = 130/267 (48%), Gaps = 23/267 (8%)

Query: 672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISS 728
           +G GS+G+VYK +    G  VA+K+   + E      +   E  IL+ + H N+V++I +
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
             + +   LV+EY   G L D   +    L   +   I + +   LEYLH   SN I+H 
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFD-YLSRGGPLSEDEAKKIALQILRGLEYLH---SNGIIHR 122

Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQ-VSIKGD 847
           D+KP N+LLD++ V  ++DFG+AK L +  S   T    T  Y+APE    G     K D
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVD 181

Query: 848 VYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQ 907
           V++ G++L E+ TG  P    F+GE      I D L  +  I+   L  ++ +       
Sbjct: 182 VWSLGVILYELLTGKPP----FSGEN-----ILDQLQLIRRILGPPLEFDEPK-----WS 227

Query: 908 SCASSVLSLAMECTSESPENRVNTKEI 934
           S +     L  +C ++ P  R   +EI
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  151 bits (384), Expect = 4e-41
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 12/217 (5%)

Query: 666 FSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLV 723
           +     +G GS+G VY  R    G  VAIKV   ++ +        E +ILK ++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++     + +   LV+EY   G L D +      L   +    +  + SALEYLH   S 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYLH---SK 116

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
            IVH D+KP N+LLD+     L+DFG+A+ L   + +  T  + T  Y+APE        
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGYG 174

Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN 880
              D+++ G++L E+ TG  P    F G+  +     
Sbjct: 175 KAVDIWSLGVILYELLTGKPP----FPGDDQLLELFK 207

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  146 bits (372), Expect = 2e-39
 Identities = 72/274 (26%), Positives = 130/274 (47%), Gaps = 30/274 (10%)

Query: 672 IGIGSYGSVYKGR-----FPDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKI 725
           +G G++G VYKG+         +EVA+K       E  +  F  E  I++ + H N+VK+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
           +  CT      +V+EYM  G L   +  +   L +   L   + +A  +EYL    S   
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIK 845
           +H D+   N L+ +++V  +SDFG+++ L ++D  ++      I ++APE  +EG+ + K
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSK 183

Query: 846 GDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
            DV+++G++L E+FT G +P             +   S   V+  +          +   
Sbjct: 184 SDVWSFGVLLWEIFTLGEQP-------------YPGMSNEEVLEYLKNGYRLPQPPN--- 227

Query: 905 AKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
               C   +  L ++C +E PE+R    E++  L
Sbjct: 228 ----CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  143 bits (362), Expect = 4e-38
 Identities = 75/275 (27%), Positives = 129/275 (46%), Gaps = 31/275 (11%)

Query: 672 IGIGSYGSVYKGR-----FPDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKI 725
           +G G++G VYKG          +EVA+K       E  +  F  E  I++ + H N+VK+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCM-YASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  CT      +V+EYMP G L D +       L +   L   + +A  +EYL    S  
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123

Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
            +H D+   N L+ +++V  +SDFG+++ L ++D  K       I ++APE  +EG+ + 
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183

Query: 845 KGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN 903
           K DV+++G++L E+FT G +P             +   S   V+  +          +  
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEP-------------YPGMSNAEVLEYLKKGYRLPKPPN-- 228

Query: 904 VAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                C   +  L ++C +E PE+R    E++  L
Sbjct: 229 -----CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  139 bits (353), Expect = 6e-37
 Identities = 75/277 (27%), Positives = 131/277 (47%), Gaps = 35/277 (12%)

Query: 672 IGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGA----LNSFDAECEILKTIRHRNL 722
           +G G++G VYKG           +VA+K     +EGA       F  E  I+K + H N+
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTL---KEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           V+++  CT      +V EYMP G L D +      L +   L + + +A  +EYL    S
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL---ES 120

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT-IGYIAPEYGREGQ 841
              VH D+   N L+ +++V  +SDFG+++ + E+D  ++       I ++APE  ++G+
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180

Query: 842 VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH 901
            + K DV+++G++L E+FT          GE       N+ +     + D   L      
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL---------GEQPYPGMSNEEVLE--LLEDGYRLP----- 224

Query: 902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                ++C   +  L ++C +  PE+R    E++  L
Sbjct: 225 ---RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  133 bits (338), Expect = 7e-35
 Identities = 79/287 (27%), Positives = 130/287 (45%), Gaps = 44/287 (15%)

Query: 670 NLIGIGSYGSVYKGRFPDG----IEVAIKVFHLQREGALNS----FDAECEILKTIRHRN 721
             +G G++G VYKG+         EVA+K     +E A       F  E  ++K + H N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT---LKEDASEEERKDFLKEARVMKKLGHPN 57

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLED------CMYASNF--NLDIFQRLGIMIDVASA 773
           +V+++  CT      LVLEYM  G L D       ++ S     L +   L   I +A  
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQTQTLATIGYI 832
           +EYL    S   VH D+   N L+ + +V  +SDFG+++ + ++D   K+T     I ++
Sbjct: 118 MEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
           APE  ++G  + K DV+++G++L E+FT G  P       E+ ++            +  
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-LEY-----------LRK 222

Query: 892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              L + E         C   +  L + C    PE+R    E++ RL
Sbjct: 223 GYRLPKPE--------YCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  131 bits (332), Expect = 4e-34
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 12/206 (5%)

Query: 670 NLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA--LNSFDAECEILKTIRHRNLVKII 726
            L+G GS+GSVY     D G  +A+K   L  +    L + + E  IL +++H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 727 SSCTN--HNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
            S  +   N   + LEY+  GSL   +         + ++      +   L YLH   SN
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY--TRQILEGLAYLH---SN 120

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPEYGREGQV 842
            IVH DIK +N+L+D   V  L+DFG AK L + ++ + T ++  T  ++APE  R  + 
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180

Query: 843 SIKGDVYNYGIMLMEVFTGMKPTNEF 868
               D+++ G  ++E+ TG  P +E 
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSEL 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  127 bits (322), Expect = 6e-33
 Identities = 69/192 (35%), Positives = 105/192 (54%), Gaps = 12/192 (6%)

Query: 671 LIGIGSYGSVYKGRFPDGIEVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKIISSC 729
            IG G +G V  G +  G +VA+K   L+ +  A  +F AE  ++ T+RH NLV+++   
Sbjct: 13  TIGKGEFGDVMLGDY-RGQKVAVKC--LKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIF-QRLGIMIDVASALEYLHFGHSNPIVHC 788
              N   +V EYM KGSL D + +    +    Q+LG  +DV   +EYL        VH 
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHR 126

Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D+   NVL+ + +VA +SDFG+AK    E S  Q      + + APE  RE + S K DV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182

Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+++
Sbjct: 183 WSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  124 bits (314), Expect = 7e-32
 Identities = 68/200 (34%), Positives = 100/200 (50%), Gaps = 6/200 (3%)

Query: 666 FSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           F     IG G +G VYK R    G EVAIKV  L+ +        E +ILK  +H N+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
              S    +   +V+E+   GSL+D + ++N  L   Q   +  ++   LEYLH   SN 
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNG 118

Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
           I+H DIK +N+LL       L DFG++  LS  D+  +   + T  ++APE         
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGKPYDY 176

Query: 845 KGDVYNYGIMLMEVFTGMKP 864
           K D+++ GI  +E+  G  P
Sbjct: 177 KADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 6e-28
 Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 8/198 (4%)

Query: 670 NLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKII 726
           +LIG G++G VYKG     G  VAIK   L++  E AL S   E ++LK ++H N+VK I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
            S    +   ++LEY   GSL        F    F    + + V   L+ L + H   ++
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQI--IKKFGP--FPESLVAVYVYQVLQGLAYLHEQGVI 121

Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H DIK +N+L     V  L+DFG+A  L++         + T  ++APE       S   
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDASVVGTPYWMAPEVIEMSGASTAS 180

Query: 847 DVYNYGIMLMEVFTGMKP 864
           D+++ G  ++E+ TG  P
Sbjct: 181 DIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  113 bits (284), Expect = 1e-27
 Identities = 78/296 (26%), Positives = 133/296 (44%), Gaps = 31/296 (10%)

Query: 666 FSEENL-----IGIGSYGSVYKGR--FPD---GIEVAIKVF-HLQREGALNSFDAECEIL 714
           F + +L     +G G +G V   R        G +VA+K   H   E   + F+ E EIL
Sbjct: 1   FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60

Query: 715 KTIRHRNLVKIISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           +T+ H N+VK    C     ++  L++EY+P GSL D +      +++ + L     +  
Sbjct: 61  RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICK 120

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL--ATIG 830
            ++YL    S   +H D+   N+L++   +  +SDFG+AK+L E+      +    + I 
Sbjct: 121 GMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNE---FFTGEMSIKRWINDSLPAVM 887
           + APE  R  + S   DV+++G+ L E+FT   P+      F   + I +         M
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ-------GQM 230

Query: 888 NIMD-TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR 942
            +     LL E E        SC   V  L   C    P++R +  ++I  + ++R
Sbjct: 231 IVTRLLELLKEGERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  112 bits (283), Expect = 1e-27
 Identities = 70/234 (29%), Positives = 106/234 (45%), Gaps = 31/234 (13%)

Query: 665 QFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHL------QREGALNSFDAECEILKTI 717
           ++     IG GS+G VY  R   DG    +K   L      +RE ALN    E +ILK +
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKL 56

Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIF---QRLGIMIDVASAL 774
            H N++K   S        +V+EY   G L   +         F   Q L   + +  AL
Sbjct: 57  NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           +YLH   S  I+H DIKP N+ L  + +  L DFGI+K+LS    + +T  + T  Y++P
Sbjct: 117 KYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSP 172

Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMN 888
           E  +    + K D+++ G +L E+ T   P    F G         ++L  +  
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEG---------ENLLELAL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  112 bits (282), Expect = 2e-27
 Identities = 69/280 (24%), Positives = 125/280 (44%), Gaps = 26/280 (9%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHR 720
           R  ++F+ E  +G G +G V++G + + + VAIK+           F  E + LK +RH+
Sbjct: 3   RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHF 779
           +L+ + + C+      ++ E M KGSL   + +     L +   + +   VA  + YL  
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL-- 120

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
                 +H D+   N+L+ + +V  ++DFG+A+L+ +ED    +       + APE    
Sbjct: 121 -EEQNSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASH 178

Query: 840 GQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED 898
           G  S K DV+++GI+L E+FT G  P       E+  +      +P              
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP-------------- 224

Query: 899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                     C   +  + +EC +  PE+R + K +   L
Sbjct: 225 ------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 2e-27
 Identities = 57/194 (29%), Positives = 105/194 (54%), Gaps = 13/194 (6%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +    +VA+K     + G +   +F  E +I+K +RH  LV++ + C
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASN---FNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
           +      +V EYM KGSL D  +  +     L + Q + +   +A  + YL    S   +
Sbjct: 71  SEEEPIYIVTEYMSKGSLLD--FLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H D+   N+L+ +++V  ++DFG+A+L+ +++   +      I + APE    G+ +IK 
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185

Query: 847 DVYNYGIMLMEVFT 860
           DV+++GI+L E+ T
Sbjct: 186 DVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  114 bits (286), Expect = 3e-27
 Identities = 85/288 (29%), Positives = 131/288 (45%), Gaps = 34/288 (11%)

Query: 671 LIGIGSYGSVYKGRFPDGIEVAIKVFHLQREG---ALNSFDAECEILKTIRH-RNLVKII 726
            +G GS+G VY  R  D   VA+KV   + E     +  F  E +IL ++ H  N+VK+ 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 727 SSCTNHNFKALVLEYMPKGSLED--CMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
               +     LV+EY+  GSLED          L   + L I+  + SALEYLH   S  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 785 IVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLA-----TIGYIAPEY-- 836
           I+H DIKP N+LLD D  V  L DFG+AKLL +  S      L      T GY+APE   
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 837 -GREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIKRWINDSLPAVMNIMDT 892
                  S   D+++ GI L E+ TG+ P            ++K  +    P++ + +  
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK 940
           +             +  + +   L  +  ++ P+NR+++   +S  + 
Sbjct: 242 SN-----------PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 5e-26
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 21/201 (10%)

Query: 671 LIGIGSYGSVYKGRFPDGIEVAIK-----VFHLQREGALNSFDAECEILKTIRHRNLVKI 725
            IG G++G VYKG      EVA+K     +    +      F  E EILK   H N+VK+
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR----KFLQEAEILKQYDHPNIVKL 57

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
           I  C       +V+E +P GSL   +      L + + L + +D A+ +EYL    S   
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNC 114

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAK-----LLSEEDSMKQTQTLATIGYIAPEYGREG 840
           +H D+   N L+ ++ V  +SDFG+++     + +  D +KQ      I + APE    G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI----PIKWTAPEALNYG 170

Query: 841 QVSIKGDVYNYGIMLMEVFTG 861
           + + + DV++YGI+L E F+ 
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  106 bits (267), Expect = 2e-25
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 34/209 (16%)

Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRNLVK----I 725
           +G GS G VYK R  P G   A+K  H+  +         E + L++     +VK     
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDVASALEY 776
                      +VLEYM  GSL D          + +++G         I   +   L+Y
Sbjct: 69  YKEGEIS----IVLEYMDGGSLAD----------LLKKVGKIPEPVLAYIARQILKGLDY 114

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPE 835
           LH      I+H DIKPSN+L++      ++DFGI+K+L  E+++ Q  T + T+ Y++PE
Sbjct: 115 LH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPE 170

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             +    S   D+++ G+ L+E   G  P
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  104 bits (261), Expect = 8e-25
 Identities = 71/205 (34%), Positives = 101/205 (49%), Gaps = 13/205 (6%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL 722
           + F     +G GSYGSVYK      G  VAIKV  +  E  L     E  ILK      +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYI 60

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           VK   S   +    +V+EY   GS+ D M  +N  L   +   I+      LEYLH   S
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---S 117

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPEYGRE 839
           N  +H DIK  N+LL++   A L+DFG++  L   D+M +  T+  IG   ++APE  +E
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTV--IGTPFWMAPEVIQE 173

Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKP 864
              + K D+++ GI  +E+  G  P
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  104 bits (261), Expect = 1e-24
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 11/197 (5%)

Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRNLVKIISSC 729
           +G G+ G V K    P G  +A+K   L+   A+      E +IL       +V    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 730 TNHNFKALVLEYMPKGSLEDCM--YASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
            N+   ++ +EYM  GSL+  +          I  +  I + V   L YLH  H   I+H
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK--IIH 124

Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGD 847
            D+KPSN+L++      L DFG++  L   +S+ +T    T  Y+APE  +    S+K D
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKTFV-GTSSYMAPERIQGNDYSVKSD 181

Query: 848 VYNYGIMLMEVFTGMKP 864
           +++ G+ L+E+ TG  P
Sbjct: 182 IWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 1e-24
 Identities = 74/274 (27%), Positives = 127/274 (46%), Gaps = 37/274 (13%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G++   I+VAIK+     EGA++   F  E +++  + H NLV++   C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      +V EYM  G L + +      L     L +  DV  A+EYL    SN  +H D
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125

Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ +  V  +SDFG+A+ + ++       T   + +  PE     + S K DV+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185

Query: 850 NYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQ-- 907
           ++G+++ EVF+          G+M  +R+ N               SE  E  +   +  
Sbjct: 186 SFGVLMWEVFSE---------GKMPYERFSN---------------SEVVESVSAGYRLY 221

Query: 908 ---SCASSVLSLAMECTSESPENRVNTKEIISRL 938
                 + V ++   C  E PE+R   K+++S+L
Sbjct: 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 2e-24
 Identities = 68/207 (32%), Positives = 96/207 (46%), Gaps = 17/207 (8%)

Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKV---FHLQREGALNSFDAECEILKTIRHRNLVKIIS 727
           +G GS+G V   R  D G   A+KV     + +   +     E  IL  I H  +VK+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
           +        LVLEY P G L   +     F+ +  +      ++  ALEYLH   S  I+
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YAAEIVLALEYLH---SLGII 115

Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPEYGREGQVSIK 845
           + D+KP N+LLD      L+DFG+AK LS E S  +T T   T  Y+APE          
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 846 GDVYNYGIMLMEVFTGMKPTNEFFTGE 872
            D ++ G++L E+ TG  P    F  E
Sbjct: 174 VDWWSLGVLLYEMLTGKPP----FYAE 196

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  104 bits (260), Expect = 2e-24
 Identities = 75/295 (25%), Positives = 123/295 (41%), Gaps = 57/295 (19%)

Query: 672 IGIGSYGSVYKGRFPDGIE------VAIKVFHLQREGALNS----FDAECEILKTIRHRN 721
           +G G++G V+ G             VA+K     +E A N     F+ E E+L   +H N
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL---KETASNDARKDFEREAELLTNFQHEN 69

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLE-------------DCMYASNFNLDIFQRLGIMI 768
           +VK    CT  +   +V EYM  G L                  +    L + Q L I +
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 769 DVASALEYL---HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQ 824
            +AS + YL   HF      VH D+   N L+   +V  + DFG+++ +   D  +    
Sbjct: 130 QIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGH 183

Query: 825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSL 883
           T+  I ++ PE     + + + DV+++G++L E+FT G +P             W   S 
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-------------WYGLSN 230

Query: 884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
             V+  +    L +          +C S V  + + C    P+ R+N K+I  RL
Sbjct: 231 EEVIECITQGRLLQRPR-------TCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  103 bits (258), Expect = 3e-24
 Identities = 81/306 (26%), Positives = 143/306 (46%), Gaps = 51/306 (16%)

Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRF--PDG----IEVAIKVFHLQREGAL-NSFDAE 710
           E+  +  +F EE  +G G++G VYKG    P+       VAIK      E  +   F  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 711 CEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL----------EDCMYASNFN--- 757
            E++  ++H N+V ++  CT      ++ EY+  G L           D    S      
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 758 --LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS 815
             LD    L I I +A+ +EYL    S+  VH D+   N L+ + +   +SDFG+++ + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 816 EEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEM 873
             D  + Q+++L  + ++ PE    G+ + + D++++G++L E+F+ G++P   F   E 
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE- 234

Query: 874 SIKRWINDSLPAVMNIMDT-NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTK 932
                       V+ ++ +  LL   E+        C + V +L +EC +E P  R   K
Sbjct: 235 ------------VIEMIRSRQLLPCPED--------CPARVYALMIECWNEIPARRPRFK 274

Query: 933 EIISRL 938
           +I +RL
Sbjct: 275 DIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  102 bits (257), Expect = 6e-24
 Identities = 66/199 (33%), Positives = 100/199 (50%), Gaps = 16/199 (8%)

Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIIS 727
           IG G+ G VYK      G EVAIK   L+   +E  +N    E  I+K  +H N+V    
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPNIVDYYD 82

Query: 728 S--CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
           S    +  +  +V+EYM  GSL D +  +   ++  Q   +  +V   LEYLH   S  +
Sbjct: 83  SYLVGDELW--VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNV 137

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIK 845
           +H DIK  N+LL       L+DFG A  L++E S + +  + T  ++APE  +      K
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-VGTPYWMAPEVIKRKDYGPK 196

Query: 846 GDVYNYGIMLMEVFTGMKP 864
            D+++ GIM +E+  G  P
Sbjct: 197 VDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  101 bits (255), Expect = 1e-23
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 37/237 (15%)

Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEIL-KTIR 718
           D F    +IG GS+ +V   +      E AIK+     L +E  +     E E+L +   
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 719 HRNLVKIISSCTNHNFKAL--VLEYMPKGSLEDCM-YASNFNLDIFQRLGIMIDVASALE 775
           H  ++K+    T  + + L  VLEY P G L   +    + +    +      ++  ALE
Sbjct: 61  HPGIIKLY--YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--YAAEILLALE 116

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG----- 830
           YLH   S  I+H D+KP N+LLD  M   ++DFG AK+L    S +  +  AT       
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 831 --------------YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFT 870
                         Y++PE   E       D++  G ++ ++ TG  P   +NE+ T
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 66/191 (34%), Positives = 103/191 (53%), Gaps = 12/191 (6%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN 731
           IG G +G V  G +  G +VA+K   ++ +    +F AE  ++  +RH NLV+++     
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 732 HNFKA-LVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 +V EYM KGSL D + +   + L     L   +DV  A+EYL    +N  VH D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127

Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   NVL+ +  VA +SDFG+ K   E  S + T  L  + + APE  RE + S K DV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLP-VKWTAPEALREKKFSTKSDVW 183

Query: 850 NYGIMLMEVFT 860
           ++GI+L E+++
Sbjct: 184 SFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 1e-23
 Identities = 56/192 (29%), Positives = 102/192 (53%), Gaps = 9/192 (4%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V++G + +   VA+K     + G ++   F AE +I+K +RH  L+++ + C
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
           T      +V E M  GSL + +       L + Q + +   VAS + YL    +   +H 
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127

Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D+   NVL+ ++ +  ++DFG+A+++ E+    +      I + APE     + SIK DV
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 188 WSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 99.6 bits (248), Expect = 3e-23
 Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 29/260 (11%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRNLVKIISSC 729
           IG G +G V+ G + +  +VAIK     REGA++   F  E +++  + H  LV++   C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T  +   LV E+M  G L D + A          LG+ +DV   + YL    S+ ++H D
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRD 125

Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ V  +SDFG+ + + ++     T T   + + +PE     + S K DV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185

Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
           ++G+++ EVF+ G  P       E      + +++ A   +    L              
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNSE------VVETINAGFRLYKPRL-------------- 225

Query: 909 CASSVLSLAMECTSESPENR 928
            + SV  L   C  E PE+R
Sbjct: 226 ASQSVYELMQHCWKERPEDR 245

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 98.1 bits (244), Expect = 1e-22
 Identities = 75/272 (27%), Positives = 117/272 (43%), Gaps = 29/272 (10%)

Query: 671 LIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN-SFDAECEILKTIRHRNLVKIISSC 729
           L+G G++G V+KG   D   VA+K         L   F +E  ILK   H N+VK+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      +V+E +P G     +      L   Q +   +D A+ + YL    S   +H D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRD 118

Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREGQVSIKGD 847
           +   N L+ ++ V  +SDFG+++   E+D +  +  L    I + APE    G+ S + D
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 848 VYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAK 906
           V++YGI+L E F+ G+ P                   P + N      + +    +    
Sbjct: 177 VWSYGILLWETFSLGVCP------------------YPGMTNQQAREQVEKGYRMS--CP 216

Query: 907 QSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           Q C   V  +   C    PENR    E+   L
Sbjct: 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 98.1 bits (244), Expect = 1e-22
 Identities = 62/195 (31%), Positives = 107/195 (54%), Gaps = 13/195 (6%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN 731
           IG G +G+V +G +  G +VA+K   ++ +    +F  E  ++  + H+NLV+++     
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKN--IKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL- 69

Query: 732 HNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
           HN   +V+E M KG+L + +       + + Q L   +DVA  +EYL    S  +VH D+
Sbjct: 70  HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
              N+L+ +  VA +SDFG+A++     SM    +   + + APE  +  + S K DV++
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWS 182

Query: 851 YGIMLMEVFT-GMKP 864
           YG++L EVF+ G  P
Sbjct: 183 YGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 96.8 bits (241), Expect = 3e-22
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 29/270 (10%)

Query: 669 ENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKII 726
           ++ +G G YG VY+G +    + VA+K   L+ +   +  F  E  ++K I+H NLV+++
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPI 785
             CT      ++ E+M  G+L D +   N   ++    L +   ++SA+EYL        
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIK 845
           +H D+   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185

Query: 846 GDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
            DV+ +G++L E+ T GM P             +    L  V  +++     E  E    
Sbjct: 186 SDVWAFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKGYRMERPE---- 228

Query: 905 AKQSCASSVLSLAMECTSESPENRVNTKEI 934
               C   V  L   C   +P +R +  EI
Sbjct: 229 ---GCPPKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 96.2 bits (239), Expect = 7e-22
 Identities = 71/287 (24%), Positives = 137/287 (47%), Gaps = 39/287 (13%)

Query: 667 SEENLIGIGSYGSVYKG--RFPDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRN 721
           +++ +IG G +G V++G  + P   EVA+ +  L+    E     F +E  I+    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           ++++    T      ++ EYM  G+L+  +   +     +Q +G++  +A+ ++YL    
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---S 124

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA----TIGYIAPEYG 837
               VH D+   N+L++ ++   +SDFG++++L  ED  + T T +     I + APE  
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDS--LPAVMNIMDTNL 894
              + +   DV+++GI++ EV + G +P  +    E  + + IND   LPA M+      
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKAINDGFRLPAPMD------ 234

Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                         C S+V  L ++C  +    R    +I++ L K+
Sbjct: 235 --------------CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 30/215 (13%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA----ECEILKTIRHRNLVKII 726
           IG G+YG VYK R    G  VA+K   ++ E     F      E ++L+ +RH N+V++ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 727 SSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
              T+    +  +V EYM    L   + +        Q    M  +   L+YLH   SN 
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNG 120

Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-------YG 837
           I+H DIK SN+L+++  V  L+DFG+A+  ++ +S   T  + T+ Y  PE       YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180

Query: 838 REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
            E  V    D+++ G +L E+F G KP    F G 
Sbjct: 181 PE--V----DMWSVGCILAELFLG-KP---IFQGS 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 15/209 (7%)

Query: 670 NLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKII 726
           N IG G++G VY     D  E+ A+K   +Q      +     E ++L+ ++H NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 727 SSCTNHNFKALVLEYMPKGSLED-CMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
               +     + +EY   G+LE+   +    +  + +   + +     L YLH   S+ I
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHGI 120

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPEYGREGQV 842
           VH DIKP+N+ LD + V  L DFG A  L    +    +  +  G   Y+APE    G+ 
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 843 SIKG---DVYNYGIMLMEVFTGMKPTNEF 868
              G   D+++ G +++E+ TG +P +E 
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSEL 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 7e-21
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 14/202 (6%)

Query: 672 IGIGSYGSVYKGRF-PDG----IEVAIKVFHLQREG--ALNSFDAECEILKTIRHRNLVK 724
           +G G++G+VYKG + P+G    I VAIKV   +     A      E  ++ ++ H ++V+
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           ++  C +     L+ + MP G L D +     N+     L   + +A  + YL       
Sbjct: 74  LLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--- 129

Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS-EEDSMKQTQTLATIGYIAPEYGREGQVS 843
           +VH D+   NVL+       ++DFG+AKLL  +E           I ++A E       +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189

Query: 844 IKGDVYNYGIMLMEVFT-GMKP 864
            K DV++YG+ + E+ T G KP
Sbjct: 190 HKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.5 bits (230), Expect = 2e-20
 Identities = 82/295 (27%), Positives = 139/295 (47%), Gaps = 56/295 (18%)

Query: 665 QFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHL----------QREGALNSFDAECEI 713
            +    LIG G+YG+VY+G+  P G  VA+K+ +L          QRE AL         
Sbjct: 2   LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVAL--------- 52

Query: 714 LKTIRH---RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG--IMI 768
           L  +R     N+ K   S        +++EY   GS+   M A      I ++    I+ 
Sbjct: 53  LSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP----IAEKYISVIIR 108

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           +V  AL+Y+H      ++H DIK +N+L+ ++    L DFG+A LL++  S + T    T
Sbjct: 109 EVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GT 164

Query: 829 IGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM 887
             ++APE   EG+    K D+++ GI + E+ TG  P ++             D+  A+M
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD------------VDAFRAMM 212

Query: 888 NIMDTNLLS-EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII-SRLIK 940
            I  +     ED  ++ + ++  A+        C  E P+ R++ +E++ S+ IK
Sbjct: 213 LIPKSKPPRLEDNGYSKLLREFVAA--------CLDEEPKERLSAEELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 91.7 bits (227), Expect = 2e-20
 Identities = 55/192 (28%), Positives = 105/192 (54%), Gaps = 10/192 (5%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-LHFGHSNPIVHC 788
           +      +V EYM KGSL D +         + RL  ++D+A+ +   + +      VH 
Sbjct: 71  SEEPI-YIVTEYMSKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126

Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 187 WSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 77/281 (27%), Positives = 117/281 (41%), Gaps = 45/281 (16%)

Query: 672 IGIGSYGSVYKG--RFPDG--IEVAIKVFHLQREGALNS-FDAECEILKTIRHRNLVKII 726
           +G G++GSV KG      G  +EVA+K    +   A    F  E  ++  + H  +V++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 727 SSCTNHNFKALVLEYMPKGSLED-CMYASNF-NLDIFQRLGIMIDVASALEYL---HFGH 781
             C       LV+E  P G L             D+     +   VA  + YL   HF  
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF-- 116

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGRE 839
               VH D+   NVLL +   A +SDFG+++ L       +  T     + + APE    
Sbjct: 117 ----VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 840 GQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL-LSE 897
           G+ S K DV++YG+ L E F+ G KP      GEM            V+ ++++   L  
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKP-----YGEM--------KGAEVIAMLESGERLPR 219

Query: 898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
            EE        C   + S+ + C    PE+R    E+ S  
Sbjct: 220 PEE--------CPQEIYSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 94.9 bits (236), Expect = 5e-20
 Identities = 57/160 (35%), Positives = 80/160 (50%), Gaps = 15/160 (9%)

Query: 477 LSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPA 536
           L    L G IP+ I  L++LQ ++L  N ++G IP S G + SLE LDLS N  +G IP 
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 537 SLEKLLYLKSLNLSFNKLVGEIPR--GGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPH 594
           SL +L  L+ LNL+ N L G +P   GG   + ++ +F  N  LCG P L        PH
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLR----ACGPH 540

Query: 595 KKSRKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRR 634
                +   +G+   +S  F+  VI      +     KRR
Sbjct: 541 LSVGAK---IGIAFGVSVAFLFLVI----CAMC--WWKRR 571

Length = 623

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 90.3 bits (224), Expect = 6e-20
 Identities = 66/267 (24%), Positives = 124/267 (46%), Gaps = 43/267 (16%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +    +VAIK     ++G+++  +F AE  ++K ++H  LV++ +  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
           T      ++ EYM  GSL D +       L I + + +   +A  + ++   +    +H 
Sbjct: 71  TQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHR 126

Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++   ++DFG+A+L+ + +   +      I + APE    G  +IK DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 849 YNYGIMLMEVFT-------GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH 901
           +++GI+L E+ T       GM  TN                 P V+     NL   +  +
Sbjct: 187 WSFGILLTEIVTYGRIPYPGM--TN-----------------PEVIQ----NL---ERGY 220

Query: 902 ANVAKQSCASSVLSLAMECTSESPENR 928
                 +C   +  L   C  E PE R
Sbjct: 221 RMPRPDNCPEELYELMRLCWKEKPEER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 7e-20
 Identities = 68/231 (29%), Positives = 102/231 (44%), Gaps = 31/231 (13%)

Query: 671 LIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRHRNLVKII 726
           ++G G+YG V K R    G  VAIK F  + E   +       E ++L+ +RH N+V + 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
            +        LV EY+ +  LE  + AS   L        +  +  A+ Y H   S+ I+
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNII 122

Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-------YGRE 839
           H DIKP N+L+ +S V  L DFG A+ L    +   T  +AT  Y APE       YG+ 
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182

Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM 890
                  DV+  G ++ E+  G       F G+  I     D L  +   +
Sbjct: 183 ------VDVWAIGCIMAELLDG----EPLFPGDSDI-----DQLYLIQKCL 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 89.7 bits (222), Expect = 9e-20
 Identities = 56/192 (29%), Positives = 104/192 (54%), Gaps = 10/192 (5%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +    +VA+K     + G ++  SF  E +I+K +RH  LV++ +  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 730 TNHNFKALVLEYMPKGSLEDCMY-ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
           +      +V EYM KGSL D +       L +   + +   VA+ + Y+   +    +H 
Sbjct: 71  SEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 126

Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ D +V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 187 WSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 57/177 (32%), Positives = 88/177 (49%), Gaps = 21/177 (11%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKII-- 726
           IG G++G V+K +    G  VA+K   L+R   G  N    E + L+  +H  +VK++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 727 ----SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
               S         LV+EYMP   L + +      L   Q    M  +   + Y+H   +
Sbjct: 68  FPHGSGF------VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---A 117

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE--YG 837
           N I+H D+KP+N+L+    V  ++DFG+A+L SEE+    +  +AT  Y APE  YG
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 53/192 (27%), Positives = 106/192 (55%), Gaps = 9/192 (4%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G + +  +VA+K     + G ++  +F  E  ++KT++H  LV++ +  
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL-EYLHFGHSNPIVHC 788
           T      ++ EYM KGSL D + +      +  +L   ID ++ + E + +      +H 
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHR 127

Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +NVL+ +S++  ++DFG+A+++ + +   +      I + APE    G  +IK DV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 188 WSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 30/279 (10%)

Query: 671 LIGIGSYGSVYKGRF----PDGIEVAIKVFHLQREGALNS-FDAECEILKTIRHRNLVKI 725
            IG G +G VY+G +     + I VA+K        ++   F  E  I++   H ++VK+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
           I   T  N   +V+E  P G L   +  + ++LD+   +     +++AL YL    S   
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRF 128

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIK 845
           VH DI   NVL+       L DFG+++ L +E   K ++    I ++APE     + +  
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA 188

Query: 846 GDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
            DV+ +G+ + E+   G+KP   F          + ++   +  I +   L         
Sbjct: 189 SDVWMFGVCMWEILMLGVKP---FQ--------GVKNN-DVIGRIENGERLPMPP----- 231

Query: 905 AKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
              +C  ++ SL  +C +  P  R    E+ ++L  I  
Sbjct: 232 ---NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 89.5 bits (223), Expect = 2e-19
 Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 24/181 (13%)

Query: 666 FSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHL--QREG----ALNSFDAECEILKTIR 718
           + +   +G G+YG VYK R    G  VA+K   L  + EG    AL     E  +LK ++
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56

Query: 719 HRNLVKIISSCTNHNFKALVLEYMP---KGSLEDCMYASNFNLDIFQRLGIMIDVASALE 775
           H N+VK++          LV EY     K  L+        + ++ +   IM  +   L 
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLD--KRPGPLSPNLIKS--IMYQLLRGLA 112

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ-TQTLATIGYIAP 834
           Y H   S+ I+H D+KP N+L++   V  L+DFG+A+       ++  T  + T+ Y AP
Sbjct: 113 YCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYTHEVVTLWYRAP 167

Query: 835 E 835
           E
Sbjct: 168 E 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 22/217 (10%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
            D+  E  ++G G+YG VY  R     + +AIK    +    +     E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-------- 773
           +V+ + S + + F  + +E +P GSL   + +         + G + D            
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRS---------KWGPLKDNEQTIIFYTKQI 117

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDD-SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYI 832
           LE L + H N IVH DIK  NVL++  S V  +SDFG +K L+  +   +T T  T+ Y+
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQYM 176

Query: 833 APEYGREGQ--VSIKGDVYNYGIMLMEVFTGMKPTNE 867
           APE   +G        D+++ G  ++E+ TG  P  E
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 31/215 (14%)

Query: 671 LIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREG-----ALNSFDAECEILKTIRHRNLVK 724
           L+G GS+GSVY+G    DG   A+K   L  +G     A+   + E  +L  ++H N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA---------SALE 775
            + +    +   + LE +P GSL            + ++ G   +             LE
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAK----------LLKKYGSFPEPVIRLYTRQILLGLE 116

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           YLH       VH DIK +N+L+D + V  L+DFG+AK + E    K  +   +  ++APE
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSPYWMAPE 171

Query: 836 Y-GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFF 869
              ++G   +  D+++ G  ++E+ TG  P ++  
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 71/282 (25%), Positives = 130/282 (46%), Gaps = 36/282 (12%)

Query: 669 ENLIGIGSYGSVYKGR----FPDGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLV 723
           E +IG G +G V +GR        I+VAIK       +     F  E  I+    H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++    T      ++ EYM  GSL+  +  ++    + Q +G++  +AS ++YL    S 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL----SE 124

Query: 784 -PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGREGQ 841
              VH D+   N+L++ ++V  +SDFG+++ L + ++   T+     I + APE     +
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184

Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDS--LPAVMNIMDTNLLSED 898
            +   DV+++GI++ EV + G +P  +  + +  IK  + D   LP  M+          
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPYWD-MSNQDVIKA-VEDGYRLPPPMD---------- 232

Query: 899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK 940
                     C S++  L ++C  +    R    +I+S L K
Sbjct: 233 ----------CPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 54/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +    +VAIK     + G +   +F  E +I+K +RH  LV + +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL-EYLHFGHSNPIVHC 788
           +      +V E+M KGSL D +   +     + +L  ++D+A+ + + + +      +H 
Sbjct: 71  SEEPI-YIVTEFMGKGSLLDFLKEGDGK---YLKLPQLVDMAAQIADGMAYIERMNYIHR 126

Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ D++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 187 WSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 28/214 (13%)

Query: 671 LIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA-----LNSFDAECEILKTIRHRNLVK 724
           L+G G++G VY     D G E+A+K      +       +N+ + E ++LK ++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSN 783
                 +    ++ +EYMP GS++D + A       + ++    I     LE + + HSN
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI-----LEGVEYLHSN 123

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPE----- 835
            IVH DIK +N+L D +    L DFG +K L +      T   +  G   +++PE     
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMKSVTGTPYWMSPEVISGE 182

Query: 836 -YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEF 868
            YGR      K DV++ G  ++E+ T   P  EF
Sbjct: 183 GYGR------KADVWSVGCTVVEMLTEKPPWAEF 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 89.9 bits (223), Expect = 3e-19
 Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 35/222 (15%)

Query: 661 RATDQFSE---ENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGAL-NSFDAECEILK 715
            A    SE    N IG G+ G+VYK    P G   A+KV +   E  +      E EIL+
Sbjct: 68  SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR 127

Query: 716 TIRHRNLVKIISSCTN---HNFK-ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA 771
            + H N+VK    C +   HN +  ++LE+M  GSLE    A    L    R      + 
Sbjct: 128 DVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-----QIL 178

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ-TQTLATIG 830
           S + YLH  H   IVH DIKPSN+L++ +    ++DFG++++L++  +M     ++ TI 
Sbjct: 179 SGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ--TMDPCNSSVGTIA 233

Query: 831 YIAPE-------YGR-EGQVSIKGDVYNYGIMLMEVFTGMKP 864
           Y++PE       +G  +G     GD+++ G+ ++E + G  P
Sbjct: 234 YMSPERINTDLNHGAYDGYA---GDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 14/208 (6%)

Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL 722
           + +     IG G+YG VYK R    G  VAIKV  L+          E  +LK  RH N+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           V    S    +   +V+EY   GSL+D    +   L   Q   +  +    L YLH    
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---E 119

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPEYG-- 837
              +H DIK +N+LL +     L+DFG++  L+   ++ + ++   IG   ++APE    
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA--TIAKRKSF--IGTPYWMAPEVAAV 175

Query: 838 -REGQVSIKGDVYNYGIMLMEVFTGMKP 864
            R+G    K D++  GI  +E+     P
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 87.9 bits (218), Expect = 6e-19
 Identities = 82/297 (27%), Positives = 132/297 (44%), Gaps = 33/297 (11%)

Query: 666 FSEENLI-----GIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAECEILK 715
           F E +L      G G++GSV   R+       G  VA+K         L  F+ E EILK
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60

Query: 716 TIRHRNLVKIISSCTN---HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           +++H N+VK    C +    N + LV+EY+P GSL D +      LD  + L     +  
Sbjct: 61  SLQHDNIVKYKGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL--SEEDSMKQTQTLATIG 830
            +EYL    S   VH D+   N+L++      + DFG+ K+L   +E    +    + I 
Sbjct: 120 GMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFT----GMKPTNEFFTGEMSIKRWINDSLPAV 886
           + APE   E + S+  DV+++G++L E+FT       P  EF        R + +     
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM-------RMMGNDKQGQ 229

Query: 887 MNIMD-TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR 942
           M +     LL  +      A   C + + ++  EC +  P  R +  E+  ++  IR
Sbjct: 230 MIVYHLIELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 86.9 bits (215), Expect = 7e-19
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 9/208 (4%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V  G++    +VAIK+    +EG++  + F  E +++  + H  LV++   C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      +V EYM  G L + +          Q L +  DV   + YL    S   +H D
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125

Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+DD     +SDFG+++ + +++      +   + +  PE     + S K DV+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185

Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIK 876
            +G+++ EV++ G  P   F   E   K
Sbjct: 186 AFGVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 87.3 bits (217), Expect = 7e-19
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 35/217 (16%)

Query: 672 IGIGSYGSVY---KGRFPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRHRNLVKI 725
           I  G+YG V+   K    D    AIKV     + R+  ++    E +IL   +   +VK+
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNP 784
             S        LV+EY+P G L   +   N   LD       + ++  ALEYLH   SN 
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLALEYLH---SNG 113

Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ-------TQTLATIGYIAPEYG 837
           I+H D+KP N+L+D +    L+DFG++K+      +          + + T  YIAPE  
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE-- 171

Query: 838 REGQVSIKGDVYNY-------GIMLMEVFTGMKPTNE 867
                 I G  ++        G +L E   G+ P + 
Sbjct: 172 -----VILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 87.5 bits (217), Expect = 8e-19
 Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 25/215 (11%)

Query: 671 LIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS 727
           L+G GSYG V K +  + G  VAIK F    +  +    A  E  +LK +RH NLV +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
                    LV E++    L+D     N  LD  +    +  +   +E+ H   S+ I+H
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIH 123

Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-------YGREG 840
            DIKP N+L+  S V  L DFG A+ L+    +  T  +AT  Y APE       YGR  
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRWYRAPELLVGDTKYGR-- 180

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI 875
                 D++  G ++ E+ TG       F G+  I
Sbjct: 181 ----AVDIWAVGCLVTEMLTG----EPLFPGDSDI 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 24/214 (11%)

Query: 665 QFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHL------QREGALNSFDAECEILKTI 717
            F     +G GSYGSVYK  R  D    A+K   L      +RE A+N    E  IL ++
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN----EIRILASV 56

Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-----EDCMYASNFNLDIFQRLGIMIDVAS 772
            H N++    +  + N   +V+EY P G L     +              R  I I +  
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--IFIQLLR 114

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYI 832
            L+ LH      I+H D+K +N+LL  + +  + D GI+K+L +  +M +TQ   T  Y+
Sbjct: 115 GLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK--NMAKTQI-GTPHYM 168

Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTN 866
           APE  +    S K D+++ G +L E+ T   P  
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 87.3 bits (216), Expect = 1e-18
 Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 7/194 (3%)

Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG G+ G+VY       G EVAIK  +LQ++        E  +++  +H N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   +V+EY+  GSL D +  +   +D  Q   +  +   ALE+LH   SN ++H DI
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141

Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  N+LL       L+DFG    ++ E S K++  + T  ++APE         K D+++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200

Query: 851 YGIMLMEVFTGMKP 864
            GIM +E+  G  P
Sbjct: 201 LGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 13/210 (6%)

Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGA-LNSFDAECEILKTIRHRN 721
           D +    +IG+G+   VY     P+  +VAIK   L++    ++    E + +    H N
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGI---MIDVASALEYLH 778
           +VK  +S    +   LV+ Y+  GSL D M  S++         I   + +V   LEYLH
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIM-KSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE--EDSMKQTQTLA-TIGYIAPE 835
              SN  +H DIK  N+LL +     ++DFG++  L++  + + K  +T   T  ++APE
Sbjct: 120 ---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFTGMKP 864
              +      K D++++GI  +E+ TG  P
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 10/202 (4%)

Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G++G VYK +  + G+  A K+  ++ E  L  F  E +IL   +H N+V +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             N   +++E+   G+L+  M      L   Q   +   +  AL +LH   S+ ++H D+
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY-----GREGQVSIK 845
           K  N+LL       L+DFG++         + T  + T  ++APE       ++     K
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPYDYK 188

Query: 846 GDVYNYGIMLMEVFTGMKPTNE 867
            D+++ GI L+E+     P +E
Sbjct: 189 ADIWSLGITLIELAQMEPPHHE 210

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 85.7 bits (212), Expect = 3e-18
 Identities = 72/282 (25%), Positives = 132/282 (46%), Gaps = 33/282 (11%)

Query: 669 ENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLV 723
           E +IG G +G V  GR   P   E+ + +  L+    E     F +E  I+    H N++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH-FGHS 782
            +    T      +V EYM  GSL+  +   +    + Q +G++  +AS ++YL   G+ 
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY- 127

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG--YIAPEYGREG 840
              VH D+   N+L++ ++V  +SDFG++++L ++     T     I   + APE     
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184

Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
           + +   DV++YGI++ EV + G +P       EMS +    D + A+           +E
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP-----YWEMSNQ----DVIKAI-----------EE 224

Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            +   A   C +++  L ++C  +    R   ++I+S L K+
Sbjct: 225 GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 28/213 (13%)

Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQ---REGALNSFDAECEILKTIRHR 720
            F    +IG G++G V   +  D  ++ A+K  + Q    +G++ +   E  IL+ + H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDVA 771
            LV +  S  +     LV++ +  G L        ++L    +            + ++ 
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLR-------YHL---SQKVKFSEEQVKFWICEIV 110

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY 831
            ALEYLH   S  I+H DIKP N+LLD+    H++DF IA  ++       T T  T GY
Sbjct: 111 LALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTSGTPGY 165

Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           +APE       S+  D ++ G+   E   G +P
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 85.3 bits (211), Expect = 3e-18
 Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 23/211 (10%)

Query: 671 LIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGA---------LNSFDAECEILKTIRHR 720
           LIG GS+GSVY G     G  +A+K   L    A         L++   E  +LK ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDC--MYASNFNLDIFQRLGIMIDVASALEYLH 778
           N+V+ + S  + +   + LEY+P GS+      Y +      F+   +   V   L+ L+
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA------FEETLVRNFVRQILKGLN 120

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-----LLSEEDSMKQTQTLATIGYIA 833
           + H+  I+H DIK +N+L+D+     +SDFGI+K      LS + +  +     ++ ++A
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           PE  ++   + K D+++ G +++E+ TG  P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 66/270 (24%), Positives = 116/270 (42%), Gaps = 27/270 (10%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G++   I+VAIK      EGA+    F  E +++  + H  LV++   C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      +V E+M  G L + +      L     L +  DV   +EYL     N  +H D
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRD 125

Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+  + V  +SDFG+ + + +++    +     + +  PE     + S K DV+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185

Query: 850 NYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSC 909
           ++G+++ EVFT          G+M  ++  N     V  I     L           +  
Sbjct: 186 SFGVLMWEVFT---------EGKMPFEKKSN--YEVVEMISRGFRLYR--------PKLA 226

Query: 910 ASSVLSLAMECTSESPENRVNTKEIISRLI 939
           + +V  +   C  E PE R    E++  + 
Sbjct: 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 69/264 (26%), Positives = 129/264 (48%), Gaps = 31/264 (11%)

Query: 669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKII 726
           E  +G G +G V+   +    +VA+K     + G+++  +F AE  ++KT++H  LVK+ 
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLH 67

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL-EYLHFGHSNPI 785
           +  T      ++ E+M KGSL D + +   +    Q L  +ID ++ + E + F      
Sbjct: 68  AVVTKEPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNY 123

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIK 845
           +H D++ +N+L+  S+V  ++DFG+A+++ + +   +      I + APE    G  +IK
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183

Query: 846 GDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
            DV+++GI+LME+ T G  P    + G  +         P V+  ++        E    
Sbjct: 184 SDVWSFGILLMEIVTYGRIP----YPGMSN---------PEVIRALERGYRMPRPE---- 226

Query: 905 AKQSCASSVLSLAMECTSESPENR 928
              +C   + ++ M C    PE R
Sbjct: 227 ---NCPEELYNIMMRCWKNRPEER 247

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 85.6 bits (212), Expect = 5e-18
 Identities = 74/218 (33%), Positives = 110/218 (50%), Gaps = 26/218 (11%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHL--QREGALNSFDAECEILKTI 717
           R  D+F     IG G+YG VYK R  D G  VA+K   L  ++EG   +   E +IL+ +
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63

Query: 718 RHRNLVKIISSCTNH----NFKA------LVLEYMPK---GSLEDCMYASNFNLDIFQRL 764
            HRN+V +    T+     +FK       LV EYM     G LE  +   +F+ D  +  
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV--HFSEDHIKSF 121

Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ 824
                +   LE L++ H    +H DIK SN+LL++     L+DFG+A+L + E+S   T 
Sbjct: 122 -----MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176

Query: 825 TLATIGYIAPE--YGREGQVSIKGDVYNYGIMLMEVFT 860
            + T+ Y  PE   G E +     DV++ G +L E+FT
Sbjct: 177 KVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 85.1 bits (210), Expect = 6e-18
 Identities = 83/312 (26%), Positives = 138/312 (44%), Gaps = 63/312 (20%)

Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGR-FPDGIE----VAIKVFH-LQREGALNSFDAEC 711
           EL  +  +F EE  +G  ++G +YKG  +  G++    VAIK    +        F  E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 712 EILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL------------------EDCMYA 753
            ++  + H N+V ++   T      ++ EY+ +G L                  ED    
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 754 SNFNLDIFQRLGIMIDVASALEYL--HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA 811
           S+ +   F  L I I +A+ +EYL  HF      VH D+   N+L+ + +   +SD G++
Sbjct: 119 SSLDHGDF--LHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLS 171

Query: 812 KLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFF 869
           + +   D  + Q ++L  I ++ PE    G+ S   D++++G++L E+F+ G++P   F 
Sbjct: 172 REIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231

Query: 870 TG---EMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPE 926
                EM  KR +   LP           SED          C   + SL  EC  E P 
Sbjct: 232 NQEVIEMVRKRQL---LPC----------SED----------CPPRMYSLMTECWQEGPS 268

Query: 927 NRVNTKEIISRL 938
            R   K+I +RL
Sbjct: 269 RRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 84.6 bits (210), Expect = 6e-18
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 23/209 (11%)

Query: 672 IGIGSYGSVYK-GRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG GS+G+V K  R  DG  +  K        E       +E  IL+ ++H N+V+    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 729 CTNHNFKAL--VLEYMPKGSL---------EDCMYASNFNLDIFQRLGIMIDVASALEYL 777
             + + + L  V+EY   G L         E       F   I  +L        AL   
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL------LLALYEC 121

Query: 778 HFGH--SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           H      N ++H D+KP+N+ LD +    L DFG+AK+L  + S  +T  + T  Y++PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSPE 180

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
                    K D+++ G ++ E+     P
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 83.7 bits (207), Expect = 9e-18
 Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 20/209 (9%)

Query: 666 FSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQ------REGALNSFDAECEILKTIR 718
           F   N IG GS+G V+K  R  D    A+K   L       RE A++    E  +L  + 
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID----EARVLAKLD 57

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALE 775
              +++   S  +     +V+EY   G L   +          D   R  I I +     
Sbjct: 58  SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG---- 113

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L   HS  I+H DIK  N+ LD      + D G+AKLLS+  +   T  + T  Y++PE
Sbjct: 114 -LAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPE 171

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
              +   + K DV+  G++L E  TG  P
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 87.6 bits (217), Expect = 1e-17
 Identities = 44/123 (35%), Positives = 65/123 (52%), Gaps = 4/123 (3%)

Query: 23  WMGITCDVYGNR----VTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIG 78
           W G  C     +    +  L + + GL G IP+ +  L  LQ++ LS N   G IP  +G
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463

Query: 79  NLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFS 138
           ++T L+ L L YN   G IPE LG L  L +L LN N L+G +PA++        + +F+
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT 523

Query: 139 DNS 141
           DN+
Sbjct: 524 DNA 526

Length = 623

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 84.3 bits (208), Expect = 1e-17
 Identities = 71/292 (24%), Positives = 124/292 (42%), Gaps = 51/292 (17%)

Query: 672 IGIGSYGSVYKGR----FP--DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI 725
           +G G++G V+        P  D + VA+K      E A   F  E E+L  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIF--------------QRLGIMIDVA 771
              CT      +V EYM  G L   + +   +  I               Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 772 SALEY---LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLA 827
           S + Y   LHF      VH D+   N L+   +V  + DFG+++ +   D  +   +T+ 
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAV 886
            I ++ PE     + + + D++++G++L E+FT G +P             W   S    
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-------------WYQLS---- 229

Query: 887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
            N      +++  E      ++C   V ++   C    P+ R+  K+I SRL
Sbjct: 230 -NTEAIECITQGRELER--PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 31/214 (14%)

Query: 670 NLIGIGSYGSVYKGRFPDGIEVAIK--VFH----LQREGALNSFDAECEILKTIRHRNLV 723
            ++G G+YG+VY G    G  +A+K         L  E        E ++LK+++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA------SALEYL 777
           + + +C + N  ++ +E++P GS+            I  R G + +          L+ +
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSIS----------SILNRFGPLPEPVFCKYTKQILDGV 115

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-------SEEDSMKQTQTLATIG 830
            + H+N +VH DIK +NV+L  + +  L DFG A+ L       +  + +K      T  
Sbjct: 116 AYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH--GTPY 173

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           ++APE   E     K D+++ G  + E+ TG  P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 83.7 bits (207), Expect = 2e-17
 Identities = 63/294 (21%), Positives = 122/294 (41%), Gaps = 43/294 (14%)

Query: 666 FSEENL-----IGIGSYGSVYKGRFPDGIE-------VAIKVF-HLQREGALNSFDAECE 712
           F   NL     +G G +G V+  +   GIE       V +K     + E   + F  E +
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAK-GIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60

Query: 713 ILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNF--------NLDIFQRL 764
           + + + H+N+V+++  C       ++LEY   G L+  + A+           L   Q++
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120

Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ 824
            +   +A  +++L        VH D+   N L+       +S   ++K +   +  K   
Sbjct: 121 ALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177

Query: 825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP 884
            L  + ++APE  +E   S K DV+++G+++ EVFT          GE+      ++ + 
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------QGELPFYGLSDEEVL 228

Query: 885 AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
             +      L   +          C S +  L   C + +P++R +  E++S L
Sbjct: 229 NRLQAGKLELPVPE---------GCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 79/309 (25%), Positives = 135/309 (43%), Gaps = 57/309 (18%)

Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQREGAL-NSFDAE 710
           E+  +T +F EE  +G   +G VYKG             VAIK    + EG L   F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 711 CEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR------- 763
             +   ++H N+V ++   T     +++  Y     L + +   + + D+          
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 764 --------LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS 815
                   + I+  +A+ +E+L   H   +VH D+   NVL+ D +   +SD G+ + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 816 EEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFF 869
             D  K    +L  I +++PE    G+ SI  D+++YG++L EVF+ G++P    +N+  
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235

Query: 870 TGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRV 929
             EM   R +              L   D+         C + V +L +EC +E P  R 
Sbjct: 236 I-EMIRNRQV--------------LPCPDD---------CPAWVYTLMLECWNEFPSRRP 271

Query: 930 NTKEIISRL 938
             K+I SRL
Sbjct: 272 RFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 68/274 (24%), Positives = 121/274 (44%), Gaps = 32/274 (11%)

Query: 672 IGIGSYGS--VYKGRFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS 727
           +G G++G   +Y+ R  D   V  K  +L R       DA  E  IL  ++H N++   +
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNL-DIFQRLGIMIDVASALEYLHFGHSNPIV 786
              + N   + +EY   G+L D +      L +    L  +  + SA+ Y+H      I+
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H DIK  N+ L  + +  L DFGI+K+L  E SM +T  + T  Y++PE  +  + + K 
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNFKS 182

Query: 847 DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMN-IMDTNLLSEDEEHANVA 905
           D++  G +L E+ T +K T +              +   ++  I+  N       +    
Sbjct: 183 DIWALGCVLYELLT-LKRTFD------------ATNPLNLVVKIVQGNYTPVVSVY---- 225

Query: 906 KQSCASSVLSLAMECTSESPENRVNTKEIISRLI 939
               +S ++SL      + PE R    E++ + +
Sbjct: 226 ----SSELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 68/274 (24%), Positives = 121/274 (44%), Gaps = 31/274 (11%)

Query: 672 IGIGSYGSVYKGRF---PDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRNLVKIIS 727
           +G G++G V KG +      I+VAIKV   + E ++ +    E EI+  + +  +V++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
            C       LV+E    G L   +      + +   + +M  V+  ++YL        VH
Sbjct: 63  VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118

Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREGQVSIK 845
            D+   NVLL +   A +SDFG++K L  +DS  + ++     + + APE     + S +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178

Query: 846 GDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
            DV++YGI + E F+ G KP  +                P VM+ ++     +       
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKM-------------KGPEVMSFIEQGKRLD------- 218

Query: 905 AKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
               C   + +L  +C     E+R N  ++  R+
Sbjct: 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERM 252

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 18/198 (9%)

Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNS-FDAECEILKTIRHRNLVKIISSC 729
           IG G++G V+ GR   D   VA+K         L + F  E  ILK   H N+V++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      +V+E +  G     +      L + + + ++ + A+ +EYL   H    +H D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---IHRD 119

Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEED-------SMKQTQTLATIGYIAPEYGREGQV 842
           +   N L+ +  V  +SDFG+++   EED        MKQ      + + APE    G+ 
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQI----PVKWTAPEALNYGRY 173

Query: 843 SIKGDVYNYGIMLMEVFT 860
           S + DV+++GI+L E F+
Sbjct: 174 SSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL 722
           + F+    IG GS+G VYK         VAIKV  L+        +AE EI    +    
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE--------EAEDEIEDIQQE--- 49

Query: 723 VKIISSC-----TN------HNFK-ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDV 770
           ++ +S C     T          K  +++EY   GS  D +     +        I+ +V
Sbjct: 50  IQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF--ILREV 107

Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG 830
              LEYLH       +H DIK +N+LL +     L+DFG++  L+   S + T  + T  
Sbjct: 108 LLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPF 163

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           ++APE  ++     K D+++ GI  +E+  G  P
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 82.7 bits (204), Expect = 4e-17
 Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 46/286 (16%)

Query: 672 IGIGSYGSVYKGR------FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI 725
           +G G++G V+           D + VA+K        A   F  E E+L  ++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYA---------------SNFNLDIFQRLGIMIDV 770
              C + +   +V EYM  G L   + A               +   L + Q L I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATI 829
           AS + YL   H    VH D+   N L+  +++  + DFG+++ +   D  +    T+  I
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMN 888
            ++ PE     + + + DV+++G++L E+FT G +P             W   S   V+ 
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-------------WFQLSNTEVIE 236

Query: 889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
            +    + E         + C   V  + + C    P+ R+N KEI
Sbjct: 237 CITQGRVLE-------RPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 81.8 bits (202), Expect = 5e-17
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 15/207 (7%)

Query: 669 ENLIGIGSYGSVYKGRF-PDG---IEVAIKVFHL-QREGALNSFDAECEILKTIRHRNLV 723
           E +IG G +G V +GR    G   I VAIK       E     F +E  I+    H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
            +    T      ++ E+M  G+L+  +  ++    + Q +G++  +A+ ++YL      
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EM 125

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYI-----APEYGR 838
             VH D+   N+L++ ++V  +SDFG+++ L E+D+   T T +  G I     APE   
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFL-EDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 839 EGQVSIKGDVYNYGIMLMEVFT-GMKP 864
             + +   DV++YGI++ EV + G +P
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 54/212 (25%), Positives = 104/212 (49%), Gaps = 25/212 (11%)

Query: 669 ENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNS---FDAECEIL-KTIRHRNLV 723
           E++IG G++G V +     DG+++   +  L+   + N    F  E E+L K   H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---------------NLDIFQRLGIMI 768
            ++ +C N  +  + +EY P G+L D +  S                  L   Q L    
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           DVA+ ++YL        +H D+   NVL+ +++ + ++DFG+++   EE  +K+T     
Sbjct: 127 DVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLP 181

Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
           + ++A E       + K DV+++G++L E+ +
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 15/212 (7%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIISS 728
           IG G+YG VYK R    G  VAIK   L+ E       A  E ++LK + H N++K++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
             +     LV E+M    L   +      L        +  +   L + H   S+ I+H 
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122

Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE--YGREGQVSIKG 846
           D+KP N+L++   V  L+DFG+A+          T  + T  Y APE   G +   S   
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVVTRWYRAPELLLG-DKGYSTPV 180

Query: 847 DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
           D+++ G +  E+ +  +P    F G+  I + 
Sbjct: 181 DIWSVGCIFAELLSR-RP---LFPGKSEIDQL 208

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 23/208 (11%)

Query: 671 LIGIGSYGSVYKGRF--PDG--IEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLV 723
            +G GS+G V +G +    G  I VA+K   L+ +     ++ F  E  I+ ++ H NL+
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKC--LKSDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID----VASALEYLHF 779
           ++      H    +V E  P GSL D +      L  F  +  + D    +A+ + YL  
Sbjct: 60  RLYGVVLTHPLM-MVTELAPLGSLLDRLRKDA--LGHFL-ISTLCDYAVQIANGMRYLE- 114

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM--KQTQTLATIGYIAPEYG 837
             S   +H D+   N+LL       + DFG+ + L + +     +        + APE  
Sbjct: 115 --SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172

Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           R    S   DV+ +G+ L E+FT G +P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 67/290 (23%), Positives = 120/290 (41%), Gaps = 51/290 (17%)

Query: 672 IGIGSYGSVYKG---RFPDG---IEVAIK-VFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +G GS+G VY+G       G     VAIK V           F  E  ++K     ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYA------SNFNLDIFQRLGIM---IDVASALE 775
           ++   +      +V+E M KG L+  + +      +N  L        +    ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAP 834
           YL    +   VH D+   N ++ + +   + DFG+ + + E D   K  + L  + ++AP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMSIKRWINDSLPAVMN- 888
           E  ++G  + K DV+++G++L E+ T   +P    +NE                  V+  
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-----------------EVLKF 233

Query: 889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           ++D   L   E         C   +L L   C   +P+ R    EI+S L
Sbjct: 234 VIDGGHLDLPEN--------CPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 15/199 (7%)

Query: 672 IGIGSYGSVYKGRFP---DGIEVAIKVFHLQREGAL---NSFDAECEILKTIRHRNLVKI 725
           +G G +G V    +    DG    + V  L+RE      + +  E  ILKT+ H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 726 ISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
              C+    K   L++EY+P GSL D  Y     L++ Q L     +   + YLH  H  
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRD--YLPKHKLNLAQLLLFAQQICEGMAYLHSQH-- 127

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--LATIGYIAPEYGREGQ 841
             +H D+   NVLLD+  +  + DFG+AK + E     + +    + + + A E  +E +
Sbjct: 128 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186

Query: 842 VSIKGDVYNYGIMLMEVFT 860
            S   DV+++G+ L E+ T
Sbjct: 187 FSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 26/222 (11%)

Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVF---HLQREGALNSFDAECEILKTIRHRNLVKIIS 727
           +G+G +G V   +        A+K     H+   G      +E EIL+   H  +VK+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 728 SCTNHNFKALVLEYMPKGSLEDCMY-ASNFNLDIFQ-RLGIMIDVASALEYLHFGHSNPI 785
           +  +  +  +++EY   G L   +     F+    +  +  ++    A EYLH   +  I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLH---NRGI 114

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGREGQVSI 844
           ++ D+KP N+LLD +    L DFG AK L    S ++T T   T  Y+APE      +  
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLK---SGQKTWTFCGTPEYVAPE-----IILN 166

Query: 845 KG-----DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND 881
           KG     D ++ GI+L E+ TG  P  E     M I   I  
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK 208

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 28/227 (12%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVA---IKVFHLQREGALNSFDAECEILKTIR 718
              F  E  IG G +  VYK     DG  VA   +++F +    A      E ++LK + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID--------- 769
           H N++K ++S   +N   +VLE    G L          +  F++   +I          
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRM-------IKHFKKQKRLIPERTIWKYFV 113

Query: 770 -VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
            + SALE++H   S  I+H DIKP+NV +  + V  L D G+ +  S + +      + T
Sbjct: 114 QLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLVGT 169

Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI 875
             Y++PE   E   + K D+++ G +L E+     P   F+  +M++
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 22/210 (10%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHL----------QREGALNSFDAECEILKTIRH 719
           LIG G+YG VY        E+ A+K   L          +++  + +  +E E LK + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDC--MYASNFNLDIFQRLGIMIDVASALEYL 777
            N+V+ +   T   + ++ LEY+P GS+  C   Y   F   + +       V   L YL
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-FEEQLVRFF--TEQVLEGLAYL 124

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPE- 835
           H   S  I+H D+K  N+L+D   +  +SDFGI+K   +     Q  ++  ++ ++APE 
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 836 -YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            +      S K D+++ G +++E+F G +P
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.8 bits (196), Expect = 4e-16
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 7/201 (3%)

Query: 665 QFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLV 723
           +++    IG G+ G+V+       G EVAIK  +LQ++        E  ++K +++ N+V
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
             + S    +   +V+EY+  GSL D +  +   +D  Q   +  +   ALE+LH   +N
Sbjct: 80  NFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLH---AN 134

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
            ++H DIK  NVLL       L+DFG    ++ E S K++  + T  ++APE        
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYG 193

Query: 844 IKGDVYNYGIMLMEVFTGMKP 864
            K D+++ GIM +E+  G  P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 79.3 bits (195), Expect = 5e-16
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)

Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G++G VYK +  + G   A KV   + E  L  +  E EIL T  H  +VK++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
                 +++E+ P G+++  M   +  L       I +     LE L + HS  I+H D+
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 791 KPSNVLLDDSMVAHLSDFGIA----KLLSEEDSMKQTQTLATIGYIAPEY-----GREGQ 841
           K  NVLL       L+DFG++    K L   DS      + T  ++APE       ++  
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF-----IGTPYWMAPEVVMCETMKDTP 191

Query: 842 VSIKGDVYNYGIMLMEVFTGMKPTNEF 868
              K D+++ GI L+E+     P +E 
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 79.3 bits (195), Expect = 5e-16
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 18/209 (8%)

Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE------VAIKVFHLQR-EGALNSFDAECEILKTIR 718
           F++   IG GS+G V+KG     I+      VAIK+  L+  E  +     E  +L    
Sbjct: 6   FTKLERIGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
              + K   S        +++EY+  GS  D + A  F  D FQ   ++ ++   L+YLH
Sbjct: 61  SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH 118

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR 838
              S   +H DIK +NVLL +     L+DFG+A  L++   +K+   + T  ++APE  +
Sbjct: 119 ---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-QIKRNTFVGTPFWMAPEVIQ 174

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKPTNE 867
           +     K D+++ GI  +E+  G  P ++
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSD 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 78.7 bits (194), Expect = 5e-16
 Identities = 65/233 (27%), Positives = 106/233 (45%), Gaps = 38/233 (16%)

Query: 671 LIGIGSYGSVYK-GRFPDGIEVAIKVF--HLQREGALNSFDAECEILKTIRHRNLVKIIS 727
           ++G G++G V+   R  D   V IK        +    +   EC++LK + H N+++   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-------LHFG 780
           +        +V+EY P G+L +          I +R   ++D  + L +       LH  
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEY---------IQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 781 HSNPIVHCDIKPSNVLLDD-SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
           H+  I+H D+K  N+LLD   MV  + DFGI+K+LS +   K    + T  YI+PE    
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEG 175

Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN-DSLPA-VMNIM 890
              + K D++  G +L E+               S+KR     +LPA V+ IM
Sbjct: 176 KPYNQKSDIWALGCVLYEL--------------ASLKRAFEAANLPALVLKIM 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 78.3 bits (193), Expect = 8e-16
 Identities = 71/294 (24%), Positives = 121/294 (41%), Gaps = 50/294 (17%)

Query: 671 LIGIGSYGSVYKGRF--PDG--IEVAIKVF----HLQREGALNSFDAECEILKTIRHRNL 722
           ++G G +GSV +G+    DG  ++VA+K      H   E  +  F +E   +K   H N+
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE--IEEFLSEAACMKDFDHPNV 63

Query: 723 VKIISSCTNHNFKA------LVLEYMPKGSLEDCMYASN-----FNLDIFQRLGIMIDVA 771
           +K+I  C   +         ++L +M  G L   +  S        L +   L  M+D+A
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIG 830
             +EYL    +   +H D+   N +L + M   ++DFG++K +   D  +Q +     + 
Sbjct: 124 LGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNI 889
           +IA E   +   + K DV+ +G+ + E+ T G  P                   P V N 
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP------------------YPGVENH 222

Query: 890 MDTNLLSEDEEHANVAKQ--SCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
              + L     H N  KQ   C   +  L   C    P++R    ++   L  I
Sbjct: 223 EIYDYL----RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 79.0 bits (194), Expect = 8e-16
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 7/194 (3%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG G+ G+VY       G EVAI+  +LQ++        E  +++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   +V+EY+  GSL D +  +   +D  Q   +  +   ALE+LH   SN ++H DI
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142

Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  N+LL       L+DFG    ++ E S K++  + T  ++APE         K D+++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201

Query: 851 YGIMLMEVFTGMKP 864
            GIM +E+  G  P
Sbjct: 202 LGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 14/217 (6%)

Query: 666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIK---VFHLQREGALNSFDAECEILKTIRHRN 721
           F  E  IG G +  VY+     DG+ VA+K   +F L    A      E ++LK + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGI---MIDVASALEYLH 778
           ++K  +S    N   +VLE    G L   +        +     +    + + SALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR 838
              S  ++H DIKP+NV +  + V  L D G+ +  S + +   +  + T  Y++PE   
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIH 179

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI 875
           E   + K D+++ G +L E+     P   F+  +M++
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 77.1 bits (189), Expect = 3e-15
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 7/194 (3%)

Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG G+ G+VY       G EVAIK  +LQ++        E  +++  ++ N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   +V+EY+  GSL D +  +   +D  Q   +  +   AL++LH   SN ++H DI
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141

Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  N+LL       L+DFG    ++ E S K++  + T  ++APE         K D+++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200

Query: 851 YGIMLMEVFTGMKP 864
            GIM +E+  G  P
Sbjct: 201 LGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 76.5 bits (189), Expect = 4e-15
 Identities = 56/184 (30%), Positives = 86/184 (46%), Gaps = 22/184 (11%)

Query: 666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIK--VFHLQREGALNSFDAECEILKTIR---H 719
           + E   IG G+YG+VYK R    G  VA+K     L  EG   S   E  +LK +    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 720 RNLVKIISSCTNHNFK-----ALVLEYMPK---GSLEDCMYASNFNLDIFQRLGIMIDVA 771
            N+V+++  C            LV E++ +     L  C        +  + L  M  + 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-KPGLPPETIKDL--MRQLL 117

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY 831
             +++LH   S+ IVH D+KP N+L+       ++DFG+A++ S E  M  T  + T+ Y
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTSVVVTLWY 172

Query: 832 IAPE 835
            APE
Sbjct: 173 RAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 30/219 (13%)

Query: 670 NLIGIGSYGSVYKGRFPD-------GIEVAIKVFHLQREGALNS----FDAECEILKTIR 718
           N +G G++G VY+G   D        I VA+K     R+GA +     F  E  ++    
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFN------LDIFQRLGIMIDVAS 772
           H N+VK++  C  +  + +++E M  G L   +  +         L + + L I +DVA 
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLL-----DDSMVAHLSDFGIAKLLSEEDSM-KQTQTL 826
              YL   H    +H D+   N L+     D   V  + DFG+A+ + + D   K+ + L
Sbjct: 118 GCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
             + ++APE   +G+ + + DV+++G+++ E+ T G +P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 30/216 (13%)

Query: 671 LIGIGSYGSVYKGRFPD-GIEVAIKVFHL-----QREGALNSFDAECEILKTIRHRNLVK 724
           L+G G++G VY     D G E+A+K         +    +N+ + E ++LK +RH  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 725 IISSCTNHNFKALVL--EYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASALEYLHFGH 781
                 +   K L +  EYMP GS++D + A      ++ +R    I     L+ + + H
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI-----LQGVSYLH 123

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPE--- 835
           SN IVH DIK +N+L D +    L DFG +K + +   M  T   +  G   +++PE   
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 836 ---YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEF 868
              YGR      K DV++    ++E+ T   P  E+
Sbjct: 183 GEGYGR------KADVWSVACTVVEMLTEKPPWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 79.5 bits (196), Expect = 6e-15
 Identities = 56/187 (29%), Positives = 86/187 (45%), Gaps = 17/187 (9%)

Query: 688 GIEVAIKVF---HLQREGALNSFDAECEILKTIRHRNLVKIISS-CTNHNFKALVLEYMP 743
           G EVAIK+      + E     F  E  +   + H N+V ++ S          V EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL---DDS 800
             +L + + A++  L   +   +M+ V  AL      H+  IVH D+KP N+++      
Sbjct: 63  GRTLREVL-AADGALPAGETGRLMLQVLDALAC---AHNQGIVHRDLKPQNIMVSQTGVR 118

Query: 801 MVAHLSDFGIAKLLSE-EDSMKQTQTLAT--IG---YIAPEYGREGQVSIKGDVYNYGIM 854
             A + DFGI  LL    D+   T T  T  +G   Y APE  R   V+   D+Y +G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 855 LMEVFTG 861
            +E  TG
Sbjct: 179 FLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 75.5 bits (185), Expect = 6e-15
 Identities = 68/215 (31%), Positives = 100/215 (46%), Gaps = 28/215 (13%)

Query: 671 LIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEI--LKTIRHRNLVK 724
           L+G G++G VY     D G E+A K      E    S +    ECEI  LK ++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 725 IISSCTNHNFKALV--LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                 +   K L   +EYMP GS++D + A     +   R          LE + + HS
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY----TRQILEGMSYLHS 124

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPE---- 835
           N IVH DIK +N+L D +    L DFG +K L +   M  T   +  G   +++PE    
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 836 --YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEF 868
             YGR      K DV++ G  ++E+ T   P  E+
Sbjct: 184 EGYGR------KADVWSLGCTVVEMLTEKPPWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 38/284 (13%)

Query: 672 IGIGSYGSVYKGRF-PDGI----EVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKI 725
           +G G +G V   R+ P+G     +VA+K    +     +     E EIL+ + H N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 726 ISSCTNH--NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
              CT    N   L++E++P GSL++ +  +   +++ Q+L   + +   ++YL    S 
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---GSR 128

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL--SEEDSMKQTQTLATIGYIAPEYGREGQ 841
             VH D+   NVL++      + DFG+ K +   +E    +    + + + APE   + +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 842 VSIKGDVYNYGIMLMEVFT----GMKPTNEFFT------GEMSIKRWINDSLPAVMNIMD 891
             I  DV+++G+ L E+ T       P   F        G+M++ R +            
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV------------ 236

Query: 892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII 935
             +L E +        +C   V  L  +C    P  R   + +I
Sbjct: 237 -RVLEEGKRLPRPP--NCPEEVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 20/201 (9%)

Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQ--REGALNSFDAECEILKTIR---HRNLVKI 725
           IG+G+YG+VYK R P  G  VA+K   +Q   +G   S   E  +LK +    H N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 726 ISSC----TNHNFK-ALVLEYMPKG--SLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           +  C    T+   K  LV E++ +   +  D +       +  + L  M      L++LH
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDL--MRQFLRGLDFLH 125

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR 838
              +N IVH D+KP N+L+       L+DFG+A++ S +  M  T  + T+ Y APE   
Sbjct: 126 ---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVLL 180

Query: 839 EGQVSIKGDVYNYGIMLMEVF 859
           +   +   D+++ G +  E+F
Sbjct: 181 QSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 12/197 (6%)

Query: 672 IGIGSYGSVYK-GRFPDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRNLVKIISSC 729
           +G G+ GSV K    P G  +A KV H+  + ++      E +I+   R   +V    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 730 TNHNFKALVLEYMPKGSLEDCMY--ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
            N N   + +E+M  GSL D +Y       ++I  +  I + V   L YL+  H   I+H
Sbjct: 73  LNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--IMH 127

Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGD 847
            DIKPSN+L++      L DFG++  L   +S+  T  + T  Y++PE  + G+ ++K D
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELI--NSIADT-FVGTSTYMSPERIQGGKYTVKSD 184

Query: 848 VYNYGIMLMEVFTGMKP 864
           V++ GI ++E+  G  P
Sbjct: 185 VWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 66/226 (29%), Positives = 109/226 (48%), Gaps = 33/226 (14%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHL----QREGALNSFDAECEILKTIRHRNLVKII 726
           IG GS G V        G +VA+K   L    +RE   N    E  I++  +H N+V++ 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN----EVVIMRDYQHPNIVEMY 82

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
           SS    +   +V+E++  G+L D +  +  N +  Q   + + V  AL +LH   +  ++
Sbjct: 83  SSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--QIATVCLAVLKALSFLH---AQGVI 137

Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY-IAPE------YGRE 839
           H DIK  ++LL       LSDFG    +S+E  + + ++L    Y +APE      YG E
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTE 195

Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE-MSIKRWINDSLP 884
                  D+++ GIM++E+  G  P   +F    +   + I D+LP
Sbjct: 196 ------VDIWSLGIMVIEMVDGEPP---YFNEPPLQAMKRIRDNLP 232

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 14/217 (6%)

Query: 666 FSEENLIGIGSYGSVYKGR-FPDGIEVAIK---VFHLQREGALNSFDAECEILKTIRHRN 721
           F  E  IG G +  VY+     D   VA+K   +F +    A      E ++LK + H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLED-CMYASNFNLDIFQRL--GIMIDVASALEYLH 778
           ++K + S    N   +VLE    G L     Y       I +R      + + SA+E++H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR 838
              S  ++H DIKP+NV +  + V  L D G+ +  S + +   +  + T  Y++PE   
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIH 179

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI 875
           E   + K D+++ G +L E+     P   F+  +M++
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 68/291 (23%), Positives = 123/291 (42%), Gaps = 46/291 (15%)

Query: 669 ENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNS---FDAECEIL-KTIRHRNLV 723
           +++IG G++G V K R   DG+ +   +  ++   + +    F  E E+L K   H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---------------NLDIFQRLGIMI 768
            ++ +C +  +  L +EY P G+L D +  S                  L   Q L    
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           DVA  ++YL        +H D+   N+L+ ++ VA ++DFG+++   +E  +K+T     
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 186

Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVM 887
           + ++A E       +   DV++YG++L E+ + G  P       E+  K      L   +
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 246

Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           N                    C   V  L  +C  E P  R +  +I+  L
Sbjct: 247 N--------------------CDDEVYDLMRQCWREKPYERPSFAQILVSL 277

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 16/204 (7%)

Query: 671 LIGIGSYGSVYKGRF-PDG----IEVAIKVFHLQREGALNSFDAECE---ILKTIRHRNL 722
           L+G G +G+V+KG + P+G    I VAIK   +Q      +F    +    + ++ H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           V+++  C   + + LV +  P GSL D +     +LD  + L   + +A  + YL     
Sbjct: 72  VRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---E 127

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT-IGYIAPEYGREGQ 841
           + +VH ++   N+LL    +  ++DFG+A LL  +D         T I ++A E    G+
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Query: 842 VSIKGDVYNYGIMLMEVFT-GMKP 864
            + + DV++YG+ + E+ + G +P
Sbjct: 188 YTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 75.3 bits (186), Expect = 2e-14
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 39/188 (20%)

Query: 670 NLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA-----ECEILKTIRHRNLV 723
             IG G+YG V        G +VAIK      +   +  DA     E ++L+ +RH N++
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENII 62

Query: 724 K---IISSCTNHNFKAL--VLEYMP---------KGSLEDCMYASNFNLDIFQRLGIMID 769
               I+   +  +F  +  V E M             L D         D  Q    +  
Sbjct: 63  GLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTD---------DHIQY--FLYQ 111

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--LA 827
           +   L+YLH  +   ++H D+KPSN+L++ +    + DFG+A+ +  ++  K   T  + 
Sbjct: 112 ILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168

Query: 828 TIGYIAPE 835
           T  Y APE
Sbjct: 169 TRWYRAPE 176

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 10/206 (4%)

Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE--VAIKVFHLQR-EGALNSFDAECEILKTIRHRNL 722
           F++   IG GS+G V+KG   +  +  VAIK+  L+  E  +     E  +L       +
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
            K   S        +++EY+  GS  D +      LD  Q   I+ ++   L+YLH   S
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---S 119

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV 842
              +H DIK +NVLL +     L+DFG+A  L++   +K+   + T  ++APE  ++   
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 843 SIKGDVYNYGIMLMEVFTGMKPTNEF 868
             K D+++ GI  +E+  G  P +E 
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 66/223 (29%), Positives = 98/223 (43%), Gaps = 39/223 (17%)

Query: 668 EENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKII 726
           +   IG G++G+V K      G  +A+K         + S   E E  + +   ++V   
Sbjct: 8   DLGEIGRGAFGTVNKMLHKPSGTIMAVK--------RIRSTVDEKEQKRLLMDLDVVMRS 59

Query: 727 SSCTN--HNFKALVLEYMPKGSLEDCMYASNFNLDIFQR--------------LG-IMID 769
           S C      + AL  E    G    CM   + +LD F +              LG I + 
Sbjct: 60  SDCPYIVKFYGALFRE----GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA 115

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
              AL YL       I+H D+KPSN+LLD +    L DFGI+  L   DS+ +T+     
Sbjct: 116 TVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCR 171

Query: 830 GYIAPE----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEF 868
            Y+APE      R+G   ++ DV++ GI L EV TG  P  ++
Sbjct: 172 PYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPKW 213

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 43/283 (15%)

Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI 725
           +G G++G V+           D I VA+K      + A   F  E E+L  ++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFN------------LDIFQRLGIMIDVASA 773
              C   +   +V EYM  G L   + A   +            L   Q L I   +A+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYI 832
           + YL   H    VH D+   N L+ ++++  + DFG+++ +   D  +    T+  I ++
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
            PE     + + + DV++ G++L E+FT G +P  +    E+            +  I  
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV------------IECITQ 237

Query: 892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
             +L           ++C   V  L + C    P  R+N KEI
Sbjct: 238 GRVLQR--------PRTCPKEVYDLMLGCWQREPHMRLNIKEI 272

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 22/216 (10%)

Query: 660 LRATDQFSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQRE--GALNSFDAECEILKT 716
            R+  +F + N IG G+YG VY+ R     E VA+K   +  E  G   S   E  +L  
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN 62

Query: 717 IRHRNLVKIISSCTNHNFKA--LVLEYMPK--GSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           +RH N+V++       +  +  LV+EY  +   SL D M          Q   +M+ +  
Sbjct: 63  LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLR 119

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED-SMKQTQTLATIGY 831
            L+YLH    N I+H D+K SN+LL D     ++DFG+A+        M  T  + T+ Y
Sbjct: 120 GLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWY 174

Query: 832 IAPE--YGREGQV-SIKGDVYNYGIMLMEVFTGMKP 864
            APE   G      +I  D++  G +L E+    KP
Sbjct: 175 RAPELLLGCTTYTTAI--DMWAVGCILAELLAH-KP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 73.2 bits (179), Expect = 4e-14
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 25/211 (11%)

Query: 670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNS---FDAECEIL-KTIRHRNLVK 724
           ++IG G++G V K R   DG+ +   +  ++   + +    F  E E+L K   H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNF---------------NLDIFQRLGIMID 769
           ++ +C +  +  L +EY P G+L D +  S                  L   Q L    D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
           VA  ++YL        +H D+   N+L+ ++ VA ++DFG+++   +E  +K+T     +
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 175

Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
            ++A E       +   DV++YG++L E+ +
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.2 bits (179), Expect = 5e-14
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 8/205 (3%)

Query: 666 FSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQR-EGALNSFDAECEILKTIRHRNLV 723
           F++   IG GS+G VYKG      EV AIK+  L+  E  +     E  +L       + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           +   S        +++EY+  GS  D +      L+      I+ ++   L+YLH   S 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLH---SE 120

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
             +H DIK +NVLL +     L+DFG+A  L++   +K+   + T  ++APE  ++    
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-QIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEF 868
            K D+++ GI  +E+  G  P ++ 
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 73.5 bits (180), Expect = 5e-14
 Identities = 59/227 (25%), Positives = 114/227 (50%), Gaps = 34/227 (14%)

Query: 665 QFSEENL-----IGIGSYGSVY--------KGRFPDGIEVAIKVFHLQ-REGALNSFDAE 710
           +FS + L     +G G +G V         K +  + + VA+K+      E  L+   +E
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70

Query: 711 CEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYAS-----NFNLDI---- 760
            E++K I +H+N++ ++ +CT      +++EY  KG+L + + A       ++ DI    
Sbjct: 71  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130

Query: 761 -----FQRL-GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL 814
                F+ L      VA  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 815 SEEDSMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
           +  D  K+T      + ++APE   +   + + DV+++G+++ E+FT
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 72.8 bits (178), Expect = 6e-14
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)

Query: 671 LIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA-----LNSFDAECEILKTIRHRNLVK 724
           L+G G++G VY     D G E+A+K      E       +N+ + E ++LK + H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 725 IISSCTNHNFKAL--VLEYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASALEYLHFGH 781
                 +   + L   +E+MP GS++D + +      ++ ++    I     LE + + H
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPE--- 835
           SN IVH DIK +N+L D      L DFG +K L +   +  T   +  G   +++PE   
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 836 ---YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEF 868
              YGR      K D+++ G  ++E+ T   P  EF
Sbjct: 183 GEGYGR------KADIWSVGCTVVEMLTEKPPWAEF 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 73.5 bits (180), Expect = 7e-14
 Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 15/225 (6%)

Query: 659 LLRATDQFSEENLIGIGSYGSVYKGRF-PDG----IEVAIKVFHLQREGALNS--FDAEC 711
           +L+ T +F +  ++G G++G+VYKG + P+G    I VAIK          N    D E 
Sbjct: 3   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EA 60

Query: 712 EILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA 771
            ++ ++ + ++ +++  C     + L+ + MP G L D +     N+     L   + +A
Sbjct: 61  YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 119

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIG 830
             + YL       +VH D+   NVL+       ++DFG+AKLL ++E           I 
Sbjct: 120 KGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
           ++A E       + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 72.6 bits (179), Expect = 9e-14
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 26/220 (11%)

Query: 665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIK-VFHLQREGALN--SFDA--ECEILKTIR 718
           ++ +   +G G+Y  VYK R    G  VAIK +   +R+ A +  +F A  E ++L+ ++
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNL---DIFQRLGIMIDVASALE 775
           H N++ ++    + +   LV E+M    LE  +   +  L   DI      M+     LE
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKS---YMLMTLRGLE 116

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           YLH   SN I+H D+KP+N+L+    V  L+DFG+A+      + K T  + T  Y APE
Sbjct: 117 YLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVVTRWYRAPE 172

Query: 836 --YG-REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
             +G R   V +  D+++ G +  E+     P   F  G+
Sbjct: 173 LLFGARHYGVGV--DMWSVGCIFAELLLR-VP---FLPGD 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 33/282 (11%)

Query: 670 NLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVK 724
            +IG G +G VY G     DG ++   V  L R      +  F  E  I+K   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 725 IISSC-TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++  C  +     +VL YM  G L + + +   N  +   +G  + VA  +EYL    S 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAK--LLSEEDSMKQ-TQTLATIGYIAPEYGREG 840
             VH D+   N +LD+S    ++DFG+A+     E  S+   T     + ++A E  +  
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
           + + K DV+++G++L E+ T G  P  +             DS    + ++    L + E
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDV------------DSFDITVYLLQGRRLLQPE 225

Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                    C   +  + + C    PE R    E++SR+ +I
Sbjct: 226 --------YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 12/211 (5%)

Query: 671 LIGIGSYGSVYKGRF-PDG----IEVAIKVFHLQREGALN-SFDAECEILKTIRHRNLVK 724
           ++G G++G+VYKG + P+G    I VAIK+ +       N  F  E  I+ ++ H +LV+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           ++  C +   + LV + MP G L D ++    N+     L   + +A  + YL       
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129

Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS-EEDSMKQTQTLATIGYIAPEYGREGQVS 843
           +VH D+   NVL+       ++DFG+A+LL  +E           I ++A E     + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 844 IKGDVYNYGIMLMEVFT-GMKPTNEFFTGEM 873
            + DV++YG+ + E+ T G KP +   T E+
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 17/208 (8%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVFHLQR------EGALNSFDAECEILKTIRHRNLV 723
            +G G++ S Y+ R    G  +A+K     R      E  + +   E  ++  + H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 724 KII-SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           +++ ++C + +F  L +E+M  GS+      S +    F+   I+      L  L + H 
Sbjct: 67  RMLGATCEDSHFN-LFVEWMAGGSVS--HLLSKYG--AFKEAVIINYTEQLLRGLSYLHE 121

Query: 783 NPIVHCDIKPSNVLLDDS-MVAHLSDFGIAKLLSEEDSMK---QTQTLATIGYIAPEYGR 838
           N I+H D+K +N+L+D +     ++DFG A  L+ + +     Q Q L TI ++APE  R
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKPTN 866
             Q     DV++ G +++E+ T   P N
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWN 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 9/214 (4%)

Query: 672 IGIGSYGSV-YKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG GS G V        G +VA+K   L+++        E  I++   H N+V + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   +V+E++  G+L D +  +  N +  Q   + + V  AL YLH   +  ++H DI
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  ++LL       LSDFG    +S+E   K+   + T  ++APE         + D+++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203

Query: 851 YGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP 884
            GIM++E+  G  P   F    +   R I D+LP
Sbjct: 204 LGIMVIEMIDGEPPY--FNEPPLQAMRRIRDNLP 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 72/315 (22%), Positives = 130/315 (41%), Gaps = 62/315 (19%)

Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQR-EGALNSFDAE 710
           EL R  D+ +    +G G++G V K          +   VA+K+      E  L+   +E
Sbjct: 8   ELPR--DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE 65

Query: 711 CEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCM---------YASNFNLDI 760
            E++K I +H+N++ ++  CT      +V+EY   G+L D +          + +     
Sbjct: 66  MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125

Query: 761 FQRL------GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL 814
            + L           VA  +E+L    S   +H D+   NVL+ +  V  ++DFG+A+ +
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182

Query: 815 SEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTN 866
              D   K T     + ++APE   +   + + DV+++G++L E+FT       G+ P  
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVE 241

Query: 867 EFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPE 926
           E F       R            M+               Q+C   +  L  +C  E P 
Sbjct: 242 ELFKLLKEGYR------------MEK-------------PQNCTQELYHLMRDCWHEVPS 276

Query: 927 NRVNTKEIISRLIKI 941
            R   K+++  L ++
Sbjct: 277 QRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 29/220 (13%)

Query: 658 ELLRATDQFSEENLIGIGSYGSVYKG----RFPDGIEVAIKVFHLQ---REGALNSFDAE 710
            LLRA         +G G++G VY+G    R  D +E+ + V  L     E   + F  E
Sbjct: 9   TLLRA---------LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLME 59

Query: 711 CEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRL 764
             I+    H+N+V++I        + ++LE M  G L+  +  +        +L +   L
Sbjct: 60  ALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119

Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD---SMVAHLSDFGIAKLLSEEDSM- 820
               DVA   +YL     N  +H DI   N LL       VA ++DFG+A+ +       
Sbjct: 120 FCARDVAKGCKYL---EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176

Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
           K  + +  I ++ PE   +G  + K DV+++G++L E+F+
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.1 bits (182), Expect = 2e-13
 Identities = 33/86 (38%), Positives = 49/86 (56%)

Query: 355 LSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSI 414
           L L +  L G +P  + +L+ LQ ++L  N   G IP      + L V+ L+ N  +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 415 PSCLGDLNSLRILSLSSNELTSVIPS 440
           P  LG L SLRIL+L+ N L+  +P+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 70/299 (23%), Positives = 125/299 (41%), Gaps = 65/299 (21%)

Query: 672 IGIGSYGSVYKGRFP------DGIEVAIKVFHLQREGAL---NSFDAECEILKTIRHRNL 722
           IG G++G V++ R P          VA+K+  L+ E +      F  E  ++    H N+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLED----------CMYASNFN-----------LDIF 761
           VK++  C       L+ EYM  G L +          C  + + +           L   
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK 821
           ++L I   VA+ + YL        VH D+   N L+ ++MV  ++DFG+++ +   D  K
Sbjct: 131 EQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 822 QTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMSI 875
            ++     I ++ PE     + + + DV+ YG++L E+F+ GM+P     +E        
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-------- 239

Query: 876 KRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
                     +  + D N+LS           +C   + +L   C S+ P +R +   I
Sbjct: 240 --------EVIYYVRDGNVLS--------CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 41/106 (38%), Positives = 58/106 (54%), Gaps = 9/106 (8%)

Query: 764 LGIM-IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ 822
           LG M + +  AL YL   H   ++H D+KPSN+LLD S    L DFGI+  L   DS  +
Sbjct: 116 LGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAK 171

Query: 823 TQTLATIGYIAPEY----GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T++     Y+APE         +  I+ DV++ GI L+E+ TG  P
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 65/203 (32%), Positives = 95/203 (46%), Gaps = 15/203 (7%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALN-SFDAECEILKTIRHRN 721
           ++  E + +G G+ GSV K R  +   + A+K         L      E EI K+ +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 722 LVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYAS--NFNLDIFQR-LG-IMIDVASALE 775
           +VK   +  + +     + +EY   GSL D +Y         I ++ LG I   V   L 
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           YLH   S  I+H DIKPSN+LL       L DFG++  L    S+  T T  T  Y+APE
Sbjct: 120 YLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN--SLAGTFT-GTSFYMAPE 173

Query: 836 YGREGQVSIKGDVYNYGIMLMEV 858
             +    SI  DV++ G+ L+EV
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 21/222 (9%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFH--LQREGALNSFDAECEILKTIRHR 720
           ++F    ++G G+YG V K R  +  E VAIK F    + E    +   E ++L+T++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY---- 776
           N+V++  +        LV EY+ K  LE      N         G+  +   +  Y    
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIK 111

Query: 777 -LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            +H+ H N IVH DIKP N+L+  + V  L DFG A+ LSE  +   T+ +AT  Y +PE
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                      D+++ G +L E+  G       F GE  I +
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDG----QPLFPGESEIDQ 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 69/311 (22%), Positives = 127/311 (40%), Gaps = 73/311 (23%)

Query: 672 IGIGSYGSVYKGR------FPDGIEVAIKVFHLQREGA----LNSFDAECEILKTIRHRN 721
           +G G +G V K              VA+K+    +E A    L    +E  +LK + H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLE---------DCMY---------ASNFNLDIFQ- 762
           ++K+  +C+      L++EY   GSL             Y         +   N D    
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 763 RLGIMIDVA----SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            +G +I  A      ++YL       +VH D+   NVL+ +     +SDFG+++ + EED
Sbjct: 125 TMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 819 S-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFFT 870
           S +K+++    + ++A E   +   + + DV+++G++L E+ T       G+ P   F  
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF-- 239

Query: 871 GEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN 930
                            N++ T    E  E       +C+  + +L + C  + P+ R  
Sbjct: 240 -----------------NLLKTGYRMERPE-------NCSEEMYNLMLTCWKQEPDKRPT 275

Query: 931 TKEIISRLIKI 941
             +I   L K+
Sbjct: 276 FADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.5 bits (172), Expect = 4e-13
 Identities = 54/191 (28%), Positives = 90/191 (47%), Gaps = 9/191 (4%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG G+YG VYK R    G   AIKV  L+          E  ++K  +H N+V    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   + +E+   GSL+D  + +           I       L+ L++ HS   +H DI
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKGKMHRDI 132

Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYG---REGQVSIKGD 847
           K +N+LL D+    L+DFG++  ++   + K+   + T  ++APE     R+G  +   D
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191

Query: 848 VYNYGIMLMEV 858
           ++  GI  +E+
Sbjct: 192 IWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 38/218 (17%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHL-------QREGALNSFDAECEILK 715
           D       +G G++G V+  R        A+KV  +       Q +   N    E  +LK
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN----EKRVLK 56

Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYAS-NFNLDIFQRLGIMI--DVAS 772
            + H  ++++  +  +  F  +++EY+P G L   +  S  F+       G+    ++  
Sbjct: 57  EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFS----NSTGLFYASEIVC 112

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGY 831
           ALEYLH   S  IV+ D+KP N+LLD      L+DFG AK L +     +T TL  T  Y
Sbjct: 113 ALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEY 164

Query: 832 IAPEYGREGQVSIKG-----DVYNYGIMLMEVFTGMKP 864
           +APE      +  KG     D +  GI++ E+  G  P
Sbjct: 165 LAPEV-----IQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 68/235 (28%), Positives = 110/235 (46%), Gaps = 23/235 (9%)

Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNL 722
            F +   +G G+Y +VYKGR    G  VA+K  HL   EG  ++   E  ++K ++H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCM--YASNFNLDIFQRLGIMIDVASALEYLHFG 780
           V++       N   LV EYM K  L+  M  +     LD          +   L+ + F 
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFC 116

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY---G 837
           H N ++H D+KP N+L++      L+DFG+A+      +   +  + T+ Y AP+     
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGS 175

Query: 838 REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           R    SI  D+++ G ++ E+ TG +P    F G  +      D L  +  IM T
Sbjct: 176 RTYSTSI--DIWSVGCIMAEMITG-RP---LFPGTNN-----EDQLLKIFRIMGT 219

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.3 bits (173), Expect = 6e-13
 Identities = 72/226 (31%), Positives = 98/226 (43%), Gaps = 63/226 (27%)

Query: 672 IGIGSYGSVYKGRFPDGIEV-AIKVFHL-------QREGALNSFDAECEILKTIRHRNLV 723
           +G GS+G V   R     +  A+K+          Q E  LN    E  IL++IRH  LV
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN----EKRILQSIRHPFLV 64

Query: 724 KIISSCTNHNFKALVLEYMPKGSL-----------ED--CMYASNFNLDIFQRLGIMIDV 770
            +  S  + +   LV+EY+P G L           E     YA+               V
Sbjct: 65  NLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ--------------V 110

Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATI 829
             ALEYLH   S  IV+ D+KP N+LLD      ++DFG AK +       +T TL  T 
Sbjct: 111 VLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTP 162

Query: 830 GYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFF 869
            Y+APE      YG+   V    D +  GI++ E+  G  P   FF
Sbjct: 163 EYLAPEIILSKGYGK--AV----DWWALGILIYEMLAGYPP---FF 199

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.1 bits (171), Expect = 6e-13
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 9/214 (4%)

Query: 672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG GS G V   R    G +VA+K+  L+++        E  I++  +H+N+V++  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
                 +++E++  G+L D +  S   L+  Q   +   V  AL YLH   S  ++H DI
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  ++LL       LSDFG    +S +D  K+   + T  ++APE         + D+++
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202

Query: 851 YGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP 884
            GIM++E+  G  P   F    +   + + DS P
Sbjct: 203 LGIMVIEMVDGEPPY--FSDSPVQAMKRLRDSPP 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 70.2 bits (172), Expect = 7e-13
 Identities = 54/219 (24%), Positives = 101/219 (46%), Gaps = 25/219 (11%)

Query: 665 QFSEENL-----IGIGSYGSVYK------GRFPDGIEVAIKVF----HLQREGALNSFDA 709
           +F   NL     +G G++G V +       +    ++VA+K+     H     AL S   
Sbjct: 31  EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS--- 87

Query: 710 ECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQRLGIM 767
           E +I+  +  H N+V ++ +CT      ++ EY   G L + +       L +   L   
Sbjct: 88  ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147

Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTL 826
             VA  + +L    S   +H D+   NVLL    +  + DFG+A+ ++++ + + +    
Sbjct: 148 YQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204

Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
             + ++APE       + + DV++YGI+L E+F+ G  P
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 69.7 bits (171), Expect = 8e-13
 Identities = 55/175 (31%), Positives = 79/175 (45%), Gaps = 24/175 (13%)

Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVF------HLQREGALNSFDAECEILKTIRHRNLVK 724
           IG GSYG V+K R  + G  VAIK F       + ++ AL     E  +LK ++H NLV 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR----LGIMIDVASALEYLHFG 780
           +I          LV EY        C +     L+   R      I   +   L+ ++F 
Sbjct: 65  LIEVFRRKRKLHLVFEY--------CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           H +  +H D+KP N+L+       L DFG A++L+       T  +AT  Y APE
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 8/202 (3%)

Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G++G VYK +  + G+  A KV   + E  L  +  E +IL +  H N+VK++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             N   +++E+   G+++  M      L   Q   I +     LE L++ H N I+H D+
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQ---IRVVCKQTLEALNYLHENKIIHRDL 129

Query: 791 KPSNVLLDDSMVAHLSDFGIA----KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           K  N+L        L+DFG++    + +   DS   T        +  E  ++     K 
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 189

Query: 847 DVYNYGIMLMEVFTGMKPTNEF 868
           DV++ GI L+E+     P +E 
Sbjct: 190 DVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 69/240 (28%), Positives = 108/240 (45%), Gaps = 47/240 (19%)

Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL----VKII 726
           +G G+YG V K R  P G  +A+K         +NS +         + R L    + + 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRAT----VNSQE---------QKRLLMDLDISMR 55

Query: 727 SSC---TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR-------------LG-IMID 769
           S     T   + AL  E    G +  CM   + +LD F +             LG I + 
Sbjct: 56  SVDCPYTVTFYGALFRE----GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS 111

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
           +  ALEYLH   S  ++H D+KPSNVL++ +    L DFGI+  L   DS+ +T      
Sbjct: 112 IVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV--DSVAKTIDAGCK 167

Query: 830 GYIAPEY----GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA 885
            Y+APE       +    +K DV++ GI ++E+ TG  P + + T    +K+ + +  P 
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ 227

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 10/204 (4%)

Query: 664 DQFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRN 721
           D F + + +G G+ G V+K    P G+ +A K+ HL+ + A+ N    E ++L       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG-IMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  +    +  Q LG + I V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 122

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L   DSM  +  + T  Y++PE  +  
Sbjct: 123 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 177

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
             S++ D+++ G+ L+E+  G  P
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 69.3 bits (169), Expect = 2e-12
 Identities = 56/217 (25%), Positives = 108/217 (49%), Gaps = 33/217 (15%)

Query: 672 IGIGSYGSVY--------KGRFPDGIEVAIKVFHLQREGA---LNSFDAECEILKTI-RH 719
           +G G +G V         K +    + VA+K+  L+ +     L+   +E E++K I +H
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYAS-----NFNLD---------IFQRL- 764
           +N++ ++ +CT      +++EY  KG+L + + A      +++ D          F+ L 
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ 824
                VA  +EYL    S   +H D+   NVL+ +  V  ++DFG+A+ +   D  K+T 
Sbjct: 138 SCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 825 T-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
                + ++APE   +   + + DV+++G++L E+FT
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 10/204 (4%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRN 721
           D F   + +G G+ G V K +  P G+ +A K+ HL+ + A+ N    E ++L       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMY-ASNFNLDIFQRLGIMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  A     +I  ++ I   V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK 122

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L   DSM  +  + T  Y++PE  +  
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 177

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
             S++ D+++ G+ L+E+  G  P
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.6 bits (165), Expect = 4e-12
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVF------HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G+ G+VYK         +A+KV        LQ++       +E EIL       ++ 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQ-----IMSELEILYKCDSPYIIG 63

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG-IMIDVASALEYLHFGHSN 783
              +    N  ++  E+M  GSL+  +Y           LG I + V   L YL    S 
Sbjct: 64  FYGAFFVENRISICTEFMDGGSLD--VYRKIPE----HVLGRIAVAVVKGLTYLW---SL 114

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
            I+H D+KPSN+L++      L DFG++  L   +S+ +T  + T  Y+APE     Q  
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTY-VGTNAYMAPERISGEQYG 171

Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI 875
           I  DV++ GI  ME+  G  P  +    + S+
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 70/236 (29%), Positives = 113/236 (47%), Gaps = 22/236 (9%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQRE--GALNSFDAECEILKTIRHR 720
           DQ+ +   IG G+YG VYK R     E +A+K   L++E  G  ++   E  +LK ++H 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHF 779
           N+V++     +     LV EY+    L+  M +S +F  +   RL I   +   L  + +
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKN--PRL-IKTYLYQILRGIAY 117

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVA-HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE--Y 836
            HS+ ++H D+KP N+L+D    A  L+DFG+A+          T  + T+ Y APE   
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-VRTFTHEVVTLWYRAPEILL 176

Query: 837 GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           G     S   D+++ G +  E+    KP    F G+  I     D L  +  I+ T
Sbjct: 177 GSR-HYSTPVDIWSVGCIFAEMVN-QKP---LFPGDSEI-----DELFKIFRILGT 222

Length = 294

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 67.3 bits (164), Expect = 5e-12
 Identities = 72/283 (25%), Positives = 121/283 (42%), Gaps = 35/283 (12%)

Query: 671 LIGIGSYGSVYKGRF-PDG----IEVAIKVFHLQREGALNS--FDAECEILKTIRHRNLV 723
           ++G G++G+VYKG + PDG    I VAIKV         N    D E  ++  +    + 
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAGVGSPYVC 72

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           +++  C     + LV + MP G L D +  +   +     L   + +A  + YL      
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EV 128

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS-EEDSMKQTQTLATIGYIAPEYGREGQV 842
            +VH D+   NVL+       ++DFG+A+LL  +E           I ++A E     + 
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188

Query: 843 SIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH 901
           + + DV++YG+ + E+ T G KP                D +PA   I D  LL + E  
Sbjct: 189 THQSDVWSYGVTVWELMTFGAKPY---------------DGIPA-REIPD--LLEKGERL 230

Query: 902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI-RD 943
                  C   V  + ++C     E R   +E++    ++ RD
Sbjct: 231 PQ--PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 77/317 (24%), Positives = 135/317 (42%), Gaps = 71/317 (22%)

Query: 665 QFSEENLI-----GIGSYGSVYKGR-------FPD-GIEVAIKVFHLQREGA---LNSFD 708
           +F  + L+     G G +G V +          PD  + VA+K+  L+       L    
Sbjct: 8   EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLI 65

Query: 709 AECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYAS-----NFNLDI-- 760
           +E E++K I +H+N++ ++  CT      +++EY  KG+L + + A      ++  DI  
Sbjct: 66  SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125

Query: 761 -------FQRL-GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK 812
                  F+ L      VA  +EYL    S   +H D+   NVL+ +  V  ++DFG+A+
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 813 LLSEEDSMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKP 864
            + + D  K+T      + ++APE   +   + + DV+++GI++ E+FT       G+ P
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-P 241

Query: 865 TNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSES 924
             E F                        LL E   H      +C   +  L  EC    
Sbjct: 242 VEELF-----------------------KLLREG--HRMDKPSNCTHELYMLMRECWHAV 276

Query: 925 PENRVNTKEIISRLIKI 941
           P  R   K+++  L K+
Sbjct: 277 PTQRPTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 11/207 (5%)

Query: 658 ELLRATDQFSEENL--IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEIL 714
           ++LR   Q   E +  +G G+YG VYK R    G   A+K+  L+     +    E  ++
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60

Query: 715 KTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
           K  +H N+V    S  +     + +EY   GSL+D  + +         L I       L
Sbjct: 61  KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETL 116

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           + L + HS   +H DIK +N+LL D+    L+DFG+A  ++   + K+   + T  ++AP
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKSFIGTPYWMAP 175

Query: 835 EYG---REGQVSIKGDVYNYGIMLMEV 858
           E     + G  +   D++  GI  +E+
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.3 bits (164), Expect = 5e-12
 Identities = 50/189 (26%), Positives = 94/189 (49%), Gaps = 21/189 (11%)

Query: 690 EVAIKVFHLQ-REGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSL 747
           +VA+K+      E  L+   +E E++K I +H+N++ ++ +CT      +++EY  KG+L
Sbjct: 52  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111

Query: 748 EDCM---------YASN------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKP 792
            + +         Y  N        L     +     VA  +EYL    S   +H D+  
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAA 168

Query: 793 SNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNY 851
            NVL+ +  V  ++DFG+A+ +   D  K+T      + ++APE   +   + + DV+++
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228

Query: 852 GIMLMEVFT 860
           G++L E+FT
Sbjct: 229 GVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 6e-12
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 26/219 (11%)

Query: 672 IGIGSYGSVYKGRFPDGIE-VAIKVFH---LQREGALNSFDAECEILKTIRHRNLVKIIS 727
           +G G YG V+  +  D  E VA+K      L +   +     E +IL T +   LVK++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGI--MIDVASALEYLHFGHSNPI 785
           +  +  +  L +EY+P G     +       +   R  +  M +   AL      H    
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL------HELGY 122

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
           +H D+KP N L+D S    L+DFG++K +++  +S+     + +  Y+APE  R      
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLRGKGYDF 177

Query: 845 KGDVYNYGIMLMEVFTGMKP-----TNEFFTGEMSIKRW 878
             D ++ G ML E   G  P      NE +    ++K W
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 66.9 bits (163), Expect = 6e-12
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 21/208 (10%)

Query: 669 ENLIGIGSYGSVYKG--RFPDGIEVAIKVFHLQREGALNS----FDAECEILKTIRHRNL 722
           E ++G G +G + +G  + P   E+ + + H  R G  +     F AE   L    H N+
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAI-HTLRAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-HFGH 781
           V++    T  N   +V EYM  G+L+  +      L   Q +G++  +AS ++YL   G+
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY 128

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL----ATIGYIAPEYG 837
               VH  +    VL++  +V  +S F       +ED  +   T     + + + APE  
Sbjct: 129 ----VHKGLAAHKVLVNSDLVCKISGFRRL----QEDKSEAIYTTMSGKSPVLWAAPEAI 180

Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           +    S   DV+++GI++ EV + G +P
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 7e-12
 Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 38/197 (19%)

Query: 665 QFSEENLIGIGSYGSVYKGR---FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIR 718
           ++  E  IG G+YG VYK +     DG E AIK F     Q  G   S   E  +L+ ++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 719 HRNLVKIISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID---VASA 773
           H N+V ++     H  K+  L+ +Y      +   +         Q   + I    V S 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHR-------QAKRVSIPPSMVKSL 113

Query: 774 ----LEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIA-------KLLSEED 818
               L  +H+ HSN ++H D+KP+N+L+     +  V  + D G+A       K L++ D
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173

Query: 819 SMKQTQTLATIGYIAPE 835
            +     + TI Y APE
Sbjct: 174 PV-----VVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 66.7 bits (163), Expect = 7e-12
 Identities = 55/178 (30%), Positives = 84/178 (47%), Gaps = 28/178 (15%)

Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G+YG VYKGR    G  VA+K   L+   EG  ++   E  +LK ++H N+V +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 729 CTNHNFKALVLEYM-----------PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
               +   L+ E++           PKG   D     ++   I Q  GI+          
Sbjct: 68  LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQ--GIL---------- 115

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            F HS  ++H D+KP N+L+D+  V  L+DFG+A+       +  T  + T+ Y APE
Sbjct: 116 -FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV-YTHEVVTLWYRAPE 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 67.1 bits (164), Expect = 8e-12
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 24/204 (11%)

Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHL---QREGALNSFDAECEILKTIRHRN 721
           F++   IG GS+G+VY  R     E VAIK       Q          E   L+ +RH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDI----FQRLGIMIDVASALEYL 777
            ++        +   LV+EY        C+ +++  L++     Q + I      AL+ L
Sbjct: 77  TIEYKGCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQGL 128

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY- 836
            + HS+  +H DIK  N+LL +     L+DFG A L+S  +S      + T  ++APE  
Sbjct: 129 AYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-----VGTPYWMAPEVI 183

Query: 837 --GREGQVSIKGDVYNYGIMLMEV 858
               EGQ   K DV++ GI  +E+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 66.9 bits (164), Expect = 8e-12
 Identities = 53/181 (29%), Positives = 92/181 (50%), Gaps = 12/181 (6%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGRFPDGIE-VAIK--VFHLQREG-ALNSFDAECEILKT 716
           R+ D++ + N I  G+YG VY+ R     E VA+K      ++EG  + S   E  IL  
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLK 60

Query: 717 IRHRNLVKI--ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
           ++H N+V +  +   +N +   +V+EY+ +  L+  M          +   +M+ + S +
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKIYMVMEYV-EHDLKSLMETMKQPFLQSEVKCLMLQLLSGV 119

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            +LH    N I+H D+K SN+LL++  +  + DFG+A+          TQ + T+ Y AP
Sbjct: 120 AHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PYTQLVVTLWYRAP 175

Query: 835 E 835
           E
Sbjct: 176 E 176

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 66.7 bits (163), Expect = 9e-12
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 10/204 (4%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRN 721
           D F +   +G G+ G V K    P G+ +A K+ HL+ +    N    E ++L       
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCM-YASNFNLDIFQRLGIMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  A     +I  +  I I V   L YL   
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK--ISIAVLRGLTYLREK 118

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L   DSM  +  + T  Y++PE  +  
Sbjct: 119 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 173

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
             +++ D+++ G+ L+E+  G  P
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 19/203 (9%)

Query: 672 IGIGSYGSVY--KGRFPDGIEVAIKVFHLQREGALNSFDAECEI--LKTIRHRNLVKIIS 727
           IG GS+G +Y  K +  D     IK   L +        ++ E+  L  ++H N+V   +
Sbjct: 8   IGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIF----QRLGIMIDVASALEYLHFGHSN 783
           S   +    +V+EY   G   D M   N    +     Q L   + ++  L+++H     
Sbjct: 67  SFQENGRLFIVMEYCDGG---DLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DR 120

Query: 784 PIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPEYGREGQ 841
            I+H DIK  N+ L  + MVA L DFGIA+ L+  DSM+   T   T  Y++PE  +   
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEICQNRP 178

Query: 842 VSIKGDVYNYGIMLMEVFTGMKP 864
            + K D+++ G +L E+ T   P
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 36/195 (18%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHR 720
            ++ +   IG G++G V+K R       VA+K   ++ E       A  E +IL+ ++H 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71

Query: 721 NLVKIISSCTN-----HNFKA---LVLEYMPKGSLEDCMY-----ASN----FNLDIFQR 763
           N+V +I  C       + +K    LV E+        C +      SN    F L   ++
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEF--------CEHDLAGLLSNKNVKFTLSEIKK 123

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS---EEDSM 820
             +M  + + L Y+H    N I+H D+K +N+L+    +  L+DFG+A+  S        
Sbjct: 124 --VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178

Query: 821 KQTQTLATIGYIAPE 835
           + T  + T+ Y  PE
Sbjct: 179 RYTNRVVTLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 57/204 (27%), Positives = 83/204 (40%), Gaps = 22/204 (10%)

Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQR-------EGALNSFDAECEILKTIRHRNLV 723
           +G G +G V   +    G   A K    +R       + ALN    E +IL+ +  R +V
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN----EKKILEKVSSRFIV 56

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI---DVASALEYLHFG 780
            +  +    +   LV+  M  G L+  +Y  N     F     +     +   LE+LH  
Sbjct: 57  SLAYAFETKDDLCLVMTLMNGGDLKYHIY--NVGEPGFPEARAIFYAAQIICGLEHLH-- 112

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
               IV+ D+KP NVLLDD     +SD G+A  L      K      T GY+APE  +  
Sbjct: 113 -QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGE 169

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
                 D +  G  L E+  G  P
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 70/223 (31%), Positives = 104/223 (46%), Gaps = 43/223 (19%)

Query: 671 LIGIGSYGSVYKGRFPDGIE----VAIKVFHLQREG-ALNSFD-----AECEILKTIRHR 720
           ++G G YG V++ R   G +     A+KV  L++     N  D     AE  IL+ ++H 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGI-MIDVAS------- 772
            +V +I +        L+LEY+  G L   M+         +R GI M D A        
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGEL--FMH--------LEREGIFMEDTACFYLSEIS 110

Query: 773 -ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY 831
            ALE+LH      I++ D+KP N+LLD      L+DFG+ K    E ++  T    TI Y
Sbjct: 111 LALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEY 166

Query: 832 IAPE-YGREGQVSIKG-DVYNYGIMLMEVFTGMKPTNEFFTGE 872
           +APE   R G    K  D ++ G ++ ++ TG  P    FT E
Sbjct: 167 MAPEILMRSGHG--KAVDWWSLGALMYDMLTGAPP----FTAE 203

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 21/155 (13%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIK--VFHLQREGALNSFDAECEILKTIRHRNLVKIISS 728
           +G G++G VYK R    G  VA+K  + H +++G   +   E +ILK ++H N+V +I  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 729 CTNHNFKA--------LVLEYMPK---GSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
                 K+        +V  YM     G LE+     +  L   Q    M+ +   + YL
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN----PSVKLTESQIKCYMLQLLEGINYL 131

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK 812
           H    N I+H DIK +N+L+D+  +  ++DFG+A+
Sbjct: 132 H---ENHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 59/221 (26%)

Query: 672 IGIGSYGSVYK-------GRFPDGIEVAIKVFHLQ--REGALNSFDAECEILK---TIRH 719
           IG G+YG V+K       GRF     VA+K   +Q   EG   S   E  +L+   T  H
Sbjct: 9   IGEGAYGKVFKARDLKNGGRF-----VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 63

Query: 720 RNLVKIISSCT-----NHNFKALVLEYM----------------PKGSLEDCMYASNFNL 758
            N+V++   CT           LV E++                P  +++D M+      
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF------ 117

Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
                          L  L F HS+ +VH D+KP N+L+  S    L+DFG+A++ S + 
Sbjct: 118 -------------QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ- 163

Query: 819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
            M  T  + T+ Y APE   +   +   D+++ G +  E+F
Sbjct: 164 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 9/214 (4%)

Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG GS G V        G  VA+K   L+++        E  I++  +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   +V+E++  G+L D +  +  N +  Q   + + V  AL  LH   +  ++H DI
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  ++LL       LSDFG    +S+E   +++  + T  ++APE         + D+++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS-LVGTPYWMAPELISRLPYGPEVDIWS 201

Query: 851 YGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP 884
            GIM++E+  G  P   F    +   + I D+LP
Sbjct: 202 LGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNLP 233

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 54/219 (24%), Positives = 102/219 (46%), Gaps = 23/219 (10%)

Query: 671 LIGIGSYGSVYKGRFPDGIE--VAIKVFHL----------QREGALNSFDAECEILK-TI 717
            +G G++G VYK R  +  +  +A+K  ++          +R+ ++    +E  I+K  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 718 RHRNLVKIISSCTNHNFKALVLEYM---PKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
           RH N+V+   +   ++   +V++ +   P G   + +          +   I + +  AL
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            YLH      IVH D+ P+N++L +     ++DFG+AK    E  +  T  + TI Y  P
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--TSVVGTILYSCP 182

Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM 873
           E  +      K DV+ +G +L ++ T   P   F++  M
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNM 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 54/172 (31%), Positives = 84/172 (48%), Gaps = 17/172 (9%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHL--QREGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H N+VK++  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LEYLHFGHSN 783
               N   LV E++ +  L+  M       D     GI + +  +     L+ L F HS+
Sbjct: 68  IHTENKLYLVFEFLHQ-DLKKFM-------DASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.4 bits (162), Expect = 5e-11
 Identities = 34/81 (41%), Positives = 52/81 (64%), Gaps = 1/81 (1%)

Query: 165 NQ-FKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEI 223
           NQ  +G IPN++   + L S++LS N   G +P  LG+ T L+ LDL +N+ NG IP+ +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 224 GNLRNLEILGIDQSNLVGFVP 244
           G L +L IL ++ ++L G VP
Sbjct: 487 GQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 64.2 bits (156), Expect = 5e-11
 Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 22/218 (10%)

Query: 666 FSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFH--LQREGALNSFDAECEILKTIRH 719
           F+   ++G G +GSV + +         +VA+K+    +     +  F  E   +K   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 720 RNLVKIISSCTNHNFKA------LVLEYMPKGSLEDCMYASN-----FNLDIFQRLGIMI 768
            N++K+I        K       ++L +M  G L   +  S      F L +   +  MI
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ-TQTLA 827
           D+AS +EYL    S   +H D+   N +L+++M   ++DFG++K +   D  +Q   +  
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
            + ++A E   +   +   DV+ +G+ + E+ T G  P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 64.6 bits (157), Expect = 5e-11
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 22/200 (11%)

Query: 672 IGIGSYGSVYKGR--FPDGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+Y +VYKGR    D + VA+K   L+  EGA  +   E  +LK ++H N+V +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 729 CTNHNFKALVLEYMPKG---SLEDC---MYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                   LV EY+ K     L+DC   +   N  L +FQ           L  L++ H 
Sbjct: 73  IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQ----------LLRGLNYCHR 122

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQ 841
             ++H D+KP N+L+++     L+DFG+A+  S   +   +  + T+ Y  P+       
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYSNEVVTLWYRPPDILLGSTD 181

Query: 842 VSIKGDVYNYGIMLMEVFTG 861
            S + D++  G +  E+ TG
Sbjct: 182 YSTQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.8 bits (158), Expect = 5e-11
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 45/217 (20%)

Query: 671 LIGIGSYGSVY---KGRFPD-GIEVAIKVFHLQREGALNSFD-----AECEILKTIRHRN 721
           ++G GS+G V+   K   PD G   A+KV    ++  L   D      E +IL  + H  
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVL---KKATLKVRDRVRTKMERDILAEVNHPF 59

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG--IMI----------D 769
           +VK+  +        L+L+++  G             D+F RL   +M           +
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAE 106

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-AT 828
           +A AL++LH   S  I++ D+KP N+LLD+     L+DFG++K     D  K+  +   T
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 161

Query: 829 IGYIAPE-YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           + Y+APE   R G  +   D +++G+++ E+ TG  P
Sbjct: 162 VEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 53/219 (24%), Positives = 102/219 (46%), Gaps = 37/219 (16%)

Query: 672 IGIGSYGSVYKGRFPDG---IEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKII 726
           +G G +GSV +G+       ++VA+K   +       +  F +E   +K   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 727 SSC----TNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLG-------------IM 767
             C     +  + +  ++L +M  G L   +        ++ RLG              M
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFL--------LYSRLGDCPQYLPTQMLVKFM 118

Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA 827
            D+AS +EYL    S   +H D+   N +L+++M   ++DFG++K +   D  +Q +   
Sbjct: 119 TDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAK 175

Query: 828 T-IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
             + +IA E   +   + K DV+++G+ + E+ T G  P
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.9 bits (155), Expect = 8e-11
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 16/183 (8%)

Query: 699 QREG---ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY-AS 754
           +R+G   ALN    E +IL+ +  R +V +  +    +   LVL  M  G L+  +Y   
Sbjct: 40  KRKGESMALN----EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG 95

Query: 755 NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL 814
               +  + +    ++   LE LH      IV+ D+KP N+LLDD     +SD G+A  +
Sbjct: 96  EAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHV 152

Query: 815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS 874
            E  ++K    + T+GY+APE  +  + +   D +  G +L E+  G  P   F   +  
Sbjct: 153 PEGQTIK--GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP---FQQRKKK 207

Query: 875 IKR 877
           IKR
Sbjct: 208 IKR 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 64.0 bits (155), Expect = 8e-11
 Identities = 70/289 (24%), Positives = 123/289 (42%), Gaps = 43/289 (14%)

Query: 666 FSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHL---QREGALNSFDAECEILKTIRHRN 721
           F++   IG GS+G+VY  R     EV AIK       Q          E + L+ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS----ALEYL 777
            ++        +   LV+EY        C+ +++  L++ ++    +++A+    AL+ L
Sbjct: 87  SIEYKGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY- 836
            + HS+ ++H DIK  N+LL +     L+DFG A + S  +S      + T  ++APE  
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF-----VGTPYWMAPEVI 193

Query: 837 --GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
               EGQ   K DV++ GI  +E+     P    F                 MN M    
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN----------------MNAMSALY 234

Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
                E   +     +    +    C  + P++R  ++E++  +  +R+
Sbjct: 235 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 63.4 bits (154), Expect = 8e-11
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 24/212 (11%)

Query: 672 IGIGSYGSVYKGRFPDGIEVA-IKVFHLQREGALNS---FDAECEILKTIRHRNLVKIIS 727
           IG G +G V  G    G   A + V  L+   ++     F  E +  ++++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 728 SCTNHNFKALVLEYMP----KGSLEDCMYASNFNLD--IFQRLGIMIDVASALEYLHFGH 781
            CT      LV+E+ P    KG L  C  A     D    QR+    ++A  L +LH   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLH--- 117

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQTQTLATIGYIAPEYGREG 840
            N  +H D+   N LL   +   + D+G++    +ED  +   Q    + +IAPE   E 
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 841 QVSI-------KGDVYNYGIMLMEVFT-GMKP 864
             ++       + +V++ G+ + E+F  G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.2 bits (159), Expect = 9e-11
 Identities = 26/90 (28%), Positives = 56/90 (62%)

Query: 181 LSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLV 240
           +  + L      G +P D+     L+S++L  N++ G IP  +G++ +LE+L +  ++  
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 241 GFVPDTIFNISTLKILSLFNNTLSGNLPSS 270
           G +P+++  +++L+IL+L  N+LSG +P++
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAA 509

Length = 623

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 63.9 bits (155), Expect = 9e-11
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 30/213 (14%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRN 721
           D + +   +G GSY +VYKG+   +G  VA+KV  LQ E G   +   E  +LK ++H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 722 LVKIISSCTNHNFKALVLEYM-----------PKGSLEDCMYASNFNLDIFQRLGIMIDV 770
           +V +           LV EY+           P G     ++  N  L +FQ L      
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPENVKLFLFQLL------ 113

Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG 830
              L Y+H      I+H D+KP N+L+ D+    L+DFG+A+  S   S   +  + T+ 
Sbjct: 114 -RGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLW 168

Query: 831 YIAPE-YGREGQVSIKGDVYNYGIMLMEVFTGM 862
           Y  P+      + S   D++  G + +E+  G+
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGV 201

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.8 bits (155), Expect = 1e-10
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV----AIKVFH----LQREGALNSFDAECEILKTIRHRNL 722
           ++G G+YG V+  R   G +     A+KV      +Q+   +     E  +L+ +R    
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 723 VKIISSCTNHNFKA-LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI---DVASALEYLH 778
           +  +        K  L+L+Y+  G     M+   +  D F    +     ++  ALE+LH
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGE----MFTHLYQRDNFSEDEVRFYSGEIILALEHLH 122

Query: 779 -FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY- 836
             G    IV+ DIK  N+LLD      L+DFG++K    E+  +      TI Y+APE  
Sbjct: 123 KLG----IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 837 -GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            G+ G      D ++ GI++ E+ TG  P
Sbjct: 179 RGKGGHGKAV-DWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.1 bits (157), Expect = 1e-10
 Identities = 64/194 (32%), Positives = 92/194 (47%), Gaps = 56/194 (28%)

Query: 672 IGIGSYGSVYKGRFPD---GIEVAIK-VFHLQREGALNSFDA-----ECEILKTIR-HRN 721
           +G G+YG V+K    D      VA+K +F   R    N+ DA     E   L+ +  H N
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFR----NATDAQRTFREIMFLQELGDHPN 68

Query: 722 LVKIISSCTNHNFKA-------LVLEYMP--------KGSLEDCMYASNFNLDIFQRLGI 766
           +VK+++       KA       LV EYM            LED          + +R  I
Sbjct: 69  IVKLLNV-----IKAENDKDIYLVFEYMETDLHAVIRANILED----------VHKRY-I 112

Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQT 825
           M  +  AL+Y+H G+   ++H D+KPSN+LL+ D  V  L+DFG+A+ LSE +   +   
Sbjct: 113 MYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRV-KLADFGLARSLSELEENPENPV 168

Query: 826 L----ATIGYIAPE 835
           L    AT  Y APE
Sbjct: 169 LTDYVATRWYRAPE 182

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 35/218 (16%)

Query: 666 FSEENLIGIGSYGSV----YKGRFPDGIEVAIKVFHLQ---REGALNSFDAECEILKTIR 718
           F     +G GS+G V    +KG    G   AIK    +   +   +     E  IL  + 
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMIDVASALEYL 777
           H  +V ++ S  + N    +LE++  G L      A  F  D+ +      ++  A EYL
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA--ELVLAFEYL 134

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEY 836
           H   S  I++ D+KP N+LLD+     ++DFG AK + +     +T TL  T  Y+APE 
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPEV 186

Query: 837 GREGQVSIKG-----DVYNYGIMLMEVFTGMKPTNEFF 869
                +  KG     D +  G++L E   G  P   FF
Sbjct: 187 -----IQSKGHGKAVDWWTMGVLLYEFIAGYPP---FF 216

Length = 329

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 63.9 bits (155), Expect = 1e-10
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 14/216 (6%)

Query: 657 DELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECE 712
           D  ++A D +    +IG G++G V   R     +V A+K+   F + +      F  E +
Sbjct: 37  DLRMKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 713 ILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           I+       +V++  +  +  +  +V+EYMP G L + M  SN+++          +V  
Sbjct: 96  IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVL 153

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYI 832
           AL+ +H   S   +H D+KP N+LLD S    L+DFG    +++E  ++    + T  YI
Sbjct: 154 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210

Query: 833 APEY----GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           +PE     G +G    + D ++ G+ L E+  G  P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 16/200 (8%)

Query: 666 FSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHL---QREGALNSFDAECEILKTIRHRN 721
           FS+   IG GS+G+VY  R     EV AIK       Q          E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
            ++        +   LV+EY   GS  D +      L   Q + I      AL+ L + H
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAVTHGALQGLAYLH 132

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY---GR 838
           S+ ++H D+K  N+LL +  +  L DFG A +++  +       + T  ++APE      
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEVILAMD 187

Query: 839 EGQVSIKGDVYNYGIMLMEV 858
           EGQ   K DV++ GI  +E+
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 13/209 (6%)

Query: 671 LIGIGSYGSVY-KGRFPDGIEVAIKVFH----LQREGALNSFDAECEILKTIRHRNLVKI 725
           +IG GS+G V    R  DG   A+KV      L+++   +       +LK ++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
             S         VL+Y+  G L   +      L+   R     +VASA+ YLH   S  I
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SLNI 117

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIK 845
           ++ D+KP N+LLD      L+DFG+ K   E +    T    T  Y+APE  R+      
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYDRT 176

Query: 846 GDVYNYGIMLMEVFTGMKPTNEFFTGEMS 874
            D +  G +L E+  G+ P   F++ ++S
Sbjct: 177 VDWWCLGAVLYEMLYGLPP---FYSRDVS 202

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 63/228 (27%), Positives = 94/228 (41%), Gaps = 33/228 (14%)

Query: 659 LLRATDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTI 717
           L   T  F    +IG G+YG VYK R    G  VAIK+  +  E        E  IL+  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKY 59

Query: 718 -RHRNLVK-----IISSCTNHNFKA-LVLEYMPKGSLEDCMYASNFNLDIFQRLG----- 765
             H N+       I  +   ++ +  LV+E    GS+ D +          +RL      
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL---RKKGKRLKEEWIA 116

Query: 766 -IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ 824
            I+ +    L YLH    N ++H DIK  N+LL  +    L DFG++  L      + T 
Sbjct: 117 YILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT- 172

Query: 825 TLATIG---YIAPE-----YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
               IG   ++APE        +     + DV++ GI  +E+  G  P
Sbjct: 173 ---FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 11/169 (6%)

Query: 699 QREG---ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN 755
           +R+G   ALN    E +IL+ +  + +V +  +    +   LVL  M  G L+  +Y  N
Sbjct: 40  KRKGESMALN----EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY--N 93

Query: 756 FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS 815
                F+    +   A  L  L   H    V+ D+KP N+LLDD     +SD G+A  + 
Sbjct: 94  MGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153

Query: 816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           E +S++    + T+GY+APE     + ++  D +  G ++ E+  G  P
Sbjct: 154 EGESIR--GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 16/210 (7%)

Query: 672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFD-----AECEIL-KTIRHRNLVK 724
           IG GS+G V   +   DG   A+KV  LQ++  L   +     AE  +L K ++H  LV 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  S    +    VL+Y+  G L   +       +   R     ++ASAL YLH   S  
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116

Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGREGQVS 843
           I++ D+KP N+LLD      L+DFG+ K     +  K T T   T  Y+APE  R+    
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEFFTGEM 873
              D +  G +L E+  G+ P     T EM
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 2e-10
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 16/214 (7%)

Query: 671 LIGIGSYGSV-YKGRFPDGIEVAIKVFHLQ--REGALNSFDAE------CEILKTIR-HR 720
           ++G G+ G+V    R  DG   A+KV  ++   E   N   AE      C+    ++ H 
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98

Query: 721 NLVKI-ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
           +  K    +  N    ALVL+Y   G L   + +       F+     +     L  +H 
Sbjct: 99  DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHH 158

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  ++H DIK +N+LL  + +  L DFG +K+ +   S    +T   T  Y+APE  R
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
               S K D+++ G++L E+ T  +P    F GE
Sbjct: 219 RKPYSKKADMFSLGVLLYELLTLKRP----FDGE 248

Length = 496

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 34/210 (16%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALN---SFDAECEILKTIRHR-NLVKII 726
           I  G++GSVY  +    G   AIKV       A N   +  AE  I+        + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID---------VASALEYL 777
            S  + ++  LV+EY+  G   DC  AS     + + LG + +         V   +E L
Sbjct: 64  YSFQSKDYLYLVMEYLNGG---DC--AS-----LIKTLGGLPEDWAKQYIAEVVLGVEDL 113

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYG 837
           H      I+H DIKP N+L+D +    L+DFG    LS      + + + T  Y+APE  
Sbjct: 114 H---QRGIIHRDIKPENLLIDQTGHLKLTDFG----LSRNGLENK-KFVGTPDYLAPET- 164

Query: 838 REGQVSIK-GDVYNYGIMLMEVFTGMKPTN 866
             G    K  D ++ G ++ E   G  P +
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 55/156 (35%), Positives = 77/156 (49%), Gaps = 32/156 (20%)

Query: 672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQ-REGALNSFDA--ECEILKTIRHRNLV---K 724
           +G GSY +VYKGR    G  VA+K   L+  EGA   F A  E  +LK ++H N+V    
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIREASLLKDLKHANIVTLHD 70

Query: 725 IISSCTNHNFKAL--VLEYMP---KGSLEDC---MYASNFNLDIFQRLGIMIDVASALEY 776
           II     H  K L  V EY+    K  ++DC   +   N  L +FQ L         L Y
Sbjct: 71  II-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL-------RGLAY 118

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK 812
            H      ++H D+KP N+L+ +     L+DFG+A+
Sbjct: 119 CHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 13/201 (6%)

Query: 672 IGIGSYGSVYKGRF---PDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKII 726
           +G G++G+V KG +        VA+K+           +    E  +++ + +  +V++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
             C   ++  LV+E    G L   +   N ++       ++  V+  ++YL        V
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLE---ETNFV 117

Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREGQVSI 844
           H D+   NVLL     A +SDFG++K L  +++  + +T     + + APE     + S 
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177

Query: 845 KGDVYNYGIMLMEVFT-GMKP 864
           K DV+++G+++ E F+ G KP
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 62.7 bits (152), Expect = 3e-10
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 13/202 (6%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEILKTIRHRNLVKII 726
           +IG G++G V   R     +V A+K+   F + +      F  E +I+       +V++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
            +  +  +  +V+EYMP G L + M  SN+++          +V  AL+ +H   S  ++
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMGLI 164

Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY----GREGQV 842
           H D+KP N+LLD      L+DFG    + E   ++    + T  YI+PE     G +G  
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYY 224

Query: 843 SIKGDVYNYGIMLMEVFTGMKP 864
             + D ++ G+ L E+  G  P
Sbjct: 225 GRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 5e-10
 Identities = 71/245 (28%), Positives = 102/245 (41%), Gaps = 60/245 (24%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFH----LQREGALNSFDAECEILKTIR 718
           D F    +IG G++G V+  R  D G   A+KV      ++R    +   AE +IL    
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADAD 59

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQ----RLGIMIDVASAL 774
              +VK+  S  +     LV+EYMP G   D M       D+F     R  I  ++  AL
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGG---DLMNLLI-RKDVFPEETARFYIA-ELVLAL 114

Query: 775 EYLH-FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK--------------------- 812
           + +H  G     +H DIKP N+L+D      L+DFG+ K                     
Sbjct: 115 DSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 813 --LLSEEDSMKQTQTLA--TIG---YIAPE------YGREGQVSIKGDVYNYGIMLMEVF 859
             +L      KQ +  A  T+G   YIAPE      YG E       D ++ G++L E+ 
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE------CDWWSLGVILYEML 224

Query: 860 TGMKP 864
            G  P
Sbjct: 225 YGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 60.9 bits (148), Expect = 6e-10
 Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 19/150 (12%)

Query: 672 IGIGSYGSVYKGRFPDGIE-VAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G+YG+V+K +  +  E VA+K   L    EG  +S   E  +LK ++H+N+V++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 729 CTNHNFKALVLEYMP---KGSLEDC---MYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
             +     LV EY     K   + C   +        +FQ           L+ L F HS
Sbjct: 68  LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ----------LLKGLAFCHS 117

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAK 812
           + ++H D+KP N+L++ +    L+DFG+A+
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 60.9 bits (147), Expect = 7e-10
 Identities = 61/218 (27%), Positives = 91/218 (41%), Gaps = 29/218 (13%)

Query: 666 FSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTI------- 717
           F    L+G G+YG VYKGR    G   AIKV  +       + D E EI + I       
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-------TGDEEEEIKQEINMLKKYS 60

Query: 718 RHRNLVKIISSCTNHNFKA------LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA 771
            HRN+     +    N         LV+E+   GS+ D +   N   +  +   I     
Sbjct: 61  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICR 118

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY 831
             L  L   H + ++H DIK  NVLL ++    L DFG++  L      + T  + T  +
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYW 177

Query: 832 IAPEY-----GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           +APE        +     K D+++ GI  +E+  G  P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.6 bits (147), Expect = 8e-10
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 25/208 (12%)

Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSC 729
           +G G+YGSVYK    P G+ +A+K   L+  E   N    E +IL       +V    + 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----LEYLHFGHSNPI 785
                  + +EYM  GSL D +YA     +      ++  +  A    L++L   H+  I
Sbjct: 69  FIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLKEEHN--I 124

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPEYGREGQV 842
           +H D+KP+NVL++ +    L DFG++  L    S+ +T     IG   Y+APE  + G  
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKTN----IGCQSYMAPERIKSGGP 178

Query: 843 ------SIKGDVYNYGIMLMEVFTGMKP 864
                 +++ DV++ G+ ++E+  G  P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 60.6 bits (147), Expect = 8e-10
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 19/206 (9%)

Query: 672 IGIGSYGSVY----KGRFPDGIEVAIKVFH----LQREGALNSFDAECEILKTIRHRN-L 722
           +G G+YG V+     G    G   A+KV      +Q+         E ++L+ +R    L
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYAS-NFNLDIFQRLGIMI-DVASALEYLHFG 780
           V +  +        L+L+Y+  G L   +Y   +F       + + I ++  AL++LH  
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLALDHLH-- 122

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
               I++ DIK  N+LLD      L+DFG++K    E+  +      TI Y+APE  R G
Sbjct: 123 -QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181

Query: 841 QV--SIKGDVYNYGIMLMEVFTGMKP 864
                   D ++ G++  E+ TG  P
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.8 bits (147), Expect = 8e-10
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 20/199 (10%)

Query: 672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSC 729
           +G G+Y +V+KGR       VA+K   L+  EGA  +   E  +LK ++H N+V +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 730 TNHNFKALVLEYMP---KGSLEDC---MYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
                  LV EY+    K  L++C   M   N  + +FQ           L  L + H  
Sbjct: 73  HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQ----------LLRGLSYCHKR 122

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQV 842
            I+H D+KP N+L+++     L+DFG+A+  S   +   +  + T+ Y  P+      + 
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 843 SIKGDVYNYGIMLMEVFTG 861
           S   D++  G +L E+ TG
Sbjct: 182 STPIDMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 58/284 (20%), Positives = 125/284 (44%), Gaps = 39/284 (13%)

Query: 672 IGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNS---FDAECEILKTIRHRNLVK 724
           +G GS+G VY    KG   D  E  + +  +    ++     F  E  ++K     ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYA-----SNFNLDIFQRLGIMI----DVASALE 775
           ++   +      +++E M +G L+  + +      N  +     L  MI    ++A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT-QTLATIGYIAP 834
           YL+   +N  VH D+   N ++ +     + DFG+ + + E D  ++  + L  + +++P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E  ++G  +   DV+++G++L E+ T  +   +  + E  ++            +M+  L
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF-----------VMEGGL 239

Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           L + +        +C   +  L   C   +P+ R +  EIIS +
Sbjct: 240 LDKPD--------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 1e-09
 Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 2/95 (2%)

Query: 130 FISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYN 189
           FI   L   +  L G  P D+   L  L+ + +S N  +G IP +L     L  + LSYN
Sbjct: 419 FID-GLGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN 476

Query: 190 QFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIG 224
            F G +P  LG  T L+ L+L  N+L+G +P  +G
Sbjct: 477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 22/200 (11%)

Query: 672 IGIGSYGSVYKGR--FPDGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+Y +V+KGR    + + VA+K   L+  EGA  +   E  +LK ++H N+V +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 729 CTNHNFKALVLEYMPKG---SLEDC---MYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                   LV EY+ K     ++DC   M   N  + ++Q           L  L + H 
Sbjct: 73  VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQ----------ILRGLAYCHR 122

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR-EGQ 841
             ++H D+KP N+L+++     L+DFG+A+  S   +   +  + T+ Y  P+      +
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSSE 181

Query: 842 VSIKGDVYNYGIMLMEVFTG 861
            S + D++  G +  E+ +G
Sbjct: 182 YSTQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 17/212 (8%)

Query: 666 FSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLV 723
           F    ++G G+YG VYKGR    G   AIKV  +  E        E  +LK    HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76

Query: 724 K-----IISSCTNHNFKA-LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
                 I  S   H+ +  LV+E+   GS+ D +  +  N    +   I       L  L
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN--ALKEDWIAYICREILRGL 134

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY- 836
              H++ ++H DIK  NVLL ++    L DFG++  L      + T  + T  ++APE  
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVI 193

Query: 837 ----GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
                 +     + D+++ GI  +E+  G  P
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 34/214 (15%)

Query: 672 IGIGSYGSVYKGR--FPDGIEVAIKVFHLQREGALNSFDAECEILKTIR-------HRNL 722
           +G G++GSVY  R      + VAIK   ++++    S++ EC  L+ ++       H N+
Sbjct: 7   LGDGTFGSVYLARNKETGEL-VAIK--KMKKK--FYSWE-ECMNLREVKSLRKLNEHPNI 60

Query: 723 VKI--ISSCTNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHF 779
           VK+  +    +  +   V EYM +G+L   M               I+  +   L ++H 
Sbjct: 61  VKLKEVFRENDELY--FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH- 116

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ-TQTLATIGYIAPE-YG 837
              +   H D+KP N+L+    V  ++DFG+A+   E  S    T  ++T  Y APE   
Sbjct: 117 --KHGFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRWYRAPEILL 171

Query: 838 REGQVSIKGDVYNYGIMLMEVFTGMKP----TNE 867
           R    S   D++  G ++ E++T ++P    ++E
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYT-LRPLFPGSSE 204

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 60.4 bits (147), Expect = 1e-09
 Identities = 71/250 (28%), Positives = 110/250 (44%), Gaps = 51/250 (20%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPD---GIEVAIKVFHLQREGALNSFDA--ECEILKTIR 718
           D++   + +G G+YG V      D   G +VAIK      + A+++     E  +LK + 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAF--DTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD 72

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLED---------CMYASNFNLDIFQRLG---I 766
           H N   +I          L+  + P  SLED          M A   N+   Q+L    I
Sbjct: 73  HEN---VIG---------LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120

Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
              V   L  L + HS  I+H D+KPSN+ +++     + DFG+A+   +E  M  T  +
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--M--TGYV 176

Query: 827 ATIGYIAPE----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS 882
           AT  Y APE    +    Q     D+++ G ++ E+ TG K     F G   I     D 
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTG-KT---LFPGSDHI-----DQ 224

Query: 883 LPAVMNIMDT 892
           L  +MN++ T
Sbjct: 225 LKRIMNLVGT 234

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 73/264 (27%), Positives = 111/264 (42%), Gaps = 54/264 (20%)

Query: 672 IGIGSYGSVYKGRFPDG--IEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVKII 726
           +G GS+G V    + +     VAIK F    + ++  ++   +E +IL  I H   V + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 727 SSCTNHNFKALVLEYMPKGSL-------------EDCMYASNFNLDIFQRLGIMIDVASA 773
            S  + ++  LVLE++  G                 C YA+   L IF            
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL-IF------------ 144

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYI 832
            EYL    S  IV+ D+KP N+LLD      ++DFG AK++       +T TL  T  YI
Sbjct: 145 -EYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-----TRTYTLCGTPEYI 195

Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE-MSIKRWINDSLPAVMNIMD 891
           APE           D +  GI + E+  G  P   F+  E + I + I + +      +D
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPP---FYANEPLLIYQKILEGIIYFPKFLD 252

Query: 892 TN-------LLSED--EEHANVAK 906
            N       LLS D  + + N+ K
Sbjct: 253 NNCKHLMKKLLSHDLTKRYGNLKK 276

Length = 340

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 15/171 (8%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G+YG VYK R    G  VA+K   L+   EG  ++   E  +LK + H N+V+++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 729 CTNHNFKALVLEYMP---KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
             + N   LV E++    K  ++         LD       +  +   + Y    HS+ +
Sbjct: 67  VHSENKLYLVFEFLDLDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYC---HSHRV 120

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ-TQTLATIGYIAPE 835
           +H D+KP N+L+D      L+DFG+A+       ++  T  + T+ Y APE
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGV--PVRTYTHEVVTLWYRAPE 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 9/194 (4%)

Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECE--ILKTIRHRNLVKIISS 728
           +G GSYG V   R   DG +  IK  +L+         AE E  +L  ++H N+V    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 729 CTNHN-FKALVLEYMPKGSLEDCMYASNFNLDI-FQRLGIMIDVASALEYLHFGHSNPIV 786
               +    +V+ +   G L   +      L    Q +   + +A AL+YLH  H   I+
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---IL 124

Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H D+K  NV L  + +  + D GIA++L  +  M  T  + T  Y++PE       + K 
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKPYNYKS 183

Query: 847 DVYNYGIMLMEVFT 860
           DV+  G  + E+ T
Sbjct: 184 DVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 13/214 (6%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFH---LQREGALNSFDAECEILKTIRH 719
             F  ++L+G G +G V   R     ++ A+KV     L  +  ++ F+ E +IL     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             + ++  +  + +   LV+EY P G L   +   N   D F        +A  +  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHS 117

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY--- 836
            H    VH DIKP NVL+D +    L+DFG A  L+    +     + T  YIAPE    
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177

Query: 837 ---GREGQVSIKGDVYNYGIMLMEVFTGMKPTNE 867
                +G   ++ D ++ G++  E+  G  P +E
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 43/170 (25%), Positives = 86/170 (50%), Gaps = 15/170 (8%)

Query: 703 ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCM----------Y 752
           A N F  E +I+  +++ N+++++  C + +   ++ EYM  G L   +          +
Sbjct: 60  ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 753 ASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA 811
           A+N  ++ I   L + + +AS ++YL    S   VH D+   N L+ +     ++DFG++
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Query: 812 KLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
           + L   D  + Q + +  I ++A E    G+ +   DV+ +G+ L E+FT
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.6 bits (147), Expect = 3e-09
 Identities = 28/74 (37%), Positives = 45/74 (60%)

Query: 346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYL 405
           I  L +L +++L  N++ G++P +LG +  L+ LDL  N F G IP+     + L ++ L
Sbjct: 438 ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497

Query: 406 NRNKLSGSIPSCLG 419
           N N LSG +P+ LG
Sbjct: 498 NGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.3 bits (144), Expect = 3e-09
 Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 31/190 (16%)

Query: 664 DQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA---------ECEI 713
            ++     IG G+YG V        G +VAIK          ++FD          E +I
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRELKI 57

Query: 714 LKTIRHRNLVKI--ISSCTNHNFKA--LVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMI 768
           L+  +H N++ I  I      +FK   +V++ M +  L   +++      +  +    + 
Sbjct: 58  LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYF--LY 114

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL---SEEDSMKQTQT 825
            +   L+Y+H   S  ++H D+KPSN+L+++     + DFG+A+ L     E     T+ 
Sbjct: 115 QLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171

Query: 826 LATIGYIAPE 835
           +AT  Y APE
Sbjct: 172 VATRWYRAPE 181

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 10/208 (4%)

Query: 671 LIGIGSYGSVYKGRF-PDGIEVAIKVFH----LQREGALNSFDAECEILKTIRHRNLVKI 725
           +IG GS+G V   R   +    A+KV      L+++   +       +LK ++H  LV +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
             S    +    VL+Y+  G L   +      L+   R     ++ASAL YLH   S  I
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLNI 117

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIK 845
           V+ D+KP N+LLD      L+DFG+ K   E +    T    T  Y+APE   +      
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPYDRT 176

Query: 846 GDVYNYGIMLMEVFTGMKPTNEFFTGEM 873
            D +  G +L E+  G+ P     T EM
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 34/206 (16%)

Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS 727
           +G GSY +VYKG  R  +G  VA+KV  ++ E  +  F A  E  +LK ++H N+V +  
Sbjct: 13  LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHD 70

Query: 728 SCTNHNFKALVLEYM-----------PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
                     V EYM           P G     ++  N  L +FQ L         L Y
Sbjct: 71  IIHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLFMFQLL-------RGLAY 118

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE- 835
           +H  H   I+H D+KP N+L+       L+DFG+A+  S   S   +  + T+ Y  P+ 
Sbjct: 119 IHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP-SQTYSSEVVTLWYRPPDV 174

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTG 861
                  S   D++  G + +E+  G
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 28/228 (12%)

Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY-ASNFNLDIFQRLGIMI 768
           E EIL+ +    +V +  +  +     LV+  M  G L+  +Y      L++ + +    
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
            +   + +LH   S  IV+ D+KP NVLLDD     LSD G+A  L +  ++  TQ   T
Sbjct: 103 QITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI--TQRAGT 157

Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEF---FTGEMSIKRWINDSLPA 885
            GY+APE  +E   S   D +  G  + E+  G  P  +       E   +R + D +  
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF 217

Query: 886 VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKE 933
                         EH N  ++S     L LA     + PE+R+ ++E
Sbjct: 218 --------------EHQNFTEESKDICRLFLA-----KKPEDRLGSRE 246

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 16/211 (7%)

Query: 671 LIGIGSYGSVY-KGRFPDGIEVAIKVFHLQREGALNSFD-----AECEIL-KTIRHRNLV 723
           +IG GS+G V    R  DG   A+KV  LQ++  LN  +     AE  +L K ++H  LV
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKV--LQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
            +  S         VL+++  G L   +       +   R     ++ASAL YLH   S 
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SI 115

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAPEYGREGQV 842
            IV+ D+KP N+LLD      L+DFG+ K  +++ D+   T    T  Y+APE  R+   
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT--TTFCGTPEYLAPEVIRKQPY 173

Query: 843 SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM 873
               D +  G +L E+  G+ P       EM
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 58.3 bits (141), Expect = 5e-09
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 10/163 (6%)

Query: 703 ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY-ASNFNLDIF 761
           ALN    E +IL+ +  R +V +  +    +   LVL  M  G L+  +Y   N   D  
Sbjct: 47  ALN----EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE 102

Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK 821
           + +    ++   LE LH      IV+ D+KP N+LLDD     +SD G+A  + E ++++
Sbjct: 103 RAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159

Query: 822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
               + T+GY+APE  +  + +   D +  G ++ E+  G  P
Sbjct: 160 --GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 13/170 (7%)

Query: 699 QREG---ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY-AS 754
           +R+G   ALN    E  IL+ +  R +V +  +    +   LVL  M  G L+  +Y   
Sbjct: 40  KRKGEAMALN----EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG 95

Query: 755 NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL 814
           N   D  + +    ++   LE L       IV+ D+KP N+LLDD     +SD G+A  +
Sbjct: 96  NPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQI 152

Query: 815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            E ++++    + T+GY+APE     + +   D +  G ++ E+  G  P
Sbjct: 153 PEGETVR--GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 58.0 bits (140), Expect = 5e-09
 Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 23/207 (11%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA----LNSFDAECEILKTIRHRNLVKIIS 727
           IG G +G V  G    G+  A  V    R  A       F  E +  + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 728 SCTNHNFKALVLEYMPKGSL------EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
            C       LVLE+ P G L         M A     D+ QR+    +VAS L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMA--CEVASGLLWLHQAD 120

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT-IGYIAPEYGREG 840
               +H D+   N  L   +   + D+G+A     ED        A  + ++APE     
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 841 QVSI-------KGDVYNYGIMLMEVFT 860
              +       K ++++ G+ + E+FT
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 58.1 bits (141), Expect = 5e-09
 Identities = 62/262 (23%), Positives = 108/262 (41%), Gaps = 38/262 (14%)

Query: 691 VAIKVFHLQREGA----LNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGS 746
           VA+KV    R  A       F  E +IL  +   N+ +++  CT      +++EYM  G 
Sbjct: 49  VAVKVL---RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105

Query: 747 L---------EDCMYASNFNLDIFQRLGIMI-DVASALEYLHFGHSNPIVHCDIKPSNVL 796
           L         E    A N     F  L  M   +AS + YL    S   VH D+   N L
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCL 162

Query: 797 LDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIML 855
           +  +    ++DFG+++ L   D  + Q +    I ++A E    G+ + K DV+ +G+ L
Sbjct: 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222

Query: 856 MEVFTGMK--PTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAK-QSCASS 912
            E+ T  +  P        ++ ++ I ++          +   +D     + +  +C   
Sbjct: 223 WEILTLCREQPYE-----HLTDQQVIENA---------GHFFRDDGRQIYLPRPPNCPKD 268

Query: 913 VLSLAMECTSESPENRVNTKEI 934
           +  L +EC     E+R   +EI
Sbjct: 269 IYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 58.6 bits (142), Expect = 6e-09
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 29/217 (13%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEILKTIRH 719
           + F    +IG G++G V   R     +V A+K+   F + +      F  E +I+     
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM--IDVASALEYL 777
             +V++  +  +  +  +V+EYMP G L + M  SN+  DI ++       +V  AL+ +
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DIPEKWARFYTAEVVLALDAI 158

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-- 835
           H   S   +H D+KP N+LLD S    L+DFG    +     ++    + T  YI+PE  
Sbjct: 159 H---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL 215

Query: 836 --------YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
                   YGRE       D ++ G+ L E+  G  P
Sbjct: 216 KSQGGDGYYGRE------CDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 24/198 (12%)

Query: 672 IGIGSYGSVYKGRFPDGIE-VAIKVFHL---QREGALNSFDAECEILKTIRHRNLVKIIS 727
           IG GS+G+VY        E VA+K       Q          E + L+ ++H N ++   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS----ALEYLHFGHSN 783
                +   LV+EY        C+ +++  L++ ++    +++A+    AL+ L + HS+
Sbjct: 89  CYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY---GREG 840
            ++H DIK  N+LL +     L+DFG A   S  +S      + T  ++APE      EG
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF-----VGTPYWMAPEVILAMDEG 195

Query: 841 QVSIKGDVYNYGIMLMEV 858
           Q   K DV++ GI  +E+
Sbjct: 196 QYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 11/164 (6%)

Query: 699 QREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLE-DCMYASNFN 757
           QR G       E  IL+ I H +++++  + T + F  L+L   P+   +  C  A+  N
Sbjct: 126 QRGGTAT----EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRN 178

Query: 758 LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
           + I   L I   V  A++YLH    N I+H DIK  N+ ++      L DFG A    + 
Sbjct: 179 IAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235

Query: 818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTG 861
           ++ K      TI   APE           D+++ GI+L E+ T 
Sbjct: 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 23/209 (11%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV----AIKVFH----LQREGALNSFDAECEILKTIRHRNL 722
           ++G G+YG V+  R   G +     A+KV      +Q+         E ++L+ IR    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 723 VKIISSCTNHNFKA-LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI---DVASALEYLH 778
           +  +      + K  L+L+Y+  G L    +      + F+   + I   ++  ALE+LH
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVLALEHLH 122

Query: 779 -FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYG 837
             G    I++ DIK  N+LLD +    L+DFG++K   E++  +      TI Y+AP+  
Sbjct: 123 KLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 838 REGQVSIKG--DVYNYGIMLMEVFTGMKP 864
           R G        D ++ G+++ E+ TG  P
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 62/284 (21%), Positives = 119/284 (41%), Gaps = 39/284 (13%)

Query: 672 IGIGSYGSVYKGRFPDGI----EVAIKVFHLQREGALNS---FDAECEILKTIRHRNLVK 724
           +G GS+G VY+G   D I    E  + V  +    +L     F  E  ++K     ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMY-----ASNFNLDIFQRLGIMI----DVASALE 775
           ++   +      +V+E M  G L+  +      A N        L  MI    ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAP 834
           YL+   +   VH D+   N ++       + DFG+ + + E D   K  + L  + ++AP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E  ++G  +   D++++G++L E+ +  +   +  + E  +K            +MD   
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF-----------VMDGGY 239

Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           L + +        +C   V  L   C   +P+ R    EI++ L
Sbjct: 240 LDQPD--------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.5 bits (136), Expect = 3e-08
 Identities = 67/243 (27%), Positives = 112/243 (46%), Gaps = 44/243 (18%)

Query: 664 DQFSEENLIGIGSYGSV---YKGRFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIR 718
           D++ +   +G G+YG+V      R   G +VAIK  +   +  L +  A  E  +LK ++
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72

Query: 719 HRNLVKIISSCTN-------HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA 771
           H N++ ++   T        H+F  LV+ +M    L   M     + D  Q L     V 
Sbjct: 73  HENVIGLLDVFTPDLSLDRFHDF-YLVMPFMGT-DLGKLMKHEKLSEDRIQFL-----VY 125

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY 831
             L+ L + H+  I+H D+KP N+ +++     + DFG+A+   + DS + T  + T  Y
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDS-EMTGYVVTRWY 181

Query: 832 IAPE----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM 887
            APE    +    Q     D+++ G ++ E+ TG KP    F G        +D L  +M
Sbjct: 182 RAPEVILNWMHYTQTV---DIWSVGCIMAEMLTG-KP---LFKG--------HDHLDQLM 226

Query: 888 NIM 890
            IM
Sbjct: 227 EIM 229

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 56.9 bits (137), Expect = 3e-08
 Identities = 89/348 (25%), Positives = 126/348 (36%), Gaps = 44/348 (12%)

Query: 91  NKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDM 150
           +     +P  L  L  L++L  +      +      NL  +        N          
Sbjct: 56  SNTLLLLPSSLSRLLSLDLLSPSGI----SSLDGSENLLNLLPLPSLDLNLNRLRSNISE 111

Query: 151 CPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDL 210
              L  L  L +  N      P        L  + LS N+    LP  L N   LK+LDL
Sbjct: 112 LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL 170

Query: 211 GFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSS 270
            FN+L+ ++P+ + NL NL  L +   N +  +P  I  +S L+ L L NN++   L S 
Sbjct: 171 SFNDLS-DLPKLLSNLSNLNNLDLS-GNKISDLPPEIELLSALEELDLSNNSIIELLSSL 228

Query: 271 KNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSE 330
            N   L NL GL L  N L                  +G  SNL+ L L  N ++  +S 
Sbjct: 229 SN---LKNLSGLELSNNKLEDLP------------ESIGNLSNLETLDLSNNQISSISS- 272

Query: 331 LMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLP-ITLGRLKKLQGLDLQNNKFEGP 389
                          +G+L NL  L L  N+LS +LP I L  L     L+L        
Sbjct: 273 ---------------LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALE 317

Query: 390 IPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSV 437
           +       +      +  N    S P  L  L SL  L    N L   
Sbjct: 318 LKLNSILLN----NNILSNGE-TSSPEALSILESLNNLWTLDNALDES 360

Length = 394

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 56.2 bits (136), Expect = 3e-08
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 40/214 (18%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAEC-----EILKTI-RHRNLV 723
           ++G GS+G V         E+ A+KV  L+++  L   D EC      +L    +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM---------IDVASAL 774
           ++ S     +    V+EY+  G   D M+         QR G            ++   L
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGG---DLMFH-------IQRSGRFDEPRARFYAAEIVLGL 109

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI----G 830
           ++LH      I++ D+K  NVLLD      ++DFG+ K     + +    T +T      
Sbjct: 110 QFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-----EGILGGVTTSTFCGTPD 161

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           YIAPE           D +  G++L E+  G  P
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 48/275 (17%)

Query: 679 SVYKGRFPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRHRNLVKI----ISSCTN 731
           S+YKG F +  EV I+ F   H   +  ++  + E + L+ I   N++KI    I    +
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 732 HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIK 791
               +L+LEY  +G L + +     +L    +L + ID    L  L+   + P  + ++ 
Sbjct: 94  LPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 792 PSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY-----IAPEYGREGQVSIKG 846
             + L+ ++    +   G+ K+LS     K    +    Y     I  EY      +IK 
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSP-PFKNVNFMVYFSYKMLNDIFSEY------TIKD 203

Query: 847 DVYNYGIMLMEVFTGMKPTNEFFTGE---MSIKRWINDSLPAVMNIMDTNLLSEDEEHAN 903
           D+Y+ G++L E+FTG  P     T E   + I +  N+SL      +  +          
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK--NNSLK-----LPLD---------- 246

Query: 904 VAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                C   +  +   CTS     R N KEI+  L
Sbjct: 247 -----CPLEIKCIVEACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 3e-08
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 50/225 (22%)

Query: 664 DQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA---------ECEI 713
            ++   + IG G+YG V      P G++VAIK         ++ F+          E +I
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK--------KISPFEHQTFCQRTLREIKI 56

Query: 714 LKTIRHRNLVKI---ISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLD-----IFQR 763
           L+  +H N++ I   I   +  +F    +V E M    L   +   + + D     ++Q 
Sbjct: 57  LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQI 115

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL--LSEEDSMK 821
           L         L+Y+H   S  ++H D+KPSN+LL+ +    + DFG+A++     + +  
Sbjct: 116 L-------RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 822 QTQTLATIGYIAPEYGREGQVSIKG-----DVYNYGIMLMEVFTG 861
            T+ +AT  Y APE      ++ KG     D+++ G +L E+ + 
Sbjct: 166 LTEYVATRWYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 56.0 bits (135), Expect = 4e-08
 Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 36/218 (16%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEILK------TIRHRNLV 723
           ++G GS+G V         E  AIK   L+++  L   D EC +++         H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMY--ASNFNLDIFQRLGIMIDVASALEYLHFGH 781
            +  +         V+EY+  G   D M+   S+   D  +      ++   L++LH   
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLH--- 113

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQ 841
              I++ D+K  NVLLD      ++DFG+ K     +    T    T  YIAPE      
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEI----- 167

Query: 842 VSIKGDVYN-------YGIMLMEVFTGMKPTNEFFTGE 872
             +KG  YN       +G++L E+  G  P    F GE
Sbjct: 168 --LKGQKYNESVDWWSFGVLLYEMLIGQSP----FHGE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.4 bits (136), Expect = 5e-08
 Identities = 29/86 (33%), Positives = 42/86 (48%)

Query: 378 GLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSV 437
           GL L N    G IP +      L  + L+ N + G+IP  LG + SL +L LS N     
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 438 IPSTFWNLEDILGFDFSSNSLNGSLP 463
           IP +   L  +   + + NSL+G +P
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 24/206 (11%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEIL-KTI-----RHRNLV 723
           ++G GS+G V         EV AIKV  L+++  L   D +C +  K I     +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMY----ASNFNLDIFQRLGIMIDVASALEYLHF 779
            +       +    V+EY+  G   D M+    +  F  D  +      +V  AL +LH 
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRKF--DEPRSRFYAAEVTLALMFLH- 113

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
              + +++ D+K  N+LLD      L+DFG+ K          T T   T  YIAPE  +
Sbjct: 114 --RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQ 169

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
           E +     D +  G+++ E+  G  P
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 55.2 bits (133), Expect = 8e-08
 Identities = 61/253 (24%), Positives = 109/253 (43%), Gaps = 45/253 (17%)

Query: 670 NLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA--------------ECEIL 714
             +G G+YG V K      G  VAIK   +       + D               E +I+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 715 KTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
             I+H N++ ++      +F  LV++ M    L+  +      L   Q   I++ + + L
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGL 132

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK---------LLSEEDSMKQ--- 822
             L   H    +H D+ P+N+ ++   +  ++DFG+A+          LS++++M++   
Sbjct: 133 NVL---HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 823 -TQTLATIGYIAPE--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI 879
            T  + T+ Y APE   G E +     D+++ G +  E+ TG KP    F GE  I    
Sbjct: 190 MTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTG-KP---LFPGENEI---- 240

Query: 880 NDSLPAVMNIMDT 892
            D L  +  ++ T
Sbjct: 241 -DQLGRIFELLGT 252

Length = 335

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 44/167 (26%), Positives = 69/167 (41%), Gaps = 11/167 (6%)

Query: 701 EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDI 760
           EGA+     E  IL  +  R +V +  +        LV+  M  G L   +Y  +     
Sbjct: 38  EGAM----VEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG 93

Query: 761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM 820
           F         A  +  L   H   I++ D+KP NVLLD+     +SD G+A  L +    
Sbjct: 94  FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD---- 149

Query: 821 KQTQT---LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            Q++T     T G++APE  +  +     D +  G+ L E+     P
Sbjct: 150 GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 67/289 (23%), Positives = 117/289 (40%), Gaps = 55/289 (19%)

Query: 672 IGIGSYGSVYKGRF---PDG--------IEVAIKVFHLQREGALNSFDAECEILKTIRHR 720
           +G G++ ++YKG      D         + V +KV       +L +F     ++  + H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
           +LVK+   C       +V EY+  G L+  ++    N+ +  +L +   +ASAL YL   
Sbjct: 62  HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL--- 117

Query: 781 HSNPIVHCDIKPSNVLL-------DDSMVAHLSDFGIAK-LLSEEDSMKQTQTLATIGYI 832
               +VH ++   N+L+              LSD GI   +LS E      + +  I +I
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE------ERVERIPWI 171

Query: 833 APEYGREGQVS--IKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNI 889
           APE  R GQ S  I  D +++G  L+E+ + G +P +   + E          LP     
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM---- 227

Query: 890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                    E             + +L  +C +  P  R + + I+  L
Sbjct: 228 -----PDCAE-------------LANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 24/206 (11%)

Query: 671 LIGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNSFDAECEILK----TIRHRN- 721
           ++G GS+G V     KG+   G   A+K   L+++  L   D EC +++     +   N 
Sbjct: 2   VLGKGSFGKVLLAELKGK---GEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENP 56

Query: 722 -LVKIISSCTNHNFKALVLEYMPKGSLEDCMY--ASNFNLDIFQRLGIMIDVASALEYLH 778
            L  +  +         V+E++  G   D M+        D+++      ++   L++LH
Sbjct: 57  FLTHLYCTFQTKEHLFFVMEFLNGG---DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR 838
              S  I++ D+K  NV+LD      ++DFG+ K     D+ + +    T  YIAPE  +
Sbjct: 114 ---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RASTFCGTPDYIAPEILQ 169

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
             + +   D +++G++L E+  G  P
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 61/222 (27%), Positives = 90/222 (40%), Gaps = 56/222 (25%)

Query: 671 LIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSC 729
           ++G GS+G V   R    G   A+KV  L+++  L   D EC + +        +I+S  
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEK-------RILSLA 52

Query: 730 TNHNFKA-------------LVLEYMPKGSL-----------ED--CMYASNFNLDIFQR 763
            NH F                V+E++  G L           E     YA+         
Sbjct: 53  RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--------- 103

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
                ++ SAL +LH      I++ D+K  NVLLD      L+DFG+ K      + K T
Sbjct: 104 -----EITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTT 153

Query: 824 QTL-ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            T   T  YIAPE  +E       D +  G++L E+  G  P
Sbjct: 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 14/196 (7%)

Query: 672 IGIGSYGS--VYKGRFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS 727
           IG GS+G   + K +  DG +  IK  ++ +       ++  E  +L  ++H N+V+   
Sbjct: 8   IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASN---FNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           S   +    +V++Y   G L   + A     F  D  Q L   + +  AL+++H      
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED--QILDWFVQICLALKHVH---DRK 121

Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
           I+H DIK  N+ L       L DFGIA++L+    + +T  + T  Y++PE       + 
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICENRPYNN 180

Query: 845 KGDVYNYGIMLMEVFT 860
           K D++  G +L E+ T
Sbjct: 181 KSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 47/228 (20%), Positives = 93/228 (40%), Gaps = 34/228 (14%)

Query: 691 VAIKVFHL--QREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLE 748
           VA+K  +L    +  L     E    + ++H N++  ++S    +   +V   M  GS E
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87

Query: 749 DCMYASNFNLDIFQRLGI---MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL 805
           D +  ++F  +    L I   + DV +AL+Y+   HS   +H  +K S++LL       L
Sbjct: 88  DLL-KTHFP-EGLPELAIAFILKDVLNALDYI---HSKGFIHRSVKASHILLSGDGKVVL 142

Query: 806 SDFGIAKLLSEEDSMKQTQTLATIG------YIAPE--------YGREGQVSIKGDVYNY 851
           S    +  + +    ++              +++PE        Y        K D+Y+ 
Sbjct: 143 SGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNE------KSDIYSV 196

Query: 852 GIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
           GI   E+  G  P  +    +M +++ +  ++P    ++D +     E
Sbjct: 197 GITACELANGHVPFKDMPATQMLLEK-VRGTVP---CLLDKSTYPLYE 240

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 28/208 (13%)

Query: 671 LIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILK------TIRHRNLV 723
           ++G GS+G V+           AIK   L+++  L   D EC +++         H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMY--ASNFNLDIFQRLGIMIDVASALEYLHFGH 781
            +  +         V+EY+  G   D M+   S    D+ +      ++   L++LH   
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGG---DLMFHIQSCHKFDLPRATFYAAEIICGLQFLH--- 113

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPE--Y 836
           S  IV+ D+K  N+LLD      ++DFG+ K    E+ +   +T    G   YIAPE   
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCK----ENMLGDAKTCTFCGTPDYIAPEILL 169

Query: 837 GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           G++   S+  D +++G++L E+  G  P
Sbjct: 170 GQKYNTSV--DWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 3e-07
 Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 32/229 (13%)

Query: 649 VMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIK--------VFHLQ 699
             +R+  +  +    +++   + +G G+YGSV        G+ VA+K        + H +
Sbjct: 2   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 61

Query: 700 REGALNSFDAECEILKTIRHRNLVKII------SSCTNHNFKALVLEYMPKGSLEDCMYA 753
           R         E  +LK ++H N++ ++       S    N   LV   M    L + +  
Sbjct: 62  RTYR------ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC 114

Query: 754 SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL 813
                D  Q L  +  +   L+Y+H   S  I+H D+KPSN+ +++     + DFG+A+ 
Sbjct: 115 QKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 169

Query: 814 LSEEDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTG 861
             +E     T  +AT  Y APE        +   D+++ G ++ E+ TG
Sbjct: 170 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 17/202 (8%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFD-----AECEILKTIRHRNLVK 724
           L+G G++G V   R    G   A+K+  L++E  +   +      E  +L+  RH  L  
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSN 783
           +  +   H+    V+EY   G L   +     F  +  +  G   ++ SALEYLH   S 
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--EIVSALEYLH---SR 114

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAPEYGREGQV 842
            +V+ DIK  N++LD      ++DFG+ K  +S+  +MK      T  Y+APE   +   
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLEDNDY 172

Query: 843 SIKGDVYNYGIMLMEVFTGMKP 864
               D +  G+++ E+  G  P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 68/239 (28%), Positives = 99/239 (41%), Gaps = 55/239 (23%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFD---AECEILKTIRH 719
           + F    LI  G+YG+VY  R  +  +  A+K  + Q     N       E +IL    +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM-IDVAS------ 772
             +V +  S        +V+EY+  G   DC         + + +G + +D+A       
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGG---DCA-------TLLKNIGALPVDMARMYFAET 110

Query: 773 --ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL--------LSEEDSMKQ 822
             ALEYLH   +  IVH D+KP N+L+       L+DFG++K+        L E    K 
Sbjct: 111 VLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167

Query: 823 T------QTLATIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFF 869
           T      Q   T  YIAPE      YG+        D +  GI+L E   G  P   FF
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGK------PVDWWAMGIILYEFLVGCVP---FF 217

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 28/221 (12%)

Query: 663 TDQFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHR 720
           TD +     IG G+YG VYK     DG   A+K+     +      +AE  IL+++  H 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHP 79

Query: 721 NLVKIISSCTNHNFKA---------LVLEYMPKGSLEDCMYASNFNLDIFQRLG---IMI 768
           N+VK         +KA         LVLE    GS+ + +      L   QRL    I  
Sbjct: 80  NVVKFYGMF----YKADKLVGGQLWLVLELCNGGSVTELVKGL---LICGQRLDEAMISY 132

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
            +  AL  L   H+N I+H D+K +N+LL       L DFG++  L+    +++  ++ T
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST-RLRRNTSVGT 191

Query: 829 IGYIAPEY-----GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             ++APE        +     + DV++ GI  +E+  G  P
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.5 bits (114), Expect = 4e-07
 Identities = 24/56 (42%), Positives = 29/56 (51%)

Query: 475 IYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDL 530
           + LS N L+        GL NL+ L L  N L    PE+F  L SL  LDLS N+L
Sbjct: 5   LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.9 bits (127), Expect = 5e-07
 Identities = 34/122 (27%), Positives = 66/122 (54%), Gaps = 5/122 (4%)

Query: 745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH 804
            S ++     ++ LD+   L     VA  +++L    S   +H D+   NVLL D  VA 
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAK 252

Query: 805 LSDFGIAK-LLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GM 862
           + DFG+A+ ++++ + + +      + ++APE   +   +++ DV++YGI+L E+F+ G 
Sbjct: 253 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK 312

Query: 863 KP 864
            P
Sbjct: 313 SP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 33/211 (15%)

Query: 671 LIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISS- 728
           +IG G +G VY  R  D G   A+K    +R         + E L  +  R ++ ++S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-----KQGETL-ALNERIMLSLVSTG 54

Query: 729 ------CTNHNFKA-----LVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASAL 774
                 C  + F        +L+ M  G L       +++L    +F    +       +
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDL-------HYHLSQHGVFSEKEMRFYATEII 107

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
             L   H+  +V+ D+KP+N+LLD+     +SD G+A   S++   K   ++ T GY+AP
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAP 164

Query: 835 EYGREGQV-SIKGDVYNYGIMLMEVFTGMKP 864
           E  ++G       D ++ G ML ++  G  P
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 51.9 bits (124), Expect = 6e-07
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 20/212 (9%)

Query: 672 IGIGSYGSVYK-GRFPDGIEVAIKVF---HLQREGALNSFDAECEILKTIR-HRNLVKII 726
           IG G+YG V+K     +G + A+K+    H   E      +AE  ILK +  H N+VK  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE----EIEAEYNILKALSDHPNVVKFY 81

Query: 727 SSCTNHNFKA-----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
                 + K      LVLE    GS+ D +       +  +   I   +  AL  L   H
Sbjct: 82  GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY-GREG 840
            N  +H D+K +N+LL       L DFG++  L+    +++  ++ T  ++APE    E 
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQ 200

Query: 841 QVSI----KGDVYNYGIMLMEVFTGMKPTNEF 868
           Q+      + DV++ GI  +E+  G  P  + 
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPLADL 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 52.3 bits (125), Expect = 7e-07
 Identities = 66/225 (29%), Positives = 100/225 (44%), Gaps = 23/225 (10%)

Query: 249 NISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALEL 308
           N+  L  L L  N L  N+     L    NL  L+L  NN++   P      S L  L+L
Sbjct: 91  NLLPLPSLDLNLNRLRSNISELLEL---TNLTSLDLDNNNITDIPPLIGLLKSNLKELDL 147

Query: 309 GYNSNLKRLGLERNYLT------FSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNL 362
             N  ++ L      L        S ++L  L           + NL NL  L L  N +
Sbjct: 148 SDN-KIESLPSPLRNLPNLKNLDLSFNDLSDLPKL--------LSNLSNLNNLDLSGNKI 198

Query: 363 SGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLN 422
           S  LP  +  L  L+ LDL NN     +     +   L  + L+ NKL   +P  +G+L+
Sbjct: 199 S-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLS 255

Query: 423 SLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIE 467
           +L  L LS+N+++S+  S+  +L ++   D S NSL+ +LPL   
Sbjct: 256 NLETLDLSNNQISSI--SSLGSLTNLRELDLSGNSLSNALPLIAL 298

Length = 394

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.0 bits (124), Expect = 7e-07
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 17/202 (8%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFD-----AECEILKTIRHRNLVK 724
           L+G G++G V   R    G   A+K+  L++E  +   +      E  +LK  RH  L  
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKI--LKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSN 783
           +  S    +    V+EY+  G L   +     F+ D  +  G   ++ SAL+YLH G   
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA--EIVSALDYLHSGK-- 115

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAPEYGREGQV 842
            IV+ D+K  N++LD      ++DFG+ K  +++  +MK      T  Y+APE   +   
Sbjct: 116 -IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK--TFCGTPEYLAPEVLEDNDY 172

Query: 843 SIKGDVYNYGIMLMEVFTGMKP 864
               D +  G+++ E+  G  P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 51.6 bits (124), Expect = 9e-07
 Identities = 64/251 (25%), Positives = 100/251 (39%), Gaps = 60/251 (23%)

Query: 672 IGIGSYGSVYKGRF---PDGIEVAIKVFHLQREGALNSFDAECEILKTIR---------- 718
           +G G+YG V   R     +   VAIK          N F  +    + +R          
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIK-------KITNVFSKKILAKRALRELKLLRHFRG 60

Query: 719 HRNLVKIISS--CTNHNFKALVLEYMPKGSLEDCMYAS-----------NFNLDIFQRLG 765
           H+N+  +         NF  L L Y     L +                +F   I+Q L 
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYL-YE---ELMEADLHQIIRSGQPLTDAHFQSFIYQIL- 115

Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE---EDSMKQ 822
                   L+Y+H   S  ++H D+KP N+L++      + DFG+A+  SE   E++   
Sbjct: 116 ------CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166

Query: 823 TQTLATIGYIAPEYGREGQVSIKG-DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND 881
           T+ +AT  Y APE     Q   K  DV++ G +L E   G KP    F G+  +     D
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGKDYV-----D 217

Query: 882 SLPAVMNIMDT 892
            L  ++ ++ T
Sbjct: 218 QLNQILQVLGT 228

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 27/204 (13%)

Query: 671 LIGIGSYGSVYKG-RFPDGIEVAIKVFH--LQREGALNSFDAECEILKTIRHRNLVKII- 726
            +G G+YGSV        G +VAIK      Q E        E  +LK ++H N++ ++ 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 727 ---SSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
              S+ +   F+   LV+ YM +  L+  M     + D  Q L     V   L  L + H
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYM-QTDLQKIM-GHPLSEDKVQYL-----VYQMLCGLKYIH 134

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YG 837
           S  I+H D+KP N+ +++     + DFG+A+    E     T  + T  Y APE    + 
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWM 190

Query: 838 REGQVSIKGDVYNYGIMLMEVFTG 861
              Q     D+++ G ++ E+ TG
Sbjct: 191 HYNQTV---DIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 51.7 bits (124), Expect = 1e-06
 Identities = 25/62 (40%), Positives = 38/62 (61%), Gaps = 3/62 (4%)

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+YLH      I+H DIKP N+L++ + V  + DFG+A++   ++S   TQ + T  Y A
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172

Query: 834 PE 835
           PE
Sbjct: 173 PE 174

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 66/257 (25%), Positives = 111/257 (43%), Gaps = 45/257 (17%)

Query: 672 IGIGSYGSV---YKGRFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKII 726
           +G G+YGSV   Y  R     +VA+K      +  +++     E  +LK ++H N++ ++
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 727 S----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---IMIDVASALEYLHF 779
                + +  NF  + L       + + M A   N+   Q+L    +   +   L  L +
Sbjct: 81  DVFTPATSIENFNEVYL-------VTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKY 133

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE---- 835
            HS  I+H D+KPSNV +++     + DFG+A+   +E     T  +AT  Y APE    
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLN 189

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN-- 893
           +    Q     D+++ G ++ E+  G       F G   I     D L  +M ++ T   
Sbjct: 190 WMHYNQTV---DIWSVGCIMAELLKG----KALFPGNDYI-----DQLKRIMEVVGTPSP 237

Query: 894 --LLSEDEEHANVAKQS 908
             L     EHA    QS
Sbjct: 238 EVLKKISSEHARKYIQS 254

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 64/240 (26%), Positives = 106/240 (44%), Gaps = 39/240 (16%)

Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI----- 725
           +G GS G V+     D    VA+K   L    ++     E +I++ + H N+VK+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 726 ---------ISSCTNHNFKALVLEYMP---KGSLEDCMYASNF-NLDIFQRLGIMIDVAS 772
                    + S T  N   +V EYM       LE    +     L ++Q L        
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL-------R 125

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATI 829
            L+Y+H   S  ++H D+KP+NV ++ + +V  + DFG+A+++    S K   ++ L T 
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 830 GYIAPEYGREGQVSIKG-DVYNYGIMLMEVFTGMKPTNEFFTG--EMSIKRWINDSLPAV 886
            Y +P          K  D++  G +  E+ TG KP    F G  E+   + I +S+P V
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KP---LFAGAHELEQMQLILESVPVV 238

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 51.5 bits (123), Expect = 1e-06
 Identities = 37/127 (29%), Positives = 65/127 (51%), Gaps = 8/127 (6%)

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQ 822
           +G    VA+ +E+L    S   VH D+   NVL+ +  +  + DFG+A+ ++ + + + +
Sbjct: 242 VGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK 298

Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEM---SIKRW 878
             T   + ++APE       +   DV+++GI+L E+FT G  P  E    E    +IKR 
Sbjct: 299 GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG 358

Query: 879 INDSLPA 885
              + PA
Sbjct: 359 YRMAKPA 365

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 26/209 (12%)

Query: 672 IGIGSYGSVYKGRFPDGI---EVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKII 726
           +G G+YG VYK +  DG    E A+K    Q EG   S  A  E  +L+ ++H N++ + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKHPNVIALQ 64

Query: 727 SSCTNHNFKA--LVLEYMPKGSLEDCMY--ASNFNLDIFQRLGIMID--VASALEYLHFG 780
               +H+ +   L+ +Y          +  AS  N    Q    M+   +   L+ +H+ 
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 781 HSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTL----ATIGYI 832
           H+N ++H D+KP+N+L+     +     ++D G A+L +    +K    L     T  Y 
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS--PLKPLADLDPVVVTFWYR 182

Query: 833 APEYGREGQVSIKG-DVYNYGIMLMEVFT 860
           APE     +   K  D++  G +  E+ T
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 30/107 (28%), Positives = 59/107 (55%), Gaps = 11/107 (10%)

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTLAT 828
           VA  +E+L    S   +H D+   N+LL ++ V  + DFG+A+ +  + D +++      
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 50.8 bits (122), Expect = 2e-06
 Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 58/223 (26%)

Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA-----ECEILKTIRHRNLVK- 724
           IG G+YG V   +  +   +VAIK      +   N  DA     E ++L+ + H N++  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAI 69

Query: 725 --IISSCTNHNFKA--LVLEYM----------PKGSLED-CMYASNFNLDIFQRLGIMID 769
             I+       F    +V E M           +   +D C Y   F   ++Q L     
Sbjct: 70  KDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQY---F---LYQLL----- 118

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE-EDSMKQTQTLAT 828
               L+Y+H   S  ++H D+KPSN+LL+ +    + DFG+A+  SE  D M  T+ + T
Sbjct: 119 --RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVT 171

Query: 829 IGYIAPE-------YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             Y APE       Y      +I  DV++ G +  E+  G KP
Sbjct: 172 RWYRAPELLLNCSEYT----TAI--DVWSVGCIFAELL-GRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 21/215 (9%)

Query: 672 IGIGSYGSVYKGRFPDGIEV----AIKVFHLQREGALNSFDAECEILKTIRHRNLVKIIS 727
           IG GS+G V + R  D   +     I+  H+     +    AE  +L  +    +V +  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 728 SCTNHNFKALVLEYMPKGSL------EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           S  +     LVL ++  G L      E     S       + L        ALE LH   
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELL-------CALENLH--- 110

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQ 841
              +++ D+KP N+LLD      L DFG+ K L+ +D  K      T  Y+APE      
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHG 169

Query: 842 VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
            +   D +  G++L E+ TG+ P  +    EM  K
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK 204

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 42/182 (23%), Positives = 86/182 (47%), Gaps = 15/182 (8%)

Query: 691 VAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL-- 747
           VA+K+      + A N F  E +I+  ++  N++++++ C   +   ++ EYM  G L  
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 748 -------EDCMYASNFNLDIFQRLGIM-IDVASALEYLHFGHSNPIVHCDIKPSNVLLDD 799
                  ++    ++     +  L  M   +AS ++YL    S   VH D+   N L+  
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165

Query: 800 SMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEV 858
           +    ++DFG+++ L   D  + Q + +  I +++ E    G+ +   DV+ +G+ L E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Query: 859 FT 860
            T
Sbjct: 226 LT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 25/92 (27%), Positives = 53/92 (57%), Gaps = 4/92 (4%)

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTLAT 828
           VA  +E+L    S   +H D+   N+LL ++ V  + DFG+A+ +  + D +++      
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
           + ++APE   +   + + DV+++G++L E+F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 8/130 (6%)

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           ++   LE++H   +  +V+ D+KP+N+LLD+     +SD G+A   S++   K   ++ T
Sbjct: 105 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGT 158

Query: 829 IGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE-MSIKRWINDSLPAV 886
            GY+APE  ++G       D ++ G ML ++  G  P  +  T +   I R        +
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 218

Query: 887 MNIMDTNLLS 896
            +     L S
Sbjct: 219 PDSFSPELRS 228

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.2 bits (108), Expect = 3e-06
 Identities = 24/60 (40%), Positives = 36/60 (60%)

Query: 495 NLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
           NL+ L L +N+L      +F  L +L+ LDLS N+L+ + P +   L  L+SL+LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.8 bits (121), Expect = 3e-06
 Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 25/169 (14%)

Query: 709 AECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL---- 764
           +E   L    H  +VK      + +   L++EY   G L         N  I QRL    
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL---------NKQIKQRLKEHL 164

Query: 765 -------GIMI-DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE 816
                  G++   +  AL+ +H   S  ++H D+K +N+ L  + +  L DFG +K  S+
Sbjct: 165 PFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221

Query: 817 EDSMKQTQTL-ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             S+    +   T  Y+APE     + S K D+++ G++L E+ T  +P
Sbjct: 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.2 bits (120), Expect = 3e-06
 Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 8/151 (5%)

Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMI 768
           E +ILKTI HR ++ +I +      K+ V   MPK   +   Y      L + Q + I  
Sbjct: 136 EIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQR 192

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA-KLLSEEDSMKQTQTLA 827
            +  AL YLH      I+H D+K  N+ LD+   A L DFG A KL +  D+ +      
Sbjct: 193 RLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249

Query: 828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEV 858
           T+   +PE         K D+++ G++L E+
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 30/104 (28%), Positives = 53/104 (50%), Gaps = 4/104 (3%)

Query: 758 LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSE 816
           L     L     VA  +E+L    S   VH D+   NVLL    +  + DFG+A+ ++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
            + + +  T   + ++APE   +   +   DV++YGI+L E+F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 50.1 bits (119), Expect = 3e-06
 Identities = 49/213 (23%), Positives = 99/213 (46%), Gaps = 18/213 (8%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFH---LQREGALNSFDAECEILKTIRH 719
           + F    +IG G++G V   +  +  +V A+K+ +   + +      F  E ++L    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCM--YASNFNLDIFQ-RLGIMIDVASALEY 776
           + +  +  +  + N   LV++Y   G L   +  +      D+ +  L  M+    ++  
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
           LH+      VH DIKP N+L+D +    L+DFG    L E+ +++ +  + T  YI+PE 
Sbjct: 121 LHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174

Query: 837 GR-----EGQVSIKGDVYNYGIMLMEVFTGMKP 864
            +     +G+   + D ++ G+ + E+  G  P
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 49.5 bits (119), Expect = 3e-06
 Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 26/167 (15%)

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + N +K+  S T      L+++Y+  G L D +      L   +   I+  +  AL  LH
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLH 126

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMV-AHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEY 836
               + I+H DIK  NVL D +    +L D+G+ K       +        T+ Y +PE 
Sbjct: 127 ---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLDYFSPE- 176

Query: 837 GREGQVSIKGDVYNY-------GIMLMEVFTGMKPTNEFFTGEMSIK 876
                  IKG  Y+        G++  E+ TG  P  E    E+ ++
Sbjct: 177 ------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217

Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 48.7 bits (116), Expect = 7e-06
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 51/232 (21%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA---------ECE 712
           T+++ +   +G+G++G V   R    G  VAIK         +  F           E +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELK 61

Query: 713 ILKTIRHRNLVKI----ISSCTNHNFKALVL-----EYMPKGSLEDCMYASNFNLDIFQR 763
           +LK +RH N++ +    IS   +  F   +L       +    LE   +   F   I + 
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEK-QFIQYFLYQILR- 119

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
                     L+Y+H   S  +VH D+KPSN+L++++    + DFG+A++  ++  M  T
Sbjct: 120 ---------GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQM--T 163

Query: 824 QTLATIGYIAPEYGREGQ-VSIKGDVYNYGIMLME------VFTGMKPTNEF 868
             ++T  Y APE     Q   ++ D+++ G +  E      +F G    N+F
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF 215

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 8e-06
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 36/168 (21%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEILKTIRHRNLVKII 726
           L+G G  G V+  R     ++ A+KV     + +   +     E EIL T+ H  L  + 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 727 SSCTNHNFKALVLEYMPKGSL--------EDCM-------YASNFNLDIFQRLGIMIDVA 771
           +S     +  LV++Y P G L          C+       YA+              +V 
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA--------------EVL 113

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS 819
            ALEYLH      IV+ D+KP N+LL +S    LSDF ++K    E  
Sbjct: 114 LALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 44/222 (19%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEIL-KTI-----RHRNLV 723
           ++G GS+G V         E+ AIK+  L+++  +   D EC ++ K +     +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID------VASALEYL 777
           ++ S     +    V+EY+  G   D MY         Q++G   +       A     L
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGG---DLMYH-------IQQVGKFKEPHAVFYAAEIAIGL 114

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPE- 835
            F HS  I++ D+K  NV+LD      ++DFG+ K        K T+T   T  YIAPE 
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEI 172

Query: 836 -----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
                YG+    S+  D + +G++L E+  G  P    F GE
Sbjct: 173 IAYQPYGK----SV--DWWAFGVLLYEMLAGQPP----FDGE 204

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 55/254 (21%), Positives = 96/254 (37%), Gaps = 36/254 (14%)

Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHR 720
           D + +   IG G+YG VYK R    G  VA+K   L+   EG   +   E  +L+ +   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 721 N-LVKIIS--SCTNHNFKA---LVLEYMPKG--SLEDCMYASNFN---LDIFQRLGIMID 769
             +V+++        N K    LV EY+        D               +    M  
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF--MYQ 118

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDS-MVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           +   + +    H + ++H D+KP N+L+D    +  ++D G+ +  S       T  + T
Sbjct: 119 LLKGVAHC---HKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIVT 174

Query: 829 IGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE------MSIKRWI-- 879
           + Y APE        S   D+++ G +  E+          F G+      + I + +  
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK----QPLFPGDSELQQLLHIFKLLGT 230

Query: 880 --NDSLPAVMNIMD 891
                 P V  + D
Sbjct: 231 PTEQVWPGVSKLRD 244

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 27/97 (27%), Positives = 55/97 (56%), Gaps = 5/97 (5%)

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTLAT 828
           VA  +E+L    S   +H D+   N+LL ++ V  + DFG+A+ +  + D +++      
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           + ++APE   +   + + DV+++G++L E+F+ G  P
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 48.6 bits (116), Expect = 1e-05
 Identities = 29/114 (25%), Positives = 49/114 (42%), Gaps = 20/114 (17%)

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL---------- 813
           L I   + + +EY+H   S  ++H D+KP N+LL       + D+G A            
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 814 --LSEEDSMKQTQT-----LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
             + E +    + T     + T  Y+APE       S   D+Y  G++L ++ T
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 50/225 (22%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAEC-----EILKTIRHRNLVK 724
           ++G GS+G V         E+ AIK+  L+++  +   D EC      +L        + 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64

Query: 725 IISSCTNHNFKAL-----VLEYMPKGSLEDCMYASNFNLDIFQRLGIMID---VASALEY 776
            + SC    F+ +     V+EY+  G   D MY         Q++G   +   V  A E 
Sbjct: 65  QLHSC----FQTVDRLYFVMEYVNGG---DLMYH-------IQQVGKFKEPQAVFYAAEI 110

Query: 777 ---LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
              L F H   I++ D+K  NV+LD      ++DFG+ K     D +       T  YIA
Sbjct: 111 SVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIA 169

Query: 834 PE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           PE      YG+    S+  D + YG++L E+  G  P    F GE
Sbjct: 170 PEIIAYQPYGK----SV--DWWAYGVLLYEMLAGQPP----FDGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 47.4 bits (112), Expect = 2e-05
 Identities = 62/242 (25%), Positives = 108/242 (44%), Gaps = 32/242 (13%)

Query: 672 IGIGSYGSVYKGRFPDGIE---VAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKII 726
           +G G+YG VYK +  DG +    A+K    Q EG   S  A  E  +L+ ++H N++ + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALK----QIEGTGISMSACREIALLRELKHPNVISLQ 64

Query: 727 SSCTNHNFKA--LVLEYMPKGSLEDCMY--ASNFNLDIFQRLGIMID--VASALEYLHFG 780
               +H  +   L+ +Y          +  AS  N    Q    M+   +   L+ +H+ 
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 781 HSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTL----ATIGYI 832
           H+N ++H D+KP+N+L+     +     ++D G A+L +    +K    L     T  Y 
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS--PLKPLADLDPVVVTFWYR 182

Query: 833 APEYGREGQVSIKG-DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR---WINDSLPAVMN 888
           APE     +   K  D++  G +  E+ T  +P   F   +  IK    + +D L  + N
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTS-EPI--FHCRQEDIKTSNPYHHDQLDRIFN 239

Query: 889 IM 890
           +M
Sbjct: 240 VM 241

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 47/194 (24%), Positives = 86/194 (44%), Gaps = 10/194 (5%)

Query: 672 IGIGSYGSVY--KGRFPDGIEVAIKVFHLQREGALNSFDA-----ECEILKTIRHRNLVK 724
           +G GS+G+VY  K +     E  +KV      G LN  +      E ++L  + H  +VK
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEE-RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
             +S    +   ++ EY     L+  +              +       L  +H+ H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
           I+H D+K  N+ L ++++  + DFG+++LL     +  T T  T  Y++PE  +      
Sbjct: 127 ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT-GTPYYMSPEALKHQGYDS 184

Query: 845 KGDVYNYGIMLMEV 858
           K D+++ G +L E+
Sbjct: 185 KSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 28/211 (13%)

Query: 669 ENLIGIGSYGSVYKG---RFPDG-----IEVAIKVFHLQREGALNSFDAECEILKTIRHR 720
           E+L G G++  ++KG      D       EV +KV          SF     ++  + H+
Sbjct: 1   ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-LHF 779
           +LV     C   +   +V EY+  GSL+  +  +   ++I  +L    +VA  L + LHF
Sbjct: 60  HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL----EVAKQLAWALHF 115

Query: 780 GHSNPIVHCDIKPSNVLL----DDSM----VAHLSDFGIAKLLSEEDSMKQTQTLATIGY 831
                + H ++   NVLL    D          LSD GI+  +  ++ +     L  I +
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL-----LERIPW 170

Query: 832 IAPEYGREGQ-VSIKGDVYNYGIMLMEVFTG 861
           + PE     Q +S+  D +++G  L E+F+G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 49/210 (23%), Positives = 95/210 (45%), Gaps = 12/210 (5%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFH---LQREGALNSFDAECEILKTIRH 719
           D F    +IG G++G V   +      + A+K+ +   + +      F  E  +L     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
           + +  +  +  + N+  LV++Y   G L   +  S F   + + +     +A  +  +H 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFY-IAEMVLAIHS 117

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
            H    VH DIKP NVLLD +    L+DFG    ++++ +++ +  + T  YI+PE  + 
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177

Query: 840 -----GQVSIKGDVYNYGIMLMEVFTGMKP 864
                G+   + D ++ G+ + E+  G  P
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 14/160 (8%)

Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMI 768
           E  +L+  RH  L  +  S   H+    V+EY   G L   +     F+ D  +  G   
Sbjct: 45  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-- 102

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           ++ SAL+YLH      +V+ D+K  N++LD      ++DFG+ K     + +K   T+ T
Sbjct: 103 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKT 155

Query: 829 I----GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
                 Y+APE   +       D +  G+++ E+  G  P
Sbjct: 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 30/203 (14%)

Query: 679 SVYKGRFPDGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL 737
           +V KGR    + VA+K+      + A N F  E +IL  ++  N+++++  C + +   +
Sbjct: 40  NVRKGR---PLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCM 96

Query: 738 VLEYMPKGSLEDCMYASNFNLD-------------------IFQRL-GIMIDVASALEYL 777
           + EYM  G L    + S+ +LD                    +  L  + + +AS ++YL
Sbjct: 97  ITEYMENGDLNQ--FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL 154

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEY 836
               S   VH D+   N L+ +++   ++DFG+++ L   D  + Q + +  I ++A E 
Sbjct: 155 ---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWEC 211

Query: 837 GREGQVSIKGDVYNYGIMLMEVF 859
              G+ +   DV+ +G+ L E+ 
Sbjct: 212 ILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 47.9 bits (114), Expect = 3e-05
 Identities = 36/116 (31%), Positives = 54/116 (46%), Gaps = 27/116 (23%)

Query: 256 LSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLK 315
           L L N  L G +P+  ++  L +L+ +NL  N++ G+IP    + + L  L+L YNS   
Sbjct: 423 LGLDNQGLRGFIPN--DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS--- 477

Query: 316 RLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLG 371
                     F+ S   SL            G L +L  L+L  N+LSG +P  LG
Sbjct: 478 ----------FNGSIPESL------------GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.3 bits (112), Expect = 3e-05
 Identities = 66/243 (27%), Positives = 111/243 (45%), Gaps = 45/243 (18%)

Query: 670 NLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI--- 725
           N+IG GS+G VY+    D  E VAIK   LQ     N    E  I+K + H N++ +   
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKV-LQDPQYKNR---ELLIMKNLNHINIIFLKDY 127

Query: 726 -ISSCTNHN----FKALVLEYMPKGSLEDCMYAS--NFNLDIFQRLGIMIDVASALEYLH 778
             + C   N    F  +V+E++P+   +   + +  N  L +F        +  AL Y+H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 779 FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAK-LLSEEDSMKQTQTLATIGYIAPEY 836
              S  I H D+KP N+L+D ++    L DFG AK LL+ + S         + YI   +
Sbjct: 188 ---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS---------VSYICSRF 235

Query: 837 GREGQVSIKG-------DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNI 889
            R  ++ +         D+++ G ++ E+  G       F+G+ S+     D L  ++ +
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP----IFSGQSSV-----DQLVRIIQV 286

Query: 890 MDT 892
           + T
Sbjct: 287 LGT 289

Length = 440

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 47/187 (25%), Positives = 88/187 (47%), Gaps = 21/187 (11%)

Query: 689 IEVAIKVFH-LQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL 747
           I+V +KV     R+ +L  F+    +++ + H+++V +   C       +V E++  G L
Sbjct: 33  IKVILKVLDPSHRDISLAFFET-ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL 91

Query: 748 EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL-------DDS 800
           +  M+  +  L    +  +   +ASAL YL       +VH ++   N+LL       +  
Sbjct: 92  DLFMHRKSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLAREGIDGECG 148

Query: 801 MVAHLSDFGIA-KLLSEEDSMKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEV 858
               LSD GI   +LS ++ +++      I +IAPE   + +  SI  D +++G  L E+
Sbjct: 149 PFIKLSDPGIPITVLSRQECVER------IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Query: 859 -FTGMKP 864
            + G  P
Sbjct: 203 CYNGEIP 209

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 17/99 (17%)

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTL-ATIG 830
           ALE+LH      IV+ D+KP N+LLD +    L DFG++K  L++  +   T T   T  
Sbjct: 108 ALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTE 161

Query: 831 YIAPEY-----GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           Y+APE      G    V    D ++ G+++ E+  G  P
Sbjct: 162 YLAPEVLLDEKGYTKHV----DFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEILK------TIRHRNLV 723
           ++G GS+G V         E+ AIK+  L+++  +   D EC +++      + +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++ S     +    V+EY+  G   D MY     +  F+    +   A     L F HS 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGG---DLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
            I++ D+K  NV+LD      ++DFG+ K  +  D +       T  YIAPE        
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179

Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
              D + +G++L E+  G  P    F GE
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAP----FEGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 3e-05
 Identities = 51/199 (25%), Positives = 77/199 (38%), Gaps = 53/199 (26%)

Query: 709 AECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
           AE +IL    +  +VK+  S  + N+  L++EY+P G     M       D F       
Sbjct: 50  AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGD----MMTLLMKKDTFTEEETRF 105

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-------------- 814
            +A  +  +   H    +H DIKP N+LLD      LSDFG+   L              
Sbjct: 106 YIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165

Query: 815 -----------SEEDSMKQTQT-------LA--TIG---YIAPE------YGREGQVSIK 845
                          S ++ +T       LA  T+G   YIAPE      Y +E      
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE------ 219

Query: 846 GDVYNYGIMLMEVFTGMKP 864
            D ++ G+++ E+  G  P
Sbjct: 220 CDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 46.7 bits (111), Expect = 4e-05
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 9/92 (9%)

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI----GYI 832
           L+F H   I++ D+K  NVLLD      L+D+G+ K     + ++   T +T      YI
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-----EGIRPGDTTSTFCGTPNYI 163

Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           APE  R        D +  G+++ E+  G  P
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 46.2 bits (110), Expect = 4e-05
 Identities = 58/230 (25%), Positives = 84/230 (36%), Gaps = 47/230 (20%)

Query: 352 LTTLSLGDNNLSGSLPIT------LGRLKKLQGLDLQNNKFEG---PIPQEFCHFSRLYV 402
           L  L L  N               L +   LQ LDL +N        + +     S L  
Sbjct: 53  LKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQE 112

Query: 403 VYLNRNKLSGS----IPSCLGDLN-SLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNS 457
           + LN N L       +   L DL  +L  L L  N L                   S  +
Sbjct: 113 LKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGA----------------SCEA 156

Query: 458 LNGSLPLEIENLKAVVDIYLSRNNLSGN-IPSTIIGLK---NLQHLSLEHNKLQ----GP 509
           L  +L     +LK +    L+ N +    I +   GLK   NL+ L L +N L       
Sbjct: 157 LAKALR-ANRDLKELN---LANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASA 212

Query: 510 IPESFGELVSLEFLDLSNNDLSGVI-----PASLEKLLYLKSLNLSFNKL 554
           + E+   L SLE L+L +N+L+         A L   + L +L+LS N +
Sbjct: 213 LAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 25/165 (15%)

Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN---FNLDIFQRLGI 766
           E  +L+  RH  L  +  S   H+    V+EY   G L    + S    F+ D  +  G 
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102

Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQT 825
             ++ SAL YLH   S  +V+ D+K  N++LD      ++DFG+ K  +S+  +MK    
Sbjct: 103 --EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TF 155

Query: 826 LATIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             T  Y+APE      YGR        D +  G+++ E+  G  P
Sbjct: 156 CGTPEYLAPEVLEDNDYGR------AVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.8 bits (99), Expect = 5e-05
 Identities = 20/60 (33%), Positives = 30/60 (50%)

Query: 399 RLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSL 458
            L  + L+ N+L+         L +L++L LS N LTS+ P  F  L  +   D S N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.8 bits (111), Expect = 5e-05
 Identities = 51/177 (28%), Positives = 89/177 (50%), Gaps = 10/177 (5%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVKIIS 727
           I  G++G VY GR   +    A+KV     +  +  ++   AE + L   +   +V +  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
           S  + N   LV+EY+  G ++  ++   +  D    +  + +VA AL+YLH  H   I+H
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH-RHG--IIH 127

Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAPEYGRE-GQV 842
            D+KP N+L+ +     L+DFG++K+ L+ E +M    T  ++     +Y R  GQV
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSRTPGQV 184

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 45.7 bits (108), Expect = 5e-05
 Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 36/172 (20%)

Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA---LNSFDAECEILKTIRHRN 721
           ++  + LIG G +G VY        E      H     A   + + + E  +++T+ + N
Sbjct: 13  EWKIDKLIGCGGFGCVY--------ETQCASDHCINNQAVAKIENLENETIVMETLVYNN 64

Query: 722 LVKI--ISSCTN-HNFKAL-VLEYMPKGSLEDCMYASNFNL---------DIFQRL---- 764
           +  I  I+   N HN   L + +Y   GS + C     F L         +IF+R+    
Sbjct: 65  IYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKN 124

Query: 765 -----GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA 811
                 IM D+ + LEY+H    + I H DIKP N+++D +   ++ D+GIA
Sbjct: 125 KKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.2 bits (109), Expect = 6e-05
 Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 25/201 (12%)

Query: 688 GIEVAIKVFH--LQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN----FKA--LVL 739
           GI VA+K      Q +        E  +LK + H+N++ +++  T       F+   LV+
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 740 EYMPKGSLEDCMYASNFNLDI-FQRLGIMI-DVASALEYLHFGHSNPIVHCDIKPSNVLL 797
           E M      D       ++++  +R+  ++  +   +++LH   S  I+H D+KPSN+++
Sbjct: 106 ELM------DANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVV 156

Query: 798 DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLME 857
                  + DFG+A+       M  T  + T  Y APE           D+++ G ++ E
Sbjct: 157 KSDCTLKILDFGLARTACTNFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214

Query: 858 VFTGMKPTNEFFTGEMSIKRW 878
           +  G    +  F G   I +W
Sbjct: 215 LVKG----SVIFQGTDHIDQW 231

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 45.5 bits (108), Expect = 6e-05
 Identities = 60/252 (23%), Positives = 109/252 (43%), Gaps = 31/252 (12%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGI-----EVAIK-VFHLQREGALNSFDAECEILKTI 717
           D+ +  +L+  G++G ++ G   D       EV +K V     E  +     E  +L  +
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 718 RHRNLVKIISSCTNHNFKALVLE-YMPKGSL----EDCMYASNFN---LDIFQRLGIMID 769
            H+N++ I+  C        VL  YM  G+L    + C      N   L   Q + + I 
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL--SEEDSMKQTQTLA 827
           +A  + YLH      ++H DI   N ++D+ +   ++D  +++ L   +   +   +   
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN-R 181

Query: 828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS--------IKRW 878
            + ++A E     + S   DV+++G++L E+ T G  P  E    EM+        + + 
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241

Query: 879 IN--DSLPAVMN 888
           IN  D L AVM 
Sbjct: 242 INCPDELFAVMA 253

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 7e-05
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 24/216 (11%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFH----LQREGALNSFDAECEILKTIR 718
           D F    +IG G++G V   +  +  +V A+K+ +    L+R      F  E ++L    
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKR-AETACFREERDVLVNGD 59

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR-----LGIMIDVASA 773
            R +  +  +  + N   LV++Y   G L   +  S F   + +      L  M+    +
Sbjct: 60  RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVLAIDS 117

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           +  L +      VH DIKP NVLLD +    L+DFG    L  + +++    + T  YI+
Sbjct: 118 VHQLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171

Query: 834 PEYGR-----EGQVSIKGDVYNYGIMLMEVFTGMKP 864
           PE  +     +G+   + D ++ G+ + E+  G  P
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 45.6 bits (108), Expect = 8e-05
 Identities = 43/187 (22%), Positives = 80/187 (42%), Gaps = 17/187 (9%)

Query: 675 GSYGSVYKGRFPDGIE--VAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNH 732
           GS G V+      G    V +K+      G   +   E  +L+ + H +++++  +  + 
Sbjct: 77  GSEGRVFVAT-KPGQPDPVVLKI------GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSG 129

Query: 733 NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKP 792
               +VL +     L   +   +  L I Q L I   +   L YLH   +  I+H D+K 
Sbjct: 130 AITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKT 185

Query: 793 SNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNY 851
            N+ ++D     + D G A+  +     +    T+ T    APE     + + K D+++ 
Sbjct: 186 ENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET---NAPEVLARDKYNSKADIWSA 242

Query: 852 GIMLMEV 858
           GI+L E+
Sbjct: 243 GIVLFEM 249

Length = 357

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 70/257 (27%), Positives = 110/257 (42%), Gaps = 34/257 (13%)

Query: 33  NRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNK 92
           + +  L +SD  +  ++PS L NL +L+ L LS N  S  +PK + NL+ L  L L  NK
Sbjct: 140 SNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK 197

Query: 93  LQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCP 152
           +  ++P E+  L+ LE L L+NN +   + +S+ NL                        
Sbjct: 198 IS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLK----------------------- 232

Query: 153 GLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGF 212
               L GL +S N+ +  +P ++ +   L ++ LS NQ +      LG+ T L+ LDL  
Sbjct: 233 ---NLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSG 286

Query: 213 NNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKN 272
           N+L+  +P     L  LE+L      L          +    ILS    T S    S   
Sbjct: 287 NSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILS-NGETSSPEALSILE 345

Query: 273 LIGLPNLEGLNLGLNNL 289
            +         L  +NL
Sbjct: 346 SLNNLWTLDNALDESNL 362

Length = 394

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 72/292 (24%), Positives = 102/292 (34%), Gaps = 58/292 (19%)

Query: 276 LPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLF 335
           L  L+ L L  N L          A+K  A  L    +LK L L  N        L SL 
Sbjct: 22  LLCLQVLRLEGNTLGEE-------AAKALASALRPQPSLKELCLSLNETGRIPRGLQSLL 74

Query: 336 SALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKK---LQGLDLQNNKFEGPIPQ 392
             L             L  L L DN L       L  L +   LQ L L NN       +
Sbjct: 75  QGL--------TKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR 126

Query: 393 EFC-----HFSRLYVVYLNRNKLSG----SIPSCLGDLNSLRILSLSSNELT-SVIPST- 441
                       L  + L RN+L G    ++   L     L+ L+L++N +  + I +  
Sbjct: 127 LLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALA 186

Query: 442 -----FWNLEDILGFDFSSNSLN--GSLPLE--IENLKAVVDIYLSRNNLSGNIPSTI-- 490
                  NLE +   D ++N L   G+  L   + +LK++  + L  NNL+    + +  
Sbjct: 187 EGLKANCNLEVL---DLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALAS 243

Query: 491 ---IGLKNLQHLSLEHNK--------LQGPIPESFGELVSLEFLDLSNNDLS 531
                  +L  LSL  N         L   + E      SL  LDL  N   
Sbjct: 244 ALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEK----ESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 44.7 bits (105), Expect = 2e-04
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 36/212 (16%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSC 729
           +IG GSY  V   R      + A+KV  +++E  L + D + + ++T +H     +    
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKV--VKKE--LVNDDEDIDWVQTEKH-----VFEQA 52

Query: 730 TNHNFKA-------------LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
           +NH F                V+EY+  G L   M       +   R     +++ AL Y
Sbjct: 53  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNY 111

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA----TIGYI 832
           LH      I++ D+K  NVLLD      L+D+G+ K     + ++   T +    T  YI
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYI 163

Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           APE  R        D +  G+++ E+  G  P
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 42/220 (19%)

Query: 669 ENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFD---------AECEILKTIR 718
           + +IG GSYG V        G +VAIK  +       + F+          E ++L+ +R
Sbjct: 5   QEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-------DVFEHVSDATRILREIKLLRLLR 57

Query: 719 HRNLVK---IISSCTNHNFKAL--VLEYMPKG-----SLEDCMYASNFNLDIFQRLGIMI 768
           H ++V+   I+   +   FK +  V E M           D +   +    ++Q L    
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL---- 113

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK--LLSEEDSMKQTQTL 826
               AL+Y+H   +  + H D+KP N+L +      + DFG+A+        ++  T  +
Sbjct: 114 ---RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167

Query: 827 ATIGYIAPEYGRE--GQVSIKGDVYNYGIMLMEVFTGMKP 864
           AT  Y APE       + +   D+++ G +  EV TG KP
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KP 206

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 44.7 bits (105), Expect = 2e-04
 Identities = 55/240 (22%), Positives = 96/240 (40%), Gaps = 44/240 (18%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFH----LQREGALNSFDAECEILKTIR 718
           + F    +IG G++G V   +  D G   A+K+      L++E  +    AE +IL    
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE-QVGHIRAERDILVEAD 59

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
              +VK+  S  +     L++E++P G +   +       D          +A  +  + 
Sbjct: 60  SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAID 115

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE--------------------- 817
             H    +H DIKP N+LLD      LSDFG+   L +                      
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 818 -DSMKQTQT---------LATIG---YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            +S ++ +T          +T+G   YIAPE   +   +   D ++ G+++ E+  G  P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 44.3 bits (104), Expect = 2e-04
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 9/92 (9%)

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI----GYI 832
           L+F H   I++ D+K  NVLLD      L+D+G+ K     + +    T +T      YI
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-----EGLGPGDTTSTFCGTPNYI 163

Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           APE  R  +     D +  G+++ E+  G  P
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 27/104 (25%), Positives = 52/104 (50%), Gaps = 4/104 (3%)

Query: 758 LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSE 816
           LD    L     VA  + +L    S   +H D+   N+LL    +  + DFG+A+ + ++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
            + + +      + ++APE       + + DV++YGI+L E+F+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 43.8 bits (104), Expect = 2e-04
 Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 18/172 (10%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVF--HLQREGALNSFDAECEILKTIR-HRNLVKIIS 727
           IG G++  V K +    G   AIK    H +    +N+   E + L+ +  H N++++I 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65

Query: 728 SCTN--HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
              +      ALV E M   +L + +      L   +    M  +  +L+++H    N I
Sbjct: 66  VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGI 121

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAPE 835
            H DIKP N+L+ D ++  L+DFG  + +      K   T+ ++T  Y APE
Sbjct: 122 FHRDIKPENILIKDDIL-KLADFGSCRGIYS----KPPYTEYISTRWYRAPE 168

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.4 bits (93), Expect = 3e-04
 Identities = 22/84 (26%), Positives = 32/84 (38%), Gaps = 24/84 (28%)

Query: 423 SLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNL 482
           +L+ L LS+N LT +    F                        + L  +  + LS NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAF------------------------KGLPNLKVLDLSGNNL 36

Query: 483 SGNIPSTIIGLKNLQHLSLEHNKL 506
           +   P    GL +L+ L L  N L
Sbjct: 37  TSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 43.5 bits (103), Expect = 3e-04
 Identities = 49/212 (23%), Positives = 74/212 (34%), Gaps = 34/212 (16%)

Query: 240 VGFVPDTIFNISTLKILSLFNNTLSGNLPSS-KNLIGLPNLEGLNLGLNNLSGSIPSFFF 298
           +  +   +     L+ L L +N L  +     ++L+   +L+ L L  N L         
Sbjct: 70  LQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDR------ 123

Query: 299 NASKLYALELGYNS-NLKRLGLERNYLTF-STSELMSLFSALVNCKSLKIGNLINLTTLS 356
              +L A  L      L++L L RN L   S   L     A  N           L  L+
Sbjct: 124 -GLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRA--NRD---------LKELN 171

Query: 357 LGDNNLSGSLPITLGR----LKKLQGLDLQNNKFEGPIPQEFC----HFSRLYVVYLNRN 408
           L +N +  +    L         L+ LDL NN                   L V+ L  N
Sbjct: 172 LANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDN 231

Query: 409 KLSGSI-----PSCLGDLNSLRILSLSSNELT 435
            L+ +       + L    SL  LSLS N++T
Sbjct: 232 NLTDAGAAALASALLSPNISLLTLSLSCNDIT 263

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 43.6 bits (103), Expect = 3e-04
 Identities = 63/245 (25%), Positives = 98/245 (40%), Gaps = 62/245 (25%)

Query: 672 IGIGSYGSVYKGRFPDGIEV-AIKVFH----LQREGALNSFDAECEILKTIRHRNLVKII 726
           IGIG++G V   R  D   + A+K       L R  A +   AE +IL    +  +VK+ 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAH-VKAERDILAEADNEWVVKLY 67

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQ----RLGIMIDVASALEYLHFGHS 782
            S  + +    V++Y+P G +   +      L IF+    R  I  ++  A+E +H    
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLL----IRLGIFEEDLARFYIA-ELTCAIESVH---K 119

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL--------------SEEDSM-------- 820
              +H DIKP N+L+D      L+DFG+                    +DSM        
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179

Query: 821 ---------------KQTQTLA-----TIGYIAPE-YGREGQVSIKGDVYNYGIMLMEVF 859
                          +  + LA     T  YIAPE   R G   +  D ++ G++L E+ 
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEML 238

Query: 860 TGMKP 864
            G  P
Sbjct: 239 VGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.9 bits (103), Expect = 3e-04
 Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 44/240 (18%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFH----LQREGALNSFDAECEILKTIR 718
           D F    +IG G++G V   +  D G   A+K+      L++E  +    AE +IL    
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE-QVAHIRAERDILVEAD 59

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
              +VK+  S  +     L++E++P G +   +       D          +A  +  + 
Sbjct: 60  GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAID 115

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE--------------------- 817
             H    +H DIKP N+LLD      LSDFG+   L +                      
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 818 -DSMKQTQT---------LATIG---YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            +S ++ +T          +T+G   YIAPE   +   +   D ++ G+++ E+  G  P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.0 bits (101), Expect = 5e-04
 Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 21/190 (11%)

Query: 689 IEVAIKVFH-LQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL 747
           + V +KV     R+ AL  F+    ++  + H +L  +   C   +   +V E++  G L
Sbjct: 45  LRVVLKVLDPSHRDIALAFFET-ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103

Query: 748 EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL-------DDS 800
           + C+      + +  ++ +   +ASAL YL       +VH ++   N+LL         S
Sbjct: 104 DVCLRKEKGRVPVAWKITVAQQLASALSYL---EDKNLVHGNVCAKNILLARLGLAEGTS 160

Query: 801 MVAHLSDFGIA-KLLSEEDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEV 858
               LSD G++   LS E+ +++      I +IAPE    G  +S   D +++G  L+E+
Sbjct: 161 PFIKLSDPGVSFTALSREERVER------IPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Query: 859 -FTGMKPTNE 867
            F G  P  E
Sbjct: 215 CFDGEVPLKE 224

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 43.3 bits (102), Expect = 6e-04
 Identities = 17/49 (34%), Positives = 29/49 (59%)

Query: 343 SLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIP 391
              +G++ +L  L L  N+ +GS+P +LG+L  L+ L+L  N   G +P
Sbjct: 459 PPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.1 bits (101), Expect = 6e-04
 Identities = 46/183 (25%), Positives = 76/183 (41%), Gaps = 42/183 (22%)

Query: 719 HRNLVKIISSCTNH-NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA---- 773
           +R LV  +  C NH N   L+  + P+ SLE+           FQ + I++++  A    
Sbjct: 71  YRELV--LMKCVNHKNIIGLLNVFTPQKSLEE-----------FQDVYIVMELMDANLCQ 117

Query: 774 ----------LEYLHFG--------HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS 815
                     + YL +         HS  I+H D+KPSN+++       + DFG+A+  +
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--T 175

Query: 816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI 875
              S   T  + T  Y APE           D+++ G ++ E+  G       F G   I
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHI 231

Query: 876 KRW 878
            +W
Sbjct: 232 DQW 234

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 7e-04
 Identities = 20/60 (33%), Positives = 25/60 (41%)

Query: 58  SLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLL 117
           +L++L LS N  +         L  LK L L  N L    PE    L  L  L L+ N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 5/156 (3%)

Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR-LGIMI 768
           E  +L  ++H N+V    S        +V+EY   G L   +      L      L   +
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
            +   ++++H      ++H DIK  N+ L  +    L DFG A+LL+   +   T  + T
Sbjct: 108 QMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGT 163

Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             Y+ PE       + K D+++ G +L E+ T   P
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.9 bits (89), Expect = 0.001
 Identities = 18/60 (30%), Positives = 25/60 (41%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
           NL +L L +N L+         L  L+ LDL  N      P+ F     L  + L+ N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.3 bits (99), Expect = 0.001
 Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 12/151 (7%)

Query: 666 FSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNS-----FDAECEILKTIRH 719
           F +   +GIG++G V      D     A+K   L+++  LN        AE +IL    +
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKT--LRKKDVLNRNQVAHVKAERDILAEADN 60

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             +VK+  S  + +    V++Y+P G +   +       ++  R  I  ++  A+E +H 
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH- 118

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGI 810
                 +H DIKP N+L+D      L+DFG+
Sbjct: 119 --KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 41.6 bits (98), Expect = 0.001
 Identities = 43/165 (26%), Positives = 70/165 (42%), Gaps = 18/165 (10%)

Query: 712 EILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA 771
           E   + RH  LV + +     +    V+EY   G   D M   + + D+F     +   A
Sbjct: 54  ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG---DLMM--HIHTDVFSEPRAVFYAA 108

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI-- 829
             +  L + H N IV+ D+K  N+LLD      ++DFG+ K    E  M      +T   
Sbjct: 109 CVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EG-MGFGDRTSTFCG 163

Query: 830 --GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
              ++APE   E   +   D +  G+++ E+  G  P    F G+
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 23/108 (21%), Positives = 48/108 (44%), Gaps = 12/108 (11%)

Query: 709 AECEILKTIRHRNLV--KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGI 766
            E  IL+ +  + L   K+++S  +  +  L++E++   +L+         +   ++  I
Sbjct: 40  REVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD--------EVSEEEKEDI 91

Query: 767 MIDVASALEYLHFGHSNP-IVHCDIKPSNVLLDDSMVAHLSDFGIAKL 813
              +A  L  LH       + H D+ P N+L+DD  +  + D+  A  
Sbjct: 92  AEQLAELLAKLH-QLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 41.2 bits (97), Expect = 0.002
 Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 33/141 (23%)

Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLED---------CMYAS-----N 755
           E  ++K + H+N++ +++  T            P+ SLE+          M A+      
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFT------------PQKSLEEFQDVYLVMELMDANLCQVIQ 112

Query: 756 FNLDIFQRLGIMI-DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL 814
            +LD  +R+  ++  +   +++LH   S  I+H D+KPSN+++       + DFG+A+  
Sbjct: 113 MDLD-HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168

Query: 815 SEEDSMKQTQTLATIGYIAPE 835
                M  T  + T  Y APE
Sbjct: 169 GTSFMM--TPYVVTRYYRAPE 187

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 38/151 (25%), Positives = 66/151 (43%), Gaps = 12/151 (7%)

Query: 666 FSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGAL-----NSFDAECEILKTIRH 719
           F +   +GIG++G V   R  D     A+K   L+++  L         AE +IL    +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKT--LRKKDVLLRNQVAHVKAERDILAEADN 60

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             +V++  S  + +    V++Y+P G +   +      + IF        +A     +  
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL----IRMGIFPEDLARFYIAELTCAVES 116

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGI 810
            H    +H DIKP N+L+D      L+DFG+
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 27/102 (26%), Positives = 49/102 (48%), Gaps = 5/102 (4%)

Query: 760 IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS 819
           + Q   IM  +  A+EY+H      ++H DIK  N+ L+      L DFG A    +E  
Sbjct: 266 LKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322

Query: 820 MKQTQTLATIGYIAPE-YGREGQVSIKGDVYNYGIMLMEVFT 860
                 + T+   +PE    +G   I  D+++ G++L+++ +
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEIT-DIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 41.2 bits (96), Expect = 0.003
 Identities = 62/264 (23%), Positives = 99/264 (37%), Gaps = 45/264 (17%)

Query: 284 LGLNNLSGSIP----SFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALV 339
           LGL  +   IP    +   + ++L +L      N+K L    N LT     + +     +
Sbjct: 188 LGLTTIPACIPEQITTLILDNNELKSLPENLQGNIKTLYANSNQLT----SIPATLPDTI 243

Query: 340 NCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSR 399
               L I  +  L             LP        LQ LDL +NK    +P+      R
Sbjct: 244 QEMELSINRITELPE----------RLP------SALQSLDLFHNKISC-LPENLPEELR 286

Query: 400 LYVVYLNR-NKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSL 458
              VY N    L   +PS +  LN      + SN LT++  +    L+ +   + +  SL
Sbjct: 287 YLSVYDNSIRTLPAHLPSGITHLN------VQSNSLTALPETLPPGLKTLEAGENALTSL 340

Query: 459 NGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELV 518
             SLP E++ L           N    +P T+     +  L +  N L   +PE+     
Sbjct: 341 PASLPPELQVLDV-------SKNQITVLPETLP--PTITTLDVSRNALTN-LPENLP--A 388

Query: 519 SLEFLDLSNNDLSGVIPASLEKLL 542
           +L+ +  S N+L   +P SL    
Sbjct: 389 ALQIMQASRNNLVR-LPESLPHFR 411

Length = 754

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 18/157 (11%)

Query: 664 DQFSEENLIGIGSYGSV-YKGRFPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    +IG G++G V    +   G   A+K      + ++  L    AE ++L     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQ----RLGIMIDVASALE 775
             +V +  S  +  +  L++E++P G L   +       D F     R   M +   A+E
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML----IKYDTFSEDVTRF-YMAECVLAIE 115

Query: 776 YLH-FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA 811
            +H  G     +H DIKP N+L+D      LSDFG++
Sbjct: 116 AVHKLGF----IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|111949 pfam03109, ABC1, ABC1 family

 Score = 38.0 bits (89), Expect = 0.004
 Identities = 18/52 (34%), Positives = 26/52 (50%), Gaps = 4/52 (7%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILK 715
            +F EE  I   S   V++    DG EVA+KV   QR G      ++ ++LK
Sbjct: 12  AEFDEEP-IAAASIAQVHRAVLKDGEEVAVKV---QRPGVKKRIRSDLKLLK 59

This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 40.1 bits (93), Expect = 0.004
 Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 22/173 (12%)

Query: 719 HRNLVKIISSCTNH-NFKALVLEYMPKGSLEDC----MYASNFNLDIFQRLGIMIDVASA 773
           +R LV  +  C NH N  +L+  + P+ SLE+     +     + ++ Q + + +D    
Sbjct: 64  YRELV--LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD-HER 120

Query: 774 LEYLHFG--------HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT 825
           + YL +         HS  I+H D+KPSN+++       + DFG+A+  +   S   T  
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 178

Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
           + T  Y APE           D+++ G ++ E    M      F G   I +W
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGE----MVRHKILFPGRDYIDQW 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 35.4 bits (82), Expect = 0.004
 Identities = 12/29 (41%), Positives = 20/29 (68%), Gaps = 2/29 (6%)

Query: 2  INDNPNNILAQNWTSNASV-CSWMGITCD 29
          +N +P+  L+ +W  ++S  CSW G+TCD
Sbjct: 15 LNGDPSGALS-SWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	952
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.98
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.78
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.78
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
PRK10345	210	hypothetical protein; Provisional	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.72
smart00090	237	RIO RIO-like kinase.	99.71
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.69
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.68
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.66
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.6
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.59
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.57
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.54
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.45
PLN03150	623	hypothetical protein; Provisional	99.43
PLN03150	623	hypothetical protein; Provisional	99.43
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.42
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.31
KOG1243	690	consensus Protein kinase [General function predict	99.3
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.29
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.29
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.29
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.27
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.26
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.24
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.21
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.2
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.2
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.19
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.16
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.15
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.15
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.14
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.12
KOG3087	229	consensus Serine/threonine protein kinase [General	99.1
COG4248	637	Uncharacterized protein with protein kinase and he	99.1
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.08
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.07
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.05
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.02
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.0
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.92
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.89
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.88
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.86
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.8
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.78
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.72
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.66
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.65
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.59
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.58
PRK09902	216	hypothetical protein; Provisional	98.56
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.56
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.53

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.3e-107  Score=1027.98  Aligned_cols=891  Identities=33%  Similarity=0.540  Sum_probs=733.0

Q ss_pred             CCCCccccccCCCCCCCCCceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcC-CcCCC
Q 002214            5 NPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIG-NLTKL   83 (952)
Q Consensus         5 ~~~~~~~~~~~~~~~~c~w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L   83 (952)
                      ||.+.+. +|..+++||.|.||+|+. ..+|++||++++++.+.+|..+..+++|++|+|++|++++.+|..+. .+++|
T Consensus        43 ~~~~~~~-~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L  120 (968)
T PLN00113         43 DPLKYLS-NWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSL  120 (968)
T ss_pred             CCcccCC-CCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCC
Confidence            6777775 887778999999999985 45899999999999999999999999999999999999999998765 89999


Q ss_pred             cEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcc
Q 002214           84 KELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVS  163 (952)
Q Consensus        84 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~  163 (952)
                      ++|+|++|.+.+.+|.  +.+++|++|+|++|.+++.+|..+.++..+ +.|++++|.+++.+|..+ ..+++|++|+|+
T Consensus       121 ~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L-~~L~L~~n~l~~~~p~~~-~~l~~L~~L~L~  196 (968)
T PLN00113        121 RYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSL-KVLDLGGNVLVGKIPNSL-TNLTSLEFLTLA  196 (968)
T ss_pred             CEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCC-CEEECccCcccccCChhh-hhCcCCCeeecc
Confidence            9999999999988775  568999999999999998999999988876 899999999998888765 578999999999


Q ss_pred             cCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccC
Q 002214          164 YNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFV  243 (952)
Q Consensus       164 ~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~  243 (952)
                      +|++.+.+|..++.+++|+.|+|++|.+++.+|..|+++++|++|+|++|.+++.+|..|+++++|+.|++++|++.+..
T Consensus       197 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~  276 (968)
T PLN00113        197 SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI  276 (968)
T ss_pred             CCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccC
Confidence            99999889999999999999999999999999999999999999999999999899999999999999999999999999


Q ss_pred             CccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhcccc------------
Q 002214          244 PDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN------------  311 (952)
Q Consensus       244 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~------------  311 (952)
                      |..+.++++|+.|++++|.+.+.+|..  +..+++|+.|++++|.+.+..|..+..+++|+.|+++.|            
T Consensus       277 p~~l~~l~~L~~L~Ls~n~l~~~~p~~--~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~  354 (968)
T PLN00113        277 PPSIFSLQKLISLDLSDNSLSGEIPEL--VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK  354 (968)
T ss_pred             chhHhhccCcCEEECcCCeeccCCChh--HcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhC
Confidence            999999999999999999998877754  678899999999999999999999999999988888766            


Q ss_pred             -CccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCC
Q 002214          312 -SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPI  390 (952)
Q Consensus       312 -~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~  390 (952)
                       .+|+.|+++.|.+.....+              .+..+++|+.|++++|++.+..|..+..+++|+.|++++|++++..
T Consensus       355 ~~~L~~L~Ls~n~l~~~~p~--------------~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~  420 (968)
T PLN00113        355 HNNLTVLDLSTNNLTGEIPE--------------GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL  420 (968)
T ss_pred             CCCCcEEECCCCeeEeeCCh--------------hHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeEC
Confidence             3677888888887632221              2456788999999999999999999999999999999999999999


Q ss_pred             CccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhccc
Q 002214          391 PQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLK  470 (952)
Q Consensus       391 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  470 (952)
                      |..|..+++|+.|++++|.+++.+|..+..+++|+.|++++|++.+..|..+ ..++|+.|++++|++++..|..+..++
T Consensus       421 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~  499 (968)
T PLN00113        421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLS  499 (968)
T ss_pred             ChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhh
Confidence            9999999999999999999999999999999999999999999998888766 468999999999999999999999999


Q ss_pred             ccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhccccccccccc
Q 002214          471 AVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLS  550 (952)
Q Consensus       471 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~  550 (952)
                      +|+.|+|++|++.+.+|..+..+++|+.|+|++|.+++.+|..|..+++|+.|||++|++++.+|..+..+++|+.|+++
T Consensus       500 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls  579 (968)
T PLN00113        500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS  579 (968)
T ss_pred             ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCcccccccccccCccCCCCCc-cCCCCCCCCCCCCccceeEEEeeecchhhHHHHHHHHHhhheeeee
Q 002214          551 FNKLVGEIPRGGAFANFSAESFIGNDLLCGSPY-LHVPLCKSSPHKKSRKQVILLGVVLPLSTVFIVTVILVLTFGLITR  629 (952)
Q Consensus       551 ~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~-~~lp~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (952)
                      +|+++|.+|..+.|..+...++.+|+.+|+.+. ...+.|....   ... ...+.+++.+++++ +++++++.+ ++++
T Consensus       580 ~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~---~~~-~~~~~~~~~~~~~~-~~~~~~~~~-~~~~  653 (968)
T PLN00113        580 HNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR---KTP-SWWFYITCTLGAFL-VLALVAFGF-VFIR  653 (968)
T ss_pred             CCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc---ccc-eeeeehhHHHHHHH-HHHHHHHHH-HHHH
Confidence            999999999999999999999999999998653 3345564221   111 11111211111111 111111111 1111


Q ss_pred             cccccCccccccccCCCCccccc-c-cCHHHHHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHH
Q 002214          630 CCKRRSTEVSHIKAGMSPQVMWR-R-YSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNS  706 (952)
Q Consensus       630 ~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~  706 (952)
                      ++++...+......+........ . ............|...+.||+|+||.||+|+. .+|+.||||+++....    .
T Consensus       654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~  729 (968)
T PLN00113        654 GRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----I  729 (968)
T ss_pred             hhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----c
Confidence            11111111111111110000000 0 01112223345677888999999999999987 5789999998854332    1


Q ss_pred             HHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 002214          707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV  786 (952)
Q Consensus       707 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~iv  786 (952)
                      ..+|++++++++|||||+++++|.+++..++||||+++|+|.++++    .++|.++.+++.|+|+|++|||..++++|+
T Consensus       730 ~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii  805 (968)
T PLN00113        730 PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVV  805 (968)
T ss_pred             cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCee
Confidence            2356889999999999999999999999999999999999999985    388999999999999999999755588999


Q ss_pred             eCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCC
Q 002214          787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTN  866 (952)
Q Consensus       787 H~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  866 (952)
                      |||+||+||+++.++.+++. ||.+.....     .....+++.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       806 H~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~  879 (968)
T PLN00113        806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD  879 (968)
T ss_pred             cCCCCHHhEEECCCCceEEE-ecccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence            99999999999999988876 666543321     122368899999999999999999999999999999999999997


Q ss_pred             ccccCccchhhhhccchhh--hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          867 EFFTGEMSIKRWINDSLPA--VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                      ..........+|.+.....  ....+|+.+.....     .+.....++.+++.+||+.||++||+|.||++.|+++.+
T Consensus       880 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        880 AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS-----VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             cccCCCCcHHHHHHHhcCccchhheeCccccCCCC-----ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            6555445555555432211  22333333322111     112345678999999999999999999999999998866

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.3e-56  Score=562.53  Aligned_cols=503  Identities=34%  Similarity=0.560  Sum_probs=462.8

Q ss_pred             CeEEEEEecCCCCcccCCcccc-CCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEe
Q 002214           33 NRVTSLTISDLGLAGTIPSHLG-NLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLV  111 (952)
Q Consensus        33 ~~~~~l~l~~~~~~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  111 (952)
                      .+++.|+++++.+.+.+|..+. .+++|++|+|++|.+++.+|.  +.+++|++|+|++|.+.+.+|..++++++|++|+
T Consensus        93 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~  170 (968)
T PLN00113         93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD  170 (968)
T ss_pred             CCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEE
Confidence            5789999999999999998876 999999999999999988886  5689999999999999989999999999999999


Q ss_pred             ecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcc
Q 002214          112 LNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQF  191 (952)
Q Consensus       112 L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l  191 (952)
                      |++|.+.+.+|..+.+++.+ ++|++++|++++.+|..+ ..+++|++|+|++|++.+.+|..+..+++|++|++++|.+
T Consensus       171 L~~n~l~~~~p~~~~~l~~L-~~L~L~~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l  248 (968)
T PLN00113        171 LGGNVLVGKIPNSLTNLTSL-EFLTLASNQLVGQIPREL-GQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL  248 (968)
T ss_pred             CccCcccccCChhhhhCcCC-CeeeccCCCCcCcCChHH-cCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCcee
Confidence            99999999999999998876 999999999998888654 5789999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCc
Q 002214          192 TGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSK  271 (952)
Q Consensus       192 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  271 (952)
                      ++.+|..|+++++|++|+|++|++.+.+|..+..+++|+.|++++|++.+.+|..+.++++|+.|++++|.+.+..|.. 
T Consensus       249 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~-  327 (968)
T PLN00113        249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA-  327 (968)
T ss_pred             ccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChh-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999998876654 


Q ss_pred             ccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhcccc-------------CccccccccCcceeechhhHHHHHHHh
Q 002214          272 NLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN-------------SNLKRLGLERNYLTFSTSELMSLFSAL  338 (952)
Q Consensus       272 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~-------------~~L~~L~L~~n~l~~~~~~~~~~~~~~  338 (952)
                       +..+++|+.|++++|++.+..|..+..+++|+.++++.|             .+|+.++++.|.+......        
T Consensus       328 -~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~--------  398 (968)
T PLN00113        328 -LTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK--------  398 (968)
T ss_pred             -HhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCH--------
Confidence             778999999999999999999999999999999999876             3578888998887643222        


Q ss_pred             hccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCcc
Q 002214          339 VNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCL  418 (952)
Q Consensus       339 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  418 (952)
                            .++.+++|+.|++++|++++..|..|..++.|+.|++++|.+++..+..+..+++|+.|+|++|++.+.+|..+
T Consensus       399 ------~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~  472 (968)
T PLN00113        399 ------SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF  472 (968)
T ss_pred             ------HHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc
Confidence                  25678999999999999999999999999999999999999999999999999999999999999998888866


Q ss_pred             CCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCce
Q 002214          419 GDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQH  498 (952)
Q Consensus       419 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  498 (952)
                       ..++|+.|++++|++++..|..|.++++|+.|++++|++.+.+|..+..+++|+.|+|++|.+++.+|..|..+++|+.
T Consensus       473 -~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  551 (968)
T PLN00113        473 -GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ  551 (968)
T ss_pred             -ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCE
Confidence             4689999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccC
Q 002214          499 LSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGE  557 (952)
Q Consensus       499 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  557 (952)
                      |+|++|++++.+|..+..+++|+.|++++|++.+.+|.. ..+..+....+.+|+..|.
T Consensus       552 L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~  609 (968)
T PLN00113        552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLCG  609 (968)
T ss_pred             EECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCccccC
Confidence            999999999999999999999999999999999988854 4455566677888885543

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-49  Score=428.04  Aligned_cols=287  Identities=40%  Similarity=0.660  Sum_probs=243.4

Q ss_pred             cccccCHHHHHHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEe
Q 002214          650 MWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSC  729 (952)
Q Consensus       650 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  729 (952)
                      ....|+++++..+|++|...+.||+|+||.||+|..++|+.||||++........++|.+|+.++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56779999999999999999999999999999999999999999988655432135699999999999999999999999


Q ss_pred             ecCC-eeEEEEEccCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEec
Q 002214          730 TNHN-FKALVLEYMPKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSD  807 (952)
Q Consensus       730 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~D  807 (952)
                      .+.+ ..+||||||++|+|.++++.... .++|.+|.+||.++|+||+|||+.....|+||||||+|||+|+++.+||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 59999999999999999998776 899999999999999999999877677899999999999999999999999


Q ss_pred             cccccccCCcCccccccc-ccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccc-cCccchhhhhccchhh
Q 002214          808 FGIAKLLSEEDSMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFF-TGEMSIKRWINDSLPA  885 (952)
Q Consensus       808 fgla~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~  885 (952)
                      ||+|+........ .... .||.+|+|||+...+..+.|+|||||||+++|++||+.|.+... .++..+..|......+
T Consensus       221 FGLa~~~~~~~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEGDTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCccccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            9999754321111 1112 79999999999999999999999999999999999999887643 3445577776554443


Q ss_pred             --hhhhccccccc-hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          886 --VMNIMDTNLLS-EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       886 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                        ..+++|+.+.. ....      .....++..++..|++.+|.+||+|.||++.|+.+..
T Consensus       300 ~~~~eiiD~~l~~~~~~~------~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPD------EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             cchhheeCCCccCCCCCh------HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence              77888888763 2211      1235569999999999999999999999999966543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=407.93  Aligned_cols=260  Identities=29%  Similarity=0.496  Sum_probs=223.8

Q ss_pred             HHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ...+.+..++.||+|.||.||.|.++....||+|.++...- ..+.|.+|+++|++|+|++||+++|+|+.++.+|||||
T Consensus       203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            33445667789999999999999997777999999976532 34778899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          741 YMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+.|+|.+++.. .+..+...+.+.++.|||+||+||   .++++|||||.++||||+++..+||+|||+|+...++.+
T Consensus       282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YL---es~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYL---ESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHH---HhCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            9999999999997 555789999999999999999999   899999999999999999999999999999997666666


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      .......-++.|+|||.+..+.++.|||||||||+|||++| |+.||..+...+             +.+.++.+     
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------------v~~~le~G-----  420 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------------VLELLERG-----  420 (468)
T ss_pred             eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------------HHHHHhcc-----
Confidence            66666778999999999999999999999999999999999 899987643221             11222211     


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                        .+...|..||+++.++|..||+.+|++|||++.+...++++...
T Consensus       421 --yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  421 --YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             --CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence              23345678999999999999999999999999999988887654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-46  Score=402.51  Aligned_cols=260  Identities=31%  Similarity=0.495  Sum_probs=215.3

Q ss_pred             cCCccceecCccceEEEEEEeCCCcEEEEEEeeccCch--hhHHHHHHHHHHHhCCCCccceeeeEeecCC-eeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREG--ALNSFDAECEILKTIRHRNLVKIISSCTNHN-FKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  741 (952)
                      .+...+.+|+|+||+||+|.+.....||||++......  ..+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            34455669999999999999954444999999755422  2568999999999999999999999999887 78999999


Q ss_pred             cCCCChhHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeCCCCCCCeeeCCCC-cEEEeccccccccCCcC
Q 002214          742 MPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASALEYLHFGHSNP-IVHCDIKPSNVLLDDSM-VAHLSDFGIAKLLSEED  818 (952)
Q Consensus       742 ~~~g~L~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~-ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~  818 (952)
                      +++|+|.++++. .+..+++..++.++.|||+||+||   |+++ ||||||||+|||++.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YL---H~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYL---HSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH---hcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            999999999988 366899999999999999999999   7888 99999999999999997 99999999998765322


Q ss_pred             cccccccccccccccccccC--cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          819 SMKQTQTLATIGYIAPEYGR--EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                       ...+...||+.|||||++.  ...|+.|+|||||||++|||+||+.||..................+            
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp------------  265 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP------------  265 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC------------
Confidence             2233367999999999999  5689999999999999999999999998754422111111111111            


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                             ..+..|++.+..+|..||+.||++||++.|++..|+.+......
T Consensus       266 -------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  266 -------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             -------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence                   12334788999999999999999999999999999999876543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=382.67  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=209.9

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCC-eeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHN-FKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  741 (952)
                      +.+..+.||+|..|+||+++++ +++.+|+|++.... +...+++.+|++++++.+||+||.+||.|..++ ..+++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3455678999999999999984 78999999996554 344678999999999999999999999999988 59999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      |++|+|++++... +++++....+|+.+|.+||.|||  ++++||||||||+|||+++.|.+||+|||.++.+...   .
T Consensus       160 MDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh--~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~  233 (364)
T KOG0581|consen  160 MDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLH--EERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I  233 (364)
T ss_pred             cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh--hccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence            9999999988765 46999999999999999999996  4699999999999999999999999999999987543   3


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      ....+||..|||||.+.+..|+.++||||||++++|+.+|+.||........++..       -+..+++.    ..   
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~-------Ll~~Iv~~----pp---  299 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE-------LLCAIVDE----PP---  299 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH-------HHHHHhcC----CC---
Confidence            34578999999999999999999999999999999999999998664111111111       11112211    11   


Q ss_pred             HHHhhhh-hHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          902 ANVAKQS-CASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       902 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       +..|.+ +++++++++..|++.||.+||+++|+++|
T Consensus       300 -P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  300 -PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             -CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             112343 89999999999999999999999999876

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-45  Score=374.90  Aligned_cols=254  Identities=27%  Similarity=0.370  Sum_probs=208.9

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCch-------hhHHHHHHHHHHHhCCCCccceeeeEeecCC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREG-------ALNSFDAECEILKTIRHRNLVKIISSCTNHN  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  733 (952)
                      ..+.|.+.+.+|+|+||.|-+|.. ++|+.||||+++.....       ....+.+|+++|++++|||||+++++++.++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456788899999999999999976 57999999999654211       1233579999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC---CcEEEecccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGI  810 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgl  810 (952)
                      +.|||||||+||.|.+.+-..+ .+.+.....+++|++.|+.||   |++||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYL---H~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYL---HSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHH---HHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999999887665 477778889999999999999   89999999999999999755   7899999999


Q ss_pred             ccccCCcCcccccccccccccccccccCcCC---cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhh
Q 002214          811 AKLLSEEDSMKQTQTLATIGYIAPEYGREGQ---VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM  887 (952)
Q Consensus       811 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  887 (952)
                      |+..+..  ......+|||.|.|||++.++.   +..++|+||+||++|-+++|.+||.+.........+...+....  
T Consensus       326 AK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f--  401 (475)
T KOG0615|consen  326 AKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF--  401 (475)
T ss_pred             hhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc--
Confidence            9987633  2344578999999999987653   34578999999999999999999988654443333333222211  


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                                    .+..+...+++..++|.+||..||++|||+.|++++
T Consensus       402 --------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  402 --------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             --------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                          112344568899999999999999999999999876

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-44  Score=389.01  Aligned_cols=248  Identities=22%  Similarity=0.353  Sum_probs=213.7

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .+|...+.||+|||+.||++++ .+|+.||+|++...   +....+.+.+|++|.++|+|||||+++++|++...+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999998 88999999999653   4556678899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |+|+.++|..++. .+..+++.+++.+++||+.|+.||   |+.+|+|||||..|++++++.++||+|||+|..+..++ 
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYL---H~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYL---HSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-  172 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHH---HhcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence            9999999999887 555899999999999999999999   89999999999999999999999999999999886443 


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                      ......+|||.|+|||++....++..+||||+|||||-|+.|++||+.-.- ...+.++                    .
T Consensus       173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-kety~~I--------------------k  231 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-KETYNKI--------------------K  231 (592)
T ss_pred             cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-HHHHHHH--------------------H
Confidence            344557899999999999999999999999999999999999999975210 0011110                    0


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...-..|...+.++.+||.++|++||.+|||+.+|+.+
T Consensus       232 ~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  232 LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            01112345668889999999999999999999999864

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.7e-44  Score=404.60  Aligned_cols=259  Identities=30%  Similarity=0.511  Sum_probs=221.6

Q ss_pred             hccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCch-hhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      +.+....+.||+|+||+||+|+..      +.+.||||.++..++. ..++|++|++++..++|||||+++|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            345566788999999999999752      4567999999877665 678999999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcC---------CC----CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc
Q 002214          736 ALVLEYMPKGSLEDCMYASN---------FN----LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV  802 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~---------~~----l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~  802 (952)
                      ++|+|||..|+|.++|....         ..    ++..+.+.||.|||.||+||   .++.+|||||.++|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YL---s~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYL---SSHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCcccccchhhhhceeccceE
Confidence            99999999999999997532         13    88899999999999999999   7889999999999999999999


Q ss_pred             EEEeccccccccCCcCccccc-ccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhc
Q 002214          803 AHLSDFGIAKLLSEEDSMKQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIN  880 (952)
Q Consensus       803 ~kl~Dfgla~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~  880 (952)
                      +||+|||+++.....+++... ...-+++|||||.+..+.||.+||||||||+|||+++ |+.||......+        
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--------  713 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--------  713 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--------
Confidence            999999999988777777665 4567899999999999999999999999999999999 999987643322        


Q ss_pred             cchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          881 DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                           +.+.+..+-       ....|++||.++++||..||+..|.+||+++||-..|+.....
T Consensus       714 -----VIe~i~~g~-------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  714 -----VIECIRAGQ-------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -----HHHHHHcCC-------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                 111111111       1224678999999999999999999999999999999876543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-44  Score=367.02  Aligned_cols=201  Identities=32%  Similarity=0.525  Sum_probs=181.4

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ..++|...+.||+|+||+||+|++ +++..||||.+...  ..+..+.+..|+.+++.++|||||++++++..++..|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            346788889999999999999998 46899999998765  445567788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC------CcEEEecccccc
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS------MVAHLSDFGIAK  812 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~------~~~kl~Dfgla~  812 (952)
                      ||||+||+|.++++..+ .+++.++..++.|+|.|+++|   |+++||||||||+|||++..      -.+||+|||+|+
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L---~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFL---HENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999998776 799999999999999999999   89999999999999999764      468999999999


Q ss_pred             ccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCcc
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEF  868 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  868 (952)
                      .+....  .....+|++-|||||++...+|+.|+|+||.|+++|+|++|+.||...
T Consensus       164 ~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  164 FLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            886433  233478999999999999999999999999999999999999999853

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-45  Score=399.09  Aligned_cols=257  Identities=25%  Similarity=0.463  Sum_probs=222.5

Q ss_pred             cCCccceecCccceEEEEEEeC----CCcEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ...+.++||.|.||+||+|+++    ....||||.++.. .++...+|..|+.||.++.||||+++.|+.+.....++|+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            3567789999999999999874    3567999999765 3556678999999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |||++|+|+.+|+...+.+.+.+...++++||.||+||   .++++|||||.++|||++++..+|++|||+++.+.++..
T Consensus       710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYL---sdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYL---SDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHH---hhcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            99999999999999998999999999999999999999   899999999999999999999999999999998754432


Q ss_pred             --ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          820 --MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       820 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                        +......-+++|.|||.+....++.+||||||||+|||.++ |..||.++...+             +++.+.     
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------------VIkaIe-----  848 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------------VIKAIE-----  848 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------------HHHHHH-----
Confidence              22223345789999999999999999999999999999988 999998764432             112111     


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                        +..+...|++||..+.+||..||+.|-.+||.+++|+.+|+++.+.
T Consensus       849 --~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  849 --QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             --hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence              1223456789999999999999999999999999999999998653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.5e-43  Score=347.67  Aligned_cols=269  Identities=25%  Similarity=0.338  Sum_probs=212.5

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      +.|+...++|+|+||.||+++.+ +|+.||||++...  ++...+-..+|++++++++|||+|.++.+|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46888889999999999999985 6999999998533  23445667899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      ||+.. +.+.+.......+.....++.+|++.|+.|+   |+++++||||||+|||++.+|.+|+||||+|+.+..+. .
T Consensus        82 ~~dhT-vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~c---Hk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-d  156 (396)
T KOG0593|consen   82 YCDHT-VLHELERYPNGVPSELVKKYLYQLLKAIHFC---HKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-D  156 (396)
T ss_pred             ecchH-HHHHHHhccCCCCHHHHHHHHHHHHHHhhhh---hhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc-c
Confidence            99874 4455666666899999999999999999999   89999999999999999999999999999999987533 3


Q ss_pred             cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCcc--chhhhhccchhhhhhhcccccc--
Q 002214          821 KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM--SIKRWINDSLPAVMNIMDTNLL--  895 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--  895 (952)
                      ..+.++.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+-|....+-+.  .+..-+....|...+++..+..  
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            4466889999999998776 6899999999999999999999888754221111  1223334444554444433221  


Q ss_pred             ---chhhHHHH---HhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          896 ---SEDEEHAN---VAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       896 ---~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         -...+..+   ..-+..+.-+.++++.|+..||++|++-++++.+
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence               11111111   1113345678999999999999999999999864

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.1e-44  Score=346.00  Aligned_cols=255  Identities=23%  Similarity=0.341  Sum_probs=203.7

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeee-EeecC-CeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIIS-SCTNH-NFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~-~~~~l  737 (952)
                      ..+|.+.++||+|+||+||++.. .+|..||.|.+...  +.+..+....|+.++++++|||||++++ .+.++ ...++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            44688999999999999999975 68999999988643  3445677889999999999999999998 44444 45899


Q ss_pred             EEEccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          738 VLEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNP-IVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~-ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      |||||++|+|...+..   .+..+++.++++++.|++.||.++|+.-.+| |+||||||.||+++.+|.+|++|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999998864   3447999999999999999999995322232 88999999999999999999999999998


Q ss_pred             cCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      +.... ......+|||.||+||.+.+..|+.||||||+||++|||+.-+.||...     .+.        ++...+...
T Consensus       178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~--------~L~~KI~qg  243 (375)
T KOG0591|consen  178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLL--------SLCKKIEQG  243 (375)
T ss_pred             hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHH--------HHHHHHHcC
Confidence            86543 3345678999999999999999999999999999999999999998652     111        111111111


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      -.      .+.....++.++..+|..|+.+||+.||+.-.+++.
T Consensus       244 d~------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d  281 (375)
T KOG0591|consen  244 DY------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD  281 (375)
T ss_pred             CC------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence            00      001124578899999999999999999985444433

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=379.89  Aligned_cols=376  Identities=24%  Similarity=0.287  Sum_probs=339.3

Q ss_pred             ccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeec
Q 002214          156 RLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGID  235 (952)
Q Consensus       156 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  235 (952)
                      .-+.|++++|++....+..|.++++|+.+++.+|.++ .+|...+...+|+.|+|.+|.|+.+-.+.+..++.|+.|+|+
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            4567999999999888999999999999999999999 788877777889999999999998888899999999999999


Q ss_pred             cccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccc
Q 002214          236 QSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLK  315 (952)
Q Consensus       236 ~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~  315 (952)
                      .|.|..+.-.+|..-.++++|+|++|.|+..  ....|.++.+|..|.|++|+++..++..|..+++|+.|+|.      
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l--~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLn------  229 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTL--ETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLN------  229 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeecccccccc--ccccccccchheeeecccCcccccCHHHhhhcchhhhhhcc------
Confidence            9999999888888888999999999999866  44568899999999999999998888888878776665554      


Q ss_pred             cccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCcccc
Q 002214          316 RLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFC  395 (952)
Q Consensus       316 ~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~  395 (952)
                           +|.|...              +.++|.++++|+.|.|..|.|.....++|..+.++++|+|+.|+++....+++.
T Consensus       230 -----rN~iriv--------------e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lf  290 (873)
T KOG4194|consen  230 -----RNRIRIV--------------EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLF  290 (873)
T ss_pred             -----ccceeee--------------hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccccc
Confidence                 4444432              234688999999999999999988899999999999999999999999999999


Q ss_pred             CCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhccccccee
Q 002214          396 HFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDI  475 (952)
Q Consensus       396 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  475 (952)
                      +++.|+.|+|++|.|..+-++...-.++|++|+|++|+|+...+..|..+..|+.|+|++|+++......|.++++|+.|
T Consensus       291 gLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~L  370 (873)
T KOG4194|consen  291 GLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKL  370 (873)
T ss_pred             ccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhh
Confidence            99999999999999998888988999999999999999999999999999999999999999998888899999999999


Q ss_pred             ecCCcccCCCCc---ccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhccccccccccccc
Q 002214          476 YLSRNNLSGNIP---STIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFN  552 (952)
Q Consensus       476 ~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  552 (952)
                      ||++|.|+..+.   ..|.+|++|+.|+|.+|+|+.+...+|.++++|+.|||.+|.|..+-|..|..| .|++|.+..-
T Consensus       371 dLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs  449 (873)
T KOG4194|consen  371 DLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS  449 (873)
T ss_pred             cCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhccc
Confidence            999999986554   458899999999999999998777899999999999999999999999999999 9999999988


Q ss_pred             ccccCCCC
Q 002214          553 KLVGEIPR  560 (952)
Q Consensus       553 ~l~~~~p~  560 (952)
                      .+-|+|.-
T Consensus       450 sflCDCql  457 (873)
T KOG4194|consen  450 SFLCDCQL  457 (873)
T ss_pred             ceEEeccH
Confidence            88888753

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-42  Score=362.04  Aligned_cols=266  Identities=27%  Similarity=0.380  Sum_probs=215.1

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecC--CeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNH--NFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  737 (952)
                      .+.|+..++||+|.||.||+|++ .+|+.||+|+++.+.  ++......+|+.||+++.||||+++.+..++.  +..||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            45678889999999999999987 679999999997765  55567788999999999999999999998876  78999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      |+|||++ +|..++....-.+++.++..++.|+++||+||   |.+||.|||||.+|||||.+|.+||+|||+|+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~c---H~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYC---HSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHH---hhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999977 88888887777899999999999999999999   8999999999999999999999999999999988877


Q ss_pred             CcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccch------------hhhhccchh
Q 002214          818 DSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI------------KRWINDSLP  884 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~------------~~~~~~~~~  884 (952)
                      .....+..+.|.+|+|||.+.+. .|+.++|+||.|||+.||++|++.|..... ..++            ..|.....|
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHHHHHHhCCCChhccccccCC
Confidence            76667888999999999987664 799999999999999999999998765211 1111            112211122


Q ss_pred             hhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          885 AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                      . ...+.+..  .........-...+....+|+..+|..||++|.||.++++
T Consensus       351 ~-~~~~kp~~--~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  351 H-ATIFKPQQ--PYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             c-ccccCCCC--cccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1 01111100  0000111113456788999999999999999999999875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=353.02  Aligned_cols=249  Identities=27%  Similarity=0.363  Sum_probs=206.5

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ..++|++.++||+|+||.||.++. ++++.+|+|++++..   .+..+...+|..++.+++||.||+++..|.+.+..|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            356899999999999999999986 468999999996542   3456788999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      |+||+.||.|..+++..+ .+++..+.-++.+|+.||.||   |++||||||+||+|||+|++|+++|+|||+|+.....
T Consensus       103 Vld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~L---H~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYL---HSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            999999999999998665 699999999999999999999   8999999999999999999999999999999965433


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      +. .....+||+.|||||++.+..|+.++|.||+|+++|||++|.+||.....     .++.+.           .....
T Consensus       179 ~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~~-----------I~~~k  241 (357)
T KOG0598|consen  179 GD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYDK-----------ILKGK  241 (357)
T ss_pred             CC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHHH-----------HhcCc
Confidence            22 23347899999999999999999999999999999999999999865211     111110           00000


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCC----CHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRV----NTKEII  935 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~ev~  935 (952)
                          ....+...+.+.++++++.+..||++|.    ++.+|.
T Consensus       242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik  279 (357)
T KOG0598|consen  242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK  279 (357)
T ss_pred             ----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence                0112233577899999999999999996    455543

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3e-46  Score=379.25  Aligned_cols=491  Identities=28%  Similarity=0.356  Sum_probs=386.6

Q ss_pred             eEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeec
Q 002214           34 RVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLN  113 (952)
Q Consensus        34 ~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~  113 (952)
                      ....++++++.++ .+-+++.++..|.+|++++|+++ ..|++++.+.+++.|+.++|++. .+|++++.+.+|.+|+.+
T Consensus        46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s  122 (565)
T KOG0472|consen   46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS  122 (565)
T ss_pred             chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence            3567888999887 67778999999999999999998 88889999999999999999998 899999999999999999


Q ss_pred             CccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccc
Q 002214          114 NNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTG  193 (952)
Q Consensus       114 ~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~  193 (952)
                      +|.+. .+|++++.+..+ ..++..+|+++ ++|.+++ .+.+|..+++.+|+++. .|+..-+++.|++||...|.++ 
T Consensus       123 ~n~~~-el~~~i~~~~~l-~dl~~~~N~i~-slp~~~~-~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-  196 (565)
T KOG0472|consen  123 SNELK-ELPDSIGRLLDL-EDLDATNNQIS-SLPEDMV-NLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-  196 (565)
T ss_pred             cccee-ecCchHHHHhhh-hhhhccccccc-cCchHHH-HHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-
Confidence            99999 889999988876 77888899988 6777664 57788999999999984 4555445999999999999998 


Q ss_pred             cCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCccc
Q 002214          194 RLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNL  273 (952)
Q Consensus       194 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l  273 (952)
                      .+|..++++.+|..|+|.+|+|. .+| .|.++..|++|+++.|.+.....+...++++|..|||.+|+++. .|..  +
T Consensus       197 tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke-~Pde--~  271 (565)
T KOG0472|consen  197 TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKE-VPDE--I  271 (565)
T ss_pred             cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecccccccc-CchH--H
Confidence            78888999999999999999998 677 89999999999999888887766777799999999999999984 4443  5


Q ss_pred             CCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHH--hhcccc-ccccCCC
Q 002214          274 IGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSA--LVNCKS-LKIGNLI  350 (952)
Q Consensus       274 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~--~~~~~~-~~~~~l~  350 (952)
                      .-+.+|++||+++|.|++.++ .++++            .|+.|.+.+|.+..+..++.+-...  +..+.+ ..-.++.
T Consensus       272 clLrsL~rLDlSNN~is~Lp~-sLgnl------------hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS  338 (565)
T KOG0472|consen  272 CLLRSLERLDLSNNDISSLPY-SLGNL------------HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLS  338 (565)
T ss_pred             HHhhhhhhhcccCCccccCCc-ccccc------------eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCC
Confidence            667889999999999996544 33333            5677778888877666654321100  111110 0001111


Q ss_pred             cccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCC--cceEEEeccccccccCCCccCCCCCCcEEe
Q 002214          351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFS--RLYVVYLNRNKLSGSIPSCLGDLNSLRILS  428 (952)
Q Consensus       351 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  428 (952)
                      +=+.=.-+.-............+.+.++|++++-+++.++.+.|....  -...+++++|++. .+|..+..+..+.+.-
T Consensus       339 ~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l  417 (565)
T KOG0472|consen  339 QSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDL  417 (565)
T ss_pred             CCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHH
Confidence            111000000000011112334467889999999999855555554332  3788999999999 7788777777665544


Q ss_pred             ccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccC
Q 002214          429 LSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQG  508 (952)
Q Consensus       429 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  508 (952)
                      +..|+..+.+|..++.+++|+.|+|++|-+. .+|.+++.+..|+.|++|+|++. ..|..+..+..|+.+-.++|++..
T Consensus       418 ~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~  495 (565)
T KOG0472|consen  418 VLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGS  495 (565)
T ss_pred             HhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccc
Confidence            4444444689999999999999999999998 68999999999999999999998 788888888888888888899998


Q ss_pred             cccccccccccccEEeCCCCcccccCccchhcccccccccccccccc
Q 002214          509 PIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLV  555 (952)
Q Consensus       509 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  555 (952)
                      +.|..+.+|.+|.+|||.+|.|. .+|..+++|++|++|+++||++.
T Consensus       496 vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  496 VDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             cChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            77777999999999999999998 78889999999999999999998

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=369.54  Aligned_cols=266  Identities=25%  Similarity=0.455  Sum_probs=218.4

Q ss_pred             HHHHHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCe
Q 002214          657 DELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNF  734 (952)
Q Consensus       657 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  734 (952)
                      +++.+..+++.+.+.||+|.||+||+|+|..  .||||++..+.  +...+.|+.|+.++++-+|.||+-+.|+|..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            5566666778889999999999999999843  69999997653  3456889999999999999999999999999887


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                       .+|+.+|+|.+|..+++..+..++..+...||+|||+||.||   |.++|||||||..||++++++.|||+|||++..-
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YL---HAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYL---HAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhh---hhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence             999999999999999998888899999999999999999999   8999999999999999999999999999999754


Q ss_pred             CCc-CcccccccccccccccccccCc---CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          815 SEE-DSMKQTQTLATIGYIAPEYGRE---GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       815 ~~~-~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      ..- .........|..-|||||+++.   .+|++.+||||||+|+|||+||..||.. ...+..+...-++..       
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifmVGrG~l-------  610 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFMVGRGYL-------  610 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEEeccccc-------
Confidence            321 1122233457889999998764   4789999999999999999999999973 333322211111100       


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                          + .   ........|++++.+|+..||..++++||.+.+|+..|+++..+
T Consensus       611 ----~-p---d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  611 ----M-P---DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ----C-c---cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence                0 0   01122357899999999999999999999999999999888664

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=395.93  Aligned_cols=263  Identities=27%  Similarity=0.524  Sum_probs=223.9

Q ss_pred             hccCCccceecCccceEEEEEEeCC--C----cEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD--G----IEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      .......+.||+|+||.||.|...+  |    ..||||.++.. +.+...+|.+|+.+|+.++|||||+++|+|.+.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3456677899999999999998742  3    34899988654 455678999999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccc
Q 002214          736 ALVLEYMPKGSLEDCMYAS------NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~------~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  809 (952)
                      ++++|||++|+|..++++.      ...++..+.+.++.|||+|+.||   +++++|||||.++|+|+++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YL---e~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYL---ESKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHH---HhCCCcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999987      55799999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCcCccccccc-ccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhh
Q 002214          810 IAKLLSEEDSMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVM  887 (952)
Q Consensus       810 la~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  887 (952)
                      +|+.+.+.+++..... .-+.+|||||.+.++.++.|+|||||||++||++| |..||......+             ++
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------------v~  914 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------------VL  914 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------------HH
Confidence            9997766666665554 56789999999999999999999999999999999 899987632211             11


Q ss_pred             h-hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhhc
Q 002214          888 N-IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANI  949 (952)
Q Consensus       888 ~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~  949 (952)
                      . ++..+        +...|..||+.+.++|.+||+.+|++||++..+++.+.++......++
T Consensus       915 ~~~~~gg--------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~  969 (1025)
T KOG1095|consen  915 LDVLEGG--------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI  969 (1025)
T ss_pred             HHHHhCC--------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence            1 11111        223467899999999999999999999999999999998887766554

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-42  Score=357.35  Aligned_cols=255  Identities=31%  Similarity=0.458  Sum_probs=207.2

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCC--eeEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN--FKALVL  739 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  739 (952)
                      ..+|...+.||+|+||+||++... +|...|||..........+.+.+|++++++++|||||+.+|......  ..++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            345778899999999999999885 49999999886654333677899999999999999999999854443  689999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-CCcEEEeccccccccCC--
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-SMVAHLSDFGIAKLLSE--  816 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgla~~~~~--  816 (952)
                      ||+++|+|.+++...+..+++..+..+.+||++||+||   |++|||||||||+|||++. ++.+||+|||.++....  
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~yl---Hs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYL---HSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            99999999999988766799999999999999999999   8999999999999999999 79999999999987753  


Q ss_pred             cCcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCcc-chhhhhccchhhhhhhccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM-SIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ..........||+.|||||++..+ ....++||||+||++.||+||+.||........ .+.......            
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~------------  240 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS------------  240 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC------------
Confidence            112223346799999999999854 334589999999999999999999977411110 011000000            


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                             .+..|..++.+..+++.+|+..||++||||.|++++--
T Consensus       241 -------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  241 -------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             -------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence                   11234557888999999999999999999999998754

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-42  Score=360.95  Aligned_cols=253  Identities=26%  Similarity=0.410  Sum_probs=212.9

Q ss_pred             HHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCe
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTI-RHRNLVKIISSCTNHNF  734 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  734 (952)
                      ++...+|..++.||+|+|++||+|+. ++++.||||++...   ++...+-+.+|-.+|.+| .||.|++++..|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            45567899999999999999999987 56999999998533   233335567899999999 89999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .|+|+||+++|+|.+++.+.+ .+++..+..++.+|..|++||   |++|||||||||+|||+|+++++||+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleyl---H~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYL---HSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            999999999999999998775 799999999999999999999   8999999999999999999999999999999988


Q ss_pred             CCcCcc----------cc--cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccc
Q 002214          815 SEEDSM----------KQ--TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS  882 (952)
Q Consensus       815 ~~~~~~----------~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  882 (952)
                      .+....          ..  ...+||..|.+||++..+..++.+|+|+|||++|+|+.|.+||.+.-+ -..+++     
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yliFqk-----  298 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLIFQK-----  298 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHHHHH-----
Confidence            642211          11  347899999999999999999999999999999999999999976211 111111     


Q ss_pred             hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                            +++         ..-..++++++.+.+|+++.|..||.+|++.++|.+|
T Consensus       299 ------I~~---------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  299 ------IQA---------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ------HHH---------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                  111         1112356678899999999999999999999998775

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-42  Score=358.06  Aligned_cols=271  Identities=21%  Similarity=0.257  Sum_probs=211.2

Q ss_pred             HHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhh-HHHHHHHHHHHhCC-CCccceeeeEeecCC-eeE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGAL-NSFDAECEILKTIR-HRNLVKIISSCTNHN-FKA  736 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~  736 (952)
                      ...++|...++||.|+||.||+|+. .+|..||||.++..-.... -.=.+|++.+++++ ||||+++.+++.+.+ ..|
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3457899999999999999999986 5689999999865543321 23368999999998 999999999998887 999


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +|||||+. +|.+++...+..+++..+..|+.||++||+|+   |++|+.|||+||+|||+.....+||+|||+||.+..
T Consensus        87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hi---Hk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHI---HKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHH---HhcCcccccCChhheEecccceeEeccccccccccc
Confidence            99999955 99999998888999999999999999999999   899999999999999999999999999999998765


Q ss_pred             cCcccccccccccccccccc-cCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccch--hhhhccch----hh---h
Q 002214          817 EDSMKQTQTLATIGYIAPEY-GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI--KRWINDSL----PA---V  886 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~--~~~~~~~~----~~---~  886 (952)
                      ..  ..+.++.|.+|+|||+ ++.+.|+.+.||||+|||++|+.+-++-|.+..+-++.+  -..++...    ++   +
T Consensus       163 kp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  163 KP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             CC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            44  3456889999999996 567789999999999999999999888775432222111  11111111    00   1


Q ss_pred             hhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...+.-.+-..........-..++.++.+++.+|+++||.+||||+|++++
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            111111111111111111223378899999999999999999999999875

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-43  Score=369.54  Aligned_cols=404  Identities=23%  Similarity=0.247  Sum_probs=351.2

Q ss_pred             ccceEEcccCcccccCCccccCC--CCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEee
Q 002214          156 RLKGLYVSYNQFKGPIPNNLWHC--KELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILG  233 (952)
Q Consensus       156 ~L~~L~L~~n~l~~~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  233 (952)
                      +-..|+++++.+.......+...  ..-+.|++++|++....+..|.++++|++++|..|.++ .+|...+...+|+.|+
T Consensus        53 ~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~  131 (873)
T KOG4194|consen   53 NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD  131 (873)
T ss_pred             CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence            34456777777764333333332  34467999999999999999999999999999999998 8898777788899999


Q ss_pred             eccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCc
Q 002214          234 IDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSN  313 (952)
Q Consensus       234 L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~  313 (952)
                      |.+|.|..+..+.+..++.|+.||||.|.|+.. +. ..+..-.++++|+|++|.|+.+....|.++.+           
T Consensus       132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i-~~-~sfp~~~ni~~L~La~N~It~l~~~~F~~lns-----------  198 (873)
T KOG4194|consen  132 LRHNLISSVTSEELSALPALRSLDLSRNLISEI-PK-PSFPAKVNIKKLNLASNRITTLETGHFDSLNS-----------  198 (873)
T ss_pred             eeccccccccHHHHHhHhhhhhhhhhhchhhcc-cC-CCCCCCCCceEEeeccccccccccccccccch-----------
Confidence            999999999999999999999999999999854 32 23566678999999999999999999887754           


Q ss_pred             cccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCcc
Q 002214          314 LKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE  393 (952)
Q Consensus       314 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~  393 (952)
                      |..|.|++|+|+.+|...              |..+++|+.|+|..|+|.-..--+|.++++|+.|.|..|.|.....+.
T Consensus       199 L~tlkLsrNrittLp~r~--------------Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~  264 (873)
T KOG4194|consen  199 LLTLKLSRNRITTLPQRS--------------FKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGA  264 (873)
T ss_pred             heeeecccCcccccCHHH--------------hhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcc
Confidence            556667788888777753              668999999999999998444668999999999999999999999999


Q ss_pred             ccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccc
Q 002214          394 FCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVV  473 (952)
Q Consensus       394 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  473 (952)
                      |..+.++++|+|+.|+++..-.+++.++++|+.|+||+|.|..+.++.....++|++|+|++|+|+...++.|..+..|+
T Consensus       265 Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le  344 (873)
T KOG4194|consen  265 FYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLE  344 (873)
T ss_pred             eeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCcccCCCCcccccCCCCCceEEccCccccCccc---ccccccccccEEeCCCCcccccCccchhccccccccccc
Q 002214          474 DIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIP---ESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLS  550 (952)
Q Consensus       474 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~  550 (952)
                      +|+|++|.+..+-..+|.++++|+.|||++|.|+..+.   ..|.+|++|+.|+|.+|+|..+....|.++++|++|||.
T Consensus       345 ~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~  424 (873)
T KOG4194|consen  345 ELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLG  424 (873)
T ss_pred             hhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCC
Confidence            99999999998888999999999999999999987654   468899999999999999998778899999999999999


Q ss_pred             ccccccCCCCCCCcccccccccccCccCCCCCccCCC
Q 002214          551 FNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVP  587 (952)
Q Consensus       551 ~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~~~lp  587 (952)
                      +|.+...-|.+..-..+..+-+..-.++|+|.+.+++
T Consensus       425 ~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~Wl~  461 (873)
T KOG4194|consen  425 DNAIASIQPNAFEPMELKELVMNSSSFLCDCQLKWLA  461 (873)
T ss_pred             CCcceeecccccccchhhhhhhcccceEEeccHHHHH
Confidence            9999987776533335555556667789999876553

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.3e-40  Score=321.91  Aligned_cols=265  Identities=25%  Similarity=0.401  Sum_probs=209.7

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .+|...+++|+|.||.||+|++ .+|+.||||+++...  ++......+|++.++.++||||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677889999999999999987 679999999987653  3445678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      ||+ .+|+..++...-.++..++..++.++.+|++||   |++.|+|||+||.|+|++++|.+||+|||+|+.+..+...
T Consensus        82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~---H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYC---HSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHH---HhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            995 599999998888899999999999999999999   8999999999999999999999999999999988765443


Q ss_pred             cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhh------hccch----hhhhhh
Q 002214          821 KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW------INDSL----PAVMNI  889 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~------~~~~~----~~~~~~  889 (952)
                       .+..+.|.+|+|||.+.+ ..|+..+||||.||++.||+.|.+-|.    ++.++.+.      ..+..    |++..+
T Consensus       158 -~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp----G~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  158 -QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP----GDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             -cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC----CCchHHHHHHHHHHcCCCCcccCcccccc
Confidence             333478999999997765 479999999999999999999866543    33333222      11111    222221


Q ss_pred             ccccccchhhH-HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          890 MDTNLLSEDEE-HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       890 ~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      -|-.-....+. .....-..++.+..+++.+++..||.+|++++|++++
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11111110000 0001223456778999999999999999999999865

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=356.61  Aligned_cols=245  Identities=25%  Similarity=0.468  Sum_probs=206.8

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      +.....+-+|.|+.|.||+|++ .++.||||+++..+       ..+++-|++|+||||+.|.|+|+....+|||||||.
T Consensus       124 e~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  124 EEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             HHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            3344567899999999999999 67899999875332       357888999999999999999999999999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      .|-|..+++..+ .+.......+..+||.||.||   |.+.|||||||.-||||..+..+||+|||-++...+.  ....
T Consensus       196 ~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YL---H~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkM  269 (904)
T KOG4721|consen  196 QGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYL---HLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKM  269 (904)
T ss_pred             cccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHH---HHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhh
Confidence            999999998765 788888999999999999999   8999999999999999999999999999999876543  2344


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN  903 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (952)
                      ..+||..|||||+++..++++|+||||||||||||+||..||.+.......   |  +.        ..+      ....
T Consensus       270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---w--GV--------GsN------sL~L  330 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---W--GV--------GSN------SLHL  330 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---E--ec--------cCC------cccc
Confidence            578999999999999999999999999999999999999998653211110   0  00        000      0122


Q ss_pred             HhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          904 VAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       904 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      ..|..||+.+.-|+++||+..|..||++.+|+.||+-.
T Consensus       331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            35678999999999999999999999999999999754

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-41  Score=366.39  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=215.2

Q ss_pred             hccCCccceecCccceEEEEEEeC--CC---cEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCe
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP--DG---IEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNF  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  734 (952)
                      -++....++||+|+||.||+|++.  ++   ..||||..+..   ......+|.+|+++|++++|||||++||++..+..
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            344556689999999999999873  22   23899998753   24557889999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .++|||+|.||+|.+++...+..++..++..++.++|+||+||   |+++++||||.++|+|++.++.+||+|||+++.-
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YL---h~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYL---HSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHH---HHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            9999999999999999999887899999999999999999999   8999999999999999999999999999999854


Q ss_pred             CCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      .. .........-+.+|+|||.+..+.+++++|||||||++||+++ |..||.+....  ...+++.          ...
T Consensus       313 ~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~----------~~~  379 (474)
T KOG0194|consen  313 SQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIV----------KNG  379 (474)
T ss_pred             cc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHH----------hcC
Confidence            21 1111112346789999999999999999999999999999999 88898764322  1111110          000


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                             .+...+...|.++..++.+||..+|++||+|.++.+.++.+.+...+
T Consensus       380 -------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  380 -------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             -------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                   11122345688899999999999999999999999999999877553

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=356.38  Aligned_cols=250  Identities=27%  Similarity=0.393  Sum_probs=212.3

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      ..|..-++||+|+-|.||.|+. .+++.||||++........+-+..|+.+|+..+|+|||++++.|...+..++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4677888999999999999976 578999999998777776778899999999999999999999999889999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      +||+|.+.+....  +++.++..|.+++++||+||   |.+||+|||||.+|||++.+|.+||+|||++..+..... ..
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fL---H~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR  426 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFL---HARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR  426 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHH---HhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence            9999999887654  89999999999999999999   899999999999999999999999999999998765443 45


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...+|||.|||||+.....|++|+||||||++++||+.|.+||-.    +..++..        .-+.+.+.. +.    
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAl--------yLIa~ng~P-~l----  489 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRAL--------YLIATNGTP-KL----  489 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHH--------HHHhhcCCC-Cc----
Confidence            567899999999999999999999999999999999999999843    1111111        111111110 00    


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ..+...+.++.+++.+||..||++||++.|+++|
T Consensus       490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence             1134467889999999999999999999999875

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2.7e-44  Score=365.09  Aligned_cols=490  Identities=27%  Similarity=0.386  Sum_probs=389.0

Q ss_pred             CeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEee
Q 002214           33 NRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVL  112 (952)
Q Consensus        33 ~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  112 (952)
                      .-+++|++.++.++ .+|+.++.+..++.|+.++|+++ .+|+.++.+..|+.|+.++|.+. .+|+.++.+..|+.|+.
T Consensus        68 ~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~  144 (565)
T KOG0472|consen   68 ACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDA  144 (565)
T ss_pred             cceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhc
Confidence            34799999999998 78999999999999999999999 99999999999999999999999 89999999999999999


Q ss_pred             cCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCccc
Q 002214          113 NNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFT  192 (952)
Q Consensus       113 ~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~  192 (952)
                      .+|++. .+|++++++.++ ..+++.+|+++ .+|.+... +.+|++||+..|-++ .+|..++.+.+|+.|+|..|+|.
T Consensus       145 ~~N~i~-slp~~~~~~~~l-~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~  219 (565)
T KOG0472|consen  145 TNNQIS-SLPEDMVNLSKL-SKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR  219 (565)
T ss_pred             cccccc-cCchHHHHHHHH-HHhhccccchh-hCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc
Confidence            999999 999999998887 67999999999 45555544 899999999999998 78999999999999999999999


Q ss_pred             ccCCccccccCCccEEEeeCCcCCccCchhhh-ccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCc
Q 002214          193 GRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIG-NLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSK  271 (952)
Q Consensus       193 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  271 (952)
                       .+| +|++++.|++|+++.|.|. .+|.+.+ ++.+|..|+|..|++... |+.+..+.+|++||+|+|.|++..+.  
T Consensus       220 -~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~-Pde~clLrsL~rLDlSNN~is~Lp~s--  293 (565)
T KOG0472|consen  220 -FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEV-PDEICLLRSLERLDLSNNDISSLPYS--  293 (565)
T ss_pred             -cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccC-chHHHHhhhhhhhcccCCccccCCcc--
Confidence             677 8999999999999999998 6777766 899999999999998875 78889999999999999999976554  


Q ss_pred             ccCCCCCcceEEcccCcCCCCCCcccccchh--hhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCC
Q 002214          272 NLIGLPNLEGLNLGLNNLSGSIPSFFFNASK--LYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNL  349 (952)
Q Consensus       272 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~--L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l  349 (952)
                       ++.+ .|+.|-+.+|.+..+--+.+.+-+.  |++|.=    ..+.-.++.-.=.....      .....-.....-.+
T Consensus       294 -Lgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs----~~~~dglS~se~~~e~~------~t~~~~~~~~~~~~  361 (565)
T KOG0472|consen  294 -LGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS----KIKDDGLSQSEGGTETA------MTLPSESFPDIYAI  361 (565)
T ss_pred             -cccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH----hhccCCCCCCccccccc------CCCCCCcccchhhh
Confidence             6666 8999999999997544333322221  222211    00000111100000000      00000111123345


Q ss_pred             CcccEEEccCCCCCCCCCcccccC--CCCcEEEccCccccCCCCccccCCCcceE-EEeccccccccCCCccCCCCCCcE
Q 002214          350 INLTTLSLGDNNLSGSLPITLGRL--KKLQGLDLQNNKFEGPIPQEFCHFSRLYV-VYLNRNKLSGSIPSCLGDLNSLRI  426 (952)
Q Consensus       350 ~~L~~L~L~~n~l~~~~~~~l~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~  426 (952)
                      .+.+.|++++-+++.++.+.|..-  .-....+++.|++. ..|..+..+..+.. +.+++|++. .+|..++.+++|..
T Consensus       362 i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~  439 (565)
T KOG0472|consen  362 ITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTF  439 (565)
T ss_pred             hhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhccee
Confidence            678899999999995444444332  23789999999998 67777776666544 556666665 88999999999999


Q ss_pred             EeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccc
Q 002214          427 LSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKL  506 (952)
Q Consensus       427 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  506 (952)
                      |+|++|-+.+ .|..++.+..|+.||+|.|++. ..|..+-.+..|+.+-.++|++..+.|+.+.++.+|.+|||.+|.|
T Consensus       440 L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdl  517 (565)
T KOG0472|consen  440 LDLSNNLLND-LPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDL  517 (565)
T ss_pred             eecccchhhh-cchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCch
Confidence            9999999974 6777888888999999999998 6888888888888888888999988888899999999999999999


Q ss_pred             cCcccccccccccccEEeCCCCcccccCccchhccccccccccccccc
Q 002214          507 QGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL  554 (952)
Q Consensus       507 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l  554 (952)
                      . .+|+.+++|.+|+.|+|++|+|+ .++..+--.+-...|..-++++
T Consensus       518 q-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~aiL~ylrdrI  563 (565)
T KOG0472|consen  518 Q-QIPPILGNMTNLRHLELDGNPFR-QPRHQILMKGTAAILSYLRDRI  563 (565)
T ss_pred             h-hCChhhccccceeEEEecCCccC-CCHHHHhccChHHHHHHhcccC
Confidence            9 78889999999999999999998 5555444334444444444443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-40  Score=338.90  Aligned_cols=261  Identities=25%  Similarity=0.405  Sum_probs=212.0

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .+.|.+.+.||.|.-++||+|+. +.++.||||++..++- ...+.+++|+..|+.++||||++.+..|..+...++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46799999999999999999976 6789999999976643 335889999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          741 YMPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||.+|++.+.+... ...+++..+..|.+++.+||.||   |++|.||||||+.|||++++|.+||+|||.+..+.....
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YL---H~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYL---HQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHH---HhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            99999999998753 34699999999999999999999   899999999999999999999999999999876654432


Q ss_pred             cc---ccccccccccccccccCc--CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          820 MK---QTQTLATIGYIAPEYGRE--GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       820 ~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ..   ....+||+.|||||++..  ..|+.|+||||||++..|+.+|..||...++-.....+.-.. .|..    +...
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~-pp~~----~t~~  256 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND-PPTL----LTSG  256 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-CCCc----cccc
Confidence            11   123579999999998543  368999999999999999999999998865543333222111 1110    0111


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...+      ....++..+.+++..|+..||++|||+++++++
T Consensus       257 ~~~d------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  257 LDKD------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CChH------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            1111      113346689999999999999999999999864

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-40  Score=357.39  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=207.4

Q ss_pred             HHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc----Cc-hhhHHHHHHHHHHHhCC-CCccceeeeEeecCC
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ----RE-GALNSFDAECEILKTIR-HRNLVKIISSCTNHN  733 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  733 (952)
                      ...+.|.+.+.||+|+||.|+.|+. .+|+.||+|++..+    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456899999999999999999976 46899999977543    12 23456778999999998 999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC-CcEEEecccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS-MVAHLSDFGIAK  812 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgla~  812 (952)
                      ..|+||||+.||+|.+++.. ..++.+.++..+++|++.|++||   |++||+||||||+||+++.+ +.+||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~---H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYC---HSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999988 55899999999999999999999   89999999999999999999 999999999999


Q ss_pred             ccCCcCcccccccccccccccccccCcCC-cC-cccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGREGQ-VS-IKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      ... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++... ...+....+          
T Consensus       170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-~~l~~ki~~----------  237 (370)
T KOG0583|consen  170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-PNLYRKIRK----------  237 (370)
T ss_pred             ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-HHHHHHHhc----------
Confidence            773 2222344578999999999998866 64 789999999999999999999977110 001111000          


Q ss_pred             cccccchhhHHHHHhhhhh-HHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSC-ASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                                ..-..|..+ +.++..++.+|+.+||.+|+++.||.+
T Consensus       238 ----------~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  238 ----------GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ----------CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                      011123444 778999999999999999999999983

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=349.76  Aligned_cols=262  Identities=26%  Similarity=0.456  Sum_probs=224.1

Q ss_pred             HHHHHHhccCCccceecCccceEEEEEEeCC-CcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          657 DELLRATDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       657 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      ++++-.+.+...-.+||-|.||.||.|.|+. .-.||||.++.+ ....++|.+|+.+|+.++|||+|+++|+|+.+...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4455555567778899999999999999954 668999998644 44568999999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          736 ALVLEYMPKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      |||+|||.+|+|.++++++.. .++.--.+.++.||+.||+||   ..+.+|||||.++|+|+.++..+||+|||+++.+
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYL---EkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHH---HHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            999999999999999988664 466677889999999999999   7899999999999999999999999999999999


Q ss_pred             CCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      ..+.++.......++.|.|||.+....++.|+|||+|||++||+.| |..||...     +..+        +.+++.. 
T Consensus       416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSq--------VY~LLEk-  481 (1157)
T KOG4278|consen  416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQ--------VYGLLEK-  481 (1157)
T ss_pred             cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHH--------HHHHHhc-
Confidence            8887777777788999999999999999999999999999999999 88887542     1111        1111111 


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                            ..+...|++||+.+.+||+.||+++|.+||+++|+-+.++.+.
T Consensus       482 ------gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  482 ------GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             ------cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence                  1223357899999999999999999999999999999998764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-40  Score=320.98  Aligned_cols=237  Identities=25%  Similarity=0.322  Sum_probs=204.1

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|...+.||.|+||+|.+++.+ +|..+|+|++..+.   -+..+....|.++++.+.||.++++++.+.+.+..|||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            457888999999999999999874 68899999997653   23456678999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||++||.|.++++..+ ++++..+.-+|.||+.|++||   |+.+|++||+||+|||+|.+|.+||+|||+|+.+... 
T Consensus       123 meyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleyl---H~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYL---HSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHH---HhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            99999999999998766 799999999999999999999   8999999999999999999999999999999987543 


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                         .-..+|||.|+|||+++...+..++|.|||||++|||+.|.+||....+ ...+.+++..                 
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~-----------------  256 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEG-----------------  256 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhC-----------------
Confidence               3347899999999999999999999999999999999999999876322 2222222211                 


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCC
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENR  928 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  928 (952)
                         ....|...+.++.+|+.+.++.|-.+|
T Consensus       257 ---~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  257 ---KVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ---cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence               112345567889999999999999999

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-39  Score=360.42  Aligned_cols=260  Identities=21%  Similarity=0.393  Sum_probs=205.9

Q ss_pred             HhccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeecC-
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNH-  732 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  732 (952)
                      ..++|++.+.||+|+||.||+|.+      .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            456799999999999999999974      235789999986443 23346789999999999 899999999988764 


Q ss_pred             CeeEEEEEccCCCChhHHhhhcC---------------------------------------------------------
Q 002214          733 NFKALVLEYMPKGSLEDCMYASN---------------------------------------------------------  755 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  755 (952)
                      +..++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46889999999999999886432                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc-cccccccccc
Q 002214          756 ----FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIG  830 (952)
Q Consensus       756 ----~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~  830 (952)
                          ..+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++........ ......+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                2477888999999999999999   7899999999999999999999999999999865433221 2223346788


Q ss_pred             cccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhh
Q 002214          831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSC  909 (952)
Q Consensus       831 y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (952)
                      |+|||++.+..++.++|||||||++|||++ |..||......+. +...          ..+...        ...+..+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~----------~~~~~~--------~~~~~~~  302 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQR----------LKDGTR--------MRAPENA  302 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHH----------HhcCCC--------CCCCCCC
Confidence            999999988899999999999999999997 9999865321110 1000          000000        0012345


Q ss_pred             HHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          910 ASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       910 ~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                      ++++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            6789999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.6e-40  Score=353.03  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=210.8

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .+.|+.++.||.|+-|.|-.|++ .+|+.+|||++....   +.....+.+|+-||+-+.||||+++|+++++....|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            35688999999999999999987 689999999986542   23356788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      .||+++|-|.+++..++ ++.+.++.++++||..|+.|+   |..+|+|||+||+|+|+|..+.+||+|||+|..-.++.
T Consensus        91 lEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yC---H~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYC---HAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHH---hhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999999997766 799999999999999999999   78999999999999999999999999999998643332


Q ss_pred             cccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      -  -...+|+|+|+|||++.+.+| +.++||||+|||+|.++||+.||++     ..++..+......            
T Consensus       167 l--LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlKV~~G------------  227 (786)
T KOG0588|consen  167 L--LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLKVQRG------------  227 (786)
T ss_pred             c--ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHHHHcC------------
Confidence            2  234689999999999999887 5889999999999999999999974     2233222211111            


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                          .-.+|...+.++++|+++|+..||++|.|++||.+|-
T Consensus       228 ----~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  228 ----VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ----cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                1113456788999999999999999999999999874

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=345.08  Aligned_cols=266  Identities=22%  Similarity=0.369  Sum_probs=222.1

Q ss_pred             HHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchh-hHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA-LNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      +..+....+.++||+|.||.|..+....+..||||+++..+... ..+|.+|+++|.+++|||||+++|+|..++..+++
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            34556678889999999999999999788999999998776554 47899999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          739 LEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      +|||++|+|.+++.++..+ .+-....+|+.|||.||+||   .+-++||||+.++|+|++.++++||+|||+++.+..+
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYL---es~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYL---ESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHH---HhhchhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999999999887543 36667788999999999999   8999999999999999999999999999999977766


Q ss_pred             Cccccc-ccccccccccccccCcCCcCcccchHhHHHHHHHHHh--CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          818 DSMKQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT--GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       818 ~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      +++... ..+-+++|||||.+.-+.++.++|||+||+++||+++  ...||.+.....         ..++..++++..-
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---------vven~~~~~~~~~  761 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---------VVENAGEFFRDQG  761 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---------HHHhhhhhcCCCC
Confidence            665543 4567899999999999999999999999999999887  778887643221         1112222222211


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      .+    .....|..|+.++.++|..||+.|.++||+++++..+|.+.
T Consensus       762 ~~----~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 RQ----VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cc----eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            11    11224677999999999999999999999999999988754

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-39  Score=343.34  Aligned_cols=257  Identities=25%  Similarity=0.454  Sum_probs=222.0

Q ss_pred             hccCCccceecCccceEEEEEEeC---CC--cEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP---DG--IEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      ++.....+.||+|.||.||+|.+.   .|  -.||||..+.+. ....+.|..|+.+|+.+.||||++++|+|.+. ..+
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            344556678999999999999863   23  358999887653 33467899999999999999999999999875 579


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +|||.++-|.|..+++..+..++..+...++.||+.||+||   |++++|||||.++|||+.+...+|++|||+++.+.+
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYL---eSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYL---ESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHH---HhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            99999999999999999998999999999999999999999   899999999999999999999999999999999988


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ..++......-++.|||||.+.-..++.+||||.|||++||++. |..||......+....                 + 
T Consensus       544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-----------------i-  605 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-----------------I-  605 (974)
T ss_pred             cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-----------------e-
Confidence            88877776677889999999999999999999999999999998 9999977544432111                 0 


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                        ....+...|+.||+.+..+|.+||+++|.+||.+.|+...|.++..
T Consensus       606 --EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  606 --ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             --cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence              1112334578899999999999999999999999999999998876

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.8e-39  Score=319.80  Aligned_cols=269  Identities=22%  Similarity=0.278  Sum_probs=207.3

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeec--CCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTN--HNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  737 (952)
                      .+.|...++|++|+||.||+|++ ++++.||+|+++.+.+  +..-...+|+.++.+.+|||||.+-.+...  -+..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            45688889999999999999998 4689999999976643  344567899999999999999999887754  367999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      |||||++ +|.+++..-++++...++..++.|+.+|++||   |...|+|||||++|+|+...|.+||+|||+|+.++.+
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~l---H~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHL---HDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---hhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999977 89999998888999999999999999999999   8999999999999999999999999999999988654


Q ss_pred             CcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhh---hhccchhhh-hhh---
Q 002214          818 DSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR---WINDSLPAV-MNI---  889 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~-~~~---  889 (952)
                      . ...+..+.|.+|+|||.+.+ ..|+.+.|+||+|||+.|++++++-|.....-+ ++.+   ......+.. ..+   
T Consensus       231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-Ql~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-QLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-HHHHHHHHhCCCccccCCCcccc
Confidence            2 34556789999999998765 468999999999999999999998875422111 1111   111111110 000   


Q ss_pred             --ccccccchhh--HHHHHhh-hhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          890 --MDTNLLSEDE--EHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       890 --~~~~~~~~~~--~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                        +......+.+  ..+...+ ...++.-.+|+...+..||.+|.|+.|.+++
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence              0000000000  0001111 1145778999999999999999999998864

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.1e-38  Score=341.79  Aligned_cols=246  Identities=24%  Similarity=0.362  Sum_probs=200.8

Q ss_pred             ceecCccceEEEEEEeCCCcEEEEEEeeccCchh---hHHHHHHHHHHHhCCCCccceeeeEeec----CCeeEEEEEcc
Q 002214          670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA---LNSFDAECEILKTIRHRNLVKIISSCTN----HNFKALVLEYM  742 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  742 (952)
                      ..||+|++|.||+|.+ +|+.||||+++......   .+.+.+|+.++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 78999999986543322   4678899999999999999999999876    34678999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS-NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~-~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      ++|+|.+++...+ .+++.....++.|++.|++||   |+ .+++||||||+||++++++.+||+|||+++......   
T Consensus       105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~l---H~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNL---YKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---  177 (283)
T ss_pred             CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHH---HhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence            9999999997654 689999999999999999999   55 588999999999999999999999999998654322   


Q ss_pred             ccccccccccccccccCc--CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          822 QTQTLATIGYIAPEYGRE--GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                       ....+++.|+|||++.+  ..++.++|||||||++|||++|+.||......+ .+...           ......    
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-~~~~i-----------~~~~~~----  240 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-IYDLI-----------INKNNS----  240 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-HHHHH-----------HhcCCC----
Confidence             22458899999999876  678999999999999999999999997532110 01100           000000    


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                         ...+..+++++.+++.+||+.||++|||++|+++.|+++..
T Consensus       241 ---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        241 ---LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ---CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence               01123467889999999999999999999999999998764

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.4e-39  Score=339.42  Aligned_cols=247  Identities=30%  Similarity=0.450  Sum_probs=208.6

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.  .+++.+.+.+|++|+++++|||||.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999864 6889999998544  34556789999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+.| +|..++...+ .++++.+..++.++..||.||   |+.+|.|||+||+||+++..+.+|++|||+|+.+.... .
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yL---hs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~  155 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYL---HSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-S  155 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHH---HhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-e
Confidence            9976 9999987655 799999999999999999999   89999999999999999999999999999999876533 3


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      ..+...|||-|||||...+.+|+..+|.||+||++||+++|++||...     .+.+.       ...+.....      
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~L-------v~~I~~d~v------  217 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQL-------VKSILKDPV------  217 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHH-------HHHHhcCCC------
Confidence            344567999999999999999999999999999999999999998541     11111       011111111      


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ..|...+..+..++...+..||.+|.+..+++.|
T Consensus       218 ---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  218 ---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence               1123457789999999999999999999998765

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-39  Score=307.17  Aligned_cols=248  Identities=24%  Similarity=0.349  Sum_probs=211.4

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|.+++.||+|.||.||.|+. +++-.||+|++...   ..+..+++.+|++|-+.|+||||.++|++|.++...|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            45799999999999999999987 46788999998543   234457899999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          739 LEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      +||..+|.+...++..+ ..+++.....+..|+|.|+.|+   |.++|+||||||+|+|++.++..|++|||.+....  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~---h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYC---HLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHh---ccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999998544 3689999999999999999999   89999999999999999999999999999998542  


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                       .......+||..|.|||+..+..++..+|+|++|++.||++.|.+||.... ....+.+..+-                
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~----------------  237 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKV----------------  237 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHc----------------
Confidence             334455789999999999999999999999999999999999999997643 22223222111                


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          .-..|...+.++.++|.+|+..+|.+|.+..|++++
T Consensus       238 ----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  238 ----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ----cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                111234567889999999999999999999999876

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=328.25  Aligned_cols=274  Identities=25%  Similarity=0.349  Sum_probs=204.8

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhC--CCCccceeeeEeecCC----eeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKIISSCTNHN----FKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~  736 (952)
                      .......++||+|.||.||+|++ +++.||||++..+.   .+.|+.|-+|++..  +|+||++++++-....    .+.
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc-cCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            34566678899999999999999 56999999996443   46788888888764  8999999998776554    789


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh------cCCCCeEeCCCCCCCeeeCCCCcEEEecccc
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF------GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGI  810 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~------~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  810 (952)
                      ||+||.+.|+|.+++..+  .++|....+|+.-+++||+|||.      .|+++|+|||||++|||+.+|+++.|+|||+
T Consensus       285 LVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            999999999999999875  59999999999999999999995      5778899999999999999999999999999


Q ss_pred             ccccCCcCccc-ccccccccccccccccCcCC------cCcccchHhHHHHHHHHHhCCCCCC--ccccCccchhhhhc-
Q 002214          811 AKLLSEEDSMK-QTQTLATIGYIAPEYGREGQ------VSIKGDVYNYGIMLMEVFTGMKPTN--EFFTGEMSIKRWIN-  880 (952)
Q Consensus       811 a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~el~tg~~p~~--~~~~~~~~~~~~~~-  880 (952)
                      |.++....... ....+||.+|||||++.+..      .-.+.||||+|.|+|||+++...+.  ...+-...+.+-+. 
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            99886543322 22368999999999886642      1235799999999999999765442  11111122221111 


Q ss_pred             -cchhhhhhhccc-cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          881 -DSLPAVMNIMDT-NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       881 -~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                       .-.+++.+.+-. ..+...++..  ..-.....+.+.+..||..||+.|.|+.=|.+++.++...
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W--~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAW--RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhh--hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence             112222222211 1111111111  0112356689999999999999999999999999887654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.9e-38  Score=336.67  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=203.6

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ..++|...++||+|+||.||+|+- ++|..+|+|+++...   ....+.+..|-.+|....+|.||+++..|.+.+..||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            457899999999999999999976 569999999997542   3456778999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC-
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE-  816 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~-  816 (952)
                      ||||++||++..+|...+ .+++..+..++.+++.|++.+   |+.|+|||||||+|+|||..|++||+|||++.-+.. 
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~i---H~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESI---HQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHH---HHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            999999999999987665 799999999999999999999   899999999999999999999999999999953211 


Q ss_pred             ---------------------cCcc-----cc-------------------cccccccccccccccCcCCcCcccchHhH
Q 002214          817 ---------------------EDSM-----KQ-------------------TQTLATIGYIAPEYGREGQVSIKGDVYNY  851 (952)
Q Consensus       817 ---------------------~~~~-----~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  851 (952)
                                           .+..     ..                   ...+|||.|+|||++.+..|+..+|.||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 0000     00                   02469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCC-
Q 002214          852 GIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN-  930 (952)
Q Consensus       852 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-  930 (952)
                      |||+|||+.|.+||....+.+ .+++++.-.         ..+...       ....+++++.+||.+|+. ||++|.- 
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~-T~rkI~nwr---------~~l~fP-------~~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQE-TYRKIVNWR---------ETLKFP-------EEVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh---------hhccCC-------CcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            999999999999997643221 111111000         000000       113356889999999999 9999985 


Q ss_pred             --HHHHHH
Q 002214          931 --TKEIIS  936 (952)
Q Consensus       931 --~~ev~~  936 (952)
                        +.||.+
T Consensus       437 ~G~~EIK~  444 (550)
T KOG0605|consen  437 KGAEEIKK  444 (550)
T ss_pred             ccHHHHhc
Confidence              555544

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=315.67  Aligned_cols=253  Identities=23%  Similarity=0.362  Sum_probs=206.0

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ..+.|++.+.||+|.|+.||++.. ++|+.+|+|++...  .....+.+.+|++|.+.++|||||++.+.+.+.+..|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            456788899999999999999865 67999999987433  223457889999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC---CCCcEEEeccccccccC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgla~~~~  815 (952)
                      +|+|+|++|..-+-.. .-+++..+-..++||.+++.|+   |.++|||||+||+|+++.   ....+|++|||+|..+.
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yC---H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYC---HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999996655433 3578888999999999999999   899999999999999995   34579999999999886


Q ss_pred             CcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                        +.......+|||+|||||+++..+|+..+|||+.||++|-++.|..||.+... ...+.++..+..       |    
T Consensus       165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye~I~~g~y-------d----  230 (355)
T KOG0033|consen  165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYEQIKAGAY-------D----  230 (355)
T ss_pred             --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhcccc-------C----
Confidence              33344567899999999999999999999999999999999999999865211 111222221111       0    


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           .....+...+++..+|+++|+..||.+|.|+.|.+++
T Consensus       231 -----~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  231 -----YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             -----CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence                 0011234567789999999999999999999998875

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=335.38  Aligned_cols=249  Identities=28%  Similarity=0.418  Sum_probs=210.3

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..|+..+.||+|+||.||+|.+ .+++.||+|++..+. +...+.+++|+.++.+.+++||.+.|+.+..+....++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4577779999999999999987 578999999997664 33467899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      |.||++.+.+.... .+++....-|++++..|+.||   |.++.+|||||+.||++.++|.+|++|||.+..+.......
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~yl---H~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYL---HSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhh---hhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence            99999999987765 458888889999999999999   89999999999999999999999999999998876544333


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                       ...+||+.|||||++....|+.|+||||+|++.+||.+|.+|+....+-.  +...+....|                 
T Consensus       169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr--vlflIpk~~P-----------------  228 (467)
T KOG0201|consen  169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR--VLFLIPKSAP-----------------  228 (467)
T ss_pred             -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce--EEEeccCCCC-----------------
Confidence             56789999999999998899999999999999999999999987754411  1111111110                 


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       +.....+++.+.+++..|++.||+.||+|.+++++
T Consensus       229 -P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  229 -PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             -CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence             01112467789999999999999999999999875

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.3e-38  Score=336.26  Aligned_cols=256  Identities=23%  Similarity=0.355  Sum_probs=207.5

Q ss_pred             hccCCccceecCccceEEEEEEeC----CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++.... .....+.+|+.++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            457889999999999999999763    467899999875532 334678899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|+|.+++......+++.+++.++.|++.|++||   |++|++||||||+||+++.++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999999987666789999999999999999999   7999999999999999999999999999988654322


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      .........++..|+|||.+.+..++.++|||||||++||+++ |..||......  ...+.           +..... 
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~-----------~~~~~~-  226 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKA-----------VEDGFR-  226 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH-----------HHCCCC-
Confidence            2222222335678999999988899999999999999999775 99998653111  11110           000000 


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                            ...+..++..+.+++.+||+.+|++||++.||.+.|+++
T Consensus       227 ------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 ------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                  012345678899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.3e-39  Score=325.51  Aligned_cols=248  Identities=23%  Similarity=0.348  Sum_probs=209.3

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ..+|.+.+.||+|.||.|-+|+. ..|+.||||.++.+   +++..-.+.+|++||..++||||+.+|.+|+..+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            34688889999999999999976 67999999998655   344556789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||..+|.|.+++...+ .+++.++.++++||..|+.|+   |+++++|||+|.+|||+|.++++||+|||++-.+....
T Consensus       132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYC---HknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYC---HKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHH---hhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            99999999999998766 799999999999999999999   89999999999999999999999999999998876544


Q ss_pred             cccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      ..  ...+|++-|.+||++.+.+| ++.+|-||+||++|-++.|..||+..... ..++++-.+            -   
T Consensus       208 fL--qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-~lvrQIs~G------------a---  269 (668)
T KOG0611|consen  208 FL--QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-RLVRQISRG------------A---  269 (668)
T ss_pred             HH--HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-HHHHHhhcc------------c---
Confidence            32  34789999999999999887 58899999999999999999999763111 011111110            0   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                            +..+.-|.+..-||++|+..+|++|.|+.+|..+-
T Consensus       270 ------YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  270 ------YREPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ------ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                  11122255678899999999999999999998874

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.2e-38  Score=343.45  Aligned_cols=261  Identities=21%  Similarity=0.376  Sum_probs=202.6

Q ss_pred             hccCCccceecCccceEEEEEEeCC-----------------CcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccce
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD-----------------GIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVK  724 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~  724 (952)
                      .++|++.+.||+|+||.||+|.+++                 +..||+|++..... .....+.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578899999999999999997532                 34799999875433 23467899999999999999999


Q ss_pred             eeeEeecCCeeEEEEEccCCCChhHHhhhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 002214          725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIV  786 (952)
Q Consensus       725 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~iv  786 (952)
                      +++++.+.+..++||||+++|+|.+++....                  ..+++..+..++.|++.|++||   |+.||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH---HHCCcc
Confidence            9999999999999999999999999885422                  2367888999999999999999   789999


Q ss_pred             eCCCCCCCeeeCCCCcEEEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh--CCC
Q 002214          787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT--GMK  863 (952)
Q Consensus       787 H~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~  863 (952)
                      ||||||+||+++.++.+||+|||+++......... .....++..|+|||++..+.++.++||||||+++|||++  |..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999998664433221 223446789999999888889999999999999999997  556


Q ss_pred             CCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          864 PTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       864 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                      ||......  ......       ..........    .....+..++..+.+++.+||+.||++|||+.||.+.|+
T Consensus       241 p~~~~~~~--~~~~~~-------~~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDE--QVIENA-------GEFFRDQGRQ----VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHH--HHHHHH-------HHHhhhcccc----ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            76543211  111000       0000000000    000112456788999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=321.40  Aligned_cols=270  Identities=21%  Similarity=0.276  Sum_probs=207.1

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEee--ccCchhhHHHHHHHHHHHhCCCCccceeeeEeec-----CC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFH--LQREGALNSFDAECEILKTIRHRNLVKIISSCTN-----HN  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~  733 (952)
                      ....|...+.||+|+||.|+.|.+ .+|+.||||++.  .+.....++..+|+++++.++|+||+.+.+++..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            345666678999999999999987 579999999986  4555567888999999999999999999998865     24


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ..|+|+|+| +.+|...++... .++......++.|+.+|++|+   |+.+|+|||+||+|++++.+...||+|||+|+.
T Consensus       100 DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyi---HSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYI---HSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchh---hcccccccccchhheeeccCCCEEeccccceee
Confidence            789999999 668988887654 589999999999999999999   899999999999999999999999999999998


Q ss_pred             cCCcC-cccccccccccccccccccC-cCCcCcccchHhHHHHHHHHHhCCCCCCccccC--ccchhhhhccchhhhh--
Q 002214          814 LSEED-SMKQTQTLATIGYIAPEYGR-EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTG--EMSIKRWINDSLPAVM--  887 (952)
Q Consensus       814 ~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~--  887 (952)
                      ..... ....+..+.|.+|.|||.+. ...|+.+.||||.||++.||++|+.-|.+...-  -..+.......-++..  
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            75431 22235578999999999654 567999999999999999999999887542110  0011111222211111  


Q ss_pred             -------hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          888 -------NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       888 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                             ..+............... +...+.+.+|+.+|+..||.+|+|++|++++
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                   111111111111111222 3567889999999999999999999999875

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.4e-38  Score=350.58  Aligned_cols=257  Identities=21%  Similarity=0.394  Sum_probs=204.8

Q ss_pred             HhccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeecCC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNHN  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  733 (952)
                      ..++|++.+.||+|+||.||+|++      +++..||||+++... ....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            345799999999999999999963      346789999986443 23446788999999999 8999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcC----------------------------------------------------------
Q 002214          734 FKALVLEYMPKGSLEDCMYASN----------------------------------------------------------  755 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  755 (952)
                      ..++||||+++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999998886422                                                          


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          756 ----------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       756 ----------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                                      ..+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                            1478889999999999999999   789999999999999999999999999999986643322


Q ss_pred             cc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          820 MK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       820 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      .. .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ...++           +...... 
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~-----------~~~~~~~-  336 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKM-----------IKEGYRM-  336 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHH-----------HHhCccC-
Confidence            11 122345678999999999999999999999999999998 888886532211 11111           1111000 


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                            ..+...+.++.+++.+||+.||++||++.||++.|++
T Consensus       337 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         337 ------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                  0112346789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-37  Score=337.21  Aligned_cols=270  Identities=24%  Similarity=0.291  Sum_probs=204.6

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++....  +...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46899999999999999999985 68899999986542  2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |++++.+..+. .....+++..+..++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||++.........
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWC---HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            99987776544 3344689999999999999999999   7899999999999999999999999999999876443332


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccc--hhhhhccchhhhhhhcccc-----
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS--IKRWINDSLPAVMNIMDTN-----  893 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-----  893 (952)
                      ......+++.|+|||++.+..++.++|||||||++|||++|+.||......+..  .........+.........     
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            333456899999999998888999999999999999999999998653211110  0000000000000000000     


Q ss_pred             ----ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 ----LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ...............++.++.+++.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                00000000011122357789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.1e-37  Score=329.81  Aligned_cols=251  Identities=24%  Similarity=0.381  Sum_probs=204.7

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      ++|++.+.||+|+||.||+|.++++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4688889999999999999999888899999876332 234678899999999999999999999999999999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +|+|.+++......+++..+..++.|++.|++||   |++||+||||+|+||+++.++.+|++|||.++...........
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL---ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            9999999876555789999999999999999999   7899999999999999999999999999999866443332222


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...++..|+|||+..+..++.++||||||+++|||++ |+.||...... ........           ...        
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-~~~~~i~~-----------~~~--------  219 (256)
T cd05114         160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMISR-----------GFR--------  219 (256)
T ss_pred             CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHC-----------CCC--------
Confidence            3345678999999988889999999999999999999 88998542110 00111000           000        


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      ...+...+.++.+++.+||+.+|++||+++|+++.|
T Consensus       220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            001122356789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-37  Score=335.22  Aligned_cols=250  Identities=22%  Similarity=0.321  Sum_probs=201.5

Q ss_pred             CCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          666 FSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      |+..+.||+|+||.||+|.. .+|+.||+|.+....   ......+.+|++++++++|++++++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67789999999999999987 579999999886432   22234678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++|+|.+.+.... ..+++..+..++.|++.|++||   |++||+||||||+||++++++.+||+|||++........ 
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL---QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-  157 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence            99999988876433 3689999999999999999999   799999999999999999999999999999987543222 


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                       .....|++.|+|||++.+..++.++|||||||++|||++|+.||........ ..        .....+...       
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~--------~~~~~~~~~-------  220 (285)
T cd05631         158 -VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-RE--------EVDRRVKED-------  220 (285)
T ss_pred             -ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HH--------HHHHHhhcc-------
Confidence             2335689999999999998999999999999999999999999875321110 00        000000000       


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVN-----TKEIISR  937 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~  937 (952)
                       ....+...+.++.+++.+||+.||++||+     ++|++++
T Consensus       221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence             00012335678999999999999999997     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.4e-37  Score=348.42  Aligned_cols=259  Identities=22%  Similarity=0.408  Sum_probs=205.6

Q ss_pred             HhccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeecCC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNHN  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  733 (952)
                      ..++|.+.+.||+|+||.||+|+.      .++..||||+++... ......+.+|+.+++.+ +||||+++++++...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            345799999999999999999874      234689999986543 23346688999999999 8999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcC----------------------------------------------------------
Q 002214          734 FKALVLEYMPKGSLEDCMYASN----------------------------------------------------------  755 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  755 (952)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999875421                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc-cc
Q 002214          756 -----------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK-QT  823 (952)
Q Consensus       756 -----------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~  823 (952)
                                 ..+++.++.+++.|++.||+||   |++||+||||||+||++++++.+||+|||+++......... ..
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                       2478888999999999999999   78999999999999999999999999999998654332211 11


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .+...           +.....       
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~-----------~~~~~~-------  333 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKM-----------VKRGYQ-------  333 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHH-----------HHcccC-------
Confidence            2335678999999988899999999999999999997 999986532211 11111           100000       


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                      ...+...+.++.+++.+||+.||++||++.||++.|+++.
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            0011224678999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=301.06  Aligned_cols=261  Identities=21%  Similarity=0.280  Sum_probs=209.0

Q ss_pred             HHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecC-----Ce
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNH-----NF  734 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  734 (952)
                      ...++|++.+.+|+|||+.||.++. .+++.||+|++.....+..+..++|++..++++||||++++++...+     ..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            3456899999999999999999985 68999999999877767778899999999999999999999877433     45


Q ss_pred             eEEEEEccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCeeeCCCCcEEEeccc
Q 002214          735 KALVLEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNP--IVHCDIKPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~--ivH~Dlk~~Nill~~~~~~kl~Dfg  809 (952)
                      .|++++|...|+|.+.+..   ++..+++.+.+.|+.++++||++|   |+..  ++||||||.||++++.+.+++.|||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~l---H~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEAL---HEKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHH---hccCCcccccCCCcceeEecCCCceEEEecc
Confidence            8999999999999998865   334689999999999999999999   6666  9999999999999999999999999


Q ss_pred             cccccCCcCcc--------cccccccccccccccccC---cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhh
Q 002214          810 IAKLLSEEDSM--------KQTQTLATIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW  878 (952)
Q Consensus       810 la~~~~~~~~~--------~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~  878 (952)
                      .+....-.-..        .......|..|+|||.+.   +...++++|||||||++|+|+.|..||+........+.-.
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA  254 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA  254 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence            99865321111        112245899999999764   4457899999999999999999999997654432222111


Q ss_pred             hccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          879 INDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       879 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      +..          +...  .+     ....+++++.+++++|+++||.+||++.|++..++.+
T Consensus       255 v~n----------~q~s--~P-----~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  255 VQN----------AQIS--IP-----NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             eec----------cccc--cC-----CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            000          0000  00     0112578899999999999999999999999988765

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-38  Score=326.43  Aligned_cols=259  Identities=27%  Similarity=0.379  Sum_probs=201.6

Q ss_pred             HHHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---------c-----hhhHHHHHHHHHHHhCCCCcc
Q 002214          658 ELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---------E-----GALNSFDAECEILKTIRHRNL  722 (952)
Q Consensus       658 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~-----~~~~~~~~E~~~l~~l~h~ni  722 (952)
                      +-....++|.+.+.||+|.||.|-+|+. .+++.||||++....         .     ...+..++|+.+|++++||||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            3345668999999999999999999987 468999999985331         1     123578999999999999999


Q ss_pred             ceeeeEeecC--CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC
Q 002214          723 VKIISSCTNH--NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS  800 (952)
Q Consensus       723 v~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~  800 (952)
                      |+++.+..+.  +..|||+|||..|.+...-... ..++..+++.+++++..||+||   |.+|||||||||+|+|++++
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~-~els~~~Ar~ylrDvv~GLEYL---H~QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK-PELSEQQARKYLRDVVLGLEYL---HYQGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCCCCc-ccccHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEEcCC
Confidence            9999998764  6889999999999876533222 1389999999999999999999   89999999999999999999


Q ss_pred             CcEEEeccccccccCCcCc----ccccccccccccccccccCcCC----cCcccchHhHHHHHHHHHhCCCCCCccccCc
Q 002214          801 MVAHLSDFGIAKLLSEEDS----MKQTQTLATIGYIAPEYGREGQ----VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE  872 (952)
Q Consensus       801 ~~~kl~Dfgla~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  872 (952)
                      |++||+|||.+........    ..-...+|||.|+|||...++.    .+.+.||||+||+||+++.|+.||.+.+.- 
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-  325 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-  325 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-
Confidence            9999999999987633211    1122368999999999876632    357789999999999999999998653211 


Q ss_pred             cchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          873 MSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                      ..+.+++           ...+....       .++..+++.+||+++|..||+.|.+..||..|..
T Consensus       326 ~l~~KIv-----------n~pL~fP~-------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  326 ELFDKIV-----------NDPLEFPE-------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             HHHHHHh-----------cCcccCCC-------cccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence            1111111           11111110       0134667999999999999999999999987754

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-38  Score=340.25  Aligned_cols=245  Identities=24%  Similarity=0.325  Sum_probs=202.0

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36889999999999999999885 68999999986432   223456889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-  155 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYL---HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-  155 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence            9999999999987654 689999999999999999999   79999999999999999999999999999998654321 


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                         ....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..           +.....     
T Consensus       156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~-----------i~~~~~-----  215 (291)
T cd05612         156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-GIYEK-----------ILAGKL-----  215 (291)
T ss_pred             ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-----------HHhCCc-----
Confidence               2346899999999999888999999999999999999999998652110 00000           000000     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVN-----TKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~  937 (952)
                          ..+..++..+.+++++||+.||.+||+     +.|++++
T Consensus       216 ----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 ----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                012234667899999999999999995     8888766

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-37  Score=316.91  Aligned_cols=266  Identities=25%  Similarity=0.413  Sum_probs=208.5

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHh--CCCCccceeeeEeecC----Cee
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKT--IRHRNLVKIISSCTNH----NFK  735 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~  735 (952)
                      ...+..+.+.||+|.||+||+|++ .|+.||||++...++   +.+.+|.+|++.  ++|+||+.+++....+    ...
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            345778889999999999999999 789999999976555   556788888886  4999999999887544    267


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEeCCCCCCCeeeCCCCcEEEecccc
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF-----GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGI  810 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~-----~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  810 (952)
                      +||++|.+.|||.|++..  .+++....++++..+|.||+|||.     .-+..|.|||||+.|||+.+++.+.|+|+|+
T Consensus       285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            899999999999999987  469999999999999999999983     2356799999999999999999999999999


Q ss_pred             ccccCCcCc---ccccccccccccccccccCcC----Cc--CcccchHhHHHHHHHHHhC----------CCCCCccccC
Q 002214          811 AKLLSEEDS---MKQTQTLATIGYIAPEYGREG----QV--SIKGDVYNYGIMLMEVFTG----------MKPTNEFFTG  871 (952)
Q Consensus       811 a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~----~~--~~~~Dv~slG~~l~el~tg----------~~p~~~~~~~  871 (952)
                      |........   ......+||.+|||||++...    .+  -..+||||||.|+||+..+          ..||.+..+.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            998765432   234457899999999987643    11  2358999999999999763          3577766666


Q ss_pred             ccchhhhhccchhhhhhhc-cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          872 EMSIKRWINDSLPAVMNIM-DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                      +..+.+..        +++ ...+....++..  ....+...+.++|+.||..+|..|-|+-.|.+.|.++.+
T Consensus       443 DPs~eeMr--------kVVCv~~~RP~ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  443 DPSFEEMR--------KVVCVQKLRPNIPNRW--KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCHHHHh--------cceeecccCCCCCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            55544322        221 112222222111  112345679999999999999999999999999998874

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.2e-38  Score=334.48  Aligned_cols=248  Identities=35%  Similarity=0.596  Sum_probs=195.5

Q ss_pred             ccceecCccceEEEEEEeC-----CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          668 EENLIGIGSYGSVYKGRFP-----DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       668 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..+.||.|+||.||+|.+.     .+..|+||+++.... ...+.+.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999875     367899999965433 3467899999999999999999999999988889999999


Q ss_pred             cCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++|+|.+++... ...+++.++..|+.||++||+||   |+++++||||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~L---h~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYL---HSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHH---HHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999887 55799999999999999999999   6889999999999999999999999999999876332222


Q ss_pred             -cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          821 -KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       821 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                       ..........|+|||.+....++.++||||||+++||+++ |+.||..... .....+.           .+..     
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~~~~~~-----------~~~~-----  222 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EEIIEKL-----------KQGQ-----  222 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HHHHHHH-----------HTTE-----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccc-----------cccc-----
Confidence             2223457789999999998889999999999999999999 6788755311 1100110           0000     


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                         ....+..++..+.+++.+||+.||++||++.|+++.|
T Consensus       223 ---~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 ---RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               0112344678899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.2e-37  Score=339.87  Aligned_cols=268  Identities=22%  Similarity=0.320  Sum_probs=205.5

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|++.+.||+|+||.||+|++. +|..||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467999999999999999999885 68899999987553 2345678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+++|+|.+++.... .+++..+..++.|++.|++|||  +..+|+||||||+||+++.++.+||+|||++.......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH--~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  158 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  158 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh--hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence            999999999987644 5889999999999999999994  23479999999999999999999999999998653321  


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccch----------------h
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL----------------P  884 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----------------~  884 (952)
                       .....|++.|+|||++.+..++.++|||||||++|||++|+.||......  .+........                +
T Consensus       159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (331)
T cd06649         159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPRPRP  235 (331)
T ss_pred             -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCccccc
Confidence             22346899999999999889999999999999999999999998642211  1111100000                0


Q ss_pred             hhh----hhccccccchhhH----H-----HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          885 AVM----NIMDTNLLSEDEE----H-----ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       885 ~~~----~~~~~~~~~~~~~----~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      ...    ...+.........    .     .......++.++.+++.+||..||++|||+.|++++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            000    0000000000000    0     0000113567899999999999999999999998874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.3e-38  Score=344.60  Aligned_cols=246  Identities=23%  Similarity=0.307  Sum_probs=202.6

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|.+.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            357899999999999999999884 68999999986432   23346788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus        97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYL---HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            99999999999887654 688999999999999999999   79999999999999999999999999999998664322


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                          ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....    . +..       ..+.....    
T Consensus       173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~-~~~-------~~i~~~~~----  232 (329)
T PTZ00263        173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----F-RIY-------EKILAGRL----  232 (329)
T ss_pred             ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----H-HHH-------HHHhcCCc----
Confidence                234689999999999988899999999999999999999999854211    0 000       00100000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVN-----TKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~  937 (952)
                           ..+..++.++.+++.+||+.||++||+     ++|++++
T Consensus       233 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 -----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 012234667899999999999999997     6888765

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.7e-37  Score=330.10  Aligned_cols=254  Identities=23%  Similarity=0.443  Sum_probs=208.1

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .++|++.++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|||++++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            457899999999999999999988888999998764332 3467899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          743 PKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       743 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      ++++|.+++... ...+++..+..++.|+++|++||   |+.+++||||||+||+++.++.+||+|||++..........
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI---ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            999999998653 34688999999999999999999   78999999999999999999999999999998765433222


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      .....++..|+|||+.....++.++|||||||++|||+| |+.||......+  ....+           ......    
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~-----------~~~~~~----  223 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSAL-----------QRGYRM----  223 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHH-----------HcCCCC----
Confidence            233346778999999988889999999999999999998 999986422111  11110           000000    


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                         .....++.++.+++.+||+.+|++||+++++.+.|++
T Consensus       224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 ---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               0112356779999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.3e-37  Score=335.17  Aligned_cols=270  Identities=25%  Similarity=0.344  Sum_probs=202.3

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|.+.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999985 689999999865432 223467889999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |++ ++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...... .
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  158 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI---HQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H  158 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence            995 688888876666789999999999999999999   79999999999999999999999999999997543222 1


Q ss_pred             cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cch----hhhhh--hc
Q 002214          821 KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSL----PAVMN--IM  890 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~----~~~~~--~~  890 (952)
                      ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...............   ...    +....  .+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            2233568999999998765 45788999999999999999999999753221111111100   000    00000  00


Q ss_pred             ccccc---chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLL---SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ++...   ..............++++.+++.+|++.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            00000   000000001111234678999999999999999999999873

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.7e-37  Score=333.64  Aligned_cols=270  Identities=22%  Similarity=0.306  Sum_probs=203.0

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            357899999999999999999874 68999999986443 2234567899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+++ +|.+++......+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||+++....... 
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC---HKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence            9974 89988876666688999999999999999999   799999999999999999999999999999976533221 


Q ss_pred             cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccc--hhhhhccchhh-hhhhcc-----
Q 002214          821 KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS--IKRWINDSLPA-VMNIMD-----  891 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~-~~~~~~-----  891 (952)
                      ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+..  ..+......++ ......     
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            1223468999999998765 56889999999999999999999998653211110  00000111111 000000     


Q ss_pred             ccccchh-hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSED-EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....... ...........+.++.+++.+|+..||.+|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000000 000000112356778999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.1e-37  Score=340.96  Aligned_cols=242  Identities=23%  Similarity=0.299  Sum_probs=197.2

Q ss_pred             ceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCC
Q 002214          670 NLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKG  745 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  745 (952)
                      +.||+|+||.||+|+. .+|+.||+|+++...   ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999987 468999999987542   233456788999999999999999999999999999999999999


Q ss_pred             ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccccc
Q 002214          746 SLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT  825 (952)
Q Consensus       746 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~  825 (952)
                      +|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+...... ......
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~  155 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYL---HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF  155 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence            9998887544 689999999999999999999   79999999999999999999999999999997532221 122335


Q ss_pred             ccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHh
Q 002214          826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVA  905 (952)
Q Consensus       826 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  905 (952)
                      .||+.|+|||++.+..++.++||||+||++|||++|+.||.....  .....          .......         ..
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~----------~~~~~~~---------~~  214 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFE----------LILMEEI---------RF  214 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--HHHHH----------HHHcCCC---------CC
Confidence            699999999999988999999999999999999999999854211  00000          0000000         01


Q ss_pred             hhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          906 KQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       906 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                      +...++++.+++.+||+.||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            234567899999999999999999     79998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.8e-37  Score=326.04  Aligned_cols=254  Identities=25%  Similarity=0.457  Sum_probs=207.3

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .+|.+.+.||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|++++++++|||++++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999874 58899999986433 33567899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          743 PKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       743 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      ++++|.+++.... ..+++..+..++.|+++|++||   |++|++||||||+||++++++.+||+|||++..........
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            9999999986543 4689999999999999999999   78999999999999999999999999999998765433222


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      .....+++.|+|||...+..++.++|||||||++|||++ |..||.....     ....        ..+.....     
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~--------~~~~~~~~-----  223 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVY--------ELLEKGYR-----  223 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH--------HHHHCCCC-----
Confidence            222335678999999988889999999999999999998 8888754211     1100        00000000     


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                        ...+..++.++.+++.+||+.+|++||++.|+.+.|+.+
T Consensus       224 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 --MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              011234678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=338.67  Aligned_cols=244  Identities=23%  Similarity=0.296  Sum_probs=203.3

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCee
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  735 (952)
                      ...++|...++||+|.||.|++|..+ +++.+|||++++..   ..+.+..+.|.+|+... +||.++.++.+|...++.
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34568999999999999999999884 68899999997653   34457788999999888 599999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      |+||||+.||++..+.+  ...+++..+.-++..|+.||.||   |++|||+||||.+|||+|.+|.+||+|||+++.--
T Consensus       445 ~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fL---H~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFL---HENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHH---HhcCceeeecchhheEEcccCcEEecccccccccC
Confidence            99999999999544333  34699999999999999999999   89999999999999999999999999999998654


Q ss_pred             CcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ..+. .+...+|||.|+|||++.+..|+.++|.|||||+||||+.|..||..... ++.+..               .+.
T Consensus       520 ~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-ee~Fds---------------I~~  582 (694)
T KOG0694|consen  520 GQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-EEVFDS---------------IVN  582 (694)
T ss_pred             CCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHH---------------Hhc
Confidence            2222 44568999999999999999999999999999999999999999975211 111111               111


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNT  931 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  931 (952)
                      .+.     .-|..++.+..+++++++..+|++|.-+
T Consensus       583 d~~-----~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 DEV-----RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCC-----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            111     1245678899999999999999999966

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.6e-38  Score=320.15  Aligned_cols=272  Identities=25%  Similarity=0.364  Sum_probs=202.5

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCC-----eeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN-----FKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  736 (952)
                      .-.|...+++|.|+||.||+|.. .+++.||||+.-.+...    -.+|+++|+++.|||||++..+|....     ...
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            34577789999999999999987 45799999987544332    147999999999999999998885432     334


Q ss_pred             EEEEccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC-CcEEEecccccc
Q 002214          737 LVLEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS-MVAHLSDFGIAK  812 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgla~  812 (952)
                      +|||||+. +|.+.++.   .+..++...+.-+..|+++|++||   |+.||+||||||+|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL---h~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL---HSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH---HhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999976 88888874   245788888899999999999999   78999999999999999965 999999999999


Q ss_pred             ccCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCcc--chhhhhccchhhhhhh
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM--SIKRWINDSLPAVMNI  889 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~  889 (952)
                      ....+..  ...+..|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....+.  .+.+..+....+....
T Consensus       175 ~L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  175 VLVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            8865443  355778999999998766 4799999999999999999999988765221111  1122222222222222


Q ss_pred             cccccc-chhhH-----HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHHH
Q 002214          890 MDTNLL-SEDEE-----HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR--LIKIRDL  944 (952)
Q Consensus       890 ~~~~~~-~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~i~~~  944 (952)
                      +.+.-. .+.+.     +........+++..+++.+++..+|.+|.++.|++.+  ++++++.
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            222210 00000     0011234567889999999999999999999999853  4555443

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-37  Score=342.20  Aligned_cols=253  Identities=22%  Similarity=0.314  Sum_probs=204.3

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||.||+|++. +++.||||+++...   ......+.+|++++.+++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999985 58999999986542   223456889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDAL---HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999987544 688999999999999999999   799999999999999999999999999999986533   


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                       ......||+.|+|||++.+..++.++|||||||++|||++|..||......+ .+.....     ....+......   
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~-----~~~~~~~~~~~---  223 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKY-----WKETLQRPVYD---  223 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHh-----ccccccCCCCC---
Confidence             2233568999999999998899999999999999999999999986532111 0000000     00000000000   


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          .....+++++.+++.+||..+|++||++.|++++
T Consensus       224 ----~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         224 ----DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ----ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                0002346789999999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-37  Score=316.07  Aligned_cols=273  Identities=25%  Similarity=0.333  Sum_probs=207.6

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCc-cceeeeEeecCC-----
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRN-LVKIISSCTNHN-----  733 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  733 (952)
                      ...|...++||+|+||+||+|+. .+|+.||+|+++.+.+  +......+|+.++++++|+| ||++++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45577778899999999999987 5789999999976644  45677889999999999999 999999998766     


Q ss_pred             -eeEEEEEccCCCChhHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccc
Q 002214          734 -FKALVLEYMPKGSLEDCMYASN---FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       734 -~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  809 (952)
                       ..++|+||++ -+|..++....   ..++...+..+++|+.+|++||   |+++|+||||||+||+++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~---H~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL---HSHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCcceEEECCCCcEeeeccc
Confidence             7899999995 49999998766   4678889999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCcCcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccch--hhhhccch---
Q 002214          810 IAKLLSEEDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI--KRWINDSL---  883 (952)
Q Consensus       810 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~--~~~~~~~~---  883 (952)
                      +|+...-+.. ..+..++|.+|+|||++.+. .|+...||||+||+++||++++.-|......+...  -+......   
T Consensus       166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9996653322 24556799999999988776 78999999999999999999888775532211100  11111111   


Q ss_pred             -hhhhhhccccc-cchhh---HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHH
Q 002214          884 -PAVMNIMDTNL-LSEDE---EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR--LIKI  941 (952)
Q Consensus       884 -~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~i  941 (952)
                       |......+-.. .....   ...... +....+..+++.+|+..+|.+|.|++.+++|  +.++
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence             11111111110 00000   000001 1122578999999999999999999999987  5554

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.5e-37  Score=327.05  Aligned_cols=252  Identities=23%  Similarity=0.414  Sum_probs=205.1

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      ++|++.+.||+|+||.||.|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4688889999999999999998777789999886433 234678999999999999999999999998888999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +|+|.+++......+++..++.++.|++.|++||   |+.|++|+||||+||+++.++.+||+|||.++....+......
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV  159 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence            9999999877655789999999999999999999   7999999999999999999999999999999866543322222


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...++..|+|||+..+..++.++|||||||++|||++ |..||......+  ....          ... ....      
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~----------~~~-~~~~------  220 (256)
T cd05113         160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEK----------VSQ-GLRL------  220 (256)
T ss_pred             CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHH----------Hhc-CCCC------
Confidence            2345678999999988889999999999999999999 999986532111  0000          000 0000      


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                       ..+...+.++.+++.+||+.+|++||++.++++.++
T Consensus       221 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 -YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             011223567999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7e-37  Score=343.56  Aligned_cols=259  Identities=22%  Similarity=0.402  Sum_probs=206.5

Q ss_pred             HhccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCC-CCccceeeeEeecCC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQRE-GALNSFDAECEILKTIR-HRNLVKIISSCTNHN  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  733 (952)
                      ..++|.+.+.||+|+||.||+|++.      .+..||||+++.... ...+.+.+|+++++++. ||||+++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            4568999999999999999999752      235799999865432 33467899999999996 999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcC----------------------------------------------------------
Q 002214          734 FKALVLEYMPKGSLEDCMYASN----------------------------------------------------------  755 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  755 (952)
                      ..|+||||+++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999998875421                                                          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC
Q 002214          756 -------------------------------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD  798 (952)
Q Consensus       756 -------------------------------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~  798 (952)
                                                           ..+++..+..++.|+++|++||   |+++|+||||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHhEEEe
Confidence                                                 1367888899999999999999   789999999999999999


Q ss_pred             CCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchh
Q 002214          799 DSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIK  876 (952)
Q Consensus       799 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~  876 (952)
                      .++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...........
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            9999999999999865432221 2223456788999999988889999999999999999997 8899865322111110


Q ss_pred             hhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                      .            +.....       ...+..++.++.+++.+||+.||++||++.+|.+.|+++.
T Consensus       352 ~------------~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         352 K------------IKSGYR-------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             H------------HhcCCC-------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            0            000000       0112345778999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1e-36  Score=326.58  Aligned_cols=256  Identities=25%  Similarity=0.451  Sum_probs=208.6

Q ss_pred             hccCCccceecCccceEEEEEEeC----CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|++.+.||+|+||.||+|.+.    +...||||+++... ......+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            357889999999999999999874    24689999886543 3345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++++|.+++......+++..+..++.|++.|++||   |+++|+||||||+||++++++.++++|||+++.....
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            9999999999999987666789999999999999999999   7899999999999999999999999999999977522


Q ss_pred             Cc-ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          818 DS-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       818 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      .. .......+++.|+|||...+..++.++||||||+++||+++ |..||......  .....           +.....
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~-----------~~~~~~  226 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKA-----------VEDGYR  226 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHH-----------HHcCCC
Confidence            21 11222345678999999988889999999999999999998 99998542111  01010           000000


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                             ...+..+++++.+++.+||+.+|++||++.||+++|+++
T Consensus       227 -------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 -------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   001234577899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-37  Score=326.50  Aligned_cols=255  Identities=25%  Similarity=0.448  Sum_probs=207.8

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..++|++.+.||+|+||.||+|.+.+++.||+|.++.... ..+.+.+|+.++++++|||++++++++...+..++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            3457899999999999999999987888999999865432 346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+++.... ..+++..+..++.|++.|++||   |++||+||||||+||++++++.+||+|||++.........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            99999999987543 4689999999999999999999   7899999999999999999999999999999876533222


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                      .......+..|+|||+..+..++.++||||||+++|||++ |+.||....... ..            ..++....    
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~------------~~~~~~~~----  222 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VL------------QQVDQGYR----  222 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HH------------HHHHcCCC----
Confidence            2222234568999999988889999999999999999999 999986531110 00            01111100    


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                         ...+..++.++.+++.+|++.+|++||++.++++.|++
T Consensus       223 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 ---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence               00123356789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.6e-37  Score=329.19  Aligned_cols=257  Identities=26%  Similarity=0.498  Sum_probs=212.4

Q ss_pred             HHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      +...+|++.+.||.|+||.||+|...+++.||+|++..........+.+|+.+++.++|||++++++++...+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567899999999999999999998899999999876655456778999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          741 YMPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |+++++|.+++... ...+++..+..++.|++.|++||   |++||+||||+|+||+++.++.+||+|||.+........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL---EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999998763 34689999999999999999999   789999999999999999999999999999987643322


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                       ......++..|+|||......++.++||||||+++|+|++ |+.||......+ .+..            +....    
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-~~~~------------~~~~~----  221 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-VYDQ------------ITAGY----  221 (261)
T ss_pred             -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-HHHH------------HHhCC----
Confidence             2223446778999999988889999999999999999998 899985432110 1110            00000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                         ....+..+++++.+++.+||+.||++|||++++++.|+.+
T Consensus       222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 ---RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence               0011234577899999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-36  Score=341.27  Aligned_cols=262  Identities=23%  Similarity=0.222  Sum_probs=198.5

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..+|.+.+.||+|+||.||+|.+ .+++.||+|...      ...+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            35799999999999999999987 468999999643      23567899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +. ++|..++.... .+++.+++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+.........
T Consensus       165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yl---H~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYL---HENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            95 68888776543 689999999999999999999   78999999999999999999999999999997543322222


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCc------cchhhhhccc-----------hh
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE------MSIKRWINDS-----------LP  884 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~~~-----------~~  884 (952)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ..+...+...           ..
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            334579999999999988899999999999999999999998864321110      0111110000           00


Q ss_pred             hhhhhc----ccccc--chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          885 AVMNIM----DTNLL--SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       885 ~~~~~~----~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .....+    .....  .....+  ......+.++.+++.+||+.||++|||+.|++++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLW--TNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCH--HHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000000    00000  000000  0112346789999999999999999999999864

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-37  Score=325.21  Aligned_cols=251  Identities=27%  Similarity=0.460  Sum_probs=204.3

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      .+|++.+.||+|+||.||+|.++++..+|+|++.... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            3588899999999999999998777889999885332 233568889999999999999999999999999999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +++|.+++......+++..+..++.|++.|++||   |+.|++||||||+||++++++.+||+|||+++...........
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            9999999987666789999999999999999999   7999999999999999999999999999999866433222222


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...++..|+|||...+..++.++||||||+++||+++ |+.||......+ ....            +.....       
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~------------~~~~~~-------  219 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVES------------VSAGYR-------  219 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-HHHH------------HHcCCc-------
Confidence            2234568999999988889999999999999999999 788886422111 0000            000000       


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      ...+..++.++.+++.+||+.+|++|||+.|+++.|
T Consensus       220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            011233577899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-36  Score=328.92  Aligned_cols=254  Identities=28%  Similarity=0.541  Sum_probs=206.6

Q ss_pred             ccCCccceecCccceEEEEEEeCC------CcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPD------GIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      ++|++.+.||+|+||.||+|....      ...||+|.+..... .....+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998632      25799998864432 33467899999999999999999999999989999


Q ss_pred             EEEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC
Q 002214          737 LVLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM  801 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~  801 (952)
                      ++|||+++|+|.+++....               ..+++..+..++.|++.|++||   |+++++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccccceEEEcCCC
Confidence            9999999999999986532               3578899999999999999999   789999999999999999999


Q ss_pred             cEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhh
Q 002214          802 VAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWI  879 (952)
Q Consensus       802 ~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~  879 (952)
                      .+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||......  ...   
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~---  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVI---  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH---
Confidence            9999999999865433322 2233456889999999988889999999999999999998 99998653211  111   


Q ss_pred             ccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          880 NDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       880 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                              ..+.....       ...+..+++++.+++.+||+.||.+||+++||+++|++
T Consensus       237 --------~~i~~~~~-------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 --------EMIRSRQL-------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --------HHHHcCCc-------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                    11111110       01234578899999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=335.44  Aligned_cols=252  Identities=25%  Similarity=0.437  Sum_probs=208.9

Q ss_pred             ccCCccceecCccceEEEEEEeC--CC--cEEEEEEeeccCch-hhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP--DG--IEVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ++....+.||+|.||.|++|.|.  +|  ..||||.++..... ....|.+|+.+|.+|+|||++++||+..+ ....||
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            34556788999999999999884  34  46899999877654 56889999999999999999999999987 567899


Q ss_pred             EEccCCCChhHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          739 LEYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||.++.|+|.+.+++ .+..+-......++.|||.||.||   ..+++||||+.++|+++-....+||+|||+.+-+...
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YL---eskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYL---ESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            999999999999987 445688888899999999999999   8999999999999999999999999999999988765


Q ss_pred             Ccccc--cccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          818 DSMKQ--TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       818 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      +.+-.  ....-+..|+|||.+....++.++|||+|||++|||+| |..||-..             .-..+.+.+|.. 
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-------------~g~qIL~~iD~~-  331 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-------------RGIQILKNIDAG-  331 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-------------CHHHHHHhcccc-
Confidence            43322  22456789999999999999999999999999999999 77887441             111222233311 


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                            .+...++.|+++++++|+.||..+|++|||+..|.+.+-
T Consensus       332 ------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  332 ------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             ------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence                  122246789999999999999999999999999975543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.8e-37  Score=341.17  Aligned_cols=246  Identities=23%  Similarity=0.304  Sum_probs=201.9

Q ss_pred             hccCCccceecCccceEEEEEEeCC--CcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD--GIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|.+.+.||+|+||.||+|.++.  +..||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4579999999999999999998643  4689999986432   2334678899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+|||++.++.+||+|||++......
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999987654 689999999999999999999   7999999999999999999999999999999865432


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..           +.....   
T Consensus       185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~-----------i~~~~~---  245 (340)
T PTZ00426        185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQK-----------ILEGII---  245 (340)
T ss_pred             ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHH-----------HhcCCC---
Confidence                12356899999999998888999999999999999999999998642110 00111           111100   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                            ..+...+.++.+++++|++.||++|+     +++|+.++
T Consensus       246 ------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 ------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                  01233466789999999999999995     89998876

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.8e-37  Score=336.79  Aligned_cols=242  Identities=23%  Similarity=0.301  Sum_probs=196.9

Q ss_pred             ceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCC
Q 002214          670 NLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKG  745 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  745 (952)
                      +.||+|+||.||+++. .+|+.||+|+++...   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999987 468999999986542   233456788999999999999999999999999999999999999


Q ss_pred             ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccccc
Q 002214          746 SLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT  825 (952)
Q Consensus       746 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~  825 (952)
                      +|..++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...... ......
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~  155 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF  155 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence            9988886544 689999999999999999999   78999999999999999999999999999987532221 122235


Q ss_pred             ccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHh
Q 002214          826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVA  905 (952)
Q Consensus       826 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  905 (952)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......           .....         ..
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~-----------~~~~~---------~~  214 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELI-----------LMEEI---------RF  214 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHH-----------hcCCC---------CC
Confidence            6899999999999889999999999999999999999998542110 000000           00000         01


Q ss_pred             hhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          906 KQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       906 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                      +..+++++.+++.+||+.||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            234577899999999999999998     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=342.18  Aligned_cols=255  Identities=25%  Similarity=0.449  Sum_probs=214.2

Q ss_pred             CCccceecCccceEEEEEEe-CCC----cEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          666 FSEENLIGIGSYGSVYKGRF-PDG----IEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .+..++||+|+||+||+|.+ +.|    .+||+|++... ..+...++..|+.+|.++.|||+++++|+|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            44568999999999999976 444    46899988543 3445678999999999999999999999998776 78999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      +||+.|+|.++++.++..+.....+.+..|||+||.||   |++++|||||.++|||+.+-..+||.|||+|+.....+.
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YL---e~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYL---EEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            99999999999999998999999999999999999999   899999999999999999999999999999998765432


Q ss_pred             -ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          820 -MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       820 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                       +.......++.|||-|.++...|+.++|||||||++||++| |..|++.....+             +.+++...    
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------------I~dlle~g----  916 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------------IPDLLEKG----  916 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------------hhHHHhcc----
Confidence             33334556789999999999999999999999999999999 999987643322             11111110    


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                         .+...|+.|+.++..+|.+||..|+..||+++++...+.+..+.
T Consensus       917 ---eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  917 ---ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             ---ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence               11234678999999999999999999999999999999876543

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.1e-36  Score=334.20  Aligned_cols=267  Identities=21%  Similarity=0.318  Sum_probs=203.3

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999885 68899999886543 3344678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+++|+|.+++.... .+++.....++.|++.|++|||  +..+|+||||||+||++++++.+||+|||++.......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH--~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--  158 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  158 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence            999999999987644 5889999999999999999995  34579999999999999999999999999997653221  


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccch----------------h
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL----------------P  884 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----------------~  884 (952)
                       .....++..|+|||++.+..++.++|||||||++|||++|+.||.......  .........                .
T Consensus       159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE--LELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH--HHHHhcCcccCCccccccCcccCCcc
Confidence             123468999999999988889999999999999999999999986422111  100000000                0


Q ss_pred             hhhhhccccccchh--hHHHH--------H-hhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          885 AVMNIMDTNLLSED--EEHAN--------V-AKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       885 ~~~~~~~~~~~~~~--~~~~~--------~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .......+......  .....        . .....+.++.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence            00000000000000  00000        0 001245779999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2e-36  Score=328.08  Aligned_cols=259  Identities=27%  Similarity=0.464  Sum_probs=209.6

Q ss_pred             hccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      ..+|.+.+.||+|+||.||++..      .++..||+|.+........+.+.+|+.++++++|||++++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            35788999999999999999974      235679999987655555678999999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEE
Q 002214          737 LVLEYMPKGSLEDCMYASN------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH  804 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~k  804 (952)
                      +||||+++++|.+++....            ..+++..+..++.|++.||+||   |++|++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l---H~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCcEE
Confidence            9999999999999986432            2489999999999999999999   789999999999999999999999


Q ss_pred             EeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccc
Q 002214          805 LSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDS  882 (952)
Q Consensus       805 l~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  882 (952)
                      |+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||......+ .......  
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~i~~--  237 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECITQ--  237 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc--
Confidence            9999999865433221 1122345778999999988889999999999999999999 888875432111 0011000  


Q ss_pred             hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                               ....        ..+..++.++.+++.+||+.||.+|||+.|+.+.|+++.+.
T Consensus       238 ---------~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         238 ---------GRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             ---------CCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence                     0000        01123466799999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-37  Score=332.98  Aligned_cols=251  Identities=25%  Similarity=0.357  Sum_probs=212.3

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCe-eEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNF-KALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv  738 (952)
                      .++|..++++|+|+||.++..+.+ +++.||+|.+....  +...+....|+.++++++|||||.+.+.+.+++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            357888999999999999998774 57899999886553  3344577899999999999999999999998887 9999


Q ss_pred             EEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          739 LEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      |+|++||++.+.+...+ .-+++..+..++.|++.|+.||   |+.+|+|||||+.||+++.++.+||+|||+|+.+..+
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl---H~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL---HENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999987765 5789999999999999999999   7999999999999999999999999999999998765


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      ... ....+||+.|+.||.+.+.+|..|+||||+||++|||++-+++|.+....     ..+.       .++ ...   
T Consensus       160 ~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----~Li~-------ki~-~~~---  222 (426)
T KOG0589|consen  160 DSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----ELIL-------KIN-RGL---  222 (426)
T ss_pred             hhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----HHHH-------HHh-hcc---
Confidence            522 34478999999999999999999999999999999999999998763211     1111       110 011   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ....+..++.++..+|..|+..+|+.||++.+++.+
T Consensus       223 ----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 ----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                112345568899999999999999999999999987

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-36  Score=334.21  Aligned_cols=257  Identities=23%  Similarity=0.401  Sum_probs=206.5

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCc----EEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGI----EVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .+|+..+.||+|+||.||+|++. +|+    .||+|+++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46899999999999999999863 333    48999986443 33456788999999999999999999998765 5679


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      |+||+++|+|.+++......+++...+.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            9999999999999987766789999999999999999999   7999999999999999999999999999999876543


Q ss_pred             Ccc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          818 DSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       818 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ... ......++..|+|||++....++.++|||||||++||+++ |+.||......  .+..+.           .....
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~-----------~~~~~  229 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL-----------EKGER  229 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH-----------hCCCC
Confidence            221 1122335678999999998899999999999999999998 99998653111  111111           00000


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                             ...+..++.++.+++.+||..+|++||++.+++..+.++.+.
T Consensus       230 -------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         230 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence                   011234567799999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-36  Score=336.50  Aligned_cols=259  Identities=22%  Similarity=0.414  Sum_probs=204.6

Q ss_pred             hccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeec-CC
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTN-HN  733 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  733 (952)
                      .++|++.+.||+|+||.||+|..      .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            45799999999999999999964      235789999986443 22345678899999999 89999999998764 45


Q ss_pred             eeEEEEEccCCCChhHHhhhcC----------------------------------------------------------
Q 002214          734 FKALVLEYMPKGSLEDCMYASN----------------------------------------------------------  755 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  755 (952)
                      ..+++|||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6889999999999998875421                                                          


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc-cccccccccccc
Q 002214          756 --FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYI  832 (952)
Q Consensus       756 --~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~  832 (952)
                        ..+++..+..++.||+.|++||   |++||+||||||+||++++++.+||+|||+++.+...... ......++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~l---H~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              2578999999999999999999   7899999999999999999999999999999876433222 222345677899


Q ss_pred             cccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHH
Q 002214          833 APEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCAS  911 (952)
Q Consensus       833 aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (952)
                      |||++.+..++.++|||||||++|||++ |..||......+ .+...           +......       ..+..++.
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~-----------~~~~~~~-------~~~~~~~~  303 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRR-----------LKEGTRM-------RAPEYATP  303 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHH-----------HhccCCC-------CCCccCCH
Confidence            9999999999999999999999999998 999986522111 11110           0000000       01223467


Q ss_pred             HHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          912 SVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       912 ~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                      ++.+++.+||+.+|++||++.|++++|+++.+
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            79999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-37  Score=336.01  Aligned_cols=240  Identities=25%  Similarity=0.311  Sum_probs=194.7

Q ss_pred             ecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCCh
Q 002214          672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL  747 (952)
Q Consensus       672 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  747 (952)
                      ||+|+||.||+|+.. +++.||+|+++..   .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999874 5889999998643   233446778999999999999999999999999999999999999999


Q ss_pred             hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccccccc
Q 002214          748 EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA  827 (952)
Q Consensus       748 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  827 (952)
                      .+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...... .......|
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g  155 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENL---HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG  155 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence            99887643 689999999999999999999   79999999999999999999999999999998543222 12233568


Q ss_pred             ccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhh
Q 002214          828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQ  907 (952)
Q Consensus       828 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  907 (952)
                      |+.|+|||++.+..++.++||||+||++|||++|+.||.....     .+...       .......         ..+.
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~-------~~~~~~~---------~~~~  214 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYR-------KILQEPL---------RFPD  214 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHH-------HHHcCCC---------CCCC
Confidence            9999999999988999999999999999999999999864211     11100       0000000         1123


Q ss_pred             hhHHHHHHHHhhccccCCCCCCC---HHHHHHH
Q 002214          908 SCASSVLSLAMECTSESPENRVN---TKEIISR  937 (952)
Q Consensus       908 ~~~~~l~~li~~cl~~dP~~RPs---~~ev~~~  937 (952)
                      .+++++.+++.+||+.||++||+   +.|++++
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            45678999999999999999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1e-36  Score=335.92  Aligned_cols=242  Identities=23%  Similarity=0.308  Sum_probs=197.3

Q ss_pred             ceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCC
Q 002214          670 NLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKG  745 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  745 (952)
                      +.||+|+||.||+++. .+|+.||+|++...   .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999987 46899999998643   2234467889999999999999999999999999999999999999


Q ss_pred             ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccccc
Q 002214          746 SLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT  825 (952)
Q Consensus       746 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~  825 (952)
                      +|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...... ......
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~  155 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYL---HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF  155 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence            9988886543 689999999999999999999   79999999999999999999999999999997543221 122235


Q ss_pred             ccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHh
Q 002214          826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVA  905 (952)
Q Consensus       826 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  905 (952)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....        ..+...        ....
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~--------~~~~~~--------~~~~  214 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLF--------ELILME--------DIKF  214 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHH--------HHhccC--------CccC
Confidence            689999999999988899999999999999999999999854211     0000        000000        0011


Q ss_pred             hhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          906 KQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       906 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                      +..++.++.+++.+||..||++||     ++.|++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            234567899999999999999997     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-36  Score=336.35  Aligned_cols=252  Identities=24%  Similarity=0.315  Sum_probs=200.2

Q ss_pred             cCCccceecCccceEEEEEEe----CCCcEEEEEEeecc----CchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCee
Q 002214          665 QFSEENLIGIGSYGSVYKGRF----PDGIEVAIKVFHLQ----REGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  735 (952)
                      +|++.+.||+|+||.||+++.    .+++.||+|++...    .....+.+..|+.+++++ +||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999975    36889999998643    223345678899999999 599999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHL---HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999887544 689999999999999999999   78999999999999999999999999999998654


Q ss_pred             CcCcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ...........||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+..    .... .+.  
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~----~~~~-~~~--  228 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSR----RILK-CDP--  228 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHH----HHhc-CCC--
Confidence            4333333345699999999998764 478899999999999999999999864321110 000000    0000 000  


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                               ..+..++.++.+++.+||+.||++||     ++++++++
T Consensus       229 ---------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         229 ---------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                     11223567789999999999999999     67788764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.7e-36  Score=322.28  Aligned_cols=254  Identities=26%  Similarity=0.457  Sum_probs=205.1

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .++|++.++||+|+||.||+|++.++..||+|+++.... ..+.+.+|++++++++|||++++++++.+ +..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            457999999999999999999987777899999875332 23578999999999999999999998754 5579999999


Q ss_pred             CCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          743 PKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       743 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      ++|+|.+++.... ..+++..+..++.|+++||+||   |+++++||||||+||+++.++.+||+|||.++.........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            9999999997643 3578999999999999999999   79999999999999999999999999999998765443322


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      .....++..|+|||+..+..++.++||||||+++||++| |..||......+ ...            .......     
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~~~------------~~~~~~~-----  221 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLD------------QVERGYR-----  221 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-HHH------------HHhcCCC-----
Confidence            233446778999999988889999999999999999999 788875432110 000            0000000     


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                        ...+..++.++.+++.+|++.+|++||+++++++.|++.
T Consensus       222 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         222 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              001234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=343.31  Aligned_cols=257  Identities=25%  Similarity=0.343  Sum_probs=207.6

Q ss_pred             hccCCccceecCccceEEEEEEeCCC-cEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCccceeee-Eeec------CC
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIIS-SCTN------HN  733 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~------~~  733 (952)
                      ..++++.+.|.+|||+.||.|.+..+ ..||+|++-..++.....+.+|+++|++|+ |||||.+++ ....      ..
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            44677889999999999999998655 999999987778888889999999999996 999999999 3321      23


Q ss_pred             eeEEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                      +++|.||||.||.|-+++.... ..+++.++++|+.|+++|+++||+ .+.+|||||||.+|||++.++..||||||.|.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            6789999999999999997532 359999999999999999999974 35679999999999999999999999999997


Q ss_pred             ccCCcCcc--------ccccccccccccccccc---CcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc
Q 002214          813 LLSEEDSM--------KQTQTLATIGYIAPEYG---REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND  881 (952)
Q Consensus       813 ~~~~~~~~--------~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~  881 (952)
                      ........        .......|+-|+|||++   .+...++|+|||++||+||-++....||++...-.         
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---------  265 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---------  265 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---------
Confidence            43322211        11124689999999964   67789999999999999999999999997732111         


Q ss_pred             chhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          882 SLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                             ++...-...       ....+++.+.+||+.||.+||.+||++.+|+..+-++..
T Consensus       266 -------Ilng~Y~~P-------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  266 -------ILNGNYSFP-------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             -------EEeccccCC-------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                   111110000       013468889999999999999999999999999887754

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3e-36  Score=323.19  Aligned_cols=258  Identities=22%  Similarity=0.334  Sum_probs=207.6

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|.+.+.||+|+||.||+|+. .+++.||||.+...   .......+.+|++++++++|||++++++++...+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5789999999999999999987 47899999987542   2333457889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          740 EYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       740 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      ||+++|+|.+++..   ....+++..+..++.|++.|++||   |+++++||||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   233578899999999999999999   799999999999999999999999999999987643


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      ... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.............           +......
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~-----------~~~~~~~  226 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK-----------IEQCDYP  226 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH-----------HhcCCCC
Confidence            221 1223458889999999988888999999999999999999999985422111111111           0000000


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                      .      .....++.++.+++.+||..+|++||++.||++.+++++
T Consensus       227 ~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         227 P------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             C------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            0      011234677999999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2e-36  Score=328.76  Aligned_cols=267  Identities=24%  Similarity=0.333  Sum_probs=197.0

Q ss_pred             ccCCccceecCccceEEEEEEeC--CCcEEEEEEeeccC--chhhHHHHHHHHHHHhC---CCCccceeeeEeec-----
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP--DGIEVAIKVFHLQR--EGALNSFDAECEILKTI---RHRNLVKIISSCTN-----  731 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  731 (952)
                      .+|++.+.||+|+||.||+|++.  +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999873  47889999886543  22234566788777766   69999999998852     


Q ss_pred             CCeeEEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccc
Q 002214          732 HNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGI  810 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  810 (952)
                      ....++||||++ ++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            356899999996 68988886543 3589999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc---chhh-h
Q 002214          811 AKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND---SLPA-V  886 (952)
Q Consensus       811 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~-~  886 (952)
                      ++.....  .......+++.|+|||.+.+..++.++|||||||++|||++|+.||......+ .+......   ..+. .
T Consensus       157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDW  233 (290)
T ss_pred             eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhc
Confidence            9865433  22233568999999999988889999999999999999999999986532111 11111100   0000 0


Q ss_pred             h---hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 M---NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 ~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .   .....................++..+.+++.+|++.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0   00000000000000011123456788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-36  Score=337.90  Aligned_cols=268  Identities=22%  Similarity=0.299  Sum_probs=197.0

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecC-----CeeE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNH-----NFKA  736 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  736 (952)
                      +|++.+.||+|+||.||+|+.. +|+.||||++...  .......+.+|++++++++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999874 6899999988643  222345688999999999999999999987543     2479


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||++ ++|.+++.... .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYI---HTANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 68988886544 689999999999999999999   789999999999999999999999999999986532


Q ss_pred             cCc--ccccccccccccccccccCc--CCcCcccchHhHHHHHHHHHhCCCCCCccccCcc--chhhhhccchhhhhhhc
Q 002214          817 EDS--MKQTQTLATIGYIAPEYGRE--GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM--SIKRWINDSLPAVMNIM  890 (952)
Q Consensus       817 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~  890 (952)
                      ...  .......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||........  ..........+.....+
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            221  11233568999999998765  5788999999999999999999999864211000  00000000000000000


Q ss_pred             cc--------cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DT--------NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..        ................+++++.+++.+||+.||++||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00        000000000000112346778999999999999999999999875

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.8e-36  Score=338.02  Aligned_cols=248  Identities=26%  Similarity=0.390  Sum_probs=195.3

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ++|...+.||+|+||.||+|++. +|+.||||++..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667789999999999999874 689999999865433 3456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++|+|.+..     ..++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||+++....... .
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~  224 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYL---HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P  224 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence            9999986532     356778889999999999999   789999999999999999999999999999987643221 1


Q ss_pred             ccccccccccccccccCc-----CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          822 QTQTLATIGYIAPEYGRE-----GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      .....||..|+|||++..     ...+.++|||||||++|||++|+.||......  ++.....       ......   
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~-------~~~~~~---  292 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMC-------AICMSQ---  292 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHH-------HHhccC---
Confidence            233568999999998743     23456899999999999999999998632111  1111100       000000   


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ....+..++.++.+++.+||+.||++||++.|++++
T Consensus       293 -----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 -----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000123456789999999999999999999999976

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.5e-36  Score=324.72  Aligned_cols=265  Identities=24%  Similarity=0.391  Sum_probs=204.8

Q ss_pred             CCccceecCccceEEEEEEe-----CCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecC--CeeEE
Q 002214          666 FSEENLIGIGSYGSVYKGRF-----PDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNH--NFKAL  737 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  737 (952)
                      |...+.||+|+||+||++..     .+++.||+|+++.... ...+.+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988653     3578999999865432 3456788999999999999999999987653  46789


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++++|.+++...  .+++.++..++.|++.|++||   |+++|+||||||+||++++++.+||+|||+++.....
T Consensus        86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYL---HSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHH---HHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            99999999999988754  489999999999999999999   7899999999999999999999999999999876433


Q ss_pred             Cccc--ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc--chhhhhhhcccc
Q 002214          818 DSMK--QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND--SLPAVMNIMDTN  893 (952)
Q Consensus       818 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  893 (952)
                      ....  .....++..|+|||...+..++.++||||||+++|||++|..||................  ......+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            2211  112335667999999988889999999999999999999999986532211111111000  000111111111


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                      ..       ...+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus       241 ~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         241 MR-------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CC-------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            10       0113456788999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-36  Score=349.58  Aligned_cols=250  Identities=21%  Similarity=0.292  Sum_probs=203.5

Q ss_pred             cCCccceecCccceEEEEEEeC-C-CcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-D-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .|.+.+.||+|+||.||+|... + ++.||+|............+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4889999999999999999763 3 6789999876655555567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          743 PKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       743 ~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ++|+|.+++..   ....+++..+..++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+|+.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV---HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999988754   233688999999999999999999   789999999999999999999999999999987643322


Q ss_pred             c-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 M-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ...       .........    
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~-------~~~~~~~~~----  288 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REI-------MQQVLYGKY----  288 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHH-------HHHHHhCCC----
Confidence            1 12335689999999999988999999999999999999999999854211     000       000000000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ...+..++.++.+++.+||..||++||++.+++++
T Consensus       289 ----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        289 ----DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                00123456789999999999999999999999754

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.3e-37  Score=338.32  Aligned_cols=253  Identities=24%  Similarity=0.327  Sum_probs=204.1

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|.+.+.||+|+||+||+|+.. +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36889999999999999999874 68999999987542   223466889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV---HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            99999999999987766799999999999999999999   799999999999999999999999999999987654433


Q ss_pred             ccccccccccccccccccC------cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          820 MKQTQTLATIGYIAPEYGR------EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      .......||+.|+|||++.      ...++.++|||||||++|||++|+.||...... ..+..           ++...
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~-----------i~~~~  225 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYNN-----------IMNFQ  225 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHHH-----------HHcCC
Confidence            3333356899999999876      456788999999999999999999998652111 01111           11000


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .....+     ....++.++.+++.+|+. +|.+||++.+++++
T Consensus       226 ~~~~~~-----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         226 RFLKFP-----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             CccCCC-----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            000000     012346778999999998 99999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.1e-36  Score=326.19  Aligned_cols=265  Identities=27%  Similarity=0.436  Sum_probs=206.6

Q ss_pred             ccCCccceecCccceEEEEEEe-----CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeec--CCeeE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-----PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN--HNFKA  736 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  736 (952)
                      .+|++.+.||+|+||.||+|..     .+++.||+|.+........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4688899999999999999974     3588999999876665556788999999999999999999998753  34688


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||+++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~L---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            99999999999999977666789999999999999999999   799999999999999999999999999999987643


Q ss_pred             cCcccc--cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccch------hhhhh
Q 002214          817 EDSMKQ--TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL------PAVMN  888 (952)
Q Consensus       817 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------~~~~~  888 (952)
                      ......  ....++..|+|||+..+..++.++|||||||++|||++|..|+.....   .+.+......      ....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccccccccchHHHHH
Confidence            322111  112244569999999888899999999999999999998877543211   1111000000      00111


Q ss_pred             hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       889 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      .+....       ....+..++.++.+++.+||+.+|++|||+.||++.|+++
T Consensus       238 ~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNG-------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCC-------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            111110       0011245677899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.8e-36  Score=324.84  Aligned_cols=254  Identities=28%  Similarity=0.493  Sum_probs=205.6

Q ss_pred             hccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCch-hhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      .++|.+.+.||+|+||.||+|...      +++.||||.++..... ..+.+.+|++++++++|||++++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            346888899999999999999763      3578999998755443 457899999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc
Q 002214          736 ALVLEYMPKGSLEDCMYASN-------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV  802 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~  802 (952)
                      ++||||+++++|.+++...+             ..+++.++..++.|++.|++||   |++|++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeeccccccceEEEcCCCe
Confidence            99999999999999986542             2478889999999999999999   7999999999999999999999


Q ss_pred             EEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhc
Q 002214          803 AHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIN  880 (952)
Q Consensus       803 ~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~  880 (952)
                      +||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||......+  ....  
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~--  236 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIEC--  236 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHH--
Confidence            999999999865332221 1223446789999999999999999999999999999999 999985422111  1110  


Q ss_pred             cchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          881 DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                               +......       ..+..++.++.+++.+||..||++||++.||++.|+
T Consensus       237 ---------~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 ---------ITQGRLL-------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---------HHcCCcC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                     0000000       012345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.8e-36  Score=325.69  Aligned_cols=258  Identities=26%  Similarity=0.456  Sum_probs=209.2

Q ss_pred             ccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .+|.+.+.||+|+||.||+|+..      ++..||+|.++.......+.+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45788899999999999999752      356799999876555555778999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc
Q 002214          738 VLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV  802 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~  802 (952)
                      ||||+++++|.+++....               ..+++..++.++.|++.|++||   |++||+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCc
Confidence            999999999999986532               2478999999999999999999   7999999999999999999999


Q ss_pred             EEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhc
Q 002214          803 AHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIN  880 (952)
Q Consensus       803 ~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~  880 (952)
                      ++|+|||++......... ......++..|+|||++.+..++.++|||||||++|||+| |+.||......+  ..    
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~----  235 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VI----  235 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----
Confidence            999999999865433221 1223456788999999988899999999999999999999 999985532111  00    


Q ss_pred             cchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          881 DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                             +.+.......       .+..++.++.+++.+||+.+|++||++.+|++.|+++.+.
T Consensus       236 -------~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         236 -------ECITQGRVLE-------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -------HHHhCCCCCC-------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                   0000000000       1123567899999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.9e-36  Score=320.90  Aligned_cols=253  Identities=27%  Similarity=0.471  Sum_probs=204.7

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++||+++++++++.+ ...++||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            457889999999999999999988888999999865433 24678999999999999999999998754 5678999999


Q ss_pred             CCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          743 PKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       743 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      ++++|.+++.... ..+++.++..++.|++.|++||   |+++|+||||||+||++++++.++|+|||.+..+.......
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI---ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            9999999987543 3589999999999999999999   78899999999999999999999999999998765433222


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      .....++..|+|||+..+..++.++||||||+++|||++ |..||......+  ....           +.....     
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~-----------~~~~~~-----  221 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQ-----------VERGYR-----  221 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHH-----------HHcCCC-----
Confidence            223345678999999888889999999999999999999 888885432111  1010           100000     


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                        ...+..++.++.+++.+|+..+|++|||++++.+.|++
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 --MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              00123456789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.4e-36  Score=325.65  Aligned_cols=263  Identities=24%  Similarity=0.438  Sum_probs=208.5

Q ss_pred             ccCCccceecCccceEEEEEEeCC-C--cEEEEEEeecc-CchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPD-G--IEVAIKVFHLQ-REGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ++|++.+.||+|+||.||+|...+ +  ..+|+|.++.. .....+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999998743 3  35788887643 233446788999999999 799999999999999999999


Q ss_pred             EEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcE
Q 002214          739 LEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVA  803 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~  803 (952)
                      |||+++++|.+++....               ..+++..+..++.|++.|++||   |++||+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCcCCcceEEECCCCeE
Confidence            99999999999986532               2478899999999999999999   78999999999999999999999


Q ss_pred             EEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccc
Q 002214          804 HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDS  882 (952)
Q Consensus       804 kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  882 (952)
                      ||+|||++.....  .........+..|+|||+.....++.++|||||||++|||++ |..||......     ..    
T Consensus       159 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-----~~----  227 (297)
T cd05089         159 KIADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-----EL----  227 (297)
T ss_pred             EECCcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HH----
Confidence            9999999864321  111111224567999999988889999999999999999998 99998542211     00    


Q ss_pred             hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhhccc
Q 002214          883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIEM  951 (952)
Q Consensus       883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~~  951 (952)
                          .........       ...+..++.++.+++.+||+.+|.+||++.++++.|+.+.+...+.+++
T Consensus       228 ----~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~~  285 (297)
T cd05089         228 ----YEKLPQGYR-------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNM  285 (297)
T ss_pred             ----HHHHhcCCC-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccccc
Confidence                000111100       0012345778999999999999999999999999999999887766543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-36  Score=334.20  Aligned_cols=242  Identities=25%  Similarity=0.333  Sum_probs=196.0

Q ss_pred             ceecCccceEEEEEEe----CCCcEEEEEEeeccC----chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          670 NLIGIGSYGSVYKGRF----PDGIEVAIKVFHLQR----EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +.||+|+||.||+++.    .+++.||||+++...    ......+.+|+.++++++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975    357899999986432    22345678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++|+|.+++.... .+.+..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....... .
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  156 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHL---HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V  156 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence            99999999886544 578889999999999999999   789999999999999999999999999999975432222 2


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||......     ..       .........       
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~-------~~~~~~~~~-------  217 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KT-------IDKILKGKL-------  217 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HH-------HHHHHcCCC-------
Confidence            22356899999999998888999999999999999999999998652110     00       011111100       


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                        ..+..+++++.+++.+||+.||++||     ++.++.++
T Consensus       218 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         218 --NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence              11234567899999999999999999     78888764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-36  Score=309.59  Aligned_cols=253  Identities=26%  Similarity=0.331  Sum_probs=206.6

Q ss_pred             hccCCccceecCccceEEEEEEeCC-CcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .+.|+..+.||+|.-|+||+++.++ +..+|+|++....   .+...+.+.|.+||+.+.||.++.+|+.++.++..|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3467788999999999999999854 6899999996542   33456788899999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC-
Q 002214          739 LEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE-  816 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~-  816 (952)
                      ||||+||+|..+.+... ..+++..+.-++.+|..||+||   |-.|||.|||||+|||+.++|++.|+||.++..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYL---HmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYL---HMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHH---HhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999999887654 3699999999999999999999   899999999999999999999999999999854311 


Q ss_pred             --------------------------------c-C---------------------cccccccccccccccccccCcCCc
Q 002214          817 --------------------------------E-D---------------------SMKQTQTLATIGYIAPEYGREGQV  842 (952)
Q Consensus       817 --------------------------------~-~---------------------~~~~~~~~~~~~y~aPE~~~~~~~  842 (952)
                                                      . .                     .......+||-.|.|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                     011122568999999999999999


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccc
Q 002214          843 SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTS  922 (952)
Q Consensus       843 ~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  922 (952)
                      +.++|.|+|||++|||+.|+.||...... .           .+.+++...+.....       ...+.++.+||++.|.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~-~-----------Tl~NIv~~~l~Fp~~-------~~vs~~akDLIr~LLv  373 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK-E-----------TLRNIVGQPLKFPEE-------PEVSSAAKDLIRKLLV  373 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCch-h-----------hHHHHhcCCCcCCCC-------CcchhHHHHHHHHHhc
Confidence            99999999999999999999999763222 2           233333333321111       1346779999999999


Q ss_pred             cCCCCCCC----HHHHHHH
Q 002214          923 ESPENRVN----TKEIISR  937 (952)
Q Consensus       923 ~dP~~RPs----~~ev~~~  937 (952)
                      .||++|..    ++||.+|
T Consensus       374 KdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  374 KDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             cChhhhhccccchHHhhcC
Confidence            99999998    8887654

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.9e-36  Score=317.55  Aligned_cols=247  Identities=28%  Similarity=0.451  Sum_probs=200.7

Q ss_pred             ceecCccceEEEEEEeCCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCChh
Q 002214          670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLE  748 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  748 (952)
                      +.||+|+||.||+|...+++.||+|+++.... .....+.+|++++++++|||++++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988899999999865433 23456889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccccccc
Q 002214          749 DCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT  828 (952)
Q Consensus       749 ~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  828 (952)
                      +++......+++..+..++.|++.|+.|+   |++|++||||+|+||+++.++.+|++|||++...............++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            99876666789999999999999999999   799999999999999999999999999999976543222222223456


Q ss_pred             cccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhh
Q 002214          829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQ  907 (952)
Q Consensus       829 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  907 (952)
                      +.|+|||+..+..++.++||||||+++||+++ |..||.......  ...           .+......       ..+.
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~-----------~~~~~~~~-------~~~~  217 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--ARE-----------QVEKGYRM-------SCPQ  217 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHH-----------HHHcCCCC-------CCCC
Confidence            78999999988889999999999999999999 999986431110  000           00000000       0122


Q ss_pred             hhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          908 SCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       908 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                      .++.++.+++.+||+.+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            35678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-36  Score=340.60  Aligned_cols=252  Identities=21%  Similarity=0.290  Sum_probs=198.2

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .|...+.||+|+||+||+|+. ++++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578899999999999999987 568999999986542   2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc-
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-  819 (952)
                      |+++|+|.+++.... .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++....... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~L---H~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESV---HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999887654 688999999999999999999   789999999999999999999999999999864311000 


Q ss_pred             ---------------------------------------------ccccccccccccccccccCcCCcCcccchHhHHHH
Q 002214          820 ---------------------------------------------MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIM  854 (952)
Q Consensus       820 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~  854 (952)
                                                                   ......+||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00112469999999999988889999999999999


Q ss_pred             HHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhh--ccccCCCCCCCHH
Q 002214          855 LMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAME--CTSESPENRVNTK  932 (952)
Q Consensus       855 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~  932 (952)
                      +|||++|+.||......+. ..           ...........+     ....+++++.+++.+  |+..+|..||++.
T Consensus       238 l~elltG~~Pf~~~~~~~~-~~-----------~i~~~~~~~~~~-----~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTET-QL-----------KVINWENTLHIP-----PQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHH-HH-----------HHHccccccCCC-----CCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            9999999999865321110 00           000000000000     011246678899988  5566777799999


Q ss_pred             HHHHH
Q 002214          933 EIISR  937 (952)
Q Consensus       933 ev~~~  937 (952)
                      |++++
T Consensus       301 ~~l~h  305 (381)
T cd05626         301 DIKAH  305 (381)
T ss_pred             HHhcC
Confidence            99876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.9e-36  Score=319.48  Aligned_cols=254  Identities=24%  Similarity=0.456  Sum_probs=206.4

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..+.|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|||++++++++. .+..++||||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3467899999999999999999998899999999864433 3467899999999999999999999874 4568999999


Q ss_pred             cCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+++.... ..+++.++..++.|++.|++||   |+.|++||||||+||++++++.++++|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI---ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            99999999886533 4689999999999999999999   7999999999999999999999999999999876533322


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                      ......++..|+|||+.....++.++||||||+++||+++ |+.||......  ...+           .+......   
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~-----------~~~~~~~~---  222 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQ-----------NLERGYRM---  222 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHH-----------HHHcCCCC---
Confidence            2233446788999999988889999999999999999999 99998653211  1110           01111000   


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                          ..+..++.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 ----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                0123346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.7e-36  Score=332.53  Aligned_cols=241  Identities=21%  Similarity=0.294  Sum_probs=191.9

Q ss_pred             ceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999874 58899999987542   22334556677777654 899999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|..++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+...... .....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~  155 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFL---HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST  155 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence            99998887644 689999999999999999999   78999999999999999999999999999998643322 22233


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+..        ..+...        ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~--------~~i~~~--------~~~  214 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELF--------DSILND--------RPH  214 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHH--------HHHHcC--------CCC
Confidence            5689999999999988899999999999999999999999865211     0000        000000        001


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRVNTK-EIIS  936 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~~  936 (952)
                      .+..++.++.+++.+||+.||++||++. ++.+
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            1234567789999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=339.48  Aligned_cols=252  Identities=27%  Similarity=0.388  Sum_probs=205.0

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|.+.+.||+|+||+||+|+.. +|+.||||+++...   ......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999985 68999999986432   234567889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC-
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED-  818 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-  818 (952)
                      ||+++|+|.+++... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~L---H~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSV---HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999998766 4789999999999999999999   78999999999999999999999999999998765432 


Q ss_pred             ---------------------------cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccC
Q 002214          819 ---------------------------SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTG  871 (952)
Q Consensus       819 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  871 (952)
                                                 ........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                       11223356899999999999999999999999999999999999998653211


Q ss_pred             ccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCC-HHHHHHH
Q 002214          872 EMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN-TKEIISR  937 (952)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~~  937 (952)
                      + ...+.        .... .....       .....+++++.+++.+|+. ||.+||+ +.|++++
T Consensus       237 ~-~~~~i--------~~~~-~~~~~-------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 E-TYNKI--------INWK-ESLRF-------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             H-HHHHH--------hccC-CcccC-------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            0 00000        0000 00000       0011247789999999997 9999999 9999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.1e-35  Score=320.58  Aligned_cols=257  Identities=23%  Similarity=0.386  Sum_probs=203.5

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCc----EEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGI----EVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ++|++.+.||+|+||+||+|.+. +++    .||+|.+..... ....++..|+.+++++.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46888899999999999999873 444    477787753322 234567888889999999999999998764 45788


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ++||+++|+|.+++......+++..+..++.|++.|++||   |+++++||||||+||++++++.+||+|||.++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL---EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            9999999999999987766799999999999999999999   7899999999999999999999999999999866433


Q ss_pred             Ccc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          818 DSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       818 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ... ......++..|+|||+..++.++.++|||||||++||+++ |+.||......  ...+++           .....
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~-----------~~~~~  229 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLL-----------EKGER  229 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH-----------HCCCc
Confidence            221 1223456778999999988889999999999999999998 99998653211  111111           10000


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      .       ..+..++.++.+++.+||..+|++|||+.|+++.|..+.+.
T Consensus       230 ~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         230 L-------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             C-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            0       01223566789999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.7e-36  Score=322.49  Aligned_cols=255  Identities=24%  Similarity=0.350  Sum_probs=203.2

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++|||++++++++..++..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            34799999999999999999987 56899999998765544456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++++|.+++.... .+++..+..++.|++.|++||   |++||+|||++|+||+++.++.+||+|||++....... ..
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~  162 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYL---HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK  162 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence            99999999886543 689999999999999999999   78999999999999999999999999999998664322 12


Q ss_pred             ccccccccccccccccC---cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          822 QTQTLATIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      .....+++.|+|||.+.   ...++.++|||||||++|||++|+.||......+... .+..           .......
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~~~~-----------~~~~~~~  230 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSK-----------SNFQPPK  230 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-eeec-----------CCCCCCC
Confidence            22346888999999874   3457789999999999999999999985432211100 0000           0000000


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      .    .....++.++.+++.+||..+|++||+++++++++
T Consensus       231 ~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         231 L----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             C----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0    00122456799999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.7e-36  Score=320.99  Aligned_cols=257  Identities=27%  Similarity=0.446  Sum_probs=208.2

Q ss_pred             ccCCccceecCccceEEEEEEeCC----CcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPD----GIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ++|.+.+.||+|+||.||+|.+.+    ...||+|...... ....+.+.+|+.++++++|||++++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            468888999999999999998643    3579999886554 3445678999999999999999999998875 457899


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++|+|.+++......+++..+..++.|++.|++||   |+.+++||||||+||+++.++.+|++|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL---ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            999999999999987666789999999999999999999   78999999999999999999999999999998765443


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      ........++..|+|||.+....++.++||||||+++||+++ |..||......+. ... ..           ...   
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~-~~-----------~~~---  225 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-IGR-IE-----------NGE---  225 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHH-HH-----------cCC---
Confidence            332333345678999999888889999999999999999996 9999865322110 000 00           000   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                          ....+..++.++.+++.+|+.++|++|||+.|+++.|+++++.
T Consensus       226 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         226 ----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                0011234677899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.1e-36  Score=332.46  Aligned_cols=248  Identities=23%  Similarity=0.299  Sum_probs=196.9

Q ss_pred             ceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999874 68999999997532   23345688999999998 799999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTST  155 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cccc
Confidence            99998886543 699999999999999999999   799999999999999999999999999999975322221 2233


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCcc---chhhhhccchhhhhhhccccccchhhHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM---SIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   ....+...      ......        
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~------~~~~~~--------  221 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ------VILEKQ--------  221 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH------HHHcCC--------
Confidence            5689999999999988999999999999999999999999964322110   01111000      000000        


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCC------HHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVN------TKEIISR  937 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~ev~~~  937 (952)
                       ...+..++.++.+++.+|++.||.+||+      +.|++++
T Consensus       222 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         222 -IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence             0123345678999999999999999997      6777654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4e-36  Score=337.10  Aligned_cols=261  Identities=22%  Similarity=0.388  Sum_probs=207.0

Q ss_pred             HHHhccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCC-CCccceeeeEeec
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQR-EGALNSFDAECEILKTIR-HRNLVKIISSCTN  731 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  731 (952)
                      ....++|.+.+.||+|+||.||+|++.      .++.||+|+++... ....+.+.+|++++.++. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            344567888999999999999999863      34689999997543 233457889999999997 9999999999999


Q ss_pred             CCeeEEEEEccCCCChhHHhhhcC--------------------------------------------------------
Q 002214          732 HNFKALVLEYMPKGSLEDCMYASN--------------------------------------------------------  755 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------  755 (952)
                      .+..++||||+++|+|.++++..+                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999999999999886432                                                        


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 002214          756 -----------------------------------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSN  794 (952)
Q Consensus       756 -----------------------------------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~N  794 (952)
                                                               ..+++.....++.|++.|++||   |+++|+||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCcCcccCCcce
Confidence                                                     1356778889999999999999   78999999999999


Q ss_pred             eeeCCCCcEEEeccccccccCCcCc-ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCc
Q 002214          795 VLLDDSMVAHLSDFGIAKLLSEEDS-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGE  872 (952)
Q Consensus       795 ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~  872 (952)
                      |++++++.+||+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |..||......+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999986533221 12223457789999999988889999999999999999998 888975532111


Q ss_pred             cchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          873 MSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                      .            ....+.....       ...+..++.++.+++.+||..+|++||+++||++.|+++.
T Consensus       350 ~------------~~~~~~~~~~-------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 Q------------FYNAIKRGYR-------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             H------------HHHHHHcCCC-------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1            0011111110       0112345778999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5e-36  Score=318.45  Aligned_cols=247  Identities=25%  Similarity=0.417  Sum_probs=198.8

Q ss_pred             ceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCCh
Q 002214          670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL  747 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  747 (952)
                      +.||+|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999874 78999999876443 33446789999999999999999999999999999999999999999


Q ss_pred             hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc-cccc
Q 002214          748 EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ-TQTL  826 (952)
Q Consensus       748 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~  826 (952)
                      .+++......+++.+++.++.|+++||+||   |++||+||||||+||+++.++.+|++|||++........... ....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            999976665789999999999999999999   799999999999999999999999999999986543211111 1122


Q ss_pred             cccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHh
Q 002214          827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVA  905 (952)
Q Consensus       827 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  905 (952)
                      .+..|+|||.+.++.++.++||||||+++|||++ |..||.......  .           ...+......       ..
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~-----------~~~~~~~~~~-------~~  217 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--T-----------REAIEQGVRL-------PC  217 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--H-----------HHHHHcCCCC-------CC
Confidence            3567999999988889999999999999999998 888875421110  0           0111111000       01


Q ss_pred             hhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          906 KQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       906 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                      +..++.++.+++.+||+.+|++||++.|+.+.|+
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2345678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.7e-36  Score=339.41  Aligned_cols=254  Identities=23%  Similarity=0.289  Sum_probs=202.2

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3568999999999999999999874 68999999986431   2233557889999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|+|.+++...  .+++..+..++.|++.||+||   |++||+||||||+|||++.++.+||+|||++......
T Consensus       121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999988654  478888999999999999999   7899999999999999999999999999999876443


Q ss_pred             CcccccccccccccccccccCcC----CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          818 DSMKQTQTLATIGYIAPEYGREG----QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      .........||+.|+|||++.+.    .++.++|||||||++|||++|+.||..... ...+.           .++...
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~-----------~i~~~~  263 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYS-----------KIMDHK  263 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-HHHHH-----------HHHcCC
Confidence            32223345699999999987643    478899999999999999999999865211 00111           111100


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPEN--RVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~  937 (952)
                      .....+     ....++.++.+++.+|+..+|.+  ||++.|++++
T Consensus       264 ~~~~~~-----~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         264 NSLTFP-----DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CcCCCC-----CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            000000     01134678999999999999998  9999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3e-36  Score=332.33  Aligned_cols=248  Identities=23%  Similarity=0.306  Sum_probs=195.7

Q ss_pred             ceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||.||+|+.. +++.||+|+++..   .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999874 6889999998754   223345678899998877 899999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|..++.... .+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~  155 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST  155 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence            99988876543 689999999999999999999   789999999999999999999999999999975432221 2233


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccc---hhhhhccchhhhhhhccccccchhhHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS---IKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ...+.       ...+...        
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~-------~~~i~~~--------  220 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-------FQVILEK--------  220 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH-------HHHHhcC--------
Confidence            56899999999999989999999999999999999999999643221110   01110       0000000        


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCC------HHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVN------TKEIISR  937 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~ev~~~  937 (952)
                      ....+..++.++.+++.+||+.||++||+      +.|++++
T Consensus       221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         221 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            00123345677899999999999999998      4676654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.2e-36  Score=333.30  Aligned_cols=245  Identities=22%  Similarity=0.304  Sum_probs=194.9

Q ss_pred             CCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHH---HhCCCCccceeeeEeecCCeeEEE
Q 002214          666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEIL---KTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      |++.+.||+|+||.||+|.+. +|+.||||+++...   ....+.+.+|.+++   ++++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999874 68999999986432   22345566776665   466799999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++|+|...+..  ..+++..+..++.|++.|++||   |++||+||||||+||++++++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYL---HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            999999999887754  3589999999999999999999   79999999999999999999999999999987533222


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                       .......|++.|+|||++.+..++.++|||||||++|||++|+.||......     ...       ..+.....    
T Consensus       156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~-------~~i~~~~~----  218 (324)
T cd05589         156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVF-------DSIVNDEV----  218 (324)
T ss_pred             -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHH-------HHHHhCCC----
Confidence             1223356899999999999889999999999999999999999998642111     000       00000000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                           ..+..++.++.+++.+||+.||.+||     ++.+++++
T Consensus       219 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         219 -----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                 11234567789999999999999999     56666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.9e-36  Score=325.03  Aligned_cols=255  Identities=22%  Similarity=0.425  Sum_probs=203.0

Q ss_pred             HhccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCe
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNF  734 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  734 (952)
                      ..++|++.+.||+|+||.||+|.+.      +++.||+|++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            5678999999999999999999753      35679999885432 2334568899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEE
Q 002214          735 KALVLEYMPKGSLEDCMYASN---------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL  805 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl  805 (952)
                      .++||||+++|+|.+++....         ..+++..+..++.|++.|++||   |+.|++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532         2357888999999999999999   7899999999999999999999999


Q ss_pred             eccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccch
Q 002214          806 SDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSL  883 (952)
Q Consensus       806 ~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  883 (952)
                      +|||+++......... .....+++.|+|||++.++.++.++|||||||++|||++ |..||......  ...+.     
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~-----  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRF-----  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH-----
Confidence            9999998654332221 122345788999999988889999999999999999999 67887542111  11100     


Q ss_pred             hhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                           .......        ..+..++.++.+++.+||+.+|++||++.|+++.|+
T Consensus       234 -----~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 -----VMEGGLL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -----HHcCCcC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                 0000000        012345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.8e-37  Score=295.18  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=208.5

Q ss_pred             HHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc--------hhhHHHHHHHHHHHhC-CCCccceeeeEe
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE--------GALNSFDAECEILKTI-RHRNLVKIISSC  729 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~~  729 (952)
                      ...-+.|...+.+|+|..++|-++.. ++|..+|+|++.....        ...+.-.+|+.|++++ .||+|+.+.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            44456788888999999999998876 5789999998854321        1234456899999998 699999999999


Q ss_pred             ecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccc
Q 002214          730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       730 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  809 (952)
                      +.+...++|+|.|+.|.|.+++...- .+++....+|++|+.+|++||   |.+.|||||+||+|||++++.++||+|||
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeyl---Ha~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYL---HARNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHH---HHhhhhhcccChhheeeccccceEEeccc
Confidence            99999999999999999999997654 789999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCcCcccccccccccccccccccC------cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccch
Q 002214          810 IAKLLSEEDSMKQTQTLATIGYIAPEYGR------EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL  883 (952)
Q Consensus       810 la~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  883 (952)
                      +|+.+.++..  -...+|||+|.|||.+.      ...|+..+|+|++||+||.++.|.+||..            +.+.
T Consensus       169 Fa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH------------RkQm  234 (411)
T KOG0599|consen  169 FACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH------------RKQM  234 (411)
T ss_pred             eeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH------------HHHH
Confidence            9998865443  34478999999999764      23578889999999999999999999843            2222


Q ss_pred             hhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      -.+..++.+...     .....+.+.+.+..+||.+|++.||++|.|++|++.|
T Consensus       235 lMLR~ImeGkyq-----F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  235 LMLRMIMEGKYQ-----FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHHHHHhcccc-----cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            222233322221     1222345678889999999999999999999999875

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6e-36  Score=323.71  Aligned_cols=254  Identities=26%  Similarity=0.473  Sum_probs=203.2

Q ss_pred             ccCCccceecCccceEEEEEEe-----CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-----PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      +.|++.+.||+|+||.||+|..     .+++.||+|.+.... ......+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4678889999999999999974     356889999986433 2334678899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC
Q 002214          738 VLEYMPKGSLEDCMYASN----------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM  801 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~----------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~  801 (952)
                      ||||+++++|.+++....                ..+++.+...++.|++.|++||   |++|++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhcCeehhccccceEEEcCCC
Confidence            999999999999885321                2478889999999999999999   789999999999999999999


Q ss_pred             cEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhh
Q 002214          802 VAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWI  879 (952)
Q Consensus       802 ~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~  879 (952)
                      .+||+|||+++........ ......++..|+|||+..+..++.++|||||||++|||++ |..||.....  ....   
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~---  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVI---  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHH---
Confidence            9999999999866433221 1222345778999999988889999999999999999999 8888754211  1111   


Q ss_pred             ccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          880 NDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       880 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                              +.+.....       ...+..++.++.+++.+||+.||++||++.+|.++|+.
T Consensus       237 --------~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 --------EMVRKRQL-------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --------HHHHcCCc-------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                    11111000       01123467789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2e-36  Score=332.65  Aligned_cols=236  Identities=24%  Similarity=0.318  Sum_probs=191.3

Q ss_pred             ceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||+||+|+.+ +++.||||++...   .....+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999874 6889999998643   233446677888888877 699999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~l---H~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~  155 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTST  155 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cccc
Confidence            99998887654 689999999999999999999   799999999999999999999999999999875432221 2233


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.....  .....          .+.....         .
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--~~~~~----------~i~~~~~---------~  214 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--DDLFE----------AILNDEV---------V  214 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHH----------HHhcCCC---------C
Confidence            5689999999999988899999999999999999999999865211  00000          0000000         0


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCCCH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRVNT  931 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RPs~  931 (952)
                      .+..++.++.+++.+|++.||++||++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            122356778999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.8e-36  Score=336.51  Aligned_cols=267  Identities=19%  Similarity=0.240  Sum_probs=199.8

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCC-----eeE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHN-----FKA  736 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  736 (952)
                      +|++.+.||+|+||.||+|.+ .+|+.||||++...  .....+++.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999987 47899999988543  2233467889999999999999999999998766     789


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+. ++|.+.+... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+....
T Consensus        81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYL---HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 5787777543 3689999999999999999999   799999999999999999999999999999986543


Q ss_pred             cCcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhh---hccchh--------
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW---INDSLP--------  884 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~~~--------  884 (952)
                      ..........+++.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+...   ......        
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhhH
Confidence            333333345688999999988764 57899999999999999999999996532111 11100   000000        


Q ss_pred             hhhhhccccccch-hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          885 AVMNIMDTNLLSE-DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       885 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .....+....... ............++++.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0000000000000 0000001122346789999999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8e-36  Score=318.41  Aligned_cols=253  Identities=26%  Similarity=0.462  Sum_probs=203.7

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .++|.+.+.||+|+||.||+|.++++..||+|.+..... ..+.+.+|++++++++|||++++++++.. +..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence            356888999999999999999987777899998764432 34678899999999999999999998754 5678999999


Q ss_pred             CCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          743 PKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       743 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      ++++|.+++.... ..+++..+..++.|++.|++||   |+.|++||||||+||++++++.++|+|||.+..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI---ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            9999999987543 3578999999999999999999   78999999999999999999999999999998764433222


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      .....++..|+|||...+..++.++||||||+++|||++ |..||......+  ...+.           ......    
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~-----------~~~~~~----  222 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQV-----------ERGYRM----  222 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-----------HcCCCC----
Confidence            223446778999999988889999999999999999999 888986532111  10100           000000    


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                         ..+...+..+.+++.+||+.||++||++++|++.|++
T Consensus       223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 ---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               0122356789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.2e-36  Score=350.91  Aligned_cols=259  Identities=22%  Similarity=0.292  Sum_probs=204.1

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.++||+|+||.||+|++. +|+.||+|+++...   +...+++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999874 58999999986432   233467899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccc
Q 002214          740 EYMPKGSLEDCMYAS----------NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       740 e~~~~g~L~~~l~~~----------~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  809 (952)
                      ||++||+|.+++...          ....++..++.++.|+++||+||   |++||+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yL---Hs~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV---HSKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHH---HHCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988642          12356778899999999999999   78999999999999999999999999999


Q ss_pred             cccccCCcCc-----------------ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCc
Q 002214          810 IAKLLSEEDS-----------------MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE  872 (952)
Q Consensus       810 la~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  872 (952)
                      +|+.......                 .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621110                 01112468999999999999999999999999999999999999986522111


Q ss_pred             cchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHHH
Q 002214          873 MSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRV-NTKEIISRLIKIRD  943 (952)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~~i~~  943 (952)
                      .......          .++      ..  ......+++.+.+++.+|++.||++|| +++++.+.|+...+
T Consensus       239 i~~~~~i----------~~P------~~--~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 ISYRDVI----------LSP------IE--VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhhhhc----------cCh------hh--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1100000          000      00  001124567799999999999999996 56777777776644

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.5e-36  Score=334.69  Aligned_cols=242  Identities=22%  Similarity=0.300  Sum_probs=196.0

Q ss_pred             ceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCC
Q 002214          670 NLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKG  745 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  745 (952)
                      +.||+|+||.||+|+. .+|+.||+|++....   ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999987 468999999986532   233456788999999999999999999999999999999999999


Q ss_pred             ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          746 SLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS-NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       746 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~-~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      +|..++.... .+++..+..++.|++.||+||   |+ +||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT  155 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence            9998876544 689999999999999999999   65 7999999999999999999999999999975432221 1223


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......  ..           ...+....        ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~-----------~~~i~~~~--------~~  214 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KL-----------FELILMEE--------IR  214 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HH-----------HHHHhcCC--------CC
Confidence            46899999999998889999999999999999999999998542110  00           00000000        00


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                      .+..+++++.+++.+||+.||++|+     ++.+++++
T Consensus       215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            1233567899999999999999997     89999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=329.11  Aligned_cols=244  Identities=26%  Similarity=0.428  Sum_probs=205.2

Q ss_pred             eecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCChhH
Q 002214          671 LIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLED  749 (952)
Q Consensus       671 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  749 (952)
                      ++|+|.||+||.|++. +...+|||-+........+-+..|+..-++++|.|||+++|.+.+.++.-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999984 567899999877766667788999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC-CCCcEEEeccccccccCCcCcccccccc
Q 002214          750 CMYASNFNL--DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTL  826 (952)
Q Consensus       750 ~l~~~~~~l--~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~  826 (952)
                      +++..=+++  .+.+.-.+.+||.+||.||   |+..|||||||..|||++ -.|.+||+|||-++++..-... +....
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYL---Hen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-TETFT  737 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYL---HENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-TETFT  737 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhh---hhcceeeccccCCcEEEeeccceEEecccccchhhccCCcc-ccccc
Confidence            998765555  7788888999999999999   899999999999999996 6899999999999988654332 33466


Q ss_pred             cccccccccccCcC--CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          827 ATIGYIAPEYGREG--QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       827 ~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ||..|||||++..+  .|+.++|||||||++.||.||++||.+......              .++.-++....    +.
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------------AMFkVGmyKvH----P~  799 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------------AMFKVGMYKVH----PP  799 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------------hhhhhcceecC----CC
Confidence            99999999998765  488999999999999999999999977543221              11222222221    22


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                      .|+..+.+...+|.+|+.+||.+||+++++++
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            46677889999999999999999999999874

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.9e-36  Score=335.88  Aligned_cols=255  Identities=22%  Similarity=0.290  Sum_probs=201.0

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+++..|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34568999999999999999999885 5889999998642   2223456789999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+++|+|.+++...  .+++..+..++.|++.||+||   |+++|+||||||+|||+++++.+||+|||+|.....
T Consensus       120 lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~L---H~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAI---HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            999999999999988654  478899999999999999999   789999999999999999999999999999987644


Q ss_pred             cCcccccccccccccccccccCcC----CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREG----QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                      ..........||+.|+|||++.+.    .++.++||||+||++|||++|+.||..... ...+           ..+++.
T Consensus       195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-~~~~-----------~~i~~~  262 (370)
T cd05621         195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-VGTY-----------SKIMDH  262 (370)
T ss_pred             CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-HHHH-----------HHHHhC
Confidence            333233346799999999987653    378899999999999999999999864211 0011           111111


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPEN--RVNTKEIISR  937 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~  937 (952)
                      ......+     .....+..+.+++.+|+..+|.+  ||++.|++++
T Consensus       263 ~~~~~~p-----~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         263 KNSLNFP-----EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CcccCCC-----CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            1000000     01234667889999999855544  8899999887

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=9.7e-36  Score=316.88  Aligned_cols=247  Identities=27%  Similarity=0.446  Sum_probs=198.1

Q ss_pred             eecCccceEEEEEEeC---CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCC
Q 002214          671 LIGIGSYGSVYKGRFP---DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGS  746 (952)
Q Consensus       671 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  746 (952)
                      .||+|+||.||+|.+.   ++..||+|+...... ...+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999763   456799999865533 234678999999999999999999998854 56799999999999


Q ss_pred             hhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc--cc
Q 002214          747 LEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQ  824 (952)
Q Consensus       747 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~--~~  824 (952)
                      |.+++......+++.+++.++.|++.|++||   |++|++||||||+||+++.++.+||+|||++...........  ..
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYL---EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999876666799999999999999999999   789999999999999999999999999999986543322111  11


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN  903 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (952)
                      ..++..|+|||......++.++|||||||++||+++ |..||......+  ...           .+....       ..
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~-----------~~~~~~-------~~  217 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMS-----------FIEQGK-------RL  217 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH-----------HHHCCC-------CC
Confidence            234678999999888889999999999999999996 999986532211  111           110000       00


Q ss_pred             HhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          904 VAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       904 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      ..+..+++++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            12244678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.4e-36  Score=332.49  Aligned_cols=242  Identities=23%  Similarity=0.295  Sum_probs=195.2

Q ss_pred             ceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.+++..+ +||+|+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999874 58899999986532   23345677899998876 799999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|...+.... .+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||++........ ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFL---HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT  155 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence            99998886554 689999999999999999999   789999999999999999999999999999975432221 2233


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..           ......         .
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-~~~~~-----------i~~~~~---------~  214 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-DLFES-----------ILHDDV---------L  214 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-HHHHH-----------HHcCCC---------C
Confidence            56899999999999888999999999999999999999998652111 00110           110000         0


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCC-------CHHHHHHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRV-------NTKEIISR  937 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RP-------s~~ev~~~  937 (952)
                      .+..++.++.+++.+||+.||++||       ++.+++++
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            1223567889999999999999999       77887765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-36  Score=331.63  Aligned_cols=255  Identities=21%  Similarity=0.269  Sum_probs=200.1

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++...   .....+.+.+|..++..++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999874 6899999998642   2233456889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++......+++..+..++.|++.||+||   |+++|+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV---HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            99999999999977666789999999999999999999   799999999999999999999999999999986644333


Q ss_pred             ccccccccccccccccccCc-----CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          820 MKQTQTLATIGYIAPEYGRE-----GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      .......||+.|+|||++..     ..++.++|||||||++|||++|+.||......+ .+...           +....
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-~~~~i-----------~~~~~  225 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKI-----------MNHKE  225 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-HHHHH-----------HcCCC
Confidence            22333568999999998763     457889999999999999999999986421110 01110           00000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPEN--RVNTKEIISR  937 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~  937 (952)
                      ....    ......+++++.+++.+|+..++++  ||++.+++++
T Consensus       226 ~~~~----~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         226 HFQF----PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cccC----CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0000    0011225677899999988654443  7899999877

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-36  Score=325.71  Aligned_cols=252  Identities=24%  Similarity=0.341  Sum_probs=211.1

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCch---hhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREG---ALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  736 (952)
                      ....|.+.+.||+|.||.||+++.+ +|+.+|+|++......   ....+.+|+.+|+++. |||||.+++++++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4567889999999999999999985 4999999999655432   3468899999999998 999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC----CcEEEecccccc
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS----MVAHLSDFGIAK  812 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgla~  812 (952)
                      +|||+++||.|.+.+...  .+++.++..++.|++.+++||   |+.||+|||+||+|+|+...    +.+|++|||+|.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~l---H~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYL---HSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHH---HhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999998776  399999999999999999999   78999999999999999643    579999999999


Q ss_pred             ccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                      ....  .......+||+.|+|||++....|+.++||||+||++|.|++|..||....... ...           .+...
T Consensus       188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-~~~-----------~i~~~  253 (382)
T KOG0032|consen  188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-IFL-----------AILRG  253 (382)
T ss_pred             EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-HHH-----------HHHcC
Confidence            8765  333455789999999999999999999999999999999999999986632211 111           11111


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....     ....+...+..+.++++.|+..||.+|+|+.++++|
T Consensus       254 ~~~f-----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 DFDF-----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCCC-----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            1111     111234567889999999999999999999999986

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.2e-36  Score=331.95  Aligned_cols=247  Identities=22%  Similarity=0.275  Sum_probs=197.1

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCC-CccceeeeEeecCCeeEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTIRH-RNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  739 (952)
                      +|++.+.||+|+||.||+|+.. +++.||||+++..   .....+.+..|.+++..++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999874 5789999998653   23345677889999999976 56888999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            9999999998886544 688999999999999999999   789999999999999999999999999999875322211


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+.           .+....      
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~-----------~i~~~~------  217 (324)
T cd05587         157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQ-----------SIMEHN------  217 (324)
T ss_pred             -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHH-----------HHHcCC------
Confidence             122356899999999999989999999999999999999999998642111 0000           011000      


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNT-----KEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~~  937 (952)
                         ...+..++.++.+++.+||..||.+||+.     +++.++
T Consensus       218 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         218 ---VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               00123356778999999999999999976     566543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.6e-36  Score=320.95  Aligned_cols=255  Identities=27%  Similarity=0.438  Sum_probs=203.5

Q ss_pred             HhccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCe
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNF  734 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  734 (952)
                      ..++|.+.+.||+|+||.||+|.+.      .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3467899999999999999999874      35789999886443 3334578999999999999999999999999889


Q ss_pred             eEEEEEccCCCChhHHhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC---cEEE
Q 002214          735 KALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM---VAHL  805 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~---~~kl  805 (952)
                      .++||||+++++|.+++....      ..+++..+..++.||+.|++||   |+++++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL---EENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchheEEEeccCCCcceEe
Confidence            999999999999999987643      2589999999999999999999   789999999999999998654   6999


Q ss_pred             eccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccch
Q 002214          806 SDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSL  883 (952)
Q Consensus       806 ~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  883 (952)
                      +|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||......+           
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-----------  229 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-----------  229 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----------
Confidence            9999998764322211 112234578999999988889999999999999999997 999986522111           


Q ss_pred             hhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                        ....+.....       ...+..++.++.+++.+||+.+|++||++.||+++|.
T Consensus       230 --~~~~~~~~~~-------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         230 --VMEFVTGGGR-------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --HHHHHHcCCc-------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence              1111111100       0112345778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=337.75  Aligned_cols=252  Identities=24%  Similarity=0.330  Sum_probs=200.7

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....   ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46889999999999999999884 68999999986532   233456789999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSI---HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999887654 689999999999999999999   789999999999999999999999999999976432110


Q ss_pred             c-------------------------------------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCC
Q 002214          820 M-------------------------------------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGM  862 (952)
Q Consensus       820 ~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~  862 (952)
                      .                                     .....+||+.|+|||++....++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            0                                     001235899999999998888999999999999999999999


Q ss_pred             CCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCC---HHHHHHH
Q 002214          863 KPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN---TKEIISR  937 (952)
Q Consensus       863 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~~  937 (952)
                      .||......+ ...           .++........+     ....+++++.+++.+|+. +|.+|++   +.|++++
T Consensus       237 ~Pf~~~~~~~-~~~-----------~i~~~~~~~~~~-----~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         237 PPFCSDNPQE-TYR-----------KIINWKETLQFP-----DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCHHH-HHH-----------HHHcCCCccCCC-----CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9986532110 000           000000000000     011246678999999997 9999998   8888774

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.4e-36  Score=347.35  Aligned_cols=255  Identities=24%  Similarity=0.335  Sum_probs=204.2

Q ss_pred             HHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCC---
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHN---  733 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  733 (952)
                      ....++|.+.+.||+|+||+||+|+. .+|+.||||++....  ......+.+|+.++..++|+|++++++.+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34557999999999999999999986 479999999986542  334567889999999999999999987765332   


Q ss_pred             -----eeEEEEEccCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEE
Q 002214          734 -----FKALVLEYMPKGSLEDCMYAS---NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL  805 (952)
Q Consensus       734 -----~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl  805 (952)
                           ..++||||+++|+|.+++...   ...+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~l---H~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV---HSKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEeCCCCEEE
Confidence                 368999999999999988643   23689999999999999999999   7999999999999999999999999


Q ss_pred             eccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchh
Q 002214          806 SDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP  884 (952)
Q Consensus       806 ~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  884 (952)
                      +|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....     ...+..    
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~----  255 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMH----  255 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHH----
Confidence            999999876432211 1223568999999999999999999999999999999999999986421     111110    


Q ss_pred             hhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          885 AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         .......        ...+..+++++.+++.+||+.||++||++.+++++
T Consensus       256 ---~~~~~~~--------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 ---KTLAGRY--------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ---HHhcCCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence               0000000        01234467789999999999999999999999875

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-36  Score=319.48  Aligned_cols=255  Identities=26%  Similarity=0.494  Sum_probs=208.2

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..++|.+.+.||+|+||.||+|..++++.||||.+..... ..+.+.+|+.++++++|||++++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            4568999999999999999999988888999999865433 346789999999999999999999999988899999999


Q ss_pred             cCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+++.... ..+++.++..++.|++.|++||   |+.+++||||+|+||++++++.+|++|||.+.........
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~l---h~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL---ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            99999999987643 4689999999999999999999   7899999999999999999999999999999876432222


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                      ......++..|+|||...+..++.++||||+|+++||+++ |+.||...... ......            .....    
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~------------~~~~~----  222 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQV------------ERGYR----  222 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH------------HcCCC----
Confidence            2222335678999999988889999999999999999999 99998542111 011110            00000    


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                         ...+..++.++.+++.+|+..+|++||+++++.+.|+.
T Consensus       223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 ---MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence               01123346789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.6e-36  Score=324.33  Aligned_cols=260  Identities=25%  Similarity=0.446  Sum_probs=207.9

Q ss_pred             HHHhccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeec
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTN  731 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  731 (952)
                      ....++|+..+.||+|+||.||+|...      ....||+|.+.... ......+.+|+.+++++ +||||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            344567899999999999999999863      24689999986543 33446688999999999 89999999999999


Q ss_pred             CCeeEEEEEccCCCChhHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCee
Q 002214          732 HNFKALVLEYMPKGSLEDCMYAS---------------NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVL  796 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nil  796 (952)
                      ++..+++|||+++|+|.+++...               ...+++..++.++.|++.|++||   |+++|+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCccccccceeeEE
Confidence            99999999999999999998642               23688999999999999999999   7899999999999999


Q ss_pred             eCCCCcEEEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccc
Q 002214          797 LDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS  874 (952)
Q Consensus       797 l~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~  874 (952)
                      ++.++.+||+|||+++.+....... .....++..|+|||+..+..++.++|||||||++||+++ |..||......   
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---  241 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---  241 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---
Confidence            9999999999999998765433221 122335678999999888889999999999999999998 88887542111   


Q ss_pred             hhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                                +....+......       ..+..++.++.+++.+||..||++|||+.|+++.|+++.
T Consensus       242 ----------~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 ----------ELFKLLKEGYRM-------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ----------HHHHHHHcCCcC-------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                      001111111100       012345678999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=317.50  Aligned_cols=251  Identities=25%  Similarity=0.363  Sum_probs=203.0

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc-----hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE-----GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      +.|...+.||+|++|.||+|.. .+++.||+|.+.....     ...+.+.+|+.++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688999999999999999987 4689999998864321     123568899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++++|.+.+.... .+++..+..++.|++.|++||   |+.||+||||+|+||++++++.++|+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999887644 588899999999999999999   7999999999999999999999999999999865432


Q ss_pred             Ccccc--cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          818 DSMKQ--TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       818 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      .....  ....++..|+|||+..+..++.++||||+|+++||+++|+.||......+ ...           ........
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~-----------~~~~~~~~  225 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-AIF-----------KIATQPTN  225 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-HHH-----------HHhccCCC
Confidence            21111  23457889999999998889999999999999999999999986521110 000           00000000


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                             ...+..++.++.+++.+||..+|.+||++.|++++
T Consensus       226 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 -------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                   01123456789999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.5e-35  Score=324.29  Aligned_cols=260  Identities=25%  Similarity=0.438  Sum_probs=207.7

Q ss_pred             hccCCccceecCccceEEEEEEeC--------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeecC
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP--------DGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNH  732 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  732 (952)
                      .++|.+.+.||+|+||.||+|+..        ++..||+|.++... ......+.+|+.+++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467999999999999999999752        23579999987543 33456788899999999 799999999999999


Q ss_pred             CeeEEEEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee
Q 002214          733 NFKALVLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL  797 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill  797 (952)
                      +..++||||+++|+|.+++....               ..+++.+++.++.|++.|++||   |++|++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHHheEE
Confidence            99999999999999999987532               2478899999999999999999   78999999999999999


Q ss_pred             CCCCcEEEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccch
Q 002214          798 DDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSI  875 (952)
Q Consensus       798 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~  875 (952)
                      +.++.+||+|||.++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.....     
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----  248 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  248 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence            999999999999998654322111 111234578999999988889999999999999999998 8888754211     


Q ss_pred             hhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          876 KRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                      .        +....+.....       ...+..++.++.+++.+||..+|++||++.||++.|+++....
T Consensus       249 ~--------~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         249 E--------ELFKLLKEGHR-------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             H--------HHHHHHHcCCC-------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            1        11111111100       0112345778999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.4e-36  Score=324.15  Aligned_cols=254  Identities=27%  Similarity=0.456  Sum_probs=203.3

Q ss_pred             ccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCch-hhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      .+|++.+.||+|+||.||+|...      +++.||+|+++..... ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            35778889999999999999863      2578999998755432 3456889999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC
Q 002214          737 LVLEYMPKGSLEDCMYAS---------------NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM  801 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~  801 (952)
                      +++||+++++|.+++...               ...+++..+..++.|++.|++|+   |++||+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l---H~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHcCccccccchhheEecCCC
Confidence            999999999999988532               12478889999999999999999   789999999999999999999


Q ss_pred             cEEEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhh
Q 002214          802 VAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWI  879 (952)
Q Consensus       802 ~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~  879 (952)
                      .+||+|||+++......... .....+++.|+|||.+.++.++.++|||||||++|||++ |..||......  .....+
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~i  239 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEMI  239 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence            99999999998664332211 222346789999999988889999999999999999998 77887542111  111100


Q ss_pred             ccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          880 NDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       880 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                                .+...        ...+.+++..+.+++.+||+.+|++||+++||++.|+.
T Consensus       240 ----------~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         240 ----------RNRQV--------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ----------HcCCc--------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                      00000        01134577889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1e-35  Score=319.16  Aligned_cols=258  Identities=24%  Similarity=0.349  Sum_probs=208.0

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||.||+|.. .+++.||||.+....   ......+.+|+.+++.++|||++++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999986 578999999875432   233467889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          740 EYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       740 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      ||+++++|.+++..   ....+++..+..++.|++.|++||   |++|++|+||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998864   233589999999999999999999   799999999999999999999999999999986643


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      ... ......++..|+|||+..+..++.++||||||+++|||++|..||...........+.       ......+    
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~~----  226 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK-------IEQCDYP----  226 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh-------hhcCCCC----
Confidence            322 1223458899999999988889999999999999999999999985422111111000       0000000    


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                            ...+..++.++.+++.+||+.+|++|||+.+|++.++++.
T Consensus       227 ------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         227 ------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                  0011235678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-35  Score=315.73  Aligned_cols=239  Identities=23%  Similarity=0.374  Sum_probs=191.0

Q ss_pred             ceecCccceEEEEEEeCC-------------CcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          670 NLIGIGSYGSVYKGRFPD-------------GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      +.||+|+||.||+|+..+             ...||+|++..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358999887655555667889999999999999999999999988999


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc-------EEEeccc
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV-------AHLSDFG  809 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~-------~kl~Dfg  809 (952)
                      +||||+++|+|..++......+++..+..++.|+++|++||   |+++|+||||||+||+++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh---hhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999998876666789999999999999999999   8999999999999999987664       8999999


Q ss_pred             cccccCCcCcccccccccccccccccccC-cCCcCcccchHhHHHHHHHHH-hCCCCCCccccCccchhhhhccchhhhh
Q 002214          810 IAKLLSEEDSMKQTQTLATIGYIAPEYGR-EGQVSIKGDVYNYGIMLMEVF-TGMKPTNEFFTGEMSIKRWINDSLPAVM  887 (952)
Q Consensus       810 la~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~  887 (952)
                      ++......     ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+  ....         
T Consensus       158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~---------  221 (262)
T cd05077         158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERF---------  221 (262)
T ss_pred             CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHH---------
Confidence            98754322     2345788999999876 467889999999999999998 5888865421110  0000         


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                        ......         .....++++.+++.+||+.||++||++.+|++++
T Consensus       222 --~~~~~~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         222 --YEGQCM---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --HhcCcc---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence              000000         0011246789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.2e-36  Score=335.50  Aligned_cols=253  Identities=23%  Similarity=0.305  Sum_probs=196.7

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++...   ......+.+|+.++.+++||+|+++++.+.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999874 68999999986532   223456788999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+|||++.++.+||+|||+|+.......
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSI---HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999987654 689999999999999999999   799999999999999999999999999999975432110


Q ss_pred             c----------------------------------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCC
Q 002214          820 M----------------------------------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPT  865 (952)
Q Consensus       820 ~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~  865 (952)
                      .                                  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                  011346999999999999889999999999999999999999999


Q ss_pred             CccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccc--cCCCCCCCHHHHHHH
Q 002214          866 NEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTS--ESPENRVNTKEIISR  937 (952)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~ev~~~  937 (952)
                      ...... ..+.+....         .....  .+     ....+++++.+++.+++.  .++..||++.|++++
T Consensus       237 ~~~~~~-~~~~~i~~~---------~~~~~--~p-----~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         237 CSETPQ-ETYKKVMNW---------KETLI--FP-----PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCHH-HHHHHHHcC---------cCccc--CC-----CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            652211 111111000         00000  00     001235567788877543  233456899999887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.3e-36  Score=328.41  Aligned_cols=241  Identities=22%  Similarity=0.321  Sum_probs=192.4

Q ss_pred             ceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||+||+|++. +++.||||+++...   +.....+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999874 57899999987542   23345567788888764 899999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|.+++... ..+++.++..++.|++.||+||   |++||+||||||+||++++++.+||+|||+++....... ....
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFL---HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT  155 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence            9999988754 3688999999999999999999   789999999999999999999999999999975322211 2233


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...+.           +...        ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~-----------i~~~--------~~~  214 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQS-----------IRMD--------NPC  214 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHH-----------HHhC--------CCC
Confidence            56899999999999888999999999999999999999998652110  00000           0000        000


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRVNTK-EIIS  936 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~~  936 (952)
                      .+..++.++.+++.+||+.||++||++. ++.+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            1223466789999999999999999997 5644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.3e-35  Score=318.22  Aligned_cols=255  Identities=27%  Similarity=0.463  Sum_probs=206.0

Q ss_pred             ccCCccceecCccceEEEEEEeC----CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .+|++.+.||+|+||.||+|...    .+..||+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57888999999999999999863    23479999886443 23356789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++++|.+++......+++.++..++.|++.|++||   |+.+++||||||+||+++.++.++++|||++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            999999999999987666789999999999999999999   79999999999999999999999999999998764432


Q ss_pred             ccccc--ccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          819 SMKQT--QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       819 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      .....  ...++..|+|||++.+..++.++||||||+++||+++ |..||......  .....+.          + ...
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~----------~-~~~  227 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIE----------E-GYR  227 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHh----------C-CCc
Confidence            21111  1223568999999988889999999999999999887 99998653211  1111110          0 000


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                             ...+..++.++.+++.+||+.+|++||++.++++.|+++
T Consensus       228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 -------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                   001233567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-36  Score=321.99  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=201.2

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .|++.+.||+|+||+||++.. .+++.||+|++....   ......+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            377889999999999999987 468999999986432   2223457789999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          741 YMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |+++|+|.+++.... ..+++..+..++.|++.|++||   |+.+|+||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL---HRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            999999998876543 4689999999999999999999   789999999999999999999999999999986543221


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        .....|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....        ....+....     
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~--------~~~~~~~~~-----  221 (285)
T cd05605         158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREE--------VERRVKEDQ-----  221 (285)
T ss_pred             --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHH--------HHHHhhhcc-----
Confidence              12346899999999998888999999999999999999999998642111 00000        000000000     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                         ...+..++..+.+++.+||+.||++||     ++.+++++
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence               001223567789999999999999999     88898775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.7e-35  Score=321.33  Aligned_cols=256  Identities=23%  Similarity=0.407  Sum_probs=204.9

Q ss_pred             cCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      +|++.+.||+|+||.||+|+..      ....||+|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999762      235789998865433 334678899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 002214          738 VLEYMPKGSLEDCMYASN-----------------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSN  794 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~N  794 (952)
                      ||||+++|+|.+++....                       ..+++.+++.++.|++.|++||   |+++++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH---HHCCeehhhhhhhe
Confidence            999999999999876421                       2478899999999999999999   78999999999999


Q ss_pred             eeeCCCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCc
Q 002214          795 VLLDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGE  872 (952)
Q Consensus       795 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~  872 (952)
                      |++++++.+||+|||+++........ ......++..|+|||+..+..++.++||||||+++|||++ |..||.....  
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--  235 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--  235 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            99999999999999999865433222 1222345778999999888889999999999999999999 9999854211  


Q ss_pred             cchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          873 MSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                      ..+.           +.+......       ..+..++.++.+++.+||+.+|++||+++|+++.|+++..
T Consensus       236 ~~~~-----------~~~~~~~~~-------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         236 ERLF-----------NLLKTGYRM-------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHH-----------HHHhCCCCC-------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            1111           111111100       1123456789999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.7e-36  Score=321.11  Aligned_cols=245  Identities=24%  Similarity=0.310  Sum_probs=195.2

Q ss_pred             ecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCCh
Q 002214          672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL  747 (952)
Q Consensus       672 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  747 (952)
                      ||+|+||+||++.+. +|+.||+|.+....   ....+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999874 68999999986432   22335678899999999999999999999999999999999999999


Q ss_pred             hHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          748 EDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       748 ~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      ...+..   ....+++..+..++.|++.|++||   |+++|+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL---HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            887753   234689999999999999999999   789999999999999999999999999999986543322 2223


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||........ .....       ........         .
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~-------~~~~~~~~---------~  219 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELK-------QRILNDSV---------T  219 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHH-------HhhcccCC---------C
Confidence            4689999999999999999999999999999999999999865221110 00000       00000000         0


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                      .+..++.++.+++.+||+.||++||     ++.|++++
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            1234577899999999999999999     67777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.4e-35  Score=323.35  Aligned_cols=258  Identities=21%  Similarity=0.377  Sum_probs=206.4

Q ss_pred             HhccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeecCC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNHN  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  733 (952)
                      ..++|.+.+.||+|+||.||+|..      .++..||||+++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            345799999999999999999974      235689999886543 33346789999999999 7999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                      ..++||||+++|+|.+++..... .+++.++..++.|++.|++||   |+++|+||||||+||+++.++.++++|||+++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999999875432 389999999999999999999   78999999999999999999999999999998


Q ss_pred             ccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          813 LLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       813 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      ........ ......++..|+|||.+.+..++.++||||+||++|||++ |..||......+ .+.           ...
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~-----------~~~  257 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFY-----------KLI  257 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHH-----------HHH
Confidence            65433221 1222346778999999988889999999999999999998 999986532211 111           111


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      +.....       ..+...+.++.+++.+||+.+|++||++.|+++.|++.
T Consensus       258 ~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         258 KEGYRM-------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HcCCcC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            111000       01123456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.2e-36  Score=329.39  Aligned_cols=240  Identities=20%  Similarity=0.297  Sum_probs=192.0

Q ss_pred             ceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||.||+|++. +|+.||+|+++...   ......+..|..++... +||+|+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999885 68999999986542   22345567788888765 899999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|..++.... .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++...... .....
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~  155 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFL---HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST  155 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence            99998886643 689999999999999999999   78999999999999999999999999999987532211 12233


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||.....  .   ...        +.+....        ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~---~~~--------~~~~~~~--------~~  214 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--D---ELF--------ESIRVDT--------PH  214 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--H---HHH--------HHHHhCC--------CC
Confidence            5689999999999988999999999999999999999999864211  0   000        0000000        01


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCCCHH-HHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRVNTK-EII  935 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~  935 (952)
                      .+..++.++.+++.+||+.||++||++. ++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            1223567789999999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.8e-36  Score=317.50  Aligned_cols=246  Identities=23%  Similarity=0.399  Sum_probs=197.8

Q ss_pred             eecCccceEEEEEEe---CCCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCC
Q 002214          671 LIGIGSYGSVYKGRF---PDGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKG  745 (952)
Q Consensus       671 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  745 (952)
                      .||+|+||.||+|.+   +++..||+|+++....  ...+.+.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999975   3578999999864432  235678899999999999999999998864 4678999999999


Q ss_pred             ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc--cc
Q 002214          746 SLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK--QT  823 (952)
Q Consensus       746 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~~  823 (952)
                      +|.+++.... .+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++.........  ..
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYL---EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999987544 689999999999999999999   78999999999999999999999999999998765433211  12


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...+++.|+|||.+....++.++|||||||++|||++ |..||......  ....           .+.....       
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~-----------~i~~~~~-------  216 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQ-----------MIESGER-------  216 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH-----------HHHCCCC-------
Confidence            2334678999999888888999999999999999998 99998653221  1111           1111110       


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      ...+..++.++.+++.+||++||++||++++|++.|+++
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            011234678899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=9.4e-36  Score=321.70  Aligned_cols=260  Identities=21%  Similarity=0.361  Sum_probs=209.1

Q ss_pred             HhccCCccceecCccceEEEEEEeCC-----CcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeec-CCe
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPD-----GIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTN-HNF  734 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  734 (952)
                      ..++|.+.+.||+|+||.||+|.+.+     +..||+|++.... ....+.+.+|+.++++++|||++++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35678999999999999999998755     7889999886443 3345678899999999999999999998766 467


Q ss_pred             eEEEEEccCCCChhHHhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEec
Q 002214          735 KALVLEYMPKGSLEDCMYASN-------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSD  807 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~D  807 (952)
                      .++++||+++|+|.+++....       ..+++.++..++.|++.|++||   |+++++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL---HKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999986532       3588999999999999999999   789999999999999999999999999


Q ss_pred             cccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhh
Q 002214          808 FGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPA  885 (952)
Q Consensus       808 fgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  885 (952)
                      ||+++.+....... .....++..|+|||++.+..++.++|||||||++||+++ |+.||.....  .....+...    
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~----  234 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKD----  234 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHc----
Confidence            99998664333211 112345678999999988889999999999999999999 9999865211  111111111    


Q ss_pred             hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          886 VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                             ...       ...+..+++++.+++.+||+.||++|||+.|+++.|+.+.++
T Consensus       235 -------~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         235 -------GYR-------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             -------CCC-------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                   000       001223567899999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.4e-35  Score=319.23  Aligned_cols=246  Identities=24%  Similarity=0.329  Sum_probs=194.2

Q ss_pred             ecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCCh
Q 002214          672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL  747 (952)
Q Consensus       672 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  747 (952)
                      ||+|+||.||+++.+ +|+.||+|.+....   ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999874 68999999985422   12234566799999999999999999999999999999999999999


Q ss_pred             hHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccccc
Q 002214          748 EDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL  826 (952)
Q Consensus       748 ~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  826 (952)
                      .+.+.... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHL---HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence            98876533 3689999999999999999999   78999999999999999999999999999998664322  223356


Q ss_pred             cccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhh
Q 002214          827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAK  906 (952)
Q Consensus       827 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  906 (952)
                      +++.|+|||++.+..++.++||||+||++|||++|+.||....... .......       ........        ...
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~-------~~~~~~~~--------~~~  219 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKR-------RTLEDEVK--------FEH  219 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHH-------Hhhccccc--------ccc
Confidence            8999999999988889999999999999999999999986532111 1111100       00000000        011


Q ss_pred             hhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          907 QSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       907 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      ..++.++.+++.+||+.||++||+++|+++..
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            23567799999999999999999997765433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-35  Score=329.27  Aligned_cols=259  Identities=21%  Similarity=0.387  Sum_probs=202.8

Q ss_pred             hccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeecC-C
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNH-N  733 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  733 (952)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            45799999999999999999974      357899999986543 23345688999999999 689999999988654 5


Q ss_pred             eeEEEEEccCCCChhHHhhhcC----------------------------------------------------------
Q 002214          734 FKALVLEYMPKGSLEDCMYASN----------------------------------------------------------  755 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  755 (952)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999886421                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc-ccccccc
Q 002214          756 --------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQTQTL  826 (952)
Q Consensus       756 --------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~  826 (952)
                              ..+++.++..++.|+++|++||   |++||+||||||+||++++++.+||+|||++........ .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    1367888899999999999999   799999999999999999999999999999986533222 1122234


Q ss_pred             cccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHh
Q 002214          827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVA  905 (952)
Q Consensus       827 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  905 (952)
                      ++..|+|||...+..++.++||||||+++|||++ |..||........ .           ...+......       ..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~-----------~~~~~~~~~~-------~~  303 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-F-----------CRRLKEGTRM-------RA  303 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-H-----------HHHHhccCCC-------CC
Confidence            5678999999888889999999999999999997 8888854321110 0           0011111000       01


Q ss_pred             hhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          906 KQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       906 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                      +..+++++.+++..||+.+|++||++.|++++|+.+.+
T Consensus       304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            12245678999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-36  Score=324.01  Aligned_cols=261  Identities=24%  Similarity=0.376  Sum_probs=200.7

Q ss_pred             hccCCccceecCccceEEEEEEeCC---------------CcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD---------------GIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKII  726 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  726 (952)
                      .++|++.+.||+|+||.||+++...               ...||+|.++... ......+.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578999999999999999987532               2358999987543 23345788999999999999999999


Q ss_pred             eEeecCCeeEEEEEccCCCChhHHhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCe
Q 002214          727 SSCTNHNFKALVLEYMPKGSLEDCMYASN-----------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNV  795 (952)
Q Consensus       727 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Ni  795 (952)
                      +++...+..++||||+++++|.+++....           ..+++..++.++.|++.|++||   |+.+++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH---HhcCeeccccChhhE
Confidence            99999999999999999999999886432           1368889999999999999999   789999999999999


Q ss_pred             eeCCCCcEEEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh--CCCCCCccccCc
Q 002214          796 LLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT--GMKPTNEFFTGE  872 (952)
Q Consensus       796 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~~~~  872 (952)
                      +++.++.+||+|||++.......... .....++..|+|||+...+.++.++|||||||++|||++  |..||..... +
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~  239 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-E  239 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-H
Confidence            99999999999999998654332211 122345778999999888889999999999999999998  5566654211 1


Q ss_pred             cchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          873 MSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                      ......        ....+......    ....+..++..+.+++.+||+.||++||++.+|++.|+
T Consensus       240 ~~~~~~--------~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 QVIENT--------GEFFRNQGRQI----YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHH--------HHhhhhccccc----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            101000        00000000000    00012235678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.5e-35  Score=319.81  Aligned_cols=258  Identities=23%  Similarity=0.404  Sum_probs=205.7

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCc----EEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGI----EVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      .++|++.+.||+|+||+||+|++ .+|+    .||+|++.... ......+.+|+.+++.++|||++++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            45788899999999999999985 3444    58999986543 33456788999999999999999999998754 468


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      ++|||+++|+|.+++......+++..++.++.|+++|++||   |+++|+||||||+||+++.++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL---EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            99999999999999987666789999999999999999999   799999999999999999999999999999987643


Q ss_pred             cCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          817 EDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       817 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      .... ......+++.|+|||...+..++.++|||||||++||+++ |..||......  ....++.           ...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~-----------~~~  228 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLE-----------KGE  228 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH-----------CCC
Confidence            3221 1122335678999999988889999999999999999998 88998642211  1111111           000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      .       ...+..++.++.+++.+||+.||++||++.|+++.|+++.+.
T Consensus       229 ~-------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         229 R-------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             c-------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            0       001234567899999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.7e-35  Score=315.83  Aligned_cols=258  Identities=24%  Similarity=0.363  Sum_probs=209.1

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++..   .....+.+.+|++++++++|++++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999885 7999999988642   2233567899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          740 EYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       740 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      ||+++|+|.+++..   ....+++.++..++.|++.|++||   |+.||+||||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM---HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998864   234589999999999999999999   799999999999999999999999999999986543


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      ... ......+++.|+|||+..+..++.++|||||||++|+|++|+.||....   ....++..        .+......
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~--------~~~~~~~~  226 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCK--------KIEKCDYP  226 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHh--------hhhcCCCC
Confidence            222 1223458889999999988889999999999999999999999985422   11111110        00000000


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                      .      .....++.++.+++.+||..+|++||++.+|++.+++++
T Consensus       227 ~------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         227 P------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             C------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            0      011245678999999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=318.20  Aligned_cols=253  Identities=25%  Similarity=0.442  Sum_probs=200.9

Q ss_pred             CCccceecCccceEEEEEEeC----CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCe-----
Q 002214          666 FSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNF-----  734 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  734 (952)
                      |.+.+.||+|+||.||+|...    .+..||+|+++...  ......+.+|+.+++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567889999999999999863    24789999987543  2334678999999999999999999998866543     


Q ss_pred             -eEEEEEccCCCChhHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecc
Q 002214          735 -KALVLEYMPKGSLEDCMYAS-----NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDF  808 (952)
Q Consensus       735 -~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Df  808 (952)
                       .++||||+++|+|..++...     ...+++..+..++.|++.||+||   |+.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchheEEECCCCeEEECCc
Confidence             78999999999999887542     23589999999999999999999   7899999999999999999999999999


Q ss_pred             ccccccCCcCcccc-cccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhh
Q 002214          809 GIAKLLSEEDSMKQ-TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAV  886 (952)
Q Consensus       809 gla~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  886 (952)
                      |+++.+........ ....++..|+|||++....++.++|||||||++|||++ |..||......  ...+.        
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~--------  227 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDY--------  227 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH--------
Confidence            99987654432221 12335678999999988889999999999999999999 88887542211  11110        


Q ss_pred             hhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       887 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                        ..+... .       ..+..++.++.+++.+||+.||++||++.|+++.|+++
T Consensus       228 --~~~~~~-~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         228 --LRHGNR-L-------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             --HHcCCC-C-------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              000000 0       01234677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.1e-36  Score=329.21  Aligned_cols=242  Identities=22%  Similarity=0.288  Sum_probs=195.7

Q ss_pred             ceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||+||+|++. +++.||||+++...   ......+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 58899999987542   23345677899999888 799999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|...+.... .+++..+..++.|++.||+||   |+++|+||||||+||++++++.+||+|||+++....... ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFL---HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST  155 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence            99998886553 689999999999999999999   799999999999999999999999999999975322221 1223


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||.....  .....          .......         .
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~----------~i~~~~~---------~  214 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQ----------SILEDEV---------R  214 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHH----------HHHcCCC---------C
Confidence            4689999999999999999999999999999999999999864211  10000          0000000         0


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRVNT-----KEIISR  937 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~~  937 (952)
                      .+..+++++.+++.+||+.||.+||++     .+++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            123356789999999999999999999     887764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2e-35  Score=314.73  Aligned_cols=249  Identities=26%  Similarity=0.372  Sum_probs=204.3

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|.+.+.||+|++|.||+|... +++.||+|.+...  .....+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999874 6899999998643  234456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+++... ...+++..+..++.|++.|++||   |++|++||||+|+||++++++.++|+|||+++........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL---HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999998764 45789999999999999999999   7899999999999999999999999999999876543222


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                       .....+++.|+|||+..+..++.++||||||+++|||++|+.||......+ ....           ... ....    
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~-----------~~~-~~~~----  219 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-LILK-----------IIR-GVFP----  219 (256)
T ss_pred             -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-----------HHc-CCCC----
Confidence             223458889999999998889999999999999999999999986532110 0000           000 0000    


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ..+..++.++.+++.+||+.+|++||++.+++++
T Consensus       220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 ---PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence               0112356779999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.1e-35  Score=320.99  Aligned_cols=253  Identities=26%  Similarity=0.454  Sum_probs=204.3

Q ss_pred             ccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .+|...++||+|+||.||+|..      .++..||+|.+..........+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            4677889999999999999964      2466899998876655556789999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcE
Q 002214          738 VLEYMPKGSLEDCMYASN--------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVA  803 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~  803 (952)
                      ||||+++|+|.+++....              ..+++..+..++.|++.|++||   |++|++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH---HHCCeecccccHhhEEEcCCCCE
Confidence            999999999999987543              2478999999999999999999   78999999999999999999999


Q ss_pred             EEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhcc
Q 002214          804 HLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIND  881 (952)
Q Consensus       804 kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  881 (952)
                      ||+|||++.......... .....+++.|+|||+..+..++.++|||||||++|||++ |..||......+  ..     
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~-----  234 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AI-----  234 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HH-----
Confidence            999999997654322211 122345788999999988899999999999999999998 888875422111  00     


Q ss_pred             chhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          882 SLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                           ........        ...+..++..+.+++.+||+.||++||++.||++.|+
T Consensus       235 -----~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 -----ECITQGRE--------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -----HHHHcCcc--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                 00000000        0112345778999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.5e-35  Score=318.10  Aligned_cols=255  Identities=25%  Similarity=0.457  Sum_probs=205.2

Q ss_pred             ccCCccceecCccceEEEEEEeCC-C---cEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPD-G---IEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ..|++.+.||+|+||.||+|.... +   ..||||++... .......|..|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457889999999999999998742 3   46999998654 333456899999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++++|.+++......+++.++..++.|++.|++||   |++|++||||||+||+++.++.+|++|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~l---H~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999999987666789999999999999999999   78999999999999999999999999999997654322


Q ss_pred             ccc-ccc---cccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          819 SMK-QTQ---TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       819 ~~~-~~~---~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      ... ...   ...+..|+|||++.+..++.++|||||||++||+++ |..||.....  .....++.           ..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~-----------~~  227 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIE-----------QD  227 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHH-----------cC
Confidence            111 111   112457999999988899999999999999999887 9999854211  11111110           00


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      .       ....+.+++..+.+++.+||..+|++||++.++++.|+++
T Consensus       228 ~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 Y-------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             C-------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0       0011234677899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.6e-36  Score=329.87  Aligned_cols=246  Identities=22%  Similarity=0.284  Sum_probs=196.8

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      +|.+.+.||+|+||.||+|+.. +++.||+|+++...   ......+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999875 57899999987542   22334567788888877 5899999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+.+.... .+++.++..++.|++.||+||   |++||+||||||+||++++++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-  155 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence            9999999998886554 689999999999999999999   78999999999999999999999999999997543222 


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....           +.....     
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~-----------i~~~~~-----  218 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQS-----------IMEHNV-----  218 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHHH-----------HHhCCC-----
Confidence            1223356899999999999999999999999999999999999998652111 01111           111000     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNT-----KEIIS  936 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~  936 (952)
                          ..+...+.++.+++.+|++.||++|++.     .++.+
T Consensus       219 ----~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         219 ----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             ----CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence                0123356778999999999999999985     55554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-35  Score=321.72  Aligned_cols=262  Identities=24%  Similarity=0.444  Sum_probs=208.7

Q ss_pred             HhccCCccceecCccceEEEEEEe--------CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeec
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF--------PDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTN  731 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  731 (952)
                      ..++|.+.+.||+|+||.||+|+.        .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            356788999999999999999974        134579999886443 33456789999999999 89999999999999


Q ss_pred             CCeeEEEEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCee
Q 002214          732 HNFKALVLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVL  796 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nil  796 (952)
                      .+..++||||+++|+|.+++....               ..+++.++..++.|+++|++||   |++||+||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH---HHCCeeecccccceEE
Confidence            999999999999999999987532               2478889999999999999999   7899999999999999


Q ss_pred             eCCCCcEEEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccc
Q 002214          797 LDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS  874 (952)
Q Consensus       797 l~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~  874 (952)
                      ++.++.+||+|||.++......... .....+++.|+|||++.+..++.++||||||+++||+++ |..||.....    
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----  245 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----  245 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----
Confidence            9999999999999998764332221 122345678999999988889999999999999999998 7788754211    


Q ss_pred             hhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHh
Q 002214          875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~  946 (952)
                       ..+.        +.+.....       ...+..++.++.+++.+||+.+|++||++.|+++.|+++...-.
T Consensus       246 -~~~~--------~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         246 -EELF--------KLLKEGHR-------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             -HHHH--------HHHHcCCc-------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence             1111        00100000       01123467789999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.8e-35  Score=317.30  Aligned_cols=256  Identities=24%  Similarity=0.472  Sum_probs=206.0

Q ss_pred             hccCCccceecCccceEEEEEEeC-CC---cEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DG---IEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|+..+.||+|+||.||+|+.. ++   ..||+|..+... ....+.+..|++++++++|||++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346788899999999999999874 23   379999886542 3345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++++|.+++......+++.++..++.|++.|++||   |+.|++||||||+||+++.++.+|++|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            9999999999999987666789999999999999999999   7899999999999999999999999999999866432


Q ss_pred             Cccccc--ccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          818 DSMKQT--QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       818 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ......  ....+..|+|||++....++.++|||||||++||+++ |+.||......  ....           .+....
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~-----------~i~~~~  227 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMK-----------AINDGF  227 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHH-----------HHhcCC
Confidence            221111  1223567999999988889999999999999999998 99998542111  1111           010000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      .       ...+..++.++.+++.+||..+|++||++.+|++.|+++
T Consensus       228 ~-------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 R-------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             C-------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0       001234567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.5e-35  Score=323.05  Aligned_cols=261  Identities=23%  Similarity=0.359  Sum_probs=204.0

Q ss_pred             hccCCccceecCccceEEEEEEeCC-----------------CcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccce
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD-----------------GIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVK  724 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~  724 (952)
                      ..+|++.+.||+|+||.||+|....                 +..||+|.+..... ...+.+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578999999999999999987632                 24689999875533 34567889999999999999999


Q ss_pred             eeeEeecCCeeEEEEEccCCCChhHHhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 002214          725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN----------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSN  794 (952)
Q Consensus       725 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~N  794 (952)
                      +++++..++..++||||+++++|.+++....          ..+++..++.++.|++.|++||   |+.||+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~L---H~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHH---HHcCccccccchhc
Confidence            9999999999999999999999999986543          2589999999999999999999   78999999999999


Q ss_pred             eeeCCCCcEEEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh--CCCCCCccccC
Q 002214          795 VLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT--GMKPTNEFFTG  871 (952)
Q Consensus       795 ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~~~  871 (952)
                      |+++.++.++|+|||+++......... .....+++.|+|||+.....++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            999999999999999998654333221 223456789999999888889999999999999999998  66777542211


Q ss_pred             ccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          872 EMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                      +  ..+..       ...+....    .......+..++.++.+++.+||+.||++|||+.||++.|+
T Consensus       241 ~--~~~~~-------~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q--VIENA-------GHFFRDDG----RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H--HHHHH-------Hhcccccc----ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            0  00000       00000000    00000012345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1e-35  Score=339.56  Aligned_cols=270  Identities=23%  Similarity=0.346  Sum_probs=197.5

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecC--------
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNH--------  732 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  732 (952)
                      ...+|.+.+.||+|+||.||+|.. .+++.||||++....    ....+|+.++++++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            346799999999999999999987 468999999875332    2345799999999999999998876432        


Q ss_pred             CeeEEEEEccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC-cEEEecc
Q 002214          733 NFKALVLEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-VAHLSDF  808 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~-~~kl~Df  808 (952)
                      ...++||||+++ ++.+++..   ....+++..+..++.|++.||+||   |++||+||||||+||+++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL---H~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI---HSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246789999975 67666643   344689999999999999999999   789999999999999999665 7999999


Q ss_pred             ccccccCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhh---hccchh
Q 002214          809 GIAKLLSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW---INDSLP  884 (952)
Q Consensus       809 gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~~~  884 (952)
                      |+|+.+....  ......+|+.|+|||++.+ ..++.++|||||||++|||++|..||......+ .+.+.   ......
T Consensus       216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCH
Confidence            9998664322  2223568999999998765 468999999999999999999999986532111 11111   111111


Q ss_pred             hhhhhcccccc------chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHH
Q 002214          885 AVMNIMDTNLL------SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR--LIKIR  942 (952)
Q Consensus       885 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~i~  942 (952)
                      +....+.+...      ..........+...++++.+++.+||..||.+|||+.|++++  +++++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence            11111110000      000111122334567889999999999999999999999855  44443

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-35  Score=319.13  Aligned_cols=267  Identities=22%  Similarity=0.401  Sum_probs=205.0

Q ss_pred             cCCccceecCccceEEEEEEe-----CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecC--CeeE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-----PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNH--NFKA  736 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  736 (952)
                      .|++.+.||+|+||.||+|+.     .++..||+|.++... ......+.+|+.++++++|||++++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            468889999999999999974     357889999986553 33346789999999999999999999998765  5688


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+++++|.+++......+++.++..++.|++.||+||   |++|++||||||+||+++.++.+||+|||+++....
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~l---H~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            99999999999999876655689999999999999999999   799999999999999999999999999999987643


Q ss_pred             cCcc--cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhh-hh-ccchhhhhhhccc
Q 002214          817 EDSM--KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR-WI-NDSLPAVMNIMDT  892 (952)
Q Consensus       817 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~  892 (952)
                      ....  ......++..|+|||+..+..++.++|||||||++||+++++.|+............ .. ..........+..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            3221  112244677899999988888999999999999999999987764321110000000 00 0000000111110


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      ..       ....+..++.++.+++.+||+.+|++||+++|+++.++++
T Consensus       242 ~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         242 GK-------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             Cc-------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00       0011234678899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.9e-35  Score=317.90  Aligned_cols=253  Identities=25%  Similarity=0.428  Sum_probs=198.0

Q ss_pred             CCccceecCccceEEEEEEeCC-Cc--EEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecC------Ce
Q 002214          666 FSEENLIGIGSYGSVYKGRFPD-GI--EVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNH------NF  734 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  734 (952)
                      |.+.+.||+|+||.||+|++.+ +.  .||+|.++..  .....+.+.+|+.++++++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567899999999999998754 33  6999988654  233456788999999999999999999987432      24


Q ss_pred             eEEEEEccCCCChhHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccc
Q 002214          735 KALVLEYMPKGSLEDCMYAS-----NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  809 (952)
                      .+++|||+++|+|.+++...     ...+++.....++.|++.|++||   |+++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887432     23588999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCcCcccc-cccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhh
Q 002214          810 IAKLLSEEDSMKQ-TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVM  887 (952)
Q Consensus       810 la~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  887 (952)
                      +++.+........ ....+++.|+|||+..+..++.++||||||+++|||++ |+.||......  .....+        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~--------  227 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYL--------  227 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH--------
Confidence            9987654332211 22346778999999998889999999999999999999 78888542111  110000        


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                        .....        ...+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       228 --~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         228 --RQGNR--------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --HcCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              00000        001234567799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=313.61  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=211.1

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .+-|...+.||+|.|..|-+|++ -+|..||||++...+  +-....+.+|++.|+-++|||||++|.+.......|+|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            34578889999999999999975 589999999996553  233467889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC-CCCcEEEeccccccccCCcC
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |.-++|+|.+++.++...+.+.-+.+++.||..|+.|+   |+-.+|||||||+||++- .-|-+|+.|||++-.+.++.
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YC---HqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYC---HQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHH---hhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            99999999999999888999999999999999999999   677899999999999885 67899999999998775543


Q ss_pred             cccccccccccccccccccCcCCcC-cccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVS-IKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                        .-+..+|+..|.|||++.+..|. +++||||+||++|-+++|+.||++....+.            +..+||      
T Consensus       174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------------LTmImD------  233 (864)
T KOG4717|consen  174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------------LTMIMD------  233 (864)
T ss_pred             --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh------------hhhhhc------
Confidence              33457899999999999988775 789999999999999999999987543321            111222      


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ..-..|...+.+.++||..|+..||.+|.+..||+.+
T Consensus       234 ---CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  234 ---CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ---ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence               1222455678899999999999999999999999764

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.5e-35  Score=321.73  Aligned_cols=259  Identities=25%  Similarity=0.443  Sum_probs=203.5

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCc--EEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGI--EVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|++.+.||+|+||.||+|.+. ++.  .+|+|.++... ......+.+|+.++.++ +||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            457888999999999999999874 454  45777765332 23446788999999999 89999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc
Q 002214          738 VLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV  802 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~  802 (952)
                      ||||+++|+|.+++....               ..+++.+++.++.|++.|++||   |++||+||||||+||++++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEecCCCc
Confidence            999999999999986532               2578999999999999999999   7999999999999999999999


Q ss_pred             EEEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhcc
Q 002214          803 AHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIND  881 (952)
Q Consensus       803 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  881 (952)
                      +||+|||++.....  ........++..|+|||+..+..++.++|||||||++|||+| |..||......  ...+    
T Consensus       163 ~kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~----  234 (303)
T cd05088         163 AKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYE----  234 (303)
T ss_pred             EEeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHH----
Confidence            99999999964321  111122234678999999888889999999999999999998 99998542111  0000    


Q ss_pred             chhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHh
Q 002214          882 SLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~  946 (952)
                             .+......       ..+..++.++.+++.+||+.+|++||++.++++.++++...-.
T Consensus       235 -------~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         235 -------KLPQGYRL-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             -------HHhcCCcC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence                   00000000       0112346678999999999999999999999999988765543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-35  Score=325.07  Aligned_cols=269  Identities=21%  Similarity=0.308  Sum_probs=202.0

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ++|.+.+.||+|+||.||+|+.+ +++.||+|.++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57899999999999999999874 688999999865432 2334678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++ +|.+.+......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++....... .
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  160 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T  160 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence            975 88888876666689999999999999999999   789999999999999999999999999999976533222 1


Q ss_pred             ccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCcc--chhhhhccchhhhhhhcc-------
Q 002214          822 QTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM--SIKRWINDSLPAVMNIMD-------  891 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~-------  891 (952)
                      .....+++.|+|||++.+ ..++.++||||+||++|||+||+.||......+.  ...+......+.....+.       
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            223457899999998754 4678999999999999999999999865322111  000000111111000000       


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .................+++++.+++.+|++.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            0000000000000112356788999999999999999999999873

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.9e-35  Score=317.04  Aligned_cols=256  Identities=25%  Similarity=0.400  Sum_probs=203.0

Q ss_pred             HHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      +.+++.+.....||+|+||.||+|.+ ++++.||+|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            34556666677899999999999986 46788999988766555567899999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-CCcEEEeccccccccC
Q 002214          739 LEYMPKGSLEDCMYASNFNL--DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-SMVAHLSDFGIAKLLS  815 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l--~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgla~~~~  815 (952)
                      +||+++++|.+++......+  ++..+..++.|++.|++||   |++||+||||||+||+++. ++.++|+|||.+....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL---HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999988654445  8888999999999999999   7899999999999999986 6799999999997654


Q ss_pred             CcCcccccccccccccccccccCcCC--cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQ--VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      .... ......+++.|+|||++....  ++.++||||||+++|+|++|+.||..........  +..            .
T Consensus       161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~~~------------~  225 (268)
T cd06624         161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--FKV------------G  225 (268)
T ss_pred             cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--hhh------------h
Confidence            3222 122245789999999876543  7889999999999999999999986532111100  000            0


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...    .....+..+++++.+++.+||+.+|++||++.|++++
T Consensus       226 ~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         226 MFK----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hhc----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            000    0001123456789999999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-36  Score=336.79  Aligned_cols=252  Identities=23%  Similarity=0.311  Sum_probs=197.9

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||+||+|.. .+++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688999999999999999987 478999999986432   233467889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+|+.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~L---H~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAV---HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999887543 688999999999999999999   799999999999999999999999999999964321100


Q ss_pred             c----------------------------------------------cccccccccccccccccCcCCcCcccchHhHHH
Q 002214          820 M----------------------------------------------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGI  853 (952)
Q Consensus       820 ~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~  853 (952)
                      .                                              .....+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0                                              001246899999999998888999999999999


Q ss_pred             HHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCC---CC
Q 002214          854 MLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR---VN  930 (952)
Q Consensus       854 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps  930 (952)
                      ++|||++|..||...... ..+.....        . ...+.  .+     ....++.++.+++.+|+. +|.+|   ++
T Consensus       237 il~elltG~~Pf~~~~~~-~~~~~i~~--------~-~~~~~--~p-----~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         237 IMFECLIGWPPFCSENSH-ETYRKIIN--------W-RETLY--FP-----DDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             hhhhhhcCCCCCCCCCHH-HHHHHHHc--------c-CCccC--CC-----CCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            999999999998642211 11111100        0 00000  00     011245678999999997 67765   59


Q ss_pred             HHHHHHH
Q 002214          931 TKEIISR  937 (952)
Q Consensus       931 ~~ev~~~  937 (952)
                      +.|++++
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9998876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-35  Score=321.58  Aligned_cols=250  Identities=26%  Similarity=0.378  Sum_probs=204.3

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .+|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|||++++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4788899999999999999986 468999999987665555677889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      ++++|.+++...  .+++.++..++.|++.|++||   |+.||+||||||+||+++.++.+||+|||++........ ..
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~L---H~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~  173 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  173 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-cc
Confidence            999999988643  478999999999999999999   789999999999999999999999999999986543221 12


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ ...+.....+        ..        
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~~~~--------~~--------  236 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP--------EL--------  236 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcCCCC--------CC--------
Confidence            234688999999999888889999999999999999999999865321110 0000000000        00        


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ..+...+..+.+++.+||..+|++||++.|++++
T Consensus       237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence             0112345678999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.2e-35  Score=321.99  Aligned_cols=260  Identities=20%  Similarity=0.382  Sum_probs=204.5

Q ss_pred             HHhccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCC
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHN  733 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  733 (952)
                      ...++|++.+.||+|+||.||+|..+      .+..||+|.+..... .....+.+|+.++++++||||+++++++.+.+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34678999999999999999999753      255899998764432 23356788999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEE
Q 002214          734 FKALVLEYMPKGSLEDCMYASN---------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH  804 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~k  804 (952)
                      ..++||||+++|+|.+++....         ...++..+..++.|++.|++||   |+++|+||||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL---NAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999986422         2356778899999999999999   799999999999999999999999


Q ss_pred             EeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccc
Q 002214          805 LSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDS  882 (952)
Q Consensus       805 l~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  882 (952)
                      ++|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||......  ...+     
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~-----  232 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLK-----  232 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH-----
Confidence            99999998654332221 122345778999999988889999999999999999999 77887542111  1111     


Q ss_pred             hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                           ...+....        ..+..+++++.+++.+|++.||++|||+.|+++.+++...
T Consensus       233 -----~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         233 -----FVMDGGYL--------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             -----HHHcCCCC--------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence                 01111110        0123346789999999999999999999999998887543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-35  Score=320.06  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=202.0

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      .|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+.+++.++|||++++++++..++..++||||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3677889999999999999885 578899999876655556778999999999999999999999999999999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +++|..++......+++..+..++.|+++||+||   |+.|++||||||+||+++.++.+|++|||++....... ....
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~L---H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~  161 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL---HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD  161 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence            9999998876556799999999999999999999   78999999999999999999999999999997653221 1222


Q ss_pred             ccccccccccccccC-----cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          824 QTLATIGYIAPEYGR-----EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      ...+++.|+|||++.     +..++.++|||||||++|||++|+.||......+ .........        ....    
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~--------~~~~----  228 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSE--------PPTL----  228 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcC--------CCCC----
Confidence            346889999999873     3457789999999999999999999986532111 000000000        0000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..+..++.++.+++.+||+.+|++||++.+++++
T Consensus       229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         229 -----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0122356789999999999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.4e-35  Score=319.33  Aligned_cols=252  Identities=24%  Similarity=0.340  Sum_probs=203.8

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      +.|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.+++.++|||++++++++..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            57889999999999999999884 58999999997766666678899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      ++++|..++......+++..+..++.|++.|++||   |+.+++||||||+||+++.++.+||+|||++...... ....
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~  167 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL---HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRR  167 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-cccc
Confidence            99999988876666789999999999999999999   7899999999999999999999999999998754322 1122


Q ss_pred             cccccccccccccccC-----cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          823 TQTLATIGYIAPEYGR-----EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      ....+++.|+|||++.     ...++.++|||||||++|||++|+.||...... ....++....        .+..   
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~--------~~~~---  235 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSE--------PPTL---  235 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcCC--------CccC---
Confidence            2345788999999874     345678999999999999999999998653211 0111110000        0000   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                            ..+..++.++.+++.+||+.+|++||++.|++++
T Consensus       236 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         236 ------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                  0122345678999999999999999999999863

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8e-36  Score=333.80  Aligned_cols=259  Identities=22%  Similarity=0.294  Sum_probs=202.4

Q ss_pred             HHHHHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCC
Q 002214          658 ELLRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHN  733 (952)
Q Consensus       658 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  733 (952)
                      ++....++|++.+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            33445678999999999999999999885 6889999998642   2223456788999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ..++||||+++|+|.+++...  .++...+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+.
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            999999999999999988654  478889999999999999999   799999999999999999999999999999987


Q ss_pred             cCCcCcccccccccccccccccccCcC----CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhh
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGREG----QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNI  889 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  889 (952)
                      .............||+.|+|||++...    .++.++|||||||++|||++|+.||..... ...+..           +
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~-----------i  259 (371)
T cd05622         192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSK-----------I  259 (371)
T ss_pred             cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-HHHHHH-----------H
Confidence            654333333346799999999987653    378899999999999999999999864211 001111           1


Q ss_pred             ccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCC--CCCHHHHHHHH
Q 002214          890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPEN--RVNTKEIISRL  938 (952)
Q Consensus       890 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~L  938 (952)
                      +...-....     .....++.++.+++..|+..++.+  ||++.|+.++.
T Consensus       260 ~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         260 MNHKNSLTF-----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HcCCCcccC-----CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            100000000     011235677899999999844433  77999998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.4e-35  Score=312.88  Aligned_cols=251  Identities=25%  Similarity=0.450  Sum_probs=204.0

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|.++.... ....+.+|++++++++||+++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46788899999999999999987788999998864332 23578899999999999999999999999999999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +++|.+++......+++..+..++.|++.|++||   |+.+++||||||+||+++.++.+||+|||.++...........
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence            9999999887666789999999999999999999   7899999999999999999999999999999865433222222


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...++.+|+|||+..++.++.++||||||+++||+++ |..||......     ....    ...    ....       
T Consensus       160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~----~~~----~~~~-------  219 (256)
T cd05112         160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVE----TIN----AGFR-------  219 (256)
T ss_pred             CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHH----HHh----CCCC-------
Confidence            2345678999999988889999999999999999998 89998642211     1100    000    0000       


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      ...+...++++.+++.+||+.+|++||++.|++++|
T Consensus       220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            001122467799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-35  Score=312.18  Aligned_cols=250  Identities=31%  Similarity=0.517  Sum_probs=206.0

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .++|++.+.||+|+||.||+|.. .|+.||+|.++.... ..+++.+|+.++++++|+|++++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            45788899999999999999987 488999999875544 4578899999999999999999999999889999999999


Q ss_pred             CCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          743 PKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       743 ~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      ++++|.+++..... .+++..+..++.|++.|++||   |++|++||||||+||+++.++.+||+|||.++.......  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            99999999876542 689999999999999999999   799999999999999999999999999999987632221  


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                        ....+..|+|||++.++.++.++||||||+++||+++ |..||......+  .           ...+......    
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~-----------~~~~~~~~~~----  218 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--V-----------VPHVEKGYRM----  218 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--H-----------HHHHhcCCCC----
Confidence              2335678999999988889999999999999999998 999986431111  0           0000000000    


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                         ..+..+++++.+++.+||..+|++||++.|+++.|+++
T Consensus       219 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         219 ---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence               01233577899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.5e-36  Score=338.12  Aligned_cols=251  Identities=23%  Similarity=0.301  Sum_probs=197.5

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      +|++.+.||+|+||.||+|+. .+++.||||++....   ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            688999999999999999987 468999999986432   2234568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC--
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED--  818 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~--  818 (952)
                      |+++|+|.+++...+ .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|..+....  
T Consensus        82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            999999999987654 578889999999999999999   78999999999999999999999999999985321000  


Q ss_pred             ----------------------------------------cccccccccccccccccccCcCCcCcccchHhHHHHHHHH
Q 002214          819 ----------------------------------------SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEV  858 (952)
Q Consensus       819 ----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el  858 (952)
                                                              ........||+.|+|||++.+..++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                    0001124689999999999988999999999999999999


Q ss_pred             HhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCC---CHHHHH
Q 002214          859 FTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRV---NTKEII  935 (952)
Q Consensus       859 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ev~  935 (952)
                      ++|+.||......+. .....        . ......  .     .....++.++.+++.+|+ .+|.+|+   ++.|++
T Consensus       238 l~G~~Pf~~~~~~~~-~~~i~--------~-~~~~~~--~-----~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell  299 (376)
T cd05598         238 LVGQPPFLADTPAET-QLKVI--------N-WETTLH--I-----PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK  299 (376)
T ss_pred             hhCCCCCCCCCHHHH-HHHHh--------c-cCcccc--C-----CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence            999999865321110 00000        0 000000  0     001234667888898876 4999999   899998


Q ss_pred             HH
Q 002214          936 SR  937 (952)
Q Consensus       936 ~~  937 (952)
                      ++
T Consensus       300 ~h  301 (376)
T cd05598         300 AH  301 (376)
T ss_pred             CC
Confidence            76

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-35  Score=318.07  Aligned_cols=238  Identities=22%  Similarity=0.398  Sum_probs=189.0

Q ss_pred             eecCccceEEEEEEeC-------------------------CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCcccee
Q 002214          671 LIGIGSYGSVYKGRFP-------------------------DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI  725 (952)
Q Consensus       671 ~lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  725 (952)
                      .||+|+||.||+|...                         ....||+|++..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999999741                         123589998865544445678899999999999999999


Q ss_pred             eeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC----
Q 002214          726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM----  801 (952)
Q Consensus       726 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~----  801 (952)
                      ++++.+....++||||+++|+|..++......+++..+..++.|+++||+||   |+++|+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYL---EDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999877666789999999999999999999   789999999999999997643    


Q ss_pred             ---cEEEeccccccccCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHH-hCCCCCCccccCccchh
Q 002214          802 ---VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVF-TGMKPTNEFFTGEMSIK  876 (952)
Q Consensus       802 ---~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~-tg~~p~~~~~~~~~~~~  876 (952)
                         .+|++|||.+......     ....++..|+|||.+.+ ..++.++|||||||++||++ +|..||......+  ..
T Consensus       159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~  231 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--KE  231 (274)
T ss_pred             ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--HH
Confidence               4899999998644221     22347788999998765 56889999999999999995 6888886532111  01


Q ss_pred             hhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      .+           .....         ..+....+++.+++.+||+.+|++||++.+|++.|
T Consensus       232 ~~-----------~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         232 RF-----------YEKKH---------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HH-----------HHhcc---------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            11           00000         01112245689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2e-35  Score=321.74  Aligned_cols=262  Identities=21%  Similarity=0.375  Sum_probs=202.5

Q ss_pred             hccCCccceecCccceEEEEEEeC-----------------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccce
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-----------------DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVK  724 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  724 (952)
                      .++|++.+.||+|+||.||++...                 ++..||+|+++... ......+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356899999999999999998532                 24469999987543 334467899999999999999999


Q ss_pred             eeeEeecCCeeEEEEEccCCCChhHHhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 002214          725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN----------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSN  794 (952)
Q Consensus       725 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~N  794 (952)
                      +++++...+..++||||+++|+|.+++....          ..+++.++..++.|++.|++||   |++|++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCeecccCChhe
Confidence            9999999999999999999999999886532          2367889999999999999999   78999999999999


Q ss_pred             eeeCCCCcEEEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh--CCCCCCccccC
Q 002214          795 VLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT--GMKPTNEFFTG  871 (952)
Q Consensus       795 ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~~~  871 (952)
                      |+++.++.++|+|||+++.+....... .....+++.|+|||....+.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999998664332221 122345678999998888889999999999999999998  67787542111


Q ss_pred             ccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          872 EMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                           +++....    ..+.......    ....+..++..+.+++.+||+.||++||++.||++.|++
T Consensus       241 -----~~~~~~~----~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 -----QVIENTG----EFFRDQGRQV----YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             -----HHHHHHH----HHHhhccccc----cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                 1111000    0000000000    000123456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.5e-38  Score=338.55  Aligned_cols=371  Identities=29%  Similarity=0.419  Sum_probs=268.5

Q ss_pred             CeEEEEEecCCCCc-ccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEe
Q 002214           33 NRVTSLTISDLGLA-GTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLV  111 (952)
Q Consensus        33 ~~~~~l~l~~~~~~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  111 (952)
                      +-|+.+|+++|++. +..|.+...++.++.|.|.+.++. .+|+.++.+.+|++|.+++|++. .+-+.++.|+.|+.++
T Consensus         7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~   84 (1255)
T KOG0444|consen    7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI   84 (1255)
T ss_pred             ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence            56889999999998 578999999999999999999998 89999999999999999999998 6778889999999999


Q ss_pred             ecCccCc-cccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCc
Q 002214          112 LNNNLLT-GTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQ  190 (952)
Q Consensus       112 L~~n~l~-~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~  190 (952)
                      +.+|++. +-+|..++.                          +..|+.||||+|+++ ..|..+...+++-.|+||+|+
T Consensus        85 ~R~N~LKnsGiP~diF~--------------------------l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~  137 (1255)
T KOG0444|consen   85 VRDNNLKNSGIPTDIFR--------------------------LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNN  137 (1255)
T ss_pred             hhccccccCCCCchhcc--------------------------cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCc
Confidence            9999887 235555553                          457888888888888 789999999999999999999


Q ss_pred             ccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCC
Q 002214          191 FTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSS  270 (952)
Q Consensus       191 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  270 (952)
                      |..+.-..|.+++.|-.||||+|++. .+|..+..|.+|++|.|++|.+..+--..+-.+++|+.|.+++.+-+-     
T Consensus       138 IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl-----  211 (1255)
T KOG0444|consen  138 IETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTL-----  211 (1255)
T ss_pred             cccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchh-----
Confidence            98655556789999999999999998 677778888888888888876655432223333344444444332210     


Q ss_pred             cccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCC
Q 002214          271 KNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLI  350 (952)
Q Consensus       271 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~  350 (952)
                                          ..+|.                                                 .+..+.
T Consensus       212 --------------------~N~Pt-------------------------------------------------sld~l~  222 (1255)
T KOG0444|consen  212 --------------------DNIPT-------------------------------------------------SLDDLH  222 (1255)
T ss_pred             --------------------hcCCC-------------------------------------------------chhhhh
Confidence                                01111                                                 123455


Q ss_pred             cccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEecc
Q 002214          351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLS  430 (952)
Q Consensus       351 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  430 (952)
                      +|..++++.|.+. .+|+.+.++++|+.|+||+|+|+.. .-.                        .+.-.+|++|+||
T Consensus       223 NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL-~~~------------------------~~~W~~lEtLNlS  276 (1255)
T KOG0444|consen  223 NLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITEL-NMT------------------------EGEWENLETLNLS  276 (1255)
T ss_pred             hhhhccccccCCC-cchHHHhhhhhhheeccCcCceeee-ecc------------------------HHHHhhhhhhccc
Confidence            6677777777777 6777777777777777777777632 112                        2223345555555


Q ss_pred             ccccCCcCCccccCCCCCceeEecCCccCC-CCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCc
Q 002214          431 SNELTSVIPSTFWNLEDILGFDFSSNSLNG-SLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGP  509 (952)
Q Consensus       431 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  509 (952)
                      .|+++ ..|++++.+++|+.|.+.+|+++- -+|..++.+.+|+.+..++|.+. ..|..+..+.+|+.|.|++|++. +
T Consensus       277 rNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-T  353 (1255)
T KOG0444|consen  277 RNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-T  353 (1255)
T ss_pred             cchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-e
Confidence            55554 344455555555555555555431 36777777888888888888887 77888888888888888888887 6


Q ss_pred             ccccccccccccEEeCCCCcccccCcc
Q 002214          510 IPESFGELVSLEFLDLSNNDLSGVIPA  536 (952)
Q Consensus       510 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~  536 (952)
                      +|+++.-++.|+.|||.+|.--..+|.
T Consensus       354 LPeaIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  354 LPEAIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             chhhhhhcCCcceeeccCCcCccCCCC
Confidence            788888888888888888865434443

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.6e-35  Score=323.20  Aligned_cols=193  Identities=22%  Similarity=0.315  Sum_probs=159.1

Q ss_pred             cceecCccceEEEEEEeC---CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeec--CCeeEEEEEccC
Q 002214          669 ENLIGIGSYGSVYKGRFP---DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN--HNFKALVLEYMP  743 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  743 (952)
                      +++||+|+||+||+|+..   +++.||+|.+....  ....+.+|+.++++++||||+++++++..  +...++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   56889999886432  23457889999999999999999998854  456889999995


Q ss_pred             CCChhHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee----CCCCcEEEeccccc
Q 002214          744 KGSLEDCMYAS--------NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIA  811 (952)
Q Consensus       744 ~g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill----~~~~~~kl~Dfgla  811 (952)
                       ++|.+++...        ...+++..+..++.|++.||+||   |++||+||||||+||++    +.++.+||+|||+|
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5787776532        12588899999999999999999   79999999999999999    46689999999999


Q ss_pred             cccCCcCc--ccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002214          812 KLLSEEDS--MKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNE  867 (952)
Q Consensus       812 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~  867 (952)
                      +.......  .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            87643221  12234568999999998876 4588999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.2e-35  Score=312.12  Aligned_cols=249  Identities=29%  Similarity=0.444  Sum_probs=201.1

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEee-cCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT-NHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~  741 (952)
                      ..+|.+.+.||+|+||.||+|.. .|+.||+|..+...  ..+.+.+|+.++++++|++++++++++. .+...++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            34788899999999999999987 57889999886433  2467889999999999999999999764 45678999999


Q ss_pred             cCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+++..... .+++..+..++.|++.|++||   |++|++||||||+||+++.++.+|++|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999999876443 488999999999999999999   79999999999999999999999999999998643322  


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        ....++..|+|||+..+..++.++|||||||++|||++ |+.||.....  ......+           ....     
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~-----------~~~~-----  216 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRV-----------EKGY-----  216 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH-----------hcCC-----
Confidence              22335678999999988889999999999999999998 9998754211  0011100           0000     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                        ....+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 --KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence              0011234577899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-35  Score=328.52  Aligned_cols=255  Identities=19%  Similarity=0.260  Sum_probs=200.1

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||+||+++.+ +++.||+|++...   .......+.+|..++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46889999999999999999875 5788999998542   1223345788999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++......+++..+..++.|++.|++||   |+++|+||||||+||+++.++.+||+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~l---H~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            99999999999987656789999999999999999999   789999999999999999999999999999976543333


Q ss_pred             ccccccccccccccccccC-----cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          820 MKQTQTLATIGYIAPEYGR-----EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...... ..+.+           +.....
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-~~~~~-----------i~~~~~  225 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGK-----------IMNHKE  225 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-HHHHH-----------HhCCCc
Confidence            2333356999999999875     346788999999999999999999998642110 01111           111000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPEN--RVNTKEIISR  937 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~  937 (952)
                      ...    .......+++++.+++.+|+..+|.+  |+++.|++++
T Consensus       226 ~~~----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 RFQ----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ccc----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            000    00011235778899999988655544  7899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=9.5e-36  Score=336.04  Aligned_cols=251  Identities=23%  Similarity=0.315  Sum_probs=195.8

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .|...+.||+|+||+||+|+. .+++.||+|++....   ......+.+|++++++++||||+++++.+.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999987 468899999986432   2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC--
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED--  818 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~--  818 (952)
                      |+++|+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+|||++.++.+||+|||+|.......  
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~l---H~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999887653 688899999999999999999   78999999999999999999999999999985321000  


Q ss_pred             --------------------------------------------cccccccccccccccccccCcCCcCcccchHhHHHH
Q 002214          819 --------------------------------------------SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIM  854 (952)
Q Consensus       819 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~  854 (952)
                                                                  .......+||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000112368999999999998899999999999999


Q ss_pred             HHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCC---H
Q 002214          855 LMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN---T  931 (952)
Q Consensus       855 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~  931 (952)
                      +|||++|+.||......+ ......        .. .....  .     ......++++.+++.+++ .+|++|++   +
T Consensus       238 l~elltG~~Pf~~~~~~~-~~~~i~--------~~-~~~~~--~-----p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLE-TQMKVI--------NW-QTSLH--I-----PPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             HHHHHhCCCCCCCCCHHH-HHHHHH--------cc-CCCcC--C-----CCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            999999999986521111 000000        00 00000  0     001224567788888876 59999997   8


Q ss_pred             HHHHHH
Q 002214          932 KEIISR  937 (952)
Q Consensus       932 ~ev~~~  937 (952)
                      .|++++
T Consensus       300 ~ei~~h  305 (382)
T cd05625         300 DEIKAH  305 (382)
T ss_pred             HHHhcC
Confidence            887764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.8e-35  Score=314.17  Aligned_cols=254  Identities=25%  Similarity=0.456  Sum_probs=205.3

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..++|++.+.||+|+||.||+|.+.++..||+|.+.... ...+.+.+|+.++++++|+|++++++++.+ ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            356789999999999999999998778889999886433 234678899999999999999999999887 678999999


Q ss_pred             cCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+++... ....++..+..++.|++.|++||   |+.|++||||+|+||+++.++.+||+|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            9999999998763 34578899999999999999999   7899999999999999999999999999999866433322


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                      ......++..|+|||++..+.++.++|||||||++|++++ |+.||.....  ........           .....   
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~-----------~~~~~---  222 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALE-----------RGYRM---  222 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHh-----------CCCCC---
Confidence            2223346678999999988889999999999999999999 8999864211  11111111           00000   


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                          ..+...+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                0112346679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.3e-35  Score=328.89  Aligned_cols=267  Identities=21%  Similarity=0.247  Sum_probs=197.9

Q ss_pred             HHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCC----
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHN----  733 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  733 (952)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||||++...  .......+.+|+.+++.++||||+++++++...+    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            3457899999999999999999987 46899999998643  2333467889999999999999999999886543    


Q ss_pred             --eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccc
Q 002214          734 --FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA  811 (952)
Q Consensus       734 --~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  811 (952)
                        ..|+||||+++ ++.+.+..   .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~L---H~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence              47999999965 56555532   478889999999999999999   7999999999999999999999999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cch-----
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSL-----  883 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~-----  883 (952)
                      +......  ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||...... ..+....+   ...     
T Consensus       171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHHHH
Confidence            7643221  223356899999999999889999999999999999999999999653211 01111000   000     


Q ss_pred             ---hhhhhhcccccc-chhh------HH----HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          884 ---PAVMNIMDTNLL-SEDE------EH----ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       884 ---~~~~~~~~~~~~-~~~~------~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ............ ....      .+    ........+.++.+++.+||..||++|||+.|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence               000000000000 0000      00    000011235678999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.5e-35  Score=322.41  Aligned_cols=261  Identities=24%  Similarity=0.435  Sum_probs=207.0

Q ss_pred             HhccCCccceecCccceEEEEEEeC--------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeec
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP--------DGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTN  731 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  731 (952)
                      ..++|.+.+.||+|+||.||+|+..        .+..||+|.++... ......+.+|+.+++++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3467889999999999999999742        24579999886443 23456788999999999 69999999999999


Q ss_pred             CCeeEEEEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCee
Q 002214          732 HNFKALVLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVL  796 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nil  796 (952)
                      .+..++||||+++|+|.+++....               ..+++.++..++.|++.|++||   |++|++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH---HHCCeeeccccceeEE
Confidence            999999999999999999986532               2488999999999999999999   7899999999999999


Q ss_pred             eCCCCcEEEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccc
Q 002214          797 LDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS  874 (952)
Q Consensus       797 l~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~  874 (952)
                      ++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......  .
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~  244 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--E  244 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence            9999999999999998664322211 111234568999999988889999999999999999999 88887542111  0


Q ss_pred             hhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                      ...           .+....       ....+..++.++.+++.+||+.+|++||++.|+++.|+++....
T Consensus       245 ~~~-----------~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         245 LFK-----------LLREGH-------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             HHH-----------HHHcCC-------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            110           000000       00112345678999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.7e-36  Score=330.69  Aligned_cols=238  Identities=25%  Similarity=0.326  Sum_probs=193.0

Q ss_pred             ceecCccceEEEEEEe----CCCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          670 NLIGIGSYGSVYKGRF----PDGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    3689999999875432  233567789999999999999999999999999999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +|+|.+++.... .+++..+..++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++...... ....
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~  156 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY  156 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence            999999886543 689999999999999999999   78999999999999999999999999999998654321 1223


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN  903 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (952)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ....           .......         
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~-----------~i~~~~~---------  215 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-ETMT-----------MILKAKL---------  215 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-HHHH-----------HHHcCCC---------
Confidence            356899999999998888899999999999999999999998642110 0000           0000000         


Q ss_pred             HhhhhhHHHHHHHHhhccccCCCCCCCHHH
Q 002214          904 VAKQSCASSVLSLAMECTSESPENRVNTKE  933 (952)
Q Consensus       904 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  933 (952)
                      ..+..+++++.+++.+||+.||++||++.+
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            012345677899999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-35  Score=328.29  Aligned_cols=255  Identities=20%  Similarity=0.261  Sum_probs=200.3

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|.+.+.||+|+||+||+++.. +++.||+|++...   .......+.+|..++..++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999874 6889999998642   2223455788999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~l---H~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI---HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999999999987656789999999999999999999   799999999999999999999999999999987654433


Q ss_pred             ccccccccccccccccccCc-----CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          820 MKQTQTLATIGYIAPEYGRE-----GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      .......|++.|+|||++.+     +.++.++|||||||++|||++|+.||......+ .+.           .+.....
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~-----------~i~~~~~  225 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYG-----------KIMNHEE  225 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-HHH-----------HHHcCCC
Confidence            33333569999999998765     467889999999999999999999986421100 011           1111000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPEN--RVNTKEIISR  937 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~  937 (952)
                      ....+    .....++.++.+++.+|+..++++  |++++++.++
T Consensus       226 ~~~~p----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         226 RFQFP----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cccCC----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            00000    001234677899999999866554  5688888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.3e-35  Score=313.29  Aligned_cols=251  Identities=25%  Similarity=0.473  Sum_probs=195.6

Q ss_pred             ceecCccceEEEEEEeC----CCcEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEee-cCCeeEEEEEccC
Q 002214          670 NLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCT-NHNFKALVLEYMP  743 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  743 (952)
                      +.||+|+||.||+|.+.    ++..||+|.+... .....+.+.+|+.+++.++|||++++++++. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863    3467999988543 2334567889999999999999999999775 4566899999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc---
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM---  820 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~---  820 (952)
                      +|+|.+++.......++..+..++.|++.|++||   |+.+++||||||+||++++++.+||+|||+++.+......   
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            9999999987665678888899999999999999   7899999999999999999999999999999865432211   


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCC-CCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGM-KPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                      ......++..|+|||+..+..++.++|||||||++|||++|. .||.....  ......          ......     
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~----------~~~~~~-----  220 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVY----------LLQGRR-----  220 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH----------HhcCCC-----
Confidence            111234677899999988888999999999999999999964 45533111  001100          000000     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                         ...+..++..+.+++.+||..+|++||++.|+++.|+++..
T Consensus       221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence               00122346779999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.2e-35  Score=316.49  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=202.4

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|.+.+.||+|+||.||+|+. .+++.||+|+++.........+.+|+.+++.++|||++++++++...+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            34788889999999999999987 46899999998766555556788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++++|.+++...+ .+++.+...++.|++.|++||   |+.|++|+||||+||+++.++.+||+|||++....... ..
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~  162 (267)
T cd06645          88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYL---HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK  162 (267)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence            99999999886544 689999999999999999999   78899999999999999999999999999997654321 12


Q ss_pred             ccccccccccccccccC---cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          822 QTQTLATIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      .....|+..|+|||++.   ...++.++||||+||++|||++|+.||.......... ....           .......
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-~~~~-----------~~~~~~~  230 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMTK-----------SNFQPPK  230 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-hhhc-----------cCCCCCc
Confidence            23356899999999874   4568889999999999999999999985432211100 0000           0000000


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .    .....++..+.+++.+||..+|++||++++++++
T Consensus       231 ~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         231 L----KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             c----cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            0    0011245678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=319.04  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=206.2

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|.+.+.||.|+||.||+|.+. +++.||+|+++.......+.+.+|+.++++++|||++++++++..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456889999999999999999874 6899999999776666667889999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++++|.+++......+++..+..++.|++.|++||   |+.+|+||||+|+||+++.++.++|+|||++........ .
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~  159 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL---HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K  159 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence            999999999887666799999999999999999999   789999999999999999999999999999876533221 2


Q ss_pred             ccccccccccccccccC-----cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          822 QTQTLATIGYIAPEYGR-----EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      .....+++.|+|||.+.     ...++.++||||||+++|||++|+.||...... .....+.....        +..  
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--------~~~--  228 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKSEP--------PTL--  228 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcCCC--------CCc--
Confidence            22346889999999864     345678999999999999999999998653211 11111100000        000  


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                             ..+..++.++.+++.+||+.+|++||++.+++++
T Consensus       229 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         229 -------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                   0123356779999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-35  Score=327.57  Aligned_cols=237  Identities=28%  Similarity=0.338  Sum_probs=188.5

Q ss_pred             ceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHH-HHHhCCCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECE-ILKTIRHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||+||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999884 68999999986432   222344555544 56789999999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|..++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTST  155 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cccc
Confidence            99998887543 689999999999999999999   789999999999999999999999999999975432221 2233


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....       ........         .
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~-------~~i~~~~~---------~  214 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMY-------DNILNKPL---------R  214 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHH-------HHHHcCCC---------C
Confidence            5689999999999988999999999999999999999999864211     1100       00000000         0


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCCCHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRVNTK  932 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RPs~~  932 (952)
                      .+...+.++.+++.+|++.||++||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            1223467789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-35  Score=312.39  Aligned_cols=255  Identities=25%  Similarity=0.354  Sum_probs=206.4

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|.+.+.||.|+||.||+|... +++.+|+|++........+.+.+|+.++++++|||++++++++...+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357889999999999999999874 5789999999766555667899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++++|.+++......+++.++..++.|++.|++||   |+.+++||||+|+||++++++.+||+|||.+....... ..
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  157 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL---HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK  157 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence            999999998877656799999999999999999999   78999999999999999999999999999998654321 11


Q ss_pred             ccccccccccccccccCcC---CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          822 QTQTLATIGYIAPEYGREG---QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      .....++..|+|||.....   .++.++||||||+++|||++|+.||.......... ...       ...+.....   
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~-------~~~~~~~~~---  226 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LIS-------KSNFPPPKL---  226 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHH-------hccCCCccc---
Confidence            2234578899999998766   78899999999999999999999986532111000 000       000000000   


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..+...+.++.+++.+||..+|.+||++.+|+.+
T Consensus       227 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         227 -----KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             -----cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 0112346679999999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.5e-35  Score=314.76  Aligned_cols=251  Identities=24%  Similarity=0.337  Sum_probs=199.3

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|++++++++|||++++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999987 578999999986542 33346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++++|..+.     .+++..+..++.|++.|++||   |+.||+|+||||+||+++.++.++|+|||++.......   
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---  149 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---  149 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence            9999986542     467888999999999999999   78999999999999999999999999999998653321   


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      .....++..|+|||++.+..++.++||||||+++|+|++|+.||........... .. ..   .....+.... .    
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~-~~---~~~~~~~~~~-~----  219 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-PL-QL---LQCIVDEDPP-V----  219 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-hH-HH---HHHHhccCCC-C----
Confidence            2234689999999999988899999999999999999999999876432221110 00 00   0000000000 0    


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                        ......+.++.+++.+||+.+|++||++.|++++
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         220 --LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              0011235678999999999999999999999876

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.1e-35  Score=313.21  Aligned_cols=251  Identities=28%  Similarity=0.399  Sum_probs=206.4

Q ss_pred             hccCCccceecCccceEEEEEEeCC-CcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|+..+.||+|+||.||+|...+ ++.||+|.+.....  .+.+.+|++++++++|||++++++++..+...++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3578899999999999999999854 88999999865433  57899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++++|.+++......+++..+..++.|+++|++||   |+.+++||||+|+||++++++.+||+|||++........ .
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL---HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K  155 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence            999999999987667899999999999999999999   789999999999999999999999999999987644321 2


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      .....++..|+|||++.+..++.++||||||+++|+|++|+.||........... .            .......    
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-~------------~~~~~~~----  218 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-I------------PNKPPPT----  218 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-h------------ccCCCCC----
Confidence            2234578899999999888899999999999999999999999865322111000 0            0000000    


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ...+..++.++.+++.+||+.+|++||++.|++++
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         219 -LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             -CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence             00122346679999999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.9e-35  Score=316.93  Aligned_cols=268  Identities=25%  Similarity=0.421  Sum_probs=209.4

Q ss_pred             ccCCccceecCccceEEEEEEeC-----CCcEEEEEEeeccCch-hhHHHHHHHHHHHhCCCCccceeeeEeec--CCee
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKIISSCTN--HNFK  735 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  735 (952)
                      +.|++.+.||+|+||.||+|.+.     +++.||||++...... ..+.+.+|++++++++|||++++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45778899999999999999853     4789999998755443 45789999999999999999999999877  5578


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||+++++|.+++......+++..+..++.|++.||+||   |+.|++||||||+||+++.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL---GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            999999999999999987666799999999999999999999   78999999999999999999999999999998765


Q ss_pred             CcCccc--ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc--cchhhhhhhcc
Q 002214          816 EEDSMK--QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN--DSLPAVMNIMD  891 (952)
Q Consensus       816 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~  891 (952)
                      ......  .....++..|+|||...+..++.++||||||+++|||++|+.|+...............  ...+...+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            332211  11233556799999998888999999999999999999999997553222111000000  00111111111


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      ....       ...+..++.++.+++.+||+.+|++||++.||+++|+++
T Consensus       241 ~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         241 EGER-------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cCCc-------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1110       011234677899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-35  Score=325.40  Aligned_cols=241  Identities=22%  Similarity=0.278  Sum_probs=193.6

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  739 (952)
                      +|+..+.||+|+||+||+|... +|+.||+|++....   ....+.+..|..++..+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677899999999999999874 68999999986432   233456778999998885 577888999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++.... .+++.++..++.|++.|++||   |++||+||||||+||++++++.+||+|||+++.......
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFL---HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            9999999999886544 689999999999999999999   789999999999999999999999999999975432221


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...           ..+.....     
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~-----------~~i~~~~~-----  218 (323)
T cd05615         157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-ELF-----------QSIMEHNV-----  218 (323)
T ss_pred             -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHH-----------HHHHhCCC-----
Confidence             222346899999999999888999999999999999999999998653110 000           01111000     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNT  931 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  931 (952)
                          ..+..++.++.+++.+||+.+|.+|++.
T Consensus       219 ----~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 ----SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ----CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                0123356778999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.5e-35  Score=317.56  Aligned_cols=250  Identities=23%  Similarity=0.345  Sum_probs=200.6

Q ss_pred             CCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      |+..+.||+|+||.||+|.+. +++.||||.+....   ....+.+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999874 68999999886432   22234577899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+++.... ..+++..+..++.|++.|++||   |+++|+||||||+||++++++.++|+|||++........ 
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL---HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            99999999886533 3689999999999999999999   789999999999999999999999999999976543221 


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                       .....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....        .....+..       
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~--------~~~~~~~~-------  220 (285)
T cd05630         158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREE--------VERLVKEV-------  220 (285)
T ss_pred             -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHH--------HHhhhhhh-------
Confidence             123468999999999998899999999999999999999999996532110 0000        00000000       


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVN-----TKEIISR  937 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~  937 (952)
                       ....+..+++++.+++.+||+.||++|||     +.|+.++
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         221 -QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             -hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence             00112345677999999999999999999     8888873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.5e-35  Score=315.57  Aligned_cols=250  Identities=23%  Similarity=0.321  Sum_probs=199.7

Q ss_pred             CCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          666 FSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      |+..+.||+|+||+||+|.+ .+++.||+|.+....   ......+.+|++++++++|++++++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778999999999999987 468999999986432   22234577899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+++.... ..+++..+..++.|++.|++||   |++||+||||||+||++++++.+||+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL---HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-  157 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence            99999998886543 3699999999999999999999   799999999999999999999999999999976543221 


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                       .....|+..|+|||++.+..++.++|||||||++|||++|..||....... ....+. .....      ..       
T Consensus       158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~-~~~~~------~~-------  221 (285)
T cd05632         158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVD-RRVLE------TE-------  221 (285)
T ss_pred             -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-Hhhhc------cc-------
Confidence             223468999999999988889999999999999999999999986521110 000000 00000      00       


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVN-----TKEIISR  937 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~  937 (952)
                        ...+..++.++.+++..||+.||++||+     +.|++++
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         222 --EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             --cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence              0012335667899999999999999999     6777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-35  Score=311.45  Aligned_cols=248  Identities=27%  Similarity=0.443  Sum_probs=198.6

Q ss_pred             ceecCccceEEEEEEeC----CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||.||+|++.    .+..||+|.+..... ...+.+.+|+++++++.|||++++++++.. ...++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            46999999999999762    237899999865543 245678999999999999999999998764 467999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc-
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT-  823 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~-  823 (952)
                      |+|.+++.... .+++..+..++.|++.|++||   |..+++||||||+||+++.++.+||+|||+++........... 
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYL---ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHH---hhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999997655 789999999999999999999   7899999999999999999999999999999876443322111 


Q ss_pred             -ccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          824 -QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       824 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                       ...++..|+|||...+..++.++||||||+++||+++ |..||.....  .....++....                  
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~------------------  215 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGE------------------  215 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCC------------------
Confidence             1223568999999988889999999999999999998 9999865321  11111111100                  


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                      ....+..++.++.+++.+||..+|++||++.++.+.|+++.
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            00112345678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.3e-35  Score=325.26  Aligned_cols=248  Identities=22%  Similarity=0.290  Sum_probs=195.3

Q ss_pred             ceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+.++.++ +||+|+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999874 67899999997542   23345688999999988 699999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|..++...+ .+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFL---HERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTST  155 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ceec
Confidence            99998876543 689999999999999999999   789999999999999999999999999999975322221 2233


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCcc-chhhhhccchhhhhhhccccccchhhHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM-SIKRWINDSLPAVMNIMDTNLLSEDEEHAN  903 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (952)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+...      ......         .
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~------~~~~~~---------~  220 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ------VILEKP---------I  220 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH------HHHhCC---------C
Confidence            5689999999999988999999999999999999999999964322111 11111000      000000         0


Q ss_pred             HhhhhhHHHHHHHHhhccccCCCCCCCH------HHHHHH
Q 002214          904 VAKQSCASSVLSLAMECTSESPENRVNT------KEIISR  937 (952)
Q Consensus       904 ~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ev~~~  937 (952)
                      ..+...+.++.+++.+||+.||++||++      .++.++
T Consensus       221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         221 RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            0123356778999999999999999985      466544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-35  Score=309.75  Aligned_cols=247  Identities=30%  Similarity=0.466  Sum_probs=200.8

Q ss_pred             ceecCccceEEEEEEeCCCcEEEEEEeeccCch-hhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCChh
Q 002214          670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLE  748 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  748 (952)
                      ++||+|+||.||+|.+.+++.||+|.+...... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999877999999988655433 4567899999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc-ccccc
Q 002214          749 DCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ-TQTLA  827 (952)
Q Consensus       749 ~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~~  827 (952)
                      +++......+++.....++.+++.|++||   |+++++||||+|+||+++.++.+||+|||++........... .....
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~l---H~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99977666789999999999999999999   799999999999999999999999999999986542221111 11234


Q ss_pred             ccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhh
Q 002214          828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAK  906 (952)
Q Consensus       828 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  906 (952)
                      +..|+|||.+.++.++.++|||||||++|||+| |..||......  .....           +.....       ...+
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~-----------~~~~~~-------~~~~  217 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRER-----------IESGYR-------MPAP  217 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHH-----------HhcCCC-------CCCC
Confidence            667999999988889999999999999999999 78887553211  11110           110000       0012


Q ss_pred             hhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          907 QSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       907 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                      ..++.++.+++.+||..+|++||++.|+++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.6e-35  Score=311.70  Aligned_cols=249  Identities=22%  Similarity=0.308  Sum_probs=202.3

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      +|++.+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++++++|||++++++.+..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999874 6899999998643 2334567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          743 PKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       743 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      ++|+|.+++... ...+++.....++.|++.|++||   |++||+|+||||+||++++++.++++|||.+......... 
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI---HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc-
Confidence            999999888653 33578999999999999999999   8999999999999999999999999999999866433221 


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      .....+++.|+|||+..+..++.++||||||+++|+|++|..||.....     .....       ....... .     
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~-------~~~~~~~-~-----  218 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLIL-------KVCQGSY-K-----  218 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHH-------HHhcCCC-C-----
Confidence            2234688899999999888899999999999999999999999864211     10000       0000000 0     


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                        ..+..++.++.+++.+||+.||++||++.|++..
T Consensus       219 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 --PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              0122345678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.7e-35  Score=318.25  Aligned_cols=263  Identities=21%  Similarity=0.320  Sum_probs=203.4

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999874 68889999886542 33345688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS-NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~-~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+++... ..+++..+..++.|+++||+||   |+ .+++||||||+||+++.++.+||+|||++.......  
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l---H~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            9999999998765 3688999999999999999999   54 689999999999999999999999999997653221  


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhh-------------
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM-------------  887 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------  887 (952)
                       .....+++.|+|||...+..++.++||||||+++|||++|+.||....  ......+.........             
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCC
Confidence             223468899999999888889999999999999999999999985422  1111111111100000             


Q ss_pred             ---------hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          888 ---------NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       888 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                               +..+.......   .......++.++.+++.+||..+|++||++.|++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPP---PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CccchhhHHHHHHHHhcCCC---ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                     00000000000   0000112567899999999999999999999998873

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.1e-35  Score=318.28  Aligned_cols=250  Identities=26%  Similarity=0.367  Sum_probs=204.6

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5789999999999999999987 579999999987655555577889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      ++++|.+++...  .+++.++..++.|++.|++||   |+.|++||||||+||+++.++.++|+|||++........ ..
T Consensus        99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~L---H~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~  172 (297)
T cd06656          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  172 (297)
T ss_pred             CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-Cc
Confidence            999999988653  478899999999999999999   789999999999999999999999999999986543322 12


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ....+++.|+|||...+..++.++|||||||++|++++|+.||............ .....+.        .        
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-~~~~~~~--------~--------  235 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPE--------L--------  235 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-ccCCCCC--------C--------
Confidence            2346888999999998888999999999999999999999998542211111000 0000000        0        


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ..+...+..+.+++.+||..+|++||++.|++++
T Consensus       236 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         236 -QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0112345678999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.1e-35  Score=316.35  Aligned_cols=253  Identities=24%  Similarity=0.370  Sum_probs=199.8

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecC------
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNH------  732 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  732 (952)
                      .+.+.|++.+.||+|+||+||+|... +++.||+|++..... ....+..|+.+++++ +|||++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677889999999999999999874 688999999865433 345788999999998 699999999998653      


Q ss_pred             CeeEEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccc
Q 002214          733 NFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA  811 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  811 (952)
                      ...++||||+++++|.+++.... ..+++..+..++.|++.|++||   |+++|+|||++|+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~L---H~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            46789999999999999987643 4689999999999999999999   7889999999999999999999999999999


Q ss_pred             cccCCcCcccccccccccccccccccC-----cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhh
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGR-----EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV  886 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  886 (952)
                      ....... .......|++.|+|||++.     +..++.++|||||||++|||++|+.||...........         .
T Consensus       159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~---------~  228 (272)
T cd06637         159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---------I  228 (272)
T ss_pred             eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH---------H
Confidence            8653322 1223356889999999875     34578899999999999999999999865321110000         0


Q ss_pred             hhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .......          ..+..++.++.+++.+||..+|.+|||+.|++++
T Consensus       229 ~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 PRNPAPR----------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             hcCCCCC----------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            0000000          0112346779999999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.7e-35  Score=317.75  Aligned_cols=266  Identities=24%  Similarity=0.341  Sum_probs=195.7

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhC---CCCccceeeeEeec-----CC
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTI---RHRNLVKIISSCTN-----HN  733 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  733 (952)
                      +|++.+.||+|+||+||+|+.. +++.||+|.++...  ......+.+|+.+++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788999999999999999874 68999999886542  22234566777777766   69999999998764     34


Q ss_pred             eeEEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                      ..++||||++ ++|.+++.... ..+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5789999997 48888876543 3589999999999999999999   79999999999999999999999999999998


Q ss_pred             ccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc---c-hhhhh-
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND---S-LPAVM-  887 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~-~~~~~-  887 (952)
                      ......  ......++..|+|||++.+..++.++||||+||++|||++|+.||......+ ...+....   . ..... 
T Consensus       157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCcc
Confidence            664322  1223468899999999988889999999999999999999999985432111 11111100   0 00000 


Q ss_pred             --hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          888 --NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       888 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                        ..-..................++.++.+++.+|++.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              00000000000000111123456788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-35  Score=311.23  Aligned_cols=247  Identities=30%  Similarity=0.542  Sum_probs=203.5

Q ss_pred             ceecCccceEEEEEEeCC----CcEEEEEEeeccCchh-hHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFPD----GIEVAIKVFHLQREGA-LNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||.||+|....    +..||+|.++...... .+.+.+|++++++++|+|++++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998753    8899999987654432 57889999999999999999999999999999999999999


Q ss_pred             CChhHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          745 GSLEDCMYAS--------NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       745 g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      ++|.+++...        ...+++..+..++.|++.|++||   |+++++||||+|+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHH---HcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        45799999999999999999999   789999999999999999999999999999987754


Q ss_pred             cCc-ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          817 EDS-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       817 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ... .......+++.|+|||......++.++||||+|+++|||++ |..||.....  ....+.          ..+.. 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~----------~~~~~-  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEY----------LRKGY-  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH----------HHcCC-
Confidence            332 12223457889999999888889999999999999999999 6899866311  111110          00000 


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                             ....+..++.++.+++.+||..+|++||++.|++++|+
T Consensus       225 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 -------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                   00112345778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.7e-35  Score=326.40  Aligned_cols=240  Identities=28%  Similarity=0.323  Sum_probs=189.1

Q ss_pred             ceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHH-HHHHhCCCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAEC-EILKTIRHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||+||+|++. +++.||+|++....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999875 57889999986432   12223444444 456788999999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|.+++.... .+.+..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~  155 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTST  155 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cccc
Confidence            99999887643 578888899999999999999   799999999999999999999999999999975432221 2233


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+.           .......         .
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~-----------~i~~~~~---------~  214 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYD-----------NILNKPL---------Q  214 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-HHH-----------HHHhCCc---------C
Confidence            569999999999999899999999999999999999999986421110 000           0000000         0


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCCCHHHHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRVNTKEII  935 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  935 (952)
                      .+..++.++.+++.+|++.||.+||++.+.+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            1234567899999999999999999887543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-34  Score=313.44  Aligned_cols=257  Identities=26%  Similarity=0.428  Sum_probs=206.7

Q ss_pred             hccCCccceecCccceEEEEEEeC-CC----cEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DG----IEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      ..+|++.+.||+|+||.||+|.++ +|    ..||+|....... .....+.+|+.++++++|||++++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            357888999999999999999863 33    3689998765533 344678899999999999999999999887 7789


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+++|+|.+++......+++..+..++.|++.|++||   |+.+++||||||+||++++++.+||+|||.++....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            99999999999999987766799999999999999999999   789999999999999999999999999999987653


Q ss_pred             cCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          817 EDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       817 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ..... .....++..|+|||......++.++||||||+++||+++ |+.||......  ...+.+           ....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~-----------~~~~  228 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLL-----------EKGE  228 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHH-----------hCCC
Confidence            32211 112234678999999888889999999999999999999 99998653211  111111           0000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                             ....+..++.++.+++.+||..+|.+||++.++++.|+++.+
T Consensus       229 -------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         229 -------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                   001123356678999999999999999999999999998855

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-35  Score=326.65  Aligned_cols=264  Identities=18%  Similarity=0.217  Sum_probs=196.6

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++......++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            4457999999999999999999874 5788999975322      23569999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+ .++|.+++......+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++......  
T Consensus       138 ~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  211 (357)
T PHA03209        138 HY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL---HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--  211 (357)
T ss_pred             cc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence            99 4688888877666799999999999999999999   78999999999999999999999999999997543221  


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCC-CccccCccchhhhhccchhhhh------------
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPT-NEFFTGEMSIKRWINDSLPAVM------------  887 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~------------  887 (952)
                      ......||+.|+|||++.+..++.++|||||||++|||+++..|+ ......................            
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            122346899999999999889999999999999999999965554 3221110000000000000000            


Q ss_pred             --------hhccccccc--hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          888 --------NIMDTNLLS--EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       888 --------~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                              ..++.....  ............++.++.+++.+||+.||++|||+.|++++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence                    000000000  00000011122456677889999999999999999999875

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-35  Score=330.71  Aligned_cols=265  Identities=22%  Similarity=0.200  Sum_probs=199.3

Q ss_pred             hccCCccceecCccceEEEEEEeC---CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP---DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ..+|.+.+.||+|+||.||+|...   .++.||+|.+...     ....+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999753   4678999987533     23468999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |++. ++|.+++.. ...+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus       166 e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~L---H~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYL---HGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9995 688888743 34789999999999999999999   789999999999999999999999999999986654332


Q ss_pred             c-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCc--cchhhhhccch-----------hh
Q 002214          820 M-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE--MSIKRWINDSL-----------PA  885 (952)
Q Consensus       820 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~-----------~~  885 (952)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+....+...           ..
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            2 1223568999999999998899999999999999999999999985532211  11111111000           00


Q ss_pred             hhhhc---cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 VMNIM---DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....+   ...................+.++.+++.+|+..||++||++.|++.+
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000   00000000000000112345678999999999999999999999876

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.6e-35  Score=313.54  Aligned_cols=253  Identities=30%  Similarity=0.465  Sum_probs=199.7

Q ss_pred             CCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhh--HHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      |++.+.||+|+||+||+|+.. +++.||+|++........  ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            677899999999999999985 567899999976654322  23456999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      ++++|.+++... ..+++..+..++.|+++||+||   |+.+|+||||||+||++++++.++|+|||.+.... ......
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~L---h~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYL---HSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF  155 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHH---HHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred             cccccccccccc-cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-cccccc
Confidence            999999999833 3689999999999999999999   68899999999999999999999999999998642 122233


Q ss_pred             cccccccccccccccC-cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          823 TQTLATIGYIAPEYGR-EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      ....++..|+|||+.. +..++.++||||+|+++|+|++|..||.....  .+......       .....    .... 
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~-------~~~~~----~~~~-  221 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIE-------KILKR----PLPS-  221 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHH-------HHHHT----HHHH-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhh-------hcccc----cccc-
Confidence            4466899999999988 78899999999999999999999999876410  00000000       00000    0000 


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ........+.++.+++.+||+.||++||++.+++++
T Consensus       222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000001113789999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.8e-35  Score=319.53  Aligned_cols=278  Identities=21%  Similarity=0.306  Sum_probs=207.9

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            357899999999999999999874 68899999986543 2234567889999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |++ ++|.+++......+++..+..++.|+++||+||   |+.||+||||||+||++++++.+||+|||++........ 
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence            996 589888877666789999999999999999999   799999999999999999999999999999976533221 


Q ss_pred             cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchh---hhhccchhh-hhhhcccccc
Q 002214          821 KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK---RWINDSLPA-VMNIMDTNLL  895 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~  895 (952)
                      ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ...   +......+. ....++....
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChhhchhhhccccc
Confidence            1122457889999998765 357889999999999999999999986532111 110   000000000 0011100000


Q ss_pred             ------chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH--HHHHHHHHHh
Q 002214          896 ------SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS--RLIKIRDLLF  946 (952)
Q Consensus       896 ------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~--~L~~i~~~~~  946 (952)
                            .............+++++.+++.+|++.||.+|||++|+++  .++.+.++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~  297 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIH  297 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhh
Confidence                  00000011122346778999999999999999999999997  4555554443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.1e-35  Score=317.98  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=204.4

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3588999999999999999986 578999999987665555677899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      ++++|..++...  .+++.++..++.|++.|++||   |+.|++||||+|+||+++.++.+||+|||++........ ..
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~L---H~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~  172 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFL---HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR  172 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence            999999988654  489999999999999999999   799999999999999999999999999999986543322 12


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ....++..|+|||.+.+..++.++|||||||++|++++|+.||........ .........        ..         
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~~~~--------~~---------  234 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGT--------PE---------  234 (296)
T ss_pred             CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCC--------cc---------
Confidence            234588899999999888899999999999999999999999865221110 000000000        00         


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...+..+++.+.+++.+||..||++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            00123356779999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-35  Score=314.94  Aligned_cols=254  Identities=23%  Similarity=0.403  Sum_probs=204.1

Q ss_pred             hccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      .++|.+.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.+++.++|||++++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            457889999999999999999863      24789999986443 23345788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEe
Q 002214          736 ALVLEYMPKGSLEDCMYASN---------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS  806 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~  806 (952)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.|++||   |+.+|+||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432         2468889999999999999999   79999999999999999999999999


Q ss_pred             ccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchh
Q 002214          807 DFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLP  884 (952)
Q Consensus       807 Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  884 (952)
                      |||+++........ ......++..|+|||...++.++.++|||||||++||+++ |..||.....  ....+...    
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~----  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVI----  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHHh----
Confidence            99999866443322 2223456789999999988889999999999999999998 8888754211  11111110    


Q ss_pred             hhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          885 AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                            +...        ...+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus       236 ------~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 ------DGGH--------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ------cCCC--------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                  0000        0112335778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-34  Score=310.54  Aligned_cols=248  Identities=26%  Similarity=0.471  Sum_probs=195.2

Q ss_pred             ceecCccceEEEEEEeC-CCc--EEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP-DGI--EVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||.||+|++. ++.  .+|+|.++... ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999874 343  56888876432 33446788999999999 799999999999999999999999999


Q ss_pred             CChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccc
Q 002214          745 GSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       745 g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  809 (952)
                      |+|.+++....               ..+++.++..++.|++.|++||   |++|++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986532               2478899999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhh
Q 002214          810 IAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMN  888 (952)
Q Consensus       810 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  888 (952)
                      ++.....  .........+..|+|||+.....++.++|||||||++|||++ |..||......     ..        ..
T Consensus       158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~--------~~  222 (270)
T cd05047         158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----EL--------YE  222 (270)
T ss_pred             Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HH--------HH
Confidence            9863221  111112234668999999988889999999999999999997 99998542111     00        00


Q ss_pred             hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       889 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                      .+......       ..+..++.++.+++.+||+.+|.+|||+.|+++.|+++.
T Consensus       223 ~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         223 KLPQGYRL-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHhCCCCC-------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            01110000       011234667899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=301.03  Aligned_cols=249  Identities=27%  Similarity=0.362  Sum_probs=209.9

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      -|.++.+||+|+||.||+|.+ .+|+.||+|.+..+.  ..+++.+|+.+|++...|+||++||.|......++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            467788999999999999977 469999999986554  35788999999999999999999999988888999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      .|+..+.++..+.++++.++..+++....||+||   |...-+|||||+.|||++.+|.+|++|||.|..+.+.- ....
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YL---H~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRN  187 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYL---HDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRN  187 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHH---HHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhC
Confidence            9999999999988999999999999999999999   67788999999999999999999999999998664322 2334


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN  903 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (952)
                      ...|||.|||||++..-.|..++||||+|++..||..|++||.+.++-...+              +.+.-  ..+-  -
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--------------MIPT~--PPPT--F  249 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--------------MIPTK--PPPT--F  249 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--------------eccCC--CCCC--C
Confidence            4679999999999998889999999999999999999999997754321111              00000  0000  0


Q ss_pred             HhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          904 VAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       904 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..|+..+.++.+++++|+...|++|-|+.++++|
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            1245568899999999999999999999998876

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.9e-35  Score=317.48  Aligned_cols=255  Identities=26%  Similarity=0.466  Sum_probs=203.7

Q ss_pred             hccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      .++|++.+.||+|+||.||+|..+      ++..||+|+++.... ...+.+.+|+.++++++|||++++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999863      467899999865432 3346788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 002214          736 ALVLEYMPKGSLEDCMYASN---------------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSN  794 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~---------------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~N  794 (952)
                      ++||||+++|+|.+++....                     ..+++..++.++.|++.|++||   |+++++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l---H~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhCCeecccccHhh
Confidence            99999999999999986432                     2467888999999999999999   78999999999999


Q ss_pred             eeeCCCCcEEEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCc
Q 002214          795 VLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGE  872 (952)
Q Consensus       795 ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~  872 (952)
                      |++++++.++|+|||++.......... ......++.|+|||...+..++.++|||||||++|||++ |..||...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            999999999999999998654332211 122345678999999888889999999999999999998 87887542111 


Q ss_pred             cchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          873 MSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                          .+.       ....+....        ..+..++.++.+++.+||+.||++||++.|+++.|++
T Consensus       240 ----~~~-------~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ----EVI-------YYVRDGNVL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----HHH-------HHHhcCCCC--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                100       011111110        0123456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.6e-35  Score=310.87  Aligned_cols=247  Identities=23%  Similarity=0.423  Sum_probs=199.3

Q ss_pred             ceecCccceEEEEEEeCC--C--cEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFPD--G--IEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|+.++++++|||++++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998743  3  3699999876655 556789999999999999999999999988 889999999999


Q ss_pred             CChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc--c
Q 002214          745 GSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM--K  821 (952)
Q Consensus       745 g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~  821 (952)
                      ++|.+++.... ..+++.....++.|++.||+||   |++|++||||+|+||+++.++.+||+|||+++........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL---ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHH---HhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999987654 4689999999999999999999   7999999999999999999999999999999876543221  1


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ......        .  ....      
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~--------~--~~~~------  219 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKID--------K--EGER------  219 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH--------h--cCCc------
Confidence            112446789999999988889999999999999999999 999985421111 000000        0  0000      


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                        ...+..++..+.+++.+||+.+|++||+++|+++.|.
T Consensus       220 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 --LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              0012235678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.5e-35  Score=328.31  Aligned_cols=267  Identities=20%  Similarity=0.217  Sum_probs=198.5

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecC-----
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNH-----  732 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  732 (952)
                      ...++|++.+.||+|+||.||+|.+. .++.||||++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45678999999999999999999874 68899999986432  23346778899999999999999999988643     


Q ss_pred             -CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccc
Q 002214          733 -NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA  811 (952)
Q Consensus       733 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  811 (952)
                       ...++||||+++ ++.+.+..   .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~L---H~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence             357999999965 66665543   478899999999999999999   7999999999999999999999999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchh----
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLP----  884 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~----  884 (952)
                      +.....  .......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+...+.   ...+    
T Consensus       167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence            865332  22234568999999999988889999999999999999999999986422111 0100000   0001    


Q ss_pred             ----hhhhhccccccc-----------hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          885 ----AVMNIMDTNLLS-----------EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       885 ----~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          .....++.....           .........+...+.++.+++.+|++.||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                111111000000           00000000111235678999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.2e-35  Score=330.49  Aligned_cols=265  Identities=20%  Similarity=0.212  Sum_probs=197.3

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ...|.+.+.||+|+||.||+|.+. +++.||||...      ...+.+|++++++++|||||++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            347999999999999999999885 57899999632      23457899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc-
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM-  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-  820 (952)
                      + .++|.+++......+++.++..++.|+++||+||   |++||+||||||+|||++.++.+||+|||+++........ 
T Consensus       242 ~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 Y-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYI---HGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            9 4688888876655799999999999999999999   7899999999999999999999999999999865432211 


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCc------cchhhhhccch---hhhhhhcc
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE------MSIKRWINDSL---PAVMNIMD  891 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~~~~---~~~~~~~~  891 (952)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..|+-......      ..+.+.+....   .+......
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            1123468999999999999899999999999999999999887643211110      01111111000   00000000


Q ss_pred             cccc------------chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLL------------SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..+.            ..............+.++.+|+.+||+.||.+|||+.|++++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0000            000000000001234578999999999999999999999875

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.6e-35  Score=326.59  Aligned_cols=238  Identities=28%  Similarity=0.336  Sum_probs=188.6

Q ss_pred             ceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHH-HHHhCCCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECE-ILKTIRHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||+||+|+. .+|+.||+|++....   ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999987 468999999986442   223345555554 46778999999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|...+.... .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~  155 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYL---HSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTT  155 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cccc
Confidence            99988876543 689999999999999999999   799999999999999999999999999999975322211 2233


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.           .......         .
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~-----------~~~~~~~---------~  214 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-EMYD-----------NILHKPL---------V  214 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-HHHH-----------HHHcCCc---------c
Confidence            56899999999999989999999999999999999999998642110 0001           1111000         0


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCCCHHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRVNTKE  933 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e  933 (952)
                      .+...+.++.+++.+|++.+|++||++.+
T Consensus       215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         215 LRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            11234667889999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.1e-35  Score=313.16  Aligned_cols=254  Identities=22%  Similarity=0.418  Sum_probs=205.3

Q ss_pred             ccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCch-hhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      ++|++.+.||+|+||.||+|+.+      +.+.||+|.+...... ..+.+.+|++++++++|||++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999863      3467999988655443 4567999999999999999999999999989999


Q ss_pred             EEEEccCCCChhHHhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecc
Q 002214          737 LVLEYMPKGSLEDCMYASN--------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDF  808 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Df  808 (952)
                      +||||+++|+|.+++....        ..+++..+..++.|++.|++||   |+.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHh---hhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999987544        1589999999999999999999   7999999999999999999999999999


Q ss_pred             ccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhh
Q 002214          809 GIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVM  887 (952)
Q Consensus       809 gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  887 (952)
                      |++...............+++.|+|||.+.+..++.++||||||+++|++++ |..||......  .......       
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~-------  232 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQ-------  232 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHH-------
Confidence            9987554333333334557788999999888888999999999999999999 77887542111  1111000       


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                         .....       ...+..++.++.+++.+||+.+|++||++.|+++.|.
T Consensus       233 ---~~~~~-------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 ---AGKLE-------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ---cCCcC-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence               00000       0012345778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.9e-35  Score=311.44  Aligned_cols=249  Identities=24%  Similarity=0.408  Sum_probs=200.5

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCch---------hhHHHHHHHHHHHhCCCCccceeeeEeecCCe
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREG---------ALNSFDAECEILKTIRHRNLVKIISSCTNHNF  734 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  734 (952)
                      +|.+.+.||+|+||.||+|.. .+++.||+|.+......         ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477889999999999999987 46889999988543221         23568899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .++||||+++++|.+++.... .+++..+..++.|++.|++||   |+.|++||||+|+||++++++.+||+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~l---H~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYL---HNRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHH---HhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999987653 688899999999999999999   7899999999999999999999999999999876


Q ss_pred             CCcCcc-----cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhh
Q 002214          815 SEEDSM-----KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNI  889 (952)
Q Consensus       815 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  889 (952)
                      ......     ......++..|+|||.+.+..++.++||||+||++|+|++|+.||...... ....+        ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~--------~~~~  227 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-QAIFK--------IGEN  227 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-HHHHH--------Hhcc
Confidence            532111     111234788999999998888999999999999999999999998652111 00000        0000


Q ss_pred             ccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       890 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..           ...+..++.++.+++.+||+.||.+||++.|++++
T Consensus       228 ~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         228 AS-----------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             CC-----------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            00           01123356789999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.5e-35  Score=315.63  Aligned_cols=268  Identities=23%  Similarity=0.324  Sum_probs=199.5

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|++.+.||+|++|.||+|+.. +++.||+|+++...  ....+.+.+|+.++++++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999874 68999999986442  22346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          742 MPKGSLEDCMYASN--FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       742 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ++ ++|.+++....  ..+++..+..++.|+++||+||   |+++|+||||+|+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC---HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 68888876433  4689999999999999999999   78999999999999999999999999999997654322 


Q ss_pred             ccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhh--hhccch----hhhhhh--c
Q 002214          820 MKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR--WINDSL----PAVMNI--M  890 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~--~~~~~~----~~~~~~--~  890 (952)
                      .......+++.|+|||++.+. .++.++|||||||++|||+||+.||......+.....  ......    +.....  .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence            122234578899999987654 4688999999999999999999998653211110000  000000    000000  0


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..................+++++.+++.+||..||++|||+.+|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00000000000011123467788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.6e-34  Score=311.41  Aligned_cols=248  Identities=26%  Similarity=0.415  Sum_probs=203.8

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..|+..+.||.|+||.||+|.+. +++.||+|++.... ......+.+|+.+++++.|||++++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777889999999999999874 58899999986543 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++|+|.+++...  .+++.+...++.|++.|++||   |+.+++|+||+|+||+++.++.++++|||++........ .
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~l---h~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYL---HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence            9999999988653  588999999999999999999   789999999999999999999999999999976643321 2


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      .....++..|+|||++.+..++.++|||||||++|||++|..||.........             .......       
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------------~~~~~~~-------  217 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------------FLIPKNN-------  217 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-------------hhhhcCC-------
Confidence            22345788999999998888999999999999999999999998653221100             0000000       


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....+..++..+.+++.+||+.+|++||++.|++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            001123457789999999999999999999999887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-34  Score=310.67  Aligned_cols=251  Identities=22%  Similarity=0.350  Sum_probs=190.8

Q ss_pred             ceecCccceEEEEEEeC---CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCC
Q 002214          670 NLIGIGSYGSVYKGRFP---DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKG  745 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  745 (952)
                      +.||+|+||.||+|...   ++..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999864   346799998865443 23457889999999999999999999999988999999999999


Q ss_pred             ChhHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          746 SLEDCMYASN----FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       746 ~L~~~l~~~~----~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +|.+++....    ...++..+..++.|++.|++||   |+++++||||||+||+++.++.+|++|||.+..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL---HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986532    2467778889999999999999   78999999999999999999999999999997543322211


Q ss_pred             -ccccccccccccccccCcC-------CcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          822 -QTQTLATIGYIAPEYGREG-------QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       822 -~~~~~~~~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                       .....++..|+|||++...       .++.++||||||+++|||++ |+.||......+.....+ .   .......++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-~---~~~~~~~~~  233 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV-R---EQQLKLPKP  233 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh-h---cccCCCCCC
Confidence             1224577889999987532       35789999999999999997 999986532211100000 0   000000000


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                                 .....+++.+.+++..|| .+|++|||++||...|+
T Consensus       234 -----------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         234 -----------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             -----------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence                       011234567889999999 58999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-35  Score=343.19  Aligned_cols=264  Identities=24%  Similarity=0.423  Sum_probs=216.6

Q ss_pred             HHHHHhccCCccceecCccceEEEEEEeC----C----CcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeee
Q 002214          658 ELLRATDQFSEENLIGIGSYGSVYKGRFP----D----GIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIIS  727 (952)
Q Consensus       658 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~  727 (952)
                      .++...++..+.+.+|+|+||.||+|...    .    ...||||.++... ..+.+.+..|+++|+.+ +||||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34445556667779999999999999742    1    4679999986543 34567899999999999 6999999999


Q ss_pred             EeecCCeeEEEEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 002214          728 SCTNHNFKALVLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKP  792 (952)
Q Consensus       728 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~  792 (952)
                      +|+..+..++|+||+..|+|.++++..+               ..++..+.+.++.|||.|++||   +++++||||+.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L---~~~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL---ASVPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH---hhCCccchhhhh
Confidence            9999999999999999999999998877               3488999999999999999999   899999999999


Q ss_pred             CCeeeCCCCcEEEeccccccccCCcCcccccccc--cccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccc
Q 002214          793 SNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL--ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFF  869 (952)
Q Consensus       793 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~  869 (952)
                      +|||+.++..+||+|||+|+.....+.+......  -+..|||||.+....|+.++|||||||++||++| |..||....
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999976655555433222  4667999999999999999999999999999999 889986522


Q ss_pred             cCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          870 TGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                      ... ++.++++.           +       .+...|..|++++.++|+.||+.+|++||++.|+++.++....
T Consensus       527 ~~~-~l~~~l~~-----------G-------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  527 PTE-ELLEFLKE-----------G-------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             cHH-HHHHHHhc-----------C-------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            111 11111111           1       1223467789999999999999999999999999999998543

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-35  Score=317.07  Aligned_cols=263  Identities=22%  Similarity=0.298  Sum_probs=205.3

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ++|++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56888899999999999999874 68999999886543 33457889999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++++|.+++...+ .+++..+..++.+++.|+.|||  +..+++||||+|+||+++.++.++|+|||++.......   
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH--HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            99999999886643 6899999999999999999995  34689999999999999999999999999987542211   


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      .....++..|+|||++.++.++.++|||||||++|++++|+.||......+... .-.................      
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~------  231 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ-DDPMGILDLLQQIVQEPPP------  231 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh-hhhhHHHHHHHHHhhccCC------
Confidence            123468999999999888889999999999999999999999997543221100 0000000000011100000      


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                       ......++.++.+++.+||+.||++||++.|++++..-
T Consensus       232 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         232 -RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             -CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence             00012256789999999999999999999999987533

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-34  Score=310.54  Aligned_cols=250  Identities=24%  Similarity=0.388  Sum_probs=201.3

Q ss_pred             cCCccceecCccceEEEEEEeCCCcEEEEEEeeccC------chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR------EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      +|...+.||+|+||+||+|...+|+.+|+|.+....      ......+.+|++++++++|+|++++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478889999999999999998889999999886432      12235688999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++++|.+++.... .+++..+..++.|++.|++||   |+.+|+|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYL---HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999987643 578999999999999999999   78999999999999999999999999999997653211


Q ss_pred             c-----ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          819 S-----MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       819 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      .     .......++..|+|||+..+..++.++|||||||++|++++|+.||....... ........          ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~----------~~  225 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYIGAH----------RG  225 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHhhhc----------cC
Confidence            1     11122458889999999988889999999999999999999999986421111 00000000          00


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                      ..       ...+..++.++.+++.+||..+|++||++.|+++
T Consensus       226 ~~-------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 LM-------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CC-------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00       0112345678999999999999999999999975

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.1e-34  Score=316.84  Aligned_cols=258  Identities=25%  Similarity=0.418  Sum_probs=204.6

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCc----EEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGI----EVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      .++|+..+.||+|+||.||+|.+. +|.    .||+|.+..... .....+.+|+.++++++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            346788899999999999999863 443    578898764432 2334688999999999999999999998754 467


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +++||+++|+|.+++......+++..+..++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---hhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            99999999999999887666789999999999999999999   789999999999999999999999999999987643


Q ss_pred             cCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          817 EDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       817 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      .... ......++..|+|||++.+..++.++|||||||++||+++ |+.||......  ....+..           ...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~~~-----------~~~  228 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDLLE-----------KGE  228 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH-----------CCC
Confidence            3221 1222345778999999988889999999999999999998 88998653211  1111111           000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      .       ...+..++.++.+++.+||..+|++||++.|+++.|+++.+.
T Consensus       229 ~-------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         229 R-------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             C-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            0       001123566789999999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=312.14  Aligned_cols=249  Identities=26%  Similarity=0.364  Sum_probs=203.7

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ++|++.+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|||++++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999874 68999999986553 33456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++++|.+++...  .+++..+..++.|++.|++||   |+++++||||+|+||++++++.++++|||+++...... ..
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  154 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYL---HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK  154 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence            9999999998765  689999999999999999999   78999999999999999999999999999998765432 12


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      .....+++.|+|||++.+..++.++||||||+++|+|+||+.||....... .....            ........   
T Consensus       155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-~~~~~------------~~~~~~~~---  218 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-VLFLI------------PKNNPPSL---  218 (274)
T ss_pred             cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-HHHHh------------hhcCCCCC---
Confidence            223467889999999988889999999999999999999999986532111 00000            00000000   


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ....++.++.+++.+||..+|++||++.+++++
T Consensus       219 ---~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         219 ---EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             ---cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence               001146678999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-34  Score=320.32  Aligned_cols=258  Identities=24%  Similarity=0.432  Sum_probs=205.3

Q ss_pred             hccCCccceecCccceEEEEEEeC--------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeecC
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP--------DGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNH  732 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  732 (952)
                      ..+|.+.+.||+|+||.||+|+..        .+..||+|.++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            346899999999999999999752        13469999886443 33456789999999999 799999999999999


Q ss_pred             CeeEEEEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee
Q 002214          733 NFKALVLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL  797 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill  797 (952)
                      +..+++|||+++|+|.+++....               ..+++.++..++.|++.|++||   |++|++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEE
Confidence            99999999999999999986532               2478899999999999999999   78999999999999999


Q ss_pred             CCCCcEEEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccch
Q 002214          798 DDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSI  875 (952)
Q Consensus       798 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~  875 (952)
                      +.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.....     
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----  242 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----  242 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence            999999999999998664332211 112234568999999988889999999999999999998 8888754211     


Q ss_pred             hhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          876 KRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                      ..+.        ..+.....       ...+..++.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus       243 ~~~~--------~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         243 EELF--------KLLKEGHR-------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHH--------HHHHcCCC-------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            1111        00000000       00123456789999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-35  Score=314.58  Aligned_cols=240  Identities=23%  Similarity=0.362  Sum_probs=190.9

Q ss_pred             ceecCccceEEEEEEeCC--------CcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          670 NLIGIGSYGSVYKGRFPD--------GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +.||+|+||.||+|....        ...||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997632        235888887655445556788999999999999999999999998899999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc--------EEEeccccccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV--------AHLSDFGIAKL  813 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~--------~kl~Dfgla~~  813 (952)
                      +++|+|.+++...+..+++..+..++.|++.|++||   |++||+||||||+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            999999999987666789999999999999999999   7999999999999999987765        69999999875


Q ss_pred             cCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCC-CCCCccccCccchhhhhccchhhhhhhcc
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGM-KPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      ....     ....+++.|+|||++.+ ..++.++|||||||++|||++|. .|+.......  ..           ....
T Consensus       158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~-----------~~~~  219 (258)
T cd05078         158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KL-----------QFYE  219 (258)
T ss_pred             cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HH-----------HHHH
Confidence            5322     22457889999998876 45789999999999999999985 4543211100  00           0000


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                      ..         ...+...+.++.+++.+||+.||++|||++|+++.|+
T Consensus       220 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 DR---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cc---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00         0112223467899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=348.01  Aligned_cols=452  Identities=29%  Similarity=0.350  Sum_probs=273.5

Q ss_pred             ccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceee
Q 002214           58 SLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDF  137 (952)
Q Consensus        58 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l  137 (952)
                      .|+.||+++|++. ..|..+..+.+|+.|+++.|.+. ..|.+.+++.+|++|+|.+|++. ..|.++..++.+ ++||+
T Consensus        46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl-~~Ldl  121 (1081)
T KOG0618|consen   46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNL-QYLDL  121 (1081)
T ss_pred             eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcc-ccccc
Confidence            3555555555554 45555555555555555555555 44555555555555555555554 555555444443 45555


Q ss_pred             ccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCc
Q 002214          138 SDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNG  217 (952)
Q Consensus       138 ~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  217 (952)
                      |.|.|. .+|.- ...+..+..+..++|.-...    ++... .+.+++..|.+.+.++.++..+++  .|||+.|.+. 
T Consensus       122 S~N~f~-~~Pl~-i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-  191 (1081)
T KOG0618|consen  122 SFNHFG-PIPLV-IEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-  191 (1081)
T ss_pred             chhccC-CCchh-HHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-
Confidence            555554 33322 22344455555555511101    11111 555555555555555555555544  4666666554 


Q ss_pred             cCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCccc
Q 002214          218 EIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFF  297 (952)
Q Consensus       218 ~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~  297 (952)
                      .  -.+..+.+|+.|....|++..+.    ...++|+.|+.++|.+....+    -..-.+|+++++++|++++ .|++.
T Consensus       192 ~--~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~----~p~p~nl~~~dis~n~l~~-lp~wi  260 (1081)
T KOG0618|consen  192 V--LDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDV----HPVPLNLQYLDISHNNLSN-LPEWI  260 (1081)
T ss_pred             h--hhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecc----ccccccceeeecchhhhhc-chHHH
Confidence            1  23455555555555555554432    123455666666665552221    1112356666666666653 23555


Q ss_pred             ccchhhhhhhcccc------------CccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCC
Q 002214          298 FNASKLYALELGYN------------SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGS  365 (952)
Q Consensus       298 ~~~~~L~~l~l~~~------------~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~  365 (952)
                      ..+.+|+.++..+|            ++|+.+.+..|.+...+..               .++++.|++|+|..|+|...
T Consensus       261 ~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~---------------le~~~sL~tLdL~~N~L~~l  325 (1081)
T KOG0618|consen  261 GACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPF---------------LEGLKSLRTLDLQSNNLPSL  325 (1081)
T ss_pred             HhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCc---------------ccccceeeeeeehhcccccc
Confidence            44444444333332            2334444444444433332               45577888888888888855


Q ss_pred             CCcccccCCC-CcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccC
Q 002214          366 LPITLGRLKK-LQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWN  444 (952)
Q Consensus       366 ~~~~l~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  444 (952)
                      ++..|..+.. |..|+.+.|++....--.=..++.|+.|++.+|.++...-..+.+.++|+.|+|++|+|..++...+.+
T Consensus       326 p~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~k  405 (1081)
T KOG0618|consen  326 PDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRK  405 (1081)
T ss_pred             chHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhc
Confidence            4444444444 778888888887443222234567888899999988777777888889999999999998777778888


Q ss_pred             CCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEe
Q 002214          445 LEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLD  524 (952)
Q Consensus       445 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  524 (952)
                      +..|+.|+||+|+++ .+|..+..+..|+.|...+|++. ..| .+..+++|+.+|+|.|+|+...-..-...++|++||
T Consensus       406 le~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLd  482 (1081)
T KOG0618|consen  406 LEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLD  482 (1081)
T ss_pred             hHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceee
Confidence            899999999999998 67888888999999999999988 566 788889999999999988753322222237899999


Q ss_pred             CCCCcccccCccchhccccccccccccc
Q 002214          525 LSNNDLSGVIPASLEKLLYLKSLNLSFN  552 (952)
Q Consensus       525 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  552 (952)
                      |++|.=..+.-..|..+.++...+++-|
T Consensus       483 lSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  483 LSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             ccCCcccccchhhhHHhhhhhheecccC
Confidence            9999744456667777777777777777

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-34  Score=323.04  Aligned_cols=268  Identities=21%  Similarity=0.285  Sum_probs=199.2

Q ss_pred             HHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecC---
Q 002214          659 LLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNH---  732 (952)
Q Consensus       659 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---  732 (952)
                      .....++|.+.+.||+|+||+||+|.. .+++.||||++.....  ...+.+.+|+.++++++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            345668899999999999999999987 4688999999864322  2345677899999999999999999887543   


Q ss_pred             ---CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccc
Q 002214          733 ---NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       733 ---~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  809 (952)
                         ...++++|++ +++|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||++++++.+||+|||
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYI---HSAGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecccCChhhEEECCCCCEEEcCCc
Confidence               3568999998 78998877543  589999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhh
Q 002214          810 IAKLLSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPA  885 (952)
Q Consensus       810 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~  885 (952)
                      +++.....    .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+.++.   ....++
T Consensus       164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~  238 (343)
T cd07878         164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPE  238 (343)
T ss_pred             cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence            99865432    233568999999998876 56889999999999999999999998642111 1111111   011111


Q ss_pred             hhhhcccc--------ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 VMNIMDTN--------LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....+...        +...............++.+.+++.+|+..||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            10000000        00000000000112345568899999999999999999999975

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.9e-35  Score=316.01  Aligned_cols=252  Identities=23%  Similarity=0.372  Sum_probs=200.9

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|.++... +.....+.+|+.++++++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999885 78999999886542 33346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          742 MPKGSLEDCMYAS--NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       742 ~~~g~L~~~l~~~--~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      +++++|..++...  ...+++..+..++.|+++|++|||  ++.+|+||||||+||+++.++.+||+|||.+....... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            9999999888764  236899999999999999999995  35699999999999999999999999999997653221 


Q ss_pred             ccccccccccccccccccCcCC------cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          820 MKQTQTLATIGYIAPEYGREGQ------VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                        .....+++.|+|||.+.+..      ++.++|||||||++|||++|+.||....... ...        ......+..
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~--------~~~~~~~~~  226 (286)
T cd06622         158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFA--------QLSAIVDGD  226 (286)
T ss_pred             --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHH--------HHHHHhhcC
Confidence              12245788999999875543      4789999999999999999999986421110 000        000111100


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .        ...+..++.++.+++.+||+.+|++||++.+++++
T Consensus       227 ~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         227 P--------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             C--------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            0        01123367789999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.2e-35  Score=323.68  Aligned_cols=237  Identities=27%  Similarity=0.322  Sum_probs=187.4

Q ss_pred             ceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHH-HHHhCCCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECE-ILKTIRHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999884 68999999986432   222344555554 67889999999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|...+... ..+++..+..++.||++||+||   |+.||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (321)
T cd05603          81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTST  155 (321)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cccc
Confidence            9998887654 3688899999999999999999   789999999999999999999999999999975422221 2233


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||....     .....       ..+.....         .
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~-------~~i~~~~~---------~  214 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMY-------DNILHKPL---------Q  214 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHH-------HHHhcCCC---------C
Confidence            568999999999998889999999999999999999999985421     11110       00000000         0


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCCCHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRVNTK  932 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RPs~~  932 (952)
                      .+...+.++.+++.+|++.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            1223466789999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.5e-34  Score=313.59  Aligned_cols=268  Identities=24%  Similarity=0.314  Sum_probs=204.8

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|++.+.||+|+||.||+|.+ .+|+.||+|++....  ......+.+|+.++++++|||++++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            478899999999999999987 468999999987554  33456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      + +++|.+++......+++.++..++.|+++|++||   |+.|++|+||||+||+++.++.++++|||.+..........
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM---HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9 9999999877666799999999999999999999   78999999999999999999999999999998765443222


Q ss_pred             ccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc---c----hhhhhhhcc--
Q 002214          822 QTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND---S----LPAVMNIMD--  891 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~----~~~~~~~~~--  891 (952)
                      .....++..|+|||++.+. .++.++||||+|+++|||++|..||...... ..+......   .    .++..+..+  
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            3345689999999987654 4689999999999999999998777542211 111111100   0    000000000  


Q ss_pred             c-cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 T-NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      . .................+.++.+++.+|++.+|++||++.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0 000000000011112446889999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=318.85  Aligned_cols=245  Identities=27%  Similarity=0.381  Sum_probs=203.0

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .|...+.||.|+||.||-|++ .+.+.||||++.-.   +.+.+..+.+|++++++++|||.+.+-|+|..+...++|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            366678899999999999987 57889999998533   33456789999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      || -|+-.+++...+.++.+.++..|..+...||+||   |+.+.||||||+.|||+++.|.+|++|||.|..+.+.   
T Consensus       107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYL---HS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHH---HHhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            99 5688999988888999999999999999999999   8999999999999999999999999999999876543   


Q ss_pred             ccccccccccccccccc---CcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          821 KQTQTLATIGYIAPEYG---REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                        ...+|||.|||||++   ..+.|+-|+||||+|++..|+...++|+-.+. ....+.-+....-|        .+   
T Consensus       180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-AMSALYHIAQNesP--------tL---  245 (948)
T KOG0577|consen  180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESP--------TL---  245 (948)
T ss_pred             --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-HHHHHHHHHhcCCC--------CC---
Confidence              346799999999975   45789999999999999999999999964421 11001000000000        00   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                             .....++.+..++..|+..-|.+|||..+++++
T Consensus       246 -------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  246 -------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             -------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                   113457889999999999999999999998875

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.9e-34  Score=308.95  Aligned_cols=250  Identities=24%  Similarity=0.345  Sum_probs=196.3

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-----chhhHHHHHHHHHHHhCCCCccceeeeEeec--CCee
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-----EGALNSFDAECEILKTIRHRNLVKIISSCTN--HNFK  735 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  735 (952)
                      .+|...+.||+|+||.||+|.. .+++.||+|++....     .+....+.+|+.++++++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3688899999999999999987 468999999886432     1234568899999999999999999998865  3577


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      +++|||+++++|.+++.... .+++.....++.|++.|++||   |+.+|+||||+|+||+++.++.+||+|||+++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~L---H~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999887644 588999999999999999999   78999999999999999999999999999998653


Q ss_pred             CcCc--ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          816 EEDS--MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       816 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      ....  .......++..|+|||++.+..++.++|||||||++||+++|+.||....... ....           .....
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-~~~~-----------~~~~~  225 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-AIFK-----------IATQP  225 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-HHHH-----------HhcCC
Confidence            2211  11122457889999999988889999999999999999999999986531111 0000           00000


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..       ...+..+++.+.+++ +||..+|++||+++||+++
T Consensus       226 ~~-------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         226 TN-------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             CC-------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            00       001223456677787 6888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.4e-35  Score=314.61  Aligned_cols=248  Identities=26%  Similarity=0.396  Sum_probs=201.7

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34667788999999999999874 58899999886443 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++++|.+++..  ..+++..+..++.|+++|++||   |+++++|+||+|+||++++++.++++|||++........ .
T Consensus        84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~l---H~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06642          84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYL---HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHH---hcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence            999999998864  3588999999999999999999   789999999999999999999999999999986643221 1


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      .....++..|+|||++.+..++.++|||||||++|||++|+.|+........  ..+.           .....      
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~-----------~~~~~------  218 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLI-----------PKNSP------  218 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhhh-----------hcCCC------
Confidence            2224578899999999888899999999999999999999999865322110  0000           00000      


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ...+..++.++.+++.+||+.+|++||++.|++++
T Consensus       219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         219 -PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             -CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence             00112346678999999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.3e-35  Score=328.78  Aligned_cols=252  Identities=24%  Similarity=0.346  Sum_probs=197.7

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|+.++.+++||+++++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999874 68999999986432   233467888999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~l---H~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI---HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            9999999999887544 689999999999999999999   799999999999999999999999999999875432110


Q ss_pred             c----------------------------------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCC
Q 002214          820 M----------------------------------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPT  865 (952)
Q Consensus       820 ~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~  865 (952)
                      .                                  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                  011246899999999999889999999999999999999999998


Q ss_pred             CccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCC---HHHHHHH
Q 002214          866 NEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN---TKEIISR  937 (952)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~~  937 (952)
                      ......+ .+....        .. .....  .+     .....++++.+++.+++. ||.+|++   +.|+.++
T Consensus       237 ~~~~~~~-~~~~i~--------~~-~~~~~--~p-----~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         237 CSETPQE-TYRKVM--------NW-KETLV--FP-----PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCHHH-HHHHHH--------cC-CCcee--cC-----CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            6532111 000000        00 00000  00     001245678889988764 9999995   6777665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.2e-34  Score=306.65  Aligned_cols=250  Identities=24%  Similarity=0.344  Sum_probs=204.5

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|+..+.||.|+||.||.++. .+++.||+|.+....  ....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478899999999999999986 468899999886542  34456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+++... ...+++.++..++.|++.|++||   |+.|++||||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI---HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999998765 34689999999999999999999   789999999999999999999999999999986644332 


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      ......+++.|+|||+..+..++.++||||||+++|||++|..||......+ ...           ........ .   
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-~~~-----------~~~~~~~~-~---  220 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-LVV-----------KIVQGNYT-P---  220 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-HHH-----------HHHcCCCC-C---
Confidence            2233568999999999888888999999999999999999999985421110 000           11101110 0   


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                          .+..++.++.+++.+||+.+|++||++.|++++.
T Consensus       221 ----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 ----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                1133567799999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.2e-34  Score=317.11  Aligned_cols=193  Identities=22%  Similarity=0.319  Sum_probs=158.3

Q ss_pred             cceecCccceEEEEEEeC---CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeec--CCeeEEEEEccC
Q 002214          669 ENLIGIGSYGSVYKGRFP---DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN--HNFKALVLEYMP  743 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  743 (952)
                      +.+||+|+||+||+|+..   +++.||+|.+.....  ...+.+|+.++++++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999864   457899998864332  3467899999999999999999998853  467899999996


Q ss_pred             CCChhHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee----CCCCcEEEeccccc
Q 002214          744 KGSLEDCMYAS--------NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIA  811 (952)
Q Consensus       744 ~g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill----~~~~~~kl~Dfgla  811 (952)
                      + +|.+++...        ...+++..+..++.|++.||+||   |+++|+||||||+||++    +.++.+||+|||+|
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            4 777766421        12578899999999999999999   79999999999999999    56789999999999


Q ss_pred             cccCCcCcc--cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002214          812 KLLSEEDSM--KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNE  867 (952)
Q Consensus       812 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~  867 (952)
                      +........  ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            876433221  1223568999999998866 4578999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.4e-35  Score=319.27  Aligned_cols=194  Identities=27%  Similarity=0.390  Sum_probs=170.3

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-C-----CccceeeeEeecCCeeEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIR-H-----RNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  737 (952)
                      +|.+.+.||+|+||.|-+|.+ ++++.||||+++.... ...+...|+++|..++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            889999999999999999987 5699999999976543 3456678999999996 4     379999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC--CCcEEEecccccccc
Q 002214          738 VLEYMPKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD--SMVAHLSDFGIAKLL  814 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgla~~~  814 (952)
                      |+|.+ .-+|.+++...+. +++...+..++.||+.||..|   |+.+|||+||||+|||+..  ...+||+|||.|+..
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L---~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFL---HELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99999 5599999987654 689999999999999999999   7999999999999999964  347999999999976


Q ss_pred             CCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNE  867 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  867 (952)
                      ...-.    ..+.+..|+|||++.+.+|+.+.||||||||++||++|.+-|..
T Consensus       342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            44322    46788999999999999999999999999999999999766644

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.7e-34  Score=307.13  Aligned_cols=246  Identities=27%  Similarity=0.490  Sum_probs=199.3

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      ++|++.+.||+|+||.||+|.. +++.||+|.++...  ..+.+.+|+.++++++|||++++++++...+ .++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence            5688999999999999999975 78889999986443  2367889999999999999999999987654 699999999


Q ss_pred             CCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          744 KGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       744 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      +++|.+++.... ..+++..+..++.|++.|++||   |+.|++||||||+||+++.++.+||+|||.+.......    
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL---ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            999999987643 3588999999999999999999   78999999999999999999999999999997543221    


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      .....+..|+|||++.++.++.++|||||||++|||++ |+.||......     ..        ...+.....      
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~--------~~~~~~~~~------  215 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EV--------KECVEKGYR------  215 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HH--------HHHHhCCCC------
Confidence            12234678999999988889999999999999999998 89998642211     10        011111100      


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                       ...+..++.++.+++.+||+.+|++||+++|+++.|++
T Consensus       216 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         216 -MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             00123456789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.4e-34  Score=311.94  Aligned_cols=269  Identities=27%  Similarity=0.348  Sum_probs=202.8

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ++|+..+.||+|+||.||+|++. +|+.||+|++....  ....+.+.+|+.++++++|||++++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999885 68999999886432  2233567899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |++++.+..+.... ..+++..+..++.|++.||+||   |+.|++||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFC---HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            99998888766543 3689999999999999999999   789999999999999999999999999999987644321 


Q ss_pred             cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccc--hhhhhccchhhhhhhcccc----
Q 002214          821 KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS--IKRWINDSLPAVMNIMDTN----  893 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~----  893 (952)
                      ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+..  ..+......+...+..+..    
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            1223457889999998765 45788999999999999999999998653322111  1111111111111111100    


Q ss_pred             -ccchhhH---HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 -LLSEDEE---HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 -~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       .......   .........+..+.+++.+||+.+|++||++.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence             0000000   0001112346789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-34  Score=342.67  Aligned_cols=255  Identities=18%  Similarity=0.305  Sum_probs=197.8

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeec--CCee
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTN--HNFK  735 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  735 (952)
                      ...++|.+.+.||+|+||+||+|++. ++..||+|++...  .......+..|+.++++++|||||++++++..  ....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34568999999999999999999874 5788999988643  23345678899999999999999999998854  3578


Q ss_pred             EEEEEccCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEeCCCCCCCeeeCC---------
Q 002214          736 ALVLEYMPKGSLEDCMYAS---NFNLDIFQRLGIMIDVASALEYLHFGH----SNPIVHCDIKPSNVLLDD---------  799 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~Lh~~h----~~~ivH~Dlk~~Nill~~---------  799 (952)
                      |+||||+++|+|.+++...   ...+++..++.|+.||+.||+|||...    .++||||||||+|||++.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999988652   246899999999999999999995321    256999999999999964         


Q ss_pred             --------CCcEEEeccccccccCCcCcccccccccccccccccccCc--CCcCcccchHhHHHHHHHHHhCCCCCCccc
Q 002214          800 --------SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE--GQVSIKGDVYNYGIMLMEVFTGMKPTNEFF  869 (952)
Q Consensus       800 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  869 (952)
                              .+.+||+|||++..+....  ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                    3358999999998664322  1233568999999998754  458899999999999999999999986421


Q ss_pred             cCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          870 TGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ....++        ..+....        .......+.++.+||..||..+|.+||++.|++++
T Consensus       248 ----~~~qli--------~~lk~~p--------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        248 ----NFSQLI--------SELKRGP--------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             ----cHHHHH--------HHHhcCC--------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence                111111        0000000        00012346779999999999999999999999853

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-34  Score=319.56  Aligned_cols=271  Identities=20%  Similarity=0.317  Sum_probs=198.9

Q ss_pred             ccceecCc--cceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          668 EENLIGIG--SYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       668 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      +.++||+|  +|++||+++. .+|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7889999987 578999999986543  233456788999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          743 PKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       743 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      ++|+|.+++... ...+++..+..++.|++.||+||   |+++|+||||||+||+++.++.++++|||.+..........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999998654 33589999999999999999999   78999999999999999999999999998765432211100


Q ss_pred             ------ccccccccccccccccCc--CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhh-----
Q 002214          822 ------QTQTLATIGYIAPEYGRE--GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMN-----  888 (952)
Q Consensus       822 ------~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  888 (952)
                            .....++..|+|||++.+  ..++.++|||||||++|||++|+.||........ .........+...+     
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhcCCccccccccchh
Confidence                  111346778999999875  3588999999999999999999999975322111 11111111100000     


Q ss_pred             -----------hccccc----------cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHH
Q 002214          889 -----------IMDTNL----------LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR--LIKIR  942 (952)
Q Consensus       889 -----------~~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~i~  942 (952)
                                 ..+...          ..............+++++.+++.+||+.||++|||++|++++  +++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                       000000          0000000000122356789999999999999999999999874  55544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.9e-34  Score=306.12  Aligned_cols=250  Identities=28%  Similarity=0.565  Sum_probs=202.5

Q ss_pred             CCccceecCccceEEEEEEeCC-----CcEEEEEEeeccCch-hhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          666 FSEENLIGIGSYGSVYKGRFPD-----GIEVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      +.+.+.||+|+||.||+|+..+     +..||+|+++..... ..+.+..|++++++++||||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999998743     488999998655433 4578899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          740 EYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      ||+++++|.+++...... +++.++..++.|++.|++||   |+.+++||||+|+||+++.++.++++|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---h~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHH---hcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999998765544 89999999999999999999   89999999999999999999999999999998765543


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      ........+++.|+|||...+..++.++||||+|+++|||++ |..||.....  ....+.           +...... 
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~-----------~~~~~~~-  223 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEY-----------LKKGYRL-  223 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH-----------HhcCCCC-
Confidence            333222347789999999988889999999999999999999 7788754111  001000           0000000 


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                            ..+..++.++.+++.+|+..+|++|||+.|+++.|
T Consensus       224 ------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 ------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                  01223577899999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-34  Score=314.43  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=202.3

Q ss_pred             HHHHHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEee---
Q 002214          656 HDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCT---  730 (952)
Q Consensus       656 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---  730 (952)
                      .+.+..+.++|++.+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.+++++ +|||++++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            344556788999999999999999999987 4688999998754322 235678899999999 6999999999874   


Q ss_pred             --cCCeeEEEEEccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEE
Q 002214          731 --NHNFKALVLEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL  805 (952)
Q Consensus       731 --~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl  805 (952)
                        .++..++||||+++++|.+++..   ....+++..+..++.|+++|+.||   |+.+|+||||||+||++++++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL---HVNKTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH---HhCCccccCCCHHhEEECCCCCEEE
Confidence              34568999999999999988753   234688899999999999999999   7899999999999999999999999


Q ss_pred             eccccccccCCcCcccccccccccccccccccCc-----CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc
Q 002214          806 SDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE-----GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN  880 (952)
Q Consensus       806 ~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~  880 (952)
                      +|||+++...... .......+++.|+|||++..     ..++.++||||+||++|||++|+.||....... .......
T Consensus       166 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~~~~~  243 (286)
T cd06638         166 VDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALFKIPR  243 (286)
T ss_pred             ccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHhhccc
Confidence            9999998664322 22233468999999998753     457889999999999999999999986532111 0000000


Q ss_pred             cchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          881 DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      ..        ....         ..+..++.++.+++.+||+.||++||++.|++++.
T Consensus       244 ~~--------~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         244 NP--------PPTL---------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             cC--------CCcc---------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            00        0000         01122456799999999999999999999999763

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.8e-35  Score=314.88  Aligned_cols=268  Identities=22%  Similarity=0.302  Sum_probs=200.3

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|.+.+.||+|+||.||+|+.. +|+.||+|.++...  ......+.+|+.++++++|||++++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999884 68999999986542  22235678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      ++ ++|.+++......+++..+..++.||++||+||   |+++|+||||||+||+++.++.+||+|||+++....... .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~  155 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC---HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C  155 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence            96 578887776556799999999999999999999   789999999999999999999999999999986543221 1


Q ss_pred             ccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cc----hhhhhhhcccc
Q 002214          822 QTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DS----LPAVMNIMDTN  893 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~----~~~~~~~~~~~  893 (952)
                      .....+++.|+|||++.+. .++.++|||||||++|||+||+.|+.........+.....   ..    .+......+..
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            2234578899999987664 4688999999999999999999986432221111111100   00    00000000000


Q ss_pred             ccchhhH--HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEE--HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .......  ........+++++.+++.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            0000000  0011122356789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-35  Score=310.54  Aligned_cols=255  Identities=21%  Similarity=0.323  Sum_probs=202.8

Q ss_pred             HHhccCCccceecCccceEEEEEEeCCCcEEEEEEeec--cCchhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHL--QREGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  737 (952)
                      .....|++.++||+||.+.||++...+.+.||+|++..  .+.+....|..|+..|.+++ |.+||++++|-..++..||
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            34457899999999999999999998888899987643  34556778999999999995 8999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||- ..+|..++...........+..+..|++.|+.++   |+.||||.||||.|+|+-. |.+||+|||.|..+..+
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~I---H~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTI---HQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---HHhceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            99987 4599999988766555347888999999999999   8999999999999999965 58999999999987654


Q ss_pred             Cc-ccccccccccccccccccCcC-----------CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhh
Q 002214          818 DS-MKQTQTLATIGYIAPEYGREG-----------QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA  885 (952)
Q Consensus       818 ~~-~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  885 (952)
                      .. ......+||+.||+||.+...           ..+.++||||+||++|+|+.|+.||+.....           ...
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-----------~aK  581 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-----------IAK  581 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-----------HHH
Confidence            32 233456899999999976432           2568899999999999999999999764221           112


Q ss_pred             hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +..+.+++...+.++.    ++  ..++.++|+.||..||.+||+..|++++
T Consensus       582 l~aI~~P~~~Iefp~~----~~--~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  582 LHAITDPNHEIEFPDI----PE--NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HHhhcCCCccccccCC----CC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            3334444332222211    11  2348999999999999999999999875

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-34  Score=324.85  Aligned_cols=267  Identities=20%  Similarity=0.218  Sum_probs=198.4

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecC-----
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNH-----  732 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  732 (952)
                      ...++|.+.+.||+|+||.||+|.+. .++.||||++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            34578999999999999999999874 6889999998643  233346788999999999999999999987543     


Q ss_pred             -CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccc
Q 002214          733 -NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA  811 (952)
Q Consensus       733 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  811 (952)
                       ...|+||||+++ ++.+.+..   .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||++
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence             357999999965 67666643   478899999999999999999   7999999999999999999999999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhhhhh
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPAVMN  888 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~  888 (952)
                      +......  ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+...+.   ...++...
T Consensus       174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence            8653321  223356899999999999889999999999999999999999998653211 11111110   00011100


Q ss_pred             --------hcccccc-chh--h--------HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          889 --------IMDTNLL-SED--E--------EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       889 --------~~~~~~~-~~~--~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                              .+..... ...  .        ..........+.++.+++.+|++.||++|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                    0000000 000  0        00000011124578999999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.4e-34  Score=308.76  Aligned_cols=250  Identities=21%  Similarity=0.327  Sum_probs=189.3

Q ss_pred             ceecCccceEEEEEEeCC---CcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCC
Q 002214          670 NLIGIGSYGSVYKGRFPD---GIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKG  745 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  745 (952)
                      +.||+|+||.||+|...+   ...+|+|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997533   4578888775443 233456889999999999999999999999999999999999999


Q ss_pred             ChhHHhhhcCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc-
Q 002214          746 SLEDCMYASNF----NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM-  820 (952)
Q Consensus       746 ~L~~~l~~~~~----~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-  820 (952)
                      +|.+++.....    ..++.....++.|++.|++||   |+++|+||||||+||++++++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL---HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHH---HhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999876432    346778899999999999999   7899999999999999999999999999999754332221 


Q ss_pred             cccccccccccccccccCc-------CCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          821 KQTQTLATIGYIAPEYGRE-------GQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                      ......+++.|+|||+...       ..++.++|||||||++|||++ |..||......+ .........        +.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~--------~~  228 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQ--------DI  228 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhcc--------Cc
Confidence            1223346778999998642       356789999999999999999 778875432111 111100000        00


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      .+.      ....+..++..+.+++..|| .||++||+++||++.|
T Consensus       229 ~~~------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         229 KLP------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             cCC------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            000      00112345677888999999 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=350.13  Aligned_cols=461  Identities=30%  Similarity=0.380  Sum_probs=317.3

Q ss_pred             EEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCcc
Q 002214           37 SLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNL  116 (952)
Q Consensus        37 ~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~  116 (952)
                      .+|+++..++ .||..+-.-..++.|++++|.+-...-+.+.+.-+|+.|+|++|++. ..|..+..+.+|+.|+++.|-
T Consensus         2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~   79 (1081)
T KOG0618|consen    2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY   79 (1081)
T ss_pred             CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence            4688888887 89998888888999999999876333344555666999999999998 899999999999999999999


Q ss_pred             CccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCC
Q 002214          117 LTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLP  196 (952)
Q Consensus       117 l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  196 (952)
                      +. .+|.+..++..+ ++|+|.+|.+. ..|.++ ..+.+|+.|+++.|++. .+|..+..+..++.+..++|.....  
T Consensus        80 i~-~vp~s~~~~~~l-~~lnL~~n~l~-~lP~~~-~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~--  152 (1081)
T KOG0618|consen   80 IR-SVPSSCSNMRNL-QYLNLKNNRLQ-SLPASI-SELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR--  152 (1081)
T ss_pred             Hh-hCchhhhhhhcc-hhheeccchhh-cCchhH-HhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh--
Confidence            99 888777766654 77778877776 566554 45677778888888777 6777777777777777777722212  


Q ss_pred             ccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCC
Q 002214          197 RDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGL  276 (952)
Q Consensus       197 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l  276 (952)
                        ++... .+.++|..|.+.+.++..+..++.  .|+|++|++..   -.+..+..|+.|.++.|++...      -...
T Consensus       153 --lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~---~dls~~~~l~~l~c~rn~ls~l------~~~g  218 (1081)
T KOG0618|consen  153 --LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV---LDLSNLANLEVLHCERNQLSEL------EISG  218 (1081)
T ss_pred             --hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhhh---hhhhhccchhhhhhhhcccceE------EecC
Confidence              22222 777888888877777777777776  78888887762   2355677788888888887633      2234


Q ss_pred             CCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEE
Q 002214          277 PNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLS  356 (952)
Q Consensus       277 ~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~  356 (952)
                      ++|+.|+.++|.++...+.             ....+|+.+++++|.+..+| +.              ++.+.+|+.+.
T Consensus       219 ~~l~~L~a~~n~l~~~~~~-------------p~p~nl~~~dis~n~l~~lp-~w--------------i~~~~nle~l~  270 (1081)
T KOG0618|consen  219 PSLTALYADHNPLTTLDVH-------------PVPLNLQYLDISHNNLSNLP-EW--------------IGACANLEALN  270 (1081)
T ss_pred             cchheeeeccCcceeeccc-------------cccccceeeecchhhhhcch-HH--------------HHhcccceEec
Confidence            6788888888888733322             12346667777777666666 32              34455666666


Q ss_pred             ccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCcc------------------
Q 002214          357 LGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCL------------------  418 (952)
Q Consensus       357 L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------------------  418 (952)
                      ..+|+++ .+|..+....+|+.|.+..|.+. -+|....+++.|+.|+|..|+|....+..+                  
T Consensus       271 ~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~  348 (1081)
T KOG0618|consen  271 ANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS  348 (1081)
T ss_pred             ccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc
Confidence            6666664 45555555555555655555555 344444455556666665555552222111                  


Q ss_pred             -------CCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCccccc
Q 002214          419 -------GDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTII  491 (952)
Q Consensus       419 -------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  491 (952)
                             ..++.|+.|++.+|.++.-.-..+.+.+.|+.|+|++|+|.......+.++..|++|+||+|+++ .+|..+.
T Consensus       349 ~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva  427 (1081)
T KOG0618|consen  349 TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVA  427 (1081)
T ss_pred             ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHH
Confidence                   22345677777777777655556677777777777777777555556677777777777777777 5667777


Q ss_pred             CCCCCceEEccCccccCcccccccccccccEEeCCCCcccccC-ccchhccccccccccccccc
Q 002214          492 GLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVI-PASLEKLLYLKSLNLSFNKL  554 (952)
Q Consensus       492 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~l~~N~l  554 (952)
                      .++.|++|...+|+|. ..| .+..++.|+.+|+|.|+|+... |... ..++|++|||+||..
T Consensus       428 ~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~-p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  428 NLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL-PSPNLKYLDLSGNTR  488 (1081)
T ss_pred             hhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC-CCcccceeeccCCcc
Confidence            7777777777777777 455 6777777777777777776432 3222 226777777777774

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-34  Score=308.16  Aligned_cols=237  Identities=25%  Similarity=0.455  Sum_probs=189.8

Q ss_pred             ceecCccceEEEEEEeCC-C----------cEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          670 NLIGIGSYGSVYKGRFPD-G----------IEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      +.||+|+||.||+|.+.+ +          ..||+|.+...... ...+.+|+.++++++|||++++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            468999999999998854 2          25788877544433 5788999999999999999999999987 778999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC-------cEEEeccccc
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-------VAHLSDFGIA  811 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~-------~~kl~Dfgla  811 (952)
                      |||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++       .+|++|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL---EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            999999999999987665789999999999999999999   799999999999999999888       7999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcC--CcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhh
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREG--QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMN  888 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  888 (952)
                      .....     .....++..|+|||++.+.  .++.++||||||+++||+++ |..||......  ....+..        
T Consensus       156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~--------  220 (259)
T cd05037         156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQ--------  220 (259)
T ss_pred             ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHh--------
Confidence            86543     1224467789999998776  78899999999999999999 56776543211  1111100        


Q ss_pred             hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       889 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                        .....          +.....++.+++.+||..+|++||++.|+++.|
T Consensus       221 --~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 --DQHRL----------PMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             --cCCCC----------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence              00000          001125689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.9e-34  Score=308.72  Aligned_cols=254  Identities=25%  Similarity=0.407  Sum_probs=199.0

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc----------hhhHHHHHHHHHHHhCCCCccceeeeEeecCC
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE----------GALNSFDAECEILKTIRHRNLVKIISSCTNHN  733 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  733 (952)
                      +|...+.||+|+||.||+|.. .+|+.||+|.++....          ...+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            477889999999999999986 4689999998753211          11346788999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ..++||||+++++|.+++.... .+++..+..++.|++.|+.||   |+++++||||+|+||++++++.++++|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYL---HSKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHH---hhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999987653 689999999999999999999   789999999999999999999999999999986


Q ss_pred             cCCcCcc-cccccccccccccccccCcCC--cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          814 LSEEDSM-KQTQTLATIGYIAPEYGREGQ--VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       814 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      ....... ......++..|+|||......  ++.++||||||+++||+++|..||......    ..+.        +..
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~--------~~~  225 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----AAMF--------KLG  225 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----HHHH--------Hhh
Confidence            5322111 122345788999999877654  789999999999999999999998542111    1110        000


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .........   ......++.++.+++.+||.++|++||++.+|+++
T Consensus       226 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         226 NKRSAPPIP---PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ccccCCcCC---ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            000000000   00112356789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.8e-34  Score=306.20  Aligned_cols=248  Identities=24%  Similarity=0.364  Sum_probs=201.9

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-----chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-----EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      +|+..+.||+|+||.||+|... +++.||+|.+....     ....+.+.+|+.++++++|||++++++++..+...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999885 78999999886543     22456788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++++|.+++.... .+++..+..++.|++.|++||   |+.|++||||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYL---HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999987654 588999999999999999999   78999999999999999999999999999998654332


Q ss_pred             cccccccccccccccccccCcCC-cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQ-VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                        ......++..|+|||...... ++.++|+||||+++|++++|+.||........ ..++           .....   
T Consensus       157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~-~~~~-----------~~~~~---  219 (258)
T cd06632         157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-VFKI-----------GRSKE---  219 (258)
T ss_pred             --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH-HHHH-----------Hhccc---
Confidence              123355888999999887666 88999999999999999999999866321110 0000           00000   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ....+..++.++.+++.+||+.+|++||++.+++++
T Consensus       220 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         220 ----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                001123356778999999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.6e-34  Score=305.96  Aligned_cols=252  Identities=23%  Similarity=0.394  Sum_probs=200.4

Q ss_pred             cCCccceecCccceEEEEEEeCC--CcEEEEEEeecc----------CchhhHHHHHHHHHHHh-CCCCccceeeeEeec
Q 002214          665 QFSEENLIGIGSYGSVYKGRFPD--GIEVAIKVFHLQ----------REGALNSFDAECEILKT-IRHRNLVKIISSCTN  731 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  731 (952)
                      .|++.+.||+|+||.||+|....  ++.+|+|.+...          ......++.+|+.++.+ ++|||++++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37788999999999999999854  788999987532          12234557788888875 799999999999999


Q ss_pred             CCeeEEEEEccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecc
Q 002214          732 HNFKALVLEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDF  808 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Df  808 (952)
                      ++..++||||+++++|.+++..   ....+++..++.++.|++.|++|||  +..+++||||+|+||++++++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc--cCCceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999988743   3446899999999999999999993  2478999999999999999999999999


Q ss_pred             ccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhh
Q 002214          809 GIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMN  888 (952)
Q Consensus       809 gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  888 (952)
                      |.+.......  ......++..|+|||+..+..++.++||||||+++|||++|+.||.....     .....       .
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~-------~  224 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLAT-------K  224 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHH-------H
Confidence            9998765433  22345688999999999888899999999999999999999999854211     00000       0


Q ss_pred             hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       889 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                      .... ....      .....+++++.+++.+||+.||++||++.|+..+++
T Consensus       225 ~~~~-~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         225 IVEA-VYEP------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             Hhhc-cCCc------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            0000 0000      011234677999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4e-34  Score=306.20  Aligned_cols=251  Identities=26%  Similarity=0.394  Sum_probs=202.1

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|...+.||+|+||.||+|... +++.||+|.++....  ...+.+..|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999874 689999999876544  2567899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++++|.+++.... .+++..+..++.|+++|++||   |+.||+||||+|+||++++++.+||+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYL---HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999987653 578999999999999999999   78999999999999999999999999999998765433222


Q ss_pred             cc---ccccccccccccccCcCC---cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          822 QT---QTLATIGYIAPEYGREGQ---VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       822 ~~---~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ..   ...+++.|+|||++.+..   ++.++||||||+++||+++|+.||........ .......         ...  
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~~~~---------~~~--  224 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFHVGA---------GHK--  224 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHHHhc---------CCC--
Confidence            11   245788999999987766   88999999999999999999999865321110 0000000         000  


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                      ...+     ....++..+.+++.+||+.+|++||++.|++.
T Consensus       225 ~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIP-----DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCC-----cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000     01123667889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.6e-34  Score=304.43  Aligned_cols=249  Identities=25%  Similarity=0.355  Sum_probs=199.9

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeec-CCeeEEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTN-HNFKALVLE  740 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  740 (952)
                      .|++.+.||+|++|.||++... +++.||+|.+....  ....+.+.+|+.++++++|||++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999874 57899999986543  2344678899999999999999999988764 446789999


Q ss_pred             ccCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          741 YMPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |+++++|.+++... ...+++.++..++.|++.|++||   |++|++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~l---H~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL---HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999988764 33589999999999999999999   799999999999999999999999999999986643222


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                       ......+++.|+|||+..+..++.++||||||++++++++|+.||....... .......            ....   
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~------------~~~~---  220 (257)
T cd08223         158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-LVYRIIE------------GKLP---  220 (257)
T ss_pred             -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHh------------cCCC---
Confidence             2223458899999999998889999999999999999999999985421100 0000000            0000   


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ..+...++++.+++.+||+.+|++||++.|++++
T Consensus       221 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         221 ----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                0122346779999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.9e-34  Score=304.77  Aligned_cols=249  Identities=21%  Similarity=0.314  Sum_probs=202.8

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|++.+.||+|+||.||++.. .+|+.||+|.+...  .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588899999999999999987 46899999998643  233446789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+.+.... ..+++.++..++.|++.|++||   |+.+++|+||+|+||+++.++.++++|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999887643 3578999999999999999999   789999999999999999999999999999986643322 


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      ......+++.|+|||+..+..++.++|||||||+++++++|+.||......+ ....+           .....      
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-~~~~~-----------~~~~~------  218 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-LVLKI-----------IRGSY------  218 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-HHHHH-----------hcCCC------
Confidence            1223457889999999988889999999999999999999999985421100 00010           00000      


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                        ...+..++.++.+++.+||+.+|++||++.||+++
T Consensus       219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         219 --PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             --CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              00123456789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.6e-34  Score=305.60  Aligned_cols=256  Identities=26%  Similarity=0.424  Sum_probs=205.7

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ++|++.+.||.|+||+||+|.. .++..||+|++.... ....+.+.+|+.+++.++|+|++++++.+..+...++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4688999999999999999986 468899999986433 23457789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          742 MPKGSLEDCMYASN--FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       742 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      +++++|.+.+....  ..+++..+..++.|++.|++||   |+.|++||||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---h~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL---HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999987642  3689999999999999999999   799999999999999999999999999999987654332


Q ss_pred             c---cccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          820 M---KQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       820 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      .   ......++..|+|||++... .++.++|||||||++|||++|+.||....... .+.+......+        .. 
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~--------~~-  227 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPP--------SL-  227 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCC--------Cc-
Confidence            2   11224588999999988776 78999999999999999999999987542211 11111111000        00 


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..     ......++.++.+++.+||..||++||++.|++++
T Consensus       228 ~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         228 ET-----GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CC-----ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00     00012456789999999999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.3e-34  Score=334.71  Aligned_cols=269  Identities=19%  Similarity=0.244  Sum_probs=193.4

Q ss_pred             HHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCC------CccceeeeEeec
Q 002214          659 LLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRH------RNLVKIISSCTN  731 (952)
Q Consensus       659 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~  731 (952)
                      +....++|++.+.||+|+||+||+|.+ .+++.||||+++... .....+..|+.+++.++|      ++++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            344567899999999999999999987 468899999986432 223456678888877754      458888888865


Q ss_pred             C-CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCeeeCCCC--------
Q 002214          732 H-NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS-NPIVHCDIKPSNVLLDDSM--------  801 (952)
Q Consensus       732 ~-~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~-~~ivH~Dlk~~Nill~~~~--------  801 (952)
                      + +..++|||++ +++|.+++...+ .+++..+..++.||+.||+||   |+ .||+||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yL---H~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYF---HTELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhcCCeecCCCCHHHEEEecCCcccccccc
Confidence            4 5788999998 778888876543 689999999999999999999   55 6999999999999998765        


Q ss_pred             --------cEEEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCcc
Q 002214          802 --------VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM  873 (952)
Q Consensus       802 --------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  873 (952)
                              .+||+|||.+....    ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  353 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH  353 (467)
T ss_pred             cccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                    49999999886432    122346799999999999999999999999999999999999999965321110


Q ss_pred             --chh--------hhhccc-hhhhhhhcccc--ccch-hhH-H------HHHhhhhhHHHHHHHHhhccccCCCCCCCHH
Q 002214          874 --SIK--------RWINDS-LPAVMNIMDTN--LLSE-DEE-H------ANVAKQSCASSVLSLAMECTSESPENRVNTK  932 (952)
Q Consensus       874 --~~~--------~~~~~~-~~~~~~~~~~~--~~~~-~~~-~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  932 (952)
                        .+.        .|.... .++....++..  +... ... .      .........+.+.+|+.+||..||++|||+.
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence              000        011000 00000111000  0000 000 0      0000011245688999999999999999999


Q ss_pred             HHHHH
Q 002214          933 EIISR  937 (952)
Q Consensus       933 ev~~~  937 (952)
                      |+++|
T Consensus       434 e~L~H  438 (467)
T PTZ00284        434 QMTTH  438 (467)
T ss_pred             HHhcC
Confidence            99874

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.7e-34  Score=307.72  Aligned_cols=253  Identities=25%  Similarity=0.330  Sum_probs=204.7

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ++|+..+.||+|+||.||+|.++ +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778889999999999999885 68999999886553 33456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS-NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~-~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+++......+++.....++.|++.|++||   |+ .|++||||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL---HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---cCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            999999999987656789999999999999999999   78 9999999999999999999999999999976533221 


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                        ....++..|+|||+..+..++.++||||||+++|+|++|+.||..............       .........     
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~-----  222 (265)
T cd06605         157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL-------QYIVNEPPP-----  222 (265)
T ss_pred             --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH-------HHHhcCCCC-----
Confidence              115688899999999888999999999999999999999999865322111111111       000100000     


Q ss_pred             HHHHhhh-hhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          901 HANVAKQ-SCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       901 ~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ..+. .++.++.+++.+||..+|++|||+.|++++
T Consensus       223 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         223 ---RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ---CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence               0011 156779999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.3e-34  Score=308.90  Aligned_cols=247  Identities=24%  Similarity=0.468  Sum_probs=196.6

Q ss_pred             ceecCccceEEEEEEeCC-------CcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          670 NLIGIGSYGSVYKGRFPD-------GIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +.||+|+||.||+|+..+       ++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       3579999875443 23456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC-----cEEEecccc
Q 002214          742 MPKGSLEDCMYAS------NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-----VAHLSDFGI  810 (952)
Q Consensus       742 ~~~g~L~~~l~~~------~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~-----~~kl~Dfgl  810 (952)
                      +++++|.+++...      ...+++.++..++.|++.|++||   |+.+++||||+|+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL---EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH---HhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998652      22478899999999999999999   789999999999999999887     899999999


Q ss_pred             ccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhh
Q 002214          811 AKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMN  888 (952)
Q Consensus       811 a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  888 (952)
                      ++......... .....++..|+|||++.++.++.++|||||||++|||++ |+.||......  .....          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~----------  225 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQH----------  225 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHH----------
Confidence            98654332211 122346788999999998899999999999999999998 99998542111  11110          


Q ss_pred             hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       889 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                       ++...       ....+..++.++.+++.+||..+|++||++.+|.+.|+
T Consensus       226 -~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         226 -VTAGG-------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -HhcCC-------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             01000       00112345778999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.8e-34  Score=305.66  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=197.2

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-----chhhHHHHHHHHHHHhCCCCccceeeeEeecC--Cee
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-----EGALNSFDAECEILKTIRHRNLVKIISSCTNH--NFK  735 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  735 (952)
                      ++|++.+.||+|+||.||+|.. ++|+.||+|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4788999999999999999987 468999999875332     12345788999999999999999999988663  467


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||+++++|.+++.... .+++.....++.|++.||+||   |+++++||||||+||+++.++.++|+|||.+....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYL---HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999887553 578889999999999999999   78999999999999999999999999999998654


Q ss_pred             CcCcc--cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          816 EEDSM--KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       816 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      .....  ......++..|+|||...+..++.++|||||||++||+++|+.||....... ...+           .....
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~-----------~~~~~  225 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-AIFK-----------IATQP  225 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-HHHH-----------HhcCC
Confidence            32111  1122458889999999888889999999999999999999999986431110 0000           00000


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .       ....+...+..+.+++.+|+. +|++||+++|++++
T Consensus       226 ~-------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         226 T-------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             C-------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            0       001123345678899999995 99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.5e-34  Score=311.05  Aligned_cols=250  Identities=27%  Similarity=0.366  Sum_probs=204.2

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      ++|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5788999999999999999986 468899999987655555677899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      ++++|.+++...  .+++..+..++.|++.|++||   |++|++||||+|+||+++.++.+||+|||++........ ..
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~L---H~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~  172 (293)
T cd06647          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  172 (293)
T ss_pred             CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence            999999988654  478899999999999999999   799999999999999999999999999999876543322 22


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ....+++.|+|||......++.++||||||+++|++++|+.||......+... .+.....+.            .    
T Consensus       173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~------------~----  235 (293)
T cd06647         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPE------------L----  235 (293)
T ss_pred             ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-ehhcCCCCC------------C----
Confidence            23458889999999888888999999999999999999999986532211100 000000000            0    


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ..+...+..+.+++.+||..+|++||++.+++.+
T Consensus       236 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         236 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0112345678999999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.9e-34  Score=312.72  Aligned_cols=269  Identities=28%  Similarity=0.376  Sum_probs=202.0

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ++|++.+.||+|+||.||+|.++ +++.||+|++....  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999985 58999999875432  2234568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |++++++..+.... ..+++..+..++.|+++|++||   |+.|++|||++|+||++++++.++|+|||++....... .
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~L---H~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~  155 (286)
T cd07846          81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFC---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E  155 (286)
T ss_pred             cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-c
Confidence            99999888766543 3589999999999999999999   78899999999999999999999999999998654332 2


Q ss_pred             cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCcc--chhhhhccchhhhhhhcccc----
Q 002214          821 KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM--SIKRWINDSLPAVMNIMDTN----  893 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~----  893 (952)
                      ......++..|+|||+..+ ..++.++||||||+++|||++|+.||......+.  ....+.....+.....++..    
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            2223457889999998765 4577899999999999999999988854221110  01111111111111111100    


Q ss_pred             --ccchhh--HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 --LLSEDE--EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 --~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                        ......  .......+.++..+.+++.+||+.+|++||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence              000000  00011123567889999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-34  Score=310.07  Aligned_cols=270  Identities=22%  Similarity=0.329  Sum_probs=199.5

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            357889999999999999999875 689999999865432 223456789999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+++ +|.+++......+++.....++.|+++||+||   |+++|+||||||+||++++++.+||+|||+++........
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC---HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            9974 89998877666789999999999999999999   7899999999999999999999999999999754322111


Q ss_pred             cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhhh-hhhcc----
Q 002214          821 KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPAV-MNIMD----  891 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~-~~~~~----  891 (952)
                       .....++..|+|||+..+ ..++.++||||+|+++|||++|+.||..............   ....+.. .....    
T Consensus       160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence             122346889999998765 4578899999999999999999999865321111111100   0000000 00000    


Q ss_pred             --cc--ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 --TN--LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 --~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                        ..  ..................++.+++.+|++.+|++||++.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence              00  00000000000001112678899999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-34  Score=311.04  Aligned_cols=270  Identities=26%  Similarity=0.346  Sum_probs=204.0

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ++|++.+.||+|+||.||+|.+. +++.||+|+++...  ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999885 58899999886432  3334678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |++++.+..+.. ....+++.++..++.|++.|++||   |+.+++|||++|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYC---HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            998876665544 344689999999999999999999   7899999999999999999999999999999876544332


Q ss_pred             cccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccc--hhhhhccchhhhhhhcccc--cc
Q 002214          821 KQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS--IKRWINDSLPAVMNIMDTN--LL  895 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~  895 (952)
                      ......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+..  .........+.....+...  ..
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            23345678899999998887 7899999999999999999999998653211100  0000111111100000000  00


Q ss_pred             -----c-h-hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          896 -----S-E-DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       896 -----~-~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           . . ........+..++.++.+++++||+.+|++||++++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                 0 0 0000011123357889999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.7e-34  Score=311.11  Aligned_cols=259  Identities=25%  Similarity=0.343  Sum_probs=201.8

Q ss_pred             HHHHHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecC-
Q 002214          656 HDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNH-  732 (952)
Q Consensus       656 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  732 (952)
                      .+++..+.++|.+.+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.+++++ +|||++++++++... 
T Consensus        14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            344555678999999999999999999987 4688999999864322 235678899999999 899999999998653 


Q ss_pred             ----CeeEEEEEccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEE
Q 002214          733 ----NFKALVLEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL  805 (952)
Q Consensus       733 ----~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl  805 (952)
                          +..++||||+++++|.+++..   ....+++..+..++.|++.|++||   |+.|++||||||+||+++.++.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL---HNNRIIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCEEE
Confidence                358999999999999998753   334689999999999999999999   7899999999999999999999999


Q ss_pred             eccccccccCCcCcccccccccccccccccccCcC-----CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc
Q 002214          806 SDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG-----QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN  880 (952)
Q Consensus       806 ~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~  880 (952)
                      +|||++........ ......++..|+|||.+...     .++.++|||||||++|||++|+.||....... ...++..
T Consensus       170 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~~~~  247 (291)
T cd06639         170 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFKIPR  247 (291)
T ss_pred             eecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHHHhc
Confidence            99999986543222 12234588899999987543     36789999999999999999999986532111 1111111


Q ss_pred             cchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          881 DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...+.        .         ..+...+.++.+++.+||+.+|++||++.|++++
T Consensus       248 ~~~~~--------~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         248 NPPPT--------L---------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             CCCCC--------C---------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            10000        0         0012234568999999999999999999999874

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.1e-34  Score=309.24  Aligned_cols=259  Identities=23%  Similarity=0.361  Sum_probs=202.8

Q ss_pred             CHHHHHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeec-
Q 002214          655 SHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTN-  731 (952)
Q Consensus       655 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  731 (952)
                      +..+...+.+.|++.+.||+|+||.||+|.+ .+++.||+|++..... ....+..|+.+++++ +|||++++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            4445555678899999999999999999987 4689999999865433 345688899999998 69999999998853 


Q ss_pred             -----CCeeEEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEE
Q 002214          732 -----HNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL  805 (952)
Q Consensus       732 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl  805 (952)
                           ....+++|||+++|+|.+++.... ..+++..+..++.|++.|++||   |+.+|+|||++|+||++++++.++|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL---HAHKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEE
Confidence                 457899999999999999887543 3578888999999999999999   7899999999999999999999999


Q ss_pred             eccccccccCCcCcccccccccccccccccccC-----cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc
Q 002214          806 SDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR-----EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN  880 (952)
Q Consensus       806 ~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~  880 (952)
                      +|||++........ ......+++.|+|||.+.     ...++.++|||||||++|||++|+.||...........    
T Consensus       163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----  237 (282)
T cd06636         163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----  237 (282)
T ss_pred             eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh----
Confidence            99999876532211 122356889999999875     34578899999999999999999999865321111000    


Q ss_pred             cchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          881 DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           .......          ......++.++.+++.+||+.||.+||++.|++++
T Consensus       238 -----~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         238 -----IPRNPPP----------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -----HhhCCCC----------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                 0000000          00112356789999999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.2e-34  Score=308.71  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=193.3

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-hhhHHHHHHHHH-HHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECEI-LKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ++|++.+.||+|+||.||+|++. +|+.||+|+++.... .....+..|..+ ++..+|||++++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999884 699999999865432 223455556665 566789999999999999999999999


Q ss_pred             ccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          741 YMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSN-PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       741 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~-~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      |++ |+|.+++..   ....+++..++.++.|++.|++||   |++ +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL---HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 688777654   234689999999999999999999   676 999999999999999999999999999986533


Q ss_pred             cCcccccccccccccccccccCc----CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGRE----GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                      ..  ......++..|+|||.+.+    ..++.++|+|||||++|||++|+.||............           ....
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----------~~~~  223 (283)
T cd06617         157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ-----------VVEE  223 (283)
T ss_pred             cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH-----------HHhc
Confidence            21  1222457889999998754    45688999999999999999999998642211111111           1100


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .. ..      .....++.++.+++.+||..+|++||++.+++++
T Consensus       224 ~~-~~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         224 PS-PQ------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             CC-CC------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00 00      0012356789999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.8e-34  Score=309.55  Aligned_cols=270  Identities=22%  Similarity=0.284  Sum_probs=199.3

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++|+||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            357899999999999999999987 468999999986543 223346788999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+. +++.+.+......+.+..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI---HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 677777765555678889999999999999999   788999999999999999999999999999976433221


Q ss_pred             ccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchh----------h
Q 002214          820 MKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLP----------A  885 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~----------~  885 (952)
                       ......+++.|+|||++.+. .++.++|||||||++|||++|+.||.........+.+...   ...+          .
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence             12234578899999988653 4788999999999999999999998653221111111000   0000          0


Q ss_pred             hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .............. .........+.++.+++.+|+..||++|||+.|++.+
T Consensus       238 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         238 YKPEWFLPCKPQQL-RVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccchhccccCCcch-hhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            00000000000000 0000001125678999999999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.4e-34  Score=302.61  Aligned_cols=248  Identities=24%  Similarity=0.398  Sum_probs=201.1

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+....  ......+.+|++++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999987 468899999986542  33456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC-CcEEEeccccccccCCcCc
Q 002214          742 MPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS-MVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       742 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgla~~~~~~~~  819 (952)
                      +++++|.+++.... ..+++..+..++.|+++|++||   |++|++||||+|+||+++.+ +.+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV---HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999997643 3589999999999999999999   78999999999999999855 4689999999987643321


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        .....++..|+|||...+..++.++||||||+++|+|++|+.||......     ...       ........     
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~-------~~~~~~~~-----  218 (256)
T cd08220         158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALV-------LKIMSGTF-----  218 (256)
T ss_pred             --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHH-------HHHHhcCC-----
Confidence              22345888999999998888899999999999999999999998542111     000       00000000     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ...+..++.++.+++.+||+.+|++|||+.|++++
T Consensus       219 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 ---APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ---CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence               00122356779999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.5e-34  Score=311.55  Aligned_cols=248  Identities=25%  Similarity=0.334  Sum_probs=199.4

Q ss_pred             CCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCC
Q 002214          666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      |.....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334457999999999999874 6899999998765544556788999999999999999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      ++|.+++..  ..+++..+..++.|++.|++||   |+.+++||||+|+||+++.++.+||+|||++....... .....
T Consensus       103 ~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~  176 (297)
T cd06659         103 GALTDIVSQ--TRLNEEQIATVCESVLQALCYL---HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS  176 (297)
T ss_pred             CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence            999987754  3589999999999999999999   79999999999999999999999999999997553322 22233


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||...... .....+ ..           .....     ..
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~-~~-----------~~~~~-----~~  238 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKRL-RD-----------SPPPK-----LK  238 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH-hc-----------cCCCC-----cc
Confidence            56889999999998888999999999999999999999998642111 001110 00           00000     00


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .....+.++.+++.+||+.+|++||++.|++++
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            112345678999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.2e-34  Score=306.35  Aligned_cols=253  Identities=25%  Similarity=0.455  Sum_probs=198.5

Q ss_pred             CCccceecCccceEEEEEEeC----CCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCC------
Q 002214          666 FSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHN------  733 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  733 (952)
                      |.+.+.||+|+||.||+|.+.    +++.||||++...  .....+++.+|++++++++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999753    4689999998654  2334567889999999999999999999886532      


Q ss_pred             eeEEEEEccCCCChhHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecc
Q 002214          734 FKALVLEYMPKGSLEDCMYAS-----NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDF  808 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Df  808 (952)
                      ..++++||+++|+|.+++...     ...+++.....++.|++.|++||   |++||+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccchhhEEEcCCCCEEECcc
Confidence            347899999999998876432     22578899999999999999999   7899999999999999999999999999


Q ss_pred             ccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhh
Q 002214          809 GIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAV  886 (952)
Q Consensus       809 gla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  886 (952)
                      |+++........ ......+++.|++||......++.++||||||+++|||++ |+.||......  ....+..      
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~------  229 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLI------  229 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHH------
Confidence            999866433221 1122345678999999988889999999999999999999 88887643211  1111100      


Q ss_pred             hhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       887 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                          .....        ..+..++.++.+++.+||+.+|++||+++|+++.|+++
T Consensus       230 ----~~~~~--------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 ----KGNRL--------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ----cCCcC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                00000        01123567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.5e-34  Score=310.70  Aligned_cols=248  Identities=24%  Similarity=0.332  Sum_probs=199.3

Q ss_pred             CCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCC
Q 002214          666 FSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      |.....||+|+||.||++.. .++..||||.+........+.+.+|+.++++++|||++++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            34446799999999999987 46889999998765555567789999999999999999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      ++|.+++...  .+++.++..++.|++.|++||   |+++|+||||||+||++++++.++|+|||++....... .....
T Consensus       104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~  177 (292)
T cd06658         104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYL---HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKS  177 (292)
T ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCce
Confidence            9999987543  588999999999999999999   78999999999999999999999999999997653322 12223


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..++..|+|||+..+..++.++||||||+++|||++|+.||...... .....        ....+.....         
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~--------~~~~~~~~~~---------  239 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-QAMRR--------IRDNLPPRVK---------  239 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH--------HHhcCCCccc---------
Confidence            46889999999998888999999999999999999999998542110 00000        0000111000         


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .....+..+.+++.+||..||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            011235678999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=319.59  Aligned_cols=240  Identities=24%  Similarity=0.282  Sum_probs=186.2

Q ss_pred             ecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC---CCCccceeeeEeecCCeeEEEEEccCC
Q 002214          672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI---RHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       672 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      ||+|+||+||+|+.. +++.||||++....   ......+..|..++.+.   +||+|+++++++.+....|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999874 68999999986432   22233455677777665   699999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|.+++.... .+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~L---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~  155 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHL---HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT  155 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence            99998886543 689999999999999999999   789999999999999999999999999999975432221 1223


Q ss_pred             cccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHH
Q 002214          825 TLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN  903 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (952)
                      ..||+.|+|||++.+. .++.++||||+||++|||++|+.||.....     .+..       .........        
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~-------~~i~~~~~~--------  215 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMY-------RNIAFGKVR--------  215 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHH-------HHHHcCCCC--------
Confidence            5689999999988654 478999999999999999999999854211     0100       000000000        


Q ss_pred             HhhhhhHHHHHHHHhhccccCCCCCC----CHHHHHH
Q 002214          904 VAKQSCASSVLSLAMECTSESPENRV----NTKEIIS  936 (952)
Q Consensus       904 ~~~~~~~~~l~~li~~cl~~dP~~RP----s~~ev~~  936 (952)
                      .....+++++.+++.+||+.||.+||    ++.|+++
T Consensus       216 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         216 FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            00112466789999999999999999    4666655

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.3e-35  Score=315.13  Aligned_cols=245  Identities=23%  Similarity=0.402  Sum_probs=202.3

Q ss_pred             CccceecCccceEEEEEEeC-CCcEEEEEEee----ccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCC--eeEEEE
Q 002214          667 SEENLIGIGSYGSVYKGRFP-DGIEVAIKVFH----LQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN--FKALVL  739 (952)
Q Consensus       667 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  739 (952)
                      +....||+|+|-+||+|.+. +|..||=--++    .+++...++|..|+.+++.|+||||+++|+++.+..  ..-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44568999999999999883 57777532221    234555689999999999999999999999987764  467899


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC-CCCcEEEeccccccccCCcC
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |.+..|+|..+..+.+ ..+......+++||.+||.|||. |..+|+|||||-.||+|+ ..|.+||+|.|+|.......
T Consensus       123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999999998776 68889999999999999999985 778999999999999997 56899999999999875432


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                         .....|||.|||||+.. ..|...+||||||++|+||+|+..||.+-......+.+...+..|+....+        
T Consensus       201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV--------  268 (632)
T KOG0584|consen  201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV--------  268 (632)
T ss_pred             ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc--------
Confidence               22368999999999887 679999999999999999999999998865555556666555555532222        


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                                -.++++++|.+|+.. .++|||+.|+++
T Consensus       269 ----------~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  269 ----------KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                      135689999999999 999999999985

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.2e-34  Score=303.81  Aligned_cols=250  Identities=20%  Similarity=0.347  Sum_probs=186.6

Q ss_pred             eecCccceEEEEEEeCCC---cEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCC
Q 002214          671 LIGIGSYGSVYKGRFPDG---IEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGS  746 (952)
Q Consensus       671 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  746 (952)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999976433   356677665433 3345688999999999999999999999999999999999999999


Q ss_pred             hhHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc-ccc
Q 002214          747 LEDCMYASN---FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQ  822 (952)
Q Consensus       747 L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~  822 (952)
                      |.+++....   ...++.....++.|+++||+||   |+.+++||||||+||+++.++.+||+|||++........ ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM---HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999987542   2456777889999999999999   789999999999999999999999999999864322211 122


Q ss_pred             cccccccccccccccCc-------CCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          823 TQTLATIGYIAPEYGRE-------GQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ....++..|+|||+...       ..++.++|||||||++|||++ |..||...... ..+.......   .....++. 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~---~~~~~~~~-  233 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKDQ---QVKLFKPQ-  233 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhhc---ccccCCCc-
Confidence            23567889999998743       245788999999999999997 46676542111 1111111100   00111111 


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                                .+...++.+.+++..|| .+|++||+++||++.|.
T Consensus       234 ----------~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         234 ----------LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ----------cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence                      11234667889999999 68999999999988763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-33  Score=302.91  Aligned_cols=252  Identities=25%  Similarity=0.350  Sum_probs=207.0

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ++|++.+.||+|++|.||+|+.. +++.||+|++..... .....+.+|+.++.+++|||++++++++..++..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999885 599999999876543 4457899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS-NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~-~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+++... ..+++..+..++.|+++|++||   |+ .+++||||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~l---h~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL---HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---hccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999998765 4689999999999999999999   78 99999999999999999999999999999876443322


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                       .....++..|+|||...+..++.++||||||+++|+|++|+.||......  ...+..       .........     
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~-------~~~~~~~~~-----  221 (264)
T cd06623         157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELM-------QAICDGPPP-----  221 (264)
T ss_pred             -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHH-------HHHhcCCCC-----
Confidence             12345788999999998888999999999999999999999998664320  111100       011100000     


Q ss_pred             HHHHhhhh-hHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          901 HANVAKQS-CASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       901 ~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ..+.. ++..+.+++.+||+.+|++||++.|++++
T Consensus       222 ---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         222 ---SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ---CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               01122 56789999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-33  Score=304.40  Aligned_cols=256  Identities=25%  Similarity=0.307  Sum_probs=200.0

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecC--CeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNH--NFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  739 (952)
                      ++|...+.||.|++|.||+|.+. +++.||+|.+..... .....+.+|++++++++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999984 689999999865432 3456789999999999999999999988653  4689999


Q ss_pred             EccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          740 EYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       740 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      ||+++++|.+++..   ....++......++.|+++|++||   |+.|++||||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL---HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887653   334688999999999999999999   799999999999999999999999999999876533


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccC---ccchhhhhccchhhhhhhcccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTG---EMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      ...   ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||......   ......+......       ..
T Consensus       158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~  227 (287)
T cd06621         158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-------PE  227 (287)
T ss_pred             ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-------hh
Confidence            221   2234788999999998888999999999999999999999998764221   1111111111000       00


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +....     ......++++.+++.+||..+|++|||+.|++++
T Consensus       228 ~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         228 LKDEP-----GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             hccCC-----CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            00000     0001235678999999999999999999999983

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.1e-34  Score=308.05  Aligned_cols=245  Identities=27%  Similarity=0.325  Sum_probs=201.3

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888999999999999999874 68999999986432   233467889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++++|.+++.... .+++..+..++.|+++||+||   |++|++||||+|+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYL---HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999987653 689999999999999999999   7899999999999999999999999999999876433  


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... .....           .......     
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~-----------~~~~~~~-----  215 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-IQIYE-----------KILEGKV-----  215 (290)
T ss_pred             --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHHH-----------HHhcCCc-----
Confidence              2234588999999998888889999999999999999999999864221 00000           0110000     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                          ..+...+..+.+++.+||..||.+||     +++|++++
T Consensus       216 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         216 ----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                01223466789999999999999999     77777654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-34  Score=305.35  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=200.6

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecCC------
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNHN------  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------  733 (952)
                      ++++|++.+.||+|+||.||+|..+ +++.||+|++..... ..+.+.+|+.+++++ .|||++++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            5678999999999999999999984 678999999865543 346789999999999 6999999999986544      


Q ss_pred             eeEEEEEccCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccc
Q 002214          734 FKALVLEYMPKGSLEDCMYAS---NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGI  810 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  810 (952)
                      ..++||||+++++|.+++...   +..+++..+..++.|++.|++||   |+.+++||||+|+||++++++.+||+|||.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL---HENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            489999999999999987653   35789999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCcCcccccccccccccccccccCc-----CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhh
Q 002214          811 AKLLSEEDSMKQTQTLATIGYIAPEYGRE-----GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA  885 (952)
Q Consensus       811 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  885 (952)
                      +....... .......++..|+|||++..     ..++.++|||||||++|+|++|+.||....... ...+......  
T Consensus       160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--  235 (275)
T cd06608         160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRNPP--  235 (275)
T ss_pred             ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhccCC--
Confidence            97654322 12233568899999998653     346788999999999999999999986432111 1111111000  


Q ss_pred             hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                            ...         ..+..++.++.+++.+||..||++|||+.|++++
T Consensus       236 ------~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         236 ------PTL---------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ------CCC---------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                  000         0112356789999999999999999999999863

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.8e-34  Score=309.76  Aligned_cols=267  Identities=23%  Similarity=0.322  Sum_probs=200.1

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCch-----hhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREG-----ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      +|...+.||+|+||.||+|... +|+.||||.++.....     ....+..|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999874 6899999998654322     335677899999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+ +|+|.+++......+++..+..++.|+++||+||   |++||+||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL---HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 8999999876554789999999999999999999   79999999999999999999999999999998764432


Q ss_pred             cccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhh----hhhhc
Q 002214          819 SMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPA----VMNIM  890 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~----~~~~~  890 (952)
                      . ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||...... ..+.+...   ...+.    .....
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhccccc
Confidence            1 1222346788999998754 46788999999999999999997776542211 11111100   00000    00000


Q ss_pred             cccccch-hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLLSE-DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +...... ............+.++.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000 0000001113346789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.2e-34  Score=310.24  Aligned_cols=246  Identities=26%  Similarity=0.366  Sum_probs=197.6

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ..|...+.||+|+||+||+|... +++.||+|.+....   ....+.+.+|+.++++++|||++++++++..++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999874 68999999886432   223456889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||++ |++.+.+......+++..+..++.|++.|+.||   |+.+|+||||+|+||+++.++.+||+|||++......  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~L---H~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYL---HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9996 577777766556799999999999999999999   7899999999999999999999999999999765322  


Q ss_pred             ccccccccccccccccccC---cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          820 MKQTQTLATIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                         ....+++.|+|||++.   ...++.++||||||+++|||++|+.||........            .......... 
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------------~~~~~~~~~~-  232 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------------LYHIAQNDSP-  232 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------------HHHHhcCCCC-
Confidence               2245788999999863   45688999999999999999999999854211100            0000000000 


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                            ...+..++.++.+++.+||+.+|++||++.+++.+
T Consensus       233 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         233 ------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  00112356789999999999999999999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-33  Score=303.30  Aligned_cols=253  Identities=23%  Similarity=0.393  Sum_probs=201.1

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC------chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR------EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      +|+..+.||+|+||.||+|.. .+++.||+|++....      ....+.+.+|++++++++|||++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999986 578999999986433      1234678999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC-cEEEeccccccccCC
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-VAHLSDFGIAKLLSE  816 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~~~  816 (952)
                      ||||+++++|.+++...+ .+++..+..++.|++.|++||   |++|++||||+|+||+++.++ .+||+|||.+.....
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~L---H~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYL---HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999987544 688999999999999999999   789999999999999998776 699999999987654


Q ss_pred             cCcc---cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          817 EDSM---KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       817 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      ....   ......++..|+|||...+..++.++||||+|+++|++++|..||....... ....+        .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~--------~~~~~~~  227 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HLALI--------FKIASAT  227 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hHHHH--------HHHhccC
Confidence            3211   1122457889999999888888999999999999999999999985421110 00000        0000000


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..       ...+...++++.+++.+|+..+|++||++.|++++
T Consensus       228 ~~-------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         228 TA-------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             CC-------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            00       01123356779999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-34  Score=306.08  Aligned_cols=248  Identities=28%  Similarity=0.469  Sum_probs=199.8

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCC---CCccceeeeEeecCCeeEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIR---HRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.+.... ....+.+.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477888999999999999987 578999999986543 334567889999999996   999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++++|.+++...  .+++.....++.|++.|++||   |+.||+||||+|+||+++.++.++++|||.+........
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYI---HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999988653  689999999999999999999   799999999999999999999999999999987654332


Q ss_pred             ccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                       ......++..|+|||...++ .++.++|||||||++|+|++|..||........  .......       ..+.+    
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~-------~~~~~----  222 (277)
T cd06917         157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA--MMLIPKS-------KPPRL----  222 (277)
T ss_pred             -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh--hhccccC-------CCCCC----
Confidence             22334688899999987654 468899999999999999999999865321110  0000000       00000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                            ....++.++.+++.+||+.||++||++.|++++
T Consensus       223 ------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         223 ------EDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                  011246679999999999999999999999764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=313.33  Aligned_cols=251  Identities=24%  Similarity=0.346  Sum_probs=207.4

Q ss_pred             cCCccceecCccceEEEEEEeCC-CcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          665 QFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      .|.++..||.|+||.||+|..++ +-..|.|++..+.....+.+.-|++|+....||+||++++.|..++..+++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            45567789999999999998754 55567899888888888999999999999999999999999999999999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      ||.++.++-.-+..+.+.++..+.+|++.||.||   |++.|||||||+.|||++-+|.++++|||.+..... ......
T Consensus       113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~L---Hs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRD  188 (1187)
T KOG0579|consen  113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWL---HSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRD  188 (1187)
T ss_pred             CchHhHHHHHhccccchHHHHHHHHHHHHHHHHH---hhcchhhhhccccceEEEecCcEeeecccccccchh-HHhhhc
Confidence            9999999888888899999999999999999999   899999999999999999999999999999865322 222344


Q ss_pred             cccccccccccccc-----CcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          824 QTLATIGYIAPEYG-----REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       824 ~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      ...|||.|||||+.     .+.+|..++||||||+++.||..+.+|.++..+ ...+.++.+..-        +.+    
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-MRVllKiaKSeP--------PTL----  255 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEP--------PTL----  255 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-HHHHHHHhhcCC--------Ccc----
Confidence            57899999999964     467899999999999999999999999654211 111111111111        111    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..|..++..+.+++..|+..+|..||+++++++|
T Consensus       256 -----lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  256 -----LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             -----cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                 1234457789999999999999999999999875

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.5e-33  Score=305.56  Aligned_cols=253  Identities=28%  Similarity=0.375  Sum_probs=206.4

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++.|...+.||+|+||.||+|.++ +++.||+|++..... ..+.+.+|++++++++|+|++++++++...+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4566888899999999999999985 689999999876544 45678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+++++|.+++......+++..+..++.|++.|++||   |+.|++|+|++|+||+++.++.++|+|||++........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL---HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            9999999999987655799999999999999999999   789999999999999999999999999999876543221 


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      ......++..|+|||++.+..++.++|||||||++|+|++|+.||....... ....+.           ..... ..  
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~-----------~~~~~-~~--  236 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLIT-----------TKGIP-PL--  236 (286)
T ss_pred             hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-----------hcCCC-CC--
Confidence            1222457889999999888889999999999999999999999986421110 000000           00000 00  


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ..+..++.++.+++.+||+.+|.+||++.+++++
T Consensus       237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         237 ---KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             ---cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence               0112356789999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-33  Score=301.69  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=201.4

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeec--CCeeEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTN--HNFKALVL  739 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  739 (952)
                      +|++.+.||.|+||.||+|.. .+++.||+|++....  ....+.+..|++++++++|||++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999987 468899999886432  3345678899999999999999999997754  45678999


Q ss_pred             EccCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          740 EYMPKGSLEDCMYAS---NFNLDIFQRLGIMIDVASALEYLHFGH--SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       740 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~Lh~~h--~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      ||+++++|.+++...   ...+++..++.++.|++.|++|||..+  +.+++||||+|+||+++.++.+|++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653   447899999999999999999993221  899999999999999999999999999999876


Q ss_pred             CCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ...... .....+++.|+|||++....++.++||||||+++|+|++|+.||.....  ....+.           +....
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~-----------~~~~~  226 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASK-----------IKEGK  226 (265)
T ss_pred             cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHH-----------HhcCC
Confidence            543321 2234689999999999888899999999999999999999999865321  111111           11000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..       ..+...+.++.+++.+|++.+|++||++.+|+++
T Consensus       227 ~~-------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 FR-------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CC-------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            00       0122346789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=291.45  Aligned_cols=267  Identities=21%  Similarity=0.299  Sum_probs=217.3

Q ss_pred             HHHHHhccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEee
Q 002214          658 ELLRATDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCT  730 (952)
Q Consensus       658 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  730 (952)
                      ++.....+++....+.+|.||+||+|.+.      +.+.|-||.++... +-....+..|.-.+..+.|||+..+.+++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            44455567888888999999999999653      34667888775443 334567889999999999999999999986


Q ss_pred             cC-CeeEEEEEccCCCChhHHhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc
Q 002214          731 NH-NFKALVLEYMPKGSLEDCMYASN-------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV  802 (952)
Q Consensus       731 ~~-~~~~lv~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~  802 (952)
                      ++ ...++.|.++.-|+|..++...+       +.++..+...++.|++.|++||   |++||||.||.++|.++|+...
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl---h~~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL---HNHGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH---HhcCcccchhhhhcceehhhee
Confidence            65 56788999999999999998322       3577788899999999999999   8999999999999999999999


Q ss_pred             EEEeccccccccCCcCccccc-ccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhc
Q 002214          803 AHLSDFGIAKLLSEEDSMKQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIN  880 (952)
Q Consensus       803 ~kl~Dfgla~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~  880 (952)
                      +||+|=.+++.+.+.++.--+ ....+..||+||.+....|+.++|||||||++|||+| |+.||.+..+.+.       
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-------  507 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-------  507 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-------
Confidence            999999999988776654333 2457889999999999999999999999999999999 9999866322110       


Q ss_pred             cchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          881 DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                           ...+.|+.        +...|-.||+++..+|..||+.+|++||++++++.-|.++..++.+
T Consensus       508 -----~~ylkdGy--------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~  561 (563)
T KOG1024|consen  508 -----EHYLKDGY--------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTR  561 (563)
T ss_pred             -----HHHHhccc--------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhh
Confidence                 01111111        2234567999999999999999999999999999999999887654

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=341.62  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=204.3

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      +-+|.....||.|.||.||-|.. ++|...|||-++.+.  ....+.+.+|+.++..++|||+|+++|+-.+.+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            34677788999999999999986 679999999876543  334466789999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |||++|+|.+.+...+ -.++.....+..|++.|++||   |+.|||||||||.||+++.+|.+|++|||.|+.+.....
T Consensus      1314 EyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~L---H~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYL---HEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHH---HhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            9999999999887654 466666777889999999999   899999999999999999999999999999998865421


Q ss_pred             c---cccccccccccccccccCcC---CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          820 M---KQTQTLATIGYIAPEYGREG---QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       820 ~---~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      .   .-...+||+.|||||++.+.   ....+.||||+|||+.||+||+.||.++...-........+..          
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~---------- 1459 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK---------- 1459 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC----------
Confidence            1   11246799999999988653   4567899999999999999999999875332211111111111          


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                               +..|+..+.+-.+++..|+..||++|.++.+++++
T Consensus      1460 ---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 ---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                     22344467888999999999999999999887764

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-33  Score=309.39  Aligned_cols=253  Identities=23%  Similarity=0.302  Sum_probs=197.9

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999874 57899999886543   233457889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++++|.+++.... .+++..+..++.|++.|++||   |+.+++||||||+||+++.++.+|++|||+++.......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYL---HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999987654 689999999999999999999   789999999999999999999999999999874211000


Q ss_pred             --------------ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhh
Q 002214          820 --------------MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA  885 (952)
Q Consensus       820 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  885 (952)
                                    .......++..|+|||.+....++.++|||||||++||+++|..||.....     .++....   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~~~~---  228 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFGQV---  228 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH---
Confidence                          011123578899999998888899999999999999999999999854211     1111000   


Q ss_pred             hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          886 VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                          ........      .....++.++.+++.+||+.+|++||++.++.+.+
T Consensus       229 ----~~~~~~~~------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll  271 (305)
T cd05609         229 ----ISDDIEWP------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK  271 (305)
T ss_pred             ----HhcccCCC------CccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence                00000000      00113567799999999999999999965554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-33  Score=304.27  Aligned_cols=248  Identities=23%  Similarity=0.324  Sum_probs=200.1

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      .|...+.||+|++|.||+|.. .+++.||+|++........+.+.+|+.++++++|||++++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            345567999999999999986 4689999999875554445678899999999999999999999999999999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +++|.+++..  ..+++..+..++.|++.|++||   |++|++||||+|+||+++.++.++++|||.+........ ...
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~  173 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFL---HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK  173 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence            9999998876  3589999999999999999999   789999999999999999999999999998875533221 222


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN  903 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (952)
                      ...+++.|+|||...+..++.++|||||||++|||++|+.||......     ....    .......... .       
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----~~~~----~~~~~~~~~~-~-------  236 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----QAMK----RIRDNLPPKL-K-------  236 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----HHHH----HHHhcCCCCC-c-------
Confidence            345889999999998888999999999999999999999998542110     0000    0000000000 0       


Q ss_pred             HhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          904 VAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       904 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                       .+..++.++.+++.+||+.+|++||++.|+++
T Consensus       237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence             01124678999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9e-34  Score=307.60  Aligned_cols=253  Identities=23%  Similarity=0.316  Sum_probs=194.6

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556788999999999999874 68999999986543 234567889999999996 99999999999988899999999


Q ss_pred             cCCCChhHHh---hh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          742 MPKGSLEDCM---YA-SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       742 ~~~g~L~~~l---~~-~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ++ +++.++.   .. ....+++..+..++.|++.|++|||  ++.+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            85 4655543   22 2346899999999999999999995  4569999999999999999999999999999765432


Q ss_pred             CcccccccccccccccccccCcC---CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          818 DSMKQTQTLATIGYIAPEYGREG---QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ..  .....+++.|+|||++.+.   .++.++|||||||++|||++|+.||.....   ...        ..........
T Consensus       162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~--------~~~~~~~~~~  228 (288)
T cd06616         162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFD--------QLTQVVKGDP  228 (288)
T ss_pred             Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHH--------HHhhhcCCCC
Confidence            21  1223578899999988765   688999999999999999999999865321   000        0111110000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          +......+..++.++.+++.+||+.+|++|||+.||+++
T Consensus       229 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 ----PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ----CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                000000112357789999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-33  Score=303.46  Aligned_cols=248  Identities=27%  Similarity=0.410  Sum_probs=201.8

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +-|+..+.||+|+||.||+|.. .+++.||+|...... ....+.+.+|+.++++++|||++++++++.++...++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            3477888999999999999987 468999999875432 33346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++++|.+++...  .+++..+..++.|++.|++||   |+.|++|+||+|+||+++.++.++++|||++........ .
T Consensus        84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06641          84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---ccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence            9999999988643  589999999999999999999   899999999999999999999999999999976543221 1


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      .....++..|+|||+..+..++.++|||||||++|+|++|..||.......  ....           +.....      
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~-----------~~~~~~------  218 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFL-----------IPKNNP------  218 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHH-----------HhcCCC------
Confidence            223457889999999988888999999999999999999999986532110  0000           000000      


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ...+..++.++.+++.+||..+|++||++.+++++
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 -PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             00122356778999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.4e-33  Score=297.86  Aligned_cols=250  Identities=30%  Similarity=0.429  Sum_probs=205.5

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      +|...+.||+|++|.||+|... +++.||+|++........+.+.+|+.++++++||+++++++++..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999985 689999999976655456789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +++|.+++......+++..+..++.|+++|++||   |++|++||||+|+||++++++.++|+|||.+........  ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~  155 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL---HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN  155 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHh---hcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence            9999999887656799999999999999999999   789999999999999999999999999999987654332  23


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN  903 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (952)
                      ...++..|+|||+..+..++.++||||||+++|+|++|+.||........ .....            ........    
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~------------~~~~~~~~----  218 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-LFKIA------------TNGPPGLR----  218 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH------------hcCCCCcC----
Confidence            35688899999999888899999999999999999999999865311100 00000            00000000    


Q ss_pred             HhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          904 VAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       904 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ....++.++.+++.+||+.||++|||+.|++++
T Consensus       219 -~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         219 -NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             -cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             011135679999999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.4e-33  Score=306.79  Aligned_cols=269  Identities=22%  Similarity=0.275  Sum_probs=200.7

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecC--CeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNH--NFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  737 (952)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.++....  .....+.+|+.++++++||||+++++++...  ...++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            357889999999999999999985 588999999865432  2234567899999999999999999998777  88999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||++ ++|.+++......+++..+..++.|++.||+||   |+++++||||||+||+++.++.+||+|||++......
T Consensus        84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL---HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999996 599998877665789999999999999999999   7899999999999999999999999999999876543


Q ss_pred             CcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhh-hhhh--c
Q 002214          818 DSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPA-VMNI--M  890 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~-~~~~--~  890 (952)
                      . .......+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||...... ....+..   ....+. ....  +
T Consensus       160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         160 L-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             c-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhcc
Confidence            2 112234578899999987654 4688999999999999999999998653211 1111100   000000 0000  0


Q ss_pred             c----cccc-chhhHHHHHhhhh-hHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 D----TNLL-SEDEEHANVAKQS-CASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~----~~~~-~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .    .... ..........+.. .++.+.+++.+||+.+|++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0    0000 0000000111111 46779999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=308.89  Aligned_cols=252  Identities=28%  Similarity=0.345  Sum_probs=201.7

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc---hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.....   ...+.+..|++++++++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999885 589999999865432   24467889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          740 EYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      ||+.+++|.+++.... ..+++..+..++.|+++|++||   |+.|++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL---HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999887542 4689999999999999999999   78999999999999999999999999999987553221


Q ss_pred             cc----------------------------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCcccc
Q 002214          819 SM----------------------------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFT  870 (952)
Q Consensus       819 ~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  870 (952)
                      ..                            ......|+..|+|||+..+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                            01123578899999999888899999999999999999999999864321


Q ss_pred             CccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCC----HHHHHHH
Q 002214          871 GEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN----TKEIISR  937 (952)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ev~~~  937 (952)
                      . ..+           ...........       .....+.++.+++.+||..||++||+    +.|++++
T Consensus       238 ~-~~~-----------~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         238 D-ETF-----------SNILKKEVTFP-------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             H-HHH-----------HHHhcCCccCC-------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            1 111           11111111000       01114678999999999999999999    7777663

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.2e-36  Score=323.92  Aligned_cols=374  Identities=30%  Similarity=0.432  Sum_probs=268.1

Q ss_pred             cCCcccCeeeccccccc-cccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccc
Q 002214           54 GNLSSLQTLVLSRNWFS-GTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIS  132 (952)
Q Consensus        54 ~~l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~  132 (952)
                      +-+|-.+-.|+++|.++ +..|.....++.+++|-|.+.++. .+|+.++.|.+|++|.+++|++. .+...+       
T Consensus         4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGEL-------   74 (1255)
T KOG0444|consen    4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGEL-------   74 (1255)
T ss_pred             cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhh-------
Confidence            34566777899999999 678999999999999999999998 89999999999999999999988 333222       


Q ss_pred             cceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeC
Q 002214          133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGF  212 (952)
Q Consensus       133 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  212 (952)
                                         +.+|.|+.+.+.+|+++.                       .-+|..+..+..|+.||||+
T Consensus        75 -------------------s~Lp~LRsv~~R~N~LKn-----------------------sGiP~diF~l~dLt~lDLSh  112 (1255)
T KOG0444|consen   75 -------------------SDLPRLRSVIVRDNNLKN-----------------------SGIPTDIFRLKDLTILDLSH  112 (1255)
T ss_pred             -------------------ccchhhHHHhhhcccccc-----------------------CCCCchhcccccceeeecch
Confidence                               245677777777777652                       12344444555555555555


Q ss_pred             CcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCC
Q 002214          213 NNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGS  292 (952)
Q Consensus       213 N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~  292 (952)
                      |+++ ..|..+..-+++-.|+|++|+|.+++...|.++..|-+||||+|++....|.   ...+..|+.|+|++|.+.  
T Consensus       113 NqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ---~RRL~~LqtL~Ls~NPL~--  186 (1255)
T KOG0444|consen  113 NQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQ---IRRLSMLQTLKLSNNPLN--  186 (1255)
T ss_pred             hhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHH---HHHHhhhhhhhcCCChhh--
Confidence            5555 4555555555555555555555555444455666666666666666543332   223334444444444443  


Q ss_pred             CCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCccccc
Q 002214          293 IPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGR  372 (952)
Q Consensus       293 ~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~  372 (952)
                                                                                             ...-..+..
T Consensus       187 -----------------------------------------------------------------------hfQLrQLPs  195 (1255)
T KOG0444|consen  187 -----------------------------------------------------------------------HFQLRQLPS  195 (1255)
T ss_pred             -----------------------------------------------------------------------HHHHhcCcc
Confidence                                                                                   111111222


Q ss_pred             CCCCcEEEccCcccc-CCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCcee
Q 002214          373 LKKLQGLDLQNNKFE-GPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGF  451 (952)
Q Consensus       373 l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  451 (952)
                      +++|++|.+++.+=+ ..+|..+..+.+|..++|+.|.+. ..|+++..+++|+.|+||+|+|+.. ......-.+|+.|
T Consensus       196 mtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL-~~~~~~W~~lEtL  273 (1255)
T KOG0444|consen  196 MTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITEL-NMTEGEWENLETL  273 (1255)
T ss_pred             chhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeee-eccHHHHhhhhhh
Confidence            334444444443321 234555555566666666666665 7788888899999999999999843 4445556789999


Q ss_pred             EecCCccCCCCchhhhcccccceeecCCcccCC-CCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcc
Q 002214          452 DFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSG-NIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDL  530 (952)
Q Consensus       452 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  530 (952)
                      +||.|+++ .+|..+..++.|+.|++.+|+++- -+|..++.+.+|+.+..++|.+. ..|+.+.++.+|+.|.|+.|++
T Consensus       274 NlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrL  351 (1255)
T KOG0444|consen  274 NLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRL  351 (1255)
T ss_pred             ccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccce
Confidence            99999999 799999999999999999999873 37899999999999999999998 8999999999999999999999


Q ss_pred             cccCccchhcccccccccccccccccCCCC
Q 002214          531 SGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       531 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      - .+|+.+.-++.|+.||+..|+=.-..|.
T Consensus       352 i-TLPeaIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  352 I-TLPEAIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             e-echhhhhhcCCcceeeccCCcCccCCCC
Confidence            7 6899999999999999999987655554

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-33  Score=308.34  Aligned_cols=269  Identities=23%  Similarity=0.329  Sum_probs=197.8

Q ss_pred             cCCccceecCccceEEEEEEeC---CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecC--CeeE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP---DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNH--NFKA  736 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  736 (952)
                      +|++.+.||+|+||.||+|...   +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999974   47999999987633   33346678899999999999999999999887  8899


Q ss_pred             EEEEccCCCChhHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC----CCcEEEecc
Q 002214          737 LVLEYMPKGSLEDCMYAS----NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD----SMVAHLSDF  808 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~----~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~----~~~~kl~Df  808 (952)
                      +||||+++ ++.+.+...    ...+++..+..++.|++.|++||   |+++|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL---HSNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 666665432    12688999999999999999999   7999999999999999999    999999999


Q ss_pred             ccccccCCcCc--ccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhh
Q 002214          809 GIAKLLSEEDS--MKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA  885 (952)
Q Consensus       809 gla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  885 (952)
                      |++........  .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||............+.......
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986643322  11223467889999997765 4578899999999999999999999875432220000000000000


Q ss_pred             hhhhcc---------------------ccccchh--hHHHHHhh--hhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 VMNIMD---------------------TNLLSED--EEHANVAK--QSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ~~~~~~---------------------~~~~~~~--~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..+.+.                     .......  .......+  ...+.++.+++.+|++.||++|||+.|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000000                     0000000  00000011  1456789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.9e-33  Score=302.68  Aligned_cols=265  Identities=22%  Similarity=0.267  Sum_probs=196.2

Q ss_pred             CCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCC-CCccceeeeEeecC--CeeEEEEE
Q 002214          666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIR-HRNLVKIISSCTNH--NFKALVLE  740 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  740 (952)
                      |++.+.||+|+||.||+|... +++.||+|.++... ........+|+.++.++. |||++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999874 68999999886542 222234457899999985 99999999999887  88999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |++ |++.+.+......+++.++..++.|++.||+||   |+.|++||||+|+||+++. +.+||+|||+++........
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM---HRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            996 588887776555789999999999999999999   7899999999999999999 99999999999876433221


Q ss_pred             cccccccccccccccccC-cCCcCcccchHhHHHHHHHHHhCCCCCCccccCcc--chhhhhccchhhhhhhcccccc--
Q 002214          821 KQTQTLATIGYIAPEYGR-EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM--SIKRWINDSLPAVMNIMDTNLL--  895 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--  895 (952)
                        ....++..|+|||++. ++.++.++||||+||++|||++|..||......+.  ..........+...........  
T Consensus       156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence              2345788999999764 45678899999999999999999999865321110  0001111111111111100000  


Q ss_pred             ----chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          896 ----SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       896 ----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          .............++.++.+++.+||+++|++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence                000000011123467899999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.6e-33  Score=304.29  Aligned_cols=258  Identities=19%  Similarity=0.242  Sum_probs=186.7

Q ss_pred             hccCCccceecCccceEEEEEEeCC----CcEEEEEEeeccCchhh-----------HHHHHHHHHHHhCCCCccceeee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD----GIEVAIKVFHLQREGAL-----------NSFDAECEILKTIRHRNLVKIIS  727 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~  727 (952)
                      .++|.+.+.||+|+||.||+|...+    +..+|+|+.........           .....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3579999999999999999998743    45677776543322110           11223334455678999999998


Q ss_pred             EeecCC----eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcE
Q 002214          728 SCTNHN----FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVA  803 (952)
Q Consensus       728 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~  803 (952)
                      ++....    ..++++|++. .++.+.+... ...++..+..++.|++.|++||   |+++|+||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~l---H~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYI---HEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCcE
Confidence            765443    4578888874 4666665443 2457888999999999999999   78999999999999999999999


Q ss_pred             EEeccccccccCCcCcc------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhh
Q 002214          804 HLSDFGIAKLLSEEDSM------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR  877 (952)
Q Consensus       804 kl~Dfgla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~  877 (952)
                      +|+|||+|+........      ......||+.|+|||+..+..++.++|||||||++|||++|+.||............
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999866432211      112246999999999999999999999999999999999999999764222111110


Q ss_pred             hhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          878 WINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      ..    .+....+..         .......+++.+.+++..|+..+|++||+++++.+.|
T Consensus       246 ~~----~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AK----CDFIKRLHE---------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hH----HHHHHHhhh---------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            00    000000000         0011234678899999999999999999999999876

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.6e-33  Score=304.98  Aligned_cols=263  Identities=24%  Similarity=0.313  Sum_probs=198.1

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|+..+.||.|++|.||+|+.. +|+.||||.+....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999874 68999999886443  22335788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +. ++|.+++... ...+++..+..++.|+++|++||   |+++++||||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---h~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 6888887653 34689999999999999999999   789999999999999999999999999999976543221 


Q ss_pred             cccccccccccccccccCcCC-cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cch----------hhh
Q 002214          821 KQTQTLATIGYIAPEYGREGQ-VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSL----------PAV  886 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~----------~~~  886 (952)
                      ......+++.|+|||+..+.. ++.++||||||+++|||+||+.||...... ....+...   ...          ++.
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            122234688999999876544 688899999999999999999998542111 11111110   000          000


Q ss_pred             hhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...+.......    .......++.++.+++.+||+.||++||++.|++++
T Consensus       235 ~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         235 KPSFPKWARQD----FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HhhcccccccC----HHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            00000000000    001112346778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-33  Score=304.12  Aligned_cols=267  Identities=26%  Similarity=0.363  Sum_probs=201.6

Q ss_pred             CCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecC--CeeEEEEE
Q 002214          666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNH--NFKALVLE  740 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  740 (952)
                      |++.+.||+|+||.||+|+.. +++.||+|+++...  ......+.+|++++++++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999885 58999999997653  33446788999999999999999999999887  88999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+++ +|.+++......+++..+..++.|+++|++||   |+.|++|+||+|+||++++++.+||+|||.+.........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL---HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9974 89888876655799999999999999999999   7889999999999999999999999999999877554322


Q ss_pred             cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhh-hhhhcc----
Q 002214          821 KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPA-VMNIMD----  891 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~-~~~~~~----  891 (952)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ........   ...+. .....+    
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccchhh
Confidence            2333457888999997654 45789999999999999999999998653211 11111100   00000 000000    


Q ss_pred             cccc--chhhH-HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLL--SEDEE-HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~--~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....  ..... ........++.++.+++.+||+.+|++||++.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            0000  00000 0011112247789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=278.65  Aligned_cols=251  Identities=21%  Similarity=0.313  Sum_probs=198.7

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +.+....+|.|+.|.||+++. ++|...|||.+.... .++.+++...++++..-+ .|.||+.+|+|..+..+.+.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            345566799999999999987 468999999886553 445678888888877665 89999999999998888999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      | ....+.++..-.+++++.-.-++...+..||.||.  ..++|+|||+||+|||+|+.|.+|++|||.+-++.+..  .
T Consensus       173 M-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK--eKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--A  247 (391)
T KOG0983|consen  173 M-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--A  247 (391)
T ss_pred             H-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH--HhcceeecccCccceEEccCCCEEeecccccceeeccc--c
Confidence            8 44677777777778999888899999999999997  56789999999999999999999999999998775433  3


Q ss_pred             ccccccccccccccccCc---CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          822 QTQTLATIGYIAPEYGRE---GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      .+...|.+.|||||.+.-   ..|..++||||||+.++|+.||..||..-...=..+.           .+.+... ...
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt-----------kvln~eP-P~L  315 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT-----------KVLNEEP-PLL  315 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH-----------HHHhcCC-CCC
Confidence            344569999999998754   3688999999999999999999999865322111111           1111111 000


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           .....+++.+.+++..|+..|+.+||...+++++
T Consensus       316 -----~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  316 -----PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             -----CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence                 0113368889999999999999999999988764

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.1e-34  Score=283.93  Aligned_cols=272  Identities=22%  Similarity=0.298  Sum_probs=199.4

Q ss_pred             HhccCCccceecCccceEEEEEEeC---C--CcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeec-CC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP---D--GIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTN-HN  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  733 (952)
                      ....|+....||+|.||.||+|.-+   +  .+.+|+|.++.+++  +.....-+|+..++.++|||++.+..++.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            4457999999999999999999542   2  34799999976543  344567899999999999999999998876 78


Q ss_pred             eeEEEEEccCCCChhHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC----CcEEE
Q 002214          734 FKALVLEYMPKGSLEDCMYASN----FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS----MVAHL  805 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~----~~~kl  805 (952)
                      .+++++||.+. +|...++.++    ..++.....+|+.||..|+.||   |+.-|+|||+||.|||+..+    |.+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL---H~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL---HSNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH---hhhheeeccCCcceEEEeccCCccCeeEe
Confidence            89999999987 7888876433    3688999999999999999999   89999999999999999877    99999


Q ss_pred             eccccccccCCcCc--ccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccc
Q 002214          806 SDFGIAKLLSEEDS--MKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS  882 (952)
Q Consensus       806 ~Dfgla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  882 (952)
                      +|||+|+.+..+-.  +.....+.|.+|+|||.+.+. .||.+.|||+.||++.||+|-.+-|........+-.-+-.++
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            99999998865432  234456789999999987764 689999999999999999997776643211100000000011


Q ss_pred             hhhhhhhccccccchh------hH------------------HHH-HhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          883 LPAVMNIMDTNLLSED------EE------------------HAN-VAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       883 ~~~~~~~~~~~~~~~~------~~------------------~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...+.+++........      ++                  ... .....-++...+|+.+++.+||.+|.|+.+++++
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            1111111110000000      00                  000 0111223458899999999999999999998875

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-34  Score=312.94  Aligned_cols=277  Identities=26%  Similarity=0.367  Sum_probs=209.0

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecC------CeeE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNH------NFKA  736 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  736 (952)
                      .|...+.||+|+||.||+|+. .+|+.||||.++.... ...+...+|++++++++|||||+++++-.+.      ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            355667899999999999996 5799999999876432 2346778999999999999999999876543      3567


Q ss_pred             EEEEccCCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC----CCCcEEEecccc
Q 002214          737 LVLEYMPKGSLEDCMYASN--FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD----DSMVAHLSDFGI  810 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~----~~~~~kl~Dfgl  810 (952)
                      +|||||.+|+|...+....  ..+++.+.+.++.+++.||.||   |++|||||||||.||++-    .....||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~L---rEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHL---RENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHH---HHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999998643  4799999999999999999999   799999999999999993    334689999999


Q ss_pred             ccccCCcCcccccccccccccccccccC-cCCcCcccchHhHHHHHHHHHhCCCCCCccccCcc----chhhhhccchhh
Q 002214          811 AKLLSEEDSMKQTQTLATIGYIAPEYGR-EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM----SIKRWINDSLPA  885 (952)
Q Consensus       811 a~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~  885 (952)
                      |+.+.++.  .....+||+.|.+||+.. .+.|+..+|.|||||++||++||..||..+.....    .+....+...+ 
T Consensus       171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~-  247 (732)
T KOG4250|consen  171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG-  247 (732)
T ss_pred             cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc-
Confidence            99886544  556688999999999888 58899999999999999999999999976544321    11111111110 


Q ss_pred             hhhhccccccchhh-----HHHHHhhhhhHHHHHHHHhhccccCCCCCC--CHHHHHHHHHHHHHHHhh
Q 002214          886 VMNIMDTNLLSEDE-----EHANVAKQSCASSVLSLAMECTSESPENRV--NTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       886 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~ev~~~L~~i~~~~~~  947 (952)
                      ..-..+....+...     .............+..++..++..+|++|.  .+.+....+..|.+..--
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vv  316 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVV  316 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhee
Confidence            00000100000000     000111233445677888889999999999  888888888888766443

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.1e-33  Score=305.61  Aligned_cols=247  Identities=26%  Similarity=0.354  Sum_probs=198.1

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .|...+.||+|+||.||+|+. .++..||+|.+....   ......+.+|++++++++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            377788999999999999987 468999999986432   2334578899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+. |++.+.+......+++.++..++.|++.|+.||   |+++|+||||+|+||+++.++.+||+|||++......   
T Consensus       106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            996 578787766666799999999999999999999   7899999999999999999999999999998754322   


Q ss_pred             cccccccccccccccccC---cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          821 KQTQTLATIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                        ....+++.|+|||++.   .+.++.++|||||||++|||++|+.||....... ....+..           ....  
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~-----------~~~~--  242 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ-----------NESP--  242 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHh-----------ccCC--
Confidence              2245788999999863   4568899999999999999999999985421110 0111110           0000  


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                           ......+++.+.+++.+||+.+|++||++.|++++..
T Consensus       243 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         243 -----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             -----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence                 0011234667899999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.8e-33  Score=299.88  Aligned_cols=248  Identities=25%  Similarity=0.348  Sum_probs=202.6

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      +|++.+.||.|+||.||+|.+. +++.||+|++....   ....+.+.+|++++++++|||++++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999885 68999999986432   2345788999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+++++|.+++... ..+++..+..++.|+++|++||   |+.+++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYL---HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999988765 4789999999999999999999   78999999999999999999999999999998664332  


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      ......++..|+|||......++.++||||||+++|+|++|..||......  .....        ......        
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~--------~~~~~~--------  216 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQI--------RAKQET--------  216 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHH--------HHHhcc--------
Confidence            223345888999999998888999999999999999999999998653221  00000        000000        


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCH--HHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNT--KEIIS  936 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~ev~~  936 (952)
                      .....+...+.++.+++.+||+.||.+||++  +|+.+
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            0011223456789999999999999999999  66553

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.3e-33  Score=310.99  Aligned_cols=267  Identities=21%  Similarity=0.239  Sum_probs=198.9

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecC-----
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNH-----  732 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  732 (952)
                      ...++|+..+.||+|+||.||+|+.. +|+.||+|.+...  .......+.+|+.++++++||||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            34578999999999999999999874 7899999998543  233345677899999999999999999988643     


Q ss_pred             -CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccc
Q 002214          733 -NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA  811 (952)
Q Consensus       733 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  811 (952)
                       ...|+||||++ ++|.+.+...   ++...+..++.|++.||+||   |+.||+||||||+||++++++.+||+|||++
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence             35799999995 5888776542   78899999999999999999   7899999999999999999999999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhhhhh
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPAVMN  888 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~  888 (952)
                      +......  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+....   ....++...
T Consensus       166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         166 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHH
Confidence            8764322  22334578899999999988999999999999999999999999864211 00111100   000011100


Q ss_pred             --------hccccccchhh---H---------HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          889 --------IMDTNLLSEDE---E---------HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       889 --------~~~~~~~~~~~---~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                              .++........   .         .....+...++++.+++.+||+.||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    00000000000   0         0000012346678999999999999999999999865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.9e-33  Score=304.69  Aligned_cols=253  Identities=23%  Similarity=0.322  Sum_probs=197.3

Q ss_pred             hccCCccceecCccceEEEEEEeCC-CcEEEEEEeeccC-chhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQR-EGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .++|++.+.||+|+||.||+|.+++ ++.||||.++... ......+.+|+.++.+.. ||||+++++++.++...++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4678899999999999999999864 8999999986543 233455677887777775 999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS-NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~-~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      ||++ +++.+++......+++..+..++.|++.|++||   |+ .||+||||+|+||++++++.+||+|||++..+....
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYL---KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9984 578877766555789999999999999999999   55 699999999999999999999999999998654322


Q ss_pred             cccccccccccccccccccCcCC----cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQ----VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      .  .....++..|+|||++.+..    ++.++||||||+++|||++|+.||...........++           +....
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----------~~~~~  236 (296)
T cd06618         170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI-----------LQEEP  236 (296)
T ss_pred             c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH-----------hcCCC
Confidence            2  22235788999999886543    7889999999999999999999986422111111111           11110


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      .. ..     ....++.++.+++.+||+.||++||++.+++++-
T Consensus       237 ~~-~~-----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         237 PS-LP-----PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CC-CC-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            00 00     0113567899999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.6e-33  Score=301.46  Aligned_cols=267  Identities=23%  Similarity=0.335  Sum_probs=200.6

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      +|+..+.||+|++|.||+|+.. +|+.||||.++.... ...+.+.+|+.++++++|||++++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788999999999999999984 689999999875532 23456788999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          743 PKGSLEDCMYASN--FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       743 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      ++ +|.+++....  ..+++..+..++.|+++|++||   |++|++||||+|+||++++++.++++|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC---HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            75 8888876543  4689999999999999999999   789999999999999999999999999999976533211 


Q ss_pred             cccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhhhh-hhc-----
Q 002214          821 KQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPAVM-NIM-----  890 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~-~~~-----  890 (952)
                      ......++..|+|||++.+. .++.++|||||||++|++++|+.||...... ....+...   ....... ...     
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            11234578899999987653 5688999999999999999999998653211 11111110   0000000 000     


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ................+.++.++.+++.+|++.||++||+++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00000000011111223457789999999999999999999999853

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-33  Score=302.70  Aligned_cols=265  Identities=24%  Similarity=0.321  Sum_probs=198.3

Q ss_pred             CCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      |++.+.||.|++|.||+|... +|+.||+|++....  ....+.+.+|++++++++|||++++++++.+++..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999874 79999999986543  223456889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          743 PKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       743 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      + ++|.+++.... ..+++..+..++.|+++||+||   |+++++||||+|+||+++.++.++|+|||.++....... .
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~l---H~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC---HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence            5 68998886544 3689999999999999999999   688999999999999999999999999999976543221 1


Q ss_pred             ccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhhh-------hhhc
Q 002214          822 QTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPAV-------MNIM  890 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~-------~~~~  890 (952)
                      .....++..|+|||++.+. .++.++||||||+++|||++|+.||......+ ...+...   ...+..       .+..
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            1223568899999987654 56889999999999999999999986421111 0111110   000000       0000


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      . .................+.++.+++.+||+.||++||++.|++++
T Consensus       235 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         235 P-TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             h-hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0 000000000011123456789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.7e-33  Score=306.91  Aligned_cols=269  Identities=24%  Similarity=0.286  Sum_probs=199.1

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecC--CeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNH--NFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  737 (952)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|+++....  .....+.+|+.++++++|+|++++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999874 689999999865432  2233567899999999999999999998755  56899


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||++ ++|.+++......+++.++..++.|+++|++||   |+.|++||||||+||+++.++.+||+|||.+......
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYL---HENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            999996 488888876656799999999999999999999   7899999999999999999999999999999876543


Q ss_pred             CcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhh---hccchhhhhhhcc--
Q 002214          818 DSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW---INDSLPAVMNIMD--  891 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~--  891 (952)
                      .. ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+...   ...........++  
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChhhchhhhcc
Confidence            21 2223346788999998765 457899999999999999999999986422110 11100   0000000000000  


Q ss_pred             -----ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 -----TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..................++++.+++.+|++.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                 0000000000000112246778999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.8e-33  Score=297.34  Aligned_cols=249  Identities=24%  Similarity=0.355  Sum_probs=200.5

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|.+.+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|+.++++++|||++++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999884 58899999986542  23345788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC-cEEEeccccccccCCcCc
Q 002214          742 MPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-VAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       742 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~  819 (952)
                      +++++|.+++.... ..+++..+..++.|+++|++||   |+.+++||||+|+||++++++ .+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI---HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999887543 3579999999999999999999   789999999999999999886 469999999987643322


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                       ......+++.|+|||+..+..++.++||||||+++||+++|..||....     ..++..       ........    
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~-------~~~~~~~~----  220 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVL-------KICQGYFA----  220 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHH-------HHhcccCC----
Confidence             1223458889999999888889999999999999999999999985421     111111       11110000    


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ......+.++.+++.+||..+|++|||+.|++++
T Consensus       221 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         221 ----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                0112345679999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.8e-33  Score=305.02  Aligned_cols=272  Identities=26%  Similarity=0.343  Sum_probs=201.7

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCC----
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHN----  733 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  733 (952)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|+++...  ......+.+|++++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999985 58999999986543  223356778999999999999999999887654    


Q ss_pred             ------eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEec
Q 002214          734 ------FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSD  807 (952)
Q Consensus       734 ------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~D  807 (952)
                            ..++|+||+++ ++.+.+......+++..+..++.|++.||+||   |+.||+||||+|+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYC---HKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999976 77777766555789999999999999999999   789999999999999999999999999


Q ss_pred             cccccccCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhh---hhccch
Q 002214          808 FGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR---WINDSL  883 (952)
Q Consensus       808 fgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~---~~~~~~  883 (952)
                      ||.+...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......   ......
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~  238 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSPC  238 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCC
Confidence            99998765433222222346788999997754 4578899999999999999999999864211 111111   111111


Q ss_pred             hh-hhhhcccccc------chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          884 PA-VMNIMDTNLL------SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       884 ~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +. ...+......      .............++.++.+++..||+.||++||++.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11 0000000000      000000011122357889999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-33  Score=296.71  Aligned_cols=250  Identities=23%  Similarity=0.324  Sum_probs=198.7

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-----chhhHHHHHHHHHHHhCCCCccceeeeEeecC--Cee
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-----EGALNSFDAECEILKTIRHRNLVKIISSCTNH--NFK  735 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  735 (952)
                      .+|++.+.||+|+||.||+|.. .+++.||+|.+....     ......+.+|+.++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788999999999999999987 468999999875321     23346788999999999999999999998654  467


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++|+||+++++|.+++.... .+++.....++.|++.|++||   |+.|++||||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999887544 588999999999999999999   79999999999999999999999999999998653


Q ss_pred             CcC--cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          816 EED--SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       816 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      ...  ........++..|+|||++.+..++.++|||||||++||+++|+.||....... ...           ......
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~-----------~~~~~~  225 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIF-----------KIATQP  225 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHH-----------HHHcCC
Confidence            211  111123458899999999988888999999999999999999999986531110 000           000000


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .       ....+...++++.+++.+||. +|.+||++.+++.+
T Consensus       226 ~-------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         226 T-------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             C-------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            0       011234456789999999999 57999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.5e-33  Score=300.02  Aligned_cols=242  Identities=22%  Similarity=0.289  Sum_probs=187.8

Q ss_pred             eecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHH---hCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          671 LIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILK---TIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       671 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      .||+|+||.||+|.. .+++.||+|.+....   ......+.+|..+++   ..+||+++.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999987 468999999886432   111233444544443   3479999999999999899999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +|+|.+++...+ .+++..+..++.|++.|++||   |+++|+||||||+||++++++.++++|||++.......   ..
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~  153 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH  153 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence            999998887544 689999999999999999999   78999999999999999999999999999997553322   12


Q ss_pred             ccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          824 QTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...+++.|+|||.... ..++.++||||+||++|||++|..||........  ..        ...... ..       .
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~--------~~~~~~-~~-------~  215 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE--------IDRMTL-TV-------N  215 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HH--------HHHHhh-cC-------C
Confidence            3468999999998764 5678999999999999999999999865322111  00        000000 00       0


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                      ...+..++.++.+++.+||+.||++||     +++|++++
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            011234577899999999999999999     69999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.1e-33  Score=302.86  Aligned_cols=269  Identities=20%  Similarity=0.252  Sum_probs=195.9

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCC-CCccceeeeEeecCCe-----
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTIR-HRNLVKIISSCTNHNF-----  734 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  734 (952)
                      ++|++.+.||+|+||.||+|.+. +++.||+|..+....  .....+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999874 689999998765432  23456888999999995 6999999998876655     


Q ss_pred             eEEEEEccCCCChhHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-CCcEEEeccc
Q 002214          735 KALVLEYMPKGSLEDCMYASN----FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-SMVAHLSDFG  809 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg  809 (952)
                      .|+||||+++ ++.+++....    ..+++..+..++.||++||+||   |+++|+||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC---HKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999975 7888775432    3579999999999999999999   7899999999999999998 8999999999


Q ss_pred             cccccCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccch--hhhhccchhh-
Q 002214          810 IAKLLSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI--KRWINDSLPA-  885 (952)
Q Consensus       810 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~-  885 (952)
                      +++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||..........  .+........ 
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            9986533211 1222356889999998754 457899999999999999999999986421111000  0000000000 


Q ss_pred             hhhhccccc----cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 VMNIMDTNL----LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .........    ....+.......+.++.++.+++.+||.+||++||++.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000000    0000000011123467789999999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.3e-33  Score=304.05  Aligned_cols=272  Identities=22%  Similarity=0.336  Sum_probs=196.6

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecCC-----
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNHN-----  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  733 (952)
                      ..++|.+.+.||+|+||.||+|... +++.||||.+.....  .....+.+|+.++++++|||++++++++...+     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457999999999999999999874 689999998864432  22345678999999999999999999886543     


Q ss_pred             ---eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccc
Q 002214          734 ---FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGI  810 (952)
Q Consensus       734 ---~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  810 (952)
                         ..++||||+. +++.+.+......+++.++..++.|++.|++||   |++|++||||||+||+++.++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI---HRNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence               4599999996 588888776655789999999999999999999   788999999999999999999999999999


Q ss_pred             ccccCCcCcc---cccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCcc--chhhhhccchh
Q 002214          811 AKLLSEEDSM---KQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM--SIKRWINDSLP  884 (952)
Q Consensus       811 a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~  884 (952)
                      +.........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||........  ...+......+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9866433221   11234578899999987654 468899999999999999999999864321100  00000000000


Q ss_pred             hhh------hhccc-cccchhhH--HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          885 AVM------NIMDT-NLLSEDEE--HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       885 ~~~------~~~~~-~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +..      ...+. ........  .....+...+..+.+++.+||..||++|||++|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000      00000 00000000  0000011134567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.9e-33  Score=295.31  Aligned_cols=249  Identities=21%  Similarity=0.289  Sum_probs=194.7

Q ss_pred             HHHHHhccCCcccee--cCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecCC
Q 002214          658 ELLRATDQFSEENLI--GIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNHN  733 (952)
Q Consensus       658 ~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  733 (952)
                      +.....++|.+.+.+  |+|+||.||++.. .+++.+|+|.+.......     .|+.....+ +|||++++++++...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            334455677777776  9999999999987 468899999986442211     122222222 7999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC-cEEEecccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-VAHLSDFGIAK  812 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~  812 (952)
                      ..++||||+++++|.+++.... .+++.++..++.|+++|++||   |+.|++||||+|+||+++.++ .++|+|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDL---HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            9999999999999999987654 789999999999999999999   789999999999999999988 99999999998


Q ss_pred             ccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                      ......     ...++..|+|||++.+..++.++||||||+++|||++|+.||......+.....+....        ..
T Consensus       159 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~  225 (267)
T PHA03390        159 IIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--------QK  225 (267)
T ss_pred             ecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--------cc
Confidence            654321     23578999999999888899999999999999999999999975433322222221111        00


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCC-HHHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN-TKEIISR  937 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~~  937 (952)
                      .         ...+..++..+.+++.+||+.+|++||+ ++|++++
T Consensus       226 ~---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        226 K---------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             c---------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            0         0011245778999999999999999996 5888753

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-33  Score=310.28  Aligned_cols=272  Identities=22%  Similarity=0.278  Sum_probs=198.9

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeecC-----Cee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNH-----NFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  735 (952)
                      .++|.+.+.||+|+||.||+|.+ .+|+.||+|.+... .......+.+|+.++++++|||++++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999987 46899999998643 233446678899999999999999999887544     357


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++|+||++ +++.+.+..  ..+++..+..++.|+++||+||   |+.||+||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~L---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999996 478777654  3589999999999999999999   78999999999999999999999999999998654


Q ss_pred             CcCccc--ccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhh---hccchhh-hhh
Q 002214          816 EEDSMK--QTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW---INDSLPA-VMN  888 (952)
Q Consensus       816 ~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~-~~~  888 (952)
                      ......  .....+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...... .....+   .....++ ...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHH
Confidence            322211  122468899999997654 56889999999999999999999998542110 000000   0000000 000


Q ss_pred             hccccc-------cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHH
Q 002214          889 IMDTNL-------LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR--LIKI  941 (952)
Q Consensus       889 ~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~i  941 (952)
                      ..+...       ...............+.++.+++.+||+.||++||++.|++++  ++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            000000       0000000000112346779999999999999999999999987  5443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.1e-34  Score=327.80  Aligned_cols=254  Identities=27%  Similarity=0.407  Sum_probs=191.4

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeec-------
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTN-------  731 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  731 (952)
                      +-..+|...+.||+||||.||+++.+ ||+.||||++... +......+.+|+.++++++|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45567888899999999999999985 8999999998655 34445778999999999999999998621100       


Q ss_pred             --------------------------------------------------------------------------------
Q 002214          732 --------------------------------------------------------------------------------  731 (952)
Q Consensus       732 --------------------------------------------------------------------------------  731 (952)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 002214          732 ------------------------H--------NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF  779 (952)
Q Consensus       732 ------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~  779 (952)
                                              +        ...||-||||+...+.++++.....-.....++++++|++||+|+  
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI--  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI--  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH--
Confidence                                    0        124678999999888888876653335788999999999999999  


Q ss_pred             cCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC-----------------CcCcccccccccccccccccccCcC--
Q 002214          780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS-----------------EEDSMKQTQTLATIGYIAPEYGREG--  840 (952)
Q Consensus       780 ~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~~~~~y~aPE~~~~~--  840 (952)
                       |++|||||||||.||+++++..+||+|||+|....                 .......+..+||.-|+|||.+.+.  
T Consensus       714 -H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  714 -HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             -HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence             89999999999999999999999999999998721                 0111234457899999999988765  


Q ss_pred             -CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhh
Q 002214          841 -QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAME  919 (952)
Q Consensus       841 -~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  919 (952)
                       .|+.|+|+||+|||++||+.   ||+........+...-.+..|....+                .....+.-+.+|++
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f----------------~~~~~~~e~slI~~  853 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADF----------------FDPEHPEEASLIRW  853 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCccc----------------ccccchHHHHHHHH
Confidence             49999999999999999996   45443222221211111111111000                11112345789999


Q ss_pred             ccccCCCCCCCHHHHHH
Q 002214          920 CTSESPENRVNTKEIIS  936 (952)
Q Consensus       920 cl~~dP~~RPs~~ev~~  936 (952)
                      +++.||.+||||.|+++
T Consensus       854 Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HhcCCCccCCCHHHHhh
Confidence            99999999999999875

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=295.19  Aligned_cols=252  Identities=24%  Similarity=0.342  Sum_probs=205.4

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .+.|+.-++||+|+||.||.++. .+|+.||.|.+..+.   .+.......|..|+.+++.+.||.+-..|...+..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            35688889999999999999976 479999999875432   23335578899999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          739 LEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      +..|.||+|.-+++..+ ..+++..+.-++.+|+.||++|   |+.+||.||+||+|||+|+.|+++|+|.|+|..+..+
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehl---H~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHL---HRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHH---HhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999998887654 4799999999999999999999   8999999999999999999999999999999988655


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      ...  ..++||.+|||||++..+.|+...|.||+||++|||+.|+.||........             .+-+|......
T Consensus       341 ~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-------------~eEvdrr~~~~  405 (591)
T KOG0986|consen  341 KPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-------------REEVDRRTLED  405 (591)
T ss_pred             Ccc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-------------HHHHHHHHhcc
Confidence            433  446899999999999999999999999999999999999999865321110             00111111111


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIIS  936 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  936 (952)
                      ..    .-+..+++++.++.+..+..||++|.     .++||-+
T Consensus       406 ~~----ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~  445 (591)
T KOG0986|consen  406 PE----EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE  445 (591)
T ss_pred             hh----hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence            11    11245678899999999999999997     4455544

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.5e-33  Score=295.37  Aligned_cols=251  Identities=27%  Similarity=0.400  Sum_probs=206.2

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecC--CeeEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNH--NFKALVL  739 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  739 (952)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+.++++++|||++++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999985 689999999865542  4457889999999999999999999999888  8899999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++++|.+++.... .+++..+..++.|+++|++||   |+.+++|||++|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~l---h~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYL---HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999987665 789999999999999999999   789999999999999999999999999999987754432


Q ss_pred             c-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 M-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      . ......++..|+|||...+..++.++||||||+++|++++|..||........           ..........    
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----------~~~~~~~~~~----  221 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-----------ALYKIGSSGE----  221 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----------HHHhccccCC----
Confidence            1 12335688899999999888899999999999999999999999866431100           0000000000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ....+...+.++.+++.+|+..+|++||++.|++++
T Consensus       222 ---~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         222 ---PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ---CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence               001223346789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=293.49  Aligned_cols=247  Identities=28%  Similarity=0.412  Sum_probs=203.4

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|++.+.||+|++|.||+|+.. +++.||+|.+.....  ...+.+.+|++++++++|||++++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999874 688999999865543  4557889999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++++|.+++... ..+++..+..++.|++.|++||   |+.||+||||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYL---HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999988765 4689999999999999999999   7999999999999999999999999999999876543321 


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      .....++..|+|||...+..++.++||||+|+++|+|++|+.||......    ...        ...... .       
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~--------~~~~~~-~-------  215 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AAL--------FRIVQD-D-------  215 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHH--------HHHhcc-C-------
Confidence            22345888999999988777889999999999999999999998642210    000        000000 0       


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                      ....+...+.++.+++.+||..+|++||++.|++.
T Consensus       216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            00112334678999999999999999999999975

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4e-33  Score=300.56  Aligned_cols=243  Identities=24%  Similarity=0.287  Sum_probs=193.1

Q ss_pred             ecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCCh
Q 002214          672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL  747 (952)
Q Consensus       672 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  747 (952)
                      ||+|+||+||+|.. .+|+.||+|.+....   ......+..|++++++++|||++++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999986 468999999986432   22345667899999999999999999999999999999999999999


Q ss_pred             hHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccccc
Q 002214          748 EDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL  826 (952)
Q Consensus       748 ~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  826 (952)
                      .+++.... ..+++..+..++.|++.|+.||   |+.|++||||+|+||++++++.+||+|||.+......  .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHL---HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence            99887644 3689999999999999999999   7899999999999999999999999999999865432  1222345


Q ss_pred             cccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhh
Q 002214          827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAK  906 (952)
Q Consensus       827 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  906 (952)
                      ++..|+|||+..+..++.++||||+|+++|+|++|+.||...... ......        ......        .....+
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~--------~~~~~~--------~~~~~~  218 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEEL--------KRRTLE--------MAVEYP  218 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHH--------Hhcccc--------ccccCC
Confidence            788999999988888999999999999999999999998653211 000000        000000        000112


Q ss_pred             hhhHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 002214          907 QSCASSVLSLAMECTSESPENRV-----NTKEIIS  936 (952)
Q Consensus       907 ~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  936 (952)
                      ..+++++.+++.+||+.+|++||     ++.++++
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            33467899999999999999999     6666765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.7e-33  Score=308.83  Aligned_cols=268  Identities=25%  Similarity=0.308  Sum_probs=199.2

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc--CchhhHHHHHHHHHHHhC-CCCccceeeeEeecC--Cee
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTI-RHRNLVKIISSCTNH--NFK  735 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  735 (952)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4568899999999999999999875 6889999987532  223345677899999999 999999999988653  367


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||++ ++|..++...  .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~L---H~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYI---HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999996 5898887654  688999999999999999999   78999999999999999999999999999998664


Q ss_pred             CcCcc----cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhh--
Q 002214          816 EEDSM----KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPA--  885 (952)
Q Consensus       816 ~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~--  885 (952)
                      .....    ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. ..+..   .....+  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  237 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDI  237 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Confidence            43221    1223458889999997654 4678899999999999999999999864322111 11100   000000  


Q ss_pred             -------hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 -------VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                             ....++............ ....++.++.+++.+||+.||++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                   000111000000000011 112367889999999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-33  Score=300.03  Aligned_cols=266  Identities=23%  Similarity=0.301  Sum_probs=202.7

Q ss_pred             CCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      |++.+.||+|++|.||+|... +++.+|+|.+.....  .....+.+|+.++++++||+++++++++..+...++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999874 689999998865432  24567889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      ++ ++.+.+......+++..+..++.|+++|++||   |+.+|+||||+|+||+++.++.+||+|||.+....... ...
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~  155 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC---HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY  155 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHH---HHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence            65 88888877656799999999999999999999   78999999999999999999999999999998765433 122


Q ss_pred             cccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhhhhhhcc-------
Q 002214          823 TQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPAVMNIMD-------  891 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~-------  891 (952)
                      ....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+ .+....   ....+.....+.       
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            234578899999988766 78899999999999999999999985422111 111100   000010000000       


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .................++.++.+++.+||++||.+||++.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            0000000000111234567889999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-33  Score=323.57  Aligned_cols=272  Identities=16%  Similarity=0.183  Sum_probs=191.4

Q ss_pred             HhccCCccceecCccceEEEEEEeCC--CcEEEEEE--------------ee---ccCchhhHHHHHHHHHHHhCCCCcc
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPD--GIEVAIKV--------------FH---LQREGALNSFDAECEILKTIRHRNL  722 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~ni  722 (952)
                      ..++|++.+.||+|+||+||++..+.  +..++.|.              +.   .........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999987532  22222221              10   0112234568899999999999999


Q ss_pred             ceeeeEeecCCeeEEEEEccCCCChhHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC
Q 002214          723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASN----FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD  798 (952)
Q Consensus       723 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~  798 (952)
                      +++++++...+..|+|+|++. +++.+++....    .......+..++.|++.||+||   |++||+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yL---H~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI---HDKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEC
Confidence            999999999999999999995 56766665432    1234566788999999999999   789999999999999999


Q ss_pred             CCCcEEEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCC-CCccccCc-cchh
Q 002214          799 DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP-TNEFFTGE-MSIK  876 (952)
Q Consensus       799 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p-~~~~~~~~-~~~~  876 (952)
                      .++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|..+ +....... ..+.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999999987654433333345799999999999988999999999999999999998754 43321111 1111


Q ss_pred             hhhccc------hh----hhhhhccccccchhhH--HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          877 RWINDS------LP----AVMNIMDTNLLSEDEE--HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       877 ~~~~~~------~~----~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +.+...      .+    ...+.++.........  .........+.++.+++.+|++.||++|||+.|++++
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            111100      00    0111111000000000  0001112345678899999999999999999999875

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-32  Score=293.14  Aligned_cols=249  Identities=27%  Similarity=0.367  Sum_probs=204.8

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|++.+.||+|+||.||++.+. +++.||+|++.....  ...+.+.+|++++++++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999884 689999999875533  4456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          742 MPKGSLEDCMYAS---NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       742 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      +++++|.+.+...   ...+++..+..++.++++|++||   |+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL---HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999998765   35799999999999999999999   78899999999999999999999999999998764432


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                       .......+++.|+|||......++.++||||+|+++++|++|+.||......     +...       .......    
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~-------~~~~~~~----  220 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELAL-------KILKGQY----  220 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHH-------HHhcCCC----
Confidence             1222346888999999988888999999999999999999999998542110     0000       0000000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ...+..++.++.+++.+||..+|++||++.|++++
T Consensus       221 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         221 ----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                01122456789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.9e-33  Score=300.95  Aligned_cols=245  Identities=24%  Similarity=0.332  Sum_probs=196.9

Q ss_pred             cceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCCh
Q 002214          669 ENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL  747 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  747 (952)
                      ...||+|+||.||+|.. .+++.||||.+..........+.+|+.++++++|||++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            36799999999999987 47899999998655555566789999999999999999999999999999999999999999


Q ss_pred             hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccccccc
Q 002214          748 EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA  827 (952)
Q Consensus       748 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  827 (952)
                      .+++...  .+++.....++.|++.|++||   |+.|++||||+|+||++++++.++|+|||++....... .......+
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---H~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~  178 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG  178 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccccc
Confidence            9877543  578999999999999999999   78899999999999999999999999999987654322 11223458


Q ss_pred             ccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhh
Q 002214          828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQ  907 (952)
Q Consensus       828 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  907 (952)
                      ++.|+|||+.....++.++||||+|+++|||++|..||.....  ........       .......    .     ...
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~-------~~~~~~~----~-----~~~  240 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIR-------DNLPPKL----K-----NLH  240 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH-------hhCCccc----C-----Ccc
Confidence            8999999998888889999999999999999999999854211  00000000       0000000    0     011


Q ss_pred             hhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          908 SCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       908 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .++.++.+++.+||..+|.+||++.|++++
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            245678999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-32  Score=294.78  Aligned_cols=242  Identities=26%  Similarity=0.341  Sum_probs=195.6

Q ss_pred             ecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCCh
Q 002214          672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL  747 (952)
Q Consensus       672 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  747 (952)
                      ||.|+||.||+|+.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999984 48999999986432   23446789999999999999999999999999999999999999999


Q ss_pred             hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccccccc
Q 002214          748 EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA  827 (952)
Q Consensus       748 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  827 (952)
                      .+++.... .+++..+..++.|+++|++||   |+++++|+||+|+||+++.++.++|+|||.+.......  ......+
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~l---H~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~  154 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG  154 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence            99987653 588999999999999999999   79999999999999999999999999999998765432  1223457


Q ss_pred             ccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhh
Q 002214          828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQ  907 (952)
Q Consensus       828 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  907 (952)
                      ++.|+|||.+.+..++.++|+||+|+++|+|++|..||.......   .+.       .....+....       ...+.
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~-------~~~~~~~~~~-------~~~~~  217 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEI-------YNDILKGNGK-------LEFPN  217 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHH-------HHHHhccCCC-------CCCCc
Confidence            889999999888888999999999999999999999986532211   000       0111110000       01122


Q ss_pred             hhHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 002214          908 SCASSVLSLAMECTSESPENRVN-----TKEIIS  936 (952)
Q Consensus       908 ~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~  936 (952)
                      .+++++.+++.+||+.+|++||+     ++|+++
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            33678999999999999999999     677665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.1e-33  Score=307.38  Aligned_cols=268  Identities=21%  Similarity=0.254  Sum_probs=198.8

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeec----CCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTN----HNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  735 (952)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368999999999999999999874 69999999986542  2334667889999999999999999988753    3468


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||+. ++|.+++.... .+++..+..++.|++.||+||   |+++|+||||||+||++++++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYI---HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 68988886544 589999999999999999999   78999999999999999999999999999997654


Q ss_pred             CcCccc---ccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhhh--
Q 002214          816 EEDSMK---QTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPAV--  886 (952)
Q Consensus       816 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~--  886 (952)
                      ......   .....++..|+|||.+.. ..++.++|||||||++|||++|+.||....... ......   ....+..  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhCCChhHhhh
Confidence            322111   123468889999998755 458899999999999999999999986532111 000000   0000000  


Q ss_pred             -------hhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 -------MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                             .+..+........ .........+.++.+++.+||+.+|++||++.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPV-PWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhchhhHHHHHhhcccCCCC-CHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                   0000000000000 0001123357889999999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-32  Score=304.40  Aligned_cols=272  Identities=21%  Similarity=0.359  Sum_probs=196.9

Q ss_pred             ceecCc--cceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIG--SYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      ..||+|  +||+||+|++ .+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  9999999987 479999999986543  23346788999999999999999999999999999999999999


Q ss_pred             CChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc--
Q 002214          745 GSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK--  821 (952)
Q Consensus       745 g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--  821 (952)
                      +++.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYL---HQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999887643 3588999999999999999999   78999999999999999999999999998664432211110  


Q ss_pred             ----ccccccccccccccccCcC--CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccc--------hhhhh
Q 002214          822 ----QTQTLATIGYIAPEYGREG--QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS--------LPAVM  887 (952)
Q Consensus       822 ----~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~~~  887 (952)
                          .....++..|+|||++.+.  .++.++|||||||++|||++|+.||.................        .+...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                0112345679999998763  478899999999999999999999975432111100000000        00000


Q ss_pred             -hh------ccc----cc-------cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHHH
Q 002214          888 -NI------MDT----NL-------LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR--LIKIRDL  944 (952)
Q Consensus       888 -~~------~~~----~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~i~~~  944 (952)
                       ..      .+.    ..       ...........+..++.++.+++++||..||++|||+.|++++  ++.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence             00      000    00       0000001111234567889999999999999999999999754  4555554

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-33  Score=301.19  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=205.5

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ....|.+.+.||+|.|+.|..|++ .+|..||+|.+....  ......+.+|+++|..++|||||+++.+...+...|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            456789999999999999999987 479999999986543  22335588999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+.+|.+.+++...+.. .+..+..++.|+.+|++||   |++.|||||||++||+++.+.++||+|||++.++....
T Consensus       134 ~eya~~ge~~~yl~~~gr~-~e~~ar~~F~q~vsaveYc---H~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRM-KEKEARAKFRQIVSAVEYC---HSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEeccCchhHHHHHhcccc-hhhhhhhhhHHHHHHHHHH---hhcceeccccchhhcccccccceeeeccccceeecccc
Confidence            9999999999999887754 4489999999999999999   89999999999999999999999999999999886332


Q ss_pred             cccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                        .....+|++.|+|||++.+..+ ++++|+||+|+++|-++.|..||+...-.+..-+.                +..+
T Consensus       210 --~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv----------------l~gk  271 (596)
T KOG0586|consen  210 --MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV----------------LRGK  271 (596)
T ss_pred             --cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh----------------eeee
Confidence              2344789999999999887655 68999999999999999999999762211111000                0000


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      ..     .+-..+.+..+++++++..+|.+|++.+++.++-
T Consensus       272 ~r-----Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  272 YR-----IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             ec-----ccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence            00     1122355678999999999999999999987653

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9.8e-33  Score=293.97  Aligned_cols=247  Identities=24%  Similarity=0.345  Sum_probs=202.3

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|++.+.||+|+||.||+++. .+++.+|+|.+....  ......+.+|++++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            478889999999999999976 468899999986542  33456778999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          742 MPKGSLEDCMYAS---NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       742 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      +++++|.+++...   ...+++..++.++.|+++|++||   |+.|++||||+|+||++++++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---h~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL---HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988652   24689999999999999999999   8999999999999999999999999999999876543 


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                        ......+++.|+|||...+..++.++|+||+|+++||+++|+.||......  ....           ........  
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~-----------~~~~~~~~--  219 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRY-----------KVQRGKYP--  219 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH-----------HHhcCCCC--
Confidence              122345788999999998888999999999999999999999998653211  0000           00111100  


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..+..++.++.+++.+|++.+|++||++.|++++
T Consensus       220 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         220 -----PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -----CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                 0112456779999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.2e-32  Score=302.86  Aligned_cols=266  Identities=19%  Similarity=0.251  Sum_probs=194.5

Q ss_pred             ccceecCccceEEEEEEeCCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCC
Q 002214          668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKG  745 (952)
Q Consensus       668 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  745 (952)
                      +.+.+|.|+++.||++.. +++.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..+++|||+++|
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            444555566666666555 7999999998754  3344578999999999999999999999999999999999999999


Q ss_pred             ChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc----
Q 002214          746 SLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM----  820 (952)
Q Consensus       746 ~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~----  820 (952)
                      +|.+++... ...+++.....++.|+++||+||   |+++|+||||||+||+++.++.+|++|||.+.........    
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~L---H~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYI---HSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999998753 34688999999999999999999   7899999999999999999999999999998755322210    


Q ss_pred             --cccccccccccccccccCcC--CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc--------cchhhhhh
Q 002214          821 --KQTQTLATIGYIAPEYGREG--QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN--------DSLPAVMN  888 (952)
Q Consensus       821 --~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  888 (952)
                        ......++..|+|||++...  .++.++|||||||++|||++|+.||...........+...        ...+....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence              11223467789999988653  5788999999999999999999999753221111111000        00000000


Q ss_pred             hccc----c-ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          889 IMDT----N-LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       889 ~~~~----~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .+..    . ................+.++.+++.+||..||++|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0000    0 00000011112233456789999999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=277.71  Aligned_cols=259  Identities=20%  Similarity=0.299  Sum_probs=202.6

Q ss_pred             ceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEccCCCCh
Q 002214          670 NLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSL  747 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  747 (952)
                      +.||+|+|+.|--+.. .+|..||||++.++......++.+|++++.+- .|+||+.++++|+++...|+|||.|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            5799999999988864 78999999999877666678899999999988 599999999999999999999999999999


Q ss_pred             hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC---cEEEeccccccccCCcCc-----
Q 002214          748 EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM---VAHLSDFGIAKLLSEEDS-----  819 (952)
Q Consensus       748 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgla~~~~~~~~-----  819 (952)
                      .+.+.+.. -+++.++.++.++||.||.+|   |.+||.|||+||+|||..+..   .+||+||.++.-+.-...     
T Consensus       164 LshI~~~~-~F~E~EAs~vvkdia~aLdFl---H~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  164 LSHIQKRK-HFNEREASRVVKDIASALDFL---HTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             HHHHHHhh-hccHHHHHHHHHHHHHHHHHH---hhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            99998766 589999999999999999999   899999999999999997544   589999998864432211     


Q ss_pred             -ccccccccccccccccccC-----cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhh--hccchhhhhhhcc
Q 002214          820 -MKQTQTLATIGYIAPEYGR-----EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW--INDSLPAVMNIMD  891 (952)
Q Consensus       820 -~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~  891 (952)
                       ..-...+|+..|||||+..     ...|..++|.||+||++|-|++|..||......+=.+.+-  -+.....+.+.+.
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ  319 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ  319 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence             1122367888999999642     2357889999999999999999999998765544333221  1111111222221


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                      .+-    .+.....+..++.+..+++...+..|+.+|.++..+++
T Consensus       320 EGk----YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  320 EGK----YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ccC----CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            111    11111223456888999999999999999999999886

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.2e-32  Score=299.58  Aligned_cols=267  Identities=22%  Similarity=0.301  Sum_probs=196.1

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ++|++.+.||+|++|+||+|.+. +|+.||+|.+....  ....+.+.+|++++++++|||++++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999874 68999999886442  2334568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-CCcEEEeccccccccCCcC
Q 002214          741 YMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-SMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~  818 (952)
                      |++ +++.+.+.... ...++..+..++.|++.||+||   |+++++||||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC---HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 57777765433 2467888899999999999999   7899999999999999985 5679999999997653221


Q ss_pred             cccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhhh-h------
Q 002214          819 SMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPAV-M------  887 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~-~------  887 (952)
                       .......+++.|+|||++.+ ..++.++||||+||++|+|+||+.||......+ ...+..   ....... .      
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhccccccch
Confidence             11123457889999998765 457889999999999999999999986422111 111100   0000000 0      


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +......... ...........++++.+++.+|++.+|++||++.+++++
T Consensus       236 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        236 DYKSAFPKWP-PKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhhcccCC-CCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000000000 000001123356778999999999999999999999864

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.4e-33  Score=301.45  Aligned_cols=255  Identities=23%  Similarity=0.304  Sum_probs=200.2

Q ss_pred             cCCccceecCccceEEEEEEe----CCCcEEEEEEeeccC----chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCee
Q 002214          665 QFSEENLIGIGSYGSVYKGRF----PDGIEVAIKVFHLQR----EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  735 (952)
                      +|++.+.||+|+||.||+|+.    .+++.||||+++...    ....+.+.+|+.++.++ +||+++++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            377889999999999999975    357899999986432    22345678999999999 599999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||+++|+|.+++.... .+++..+..++.|+++||+||   |+.+++||||+|+||+++.++.++++|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~l---H~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHL---HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999887543 688999999999999999999   78999999999999999999999999999998765


Q ss_pred             CcCcccccccccccccccccccCcCC--cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQ--VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      ...........++..|+|||...+..  .+.++||||||+++|||++|..||...... .....+..       ..... 
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~-------~~~~~-  227 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISR-------RILKS-  227 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHH-------HHHcc-
Confidence            44332233345889999999877654  788999999999999999999998542110 00111000       00000 


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                              ....+..++.++.+++.+||+.||++|||+.++.+.|+.
T Consensus       228 --------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 --------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             --------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                    001123356778999999999999999998888766654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-34  Score=323.63  Aligned_cols=258  Identities=24%  Similarity=0.317  Sum_probs=211.8

Q ss_pred             HHHHHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeec---cCchhhHHHHHHHHHHHhCCCCccceeeeEeecCC
Q 002214          658 ELLRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL---QREGALNSFDAECEILKTIRHRNLVKIISSCTNHN  733 (952)
Q Consensus       658 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  733 (952)
                      ++.-..++|.+.++||+|+||.|..++.+ +++.||+|++..   -+.....-|..|-.+|..-..+=|+.++..|.++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            34445678999999999999999999884 688999999864   22334467889999999889999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      +.|+|||||+||+|-.++.... ++++..+..++..|.-|+..+   |+.|+|||||||.|||+|..|++||+|||.+..
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldsl---H~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSL---HSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHH---HhccceeccCCcceeEecccCcEeeccchhHHh
Confidence            9999999999999999998877 799999999999999999999   899999999999999999999999999999999


Q ss_pred             cCCcCcccccccccccccccccccC----c-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhh
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGR----E-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMN  888 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  888 (952)
                      +..++.......+|||.|++||++.    + +.|+..+|.||+||++|||+.|..||...            ..++....
T Consensus       225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------------slveTY~K  292 (1317)
T KOG0612|consen  225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------------SLVETYGK  292 (1317)
T ss_pred             cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------------HHHHHHHH
Confidence            9877776777789999999999764    3 57899999999999999999999998652            11122222


Q ss_pred             hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCC---HHHHHHH
Q 002214          889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN---TKEIISR  937 (952)
Q Consensus       889 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~~  937 (952)
                      +++..-.-..+     .....+.+..+||...+. +|+.|..   +.|+-.|
T Consensus       293 Im~hk~~l~FP-----~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  293 IMNHKESLSFP-----DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             HhchhhhcCCC-----cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            33221100011     013367889999999887 8888887   8887665

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.5e-32  Score=300.46  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=197.5

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      +.|...+.||+|+||.||+|+.. +++.||+|.+...   ......++.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777788999999999999874 6789999988643   2233456889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+. |++.+.+......+++.++..++.|++.|++||   |+.+++||||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9996 688887766566789999999999999999999   7899999999999999999999999999999765332  


Q ss_pred             ccccccccccccccccccC---cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          820 MKQTQTLATIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                         ....+++.|+|||.+.   ...++.++|||||||++|||++|+.||......+ ....+.....+            
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~------------  232 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP------------  232 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCCC------------
Confidence               2245788999999864   3567889999999999999999999975421110 00001000000            


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                            ......++..+.+++.+||+.+|++||++.+++++-.
T Consensus       233 ------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         233 ------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             ------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence                  0011235677899999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-32  Score=304.94  Aligned_cols=274  Identities=21%  Similarity=0.244  Sum_probs=203.5

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecC-----Ce
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNH-----NF  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  734 (952)
                      .++|.+.+.||+|+||+||+|+. .+++.||||.++..  .......+.+|+.+++.++|||++++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45799999999999999999987 46899999988643  222345677899999999999999999987644     35


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .++||||+. ++|.+++... ..+++..+..++.|++.||+||   |+++++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYI---HSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999995 6888887654 3689999999999999999999   7899999999999999999999999999999866


Q ss_pred             CCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchh---hhhccchhh-----
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK---RWINDSLPA-----  885 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~-----  885 (952)
                      .... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..... .....   .......++     
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhhc
Confidence            4332 11223457889999997754 4688999999999999999999999864211 00000   000000000     


Q ss_pred             ----hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHHH
Q 002214          886 ----VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR--LIKIRDL  944 (952)
Q Consensus       886 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~i~~~  944 (952)
                          ..+.++......... .......+++++.+++.+||+.+|++|||+.|++++  ++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQS-FARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             CchhhhHHHHhcCcccccC-HHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                000000000000000 011123567889999999999999999999999988  6655443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.1e-32  Score=298.70  Aligned_cols=244  Identities=25%  Similarity=0.323  Sum_probs=194.6

Q ss_pred             CCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          666 FSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      |...+.||+|+||+||+|+. .+|+.||+|++....   ......+.+|++++++++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66677899999999999987 468999999986432   22345688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +. |++.+.+......+++.++..++.|++.|++||   |++|++||||+|+||+++.++.+||+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            95 578887776666799999999999999999999   789999999999999999999999999999864322     


Q ss_pred             ccccccccccccccccC---cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          822 QTQTLATIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      .....++..|+|||++.   ...++.++|||||||++|||++|..||......... ....           .....   
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-~~~~-----------~~~~~---  238 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIA-----------QNDSP---  238 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHH-----------hcCCC---
Confidence            12345888999999874   456888999999999999999999998553111100 0000           00000   


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ......++..+.+++.+||+.+|.+||++.|++.+
T Consensus       239 ----~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 ----TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00012235668999999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-34  Score=296.92  Aligned_cols=245  Identities=25%  Similarity=0.385  Sum_probs=201.6

Q ss_pred             cceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCC
Q 002214          669 ENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKG  745 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  745 (952)
                      .++||.|.||+||-|++ ++|+.||||++.+..  .+....+++|+.|++.++||.||.+...|+..+..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            47899999999999987 689999999986432  233477899999999999999999999999999999999999776


Q ss_pred             ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC---CcEEEeccccccccCCcCcccc
Q 002214          746 SLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       746 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      -|+-.+.....++++.....+..||..||.||   |-++|||+|+||+|||+.+.   -.+||+|||+|+.+++..  -.
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~L---H~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FR  723 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYL---HFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FR  723 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHh---hhcceeeccCCchheeeccCCCCCceeeccccceeecchhh--hh
Confidence            66777777778899999999999999999999   78999999999999999654   379999999999886543  23


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...+|||.|.|||+++.+.|...-|+||.||++|--++|..||++.    +++..    +++. ..+|.+          
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdInd----QIQN-AaFMyP----------  784 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDIND----QIQN-AAFMYP----------  784 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhH----Hhhc-cccccC----------
Confidence            4578999999999999999999999999999999999999999762    12111    1111 011111          


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...+.+.+.+..++|...++..-++|.+....+.+
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            11345567789999999999999999998877655

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-32  Score=298.79  Aligned_cols=252  Identities=24%  Similarity=0.314  Sum_probs=197.5

Q ss_pred             cCCccceecCccceEEEEEEe----CCCcEEEEEEeeccC----chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCee
Q 002214          665 QFSEENLIGIGSYGSVYKGRF----PDGIEVAIKVFHLQR----EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  735 (952)
                      .|++.+.||+|+||.||+|+.    .+|+.||+|+++...    ....+.+.+|+++++++ +|++|+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999986    368999999986432    22346678899999999 599999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||+++++|.+++.... .+++..+..++.|+++||+||   |+.|++||||+|+||+++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999887654 688999999999999999999   78999999999999999999999999999998764


Q ss_pred             CcCcccccccccccccccccccCcC--CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREG--QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      ...........++..|+|||.....  .++.++||||||+++|+|++|+.||...... .....+..       ......
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~-------~~~~~~  228 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISR-------RILKSE  228 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHH-------HhhccC
Confidence            4332222335588999999987653  4678899999999999999999998532111 01111100       000000


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                               ...+..++..+.+++.+||+.||++||     ++.++..+
T Consensus       229 ---------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         229 ---------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ---------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                     001233567789999999999999997     67777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.6e-33  Score=296.89  Aligned_cols=242  Identities=28%  Similarity=0.385  Sum_probs=194.7

Q ss_pred             ecCccceEEEEEEeC-CCcEEEEEEeeccCc---hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCCh
Q 002214          672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL  747 (952)
Q Consensus       672 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  747 (952)
                      ||+|+||.||+|++. +|+.||+|++.....   ...+.+.+|++++++++|||++++++.+..+...|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999985 499999999865432   3456788999999999999999999999999999999999999999


Q ss_pred             hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc-------c
Q 002214          748 EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-------M  820 (952)
Q Consensus       748 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-------~  820 (952)
                      .+++.... .+++..+..++.|+++||+||   |+.+++||||+|+||++++++.++|+|||++........       .
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYL---HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99987655 689999999999999999999   789999999999999999999999999999976533211       1


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      ......++..|+|||......++.++||||||+++||+++|..||......+ ...           ........     
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~-----------~~~~~~~~-----  219 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-IFQ-----------NILNGKIE-----  219 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHH-----------HHhcCCcC-----
Confidence            2223457889999999888889999999999999999999999986532110 000           00000000     


Q ss_pred             HHHHhhhh--hHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          901 HANVAKQS--CASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       901 ~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                          .+..  .+.++.+++.+||+.+|++|||+.++.+.+
T Consensus       220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         220 ----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                0111  267899999999999999999995555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-32  Score=303.63  Aligned_cols=267  Identities=20%  Similarity=0.260  Sum_probs=199.4

Q ss_pred             HHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCC--
Q 002214          659 LLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHN--  733 (952)
Q Consensus       659 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  733 (952)
                      ++...++|++.+.||+|+||.||+|.. .+|+.||||++....  ......+.+|+.++++++||||+++++++..+.  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            445677899999999999999999986 478999999885432  223456889999999999999999999886543  


Q ss_pred             ----eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccc
Q 002214          734 ----FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       734 ----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  809 (952)
                          ..++||||+ +++|.+++..  ..+++..+..++.|+++|++||   |+.||+||||||+||+++.++.+|++|||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~L---H~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYI---HAAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence                458999999 7799887764  3589999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhh
Q 002214          810 IAKLLSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPA  885 (952)
Q Consensus       810 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~  885 (952)
                      ++......    .....+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||...... ........   ...+.
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~  238 (343)
T cd07880         164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSKE  238 (343)
T ss_pred             cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHH
Confidence            99865322    123457889999998765 45788999999999999999999998643211 01111000   00000


Q ss_pred             hhhhcccc--------ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          886 VMNIMDTN--------LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       886 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                      +...+...        ...............++.++.+++.+|++.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000000        0000000011122356778999999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-32  Score=303.64  Aligned_cols=273  Identities=20%  Similarity=0.267  Sum_probs=206.2

Q ss_pred             cCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCC-----eeE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHN-----FKA  736 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  736 (952)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788999999999999999975 58999999886543  334567899999999999999999999987765     789


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||++ ++|.+++.... .+++..+..++.|+++|++||   |++||+||||||+||+++.++.++|+|||.+.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~L---H~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYL---HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 58888886544 789999999999999999999   789999999999999999999999999999987654


Q ss_pred             cCc--ccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhh---hccchhh-----
Q 002214          817 EDS--MKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW---INDSLPA-----  885 (952)
Q Consensus       817 ~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~-----  885 (952)
                      ...  .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+ .+...   .....++     
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHhcCCCChhHhhhc
Confidence            321  112334578899999998877 78999999999999999999999986532111 00000   0000000     


Q ss_pred             ----hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHHH
Q 002214          886 ----VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR--LIKIRDL  944 (952)
Q Consensus       886 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~i~~~  944 (952)
                          ..+.+.. ................+.++.+++.+||+.+|++||++.+++++  ++++++.
T Consensus       235 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         235 TSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             cccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                0000000 00000000011122357789999999999999999999999985  6655543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-32  Score=294.05  Aligned_cols=265  Identities=23%  Similarity=0.301  Sum_probs=196.2

Q ss_pred             CCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhC---CCCccceeeeEeecCCe-----
Q 002214          666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTI---RHRNLVKIISSCTNHNF-----  734 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  734 (952)
                      |++.+.||+|+||.||+|+.+ +++.||+|+++....  .....+.+|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999986 489999999864422  2234566788877766   59999999999987766     


Q ss_pred             eEEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      .+++|||++ ++|.+++.... ..+++..+..++.|+++||+||   |+.+++|+|++|+||+++.++.+||+|||.+..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~L---H~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL---HSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999996 48888876643 3689999999999999999999   789999999999999999999999999999987


Q ss_pred             cCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchh-hhhhhcc-
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP-AVMNIMD-  891 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~-  891 (952)
                      ......  .....++..|+|||++.+..++.++|||||||++|||++|..||..... .....++...... ....... 
T Consensus       157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCCC
Confidence            643322  1223478899999999888899999999999999999999988865321 1111111110000 0000000 


Q ss_pred             -----ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 -----TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..................+..+.+++.+||+.||++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                 0000000000011112346778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-32  Score=303.73  Aligned_cols=270  Identities=21%  Similarity=0.286  Sum_probs=198.7

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecC------
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNH------  732 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  732 (952)
                      ..++|...+.||+|+||.||+|.. .+|+.||||++...  .+.....+.+|+.++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            347899999999999999999987 46899999988643  222345678999999999999999999988654      


Q ss_pred             CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          733 NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                      ...++|+||+.. ++.++..   ..+++..+..++.|++.|++||   |+.+|+||||||+||+++.++.+||+|||+++
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYI---HSAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             ceEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            246899999964 6766542   3588999999999999999999   78999999999999999999999999999998


Q ss_pred             ccCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhhhhh
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPAVMN  888 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~  888 (952)
                      .....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+.....   ...+...+
T Consensus       166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHH
Confidence            64321    123457889999998766 4688899999999999999999999864211 011111110   11111111


Q ss_pred             hccccccch--------hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHH
Q 002214          889 IMDTNLLSE--------DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR--LIKIRD  943 (952)
Q Consensus       889 ~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~i~~  943 (952)
                      .........        ............+.++.+++.+||+.||++||+++|++.+  ++.+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            111000000        0000001112346678999999999999999999999966  766654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=292.94  Aligned_cols=241  Identities=24%  Similarity=0.329  Sum_probs=187.0

Q ss_pred             ceecCccceEEEEEEe-CCCcEEEEEEeeccCc---hhhHHHHHHHHHH-HhCCCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE---GALNSFDAECEIL-KTIRHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||.||+|.. .+|+.||+|+++....   .....+..|..++ ...+|||++++++++...+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5699999999999987 4689999999864321   1223345555544 445899999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      ++|.+++.... .+++..+..++.|++.||+||   |+.+++||||+|+||++++++.+||+|||++.....     ...
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~  152 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDL---HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK  152 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence            99999887544 688999999999999999999   789999999999999999999999999999975432     122


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..+++.|+|||...+..++.++||||||+++|||++|..||......     ....       ........     ....
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~-------~~~~~~~~-----~~~~  215 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-----AVFD-------NILSRRIN-----WPEE  215 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHHH-------HHHhcccC-----CCCc
Confidence            45788999999988888899999999999999999999998642111     1000       00000000     0001


Q ss_pred             hhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          905 AKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       905 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                      ....+++++.+++.+||+.+|++||++.++.+
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            12245788999999999999999997754433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-32  Score=303.69  Aligned_cols=273  Identities=19%  Similarity=0.255  Sum_probs=202.1

Q ss_pred             cCHHHHHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEee
Q 002214          654 YSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCT  730 (952)
Q Consensus       654 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  730 (952)
                      ....++...+++|.+.+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|+.++++++||||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            34456677889999999999999999999986 578999999886432  223456788999999999999999999885


Q ss_pred             cC------CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEE
Q 002214          731 NH------NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH  804 (952)
Q Consensus       731 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~k  804 (952)
                      ..      ...+++++++ +++|.+++...  .+++..+..++.|+++|++||   |+.||+||||||+||++++++.+|
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEcCCCCEE
Confidence            43      3467888887 78998877643  589999999999999999999   789999999999999999999999


Q ss_pred             EeccccccccCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhh---hc
Q 002214          805 LSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW---IN  880 (952)
Q Consensus       805 l~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~  880 (952)
                      |+|||+++.....    .....++..|+|||...+ ..++.++|||||||++|||++|+.||..... .......   ..
T Consensus       161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~  235 (345)
T cd07877         161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVG  235 (345)
T ss_pred             Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhC
Confidence            9999999864321    223457889999998765 4678899999999999999999999854221 1111111   11


Q ss_pred             cchhhhhhhccccccchh--------hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          881 DSLPAVMNIMDTNLLSED--------EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...+.....+........        ...........++++.+++.+|++.||++||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            111111111110000000        000000011346678999999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.2e-33  Score=298.83  Aligned_cols=249  Identities=26%  Similarity=0.405  Sum_probs=202.6

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  738 (952)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++...   .....+.+.+|+.++++++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888999999999999999874 7999999998643   2233467889999999998 99999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++++|.+++.... .+++..+..++.|++.|++||   |+.|++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~L---h~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYL---HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999987654 699999999999999999999   78999999999999999999999999999998765432


Q ss_pred             c-------------------ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh
Q 002214          819 S-------------------MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI  879 (952)
Q Consensus       819 ~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~  879 (952)
                      .                   .......++..|+|||......++.++||||||++++++++|+.||.....    ..   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~---  229 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YL---  229 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----HH---
Confidence            2                   111224578899999998888899999999999999999999999865321    00   


Q ss_pred             ccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCH----HHHHHH
Q 002214          880 NDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNT----KEIISR  937 (952)
Q Consensus       880 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~ev~~~  937 (952)
                           .........         ...+...++.+.+++.+||+.+|++||++    .+++++
T Consensus       230 -----~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         230 -----TFQKILKLE---------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             -----HHHHHHhcC---------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                 000000000         01122346779999999999999999999    777653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-33  Score=277.20  Aligned_cols=249  Identities=23%  Similarity=0.294  Sum_probs=202.3

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ..++|...++||+|.||.|-.++-+ +|+.+|+|+++.+.   ..+...-..|-++++.-+||.+..+-..|...+..|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            4578999999999999999999864 69999999987552   2334556789999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+.||.|.-++...+ .+++.....+..+|..||.||   |+++||.||+|.+|.|+|.+|++||+|||+++.--..
T Consensus       246 VMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YL---Hs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYL---HSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhh---hhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            999999999988887654 688888888999999999999   7899999999999999999999999999999853322


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      . ......+|||.|.|||++.+..|+.++|.|.+||++|||++|+.||..-..+ .            +.+++   +.. 
T Consensus       322 g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-k------------LFeLI---l~e-  383 (516)
T KOG0690|consen  322 G-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-K------------LFELI---LME-  383 (516)
T ss_pred             c-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-H------------HHHHH---Hhh-
Confidence            2 2233478999999999999999999999999999999999999998652111 0            00100   000 


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIIS  936 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~  936 (952)
                          ....|...+++...|+...+..||.+|.     ++.||.+
T Consensus       384 ----d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  384 ----DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             ----hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence                0112445677899999999999999997     4555543

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4e-32  Score=292.59  Aligned_cols=242  Identities=22%  Similarity=0.282  Sum_probs=187.2

Q ss_pred             eecCccceEEEEEEe-CCCcEEEEEEeeccCc---hhhHHHHHHHH---HHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          671 LIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE---GALNSFDAECE---ILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       671 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      .||+|+||.||+|.. .+++.||+|.+.....   .....+..|..   .++...||+++++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999987 4689999998864321   11122334443   3444579999999999999999999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +|+|..++... ..+++..+..++.|+++|++||   |+++|+||||||+||++++++.+||+|||++.......   ..
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~  153 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH  153 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence            99999888654 3689999999999999999999   78999999999999999999999999999997653322   12


Q ss_pred             ccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          824 QTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...|+..|+|||++.++ .++.++||||+||++|||++|+.||........  ...     ........           
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~-----~~~~~~~~-----------  215 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEI-----DRMTLTMA-----------  215 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHH-----HHHhhccC-----------
Confidence            34689999999998754 588999999999999999999999865322111  000     00000000           


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                      ...+..++.++.+++.+|+..+|.+||     ++.|++++
T Consensus       216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            011223467899999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.5e-32  Score=299.83  Aligned_cols=268  Identities=22%  Similarity=0.311  Sum_probs=199.5

Q ss_pred             HHHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeec-CCee
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTN-HNFK  735 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  735 (952)
                      ...+++|++.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.++++++|||++++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            446788999999999999999999864 7899999987532  22334678899999999999999999998865 4578


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||+ +++|.+++...  .+++.....++.|+++|++||   |+++|+||||+|+||++++++.+||+|||.+....
T Consensus        86 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~L---H~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYV---HSAGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            8999999 56888877643  478888899999999999999   79999999999999999999999999999997543


Q ss_pred             CcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCc--cchhhhhccchhhhhh-hcc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE--MSIKRWINDSLPAVMN-IMD  891 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~-~~~  891 (952)
                      ..    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......  ....++.....++..+ ..+
T Consensus       160 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         160 PQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             CC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            21    123457889999998765 568899999999999999999999986432100  0001111111111110 000


Q ss_pred             cc-------ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TN-------LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..       ...............+++++.+++.+||+.+|++||++.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00       00000000001112456789999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.3e-32  Score=300.24  Aligned_cols=270  Identities=22%  Similarity=0.286  Sum_probs=195.9

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecC-------
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNH-------  732 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  732 (952)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|++++++++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999874 689999998864432  2234677899999999999999999887543       


Q ss_pred             -CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccc
Q 002214          733 -NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA  811 (952)
Q Consensus       733 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  811 (952)
                       ...++||||+++ ++...+......+++..+..++.|+++||+||   |++||+||||||+||++++++.+||+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYL---HENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             346999999965 67777765555799999999999999999999   7899999999999999999999999999999


Q ss_pred             cccCCcCccc----------ccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh-
Q 002214          812 KLLSEEDSMK----------QTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI-  879 (952)
Q Consensus       812 ~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-  879 (952)
                      +.........          .....+++.|+|||...+ ..++.++|||||||++|||++|+.||...... ....... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence            8654322111          112356788999997755 45789999999999999999999998642211 0111100 


Q ss_pred             --ccchhh-------hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          880 --NDSLPA-------VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       880 --~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                        ....+.       .....+.......+............++.+++.+|+..||++|||+.|++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence              000000       0000000000000000000112234678999999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=274.83  Aligned_cols=253  Identities=23%  Similarity=0.296  Sum_probs=197.6

Q ss_pred             HhccCCcc-ceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeec----CCe
Q 002214          662 ATDQFSEE-NLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTN----HNF  734 (952)
Q Consensus       662 ~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  734 (952)
                      .+++|++. ++||-|-.|.|-.+.. .+|+.+|+|++. ++    ...++|++.--+. .|||||.++++|..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-DS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-cC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34556554 5789999999999977 479999999884 22    3346777765544 69999999998864    345


Q ss_pred             eEEEEEccCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC---CCCcEEEecccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGI  810 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgl  810 (952)
                      ..+|||.|+||.|.+.++..+. .+++.++..|++||+.|+.||   |+..|.||||||+|+|..   .+..+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l---H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL---HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH---HhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            6789999999999998877653 699999999999999999999   899999999999999996   456899999999


Q ss_pred             ccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          811 AKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       811 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      |+......  .....+.||.|.|||++....|+...|+||+||++|-|++|.+||.......  +..-.+          
T Consensus       211 AK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--ispgMk----------  276 (400)
T KOG0604|consen  211 AKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMK----------  276 (400)
T ss_pred             ccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--CChhHH----------
Confidence            99764322  2345678999999999999999999999999999999999999987644321  111000          


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ..+...........+...+++..++|+.++..+|++|.|+.|+.++
T Consensus       277 -~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  277 -RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             -hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence             1111111111222345578899999999999999999999998764

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=4.2e-32  Score=293.64  Aligned_cols=266  Identities=24%  Similarity=0.317  Sum_probs=200.4

Q ss_pred             CCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      |+..+.||+|+||.||+|+.. +++.||+|++....  ....+.+..|+.++++++|||++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999885 59999999987653  333467788999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      + ++|.+++......+++..+..++.|++.|++||   |+.||+||||+|+||++++++.+||+|||.+........ ..
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~  155 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC---HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY  155 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence            7 589999987655799999999999999999999   788999999999999999999999999999986643321 22


Q ss_pred             cccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhh---hhccchhhhh-hhc-----cc
Q 002214          823 TQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR---WINDSLPAVM-NIM-----DT  892 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~-~~~-----~~  892 (952)
                      ....++..|+|||.+.+. .++.++|||||||++||+++|+.||...... ..+.+   ......+... ...     +.
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            233467789999988766 7889999999999999999999998552211 01100   0000001000 000     00


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..............+..+.++.+++.+||..||++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            000000000000112236789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=6e-32  Score=292.56  Aligned_cols=265  Identities=20%  Similarity=0.247  Sum_probs=196.4

Q ss_pred             CCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEEEEcc
Q 002214          666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      |.+.+.||+|++|+||+|+.. +++.||+|.+..... .......+|+..+++++ |||++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999985 588999998864432 12234567999999998 999999999999999999999999


Q ss_pred             CCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          743 PKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       743 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                       +|+|.+.+.... ..+++..+..++.|++.|++||   |+++++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI---HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             889988887654 4689999999999999999999   789999999999999999999999999999986643322  


Q ss_pred             ccccccccccccccccC-cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccch--hhhhccchh----h---hhhhcc
Q 002214          822 QTQTLATIGYIAPEYGR-EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI--KRWINDSLP----A---VMNIMD  891 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~--~~~~~~~~~----~---~~~~~~  891 (952)
                      .....++..|+|||++. ...++.++||||||+++|||++|+.||......+...  ..+......    +   ....++
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            22345788999999774 4457899999999999999999999985432111100  000000000    0   000000


Q ss_pred             ccccchh-hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSED-EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....... ....... ...+.++.+++++||..+|++||++.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         235 FRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000 0001111 1225779999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=3e-32  Score=302.57  Aligned_cols=268  Identities=21%  Similarity=0.309  Sum_probs=195.6

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecC---------
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNH---------  732 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  732 (952)
                      ..+|.+.+.||+|+||.||+|.. .+|+.||+|.+........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36799999999999999999987 46899999998766655567788999999999999999999766543         


Q ss_pred             -----CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC-CCCcEEEe
Q 002214          733 -----NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLS  806 (952)
Q Consensus       733 -----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~-~~~~~kl~  806 (952)
                           ...++||||++ ++|.+++...  .+++..+..++.|+++|++||   |+.||+||||||+||+++ +++.+|++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~L---H~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYI---HSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999996 5888877543  588999999999999999999   789999999999999997 55678999


Q ss_pred             ccccccccCCcCccc--ccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc--
Q 002214          807 DFGIAKLLSEEDSMK--QTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND--  881 (952)
Q Consensus       807 Dfgla~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--  881 (952)
                      |||.+..........  .....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+. .......  
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~  236 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVP  236 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence            999998654321111  112357889999997644 5678899999999999999999999965321110 0000000  


Q ss_pred             -----chhhhhhhcccccc---chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          882 -----SLPAVMNIMDTNLL---SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       882 -----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..............   ..............+.++.+++.+||+.||++||++.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence                 00000000000000   000000000112356789999999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=7.7e-34  Score=271.86  Aligned_cols=272  Identities=21%  Similarity=0.358  Sum_probs=201.7

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeec--cCchhhHHHHHHHHHHHhCCCCccceeeeEeec--------
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHRNLVKIISSCTN--------  731 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  731 (952)
                      ...|....+||+|.||+||+|+.+ +|+.||+|+.-.  ++++......+|++++..++|+|++.++..|..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            345666788999999999999874 588899987643  345556778899999999999999999988743        


Q ss_pred             CCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccc
Q 002214          732 HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA  811 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  811 (952)
                      ....|+||++|+. +|..++.....+++..++.+++.++..||.|+   |+..|+|||+||+|+|++.+|.+||+|||+|
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i---Hr~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI---HRNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHH---HHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            2357999999976 88888887777899999999999999999999   8999999999999999999999999999999


Q ss_pred             cccCCcCc---ccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCc-----------cchh
Q 002214          812 KLLSEEDS---MKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE-----------MSIK  876 (952)
Q Consensus       812 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-----------~~~~  876 (952)
                      +.+...+.   ...+.++.|.+|.+||.+.+ ..++++.|||+.||++.||+||.+-+.......           ..-.
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            76653332   22344678999999997655 578999999999999999999988765422110           0111


Q ss_pred             hhhccchhhhhhhccccccchhhHHHH---HhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          877 RWINDSLPAVMNIMDTNLLSEDEEHAN---VAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      .|.+-..-.+...+......+......   ..+-.-.++..+++.+++..||.+|+++++++.+-
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            122111111222221111111110000   01111235788999999999999999999998763

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=3.2e-32  Score=302.51  Aligned_cols=264  Identities=21%  Similarity=0.283  Sum_probs=198.1

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCe----
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNF----  734 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  734 (952)
                      ..++|.+.+.||+|+||.||+|+.. +++.||+|++...  .....+.+.+|+.++++++|||++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999884 5889999988643  22234567789999999999999999988766554    


Q ss_pred             --eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          735 --KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       735 --~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                        .++|+||+ +++|.+++...  .+++..+..++.|+++|++||   |+.||+||||+|+||+++.++.+||+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYI---HSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence              89999999 67999888653  589999999999999999999   78999999999999999999999999999998


Q ss_pred             ccCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhhhhh
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPAVMN  888 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~  888 (952)
                      .....    .....++..|+|||...+ ..++.++|||||||++||+++|+.||...... ..+....   ....+....
T Consensus       167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHh
Confidence            65432    223457889999998755 36788999999999999999999998642211 1111110   000011000


Q ss_pred             ---------hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          889 ---------IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       889 ---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                               .+......... .........++++.+++.+|++.+|++|||+.||+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         242 KISSESARNYIQSLPQMPKK-DFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             hccchhHHHHHHhccccCCC-CHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                     00000000000 0011112347789999999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=7.5e-32  Score=299.09  Aligned_cols=269  Identities=20%  Similarity=0.300  Sum_probs=196.2

Q ss_pred             hccCCc-cceecCccceEEEEEEeC-CCcEEEEEEeeccCchh--------------hHHHHHHHHHHHhCCCCccceee
Q 002214          663 TDQFSE-ENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGA--------------LNSFDAECEILKTIRHRNLVKII  726 (952)
Q Consensus       663 ~~~~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~  726 (952)
                      .++|.. .+.||+|+||+||+|.+. +++.||||.++......              ...+.+|++++++++|||+++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            345653 577999999999999874 68999999886432211              12477899999999999999999


Q ss_pred             eEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEe
Q 002214          727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS  806 (952)
Q Consensus       727 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~  806 (952)
                      +++..++..++||||++ |+|.+++... ..+++.....++.|++.|++||   |++||+||||+|+||+++.++.+|++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~L---H~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVL---HKWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHeEECCCCCEEEC
Confidence            99999999999999996 6898888653 3689999999999999999999   78999999999999999999999999


Q ss_pred             ccccccccCCcC-------------cccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCc
Q 002214          807 DFGIAKLLSEED-------------SMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE  872 (952)
Q Consensus       807 Dfgla~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  872 (952)
                      |||++.......             ........++..|+|||++.+. .++.++||||+||++|||++|+.||......+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999998664111             0111123467889999988654 46889999999999999999999986532111


Q ss_pred             cchhhh---hccchhh-hhhhcccccc----chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          873 MSIKRW---INDSLPA-VMNIMDTNLL----SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       873 ~~~~~~---~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       .+...   .....+. +....+....    ...+.........+++++.+++.+||+.+|++||++.|++.+
T Consensus       242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        242 -QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             -HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence             11110   0000000 0000000000    000000011123356789999999999999999999999864

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.98  E-value=6.9e-32  Score=288.12  Aligned_cols=248  Identities=20%  Similarity=0.294  Sum_probs=194.3

Q ss_pred             cCCccceecCccceEEEEEEeCC-CcEEEEEEeecc-----CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQ-----REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      +|.+.+.||+|+||.||++++.. +..+++|+.+..     .......+.+|+.++++++|||++++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            57888999999999999998743 455666665421     122234577899999999999999999999988899999


Q ss_pred             EEccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          739 LEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      |||+++++|.+++..   ....+++..+..++.|+++|++||   |+.|++|+|++|+||+++. +.+||+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM---HQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH---HHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988864   234689999999999999999999   7899999999999999975 569999999998764


Q ss_pred             CcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      .... ......+++.|+|||...+..++.++||||||+++|++++|..||.....     ....       ........ 
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~-------~~~~~~~~-  222 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVV-------LRIVEGPT-  222 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHH-------HHHHcCCC-
Confidence            3322 12234578899999998888888999999999999999999999854211     0100       00000000 


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                             ...+..++.++.+++.+||+.+|++||++.|++++
T Consensus       223 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         223 -------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                   00123456789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=1.7e-31  Score=295.51  Aligned_cols=267  Identities=21%  Similarity=0.225  Sum_probs=192.8

Q ss_pred             cCCccceecCccceEEEEEEeC-C--CcEEEEEEeeccC--chhhHHHHHHHHHHHhC-CCCccceeeeEeec----CCe
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-D--GIEVAIKVFHLQR--EGALNSFDAECEILKTI-RHRNLVKIISSCTN----HNF  734 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  734 (952)
                      +|++.+.||+|+||.||+|+.. +  +..||+|++....  ....+.+.+|+.+++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999874 3  7899999886432  22345678899999999 59999999987532    245


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .++++||+. ++|.+.+.... .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYI---HSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            789999985 68988886543 689999999999999999999   7899999999999999999999999999999865


Q ss_pred             CCcCcc---cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhh-h
Q 002214          815 SEEDSM---KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPA-V  886 (952)
Q Consensus       815 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~-~  886 (952)
                      ......   ......++..|+|||+..+ ..++.++||||+||++|++++|+.||...... ..+....   ....++ .
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETL  234 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            432211   1123468999999998765 46889999999999999999999998652210 0010000   000000 0


Q ss_pred             hhhcccc-------ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 MNIMDTN-------LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .......       ...............++.++.+++.+|++.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000       00000000011112346789999999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=8e-34  Score=274.21  Aligned_cols=252  Identities=24%  Similarity=0.276  Sum_probs=194.3

Q ss_pred             CccceecCccceEEEEEEe-CCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEccC
Q 002214          667 SEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE-GALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       667 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      +....||.|+||+|++-.+ +.|+..|||+++.... .+.+++..|.+...+- +.||||++||.+-.++..++.||.| 
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-  145 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-  145 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence            3456799999999999877 5799999999976643 5667888888876554 7899999999998888999999999 


Q ss_pred             CCChhHHhh----hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          744 KGSLEDCMY----ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       744 ~g~L~~~l~----~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ..|++.+..    ..+..+++.-.-+|..-...||.||.  ....|+|||+||+|||++..|.+|+||||.+-.+.  ++
T Consensus       146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK--~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv--~S  221 (361)
T KOG1006|consen  146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLK--EELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV--DS  221 (361)
T ss_pred             hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHH--HHhhhhhccCChhheEEecCCCEeeecccchHhHH--HH
Confidence            457765532    13346888888888889999999997  56679999999999999999999999999997653  34


Q ss_pred             ccccccccccccccccccCc--CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          820 MKQTQTLATIGYIAPEYGRE--GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      ...+...|...|||||.+..  ..|..+|||||+|+++||+.||+.||..+..           ..+++..++......-
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----------vfeql~~Vv~gdpp~l  290 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----------VFEQLCQVVIGDPPIL  290 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----------HHHHHHHHHcCCCCee
Confidence            44555678999999997753  3588999999999999999999999876432           2222222222211100


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..   .......+..+..++..|+..|-..||.+.++.++
T Consensus       291 ~~---~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  291 LF---DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cC---cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            00   00112356779999999999999999999998753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-32  Score=296.07  Aligned_cols=240  Identities=23%  Similarity=0.284  Sum_probs=194.9

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ++.|.....+|.|+|+.|-.+.. .+++..|||++....    ..-.+|+.++.+. +|||++++.+.+.+....|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            45677777899999999988876 578999999986552    2234677666666 79999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee-CCCCcEEEeccccccccCCcCc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL-DDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill-~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      .+.++-+.+.+...+  ....++..|+.+++.|+.||   |++||||||+||+|||+ ++.+.++|+|||.++...+.  
T Consensus       397 ~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~L---H~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYL---HEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             hccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHH---HhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            999998877766544  22377888999999999999   78999999999999999 69999999999999976543  


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        ....+-|..|.|||++....+++++|+||||+++|+|++|+.||.....+.....+            +...      
T Consensus       470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~------------i~~~------  529 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR------------IQMP------  529 (612)
T ss_pred             --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh------------hcCC------
Confidence              23356788999999999999999999999999999999999999775444111111            0000      


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ......++++++|+.+||+.||.+||+|+++..+
T Consensus       530 ----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  530 ----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ----ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence                0114467889999999999999999999998754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=280.41  Aligned_cols=257  Identities=24%  Similarity=0.380  Sum_probs=197.5

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-------chhhHHHHHHHHHHHhCCCCccceeeeEeec-CC
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-------EGALNSFDAECEILKTIRHRNLVKIISSCTN-HN  733 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  733 (952)
                      .++|-....||+|||+.||+|.+ ...+.||||+-...+       +...+...+|.+|-+.+.||.||++|+++.- .+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            35688888999999999999987 457889999875432       1123457789999999999999999999965 46


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC---CCCcEEEecccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGI  810 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgl  810 (952)
                      ..|-|+|||+|.+|+-++..++ .+++.++..|+.||+.||.||.+ -+.+|||-||||.|||+.   .-|.+||.|||+
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            7889999999999998887765 68999999999999999999953 467899999999999994   567899999999


Q ss_pred             ccccCCcCccc------ccccccccccccccccCcC----CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc
Q 002214          811 AKLLSEEDSMK------QTQTLATIGYIAPEYGREG----QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN  880 (952)
Q Consensus       811 a~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~  880 (952)
                      ++.+.++.+..      +....||.+|++||.+.-+    ..+.|+||||.||++|.++.|+.||+......    .++ 
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ----dIL-  694 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ----DIL-  694 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH----HHH-
Confidence            99987544321      1235799999999965433    45788999999999999999999997632211    110 


Q ss_pred             cchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          881 DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                                ..+..-+..+..-...+..+.+..++|++|+.+--++|.+..++..
T Consensus       695 ----------qeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  695 ----------QENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             ----------hhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                      0000000000011112345678999999999999999998887753

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.2e-31  Score=279.58  Aligned_cols=236  Identities=28%  Similarity=0.328  Sum_probs=192.3

Q ss_pred             ecCccceEEEEEEeC-CCcEEEEEEeeccCc---hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCCh
Q 002214          672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL  747 (952)
Q Consensus       672 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  747 (952)
                      ||+|+||.||++... +++.||+|++.....   .....+..|+.++++++|||++++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999875 589999999865432   2345788999999999999999999999999999999999999999


Q ss_pred             hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccccccc
Q 002214          748 EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA  827 (952)
Q Consensus       748 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  827 (952)
                      .+++.... .+++.....++.|+++|+.|+   |+.+++|+||+|+||+++.++.++|+|||.+....... .......+
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---h~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~  155 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYL---HSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG  155 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence            99987654 589999999999999999999   78999999999999999999999999999998764332 12233557


Q ss_pred             ccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhh
Q 002214          828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQ  907 (952)
Q Consensus       828 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  907 (952)
                      +..|+|||...+...+.++|+||||+++|++++|..||.....  ....          .......         ...+.
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~----------~~~~~~~---------~~~~~  214 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIY----------EKILKDP---------LRFPE  214 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHH----------HHHhcCC---------CCCCC
Confidence            8899999999888889999999999999999999999854211  0000          0000000         01122


Q ss_pred             hhHHHHHHHHhhccccCCCCCCCHHH
Q 002214          908 SCASSVLSLAMECTSESPENRVNTKE  933 (952)
Q Consensus       908 ~~~~~l~~li~~cl~~dP~~RPs~~e  933 (952)
                      ..++++.+++.+||..||++||++++
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            33677899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=6e-31  Score=314.24  Aligned_cols=146  Identities=29%  Similarity=0.438  Sum_probs=131.3

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|.+.+.||+|+||.||+|.+. +++.||||+++...   ......+.+|+.+++.++||||+++++++......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            357899999999999999999985 68999999986432   23346788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                      |||+++++|.+++...+ .+++..++.++.||+.||+||   |.++|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yL---H~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYL---HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999987644 588899999999999999999   68899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=243.12  Aligned_cols=266  Identities=23%  Similarity=0.326  Sum_probs=200.2

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +|...++||+|.||+||+|+. .+++.||+|.++.++  ++......+|+-+++.++|.|||+++++...+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            466678999999999999987 468899999987654  45567889999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      |+. +|..+.....+.++.....+++.|+.+|+.++   |++.+.|||+||.|.++..+|..|++|||+|+.++-+-. -
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fc---hshnvlhrdlkpqnllin~ngelkladfglarafgipvr-c  157 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFC---HSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-C  157 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhh---hhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-e
Confidence            954 89998888888899999999999999999999   899999999999999999999999999999997754322 1


Q ss_pred             ccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCC-CCccccCccchhhhh---c----cchhhhhhhccc
Q 002214          822 QTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKP-TNEFFTGEMSIKRWI---N----DSLPAVMNIMDT  892 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p-~~~~~~~~~~~~~~~---~----~~~~~~~~~~~~  892 (952)
                      ....+.|.+|.+|.++.+. -|+...|+||.||++.|+.....| |.... -+.++.++.   .    +..|.+...-|-
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d-vddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc-HHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            2335689999999988765 578889999999999999984444 43311 111122211   1    111222111111


Q ss_pred             cccchh---hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          893 NLLSED---EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       893 ~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ......   ..+....| .....=++++.+.+.-+|..|.++.+.+++
T Consensus       237 k~yp~ypattswsqivp-~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVP-KLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cccCCccccchHHHHhh-hhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            111111   11111111 223345778888888899999999998764

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3.8e-32  Score=256.77  Aligned_cols=279  Identities=19%  Similarity=0.294  Sum_probs=207.4

Q ss_pred             CcccccccCHHHHHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCccce
Q 002214          647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVK  724 (952)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~  724 (952)
                      |+..|........+...++|++.+++|+|.|++||.|.. .+.+.++||++++-..   +.+.+|+.|++.++ ||||++
T Consensus        21 p~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~   97 (338)
T KOG0668|consen   21 PREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIK   97 (338)
T ss_pred             chhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeee
Confidence            445555444444445667899999999999999999975 5788999999975543   67889999999997 999999


Q ss_pred             eeeEeecC--CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC-CCC
Q 002214          725 IISSCTNH--NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSM  801 (952)
Q Consensus       725 l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~-~~~  801 (952)
                      ++++..++  ....+|+||+++.+...+..    +++..++...+.++..||.|+   |++||+|||+||.|||+| +..
T Consensus        98 L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyC---HS~GImHRDVKPhNvmIdh~~r  170 (338)
T KOG0668|consen   98 LLDIVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYC---HSMGIMHRDVKPHNVMIDHELR  170 (338)
T ss_pred             hhhhhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHH---HhcCcccccCCcceeeechhhc
Confidence            99998765  56789999999988766543    477788899999999999999   899999999999999998 456


Q ss_pred             cEEEeccccccccCCcCcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc
Q 002214          802 VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN  880 (952)
Q Consensus       802 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~  880 (952)
                      ..+++|||+|.++.++..+  .-++.+..|.-||.+.+- .|...-|+|||||++..|+..+.||-.-.....++.+.++
T Consensus       171 kLrlIDWGLAEFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak  248 (338)
T KOG0668|consen  171 KLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK  248 (338)
T ss_pred             eeeeeecchHhhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence            8999999999998766544  335678889999977653 4677789999999999999999997432222222222221


Q ss_pred             ---c-------------chhhhhhhccccccchhhHHHHHhhh-hhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          881 ---D-------------SLPAVMNIMDTNLLSEDEEHANVAKQ-SCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       881 ---~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         +             .-++..+++................. -.++++.+++.+.+..|-++|||++|+..+
T Consensus       249 VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  249 VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence               1             11112222222221111111111111 235789999999999999999999999865

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=4.4e-31  Score=277.23  Aligned_cols=221  Identities=20%  Similarity=0.155  Sum_probs=177.7

Q ss_pred             ccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCChhHHhhh
Q 002214          675 GSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA  753 (952)
Q Consensus       675 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  753 (952)
                      |.||.||++++ .+++.||+|+++....     +.+|...+....|||++++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999988 4689999999865432     23455555566799999999999999999999999999999998865


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccccccccccccc
Q 002214          754 SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA  833 (952)
Q Consensus       754 ~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~a  833 (952)
                      .. .+++..+..++.|+++|++||   |++||+||||||+||+++.++.++++|||.+.......    ....++..|+|
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a  150 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDAL---HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA  150 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence            44 589999999999999999999   78999999999999999999999999999887654321    12345778999


Q ss_pred             ccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHH
Q 002214          834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSV  913 (952)
Q Consensus       834 PE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  913 (952)
                      ||......++.++||||+|+++|||++|+.|+..........              .  .         ...+..++.++
T Consensus       151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~--------------~--~---------~~~~~~~~~~~  205 (237)
T cd05576         151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTH--------------T--T---------LNIPEWVSEEA  205 (237)
T ss_pred             CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccc--------------c--c---------cCCcccCCHHH
Confidence            999888888999999999999999999998864321110000              0  0         00122346678


Q ss_pred             HHHHhhccccCCCCCCCHHH
Q 002214          914 LSLAMECTSESPENRVNTKE  933 (952)
Q Consensus       914 ~~li~~cl~~dP~~RPs~~e  933 (952)
                      .+++.+|++.||++||++.+
T Consensus       206 ~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         206 RSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             HHHHHHHccCCHHHhcCCCc
Confidence            99999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-32  Score=283.58  Aligned_cols=249  Identities=20%  Similarity=0.284  Sum_probs=203.9

Q ss_pred             ccCCccceecCccceEEEEEEeCCCc-EEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGI-EVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .++..+..||-|+||.|=+++.++.. .+|+|+++..   +....+.+..|-.||...+.|.||++|..|.++.++|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45566778999999999998875433 4888877543   4555678899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |-|-||.++..++..+ .++..++..++..+.+|++||   |++|||.|||||+|.+++.+|-+||.|||+|+.+..+..
T Consensus       500 EaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYL---H~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYL---HRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             HhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHH---HhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            9999999999997665 789999999999999999999   899999999999999999999999999999999876544


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                      +  -..+|||.|.|||++..+....++|.||+|+++||+++|.+||.... ....+..+.++.     +           
T Consensus       576 T--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d-pmktYn~ILkGi-----d-----------  636 (732)
T KOG0614|consen  576 T--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD-PMKTYNLILKGI-----D-----------  636 (732)
T ss_pred             e--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc-hHHHHHHHHhhh-----h-----------
Confidence            3  34789999999999999999999999999999999999999997621 111111111110     0           


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVN-----TKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~  937 (952)
                        ....|...+....++|++....+|.+|.-     +.||.+|
T Consensus       637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  637 --KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             --hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence              11124456777899999999999999985     5566554

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.1e-30  Score=303.52  Aligned_cols=265  Identities=19%  Similarity=0.224  Sum_probs=171.2

Q ss_pred             HhccCCccceecCccceEEEEEEeC-C----CcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeE------ee
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-D----GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISS------CT  730 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  730 (952)
                      ..++|.+.+.||+|+||.||+|++. +    +..||||++......  +....|  .++...+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999874 4    689999987533221  111111  1122222222222211      24


Q ss_pred             cCCeeEEEEEccCCCChhHHhhhcCCCC-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 002214          731 NHNFKALVLEYMPKGSLEDCMYASNFNL-------------------DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIK  791 (952)
Q Consensus       731 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l-------------------~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk  791 (952)
                      .+...++||||+++++|.+++.......                   ....+..++.|++.||+||   |+++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yL---H~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGL---HSTGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHH---HHCCEEeCcCC
Confidence            5567899999999999999886543211                   1234567999999999999   78999999999


Q ss_pred             CCCeeeCC-CCcEEEeccccccccCCcCcccccccccccccccccccCcC----------------------CcCcccch
Q 002214          792 PSNVLLDD-SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG----------------------QVSIKGDV  848 (952)
Q Consensus       792 ~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv  848 (952)
                      |+|||++. ++.+||+|||+|+.+............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 58999999999987654433334456789999999954321                      13446799


Q ss_pred             HhHHHHHHHHHhCCCCCCccccCccchhhhhcc---chhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCC
Q 002214          849 YNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND---SLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESP  925 (952)
Q Consensus       849 ~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  925 (952)
                      |||||++|||+++..|++...   ..+.+.+..   ....+.................. ......+..+|+.+|++.||
T Consensus       363 wSlGviL~el~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEV-LDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhh-ccccchHHHHHHHHHccCCc
Confidence            999999999999877654310   011110100   00111111111100000000000 00112345689999999999


Q ss_pred             CCCCCHHHHHHH
Q 002214          926 ENRVNTKEIISR  937 (952)
Q Consensus       926 ~~RPs~~ev~~~  937 (952)
                      ++|||+.|+++|
T Consensus       439 ~kR~ta~e~L~H  450 (566)
T PLN03225        439 RQRISAKAALAH  450 (566)
T ss_pred             ccCCCHHHHhCC
Confidence            999999999876

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=271.89  Aligned_cols=242  Identities=22%  Similarity=0.270  Sum_probs=195.2

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  736 (952)
                      ...+|....+||+|+||.|.+|..+ +.+.+|||+++.+-   +...+--+.|-+++... +-|.++.++.++..-+..|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3457899999999999999999764 56789999987542   11223345677777766 5789999999999999999


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+.||+|--.++.-+ .+.+..+.-+|.+||-||-+|   |++||+.||||..|||+|.+|.+||+|||+++.---
T Consensus       427 FVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFL---h~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             eEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhh---hcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            9999999999987777654 688889999999999999999   899999999999999999999999999999985433


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      ++. .+...+|||.|+|||++...+|+..+|.|||||++|||+.|..||+.... ++.+           ..+++..   
T Consensus       503 ~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-~elF-----------~aI~ehn---  566 (683)
T KOG0696|consen  503 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELF-----------QAIMEHN---  566 (683)
T ss_pred             CCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH-HHHH-----------HHHHHcc---
Confidence            222 23447899999999999999999999999999999999999999976311 1111           1222211   


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCC
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRV  929 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  929 (952)
                            ..-|...+.+..++.+..+...|.+|.
T Consensus       567 ------vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 ------VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ------CcCcccccHHHHHHHHHHhhcCCcccc
Confidence                  122455688899999999999999997

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.6e-30  Score=292.03  Aligned_cols=265  Identities=20%  Similarity=0.248  Sum_probs=182.4

Q ss_pred             HhccCCccceecCccceEEEEEEe-----------------CCCcEEEEEEeeccCchhhH--------------HHHHH
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-----------------PDGIEVAIKVFHLQREGALN--------------SFDAE  710 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E  710 (952)
                      ..++|++.++||+|+||+||+|..                 ..++.||||++........+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                 24578999998654432222              23457


Q ss_pred             HHHHHhCCCCcc-----ceeeeEeec--------CCeeEEEEEccCCCChhHHhhhcC----------------------
Q 002214          711 CEILKTIRHRNL-----VKIISSCTN--------HNFKALVLEYMPKGSLEDCMYASN----------------------  755 (952)
Q Consensus       711 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  755 (952)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777778866554     667777653        356899999999999999886421                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccccccccccccc
Q 002214          756 -FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP  834 (952)
Q Consensus       756 -~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aP  834 (952)
                       ..+++..+..++.|+++|++||   |+++|+||||||+||+++.++.+||+|||+++.+............+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~l---H~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKL---HRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence             1346778889999999999999   788999999999999999999999999999976543322222223458899999


Q ss_pred             cccCcCC--------------------c--CcccchHhHHHHHHHHHhCCC-CCCccccCccchhhhhccchhhhhhhcc
Q 002214          835 EYGREGQ--------------------V--SIKGDVYNYGIMLMEVFTGMK-PTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       835 E~~~~~~--------------------~--~~~~Dv~slG~~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      |.+....                    +  ..+.||||+||+++||++|.. |+.....-......+ ......+... .
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~-~~~~~~~r~~-~  457 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY-DNDLNRWRMY-K  457 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc-cchHHHHHhh-c
Confidence            9765322                    1  134699999999999999875 654321100000000 0000000000 0


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCC---CCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESP---ENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~ev~~~  937 (952)
                      .....      .......+++..+++.+++..+|   .+|+|++|+++|
T Consensus       458 ~~~~~------~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        458 GQKYD------FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             ccCCC------cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            00000      00112346778999999999766   689999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-31  Score=269.42  Aligned_cols=266  Identities=21%  Similarity=0.275  Sum_probs=200.3

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-C-Cc----cceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIR-H-RN----LVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~n----iv~l~~~~~~~~~~  735 (952)
                      .++|.+...+|+|.||.|-++.+. .+..||||+++.-.. ..+..+-|+++++++. + |+    +|.+.++|...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            778999999999999999999873 478999999864432 3456678999999993 3 33    67788899999999


Q ss_pred             EEEEEccCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC---------------
Q 002214          736 ALVLEYMPKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD---------------  799 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~---------------  799 (952)
                      |+|+|.+ |-|+.+++..... +++...+..|+.|+++++++|   |+.+++|-||||+||++.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fL---h~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFL---HDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHH---HhcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999999 7799999987554 789999999999999999999   8999999999999999932               


Q ss_pred             -----CCcEEEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCcc-
Q 002214          800 -----SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM-  873 (952)
Q Consensus       800 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-  873 (952)
                           ...+||+|||.|.+.....    ...+.|..|.|||++.+-.++.++||||+||||+|++||..-|......+. 
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                 3468999999998754332    346789999999999999999999999999999999999988765332221 


Q ss_pred             chhhhhccchhh-hhh------hccccccc----------------hhhHHHHH-hhhhhHHHHHHHHhhccccCCCCCC
Q 002214          874 SIKRWINDSLPA-VMN------IMDTNLLS----------------EDEEHANV-AKQSCASSVLSLAMECTSESPENRV  929 (952)
Q Consensus       874 ~~~~~~~~~~~~-~~~------~~~~~~~~----------------~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RP  929 (952)
                      ...+-+-++.|. .+.      .+.....+                ..+....+ .......++.+|+++|+..||.+|+
T Consensus       319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence            111112222222 000      01100000                00000111 1112345699999999999999999


Q ss_pred             CHHHHHHH
Q 002214          930 NTKEIISR  937 (952)
Q Consensus       930 s~~ev~~~  937 (952)
                      |+.|++.+
T Consensus       399 Tl~EAL~H  406 (415)
T KOG0671|consen  399 TLREALSH  406 (415)
T ss_pred             cHHHHhcC
Confidence            99999864

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-30  Score=287.48  Aligned_cols=258  Identities=24%  Similarity=0.362  Sum_probs=208.8

Q ss_pred             HHHHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeec---
Q 002214          657 DELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTN---  731 (952)
Q Consensus       657 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---  731 (952)
                      +.+...++.|.+.+.||.|.+|.||+++. ++|+.+|+|+.....+.+ +++..|..|++.. .|||++.++|++..   
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            33444567899999999999999999986 579999999987665543 6778899999988 69999999998853   


Q ss_pred             --CCeeEEEEEccCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecc
Q 002214          732 --HNFKALVLEYMPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDF  808 (952)
Q Consensus       732 --~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Df  808 (952)
                        ++..++|||||.+|+.-+++..- +.++.|..+..|.+.++.|+.+|   |...++|||||-.|||++.++.+|++||
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HL---H~nkviHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHL---HNNKVIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHH---hhcceeeecccCceEEEeccCcEEEeee
Confidence              57899999999999999988653 44799999999999999999999   8999999999999999999999999999


Q ss_pred             ccccccCCcCcccccccccccccccccccCc-----CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccch
Q 002214          809 GIAKLLSEEDSMKQTQTLATIGYIAPEYGRE-----GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL  883 (952)
Q Consensus       809 gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  883 (952)
                      |.+..+... ........||+.|||||++..     ..|+.++|+||+|++..||-.|.+|+.++++--..+. ..+..-
T Consensus       168 GvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-IpRNPP  245 (953)
T KOG0587|consen  168 GVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-IPRNPP  245 (953)
T ss_pred             eeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-CCCCCC
Confidence            999876532 233445789999999998753     3467889999999999999999999877654321111 000000


Q ss_pred             hhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      |                 ....++..++++-++|..|+..|.++||++.+++++
T Consensus       246 P-----------------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  246 P-----------------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             c-----------------cccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            0                 111234568899999999999999999999998865

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.4e-29  Score=267.00  Aligned_cols=238  Identities=29%  Similarity=0.364  Sum_probs=193.3

Q ss_pred             cceEEEEEEeC-CCcEEEEEEeeccCchh-hHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCChhHHhhh
Q 002214          676 SYGSVYKGRFP-DGIEVAIKVFHLQREGA-LNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA  753 (952)
Q Consensus       676 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  753 (952)
                      +||.||+|... +|+.||+|++....... .+.+.+|++.+++++|++++++++++......+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999985 58999999997655443 67899999999999999999999999998999999999999999998876


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccccccccccccc
Q 002214          754 SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA  833 (952)
Q Consensus       754 ~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~a  833 (952)
                      .. .+++..+..++.+++++++||   |+.+++|+||+|+||++++++.++++|||.+.......  ......++..|+|
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~  154 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYL---HSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA  154 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHH---HHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence            54 389999999999999999999   78899999999999999999999999999998765432  2233568889999


Q ss_pred             ccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHH
Q 002214          834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSV  913 (952)
Q Consensus       834 PE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  913 (952)
                      ||......++.++||||||++++++++|..||....... ...+.           ..........     ....++.++
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~-----------~~~~~~~~~~-----~~~~~~~~~  217 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKK-----------IGKPKPPFPP-----PEWKISPEA  217 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHH-----------HhccCCCCcc-----ccccCCHHH
Confidence            999888888999999999999999999999986531111 11111           1100000000     000156789


Q ss_pred             HHHHhhccccCCCCCCCHHHHHH
Q 002214          914 LSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       914 ~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                      .+++.+|+..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            99999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=4.4e-31  Score=293.30  Aligned_cols=244  Identities=27%  Similarity=0.436  Sum_probs=189.5

Q ss_pred             CCccceecCccceE-EEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEccC
Q 002214          666 FSEENLIGIGSYGS-VYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       666 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      |...+++|.|+.|+ ||+|.. +|+.||||++-...   ....++|+..++.- .|||||++++.-.++...|++.|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            44456789999886 599999 78999999875332   35568999999887 6999999999999999999999999 


Q ss_pred             CCChhHHhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-----CCcEEEeccccccccC
Q 002214          744 KGSLEDCMYASNFN---LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-----SMVAHLSDFGIAKLLS  815 (952)
Q Consensus       744 ~g~L~~~l~~~~~~---l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfgla~~~~  815 (952)
                      ..+|++++......   ......+.+..|++.||++|   |+-+||||||||.||||+.     ..+++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHL---Hsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHL---HSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHH---HhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            45999999874211   11145578899999999999   7899999999999999975     2579999999999987


Q ss_pred             CcCcc--cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhC-CCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          816 EEDSM--KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTG-MKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       816 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                      .+...  ......||-+|+|||++....-+.++||||+||++|+.++| .+||++....+..+..-....          
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L----------  732 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL----------  732 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce----------
Confidence            55432  22345699999999999998888899999999999999995 999987544332221100000          


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....        ...+|  ++.+||.+|++++|..||++.+|+.|
T Consensus       733 ~~L~--------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  733 VHLE--------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             eeec--------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            0000        01122  68999999999999999999999753

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-30  Score=256.53  Aligned_cols=247  Identities=23%  Similarity=0.296  Sum_probs=199.3

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|+..++||+|+|+.|-.+++ ++.+.+|+|+++.+   .++...-.+.|..+..+. +||.+|.++.+|..+...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            46799999999999999999987 56889999998754   344556678888888887 79999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      |.||++||+|--+++..+ .++++.+..+..+|.-||.||   |++||+.||+|..|||+|..|.+|+.|+|+++.--.+
T Consensus       329 vieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~fl---h~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHH---hhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            999999999976665544 699999999999999999999   8999999999999999999999999999999865443


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCcccc--Cccchhhhhccchhhhhhhcccccc
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFT--GEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ... +...+|||.|+|||++++..|+..+|.|++||+++||+.|+.||+....  .+..-..+.-..      ++     
T Consensus       405 gd~-tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv------il-----  472 (593)
T KOG0695|consen  405 GDT-TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV------IL-----  472 (593)
T ss_pred             Ccc-cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH------Hh-----
Confidence            332 3347899999999999999999999999999999999999999975431  111111111000      00     


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCC
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRV  929 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  929 (952)
                          +..--.|...+.+...+++.-++.||.+|.
T Consensus       473 ----ekqiriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  473 ----EKQIRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ----hhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence                000112344566778899999999999986

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-31  Score=256.78  Aligned_cols=269  Identities=19%  Similarity=0.278  Sum_probs=197.2

Q ss_pred             CccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecC-----CeeEEE
Q 002214          667 SEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNH-----NFKALV  738 (952)
Q Consensus       667 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv  738 (952)
                      +..+.||.|+||.||..++ ++|+.||+|++...  .-...+++.+|++++...+|+||+..+++....     .+.|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3457899999999999988 57999999988532  223457889999999999999999988876543     256789


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      +|.| ..+|...+-. .+.++...+.-+..||.+||+||   |+.+|.||||||.|.+++++...||+|||+|+.-..++
T Consensus       136 TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYL---HsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYL---HTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHH---hhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            9998 5577776654 44788889999999999999999   89999999999999999999999999999999766555


Q ss_pred             cccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCcc--chhhhhccchhh---------h
Q 002214          819 SMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM--SIKRWINDSLPA---------V  886 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~---------~  886 (952)
                      ....+..+.|..|+|||++.+. .|+.+.||||.||++.|++..+..|....+-+.  .+.....+...+         .
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            5556667889999999988764 689999999999999999999888765322110  011111111111         0


Q ss_pred             hhhccccccchhhHHH--HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          887 MNIMDTNLLSEDEEHA--NVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       887 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                      ..++............  ...+..-..+...+..+++..||++|.+..+.+.+...
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            0111111111100000  00011223457788899999999999999998877643

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=5.7e-30  Score=238.68  Aligned_cols=217  Identities=24%  Similarity=0.316  Sum_probs=174.2

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      +.......||+|+||.|-+-++ .+|+..|+|.++..- .+..++...|+.+..+- ..|.+|.++|.+...+..++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            3444556799999999987776 589999999986543 34456778888876654 78999999999988889999999


Q ss_pred             ccCCCChhHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          741 YMPKGSLEDCMY---ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       741 ~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      .| ..||+.+-.   ..+...++.-.-+|+..+.+||.|||  .+..++|||+||+|||++.+|.+|+||||.+-.+.+ 
T Consensus       126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~--~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d-  201 (282)
T KOG0984|consen  126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLH--SKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD-  201 (282)
T ss_pred             Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHH--HHhhhhhccCCcceEEEccCCcEEEcccccceeehh-
Confidence            99 458876643   34557899999999999999999997  567899999999999999999999999999987643 


Q ss_pred             CcccccccccccccccccccCc----CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhh
Q 002214          818 DSMKQTQTLATIGYIAPEYGRE----GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA  885 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  885 (952)
                       +...+...|...|||||.+..    ..|+.|+||||+|+.+.||.+++.||+..+..=..+.+.++..-|.
T Consensus       202 -SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~  272 (282)
T KOG0984|consen  202 -SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ  272 (282)
T ss_pred             -hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence             233333558889999997643    4789999999999999999999999988666555555555544433

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2e-29  Score=269.65  Aligned_cols=206  Identities=24%  Similarity=0.358  Sum_probs=174.4

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      -|..++.||-|+||+|.+++. ++...||+|.+++.+   .........|-+||.....+=||++|..|.+++..|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            367788999999999999964 567789999986553   2344667899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC-----
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS-----  815 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~-----  815 (952)
                      |++||++-.+|-..+ -+.+.-+..++.++.+|+++.   |.+|+|||||||.|||||.+|.+||.|||++.-+.     
T Consensus       710 YIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesV---HkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             ccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHH---HhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            999999998876654 578888888999999999999   89999999999999999999999999999995331     


Q ss_pred             ----CcCc--------------------------------ccccccccccccccccccCcCCcCcccchHhHHHHHHHHH
Q 002214          816 ----EEDS--------------------------------MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF  859 (952)
Q Consensus       816 ----~~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~  859 (952)
                          .++-                                ......+||+.|+|||++....++..+|.||.||+||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                1000                                0001246999999999999889999999999999999999


Q ss_pred             hCCCCCCccccCccc
Q 002214          860 TGMKPTNEFFTGEMS  874 (952)
Q Consensus       860 tg~~p~~~~~~~~~~  874 (952)
                      .|+.||....+++..
T Consensus       866 ~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQ  880 (1034)
T ss_pred             hCCCCccCCCCCcce
Confidence            999999876665543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=243.77  Aligned_cols=261  Identities=23%  Similarity=0.292  Sum_probs=195.6

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCC------
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHN------  733 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  733 (952)
                      ..+|...+.+|.|+- .|..|.+ -.+++||+|+....  .....++..+|..++..++|+|+++++.+++...      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            346777888999998 6666655 35899999987433  2344577899999999999999999999997543      


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ..|+|||+| ..+|...+..   .++-.+...++.|+.+|++||   |+.||+||||||+||++..++.+||.|||+|+.
T Consensus        95 e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~l---hs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHL---HSAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHH---HhcceeecccCcccceecchhheeeccchhhcc
Confidence            578999999 5588888773   467889999999999999999   899999999999999999999999999999985


Q ss_pred             cCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc------cchhhhh
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN------DSLPAVM  887 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~------~~~~~~~  887 (952)
                      -.  .....+..+.|..|.|||++.+-.+.+.+||||.||++.||++|+.-|.    +...+.+|.+      ..-+.++
T Consensus       168 e~--~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  168 ED--TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             cC--cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHHHH
Confidence            43  2346677889999999999888889999999999999999999998764    3333333322      1111111


Q ss_pred             --------hhcc---ccccchhhH------HHHH--hhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          888 --------NIMD---TNLLSEDEE------HANV--AKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       888 --------~~~~---~~~~~~~~~------~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                              ..+.   .........      +...  .+.--+..+.+++.+|+..+|++|.+++++++|
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                    1110   000000000      0000  001113458999999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=261.79  Aligned_cols=197  Identities=26%  Similarity=0.365  Sum_probs=169.1

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--------chhhHHHHHHHHHHHhCC---CCccceeeeEee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--------EGALNSFDAECEILKTIR---HRNLVKIISSCT  730 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  730 (952)
                      ...|...+.+|+|+||.|+.|.++ +...|+||.+.+.+        +.....+-.|++||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            346889999999999999999985 46679999886542        112234567999999997   999999999999


Q ss_pred             cCCeeEEEEEcc-CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccc
Q 002214          731 NHNFKALVLEYM-PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       731 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  809 (952)
                      +++.+|++||-. ++-+|.+++..+. .+++.++..|++||+.|+++|   |+.||||||||-+||.++.+|.+||+|||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hl---h~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHL---HDQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccc---cccCceecccccccEEEecCCeEEEeecc
Confidence            999999999976 4558888887655 799999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCcCcccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCC
Q 002214          810 IAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTN  866 (952)
Q Consensus       810 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~  866 (952)
                      .|.....+.   ....+||..|.|||++.+..| +..-|||++|+++|.++....||.
T Consensus       716 saa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            998764432   344679999999999998877 455799999999999999988874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=7e-27  Score=240.61  Aligned_cols=211  Identities=36%  Similarity=0.563  Sum_probs=184.3

Q ss_pred             ecCccceEEEEEEeCC-CcEEEEEEeeccCch-hhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCChhH
Q 002214          672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLED  749 (952)
Q Consensus       672 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  749 (952)
                      ||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999854 899999998765442 34678999999999999999999999999899999999999999999


Q ss_pred             HhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-CCcEEEeccccccccCCcCcccccccccc
Q 002214          750 CMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-SMVAHLSDFGIAKLLSEEDSMKQTQTLAT  828 (952)
Q Consensus       750 ~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  828 (952)
                      ++......+++..+..++.+++++++||   |++|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~  156 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT  156 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence            9877645689999999999999999999   7889999999999999999 89999999999987654321 12234578


Q ss_pred             cccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhh
Q 002214          829 IGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQ  907 (952)
Q Consensus       829 ~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  907 (952)
                      ..|++||..... .++.++|+|++|++++++                                                 
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------------  187 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------------  187 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence            899999988777 788999999999999999                                                 


Q ss_pred             hhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          908 SCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       908 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                         .++.+++..|++.+|++||++.++++++
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence               2368899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.8e-27  Score=244.81  Aligned_cols=131  Identities=24%  Similarity=0.390  Sum_probs=111.5

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-----C---CccceeeeEeec--
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIR-----H---RNLVKIISSCTN--  731 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~--  731 (952)
                      ..+|.+.++||=|.|++||+|.+ .+.+.||+|+.+.... ..+....|++++++++     |   .+||++++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            36899999999999999999987 4578899999865432 3466788999999984     2   369999999965  


Q ss_pred             --CCeeEEEEEccCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee
Q 002214          732 --HNFKALVLEYMPKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL  797 (952)
Q Consensus       732 --~~~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill  797 (952)
                        +.++|||+|++ |.+|..++....+ .++...+..|++||+.||.|||  .+.||||.||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH--~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLH--RECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHH--HhcCccccCCCcceeee
Confidence              35899999999 7788888876554 6999999999999999999998  56799999999999999

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=4.5e-26  Score=237.29  Aligned_cols=199  Identities=30%  Similarity=0.427  Sum_probs=173.2

Q ss_pred             CCccceecCccceEEEEEEeCC-CcEEEEEEeeccCch-hhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          666 FSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      |++.+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677899999999999999864 899999999766554 56788999999999999999999999998899999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +++|.+++......+++.....++.+++.++.+|   |+.+++|+|++|+||+++.++.++|+|||.+............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYL---HSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            9999999876553388999999999999999999   7889999999999999999999999999999876543211222


Q ss_pred             cccccccccccccc-CcCCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002214          824 QTLATIGYIAPEYG-REGQVSIKGDVYNYGIMLMEVFTGMKPTNE  867 (952)
Q Consensus       824 ~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  867 (952)
                      ...++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            34577889999988 666778899999999999999999999854

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-28  Score=249.72  Aligned_cols=383  Identities=22%  Similarity=0.242  Sum_probs=201.7

Q ss_pred             ccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeC-CcCCccCchhhhccCCCcEeee
Q 002214          156 RLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGF-NNLNGEIPQEIGNLRNLEILGI  234 (952)
Q Consensus       156 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L  234 (952)
                      .-++++|..|+|+.+.|.+|..+++|+.||||+|.|+.+-|.+|.++.+|.+|-+.+ |+|+...-+.|++|..|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            456666777777666666666777777777777777766677777766666654444 6666555556677777777777


Q ss_pred             ccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhh------hhc
Q 002214          235 DQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYA------LEL  308 (952)
Q Consensus       235 ~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~------l~l  308 (952)
                      .-|++.-+..+.|..+++|..|.+-+|.+...  ....+..+..++.+.+..|.+..     .++++.+..      ...
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i--~~~tf~~l~~i~tlhlA~np~ic-----dCnL~wla~~~a~~~iet  220 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSI--CKGTFQGLAAIKTLHLAQNPFIC-----DCNLPWLADDLAMNPIET  220 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhhhh--ccccccchhccchHhhhcCcccc-----ccccchhhhHHhhchhhc
Confidence            66666666666666677777777777766533  22345666666666666666321     111111111      111


Q ss_pred             cccCccccccccCcceeechhhHHHHH------------HHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCC
Q 002214          309 GYNSNLKRLGLERNYLTFSTSELMSLF------------SALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKL  376 (952)
Q Consensus       309 ~~~~~L~~L~L~~n~l~~~~~~~~~~~------------~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L  376 (952)
                      +...-..-..+..+++...+.+.+...            .....+....|..+++|+.|+|++|+|+.+.+.+|.++.++
T Consensus       221 sgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l  300 (498)
T KOG4237|consen  221 SGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAEL  300 (498)
T ss_pred             ccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhh
Confidence            111111122222233333332222111            00111222235556666666666666666666666666666


Q ss_pred             cEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCC---------------cCCcc
Q 002214          377 QGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTS---------------VIPST  441 (952)
Q Consensus       377 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---------------~~~~~  441 (952)
                      ++|.|..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|.+.-               .....
T Consensus       301 ~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~  380 (498)
T KOG4237|consen  301 QELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNP  380 (498)
T ss_pred             hhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCC
Confidence            666666666655555566666666666666666665566666666666666665554320               00000


Q ss_pred             -ccCCCCCceeEecCCccCC---CCchhh---------hccccccee-ecCCcccCCCCcccccCCCCCceEEccCcccc
Q 002214          442 -FWNLEDILGFDFSSNSLNG---SLPLEI---------ENLKAVVDI-YLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQ  507 (952)
Q Consensus       442 -~~~l~~L~~L~Ls~N~l~~---~~~~~~---------~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  507 (952)
                       -.....++.++++.+.+..   ..|++.         ..++.+.+. .-|++.++ .+|..+.  ..-.+|++.+|.++
T Consensus       381 ~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~  457 (498)
T KOG4237|consen  381 RCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT  457 (498)
T ss_pred             CCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc
Confidence             0112233444444443321   111111         111222221 22222222 3333222  23566777777777


Q ss_pred             CcccccccccccccEEeCCCCcccccCccchhccccccccccccc
Q 002214          508 GPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFN  552 (952)
Q Consensus       508 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  552 (952)
                       .+|..  .+.+| .+|+++|+|+..-...|.+|++|.+|-|++|
T Consensus       458 -~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  458 -SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             -ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence             44444  45566 7777777777666667777777777777665

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=225.42  Aligned_cols=252  Identities=19%  Similarity=0.300  Sum_probs=189.9

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeE-eecCCeeEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISS-CTNHNFKALV  738 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv  738 (952)
                      ..+.|.+.+.+|+|.||.+-++.++ +.+.+|+|.++..-. ..++|.+|...--.| .|.||+.-|++ |...+.+.++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            4467999999999999999999884 578899998865433 347899998776666 58999988765 5667788899


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC--CCCcEEEeccccccccCC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD--DSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~--~~~~~kl~Dfgla~~~~~  816 (952)
                      +||++.|+|.+-+...  .+.+....+++.|++.|++|+   |++.+||||||.+|||+-  +..++|++|||..+..+.
T Consensus       101 qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fM---HsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFM---HSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             eccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHh---hccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            9999999999877654  488888999999999999999   899999999999999993  345899999999986532


Q ss_pred             cCcccccccccccccccccccCcC-----CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhh---hccchhhhhh
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREG-----QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW---INDSLPAVMN  888 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~~  888 (952)
                      .-    ....-+-.|.|||.....     ...+.+|||.||+++|.++||+.||+...-.+..+.+|   .....+...+
T Consensus       176 tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~  251 (378)
T KOG1345|consen  176 TV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK  251 (378)
T ss_pred             ee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence            11    112245568899964322     35677899999999999999999998655444444443   3332222111


Q ss_pred             hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       889 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                      .+                ...++.+.++.++-+.++|++|=...++.+.-+
T Consensus       252 ~F----------------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  252 KF----------------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             hh----------------cccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            11                124667889999999999999955555544433

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=2.1e-26  Score=238.81  Aligned_cols=270  Identities=22%  Similarity=0.332  Sum_probs=199.5

Q ss_pred             HHHHhccCCccceecCccceEEEEEEeC----CCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecCC
Q 002214          659 LLRATDQFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNHN  733 (952)
Q Consensus       659 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  733 (952)
                      +....+.|..+++||+|.|++||+|.+.    ..+.||+|.+......  .++..|++++..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3445577999999999999999999763    4678999988655443  6789999999999 5999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC-CCCcEEEecccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAK  812 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgla~  812 (952)
                      .+.+|+||+++....++..    .++..++..+++.+..||+++   |..|||||||||+|++.+ ..+.-.|+|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~---h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHL---HKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhh---hccCccccCCCccccccccccCCceEEechhHH
Confidence            9999999999988888776    367889999999999999999   899999999999999997 56788999999997


Q ss_pred             ccCC----------------c------------------Ccc---------cccccccccccccccccCc-CCcCcccch
Q 002214          813 LLSE----------------E------------------DSM---------KQTQTLATIGYIAPEYGRE-GQVSIKGDV  848 (952)
Q Consensus       813 ~~~~----------------~------------------~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv  848 (952)
                      ....                +                  ...         ....+.||++|.|||++.. ...++++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            2210                0                  000         0112469999999998765 456889999


Q ss_pred             HhHHHHHHHHHhCCCCCCccccCccchhhhhc----------------------cchhh---hhh---hcc-ccccchhh
Q 002214          849 YNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN----------------------DSLPA---VMN---IMD-TNLLSEDE  899 (952)
Q Consensus       849 ~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~----------------------~~~~~---~~~---~~~-~~~~~~~~  899 (952)
                      ||.||+++.+++++.||-.....-..+...+.                      ..++.   ...   -++ ..+.....
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            99999999999999998654333222211110                      11111   000   000 00111000


Q ss_pred             --HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 --EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 --~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                        ..........+..+.+++.+|+..||.+|.|++|.++|
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence              00111112345579999999999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3.7e-27  Score=255.12  Aligned_cols=253  Identities=24%  Similarity=0.367  Sum_probs=203.1

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|....++|.|.||.||||++ .+++..|+|+++.......+.+++|+-+++.-+|||||.++|.+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            45788999999999999999998 46899999999988777778889999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      |.+|+|++.-+... .+++.++..+.++..+|++||   |++|=+|||||-.||++++.|.+|++|||.+..+... ...
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~yl---hs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~K  168 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYL---HSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAK  168 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhh---hcCCcccccccccceeecccCceeecccCchhhhhhh-hhh
Confidence            99999998665443 799999999999999999999   8999999999999999999999999999999766432 223


Q ss_pred             cccccccccccccccc---CcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          822 QTQTLATIGYIAPEYG---REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      .....||+.|||||+.   +.+.|...+|||+.|+...|+-.-..|....++-...+        -.....+++......
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~--------LmTkS~~qpp~lkDk  240 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF--------LMTKSGFQPPTLKDK  240 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH--------HhhccCCCCCcccCC
Confidence            3457899999999964   45678899999999999999988777732211100000        000111121111111


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                              ...++.+.++++.|+..+|.+||++..+++
T Consensus       241 --------~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  241 --------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             --------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                    123567899999999999999999987765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=1.3e-26  Score=243.47  Aligned_cols=200  Identities=26%  Similarity=0.317  Sum_probs=170.5

Q ss_pred             HHHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCC------CCccceeeeEeecC
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIR------HRNLVKIISSCTNH  732 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~  732 (952)
                      +....+|.+....|+|-|++|.+|.+. .|..||||+++.... ..+.=.+|++||++|+      --|+++++..|...
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            345678999999999999999999874 478999999975432 2345578999999995      24789999999999


Q ss_pred             CeeEEEEEccCCCChhHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC-CcEEEeccc
Q 002214          733 NFKALVLEYMPKGSLEDCMYASNF--NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS-MVAHLSDFG  809 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~-~~~kl~Dfg  809 (952)
                      .+.|||+|-+ .-+|.+++...+.  .+....+..++.|+.-||..|   -..||+|.||||.|||+.+. ..+||||||
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklL---K~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLL---KKCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHH---HhcCeeecccCccceEeccCcceeeeccCc
Confidence            9999999988 4589999987554  577888999999999999999   78999999999999999864 578999999


Q ss_pred             cccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002214          810 IAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNE  867 (952)
Q Consensus       810 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  867 (952)
                      .|.......   .+++..+..|.|||++.+-+|...-|+||.||+|||++||+..|..
T Consensus       583 SA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  583 SASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             ccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            998765443   3456678899999999999999999999999999999999988765

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=1e-27  Score=244.58  Aligned_cols=422  Identities=25%  Similarity=0.290  Sum_probs=278.0

Q ss_pred             EEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecC-
Q 002214           36 TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNN-  114 (952)
Q Consensus        36 ~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~-  114 (952)
                      ..+|=++.+++ .+|..+..  +...++|..|+|+...|.+|..+++|+.||||+|.|+.+-|++|.++.+|..|.+.+ 
T Consensus        49 ~~VdCr~~GL~-eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~  125 (498)
T KOG4237|consen   49 GIVDCRGKGLT-EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGN  125 (498)
T ss_pred             ceEEccCCCcc-cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcC
Confidence            34455666666 45654432  556688888888855556788888888888888888888888888888877776655 


Q ss_pred             ccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCccccc
Q 002214          115 NLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGR  194 (952)
Q Consensus       115 n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  194 (952)
                      |+|+                          ++|...|.++.+|+.|.+.-|++.-...+.|+++++|..|.+-+|.+..+
T Consensus       126 NkI~--------------------------~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i  179 (498)
T KOG4237|consen  126 NKIT--------------------------DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSI  179 (498)
T ss_pred             Cchh--------------------------hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhh
Confidence            6666                          66677777888999999999999877788899999999999999999855


Q ss_pred             CCccccccCCccEEEeeCCcCC------------ccCchhhhccCCCcEeeeccccccccCCccccC-CCCccEEEeeCc
Q 002214          195 LPRDLGNSTKLKSLDLGFNNLN------------GEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFN-ISTLKILSLFNN  261 (952)
Q Consensus       195 ~~~~~~~l~~L~~L~L~~N~l~------------~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~-l~~L~~L~Ls~N  261 (952)
                      ...+|..+..++.+++..|.+.            ...|..++..+...-..+.+.++..+.+..|.- ++++..=-.+.+
T Consensus       180 ~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d  259 (498)
T KOG4237|consen  180 CKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSED  259 (498)
T ss_pred             ccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhcccc
Confidence            5558999999999999999832            244556677777777777777776665555432 223322222333


Q ss_pred             cccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhcc
Q 002214          262 TLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNC  341 (952)
Q Consensus       262 ~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~  341 (952)
                      ...+..| ...|..+++|+.|+|++|+++.+.+.+|.++.++++|.           |.+|+|..+...           
T Consensus       260 ~~d~~cP-~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~-----------L~~N~l~~v~~~-----------  316 (498)
T KOG4237|consen  260 FPDSICP-AKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELY-----------LTRNKLEFVSSG-----------  316 (498)
T ss_pred             CcCCcCh-HHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhh-----------cCcchHHHHHHH-----------
Confidence            3333333 45689999999999999999999999998877655544           444555544443           


Q ss_pred             ccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCC-CCccccCCCcceEEEeccccccccCCCccCC
Q 002214          342 KSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGP-IPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD  420 (952)
Q Consensus       342 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  420 (952)
                         .|.++..|+.|+|.+|+|+..-|.+|..+.+|.+|+|-.|++-.. .-.++..       .|..+.-. ..|.+ +.
T Consensus       317 ---~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------Wlr~~~~~-~~~~C-q~  384 (498)
T KOG4237|consen  317 ---MFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------WLRKKSVV-GNPRC-QS  384 (498)
T ss_pred             ---hhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------HHhhCCCC-CCCCC-CC
Confidence               356777888888888888877888888888888888887776421 0011110       01112211 11221 22


Q ss_pred             CCCCcEEeccccccCCc---CCccc---------cCCCCCc-eeEecCCccCCCCchhhhcccccceeecCCcccCCCCc
Q 002214          421 LNSLRILSLSSNELTSV---IPSTF---------WNLEDIL-GFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIP  487 (952)
Q Consensus       421 l~~L~~L~L~~N~l~~~---~~~~~---------~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  487 (952)
                      ...++.+.++.+.+...   .|+..         ...+-+. ....|++.++ .+|..+-  ...++|++.+|.++ .+|
T Consensus       385 p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp  460 (498)
T KOG4237|consen  385 PGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVP  460 (498)
T ss_pred             CchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccC
Confidence            23455555555544321   11111         1111222 2233444444 3333221  23467788888888 455


Q ss_pred             ccccCCCCCceEEccCccccCcccccccccccccEEeCCCC
Q 002214          488 STIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN  528 (952)
Q Consensus       488 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  528 (952)
                      ..  .+..| .+||++|+|.......|.+|.+|.+|-||+|
T Consensus       461 ~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  461 DE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             HH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            55  55667 8888888888655667888888888888876

>PLN03210 Resistant to P

Probab=99.92  E-value=1.2e-23  Score=265.87  Aligned_cols=184  Identities=19%  Similarity=0.239  Sum_probs=126.4

Q ss_pred             cCChhhcCCCCCCeEeecCcc------CccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccc
Q 002214           96 EIPEELGNLAELEMLVLNNNL------LTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG  169 (952)
Q Consensus        96 ~~p~~l~~l~~L~~L~L~~n~------l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  169 (952)
                      ..+.+|.++.+|+.|.+..+.      +...+|.++..+...++.|.+.++.+. .+|..+  ...+|++|+|++|++. 
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~-  624 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLE-  624 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCcccc-
Confidence            345678889999999987654      333567777666666677777777765 666655  3567788888888776 


Q ss_pred             cCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccC
Q 002214          170 PIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFN  249 (952)
Q Consensus       170 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~  249 (952)
                      .++..+..+++|+.|+|++|.....+| .++.+++|++|+|++|.....+|..++.+++|+.|++++|+..+.+|..+ +
T Consensus       625 ~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~  702 (1153)
T PLN03210        625 KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-N  702 (1153)
T ss_pred             ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-C
Confidence            567777777788888887765443555 36777778888887776555777777777788888887776555556544 6


Q ss_pred             CCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCC
Q 002214          250 ISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLS  290 (952)
Q Consensus       250 l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~  290 (952)
                      +++|+.|++++|.....+|..     ..+|++|++++|.+.
T Consensus       703 l~sL~~L~Lsgc~~L~~~p~~-----~~nL~~L~L~~n~i~  738 (1153)
T PLN03210        703 LKSLYRLNLSGCSRLKSFPDI-----STNISWLDLDETAIE  738 (1153)
T ss_pred             CCCCCEEeCCCCCCccccccc-----cCCcCeeecCCCccc
Confidence            777777777777544333321     346677777777665

syringae 6; Provisional

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=4.5e-25  Score=270.94  Aligned_cols=196  Identities=17%  Similarity=0.256  Sum_probs=139.9

Q ss_pred             hCCC-CccceeeeEe-------ecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 002214          716 TIRH-RNLVKIISSC-------TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH  787 (952)
Q Consensus       716 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH  787 (952)
                      .++| +||+++++++       .+.+..+.++||+ +++|.+++......+++.++..++.||++||+||   |++||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAA---HSQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHH---HhCCeee
Confidence            3445 5788888877       2234567788988 6699999976666799999999999999999999   7999999


Q ss_pred             CCCCCCCeeeCC-------------------CCcEEEeccccccccCCcC---------------ccccccccccccccc
Q 002214          788 CDIKPSNVLLDD-------------------SMVAHLSDFGIAKLLSEED---------------SMKQTQTLATIGYIA  833 (952)
Q Consensus       788 ~Dlk~~Nill~~-------------------~~~~kl~Dfgla~~~~~~~---------------~~~~~~~~~~~~y~a  833 (952)
                      |||||+|||++.                   ++.+|++|||+++......               ........||+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999954                   4456666777665421100               000112357889999


Q ss_pred             ccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHH
Q 002214          834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSV  913 (952)
Q Consensus       834 PE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  913 (952)
                      ||++.+..++.++|||||||++|||++|..|+.....   ....+.       ...+.+     .       ......+.
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~-------~~~~~~-----~-------~~~~~~~~  241 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLR-------HRVLPP-----Q-------ILLNWPKE  241 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHH-------HhhcCh-----h-------hhhcCHHH
Confidence            9999999999999999999999999998887543100   000000       000000     0       00112345


Q ss_pred             HHHHhhccccCCCCCCCHHHHHHH
Q 002214          914 LSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       914 ~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..++.+||+++|.+||++.|++++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            688899999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=4.2e-24  Score=213.13  Aligned_cols=170  Identities=21%  Similarity=0.212  Sum_probs=129.4

Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      |+|.+++...+..+++.+++.++.|+++||+||   |+++      ||+||+++.++.+|+  ||.++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALREL---HRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH---HhcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            689999987666799999999999999999999   5555      999999999999999  99998654321      


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHH
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV  904 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (952)
                      ..|++.|+|||++.+..++.++|||||||++|||+||+.||............+.....        ........     
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~-----  130 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP--------ADDPRDRS-----  130 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc--------cCCccccc-----
Confidence            25889999999999999999999999999999999999998653222211222111100        00000000     


Q ss_pred             hhhhhHH--HHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          905 AKQSCAS--SVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       905 ~~~~~~~--~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      .+...+.  ++.+++.+||+.+|++||++.|+++++..+...
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            0112233  699999999999999999999999999877554

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN03210 Resistant to P

Probab=99.90  E-value=4.1e-23  Score=260.98  Aligned_cols=306  Identities=24%  Similarity=0.257  Sum_probs=154.6

Q ss_pred             ccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEc
Q 002214          205 LKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNL  284 (952)
Q Consensus       205 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L  284 (952)
                      |+.|++.++.+. .+|..| ...+|+.|++.+|++.. ++..+..+++|+.|+|++|.....+|.   +..+++|+.|+|
T Consensus       591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~-L~~~~~~l~~Lk~L~Ls~~~~l~~ip~---ls~l~~Le~L~L  664 (1153)
T PLN03210        591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK-LWDGVHSLTGLRNIDLRGSKNLKEIPD---LSMATNLETLKL  664 (1153)
T ss_pred             cEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc-cccccccCCCCCEEECCCCCCcCcCCc---cccCCcccEEEe
Confidence            444444444443 333333 23444444444444332 233334444444444444332222221   333444444444


Q ss_pred             ccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCC
Q 002214          285 GLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSG  364 (952)
Q Consensus       285 ~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~  364 (952)
                      ++|.....+|..+..+++|+.|+++.|.+++.+...                          .++++|+.|++++|....
T Consensus       665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~--------------------------i~l~sL~~L~Lsgc~~L~  718 (1153)
T PLN03210        665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG--------------------------INLKSLYRLNLSGCSRLK  718 (1153)
T ss_pred             cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc--------------------------CCCCCCCEEeCCCCCCcc
Confidence            444433344444444444444444444333332110                          134455555555554333


Q ss_pred             CCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEecccccc-------ccCCCccCCCCCCcEEeccccccCCc
Q 002214          365 SLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLS-------GSIPSCLGDLNSLRILSLSSNELTSV  437 (952)
Q Consensus       365 ~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-------~~~~~~~~~l~~L~~L~L~~N~l~~~  437 (952)
                      ..|..   .++|++|++++|.+. ..|..+ .+++|+.|.+.++...       ...+..+...++|+.|+|++|.....
T Consensus       719 ~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~  793 (1153)
T PLN03210        719 SFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVE  793 (1153)
T ss_pred             ccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccc
Confidence            33322   245556666666554 233332 3455555555543221       11111222345667777777665555


Q ss_pred             CCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCccccccccc
Q 002214          438 IPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGEL  517 (952)
Q Consensus       438 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  517 (952)
                      +|..+.++++|+.|++++|..-+.+|... .+++|+.|+|++|......|..   .++|+.|+|++|.|+ .+|..+..+
T Consensus       794 lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l  868 (1153)
T PLN03210        794 LPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKF  868 (1153)
T ss_pred             cChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcC
Confidence            66666777777777776654333455444 5667777777776543334432   356777777777776 456667777


Q ss_pred             ccccEEeCCCC-cccccCccchhcccccccccccccc
Q 002214          518 VSLEFLDLSNN-DLSGVIPASLEKLLYLKSLNLSFNK  553 (952)
Q Consensus       518 ~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~l~~N~  553 (952)
                      ++|+.|+|++| ++. .+|..+..+++|+.+++++|.
T Consensus       869 ~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        869 SNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            77777777763 444 455566667777777777664

syringae 6; Provisional

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-23  Score=200.16  Aligned_cols=266  Identities=20%  Similarity=0.240  Sum_probs=210.7

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCC-CccceeeeEeecCCeeEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRH-RNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  739 (952)
                      ..++|+.+++||.|+||.+|.|.. .+|..||||+-+....  ..++..|.++++.+++ ..|..+..+..+..+-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            456899999999999999999975 6899999998754433  2467789999999975 77888888889999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC---CCCcEEEeccccccccCC
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgla~~~~~  816 (952)
                      |.. |.+|++++.-+...++..+.+..+.|+..-++|+   |.++++||||||+|+|+.   ....+.++|||+|+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyv---H~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYV---HLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHH---HhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            999 8899999988888899999999999999999999   899999999999999996   445789999999998754


Q ss_pred             cCcc------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCcc--chhhhhccchhhhhh
Q 002214          817 EDSM------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM--SIKRWINDSLPAVMN  888 (952)
Q Consensus       817 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~  888 (952)
                      ....      ......||.+|.+--...+...+.+.|+=|+|.++..+--|..||+.......  .+.++.+...     
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~-----  241 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM-----  241 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc-----
Confidence            3321      12234699999988877777778899999999999999999999987543211  1111111000     


Q ss_pred             hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 002214          889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFAN  948 (952)
Q Consensus       889 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~  948 (952)
                          ..      ..+....++|.++.-.+.-|=..--++-|+..-+-+.++-+.+.+.-+
T Consensus       242 ----s~------~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~  291 (341)
T KOG1163|consen  242 ----ST------PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQ  291 (341)
T ss_pred             ----CC------CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcccc
Confidence                00      112234567889999999999999999999988888887776665433

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.7e-22  Score=221.09  Aligned_cols=260  Identities=21%  Similarity=0.242  Sum_probs=200.1

Q ss_pred             cCCccceecCccceEEEEEEeCCC--cEEEEEEeeccCchhhHHHHHHHHHHHhCCC----CccceeeeEe-ecCCeeEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFPDG--IEVAIKVFHLQREGALNSFDAECEILKTIRH----RNLVKIISSC-TNHNFKAL  737 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  737 (952)
                      +|.+.+.||+|+||.||.+.....  ..+|+|+...........+..|..++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997553  5899998765543322367889999998863    6889999988 57788999


Q ss_pred             EEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC-----CcEEEeccccc
Q 002214          738 VLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS-----MVAHLSDFGIA  811 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~-----~~~kl~Dfgla  811 (952)
                      ||+.+ |.+|.++..... ..++..++.+|+.|+..+|+++   |+.|++||||||.|+++...     ..+.+.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~l---H~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDL---HSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHH---HhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99998 889999886554 6899999999999999999999   89999999999999999754     46999999999


Q ss_pred             c--ccCCcCcc----c---ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccc
Q 002214          812 K--LLSEEDSM----K---QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS  882 (952)
Q Consensus       812 ~--~~~~~~~~----~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  882 (952)
                      +  .+......    .   .....||..|+++....+...+.+.|+||++.++.|+..|..||........ ..+.....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence            9  43222211    1   1234599999999999999999999999999999999999999865332211 11110000


Q ss_pred             hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      ...        ....       .....+.++.++...+-..+..++|....+...+++....
T Consensus       254 ~~~--------~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  254 RKL--------LTDR-------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             hhh--------cccc-------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            000        0000       1122356677788888789999999999999998877665

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.6e-22  Score=202.36  Aligned_cols=265  Identities=18%  Similarity=0.217  Sum_probs=213.6

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ..-.|+++++||+|+||.++.|+. -+++.||||.-...++  ..++..|.+.++.|. .++|..++.+..++.+-.||+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            345799999999999999999975 5799999997654433  367888999999985 689999998888888889999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-----CCcEEEecccccccc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-----SMVAHLSDFGIAKLL  814 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfgla~~~  814 (952)
                      |.+ |.+|++++.-++.+++..+++.||.|+..-++|+   |++..|.|||||+|+||..     ...+.++|||+|+.+
T Consensus       104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~v---H~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYV---HEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHH---HhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999 8899999998999999999999999999999999   8999999999999999964     346899999999988


Q ss_pred             CCcCcccc------cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccC--ccchhhhhccchhhh
Q 002214          815 SEEDSMKQ------TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTG--EMSIKRWINDSLPAV  886 (952)
Q Consensus       815 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~  886 (952)
                      .++.....      ....||.+||+=-...+...+.+.|.=|+|-|++..+-|..||......  ...+.++-...... 
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T-  258 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST-  258 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC-
Confidence            76654322      2345999999999989999999999999999999999999999875322  12222221111111 


Q ss_pred             hhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       887 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                                .    .....+++|.++..-++-.=+.+-++-|+.+-+..-+..+.+++..
T Consensus       259 ----------~----i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~  305 (449)
T KOG1165|consen  259 ----------P----IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE  305 (449)
T ss_pred             ----------C----HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence                      0    1122355788888888888888999999999888888888776543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=5.1e-23  Score=223.03  Aligned_cols=169  Identities=21%  Similarity=0.227  Sum_probs=130.8

Q ss_pred             HHHHHhccCCccceecCccceEEEEEEeC--CCcEEEEEEeecc-----CchhhHHHHHHHHHHHhCCCCccceeeeEee
Q 002214          658 ELLRATDQFSEENLIGIGSYGSVYKGRFP--DGIEVAIKVFHLQ-----REGALNSFDAECEILKTIRHRNLVKIISSCT  730 (952)
Q Consensus       658 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  730 (952)
                      ......++|.+.+.||+|+||+||+|.++  +++.||||+....     .....+.+.+|++++++++|+|+++.+..+ 
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            34456678999999999999999999874  5788899986532     122346789999999999999998533222 


Q ss_pred             cCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCCCeeeCCCCcEEEeccc
Q 002214          731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI-KPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       731 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dl-k~~Nill~~~~~~kl~Dfg  809 (952)
                        +..|+||||++|++|.. ...    ..   ...++.|+++||+||   |++||+|||| ||+|||++.++.+||+|||
T Consensus        91 --~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~l---H~~gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDL---HRAGITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             --CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHH---HHCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence              45799999999999963 211    11   146789999999999   7899999999 9999999999999999999


Q ss_pred             cccccCCcCcccc-------cccccccccccccccCcC
Q 002214          810 IAKLLSEEDSMKQ-------TQTLATIGYIAPEYGREG  840 (952)
Q Consensus       810 la~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~  840 (952)
                      +|+.+........       +...+++.|+|||++...
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9997754331111       234678889999987543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=5.6e-24  Score=206.36  Aligned_cols=250  Identities=20%  Similarity=0.338  Sum_probs=191.5

Q ss_pred             CCccceecCccceEEEEEEeCCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          666 FSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      .....+|.+...|+.|+|++ .|..+++|++....  ....+.|..|.-.++-+.||||.+++|.|..+....++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            44556788999999999999 56677788775442  2234678899989999999999999999999999999999999


Q ss_pred             CCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          744 KGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       744 ~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      .|+|...++.... ..+..++.+++.++|+|++|||.. +.-|..--+.++.|++|++.+++|+ .+-+++.     .+.
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfs-----fqe  343 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS-----FQE  343 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceee-----eec
Confidence            9999999987553 478889999999999999999632 2224445688999999999998875 1112211     122


Q ss_pred             cccccccccccccccCcCCc---CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          823 TQTLATIGYIAPEYGREGQV---SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                      ....-.|.||+||.++..+.   -.++|+|||++++||+.|...||.+..+-+-...            +.-.++     
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk------------ialegl-----  406 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK------------IALEGL-----  406 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh------------hhhccc-----
Confidence            23446789999998876543   3568999999999999999999987543322111            111111     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                        +...|++.+..+.++|.-|++.||.+||.+..|+-.|++++
T Consensus       407 --rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  407 --RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence              22346677888999999999999999999999999988764

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=1.4e-22  Score=236.64  Aligned_cols=181  Identities=27%  Similarity=0.342  Sum_probs=111.6

Q ss_pred             cccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEecc
Q 002214          351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLS  430 (952)
Q Consensus       351 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  430 (952)
                      +|+.|++++|+++. +|.   .+++|+.|++++|+|+++ |..+   .+|+.|++++|+|++ +|..   ..+|+.|+|+
T Consensus       283 ~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~L-p~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS  350 (788)
T PRK15387        283 GLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASL-PALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVS  350 (788)
T ss_pred             hcCEEECcCCcccc-ccc---cccccceeECCCCccccC-CCCc---ccccccccccCcccc-cccc---ccccceEecC
Confidence            35556666666653 232   135566666666666542 3221   345566666666663 3321   2366777777


Q ss_pred             ccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcc
Q 002214          431 SNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPI  510 (952)
Q Consensus       431 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  510 (952)
                      +|+|+++++ .   ..+|+.|++++|+|+. +|..   ..+|+.|+|++|+|+. +|..   .++|+.|++++|+|++ +
T Consensus       351 ~N~Ls~LP~-l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-I  417 (788)
T PRK15387        351 DNQLASLPT-L---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-L  417 (788)
T ss_pred             CCccCCCCC-C---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-C
Confidence            777765332 2   2456667777777763 4432   2457777788887774 3432   2567888888888874 5


Q ss_pred             cccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          511 PESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       511 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      |..+   .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.+|.
T Consensus       418 P~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        418 PMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             Ccch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            5432   46777888888887 5677788888888888888888876654

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.88  E-value=2.6e-22  Score=234.51  Aligned_cols=166  Identities=29%  Similarity=0.359  Sum_probs=104.3

Q ss_pred             cccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEecc
Q 002214          351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLS  430 (952)
Q Consensus       351 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  430 (952)
                      +|+.|+|++|+++++ |..   ..+|+.|++++|.|++ +|..   ..+|+.|+|++|+|++ +|..   .++|+.|+++
T Consensus       303 ~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls  370 (788)
T PRK15387        303 GLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAY  370 (788)
T ss_pred             ccceeECCCCccccC-CCC---cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhh
Confidence            455555555555532 221   1235555555555553 2221   1355666666666662 3332   2456666777


Q ss_pred             ccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcc
Q 002214          431 SNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPI  510 (952)
Q Consensus       431 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  510 (952)
                      +|+|+++ |..   ..+|+.|++++|+|++ +|..   .++|+.|++++|+|+. +|..   ..+|+.|+|++|+|+ .+
T Consensus       371 ~N~L~~L-P~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~L  437 (788)
T PRK15387        371 NNRLTSL-PAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RL  437 (788)
T ss_pred             ccccccC-ccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-cc
Confidence            7777643 322   2467777777777774 4432   2567888888888884 4543   346888999999998 67


Q ss_pred             cccccccccccEEeCCCCcccccCccchhcc
Q 002214          511 PESFGELVSLEFLDLSNNDLSGVIPASLEKL  541 (952)
Q Consensus       511 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  541 (952)
                      |..+..+++|+.|+|++|+|++..+..+..+
T Consensus       438 P~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        438 PESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             ChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence            8888999999999999999998777766444

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=3.9e-22  Score=230.87  Aligned_cols=262  Identities=20%  Similarity=0.235  Sum_probs=193.2

Q ss_pred             CccceecCccceEEEEEEeC-CCcEEEEEEee----c-cCch-hhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          667 SEENLIGIGSYGSVYKGRFP-DGIEVAIKVFH----L-QREG-ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       667 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~-~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .....+|.|++|.|+.+... .....+.|.++    . ..+. ....+..|+.+-..++|||++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34578999999988877642 33444444432    1 1111 1122667888888899999988877777666666669


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++ +|...+... ..+...++..++.|+..|++|+   |..||.|||+|++|+++..+|.+||+|||.+....-+..
T Consensus       401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~---h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYL---HSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHH---HhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 999888765 2588899999999999999999   899999999999999999999999999999987654332


Q ss_pred             ---ccccccccccccccccccCcCCcCc-ccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          820 ---MKQTQTLATIGYIAPEYGREGQVSI-KGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       820 ---~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                         ......+|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||......+..+..-   ..         ...
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~---~~---------~~~  543 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN---NY---------SDQ  543 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh---cc---------ccc
Confidence               3445578999999999999888765 4799999999999999999997655444332000   00         000


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhhccc
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIEM  951 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~~  951 (952)
                      ..............+.+.+.++.+++++||.+|.|+++|++      +.+...|++
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~------d~W~~~i~~  593 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN------DEWIRSIEC  593 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh------ChHhhhcce
Confidence            01111112234556788999999999999999999999973      445555544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=5.5e-21  Score=190.88  Aligned_cols=141  Identities=17%  Similarity=0.158  Sum_probs=111.1

Q ss_pred             cceecCccceEEEEEEeCCCcEEEEEEeeccCch--h-------h-----------------HHHHHHHHHHHhCCCCcc
Q 002214          669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREG--A-------L-----------------NSFDAECEILKTIRHRNL  722 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni  722 (952)
                      ...||+|+||.||+|..++|+.||||+++.....  .       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999998654211  0       0                 122359999999988877


Q ss_pred             ceeeeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc
Q 002214          723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV  802 (952)
Q Consensus       723 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~  802 (952)
                      .....+...  ..++||||++++++...... ...++..+...++.|++.+++|+|  |+.||+||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~--H~~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILY--QDCRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHH--HhCCcccCCCCHHHEEEE-CCc
Confidence            544433222  23899999998877654332 236889999999999999999997  789999999999999998 478


Q ss_pred             EEEeccccccccC
Q 002214          803 AHLSDFGIAKLLS  815 (952)
Q Consensus       803 ~kl~Dfgla~~~~  815 (952)
                      ++|+|||+|....
T Consensus       156 v~LiDFG~a~~~~  168 (190)
T cd05147         156 LYIIDVSQSVEHD  168 (190)
T ss_pred             EEEEEccccccCC
Confidence            9999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=8e-20  Score=203.21  Aligned_cols=256  Identities=32%  Similarity=0.458  Sum_probs=196.7

Q ss_pred             CCccceecCccceEEEEEEeCCCcEEEEEEeeccCch---hhHHHHHHHHHHHhCCCC-ccceeeeEeecCCeeEEEEEc
Q 002214          666 FSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREG---ALNSFDAECEILKTIRHR-NLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  741 (952)
                      |...+.||.|+||.||++...  ..+|+|.+......   ....+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667889999999999999986  88999988655432   367899999999999988 799999999777778999999


Q ss_pred             cCCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC-cEEEeccccccccCCcC
Q 002214          742 MPKGSLEDCMYASN--FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-VAHLSDFGIAKLLSEED  818 (952)
Q Consensus       742 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~  818 (952)
                      +.++++.+.+....  ..+.......++.|++.+++|+   |+.+++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL---HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997666544  2688999999999999999999   899999999999999999988 79999999998665433


Q ss_pred             cc-----cccccccccccccccccCc---CCcCcccchHhHHHHHHHHHhCCCCCCccccC--ccchhhhh-ccchhhhh
Q 002214          819 SM-----KQTQTLATIGYIAPEYGRE---GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTG--EMSIKRWI-NDSLPAVM  887 (952)
Q Consensus       819 ~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~-~~~~~~~~  887 (952)
                      ..     ......++..|+|||...+   ..+....|+||+|++++++++|..||......  .......+ ....+   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence            22     2345679999999998887   57888999999999999999999996543221  00111100 00000   


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ..........       .......+.+++..|+..+|..|.++.+....
T Consensus       234 -~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -SLASPLSPSN-------PELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -ccccccCccc-------cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             0000000000       01123568899999999999999999988765

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.84  E-value=7.7e-21  Score=224.02  Aligned_cols=119  Identities=27%  Similarity=0.392  Sum_probs=60.3

Q ss_pred             CCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceE
Q 002214           81 TKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGL  160 (952)
Q Consensus        81 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L  160 (952)
                      .+...|++++++++ .+|..+.  ++|+.|+|++|.++ .+|..+..   .++.|++++|+++ .+|..+.   ++|+.|
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~~---nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L  246 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQG---NIKTLYANSNQLT-SIPATLP---DTIQEM  246 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhcc---CCCEEECCCCccc-cCChhhh---ccccEE
Confidence            34567777777777 5665553  46777777777776 45544321   1244444444443 3333221   245555


Q ss_pred             EcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCC
Q 002214          161 YVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLN  216 (952)
Q Consensus       161 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  216 (952)
                      +|++|++. .+|..+.  .+|+.|+|++|+++ .+|..+.  ++|+.|+|++|+++
T Consensus       247 ~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt  296 (754)
T PRK15370        247 ELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR  296 (754)
T ss_pred             ECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc
Confidence            55555554 3444332  34555555555555 2343332  24555555555554

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=5.6e-21  Score=191.82  Aligned_cols=173  Identities=14%  Similarity=0.129  Sum_probs=134.4

Q ss_pred             HHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhh---HH------HHHHHHHHHhCCCCccceeeeEeec
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL---NS------FDAECEILKTIRHRNLVKIISSCTN  731 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~h~niv~l~~~~~~  731 (952)
                      ...++|+..+.+|.|+||.||.+.. ++..+|+|+++.......   ..      +.+|++.+.+++||++..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4467899999999999999999766 677899999975433222   22      6799999999999999999888653


Q ss_pred             C--------CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcE
Q 002214          732 H--------NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVA  803 (952)
Q Consensus       732 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~  803 (952)
                      .        +..++||||++|.+|.++..     ++.    ....+++.+++.+   |+.|++|||++|+||+++.++ +
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~l---H~~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESL---HQHGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHH---HHcCCccCCCChHHEEEeCCC-E
Confidence            3        35789999999999987632     222    2466999999999   899999999999999999988 9


Q ss_pred             EEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh
Q 002214          804 HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT  860 (952)
Q Consensus       804 kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t  860 (952)
                      +++|||...........             ..+.....+..++|+|+||+.+.....
T Consensus       174 ~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            99999988754221110             113444556678999999998876543

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.83  E-value=7.6e-21  Score=224.06  Aligned_cols=204  Identities=27%  Similarity=0.453  Sum_probs=115.3

Q ss_pred             eEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeec
Q 002214           34 RVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLN  113 (952)
Q Consensus        34 ~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~  113 (952)
                      +.++|++++++++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+++ .+|..+.  .+|+.|+|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls  249 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS  249 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence            3455555555555 3444442  34555555555555 4444332  35555555555555 3444332  245555555


Q ss_pred             CccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccc
Q 002214          114 NNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTG  193 (952)
Q Consensus       114 ~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~  193 (952)
                      +|+++ .+|.                         .+.   .+|+.|+|++|+++ .+|..+.  .+|+.|+|++|+++.
T Consensus       250 ~N~L~-~LP~-------------------------~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~  297 (754)
T PRK15370        250 INRIT-ELPE-------------------------RLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT  297 (754)
T ss_pred             CCccC-cCCh-------------------------hHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc
Confidence            55554 3443                         332   25666666666666 3555443  366777777777663


Q ss_pred             cCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCccc
Q 002214          194 RLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNL  273 (952)
Q Consensus       194 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l  273 (952)
                       +|..+.  ++|+.|++++|+++ .+|..+.  ++|+.|++++|.+..+ |..+.  ++|+.|++++|+|+. +|..  +
T Consensus       298 -LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~L-P~~l~--~sL~~L~Ls~N~L~~-LP~~--l  365 (754)
T PRK15370        298 -LPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTSL-PASLP--PELQVLDVSKNQITV-LPET--L  365 (754)
T ss_pred             -Ccccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCccccC-Chhhc--CcccEEECCCCCCCc-CChh--h
Confidence             444332  35677777777776 3444332  5677777777776653 44332  578888888888763 3432  1


Q ss_pred             CCCCCcceEEcccCcCCCC
Q 002214          274 IGLPNLEGLNLGLNNLSGS  292 (952)
Q Consensus       274 ~~l~~L~~L~L~~N~l~~~  292 (952)
                        .++|+.|++++|+++.+
T Consensus       366 --p~~L~~LdLs~N~Lt~L  382 (754)
T PRK15370        366 --PPTITTLDVSRNALTNL  382 (754)
T ss_pred             --cCCcCEEECCCCcCCCC
Confidence              25788888888888743

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=2.7e-19  Score=179.79  Aligned_cols=142  Identities=19%  Similarity=0.223  Sum_probs=111.8

Q ss_pred             cceecCccceEEEEEEeCCCcEEEEEEeeccCch--------------------------hhHHHHHHHHHHHhCCCCcc
Q 002214          669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREG--------------------------ALNSFDAECEILKTIRHRNL  722 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  722 (952)
                      .+.||+|+||.||+|...+|+.||||+++.....                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5689999999999999878999999998754211                          01224678999999999987


Q ss_pred             ceeeeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc
Q 002214          723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV  802 (952)
Q Consensus       723 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~  802 (952)
                      .....+....  .++||||++++++...... ...++..+...++.|++.++.++|  +..||+||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH--~~~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLY--QEAGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCChhhEEEE-CCC
Confidence            6555444332  4899999988865433222 235788899999999999999994  339999999999999999 899


Q ss_pred             EEEeccccccccCC
Q 002214          803 AHLSDFGIAKLLSE  816 (952)
Q Consensus       803 ~kl~Dfgla~~~~~  816 (952)
                      ++|+|||+|.....
T Consensus       156 ~~liDFG~a~~~~~  169 (190)
T cd05145         156 PYIIDVSQAVELDH  169 (190)
T ss_pred             EEEEEcccceecCC
Confidence            99999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=3.6e-19  Score=174.33  Aligned_cols=185  Identities=14%  Similarity=0.091  Sum_probs=138.9

Q ss_pred             CccceecCccceEEEEEEeCCCcEEEEEEeeccCc----hhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEEEEc
Q 002214          667 SEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE----GALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       667 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .+...|++|+||+||.+.. .+.+++.+.+.....    -....+.+|+++|+++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999997766 678888777654322    11235889999999995 5889999886    346999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI-KPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dl-k~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      ++|.+|.+....        ....++.|++++++++   |+.||+|||| ||+||++++++.++|+|||+|.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~l---H~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQL---HRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHH---HHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998654321        1235788999999999   8999999999 799999999999999999999865433210


Q ss_pred             ----c--------ccccccccccccccccCcC-CcC-cccchHhHHHHHHHHHhCCCCCCc
Q 002214          821 ----K--------QTQTLATIGYIAPEYGREG-QVS-IKGDVYNYGIMLMEVFTGMKPTNE  867 (952)
Q Consensus       821 ----~--------~~~~~~~~~y~aPE~~~~~-~~~-~~~Dv~slG~~l~el~tg~~p~~~  867 (952)
                          .        ......++.|++|+.-..- ..+ .+.+.++-|..+|.++||+.|...
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                0        1112367788888743221 223 566889999999999999998644

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.80  E-value=1.5e-21  Score=176.99  Aligned_cols=180  Identities=29%  Similarity=0.512  Sum_probs=145.0

Q ss_pred             cccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCc
Q 002214          370 LGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDIL  449 (952)
Q Consensus       370 l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  449 (952)
                      +.++..++.|.||+|+++ ..|..++.+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            445566777777788877 55566777778888888888887 67777888888888888888886 6788888888888


Q ss_pred             eeEecCCccCC-CCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCC
Q 002214          450 GFDFSSNSLNG-SLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN  528 (952)
Q Consensus       450 ~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  528 (952)
                      .|||++|++.. .+|+.|..++.|+.|+|+.|.+. .+|..++.+++|+.|.+..|.+- .+|..++.+..|++|++++|
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn  183 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN  183 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence            99998888864 68999999999999999999998 78888999999999999999988 68899999999999999999


Q ss_pred             cccccCccchhccccc---ccccccccccc
Q 002214          529 DLSGVIPASLEKLLYL---KSLNLSFNKLV  555 (952)
Q Consensus       529 ~l~~~~~~~~~~l~~L---~~L~l~~N~l~  555 (952)
                      +++ ++|.+++++.-+   +.+.+.+|+|.
T Consensus       184 rl~-vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  184 RLT-VLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             eee-ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            998 777776665322   23445555554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=3.8e-19  Score=184.05  Aligned_cols=231  Identities=21%  Similarity=0.288  Sum_probs=147.7

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc---hhhHHHHHHHHHHHhCCC----------CccceeeeEee
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRH----------RNLVKIISSCT  730 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~  730 (952)
                      .+...+.||.|+++.||.+++ .+|+++|||++.....   ...+.+.+|.-....+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            345678899999999999998 4699999999865432   235666676655555322          12222222221


Q ss_pred             ---------cC---C-----eeEEEEEccCCCChhHHhhh---cCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 002214          731 ---------NH---N-----FKALVLEYMPKGSLEDCMYA---SNF---NLDIFQRLGIMIDVASALEYLHFGHSNPIVH  787 (952)
Q Consensus       731 ---------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~---~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH  787 (952)
                               ..   .     ..+++|+-+ .++|.+++..   ...   .+....++.+..|+.+.+++|   |..|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~L---h~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANL---HSYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH---HHTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHH---hhcceEe
Confidence                     11   1     236788888 5688877542   222   133445567778999999999   7999999


Q ss_pred             CCCCCCCeeeCCCCcEEEeccccccccCCcCcccccccccccccccccccCc--------CCcCcccchHhHHHHHHHHH
Q 002214          788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE--------GQVSIKGDVYNYGIMLMEVF  859 (952)
Q Consensus       788 ~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~  859 (952)
                      +||+|+|++++.+|.++|+||+.....+.....    ...+..|.+||....        -.++.+.|.|++|+++|.++
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999988765432211    335678999996533        24788899999999999999


Q ss_pred             hCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCC
Q 002214          860 TGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR  928 (952)
Q Consensus       860 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  928 (952)
                      +|+.||+...........|                       . ... +.|+.++.||..+++.+|++|
T Consensus       245 C~~lPf~~~~~~~~~~~~f-----------------------~-~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEWDF-----------------------S-RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGGGG-----------------------T-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccccc-----------------------h-hcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999997642221110000                       0 011 457889999999999999998

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=3.6e-19  Score=195.86  Aligned_cols=217  Identities=29%  Similarity=0.421  Sum_probs=164.9

Q ss_pred             HHhCCCCccceeeeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 002214          714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPS  793 (952)
Q Consensus       714 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~  793 (952)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+......+++.....+.++++.||+|+|  ++....|+.++++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh--~s~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH--NSPIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh--cCcceeeeeeccc
Confidence            35688999999999999999999999999999999999988889999999999999999999996  5555599999999


Q ss_pred             CeeeCCCCcEEEeccccccccCCc-CcccccccccccccccccccCcC-------CcCcccchHhHHHHHHHHHhCCCCC
Q 002214          794 NVLLDDSMVAHLSDFGIAKLLSEE-DSMKQTQTLATIGYIAPEYGREG-------QVSIKGDVYNYGIMLMEVFTGMKPT  865 (952)
Q Consensus       794 Nill~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~el~tg~~p~  865 (952)
                      |.++|....+|++|||+....... .........-..-|.|||.++..       ..+.+.||||||++++|+++.+.||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999999876421 11111122345579999987763       1467799999999999999999999


Q ss_pred             CccccCccc--hhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          866 NEFFTGEMS--IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       866 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                      +.....+..  ....++.   .....    ........     ...++++..++.+||..+|++||+++.|-..++.+..
T Consensus       159 ~~~~~~~~~~eii~~~~~---~~~~~----~rP~i~~~-----~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKK---GGSNP----FRPSIELL-----NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccCChHHHHHHHHh---cCCCC----cCcchhhh-----hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            874433322  1111111   00000    11111100     0334578999999999999999999999988887655


Q ss_pred             H
Q 002214          944 L  944 (952)
Q Consensus       944 ~  944 (952)
                      .
T Consensus       227 ~  227 (484)
T KOG1023|consen  227 G  227 (484)
T ss_pred             c
Confidence            3

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.78  E-value=5.6e-20  Score=210.30  Aligned_cols=247  Identities=19%  Similarity=0.263  Sum_probs=177.4

Q ss_pred             cCCccceecCccceEEEEEEeCCCcEEEEEEeeccCch-hhHHHHH---HHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREG-ALNSFDA---ECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ++...+.+|.+.|=.|.+|+++.|. |+||++..+.+. ..+.|.+   |++ ....+|||++++.-+-..+...|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5777889999999999999998887 999999766532 2333333   344 455689999999887777778889999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC--CcC
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS--EED  818 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~--~~~  818 (952)
                      |+.+ +|.|.+.... -+...+..-|+.|+..|+..+   |+.||+|||||.+|||+++-..+.|+||..-+...  .++
T Consensus       102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qc---H~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQC---HKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHH---HHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            9855 8888776544 366677788999999999999   89999999999999999999999999998775432  111


Q ss_pred             cccc----cccccccccccccccCc----------CC-cCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccc
Q 002214          819 SMKQ----TQTLATIGYIAPEYGRE----------GQ-VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDS  882 (952)
Q Consensus       819 ~~~~----~~~~~~~~y~aPE~~~~----------~~-~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  882 (952)
                      ....    .....-..|+|||.+-.          .. .+++-||||+||+++|+++ |++||.-.     ++-.+....
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~  251 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN  251 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence            1111    11223446999996432          12 5678899999999999999 67877531     111111110


Q ss_pred             hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      .      .++         .....+-....++.++..|++.||++|.++.+.++.-
T Consensus       252 ~------~~~---------e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  252 A------DDP---------EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             c------cCH---------HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence            0      000         0000000123589999999999999999999998763

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=3.2e-19  Score=182.73  Aligned_cols=197  Identities=18%  Similarity=0.251  Sum_probs=142.9

Q ss_pred             CCCccceeeeEeec---------------------------CCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHH
Q 002214          718 RHRNLVKIISSCTN---------------------------HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDV  770 (952)
Q Consensus       718 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i  770 (952)
                      +|||||++.++|.+                           ....|+||...+. +|..++....  .+...+.-|+.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            49999999877643                           2357899998855 8998887654  6777888899999


Q ss_pred             HHHHHHHHhcCCCCeEeCCCCCCCeeeC--CCC--cEEEeccccccccCCcC---cc--cccccccccccccccccCcCC
Q 002214          771 ASALEYLHFGHSNPIVHCDIKPSNVLLD--DSM--VAHLSDFGIAKLLSEED---SM--KQTQTLATIGYIAPEYGREGQ  841 (952)
Q Consensus       771 a~~l~~Lh~~h~~~ivH~Dlk~~Nill~--~~~--~~kl~Dfgla~~~~~~~---~~--~~~~~~~~~~y~aPE~~~~~~  841 (952)
                      .+|+.||   |++||.|||+|+.|||+.  +|+  ...|+|||.+---....   .+  .....-|.-.-||||+....+
T Consensus       351 LEav~hL---~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHL---HKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHH---HHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999   899999999999999993  444  46789999875321111   01  111234677889999765432


Q ss_pred             ------cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHH
Q 002214          842 ------VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLS  915 (952)
Q Consensus       842 ------~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  915 (952)
                            .-.|+|.|+.|-+.||+++...||..-..-..+.+.+-+.+                   .+..+..|++.+++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q-------------------LPalp~~vpp~~rq  488 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ-------------------LPALPSRVPPVARQ  488 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh-------------------CCCCcccCChHHHH
Confidence                  23578999999999999999999865222122222222222                   22245668889999


Q ss_pred             HHhhccccCCCCCCCHHHHHHHHH
Q 002214          916 LAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       916 li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                      ++...++.||.+||+..-..+.+.
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHH
Confidence            999999999999999876666553

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=2e-18  Score=202.93  Aligned_cols=254  Identities=24%  Similarity=0.257  Sum_probs=186.0

Q ss_pred             HHHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC---CCccceeeeEeecCCee
Q 002214          659 LLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIR---HRNLVKIISSCTNHNFK  735 (952)
Q Consensus       659 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~  735 (952)
                      .....+.|.+.+.||+|+||.||+|...+|+.||+|+-++...-   +|.-=.+++.||+   -+.|+.+...+...+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            34456789999999999999999999988999999997665432   1222334555665   23455555555666778


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC-------CCCcEEEecc
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-------DSMVAHLSDF  808 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~-------~~~~~kl~Df  808 (952)
                      ++|+||.+.|+|.+++.. ....++.-...+..|++..+++|   |..+||||||||+|+|+.       ....++|+||
T Consensus       770 ~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~l---H~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHL---HAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHH---HhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence            899999999999999984 44789999999999999999999   899999999999999994       3457999999


Q ss_pred             ccccccCC-cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhh
Q 002214          809 GIAKLLSE-EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM  887 (952)
Q Consensus       809 gla~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  887 (952)
                      |.|..+.- ++.......++|-.+-.+|+..+++++...|.|.++-+++-|+.|+.--  . .+.   ..|         
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~-~~g---~~~---------  910 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--V-KNG---SSW---------  910 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--h-cCC---cce---------
Confidence            99976642 2333445567899999999999999999999999999999999996541  0 000   000         


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                       .++..       .......+.   +.+++..+|++|=..=|...++...+++..++-
T Consensus       911 -~~~~~-------~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~  957 (974)
T KOG1166|consen  911 -MVKTN-------FPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH  957 (974)
T ss_pred             -ecccc-------chhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence             01111       011111222   345556666666666777788877777766553

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=1e-20  Score=171.62  Aligned_cols=161  Identities=32%  Similarity=0.519  Sum_probs=106.0

Q ss_pred             cccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCccccccccc
Q 002214           52 HLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFI  131 (952)
Q Consensus        52 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l  131 (952)
                      .+..+.+++.|.||+|+++ .+|..|..+++|+.|++++|++. .+|.+++.+++|++|++.-|++. .+|.+|+.+..+
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l  104 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL  104 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence            4567778888888888888 77778888888899999888888 78888888888888888888888 778877655433


Q ss_pred             ccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEee
Q 002214          132 STALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLG  211 (952)
Q Consensus       132 ~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  211 (952)
                       +.||+++|++.+                        ..+|..|..+..|+-|+|++|.+. .+|..++.+++|+.|.+.
T Consensus       105 -evldltynnl~e------------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lr  158 (264)
T KOG0617|consen  105 -EVLDLTYNNLNE------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLR  158 (264)
T ss_pred             -hhhhcccccccc------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeec
Confidence             444444444432                        234455555555555555555554 455555555555555555


Q ss_pred             CCcCCccCchhhhccCCCcEeeecccccccc
Q 002214          212 FNNLNGEIPQEIGNLRNLEILGIDQSNLVGF  242 (952)
Q Consensus       212 ~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~  242 (952)
                      .|.+. .+|..++.+++|++|++.+|++...
T Consensus       159 dndll-~lpkeig~lt~lrelhiqgnrl~vl  188 (264)
T KOG0617|consen  159 DNDLL-SLPKEIGDLTRLRELHIQGNRLTVL  188 (264)
T ss_pred             cCchh-hCcHHHHHHHHHHHHhcccceeeec
Confidence            55554 4555555555555555555554443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=7.6e-20  Score=200.16  Aligned_cols=225  Identities=26%  Similarity=0.300  Sum_probs=177.7

Q ss_pred             eecCccceEEEEEEe----CCCcEEEEEEeeccCch--hhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEEEEccC
Q 002214          671 LIGIGSYGSVYKGRF----PDGIEVAIKVFHLQREG--ALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       671 ~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      .+|+|+||.|+.++-    +.|..+|+|+.+.....  .......|..++...+ ||.+|++...+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999997642    45788999988654321  1224556888888886 9999999999999999999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +|.+...+.... .++..........++-+++++   |+.+|+|||+|++||+++.+|.+++.|||+++..-....    
T Consensus        81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~l---h~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHL---HKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----  152 (612)
T ss_pred             cchhhhccccCC-chHHHHHHHHHHHHHHHHhhc---chhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence            999987766544 567777777778888899999   899999999999999999999999999999986543322    


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN  903 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (952)
                       .+||..|||||++.  ....++|.||||++++||+||..||..     .....+           .         ....
T Consensus       153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~I-----------l---------~~~~  204 (612)
T KOG0603|consen  153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRI-----------L---------KAEL  204 (612)
T ss_pred             -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHH-----------h---------hhcc
Confidence             27999999999988  466789999999999999999999865     011111           0         1112


Q ss_pred             HhhhhhHHHHHHHHhhccccCCCCCCCH
Q 002214          904 VAKQSCASSVLSLAMECTSESPENRVNT  931 (952)
Q Consensus       904 ~~~~~~~~~l~~li~~cl~~dP~~RPs~  931 (952)
                      ..|...+..+.+++..+...+|..|.-.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            2345567778889999999999998855

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=1.7e-17  Score=166.78  Aligned_cols=137  Identities=17%  Similarity=0.299  Sum_probs=106.9

Q ss_pred             CCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-----CCCccceeeeEeecCC---eeE-
Q 002214          666 FSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI-----RHRNLVKIISSCTNHN---FKA-  736 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-  736 (952)
                      +...+.||+|+||.||.  +++....+||+.........+.+.+|+++++.+     .||||++++|++.++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34467899999999996  433333479988765555567899999999999     5799999999998763   434 


Q ss_pred             EEEEc--cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeCCCCCCCeeeCC----CCcEEEeccc
Q 002214          737 LVLEY--MPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL-EYLHFGHSNPIVHCDIKPSNVLLDD----SMVAHLSDFG  809 (952)
Q Consensus       737 lv~e~--~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l-~~Lh~~h~~~ivH~Dlk~~Nill~~----~~~~kl~Dfg  809 (952)
                      +|+||  +.+|+|.+++...  .+++.  ..++.+++.++ +||   |+.+|+||||||+||+++.    ++.++|+||+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yL---h~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYL---LDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            78999  5579999999654  35544  35677888777 999   7999999999999999974    3479999955


Q ss_pred             cc
Q 002214          810 IA  811 (952)
Q Consensus       810 la  811 (952)
                      -+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            44

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=6.9e-17  Score=166.13  Aligned_cols=134  Identities=25%  Similarity=0.362  Sum_probs=113.8

Q ss_pred             ceecCccceEEEEEEeCCCcEEEEEEeeccCch--------hhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREG--------ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +.||+|++|.||+|.. .|..|++|+.......        ....+.+|+.++..++|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 7788999986543211        124578899999999999988877777777778999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ++|++|.+++....    + .+..++.+++.+++++   |+.|++|||++|+||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~l---H~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKL---HSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHH---HhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886532    2 7889999999999999   799999999999999999 78999999998864

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.72  E-value=2.9e-19  Score=196.82  Aligned_cols=137  Identities=24%  Similarity=0.262  Sum_probs=80.3

Q ss_pred             cCCCCCCcEEeccccccCCc----CCccccCCCCCceeEecCCccCCC----CchhhhcccccceeecCCcccCCCCccc
Q 002214          418 LGDLNSLRILSLSSNELTSV----IPSTFWNLEDILGFDFSSNSLNGS----LPLEIENLKAVVDIYLSRNNLSGNIPST  489 (952)
Q Consensus       418 ~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  489 (952)
                      +..+++|++|++++|.+++.    .+..+..+++|+.|++++|.+++.    ++..+..+++|++|++++|.+++.....
T Consensus       161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~  240 (319)
T cd00116         161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAA  240 (319)
T ss_pred             HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHH
Confidence            34445555555555555421    112233344566666666655432    2233445666777777777766422222


Q ss_pred             cc-----CCCCCceEEccCccccC----cccccccccccccEEeCCCCccccc----Cccchhcc-ccccccccccccc
Q 002214          490 II-----GLKNLQHLSLEHNKLQG----PIPESFGELVSLEFLDLSNNDLSGV----IPASLEKL-LYLKSLNLSFNKL  554 (952)
Q Consensus       490 ~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l-~~L~~L~l~~N~l  554 (952)
                      +.     ..++|+.|++++|.++.    .+...+..+++|+.+++++|.++..    ....+... +.|++|++.+|+|
T Consensus       241 l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         241 LASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            22     23678888888888762    2334556667888888888888744    34444445 6788888888865

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=5.6e-17  Score=167.69  Aligned_cols=142  Identities=18%  Similarity=0.174  Sum_probs=111.5

Q ss_pred             cCCccceecCccceEEEEEE--eCCCcEEEEEEeeccCch------------------------hhHHHHHHHHHHHhCC
Q 002214          665 QFSEENLIGIGSYGSVYKGR--FPDGIEVAIKVFHLQREG------------------------ALNSFDAECEILKTIR  718 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  718 (952)
                      .|.+.+.||+|+||.||+|.  ..+|+.||+|+++.....                        ....+.+|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            57889999999999999998  468999999998643210                        1123568999999997


Q ss_pred             CCc--cceeeeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeCCCCCCCe
Q 002214          719 HRN--LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP-IVHCDIKPSNV  795 (952)
Q Consensus       719 h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~-ivH~Dlk~~Ni  795 (952)
                      +..  +.+++++    ...++||||++++++....... ...+..+...++.|++.++++|   |+.| |+|||+||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~L---H~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKL---YKEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHH---HhcCCEEeCCCChhhE
Confidence            533  3444443    2358999999998887654322 2456667789999999999999   7899 99999999999


Q ss_pred             eeCCCCcEEEeccccccccC
Q 002214          796 LLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       796 ll~~~~~~kl~Dfgla~~~~  815 (952)
                      +++ ++.++++|||.|....
T Consensus       181 li~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEE-CCCEEEEEChhhhccC
Confidence            999 8899999999997543

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.71  E-value=2.8e-19  Score=197.05  Aligned_cols=88  Identities=24%  Similarity=0.221  Sum_probs=45.2

Q ss_pred             CCCccceEEcccCcccc----cCCccccCCCCCcEEEccCCccc------ccCCccccccCCccEEEeeCCcCCccCchh
Q 002214          153 GLPRLKGLYVSYNQFKG----PIPNNLWHCKELSSVSLSYNQFT------GRLPRDLGNSTKLKSLDLGFNNLNGEIPQE  222 (952)
Q Consensus       153 ~l~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~N~l~------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  222 (952)
                      .+++|+.|++++|.++.    .++..+...++|++|+++++.+.      ..++..+..+++|+.|++++|.+.+..+..
T Consensus        21 ~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~  100 (319)
T cd00116          21 KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGV  100 (319)
T ss_pred             HHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHH
Confidence            34456666666666532    13334445555666666666554      122334445556666666666655444444


Q ss_pred             hhccCC---CcEeeecccccc
Q 002214          223 IGNLRN---LEILGIDQSNLV  240 (952)
Q Consensus       223 ~~~l~~---L~~L~L~~n~~~  240 (952)
                      +..+.+   |+.|++++|++.
T Consensus       101 ~~~l~~~~~L~~L~ls~~~~~  121 (319)
T cd00116         101 LESLLRSSSLQELKLNNNGLG  121 (319)
T ss_pred             HHHHhccCcccEEEeeCCccc
Confidence            444443   555555555444

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.69  E-value=1.3e-16  Score=161.74  Aligned_cols=144  Identities=24%  Similarity=0.257  Sum_probs=112.4

Q ss_pred             HHHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCch----------------------hhHHHHHHHHHHHh
Q 002214          659 LLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREG----------------------ALNSFDAECEILKT  716 (952)
Q Consensus       659 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~  716 (952)
                      +......|.+.+.||+|+||.||+|..++|+.||||+++.....                      ....+..|..++..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33444458888999999999999999888999999987543210                      11235778999999


Q ss_pred             CCCCc--cceeeeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 002214          717 IRHRN--LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSN  794 (952)
Q Consensus       717 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~N  794 (952)
                      +.|++  +...++.    ...++||||+++++|......       .....++.+++.++.++   |+.||+||||+|+|
T Consensus        90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~l---h~~gi~H~Dl~p~N  155 (198)
T cd05144          90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKA---YKHGIIHGDLSEFN  155 (198)
T ss_pred             HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHH---HHCCCCcCCCCccc
Confidence            97774  4444432    345899999999998765431       34567889999999999   68999999999999


Q ss_pred             eeeCCCCcEEEeccccccccCC
Q 002214          795 VLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       795 ill~~~~~~kl~Dfgla~~~~~  816 (952)
                      |++++++.++|+|||.|.....
T Consensus       156 ill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.68  E-value=1.8e-16  Score=161.28  Aligned_cols=131  Identities=24%  Similarity=0.342  Sum_probs=107.6

Q ss_pred             eecCccceEEEEEEeCCCcEEEEEEeeccCc--------hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          671 LIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE--------GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       671 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .||+|+||.||+|.+ +|..|++|+......        ....++.+|+++++.++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999986 678999998643211        11356778999999999887666555556666778999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      +|++|.+.+.....        .++.+++++++++   |+.|++|||++|+||+++ ++.++++|||.+...
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~l---H~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKL---HKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHH---HHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999987754321        7899999999999   899999999999999999 899999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.66  E-value=2.8e-17  Score=176.76  Aligned_cols=242  Identities=22%  Similarity=0.255  Sum_probs=157.7

Q ss_pred             cCCccceecCccceEEEEEEeCCC----cEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceee------eEee---
Q 002214          665 QFSEENLIGIGSYGSVYKGRFPDG----IEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKII------SSCT---  730 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~------~~~~---  730 (952)
                      ...+.+..+..++|.++.++...+    ..++.|.....+-.......+++-.+... +|+..+..-      ....   
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~  324 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNK  324 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccc
Confidence            344555666777777666544322    23344443333312222223333333333 344433221      0111   


Q ss_pred             --cCCeeEEEEEccCCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEe
Q 002214          731 --NHNFKALVLEYMPKGSLEDCMYASN--FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS  806 (952)
Q Consensus       731 --~~~~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~  806 (952)
                        ...+.|+.|++|+..+|.+++...+  ...++.....++.|++.|++|      ++.+|||+||.||++..+..+||+
T Consensus       325 v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIg  398 (516)
T KOG1033|consen  325 VGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIG  398 (516)
T ss_pred             cccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhh
Confidence              1235789999999999999996433  367888999999999999988      789999999999999999999999


Q ss_pred             ccccccccCCcC-----cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhc
Q 002214          807 DFGIAKLLSEED-----SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIN  880 (952)
Q Consensus       807 Dfgla~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~  880 (952)
                      |||+...+....     ....+..+||..||+||.+.+..|+.|+||||+|++++|++. =..++..    ...      
T Consensus       399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t------  468 (516)
T KOG1033|consen  399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IAT------  468 (516)
T ss_pred             hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHh------
Confidence            999998765444     334455689999999999999999999999999999999998 2222211    100      


Q ss_pred             cchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHH
Q 002214          881 DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII  935 (952)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  935 (952)
                           ..++-|..+ .+.      ...+. ++-..++.+++.+.|.+||++.++.
T Consensus       469 -----~~d~r~g~i-p~~------~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  469 -----LTDIRDGII-PPE------FLQDY-PEEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             -----hhhhhcCCC-ChH------HhhcC-cHHHHHHHHhcCCCcccCchHHHHh
Confidence                 111111111 100      00111 2245799999999999999555543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.65  E-value=6.1e-16  Score=181.06  Aligned_cols=138  Identities=24%  Similarity=0.312  Sum_probs=112.5

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeecc--Cc------hhhHHHHHHHHHHHhCCCCccceeeeEeecCCe
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQ--RE------GALNSFDAECEILKTIRHRNLVKIISSCTNHNF  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  734 (952)
                      ...|...+.||+|+||+||+|.+.. ..+++|+....  ..      ...+++.+|++++++++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            4455678999999999999998744 34455543211  11      123568899999999999999988877777777


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .++||||+++++|.+++.         ....++.+++++++||   |+.|++|||+||+||++ .++.++|+|||+|+..
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~l---H~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKL---HKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHH---HhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            899999999999998775         3567899999999999   79999999999999999 6789999999999753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.60  E-value=7.4e-16  Score=177.11  Aligned_cols=211  Identities=27%  Similarity=0.325  Sum_probs=144.0

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..+|..++.|..|+||.||..+++ +.+++|+|+-+ +.     -+.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee------------------
Confidence            357889999999999999999885 46788885422 11     01111  33333344433                  


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc--
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--  819 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~--  819 (952)
                         |+-...+..-+ .++..        ++.+++|+   |+.||+|||+||.|.+|+.-|.+|+.|||+++.......  
T Consensus       136 ---gDc~tllk~~g-~lPvd--------mvla~Eyl---h~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG-PLPVD--------MVLAVEYL---HSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ---chhhhhcccCC-CCcch--------hhHHhHhh---ccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence               22222222211 22221        26789999   899999999999999999999999999999975421110  


Q ss_pred             ------------ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhh
Q 002214          820 ------------MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM  887 (952)
Q Consensus       820 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  887 (952)
                                  ......+||+.|+|||++.-..|+..+|.|++|+++||.+-|+.||....+ ++.+.+++.+.+.-  
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~visd~i~w--  277 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIEW--  277 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhhhhhccc--
Confidence                        111235799999999999988999999999999999999999999866322 22233333222110  


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTK  932 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  932 (952)
                               ..      ..+..++++++++.+.++.+|..|--..
T Consensus       278 ---------pE------~dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  278 ---------PE------EDEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             ---------cc------cCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence                     00      1133467899999999999999997433

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.59  E-value=1e-14  Score=141.51  Aligned_cols=135  Identities=21%  Similarity=0.275  Sum_probs=115.1

Q ss_pred             ccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCC--CccceeeeEeecCCeeEEEEEccCCC
Q 002214          668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRH--RNLVKIISSCTNHNFKALVLEYMPKG  745 (952)
Q Consensus       668 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  745 (952)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+.+++.++|  ..+.+++++...++..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999844 7899999865433  4678899999999976  58899999888888899999999988


Q ss_pred             ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          746 SLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       746 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      .+...        +......++.+++++++++|..+..+++|||++|+||++++.+.++++|||.++.
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77653        5567788899999999999755557899999999999999999999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=7.9e-15  Score=147.65  Aligned_cols=137  Identities=22%  Similarity=0.237  Sum_probs=98.8

Q ss_pred             cceecCccceEEEEEEeCCCcEEEEEEeeccCchh--hHH----------------------HHHHHHHHHhCCCCc--c
Q 002214          669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA--LNS----------------------FDAECEILKTIRHRN--L  722 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--i  722 (952)
                      .+.||+|+||+||+|...+|+.||||+++......  ...                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999986532211  111                      135666666664433  3


Q ss_pred             ceeeeEeecCCeeEEEEEccCCCChhH-HhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCeeeCCC
Q 002214          723 VKIISSCTNHNFKALVLEYMPKGSLED-CMYASNFNLDIFQRLGIMIDVASALEYLHFGHS-NPIVHCDIKPSNVLLDDS  800 (952)
Q Consensus       723 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~-~~ivH~Dlk~~Nill~~~  800 (952)
                      .+.+++    ...++||||++++.+.. .+....  .. ..+..++.+++.++.++   |. .+|+|||+||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~l---h~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKL---YREAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHH---hhccCcCcCCCChhhEEEE-C
Confidence            444433    23589999999854321 111111  11 56788999999999999   66 9999999999999999 9


Q ss_pred             CcEEEeccccccccCC
Q 002214          801 MVAHLSDFGIAKLLSE  816 (952)
Q Consensus       801 ~~~kl~Dfgla~~~~~  816 (952)
                      +.++++|||.|.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            9999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=2.7e-16  Score=182.46  Aligned_cols=254  Identities=25%  Similarity=0.309  Sum_probs=198.2

Q ss_pred             hccCCccceecCccceEEEEEEeC--CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP--DGIEVAIKVFHLQR--EGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  737 (952)
                      ...|...+.||+|+|+.|-.....  ....+|+|.+....  .........|..+-..+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            456778888999999999887653  34566777664432  333455566888877776 9999999999999999999


Q ss_pred             EEEccCCCChhHHh-hhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEeCCCCCCCeeeCCCC-cEEEecccccccc
Q 002214          738 VLEYMPKGSLEDCM-YASNFNLDIFQRLGIMIDVASALEYLHFGH-SNPIVHCDIKPSNVLLDDSM-VAHLSDFGIAKLL  814 (952)
Q Consensus       738 v~e~~~~g~L~~~l-~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h-~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~  814 (952)
                      +++|.+++++.+-+ .......+.......+.|+..++.|+   | ..++.|||+||+|.+++..+ ..+++|||+|..+
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~---H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYL---HPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCcccc---CcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            99999999998887 43333567778888999999999999   8 99999999999999999999 9999999999877


Q ss_pred             CC--cCccccccccc-ccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          815 SE--EDSMKQTQTLA-TIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       815 ~~--~~~~~~~~~~~-~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      ..  +........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+......+..+..|.......     
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  250 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF-----  250 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc-----
Confidence            65  23333344678 999999998877 4557789999999999999999999987666666666665443110     


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII  935 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  935 (952)
                                 ....+........++..+++..+|..|.+..++.
T Consensus       251 -----------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  251 -----------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -----------ccCccccCChhhhhcccccccCCchhcccccccc
Confidence                       0001222345678889999999999999988764

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.54  E-value=4.6e-14  Score=146.31  Aligned_cols=136  Identities=16%  Similarity=0.207  Sum_probs=105.4

Q ss_pred             cceec-CccceEEEEEEeCCCcEEEEEEeeccC-------------chhhHHHHHHHHHHHhCCCCcc--ceeeeEeecC
Q 002214          669 ENLIG-IGSYGSVYKGRFPDGIEVAIKVFHLQR-------------EGALNSFDAECEILKTIRHRNL--VKIISSCTNH  732 (952)
Q Consensus       669 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  732 (952)
                      ...|| .|+.|+||.+.. .+..+|||.+....             ......+.+|+.++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 899999999987 47789999885311             1123567889999999998775  6677664332


Q ss_pred             -C---eeEEEEEccCC-CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEec
Q 002214          733 -N---FKALVLEYMPK-GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSD  807 (952)
Q Consensus       733 -~---~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~D  807 (952)
                       +   ..++||||++| .+|.+++...  .++..    .+.++++++++|   |++||+||||||.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~l---H~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARF---HDAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHH---HHCCCCCCCCCchhEEEcCCCCEEEEE
Confidence             2   23599999997 6898887543  34433    367899999999   899999999999999999999999999


Q ss_pred             ccccccc
Q 002214          808 FGIAKLL  814 (952)
Q Consensus       808 fgla~~~  814 (952)
                      ||.+...
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9988753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.45  E-value=2.4e-13  Score=153.39  Aligned_cols=142  Identities=23%  Similarity=0.288  Sum_probs=100.7

Q ss_pred             cceecCccceEEEEEEeCCCcEEEEEEeeccCchhh----------------------------------------HHHH
Q 002214          669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL----------------------------------------NSFD  708 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  708 (952)
                      .+.||.|++|.||+|+.++|+.||||+.++......                                        -.|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999864321100                                        0244


Q ss_pred             HHHHHHHhCC----CCccceeeeEe-ecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 002214          709 AECEILKTIR----HRNLVKIISSC-TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS-ALEYLHFGHS  782 (952)
Q Consensus       709 ~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~-~l~~Lh~~h~  782 (952)
                      +|++.+.+++    |.+-+.+-.++ ......++||||++|++|.+.........   .+..++..++. .+..+   |.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql---~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV---LR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH---Hh
Confidence            5666555552    32223332222 23445789999999999988765432222   23456666665 35666   78


Q ss_pred             CCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       783 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      .|++|+|++|.||+++.++.++++|||++..+..
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN03150 hypothetical protein; Provisional

Probab=99.43  E-value=2.6e-13  Score=160.40  Aligned_cols=118  Identities=39%  Similarity=0.620  Sum_probs=91.1

Q ss_pred             ccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhccccccccccc
Q 002214          471 AVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLS  550 (952)
Q Consensus       471 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~  550 (952)
                      .++.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..++.+++|+.|+|++|+|++.+|..+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            36777888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             ccccccCCCCC--CCcccccccccccCccCCCCCccCCCCCC
Q 002214          551 FNKLVGEIPRG--GAFANFSAESFIGNDLLCGSPYLHVPLCK  590 (952)
Q Consensus       551 ~N~l~~~~p~~--~~~~~~~~~~~~~n~~~c~~p~~~lp~c~  590 (952)
                      +|+++|.+|..  ..+.......+.+|+.+|+.|.  ++.|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence            88888888863  1122334556789999998774  45674

>PLN03150 hypothetical protein; Provisional

Probab=99.43  E-value=2.9e-13  Score=160.06  Aligned_cols=115  Identities=37%  Similarity=0.689  Sum_probs=103.8

Q ss_pred             ccCCCCCCC----CCceEEEeCCC----CeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCc
Q 002214           13 NWTSNASVC----SWMGITCDVYG----NRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLK   84 (952)
Q Consensus        13 ~~~~~~~~c----~w~~v~c~~~~----~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~   84 (952)
                      +|.+ ..||    .|.||.|....    ..++.|+|+++++.|.+|+.++.+++|+.|+|++|.+++.+|..++.+++|+
T Consensus       391 ~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~  469 (623)
T PLN03150        391 GWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE  469 (623)
T ss_pred             CCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC
Confidence            7864 3342    79999996322    2599999999999999999999999999999999999999999999999999


Q ss_pred             EEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccc
Q 002214           85 ELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNL  128 (952)
Q Consensus        85 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l  128 (952)
                      .|+|++|++.+.+|+.++++++|++|+|++|.+++.+|..+..+
T Consensus       470 ~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~  513 (623)
T PLN03150        470 VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR  513 (623)
T ss_pred             EEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc
Confidence            99999999999999999999999999999999999999887653

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.42  E-value=6.2e-15  Score=158.44  Aligned_cols=194  Identities=30%  Similarity=0.448  Sum_probs=126.6

Q ss_pred             CCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEe
Q 002214          349 LINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILS  428 (952)
Q Consensus       349 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  428 (952)
                      +..-...+|+.|++. .+|..+..+..|+.+.|+.|.|. .+|..++++..|.+|+|+.|+++ ..|..+..|+ |+.|-
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli  149 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI  149 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence            344456677777776 66666777777777777777776 56667777777777777777777 5555555555 67777


Q ss_pred             ccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccC
Q 002214          429 LSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQG  508 (952)
Q Consensus       429 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  508 (952)
                      +++|+++ ..|..++.++.|..||.+.|.+. .+|..+.++.+|+.|.+..|++.. .|..+.. -.|..||+|.|+++ 
T Consensus       150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~El~~-LpLi~lDfScNkis-  224 (722)
T KOG0532|consen  150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEELCS-LPLIRLDFSCNKIS-  224 (722)
T ss_pred             EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHHHhC-CceeeeecccCcee-
Confidence            7777776 34555666667777777777776 566677777777777777777763 4444443 35667777777776 


Q ss_pred             cccccccccccccEEeCCCCcccccCccchhccc---cccccccccc
Q 002214          509 PIPESFGELVSLEFLDLSNNDLSGVIPASLEKLL---YLKSLNLSFN  552 (952)
Q Consensus       509 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~---~L~~L~l~~N  552 (952)
                      .+|-.|.+|..|++|-|.+|.|+ .+|..+....   -.++|+..-+
T Consensus       225 ~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  225 YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence            56667777777777777777776 5555543322   2345555444

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.40  E-value=1.2e-14  Score=156.16  Aligned_cols=194  Identities=31%  Similarity=0.452  Sum_probs=160.7

Q ss_pred             EEEccCCCCCCCCCccc-ccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEecccc
Q 002214          354 TLSLGDNNLSGSLPITL-GRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSN  432 (952)
Q Consensus       354 ~L~L~~n~l~~~~~~~l-~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  432 (952)
                      +|.|++-++...+-++. ..+.--...||+.|++. ..|..++.+..|+.+.|..|.|. .+|.++.++..|+.|+|+.|
T Consensus        54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N  131 (722)
T KOG0532|consen   54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN  131 (722)
T ss_pred             ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence            35555555553332333 34556678899999998 78889999999999999999998 88888999999999999999


Q ss_pred             ccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccc
Q 002214          433 ELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPE  512 (952)
Q Consensus       433 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  512 (952)
                      +++ ..|..++.++ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|+
T Consensus       132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~  206 (722)
T KOG0532|consen  132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPE  206 (722)
T ss_pred             hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCH
Confidence            998 4566666664 888999999998 68888888899999999999998 67888999999999999999998 5677


Q ss_pred             cccccccccEEeCCCCcccccCccchhccccccccccccccccc
Q 002214          513 SFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVG  556 (952)
Q Consensus       513 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  556 (952)
                      .+..| .|..||+|.|+++ .+|..|.+|..|++|-|++|||..
T Consensus       207 El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  207 ELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             HHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence            77754 6899999999998 789999999999999999999974

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=1e-12  Score=145.09  Aligned_cols=247  Identities=22%  Similarity=0.211  Sum_probs=182.7

Q ss_pred             cCCccceecC--ccceEEEEEEe---CCCcEEEEEEeeccCc--hhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeE
Q 002214          665 QFSEENLIGI--GSYGSVYKGRF---PDGIEVAIKVFHLQRE--GALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       665 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  736 (952)
                      .|.+...+|.  |.+|.||.+..   .++..+|+|.-+....  ....+-.+|+.....+ .|++.++.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4566788999  99999999976   4688999998543322  2223345677777777 4999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeCCCCCCCeeeCCC-CcEEEeccccc
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS----ALEYLHFGHSNPIVHCDIKPSNVLLDDS-MVAHLSDFGIA  811 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~----~l~~Lh~~h~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgla  811 (952)
                      +-+|++ +.++.++.+.....++....+.+..+..+    |+.++   |..+++|-|+||.||++.++ ..++++|||+.
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~---hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHL---HSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhccccccccc---CCCcccccccchhheecccccceeecCCccee
Confidence            999999 46888877665555777888888888888    99999   89999999999999999999 89999999999


Q ss_pred             cccCCcCccccc----ccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhh
Q 002214          812 KLLSEEDSMKQT----QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM  887 (952)
Q Consensus       812 ~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  887 (952)
                      ..+.........    ...+...|++||...+ -++.++|+|++|.++.+..+|..+...-     ....|.....    
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g-----~~~~W~~~r~----  340 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVG-----KNSSWSQLRQ----  340 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCC-----CCCCcccccc----
Confidence            988765422211    1257788999998764 6788999999999999999987663221     0111111100    


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                       ..++     .+.     -..-+.++...+..+++.+|..|++++++..
T Consensus       341 -~~ip-----~e~-----~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  341 -GYIP-----LEF-----CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -ccCc-----hhh-----hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             0000     000     0112445666999999999999999988764

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.31  E-value=1.5e-12  Score=147.63  Aligned_cols=198  Identities=40%  Similarity=0.545  Sum_probs=140.2

Q ss_pred             EEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCC-cceEEEeccccccccCCCccCCCCCCcEEecccc
Q 002214          354 TLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFS-RLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSN  432 (952)
Q Consensus       354 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  432 (952)
                      .+.+..|.+. .....+..++.++.|++.+|.+. .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            5666666664 22334455567777777777776 3444455553 7777777777777 55556677788888888888


Q ss_pred             ccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccc
Q 002214          433 ELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPE  512 (952)
Q Consensus       433 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  512 (952)
                      +++.+ +.....++.|+.|++++|+++ .+|........|++|.+++|++. ..+..+..+.++..|.+++|++. ..+.
T Consensus       174 ~l~~l-~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~  249 (394)
T COG4886         174 DLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE  249 (394)
T ss_pred             hhhhh-hhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence            88744 333336777888888888887 46665556666888888888644 45667778888888888888887 3466


Q ss_pred             cccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          513 SFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       513 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      .++.+++|+.|++++|+++...+  +..+.+|+.|++++|.+....|.
T Consensus       250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             hhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence            77888888888888888875443  77888888888888888776665

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.30  E-value=3.5e-11  Score=133.86  Aligned_cols=168  Identities=19%  Similarity=0.235  Sum_probs=130.3

Q ss_pred             eCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHH
Q 002214          685 FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL  764 (952)
Q Consensus       685 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~  764 (952)
                      ..++.+|.|..++...........+-++-++.++||+|+++++.+..++..|+|+|.+.  .|..++..    +......
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v~  107 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEVC  107 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHHH
Confidence            34688999998876655445567788889999999999999999999999999999985  46666654    3356677


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccccccccccccccccCcCCcCc
Q 002214          765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI  844 (952)
Q Consensus       765 ~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  844 (952)
                      ..++||+.||.+||  ++.+++|++|.-..|++++.|..||++|.++.....-.. ......--..|..|+.+....  -
T Consensus       108 ~Gl~qIl~AL~FL~--~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  108 LGLFQILAALSFLN--DDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHHh--ccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--c
Confidence            78899999999997  789999999999999999999999999999875533221 111122233466776544322  3


Q ss_pred             ccchHhHHHHHHHHHhCCC
Q 002214          845 KGDVYNYGIMLMEVFTGMK  863 (952)
Q Consensus       845 ~~Dv~slG~~l~el~tg~~  863 (952)
                      ..|.|.||++++|++.|..
T Consensus       183 s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             chhhhhHHHHHHHHhCccc
Confidence            4599999999999999943

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.29  E-value=7.5e-12  Score=142.44  Aligned_cols=147  Identities=18%  Similarity=0.205  Sum_probs=95.7

Q ss_pred             hccCCccceecCccceEEEEEEeCC-CcEEEEEEeeccCch----------------------------------hhHH-
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREG----------------------------------ALNS-  706 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~-  706 (952)
                      ...|.. +.||.|++|.||+|+.++ |+.||||+.++....                                  ..+. 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 789999999999999977 999999998744210                                  0111 


Q ss_pred             -----HHHHHHHHHhCC----CCccceeeeEeec-CCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHH-HH
Q 002214          707 -----FDAECEILKTIR----HRNLVKIISSCTN-HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-LE  775 (952)
Q Consensus       707 -----~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~-l~  775 (952)
                           +.+|+.-+.+++    +...+.+-.++.+ ....++||||++|+++.+.-.......+...   ++...++. +.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~  274 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFT  274 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHH
Confidence                 344444444442    3333333333322 3457899999999999874321121223222   22222221 22


Q ss_pred             HHHhcCCCCeEeCCCCCCCeeeCCCC----cEEEeccccccccCC
Q 002214          776 YLHFGHSNPIVHCDIKPSNVLLDDSM----VAHLSDFGIAKLLSE  816 (952)
Q Consensus       776 ~Lh~~h~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgla~~~~~  816 (952)
                      .+   ...|++|+|++|.||+++.++    .++++|||++..+..
T Consensus       275 Qi---f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QV---FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH---HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            23   578999999999999999888    999999999987754

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.29  E-value=4.5e-11  Score=117.88  Aligned_cols=138  Identities=17%  Similarity=0.177  Sum_probs=100.8

Q ss_pred             cceecCccceEEEEEEeCC-------CcEEEEEEeeccC------------c----------hhhHHH----HHHHHHHH
Q 002214          669 ENLIGIGSYGSVYKGRFPD-------GIEVAIKVFHLQR------------E----------GALNSF----DAECEILK  715 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~  715 (952)
                      ...||.|.-+.||.|...+       +..+|||+++...            +          ...+.+    .+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998643       5799999875221            0          011223    38999999


Q ss_pred             hCCC--CccceeeeEeecCCeeEEEEEccCCCChhH-HhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 002214          716 TIRH--RNLVKIISSCTNHNFKALVLEYMPKGSLED-CMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKP  792 (952)
Q Consensus       716 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~  792 (952)
                      ++..  -++..++++    ...++||||+.++.+.. .+..  ..++..+...+..+++.++.+++  |+.|+||||+++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~--H~~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLY--KECNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHH--HhCCeecCCCCH
Confidence            9853  456666654    34689999997654422 1221  13455566778899999999996  789999999999


Q ss_pred             CCeeeCCCCcEEEeccccccccC
Q 002214          793 SNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       793 ~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      .||+++ ++.++++|||.|....
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCC
Confidence            999997 4689999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.29  E-value=3.1e-12  Score=145.07  Aligned_cols=200  Identities=34%  Similarity=0.493  Sum_probs=105.4

Q ss_pred             eeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCC-CCCeEeecCccCccccCcccccccccccceeecc
Q 002214           61 TLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLA-ELEMLVLNNNLLTGTIPASIFNLSFISTALDFSD  139 (952)
Q Consensus        61 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~  139 (952)
                      .|+++.|.+. .....+..++.++.|++.+|.+. .+|...+.+. +|+.|++++|.+. .+|..+.             
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~-------------  160 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLR-------------  160 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhh-------------
Confidence            3555555543 12223444455555555555555 4555455443 5555555555555 3322111             


Q ss_pred             ccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccC
Q 002214          140 NSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEI  219 (952)
Q Consensus       140 n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  219 (952)
                                   .+++|+.|++++|++. .+|.....+..|+.|++++|+++ .+|...+....|++|.+++|.+. ..
T Consensus       161 -------------~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~  224 (394)
T COG4886         161 -------------NLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-EL  224 (394)
T ss_pred             -------------ccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ec
Confidence                         2344555555555554 33433334555555555555555 34444444445666666666433 34


Q ss_pred             chhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCccc
Q 002214          220 PQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFF  297 (952)
Q Consensus       220 p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~  297 (952)
                      +..+..+.++..|.+.+|++... +..+..++++++|++++|.++....    +..+.+++.|++++|.+....+...
T Consensus       225 ~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~~i~~----~~~~~~l~~L~~s~n~~~~~~~~~~  297 (394)
T COG4886         225 LSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQISSISS----LGSLTNLRELDLSGNSLSNALPLIA  297 (394)
T ss_pred             chhhhhcccccccccCCceeeec-cchhccccccceecccccccccccc----ccccCccCEEeccCccccccchhhh
Confidence            45566666666666555554443 4555666667777777777663311    5566677777777777766555443

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.27  E-value=9.2e-13  Score=130.78  Aligned_cols=203  Identities=23%  Similarity=0.204  Sum_probs=136.5

Q ss_pred             CCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccc-cccccCCCccCCCCCCcE
Q 002214          348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRN-KLSGSIPSCLGDLNSLRI  426 (952)
Q Consensus       348 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~  426 (952)
                      -+.+|..+.++.+.-..+ .+....-|.|+++...+..++. .|. +-....+....-+.- -.+|..-........|++
T Consensus       212 ~f~~l~~~~~s~~~~~~i-~~~~~~kptl~t~~v~~s~~~~-~~~-l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~Lte  288 (490)
T KOG1259|consen  212 AFRNLKTLKFSALSTENI-VDIELLKPTLQTICVHNTTIQD-VPS-LLPETILADPSGSEPSTSNGSALVSADTWQELTE  288 (490)
T ss_pred             Hhhhhheeeeeccchhhe-eceeecCchhheeeeecccccc-ccc-ccchhhhcCccCCCCCccCCceEEecchHhhhhh
Confidence            345566666665554322 1222223677777776665542 121 111111111111110 011111222233457899


Q ss_pred             EeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccc
Q 002214          427 LSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKL  506 (952)
Q Consensus       427 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  506 (952)
                      +|||+|.|+. +..+..-+|.++.|++|+|+|..  -+.++.+++|+.||||+|.++ .+.+.-..+.+.+.|.|++|.|
T Consensus       289 lDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~--v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~i  364 (490)
T KOG1259|consen  289 LDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRT--VQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKI  364 (490)
T ss_pred             ccccccchhh-hhhhhhhccceeEEeccccceee--ehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhH
Confidence            9999999984 45566778899999999999983  334889999999999999998 4556667789999999999999


Q ss_pred             cCcccccccccccccEEeCCCCcccccC-ccchhcccccccccccccccccCCC
Q 002214          507 QGPIPESFGELVSLEFLDLSNNDLSGVI-PASLEKLLYLKSLNLSFNKLVGEIP  559 (952)
Q Consensus       507 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p  559 (952)
                      ...  ..++.+-+|..||+++|+|.... -..++++|-|+.+.|.+||+.+.+-
T Consensus       365 E~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  365 ETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             hhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            732  46888899999999999998543 3568899999999999999987553

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.26  E-value=2.1e-11  Score=120.57  Aligned_cols=128  Identities=22%  Similarity=0.227  Sum_probs=96.0

Q ss_pred             cceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccc-eeeeEeecCCeeEEEEEccCCCCh
Q 002214          669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLV-KIISSCTNHNFKALVLEYMPKGSL  747 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L  747 (952)
                      .+.++.|.++.||+++.. ++.|++|+...... ....+.+|+.+++.+.+.+++ +++++..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            457899999999999874 78899998754432 123467899999998655544 4444433  335799999999887


Q ss_pred             hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          748 EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP-----IVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       748 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~-----ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      .+.    .     .....++.+++++++.|   |+.+     ++|||++|.||+++ ++.++++|||.|..
T Consensus        79 ~~~----~-----~~~~~~~~~l~~~l~~L---H~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE----D-----FSDPENLEKIAKLLKKL---HSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc----c-----ccCHHHHHHHHHHHHHH---hCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            643    0     11234578899999999   5555     59999999999999 67899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.24  E-value=2e-13  Score=139.21  Aligned_cols=246  Identities=23%  Similarity=0.271  Sum_probs=174.6

Q ss_pred             CCeEEEEEecCCCCc----ccCCccccCCcccCeeeccc---cccccccCCC-------cCCcCCCcEEeCcCCcccccC
Q 002214           32 GNRVTSLTISDLGLA----GTIPSHLGNLSSLQTLVLSR---NWFSGTIPKE-------IGNLTKLKELHLDYNKLQGEI   97 (952)
Q Consensus        32 ~~~~~~l~l~~~~~~----~~~p~~l~~l~~L~~L~L~~---n~l~~~~p~~-------l~~l~~L~~L~L~~n~l~~~~   97 (952)
                      ...++.+++|+|.+.    ..+...|.+.++|+..++|+   -+...++|+.       +-..++|++||||+|.+.-.-
T Consensus        29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g  108 (382)
T KOG1909|consen   29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG  108 (382)
T ss_pred             cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence            357899999999984    34677888999999999987   2444456654       345679999999999998544


Q ss_pred             Ch----hhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccc----
Q 002214           98 PE----ELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG----  169 (952)
Q Consensus        98 p~----~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~----  169 (952)
                      +.    -+..++.|++|+|.+|.+.   |..-..+..-+  .++..|+..        ..-+.|+++..++|++..    
T Consensus       109 ~~~l~~ll~s~~~L~eL~L~N~Glg---~~ag~~l~~al--~~l~~~kk~--------~~~~~Lrv~i~~rNrlen~ga~  175 (382)
T KOG1909|consen  109 IRGLEELLSSCTDLEELYLNNCGLG---PEAGGRLGRAL--FELAVNKKA--------ASKPKLRVFICGRNRLENGGAT  175 (382)
T ss_pred             hHHHHHHHHhccCHHHHhhhcCCCC---hhHHHHHHHHH--HHHHHHhcc--------CCCcceEEEEeeccccccccHH
Confidence            43    3467899999999999887   32222222211  122233322        234689999999999874    


Q ss_pred             cCCccccCCCCCcEEEccCCcccc----cCCccccccCCccEEEeeCCcCCc----cCchhhhccCCCcEeeeccccccc
Q 002214          170 PIPNNLWHCKELSSVSLSYNQFTG----RLPRDLGNSTKLKSLDLGFNNLNG----EIPQEIGNLRNLEILGIDQSNLVG  241 (952)
Q Consensus       170 ~~~~~l~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~n~~~~  241 (952)
                      .+...|...+.|+.+.++.|.|..    .+..+|..+++|+.|||++|-++.    .+...++.+++|+.|++++|.+..
T Consensus       176 ~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~  255 (382)
T KOG1909|consen  176 ALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLEN  255 (382)
T ss_pred             HHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccccc
Confidence            234556677899999999998862    234567888999999999999874    345567888899999999999887


Q ss_pred             cCCcccc-----CCCCccEEEeeCccccccC--CCCcccCCCCCcceEEcccCcCC
Q 002214          242 FVPDTIF-----NISTLKILSLFNNTLSGNL--PSSKNLIGLPNLEGLNLGLNNLS  290 (952)
Q Consensus       242 ~~~~~~~-----~l~~L~~L~Ls~N~l~~~~--~~~~~l~~l~~L~~L~L~~N~l~  290 (952)
                      .....|.     ..++|+.|.|.+|.|+..-  .........|.|+.|+|++|.+.
T Consensus       256 ~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  256 EGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             ccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            6554443     3678888999888886321  01112344677888888888874

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=1.6e-11  Score=123.96  Aligned_cols=201  Identities=19%  Similarity=0.300  Sum_probs=138.4

Q ss_pred             HHhCCCCccceeeeEeecCC-----eeEEEEEccCCCChhHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 002214          714 LKTIRHRNLVKIISSCTNHN-----FKALVLEYMPKGSLEDCMYASN---FNLDIFQRLGIMIDVASALEYLHFGHSNPI  785 (952)
Q Consensus       714 l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~i  785 (952)
                      +-++-|.|+|+++.|+.+..     ...+++|||+-|++.+++++.+   ..+......++..||..||.|||. .+..|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence            44556999999999987643     4678999999999999997633   357777888999999999999974 57889


Q ss_pred             EeCCCCCCCeeeCCCCcEEEeccccccccC---CcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCC
Q 002214          786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLS---EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGM  862 (952)
Q Consensus       786 vH~Dlk~~Nill~~~~~~kl~Dfgla~~~~---~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~  862 (952)
                      +|+++..+-|++..+|-+|++--.-.....   ...........+-++|.|||+-.....+.++|||+||+...||.-|.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            999999999999999988885211111000   00001111234678999999988878888999999999999998875


Q ss_pred             CCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          863 KPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       863 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      .--...   +..+.  .+   ....+.+ ..+.              ...-+.++.+|++..|..||+|.+.+.|.
T Consensus       280 iq~tns---eS~~~--~e---e~ia~~i-~~le--------------n~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  280 IQSTNS---ESKVE--VE---ENIANVI-IGLE--------------NGLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             eccCCC---cceee--hh---hhhhhhe-eecc--------------CccccCcCcccccCCCCCCcchhhhhcCc
Confidence            542111   00000  00   0000000 0000              01125678899999999999999987654

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.20  E-value=5.7e-13  Score=135.96  Aligned_cols=140  Identities=24%  Similarity=0.317  Sum_probs=70.1

Q ss_pred             CCCccceEEcccCcccccCCcc----ccCCCCCcEEEccCCcccccC-------------CccccccCCccEEEeeCCcC
Q 002214          153 GLPRLKGLYVSYNQFKGPIPNN----LWHCKELSSVSLSYNQFTGRL-------------PRDLGNSTKLKSLDLGFNNL  215 (952)
Q Consensus       153 ~l~~L~~L~L~~n~l~~~~~~~----l~~l~~L~~L~L~~N~l~~~~-------------~~~~~~l~~L~~L~L~~N~l  215 (952)
                      +.|+|+.|+||+|-+.-..+..    +.++..|++|.|.+|.+.-.-             ..-.+.-+.|+++..++|++
T Consensus        90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrl  169 (382)
T KOG1909|consen   90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRL  169 (382)
T ss_pred             cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccc
Confidence            3445555555555554322222    223455555555555543110             11122335677777777777


Q ss_pred             Ccc----CchhhhccCCCcEeeecccccccc----CCccccCCCCccEEEeeCcccccc--CCCCcccCCCCCcceEEcc
Q 002214          216 NGE----IPQEIGNLRNLEILGIDQSNLVGF----VPDTIFNISTLKILSLFNNTLSGN--LPSSKNLIGLPNLEGLNLG  285 (952)
Q Consensus       216 ~~~----~p~~~~~l~~L~~L~L~~n~~~~~----~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~l~~l~~L~~L~L~  285 (952)
                      ...    +...|...+.|+.+.+..|.|...    +...+..+++|+.|||.+|.++..  ..-...+..+++|++|+++
T Consensus       170 en~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~  249 (382)
T KOG1909|consen  170 ENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLG  249 (382)
T ss_pred             ccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccc
Confidence            532    233455666677776666665432    233445566666666666655421  0011224445556666666


Q ss_pred             cCcCCCC
Q 002214          286 LNNLSGS  292 (952)
Q Consensus       286 ~N~l~~~  292 (952)
                      +|.+...
T Consensus       250 dcll~~~  256 (382)
T KOG1909|consen  250 DCLLENE  256 (382)
T ss_pred             ccccccc
Confidence            6655543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.20  E-value=1.5e-10  Score=109.24  Aligned_cols=132  Identities=24%  Similarity=0.340  Sum_probs=101.8

Q ss_pred             ceecCccceEEEEEEeCCCcEEEEEEeeccC--c------hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--E------GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..+++|+-+.||.+.+ -|.++++|.-.++.  .      -...+-.+|++++.+++--.|...+-+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            3578999999999977 34456666432221  1      1234567899999999776776666666777778899999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      ++|..|.+.+...        +..++..+-.-+.-|   |..||+|||+.++||++..+. +.++|||++.+.
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~l---H~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKL---HKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHH---HhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999999888754        245667777777788   899999999999999998776 999999999853

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.19  E-value=2.7e-12  Score=134.52  Aligned_cols=226  Identities=24%  Similarity=0.266  Sum_probs=102.7

Q ss_pred             eeeccccccccccCCCc----CCcCCCcEEeCcCCcccccCC--hhhcCCCCCCeEeecCccCccccC--cccccccccc
Q 002214           61 TLVLSRNWFSGTIPKEI----GNLTKLKELHLDYNKLQGEIP--EELGNLAELEMLVLNNNLLTGTIP--ASIFNLSFIS  132 (952)
Q Consensus        61 ~L~L~~n~l~~~~p~~l----~~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~L~~n~l~~~~p--~~~~~l~~l~  132 (952)
                      .+.+++-++.+.--+.+    .++++|++..|.++.+. ..+  +....|++++.||||+|-+....|  .-...+.. +
T Consensus        97 ~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~-L  174 (505)
T KOG3207|consen   97 VLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPS-L  174 (505)
T ss_pred             HhhhcCceeEEecHHHHHHHhhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhccc-c
Confidence            44455545543322222    46788888888888877 333  366778888888888887763211  11112222 1


Q ss_pred             cceeeccccccccCCCCCCCCCCccceEEcccCcccc-cCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEee
Q 002214          133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG-PIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLG  211 (952)
Q Consensus       133 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  211 (952)
                      +.|+++.|++........-..++.|+.|.|+.|.++- .+...+..+++|+.|+|++|..-..-.....-+..|++|||+
T Consensus       175 e~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs  254 (505)
T KOG3207|consen  175 ENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLS  254 (505)
T ss_pred             hhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhcccc
Confidence            4444444444322222222234445555555555441 111122234455555555552111222223334445555555


Q ss_pred             CCcCCccCc--hhhhccCCCcEeeecccccccc-CCcc-----ccCCCCccEEEeeCccccccCCCCcccCCCCCcceEE
Q 002214          212 FNNLNGEIP--QEIGNLRNLEILGIDQSNLVGF-VPDT-----IFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLN  283 (952)
Q Consensus       212 ~N~l~~~~p--~~~~~l~~L~~L~L~~n~~~~~-~~~~-----~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~  283 (952)
                      +|++.. .+  ...+.++.|+.|+++.|.+..+ .|+.     ....++|++|+++.|+|. ..++...+..+++|+.|.
T Consensus       255 ~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~  332 (505)
T KOG3207|consen  255 NNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLR  332 (505)
T ss_pred             CCcccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhh
Confidence            554431 11  2344445555555554444433 1221     123444444444444443 222333333344444444


Q ss_pred             cccCcCC
Q 002214          284 LGLNNLS  290 (952)
Q Consensus       284 L~~N~l~  290 (952)
                      +..|.++
T Consensus       333 ~~~n~ln  339 (505)
T KOG3207|consen  333 ITLNYLN  339 (505)
T ss_pred             ccccccc
Confidence            4444443

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.16  E-value=2.3e-11  Score=117.43  Aligned_cols=124  Identities=27%  Similarity=0.284  Sum_probs=36.0

Q ss_pred             CCCCcEEeccccccCCcCCcccc-CCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceE
Q 002214          421 LNSLRILSLSSNELTSVIPSTFW-NLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHL  499 (952)
Q Consensus       421 l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  499 (952)
                      ..++++|+|++|+|+.+.  .+. .+.+|+.|+|++|.|+..  +.+..++.|+.|++++|+|+.+.+.....+++|++|
T Consensus        18 ~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L   93 (175)
T PF14580_consen   18 PVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQEL   93 (175)
T ss_dssp             --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EE
T ss_pred             cccccccccccccccccc--chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEE
Confidence            334556666666665331  222 345555555555555532  234555666666666666664322212346666666


Q ss_pred             EccCccccCcc-cccccccccccEEeCCCCcccccC---ccchhccccccccc
Q 002214          500 SLEHNKLQGPI-PESFGELVSLEFLDLSNNDLSGVI---PASLEKLLYLKSLN  548 (952)
Q Consensus       500 ~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~  548 (952)
                      +|++|+|.... -..+..+++|+.|+|.+|+++...   ...+..+|+|+.||
T Consensus        94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred             ECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence            66666665321 134556677777777777766321   12345567776665

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.15  E-value=3.4e-12  Score=133.78  Aligned_cols=210  Identities=20%  Similarity=0.211  Sum_probs=161.3

Q ss_pred             cCCcccCeeeccccccccccC--CCcCCcCCCcEEeCcCCcccc--cCChhhcCCCCCCeEeecCccCccccCccccccc
Q 002214           54 GNLSSLQTLVLSRNWFSGTIP--KEIGNLTKLKELHLDYNKLQG--EIPEELGNLAELEMLVLNNNLLTGTIPASIFNLS  129 (952)
Q Consensus        54 ~~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~  129 (952)
                      +++.+|+...|.++.+. ..+  .....+++++.||||+|-+..  .+-.-..+|++|+.|+|+.|++.........-..
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            67788999999998887 344  356789999999999998863  2334557899999999999998844443333344


Q ss_pred             ccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCC--ccccccCCccE
Q 002214          130 FISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLP--RDLGNSTKLKS  207 (952)
Q Consensus       130 ~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~  207 (952)
                      ..++.|.+++|.+++.-...+...+|+|+.|+|+.|...........-++.|+.|+|++|.+-. .+  ...+.++.|+.
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~  275 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQ  275 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhh
Confidence            4568899999999866566667789999999999996443445556668999999999999873 33  45688999999


Q ss_pred             EEeeCCcCCcc-Cchh-----hhccCCCcEeeeccccccccC-CccccCCCCccEEEeeCccccc
Q 002214          208 LDLGFNNLNGE-IPQE-----IGNLRNLEILGIDQSNLVGFV-PDTIFNISTLKILSLFNNTLSG  265 (952)
Q Consensus       208 L~L~~N~l~~~-~p~~-----~~~l~~L~~L~L~~n~~~~~~-~~~~~~l~~L~~L~Ls~N~l~~  265 (952)
                      |+++.|.+.++ .|+.     ...+++|+.|+++.|++..+. -..+..+++|+.|.+..|.+..
T Consensus       276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            99999998753 2333     466899999999999997652 3445667888999988888863

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.15  E-value=8.6e-12  Score=124.00  Aligned_cols=134  Identities=27%  Similarity=0.284  Sum_probs=110.0

Q ss_pred             CCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEe
Q 002214          153 GLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEIL  232 (952)
Q Consensus       153 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  232 (952)
                      ....|+++|||+|.|+ .+.++..-+++++.|++|+|.|+.+  ..++.+.+|+.||||+|.++ .+.+.=..+-+.+.|
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL  357 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence            3467999999999998 6778888889999999999999843  34888999999999999998 566666778889999


Q ss_pred             eeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCC
Q 002214          233 GIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSI  293 (952)
Q Consensus       233 ~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~  293 (952)
                      .|++|.+...  ..+..+=+|..||+++|+|. .+.....++.+|.|+++.|.+|.+.++.
T Consensus       358 ~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  358 KLAQNKIETL--SGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             ehhhhhHhhh--hhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCccccc
Confidence            9999887765  45677888999999999997 3444556888999999999999998543

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.14  E-value=4.9e-11  Score=115.24  Aligned_cols=122  Identities=30%  Similarity=0.385  Sum_probs=43.8

Q ss_pred             cceEEEeccccccccCCCccC-CCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhh-hcccccceee
Q 002214          399 RLYVVYLNRNKLSGSIPSCLG-DLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVVDIY  476 (952)
Q Consensus       399 ~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~  476 (952)
                      ++++|+|++|+|+. +. .++ .+.+|+.|+|++|.|+.+.  .+..++.|+.|++++|+|+. ++..+ ..+++|+.|+
T Consensus        20 ~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~   94 (175)
T PF14580_consen   20 KLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY   94 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred             cccccccccccccc-cc-chhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence            44555555555542 22 233 3566666666666666542  35566777777777777764 33333 4577788888


Q ss_pred             cCCcccCCCC-cccccCCCCCceEEccCccccCcc---cccccccccccEEeC
Q 002214          477 LSRNNLSGNI-PSTIIGLKNLQHLSLEHNKLQGPI---PESFGELVSLEFLDL  525 (952)
Q Consensus       477 Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~L  525 (952)
                      |++|+|.... -..+..+++|+.|+|.+|.+....   ...+..+|+|+.||-
T Consensus        95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            8888776432 245667888888888888887431   123567888888874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.12  E-value=5.2e-11  Score=131.67  Aligned_cols=254  Identities=21%  Similarity=0.159  Sum_probs=178.3

Q ss_pred             HHHHhccCCccceecCccceEEEEEEe--CCCcEEEEEEeeccCchhhHH--HHHHHHHHHhC-CCCccceeeeEeecCC
Q 002214          659 LLRATDQFSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQREGALNS--FDAECEILKTI-RHRNLVKIISSCTNHN  733 (952)
Q Consensus       659 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~  733 (952)
                      -.....+|..+..||.|.|+.|+....  .++..|++|...........+  -..|+.+...+ .|.++++.+..+....
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            344567899999999999999998764  467889999775433222222  23456665555 5888888887777777


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC-CcEEEecccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS-MVAHLSDFGIAK  812 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgla~  812 (952)
                      ..|+--||++++++.... .....+++..++++..|++.++.++   |++.++|+|+||+||++..+ +..+++|||.+.
T Consensus       340 ~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i---~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVI---HSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccc---cchhhhcccccccceeeccchhhhhcccccccc
Confidence            778999999999887655 2333678888999999999999998   89999999999999999886 889999999997


Q ss_pred             ccCCcCccccccccccccc-ccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          813 LLSEEDSMKQTQTLATIGY-IAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      .+.-..   ....-.+..| .+|+......+..+.|+||||.-+.|.++|..--.. ..   .+.....+..+.      
T Consensus       416 ~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~~---~~~~i~~~~~p~------  482 (524)
T KOG0601|consen  416 RLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-GV---QSLTIRSGDTPN------  482 (524)
T ss_pred             ccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcc-cc---cceeeecccccC------
Confidence            432111   1111123334 355566666788899999999999999998543111 01   111110111110      


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                                    .......+..+.+.+..+++..||.+.+...+.+-+++
T Consensus       483 --------------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  483 --------------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             --------------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                          01112567888899999999999999998877665544

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.10  E-value=9.4e-10  Score=103.02  Aligned_cols=142  Identities=20%  Similarity=0.262  Sum_probs=104.8

Q ss_pred             ccceecCccceEEEEEEeCCCcEEEEEEeeccC--------chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--------EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       668 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ....+-+|+-+.|+++.+ .|+...||.-..+.        .-..++..+|++.+.+.+--.|....-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            467889999999999998 67777777432221        112456788999999986555555444555555667999


Q ss_pred             EccCC-CChhHHhhhcCCCCCHHHH-HHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC---cEEEeccccccc
Q 002214          740 EYMPK-GSLEDCMYASNFNLDIFQR-LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM---VAHLSDFGIAKL  813 (952)
Q Consensus       740 e~~~~-g~L~~~l~~~~~~l~~~~~-~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgla~~  813 (952)
                      ||++| .++.+++...-..-..... ...+..|-+.+.-|   |..+|+||||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igkl---H~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKL---HDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHh---hhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99976 3777777654433333333 67888899999999   899999999999999997554   458999999864

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.10  E-value=2.3e-09  Score=112.37  Aligned_cols=267  Identities=13%  Similarity=0.119  Sum_probs=165.5

Q ss_pred             CccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeE------e-ecCCeeEEE
Q 002214          667 SEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISS------C-TNHNFKALV  738 (952)
Q Consensus       667 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~-~~~~~~~lv  738 (952)
                      ...+.||+|+-+.+|-.-  .-...+.|+++........+.   +..|... .||-+-.-+.+      . .......+.
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            456789999999999532  223345677765544322222   2223333 45543321111      1 112336678


Q ss_pred             EEccCCC-ChhHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          739 LEYMPKG-SLEDCMYA-----SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       739 ~e~~~~g-~L~~~l~~-----~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                      |..+++- ....+...     .-...+|...+++++.+|.+.+.|   |..|.+-||+.++|+|+++++.+.+.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~l---H~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATL---HEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHH---HhcCCcccccCccceeeecCceEEEEccccee
Confidence            8887654 22222211     111478999999999999999999   78999999999999999999999999865443


Q ss_pred             ccCCcCcccccccccccccccccccC-----cCCcCcccchHhHHHHHHHHHhC-CCCCCccccC---ccchh-hhhccc
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGR-----EGQVSIKGDVYNYGIMLMEVFTG-MKPTNEFFTG---EMSIK-RWINDS  882 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~---~~~~~-~~~~~~  882 (952)
                      .-..  .......+|...|.+||...     +-.-+...|-|.+||++++++.| ++||......   ...+. .+....
T Consensus       166 i~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         166 INAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            3222  22233467899999999644     22345668999999999999986 9999765321   11111 111111


Q ss_pred             hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccC--CCCCCCHHHHHHHHHHHHHHHhh
Q 002214          883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSES--PENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                      +...   -|... ...+-.......-.++++..+..+|+...  +.-||+++..+..|..+++++..
T Consensus       244 f~ya---~~~~~-g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         244 FAYA---SDQRR-GLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             eeec---hhccC-CCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            1000   00000 00000011122335678899999998643  56899999999999999998864

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.08  E-value=1.4e-11  Score=139.76  Aligned_cols=85  Identities=28%  Similarity=0.325  Sum_probs=51.3

Q ss_pred             cceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCccccc---Cccc-hhcccccccc
Q 002214          472 VVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGV---IPAS-LEKLLYLKSL  547 (952)
Q Consensus       472 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~-~~~l~~L~~L  547 (952)
                      |+.+++++|++. ..+..+..+.++..|++++|++...  ..+...+.+..+.+..|.+...   .... ....+.+..+
T Consensus       234 L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (414)
T KOG0531|consen  234 LRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTL  310 (414)
T ss_pred             HHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcccccccccccccc
Confidence            566666666666 2334556666777777777777632  3355556667777777766522   1111 4456677777


Q ss_pred             cccccccccCCC
Q 002214          548 NLSFNKLVGEIP  559 (952)
Q Consensus       548 ~l~~N~l~~~~p  559 (952)
                      .+.+|+.....+
T Consensus       311 ~~~~~~~~~~~~  322 (414)
T KOG0531|consen  311 TLELNPIRKISS  322 (414)
T ss_pred             ccccCccccccc
Confidence            777777766554

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.07  E-value=1.2e-09  Score=113.40  Aligned_cols=142  Identities=19%  Similarity=0.220  Sum_probs=110.2

Q ss_pred             ceecCccceEEEEEEeCCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCC--ccceeeeEeecC---CeeEEEEEccC
Q 002214          670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHR--NLVKIISSCTNH---NFKALVLEYMP  743 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~  743 (952)
                      +.++.|..+.||++...+|+.+++|+...... .....+.+|+++++.+++.  .+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999887778999998754432 1345788999999999763  456677776654   35689999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG-------------------------------------------  780 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-------------------------------------------  780 (952)
                      |.++.+.+..  ..++..+...++.++++++++||..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9988775532  2467777888888888888888731                                           


Q ss_pred             ----------CCCCeEeCCCCCCCeeeCC--CCcEEEeccccccc
Q 002214          781 ----------HSNPIVHCDIKPSNVLLDD--SMVAHLSDFGIAKL  813 (952)
Q Consensus       781 ----------h~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgla~~  813 (952)
                                -...++|+|+.|.||+++.  ++.+.++||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      1255799999999999998  67789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.05  E-value=1.7e-11  Score=139.07  Aligned_cols=87  Identities=26%  Similarity=0.256  Sum_probs=48.6

Q ss_pred             CceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCc---ccc-cccccccccEE
Q 002214          448 ILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGP---IPE-SFGELVSLEFL  523 (952)
Q Consensus       448 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~-~~~~l~~L~~L  523 (952)
                      |+.+++++|++. ..+..+..+..+..|++++|++...  ..+...+.+..+.++.|.+...   ... .....++++.+
T Consensus       234 L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (414)
T KOG0531|consen  234 LRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTL  310 (414)
T ss_pred             HHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcccccccccccccc
Confidence            444444444444 1224445555666666666666532  2344556666777777766521   111 14556788888


Q ss_pred             eCCCCcccccCccc
Q 002214          524 DLSNNDLSGVIPAS  537 (952)
Q Consensus       524 ~Ls~N~l~~~~~~~  537 (952)
                      .+..|.+....+..
T Consensus       311 ~~~~~~~~~~~~~~  324 (414)
T KOG0531|consen  311 TLELNPIRKISSLD  324 (414)
T ss_pred             ccccCccccccccc
Confidence            88888887655433

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.02  E-value=1.7e-09  Score=106.46  Aligned_cols=127  Identities=26%  Similarity=0.292  Sum_probs=85.4

Q ss_pred             EEEEEEeCCCcEEEEEEeeccC--------------c------------hhhHHHHHHHHHHHhCCCC--ccceeeeEee
Q 002214          679 SVYKGRFPDGIEVAIKVFHLQR--------------E------------GALNSFDAECEILKTIRHR--NLVKIISSCT  730 (952)
Q Consensus       679 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  730 (952)
                      .||.|...+|..+|||+.+...              .            .......+|++.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999999999999875321              0            0123467899999999766  455665443 


Q ss_pred             cCCeeEEEEEccC--CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecc
Q 002214          731 NHNFKALVLEYMP--KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDF  808 (952)
Q Consensus       731 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Df  808 (952)
                         ..++||||++  |..+..+....   ++......++.++...+..++  |+.||+|||+.+.||+++++ .+.++||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~--~~~givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKML--HKAGIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHH--HCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHH--HhcCceecCCChhhEEeecc-eEEEEec
Confidence               2479999998  65554433221   113445667778887666654  79999999999999999988 9999999


Q ss_pred             ccccccC
Q 002214          809 GIAKLLS  815 (952)
Q Consensus       809 gla~~~~  815 (952)
                      |.|....
T Consensus       151 ~qav~~~  157 (188)
T PF01163_consen  151 GQAVDSS  157 (188)
T ss_dssp             TTEEETT
T ss_pred             CcceecC
Confidence            9987553

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.00  E-value=4.9e-10  Score=135.22  Aligned_cols=104  Identities=23%  Similarity=0.399  Sum_probs=50.4

Q ss_pred             ccceEEcccCc--ccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEee
Q 002214          156 RLKGLYVSYNQ--FKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILG  233 (952)
Q Consensus       156 ~L~~L~L~~n~--l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  233 (952)
                      +|++|-+..|.  +....++.|..++.|+.|||++|.-.+.+|+.++.|-+|++|+|+++.+. .+|..+++|+.|.+|+
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence            45555555553  33222222444555555555555444455555555555555555555554 4555555555555555


Q ss_pred             eccccccccCCccccCCCCccEEEeeC
Q 002214          234 IDQSNLVGFVPDTIFNISTLKILSLFN  260 (952)
Q Consensus       234 L~~n~~~~~~~~~~~~l~~L~~L~Ls~  260 (952)
                      +..+.....+|.....+++|++|.+-.
T Consensus       625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~  651 (889)
T KOG4658|consen  625 LEVTGRLESIPGILLELQSLRVLRLPR  651 (889)
T ss_pred             cccccccccccchhhhcccccEEEeec
Confidence            554444444444444455555554443

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.93  E-value=1.6e-09  Score=130.82  Aligned_cols=58  Identities=31%  Similarity=0.276  Sum_probs=34.9

Q ss_pred             CCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCC-CCccccCCCcceEEEe
Q 002214          348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGP-IPQEFCHFSRLYVVYL  405 (952)
Q Consensus       348 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L  405 (952)
                      ..++|+.|++..+.....+.+....+..++.+-+..+.+.+. .-....+++++..+.+
T Consensus       768 f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l  826 (889)
T KOG4658|consen  768 FAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPL  826 (889)
T ss_pred             ccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEeccc
Confidence            356788888888777766666666677777666666666544 2333333444433333

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.92  E-value=3e-10  Score=131.76  Aligned_cols=250  Identities=23%  Similarity=0.270  Sum_probs=171.2

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      ...+.+.+.+-+.+|+++.++.++-. .|...+.|+.....   ....+....+-.+.-..++|.+++....+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34566778888999999999987642 34444444432211   112233333433443456688887766666667789


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +|++|..++++...++... ..+...+......+.++.+||   |...+.|||++|.|.+...++..++.|||.......
T Consensus       881 L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L---~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESL---HSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhcc---ccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            9999999999998887655 345555556666777899999   788899999999999999999999999984433210


Q ss_pred             c------------------------C------cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCC
Q 002214          817 E------------------------D------SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTN  866 (952)
Q Consensus       817 ~------------------------~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  866 (952)
                      -                        .      ........+|+.|.+||...+......+|.|++|++++|.++|..||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            0                        0      011223568999999999999999999999999999999999999987


Q ss_pred             ccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHH
Q 002214          867 EFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTK  932 (952)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  932 (952)
                      ...+.. .+........         ..        ...+...+.++++++...+..+|.+|-.|.
T Consensus      1037 a~tpq~-~f~ni~~~~~---------~~--------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQ-IFENILNRDI---------PW--------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhh-hhhccccCCC---------CC--------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            643321 1111111000         00        001223356678888888899999998765

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.89  E-value=2e-08  Score=105.30  Aligned_cols=140  Identities=15%  Similarity=0.076  Sum_probs=101.4

Q ss_pred             ceecCccceEEEEEEeCCCcEEEEEEeeccCch-hh----------HHHHHHHHHHHhCCCCc--cceeeeEeec-----
Q 002214          670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREG-AL----------NSFDAECEILKTIRHRN--LVKIISSCTN-----  731 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----  731 (952)
                      +.+-+.....|+++.. +|+.|.||........ ..          ..+.+|.+.+.++..-+  +..++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4444444555777766 6789999977433211 01          14779999998885433  3344555543     


Q ss_pred             CCeeEEEEEccCCC-ChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-------CCc
Q 002214          732 HNFKALVLEYMPKG-SLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-------SMV  802 (952)
Q Consensus       732 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-------~~~  802 (952)
                      ....++|||++++. +|.+++... ....+...+..++.+++..++.|   |..||+|||++++|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L---H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM---HAAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HHCcCccCCCChhhEEEeccccCCCCCce
Confidence            23578999999886 888887532 22456677789999999999999   8999999999999999975       468


Q ss_pred             EEEeccccccc
Q 002214          803 AHLSDFGIAKL  813 (952)
Q Consensus       803 ~kl~Dfgla~~  813 (952)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998864

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.88  E-value=1.1e-09  Score=87.05  Aligned_cols=59  Identities=46%  Similarity=0.650  Sum_probs=29.8

Q ss_pred             CCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccc
Q 002214          495 NLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNK  553 (952)
Q Consensus       495 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  553 (952)
                      +|++|++++|+|+.+.+..|..+++|++|++++|.|+.+.|..|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            44455555555554444445555555555555555554444455555555555555554

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.86  E-value=1.7e-09  Score=85.86  Aligned_cols=60  Identities=38%  Similarity=0.595  Sum_probs=42.0

Q ss_pred             ccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcc
Q 002214          471 AVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDL  530 (952)
Q Consensus       471 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  530 (952)
                      +|++|++++|+|+.+.+..|.++++|++|++++|+|+.+.|..|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            566667777777666666777777777777777777766666777777777777777764

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.80  E-value=2.2e-08  Score=100.49  Aligned_cols=136  Identities=25%  Similarity=0.251  Sum_probs=100.6

Q ss_pred             cCCccceecCccceEEEEEEeCCCcEEEEEEeeccCc----------------------hhhHHHHHHHHHHHhCCCC--
Q 002214          665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE----------------------GALNSFDAECEILKTIRHR--  720 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--  720 (952)
                      -..+++.||.|.-+.||.|..+.|.++|||.-+...+                      -.....++|.++|.++...  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            3567789999999999999999999999996532110                      0123467899999999655  


Q ss_pred             ccceeeeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC
Q 002214          721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS  800 (952)
Q Consensus       721 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~  800 (952)
                      .|.+.+++    +..++||||++|-.|...-      ++....-.++..|.+-++-.   -..||||||+++-||+++++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~---~~~GiVHGDlSefNIlV~~d  238 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKA---YRRGIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHH---HHcCccccCCchheEEEecC
Confidence            56666654    3457999999987665422      12334445555555555555   46899999999999999999


Q ss_pred             CcEEEeccccccc
Q 002214          801 MVAHLSDFGIAKL  813 (952)
Q Consensus       801 ~~~kl~Dfgla~~  813 (952)
                      |.+.++||--+..
T Consensus       239 g~~~vIDwPQ~v~  251 (304)
T COG0478         239 GDIVVIDWPQAVP  251 (304)
T ss_pred             CCEEEEeCccccc
Confidence            9999999976654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.78  E-value=1.8e-10  Score=127.64  Aligned_cols=183  Identities=27%  Similarity=0.284  Sum_probs=128.4

Q ss_pred             CcccccCCCCcEEEccCccccCCCCccccCC-CcceEEEecccccc---ccCCCccC---C---CCCCcEEeccccccCC
Q 002214          367 PITLGRLKKLQGLDLQNNKFEGPIPQEFCHF-SRLYVVYLNRNKLS---GSIPSCLG---D---LNSLRILSLSSNELTS  436 (952)
Q Consensus       367 ~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l-~~L~~L~L~~N~l~---~~~~~~~~---~---l~~L~~L~L~~N~l~~  436 (952)
                      |-.+..+.+|+.|.|.++.|..  ...+..+ ..|+.|.-. |.+.   ..+..+.+   +   -..|.+.+.++|+++ 
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence            5556677788888888877753  1111111 233333322 1111   11111111   1   236888999999998 


Q ss_pred             cCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccc
Q 002214          437 VIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGE  516 (952)
Q Consensus       437 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  516 (952)
                      ....++.-++.|+.|||++|+++..  +.+..++.|++|||+.|.++.+.--...++. |+.|.|++|.++..  ..+.+
T Consensus       178 ~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~  252 (1096)
T KOG1859|consen  178 LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIEN  252 (1096)
T ss_pred             hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHh
Confidence            4556778889999999999999843  3788999999999999999965444555555 99999999999843  35788


Q ss_pred             cccccEEeCCCCcccccCc-cchhcccccccccccccccccCC
Q 002214          517 LVSLEFLDLSNNDLSGVIP-ASLEKLLYLKSLNLSFNKLVGEI  558 (952)
Q Consensus       517 l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~  558 (952)
                      |.+|+.||+++|-|.+.-. .-+..|..|+.|+|.|||+.|-.
T Consensus       253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            9999999999999876432 33567889999999999997643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.72  E-value=3.7e-09  Score=118.54  Aligned_cols=152  Identities=18%  Similarity=0.278  Sum_probs=105.4

Q ss_pred             HHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc---c-----cccccccccccccC
Q 002214          767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT---Q-----TLATIGYIAPEYGR  838 (952)
Q Consensus       767 ~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~---~-----~~~~~~y~aPE~~~  838 (952)
                      +.+++.|+.|+|  .+.++||++|.|++|.++..+.+||+.|+++.....+..+...   .     ......|.|||++.
T Consensus       105 l~~v~dgl~flh--~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLH--RSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhc--cCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            334558999997  6789999999999999999999999999999765442222111   1     12455799999999


Q ss_pred             cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHh
Q 002214          839 EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAM  918 (952)
Q Consensus       839 ~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  918 (952)
                      +...+.++|+||+||.+|.+..|..+--........+..-.        ...+.....        .....|.++.+=+.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~--------~~~~~~~~~--------~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR--------NLLNAGAFG--------YSNNLPSELRESLK  246 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh--------ccccccccc--------ccccCcHHHHHHHH
Confidence            98899999999999999999965555322222211111100        000101100        11345778999999


Q ss_pred             hccccCCCCCCCHHHHHH
Q 002214          919 ECTSESPENRVNTKEIIS  936 (952)
Q Consensus       919 ~cl~~dP~~RPs~~ev~~  936 (952)
                      +++..++..||++.++..
T Consensus       247 k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHhcCCcccCcchhhhhc
Confidence            999999999998777653

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.66  E-value=2.7e-10  Score=126.28  Aligned_cols=128  Identities=32%  Similarity=0.374  Sum_probs=91.3

Q ss_pred             CccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCch-hhhccCCCcEee
Q 002214          155 PRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQ-EIGNLRNLEILG  233 (952)
Q Consensus       155 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~  233 (952)
                      -.|...+.++|.+. .+.+++.-++.|+.|+|++|+++..  +.+..+++|++|||+.|.+. .+|. ....+. |+.|.
T Consensus       164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~  238 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN  238 (1096)
T ss_pred             hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence            36777788888887 5667777788888888888888744  36778888888888888887 4444 233343 88888


Q ss_pred             eccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCC
Q 002214          234 IDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLS  290 (952)
Q Consensus       234 L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~  290 (952)
                      |++|.+++.  ..+.+|++|+.||+++|-|.+. .....+..+..|..|+|.+|.+-
T Consensus       239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~h-seL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEH-SELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ecccHHHhh--hhHHhhhhhhccchhHhhhhcc-hhhhHHHHHHHHHHHhhcCCccc
Confidence            888777665  4466788888888888887642 12223455667778888888775

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.65  E-value=9e-07  Score=95.97  Aligned_cols=214  Identities=20%  Similarity=0.275  Sum_probs=148.6

Q ss_pred             ceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEee----cCCeeEEEEEccCCC-ChhHH
Q 002214          677 YGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT----NHNFKALVLEYMPKG-SLEDC  750 (952)
Q Consensus       677 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~g-~L~~~  750 (952)
                      -.+.|++.. -||..|++|+++............-+++++++.|+|||++.+++.    .+...++||+|.++. +|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            346788876 479999999996554433333345678899999999999998876    345788999998754 66554


Q ss_pred             hhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          751 MYAS--------------NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       751 l~~~--------------~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      ....              +...++...|.++.|+..||.++   |+.|..-+-+.+++|+++.+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sI---HssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSI---HSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHH---HhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            3221              12467889999999999999999   789999999999999999999999998888776543


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      +..               |.+.+   -.+-|.=.||.+++.+.||..--..            .+...+           
T Consensus       446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~------------~d~~~~-----------  484 (655)
T KOG3741|consen  446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTENSNR------------TDSTQS-----------  484 (655)
T ss_pred             CCC---------------cchhH---HhhhhHHHHHHHHHHHhhccccccc------------ccchHH-----------
Confidence            320               11111   1256888999999999999553110            000000           


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                         .+.......++.++++++.-.....+++ -+..+++.++
T Consensus       485 ---s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  485 ---SHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             ---HHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence               0011123345677777888777777776 5555555443

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.59  E-value=1.8e-07  Score=106.18  Aligned_cols=141  Identities=21%  Similarity=0.208  Sum_probs=97.4

Q ss_pred             ceecCccceEEEEEEeCCCcEEEEEEeeccCch------------------------------h----hH------HHHH
Q 002214          670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREG------------------------------A----LN------SFDA  709 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------------------~----~~------~~~~  709 (952)
                      +.|+.++-|.||+|++++|+.||||+.++.-..                              .    .+      .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            679999999999999999999999997533110                              0    01      2345


Q ss_pred             HHHHHHhCC-----CCccceeeeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHH-HHHHHhcCCC
Q 002214          710 ECEILKTIR-----HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-LEYLHFGHSN  783 (952)
Q Consensus       710 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~-l~~Lh~~h~~  783 (952)
                      |+.-+.+++     .|.+.-..-+.+..+...++|||++|-.+.+.........+....   +..++++ +..+   -..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~i---a~~~~~~f~~q~---~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKEL---AELLVRAFLRQL---LRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHH---HHHHHHHHHHHH---Hhc
Confidence            555555542     344332222333345678999999999998885444455664443   3333322 3333   357


Q ss_pred             CeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       784 ~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      |++|+|..|.||+++.+|.+.+.|||+.....+
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            999999999999999999999999999987654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.58  E-value=5.2e-07  Score=90.05  Aligned_cols=155  Identities=21%  Similarity=0.240  Sum_probs=104.8

Q ss_pred             ccCHHHHHHHhccCCccce---ecCccceEEEEEEeCCCcEEEEEEeeccCch------------------------hhH
Q 002214          653 RYSHDELLRATDQFSEENL---IGIGSYGSVYKGRFPDGIEVAIKVFHLQREG------------------------ALN  705 (952)
Q Consensus       653 ~~~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------------~~~  705 (952)
                      ..+...+.....+..+...   |+.|.-+.||+|...++..||||+++.....                        ...
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            3445556666666655554   5577778999999888999999998643211                        011


Q ss_pred             HHHHHHHHHHhCC--CCccceeeeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 002214          706 SFDAECEILKTIR--HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN  783 (952)
Q Consensus       706 ~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~  783 (952)
                      ...+|.+-|.++.  +-.+.+.+++..    -.+||||+..... -.-.-...++...+...+..++.+.++-|-  +..
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~-pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~--~~a  186 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGL-PAPRLKDVPLELEEAEGLYEDVVEYMRRLY--KEA  186 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCC-CCCCcccCCcCchhHHHHHHHHHHHHHHHH--Hhc
Confidence            2356777777773  344455555443    3599999954311 100011112333467778888888888885  569


Q ss_pred             CeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       784 ~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||+||+.-|||+. ++.+.++|||-|....
T Consensus       187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            999999999999999 8899999999998654

>PRK09902 hypothetical protein; Provisional

Probab=98.56  E-value=7e-07  Score=88.20  Aligned_cols=138  Identities=16%  Similarity=0.050  Sum_probs=101.9

Q ss_pred             ecCccceEEEEEEeCCCcEEEEEEeeccC------chhhHHHHHHHHHHHhCCCC--ccceeeeEeec----CCeeEEEE
Q 002214          672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQR------EGALNSFDAECEILKTIRHR--NLVKIISSCTN----HNFKALVL  739 (952)
Q Consensus       672 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~----~~~~~lv~  739 (952)
                      -|+||-+.|++... +|+.+-+|.-...-      +-....|.+|...+.++..-  .+.+++.....    ....+||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            46789999999877 45578888753111      22346899999999998532  24444422211    12467999


Q ss_pred             EccCC-CChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc--EEEeccccccc
Q 002214          740 EYMPK-GSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV--AHLSDFGIAKL  813 (952)
Q Consensus       740 e~~~~-g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgla~~  813 (952)
                      |-+++ -+|.+++.... .+.+...+..+..++++.++-|   |+.|+.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~L---H~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKM---HSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97753 48888875533 2467778889999999999999   8999999999999999986667  99999987764

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.56  E-value=5.4e-09  Score=92.57  Aligned_cols=134  Identities=22%  Similarity=0.335  Sum_probs=85.9

Q ss_pred             CCcEEeccccccCCcCCcc---ccCCCCCceeEecCCccCCCCchhhh-cccccceeecCCcccCCCCcccccCCCCCce
Q 002214          423 SLRILSLSSNELTSVIPST---FWNLEDILGFDFSSNSLNGSLPLEIE-NLKAVVDIYLSRNNLSGNIPSTIIGLKNLQH  498 (952)
Q Consensus       423 ~L~~L~L~~N~l~~~~~~~---~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  498 (952)
                      .+..++|+++++.. +++.   +.....|+..+|++|.+.. +|..|. ..+.++.|+|++|.|+ .+|..+..++.|+.
T Consensus        28 E~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~  104 (177)
T KOG4579|consen   28 ELHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS  104 (177)
T ss_pred             HhhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence            34556666666542 2222   2334455556677777763 444443 3456777777777777 45666777888888


Q ss_pred             EEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCC
Q 002214          499 LSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG  561 (952)
Q Consensus       499 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  561 (952)
                      |+++.|.+. ..|..+..|.+|-.||..+|.+. .+|..+-.-......++.+++|.+.+|..
T Consensus       105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k  165 (177)
T KOG4579|consen  105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK  165 (177)
T ss_pred             cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence            888888877 56666767888888888888776 44433433344455667888888877764

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.53  E-value=6.8e-07  Score=90.82  Aligned_cols=106  Identities=24%  Similarity=0.269  Sum_probs=84.4

Q ss_pred             HHHHHHHHHHHhCCCC--ccceeeeEeecC----CeeEEEEEccCCC-ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 002214          705 NSFDAECEILKTIRHR--NLVKIISSCTNH----NFKALVLEYMPKG-SLEDCMYASNFNLDIFQRLGIMIDVASALEYL  777 (952)
Q Consensus       705 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~L  777 (952)
                      .+..+|...+.++..-  .+.+++++....    ...++|+|++++. +|.+++..... .+......++.++++.++-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            4678888888888533  345566666542    2458999999885 78888876432 66677889999999999999


Q ss_pred             HhcCCCCeEeCCCCCCCeeeCCCC---cEEEecccccccc
Q 002214          778 HFGHSNPIVHCDIKPSNVLLDDSM---VAHLSDFGIAKLL  814 (952)
Q Consensus       778 h~~h~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgla~~~  814 (952)
                         |+.||+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       135 ---H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 ---HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             ---HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence               899999999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	952
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-39
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-38
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-29
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-29
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		6e-25
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		8e-21
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		6e-25
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-24
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-23
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-23
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-23
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-19
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-15
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		9e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-11
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-11
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		8e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-06
3soa_A	444	Full-Length Human Camkii Length = 444		3e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		2e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		4e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-05
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		2e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		3e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		5e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-04
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		7e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		7e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		8e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  160 bits (405), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 110/324 (33%), Positives = 161/324 (49%), Gaps = 28/324 (8%)
Query: 633 RRSTEVSH---IKAGMSPQV---MWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFP 686
           RR     H   + A   P+V     +R+S  EL  A+D FS +N++G G +G VYKGR  
Sbjct: 1   RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 687 DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKG 745
           DG  VA+K    +R +G    F  E E++    HRNL+++   C     + LV  YM  G
Sbjct: 61  DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 746 SLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNP-IVHCDIKPSNVLLDDSM 801
           S+  C+     S   LD  +R  I +  A  L YLH  H +P I+H D+K +N+LLD+  
Sbjct: 121 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEF 179
Query: 802 VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTG 861
            A + DFG+AKL+  +D         TIG+IAPEY   G+ S K DV+ YG+ML+E+ TG
Sbjct: 180 EAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 239
Query: 862 MKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVA-------KQSCASSVL 914
            +           + R  ND    +++ +   LL E +  A V        K      ++
Sbjct: 240 QRA--------FDLARLANDDDVMLLDWV-KGLLKEKKLEALVDVDLQGNYKDEEVEQLI 290
Query: 915 SLAMECTSESPENRVNTKEIISRL 938
            +A+ CT  SP  R    E++  L
Sbjct: 291 QVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  156 bits (394), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 102/299 (34%), Positives = 152/299 (50%), Gaps = 22/299 (7%)
Query: 652 RRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR-EGALNSFDAE 710
           +R+S  EL  A+D F  +N++G G +G VYKGR  DG  VA+K    +R +G    F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 711 CEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA---SNFNLDIFQRLGIM 767
            E++    HRNL+++   C     + LV  YM  GS+  C+     S   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 768 IDVASALEYLHFGHSNP-IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
           +  A  L YLH  H +P I+H D+K +N+LLD+   A + DFG+AKL+  +D        
Sbjct: 138 LGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 196
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV 886
             IG+IAPEY   G+ S K DV+ YG+ML+E+ TG +  +        + R  ND    +
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD--------LARLANDDDVML 248
Query: 887 MNIMDTNLLSEDEEHANVA-------KQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           ++ +   LL E +  A V        K      ++ +A+ CT  SP  R    E++  L
Sbjct: 249 LDWV-KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  128 bits (322), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 93/288 (32%), Positives = 149/288 (51%), Gaps = 17/288 (5%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI 717
           +L  AT+ F  + LIG G +G VYKG   DG +VA+K    +    +  F+ E E L   
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---NLDIFQRLGIMIDVASAL 774
           RH +LV +I  C   N   L+ +YM  G+L+  +Y S+    ++   QRL I I  A  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIA 833
            YL   H+  I+H D+K  N+LLD++ V  ++DFGI+K  +E D       +  T+GYI 
Sbjct: 153 HYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM-SIKRWINDSL--PAVMNIM 890
           PEY  +G+++ K DVY++G++L EV        +    EM ++  W  +S     +  I+
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           D NL       A+  +          A++C + S E+R +  +++ +L
Sbjct: 270 DPNL-------ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  126 bits (316), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 150/291 (51%), Gaps = 23/291 (7%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI 717
           +L  AT+ F  + LIG G +G VYKG   DG +VA+K    +    +  F+ E E L   
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---NLDIFQRLGIMIDVASAL 774
           RH +LV +I  C   N   L+ +YM  G+L+  +Y S+    ++   QRL I I  A  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ----TLATIG 830
            YL   H+  I+H D+K  N+LLD++ V  ++DFGI+K  +E   + QT        T+G
Sbjct: 153 HYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE---LGQTHLXXVVKGTLG 206
Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM-SIKRWINDSL--PAVM 887
           YI PEY  +G+++ K DVY++G++L EV        +    EM ++  W  +S     + 
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
            I+D NL       A+  +          A++C + S E+R +  +++ +L
Sbjct: 267 QIVDPNL-------ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  113 bits (282), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 84/235 (35%), Positives = 125/235 (53%), Gaps = 5/235 (2%)
Query: 38  LTISDLGLAGTIPSHL-GNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGE 96
           L++++    G IP  L G   +L  L LS N F G +P   G+ + L+ L L  N   GE
Sbjct: 271 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 330
Query: 97  IP-EELGXXXXXXXXXXXXXXXTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLP 155
           +P + L                +G +P S+ NLS     LD S N+ +G    ++C   P
Sbjct: 331 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN-P 389
Query: 156 R--LKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFN 213
           +  L+ LY+  N F G IP  L +C EL S+ LS+N  +G +P  LG+ +KL+ L L  N
Sbjct: 390 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 449
Query: 214 NLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLP 268
            L GEIPQE+  ++ LE L +D ++L G +P  + N + L  +SL NN L+G +P
Sbjct: 450 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 504

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 163/659 (24%), Positives = 248/659 (37%), Gaps = 141/659 (21%)
Query: 10  LAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWF 69
           L+ N  S A+V  W  +  D  G  +  L IS   ++G +   +    +L+ L +S N F
Sbjct: 155 LSANSISGANVVGW--VLSDGCG-ELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNF 209
Query: 70  SGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGXXXXXXXXXXXXXXXTGTIPA-SIFNL 128
           S  IP  +G+ + L+ L +  NKL G+    +                 G IP   + +L
Sbjct: 210 STGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSL 268
Query: 129 SFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSY 188
            ++S A    +N  TG  P  +      L GL +S N F G +P     C  L S++LS 
Sbjct: 269 QYLSLA----ENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 324
Query: 189 NQFTGRLPRD-LGNSTKLKSLDLGFNNLNGEIPQEIGNLR-NLEILGIDQSNLVG-FVPD 245
           N F+G LP D L     LK LDL FN  +GE+P+ + NL  +L  L +  +N  G  +P+
Sbjct: 325 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 384
Query: 246 TIFN-ISTLKILSLFNNTLSGNLPSSKXXXXXXXXXXXXXXXXXXXXXXXSFFFNASKLY 304
              N  +TL+ L L NN  +G +P +                            N S+L 
Sbjct: 385 LCQNPKNTLQELYLQNNGFTGKIPPT--------------------------LSNCSELV 418
Query: 305 ALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTXXXXXXXXXX 364
           +L L +N           YL+     + S   +L   + LK+   +N+            
Sbjct: 419 SLHLSFN-----------YLS---GTIPSSLGSLSKLRDLKL--WLNM---------LEG 453
Query: 365 XXPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDXXXX 424
             P  L  +K L+ L L  N   G IP    + + L  + L+ N+L+G IP  +G     
Sbjct: 454 EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENL 513
Query: 425 XXXXXXXXXXTSVIPSTFWNLEDILGFDFSSNSLNGSLP--------------------- 463
                     +  IP+   +   ++  D ++N  NG++P                     
Sbjct: 514 AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 573
Query: 464 -----------------LEIENLKAVVDIYLSRNNLSGNIPSTIIGLK---------NLQ 497
                            LE + +++     LS  N   NI S + G           ++ 
Sbjct: 574 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN-PCNITSRVYGGHTSPTFDNNGSMM 632
Query: 498 HLSLEHNKLQGPIPESFG------------------------ELVSLEFLDLSNNDLSGV 533
            L + +N L G IP+  G                        +L  L  LDLS+N L G 
Sbjct: 633 FLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGR 692
Query: 534 IPAXXXXXXXXXXXXXXXXXXVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSS 592
           IP                    G IP  G F  F    F+ N  LCG P   +P C  S
Sbjct: 693 IPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPS 748

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  113 bits (282), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 84/235 (35%), Positives = 125/235 (53%), Gaps = 5/235 (2%)
Query: 38  LTISDLGLAGTIPSHL-GNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGE 96
           L++++    G IP  L G   +L  L LS N F G +P   G+ + L+ L L  N   GE
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333
Query: 97  IP-EELGXXXXXXXXXXXXXXXTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLP 155
           +P + L                +G +P S+ NLS     LD S N+ +G    ++C   P
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN-P 392
Query: 156 R--LKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFN 213
           +  L+ LY+  N F G IP  L +C EL S+ LS+N  +G +P  LG+ +KL+ L L  N
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452
Query: 214 NLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLP 268
            L GEIPQE+  ++ LE L +D ++L G +P  + N + L  +SL NN L+G +P
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 163/659 (24%), Positives = 248/659 (37%), Gaps = 141/659 (21%)
Query: 10  LAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWF 69
           L+ N  S A+V  W  +  D  G  +  L IS   ++G +   +    +L+ L +S N F
Sbjct: 158 LSANSISGANVVGW--VLSDGCG-ELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNF 212
Query: 70  SGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGXXXXXXXXXXXXXXXTGTIPA-SIFNL 128
           S  IP  +G+ + L+ L +  NKL G+    +                 G IP   + +L
Sbjct: 213 STGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSL 271
Query: 129 SFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSY 188
            ++S A    +N  TG  P  +      L GL +S N F G +P     C  L S++LS 
Sbjct: 272 QYLSLA----ENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327
Query: 189 NQFTGRLPRD-LGNSTKLKSLDLGFNNLNGEIPQEIGNLR-NLEILGIDQSNLVG-FVPD 245
           N F+G LP D L     LK LDL FN  +GE+P+ + NL  +L  L +  +N  G  +P+
Sbjct: 328 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387
Query: 246 TIFNI-STLKILSLFNNTLSGNLPSSKXXXXXXXXXXXXXXXXXXXXXXXSFFFNASKLY 304
              N  +TL+ L L NN  +G +P +                            N S+L 
Sbjct: 388 LCQNPKNTLQELYLQNNGFTGKIPPT--------------------------LSNCSELV 421
Query: 305 ALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTXXXXXXXXXX 364
           +L L +N           YL+     + S   +L   + LK+   +N+            
Sbjct: 422 SLHLSFN-----------YLS---GTIPSSLGSLSKLRDLKL--WLNM---------LEG 456
Query: 365 XXPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDXXXX 424
             P  L  +K L+ L L  N   G IP    + + L  + L+ N+L+G IP  +G     
Sbjct: 457 EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENL 516
Query: 425 XXXXXXXXXXTSVIPSTFWNLEDILGFDFSSNSLNGSLP--------------------- 463
                     +  IP+   +   ++  D ++N  NG++P                     
Sbjct: 517 AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 576
Query: 464 -----------------LEIENLKAVVDIYLSRNNLSGNIPSTIIGLK---------NLQ 497
                            LE + +++     LS  N   NI S + G           ++ 
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN-PCNITSRVYGGHTSPTFDNNGSMM 635
Query: 498 HLSLEHNKLQGPIPESFG------------------------ELVSLEFLDLSNNDLSGV 533
            L + +N L G IP+  G                        +L  L  LDLS+N L G 
Sbjct: 636 FLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGR 695
Query: 534 IPAXXXXXXXXXXXXXXXXXXVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSS 592
           IP                    G IP  G F  F    F+ N  LCG P   +P C  S
Sbjct: 696 IPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPS 751

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  109 bits (272), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 111/200 (55%), Gaps = 13/200 (6%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKV-----FHLQREGALNSFDAECEILKTIRHRNLVKII 726
           IG GS+G+V++  +  G +VA+K+     FH +R   +N F  E  I+K +RH N+V  +
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER---VNEFLREVAIMKRLRHPNIVLFM 100
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNF--NLDIFQRLGIMIDVASALEYLHFGHSNP 784
            + T     ++V EY+ +GSL   ++ S     LD  +RL +  DVA  + YLH   + P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
           IVH D+K  N+L+D      + DFG+++L +    +       T  ++APE  R+   + 
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASX-FLXSKXAAGTPEWMAPEVLRDEPSNE 218
Query: 845 KGDVYNYGIMLMEVFTGMKP 864
           K DVY++G++L E+ T  +P
Sbjct: 219 KSDVYSFGVILWELATLQQP 238

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 124/231 (53%), Gaps = 20/231 (8%)
Query: 651 WRRYSHDELLRATDQFSEE------NLIGIGSYGSVYKGRFPDGIEVAIK----VFHLQR 700
           +  +S  EL   T+ F E       N +G G +G VYKG + +   VA+K    +  +  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 70
Query: 701 EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLED---CMYASNFN 757
           E     FD E +++   +H NLV+++   ++ +   LV  YMP GSL D   C+  +   
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-P 129
Query: 758 LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE- 816
           L    R  I    A+ + +LH  H    +H DIK +N+LLD++  A +SDFG+A+   + 
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNE 867
             ++  ++ + T  Y+APE  R G+++ K D+Y++G++L+E+ TG+   +E
Sbjct: 187 AQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  107 bits (268), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 150/300 (50%), Gaps = 30/300 (10%)
Query: 651 WRRYSHDELLRATDQFSEE------NLIGIGSYGSVYKGRFPDGIEVAIK----VFHLQR 700
           +  +S  EL   T+ F E       N +G G +G VYKG + +   VA+K    +  +  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 70
Query: 701 EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLED---CMYASNFN 757
           E     FD E +++   +H NLV+++   ++ +   LV  YMP GSL D   C+  +   
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-P 129
Query: 758 LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE- 816
           L    R  I    A+ + +LH  H    +H DIK +N+LLD++  A +SDFG+A+   + 
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE--MS 874
             ++   + + T  Y+APE  R G+++ K D+Y++G++L+E+ TG+   +E    +  + 
Sbjct: 187 AQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245
Query: 875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
           IK  I D    + + +D  +        N A  +   ++ S+A +C  E    R + K++
Sbjct: 246 IKEEIEDEEKTIEDYIDKKM--------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 111/200 (55%), Gaps = 13/200 (6%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKV-----FHLQREGALNSFDAECEILKTIRHRNLVKII 726
           IG GS+G+V++  +  G +VA+K+     FH +R   +N F  E  I+K +RH N+V  +
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER---VNEFLREVAIMKRLRHPNIVLFM 100
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNF--NLDIFQRLGIMIDVASALEYLHFGHSNP 784
            + T     ++V EY+ +GSL   ++ S     LD  +RL +  DVA  + YLH   + P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
           IVH ++K  N+L+D      + DFG+++L +    +       T  ++APE  R+   + 
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 845 KGDVYNYGIMLMEVFTGMKP 864
           K DVY++G++L E+ T  +P
Sbjct: 219 KSDVYSFGVILWELATLQQP 238

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  107 bits (266), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 149/300 (49%), Gaps = 30/300 (10%)
Query: 651 WRRYSHDELLRATDQFSEE------NLIGIGSYGSVYKGRFPDGIEVAIK----VFHLQR 700
           +  +S  EL   T+ F E       N +G G +G VYKG + +   VA+K    +  +  
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 64
Query: 701 EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLED---CMYASNFN 757
           E     FD E +++   +H NLV+++   ++ +   LV  YMP GSL D   C+  +   
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-P 123
Query: 758 LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE- 816
           L    R  I    A+ + +LH  H    +H DIK +N+LLD++  A +SDFG+A+   + 
Sbjct: 124 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE--MS 874
              +   + + T  Y+APE  R G+++ K D+Y++G++L+E+ TG+   +E    +  + 
Sbjct: 181 AQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 239
Query: 875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
           IK  I D    + + +D  +        N A  +   ++ S+A +C  E    R + K++
Sbjct: 240 IKEEIEDEEKTIEDYIDKKM--------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 291

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 119/231 (51%), Gaps = 20/231 (8%)
Query: 651 WRRYSHDELLRATDQFSEE------NLIGIGSYGSVYKGRFPDGIEVAIK----VFHLQR 700
           +  +S  EL   T+ F E       N  G G +G VYKG + +   VA+K    +  +  
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 61
Query: 701 EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLED---CMYASNFN 757
           E     FD E ++    +H NLV+++   ++ +   LV  Y P GSL D   C+  +   
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTP-P 120
Query: 758 LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE- 816
           L    R  I    A+ + +LH  H    +H DIK +N+LLD++  A +SDFG+A+   + 
Sbjct: 121 LSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNE 867
              +  ++ + T  Y APE  R G+++ K D+Y++G++L+E+ TG+   +E
Sbjct: 178 AQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 144/303 (47%), Gaps = 31/303 (10%)
Query: 660 LRATDQFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDA 709
           +R   QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ 
Sbjct: 1   MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM 767
           E EILK+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-- 825
             +   +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +   
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWIND 881
            + I + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I +
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGN 230
Query: 882 SLPAVMNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIK 940
                M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +
Sbjct: 231 DKQGQMIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 941 IRD 943
           IRD
Sbjct: 289 IRD 291

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 144/302 (47%), Gaps = 31/302 (10%)
Query: 661 RATDQFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAE 710
           R   QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 711 CEILKTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
            EILK+++H N+VK    C +   +   L++EY+P GSL D + A    +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS 124
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--L 826
            +   +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    
Sbjct: 125 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDS 882
           + I + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I + 
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGND 234
Query: 883 LPAVMNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
               M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +I
Sbjct: 235 KQGQMIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292
Query: 942 RD 943
           RD
Sbjct: 293 RD 294

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 144/304 (47%), Gaps = 31/304 (10%)
Query: 661 RATDQFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAE 710
           R   QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E
Sbjct: 33  RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 711 CEILKTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
            EILK+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L    
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--L 826
            +   +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    
Sbjct: 153 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 209
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDS 882
           + I + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I + 
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGND 262
Query: 883 LPAVMNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
               M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +I
Sbjct: 263 KQGQMIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
Query: 942 RDLL 945
           RD +
Sbjct: 321 RDQM 324

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 143/302 (47%), Gaps = 31/302 (10%)
Query: 661 RATDQFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAE 710
           R   QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 711 CEILKTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
            EILK+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L    
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 128
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--L 826
            +   +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    
Sbjct: 129 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 185
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDS 882
           + I + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I + 
Sbjct: 186 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGND 238
Query: 883 LPAVMNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
               M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +I
Sbjct: 239 KQGQMIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 296
Query: 942 RD 943
           RD
Sbjct: 297 RD 298

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 143/302 (47%), Gaps = 31/302 (10%)
Query: 661 RATDQFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAE 710
           R   QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 711 CEILKTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
            EILK+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L    
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 120
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--L 826
            +   +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    
Sbjct: 121 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 177
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDS 882
           + I + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I + 
Sbjct: 178 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGND 230
Query: 883 LPAVMNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
               M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +I
Sbjct: 231 KQGQMIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 288
Query: 942 RD 943
           RD
Sbjct: 289 RD 290

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 143/302 (47%), Gaps = 31/302 (10%)
Query: 661 RATDQFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAE 710
           R   QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 711 CEILKTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
            EILK+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L    
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 125
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--L 826
            +   +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    
Sbjct: 126 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 182
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDS 882
           + I + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I + 
Sbjct: 183 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGND 235
Query: 883 LPAVMNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
               M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +I
Sbjct: 236 KQGQMIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 293
Query: 942 RD 943
           RD
Sbjct: 294 RD 295

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 143/302 (47%), Gaps = 31/302 (10%)
Query: 661 RATDQFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAE 710
           R   QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 711 CEILKTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
            EILK+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 124
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--L 826
            +   +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    
Sbjct: 125 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDS 882
           + I + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I + 
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGND 234
Query: 883 LPAVMNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
               M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +I
Sbjct: 235 KQGQMIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292
Query: 942 RD 943
           RD
Sbjct: 293 RD 294

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 143/302 (47%), Gaps = 31/302 (10%)
Query: 661 RATDQFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAE 710
           R   QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 711 CEILKTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
            EILK+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L    
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 126
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--L 826
            +   +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    
Sbjct: 127 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 183
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDS 882
           + I + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I + 
Sbjct: 184 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGND 236
Query: 883 LPAVMNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
               M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +I
Sbjct: 237 KQGQMIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 294
Query: 942 RD 943
           RD
Sbjct: 295 RD 296

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 142/298 (47%), Gaps = 31/298 (10%)
Query: 665 QFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAECEIL 714
           QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E EIL
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 715 KTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           K+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--LATIG 830
            +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    + I 
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDSLPAV 886
           + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I +     
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQ 253
Query: 887 MNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
           M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +IRD
Sbjct: 254 MIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 309

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 143/302 (47%), Gaps = 31/302 (10%)
Query: 661 RATDQFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAE 710
           R   QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E
Sbjct: 8   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 711 CEILKTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
            EILK+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L    
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 127
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--L 826
            +   +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    
Sbjct: 128 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 184
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDS 882
           + I + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I + 
Sbjct: 185 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGND 237
Query: 883 LPAVMNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
               M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +I
Sbjct: 238 KQGQMIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 295
Query: 942 RD 943
           RD
Sbjct: 296 RD 297

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 142/298 (47%), Gaps = 31/298 (10%)
Query: 665 QFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAECEIL 714
           QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E EIL
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 715 KTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           K+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--LATIG 830
            +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    + I 
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDSLPAV 886
           + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I +     
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQ 253
Query: 887 MNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
           M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +IRD
Sbjct: 254 MIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 309

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 143/300 (47%), Gaps = 31/300 (10%)
Query: 665 QFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAECEIL 714
           QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E EIL
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 63
Query: 715 KTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           K+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L     +  
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 123
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--LATIG 830
            +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    + I 
Sbjct: 124 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 180
Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDSLPAV 886
           + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I +     
Sbjct: 181 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQ 233
Query: 887 MNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL 945
           M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +IRD +
Sbjct: 234 MIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 291

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 142/298 (47%), Gaps = 31/298 (10%)
Query: 665 QFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAECEIL 714
           QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E EIL
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 715 KTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           K+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--LATIG 830
            +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    + I 
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDSLPAV 886
           + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I +     
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQ 235
Query: 887 MNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
           M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +IRD
Sbjct: 236 MIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 142/298 (47%), Gaps = 31/298 (10%)
Query: 665 QFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAECEIL 714
           QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E EIL
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 715 KTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           K+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--LATIG 830
            +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    + I 
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDSLPAV 886
           + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I +     
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGNDKQGQ 235
Query: 887 MNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
           M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +IRD
Sbjct: 236 MIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 143/302 (47%), Gaps = 31/302 (10%)
Query: 661 RATDQFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAE 710
           R   QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 711 CEILKTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
            EILK+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L    
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 122
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--L 826
            +   +EYL    +   +H ++   N+L+++     + DFG+ K+L ++    + +    
Sbjct: 123 QICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 179
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDS 882
           + I + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I + 
Sbjct: 180 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGND 232
Query: 883 LPAVMNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
               M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +I
Sbjct: 233 KQGQMIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 290
Query: 942 RD 943
           RD
Sbjct: 291 RD 292

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 143/302 (47%), Gaps = 31/302 (10%)
Query: 661 RATDQFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAE 710
           R   QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 711 CEILKTIRHRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
            EILK+++H N+VK    C +   +   L++E++P GSL + +      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS 124
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--L 826
            +   +EYL    +   +H D+   N+L+++     + DFG+ K+L ++    + +    
Sbjct: 125 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK----PTNEFFTGEMSIKRWINDS 882
           + I + APE   E + S+  DV+++G++L E+FT ++    P  EF        R I + 
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-------RMIGND 234
Query: 883 LPAVMNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
               M +   +L+   + +  + +   C   +  +  EC + +   R + +++  R+ +I
Sbjct: 235 KQGQMIVF--HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292
Query: 942 RD 943
           RD
Sbjct: 293 RD 294

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAI-KVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG GS+G+VYKG++   + V I KV     E    +F  E  +L+  RH N++  +   T
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPE-QFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             N  A+V ++    SL   ++       +FQ + I    A  ++YLH   +  I+H D+
Sbjct: 103 KDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDM 158
Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT-QTLATIGYIAPEYGR---EGQVSIKG 846
           K +N+ L + +   + DFG+A + S     +Q  Q   ++ ++APE  R       S + 
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS 218
Query: 847 DVYNYGIMLMEVFTGMKP 864
           DVY+YGI+L E+ TG  P
Sbjct: 219 DVYSYGIVLYELMTGELP 236

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 138/296 (46%), Gaps = 34/296 (11%)
Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN- 705
           PQ  W +   D      +    E  +G G +G V+   +    +VA+K     + G+++ 
Sbjct: 174 PQKPWEK---DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSV 227
Query: 706 -SFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL 764
            +F AE  ++KT++H  LVK+ +  T      ++ E+M KGSL D + +   +    Q L
Sbjct: 228 EAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSK---QPL 283
Query: 765 GIMIDVASAL-EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
             +ID ++ + E + F      +H D++ +N+L+  S+V  ++DFG+A+++ + +   + 
Sbjct: 284 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343
Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDS 882
                I + APE    G  +IK DV+++GI+LME+ T G  P             +   S
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP-------------YPGMS 390
Query: 883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
            P V+  ++        E+       C   + ++ M C    PE R   + I S L
Sbjct: 391 NPEVIRALERGYRMPRPEN-------CPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 134/288 (46%), Gaps = 40/288 (13%)
Query: 667 SEENLIGIGSYGSVYKGRFPDG-----IEVAIKVFHL-QREGALNSFDAECEILKTIRHR 720
           + + +IG G +G VYKG          + VAIK       E     F  E  I+    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
           N++++    + +    ++ EYM  G+L+  +   +    + Q +G++  +A+ ++YL   
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL--A 164
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA----TIGYIAPEY 836
           + N  VH D+   N+L++ ++V  +SDFG++++L  ED  + T T +     I + APE 
Sbjct: 165 NMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSGGKIPIRWTAPEA 221
Query: 837 GREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDS--LPAVMNIMDTN 893
               + +   DV+++GI++ EV T G +P  E    E  + + IND   LP  M+     
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAINDGFRLPTPMD----- 274
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                          C S++  L M+C  +    R    +I+S L K+
Sbjct: 275 ---------------CPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Composition-based stats.
 Identities = 74/293 (25%), Positives = 138/293 (47%), Gaps = 33/293 (11%)
Query: 639 SHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHL 698
           SH++    PQ  W      E+ R T +  E   +G G +G V+ G +    +VA+K    
Sbjct: 2   SHMQT-QKPQKPWWE-DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-- 55
Query: 699 QREGAL--NSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SN 755
            ++G++  ++F AE  ++K ++H+ LV++ +  T      ++ EYM  GSL D +   S 
Sbjct: 56  -KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG 113
Query: 756 FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS 815
             L I + L +   +A  + ++        +H D++ +N+L+ D++   ++DFG+A+L+ 
Sbjct: 114 IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 170
Query: 816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI 875
           + +   +      I + APE    G  +IK DV+++GI+L E+ T          G +  
Sbjct: 171 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPY 221
Query: 876 KRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
               N   P V+  ++         +  V   +C   +  L   C  E PE+R
Sbjct: 222 PGMTN---PEVIQNLERG-------YRMVRPDNCPEELYQLMRLCWKERPEDR 264

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 70/215 (32%), Positives = 111/215 (51%), Gaps = 21/215 (9%)
Query: 655 SHDELLRATDQFSEENL-----IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDA 709
           + DE  R+    + + L     IG G +G V  G +  G +VA+K   ++ +    +F A
Sbjct: 7   AQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLA 63
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKA-LVLEYMPKGSLEDCMYASNFNL---DIFQRLG 765
           E  ++  +RH NLV+++           +V EYM KGSL D + +   ++   D    L 
Sbjct: 64  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LK 121
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT 825
             +DV  A+EYL     N  VH D+   NVL+ +  VA +SDFG+ K   E  S + T  
Sbjct: 122 FSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGK 175
Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
           L  + + APE  RE + S K DV+++GI+L E+++
Sbjct: 176 LP-VKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 72/285 (25%), Positives = 134/285 (47%), Gaps = 32/285 (11%)
Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL-- 704
           PQ  W      E+ R T +  E   +G G +G V+ G +    +VA+K     ++G++  
Sbjct: 7   PQKPWWE-DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSP 60
Query: 705 NSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQR 763
           ++F AE  ++K ++H+ LV++ +  T      ++ EYM  GSL D +   S   L I + 
Sbjct: 61  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKL 119
Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
           L +   +A  + ++        +H D++ +N+L+ D++   ++DFG+A+L+ + +   + 
Sbjct: 120 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 176
Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL 883
                I + APE    G  +IK DV+++GI+L E+ T          G +      N   
Sbjct: 177 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPYPGMTN--- 224
Query: 884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
           P V+  ++         +  V   +C   +  L   C  E PE+R
Sbjct: 225 PEVIQNLERG-------YRMVRPDNCPEELYQLMRLCWKERPEDR 262

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 72/285 (25%), Positives = 134/285 (47%), Gaps = 32/285 (11%)
Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL-- 704
           PQ  W      E+ R T +  E   +G G +G V+ G +    +VA+K     ++G++  
Sbjct: 5   PQKPWWE-DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSP 58
Query: 705 NSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQR 763
           ++F AE  ++K ++H+ LV++ +  T      ++ EYM  GSL D +   S   L I + 
Sbjct: 59  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKL 117
Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
           L +   +A  + ++        +H D++ +N+L+ D++   ++DFG+A+L+ + +   + 
Sbjct: 118 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 174
Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL 883
                I + APE    G  +IK DV+++GI+L E+ T          G +      N   
Sbjct: 175 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPYPGMTN--- 222
Query: 884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
           P V+  ++         +  V   +C   +  L   C  E PE+R
Sbjct: 223 PEVIQNLERG-------YRMVRPDNCPEELYQLMRLCWKERPEDR 260

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 72/285 (25%), Positives = 134/285 (47%), Gaps = 32/285 (11%)
Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL-- 704
           PQ  W      E+ R T +  E   +G G +G V+ G +    +VA+K     ++G++  
Sbjct: 1   PQKPWWE-DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSP 54
Query: 705 NSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQR 763
           ++F AE  ++K ++H+ LV++ +  T      ++ EYM  GSL D +   S   L I + 
Sbjct: 55  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKL 113
Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
           L +   +A  + ++        +H D++ +N+L+ D++   ++DFG+A+L+ + +   + 
Sbjct: 114 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 170
Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL 883
                I + APE    G  +IK DV+++GI+L E+ T          G +      N   
Sbjct: 171 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPYPGMTN--- 218
Query: 884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
           P V+  ++         +  V   +C   +  L   C  E PE+R
Sbjct: 219 PEVIQNLERG-------YRMVRPDNCPEELYQLMRLCWKERPEDR 256

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 72/285 (25%), Positives = 134/285 (47%), Gaps = 32/285 (11%)
Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL-- 704
           PQ  W      E+ R T +  E   +G G +G V+ G +    +VA+K     ++G++  
Sbjct: 8   PQKPWWE-DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSP 61
Query: 705 NSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQR 763
           ++F AE  ++K ++H+ LV++ +  T      ++ EYM  GSL D +   S   L I + 
Sbjct: 62  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKL 120
Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
           L +   +A  + ++        +H D++ +N+L+ D++   ++DFG+A+L+ + +   + 
Sbjct: 121 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 177
Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL 883
                I + APE    G  +IK DV+++GI+L E+ T          G +      N   
Sbjct: 178 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPYPGMTN--- 225
Query: 884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
           P V+  ++         +  V   +C   +  L   C  E PE+R
Sbjct: 226 PEVIQNLERG-------YRMVRPDNCPEELYQLMRLCWKERPEDR 263

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 31/274 (11%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILK 715
           E+ R T +  E   +G G +G V+ G +    +VA+K     ++G++  ++F AE  ++K
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMK 63
Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASAL 774
            ++H+ LV++ +  T      ++ EYM  GSL D +   S   L I + L +   +A  +
Sbjct: 64  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            ++        +H D++ +N+L+ D++   ++DFG+A+L+ + +   +      I + AP
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 179
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E    G  +IK DV+++GI+L E+ T          G +      N   P V+  ++   
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPYPGMTN---PEVIQNLERG- 226
Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
                 +  V   +C   +  L   C  E PE+R
Sbjct: 227 ------YRMVRPDNCPEELYQLMRLCWKERPEDR 254

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 31/274 (11%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILK 715
           E+ R T +  E   +G G +G V+ G +    +VA+K     ++G++  ++F AE  ++K
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMK 63
Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASAL 774
            ++H+ LV++ +  T      ++ EYM  GSL D +   S   L I + L +   +A  +
Sbjct: 64  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            ++        +H D++ +N+L+ D++   ++DFG+A+L+ + +   +      I + AP
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 179
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E    G  +IK DV+++GI+L E+ T          G +      N   P V+  ++   
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPYPGMTN---PEVIQNLERG- 226
Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
                 +  V   +C   +  L   C  E PE+R
Sbjct: 227 ------YRMVRPDNCPEELYQLMRLCWKERPEDR 254

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 31/274 (11%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILK 715
           E+ R T +  E   +G G +G V+ G +    +VA+K     ++G++  ++F AE  ++K
Sbjct: 10  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMK 64
Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASAL 774
            ++H+ LV++ +  T      ++ EYM  GSL D +   S   L I + L +   +A  +
Sbjct: 65  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 123
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            ++        +H D++ +N+L+ D++   ++DFG+A+L+ + +   +      I + AP
Sbjct: 124 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 180
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E    G  +IK DV+++GI+L E+ T          G +      N   P V+  ++   
Sbjct: 181 EAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPYPGMTN---PEVIQNLERG- 227
Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
                 +  V   +C   +  L   C  E PE+R
Sbjct: 228 ------YRMVRPDNCPEELYQLMRLCWKERPEDR 255

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Composition-based stats.
 Identities = 66/193 (34%), Positives = 103/193 (53%), Gaps = 16/193 (8%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN 731
           IG G +G V  G +  G +VA+K   ++ +    +F AE  ++  +RH NLV+++     
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 732 HNFKA-LVLEYMPKGSLEDCMYASNFNL---DIFQRLGIMIDVASALEYLHFGHSNPIVH 787
                 +V EYM KGSL D + +   ++   D    L   +DV  A+EYL     N  VH
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNFVH 125
Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGD 847
            D+   NVL+ +  VA +SDFG+ K   E  S + T  L  + + APE  RE + S K D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLP-VKWTAPEALREKKFSTKSD 181
Query: 848 VYNYGIMLMEVFT 860
           V+++GI+L E+++
Sbjct: 182 VWSFGILLWEIYS 194

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 131/285 (45%), Gaps = 33/285 (11%)
Query: 666 FSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHR 720
            S + ++G G +G V  GR   P   E+++ +  L+    E     F  E  I+    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-HF 779
           N++++    T      +V EYM  GSL+  +   +    + Q +G++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYG 837
           G+    VH D+   N+L++ ++V  +SDFG+A++L ++     T       I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
              + +   DV++YGI+L EV + G +P  E             D + AV          
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAV---------- 263
Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            DE +       C +++  L ++C  +   NR   ++I+S L K+
Sbjct: 264 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 106/195 (54%), Gaps = 10/195 (5%)
Query: 669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKII 726
           E  +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ 
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPI 785
           +  +      +V EYM KGSL D +       L + Q + +   +AS + Y+   +    
Sbjct: 329 AVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---Y 384
Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIK 845
           VH D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 846 GDVYNYGIMLMEVFT 860
            DV+++GI+L E+ T
Sbjct: 445 SDVWSFGILLTELTT 459

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 66/193 (34%), Positives = 102/193 (52%), Gaps = 16/193 (8%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN 731
           IG G +G V  G +  G +VA+K   ++ +    +F AE  ++  +RH NLV+++     
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 732 HNFKA-LVLEYMPKGSLEDCMYASNFNL---DIFQRLGIMIDVASALEYLHFGHSNPIVH 787
                 +V EYM KGSL D + +   ++   D    L   +DV  A+EYL     N  VH
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNFVH 131
Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGD 847
            D+   NVL+ +  VA +SDFG+ K   E  S + T  L  + + APE  RE   S K D
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLP-VKWTAPEALREAAFSTKSD 187
Query: 848 VYNYGIMLMEVFT 860
           V+++GI+L E+++
Sbjct: 188 VWSFGILLWEIYS 200

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-19,   Method: Composition-based stats.
 Identities = 72/274 (26%), Positives = 132/274 (48%), Gaps = 31/274 (11%)
Query: 669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKII 726
           E  +G G +G V+   +    +VA+K     + G+++  +F AE  ++KT++H  LVK+ 
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLH 76
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL-EYLHFGHSNPI 785
           +  T      ++ E+M KGSL D + +   +    Q L  +ID ++ + E + F      
Sbjct: 77  AVVTKEPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNY 132
Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIK 845
           +H D++ +N+L+  S+V  ++DFG+A+++ + +   +      I + APE    G  +IK
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 846 GDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
            DV+++GI+LME+ T G  P             +   S P V+  ++        E    
Sbjct: 193 SDVWSFGILLMEIVTYGRIP-------------YPGMSNPEVIRALERGYRMPRPE---- 235
Query: 905 AKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +C   + ++ M C    PE R   + I S L
Sbjct: 236 ---NCPEELYNIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 106/195 (54%), Gaps = 10/195 (5%)
Query: 669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKII 726
           E  +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ 
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPI 785
           +  +      +V EYM KGSL D +       L + Q + +   +AS + Y+   +    
Sbjct: 246 AVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---Y 301
Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIK 845
           VH D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 846 GDVYNYGIMLMEVFT 860
            DV+++GI+L E+ T
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 111/215 (51%), Gaps = 21/215 (9%)
Query: 655 SHDELLRATDQFSEENL-----IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDA 709
           + DE  R+    + + L     IG G +G V  G +  G +VA+K   ++ +    +F A
Sbjct: 179 AQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLA 235
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFK-ALVLEYMPKGSLEDCMYASNFNL---DIFQRLG 765
           E  ++  +RH NLV+++           +V EYM KGSL D + +   ++   D    L 
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LK 293
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT 825
             +DV  A+EYL     N  VH D+   NVL+ +  VA +SDFG+ K   E  S + T  
Sbjct: 294 FSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGK 347
Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
           L  + + APE  RE + S K DV+++GI+L E+++
Sbjct: 348 LP-VKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 72/285 (25%), Positives = 134/285 (47%), Gaps = 32/285 (11%)
Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL-- 704
           PQ  W      E+ R T +  E   +G G +G V+ G +    +VA+K     ++G++  
Sbjct: 5   PQKPWWE-DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSP 58
Query: 705 NSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQR 763
           ++F AE  ++K ++H+ LV++ +  T      ++ EYM  GSL D +   S   L I + 
Sbjct: 59  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKL 117
Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
           L +   +A  + ++        +H D++ +N+L+ D++   ++DFG+A+L+ + +   + 
Sbjct: 118 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 174
Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL 883
                I + APE    G  +IK DV+++GI+L E+ T          G +      N   
Sbjct: 175 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPYPGMTN--- 222
Query: 884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
           P V+  ++         +  V   +C   +  L   C  E PE+R
Sbjct: 223 PEVIQNLERG-------YRMVRPDNCPEELYQLMRLCWKERPEDR 260

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 72/285 (25%), Positives = 134/285 (47%), Gaps = 32/285 (11%)
Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL-- 704
           PQ  W      E+ R T +  E   +G G +G V+ G +    +VA+K     ++G++  
Sbjct: 4   PQKPWWE-DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSP 57
Query: 705 NSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQR 763
           ++F AE  ++K ++H+ LV++ +  T      ++ EYM  GSL D +   S   L I + 
Sbjct: 58  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKL 116
Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
           L +   +A  + ++        +H D++ +N+L+ D++   ++DFG+A+L+ + +   + 
Sbjct: 117 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 173
Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL 883
                I + APE    G  +IK DV+++GI+L E+ T          G +      N   
Sbjct: 174 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPYPGMTN--- 221
Query: 884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
           P V+  ++         +  V   +C   +  L   C  E PE+R
Sbjct: 222 PEVIQNLERG-------YRMVRPDNCPEELYQLMRLCWKERPEDR 259

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 31/274 (11%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILK 715
           E+ R T +  E   +G G +G V+ G +    +VA+K     ++G++  ++F AE  ++K
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMK 63
Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASAL 774
            ++H+ LV++ +  T      ++ EYM  GSL D +   S   L I + L +   +A  +
Sbjct: 64  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            ++        +H D++ +N+L+ D++   ++DFG+A+L+ + +   +      I + AP
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E    G  +IK DV+++GI+L E+ T          G +      N   P V+  ++   
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPYPGMTN---PEVIQNLERG- 226
Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
                 +  V   +C   +  L   C  E PE+R
Sbjct: 227 ------YRMVRPDNCPEELYQLMRLCWKERPEDR 254

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 31/274 (11%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILK 715
           E+ R T +  E   +G G +G V+ G +    +VA+K     ++G++  ++F AE  ++K
Sbjct: 4   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMK 58
Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASAL 774
            ++H+ LV++ +  T      ++ EYM  GSL D +   S   L I + L +   +A  +
Sbjct: 59  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 117
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            ++        +H D++ +N+L+ D++   ++DFG+A+L+ + +   +      I + AP
Sbjct: 118 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 174
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E    G  +IK DV+++GI+L E+ T          G +      N   P V+  ++   
Sbjct: 175 EAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPYPGMTN---PEVIQNLERG- 221
Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
                 +  V   +C   +  L   C  E PE+R
Sbjct: 222 ------YRMVRPDNCPEELYQLMRLCWKERPEDR 249

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 106/195 (54%), Gaps = 10/195 (5%)
Query: 669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKII 726
           E  +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ 
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPI 785
           +  +      +V EYM KGSL D +       L + Q + +   +AS + Y+   +    
Sbjct: 246 AVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---Y 301
Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIK 845
           VH D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 846 GDVYNYGIMLMEVFT 860
            DV+++GI+L E+ T
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 131/274 (47%), Gaps = 31/274 (11%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILK 715
           E+ R T +  E   +G G +G V+ G +    +VA+K     ++G++  ++F AE  ++K
Sbjct: 5   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMK 59
Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASAL 774
            ++H+ LV++ +  T      ++ EYM  GSL D +   S   L I + L +   +A  +
Sbjct: 60  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 118
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            ++        +H +++ +N+L+ D++   ++DFG+A+L+ + +   +      I + AP
Sbjct: 119 AFIE---ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 175
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E    G  +IK DV+++GI+L E+ T          G +      N   P V+  ++   
Sbjct: 176 EAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPYPGMTN---PEVIQNLERG- 222
Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
                 +  V   +C   +  L   C  E PE+R
Sbjct: 223 ------YRMVRPDNCPEELYQLMRLCWKERPEDR 250

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 33/285 (11%)
Query: 666 FSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHR 720
            S + ++G G +G V  GR   P   E+++ +  L+    E     F  E  I+    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-HF 779
           N++++    T      +V EYM  GSL+  +   +    + Q +G++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYG 837
           G+    VH D+   N+L++ ++V  +SDFG++++L ++     T       I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
              + +   DV++YGI+L EV + G +P  E             D + AV          
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAV---------- 263
Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            DE +       C +++  L ++C  +   NR   ++I+S L K+
Sbjct: 264 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 129/281 (45%), Gaps = 23/281 (8%)
Query: 652 RRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAEC 711
           RR S D+      Q +    IG GS+G+VYKG++   + V +          L +F  E 
Sbjct: 23  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 82
Query: 712 EILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA 771
            +L+  RH N++  +   T     A+V ++    SL   ++      ++ + + I    A
Sbjct: 83  GVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 141
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIG 830
             ++YL   H+  I+H D+K +N+ L + +   + DFG+A + S      Q + L+ +I 
Sbjct: 142 QGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 831 YIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM 887
           ++APE  R   +   S + DVY +GI+L E+ TG  P +            IN+    ++
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN-----------INNR-DQII 246
Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
            ++    LS D    +  + +C  ++  L  EC  +  + R
Sbjct: 247 FMVGRGYLSPD---LSKVRSNCPKAMKRLMAECLKKKRDER 284

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 129/281 (45%), Gaps = 23/281 (8%)
Query: 652 RRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAEC 711
           RR S D+      Q +    IG GS+G+VYKG++   + V +          L +F  E 
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 83
Query: 712 EILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA 771
            +L+  RH N++  +   T     A+V ++    SL   ++      ++ + + I    A
Sbjct: 84  GVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 142
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIG 830
             ++YL   H+  I+H D+K +N+ L + +   + DFG+A + S      Q + L+ +I 
Sbjct: 143 QGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 831 YIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM 887
           ++APE  R   +   S + DVY +GI+L E+ TG  P +            IN+    ++
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN-----------INNR-DQII 247
Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
            ++    LS D    +  + +C  ++  L  EC  +  + R
Sbjct: 248 FMVGRGYLSPD---LSKVRSNCPKAMKRLMAECLKKKRDER 285

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 33/285 (11%)
Query: 666 FSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHR 720
            S + ++G G +G V  GR   P   E+++ +  L+    E     F  E  I+    H 
Sbjct: 35  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 94
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-HF 779
           N++++    T      +V EYM  GSL+  +   +    + Q +G++  +AS ++YL   
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYG 837
           G+    VH D+   N+L++ ++V  +SDFG++++L ++     T       I + +PE  
Sbjct: 155 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 210
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
              + +   DV++YGI+L EV + G +P  E             D + AV          
Sbjct: 211 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAV---------- 251
Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            DE +       C +++  L ++C  +   NR   ++I+S L K+
Sbjct: 252 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 33/285 (11%)
Query: 666 FSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHR 720
            S + ++G G +G V  GR   P   E+++ +  L+    E     F  E  I+    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-HF 779
           N++++    T      +V EYM  GSL+  +   +    + Q +G++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYG 837
           G+    VH D+   N+L++ ++V  +SDFG++++L ++     T       I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
              + +   DV++YGI+L EV + G +P  E             D + AV          
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAV---------- 263
Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            DE +       C +++  L ++C  +   NR   ++I+S L K+
Sbjct: 264 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 33/285 (11%)
Query: 666 FSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHR 720
            S + ++G G +G V  GR   P   E+++ +  L+    E     F  E  I+    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-HF 779
           N++++    T      +V EYM  GSL+  +   +    + Q +G++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYG 837
           G+    VH D+   N+L++ ++V  +SDFG++++L ++     T       I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
              + +   DV++YGI+L EV + G +P  E             D + AV          
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAV---------- 263
Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            DE +       C +++  L ++C  +   NR   ++I+S L K+
Sbjct: 264 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 129/283 (45%), Gaps = 31/283 (10%)
Query: 667 SEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRN 721
           S + ++G G +G V  GR   P   E+++ +  L+    E     F  E  I+    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           ++++    T      +V EYM  GSL+  +   +    + Q +G++  +AS ++YL    
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGRE 839
               VH D+   N+L++ ++V  +SDFG++++L ++     T       I + +PE    
Sbjct: 165 DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 840 GQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED 898
            + +   DV++YGI+L EV + G +P  E             D + AV           D
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAV-----------D 264
Query: 899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
           E +       C +++  L ++C  +   NR   ++I+S L K+
Sbjct: 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 106/195 (54%), Gaps = 10/195 (5%)
Query: 669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKII 726
           E  +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ 
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPI 785
           +  +      +V EYM KGSL D +       L + Q + +   +AS + Y+   +    
Sbjct: 246 AVVSEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---Y 301
Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIK 845
           VH D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 846 GDVYNYGIMLMEVFT 860
            DV+++GI+L E+ T
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 33/285 (11%)
Query: 666 FSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHR 720
            S + ++G G +G V  GR   P   E+++ +  L+    E     F  E  I+    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-HF 779
           N++++    T      +V EYM  GSL+  +   +    + Q +G++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYG 837
           G+    VH D+   N+L++ ++V  +SDFG++++L ++     T       I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
              + +   DV++YGI+L EV + G +P  E             D + AV          
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAV---------- 263
Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            DE +       C +++  L ++C  +   NR   ++I+S L K+
Sbjct: 264 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 33/285 (11%)
Query: 666 FSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHR 720
            S + ++G G +G V  GR   P   E+++ +  L+    E     F  E  I+    H 
Sbjct: 45  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 104
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-HF 779
           N++++    T      +V EYM  GSL+  +   +    + Q +G++  +AS ++YL   
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 164
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYG 837
           G+    VH D+   N+L++ ++V  +SDFG++++L ++     T       I + +PE  
Sbjct: 165 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 220
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
              + +   DV++YGI+L EV + G +P  E             D + AV          
Sbjct: 221 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAV---------- 261
Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            DE +       C +++  L ++C  +   NR   ++I+S L K+
Sbjct: 262 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 33/285 (11%)
Query: 666 FSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHR 720
            S + ++G G +G V  GR   P   E+++ +  L+    E     F  E  I+    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-HF 779
           N++++    T      +V EYM  GSL+  +   +    + Q +G++  +AS ++YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYG 837
           G+    VH D+   N+L++ ++V  +SDFG++++L ++     T       I + +PE  
Sbjct: 138 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
              + +   DV++YGI+L EV + G +P  E             D + AV          
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAV---------- 234
Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            DE +       C +++  L ++C  +   NR   ++I+S L K+
Sbjct: 235 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 55/192 (28%), Positives = 107/192 (55%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-LHFGHSNPIVHC 788
           +      +V+EYM KGSL D +      +  + RL  ++D+A+ +   + +      VH 
Sbjct: 83  SEEPI-YIVIEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 199 WSFGILLTELTT 210

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 130/285 (45%), Gaps = 33/285 (11%)
Query: 666 FSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHR 720
            S + ++G G +G V  GR   P   E+++ +  L+    E     F  E  I+    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-HF 779
           N++++    T      +V EYM  GSL+  +   +    + Q +G++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYG 837
           G+    VH D+   N+L++ ++V  +SDFG+ ++L ++     T       I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
              + +   DV++YGI+L EV + G +P  E             D + AV          
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAV---------- 263
Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            DE +       C +++  L ++C  +   NR   ++I+S L K+
Sbjct: 264 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 55/192 (28%), Positives = 107/192 (55%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-LHFGHSNPIVHC 788
           +      +V+EYM KGSL D +      +  + RL  ++D+A+ +   + +      VH 
Sbjct: 83  SEEPI-YIVIEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 199 WSFGILLTELTT 210

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 29/275 (10%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRNLVKIISSC 729
           IG G +G V+ G + +  +VAIK     REGA++   F  E E++  + H  LV++   C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                  LV E+M  G L D +            LG+ +DV   + YL       ++H D
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 131
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ V  +SDFG+ + + ++     T T   + + +PE     + S K DV+
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191
Query: 850 NYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSC 909
           ++G+++ EVF+  K   E            N S   V+  + T           + K   
Sbjct: 192 SFGVLMWEVFSEGKIPYE------------NRSNSEVVEDISTGF--------RLYKPRL 231
Query: 910 ASS-VLSLAMECTSESPENRVNTKEIISRLIKIRD 943
           AS+ V  +   C  E PE+R     ++ +L +I +
Sbjct: 232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 132/290 (45%), Gaps = 23/290 (7%)
Query: 653 RYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECE 712
           R S D+      Q +    IG GS+G+VYKG++   + V +          L +F  E  
Sbjct: 1   RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVG 60
Query: 713 ILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           +L+  RH N++  +   T     A+V ++    SL   ++AS    ++ + + I    A 
Sbjct: 61  VLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 119
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGY 831
            ++YL   H+  I+H D+K +N+ L +     + DFG+A + S      Q + L+ +I +
Sbjct: 120 GMDYL---HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 176
Query: 832 IAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMN 888
           +APE  R       S + DVY +GI+L E+ TG  P +            IN+    ++ 
Sbjct: 177 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN-----------INNR-DQIIE 224
Query: 889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           ++    LS D    +  + +C   +  L  EC  +  + R +   I++ +
Sbjct: 225 MVGRGSLSPD---LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 271

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 56/192 (29%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K IRH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV 82
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-LHFGHSNPIVHC 788
           +      +V EYM KGSL D +      +  + RL  ++D+A+ +   + +      VH 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 199 WSFGILLTELTT 210

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 69/274 (25%), Positives = 130/274 (47%), Gaps = 31/274 (11%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILK 715
           E+ R T +  E   +G G  G V+ G +    +VA+K     ++G++  ++F AE  ++K
Sbjct: 9   EVPRETLKLVER--LGAGQAGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMK 63
Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASAL 774
            ++H+ LV++ +  T      ++ EYM  GSL D +   S   L I + L +   +A  +
Sbjct: 64  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            ++        +H D++ +N+L+ D++   ++DFG+A+L+ + +   +      I + AP
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAP 179
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E    G  +IK DV+++GI+L E+ T          G +      N   P V+  ++   
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT---------HGRIPYPGMTN---PEVIQNLERG- 226
Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
                 +  V   +C   +  L   C  E PE+R
Sbjct: 227 ------YRMVRPDNCPEELYQLMRLCWKERPEDR 254

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 29/275 (10%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRNLVKIISSC 729
           IG G +G V+ G + +  +VAIK     REGA++   F  E E++  + H  LV++   C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                  LV E+M  G L D +            LG+ +DV   + YL       ++H D
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 128
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ V  +SDFG+ + + ++     T T   + + +PE     + S K DV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 850 NYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSC 909
           ++G+++ EVF+  K   E            N S   V+  + T           + K   
Sbjct: 189 SFGVLMWEVFSEGKIPYE------------NRSNSEVVEDISTGF--------RLYKPRL 228
Query: 910 ASS-VLSLAMECTSESPENRVNTKEIISRLIKIRD 943
           AS+ V  +   C  E PE+R     ++ +L +I +
Sbjct: 229 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 29/273 (10%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRNLVKIISSC 729
           IG G +G V+ G + +  +VAIK     REGA++   F  E E++  + H  LV++   C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                  LV E+M  G L D +            LG+ +DV   + YL       ++H D
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRD 128
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ V  +SDFG+ + + ++     T T   + + +PE     + S K DV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 850 NYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSC 909
           ++G+++ EVF+  K   E            N S   V+  + T           + K   
Sbjct: 189 SFGVLMWEVFSEGKIPYE------------NRSNSEVVEDISTGF--------RLYKPRL 228
Query: 910 ASS-VLSLAMECTSESPENRVNTKEIISRLIKI 941
           AS+ V  +   C  E PE+R     ++ +L  I
Sbjct: 229 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 53/192 (27%), Positives = 106/192 (55%), Gaps = 9/192 (4%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G + +  +VA+K     + G ++  +F  E  ++KT++H  LV++ +  
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL-EYLHFGHSNPIVHC 788
           T      ++ EYM KGSL D + +      +  +L   ID ++ + E + +      +H 
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHR 134
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +NVL+ +S++  ++DFG+A+++ + +   +      I + APE    G  +IK DV
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 195 WSFGILLYEIVT 206

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 29/275 (10%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRNLVKIISSC 729
           IG G +G V+ G + +  +VAIK     REGA++   F  E E++  + H  LV++   C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                  LV E+M  G L D +            LG+ +DV   + YL       ++H D
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 126
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ V  +SDFG+ + + ++     T T   + + +PE     + S K DV+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 850 NYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSC 909
           ++G+++ EVF+  K   E            N S   V+  + T           + K   
Sbjct: 187 SFGVLMWEVFSEGKIPYE------------NRSNSEVVEDISTGF--------RLYKPRL 226
Query: 910 ASS-VLSLAMECTSESPENRVNTKEIISRLIKIRD 943
           AS+ V  +   C  E PE+R     ++ +L +I +
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 56/192 (29%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 72
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
           +      +V EYM KGSL D +       L + Q + +   +AS + Y+   +    VH 
Sbjct: 73  SEEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 128
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 189 WSFGILLTELTT 200

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 128/281 (45%), Gaps = 23/281 (8%)
Query: 652 RRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAEC 711
           RR S D+      Q +    IG GS+G+VYKG++   + V +          L +F  E 
Sbjct: 16  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 75
Query: 712 EILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA 771
            +L+  RH N++  +   T     A+V ++    SL   ++      ++ + + I    A
Sbjct: 76  GVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 134
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIG 830
             ++YL   H+  I+H D+K +N+ L + +   + DFG+A   S      Q + L+ +I 
Sbjct: 135 QGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 831 YIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM 887
           ++APE  R   +   S + DVY +GI+L E+ TG  P +            IN+    ++
Sbjct: 192 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN-----------INNR-DQII 239
Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
            ++    LS D    +  + +C  ++  L  EC  +  + R
Sbjct: 240 FMVGRGYLSPD---LSKVRSNCPKAMKRLMAECLKKKRDER 277

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 128/281 (45%), Gaps = 23/281 (8%)
Query: 652 RRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAEC 711
           RR S D+      Q +    IG GS+G+VYKG++   + V +          L +F  E 
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 83
Query: 712 EILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA 771
            +L+  RH N++  +   T     A+V ++    SL   ++      ++ + + I    A
Sbjct: 84  GVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 142
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIG 830
             ++YL   H+  I+H D+K +N+ L + +   + DFG+A   S      Q + L+ +I 
Sbjct: 143 QGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 831 YIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM 887
           ++APE  R   +   S + DVY +GI+L E+ TG  P +            IN+    ++
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN-----------INNR-DQII 247
Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
            ++    LS D    +  + +C  ++  L  EC  +  + R
Sbjct: 248 FMVGRGYLSPD---LSKVRSNCPKAMKRLMAECLKKKRDER 285

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 126/262 (48%), Gaps = 33/262 (12%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTL---KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVV 249
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-LHFGHSNPIVHC 788
           +      +V EYM KGSL D +      +  + RL  ++D+A+ +   + +      VH 
Sbjct: 250 SEEPI-YIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 305
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+ +L+ + +   +      I + APE    G+ +IK DV
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 849 YNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV-AK 906
           +++GI+L E+ T G  P                   P ++N     +L + E    +   
Sbjct: 366 WSFGILLTELTTKGRVP------------------YPGMVN---REVLDQVERGYRMPCP 404
Query: 907 QSCASSVLSLAMECTSESPENR 928
             C  S+  L  +C  + PE R
Sbjct: 405 PECPESLHDLMCQCWRKDPEER 426

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 29/275 (10%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRNLVKIISSC 729
           IG G +G V+ G + +  +VAIK     REGA++   F  E E++  + H  LV++   C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                  LV E+M  G L D +            LG+ +DV   + YL       ++H D
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 129
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ V  +SDFG+ + + ++     T T   + + +PE     + S K DV+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 850 NYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSC 909
           ++G+++ EVF+  K   E            N S   V+  + T           + K   
Sbjct: 190 SFGVLMWEVFSEGKIPYE------------NRSNSEVVEDISTGF--------RLYKPRL 229
Query: 910 ASS-VLSLAMECTSESPENRVNTKEIISRLIKIRD 943
           AS+ V  +   C  E PE+R     ++ +L +I +
Sbjct: 230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 124/275 (45%), Gaps = 29/275 (10%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V  G++    +VAIK+    +EG++  + F  E +++  + H  LV++   C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      ++ EYM  G L + +          Q L +  DV  A+EYL    S   +H D
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L++D  V  +SDFG+++ + +++      +   + +  PE     + S K D++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G+++ E+++ G  P   F   E +      + +   + +   +L SE           
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETA------EHIAQGLRLYRPHLASE----------- 248
Query: 909 CASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
               V ++   C  E  + R   K ++S ++ + D
Sbjct: 249 ---KVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 134/302 (44%), Gaps = 23/302 (7%)
Query: 641 IKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR 700
           +K G        R S D+      Q +    IG GS+G+VYKG++   + V +       
Sbjct: 1   MKKGHHHHHHGSRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT 60
Query: 701 EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDI 760
              L +F  E  +L+  RH N++  +   T     A+V ++    SL   ++AS    ++
Sbjct: 61  PQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEM 119
Query: 761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM 820
            + + I    A  ++YL   H+  I+H D+K +N+ L +     + DFG+A   S     
Sbjct: 120 KKLIDIARQTARGMDYL---HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176
Query: 821 KQTQTLA-TIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
            Q + L+ +I ++APE  R       S + DVY +GI+L E+ TG  P +          
Sbjct: 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN--------- 227
Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
             IN+    ++ ++    LS D    +  + +C   +  L  EC  +  + R +   I++
Sbjct: 228 --INNR-DQIIEMVGRGSLSPD---LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281
Query: 937 RL 938
            +
Sbjct: 282 EI 283

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 55/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 71
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-LHFGHSNPIVHC 788
           +      +V EYM KGSL D +      +  + RL  ++D+A+ +   + +      VH 
Sbjct: 72  SEEPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 127
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 188 WSFGILLTELTT 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 55/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 73
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-LHFGHSNPIVHC 788
           +      +V EYM KGSL D +      +  + RL  ++D+A+ +   + +      VH 
Sbjct: 74  SEEPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 129
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 190 WSFGILLTELTT 201

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 55/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-LHFGHSNPIVHC 788
           +      +V EYM KGSL D +      +  + RL  ++D+A+ +   + +      VH 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 199 WSFGILLTELTT 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 55/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-LHFGHSNPIVHC 788
           +      +V EYM KGSL D +      +  + RL  ++D+A+ +   + +      VH 
Sbjct: 83  SEEPI-YIVCEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 199 WSFGILLTELTT 210

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 124/275 (45%), Gaps = 29/275 (10%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V  G++    +VAIK+    +EG++  + F  E +++  + H  LV++   C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      ++ EYM  G L + +          Q L +  DV  A+EYL    S   +H D
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L++D  V  +SDFG+++ + +++      +   + +  PE     + S K D++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G+++ E+++ G  P   F   E +      + +   + +   +L SE           
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETA------EHIAQGLRLYRPHLASE----------- 248
Query: 909 CASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
               V ++   C  E  + R   K ++S ++ + D
Sbjct: 249 ---KVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 56/192 (29%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 75
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
           +      +V EYM KGSL D +       L + Q + +   +AS + Y+   +    VH 
Sbjct: 76  SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 131
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 192 WSFGILLTELTT 203

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Composition-based stats.
 Identities = 72/265 (27%), Positives = 118/265 (44%), Gaps = 27/265 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 +V EYMP G+L D +   N   +     L +   ++SA+EYL        +H D
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ V  ++DFG+++L++ +           I + APE       SIK DV+
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVW 215
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V ++++     E  E        
Sbjct: 216 AFGVLLWEIATYGMSP-------------YPGIDLSQVYDLLEKGYRMEQPE-------G 255
Query: 909 CASSVLSLAMECTSESPENRVNTKE 933
           C   V  L   C   SP +R +  E
Sbjct: 256 CPPKVYELMRACWKWSPADRPSFAE 280

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 122/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 +++E+M  G+L D +   N   ++    L +   ++SA+EYL        +H D
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 197
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 198 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 237
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 124/275 (45%), Gaps = 29/275 (10%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V  G++    +VAIK+    +EG++  + F  E +++  + H  LV++   C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      ++ EYM  G L + +          Q L +  DV  A+EYL    S   +H D
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L++D  V  +SDFG+++ + +++      +   + +  PE     + S K D++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G+++ E+++ G  P   F   E +      + +   + +   +L SE           
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSETA------EHIAQGLRLYRPHLASE----------- 233
Query: 909 CASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
               V ++   C  E  + R   K ++S ++ + D
Sbjct: 234 ---KVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-LHFGHSNPIVHC 788
           +      +V+EYM KG L D +      +  + RL  ++D+A+ +   + +      VH 
Sbjct: 83  SEEPI-YIVMEYMSKGCLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 199 WSFGILLTELTT 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 125/262 (47%), Gaps = 33/262 (12%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +    +VAIK     + G ++  SF  E +I+K ++H  LV++ +  
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTL---KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 730 TNHNFKALVLEYMPKGSLEDCMY-ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
           +      +V EYM KGSL D +       L +   + +   VA+ + Y+   +    +H 
Sbjct: 74  SEEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 129
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ + ++  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 849 YNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV-AK 906
           +++GI+L E+ T G  P                   P + N     +L + E    +   
Sbjct: 190 WSFGILLTELVTKGRVP------------------YPGMNN---REVLEQVERGYRMPCP 228
Query: 907 QSCASSVLSLAMECTSESPENR 928
           Q C  S+  L + C  + PE R
Sbjct: 229 QDCPISLHELMIHCWKKDPEER 250

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 124/268 (46%), Gaps = 23/268 (8%)
Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           Q +    IG GS+G+VYKG++   + V +          L +F  E  +L+  RH N++ 
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 73
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
            +   T     A+V ++    SL   ++      ++ + + I    A  ++YLH   +  
Sbjct: 74  FMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKS 129
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPEYGR---EG 840
           I+H D+K +N+ L + +   + DFG+A + S      Q + L+ +I ++APE  R   + 
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
             S + DVY +GI+L E+ TG  P +            IN+    ++ ++    LS D  
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSN-----------INNR-DQIIFMVGRGYLSPD-- 235
Query: 901 HANVAKQSCASSVLSLAMECTSESPENR 928
             +  + +C  ++  L  EC  +  + R
Sbjct: 236 -LSKVRSNCPKAMKRLMAECLKKKRDER 262

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 124/268 (46%), Gaps = 23/268 (8%)
Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           Q +    IG GS+G+VYKG++   + V +          L +F  E  +L+  RH N++ 
Sbjct: 11  QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 70
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
            +   T     A+V ++    SL   ++      ++ + + I    A  ++YLH   +  
Sbjct: 71  FMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKS 126
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPEYGR---EG 840
           I+H D+K +N+ L + +   + DFG+A + S      Q + L+ +I ++APE  R   + 
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
             S + DVY +GI+L E+ TG  P +            IN+    ++ ++    LS D  
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLPYSN-----------INNR-DQIIFMVGRGYLSPD-- 232
Query: 901 HANVAKQSCASSVLSLAMECTSESPENR 928
             +  + +C  ++  L  EC  +  + R
Sbjct: 233 -LSKVRSNCPKAMKRLMAECLKKKRDER 259

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 124/275 (45%), Gaps = 29/275 (10%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V  G++    +VAIK+    +EG++  + F  E +++  + H  LV++   C
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      ++ EYM  G L + +          Q L +  DV  A+EYL    S   +H D
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 136
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L++D  V  +SDFG+++ + +++      +   + +  PE     + S K D++
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 196
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G+++ E+++ G  P   F   E +      + +   + +   +L SE           
Sbjct: 197 AFGVLMWEIYSLGKMPYERFTNSETA------EHIAQGLRLYRPHLASE----------- 239
Query: 909 CASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
               V ++   C  E  + R   K ++S ++ + D
Sbjct: 240 ---KVYTIMYSCWHEKADERPTFKILLSNILDVMD 271

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 124/268 (46%), Gaps = 23/268 (8%)
Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           Q +    IG GS+G+VYKG++   + V +          L +F  E  +L+  RH N++ 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
            +   T     A+V ++    SL   ++      ++ + + I    A  ++YLH   +  
Sbjct: 69  FMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKS 124
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPEYGR---EG 840
           I+H D+K +N+ L + +   + DFG+A + S      Q + L+ +I ++APE  R   + 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
             S + DVY +GI+L E+ TG  P +            IN+    ++ ++    LS D  
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSN-----------INNR-DQIIFMVGRGYLSPD-- 230
Query: 901 HANVAKQSCASSVLSLAMECTSESPENR 928
             +  + +C  ++  L  EC  +  + R
Sbjct: 231 -LSKVRSNCPKAMKRLMAECLKKKRDER 257

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 124/268 (46%), Gaps = 23/268 (8%)
Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           Q +    IG GS+G+VYKG++   + V +          L +F  E  +L+  RH N++ 
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 73
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
            +   T     A+V ++    SL   ++      ++ + + I    A  ++YLH   +  
Sbjct: 74  FMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKS 129
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPEYGR---EG 840
           I+H D+K +N+ L + +   + DFG+A + S      Q + L+ +I ++APE  R   + 
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
             S + DVY +GI+L E+ TG  P +            IN+    ++ ++    LS D  
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSN-----------INNR-DQIIFMVGRGYLSPD-- 235
Query: 901 HANVAKQSCASSVLSLAMECTSESPENR 928
             +  + +C  ++  L  EC  +  + R
Sbjct: 236 -LSKVRSNCPKAMKRLMAECLKKKRDER 262

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 124/275 (45%), Gaps = 29/275 (10%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V  G++    +VAIK+    +EG++  + F  E +++  + H  LV++   C
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      ++ EYM  G L + +          Q L +  DV  A+EYL    S   +H D
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 129
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L++D  V  +SDFG+++ + +++      +   + +  PE     + S K D++
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 189
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G+++ E+++ G  P   F   E +      + +   + +   +L SE           
Sbjct: 190 AFGVLMWEIYSLGKMPYERFTNSETA------EHIAQGLRLYRPHLASE----------- 232
Query: 909 CASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
               V ++   C  E  + R   K ++S ++ + D
Sbjct: 233 ---KVYTIMYSCWHEKADERPTFKILLSNILDVMD 264

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 77/294 (26%), Positives = 134/294 (45%), Gaps = 34/294 (11%)
Query: 644 GMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREG 702
           GMSP      Y   E+ R TD  + ++ +G G YG VY+G +    + VA+K    +   
Sbjct: 1   GMSPN-----YDKWEMER-TD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTM 52
Query: 703 ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFN-LDIF 761
            +  F  E  ++K I+H NLV+++  CT      ++ E+M  G+L D +   N   ++  
Sbjct: 53  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV 112
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK 821
             L +   ++SA+EYL        +H D+   N L+ ++ +  ++DFG+++L++ +    
Sbjct: 113 VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 169
Query: 822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIN 880
                  I + APE     + SIK DV+ +G++L E+ T GM P             +  
Sbjct: 170 PAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-------------YPG 216
Query: 881 DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
             L  V  +++ +   E  E        C   V  L   C   +P +R +  EI
Sbjct: 217 IDLSQVYELLEKDYRMERPE-------GCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 56/192 (29%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
           +      +V EYM KGSL D +       L + Q + +   +AS + Y+   +    VH 
Sbjct: 80  SEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHR 135
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 196 WSFGILLTELTT 207

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 136/311 (43%), Gaps = 44/311 (14%)
Query: 647 PQVMWRRYSHDELLRATDQFSEE---------NLIGIGSYGSVYKGRF--PDGIEVAIKV 695
           PQ     ++++E  RA   F+ E          +IG G  G V  GR   P   +V + +
Sbjct: 23  PQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 696 FHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY 752
             L+    E     F +E  I+    H N++++    T      +V EYM  GSL+  + 
Sbjct: 83  KALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 753 ASNFNLDIFQRLGIMIDVASALEYL-HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA 811
             +    I Q +G++  V + + YL   G+    VH D+   NVL+D ++V  +SDFG++
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLS 198
Query: 812 KLLSEEDSMKQTQTLAT--IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEF 868
           ++L ++     T T     I + APE       S   DV+++G+++ EV   G +P    
Sbjct: 199 RVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY--- 255
Query: 869 FTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV-AKQSCASSVLSLAMECTSESPEN 927
                    W         N+ + +++S  EE   + A   C  ++  L ++C  +    
Sbjct: 256 ---------W---------NMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQ 297
Query: 928 RVNTKEIISRL 938
           R    +I+S L
Sbjct: 298 RPRFSQIVSVL 308

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 122/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 +++E+M  G+L D +   N   ++    L +   ++SA+EYL        +H D
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 202 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 241
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 124/275 (45%), Gaps = 29/275 (10%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V  G++    +VAIK+    +EG++  + F  E +++  + H  LV++   C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      ++ EYM  G L + +          Q L +  DV  A+EYL    S   +H D
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L++D  V  +SDFG+++ + +++      +   + +  PE     + S K D++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G+++ E+++ G  P   F   E +      + +   + +   +L SE           
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSETA------EHIAQGLRLYRPHLASE----------- 233
Query: 909 CASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
               V ++   C  E  + R   K ++S ++ + D
Sbjct: 234 ---KVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 72/293 (24%), Positives = 139/293 (47%), Gaps = 34/293 (11%)
Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFH--LQREGALN-SFDAECEILKTIR 718
           +D++    ++G G    V+  R   D  +VA+KV    L R+ +    F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 719 HRNLVKIISSCTNHN----FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
           H  +V +  +            +V+EY+   +L D ++       +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---Y 831
           + L+F H N I+H D+KP+N+++  +    + DFGIA+ +++  +   TQT A IG   Y
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAAVIGTAQY 185
Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
           ++PE  R   V  + DVY+ G +L EV TG  P    FTG+  +              + 
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVS-------------VA 228
Query: 892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNT-KEIISRLIKIRD 943
              + ED    +   +  ++ + ++ ++  +++PENR  T  E+ + L+++ +
Sbjct: 229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 55/192 (28%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-LHFGHSNPIVHC 788
           +      +V EYM KGSL D +      +  + RL  ++D+A+ +   + +      VH 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D+  +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 199 WSFGILLTELTT 210

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 136/311 (43%), Gaps = 44/311 (14%)
Query: 647 PQVMWRRYSHDELLRATDQFSEE---------NLIGIGSYGSVYKGRF--PDGIEVAIKV 695
           PQ     ++++E  RA   F+ E          +IG G  G V  GR   P   +V + +
Sbjct: 23  PQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 696 FHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY 752
             L+    E     F +E  I+    H N++++    T      +V EYM  GSL+  + 
Sbjct: 83  KALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 753 ASNFNLDIFQRLGIMIDVASALEYL-HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA 811
             +    I Q +G++  V + + YL   G+    VH D+   NVL+D ++V  +SDFG++
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLS 198
Query: 812 KLLSEEDSMKQTQTLAT--IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEF 868
           ++L ++     T T     I + APE       S   DV+++G+++ EV   G +P    
Sbjct: 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY--- 255
Query: 869 FTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV-AKQSCASSVLSLAMECTSESPEN 927
                    W         N+ + +++S  EE   + A   C  ++  L ++C  +    
Sbjct: 256 ---------W---------NMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQ 297
Query: 928 RVNTKEIISRL 938
           R    +I+S L
Sbjct: 298 RPRFSQIVSVL 308

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 56/192 (29%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
           +      +V EYM KGSL D +       L + Q + +   +AS + Y+   +    VH 
Sbjct: 80  SEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHR 135
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 196 WSFGILLTELTT 207

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 124/268 (46%), Gaps = 23/268 (8%)
Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           Q +    IG GS+G+VYKG++   + V +          L +F  E  +L+  RH N++ 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
            +   T     A+V ++    SL   ++      ++ + + I    A  ++YLH   +  
Sbjct: 69  FMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKS 124
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPEYGR---EG 840
           I+H D+K +N+ L + +   + DFG+A + S      Q + L+ +I ++APE  R   + 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
             S + DVY +GI+L E+ TG  P +            IN+    ++ ++    LS D  
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSN-----------INNR-DQIIFMVGRGYLSPD-- 230
Query: 901 HANVAKQSCASSVLSLAMECTSESPENR 928
             +  + +C  ++  L  EC  +  + R
Sbjct: 231 -LSKVRSNCPKAMKRLMAECLKKKRDER 257

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 130/285 (45%), Gaps = 33/285 (11%)
Query: 666 FSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHR 720
            S + ++G G +G V  GR   P   E+++ +  L+    E     F  E  I+    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-HF 779
           N++++    T      +V E M  GSL+  +   +    + Q +G++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYG 837
           G+    VH D+   N+L++ ++V  +SDFG++++L ++     T       I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
              + +   DV++YGI+L EV + G +P  E             D + AV          
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAV---------- 263
Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            DE +       C +++  L ++C  +   NR   ++I+S L K+
Sbjct: 264 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 29/275 (10%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSC 729
           IG G +G V+ G + +  +VAIK     +EG++  + F  E E++  + H  LV++   C
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTI---KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                  LV E+M  G L D +            LG+ +DV   + YL       ++H D
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 148
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ V  +SDFG+ + + ++     T T   + + +PE     + S K DV+
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 208
Query: 850 NYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSC 909
           ++G+++ EVF+  K   E            N S   V+  + T           + K   
Sbjct: 209 SFGVLMWEVFSEGKIPYE------------NRSNSEVVEDISTGF--------RLYKPRL 248
Query: 910 ASS-VLSLAMECTSESPENRVNTKEIISRLIKIRD 943
           AS+ V  +   C  E PE+R     ++ +L +I +
Sbjct: 249 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 124/275 (45%), Gaps = 29/275 (10%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V  G++    +VAIK+    +EG++  + F  E +++  + H  LV++   C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      ++ EYM  G L + +          Q L +  DV  A+EYL    S   +H D
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 125
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L++D  V  +SDFG+++ + +++      +   + +  PE     + S K D++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G+++ E+++ G  P   F   E +      + +   + +   +L SE           
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETA------EHIAQGLRLYRPHLASE----------- 228
Query: 909 CASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
               V ++   C  E  + R   K ++S ++ + D
Sbjct: 229 ---KVYTIMYSCWHEKADERPTFKILLSNILDVMD 260

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 130/285 (45%), Gaps = 33/285 (11%)
Query: 666 FSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHR 720
            S + ++G G +G V  GR   P   E+++ +  L+    E     F  E  I+    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-HF 779
           N++++    T      +V E M  GSL+  +   +    + Q +G++  +AS ++YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYG 837
           G+    VH D+   N+L++ ++V  +SDFG++++L ++     T       I + +PE  
Sbjct: 138 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
              + +   DV++YGI+L EV + G +P  E             D + AV          
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAV---------- 234
Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            DE +       C +++  L ++C  +   NR   ++I+S L K+
Sbjct: 235 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 +++E+M  G+L D +   N   +     L +   ++SA+EYL        +H D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 197 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 236
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 75/293 (25%), Positives = 140/293 (47%), Gaps = 34/293 (11%)
Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFH--LQREGALN-SFDAECEILKTIR 718
           +D++    ++G G    V+  R   D  +VA+KV    L R+ +    F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 719 HRNLVKIISSCTNHN----FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
           H  +V +  +            +V+EY+   +L D ++       +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---Y 831
           + L+F H N I+H D+KP+N+++  +    + DFGIA+ +++  +   TQT A IG   Y
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAAVIGTAQY 185
Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
           ++PE  R   V  + DVY+ G +L EV TG  P    FTG         DS  +V     
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTG---------DSPDSVA---- 228
Query: 892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNT-KEIISRLIKIRD 943
              + ED    +   +  ++ + ++ ++  +++PENR  T  E+ + L+++ +
Sbjct: 229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 +++E+M  G+L D +   N   +     L +   ++SA+EYL        +H D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 197 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 236
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   ++    L +   ++SA+EYL        +H D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 202 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 241
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 128/284 (45%), Gaps = 31/284 (10%)
Query: 666 FSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHR 720
            S + ++G G +G V  GR   P   E+++ +  L+    E     F  E  I+    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
           N++++    T      +V E M  GSL+  +   +    + Q +G++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGR 838
                VH D+   N+L++ ++V  +SDFG++++L ++     T       I + +PE   
Sbjct: 164 SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 839 EGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE 897
             + +   DV++YGI+L EV + G +P  E             D + AV           
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAV----------- 263
Query: 898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
           DE +       C +++  L ++C  +   NR   ++I+S L K+
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 134/302 (44%), Gaps = 23/302 (7%)
Query: 641 IKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR 700
           +K G        R + D+      Q +    IG GS+G+VYKG++   + V +       
Sbjct: 1   MKKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT 60
Query: 701 EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDI 760
              L +F  E  +L+  RH N++  +   T     A+V ++    SL   ++AS    ++
Sbjct: 61  PQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEM 119
Query: 761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM 820
            + + I    A  ++YL   H+  I+H D+K +N+ L +     + DFG+A   S     
Sbjct: 120 KKLIDIARQTARGMDYL---HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176
Query: 821 KQTQTLA-TIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
            Q + L+ +I ++APE  R       S + DVY +GI+L E+ TG  P +          
Sbjct: 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN--------- 227
Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
             IN+    ++ ++    LS D    +  + +C   +  L  EC  +  + R +   I++
Sbjct: 228 --INNR-DQIIEMVGRGSLSPD---LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281
Query: 937 RL 938
            +
Sbjct: 282 EI 283

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G +     VAIK     + G ++  +F  E +++K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-LHFGHSNPIVHC 788
           +      +V EYM KG L D +      +  + RL  ++D+A+ +   + +      VH 
Sbjct: 83  SEEPI-YIVTEYMSKGCLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G+ +IK DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 199 WSFGILLTELTT 210

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 121/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   ++    L +   ++SA+EYL        +H +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRN 382
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 442
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 443 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 482
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 483 CPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 23/268 (8%)
Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           Q +    IG GS+G+VYKG++   + V +          L +F  E  +L+  RH N++ 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
            +   T     A+V ++    SL   ++      ++ + + I    A  ++YL   H+  
Sbjct: 69  FMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKS 124
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPEYGR---EG 840
           I+H D+K +N+ L + +   + DFG+A   S      Q + L+ +I ++APE  R   + 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
             S + DVY +GI+L E+ TG  P +            IN+    ++ ++    LS D  
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSN-----------INNR-DQIIFMVGRGYLSPD-- 230
Query: 901 HANVAKQSCASSVLSLAMECTSESPENR 928
             +  + +C  ++  L  EC  +  + R
Sbjct: 231 -LSKVRSNCPKAMKRLMAECLKKKRDER 257

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 119/266 (44%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 +++E+M  G+L D +   N   +     L +   ++SA+EYL        +H D
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P                   P +       LL +D        + 
Sbjct: 195 AFGVLLWEIATYGMSP------------------YPGIDPSQVYELLEKDYRMER--PEG 234
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   ++    L +   ++SA+EYL        +H D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 202 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 241
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   ++    L +   ++SA+EYL        +H D
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 149
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 209
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 210 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 249
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 250 CPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 71/292 (24%), Positives = 139/292 (47%), Gaps = 32/292 (10%)
Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFH--LQREGALN-SFDAECEILKTIR 718
           +D++    ++G G    V+  R   D  +VA+KV    L R+ +    F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 719 HRNLVKIISSCTNHN----FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
           H  +V +  +            +V+EY+   +L D ++       +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE-DSMKQT-QTLATIGYI 832
           + L+F H N I+H D+KP+N+L+  +    + DFGIA+ +++  +S+ QT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           +PE  R   V  + DVY+ G +L EV TG  P    FTG+  +              +  
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVS-------------VAY 229
Query: 893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNT-KEIISRLIKIRD 943
             + ED    +   +  ++ + ++ ++  +++PENR  T  E+ + L+++ +
Sbjct: 230 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   ++    L +   ++SA+EYL        +H D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 202 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 241
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   ++    L +   ++SA+EYL        +H D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 197 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 236
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   ++    L +   ++SA+EYL        +H D
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 140
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 200
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 201 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 240
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   ++    L +   ++SA+EYL        +H D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 197 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 236
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   ++    L +   ++SA+EYL        +H D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 199 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 238
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   ++    L +   ++SA+EYL        +H D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 199 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 238
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 137/296 (46%), Gaps = 44/296 (14%)
Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN- 705
           PQ  W +   D      +    E  +G G +G V+   +    +VA+K     + G+++ 
Sbjct: 168 PQKPWEK---DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSV 221
Query: 706 -SFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL 764
            +F AE  ++KT++H  LVK+ +  T      ++ E+M KGSL D + +   +    Q L
Sbjct: 222 EAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSK---QPL 277
Query: 765 GIMIDVASAL-EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
             +ID ++ + E + F      +H D++ +N+L+  S+V  ++DFG+A++ ++       
Sbjct: 278 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAK------- 330
Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDS 882
                I + APE    G  +IK DV+++GI+LME+ T G  P    + G          S
Sbjct: 331 ---FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP----YPGM---------S 374
Query: 883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
            P V+  ++        E+       C   + ++ M C    PE R   + I S L
Sbjct: 375 NPEVIRALERGYRMPRPEN-------CPEELYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 51/192 (26%), Positives = 106/192 (55%), Gaps = 9/192 (4%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRNLVKIISSC 729
           +G G +G V+ G + +  +VA+K     + G ++  +F  E  ++KT++H  LV++ +  
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL-EYLHFGHSNPIVHC 788
           T      ++ E+M KGSL D + +      +  +L   ID ++ + E + +      +H 
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHR 133
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDV 848
           D++ +NVL+ +S++  ++DFG+A+++ + +   +      I + APE    G  +IK +V
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 849 YNYGIMLMEVFT 860
           +++GI+L E+ T
Sbjct: 194 WSFGILLYEIVT 205

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 8/201 (3%)
Query: 689 IEVAIKVFHL---QREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKG 745
           I+VAIK   +   ++E  L  F+ E      + H+N+V +I      +   LV+EY+   
Sbjct: 37  IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGP 96
Query: 746 SLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL 805
           +L + +  S+  L +   +     +   +++    H   IVH DIKP N+L+D +    +
Sbjct: 97  TLSEYI-ESHGPLSVDTAINFTNQILDGIKH---AHDMRIVHRDIKPQNILIDSNKTLKI 152
Query: 806 SDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPT 865
            DFGIAK LSE    +    L T+ Y +PE  +        D+Y+ GI+L E+  G  P 
Sbjct: 153 FDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212
Query: 866 NEFFTGEMSIKRWINDSLPAV 886
           N      ++IK  I DS+P V
Sbjct: 213 NGETAVSIAIKH-IQDSVPNV 232

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 120/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   +     L +   ++SA+EYL        +H D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 197 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 236
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 120/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   +     L +   ++SA+EYL        +H D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 197 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 236
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 120/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   +     L +   ++SA+EYL        +H D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 202 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 241
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE----GALNSFDAECEILKTIRHR 720
           + + E +IGIG +G VY+  F  G EVA+K      +      + +   E ++   ++H 
Sbjct: 8   ELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
           N++ +   C       LV+E+   G L   +       DI     + I  A  + YLH  
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI--ARGMNYLHDE 124
Query: 781 HSNPIVHCDIKPSNVLLDDSM--------VAHLSDFGIAKLLSEEDSMKQTQTLATIGYI 832
              PI+H D+K SN+L+   +        +  ++DFG+A+       M      A   ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA---WM 181
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           APE  R    S   DV++YG++L E+ TG  P
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   ++    L +   ++SA+EYL        +H D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 199 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 238
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 120/266 (45%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   +     L +   ++SA+EYL        +H +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P             +    L  V  +++ +   E  E        
Sbjct: 404 AFGVLLWEIATYGMSP-------------YPGIDLSQVYELLEKDYRMERPE-------G 443
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 444 CPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 68/290 (23%), Positives = 129/290 (44%), Gaps = 29/290 (10%)
Query: 656 HDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL--NSFDAECEI 713
           H EL R      +E  +G G +G V  G++    +VA+K+    +EG++  + F  E + 
Sbjct: 2   HMELKREEITLLKE--LGSGQFGVVKLGKWKGQYDVAVKMI---KEGSMSEDEFFQEAQT 56
Query: 714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
           +  + H  LVK    C+      +V EY+  G L + + +    L+  Q L +  DV   
Sbjct: 57  MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           + +L    S+  +H D+   N L+D  +   +SDFG+ + + ++  +    T   + + A
Sbjct: 117 MAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA 173
Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           PE     + S K DV+ +GI++ EVF+          G+M    + N  +          
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFS---------LGKMPYDLYTNSEV---------- 214
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
           +L   + H        + ++  +   C  E PE R   ++++S +  +R+
Sbjct: 215 VLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 118/266 (44%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G YG VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   +     L +   ++SA+EYL        +H D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P                   P +       LL +D        + 
Sbjct: 195 AFGVLLWEIATYGMSP------------------YPGIDPSQVYELLEKDYRMER--PEG 234
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 71/293 (24%), Positives = 139/293 (47%), Gaps = 34/293 (11%)
Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFH--LQREGALN-SFDAECEILKTIR 718
           +D++    ++G G    V+  R      +VA+KV    L R+ +    F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 719 HRNLVKIISSCTNHN----FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
           H  +V + ++            +V+EY+   +L D ++       +  +  I + +A A 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---Y 831
           + L+F H N I+H D+KP+N+++  +    + DFGIA+ +++  +   TQT A IG   Y
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAAVIGTAQY 185
Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
           ++PE  R   V  + DVY+ G +L EV TG  P    FTG+  +              + 
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVS-------------VA 228
Query: 892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNT-KEIISRLIKIRD 943
              + ED    +   +  ++ + ++ ++  +++PENR  T  E+ + L+++ +
Sbjct: 229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 67/266 (25%), Positives = 118/266 (44%), Gaps = 27/266 (10%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G +G VY+G +    + VA+K    +    +  F  E  ++K I+H NLV+++  CT
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                 ++ E+M  G+L D +   N   +     L +   ++SA+EYL        +H D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVY 849
           +   N L+ ++ +  ++DFG+++L++ +           I + APE     + SIK DV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 850 NYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQS 908
            +G++L E+ T GM P                   P +       LL +D        + 
Sbjct: 195 AFGVLLWEIATYGMSP------------------YPGIDPSQVYELLEKDYRMER--PEG 234
Query: 909 CASSVLSLAMECTSESPENRVNTKEI 934
           C   V  L   C   +P +R +  EI
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 135/297 (45%), Gaps = 33/297 (11%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA--ECEILKT 716
            ++ +++    L+G GSYG V K R  D G  VAIK F    +  +    A  E ++LK 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDC-MYASNFNLDIFQRLGIMIDVASALE 775
           +RH NLV ++  C       LV E++    L+D  ++ +  +  + Q+    I     + 
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-----IN 135
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            + F HS+ I+H DIKP N+L+  S V  L DFG A+ L+    +   + +AT  Y APE
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE-VATRWYRAPE 194
Query: 836 -------YGREGQVSIKGDVYNYGIMLMEVFTG--MKPTNEFFTGEMSIKRWINDSLPAV 886
                  YG+        DV+  G ++ E+F G  + P +        I   + + +P  
Sbjct: 195 LLVGDVKYGK------AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248
Query: 887 MNIMDTN------LLSEDEEHANVAKQ--SCASSVLSLAMECTSESPENRVNTKEII 935
             + + N       L E +E   + ++    +  V+ LA +C    P+ R    E++
Sbjct: 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 71/293 (24%), Positives = 138/293 (47%), Gaps = 34/293 (11%)
Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFH--LQREGALN-SFDAECEILKTIR 718
           +D++    ++G G    V+  R      +VA+KV    L R+ +    F  E +    + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 719 HRNLVKIISSCTNHN----FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
           H  +V +  +            +V+EY+   +L D ++       +  +  I + +A A 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 143
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---Y 831
           + L+F H N I+H D+KP+N+++  +    + DFGIA+ +++  +   TQT A IG   Y
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAAVIGTAQY 202
Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
           ++PE  R   V  + DVY+ G +L EV TG  P    FTG+  +              + 
Sbjct: 203 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVS-------------VA 245
Query: 892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNT-KEIISRLIKIRD 943
              + ED    +   +  ++ + ++ ++  +++PENR  T  E+ + L+++ +
Sbjct: 246 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 298

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 71/293 (24%), Positives = 138/293 (47%), Gaps = 34/293 (11%)
Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFH--LQREGALN-SFDAECEILKTIR 718
           +D++    ++G G    V+  R      +VA+KV    L R+ +    F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 719 HRNLVKIISSCTNHN----FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
           H  +V +  +            +V+EY+   +L D ++       +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---Y 831
           + L+F H N I+H D+KP+N+++  +    + DFGIA+ +++  +   TQT A IG   Y
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAAVIGTAQY 185
Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
           ++PE  R   V  + DVY+ G +L EV TG  P    FTG+  +              + 
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVS-------------VA 228
Query: 892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNT-KEIISRLIKIRD 943
              + ED    +   +  ++ + ++ ++  +++PENR  T  E+ + L+++ +
Sbjct: 229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 127/292 (43%), Gaps = 39/292 (13%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHL-QREG------ALNSFDAECEI 713
           A ++   E  IG G +G V+KGR   D   VAIK   L   EG          F  E  I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
           +  + H N+VK+      HN   +V+E++P G L   +      +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDD-----SMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           +EY+    + PIVH D++  N+ L        + A ++DFG    LS++     +  L  
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG----LSQQSVHSVSGLLGN 189
Query: 829 IGYIAPEY--GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV 886
             ++APE     E   + K D Y++ ++L  + TG  P +E+  G++             
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF----------- 238
Query: 887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                 N++ E+     +  + C   + ++   C S  P+ R +   I+  L
Sbjct: 239 -----INMIREEGLRPTIP-EDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 124/264 (46%), Gaps = 21/264 (7%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL 722
           D+  +  ++G G+YG VY GR   + + +AIK    +          E  + K ++H+N+
Sbjct: 8   DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 67
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNL-DIFQRLGIMIDVASALEYLHFGH 781
           V+ + S + + F  + +E +P GSL   + +    L D  Q +G        LE L + H
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY--TKQILEGLKYLH 125
Query: 782 SNPIVHCDIKPSNVLLDD-SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
            N IVH DIK  NVL++  S V  +SDFG +K L+  +   +T T  T+ Y+APE   +G
Sbjct: 126 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKG 184
Query: 841 QVSI--KGDVYNYGIMLMEVFTGMKPTNE--------FFTGEMSIKRWINDSLPAVMNIM 890
                   D+++ G  ++E+ TG  P  E        F  G   +   I +S+ A     
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 244
Query: 891 DTNLLSEDEEHANVAKQSCASSVL 914
                  D +     K++CA+ +L
Sbjct: 245 ILKCFEPDPD-----KRACANDLL 263

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 129/282 (45%), Gaps = 33/282 (11%)
Query: 669 ENLIGIGSYGSVYKGRF--PDGIE--VAIKVFHL-QREGALNSFDAECEILKTIRHRNLV 723
           E +IG G +G V  GR   P   E  VAIK   +   E     F  E  I+    H N++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-HFGHS 782
            +    T      +V EYM  GSL+  +  ++    + Q +G++  +++ ++YL   G+ 
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY- 145
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREG 840
              VH D+   N+L++ ++V  +SDFG++++L ++     T       I + APE     
Sbjct: 146 ---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
           + +   DV++YGI++ EV + G +P  E             D + AV           +E
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERPYWEMTN---------QDVIKAV-----------EE 242
Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            +   +   C +++  L ++C  +   +R    EI++ L K+
Sbjct: 243 GYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 124/264 (46%), Gaps = 21/264 (7%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL 722
           D+  +  ++G G+YG VY GR   + + +AIK    +          E  + K ++H+N+
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNL-DIFQRLGIMIDVASALEYLHFGH 781
           V+ + S + + F  + +E +P GSL   + +    L D  Q +G        LE L + H
Sbjct: 82  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY--TKQILEGLKYLH 139
Query: 782 SNPIVHCDIKPSNVLLDD-SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
            N IVH DIK  NVL++  S V  +SDFG +K L+  +   +T T  T+ Y+APE   +G
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKG 198
Query: 841 QVSI--KGDVYNYGIMLMEVFTGMKPTNE--------FFTGEMSIKRWINDSLPAVMNIM 890
                   D+++ G  ++E+ TG  P  E        F  G   +   I +S+ A     
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258
Query: 891 DTNLLSEDEEHANVAKQSCASSVL 914
                  D +     K++CA+ +L
Sbjct: 259 ILKCFEPDPD-----KRACANDLL 277

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 135/299 (45%), Gaps = 42/299 (14%)
Query: 661 RATDQFSEE---------NLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNS 706
           RA  QF++E          +IG G +G V  GR   P   +VA+ +  L+    E     
Sbjct: 31  RAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRD 90
Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGI 766
           F  E  I+    H N+V +    T      +V+E+M  G+L+  +   +    + Q +G+
Sbjct: 91  FLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGM 150
Query: 767 MIDVASALEYL-HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT 825
           +  +A+ + YL   G+    VH D+   N+L++ ++V  +SDFG+++++ ++     T T
Sbjct: 151 LRGIAAGMRYLADMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTT 206
Query: 826 LATI--GYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDS 882
              I   + APE  +  + +   DV++YGI++ EV + G +P  +             D 
Sbjct: 207 GGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---------QDV 257
Query: 883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
           + A+           +E +   A   C + +  L ++C  +    R   ++I+  L K+
Sbjct: 258 IKAI-----------EEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKM 305

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 133/284 (46%), Gaps = 35/284 (12%)
Query: 669 ENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLV 723
           E +IG G +G V +GR   P   E  + +  L+    E     F +E  I+    H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++    TN     ++ E+M  G+L+  +  ++    + Q +G++  +AS + YL      
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEM 137
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-----TIGYIAPEYGR 838
             VH D+   N+L++ ++V  +SDFG+++ L EE+S   T+T +      I + APE   
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFL-EENSSDPTETSSLGGKIPIRWTAPEAIA 196
Query: 839 EGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE 897
             + +   D ++YGI++ EV + G +P       +MS +  IN               + 
Sbjct: 197 FRKFTSASDAWSYGIVMWEVMSFGERP-----YWDMSNQDVIN---------------AI 236
Query: 898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
           ++++       C +S+  L ++C  +    R    +++S L K+
Sbjct: 237 EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 126/292 (43%), Gaps = 39/292 (13%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHL-QREG------ALNSFDAECEI 713
           A ++   E  IG G +G V+KGR   D   VAIK   L   EG          F  E  I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
           +  + H N+VK+      HN   +V+E++P G L   +      +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDD-----SMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           +EY+    + PIVH D++  N+ L        + A ++DFG     S++     +  L  
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGT----SQQSVHSVSGLLGN 189
Query: 829 IGYIAPEY--GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV 886
             ++APE     E   + K D Y++ ++L  + TG  P +E+  G++             
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF----------- 238
Query: 887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                 N++ E+     +  + C   + ++   C S  P+ R +   I+  L
Sbjct: 239 -----INMIREEGLRPTIP-EDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 125/289 (43%), Gaps = 45/289 (15%)
Query: 672 IGIGSYGSVYKGR----FP--DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI 725
           +G G++G V+        P  D + VA+K      E A   F  E E+L  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFN--------------LDIFQRLGIMIDVA 771
              CT      +V EYM  G L   + +   +              L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIG 830
           + + YL   H    VH D+   N L+   +V  + DFG+++ +   D  +   +T+  I 
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNI 889
           ++ PE     + + + DV+++G++L E+FT G +P             W   S     N 
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-------------WYQLS-----NT 267
Query: 890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              + +++  E      ++C   V ++   C    P+ R + K++ +RL
Sbjct: 268 EAIDCITQGRELER--PRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 132/284 (46%), Gaps = 35/284 (12%)
Query: 669 ENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLV 723
           E +IG G +G V +GR   P   E  + +  L+    E     F +E  I+    H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++    TN     ++ E+M  G+L+  +  ++    + Q +G++  +AS + YL      
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEM 135
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-----TIGYIAPEYGR 838
             VH D+   N+L++ ++V  +SDFG+++ L EE+S   T T +      I + APE   
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFL-EENSSDPTYTSSLGGKIPIRWTAPEAIA 194
Query: 839 EGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE 897
             + +   D ++YGI++ EV + G +P       +MS +  IN               + 
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMSFGERP-----YWDMSNQDVIN---------------AI 234
Query: 898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
           ++++       C +S+  L ++C  +    R    +++S L K+
Sbjct: 235 EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 92/230 (40%), Gaps = 28/230 (12%)
Query: 384 NKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDXXXXXXXXXXXXXXTSVIPSTFW 443
           N   GPIP      ++L+ +Y+    +SG+IP  L                +  +P +  
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 444 NLEDILGFDFSSNSLNGSLPLEIENL-KAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLE 502
           +L +++G  F  N ++G++P    +  K    + +SRN L+G IP T   L NL  + L 
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLS 205
Query: 503 HNKLQGPIPESFGE----------LVSLEF-------------LDLSNNDLSGVIPAXXX 539
            N L+G     FG             SL F             LDL NN + G +P    
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 540 XXXXXXXXXXXXXXXVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLC 589
                           GEIP+GG    F   ++  N  LCGSP   +P C
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG G+ G+VY       G EVAI+  +LQ++        E  +++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   +V+EY+  GSL D +  +   +D  Q   +  +   ALE+LH   SN ++H DI
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  N+LL       L+DFG    ++ E S K+++ + T  ++APE         K D+++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSEMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 851 YGIMLMEVFTGMKP 864
            GIM +E+  G  P
Sbjct: 202 LGIMAIEMIEGEPP 215

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 134/284 (47%), Gaps = 35/284 (12%)
Query: 669 ENLIGIGSYGSVYKG--RFPDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLV 723
           E +IG G +G V  G  + P   E+ + +  L+    E     F +E  I+    H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
            +    T      ++ E+M  GSL+  +  ++    + Q +G++  +A+ ++YL      
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADM 154
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-----TIGYIAPEYGR 838
             VH D+   N+L++ ++V  +SDFG+++ L E+D+   T T A      I + APE  +
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFL-EDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 839 EGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE 897
             + +   DV++YGI++ EV + G +P       +M+ +  IN               + 
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMSYGERP-----YWDMTNQDVIN---------------AI 253
Query: 898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
           ++++       C S++  L ++C  +   +R    +I++ L K+
Sbjct: 254 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 126/292 (43%), Gaps = 39/292 (13%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHL-QREG------ALNSFDAECEI 713
           A ++   E  IG G +G V+KGR   D   VAIK   L   EG          F  E  I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
           +  + H N+VK+      HN   +V+E++P G L   +      +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDD-----SMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           +EY+    + PIVH D++  N+ L        + A ++DF     LS++     +  L  
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFS----LSQQSVHSVSGLLGN 189
Query: 829 IGYIAPEY--GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV 886
             ++APE     E   + K D Y++ ++L  + TG  P +E+  G++             
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF----------- 238
Query: 887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                 N++ E+     +  + C   + ++   C S  P+ R +   I+  L
Sbjct: 239 -----INMIREEGLRPTIP-EDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 77/271 (28%), Positives = 121/271 (44%), Gaps = 32/271 (11%)
Query: 669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISS 728
           E ++G G++G V K ++    +VAIK   ++ E    +F  E   L  + H N+VK+  +
Sbjct: 14  EEVVGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM---IDVASALEYLHFGHSNPI 785
           C N     LV+EY   GSL + ++ +   L  +     M   +  +  + YLH      +
Sbjct: 71  CLNP--VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 786 VHCDIKPSNVLL-DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
           +H D+KP N+LL     V  + DFG A     +     T    +  ++APE       S 
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 183
Query: 845 KGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
           K DV+++GI+L EV T  KP +E       I  W      AV N     L+       N+
Sbjct: 184 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-W------AVHNGTRPPLIK------NL 230
Query: 905 AKQSCASSVLSLAMECTSESPENRVNTKEII 935
            K      + SL   C S+ P  R + +EI+
Sbjct: 231 PK-----PIESLMTRCWSKDPSQRPSMEEIV 256

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 77/271 (28%), Positives = 121/271 (44%), Gaps = 32/271 (11%)
Query: 669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISS 728
           E ++G G++G V K ++    +VAIK   ++ E    +F  E   L  + H N+VK+  +
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM---IDVASALEYLHFGHSNPI 785
           C N     LV+EY   GSL + ++ +   L  +     M   +  +  + YLH      +
Sbjct: 70  CLNP--VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 786 VHCDIKPSNVLL-DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
           +H D+KP N+LL     V  + DFG A     +     T    +  ++APE       S 
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 845 KGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
           K DV+++GI+L EV T  KP +E       I  W      AV N     L+       N+
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-W------AVHNGTRPPLIK------NL 229
Query: 905 AKQSCASSVLSLAMECTSESPENRVNTKEII 935
            K      + SL   C S+ P  R + +EI+
Sbjct: 230 PK-----PIESLMTRCWSKDPSQRPSMEEIV 255

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 64/241 (26%), Positives = 107/241 (44%), Gaps = 23/241 (9%)
Query: 633 RRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPD-GIEV 691
           R+S E  H++  + P  +W                    +G G++G VYK +  + G   
Sbjct: 3   RKSREYEHVRRDLDPNEVWEIVGE---------------LGDGAFGKVYKAKNKETGALA 47
Query: 692 AIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCM 751
           A KV   + E  L  +  E EIL T  H  +VK++ +  +     +++E+ P G+++  M
Sbjct: 48  AAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM 107
Query: 752 YASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA 811
              +  L   Q   I +     LE L+F HS  I+H D+K  NVL+       L+DFG++
Sbjct: 108 LELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164
Query: 812 ----KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNE 867
               K L + DS   T        +  E  ++     K D+++ GI L+E+     P +E
Sbjct: 165 AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
Query: 868 F 868
Sbjct: 225 L 225

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 669 ENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLV 723
           E +IG+G +G V  GR   P   E+ + +  L+    +     F +E  I+    H N++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
            +    T      ++ EYM  GSL+  +  ++    + Q +G++  + S ++YL      
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDM 150
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREGQ 841
             VH D+   N+L++ ++V  +SDFG++++L ++     T       I + APE     +
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKP 864
            +   DV++YGI++ EV + G +P
Sbjct: 211 FTSASDVWSYGIVMWEVMSYGERP 234

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG G+ G+VY       G EVAI+  +LQ++        E  +++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   +V+EY+  GSL D +  +   +D  Q   +  +   ALE+LH   SN ++H DI
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  N+LL       L+DFG    ++ E S K++  + T  ++APE         K D+++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSXMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 851 YGIMLMEVFTGMKP 864
            GIM +E+  G  P
Sbjct: 202 LGIMAIEMIEGEPP 215

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 48/290 (16%)
Query: 672 IGIGSYGSVYKGRF-PDGI----EVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKI 725
           +G G +G V   R+ P+G     +VA+K    +  G  +     E EIL+ + H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 726 ISSCTNH--NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
              CT    N   L++E++P GSL++ +  +   +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSR 145
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS--EEDSMKQTQTLATIGYIAPEYGREGQ 841
             VH D+   NVL++      + DFG+ K +   +E    +    + + + APE   + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 205
Query: 842 VSIKGDVYNYGIMLMEVFT----GMKPTNEFFT------GEMSIKRWIN-----DSLPAV 886
             I  DV+++G+ L E+ T       P   F        G+M++ R +N       LP  
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP 265
Query: 887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
            N                    C   V  L  +C    P NR + + +I 
Sbjct: 266 PN--------------------CPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 10/221 (4%)
Query: 647 PQVMWRRYSHDELLRATDQ-FSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGAL 704
           P+   ++   D L +  ++ F     +G GSYGSVYK    + G  VAIK   +  E  L
Sbjct: 11  PRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDL 68
Query: 705 NSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL 764
                E  I++     ++VK   S   +    +V+EY   GS+ D +   N  L   +  
Sbjct: 69  QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA 128
Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM-KQT 823
            I+      LEYLHF      +H DIK  N+LL+    A L+DFG+A  L+  D M K+ 
Sbjct: 129 TILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLT--DXMAKRN 183
Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             + T  ++APE  +E   +   D+++ GI  +E+  G  P
Sbjct: 184 XVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG G+ G+VY       G EVAI+  +LQ++        E  +++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   +V+EY+  GSL D +  +   +D  Q   +  +   ALE+LH   SN ++H DI
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  N+LL       L+DFG    ++ E S K++  + T  ++APE         K D+++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 851 YGIMLMEVFTGMKP 864
            GIM +E+  G  P
Sbjct: 202 LGIMAIEMIEGEPP 215

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 48/290 (16%)
Query: 672 IGIGSYGSVYKGRF-PDGI----EVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKI 725
           +G G +G V   R+ P+G     +VA+K    +  G  +     E EIL+ + H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 726 ISSCTNH--NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
              CT    N   L++E++P GSL++ +  +   +++ Q+L   + +   ++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSR 133
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS--EEDSMKQTQTLATIGYIAPEYGREGQ 841
             VH D+   NVL++      + DFG+ K +   +E    +    + + + APE   + +
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 842 VSIKGDVYNYGIMLMEVFT----GMKPTNEFFT------GEMSIKRWIN-----DSLPAV 886
             I  DV+++G+ L E+ T       P   F        G+M++ R +N       LP  
Sbjct: 194 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP 253
Query: 887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
            N                    C   V  L  +C    P NR + + +I 
Sbjct: 254 PN--------------------CPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG G+ G+VY       G EVAI+  +LQ++        E  +++  ++ N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   +V+EY+  GSL D +  +   +D  Q   +  +   ALE+LH   SN ++H DI
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 143
Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  N+LL       L+DFG    ++ E S K++  + T  ++APE         K D+++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSXMVGTPYWMAPEVVTRKAYGPKVDIWS 202
Query: 851 YGIMLMEVFTGMKP 864
            GIM +E+  G  P
Sbjct: 203 LGIMAIEMIEGEPP 216

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 669 ENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLV 723
           E +IG+G +G V  GR   P   E+ + +  L+    +     F +E  I+    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
            +    T      ++ EYM  GSL+  +  ++    + Q +G++  + S ++YL      
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDM 129
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREGQ 841
             VH D+   N+L++ ++V  +SDFG++++L ++     T       I + APE     +
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKP 864
            +   DV++YGI++ EV + G +P
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 669 ENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLV 723
           E +IG+G +G V  GR   P   E+ + +  L+    +     F +E  I+    H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
            +    T      ++ EYM  GSL+  +  ++    + Q +G++  + S ++YL      
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDM 135
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREGQ 841
             VH D+   N+L++ ++V  +SDFG++++L ++     T       I + APE     +
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKP 864
            +   DV++YGI++ EV + G +P
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERP 219

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 49/298 (16%)
Query: 665 QFSEENLIGIGSYGSVYKGRF--PDGIE----VAIKVFHLQREGAL-NSFDAECEILKTI 717
           +F EE  +G   +G VYKG    P   E    VAIK    + EG L   F  E  +   +
Sbjct: 29  RFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL 86
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR-------------- 763
           +H N+V ++   T     +++  Y   G L + +   + + D+                 
Sbjct: 87  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 146
Query: 764 -LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ 822
            + ++  +A+ +EYL   H   +VH D+   NVL+ D +   +SD G+ + +   D  K 
Sbjct: 147 FVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 203
Query: 823 T-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIN 880
              +L  I ++APE    G+ SI  D+++YG++L EVF+ G++P   +   ++       
Sbjct: 204 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV------- 256
Query: 881 DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                V  I +  +L             C + V +L +EC +E P  R   K+I SRL
Sbjct: 257 -----VEMIRNRQVLP--------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 49/298 (16%)
Query: 665 QFSEENLIGIGSYGSVYKGRF--PDGIE----VAIKVFHLQREGAL-NSFDAECEILKTI 717
           +F EE  +G   +G VYKG    P   E    VAIK    + EG L   F  E  +   +
Sbjct: 12  RFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL 69
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR-------------- 763
           +H N+V ++   T     +++  Y   G L + +   + + D+                 
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 764 -LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ 822
            + ++  +A+ +EYL   H   +VH D+   NVL+ D +   +SD G+ + +   D  K 
Sbjct: 130 FVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186
Query: 823 T-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIN 880
              +L  I ++APE    G+ SI  D+++YG++L EVF+ G++P   +   ++       
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV------- 239
Query: 881 DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                V  I +  +L             C + V +L +EC +E P  R   K+I SRL
Sbjct: 240 -----VEMIRNRQVLP--------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNS-FDAECEILKTIRHRNLVKIISSC 729
           IG G++G V+ GR   D   VA+K         L + F  E  ILK   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      +V+E +  G     +      L +   L ++ D A+ +EYL    S   +H D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRD 238
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ---TLATIGYIAPEYGREGQVSIKG 846
           +   N L+ +  V  +SDFG+++   E D +           + + APE    G+ S + 
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR--EEADGVXAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+++GI+L E F+ G  P
Sbjct: 297 DVWSFGILLWETFSLGASP 315

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 46/286 (16%)
Query: 672 IGIGSYGSVYKGR------FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI 725
           +G G++G V+           D + VA+K        A   F  E E+L  ++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYA---------------SNFNLDIFQRLGIMIDV 770
              C + +   +V EYM  G L   + A               +   L + Q L I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATI 829
           AS + YL   H    VH D+   N L+  +++  + DFG+++ +   D  +    T+  I
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMN 888
            ++ PE     + + + DV+++G++L E+FT G +P             W   S   V+ 
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-------------WFQLSNTEVIE 246
Query: 889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
            +    + E         + C   V  + + C    P+ R+N KEI
Sbjct: 247 CITQGRVLE-------RPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 130/284 (45%), Gaps = 35/284 (12%)
Query: 669 ENLIGIGSYGSVYKG--RFPDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLV 723
           E +IG G +G V  G  + P   E+ + +  L+    E     F +E  I+    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
            +    T      ++ E+M  GSL+  +  ++    + Q +G++  +A+ ++YL      
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADM 128
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-----TIGYIAPEYGR 838
             VH  +   N+L++ ++V  +SDFG+++ L E+D+   T T A      I + APE  +
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFL-EDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 839 EGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE 897
             + +   DV++YGI++ EV + G +P  +    ++      +  LP  M+         
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD--------- 238
Query: 898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                      C S++  L ++C  +   +R    +I++ L K+
Sbjct: 239 -----------CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 666 FSEENL-----IGIGSYGSVYKGRFP---DGIEVAIKVFHLQREGA--LNSFDAECEILK 715
           F E +L     +G G++GSV   R+    D     + V  LQ  G      F  E +ILK
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 716 TIRHRNLVKI--ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
            +    +VK   +S         LV+EY+P G L D +      LD  + L     +   
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL--LSEEDSMKQTQTLATIGY 831
           +EYL    S   VH D+   N+L++      ++DFG+AKL  L ++  + +    + I +
Sbjct: 140 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFT----GMKPTNEFFTGEMSIKRWINDSLPAVM 887
            APE   +   S + DV+++G++L E+FT       P+ EF    M  +R     +PA+ 
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCER----DVPALS 251
Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
            +++     +       A  +C + V  L   C + SP++R
Sbjct: 252 RLLELLEEGQRLP----APPACPAEVHELMKLCWAPSPQDR 288

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG G+ G+VY       G EVAI+  +LQ++        E  +++  ++ N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   +V+EY+  GSL D +  +   +D  Q   +  +   ALE+LH   SN ++H +I
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRNI 143
Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  N+LL       L+DFG    ++ E S K++  + T  ++APE         K D+++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 202
Query: 851 YGIMLMEVFTGMKP 864
            GIM +E+  G  P
Sbjct: 203 LGIMAIEMIEGEPP 216

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNS-FDAECEILKTIRHRNLVKIISSC 729
           IG G++G V+ GR   D   VA+K         L + F  E  ILK   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
           T      +V+E +  G     +      L +   L ++ D A+ +EYL    S   +H D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRD 238
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ---TLATIGYIAPEYGREGQVSIKG 846
           +   N L+ +  V  +SDFG+++   E D +           + + APE    G+ S + 
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+++GI+L E F+ G  P
Sbjct: 297 DVWSFGILLWETFSLGASP 315

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 125/281 (44%), Gaps = 33/281 (11%)
Query: 671 LIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKI 725
           +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 726 ISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  C       LV L YM  G L + +     N  +   +G  + VA  ++YL    S  
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKK 152
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK---QTQTLATIGYIAPEYGREGQ 841
            VH D+   N +LD+     ++DFG+A+ + +++      +T     + ++A E  +  +
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQK 212
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E 
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQPE- 259
Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                   C   +  + ++C     E R +  E++SR+  I
Sbjct: 260 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 125/282 (44%), Gaps = 33/282 (11%)
Query: 670 NLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVK 724
            +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 725 IISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++  C       LV L YM  G L + +     N  +   +G  + VA  ++YL    S 
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SK 144
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK---QTQTLATIGYIAPEYGREG 840
             VH D+   N +LD+     ++DFG+A+ + +++      +T     + ++A E  +  
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
           + + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E
Sbjct: 205 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQPE 252
Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                    C   +  + ++C     E R +  E++SR+  I
Sbjct: 253 --------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 122/287 (42%), Gaps = 44/287 (15%)
Query: 672 IGIGSYGSVYKGRF--PDG--IEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVK 724
           +G GS+G V +G +  P G  + VA+K      L +  A++ F  E   + ++ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCM--YASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           +         K +V E  P GSL D +  +  +F L    R  +   VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAEGMGYLE---S 133
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--MKQTQTLATIGYIAPEYGREG 840
              +H D+   N+LL    +  + DFG+ + L + D   + Q        + APE  +  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
             S   D + +G+ L E+FT G +P             WI  +   +++ +D       E
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP-------------WIGLNGSQILHKIDK------E 234
Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF 946
                  + C   + ++ ++C +  PE+R          + +RD L 
Sbjct: 235 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPT-------FVALRDFLL 274

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 125/281 (44%), Gaps = 33/281 (11%)
Query: 671 LIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKI 725
           +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ +
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 726 ISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  C       LV L YM  G L + +     N  +   +G  + VA  ++YL    S  
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKK 172
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK---QTQTLATIGYIAPEYGREGQ 841
            VH D+   N +LD+     ++DFG+A+ + +++      +T     + ++A E  +  +
Sbjct: 173 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 232
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E 
Sbjct: 233 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQPE- 279
Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                   C   +  + ++C     E R +  E++SR+  I
Sbjct: 280 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 125/281 (44%), Gaps = 33/281 (11%)
Query: 671 LIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKI 725
           +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ +
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 726 ISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  C       LV L YM  G L + +     N  +   +G  + VA  ++YL    S  
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKK 171
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK---QTQTLATIGYIAPEYGREGQ 841
            VH D+   N +LD+     ++DFG+A+ + +++      +T     + ++A E  +  +
Sbjct: 172 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 231
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E 
Sbjct: 232 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQPE- 278
Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                   C   +  + ++C     E R +  E++SR+  I
Sbjct: 279 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 125/281 (44%), Gaps = 33/281 (11%)
Query: 671 LIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKI 725
           +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 726 ISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  C       LV L YM  G L + +     N  +   +G  + VA  ++YL    S  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKK 153
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK---QTQTLATIGYIAPEYGREGQ 841
            VH D+   N +LD+     ++DFG+A+ + +++      +T     + ++A E  +  +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E 
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQPE- 260
Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                   C   +  + ++C     E R +  E++SR+  I
Sbjct: 261 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 125/282 (44%), Gaps = 33/282 (11%)
Query: 670 NLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVK 724
            +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 725 IISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++  C       LV L YM  G L + +     N  +   +G  + VA  ++YL    S 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SK 147
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK---QTQTLATIGYIAPEYGREG 840
             VH D+   N +LD+     ++DFG+A+ + +++      +T     + ++A E  +  
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
           + + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQPE 255
Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                    C   +  + ++C     E R +  E++SR+  I
Sbjct: 256 --------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 125/281 (44%), Gaps = 33/281 (11%)
Query: 671 LIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKI 725
           +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 726 ISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  C       LV L YM  G L + +     N  +   +G  + VA  ++YL    S  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKK 153
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK---QTQTLATIGYIAPEYGREGQ 841
            VH D+   N +LD+     ++DFG+A+ + +++      +T     + ++A E  +  +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E 
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQPE- 260
Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                   C   +  + ++C     E R +  E++SR+  I
Sbjct: 261 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 125/282 (44%), Gaps = 33/282 (11%)
Query: 670 NLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVK 724
            +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 725 IISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++  C       LV L YM  G L + +     N  +   +G  + VA  ++YL    S 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SK 150
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK---QTQTLATIGYIAPEYGREG 840
             VH D+   N +LD+     ++DFG+A+ + +++      +T     + ++A E  +  
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 210
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
           + + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQPE 258
Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                    C   +  + ++C     E R +  E++SR+  I
Sbjct: 259 --------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 125/281 (44%), Gaps = 33/281 (11%)
Query: 671 LIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKI 725
           +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 726 ISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  C       LV L YM  G L + +     N  +   +G  + VA  ++YL    S  
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKK 152
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK---QTQTLATIGYIAPEYGREGQ 841
            VH D+   N +LD+     ++DFG+A+ + +++      +T     + ++A E  +  +
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 212
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E 
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQPE- 259
Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                   C   +  + ++C     E R +  E++SR+  I
Sbjct: 260 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 125/282 (44%), Gaps = 33/282 (11%)
Query: 670 NLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVK 724
            +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 725 IISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++  C       LV L YM  G L + +     N  +   +G  + VA  ++YL    S 
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SK 149
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK---QTQTLATIGYIAPEYGREG 840
             VH D+   N +LD+     ++DFG+A+ + +++      +T     + ++A E  +  
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
           + + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQPE 257
Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                    C   +  + ++C     E R +  E++SR+  I
Sbjct: 258 --------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 126/281 (44%), Gaps = 33/281 (11%)
Query: 671 LIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKI 725
           +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 726 ISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  C       LV L YM  G L + +     N  +   +G  + VA  +++L    S  
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKK 154
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAK--LLSEEDSMK-QTQTLATIGYIAPEYGREGQ 841
            VH D+   N +LD+     ++DFG+A+  L  E DS+  +T     + ++A E  +  +
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E 
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------------LLQGRRLLQPE- 261
Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                   C   +  + ++C     E R +  E++SR+  I
Sbjct: 262 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 68/289 (23%), Positives = 125/289 (43%), Gaps = 45/289 (15%)
Query: 672 IGIGSYGSVYKGR----FP--DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI 725
           +G G++G V+        P  D + VA+K      E A   F  E E+L  ++H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFN--------------LDIFQRLGIMIDVA 771
              CT      +V EYM  G L   + +   +              L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIG 830
           + + YL   H    VH D+   N L+   +V  + DFG+++ +   D  +   +T+  I 
Sbjct: 146 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNI 889
           ++ PE     + + + DV+++G++L E+FT G +P             W   S     N 
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-------------WYQLS-----NT 244
Query: 890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              + +++  E      ++C   V ++   C    P+ R + K++ +RL
Sbjct: 245 EAIDCITQGRELER--PRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 291

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 68/289 (23%), Positives = 125/289 (43%), Gaps = 45/289 (15%)
Query: 672 IGIGSYGSVYKGR----FP--DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI 725
           +G G++G V+        P  D + VA+K      E A   F  E E+L  ++H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFN--------------LDIFQRLGIMIDVA 771
              CT      +V EYM  G L   + +   +              L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIG 830
           + + YL   H    VH D+   N L+   +V  + DFG+++ +   D  +   +T+  I 
Sbjct: 140 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNI 889
           ++ PE     + + + DV+++G++L E+FT G +P             W   S     N 
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-------------WYQLS-----NT 238
Query: 890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              + +++  E      ++C   V ++   C    P+ R + K++ +RL
Sbjct: 239 EAIDCITQGRELER--PRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 285

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P+G + ++    S F+    QR    I ++A+AL 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE---QRTATYITELANALS 127
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ PE
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPE 181
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 222

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 33/281 (11%)
Query: 671 LIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKI 725
           +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 726 ISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  C       LV L YM  G L + +     N  +   +G  + VA  +++L    S  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKK 153
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLL--SEEDSMK-QTQTLATIGYIAPEYGREGQ 841
            VH D+   N +LD+     ++DFG+A+ +   E DS+  +T     + ++A E  +  +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 213
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E 
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQPE- 260
Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                   C   +  + ++C     E R +  E++SR+  I
Sbjct: 261 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 33/281 (11%)
Query: 671 LIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKI 725
           +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ +
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 726 ISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  C       LV L YM  G L + +     N  +   +G  + VA  +++L    S  
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKK 158
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLL--SEEDSMK-QTQTLATIGYIAPEYGREGQ 841
            VH D+   N +LD+     ++DFG+A+ +   E DS+  +T     + ++A E  +  +
Sbjct: 159 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 218
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E 
Sbjct: 219 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------------LLQGRRLLQPE- 265
Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                   C   +  + ++C     E R +  E++SR+  I
Sbjct: 266 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 33/281 (11%)
Query: 671 LIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKI 725
           +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ +
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 726 ISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  C       LV L YM  G L + +     N  +   +G  + VA  +++L    S  
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKK 212
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLL--SEEDSMK-QTQTLATIGYIAPEYGREGQ 841
            VH D+   N +LD+     ++DFG+A+ +   E DS+  +T     + ++A E  +  +
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E 
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------------LLQGRRLLQPE- 319
Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                   C   +  + ++C     E R +  E++SR+  I
Sbjct: 320 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T+   T+ Y+ PE
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTELCGTLDYLPPE 176
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 217

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 666 FSEENLIGIGSYGSVYKGR-FPDGIEVAIK---VFHLQREGALNSFDAECEILKTIRHRN 721
           F  E  IG G +  VY+     DG+ VA+K   +F L    A      E ++LK + H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGI---MIDVASALEYLH 778
           ++K  +S    N   +VLE    G L   +        +     +    + + SALE++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR 838
              S  ++H DIKP+NV +  + V  L D G+ +  S + +   +  + T  Y++PE   
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIH 209
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI 875
           E   + K D+++ G +L E+     P   F+  +M++
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 243

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 33/281 (11%)
Query: 671 LIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKI 725
           +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 726 ISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  C       LV L YM  G L + +     N  +   +G  + VA  +++L    S  
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKK 154
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLL--SEEDSMK-QTQTLATIGYIAPEYGREGQ 841
            VH D+   N +LD+     ++DFG+A+ +   E DS+  +T     + ++A E  +  +
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E 
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------------LLQGRRLLQPE- 261
Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                   C   +  + ++C     E R +  E++SR+  I
Sbjct: 262 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 33/281 (11%)
Query: 671 LIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKI 725
           +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 726 ISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  C       LV L YM  G L + +     N  +   +G  + VA  +++L    S  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKK 153
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLL--SEEDSMK-QTQTLATIGYIAPEYGREGQ 841
            VH D+   N +LD+     ++DFG+A+ +   E DS+  +T     + ++A E  +  +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 213
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E 
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQPE- 260
Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                   C   +  + ++C     E R +  E++SR+  I
Sbjct: 261 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 33/281 (11%)
Query: 671 LIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRHRNLVKI 725
           +IG G +G VY G     DG ++   V  L R    G ++ F  E  I+K   H N++ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 726 ISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  C       LV L YM  G L + +     N  +   +G  + VA  +++L    S  
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKK 151
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLL--SEEDSMK-QTQTLATIGYIAPEYGREGQ 841
            VH D+   N +LD+     ++DFG+A+ +   E DS+  +T     + ++A E  +  +
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 211
Query: 842 VSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + K DV+++G++L E+ T G  P  +  T ++++             ++    L + E 
Sbjct: 212 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQPE- 258
Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                   C   +  + ++C     E R +  E++SR+  I
Sbjct: 259 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 669 ENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNS---FDAECEIL-KTIRHRNLV 723
           +++IG G++G V K R   DG+ +   +  ++   + +    F  E E+L K   H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---------------NLDIFQRLGIMI 768
            ++ +C +  +  L +EY P G+L D +  S                  L   Q L    
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           DVA  ++YL        +H D+   N+L+ ++ VA ++DFG+++   +E  +K+T     
Sbjct: 140 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 194
Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVM 887
           + ++A E       +   DV++YG++L E+ + G  P       E+  K      LP   
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LPQGY 248
Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            +         E+  N     C   V  L  +C  E P  R +  +I+  L ++
Sbjct: 249 RL---------EKPLN-----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 288

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 19/187 (10%)
Query: 705 NSFDAECEILKTIRHRNLVKIISSCTNHNFKAL--VLEYMPKGSLEDCMYASNFNLDIFQ 762
           + +  E +IL+T+ H +++K    C +    +L  V+EY+P GSL D  Y    ++ + Q
Sbjct: 78  SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQ 135
Query: 763 RLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE--EDSM 820
            L     +   + YLH  H    +H D+   NVLLD+  +  + DFG+AK + E  E   
Sbjct: 136 LLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYR 192
Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT----GMKPTNEFF------T 870
            +    + + + APE  +E +     DV+++G+ L E+ T       P  +F        
Sbjct: 193 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252
Query: 871 GEMSIKR 877
           G+M++ R
Sbjct: 253 GQMTVLR 259

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 669 ENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNS---FDAECEIL-KTIRHRNLV 723
           +++IG G++G V K R   DG+ +   +  ++   + +    F  E E+L K   H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---------------NLDIFQRLGIMI 768
            ++ +C +  +  L +EY P G+L D +  S                  L   Q L    
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           DVA  ++YL        +H D+   N+L+ ++ VA ++DFG+++   +E  +K+T     
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 204
Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVM 887
           + ++A E       +   DV++YG++L E+ + G  P       E+  K      LP   
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LPQGY 258
Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            +         E+  N     C   V  L  +C  E P  R +  +I+  L ++
Sbjct: 259 RL---------EKPLN-----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 109/204 (53%), Gaps = 13/204 (6%)
Query: 670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALN---SFDAECEILKTIRHRNLVKI 725
           + +G+G++G V  G+    G +VA+K+ + Q+  +L+       E + LK  RH +++K+
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
               +  +   +V+EY+  G L D +   N  LD  +   +   + S ++Y H    + +
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH---RHMV 137
Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY--GREGQVS 843
           VH D+KP NVLLD  M A ++DFG++ ++S+ + ++   +  +  Y APE   GR     
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR--XSCGSPNYAAPEVISGR-LYAG 194
Query: 844 IKGDVYNYGIMLMEVFTGMKPTNE 867
            + D+++ G++L  +  G  P ++
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFDD 218

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 17/232 (7%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHL--QREGALNSFDAECEILKTIRHRN 721
           +++ +   +G G+YG VYK +   G  VA+K   L  + EG  ++   E  +LK + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +V +I    +     LV E+M K    D     + N    Q   I I +   L  +   H
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY-GREG 840
            + I+H D+KP N+L++      L+DFG+A+          T  + T+ Y AP+      
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVVTLWYRAPDVLMGSK 195
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           + S   D+++ G +  E+ TG KP    F G        +D LP + +I+ T
Sbjct: 196 KYSTSVDIWSIGCIFAEMITG-KP---LFPGVTD-----DDQLPKIFSILGT 238

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 17/232 (7%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHL--QREGALNSFDAECEILKTIRHRN 721
           +++ +   +G G+YG VYK +   G  VA+K   L  + EG  ++   E  +LK + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +V +I    +     LV E+M K    D     + N    Q   I I +   L  +   H
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY-GREG 840
            + I+H D+KP N+L++      L+DFG+A+          T  + T+ Y AP+      
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVVTLWYRAPDVLMGSK 195
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           + S   D+++ G +  E+ TG KP    F G        +D LP + +I+ T
Sbjct: 196 KYSTSVDIWSIGCIFAEMITG-KP---LFPGVTD-----DDQLPKIFSILGT 238

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 18/223 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGALNSFDAECEILKT 716
           A + F     +G G +G+VY  R     F   ++V  K   L++ G  +    E EI   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASAL 774
           +RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 121
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPP 175
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           E         K D+++ G++  E   G KP  E  T + + KR
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 217

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 672 IGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKII 726
           +G G +G+VY  R     F   ++V  K   L++ G  +    E EI   +RH N++++ 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKT-QLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 727 SSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALEYLHFGHSNP 784
               +     L+LEY P G++  +    S F+    QR    I ++A+AL Y H   S  
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRTATYITELANALSYCH---SKR 132
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
           ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ PE         
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 189
Query: 845 KGDVYNYGIMLMEVFTGMKP 864
           K D+++ G++  E   GM P
Sbjct: 190 KVDLWSLGVLCYEFLVGMPP 209

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 8/204 (3%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSF-DAECEILKTIRHRNLV 723
           F++   IG GS+G V+KG      +V AIK+  L+           E  +L       + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           K   S    +   +++EY+  GS  D + A  F  D FQ   ++ ++   L+YLH   S 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---SE 139
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
             +H DIK +NVLL +     L+DFG+A  L++   +K+   + T  ++APE  ++    
Sbjct: 140 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-QIKRNTFVGTPFWMAPEVIQQSAYD 198
Query: 844 IKGDVYNYGIMLMEVFTGMKPTNE 867
            K D+++ GI  +E+  G  P ++
Sbjct: 199 SKADIWSLGITAIELAKGEPPNSD 222

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 123
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ PE
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPE 177
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 218

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 18/223 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGALNSFDAECEILKT 716
           A + F     +G G +G+VY  R     F   ++V  K   L++ G  +    E EI   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASAL 774
           +RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 121
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPP 175
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           E         K D+++ G++  E   G KP  E  T + + KR
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 217

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ PE
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPE 176
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 217

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 18/223 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGALNSFDAECEILKT 716
           A + F     +G G +G+VY  R     F   ++V  K   L++ G  +    E EI   
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 69
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASAL 774
           +RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 126
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ P
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPP 180
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           E         K D+++ G++  E   G KP  E  T + + KR
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 222

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 18/223 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGALNSFDAECEILKT 716
           A + F     +G G +G+VY  R     F   ++V  K   L++ G  +    E EI   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASAL 774
           +RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 121
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLDYLPP 175
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           E         K D+++ G++  E   G KP  E  T + + KR
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 217

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R      + A+KV     L++ G  +    E EI   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 148
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ PE
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPE 202
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 203 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 243

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 18/223 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGALNSFDAECEILKT 716
           A + F     +G G +G+VY  R     F   ++V  K   L++ G  +    E EI   
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 68
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASAL 774
           +RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 125
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ P
Sbjct: 126 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPP 179
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           E         K D+++ G++  E   G KP  E  T + + KR
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 8/202 (3%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G++G VYK +  + G   A KV   + E  L  +  E EIL T  H  +VK++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
           +     +++E+ P G+++  M   +  L   Q   I +     LE L+F HS  I+H D+
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 791 KPSNVLLDDSMVAHLSDFGIA----KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           K  NVL+       L+DFG++    K L + DS   T        +  E  ++     K 
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 195
Query: 847 DVYNYGIMLMEVFTGMKPTNEF 868
           D+++ GI L+E+     P +E 
Sbjct: 196 DIWSLGITLIEMAQIEPPHHEL 217

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ PE
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPE 179
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 220

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 109/241 (45%), Gaps = 40/241 (16%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIR 718
           LR    F E  ++G G++G V K R   D    AIK      E  L++  +E  +L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 719 H-------------RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFN--LDIFQR 763
           H             RN VK +++    +   + +EY   G+L D +++ N N   D + R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE-DSMK- 821
           L   I     LE L + HS  I+H D+KP N+ +D+S    + DFG+AK +    D +K 
Sbjct: 121 LFRQI-----LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 822 -----------QTQTLATIGYIAPEY-GREGQVSIKGDVYNYGIMLMEVF----TGMKPT 865
                       T  + T  Y+A E     G  + K D+Y+ GI+  E+     TGM+  
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235
Query: 866 N 866
           N
Sbjct: 236 N 236

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 18/223 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGALNSFDAECEILKT 716
           A + F     +G G +G+VY  R     F   ++V  K   L++ G  +    E EI   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASAL 774
           +RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 124
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ P
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPP 178
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           E         K D+++ G++  E   G KP  E  T + + KR
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 220

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 127
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ PE
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPE 181
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 222

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 666 FSEENL-----IGIGSYGSVYKGRFP---DGIEVAIKVFHLQREGA--LNSFDAECEILK 715
           F E +L     +G G++GSV   R+    D     + V  LQ  G      F  E +ILK
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 716 TIRHRNLVKI--ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
            +    +VK   +S         LV+EY+P G L D +      LD  + L     +   
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL--LSEEDSMKQTQTLATIGY 831
           +EYL    S   VH D+   N+L++      ++DFG+AKL  L ++  + +    + I +
Sbjct: 124 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFT----GMKPTNEFFTGEMSIKRWINDSLPAVM 887
            APE   +   S + DV+++G++L E+FT       P+ EF    M  +R     +PA+ 
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCER----DVPALC 235
Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
            +++     +       A  +C + V  L   C + SP++R
Sbjct: 236 RLLELLEEGQRLP----APPACPAEVHELMKLCWAPSPQDR 272

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P+G + ++    S F+    QR    I ++A+AL 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE---QRTATYITELANALS 127
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++     T+ Y+ PE
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLXGTLDYLPPE 181
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 222

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 666 FSEENL-----IGIGSYGSVYKGRFP---DGIEVAIKVFHLQREGA--LNSFDAECEILK 715
           F E +L     +G G++GSV   R+    D     + V  LQ  G      F  E +ILK
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 716 TIRHRNLVKI--ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
            +    +VK   +S         LV+EY+P G L D +      LD  + L     +   
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL--LSEEDSMKQTQTLATIGY 831
           +EYL    S   VH D+   N+L++      ++DFG+AKL  L ++  + +    + I +
Sbjct: 128 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFT----GMKPTNEFFTGEMSIKRWINDSLPAVM 887
            APE   +   S + DV+++G++L E+FT       P+ EF    M  +R     +PA+ 
Sbjct: 185 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCER----DVPALC 239
Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
            +++     +       A  +C + V  L   C + SP++R
Sbjct: 240 RLLELLEEGQRLP----APPACPAEVHELMKLCWAPSPQDR 276

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R      + A+KV     L++ G  +    E EI   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 139
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ PE
Sbjct: 140 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPE 193
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 194 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 234

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 123
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ PE
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDYLPPE 177
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 218

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 44/287 (15%)
Query: 672 IGIGSYGSVYKGRF--PDG--IEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVK 724
           +G GS+G V +G +  P G  + VA+K      L +  A++ F  E   + ++ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCM--YASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           +         K +V E  P GSL D +  +  +F L    R  +   VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 133
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--MKQTQTLATIGYIAPEYGREG 840
              +H D+   N+LL    +  + DFG+ + L + D   + Q        + APE  +  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
             S   D + +G+ L E+FT G +P             WI  +   +++ +D     E E
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP-------------WIGLNGSQILHKID----KEGE 236
Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF 946
                  + C   + ++ ++C +  PE+R          + +RD L 
Sbjct: 237 RLPR--PEDCPQDIYNVMVQCWAHKPEDR-------PTFVALRDFLL 274

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 44/287 (15%)
Query: 672 IGIGSYGSVYKGRF--PDG--IEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVK 724
           +G GS+G V +G +  P G  + VA+K      L +  A++ F  E   + ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCM--YASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           +         K +V E  P GSL D +  +  +F L    R  +   VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 129
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--MKQTQTLATIGYIAPEYGREG 840
              +H D+   N+LL    +  + DFG+ + L + D   + Q        + APE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
             S   D + +G+ L E+FT G +P             WI  +   +++ +D     E E
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP-------------WIGLNGSQILHKID----KEGE 232
Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF 946
                  + C   + ++ ++C +  PE+R          + +RD L 
Sbjct: 233 RLPR--PEDCPQDIYNVMVQCWAHKPEDR-------PTFVALRDFLL 270

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 44/287 (15%)
Query: 672 IGIGSYGSVYKGRF--PDG--IEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVK 724
           +G GS+G V +G +  P G  + VA+K      L +  A++ F  E   + ++ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCM--YASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           +         K +V E  P GSL D +  +  +F L    R  +   VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 139
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--MKQTQTLATIGYIAPEYGREG 840
              +H D+   N+LL    +  + DFG+ + L + D   + Q        + APE  +  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
             S   D + +G+ L E+FT G +P             WI  +   +++ +D     E E
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP-------------WIGLNGSQILHKID----KEGE 242
Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF 946
                  + C   + ++ ++C +  PE+R          + +RD L 
Sbjct: 243 RLPR--PEDCPQDIYNVMVQCWAHKPEDR-------PTFVALRDFLL 280

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 44/287 (15%)
Query: 672 IGIGSYGSVYKGRF--PDG--IEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVK 724
           +G GS+G V +G +  P G  + VA+K      L +  A++ F  E   + ++ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCM--YASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           +         K +V E  P GSL D +  +  +F L    R  +   VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 139
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--MKQTQTLATIGYIAPEYGREG 840
              +H D+   N+LL    +  + DFG+ + L + D   + Q        + APE  +  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
             S   D + +G+ L E+FT G +P             WI  +   +++ +D     E E
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP-------------WIGLNGSQILHKID----KEGE 242
Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF 946
                  + C   + ++ ++C +  PE+R          + +RD L 
Sbjct: 243 RLPR--PEDCPQDIYNVMVQCWAHKPEDR-------PTFVALRDFLL 280

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 44/287 (15%)
Query: 672 IGIGSYGSVYKGRF--PDG--IEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVK 724
           +G GS+G V +G +  P G  + VA+K      L +  A++ F  E   + ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCM--YASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           +         K +V E  P GSL D +  +  +F L    R  +   VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 129
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--MKQTQTLATIGYIAPEYGREG 840
              +H D+   N+LL    +  + DFG+ + L + D   + Q        + APE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
             S   D + +G+ L E+FT G +P             WI  +   +++ +D     E E
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP-------------WIGLNGSQILHKID----KEGE 232
Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF 946
                  + C   + ++ ++C +  PE+R          + +RD L 
Sbjct: 233 RLPR--PEDCPQDIYNVMVQCWAHKPEDR-------PTFVALRDFLL 270

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 44/287 (15%)
Query: 672 IGIGSYGSVYKGRF--PDG--IEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVK 724
           +G GS+G V +G +  P G  + VA+K      L +  A++ F  E   + ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCM--YASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           +         K +V E  P GSL D +  +  +F L    R  +   VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 129
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--MKQTQTLATIGYIAPEYGREG 840
              +H D+   N+LL    +  + DFG+ + L + D   + Q        + APE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
             S   D + +G+ L E+FT G +P             WI  +   +++ +D     E E
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP-------------WIGLNGSQILHKID----KEGE 232
Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF 946
                  + C   + ++ ++C +  PE+R          + +RD L 
Sbjct: 233 RLPR--PEDCPQDIYNVMVQCWAHKPEDR-------PTFVALRDFLL 270

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 51/182 (28%), Positives = 90/182 (49%), Gaps = 19/182 (10%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKAL--VLEYMPKGSLEDCMYASNFNLDIFQRLGIM 767
           E +IL+T+ H +++K    C +   K+L  V+EY+P GSL D  Y    ++ + Q L   
Sbjct: 66  EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFA 123
Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-- 825
             +   + YLH  H    +H ++   NVLLD+  +  + DFG+AK + E     + +   
Sbjct: 124 QQICEGMAYLHAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT----GMKPTNEFF------TGEMSI 875
            + + + APE  +E +     DV+++G+ L E+ T       P  +F        G+M++
Sbjct: 181 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 240
Query: 876 KR 877
            R
Sbjct: 241 LR 242

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 51/182 (28%), Positives = 90/182 (49%), Gaps = 19/182 (10%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKAL--VLEYMPKGSLEDCMYASNFNLDIFQRLGIM 767
           E +IL+T+ H +++K    C +   K+L  V+EY+P GSL D  Y    ++ + Q L   
Sbjct: 66  EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFA 123
Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-- 825
             +   + YLH  H    +H ++   NVLLD+  +  + DFG+AK + E     + +   
Sbjct: 124 QQICEGMAYLHSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT----GMKPTNEFF------TGEMSI 875
            + + + APE  +E +     DV+++G+ L E+ T       P  +F        G+M++
Sbjct: 181 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 240
Query: 876 KR 877
            R
Sbjct: 241 LR 242

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 666 FSEENL-----IGIGSYGSVYKGRFP---DGIEVAIKVFHLQREGA--LNSFDAECEILK 715
           F E +L     +G G++GSV   R+    D     + V  LQ  G      F  E +ILK
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 716 TIRHRNLVKI--ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
            +    +VK   +S         LV+EY+P G L D +      LD  + L     +   
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 126
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL--LSEEDSMKQTQTLATIGY 831
           +EYL    S   VH D+   N+L++      ++DFG+AKL  L ++  + +    + I +
Sbjct: 127 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 183
Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFT----GMKPTNEFFTGEMSIKRWINDSLPAVM 887
            APE   +   S + DV+++G++L E+FT       P+ EF    M  +R     +PA+ 
Sbjct: 184 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGSER----DVPALS 238
Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
            +++     +       A  +C + V  L   C + SP++R
Sbjct: 239 RLLELLEEGQRLP----APPACPAEVHELMKLCWAPSPQDR 275

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 665 QFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHL--------QREGALNSFDAECEILK 715
           ++  +++IG G    V +      G E A+K+  +        Q E    +   E  IL+
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 716 TIR-HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
            +  H +++ +I S  + +F  LV + M KG L D +      L   +   IM    S L
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIM---RSLL 210
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           E + F H+N IVH D+KP N+LLDD+M   LSDFG +  L  E   K  +   T GY+AP
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYLAP 268
Query: 835 E------------YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           E            YG+E       D++  G++L  +  G  P
Sbjct: 269 EILKCSMDETHPGYGKE------VDLWACGVILFTLLAGSPP 304

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 669 ENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNS---FDAECEIL-KTIRHRNLV 723
           +++IG G++G V K R   DG+ +   +  ++   + +    F  E E+L K   H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---------------NLDIFQRLGIMI 768
            ++ +C +  +  L +EY P G+L D +  S                  L   Q L    
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           DVA  ++YL        +H ++   N+L+ ++ VA ++DFG+++   +E  +K+T     
Sbjct: 147 DVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 201
Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVM 887
           + ++A E       +   DV++YG++L E+ + G  P       E+  K      LP   
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LPQGY 255
Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            +         E+  N     C   V  L  +C  E P  R +  +I+  L ++
Sbjct: 256 RL---------EKPLN-----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 295

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 12/217 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDG----IEVAIKVFHLQREGALN-SFDAECEILKTIR 718
           +     ++G G++G+VYKG + P+G    I VAIK+ +       N  F  E  I+ ++ 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           H +LV+++  C +   + LV + MP G L + ++    N+     L   + +A  + YL 
Sbjct: 99  HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 157
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS-EEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+A+LL  +E           I ++A E  
Sbjct: 158 ---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEM 873
              + + + DV++YG+ + E+ T G KP +   T E+
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 251

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/303 (23%), Positives = 135/303 (44%), Gaps = 62/303 (20%)
Query: 672 IGIGSYGSVY--------KGRFPDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRN 721
           +G G++G V         K +  + + VA+K+      E  L+   +E E++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-----FNLDI---------FQRL-GI 766
           ++ ++ +CT      +++EY  KG+L + + A       ++ DI         F+ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT- 825
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D  K+T   
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFFTGEMSIKRW 878
              + ++APE   +   + + DV+++G+++ E+FT       G+ P  E F         
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF--------- 269
Query: 879 INDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                          LL E   H      +C + +  +  +C    P  R   K+++  L
Sbjct: 270 --------------KLLKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313
Query: 939 IKI 941
            +I
Sbjct: 314 DRI 316

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 57/209 (27%), Positives = 110/209 (52%), Gaps = 23/209 (11%)
Query: 670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALN---SFDAECEILKTIRHRNLVKI 725
           + +G+G++G V  G     G +VA+K+ + Q+  +L+       E + LK  RH +++K+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 726 ISSCTNHNFKALVLEYMPKGSLED--CMYASNFNLD---IFQRLGIMIDVASALEYLHFG 780
               +      +V+EY+  G L D  C +     ++   +FQ+      + SA++Y H  
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ------ILSAVDYCH-- 128
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY--GR 838
             + +VH D+KP NVLLD  M A ++DFG++ ++S+ + ++   +  +  Y APE   GR
Sbjct: 129 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR--DSCGSPNYAAPEVISGR 185
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKPTNE 867
                 + D+++ G++L  +  G  P ++
Sbjct: 186 L-YAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 34/232 (14%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDV 770
              VK+  +  +       L Y   G L          L   +++G            ++
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYTAEI 139
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG 830
            SALEYLH      I+H D+KP N+LL++ M   ++DFG AK+LS E   KQ +  A +G
Sbjct: 140 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANAFVG 194
Query: 831 ---YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
              Y++PE   E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R  +    +A+KV     L++ G  +    E EI   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++     T+ Y+ PE
Sbjct: 123 YCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPE 176
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQDTYKR 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 12/221 (5%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
              VK+  +  +       L Y   G L   +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGR 838
                I+H D+KP N+LL++ M   ++DFG AK+LS E    +  + + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
           E   S   D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 248

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/311 (22%), Positives = 138/311 (44%), Gaps = 62/311 (19%)
Query: 664 DQFSEENLIGIGSYGSVY--------KGRFPDGIEVAIKVFHLQR-EGALNSFDAECEIL 714
           D+ +    +G G++G V         K +  + + VA+K+      E  L+   +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 715 KTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-----FNLDI-------- 760
           K I +H+N++ ++ +CT      +++EY  KG+L + + A       ++ DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 761 -FQRL-GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            F+ L      +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 819 SMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFFT 870
             K+T      + ++APE   +   + + DV+++G+++ E+FT       G+ P  E F 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF- 269
Query: 871 GEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN 930
                                  LL E   H      +C + +  +  +C    P  R  
Sbjct: 270 ----------------------KLLKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPT 305
Query: 931 TKEIISRLIKI 941
            K+++  L +I
Sbjct: 306 FKQLVEDLDRI 316

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/311 (22%), Positives = 138/311 (44%), Gaps = 62/311 (19%)
Query: 664 DQFSEENLIGIGSYGSVY--------KGRFPDGIEVAIKVFHLQR-EGALNSFDAECEIL 714
           D+ +    +G G++G V         K +  + + VA+K+      E  L+   +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 715 KTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-----FNLDI-------- 760
           K I +H+N++ ++ +CT      +++EY  KG+L + + A       ++ DI        
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 761 -FQRL-GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            F+ L      +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 819 SMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFFT 870
             K+T      + ++APE   +   + + DV+++G+++ E+FT       G+ P  E F 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF- 269
Query: 871 GEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN 930
                                  LL E   H      +C + +  +  +C    P  R  
Sbjct: 270 ----------------------KLLKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPT 305
Query: 931 TKEIISRLIKI 941
            K+++  L +I
Sbjct: 306 FKQLVEDLDRI 316

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/311 (22%), Positives = 138/311 (44%), Gaps = 62/311 (19%)
Query: 664 DQFSEENLIGIGSYGSVY--------KGRFPDGIEVAIKVFHLQR-EGALNSFDAECEIL 714
           D+ +    +G G++G V         K +  + + VA+K+      E  L+   +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 715 KTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-----FNLDI-------- 760
           K I +H+N++ ++ +CT      +++EY  KG+L + + A       ++ DI        
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 761 -FQRL-GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            F+ L      +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 819 SMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFFT 870
             K+T      + ++APE   +   + + DV+++G+++ E+FT       G+ P  E F 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF- 269
Query: 871 GEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN 930
                                  LL E   H      +C + +  +  +C    P  R  
Sbjct: 270 ----------------------KLLKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPT 305
Query: 931 TKEIISRLIKI 941
            K+++  L +I
Sbjct: 306 FKQLVEDLDRI 316

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 18/223 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGALNSFDAECEILKT 716
           A + F     +G G +G+VY  R     F   ++V  K   L++ G  +    E EI   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASAL 774
           +RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 124
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++     T+ Y+ P
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPP 178
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           E         K D+++ G++  E   G KP  E  T + + KR
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 220

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 67/283 (23%), Positives = 116/283 (40%), Gaps = 43/283 (15%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI 725
           +G G++G V+           D I VA+K      + A   F  E E+L  ++H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFN------------LDIFQRLGIMIDVASA 773
              C   +   +V EYM  G L   + A   +            L   Q L I   +A+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYI 832
           + YL   H    VH D+   N L+ ++++  + DFG+++ +   D  +    T+  I ++
Sbjct: 141 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
            PE     + + + DV++ G++L E+FT G +P  +    E+            +  I  
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV------------IECITQ 245
Query: 892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
             +L           ++C   V  L + C    P  R N K I
Sbjct: 246 GRVLQR--------PRTCPQEVYELMLGCWQREPHMRKNIKGI 280

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 12/212 (5%)
Query: 670 NLIGIGSYGSVYKGRF-PDG----IEVAIKVFHLQREGALN-SFDAECEILKTIRHRNLV 723
            ++G G++G+VYKG + P+G    I VAIK+ +       N  F  E  I+ ++ H +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           +++  C +   + LV + MP G L + ++    N+     L   + +A  + YL      
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ER 136
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS-EEDSMKQTQTLATIGYIAPEYGREGQV 842
            +VH D+   NVL+       ++DFG+A+LL  +E           I ++A E     + 
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 843 SIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEM 873
           + + DV++YG+ + E+ T G KP +   T E+
Sbjct: 197 THQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 18/223 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGALNSFDAECEILKT 716
           A + F     +G G +G+VY  R     F   ++V  K   L++ G  +    E EI   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASAL 774
           +RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 124
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            Y H   S  ++H DIKP N+LL  +    +++FG +       S ++T    T+ Y+ P
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPP 178
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           E         K D+++ G++  E   G KP  E  T + + KR
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 220

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 18/223 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGALNSFDAECEILKT 716
           A + F     +G G +G+VY  R     F   ++V  K   L++ G  +    E EI   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASAL 774
           +RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 124
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++     T+ Y+ P
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPP 178
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           E         K D+++ G++  E   G KP  E  T + + KR
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 220

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 18/223 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGALNSFDAECEILKT 716
           A + F     +G G +G+VY  R     F   ++V  K   L++ G  +    E EI   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASAL 774
           +RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 121
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++     T+ Y+ P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPP 175
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           E         K D+++ G++  E   G KP  E  T + + KR
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 217

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 124
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++     T+ Y+ PE
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPE 178
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 219

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 672 IGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKII 726
           +G G +G+VY  R     F   ++V  K   L++ G  +    E EI   +RH N++++ 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKT-QLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 727 SSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALEYLHFGHSNP 784
               +     L+LEY P G++  +    S F+    QR    I ++A+AL Y H   S  
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRTATYITELANALSYCH---SKR 132
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
           ++H DIKP N+LL  +    ++DFG +       S ++     T+ Y+ PE         
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRMHDE 189
Query: 845 KGDVYNYGIMLMEVFTGMKP 864
           K D+++ G++  E   GM P
Sbjct: 190 KVDLWSLGVLCYEFLVGMPP 209

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 116/245 (47%), Gaps = 20/245 (8%)
Query: 667 SEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI 725
           S+  ++G G +G V+K      G+++A K+   +          E  ++  + H NL+++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
             +  + N   LV+EY+  G L D +   ++NL     +  M  +   + ++H  +   I
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---I 208
Query: 786 VHCDIKPSNVLL--DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
           +H D+KP N+L    D+    + DFG+A+     + +K      T  ++APE      VS
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK--VNFGTPEFLAPEVVNYDFVS 266
Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN 903
              D+++ G++   + +G+ P    F G+       ND+   + NI+      EDEE  +
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSP----FLGD-------NDA-ETLNNILACRWDLEDEEFQD 314
Query: 904 VAKQS 908
           +++++
Sbjct: 315 ISEEA 319

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 121
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ PE
Sbjct: 122 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPE 175
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 176 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 216

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 18/223 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGR-----FPDGIEVAIKVFHLQREGALNSFDAECEILKT 716
           A + F     +G G +G+VY  R     F   ++V  K   L++ G  +    E EI   
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 61
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASAL 774
           +RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 118
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ P
Sbjct: 119 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPP 172
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           E         K D+++ G++  E   G KP  E  T + + KR
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 214

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 127
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ PE
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPE 181
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 182 XIEGRXHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 222

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/311 (22%), Positives = 138/311 (44%), Gaps = 62/311 (19%)
Query: 664 DQFSEENLIGIGSYGSVY--------KGRFPDGIEVAIKVFHLQR-EGALNSFDAECEIL 714
           D+ +    +G G++G V         K +  + + VA+K+      E  L+   +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 715 KTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-----FNLDI-------- 760
           K I +H+N++ ++ +CT      +++EY  KG+L + + A       ++ DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 761 -FQRL-GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            F+ L      +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 819 SMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFFT 870
             K+T      + ++APE   +   + + DV+++G+++ E+FT       G+ P  E F 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF- 269
Query: 871 GEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN 930
                                  LL E   H      +C + +  +  +C    P  R  
Sbjct: 270 ----------------------KLLKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPT 305
Query: 931 TKEIISRLIKI 941
            K+++  L +I
Sbjct: 306 FKQLVEDLDRI 316

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDV 770
              VK+  +  +       L Y   G L          L   +++G            ++
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYTAEI 116
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATI 829
            SALEYLH      I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T 
Sbjct: 117 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
            Y++PE   E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 223

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R      + A+KV     L++ G  +    E EI   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 148
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++     T+ Y+ PE
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPE 202
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 203 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 243

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDV 770
              VK+  +  +       L Y   G L          L   +++G            ++
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYTAEI 139
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATI 829
            SALEYLH      I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T 
Sbjct: 140 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
            Y++PE   E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDV 770
              VK+  +  +       L Y   G L          L   +++G            ++
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYTAEI 141
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATI 829
            SALEYLH      I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T 
Sbjct: 142 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
            Y++PE   E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 248

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDV 770
              VK+  +  +       L Y   G L          L   +++G            ++
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYTAEI 142
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATI 829
            SALEYLH      I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T 
Sbjct: 143 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
            Y++PE   E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 249

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDV 770
              VK+  +  +       L Y   G L          L   +++G            ++
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYTAEI 118
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATI 829
            SALEYLH      I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T 
Sbjct: 119 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
            Y++PE   E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 225

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDV 770
              VK+  +  +       L Y   G L          L   +++G            ++
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYTAEI 119
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATI 829
            SALEYLH      I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T 
Sbjct: 120 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
            Y++PE   E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 226

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDV 770
              VK+  +  +       L Y   G L          L   +++G            ++
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYTAEI 123
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATI 829
            SALEYLH      I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T 
Sbjct: 124 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
            Y++PE   E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 230

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDV 770
              VK+  +  +       L Y   G L          L   +++G            ++
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYTAEI 117
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATI 829
            SALEYLH      I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T 
Sbjct: 118 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
            Y++PE   E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 123
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++     T+ Y+ PE
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPE 177
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 218

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 9/155 (5%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIM 767
           E EIL+T+ H ++VK    C +   K+  LV+EY+P GSL D  Y     + + Q L   
Sbjct: 60  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFA 117
Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-- 825
             +   + YLH  H    +H  +   NVLLD+  +  + DFG+AK + E     + +   
Sbjct: 118 QQICEGMAYLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 174
Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
            + + + APE  +E +     DV+++G+ L E+ T
Sbjct: 175 DSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 9/155 (5%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIM 767
           E EIL+T+ H ++VK    C +   K+  LV+EY+P GSL D  Y     + + Q L   
Sbjct: 61  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFA 118
Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-- 825
             +   + YLH  H    +H  +   NVLLD+  +  + DFG+AK + E     + +   
Sbjct: 119 QQICEGMAYLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 175
Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
            + + + APE  +E +     DV+++G+ L E+ T
Sbjct: 176 DSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 124
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    +++FG +       S ++T    T+ Y+ PE
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPE 178
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 219

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/311 (22%), Positives = 137/311 (44%), Gaps = 62/311 (19%)
Query: 664 DQFSEENLIGIGSYGSVY--------KGRFPDGIEVAIKVFHLQR-EGALNSFDAECEIL 714
           D+ +    +G G +G V         K +  + + VA+K+      E  L+   +E E++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 715 KTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-----FNLDI-------- 760
           K I +H+N++ ++ +CT      +++EY  KG+L + + A       ++ DI        
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 761 -FQRL-GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            F+ L      +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D
Sbjct: 201 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 819 SMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFFT 870
             K+T      + ++APE   +   + + DV+++G+++ E+FT       G+ P  E F 
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF- 315
Query: 871 GEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN 930
                                  LL E   H      +C + +  +  +C    P  R  
Sbjct: 316 ----------------------KLLKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPT 351
Query: 931 TKEIISRLIKI 941
            K+++  L +I
Sbjct: 352 FKQLVEDLDRI 362

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 9/214 (4%)
Query: 672 IGIGSYGSV-YKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG GS G V        G +VA+K   L+++        E  I++   H N+V + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   +V+E++  G+L D +  +  N +  Q   + + V  AL YLH   +  ++H DI
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  ++LL       LSDFG    +S+E   K+   + T  ++APE         + D+++
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKXLVGTPYWMAPEVISRLPYGTEVDIWS 226
Query: 851 YGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP 884
            GIM++E+  G  P   F    +   R I DSLP
Sbjct: 227 LGIMVIEMIDGEPPY--FNEPPLQAMRRIRDSLP 258

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           D F     +G G +G+VY  R   +   +A+KV     L++EG  +    E EI   +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
            N++++ +   +     L+LE+ P+G L   +       D  +    M ++A AL   H+
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADAL---HY 130
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
            H   ++H DIKP N+L+       ++DFG +       S+++     T+ Y+ PE    
Sbjct: 131 CHERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRXMCGTLDYLPPEMIEG 187
Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKP 864
                K D++  G++  E   GM P
Sbjct: 188 KTHDEKVDLWCAGVLCYEFLVGMPP 212

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 18/223 (8%)
Query: 646 SPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQRE 701
           +P ++ R ++        D F     +G G +G+VY  R       VA+KV     +++E
Sbjct: 12  TPDILTRHFT-------IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKE 64
Query: 702 GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIF 761
           G  +    E EI   + H N++++ +   +     L+LEY P+G L   +  S    D  
Sbjct: 65  GVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQ 123
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK 821
           +   IM ++A AL Y    H   ++H DIKP N+LL       ++DFG +       S++
Sbjct: 124 RTATIMEELADALMYC---HGKKVIHRDIKPENLLLGLKGELKIADFGWS---VHAPSLR 177
Query: 822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           +     T+ Y+ PE       + K D++  G++  E+  G  P
Sbjct: 178 RKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/311 (22%), Positives = 137/311 (44%), Gaps = 62/311 (19%)
Query: 664 DQFSEENLIGIGSYGSVY--------KGRFPDGIEVAIKVFHLQR-EGALNSFDAECEIL 714
           D+ +    +G G++G V         K +  + + VA+K+      E  L+   +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 715 KTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-----FNLDI-------- 760
           K I +H+N++ ++ +CT      +++EY  KG+L + + A       ++ DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 761 -FQRL-GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            F+ L      +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 819 SMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFFT 870
             K T      + ++APE   +   + + DV+++G+++ E+FT       G+ P  E F 
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF- 269
Query: 871 GEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN 930
                                  LL E   H      +C + +  +  +C    P  R  
Sbjct: 270 ----------------------KLLKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPT 305
Query: 931 TKEIISRLIKI 941
            K+++  L +I
Sbjct: 306 FKQLVEDLDRI 316

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 108/204 (52%), Gaps = 13/204 (6%)
Query: 670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALN---SFDAECEILKTIRHRNLVKI 725
           + +G+G++G V  G     G +VA+K+ + Q+  +L+       E + LK  RH +++K+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
               +      +V+EY+  G L D +   +  ++  +   +   + SA++Y H    + +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYCH---RHMV 132
Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY--GREGQVS 843
           VH D+KP NVLLD  M A ++DFG++ ++S+ + ++   +  +  Y APE   GR     
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR--TSCGSPNYAAPEVISGRL-YAG 189
Query: 844 IKGDVYNYGIMLMEVFTGMKPTNE 867
            + D+++ G++L  +  G  P ++
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           D F     +G G +G+VY  R   +   +A+KV     L++EG  +    E EI   +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
            N++++ +   +     L+LE+ P+G L   +       D  +    M ++A AL   H+
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADAL---HY 129
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
            H   ++H DIKP N+L+       ++DFG +       S+++     T+ Y+ PE    
Sbjct: 130 CHERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRXMCGTLDYLPPEMIEG 186
Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKP 864
                K D++  G++  E   GM P
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPP 211

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 108/241 (44%), Gaps = 40/241 (16%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIR 718
           LR    F E  ++G G++G V K R   D    AIK      E  L++  +E  +L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 719 H-------------RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFN--LDIFQR 763
           H             RN VK +++    +   + +EY    +L D +++ N N   D + R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE-DSMK- 821
           L   I     LE L + HS  I+H D+KP N+ +D+S    + DFG+AK +    D +K 
Sbjct: 121 LFRQI-----LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 822 -----------QTQTLATIGYIAPEY-GREGQVSIKGDVYNYGIMLMEVF----TGMKPT 865
                       T  + T  Y+A E     G  + K D+Y+ GI+  E+     TGM+  
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235
Query: 866 N 866
           N
Sbjct: 236 N 236

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDV 770
              VK+  +  +       L Y   G L          L   +++G            ++
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYTAEI 141
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATI 829
            SALEYLH      I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T 
Sbjct: 142 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            Y++PE   E       D++  G ++ ++  G+ P
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 18/216 (8%)
Query: 664 DQFSEENLIGIGSYGSVY-KGRFPDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRN 721
           D F  +  +G G++G V+       G+E  IK  +  R +  +   +AE E+LK++ H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR---LGIMIDVASALEYLH 778
           ++KI     +++   +V+E    G L + + ++              +M  + +AL Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVA---HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
             H   +VH D+KP N+L  D+       + DFG+A+L   ++    T    T  Y+APE
Sbjct: 142 SQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPE 196
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTG 871
             +   V+ K D+++ G+++  + TG  P    FTG
Sbjct: 197 VFKR-DVTFKCDIWSAGVVMYFLLTGCLP----FTG 227

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 27/220 (12%)
Query: 657 DELLRATDQFSEENLIGIGSYGSVYKGRFPD--GIEVAIKVFHLQ--REGALNSFDAECE 712
           D L RA  Q+     IG G+YG V+K R     G  VA+K   +Q   EG   S   E  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 713 ILK---TIRHRNLVKIISSCT-----NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL 764
           +L+   T  H N+V++   CT           LV E++ +             LD     
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL--------TTYLDKVPEP 115
Query: 765 GIMIDVASALEY-----LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS 819
           G+  +    + +     L F HS+ +VH D+KP N+L+  S    L+DFG+A++ S +  
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
           M  T  + T+ Y APE   +   +   D+++ G +  E+F
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 12/221 (5%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
              VK+  +  +       L Y   G L   +       +   R     ++ SALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGR 838
                I+H D+KP N+LL++ M   ++DFG AK+LS E    +  + + T  Y++PE   
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
           E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 249

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/303 (23%), Positives = 134/303 (44%), Gaps = 62/303 (20%)
Query: 672 IGIGSYGSVY--------KGRFPDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRN 721
           +G G++G V         K +  + + VA+K+      E  L+   +E E++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-----FNLDI---------FQRL-GI 766
           ++ ++ +CT      +++EY  KG+L + + A        + DI         F+ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT- 825
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D  K+T   
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFFTGEMSIKRW 878
              + ++APE   +   + + DV+++G+++ E+FT       G+ P  E F         
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF--------- 269
Query: 879 INDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                          LL E   H      +C + +  +  +C    P  R   K+++  L
Sbjct: 270 --------------KLLKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313
Query: 939 IKI 941
            +I
Sbjct: 314 DRI 316

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 30/230 (13%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDV 770
              VK+  +  +       L Y   G L          L   +++G            ++
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYTAEI 138
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATI 829
            SALEYLH      I+H D+KP N+LL++ M   ++DFG AK+LS E    +  + + T 
Sbjct: 139 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
            Y++PE   E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 245

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 12/221 (5%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
              VK+  +  +       L Y   G L   +       +   R     ++ SALEYLH 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 152
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGR 838
                I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T  Y++PE   
Sbjct: 153 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
           E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 251

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 670 NLIGIGSYGSVYKG--RFPDG--IEVAIKVFHL----QREGALNSFDAECEILKTIRHRN 721
            ++G G +GSV +G  +  DG  ++VA+K   L    QRE  +  F +E   +K   H N
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE--IEEFLSEAACMKDFSHPN 97
Query: 722 LVKIISSCTNHNFKAL-----VLEYMPKGSLEDCMYASNF-----NLDIFQRLGIMIDVA 771
           +++++  C   + + +     +L +M  G L   +  S       ++ +   L  M+D+A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT-IG 830
             +EYL    +   +H D+   N +L D M   ++DFG++K +   D  +Q +     + 
Sbjct: 158 LGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           +IA E   +   + K DV+ +G+ + E+ T GM P
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 12/221 (5%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
              VK+  +  +       L Y   G L   +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGR 838
                I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
           E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 248

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 29/291 (9%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA--ECEILKTIRHR 720
           +++ +   IG GSYG V+K R  D G  VAIK F    +  +    A  E  +LK ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           NLV ++          LV EY        C +     LD +QR G+   +  +     L+
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEY--------CDHTVLHELDRYQR-GVPEHLVKSITWQTLQ 113
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            ++F H +  +H D+KP N+L+    V  L DFG A+LL+        + +AT  Y +PE
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE-VATRWYRSPE 172
Query: 836 -YGREGQVSIKGDVYNYGIMLMEVFTGMK--PTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
               + Q     DV+  G +  E+ +G+   P          I++ + D +P    +  T
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232
Query: 893 NLL--------SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII 935
           N           ED E   +   + +   L L   C    P  R+  ++++
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 119/245 (48%), Gaps = 20/245 (8%)
Query: 639 SHIKAGMSP-QVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVF 696
           SH+ +G +P Q + R      +L+ T +F +  ++G G++G+VYKG + P+G +V I V 
Sbjct: 2   SHMASGEAPNQALLR------ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA 54
Query: 697 HLQ-REG----ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCM 751
             + RE     A      E  ++ ++ + ++ +++  C     + L+ + MP G L D +
Sbjct: 55  IKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 113
Query: 752 YASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA 811
                N+     L   + +A  + YL       +VH D+   NVL+       ++DFG+A
Sbjct: 114 REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 170
Query: 812 KLL-SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFF 869
           KLL +EE           I ++A E       + + DV++YG+ + E+ T G KP +   
Sbjct: 171 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 230
Query: 870 TGEMS 874
             E+S
Sbjct: 231 ASEIS 235

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 12/221 (5%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
              VK+  +  +       L Y   G L   +       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGR 838
                I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
           E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 670 NLIGIGSYGSVYKGRF-PDG----IEVAIKVFHLQREGALNSFDAECE---ILKTIRHRN 721
            ++G G +G+V+KG + P+G    I V IKV  ++ +    SF A  +    + ++ H +
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAH 94
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +V+++  C   + + LV +Y+P GSL D +      L     L   + +A  + YL    
Sbjct: 95  IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--- 150
Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED-SMKQTQTLATIGYIAPEYGREG 840
            + +VH ++   NVLL       ++DFG+A LL  +D  +  ++    I ++A E    G
Sbjct: 151 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKP 864
           + + + DV++YG+ + E+ T G +P
Sbjct: 211 KYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 12/221 (5%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
              VK+  +  +       L Y   G L   +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGR 838
                I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
           E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 248

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 670 NLIGIGSYGSVYKGRF-PDG----IEVAIKVFHLQREGALNSFDAECE---ILKTIRHRN 721
            ++G G +G+V+KG + P+G    I V IKV  ++ +    SF A  +    + ++ H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +V+++  C   + + LV +Y+P GSL D +      L     L   + +A  + YL    
Sbjct: 77  IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED-SMKQTQTLATIGYIAPEYGREG 840
            + +VH ++   NVLL       ++DFG+A LL  +D  +  ++    I ++A E    G
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKP 864
           + + + DV++YG+ + E+ T G +P
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 18/215 (8%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQ-REGALNSFDAECEILKTI 717
           + ++ QF +   +G G+Y +VYKG     G+ VA+K   L   EG  ++   E  ++K +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY- 776
           +H N+V++       N   LV E+M    L+  M +           G+ +++    ++ 
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVG---NTPRGLELNLVKYFQWQ 116
Query: 777 ----LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYI 832
               L F H N I+H D+KP N+L++      L DFG+A+      +   ++ + T+ Y 
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE-VVTLWYR 175
Query: 833 APEY---GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           AP+     R    SI  D+++ G +L E+ TG KP
Sbjct: 176 APDVLMGSRTYSTSI--DIWSCGCILAEMITG-KP 207

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 133/302 (44%), Gaps = 49/302 (16%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKIISS- 728
           +G G YG V++G +  G  VA+K+F  + E    S+  E E+  T+  RH N++  I+S 
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 100
Query: 729 -CTNHNFKALVL--EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH---FGHS 782
             + H+   L L   Y   GSL D  Y     LD    L I++ +AS L +LH   FG  
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 783 N--PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPEYG 837
               I H D+K  N+L+  +    ++D G+A + S+  +         +G   Y+APE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 838 REG-QVSI-----KGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
            E  QV       + D++ +G++L EV   M                + D  P   +++ 
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI-----------VEDYKPPFYDVVP 267
Query: 892 TN--------LLSEDEEHANVAKQSCA----SSVLSLAMECTSESPENRVNTKEIISRLI 939
            +        ++  D++  N+  +  +    +S+  L  EC  ++P  R+    I   L 
Sbjct: 268 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 327
Query: 940 KI 941
           KI
Sbjct: 328 KI 329

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 56/223 (25%), Positives = 112/223 (50%), Gaps = 29/223 (13%)
Query: 664 DQFSEENLIGIGSYGSVY--------KGRFPDGIEVAIKVFHLQ-REGALNSFDAECEIL 714
           D+ +    +G G +G V         K +  + + VA+K+      E  L+   +E E++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 715 KTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYAS-----NFNLDI-------- 760
           K I +H+N++ ++ +CT      +++EY  KG+L + + A       ++ DI        
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 761 -FQRL-GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            F+ L      +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D
Sbjct: 142 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 819 SMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
             K+T      + ++APE   +   + + DV+++G+++ E+FT
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDV 770
              VK+  +  +       L Y   G L          L   +++G            ++
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYTAEI 138
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATI 829
            SALEYLH      I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T 
Sbjct: 139 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
            Y++PE   E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 245

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 56/223 (25%), Positives = 112/223 (50%), Gaps = 29/223 (13%)
Query: 664 DQFSEENLIGIGSYGSVY--------KGRFPDGIEVAIKVFHLQ-REGALNSFDAECEIL 714
           D+ +    +G G +G V         K +  + + VA+K+      E  L+   +E E++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 715 KTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYAS-----NFNLDI-------- 760
           K I +H+N++ ++ +CT      +++EY  KG+L + + A       ++ DI        
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 761 -FQRL-GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            F+ L      +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D
Sbjct: 147 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 819 SMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
             K+T      + ++APE   +   + + DV+++G+++ E+FT
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 56/223 (25%), Positives = 112/223 (50%), Gaps = 29/223 (13%)
Query: 664 DQFSEENLIGIGSYGSVY--------KGRFPDGIEVAIKVFHLQ-REGALNSFDAECEIL 714
           D+ +    +G G +G V         K +  + + VA+K+      E  L+   +E E++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 715 KTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYAS-----NFNLDI-------- 760
           K I +H+N++ ++ +CT      +++EY  KG+L + + A       ++ DI        
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 761 -FQRL-GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            F+ L      +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D
Sbjct: 144 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 819 SMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
             K+T      + ++APE   +   + + DV+++G+++ E+FT
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++     T+ Y+ PE
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPE 176
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 217

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 9/206 (4%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
              VK+  +  +       L Y   G L   +       +   R     ++ SALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGR 838
                I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T  Y++PE   
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
           E       D++  G ++ ++  G+ P
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/311 (22%), Positives = 137/311 (44%), Gaps = 62/311 (19%)
Query: 664 DQFSEENLIGIGSYGSVY--------KGRFPDGIEVAIKVFHLQR-EGALNSFDAECEIL 714
           D+ +    +G G++G V         K +  + + VA+K+      E  L+   +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 715 KTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-----FNLDI-------- 760
           K I +H+N++ ++ +CT      +++ Y  KG+L + + A       ++ DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 761 -FQRL-GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            F+ L      +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 819 SMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFFT 870
             K+T      + ++APE   +   + + DV+++G+++ E+FT       G+ P  E F 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF- 269
Query: 871 GEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN 930
                                  LL E   H      +C + +  +  +C    P  R  
Sbjct: 270 ----------------------KLLKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPT 305
Query: 931 TKEIISRLIKI 941
            K+++  L +I
Sbjct: 306 FKQLVEDLDRI 316

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 16/222 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVF---HLQREGALNSFDAECEILKTI 717
           A + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMI-DVASALE 775
           RH N++++     +     L+LEY P G++  +    S F+    QR    I ++A+AL 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           Y H   S  ++H DIKP N+LL  +    ++DFG +       S ++     T+ Y+ PE
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPE 179
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                    K D+++ G++  E   G KP  E  T + + KR
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQETYKR 220

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 26/210 (12%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAEC---EILKTIRHRNLVKI-- 725
           +G G +G V +    D G +VAIK    ++E +  + +  C   +I+K + H N+V    
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 726 ----ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG----IMIDVASALEYL 777
               +     ++   L +EY   G L    Y + F      + G    ++ D++SAL YL
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRK--YLNQFENCCGLKEGPIRTLLSDISSALRYL 138
Query: 778 HFGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           H    N I+H D+KP N++L      ++  + D G AK L + +    T+ + T+ Y+AP
Sbjct: 139 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLAP 193
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           E   + + ++  D +++G +  E  TG +P
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 26/210 (12%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAEC---EILKTIRHRNLVKI-- 725
           +G G +G V +    D G +VAIK    ++E +  + +  C   +I+K + H N+V    
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 726 ----ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG----IMIDVASALEYL 777
               +     ++   L +EY   G L    Y + F      + G    ++ D++SAL YL
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRK--YLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 778 HFGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           H    N I+H D+KP N++L      ++  + D G AK L + +    T+ + T+ Y+AP
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLAP 192
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           E   + + ++  D +++G +  E  TG +P
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 113/230 (49%), Gaps = 28/230 (12%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYK------GRFPDGIEVAIKVF----HLQREGALNSF 707
           E  R   QF +   +G G++G V +      G+    ++VA+K+     H   + AL S 
Sbjct: 42  EFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS- 98
Query: 708 DAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGI 766
             E +I+  + +H N+V ++ +CT+     ++ EY   G L + +   +  L+      I
Sbjct: 99  --ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 767 MIDVASALEYLHFGH----------SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLS 815
               AS  + LHF            S   +H D+   NVLL +  VA + DFG+A+ +++
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           + + + +      + ++APE   +   +++ DV++YGI+L E+F+ G+ P
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSF-DAECEILKTIRHRNLV 723
           F++   IG GS+G V+KG      +V AIK+  L+           E  +L       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           K   S        +++EY+  GS  D +      LD  Q   I+ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 123
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
             +H DIK +NVLL +     L+DFG+A  L+ +  +K+   + T  ++APE  ++    
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVIKQSAYD 182
Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEF 868
            K D+++ GI  +E+  G  P +E 
Sbjct: 183 SKADIWSLGITAIELARGEPPHSEL 207

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V  ++ RE     A      E  ++ ++ 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 110 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 168
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 169 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 225
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 226 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSF-DAECEILKTIRHRNLV 723
           F++   IG GS+G V+KG      +V AIK+  L+           E  +L       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           K   S        +++EY+  GS  D +      LD  Q   I+ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 123
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
             +H DIK +NVLL +     L+DFG+A  L+ +  +K+   + T  ++APE  ++    
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYD 182
Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEF 868
            K D+++ GI  +E+  G  P +E 
Sbjct: 183 SKADIWSLGITAIELARGEPPHSEL 207

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSF-DAECEILKTIRHRNLV 723
           F++   IG GS+G V+KG      +V AIK+  L+           E  +L       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           K   S        +++EY+  GS  D +      LD  Q   I+ ++   L+YLH   S 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 138
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
             +H DIK +NVLL +     L+DFG+A  L+ +  +K+   + T  ++APE  ++    
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVIKQSAYD 197
Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEF 868
            K D+++ GI  +E+  G  P +E 
Sbjct: 198 SKADIWSLGITAIELARGEPPHSEL 222

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/311 (22%), Positives = 137/311 (44%), Gaps = 62/311 (19%)
Query: 664 DQFSEENLIGIGSYGSVY--------KGRFPDGIEVAIKVFHLQR-EGALNSFDAECEIL 714
           D+ +    +G G++G V         K +  + + VA+K+      E  L+   +E E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 715 KTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-----FNLDI-------- 760
           K I +H+N++ ++ +CT      +++ Y  KG+L + + A       ++ DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 761 -FQRL-GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            F+ L      +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 819 SMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFFT 870
             K+T      + ++APE   +   + + DV+++G+++ E+FT       G+ P  E F 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF- 269
Query: 871 GEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN 930
                                  LL E   H      +C + +  +  +C    P  R  
Sbjct: 270 ----------------------KLLKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPT 305
Query: 931 TKEIISRLIKI 941
            K+++  L +I
Sbjct: 306 FKQLVEDLDRI 316

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 130/303 (42%), Gaps = 62/303 (20%)
Query: 672 IGIGSYGSVY--------KGRFPDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRN 721
           +G G++G V         K +     +VA+K+      E  L+   +E E++K I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYAS-------NFN--------LDIFQRLGI 766
           ++ ++ +CT      +++EY  KG+L + + A        +FN        L     +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT- 825
              VA  +EYL    S   +H D+   NVL+ +  V  ++DFG+A+ +   D  K+T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFFTGEMSIKRW 878
              + ++APE   +   + + DV+++G++L E+FT       G+ P  E F         
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELF--------- 262
Query: 879 INDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                          LL E   H      +C + +  +  +C    P  R   K+++  L
Sbjct: 263 --------------KLLKEG--HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306
Query: 939 IKI 941
            +I
Sbjct: 307 DRI 309

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 12/221 (5%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
              VK+     +       L Y   G L   +       +   R     ++ SALEYLH 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 154
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGR 838
                I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T  Y++PE   
Sbjct: 155 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
           E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 253

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 8/202 (3%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G++G VYK +  +  +  A KV   + E  L  +  E +IL +  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             N   +++E+   G+++  M      L   Q   I +     L+ L++ H N I+H D+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQ---IQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 791 KPSNVLLDDSMVAHLSDFGIA----KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           K  N+L        L+DFG++    + +   DS   T        +  E  ++     K 
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 221
Query: 847 DVYNYGIMLMEVFTGMKPTNEF 868
           DV++ GI L+E+     P +E 
Sbjct: 222 DVWSLGITLIEMAEIEPPHHEL 243

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSF-DAECEILKTIRHRNLV 723
           F++   IG GS+G V+KG      +V AIK+  L+           E  +L       + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           K   S        +++EY+  GS  D +      LD  Q   I+ ++   L+YLH   S 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 143
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
             +H DIK +NVLL +     L+DFG+A  L+ +  +K+   + T  ++APE  ++    
Sbjct: 144 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYD 202
Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEF 868
            K D+++ GI  +E+  G  P +E 
Sbjct: 203 SKADIWSLGITAIELARGEPPHSEL 227

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 8/202 (3%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G++G VYK +  +  +  A KV   + E  L  +  E +IL +  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             N   +++E+   G+++  M      L   Q   I +     L+ L++ H N I+H D+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQ---IQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 791 KPSNVLLDDSMVAHLSDFGIA----KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           K  N+L        L+DFG++    + +   DS   T        +  E  ++     K 
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 221
Query: 847 DVYNYGIMLMEVFTGMKPTNEF 868
           DV++ GI L+E+     P +E 
Sbjct: 222 DVWSLGITLIEMAEIEPPHHEL 243

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 664 DQFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRN 721
           D F + + +G G+ G V+K    P G+ +A K+ HL+ + A+ N    E ++L       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG-IMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  +    +  Q LG + I V   L YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 126
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L +E +    + + T  Y++PE  +  
Sbjct: 127 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA---NEFVGTRSYMSPERLQGT 181
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
             S++ D+++ G+ L+E+  G  P
Sbjct: 182 HYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 664 DQFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRN 721
           D F + + +G G+ G V+K    P G+ +A K+ HL+ + A+ N    E ++L       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG-IMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  +    +  Q LG + I V   L YL   
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 185
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L   DSM  +  + T  Y++PE  +  
Sbjct: 186 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 240
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
             S++ D+++ G+ L+E+  G  P
Sbjct: 241 HYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 134/302 (44%), Gaps = 49/302 (16%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKIISS- 728
           +G G YG V++G +  G  VA+K+F  + E    S+  E E+  T+  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71
Query: 729 -CTNHNFKALVL--EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH---FGHS 782
             + H+   L L   Y   GSL D  Y     LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 783 N--PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS---MKQTQTLATIGYIAPEYG 837
               I H D+K  N+L+  +    ++D G+A + S+  +   +     + T  Y+APE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 838 REG-QVSI-----KGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
            E  QV       + D++ +G++L EV   M                + D  P   +++ 
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI-----------VEDYKPPFYDVVP 238
Query: 892 TN--------LLSEDEEHANVAKQSCA----SSVLSLAMECTSESPENRVNTKEIISRLI 939
            +        ++  D++  N+  +  +    +S+  L  EC  ++P  R+    I   L 
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 940 KI 941
           KI
Sbjct: 299 KI 300

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 133/302 (44%), Gaps = 49/302 (16%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKIISS- 728
           +G G YG V++G +  G  VA+K+F  + E    S+  E E+  T+  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71
Query: 729 -CTNHNFKALVL--EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH---FGHS 782
             + H+   L L   Y   GSL D  Y     LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 783 N--PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPEYG 837
               I H D+K  N+L+  +    ++D G+A + S+  +         +G   Y+APE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 838 REG-QVSI-----KGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
            E  QV       + D++ +G++L EV   M                + D  P   +++ 
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI-----------VEDYKPPFYDVVP 238
Query: 892 TN--------LLSEDEEHANVAKQSCA----SSVLSLAMECTSESPENRVNTKEIISRLI 939
            +        ++  D++  N+  +  +    +S+  L  EC  ++P  R+    I   L 
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 940 KI 941
           KI
Sbjct: 299 KI 300

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 664 DQFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRN 721
           D F + + +G G+ G V+K    P G+ +A K+ HL+ + A+ N    E ++L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG-IMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  +    +  Q LG + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 123
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L   DSM  +  + T  Y++PE  +  
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 178
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP--AVMNIMDTNLLSED 898
             S++ D+++ G+ L+E+  G  P       E        DS P  A+  ++D  +    
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE--------DSRPPMAIFELLDYIV---- 226
Query: 899 EEHANVAKQSCASSVLSLAME-----CTSESPENRVNTKEII 935
               N       S V SL  +     C  ++P  R + K+++
Sbjct: 227 ----NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 264

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 116/251 (46%), Gaps = 40/251 (15%)
Query: 649 VMWRRYSHD---ELLRATDQFSEENLIGIGSYGSVYK----GRFPDGIEVAIKVFHLQRE 701
           V +R Y +D   E  R   +F +  ++G G++G V      G    G+ + + V  L+ +
Sbjct: 29  VDFREYEYDLKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 86
Query: 702 GALNSFDAECEILKTI----RHRNLVKIISSCTNHNFKALVLEYMPKGSL---------- 747
              +  +A    LK +     H N+V ++ +CT      L+ EY   G L          
Sbjct: 87  ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 146
Query: 748 ---EDCMYASNFNLDIFQRLGIMI---------DVASALEYLHFGHSNPIVHCDIKPSNV 795
              ++  Y +   L+  + L ++           VA  +E+L F      VH D+   NV
Sbjct: 147 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNV 203
Query: 796 LLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIM 854
           L+    V  + DFG+A+ ++S+ + + +      + ++APE   EG  +IK DV++YGI+
Sbjct: 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 855 LMEVFT-GMKP 864
           L E+F+ G+ P
Sbjct: 264 LWEIFSLGVNP 274

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 11/215 (5%)
Query: 664 DQFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRN 721
           D F + + +G G+ G V+K    P G+ +A K+ HL+ + A+ N    E ++L       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG-IMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  +    +  Q LG + I V   L YL   
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 142
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L   DSM  +  + T  Y++PE  +  
Sbjct: 143 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 197
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI 875
             S++ D+++ G+ L+E+  G  P     +G M+I
Sbjct: 198 HYSVQSDIWSMGLSLVEMAVGRYPIGS-GSGSMAI 231

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+++ MP G L D +     N+     L   + +A  + YL 
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 139 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFH---LQREGALNSFDAECEILKTIRH 719
           + F   NL+G GS+  VY+      G+EVAIK+     + + G +     E +I   ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
            +++++ +   + N+  LVLE    G +   +          +    M  + + + YLH 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH- 129
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
             S+ I+H D+  SN+LL  +M   ++DFG+A  L      K      T  YI+PE    
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-KHYTLCGTPNYISPEIATR 186
Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKP 864
               ++ DV++ G M   +  G  P
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPP 211

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+++ MP G L D +     N+     L   + +A  + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + ++LE M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 276
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 277 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+++ MP G L D +     N+     L   + +A  + YL 
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 136 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+  + H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + ++LE M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 262
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 263 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+++ MP G L D +     N+     L   + +A  + YL 
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 136 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 672 IGIGSYGSVYKGRF--PD--GIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVKII 726
           IG G +G V++G +  P+   + VAIK   +   +     F  E   ++   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
              T  N   +++E    G L   +    F+LD+   +     +++AL YL    S   V
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H DI   NVL+  +    L DFG+++ + +    K ++    I ++APE     + +   
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSAS 193
Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+ +G+ + E+   G+KP
Sbjct: 194 DVWMFGVCMWEILMHGVKP 212

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+++ MP G L D +     N+     L   + +A  + YL 
Sbjct: 79  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+  + H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + ++LE M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 276
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 277 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 664 DQFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRN 721
           D F + + +G G+ G V+K    P G+ +A K+ HL+ + A+ N    E ++L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG-IMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  +    +  Q LG + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 123
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L   DSM  +  + T  Y++PE  +  
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 178
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
             S++ D+++ G+ L+E+  G  P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+++ MP G L D +     N+     L   + +A  + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 664 DQFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRN 721
           D F + + +G G+ G V+K    P G+ +A K+ HL+ + A+ N    E ++L       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG-IMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  +    +  Q LG + I V   L YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 150
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L   DSM  +  + T  Y++PE  +  
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 205
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
             S++ D+++ G+ L+E+  G  P
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 664 DQFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRN 721
           D F + + +G G+ G V+K    P G+ +A K+ HL+ + A+ N    E ++L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG-IMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  +    +  Q LG + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 123
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L   DSM  +  + T  Y++PE  +  
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 178
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
             S++ D+++ G+ L+E+  G  P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 27/220 (12%)
Query: 657 DELLRATDQFSEENLIGIGSYGSVYKGR--FPDGIEVAIKVFHLQ--REGALNSFDAECE 712
           D L RA  Q+     IG G+YG V+K R     G  VA+K   +Q   EG   S   E  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 713 ILK---TIRHRNLVKIISSCT-----NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL 764
           +L+   T  H N+V++   CT           LV E++ +   +   Y     LD     
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTY-----LDKVPEP 115
Query: 765 GIMIDVASALEY-----LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS 819
           G+  +    + +     L F HS+ +VH D+KP N+L+  S    L+DFG+A++ S +  
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
           M  T  + T+ Y APE   +   +   D+++ G +  E+F
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 27/220 (12%)
Query: 657 DELLRATDQFSEENLIGIGSYGSVYKGR--FPDGIEVAIKVFHLQ--REGALNSFDAECE 712
           D L RA  Q+     IG G+YG V+K R     G  VA+K   +Q   EG   S   E  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 713 ILK---TIRHRNLVKIISSCT-----NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL 764
           +L+   T  H N+V++   CT           LV E++ +   +   Y     LD     
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTY-----LDKVPEP 115
Query: 765 GIMIDVASALEY-----LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS 819
           G+  +    + +     L F HS+ +VH D+KP N+L+  S    L+DFG+A++ S +  
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
           M  T  + T+ Y APE   +   +   D+++ G +  E+F
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 12/221 (5%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +    R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
              VK+  +  +       L Y   G L   +       +   R     ++ SALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGR 838
                I+H D+KP N+LL++ M   ++DFG AK+LS E    +    + T  Y++PE   
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIK 876
           E       D++  G ++ ++  G+ P    NE+   +  IK
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 664 DQFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRN 721
           D F + + +G G+ G V+K    P G+ +A K+ HL+ + A+ N    E ++L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG-IMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  +    +  Q LG + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 123
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L   DSM  +  + T  Y++PE  +  
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 178
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
             S++ D+++ G+ L+E+  G  P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 664 DQFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRN 721
           D F + + +G G+ G V+K    P G+ +A K+ HL+ + A+ N    E ++L       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG-IMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  +    +  Q LG + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 123
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L   DSM  +  + T  Y++PE  +  
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 178
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
             S++ D+++ G+ L+E+  G  P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 13/215 (6%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEI 713
           +L    + +    +IG G++G V   R     +V A+K+   F + +      F  E +I
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
           +       +V++  +  +  +  +V+EYMP G L + M  SN+++          +V  A
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLA 180
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ +H   S   +H D+KP N+LLD S    L+DFG    +++E  ++    + T  YI+
Sbjct: 181 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 834 PEY----GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           PE     G +G    + D ++ G+ L E+  G  P
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 13/215 (6%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEI 713
           +L    + +    +IG G++G V   R     +V A+K+   F + +      F  E +I
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
           +       +V++  +  +  +  +V+EYMP G L + M  SN+++          +V  A
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLA 185
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ +H   S   +H D+KP N+LLD S    L+DFG    +++E  ++    + T  YI+
Sbjct: 186 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 242
Query: 834 PEY----GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           PE     G +G    + D ++ G+ L E+  G  P
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 121
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 180
Query: 836 --YGREGQVSIKGDVYNYGIMLMEVFT 860
              G +   S   D+++ G +  E+ T
Sbjct: 181 ILLGXK-YYSTAVDIWSLGCIFAEMVT 206

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 127/281 (45%), Gaps = 43/281 (15%)
Query: 690 EVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSL 747
           +VA+K+      E  L+   +E E++K I +H+N++ ++ +CT      +++EY  KG+L
Sbjct: 103 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 748 EDCM---------YASNFNLDIFQRL------GIMIDVASALEYLHFGHSNPIVHCDIKP 792
            + +         Y+ N + +  ++L           VA  +EYL    S   +H D+  
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 219
Query: 793 SNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNY 851
            NVL+ +  V  ++DFG+A+ +   D  K+T      + ++APE   +   + + DV+++
Sbjct: 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279
Query: 852 GIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCA 910
           G++L E+FT G  P                   P V       LL E   H      +C 
Sbjct: 280 GVLLWEIFTLGGSP------------------YPGVPVEELFKLLKEG--HRMDKPSNCT 319
Query: 911 SSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIEM 951
           + +  +  +C    P  R   K+++  L +I  L  +N EM
Sbjct: 320 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT-SNQEM 359

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIR 718
           AT ++     IG+G+YG+VYK R P  G  VA+K   +    EG   S   E  +L+ + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 719 ---HRNLVKIISSC----TNHNFK-ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDV 770
              H N+V+++  C    T+   K  LV E++ +        A    L       +M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG 830
              L++LH   +N IVH D+KP N+L+       L+DFG+A++ S +  M     + T+ 
Sbjct: 122 LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALAPVVVTLW 176
Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
           Y APE   +   +   D+++ G +  E+F
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGAL-NSFDAECEILKTIRHRN 721
           D F   + +G G+ G V K +  P G+ +A K+ HL+ + A+ N    E ++L       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMY-ASNFNLDIFQRLGIMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  A     +I  ++ I   V   L YL   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK 133
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L   DSM  +  + T  Y+APE  +  
Sbjct: 134 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMAPERLQGT 188
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
             S++ D+++ G+ L+E+  G  P
Sbjct: 189 HYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/291 (22%), Positives = 123/291 (42%), Gaps = 42/291 (14%)
Query: 657 DELLRATDQFSEENLIGIGSYGSVYKGRFP--DG--IEVAIKVFH--LQREGALNSFDAE 710
           +++L    QF+   ++G G +GSV + +    DG  ++VA+K+    +     +  F  E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 711 CEILKTIRHRNLVKIISSCTNHNFKA------LVLEYMPKGSLEDCMYASN-----FNLD 759
              +K   H ++ K++        K       ++L +M  G L   + AS      FNL 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 760 IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS 819
           +   +  M+D+A  +EYL    S   +H D+   N +L + M   ++DFG+++ +   D 
Sbjct: 136 LQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 820 MKQ-TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKR 877
            +Q   +   + ++A E   +   ++  DV+ +G+ + E+ T G  P       E+    
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---- 248
Query: 878 WINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
                      ++  N L +  E        C   V  L  +C S  P+ R
Sbjct: 249 --------YNYLIGGNRLKQPPE--------CMEEVYDLMYQCWSADPKQR 283

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 13/215 (6%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEI 713
           +L    + +    +IG G++G V   R     +V A+K+   F + +      F  E +I
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
           +       +V++  +  +  +  +V+EYMP G L + M  SN+++          +V  A
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLA 185
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ +H   S   +H D+KP N+LLD S    L+DFG    +++E  ++    + T  YI+
Sbjct: 186 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 242
Query: 834 PEY----GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           PE     G +G    + D ++ G+ L E+  G  P
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + ++LE M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 262
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 263 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKT 716
           L + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA--- 773
           + H N+VK++      N   LV E++    L+D M AS          GI + +  +   
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALT-------GIPLPLIKSYLF 113
Query: 774 --LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY 831
             L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 832 IAPEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
            APE     +  S   D+++ G +  E+ T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 114
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 836 --YGREGQVSIKGDVYNYGIMLMEVFT 860
              G +   S   D+++ G +  E+ T
Sbjct: 174 ILLGXK-YYSTAVDIWSLGCIFAEMVT 199

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+    H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + ++LE M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 150 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 253
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 254 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKT 716
           L + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK 
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA--- 773
           + H N+VK++      N   LV E++    L+D M AS          GI + +  +   
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALT-------GIPLPLIKSYLF 112
Query: 774 --LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY 831
             L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y
Sbjct: 113 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 171
Query: 832 IAPEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
            APE     +  S   D+++ G +  E+ T
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+D M AS          GI + +  +     
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALT-------GIPLPLIKSYLFQL 112
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 113 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 171
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+    H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + ++LE M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 165 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 268
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 269 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 306

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 672 IGIGSYGSVYKGRF--PD--GIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVKII 726
           IG G +G V++G +  P+   + VAIK   +   +     F  E   ++   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
              T  N   +++E    G L   +    F+LD+   +     +++AL YL    S   V
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H DI   NVL+  +    L DFG+++ + +    K ++    I ++APE     + +   
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 193
Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+ +G+ + E+   G+KP
Sbjct: 194 DVWMFGVCMWEILMHGVKP 212

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 8/205 (3%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSF-DAECEILKTIRHRNLV 723
           F++ + IG GS+G VYKG      EV AIK+  L+           E  +L       + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           +   S        +++EY+  GS  D +              I+ ++   L+YLH   S 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA--TILREILKGLDYLH---SE 135
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
             +H DIK +NVLL +     L+DFG+A  L+ +  +K+   + T  ++APE  ++    
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVIKQSAYD 194
Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEF 868
            K D+++ GI  +E+  G  P ++ 
Sbjct: 195 FKADIWSLGITAIELAKGEPPNSDL 219

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 15/217 (6%)
Query: 672 IGIGSYGSVYK-GRFPDGIEVAIKVFHL--QREGALNSFDAECEILKTIRHRNLVKIISS 728
           IG GSYG   K  R  DG  +  K        E       +E  +L+ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 729 CTNHNFKAL--VLEYMPKGSLEDCMYASNFN---LDIFQRLGIMIDVASALEYLHF---- 779
             +     L  V+EY   G L   +         LD    L +M  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
           GH+  ++H D+KP+NV LD      L DFG+A++L+ + S  +T  + T  Y++PE    
Sbjct: 134 GHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQMNR 190
Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
              + K D+++ G +L E+   M P   F   E++ K
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 118/243 (48%), Gaps = 20/243 (8%)
Query: 641 IKAGMSP-QVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHL 698
           I++G +P Q + R      +L+ T +F +  ++G G++G+VYKG + P+G +V I V   
Sbjct: 5   IRSGEAPNQALLR------ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 57
Query: 699 Q-REG----ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA 753
           + RE     A      E  ++ ++ + ++ +++  C     + L+ + MP G L D +  
Sbjct: 58  ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE 116
Query: 754 SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL 813
              N+     L   + +A  + YL       +VH D+   NVL+       ++DFG+AKL
Sbjct: 117 HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 173
Query: 814 L-SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTG 871
           L +EE           I ++A E       + + DV++YG+ + E+ T G KP +     
Sbjct: 174 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 233
Query: 872 EMS 874
           E+S
Sbjct: 234 EIS 236

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + ++LE M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 261
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 262 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIR 718
           AT ++     IG+G+YG+VYK R P  G  VA+K   +    EG   S   E  +L+ + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 719 ---HRNLVKIISSC----TNHNFK-ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDV 770
              H N+V+++  C    T+   K  LV E++ +        A    L       +M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG 830
              L++LH   +N IVH D+KP N+L+       L+DFG+A++ S +  M     + T+ 
Sbjct: 122 LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALDPVVVTLW 176
Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
           Y APE   +   +   D+++ G +  E+F
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+    H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + ++LE M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 302
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 303 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + ++LE M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 262
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 263 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+    H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + ++LE M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 175 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 278
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 279 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 316

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 121
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 180
Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFT 860
                +  S   D+++ G +  E+ T
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 663 TDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGA--LNSFDAECEILKTIRH 719
           +D +  +  +G G++  V +      G+E A K+ + ++  A      + E  I + ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
            N+V++  S    +F  LV + +  G L + + A  F    +        +   LE + +
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 143
Query: 780 GHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
            HSN IVH ++KP N+LL          L+DFG+A  +   DS        T GY++PE 
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEV 201
Query: 837 GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            ++   S   D++  G++L  +  G  P
Sbjct: 202 LKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 114
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 115 GLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFT 860
                +  S   D+++ G +  E+ T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 114
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFT 860
                +  S   D+++ G +  E+ T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 113
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 172
Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFT 860
                +  S   D+++ G +  E+ T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 114
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFT 860
                +  S   D+++ G +  E+ T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+    H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + ++LE M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 176 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 279
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 280 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 317

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+  M AS          GI + +  +     
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQL 113
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y A
Sbjct: 114 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRA 172
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 113
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 172
Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFT 860
                +  S   D+++ G +  E+ T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 9/214 (4%)
Query: 672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG GS G V   R    G +VA+K+  L+++        E  I++  +H N+V++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
                 +++E++  G+L D +  S   L+  Q   +   V  AL YLH   +  ++H DI
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  ++LL       LSDFG    +S +D  K+   + T  ++APE       + + D+++
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 851 YGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP 884
            GIM++E+  G  P   F    +   + + DS P
Sbjct: 227 LGIMVIEMVDGEPPY--FSDSPVQAMKRLRDSPP 258

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIR 718
           AT ++     IG+G+YG+VYK R P  G  VA+K   +    EG   S   E  +L+ + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 719 ---HRNLVKIISSC----TNHNFK-ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDV 770
              H N+V+++  C    T+   K  LV E++ +        A    L       +M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG 830
              L++LH   +N IVH D+KP N+L+       L+DFG+A++ S +  M     + T+ 
Sbjct: 122 LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALFPVVVTLW 176
Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
           Y APE   +   +   D+++ G +  E+F
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+    H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + ++LE M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 185 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 288
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 289 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 326

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 86  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 145 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 201
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 202 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 8/202 (3%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G++G VYK +  +  +  A KV   + E  L  +  E +IL +  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             N   +++E+   G+++  M      L   Q   I +     L+ L++ H N I+H D+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQ---IQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 791 KPSNVLLDDSMVAHLSDFGIA----KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           K  N+L        L+DFG++    + +   D    T        +  E  ++     K 
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKA 221
Query: 847 DVYNYGIMLMEVFTGMKPTNEF 868
           DV++ GI L+E+     P +E 
Sbjct: 222 DVWSLGITLIEMAEIEPPHHEL 243

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + +++E M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 276
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 277 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 123/277 (44%), Gaps = 54/277 (19%)
Query: 690 EVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSL 747
           +VA+K+      E  L+   +E E++K I +H+N++ ++ +CT      +++EY  KG+L
Sbjct: 51  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 110
Query: 748 EDCM---------YASNFNLDIFQRL------GIMIDVASALEYLHFGHSNPIVHCDIKP 792
            + +         Y+ N + +  ++L           VA  +EYL    S   +H D+  
Sbjct: 111 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 167
Query: 793 SNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNY 851
            NVL+ +  V  ++DFG+A+ +   D  K+T      + ++APE   +   + + DV+++
Sbjct: 168 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 227
Query: 852 GIMLMEVFT-------GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
           G++L E+FT       G+ P  E F                        LL E   H   
Sbjct: 228 GVLLWEIFTLGGSPYPGV-PVEELF-----------------------KLLKEG--HRMD 261
Query: 905 AKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
              +C + +  +  +C    P  R   K+++  L +I
Sbjct: 262 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 70  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+++ MP G L D +     N+     L   + +A  + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG AKLL +EE           I ++A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 123/277 (44%), Gaps = 54/277 (19%)
Query: 690 EVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSL 747
           +VA+K+      E  L+   +E E++K I +H+N++ ++ +CT      +++EY  KG+L
Sbjct: 54  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 113
Query: 748 EDCM---------YASNFNLDIFQRL------GIMIDVASALEYLHFGHSNPIVHCDIKP 792
            + +         Y+ N + +  ++L           VA  +EYL    S   +H D+  
Sbjct: 114 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 170
Query: 793 SNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNY 851
            NVL+ +  V  ++DFG+A+ +   D  K+T      + ++APE   +   + + DV+++
Sbjct: 171 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 230
Query: 852 GIMLMEVFT-------GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
           G++L E+FT       G+ P  E F                        LL E   H   
Sbjct: 231 GVLLWEIFTLGGSPYPGV-PVEELF-----------------------KLLKEG--HRMD 264
Query: 905 AKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
              +C + +  +  +C    P  R   K+++  L +I
Sbjct: 265 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 672 IGIGSYGSVYKGRF------PDGIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVK 724
           +G G++G VY+G+       P  ++VA+K    +  E     F  E  I+    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLH 778
            I        + +++E M  G L+  +  +        +L +   L +  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 779 FGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAP 834
             H    +H DI   N LL       VA + DFG+A+ +      ++    +  + ++ P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           E   EG  + K D +++G++L E+F+ G  P             + + S   V+  + + 
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------YPSKSNQEVLEFVTSG 261
Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
              +         ++C   V  +  +C    PE+R N   I+ R+
Sbjct: 262 GRMD-------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 123/277 (44%), Gaps = 54/277 (19%)
Query: 690 EVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSL 747
           +VA+K+      E  L+   +E E++K I +H+N++ ++ +CT      +++EY  KG+L
Sbjct: 62  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 748 EDCM---------YASNFNLDIFQRL------GIMIDVASALEYLHFGHSNPIVHCDIKP 792
            + +         Y+ N + +  ++L           VA  +EYL    S   +H D+  
Sbjct: 122 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 793 SNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNY 851
            NVL+ +  V  ++DFG+A+ +   D  K+T      + ++APE   +   + + DV+++
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 852 GIMLMEVFT-------GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
           G++L E+FT       G+ P  E F                        LL E   H   
Sbjct: 239 GVLLWEIFTLGGSPYPGV-PVEELF-----------------------KLLKEG--HRMD 272
Query: 905 AKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
              +C + +  +  +C    P  R   K+++  L +I
Sbjct: 273 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 112/230 (48%), Gaps = 28/230 (12%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYK------GRFPDGIEVAIKVF----HLQREGALNSF 707
           E  R   QF +   +G G++G V +      G+    ++VA+K+     H   + AL S 
Sbjct: 42  EFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS- 98
Query: 708 DAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGI 766
             E +I+  + +H N+V ++ +CT+     ++ EY   G L + +   +  L+      I
Sbjct: 99  --ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 767 MIDVASALEYLHFGH----------SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLS 815
                S  + LHF            S   +H D+   NVLL +  VA + DFG+A+ +++
Sbjct: 157 ANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           + + + +      + ++APE   +   +++ DV++YGI+L E+F+ G+ P
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 672 IGIGSYGSVYKGRF--PD--GIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVKII 726
           IG G +G V++G +  P+   + VAIK   +   +     F  E   ++   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
              T  N   +++E    G L   +    F+LD+   +     +++AL YL    S   V
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H DI   NVL+  +    L DFG+++ + +    K ++    I ++APE     + +   
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 573
Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+ +G+ + E+   G+KP
Sbjct: 574 DVWMFGVCMWEILMHGVKP 592

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+++ MP G L D +     N+     L   + +A  + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG AKLL +EE           I ++A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 123/277 (44%), Gaps = 54/277 (19%)
Query: 690 EVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSL 747
           +VA+K+      E  L+   +E E++K I +H+N++ ++ +CT      +++EY  KG+L
Sbjct: 55  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 114
Query: 748 EDCM---------YASNFNLDIFQRL------GIMIDVASALEYLHFGHSNPIVHCDIKP 792
            + +         Y+ N + +  ++L           VA  +EYL    S   +H D+  
Sbjct: 115 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 171
Query: 793 SNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNY 851
            NVL+ +  V  ++DFG+A+ +   D  K+T      + ++APE   +   + + DV+++
Sbjct: 172 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 231
Query: 852 GIMLMEVFT-------GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
           G++L E+FT       G+ P  E F                        LL E   H   
Sbjct: 232 GVLLWEIFTLGGSPYPGV-PVEELF-----------------------KLLKEG--HRMD 265
Query: 905 AKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
              +C + +  +  +C    P  R   K+++  L +I
Sbjct: 266 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 123/277 (44%), Gaps = 54/277 (19%)
Query: 690 EVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSL 747
           +VA+K+      E  L+   +E E++K I +H+N++ ++ +CT      +++EY  KG+L
Sbjct: 62  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 748 EDCM---------YASNFNLDIFQRL------GIMIDVASALEYLHFGHSNPIVHCDIKP 792
            + +         Y+ N + +  ++L           VA  +EYL    S   +H D+  
Sbjct: 122 REYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 793 SNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNY 851
            NVL+ +  V  ++DFG+A+ +   D  K+T      + ++APE   +   + + DV+++
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 852 GIMLMEVFT-------GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
           G++L E+FT       G+ P  E F                        LL E   H   
Sbjct: 239 GVLLWEIFTLGGSPYPGV-PVEELF-----------------------KLLKEG--HRMD 272
Query: 905 AKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
              +C + +  +  +C    P  R   K+++  L +I
Sbjct: 273 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+++ MP G L D +     N+     L   + +A  + YL 
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG AKLL +EE           I ++A E  
Sbjct: 139 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 109/224 (48%), Gaps = 13/224 (5%)
Query: 659 LLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECE 712
           +L+ T +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  
Sbjct: 36  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 713 ILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           ++ ++ + ++ +++  C     + L+ + MP G L D +     N+     L   + +A 
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 153
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGY 831
            + YL       +VH D+   NVL+       ++DFG+AKLL +EE           I +
Sbjct: 154 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
           +A E       + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 254

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 73  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE 131
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 132 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 188
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 189 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 226

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 672 IGIGSYGSVYKGRF--PD--GIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVKII 726
           IG G +G V++G +  P+   + VAIK   +   +     F  E   ++   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
              T  N   +++E    G L   +    F+LD+   +     +++AL YL    S   V
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H DI   NVL+  +    L DFG+++ + +    K ++    I ++APE     + +   
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 573
Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+ +G+ + E+   G+KP
Sbjct: 574 DVWMFGVCMWEILMHGVKP 592

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 120/277 (43%), Gaps = 54/277 (19%)
Query: 690 EVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSL 747
           +VA+K+      E  L+   +E E++K I +H+N++ ++ +CT      +++EY  KG+L
Sbjct: 62  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 748 EDCMYASN-------FN--------LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKP 792
            + + A         +N        L     +     VA  +EYL    S   +H D+  
Sbjct: 122 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 793 SNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNY 851
            NVL+ +  V  ++DFG+A+ +   D  K+T      + ++APE   +   + + DV+++
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 852 GIMLMEVFT-------GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
           G++L E+FT       G+ P  E F                        LL E   H   
Sbjct: 239 GVLLWEIFTLGGSPYPGV-PVEELF-----------------------KLLKEG--HRMD 272
Query: 905 AKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
              +C + +  +  +C    P  R   K+++  L +I
Sbjct: 273 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 663 TDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRH 719
           TD++     +G G++  V +  + P G E A K+ + ++  A +    + E  I + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
            N+V++  S +   F  LV + +  G L + + A  +    +        +   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNH 118
Query: 780 GHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
            H N IVH D+KP N+LL          L+DFG+A +  + D         T GY++PE 
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEV 177
Query: 837 GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            R+       D++  G++L  +  G  P
Sbjct: 178 LRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/303 (23%), Positives = 129/303 (42%), Gaps = 62/303 (20%)
Query: 672 IGIGSYGSVY--------KGRFPDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRN 721
           +G G++G V         K +     +VA+K+      E  L+   +E E++K I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-------FN--------LDIFQRLGI 766
           ++ ++ +CT      +++EY  KG+L + + A         +N        L     +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT- 825
              VA  +EYL    S   +H D+   NVL+ +  V  ++DFG+A+ +   D  K+T   
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFFTGEMSIKRW 878
              + ++APE   +   + + DV+++G++L E+FT       G+ P  E F         
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELF--------- 247
Query: 879 INDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                          LL E   H      +C + +  +  +C    P  R   K+++  L
Sbjct: 248 --------------KLLKEG--HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
Query: 939 IKI 941
            +I
Sbjct: 292 DRI 294

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 663 TDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGA--LNSFDAECEILKTIRH 719
           +D +  +  +G G++  V +      G+E A K+ + ++  A      + E  I + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
            N+V++  S    +F  LV + +  G L + + A  F    +        +   LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 120
Query: 780 GHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
            HSN IVH ++KP N+LL          L+DFG+A  +   DS        T GY++PE 
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEV 178
Query: 837 GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            ++   S   D++  G++L  +  G  P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 663 TDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGA--LNSFDAECEILKTIRH 719
           +D +  +  +G G++  V +      G+E A K+ + ++  A      + E  I + ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
            N+V++  S    +F  LV + +  G L + + A  F    +        +   LE + +
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 119
Query: 780 GHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
            HSN IVH ++KP N+LL          L+DFG+A  +   DS        T GY++PE 
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEV 177
Query: 837 GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            ++   S   D++  G++L  +  G  P
Sbjct: 178 LKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 663 TDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGA--LNSFDAECEILKTIRH 719
           +D +  +  +G G++  V +      G+E A K+ + ++  A      + E  I + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
            N+V++  S    +F  LV + +  G L + + A  F    +        +   LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 120
Query: 780 GHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
            HSN IVH ++KP N+LL          L+DFG+A  +   DS        T GY++PE 
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEV 178
Query: 837 GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            ++   S   D++  G++L  +  G  P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 25/255 (9%)
Query: 644 GMSPQVMWRRYSHDELLRAT-------------DQFSEENLIGIGSYGSVYKGRF-PDGI 689
           G SPQ   +R SH++   A              D F +   IG GS G V        G 
Sbjct: 1   GSSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIK---IGEGSTGIVCIATVRSSGK 57
Query: 690 EVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLED 749
            VA+K   L+++        E  I++  +H N+V++ +S    +   +V+E++  G+L D
Sbjct: 58  LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 117
Query: 750 CMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFG 809
            +  +  N +  Q   + + V  AL  LH   +  ++H DIK  ++LL       LSDFG
Sbjct: 118 IVTHTRMNEE--QIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG 172
Query: 810 IAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFF 869
               +S+E   ++   + T  ++APE         + D+++ GIM++E+  G  P   F 
Sbjct: 173 FCAQVSKEVP-RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY--FN 229
Query: 870 TGEMSIKRWINDSLP 884
              +   + I D+LP
Sbjct: 230 EPPLKAMKMIRDNLP 244

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 672 IGIGSYGSVYKGRF--PD--GIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVKII 726
           IG G +G V++G +  P+   + VAIK   +   +     F  E   ++   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
              T  N   +++E    G L   +    ++LD+   +     +++AL YL    S   V
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H DI   NVL+  +    L DFG+++ + +    K ++    I ++APE     + +   
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 193
Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+ +G+ + E+   G+KP
Sbjct: 194 DVWMFGVCMWEILMHGVKP 212

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 672 IGIGSYGSVYKGRF--PD--GIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVKII 726
           IG G +G V++G +  P+   + VAIK   +   +     F  E   ++   H ++VK+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
              T  N   +++E    G L   +    ++LD+   +     +++AL YL    S   V
Sbjct: 106 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H DI   NVL+  +    L DFG+++ + +    K ++    I ++APE     + +   
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 221
Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+ +G+ + E+   G+KP
Sbjct: 222 DVWMFGVCMWEILMHGVKP 240

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 118/243 (48%), Gaps = 20/243 (8%)
Query: 641 IKAGMSP-QVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHL 698
           I++G +P Q + R      +L+ T +F +  ++  G++G+VYKG + P+G +V I V   
Sbjct: 5   IRSGEAPNQALLR------ILKET-EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIK 57
Query: 699 Q-REG----ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA 753
           + RE     A      E  ++ ++ + ++ +++  C     + L+++ MP G L D +  
Sbjct: 58  ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE 116
Query: 754 SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL 813
              N+     L   + +A  + YL       +VH D+   NVL+       ++DFG+AKL
Sbjct: 117 HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 173
Query: 814 L-SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTG 871
           L +EE           I ++A E       + + DV++YG+ + E+ T G KP +     
Sbjct: 174 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 233
Query: 872 EMS 874
           E+S
Sbjct: 234 EIS 236

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 104/231 (45%), Gaps = 40/231 (17%)
Query: 671 LIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKT--IRHRNLVKII-- 726
           LIG G YG+VYKG   D   VA+KVF         +F  E  I +   + H N+ + I  
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 727 ---SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF---- 779
               +        LV+EY P GSL    Y S    D      +   V   L YLH     
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 780 -GHSNP-IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS--------EEDSMKQTQTLATI 829
             H  P I H D+   NVL+ +     +SDFG++  L+        EED+   ++ + TI
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE-VGTI 192
Query: 830 GYIAPEYGREGQVSIKG--------DVYNYGIMLMEVFTGMKPTNEFFTGE 872
            Y+APE   EG V+++         D+Y  G++  E+F  M+ T+  F GE
Sbjct: 193 RYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIF--MRCTD-LFPGE 239

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 672 IGIGSYGSVYKGRF--PD--GIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVKII 726
           IG G +G V++G +  P+   + VAIK   +   +     F  E   ++   H ++VK+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
              T  N   +++E    G L   +    ++LD+   +     +++AL YL    S   V
Sbjct: 81  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H DI   NVL+  +    L DFG+++ + +    K ++    I ++APE     + +   
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 196
Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+ +G+ + E+   G+KP
Sbjct: 197 DVWMFGVCMWEILMHGVKP 215

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 672 IGIGSYGSVYKGRF--PD--GIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVKII 726
           IG G +G V++G +  P+   + VAIK   +   +     F  E   ++   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
              T  N   +++E    G L   +    ++LD+   +     +++AL YL    S   V
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H DI   NVL+  +    L DFG+++ + +    K ++    I ++APE     + +   
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 193
Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+ +G+ + E+   G+KP
Sbjct: 194 DVWMFGVCMWEILMHGVKP 212

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 118
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 177
Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFT 860
                +  S   D+++ G +  E+ T
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/285 (22%), Positives = 114/285 (40%), Gaps = 36/285 (12%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAI-KVFHLQREGALNSFDAECEILKT 716
            + R +D    E ++G G +G   K    +  EV + K      E    +F  E ++++ 
Sbjct: 5   RIFRPSDLIHGE-VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
           + H N++K I           + EY+  G+L   + + +      QR+    D+AS + Y
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE-------------DSMKQT 823
           L   HS  I+H D+   N L+ ++    ++DFG+A+L+ +E             D  K+ 
Sbjct: 124 L---HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL 883
             +    ++APE         K DV+++GI+L E+   +    ++    M       D  
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM-------DFG 233
Query: 884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
             V   +D                +C  S   + + C    PE R
Sbjct: 234 LNVRGFLD-----------RYCPPNCPPSFFPITVRCCDLDPEKR 267

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALT-------GIPLPLIKSYLFQLLQ 113
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 172
Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFT 860
                +  S   D+++ G +  E+ T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 672 IGIGSYGSVYKGRF--PD--GIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVKII 726
           IG G +G V++G +  P+   + VAIK   +   +     F  E   ++   H ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
              T  N   +++E    G L   +    ++LD+   +     +++AL YL    S   V
Sbjct: 83  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H DI   NVL+  +    L DFG+++ + +    K ++    I ++APE     + +   
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 198
Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+ +G+ + E+   G+KP
Sbjct: 199 DVWMFGVCMWEILMHGVKP 217

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 672 IGIGSYGSVYKGRF--PD--GIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVKII 726
           IG G +G V++G +  P+   + VAIK   +   +     F  E   ++   H ++VK+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
              T  N   +++E    G L   +    ++LD+   +     +++AL YL    S   V
Sbjct: 80  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H DI   NVL+  +    L DFG+++ + +    K ++    I ++APE     + +   
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 195
Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+ +G+ + E+   G+KP
Sbjct: 196 DVWMFGVCMWEILMHGVKP 214

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/304 (21%), Positives = 129/304 (42%), Gaps = 58/304 (19%)
Query: 672 IGIGSYGSVYKGRFPDGIE------VAIKVFHLQREGALNS-FDAECEILKTIRHRNLVK 724
           IG G++G V++ R P  +       VA+K+   +    + + F  E  ++    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFN-----------------------LDIF 761
           ++  C       L+ EYM  G L + + + + +                       L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK 821
           ++L I   VA+ + YL        VH D+   N L+ ++MV  ++DFG+++ +   D  K
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 822 QTQTLA-TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWI 879
                A  I ++ PE     + + + DV+ YG++L E+F+ G++P       E+      
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV------ 285
Query: 880 NDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR---VNTKEIIS 936
                 +  + D N+L+          ++C   + +L   C S+ P +R    +   I+ 
Sbjct: 286 ------IYYVRDGNILA--------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331
Query: 937 RLIK 940
           R+ +
Sbjct: 332 RMCE 335

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 663 TDQFSEENLIGIGSYGSVY--KGRFPDGIEVAIKVF---HLQREGALNSFDAECEILKTI 717
           +D++  + ++G GS+G V   K +   G E A+KV     ++++    S   E ++LK +
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
            H N++K+     +  +  LV E    G L D +  S           I+  V S + Y+
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYM 148
Query: 778 HFGHSNPIVHCDIKPSNVLLD-DSMVAHLS--DFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           H    N IVH D+KP N+LL+  S  A++   DFG++     E S K    + T  YIAP
Sbjct: 149 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 203
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTN 866
           E    G    K DV++ G++L  + +G  P N
Sbjct: 204 EV-LHGTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 672 IGIGSYGSVYKGRF--PD--GIEVAIKVF-HLQREGALNSFDAECEILKTIRHRNLVKII 726
           IG G +G V++G +  P+   + VAIK   +   +     F  E   ++   H ++VK+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
              T  N   +++E    G L   +    ++LD+   +     +++AL YL    S   V
Sbjct: 75  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H DI   NVL+  +    L DFG+++ + +    K ++    I ++APE     + +   
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 190
Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+ +G+ + E+   G+KP
Sbjct: 191 DVWMFGVCMWEILMHGVKP 209

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 20/243 (8%)
Query: 641 IKAGMSP-QVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHL 698
           I++G +P Q + R      +L+ T +F +  ++G G++G+VYKG + P+G +V I V   
Sbjct: 5   IRSGEAPNQALLR------ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 57
Query: 699 Q-REG----ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA 753
           + RE     A      E  ++ ++ + ++ +++  C     + L+ + MP G L D +  
Sbjct: 58  ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE 116
Query: 754 SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL 813
              N+     L   + +A  + YL       +VH D+   NVL+       ++DFG AKL
Sbjct: 117 HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKL 173
Query: 814 L-SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTG 871
           L +EE           I ++A E       + + DV++YG+ + E+ T G KP +     
Sbjct: 174 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 233
Query: 872 EMS 874
           E+S
Sbjct: 234 EIS 236

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKT 716
           L + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK 
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA--- 773
           + H N+VK++      N   LV E++ +  L+  M AS          GI + +  +   
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLF 114
Query: 774 --LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY 831
             L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y
Sbjct: 115 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 173
Query: 832 IAPEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
            APE     +  S   D+++ G +  E+ T
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 15/217 (6%)
Query: 672 IGIGSYGSVYK-GRFPDGIEVAIKVFHL--QREGALNSFDAECEILKTIRHRNLVKIISS 728
           IG GSYG   K  R  DG  +  K        E       +E  +L+ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 729 CTNHNFKAL--VLEYMPKGSLEDCMYASNFN---LDIFQRLGIMIDVASALEYLHF---- 779
             +     L  V+EY   G L   +         LD    L +M  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
           GH+  ++H D+KP+NV LD      L DFG+A++L+ ++   + + + T  Y++PE    
Sbjct: 134 GHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK-EFVGTPYYMSPEQMNR 190
Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
              + K D+++ G +L E+   M P   F   E++ K
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 15/217 (6%)
Query: 672 IGIGSYGSVYK-GRFPDGIEVAIKVFHL--QREGALNSFDAECEILKTIRHRNLVKIISS 728
           IG GSYG   K  R  DG  +  K        E       +E  +L+ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 729 CTNHNFKAL--VLEYMPKGSLEDCMYASNFN---LDIFQRLGIMIDVASALEYLHF---- 779
             +     L  V+EY   G L   +         LD    L +M  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
           GH+  ++H D+KP+NV LD      L DFG+A++L+ + S  +   + T  Y++PE    
Sbjct: 134 GHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNR 190
Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
              + K D+++ G +L E+   M P   F   E++ K
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--------------REGALNS 706
           AT ++     IG+G+YG+VYK R P  G  VA+K   +               RE AL  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL-- 64
Query: 707 FDAECEILKTIRHRNLVKIISSC----TNHNFK-ALVLEYMPKGSLEDCMYASNFNLDIF 761
                  L+   H N+V+++  C    T+   K  LV E++ +        A    L   
Sbjct: 65  ----LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK 821
               +M      L++LH   +N IVH D+KP N+L+       L+DFG+A++ S +  M 
Sbjct: 121 TIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MA 175
Query: 822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
            T  + T+ Y APE   +   +   D+++ G +  E+F
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKT 716
           L + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA--- 773
           + H N+VK++      N   LV E++ +  L+  M AS          GI + +  +   
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLF 113
Query: 774 --LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY 831
             L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 832 IAPEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
            APE     +  S   D+++ G +  E+ T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 672 IGIGSYGSVYKGRF---PDGIEVAIKVFHLQREGA-LNSFDAECEILKTIRHRNLVKIIS 727
           +G G++GSV +G +      I+VAIKV     E A       E +I+  + +  +V++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
            C       LV+E    G L   +      + +     ++  V+  ++YL        VH
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 133
Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREGQVSIK 845
            D+   NVLL +   A +SDFG++K L  +DS    ++     + + APE     + S +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 846 GDVYNYGIMLMEVFT-GMKP 864
            DV++YG+ + E  + G KP
Sbjct: 194 SDVWSYGVTMWEALSYGQKP 213

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 663 TDQFSEENLIGIGSYGSVY--KGRFPDGIEVAIKVF---HLQREGALNSFDAECEILKTI 717
           +D++  + ++G GS+G V   K +   G E A+KV     ++++    S   E ++LK +
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
            H N++K+     +  +  LV E    G L D +  S           I+  V S + Y+
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYM 165
Query: 778 HFGHSNPIVHCDIKPSNVLLD-DSMVAHLS--DFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           H    N IVH D+KP N+LL+  S  A++   DFG++     E S K    + T  YIAP
Sbjct: 166 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 220
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTN 866
           E    G    K DV++ G++L  + +G  P N
Sbjct: 221 EV-LHGTYDEKCDVWSTGVILYILLSGCPPFN 251

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 115/251 (45%), Gaps = 21/251 (8%)
Query: 646 SPQVMWRRYSHDELLRATDQFSEEN-----------LIGIGSYGSVYKGRF-PDGIEVAI 693
           SPQ   +R SH++  RA  Q   +             IG GS G V        G  VA+
Sbjct: 46  SPQREPQRVSHEQF-RAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAV 104
Query: 694 KVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA 753
           K   L+++        E  I++  +H N+V++ +S    +   +V+E++  G+L D +  
Sbjct: 105 KKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH 164
Query: 754 SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL 813
           +  N +  Q   + + V  AL  LH   +  ++H DIK  ++LL       LSDFG    
Sbjct: 165 TRMNEE--QIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 219
Query: 814 LSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM 873
           +S+E   ++   + T  ++APE         + D+++ GIM++E+  G  P   F    +
Sbjct: 220 VSKEVP-RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY--FNEPPL 276
Query: 874 SIKRWINDSLP 884
              + I D+LP
Sbjct: 277 KAMKMIRDNLP 287

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG AKLL +EE           I ++A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 663 TDQFSEENLIGIGSYGSVY--KGRFPDGIEVAIKVF---HLQREGALNSFDAECEILKTI 717
           +D++  + ++G GS+G V   K +   G E A+KV     ++++    S   E ++LK +
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
            H N++K+     +  +  LV E    G L D +  S           I+  V S + Y+
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYM 166
Query: 778 HFGHSNPIVHCDIKPSNVLLD-DSMVAHLS--DFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           H    N IVH D+KP N+LL+  S  A++   DFG++     E S K    + T  YIAP
Sbjct: 167 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 221
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTN 866
           E    G    K DV++ G++L  + +G  P N
Sbjct: 222 EV-LHGTYDEKCDVWSTGVILYILLSGCPPFN 252

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 663 TDQFSEENLIGIGSYGSVY--KGRFPDGIEVAIKVF---HLQREGALNSFDAECEILKTI 717
           +D++  + ++G GS+G V   K +   G E A+KV     ++++    S   E ++LK +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
            H N++K+     +  +  LV E    G L D +  S           I+  V S + Y+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYM 142
Query: 778 HFGHSNPIVHCDIKPSNVLLD-DSMVAHLS--DFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           H    N IVH D+KP N+LL+  S  A++   DFG++     E S K    + T  YIAP
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 197
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTN 866
           E    G    K DV++ G++L  + +G  P N
Sbjct: 198 EV-LHGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+  M AS          GI + +  +     
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQL 114
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 115 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 173
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++G G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG AKLL +EE           I ++A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+  M AS          GI + +  +     
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQL 114
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 115 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 173
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 663 TDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRH 719
           TD++     +G G++  V +  + P G E A K+ + ++  A +    + E  I + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
            N+V++  S +   F  LV + +  G L + + A  +    +        +   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNH 118
Query: 780 GHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
            H N IVH D+KP N+LL          L+DFG+A +  + D         T GY++PE 
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEV 177
Query: 837 GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            R+       D++  G++L  +  G  P
Sbjct: 178 LRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 663 TDQFSEENLIGIGSYGSVY--KGRFPDGIEVAIKVF---HLQREGALNSFDAECEILKTI 717
           +D++  + ++G GS+G V   K +   G E A+KV     ++++    S   E ++LK +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
            H N+ K+     +  +  LV E    G L D + +       F  +     +   L  +
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGI 139
Query: 778 HFGHSNPIVHCDIKPSNVLLD-DSMVAHLS--DFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            + H N IVH D+KP N+LL+  S  A++   DFG++     E S K    + T  YIAP
Sbjct: 140 TYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXKDKIGTAYYIAP 197
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTN 866
           E    G    K DV++ G++L  + +G  P N
Sbjct: 198 EV-LHGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+  M AS          GI + +  +     
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQL 113
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 114 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 172
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+  M AS          GI + +  +     
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQL 115
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 174
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+  M AS          GI + +  +     
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQL 112
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 171
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+  M AS          GI + +  +     
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQL 114
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 115 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 173
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+  M AS          GI + +  +     
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQL 113
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 114 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 172
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+  M AS          GI + +  +     
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQL 112
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 171
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+  M AS          GI + +  +     
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQL 112
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 171
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 113
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y APE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRAPE 172
Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFT 860
                +  S   D+++ G +  E+ T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 8/149 (5%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRN 721
           +Q     LIG G +G VY GR+    EVAI++  ++R  E  L +F  E    +  RH N
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +V  + +C +    A++       +L   +  +   LD+ +   I  ++   + YL   H
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---H 147
Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGI 810
           +  I+H D+K  NV  D+  V  ++DFG+
Sbjct: 148 AKGILHKDLKSKNVFYDNGKVV-ITDFGL 175

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKT 716
           L + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA--- 773
           + H N+VK++      N   LV E++    L+  M AS          GI + +  +   
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALT-------GIPLPLIKSYLF 113
Query: 774 --LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY 831
             L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 832 IAPEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
            APE     +  S   D+++ G +  E+ T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 117/243 (48%), Gaps = 20/243 (8%)
Query: 641 IKAGMSP-QVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHL 698
           I++G +P Q + R      +L+ T +F +  ++  G++G+VYKG + P+G +V I V   
Sbjct: 5   IRSGEAPNQALLR------ILKET-EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIK 57
Query: 699 Q-REG----ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA 753
           + RE     A      E  ++ ++ + ++ +++  C     + L+ + MP G L D +  
Sbjct: 58  ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE 116
Query: 754 SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL 813
              N+     L   + +A  + YL       +VH D+   NVL+       ++DFG+AKL
Sbjct: 117 HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 173
Query: 814 L-SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTG 871
           L +EE           I ++A E       + + DV++YG+ + E+ T G KP +     
Sbjct: 174 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 233
Query: 872 EMS 874
           E+S
Sbjct: 234 EIS 236

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+    L  + EG  ++   E  +LK + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 114
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFT 860
                +  S   D+++ G +  E+ T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+    L  + EG  ++   E  +LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 113
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 172
Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFT 860
                +  S   D+++ G +  E+ T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 113
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y APE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRAPE 172
Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFT 860
                +  S   D+++ G +  E+ T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 115/251 (45%), Gaps = 21/251 (8%)
Query: 646 SPQVMWRRYSHDELLRATDQFSEEN-----------LIGIGSYGSVYKGRF-PDGIEVAI 693
           SPQ   +R SH++  RA  Q   +             IG GS G V        G  VA+
Sbjct: 123 SPQREPQRVSHEQF-RAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAV 181
Query: 694 KVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA 753
           K   L+++        E  I++  +H N+V++ +S    +   +V+E++  G+L D +  
Sbjct: 182 KKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH 241
Query: 754 SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL 813
           +  N +  Q   + + V  AL  LH   +  ++H DIK  ++LL       LSDFG    
Sbjct: 242 TRMNEE--QIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 296
Query: 814 LSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM 873
           +S+E   ++   + T  ++APE         + D+++ GIM++E+  G  P   F    +
Sbjct: 297 VSKEVPRRKX-LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY--FNEPPL 353
Query: 874 SIKRWINDSLP 884
              + I D+LP
Sbjct: 354 KAMKMIRDNLP 364

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 670 NLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRHRNLVKI 725
           +++G G+  +V++GR    G   AIKVF+      L   D    E E+LK + H+N+VK+
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFN--NISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 726 --ISSCTNHNFKALVLEYMPKGSLEDCMY--ASNFNLDIFQRLGIMIDVASALEYLHFGH 781
             I   T    K L++E+ P GSL   +   ++ + L   + L ++ DV   + +L    
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---R 129
Query: 782 SNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-Y 836
            N IVH +IKP N++     D   V  L+DFG A+ L  ED  +      T  Y+ P+ Y
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVXLYGTEEYLHPDMY 187
Query: 837 GR-------EGQVSIKGDVYNYGIMLMEVFTGMKPTNEF 868
            R       + +     D+++ G+      TG  P   F
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+  M AS          GI + +  +     
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQL 112
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 171
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+  M AS          GI + +  +     
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALT-------GIPLPLIKSYLFQL 115
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 174
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA-----LE 775
           N+VK++      N   LV E++ +  L+  M AS          GI + +  +     L+
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQ 115
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y APE
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRAPE 174
Query: 836 YGREGQ-VSIKGDVYNYGIMLMEVFT 860
                +  S   D+++ G +  E+ T
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 670 NLIGIGSYGSVYKGRFPD--GIEVAIKVFHLQREGALN---SFDAECEILKTIRHRNLVK 724
            ++G G +G VY+G + +  G ++ + V   +++  L+    F +E  I+K + H ++VK
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +I          +++E  P G L   +  +  +L +   +   + +  A+ YL    S  
Sbjct: 90  LIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SIN 145
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
            VH DI   N+L+       L DFG+++ + +ED  K + T   I +++PE     + + 
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 205
Query: 845 KGDVYNYGIMLMEVFT-GMKP 864
             DV+ + + + E+ + G +P
Sbjct: 206 ASDVWMFAVCMWEILSFGKQP 226

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 67/253 (26%), Positives = 115/253 (45%), Gaps = 25/253 (9%)
Query: 646 SPQVMWRRYSHDELLRAT-------------DQFSEENLIGIGSYGSVYKGRF-PDGIEV 691
           SPQ   +R SH++   A              D F +   IG GS G V        G  V
Sbjct: 1   SPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLV 57
Query: 692 AIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCM 751
           A+K   L+++        E  I++  +H N+V++ +S    +   +V+E++  G+L D +
Sbjct: 58  AVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 117
Query: 752 YASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA 811
             +  N +  Q   + + V  AL  LH   +  ++H DIK  ++LL       LSDFG  
Sbjct: 118 THTRMNEE--QIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFC 172
Query: 812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTG 871
             +S+E   ++   + T  ++APE         + D+++ GIM++E+  G  P   F   
Sbjct: 173 AQVSKEVP-RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY--FNEP 229
Query: 872 EMSIKRWINDSLP 884
            +   + I D+LP
Sbjct: 230 PLKAMKMIRDNLP 242

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 670 NLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRHRNLVKI 725
           +++G G+  +V++GR    G   AIKVF+      L   D    E E+LK + H+N+VK+
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFN--NISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 726 --ISSCTNHNFKALVLEYMPKGSLEDCMY--ASNFNLDIFQRLGIMIDVASALEYLHFGH 781
             I   T    K L++E+ P GSL   +   ++ + L   + L ++ DV   + +L    
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---R 129
Query: 782 SNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-Y 836
            N IVH +IKP N++     D   V  L+DFG A+ L  ED  +      T  Y+ P+ Y
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLHPDMY 187
Query: 837 GR-------EGQVSIKGDVYNYGIMLMEVFTGMKPTNEF 868
            R       + +     D+++ G+      TG  P   F
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++    L+  M AS          GI + +  +     
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALT-------GIPLPLIKSYLFQL 113
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 114 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 172
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEILK 715
           ++A D +    +IG G++G V   R     +V A+K+   F + +      F  E +I+ 
Sbjct: 72  MKAED-YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALE 775
                 +V++  +  +  +  +V+EYMP G L + M  SN+++          +V  AL+
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALD 188
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            +H   S  ++H D+KP N+LLD      L+DFG    + E   +     + T  YI+PE
Sbjct: 189 AIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPE 245
Query: 836 Y----GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
                G +G    + D ++ G+ L E+  G  P
Sbjct: 246 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 670 NLIGIGSYGSVYKGRFPD--GIEVAIKVFHLQREGALN---SFDAECEILKTIRHRNLVK 724
            ++G G +G VY+G + +  G ++ + V   +++  L+    F +E  I+K + H ++VK
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +I          +++E  P G L   +  +  +L +   +   + +  A+ YL    S  
Sbjct: 74  LIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SIN 129
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
            VH DI   N+L+       L DFG+++ + +ED  K + T   I +++PE     + + 
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 189
Query: 845 KGDVYNYGIMLMEVFT-GMKP 864
             DV+ + + + E+ + G +P
Sbjct: 190 ASDVWMFAVCMWEILSFGKQP 210

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 670 NLIGIGSYGSVYKGRFPD--GIEVAIKVFHLQREGALN---SFDAECEILKTIRHRNLVK 724
            ++G G +G VY+G + +  G ++ + V   +++  L+    F +E  I+K + H ++VK
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +I          +++E  P G L   +  +  +L +   +   + +  A+ YL    S  
Sbjct: 78  LIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SIN 133
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
            VH DI   N+L+       L DFG+++ + +ED  K + T   I +++PE     + + 
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 845 KGDVYNYGIMLMEVFT-GMKP 864
             DV+ + + + E+ + G +P
Sbjct: 194 ASDVWMFAVCMWEILSFGKQP 214

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL--QREGALNSFDAECEILKTIR 718
           + + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA----- 773
           H N+VK++      N   LV E++ +  L+  M AS          GI + +  +     
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALT-------GIPLPLIKSYLFQL 115
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+ L F HS+ ++H D+KP N+L++      L+DFG+A+             + T+ Y A
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRA 174
Query: 834 PEYGREGQ-VSIKGDVYNYGIMLMEVFT 860
           PE     +  S   D+++ G +  E+ T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 12/218 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REG----ALNSFDAECEILKTIR 718
           +F +  ++  G++G+VYKG + P+G +V I V   + RE     A      E  ++ ++ 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  + YL 
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+AKLL +EE           I ++A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS 874
                + + DV++YG+ + E+ T G KP +     E+S
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 36/228 (15%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIR 718
           LR    F E  ++G G++G V K R   D    AIK      E  L++  +E  +L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLN 60
Query: 719 H-------------RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFN--LDIFQR 763
           H             RN VK  ++    +   +  EY    +L D +++ N N   D + R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE-DSMK- 821
           L   I     LE L + HS  I+H ++KP N+ +D+S    + DFG+AK +    D +K 
Sbjct: 121 LFRQI-----LEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 822 -----------QTQTLATIGYIAPEY-GREGQVSIKGDVYNYGIMLME 857
                       T  + T  Y+A E     G  + K D Y+ GI+  E
Sbjct: 176 DSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 672 IGIGSYGSVYKGRF---PDGIEVAIKVFHLQREGA-LNSFDAECEILKTIRHRNLVKIIS 727
           +G G++GSV +G +      I+VAIKV     E A       E +I+  + +  +V++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
            C       LV+E    G L   +      + +     ++  V+  ++YL        VH
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 459
Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREGQVSIK 845
            ++   NVLL +   A +SDFG++K L  +DS    ++     + + APE     + S +
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 846 GDVYNYGIMLMEVFT-GMKPTNEF 868
            DV++YG+ + E  + G KP  + 
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKM 543

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKIISS- 728
           IG G YG V+ G++  G +VA+KVF    E    S+  E EI +T+  RH N++  I++ 
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAAD 100
Query: 729 ---CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF----GH 781
                +     L+ +Y   GSL D  Y  +  LD    L +     S L +LH       
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYD--YLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 782 SNP-IVHCDIKPSNVLLDDSMVAHLSDFGIA-KLLSE--EDSMKQTQTLATIGYIAPEYG 837
             P I H D+K  N+L+  +    ++D G+A K +S+  E  +     + T  Y+ PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 838 REG------QVSIKGDVYNYGIMLMEV 858
            E       Q  I  D+Y++G++L EV
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKIISSC 729
           IG G +G V++G++  G EVA+K+F  + E    S+  E EI +T+  RH N++  I++ 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 730 TNHNFKA----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF----GH 781
              N       LV +Y   GSL D  Y + + + +   + + +  AS L +LH       
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 782 SNP-IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA------TIGYIAP 834
             P I H D+K  N+L+  +    ++D G+A      DS   T  +A      T  Y+AP
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 835 EY------GREGQVSIKGDVYNYGIMLMEV 858
           E        +  +   + D+Y  G++  E+
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKIISSC 729
           IG G +G V++G++  G EVA+K+F  + E    S+  E EI +T+  RH N++  I++ 
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 730 TNHNFKA----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF----GH 781
              N       LV +Y   GSL D  Y + + + +   + + +  AS L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 782 SNP-IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA------TIGYIAP 834
             P I H D+K  N+L+  +    ++D G+A      DS   T  +A      T  Y+AP
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 835 EY------GREGQVSIKGDVYNYGIMLMEV 858
           E        +  +   + D+Y  G++  E+
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHL---QREGALNSFDAECEILKTIRHRN 721
           FS+   IG GS+G+VY  R     EV AIK       Q          E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS----ALEYL 777
            ++        +   LV+EY        C+ +++  L++ ++    +++A+    AL+ L
Sbjct: 116 TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY- 836
            + HS+ ++H D+K  N+LL +  +  L DFG A +++  +       + T  ++APE  
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEVI 222
Query: 837 --GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
               EGQ   K DV++ GI  +E+     P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 58/299 (19%), Positives = 133/299 (44%), Gaps = 39/299 (13%)
Query: 657 DELLRATDQFSEENLIGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNS---FDA 709
           DE   A ++ +    +G GS+G VY    KG   D  E  + +  +    ++     F  
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD---------I 760
           E  ++K     ++V+++   +      +++E M +G L+  + +    ++         +
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM 820
            + + +  ++A  + YL+   +N  VH D+   N ++ +     + DFG+ + + E D  
Sbjct: 123 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 821 KQ-TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI 879
           ++  + L  + +++PE  ++G  +   DV+++G++L E+ T  +   +  + E  ++   
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-- 237
Query: 880 NDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                    +M+  LL + +        +C   +L L   C   +P+ R +  EIIS +
Sbjct: 238 ---------VMEGGLLDKPD--------NCPDMLLELMRMCWQYNPKMRPSFLEIISSI 279

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/302 (19%), Positives = 133/302 (44%), Gaps = 39/302 (12%)
Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNS--- 706
           Y  DE   A ++ +    +G GS+G VY    KG   D  E  + +  +    ++     
Sbjct: 37  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 96
Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------- 759
           F  E  ++K     ++V+++   +      +++E M +G L+  + +    ++       
Sbjct: 97  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 156
Query: 760 --IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
             + + + +  ++A  + YL+   +N  VH D+   N ++ +     + DFG+ + + E 
Sbjct: 157 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 213
Query: 818 DSMKQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
           D  ++  + L  + +++PE  ++G  +   DV+++G++L E+ T  +   +  + E  ++
Sbjct: 214 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 273
Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                       +M+  LL + +        +C   +  L   C   +P+ R +  EIIS
Sbjct: 274 -----------FVMEGGLLDKPD--------NCPDMLFELMRMCWQYNPKMRPSFLEIIS 314
Query: 937 RL 938
            +
Sbjct: 315 SI 316

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 64/287 (22%), Positives = 125/287 (43%), Gaps = 30/287 (10%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRN 721
           D +  + +IG G+   V      P   +VAIK  +L++ + +++    E + +    H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCM--------YASNFNLDIFQRLGIMIDVASA 773
           +V   +S    +   LV++ +  GS+ D +        + S   LD      I+ +V   
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEG 128
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT----LATI 829
           LEYLH    N  +H D+K  N+LL +     ++DFG++  L+    + + +     + T 
Sbjct: 129 LEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 830 GYIAPEYGREGQ-VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMN 888
            ++APE   + +    K D++++GI  +E+ TG  P +++   ++ +    ND       
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 245
Query: 889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII 935
           + D  +L           +    S   +   C  + PE R    E++
Sbjct: 246 VQDKEML-----------KKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 19/217 (8%)
Query: 656 HDELLRATDQFSEENLIGIGSYG----SVYKGRFPDGIEVAIKVFHLQREGALNSFDAEC 711
           H   ++ TD +  +  IG+GSY      ++K      +E A+K+    +       +   
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKRDPTEEIEI-- 68
Query: 712 EILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA 771
            +L+  +H N++ +     +  +  +V E M  G L D +    F     +   ++  + 
Sbjct: 69  -LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVLFTIT 126
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSM----VAHLSDFGIAKLLSEEDSMKQTQTLA 827
             +EYLH   +  +VH D+KPSN+L  D         + DFG AK L  E+ +  T    
Sbjct: 127 KTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY- 182
Query: 828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T  ++APE           D+++ G++L  + TG  P
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 126/287 (43%), Gaps = 30/287 (10%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRN 721
           D +  + +IG G+   V      P   +VAIK  +L++ + +++    E + +    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCM--------YASNFNLDIFQRLGIMIDVASA 773
           +V   +S    +   LV++ +  GS+ D +        + S   LD      I+ +V   
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEG 133
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT-IG-- 830
           LEYLH    N  +H D+K  N+LL +     ++DFG++  L+    + + +   T +G  
Sbjct: 134 LEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 831 -YIAPEYGREGQ-VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMN 888
            ++APE   + +    K D++++GI  +E+ TG  P +++   ++ +    ND       
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII 935
           + D  +L           +    S   +   C  + PE R    E++
Sbjct: 251 VQDKEML-----------KKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 58/302 (19%), Positives = 133/302 (44%), Gaps = 39/302 (12%)
Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNS--- 706
           Y  DE   A ++ +    +G GS+G VY    KG   D  E  + +  +    ++     
Sbjct: 9   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------- 759
           F  E  ++K     ++V+++   +      +++E M +G L+  + +    ++       
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 760 --IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
             + + + +  ++A  + YL+   +N  VH D+   N ++ +     + DFG+ + + E 
Sbjct: 129 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 185
Query: 818 DSMKQ-TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
           D  ++  + L  + +++PE  ++G  +   DV+++G++L E+ T  +   +  + E  ++
Sbjct: 186 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                       +M+  LL + +        +C   +  L   C   +P+ R +  EIIS
Sbjct: 246 F-----------VMEGGLLDKPD--------NCPDMLFELMRMCWQYNPKMRPSFLEIIS 286
Query: 937 RL 938
            +
Sbjct: 287 SI 288

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHL---QREGALNSFDAECEILKTIRHRN 721
           FS+   IG GS+G+VY  R     EV AIK       Q          E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS----ALEYL 777
            ++        +   LV+EY        C+ +++  L++ ++    +++A+    AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY- 836
            + HS+ ++H D+K  N+LL +  +  L DFG A +++  +       + T  ++APE  
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEVI 183
Query: 837 --GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
               EGQ   K DV++ GI  +E+     P
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 107/232 (46%), Gaps = 26/232 (11%)
Query: 670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIIS-- 727
            +IG GS+G V++ +  +  EVAIK   LQ +   N    E +I++ ++H N+V + +  
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKRFKNR---ELQIMRIVKHPNVVDLKAFF 101
Query: 728 ----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
                  +  F  LVLEY+P+       + +         L I + +   L  L + HS 
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK-QTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 784 PIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE--YGREG 840
            I H DIKP N+LLD  S V  L DFG AK+L   +       + +  Y APE  +G   
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSXICSRYYRAPELIFG-AT 217
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
             +   D+++ G ++ E+  G       F GE  I     D L  ++ ++ T
Sbjct: 218 NYTTNIDIWSTGCVMAELMQG----QPLFPGESGI-----DQLVEIIKVLGT 260

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 111/244 (45%), Gaps = 50/244 (20%)
Query: 640 HIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVY---KGRFPD-GIEVAIKV 695
           H+KAG          SH ELL+         ++G GS+G V+   K   PD G   A+KV
Sbjct: 17  HVKAGSEKA----DPSHFELLK---------VLGQGSFGKVFLVRKVTRPDSGHLYAMKV 63
Query: 696 FHLQREGALNSFDA-----ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDC 750
               ++  L   D      E +IL  + H  +VK+  +        L+L+++  G     
Sbjct: 64  L---KKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGG----- 115
Query: 751 MYASNFNLDIFQRLGIMI-----DVASALEYLHFG----HSNPIVHCDIKPSNVLLDDSM 801
                   D+F RL   +     DV   L  L  G    HS  I++ D+KP N+LLD+  
Sbjct: 116 --------DLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEG 167
Query: 802 VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQVSIKGDVYNYGIMLMEVFT 860
              L+DFG++K   + +  K      T+ Y+APE   R+G  S   D ++YG+++ E+ T
Sbjct: 168 HIKLTDFGLSKEAIDHEK-KAYSFCGTVEYMAPEVVNRQGH-SHSADWWSYGVLMFEMLT 225
Query: 861 GMKP 864
           G  P
Sbjct: 226 GSLP 229

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/302 (19%), Positives = 133/302 (44%), Gaps = 39/302 (12%)
Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNS--- 706
           Y  DE   A ++ +    +G GS+G VY    KG   D  E  + +  +    ++     
Sbjct: 15  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------- 759
           F  E  ++K     ++V+++   +      +++E M +G L+  + +    ++       
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 134
Query: 760 --IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
             + + + +  ++A  + YL+   +N  VH D+   N ++ +     + DFG+ + + E 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191
Query: 818 DSMKQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
           D  ++  + L  + +++PE  ++G  +   DV+++G++L E+ T  +   +  + E  ++
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                       +M+  LL + +        +C   +  L   C   +P+ R +  EIIS
Sbjct: 252 -----------FVMEGGLLDKPD--------NCPDMLFELMRMCWQYNPKMRPSFLEIIS 292
Query: 937 RL 938
            +
Sbjct: 293 SI 294

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 9/214 (4%)
Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG GS G V        G  VA+K   L+++        E  I++  +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   +V+E++  G+L D +  +  N +  Q   + + V  AL  LH   +  ++H DI
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  ++LL       LSDFG    +S+E   ++   + T  ++APE         + D+++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKXLVGTPYWMAPELISRLPYGPEVDIWS 201
Query: 851 YGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP 884
            GIM++E+  G  P   F    +   + I D+LP
Sbjct: 202 LGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNLP 233

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 9/214 (4%)
Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           IG GS G V        G  VA+K   L+++        E  I++  +H N+V++ +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI 790
             +   +V+E++  G+L D +  +  N +  Q   + + V  AL  LH   +  ++H DI
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           K  ++LL       LSDFG    +S+E   ++   + T  ++APE         + D+++
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKXLVGTPYWMAPELISRLPYGPEVDIWS 205
Query: 851 YGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP 884
            GIM++E+  G  P   F    +   + I D+LP
Sbjct: 206 LGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNLP 237

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 114/227 (50%), Gaps = 26/227 (11%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYK------GRFPDGIEVAIKVF----HLQREGALNSF 707
           E  R   QF +   +G G++G V +      G+    ++VA+K+     H   + AL S 
Sbjct: 34  EFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS- 90
Query: 708 DAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGI 766
             E +I+  + +H N+V ++ +CT+     ++ EY   G L + +       D+ +  G 
Sbjct: 91  --ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL-RRKAEADLDKEDGR 147
Query: 767 MIDVASALEY-------LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEED 818
            +++   L +       + F  S   +H D+   NVLL +  VA + DFG+A+ ++++ +
Sbjct: 148 PLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 207
Query: 819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
            + +      + ++APE   +   +++ DV++YGI+L E+F+ G+ P
Sbjct: 208 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 254

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHL-----QREGALNSFDAECEILKTIR 718
           ++ + + +G G + +VYK R  +  + VAIK   L      ++G   +   E ++L+ + 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           H N++ ++ +  + +  +LV ++M +  LE  +  ++  L        M+     LEYLH
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE--Y 836
               + I+H D+KP+N+LLD++ V  L+DFG+AK     +     Q + T  Y APE  +
Sbjct: 130 ---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPELLF 185
Query: 837 GREGQVSIKGDVYNYGIMLMEVF 859
           G      +  D++  G +L E+ 
Sbjct: 186 GAR-MYGVGVDMWAVGCILAELL 207

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 62/302 (20%), Positives = 133/302 (44%), Gaps = 39/302 (12%)
Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNS--- 706
           Y  DE   A ++ +    +G GS+G VY    KG   D  E  + +  +    ++     
Sbjct: 5   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 64
Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-----SNFNLDIF 761
           F  E  ++K     ++V+++   +      +++E M +G L+  + +     +N  +   
Sbjct: 65  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 124
Query: 762 QRLGIMI----DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
             L  MI    ++A  + YL+   +N  VH D+   N ++ +     + DFG+ + + E 
Sbjct: 125 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 181
Query: 818 DSMKQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
           D  ++  + L  + +++PE  ++G  +   DV+++G++L E+ T  +   +  + E  ++
Sbjct: 182 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241
Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                       +M+  LL + +        +C   +  L   C   +P+ R +  EIIS
Sbjct: 242 F-----------VMEGGLLDKPD--------NCPDMLFELMRMCWQYNPKMRPSFLEIIS 282
Query: 937 RL 938
            +
Sbjct: 283 SI 284

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/302 (19%), Positives = 133/302 (44%), Gaps = 39/302 (12%)
Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNS--- 706
           Y  DE   A ++ +    +G GS+G VY    KG   D  E  + +  +    ++     
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------- 759
           F  E  ++K     ++V+++   +      +++E M +G L+  + +    ++       
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 760 --IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
             + + + +  ++A  + YL+   +N  VH D+   N ++ +     + DFG+ + + E 
Sbjct: 128 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184
Query: 818 DSMKQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
           D  ++  + L  + +++PE  ++G  +   DV+++G++L E+ T  +   +  + E  ++
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                       +M+  LL + +        +C   +  L   C   +P+ R +  EIIS
Sbjct: 245 F-----------VMEGGLLDKPD--------NCPDMLFELMRMCWQYNPKMRPSFLEIIS 285
Query: 937 RL 938
            +
Sbjct: 286 SI 287

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 8/193 (4%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSC 729
           IG G+YG VYK +   G   A+K   L++E  G  ++   E  ILK ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                  LV E++ +  L+  +      L+       ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY-GREGQVSIKGDV 848
           +KP N+L++      ++DFG+A+        K T  + T+ Y AP+      + S   D+
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 849 YNYGIMLMEVFTG 861
           ++ G +  E+  G
Sbjct: 185 WSVGCIFAEMVNG 197

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 670 NLIGIGSYGSVYKGRF-PDGIEVAIKVFH----LQREGALNSFDAECEILKTIRHRNLVK 724
            +IG GS+G V   R   + +  A+KV      L+++   +       +LK ++H  LV 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +  S    +    VL+Y+  G L   +      L+   R     ++ASAL YLH   S  
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLN 159
Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
           IV+ D+KP N+LLD      L+DFG+ K   E +S   T    T  Y+APE   +     
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPEVLHKQPYDR 218
Query: 845 KGDVYNYGIMLMEVFTGMKPTNEFFTGEM 873
             D +  G +L E+  G+ P     T EM
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 114/227 (50%), Gaps = 26/227 (11%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYK------GRFPDGIEVAIKVF----HLQREGALNSF 707
           E  R   QF +   +G G++G V +      G+    ++VA+K+     H   + AL S 
Sbjct: 42  EFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS- 98
Query: 708 DAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGI 766
             E +I+  + +H N+V ++ +CT+     ++ EY   G L + +       D+ +  G 
Sbjct: 99  --ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL-RRKAEADLDKEDGR 155
Query: 767 MIDVASALEY-------LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEED 818
            +++   L +       + F  S   +H D+   NVLL +  VA + DFG+A+ ++++ +
Sbjct: 156 PLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 215
Query: 819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
            + +      + ++APE   +   +++ DV++YGI+L E+F+ G+ P
Sbjct: 216 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 262

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 59/302 (19%), Positives = 133/302 (44%), Gaps = 39/302 (12%)
Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNS--- 706
           Y  DE   A ++ +    +G GS+G VY    KG   D  E  + +  +    ++     
Sbjct: 2   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 61
Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------- 759
           F  E  ++K     ++V+++   +      +++E M +G L+  + +    ++       
Sbjct: 62  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 121
Query: 760 --IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
             + + + +  ++A  + YL+   +N  VH D+   N  + +     + DFG+ + + E 
Sbjct: 122 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYET 178
Query: 818 DSMKQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
           D  ++  + L  + +++PE  ++G  +   DV+++G++L E+ T  +   +  + E  ++
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                       +M+  LL + +        +C   +L L   C   +P+ R +  EIIS
Sbjct: 239 F-----------VMEGGLLDKPD--------NCPDMLLELMRMCWQYNPKMRPSFLEIIS 279
Query: 937 RL 938
            +
Sbjct: 280 SI 281

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 58/302 (19%), Positives = 133/302 (44%), Gaps = 39/302 (12%)
Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNS--- 706
           Y  DE   A ++ +    +G GS+G VY    KG   D  E  + +  +    ++     
Sbjct: 9   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------- 759
           F  E  ++K     ++V+++   +      +++E M +G L+  + +    ++       
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 760 --IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
             + + + +  ++A  + YL+   +N  VH D+   N ++ +     + DFG+ + + E 
Sbjct: 129 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 185
Query: 818 DSMKQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
           D  ++  + L  + +++PE  ++G  +   DV+++G++L E+ T  +   +  + E  ++
Sbjct: 186 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                       +M+  LL + +        +C   +  L   C   +P+ R +  EIIS
Sbjct: 246 F-----------VMEGGLLDKPD--------NCPDMLFELMRMCWQYNPKMRPSFLEIIS 286
Query: 937 RL 938
            +
Sbjct: 287 SI 288

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 8/193 (4%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSC 729
           IG G+YG VYK +   G   A+K   L++E  G  ++   E  ILK ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                  LV E++ +  L+  +      L+       ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY-GREGQVSIKGDV 848
           +KP N+L++      ++DFG+A+        K T  + T+ Y AP+      + S   D+
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 849 YNYGIMLMEVFTG 861
           ++ G +  E+  G
Sbjct: 185 WSVGCIFAEMVNG 197

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 58/302 (19%), Positives = 133/302 (44%), Gaps = 39/302 (12%)
Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNS--- 706
           Y  DE   A ++ +    +G GS+G VY    KG   D  E  + +  +    ++     
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------- 759
           F  E  ++K     ++V+++   +      +++E M +G L+  + +    ++       
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 760 --IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
             + + + +  ++A  + YL+   +N  VH D+   N ++ +     + DFG+ + + E 
Sbjct: 128 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184
Query: 818 DSMKQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
           D  ++  + L  + +++PE  ++G  +   DV+++G++L E+ T  +   +  + E  ++
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                       +M+  LL + +        +C   +  L   C   +P+ R +  EIIS
Sbjct: 245 F-----------VMEGGLLDKPD--------NCPDMLFELMRMCWQYNPKMRPSFLEIIS 285
Query: 937 RL 938
            +
Sbjct: 286 SI 287

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/299 (20%), Positives = 133/299 (44%), Gaps = 33/299 (11%)
Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNS--- 706
           Y  DE   A ++ +    +G GS+G VY    KG   D  E  + +  +    ++     
Sbjct: 15  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA-----SNFNLDIF 761
           F  E  ++K     ++V+++   +      +++E M +G L+  + +     +N  +   
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 762 QRLGIMIDVASAL-EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM 820
             L  MI +A  + + + + ++N  VH D+   N ++ +     + DFG+ + + E D  
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 821 KQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI 879
           ++  + L  + +++PE  ++G  +   DV+++G++L E+ T  +   +  + E  ++   
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--- 251
Query: 880 NDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                    +M+  LL + +        +C   +  L   C   +P+ R +  EIIS +
Sbjct: 252 --------FVMEGGLLDKPD--------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 8/193 (4%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSC 729
           IG G+YG VYK +   G   A+K   L++E  G  ++   E  ILK ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
                  LV E++ +  L+  +      L+       ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY-GREGQVSIKGDV 848
           +KP N+L++      ++DFG+A+        K T  + T+ Y AP+      + S   D+
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 849 YNYGIMLMEVFTG 861
           ++ G +  E+  G
Sbjct: 185 WSVGCIFAEMVNG 197

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 22/233 (9%)
Query: 650 MWRRY-------SHDELLRATDQFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQRE 701
           +W++Y        HD +L   D +     +G G++G V++      G   A K      E
Sbjct: 139 IWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 195
Query: 702 GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIF 761
               +   E + +  +RH  LV +  +  + N   ++ E+M  G L + +   +  +   
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED 255
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS--DFGIAKLLSEEDS 819
           + +  M  V   L ++   H N  VH D+KP N++        L   DFG+   L  + S
Sbjct: 256 EAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312
Query: 820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           +K   T  T  + APE      V    D+++ G++   + +G+ P    F GE
Sbjct: 313 VK--VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP----FGGE 359

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 22/233 (9%)
Query: 650 MWRRY-------SHDELLRATDQFSEENLIGIGSYGSVYK-GRFPDGIEVAIKVFHLQRE 701
           +W++Y        HD +L   D +     +G G++G V++      G   A K      E
Sbjct: 33  IWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 89
Query: 702 GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIF 761
               +   E + +  +RH  LV +  +  + N   ++ E+M  G L + +   +  +   
Sbjct: 90  SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED 149
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS--DFGIAKLLSEEDS 819
           + +  M  V   L ++   H N  VH D+KP N++        L   DFG+   L  + S
Sbjct: 150 EAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 206
Query: 820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           +K   T  T  + APE      V    D+++ G++   + +G+ P    F GE
Sbjct: 207 VK--VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP----FGGE 253

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 675 GSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKT--IRHRNLVKIISS-CTN 731
           G +G V+K +  +   VA+K+F LQ +    S+ +E EI  T  ++H NL++ I++    
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQDK---QSWQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 732 HNFKA---LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS-ALEYLHF-------- 779
            N +    L+  +  KGSL D +     N+  +  L  + +  S  L YLH         
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYLKG---NIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAPEYGR 838
           GH   I H D K  NVLL   + A L+DFG+A           T   + T  Y+APE   
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV-L 197
Query: 839 EGQVS------IKGDVYNYGIMLMEVFTGMK----PTNEF 868
           EG ++      ++ D+Y  G++L E+ +  K    P +E+
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEY 237

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 17/218 (7%)
Query: 656 HDELLRATDQFSEENLIGIGSYGSVYKGRFPDG----IEVAIKVF-HLQREGALNSFDAE 710
           H+ ++  +D+     +IG G +G VY G + D     I+ AIK    +     + +F  E
Sbjct: 18  HERVVTHSDR-----VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72
Query: 711 CEILKTIRHRNLVKIIS-SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID 769
             +++ + H N++ +I           ++L YM  G L   + +   N  +   +   + 
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTLA- 827
           VA  +EYL        VH D+   N +LD+S    ++DFG+A+ +L  E    Q    A 
Sbjct: 133 VARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 828 -TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             + + A E  +  + + K DV+++G++L E+ T   P
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 22/200 (11%)
Query: 672 IGIGSYGSVYKGR--FPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+Y +VYKG+    D + VA+K   L+ E GA  +   E  +LK ++H N+V +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 729 CTNHNFKALVLEYMPKG---SLEDC---MYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                   LV EY+ K     L+DC   +   N  L +FQ           L  L + H 
Sbjct: 69  IHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ----------LLRGLAYCHR 118
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR-EGQ 841
             ++H D+KP N+L+++     L+DFG+A+  S        + + T+ Y  P+       
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE-VVTLWYRPPDILLGSTD 177
Query: 842 VSIKGDVYNYGIMLMEVFTG 861
            S + D++  G +  E+ TG
Sbjct: 178 YSTQIDMWGVGCIFYEMATG 197

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQ----REGALNSFD 708
           + H E+LRA         IG GS+G V   +  D  ++ A+K  + Q    R    N F 
Sbjct: 14  FDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF- 63
Query: 709 AECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
            E +I++ + H  LV +  S  +     +V++ +  G L    Y    N+  F+   + +
Sbjct: 64  KELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR---YHLQQNVH-FKEETVKL 119
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
            +   +  L +  +  I+H D+KP N+LLD+    H++DF IA +L  E  +  T    T
Sbjct: 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGT 177
Query: 829 IGYIAPEY--GREGQ-VSIKGDVYNYGIMLMEVFTGMKP 864
             Y+APE    R+G   S   D ++ G+   E+  G +P
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 34/211 (16%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKIISSC 729
           IG G +G V++G++  G EVA+K+F  + E    S+  E EI +T+  RH N++  I++ 
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 730 TNHNFKA----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF----GH 781
              N       LV +Y   GSL D  Y + + + +   + + +  AS L +LH       
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 782 SNP-IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA------TIGYIAP 834
             P I H D+K  N+L+  +    ++D G+A      DS   T  +A      T  Y+AP
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 835 EYGREGQVSIK-------GDVYNYGIMLMEV 858
           E   +  +++K        D+Y  G++  E+
Sbjct: 183 EV-LDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 34/211 (16%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKIISSC 729
           IG G +G V++G++  G EVA+K+F  + E    S+  E EI +T+  RH N++  I++ 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 730 TNHNFKA----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF----GH 781
              N       LV +Y   GSL D  Y + + + +   + + +  AS L +LH       
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 782 SNP-IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA------TIGYIAP 834
             P I H D+K  N+L+  +    ++D G+A      DS   T  +A      T  Y+AP
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 835 EYGREGQVSIK-------GDVYNYGIMLMEV 858
           E   +  +++K        D+Y  G++  E+
Sbjct: 182 EV-LDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 34/211 (16%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKIISSC 729
           IG G +G V++G++  G EVA+K+F  + E    S+  E EI +T+  RH N++  I++ 
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 730 TNHNFKA----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF----GH 781
              N       LV +Y   GSL D  Y + + + +   + + +  AS L +LH       
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 782 SNP-IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA------TIGYIAP 834
             P I H D+K  N+L+  +    ++D G+A      DS   T  +A      T  Y+AP
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 835 EYGREGQVSIK-------GDVYNYGIMLMEV 858
           E   +  +++K        D+Y  G++  E+
Sbjct: 188 EV-LDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 34/211 (16%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKIISSC 729
           IG G +G V++G++  G EVA+K+F  + E    S+  E EI +T+  RH N++  I++ 
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 730 TNHNFKA----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF----GH 781
              N       LV +Y   GSL D  Y + + + +   + + +  AS L +LH       
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 782 SNP-IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA------TIGYIAP 834
             P I H D+K  N+L+  +    ++D G+A      DS   T  +A      T  Y+AP
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 835 EYGREGQVSIK-------GDVYNYGIMLMEV 858
           E   +  +++K        D+Y  G++  E+
Sbjct: 185 EV-LDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 57/299 (19%), Positives = 132/299 (44%), Gaps = 39/299 (13%)
Query: 657 DELLRATDQFSEENLIGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNS---FDA 709
           DE   A ++ +    +G GS+G VY    KG   D  E  + +  +    ++     F  
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 68
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD---------I 760
           E  ++K     ++V+++   +      +++E M +G L+  + +    ++         +
Sbjct: 69  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM 820
            + + +  ++A  + YL+   +N  VH D+   N ++ +     + DFG+ + + E D  
Sbjct: 129 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 185
Query: 821 KQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI 879
           ++  + L  + +++PE  ++G  +   DV+++G++L E+ T  +   +  + E  ++   
Sbjct: 186 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-- 243
Query: 880 NDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                    +M+  LL + +        +C   +  L   C   +P+ R +  EIIS +
Sbjct: 244 ---------VMEGGLLDKPD--------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 285

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 115/241 (47%), Gaps = 35/241 (14%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 85
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASALE 775
           +     SS    +  +  LVL+Y+P+       + S        I+ +L  M  +  +L 
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 144
Query: 776 YLH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           Y+H FG    I H DIKP N+LLD D+ V  L DFG AK L   +       + +  Y A
Sbjct: 145 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 198
Query: 834 PE--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
           PE  +G     S   DV++ G +L E+  G       F G+  +     D L  ++ ++ 
Sbjct: 199 PELIFGATDYTS-SIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEIIKVLG 248
Query: 892 T 892
           T
Sbjct: 249 T 249

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 57/299 (19%), Positives = 132/299 (44%), Gaps = 39/299 (13%)
Query: 657 DELLRATDQFSEENLIGIGSYGSVY----KGRFPDGIEVAIKVFHLQREGALNS---FDA 709
           DE   A ++ +    +G GS+G VY    KG   D  E  + +  +    ++     F  
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD---------I 760
           E  ++K     ++V+++   +      +++E M +G L+  + +    ++         +
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM 820
            + + +  ++A  + YL+   +N  VH D+   N ++ +     + DFG+ + + E D  
Sbjct: 125 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 821 KQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI 879
           ++  + L  + +++PE  ++G  +   DV+++G++L E+ T  +   +  + E  ++   
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-- 239
Query: 880 NDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                    +M+  LL + +        +C   +  L   C   +P+ R +  EIIS +
Sbjct: 240 ---------VMEGGLLDKPD--------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 115/241 (47%), Gaps = 35/241 (14%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 111
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASALE 775
           +     SS    +  +  LVL+Y+P+       + S        I+ +L  M  +  +L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 170
Query: 776 YLH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           Y+H FG    I H DIKP N+LLD D+ V  L DFG AK L   +       + +  Y A
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 224
Query: 834 PE--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
           PE  +G     S   DV++ G +L E+  G       F G+  +     D L  ++ ++ 
Sbjct: 225 PELIFGATDYTS-SIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEIIKVLG 274
Query: 892 T 892
           T
Sbjct: 275 T 275

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDG----IEVAIKVFHLQREGALNS-FDAECEILKTIR 718
           +  +  ++G G++G+VYKG + PDG    I VAIKV         N     E  ++  + 
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 77
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
              + +++  C     + LV + MP G L D +  +   L     L   + +A  + YL 
Sbjct: 78  SPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE 136
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS-EEDSMKQTQTLATIGYIAPEYG 837
                 +VH D+   NVL+       ++DFG+A+LL  +E           I ++A E  
Sbjct: 137 ---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 193
Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKPTN 866
              + + + DV++YG+ + E+ T G KP +
Sbjct: 194 LRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 113/240 (47%), Gaps = 33/240 (13%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNR---ELQIMRKLDHCNIVR 77
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFN--LDIFQRLGIMIDVASALEY 776
           +     SS    +  +  LVL+Y+P+       + S     L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 777 LH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           +H FG    I H DIKP N+LLD D+ V  L DFG AK L   +       + +  Y AP
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAP 191
Query: 835 E--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           E  +G     S   DV++ G +L E+  G       F G+  +     D L  ++ ++ T
Sbjct: 192 ELIFGATDYTS-SIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEIIKVLGT 241

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 114/248 (45%), Gaps = 33/248 (13%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNR---ELQIMRKLDHCNIVR 77
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFN--LDIFQRLGIMIDVASALEY 776
           +     SS    +  +  LVL+Y+P        + S     L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 777 LH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           +H FG    I H DIKP N+LLD D+ V  L DFG AK L   +       + +  Y AP
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRAP 191
Query: 835 E--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           E  +G     S   DV++ G +L E+  G       F G+  +     D L  ++ ++ T
Sbjct: 192 ELIFGATDYTS-SIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEIIKVLGT 241
Query: 893 NLLSEDEE 900
               +  E
Sbjct: 242 PTREQIRE 249

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 115/241 (47%), Gaps = 35/241 (14%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 81
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASALE 775
           +     SS    +  +  LVL+Y+P+       + S        I+ +L  M  +  +L 
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 140
Query: 776 YLH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           Y+H FG    I H DIKP N+LLD D+ V  L DFG AK L   +       + +  Y A
Sbjct: 141 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 194
Query: 834 PE--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
           PE  +G     S   DV++ G +L E+  G       F G+  +     D L  ++ ++ 
Sbjct: 195 PELIFGATDYTS-SIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEIIKVLG 244
Query: 892 T 892
           T
Sbjct: 245 T 245

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 115/241 (47%), Gaps = 35/241 (14%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 96
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASALE 775
           +     SS    +  +  LVL+Y+P+       + S        I+ +L  M  +  +L 
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 155
Query: 776 YLH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           Y+H FG    I H DIKP N+LLD D+ V  L DFG AK L   +       + +  Y A
Sbjct: 156 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 209
Query: 834 PE--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
           PE  +G     S   DV++ G +L E+  G       F G+  +     D L  ++ ++ 
Sbjct: 210 PELIFGATDYTS-SIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEIIKVLG 259
Query: 892 T 892
           T
Sbjct: 260 T 260

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 115/241 (47%), Gaps = 35/241 (14%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 89
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASALE 775
           +     SS    +  +  LVL+Y+P+       + S        I+ +L  M  +  +L 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 148
Query: 776 YLH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           Y+H FG    I H DIKP N+LLD D+ V  L DFG AK L   +       + +  Y A
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 202
Query: 834 PE--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
           PE  +G     S   DV++ G +L E+  G       F G+  +     D L  ++ ++ 
Sbjct: 203 PELIFGATDYTS-SIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEIIKVLG 252
Query: 892 T 892
           T
Sbjct: 253 T 253

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 111/245 (45%), Gaps = 43/245 (17%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNR---ELQIMRKLDHCNIVR 77
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFN--LDIFQRLGIMIDVASALEY 776
           +     SS    +  +  LVL+Y+P+       + S     L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 777 LH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           +H FG    I H DIKP N+LLD D+ V  L DFG AK L   +          + YI  
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--------NVSYICS 185
Query: 835 EYGREGQVSIKG-------DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM 887
            Y R  ++           DV++ G +L E+  G       F G+  +     D L  ++
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEII 236
Query: 888 NIMDT 892
            ++ T
Sbjct: 237 KVLGT 241

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 113/240 (47%), Gaps = 33/240 (13%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFN--LDIFQRLGIMIDVASALEY 776
           +     SS    +  +  LVL+Y+P+       + S     L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 777 LH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           +H FG    I H DIKP N+LLD D+ V  L DFG AK L   +       + +  Y AP
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRAP 191
Query: 835 E--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           E  +G     S   DV++ G +L E+  G       F G+  +     D L  ++ ++ T
Sbjct: 192 ELIFGATDYTS-SIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEIIKVLGT 241

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 115/241 (47%), Gaps = 35/241 (14%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 89
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASALE 775
           +     SS    +  +  LVL+Y+P+       + S        I+ +L  M  +  +L 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 148
Query: 776 YLH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           Y+H FG    I H DIKP N+LLD D+ V  L DFG AK L   +       + +  Y A
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRA 202
Query: 834 PE--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
           PE  +G     S   DV++ G +L E+  G       F G+  +     D L  ++ ++ 
Sbjct: 203 PELIFGATDYTS-SIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEIIKVLG 252
Query: 892 T 892
           T
Sbjct: 253 T 253

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 113/240 (47%), Gaps = 33/240 (13%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 78
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFN--LDIFQRLGIMIDVASALEY 776
           +     SS    +  +  LVL+Y+P+       + S     L +      M  +  +L Y
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 777 LH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           +H FG    I H DIKP N+LLD D+ V  L DFG AK L   +       + +  Y AP
Sbjct: 139 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRAP 192
Query: 835 E--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           E  +G     S   DV++ G +L E+  G       F G+  +     D L  ++ ++ T
Sbjct: 193 ELIFGATDYTS-SIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEIIKVLGT 242

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 113/240 (47%), Gaps = 33/240 (13%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFN--LDIFQRLGIMIDVASALEY 776
           +     SS    +  +  LVL+Y+P+       + S     L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 777 LH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           +H FG    I H DIKP N+LLD D+ V  L DFG AK L   +       + +  Y AP
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRAP 191
Query: 835 E--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           E  +G     S   DV++ G +L E+  G       F G+  +     D L  ++ ++ T
Sbjct: 192 ELIFGATDYTS-SIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEIIKVLGT 241

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 113/246 (45%), Gaps = 45/246 (18%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 105
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASALE 775
           +     SS    +  +  LVL+Y+P+       + S        I+ +L  M  +  +L 
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 164
Query: 776 YLH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           Y+H FG    I H DIKP N+LLD D+ V  L DFG AK L   +          + YI 
Sbjct: 165 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--------PNVSYIC 212
Query: 834 PEYGREGQVSIKG-------DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV 886
             Y R  ++           DV++ G +L E+  G       F G+  +     D L  +
Sbjct: 213 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEI 263
Query: 887 MNIMDT 892
           + ++ T
Sbjct: 264 IKVLGT 269

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 113/240 (47%), Gaps = 33/240 (13%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFN--LDIFQRLGIMIDVASALEY 776
           +     SS    +  +  LVL+Y+P+       + S     L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 777 LH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           +H FG    I H DIKP N+LLD D+ V  L DFG AK L   +       + +  Y AP
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYYRAP 191
Query: 835 E--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           E  +G     S   DV++ G +L E+  G       F G+  +     D L  ++ ++ T
Sbjct: 192 ELIFGATDYTS-SIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEIIKVLGT 241

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 74/295 (25%), Positives = 126/295 (42%), Gaps = 60/295 (20%)
Query: 666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           F E  LIG G +G V+K +   DG    IK      E A    + E + L  + H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVH 68
Query: 725 I------------ISSCTNHNFKA----LVLEYMPKGSLEDCMYASNF-NLDIFQRLGIM 767
                         SS  +   K     + +E+  KG+LE  +       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA 827
             +   ++Y+H   S  +++ D+KPSN+ L D+    + DFG+   L  +   K+ ++  
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRXRSKG 183
Query: 828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF----TGMKPTNEFFTGEMSIKRWINDSL 883
           T+ Y++PE         + D+Y  G++L E+     T  + T++FFT        + D +
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-TSKFFTD-------LRDGI 235
Query: 884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
             + +I D     + E+              +L  +  S+ PE+R NT EI+  L
Sbjct: 236 --ISDIFD-----KKEK--------------TLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 113/246 (45%), Gaps = 45/246 (18%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 82
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASALE 775
           +     SS    +  +  LVL+Y+P+       + S        I+ +L  M  +  +L 
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 141
Query: 776 YLH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           Y+H FG    I H DIKP N+LLD D+ V  L DFG AK L   +          + YI 
Sbjct: 142 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--------NVSYIC 189
Query: 834 PEYGREGQVSIKG-------DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV 886
             Y R  ++           DV++ G +L E+  G       F G+  +     D L  +
Sbjct: 190 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEI 240
Query: 887 MNIMDT 892
           + ++ T
Sbjct: 241 IKVLGT 246

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 115/254 (45%), Gaps = 45/254 (17%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 115
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASALE 775
           +     SS    +  +  LVL+Y+P+       + S        I+ +L  M  +  +L 
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 174
Query: 776 YLH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           Y+H FG    I H DIKP N+LLD D+ V  L DFG AK L   +          + YI 
Sbjct: 175 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--------PNVSYIC 222
Query: 834 PEYGREGQVSIKG-------DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV 886
             Y R  ++           DV++ G +L E+  G       F G+  +     D L  +
Sbjct: 223 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEI 273
Query: 887 MNIMDTNLLSEDEE 900
           + ++ T    +  E
Sbjct: 274 IKVLGTPTREQIRE 287

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 113/246 (45%), Gaps = 45/246 (18%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 90
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASALE 775
           +     SS    +  +  LVL+Y+P+       + S        I+ +L  M  +  +L 
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 149
Query: 776 YLH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           Y+H FG    I H DIKP N+LLD D+ V  L DFG AK L   +          + YI 
Sbjct: 150 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--------PNVSYIC 197
Query: 834 PEYGREGQVSIKG-------DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV 886
             Y R  ++           DV++ G +L E+  G       F G+  +     D L  +
Sbjct: 198 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEI 248
Query: 887 MNIMDT 892
           + ++ T
Sbjct: 249 IKVLGT 254

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 115/254 (45%), Gaps = 45/254 (17%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 111
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASALE 775
           +     SS    +  +  LVL+Y+P+       + S        I+ +L  M  +  +L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 170
Query: 776 YLH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           Y+H FG    I H DIKP N+LLD D+ V  L DFG AK L   +          + YI 
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--------PNVSYIC 218
Query: 834 PEYGREGQVSIKG-------DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV 886
             Y R  ++           DV++ G +L E+  G       F G+  +     D L  +
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEI 269
Query: 887 MNIMDTNLLSEDEE 900
           + ++ T    +  E
Sbjct: 270 IKVLGTPTREQIRE 283

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 115/254 (45%), Gaps = 45/254 (17%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 156
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASALE 775
           +     SS    +  +  LVL+Y+P+       + S        I+ +L  M  +  +L 
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 215
Query: 776 YLH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           Y+H FG    I H DIKP N+LLD D+ V  L DFG AK L   +          + YI 
Sbjct: 216 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--------PNVSYIC 263
Query: 834 PEYGREGQVSIKG-------DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV 886
             Y R  ++           DV++ G +L E+  G       F G+  +     D L  +
Sbjct: 264 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEI 314
Query: 887 MNIMDTNLLSEDEE 900
           + ++ T    +  E
Sbjct: 315 IKVLGTPTREQIRE 328

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 115/254 (45%), Gaps = 45/254 (17%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 113
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMIDVASALE 775
           +     SS    +  +  LVL+Y+P+       + S        I+ +L  M  +  +L 
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 172
Query: 776 YLH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           Y+H FG    I H DIKP N+LLD D+ V  L DFG AK L   +          + YI 
Sbjct: 173 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--------PNVSYIC 220
Query: 834 PEYGREGQVSIKG-------DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV 886
             Y R  ++           DV++ G +L E+  G       F G+  +     D L  +
Sbjct: 221 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEI 271
Query: 887 MNIMDTNLLSEDEE 900
           + ++ T    +  E
Sbjct: 272 IKVLGTPTREQIRE 285

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 111/245 (45%), Gaps = 43/245 (17%)
Query: 666 FSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           +++  +IG GS+G VY+ +  D  E VAIK   LQ +   N    E +I++ + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 725 I----ISSCTNHN--FKALVLEYMPKGSLEDCMYASNFN--LDIFQRLGIMIDVASALEY 776
           +     SS    +  +  LVL+Y+P+       + S     L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 777 LH-FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           +H FG    I H DIKP N+LLD D+ V  L DFG AK L   +          + YI  
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--------PNVSYICS 185
Query: 835 EYGREGQVSIKG-------DVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM 887
            Y R  ++           DV++ G +L E+  G       F G+  +     D L  ++
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG----QPIFPGDSGV-----DQLVEII 236
Query: 888 NIMDT 892
            ++ T
Sbjct: 237 KVLGT 241

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 119/288 (41%), Gaps = 53/288 (18%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEI-LKTIRHRNLVKIISSCT 730
           +G GS+G V+           I+  H  R  A+     E  + LK + H N  +++ S  
Sbjct: 14  LGTGSFGRVH----------LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 731 NHNFKA-------------LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
            H F               ++++Y+  G L   +  S    +   +     +V  ALEYL
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYL 122
Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEY 836
           H   S  I++ D+KP N+LLD +    ++DFG AK + +      T  L  T  YIAPE 
Sbjct: 123 H---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDYIAPEV 174
Query: 837 GREGQVSIKGDVYNYGIMLMEVFTG---------MKPTNEFFTGEMSIKRWINDSLPAVM 887
                 +   D +++GI++ E+  G         MK   +    E+    + N+ +  ++
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 234
Query: 888 NIMDTNLLS----------EDEEHANVAKQSCASSVLSLAMECTSESP 925
           + + T  LS          ED ++    K+     +LS  +E   E P
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP 282

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 672 IGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFD-----AECEILKTIRHRNLVKI 725
           +G G+YG V   R     +E AIK+    R+ ++++        E  +LK + H N++K+
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKII---RKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 726 ISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
                +     LV+E    G L ++ ++   FN        I+  V S + YLH    + 
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE--VDAAVIIKQVLSGVTYLH---KHN 156
Query: 785 IVHCDIKPSNVLLD----DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           IVH D+KP N+LL+    D+++  + DFG++ +   +  MK  + L T  YIAPE  R+ 
Sbjct: 157 IVHRDLKPENLLLESKEKDALIK-IVDFGLSAVFENQKKMK--ERLGTAYYIAPEVLRK- 212
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
           +   K DV++ G++L  +  G  P
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPP 236

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEV----AIKVFHLQREGALNSFDA-----ECEILK 715
           QF    ++G GS+G V+  +   G +     A+KV    ++  L   D      E +IL 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL---KKATLKVRDRVRTKMERDILV 81
Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSL-----EDCMYASNFNLDIFQRLGIMIDV 770
            + H  +VK+  +        L+L+++  G L     ++ M+    ++  +     + ++
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-DVKFY-----LAEL 135
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG 830
           A AL++LH   S  I++ D+KP N+LLD+     L+DFG++K  S +   K      T+ 
Sbjct: 136 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVE 191
Query: 831 YIAPE-YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           Y+APE   R G      D +++G+++ E+ TG  P
Sbjct: 192 YMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 43/222 (19%)
Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEV----AIKVFHLQREGALNSFD-----AECEILK 715
           QF    ++G GS+G V+  +   G +     A+KV    ++  L   D      E +IL 
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL---KKATLKVRDRVRTKMERDILV 82
Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------- 765
            + H  +VK+  +        L+L+++  G             D+F RL           
Sbjct: 83  EVNHPFIVKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDV 129
Query: 766 --IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
              + ++A AL++LH   S  I++ D+KP N+LLD+     L+DFG++K  S +   K  
Sbjct: 130 KFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAY 185
Query: 824 QTLATIGYIAPE-YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
               T+ Y+APE   R G      D +++G+++ E+ TG  P
Sbjct: 186 SFCGTVEYMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 43/222 (19%)
Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEV----AIKVFHLQREGALNSFD-----AECEILK 715
           QF    ++G GS+G V+  +   G +     A+KV    ++  L   D      E +IL 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL---KKATLKVRDRVRTKMERDILV 81
Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------- 765
            + H  +VK+  +        L+L+++  G             D+F RL           
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDV 128
Query: 766 --IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
              + ++A AL++LH   S  I++ D+KP N+LLD+     L+DFG++K  S +   K  
Sbjct: 129 KFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAY 184
Query: 824 QTLATIGYIAPE-YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
               T+ Y+APE   R G      D +++G+++ E+ TG  P
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGTLP 225

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 91/186 (48%), Gaps = 18/186 (9%)
Query: 682 KGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY 741
           KGR+ D     I+ FH   E   N    E  +LK++ H N++K+     +  +  LV E+
Sbjct: 76  KGRYSDD-NKNIEKFH---EEIYN----EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127
Query: 742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS- 800
              G L + +  +    D      IM  + S + YLH    + IVH DIKP N+LL++  
Sbjct: 128 YEGGELFEQI-INRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKN 183
Query: 801 --MVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEV 858
             +   + DFG++   S++   K    L T  YIAPE  ++ + + K DV++ G+++  +
Sbjct: 184 SLLNIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYIL 240
Query: 859 FTGMKP 864
             G  P
Sbjct: 241 LCGYPP 246

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 138/298 (46%), Gaps = 41/298 (13%)
Query: 675 GSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEI--LKTIRHRNLVKIISS---C 729
           G +G V+K +  +   VA+K+F +Q +    S+  E E+  L  ++H N+++ I +    
Sbjct: 35  GRFGCVWKAQLLNEY-VAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGAEKRG 90
Query: 730 TNHNFK-ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF-------GH 781
           T+ +    L+  +  KGSL D + A+  + +  +   I   +A  L YLH        GH
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKANVVSWN--ELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ-TLATIGYIAPEYGREG 840
              I H DIK  NVLL +++ A ++DFG+A       S   T   + T  Y+APE   EG
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV-LEG 207
Query: 841 QVS------IKGDVYNYGIMLMEVFTGMK----PTNEF---FTGEMSIKRWINDSLPAVM 887
            ++      ++ D+Y  G++L E+ +       P +E+   F  E+     + D    V+
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 267
Query: 888 NIMDTNLLSED-EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL 944
           +     +L +  ++HA +A       +     EC     E R++   +  R+ +++ L
Sbjct: 268 HKKKRPVLRDYWQKHAGMA------MLCETIEECWDHDAEARLSAGCVGERITQMQRL 319

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKAL--VLEYMPKGSLEDCMYASNFNLDIFQRLGIM 767
           E ++L+ +RH+N+++++    N   + +  V+EY   G  E           + Q  G  
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL---SEEDSMKQTQ 824
             +   LEYLH   S  IVH DIKP N+LL       +S  G+A+ L   + +D+ + +Q
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 825 TLATIGYIAPEY--GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
              +  +  PE   G +     K D+++ G+ L  + TG+ P
Sbjct: 173 --GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 90/213 (42%), Gaps = 29/213 (13%)
Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTI-------RHRNL 722
           L+G G+YG VYKGR    G   AIKV  +       + D E EI + I        HRN+
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDV-------TGDEEEEIKQEINMLKKYSHHRNI 83
Query: 723 VKIISSCTNHNFKA------LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
                +    N         LV+E+   GS+ D +   N   +  +   I       L  
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRG 141
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
           L   H + ++H DIK  NVLL ++    L DFG++  L      + T  + T  ++APE 
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEV 200
Query: 837 -----GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
                  +     K D+++ GI  +E+  G  P
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 656 HDELLRATDQFSEENLIGIGSYGSVYKGRFPDGI--EVAIKVFHLQREGALNSFDAECEI 713
           H   ++ TD +  +  IG+GSY SV K         E A+K+    +       +    +
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI---L 69
Query: 714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
           L+  +H N++ +     +  +  +V E    G L D +    F     +   ++  +   
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-FSEREASAVLFTITKT 128
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSM----VAHLSDFGIAKLLSEEDSMKQTQTLATI 829
           +EYLH   +  +VH D+KPSN+L  D         + DFG AK L  E+ +  T    T 
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TA 184
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            ++APE           D+++ G++L    TG  P
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 19/215 (8%)
Query: 660 LRATDQFSEENLIGIGSYGSVY--KGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI 717
           +R T  F E  ++G G++  V+  K R   G   A+K          +S + E  +LK I
Sbjct: 7   IRKTFIFME--VLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKI 63
Query: 718 RHRNLVKI--ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALE 775
           +H N+V +  I   T H +  LV++ +  G L D +       +    L I   V SA++
Sbjct: 64  KHENIVTLEDIYESTTHYY--LVMQLVSGGELFDRILERGVYTEKDASLVIQ-QVLSAVK 120
Query: 776 YLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYI 832
           YLH    N IVH D+KP N+L    +++    ++DFG++K+  E++ +  T    T GY+
Sbjct: 121 YLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMST-ACGTPGYV 174
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNE 867
           APE   +   S   D ++ G++   +  G  P  E
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 653 RYSHDELLRATDQFSEENLIGIGSYGS----VYKGRFPDGIEVAIKVFHLQREGALNSFD 708
           R SH  L+  +D +  +  IG+GSY      V+K      +E A+KV    +        
Sbjct: 17  RGSHMNLV-FSDGYVVKETIGVGSYSECKRCVHKA---TNMEYAVKVIDKSKRDP----S 68
Query: 709 AECEIL-KTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM 767
            E EIL +  +H N++ +     +     LV E M  G L D +    F     +   ++
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVL 127
Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM----VAHLSDFGIAKLLSEEDSMKQT 823
             +   +EYLH   S  +VH D+KPSN+L  D         + DFG AK L  E+ +  T
Sbjct: 128 HTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT 184
Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
               T  ++APE  +        D+++ GI+L  +  G  P
Sbjct: 185 PCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 17/235 (7%)
Query: 660 LRATDQFSEENLIGIGSYG-SVYKGRFPDGIEVAIKVFHLQREGALNSFDA--ECEILKT 716
            ++ +++     IG GS+G ++      DG +  IK  ++ R  +    ++  E  +L  
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN---FNLDIFQRLGIMIDVASA 773
           ++H N+V+   S   +    +V++Y   G L   + A     F  D  Q L   + +  A
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED--QILDWFVQICLA 137
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           L+++H      I+H DIK  N+ L       L DFGIA++L+    + +   + T  Y++
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLS 193
Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS--IKRWINDSLPAV 886
           PE       + K D++  G +L E+ T     + F  G M   + + I+ S P V
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCT---LKHAFEAGSMKNLVLKIISGSFPPV 245

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/324 (21%), Positives = 131/324 (40%), Gaps = 80/324 (24%)
Query: 665 QFSEENLI-----GIGSYGSVYK-------GRFPDGIEVAIKVFHLQREGA----LNSFD 708
           +F  +NL+     G G +G V K       GR      VA+K+    +E A    L    
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKML---KENASPSELRDLL 74
Query: 709 AECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN------------- 755
           +E  +LK + H +++K+  +C+      L++EY   GSL   +  S              
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 756 ----------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL 805
                       L +   +     ++  ++YL       +VH D+   N+L+ +     +
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKI 191
Query: 806 SDFGIAKLLSEEDS-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT---- 860
           SDFG+++ + EEDS +K++Q    + ++A E   +   + + DV+++G++L E+ T    
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 861 ---GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLA 917
              G+ P   F                   N++ T        H      +C+  +  L 
Sbjct: 252 PYPGIPPERLF-------------------NLLKTG-------HRMERPDNCSEEMYRLM 285
Query: 918 MECTSESPENRVNTKEIISRLIKI 941
           ++C  + P+ R    +I   L K+
Sbjct: 286 LQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 9/169 (5%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY-ASNFNLDIFQRLGIMI 768
           E +IL+ +  R +V +  +    +   LVL  M  G L+  +Y          + +    
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           ++   LE LH      IV+ D+KP N+LLDD     +SD G+A  + E  ++K    + T
Sbjct: 294 EICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRVGT 348
Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           +GY+APE  +  + +   D +  G +L E+  G  P   F   +  IKR
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP---FQQRKKKIKR 394

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 76/313 (24%), Positives = 131/313 (41%), Gaps = 83/313 (26%)
Query: 666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           F E  LIG G +G V+K +   DG    I+      E A    + E + L  + H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIVH 69
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------------------------- 759
             + C +        +Y P+ S +D + +S+++ +                         
Sbjct: 70  Y-NGCWDG------FDYDPETS-DDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL 121
Query: 760 ---IFQRLGIMIDVASALEYLH-------FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFG 809
              I +R G  +D   ALE          + HS  ++H D+KPSN+ L D+    + DFG
Sbjct: 122 EQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 810 IAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF----TGMKPT 865
           +   L  +   K+T++  T+ Y++PE         + D+Y  G++L E+     T  + T
Sbjct: 182 LVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-T 238
Query: 866 NEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESP 925
           ++FFT        + D +  + +I D     + E+              +L  +  S+ P
Sbjct: 239 SKFFTD-------LRDGI--ISDIFD-----KKEK--------------TLLQKLLSKKP 270
Query: 926 ENRVNTKEIISRL 938
           E+R NT EI+  L
Sbjct: 271 EDRPNTSEILRTL 283

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 51/303 (16%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKIISS- 728
           +G G YG V++G +  G  VA+K+F  + E    S+  E EI  T+  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGLW-HGESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 729 CTNHNFKA---LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH---FGHS 782
            T+ N      L+  Y   GSL D +        +  RL +    A  L +LH   FG  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAV--SAACGLAHLHVEIFGTQ 129
Query: 783 N--PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED---SMKQTQTLATIGYIAPEYG 837
               I H D K  NVL+  ++   ++D G+A + S+      +     + T  Y+APE  
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 838 REGQVSIK-------GDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM 890
            E Q+           D++ +G++L E+                +   + D  P   +++
Sbjct: 190 DE-QIRTDCFESYKWTDIWAFGLVLWEI-----------ARRTIVNGIVEDYRPPFYDVV 237
Query: 891 DTN--------LLSEDEEHANVAKQSCASSVLS----LAMECTSESPENRVNTKEIISRL 938
             +        ++  D++   +  +  A  VLS    +  EC   +P  R+    I   L
Sbjct: 238 PNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTL 297
Query: 939 IKI 941
            KI
Sbjct: 298 QKI 300

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA-----LNSFDAECEILKTIRHRNL 722
           E+  +G G++G+V KG +     V      + +  A      +   AE  +++ + +  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           V++I  C   ++  LV+E    G L   +   N ++     + ++  V+  ++YL    S
Sbjct: 433 VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE--ES 488
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREG 840
           N  VH D+   NVLL     A +SDFG++K L  +++  + QT     + + APE     
Sbjct: 489 N-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKP 864
           + S K DV+++G+++ E F+ G KP
Sbjct: 548 KFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 117/232 (50%), Gaps = 30/232 (12%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYK------GRFPDGIEVAIKVF----HLQREGALNSF 707
           E  R   QF +   +G G++G V +      G+    ++VA+K+     H   + AL S 
Sbjct: 42  EFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS- 98
Query: 708 DAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCM---------YASNFN 757
             E +I+  + +H N+V ++ +CT+     ++ EY   G L + +         Y+ N +
Sbjct: 99  --ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPS 156
Query: 758 LDIFQRLG---IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-L 813
            +  ++L    ++   +   + + F  S   +H D+   NVLL +  VA + DFG+A+ +
Sbjct: 157 HNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 216
Query: 814 LSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           +++ + + +      + ++APE   +   +++ DV++YGI+L E+F+ G+ P
Sbjct: 217 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 268

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/324 (21%), Positives = 131/324 (40%), Gaps = 80/324 (24%)
Query: 665 QFSEENLI-----GIGSYGSVYK-------GRFPDGIEVAIKVFHLQREGA----LNSFD 708
           +F  +NL+     G G +G V K       GR      VA+K+    +E A    L    
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKML---KENASPSELRDLL 74
Query: 709 AECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN------------- 755
           +E  +LK + H +++K+  +C+      L++EY   GSL   +  S              
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 756 ----------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL 805
                       L +   +     ++  ++YL       +VH D+   N+L+ +     +
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKI 191
Query: 806 SDFGIAKLLSEEDS-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT---- 860
           SDFG+++ + EEDS +K++Q    + ++A E   +   + + DV+++G++L E+ T    
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 861 ---GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLA 917
              G+ P   F                   N++ T        H      +C+  +  L 
Sbjct: 252 PYPGIPPERLF-------------------NLLKTG-------HRMERPDNCSEEMYRLM 285
Query: 918 MECTSESPENRVNTKEIISRLIKI 941
           ++C  + P+ R    +I   L K+
Sbjct: 286 LQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/324 (21%), Positives = 131/324 (40%), Gaps = 80/324 (24%)
Query: 665 QFSEENLI-----GIGSYGSVYK-------GRFPDGIEVAIKVFHLQREGA----LNSFD 708
           +F  +NL+     G G +G V K       GR      VA+K+    +E A    L    
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKML---KENASPSELRDLL 74
Query: 709 AECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN------------- 755
           +E  +LK + H +++K+  +C+      L++EY   GSL   +  S              
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 756 ----------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL 805
                       L +   +     ++  ++YL       +VH D+   N+L+ +     +
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKI 191
Query: 806 SDFGIAKLLSEEDS-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT---- 860
           SDFG+++ + EEDS +K++Q    + ++A E   +   + + DV+++G++L E+ T    
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 861 ---GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLA 917
              G+ P   F                   N++ T        H      +C+  +  L 
Sbjct: 252 PYPGIPPERLF-------------------NLLKTG-------HRMERPDNCSEEMYRLM 285
Query: 918 MECTSESPENRVNTKEIISRLIKI 941
           ++C  + P+ R    +I   L K+
Sbjct: 286 LQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 663 TDQFSEENLIGIGSYGS----VYKGRFPDGIEVAIKVFHLQREGALNSFDAECEIL-KTI 717
           +D +  +  IG+GSY      V+K      +E A+KV    +         E EIL +  
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDP----SEEIEILLRYG 78
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
           +H N++ +     +     LV E M  G L D +    F     +   ++  +   +EYL
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGKTVEYL 137
Query: 778 HFGHSNPIVHCDIKPSNVLLDDSM----VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           H   S  +VH D+KPSN+L  D         + DFG AK L  E+ +  T    T  ++A
Sbjct: 138 H---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVA 193
Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           PE  +        D+++ GI+L  +  G  P
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA-----LNSFDAECEILKTIRHRNL 722
           E+  +G G++G+V KG +     V      + +  A      +   AE  +++ + +  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           V++I  C   ++  LV+E    G L   +   N ++     + ++  V+  ++YL    S
Sbjct: 434 VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE--ES 489
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREG 840
           N  VH D+   NVLL     A +SDFG++K L  +++  + QT     + + APE     
Sbjct: 490 N-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKP 864
           + S K DV+++G+++ E F+ G KP
Sbjct: 549 KFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 9/169 (5%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY-ASNFNLDIFQRLGIMI 768
           E +IL+ +  R +V +  +    +   LVL  M  G L+  +Y          + +    
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           ++   LE LH      IV+ D+KP N+LLDD     +SD G+A  + E  ++K    + T
Sbjct: 294 EICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRVGT 348
Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           +GY+APE  +  + +   D +  G +L E+  G  P   F   +  IKR
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP---FQQRKKKIKR 394

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID 769
           E  I+  + H  L+ +  +  +     L+LE++  G L D + A ++ +   + +  M  
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS--DFGIAKLLSEEDSMKQTQTLA 827
               L+++   H + IVH DIKP N++ +    + +   DFG+A  L+ ++ +K   T A
Sbjct: 158 ACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK--VTTA 212
Query: 828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM 887
           T  + APE      V    D++  G++   + +G+ P    F GE        D L  + 
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----FAGE--------DDLETLQ 260
Query: 888 NIMDTNLLSEDEEHANVAKQS 908
           N+   +   +++  ++V+ ++
Sbjct: 261 NVKRCDWEFDEDAFSSVSPEA 281

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 663 TDQFSEENLIGIGSYGSVY--KGRFPDGIEVAIKVFHLQREGALNSFDA---ECEILKTI 717
           +D++     +G G+YG V   K +   G E AIK+         ++  A   E  +LK +
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
            H N++K+     +     LV+E    G L D +       ++   + IM  V S   YL
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-IMKQVLSGTTYL 137
Query: 778 HFGHSNPIVHCDIKPSNVLLD----DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           H    + IVH D+KP N+LL+    D+++  + DFG++        MK  + L T  YIA
Sbjct: 138 H---KHNIVHRDLKPENLLLESKSRDALIK-IVDFGLSAHFEVGGKMK--ERLGTAYYIA 191
Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           PE  R+ +   K DV++ G++L  +  G  P
Sbjct: 192 PEVLRK-KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 651 WRRYSHDELLRATDQFSEENLIGIGSYGSVY-KGRFPDGIEVAIKVFHLQR-EGALNSFD 708
           W++ + D  ++   +F E   +G G++  V        G   A+K    +  +G  +S +
Sbjct: 13  WKKQAED--IKKIFEFKE--TLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIE 68
Query: 709 AECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
            E  +L+ I+H N+V +     + N   LV++ +  G L D +    F    +       
Sbjct: 69  NEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGF----YTEKDAST 124
Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQTQT 825
            +   L+ +++ H   IVH D+KP N+L    D+     +SDFG++K+  + D M  +  
Sbjct: 125 LIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVM--STA 182
Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             T GY+APE   +   S   D ++ G++   +  G  P
Sbjct: 183 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 672 IGIGSYGSV-YKGRFPDGIEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVKIIS 727
           +G GS+G V     +    +VA+K      L++       + E   LK +RH +++K+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
             T      +V+EY      +  +       D  +R      +  A+EY H    + IVH
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF--FQQIICAIEYCH---RHKIVH 131
Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY-GREGQVSIKG 846
            D+KP N+LLDD++   ++DFG++ ++++ + +K   +  +  Y APE    +     + 
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK--TSCGSPNYAAPEVINGKLYAGPEV 189
Query: 847 DVYNYGIMLMEVFTGMKPTNEFF 869
           DV++ GI+L  +  G  P ++ F
Sbjct: 190 DVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 671 LIGIGSYGSVYKGRFPDGI---EVAIKVFHLQREGALNSFDA----ECEILKTIRHRNLV 723
           ++G GS+G V K +  D I   E A+KV  + +  A N   +    E E+LK + H N++
Sbjct: 29  MLGKGSFGEVLKCK--DRITQQEYAVKV--INKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 724 KIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           K+     + +   +V E    G L ++ +    F+     R  I+  V S + Y+H    
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYMH---K 139
Query: 783 NPIVHCDIKPSNVLLDDSMV---AHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
           + IVH D+KP N+LL+         + DFG++    +   MK    + T  YIAPE  R 
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK--DRIGTAYYIAPEVLR- 196
Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKP 864
           G    K DV++ G++L  + +G  P
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 142
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T TL  T  Y+APE   
Sbjct: 143 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPEYLAPEIIL 197
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     IG GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EYMP G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGD----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     IG GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EYMP G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGD----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T TL  T  Y+APE   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPEYLAPEIIL 212
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 663 TDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRH 719
           TD++     IG G++  V +  +   G E A K+ + ++  A +    + E  I + ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
            N+V++  S +   F  LV + +  G L + + A  +    +        +   LE +  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLH 118
Query: 780 GHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
            H   +VH D+KP N+LL          L+DFG+A +  + D         T GY++PE 
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEV 177
Query: 837 GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            R+       D++  G++L  +  G  P
Sbjct: 178 LRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 122/274 (44%), Gaps = 36/274 (13%)
Query: 666 FSEENLIGIGSYG----SVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
           ++ EN IG GS+G    +V KG     I  A K         ++ F  E EI+K++ H N
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
           ++++  +  ++    LV+E    G L E  ++   F      R  IM DV SA+ Y H  
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCHKL 125
Query: 781 HSNPIVHCDIKPSNVL-LDDSMVAHLS--DFGIAKLLSEEDSMKQTQTLATIGYIAPEYG 837
           +   + H D+KP N L L DS  + L   DFG+A        M+    + T  Y++P+  
Sbjct: 126 N---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR--TKVGTPYYVSPQV- 179
Query: 838 REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE 897
            EG    + D ++ G+M+  +  G  P +     E+ +K            I +      
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLK------------IREGTFTFP 227
Query: 898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNT 931
           +++  NV+ Q+      SL     ++SP+ R+ +
Sbjct: 228 EKDWLNVSPQA-----ESLIRRLLTKSPKQRITS 256

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 36/237 (15%)
Query: 670 NLIGIGSYGSVYKGRFPDG--------IEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
            ++G G YG V++ R   G        ++V  K   ++         AE  IL+ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID---------VAS 772
           +V +I +        L+LEY+  G L              +R GI ++         ++ 
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGEL----------FMQLEREGIFMEDTACFYLAEISM 132
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYI 832
           AL +LH      I++ D+KP N++L+      L+DFG+ K    + ++  T    TI Y+
Sbjct: 133 ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYM 188
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNI 889
           APE       +   D ++ G ++ ++ TG  P    FTGE + K+ I+  L   +N+
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGE-NRKKTIDKILKCKLNL 240

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEILK------T 716
           + F    ++G GS+G V+   F    +  AIK   L+++  L   D EC +++       
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLA 75
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY--ASNFNLDIFQRLGIMIDVASAL 774
             H  L  +  +         V+EY+  G   D MY   S    D+ +      ++   L
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAEIILGL 132
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           ++LH   S  IV+ D+K  N+LLD      ++DFG+ K     D+ K  +   T  YIAP
Sbjct: 133 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNEFCGTPDYIAP 188
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           E     + +   D +++G++L E+  G  P
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/302 (19%), Positives = 127/302 (42%), Gaps = 39/302 (12%)
Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGI----EVAIKVFHLQREGALNS--- 706
           Y  DE   + ++ +    +G GS+G VY+G   D I    E  + V  +    +L     
Sbjct: 7   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------- 759
           F  E  ++K     ++V+++   +      +V+E M  G L+  + +     +       
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 760 --IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
             + + + +  ++A  + YL+   +   VH D+   N ++       + DFG+ + + E 
Sbjct: 127 PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 183
Query: 818 DSMKQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
           D  ++  + L  + ++APE  ++G  +   D++++G++L E+ +  +   +  + E  +K
Sbjct: 184 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                       +MD   L + +        +C   V  L   C   +P  R    EI++
Sbjct: 244 -----------FVMDGGYLDQPD--------NCPERVTDLMRMCWQFNPNMRPTFLEIVN 284
Query: 937 RL 938
            L
Sbjct: 285 LL 286

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 122/274 (44%), Gaps = 36/274 (13%)
Query: 666 FSEENLIGIGSYG----SVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
           ++ EN IG GS+G    +V KG     I  A K         ++ F  E EI+K++ H N
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
           ++++  +  ++    LV+E    G L E  ++   F      R  IM DV SA+ Y H  
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCHKL 142
Query: 781 HSNPIVHCDIKPSNVL-LDDSMVAHLS--DFGIAKLLSEEDSMKQTQTLATIGYIAPEYG 837
           +   + H D+KP N L L DS  + L   DFG+A        M+    + T  Y++P+  
Sbjct: 143 N---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR--TKVGTPYYVSPQV- 196
Query: 838 REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE 897
            EG    + D ++ G+M+  +  G  P +     E+ +K            I +      
Sbjct: 197 LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLK------------IREGTFTFP 244
Query: 898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNT 931
           +++  NV+ Q+      SL     ++SP+ R+ +
Sbjct: 245 EKDWLNVSPQA-----ESLIRRLLTKSPKQRITS 273

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 113/242 (46%), Gaps = 43/242 (17%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYK------GRFPDGIEVAIKVF----HLQREGALNSF 707
           E  R   QF +   +G G++G V +      G+    ++VA+K+     H   + AL S 
Sbjct: 27  EFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS- 83
Query: 708 DAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSL-------EDCMYASNFN-- 757
             E +I+  + +H N+V ++ +CT+     ++ EY   G L        + M   +    
Sbjct: 84  --ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPG 141
Query: 758 -------------LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH 804
                        L++   L     VA  + +L    S   +H D+   NVLL +  VA 
Sbjct: 142 QDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAK 198
Query: 805 LSDFGIAK-LLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GM 862
           + DFG+A+ ++++ + + +      + ++APE   +   +++ DV++YGI+L E+F+ G+
Sbjct: 199 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 258
Query: 863 KP 864
            P
Sbjct: 259 NP 260

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 671 LIGIGSYGSVYKGRFPDGI---EVAIKVFHLQREGALNSFDA----ECEILKTIRHRNLV 723
           ++G GS+G V K +  D I   E A+KV  + +  A N   +    E E+LK + H N++
Sbjct: 29  MLGKGSFGEVLKCK--DRITQQEYAVKV--INKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 724 KIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           K+     + +   +V E    G L ++ +    F+     R  I+  V S + Y+H    
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYMH---K 139
Query: 783 NPIVHCDIKPSNVLLDDSMV---AHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
           + IVH D+KP N+LL+         + DFG++    +   MK    + T  YIAPE  R 
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK--DRIGTAYYIAPEVLR- 196
Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKP 864
           G    K DV++ G++L  + +G  P
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 671 LIGIGSYGSVYKGRFPDGI---EVAIKVFHLQREGALNSFDA----ECEILKTIRHRNLV 723
           ++G GS+G V K +  D I   E A+KV  + +  A N   +    E E+LK + H N++
Sbjct: 29  MLGKGSFGEVLKCK--DRITQQEYAVKV--INKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 724 KIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           K+     + +   +V E    G L ++ +    F+     R  I+  V S + Y+H    
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYMH---K 139
Query: 783 NPIVHCDIKPSNVLLDDSMV---AHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
           + IVH D+KP N+LL+         + DFG++    +   MK    + T  YIAPE  R 
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK--DRIGTAYYIAPEVLR- 196
Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKP 864
           G    K DV++ G++L  + +G  P
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 663 TDQFSEENLIGIGSYGSVY--KGRFPDGIEVAIKVFHLQREGALNSFDA---ECEILKTI 717
           +D++     +G G+YG V   K +   G E AIK+         ++  A   E  +LK +
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
            H N++K+     +     LV+E    G L D +       ++   + IM  V S   YL
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-IMKQVLSGTTYL 120
Query: 778 HFGHSNPIVHCDIKPSNVLLD----DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           H    + IVH D+KP N+LL+    D+++  + DFG++        MK  + L T  YIA
Sbjct: 121 H---KHNIVHRDLKPENLLLESKSRDALIK-IVDFGLSAHFEVGGKMK--ERLGTAYYIA 174
Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           PE  R+ +   K DV++ G++L  +  G  P
Sbjct: 175 PEVLRK-KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/284 (19%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 672 IGIGSYGSVYKGRFPDGI----EVAIKVFHLQREGALNS---FDAECEILKTIRHRNLVK 724
           +G GS+G VY+G   D I    E  + V  +    +L     F  E  ++K     ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD---------IFQRLGIMIDVASALE 775
           ++   +      +V+E M  G L+  + +     +         + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT-QTLATIGYIAP 834
           YL+   +   VH D+   N ++       + DFG+ + + E D  ++  + L  + ++AP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E  ++G  +   D++++G++L E+ +  +   +  + E  +K            +MD   
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK-----------FVMDGGY 247
Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           L + +        +C   V  L   C   +P+ R    EI++ L
Sbjct: 248 LDQPD--------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 59/235 (25%), Positives = 111/235 (47%), Gaps = 20/235 (8%)
Query: 645 MSPQVMWRRYSHDELLRATDQFSEENLI-------GIGSYGSVYKGRFPDGIEVAIKVFH 697
           M  +V    Y+  E +R  + + +  L+       G G++G+V KG +     V      
Sbjct: 1   MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVK 60
Query: 698 LQREGA-----LNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY 752
           + +  A      +   AE  +++ + +  +V++I  C   ++  LV+E    G L   + 
Sbjct: 61  ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL- 118
Query: 753 ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK 812
             N ++     + ++  V+  ++YL    SN  VH D+   NVLL     A +SDFG++K
Sbjct: 119 QQNRHVKDKNIIELVHQVSMGMKYLE--ESN-FVHRDLAARNVLLVTQHYAKISDFGLSK 175
Query: 813 LLSEEDSMKQTQTLAT--IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
            L  +++  + QT     + + APE     + S K DV+++G+++ E F+ G KP
Sbjct: 176 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 59/235 (25%), Positives = 111/235 (47%), Gaps = 20/235 (8%)
Query: 645 MSPQVMWRRYSHDELLRATDQFSEENLI-------GIGSYGSVYKGRFPDGIEVAIKVFH 697
           M  +V    Y+  E +R  + + +  L+       G G++G+V KG +     V      
Sbjct: 1   MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVK 60
Query: 698 LQREGA-----LNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY 752
           + +  A      +   AE  +++ + +  +V++I  C   ++  LV+E    G L   + 
Sbjct: 61  ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL- 118
Query: 753 ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK 812
             N ++     + ++  V+  ++YL    SN  VH D+   NVLL     A +SDFG++K
Sbjct: 119 QQNRHVKDKNIIELVHQVSMGMKYLE--ESN-FVHRDLAARNVLLVTQHYAKISDFGLSK 175
Query: 813 LLSEEDSMKQTQTLAT--IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
            L  +++  + QT     + + APE     + S K DV+++G+++ E F+ G KP
Sbjct: 176 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH-FGHSNPIVH 787
               N + L LEY   G L D +   +  +           + + + YLH  G    I H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG----ITH 127
Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGREGQVSIKG 846
            DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +  +   + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 847 -DVYNYGIMLMEVFTGMKPTNE 867
            DV++ GI+L  +  G  P ++
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH-FGHSNPIVH 787
               N + L LEY   G L D +   +  +           + + + YLH  G    I H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG----ITH 128
Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGREGQVSIKG 846
            DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +  +   + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 847 -DVYNYGIMLMEVFTGMKPTNE 867
            DV++ GI+L  +  G  P ++
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA-----LNSFDAECEILKTIRHRNL 722
           E+  +G G++G+V KG +     V      + +  A      +   AE  +++ + +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           V++I  C   ++  LV+E    G L   +   N ++     + ++  V+  ++YL    S
Sbjct: 75  VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE--ES 130
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREG 840
           N  VH D+   NVLL     A +SDFG++K L  +++  + QT     + + APE     
Sbjct: 131 N-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKP 864
           + S K DV+++G+++ E F+ G KP
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA-----LNSFDAECEILKTIRHRNL 722
           E+  +G G++G+V KG +     V      + +  A      +   AE  +++ + +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           V++I  C   ++  LV+E    G L   +   N ++     + ++  V+  ++YL    S
Sbjct: 81  VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE--ES 136
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREG 840
           N  VH D+   NVLL     A +SDFG++K L  +++  + QT     + + APE     
Sbjct: 137 N-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKP 864
           + S K DV+++G+++ E F+ G KP
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA-----LNSFDAECEILKTIRHRNL 722
           E+  +G G++G+V KG +     V      + +  A      +   AE  +++ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           V++I  C   ++  LV+E    G L   +   N ++     + ++  V+  ++YL    S
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE--ES 126
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREG 840
           N  VH D+   NVLL     A +SDFG++K L  +++  + QT     + + APE     
Sbjct: 127 N-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKP 864
           + S K DV+++G+++ E F+ G KP
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA-----LNSFDAECEILKTIRHRNL 722
           E+  +G G++G+V KG +     V      + +  A      +   AE  +++ + +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           V++I  C   ++  LV+E    G L   +   N ++     + ++  V+  ++YL    S
Sbjct: 69  VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE--ES 124
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREG 840
           N  VH D+   NVLL     A +SDFG++K L  +++  + QT     + + APE     
Sbjct: 125 N-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKP 864
           + S K DV+++G+++ E F+ G KP
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA-----LNSFDAECEILKTIRHRNL 722
           E+  +G G++G+V KG +     V      + +  A      +   AE  +++ + +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           V++I  C   ++  LV+E    G L   +   N ++     + ++  V+  ++YL    S
Sbjct: 75  VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE--ES 130
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREG 840
           N  VH D+   NVLL     A +SDFG++K L  +++  + QT     + + APE     
Sbjct: 131 N-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKP 864
           + S K DV+++G+++ E F+ G KP
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA-----LNSFDAECEILKTIRHRNL 722
           E+  +G G++G+V KG +     V      + +  A      +   AE  +++ + +  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           V++I  C   ++  LV+E    G L   +   N ++     + ++  V+  ++YL    S
Sbjct: 89  VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE--ES 144
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREG 840
           N  VH D+   NVLL     A +SDFG++K L  +++  + QT     + + APE     
Sbjct: 145 N-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKP 864
           + S K DV+++G+++ E F+ G KP
Sbjct: 204 KFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 110/235 (46%), Gaps = 48/235 (20%)
Query: 672 IGIGSYGSVYKGRFPDGIE-------VAIKVFHLQREGALNS----FDAECEILKTIRHR 720
           +G G++G V +     GI+       VA+K+    +EGA +S      +E +IL  I H 
Sbjct: 36  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 91
Query: 721 -NLVKIISSCTNHNFKALVL------------------EYMPKGSLEDCMYASNFNLDIF 761
            N+V ++ +CT      +V+                  E++P  + ED +Y     L+  
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPED-LYKDFLTLE-- 148
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSM 820
             +     VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           ++      + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 36/237 (15%)
Query: 670 NLIGIGSYGSVYKGRFPDG--------IEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
            ++G G YG V++ R   G        ++V  K   ++         AE  IL+ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID---------VAS 772
           +V +I +        L+LEY+  G L              +R GI ++         ++ 
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGEL----------FMQLEREGIFMEDTACFYLAEISM 132
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYI 832
           AL +LH      I++ D+KP N++L+      L+DFG+ K  S  D         TI Y+
Sbjct: 133 ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGTIEYM 188
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNI 889
           APE       +   D ++ G ++ ++ TG  P    FTGE + K+ I+  L   +N+
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGE-NRKKTIDKILKCKLNL 240

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 11/172 (6%)
Query: 698 LQREGALNSFDAECEILKTIRHRNLVKIISSCT--NHNFKALVLEYMPKGSLEDCMYASN 755
           +Q  G +     E  ILK + H N+VK++      N +   +V E + +G + +      
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 756 FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS 815
            + D  Q      D+   +EYLH+     I+H DIKPSN+L+ +     ++DFG++    
Sbjct: 134 LSED--QARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKG---DVYNYGIMLMEVFTGMKP 864
             D++  + T+ T  ++APE   E +    G   DV+  G+ L     G  P
Sbjct: 189 GSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 10/201 (4%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
               N + L LEY   G L D +   +  +           + + + YLH      I H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 129
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGREGQVSIKG- 846
           DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +  +   +  
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 847 DVYNYGIMLMEVFTGMKPTNE 867
           DV++ GI+L  +  G  P ++
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 10/201 (4%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
               N + L LEY   G L D +   +  +           + + + YLH      I H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 129
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGREGQVSIKG- 846
           DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +  +   +  
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 847 DVYNYGIMLMEVFTGMKPTNE 867
           DV++ GI+L  +  G  P ++
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 10/201 (4%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
               N + L LEY   G L D +   +  +           + + + YLH      I H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 129
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGREGQVSIKG- 846
           DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +  +   +  
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 847 DVYNYGIMLMEVFTGMKPTNE 867
           DV++ GI+L  +  G  P ++
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQ 210

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 34/201 (16%)
Query: 686 PDGIEVAIKVFHLQREGALNSFDA---------ECEILKTIR-HRNLVKIISSCTNHNFK 735
           P   E A+K+  +   G+ ++ +          E +IL+ +  H N++++  +   + F 
Sbjct: 27  PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 86
Query: 736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNV 795
            LV + M KG L D +      L   +   IM    + LE +   H   IVH D+KP N+
Sbjct: 87  FLVFDLMKKGELFDYL-TEKVTLSEKETRKIM---RALLEVICALHKLNIVHRDLKPENI 142
Query: 796 LLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE------------YGREGQVS 843
           LLDD M   L+DFG +  L   + ++  +   T  Y+APE            YG+E    
Sbjct: 143 LLDDDMNIKLTDFGFSCQLDPGEKLR--EVCGTPSYLAPEIIECSMNDNHPGYGKE---- 196
Query: 844 IKGDVYNYGIMLMEVFTGMKP 864
              D+++ G+++  +  G  P
Sbjct: 197 --VDMWSTGVIMYTLLAGSPP 215

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 25/223 (11%)
Query: 653 RYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQR-EGALNSFDAE 710
           R+   E +R  D +   +++G G++  V         + VAIK    +  EG   S + E
Sbjct: 9   RWKQAEDIR--DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 711 CEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------IFQRL 764
             +L  I+H N+V +     +     L+++ +  G L D +    F  +      IFQ  
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ-- 124
Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVL---LDDSMVAHLSDFGIAKLLSEEDSMK 821
                V  A++YL   H   IVH D+KP N+L   LD+     +SDFG++K+  E+    
Sbjct: 125 -----VLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSV 174
Query: 822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            +    T GY+APE   +   S   D ++ G++   +  G  P
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 25/223 (11%)
Query: 653 RYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQR-EGALNSFDAE 710
           R+   E +R  D +   +++G G++  V         + VAIK    +  EG   S + E
Sbjct: 9   RWKQAEDIR--DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 711 CEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------IFQRL 764
             +L  I+H N+V +     +     L+++ +  G L D +    F  +      IFQ  
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ-- 124
Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVL---LDDSMVAHLSDFGIAKLLSEEDSMK 821
                V  A++YL   H   IVH D+KP N+L   LD+     +SDFG++K+  E+    
Sbjct: 125 -----VLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSV 174
Query: 822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            +    T GY+APE   +   S   D ++ G++   +  G  P
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G++  V   R    G EVA+K+    +    +L     E  I+K + H N+VK+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
                   LV+EY   G + D + A  +  +   R      + SA++Y H      IVH 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 130
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQVSIKGD 847
           D+K  N+LLD  M   ++DFG +   +  + +       +  Y APE +  +     + D
Sbjct: 131 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPPYAAPELFQGKKYDGPEVD 188
Query: 848 VYNYGIMLMEVFTGMKP 864
           V++ G++L  + +G  P
Sbjct: 189 VWSLGVILYTLVSGSLP 205

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFEY 149
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 204
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 21/220 (9%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGA------LNSFDAECEILKT 716
           D +     +G G +  V K R    G E A K    +R  +          + E  IL+ 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
           IRH N++ +     N     L+LE +  G L D + A   +L   +    +  +   + Y
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHY 123
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAH----LSDFGIAKLLSEEDSMKQTQTLATIGYI 832
           LH   S  I H D+KP N++L D  V +    L DFGIA  +   +  K      T  ++
Sbjct: 124 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK--NIFGTPEFV 178
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           APE      + ++ D+++ G++   + +G  P    F GE
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGE 214

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 177
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 232
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 149
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 204
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 34/201 (16%)
Query: 686 PDGIEVAIKVFHLQREGALNSFDA---------ECEILKTIR-HRNLVKIISSCTNHNFK 735
           P   E A+K+  +   G+ ++ +          E +IL+ +  H N++++  +   + F 
Sbjct: 40  PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 99
Query: 736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNV 795
            LV + M KG L D +      L   +   IM    + LE +   H   IVH D+KP N+
Sbjct: 100 FLVFDLMKKGELFDYL-TEKVTLSEKETRKIM---RALLEVICALHKLNIVHRDLKPENI 155
Query: 796 LLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE------------YGREGQVS 843
           LLDD M   L+DFG +  L   + ++  +   T  Y+APE            YG+E    
Sbjct: 156 LLDDDMNIKLTDFGFSCQLDPGEKLR--EVCGTPSYLAPEIIECSMNDNHPGYGKE---- 209
Query: 844 IKGDVYNYGIMLMEVFTGMKP 864
              D+++ G+++  +  G  P
Sbjct: 210 --VDMWSTGVIMYTLLAGSPP 228

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 212
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 212
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 212
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 21/220 (9%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGA------LNSFDAECEILKT 716
           D +     +G G +  V K R    G E A K    +R  +          + E  IL+ 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
           IRH N++ +     N     L+LE +  G L D + A   +L   +    +  +   + Y
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHY 130
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAH----LSDFGIAKLLSEEDSMKQTQTLATIGYI 832
           LH   S  I H D+KP N++L D  V +    L DFGIA  +   +  K      T  ++
Sbjct: 131 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK--NIFGTPEFV 185
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           APE      + ++ D+++ G++   + +G  P    F GE
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGE 221

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-----EG-ALNSFDAECEILKT 716
           D +     +G G +  V K R    G E A K    +R      G +    + E  IL+ 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
           IRH N++ +     N     L+LE +  G L D + A   +L   +    +  +   + Y
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHY 144
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAH----LSDFGIAKLLSEEDSMKQTQTLATIGYI 832
           LH   S  I H D+KP N++L D  V +    L DFGIA  +   +  K      T  ++
Sbjct: 145 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK--NIFGTPEFV 199
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           APE      + ++ D+++ G++   + +G  P    F GE
Sbjct: 200 APEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGE 235

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/284 (19%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 672 IGIGSYGSVYKGRFPDGI----EVAIKVFHLQREGALNS---FDAECEILKTIRHRNLVK 724
           +G GS+G VY+G   D I    E  + V  +    +L     F  E  ++K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD---------IFQRLGIMIDVASALE 775
           ++   +      +V+E M  G L+  + +     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT-QTLATIGYIAP 834
           YL+   +   VH D+   N ++       + DFG+ + + E D  ++  + L  + ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E  ++G  +   D++++G++L E+ +  +   +  + E  +K            +MD   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK-----------FVMDGGY 250
Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           L + +        +C   V  L   C   +P+ R    EI++ L
Sbjct: 251 LDQPD--------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 115/294 (39%), Gaps = 49/294 (16%)
Query: 657 DELLRATDQFSEENLIGIGSYGSVYKGRFPD---GIEVAIKVFHLQREGALNSFDAE--- 710
           +E+  AT Q      +G GS+G V+  R  D   G + A+K   L+       F AE   
Sbjct: 71  EEVHWATHQLR----LGRGSFGEVH--RMEDKQTGFQCAVKKVRLE------VFRAEELM 118
Query: 711 -CEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID 769
            C  L + R   +V +  +     +  + +E +  GSL   +               +  
Sbjct: 119 ACAGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQG----CLPEDRALYY 171
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLL-DDSMVAHLSDFGIAKLLSEE----DSMKQTQ 824
           +  ALE L + HS  I+H D+K  NVLL  D   A L DFG A  L  +    D +    
Sbjct: 172 LGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY 231
Query: 825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP 884
              T  ++APE         K DV++   M++ +  G  P  +FF G + +K  I    P
Sbjct: 232 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK--IASEPP 289
Query: 885 AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
            V  I                  SCA        E   + P +RV+  E+  ++
Sbjct: 290 PVREI----------------PPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKV 327

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 106/249 (42%), Gaps = 54/249 (21%)
Query: 642 KAGMSPQVMWRRYSHDELLRATDQFSEENL-----IGIGSYGSVYKG-RFPDGIEVAIKV 695
           K  +SP+  W              F+ E+L     IG G+YGSV K    P G  +A+K 
Sbjct: 8   KLKISPEQHW-------------DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVK- 53
Query: 696 FHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN--HNFKALVLEYMPKGSLEDCMYA 753
                   + S   E E  + +   ++V   S C      + AL  E    G    CM  
Sbjct: 54  -------RIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE----GDCWICMEL 102
Query: 754 SNFNLDIFQRL--GIMIDV-----------ASALEYLHFGHSNPIVHCDIKPSNVLLDDS 800
            + + D F +    ++ DV           A+     H   +  I+H DIKPSN+LLD S
Sbjct: 103 MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS 162
Query: 801 MVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY-----GREGQVSIKGDVYNYGIML 855
               L DFGI+  L   DS+ +T+      Y+APE       R+G   ++ DV++ GI L
Sbjct: 163 GNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPERIDPSASRQG-YDVRSDVWSLGITL 219
Query: 856 MEVFTGMKP 864
            E+ TG  P
Sbjct: 220 YELATGRFP 228

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 113/290 (38%), Gaps = 49/290 (16%)
Query: 657 DELLRATDQFSEENLIGIGSYGSVYKGRFPD---GIEVAIKVFHLQREGALNSFDAE--- 710
           +E+  AT Q      +G GS+G V+  R  D   G + A+K   L+       F AE   
Sbjct: 90  EEVHWATHQLR----LGRGSFGEVH--RMEDKQTGFQCAVKKVRLE------VFRAEELM 137
Query: 711 -CEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID 769
            C  L + R   +V +  +     +  + +E +  GSL   +               +  
Sbjct: 138 ACAGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQG----CLPEDRALYY 190
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLL-DDSMVAHLSDFGIAKLLSEEDSMKQTQT--- 825
           +  ALE L + HS  I+H D+K  NVLL  D   A L DFG A  L  +   K   T   
Sbjct: 191 LGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250
Query: 826 -LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP 884
              T  ++APE         K DV++   M++ +  G  P  +FF G + +K  I    P
Sbjct: 251 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK--IASEPP 308
Query: 885 AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
            V  I                  SCA        E   + P +RV+  E+
Sbjct: 309 PVREI----------------PPSCAPLTAQAIQEGLRKEPIHRVSAAEL 342

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     IG GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 13/211 (6%)
Query: 661 RATDQFSEENLIGIGSYGSVYK--GRFPDGIEVAIKVFHLQREGALN--SFDAECEILKT 716
           R TD +     +G G++  V +   + P   E A K+ + ++  A +    + E  I + 
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQ-EYAAKIINTKKLSARDHQKLEREARICRL 86
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
           ++H N+V++  S +   F  LV + +  G L + + A  +    +        +   LE 
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIHQILES 142
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           ++  H + IVH D+KP N+LL          L+DFG+A +  + +         T GY++
Sbjct: 143 VNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYLS 201
Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           PE  R+       D++  G++L  +  G  P
Sbjct: 202 PEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEILK------T 716
           + F    ++G GS+G V+   F    +  AIK   L+++  L   D EC +++       
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY--ASNFNLDIFQRLGIMIDVASAL 774
             H  L  +  +         V+EY+  G   D MY   S    D+ +      ++   L
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           ++LH   S  IV+ D+K  N+LLD      ++DFG+ K     D+ K      T  YIAP
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNXFCGTPDYIAP 187
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           E     + +   D +++G++L E+  G  P
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/284 (19%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 672 IGIGSYGSVYKGRFPDGI----EVAIKVFHLQREGALNS---FDAECEILKTIRHRNLVK 724
           +G GS+G VY+G   D I    E  + V  +    +L     F  E  ++K     ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD---------IFQRLGIMIDVASALE 775
           ++   +      +V+E M  G L+  + +     +         + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT-QTLATIGYIAP 834
           YL+   +   VH D+   N ++       + DFG+ + + E D  ++  + L  + ++AP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E  ++G  +   D++++G++L E+ +  +   +  + E  +K            +MD   
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK-----------FVMDGGY 249
Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           L + +        +C   V  L   C   +P+ R    EI++ L
Sbjct: 250 LDQPD--------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 212
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 212
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 34/201 (16%)
Query: 686 PDGIEVAIKVFHLQREGALNSFDA---------ECEILKTIR-HRNLVKIISSCTNHNFK 735
           P   E A+K+  +   G+ ++ +          E +IL+ +  H N++++  +   + F 
Sbjct: 40  PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 99
Query: 736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNV 795
            LV + M KG L D +      L   +   IM    + LE +   H   IVH D+KP N+
Sbjct: 100 FLVFDLMKKGELFDYL-TEKVTLSEKETRKIM---RALLEVICALHKLNIVHRDLKPENI 155
Query: 796 LLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE------------YGREGQVS 843
           LLDD M   L+DFG +  L   + ++      T  Y+APE            YG+E    
Sbjct: 156 LLDDDMNIKLTDFGFSCQLDPGEKLR--SVCGTPSYLAPEIIECSMNDNHPGYGKE---- 209
Query: 844 IKGDVYNYGIMLMEVFTGMKP 864
              D+++ G+++  +  G  P
Sbjct: 210 --VDMWSTGVIMYTLLAGSPP 228

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 23/243 (9%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G+E A K    ++  A          + E  IL+ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  +      L DFG+A  +  ED ++      T  ++APE     
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + ++ D+++ G++   + +G  P    F G+   +   N  + AV    D    S+  E
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP----FLGDTKQETLAN--ITAVSYDFDEEFFSQTSE 247
Query: 901 HAN 903
            A 
Sbjct: 248 LAK 250

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 108/235 (45%), Gaps = 47/235 (20%)
Query: 672 IGIGSYGSVYKGRFPDGIE-------VAIKVFHLQREGALNS----FDAECEILKTIRHR 720
           +G G++G V +     GI+       VA+K+    +EGA +S      +E +IL  I H 
Sbjct: 26  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 81
Query: 721 -NLVKIISSCTNHNFKALVL------------------EYMPKGSLEDCMYASNFNLDIF 761
            N+V ++ +CT      +V+                  E++P     + +Y     L+  
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE-- 139
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSM 820
             +     VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +
Sbjct: 140 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 196
Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           ++      + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 251

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 23/243 (9%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G+E A K    ++  A          + E  IL+ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  +      L DFG+A  +  ED ++      T  ++APE     
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + ++ D+++ G++   + +G  P    F G+   +   N  + AV    D    S+  E
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP----FLGDTKQETLAN--ITAVSYDFDEEFFSQTSE 247
Query: 901 HAN 903
            A 
Sbjct: 248 LAK 250

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 669 ENL--IGIGSYGSVYKGRFPDGIEVAIKVFHLQREG-------ALNSFDAECEILKTIRH 719
           ENL  +G G+ G V+K RF     V I V  ++R G        L   D    +LK+   
Sbjct: 28  ENLGEMGSGTCGQVWKMRFRKTGHV-IAVKQMRRSGNKEENKRILMDLDV---VLKSHDC 83
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR-LGIM-IDVASALEYL 777
             +V+   +   +    + +E M  G+  + +        I +R LG M + +  AL YL
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELM--GTCAEKL-KKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY- 836
              H   ++H D+KPSN+LLD+     L DFGI+  L ++ +  ++   A   Y+APE  
Sbjct: 141 KEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA--YMAPERI 196
Query: 837 ----GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
                 +    I+ DV++ GI L+E+ TG  P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 108/235 (45%), Gaps = 47/235 (20%)
Query: 672 IGIGSYGSVYKGRFPDGIE-------VAIKVFHLQREGALNS----FDAECEILKTIRHR 720
           +G G++G V +     GI+       VA+K+    +EGA +S      +E +IL  I H 
Sbjct: 37  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 92
Query: 721 -NLVKIISSCTNHNFKALVL------------------EYMPKGSLEDCMYASNFNLDIF 761
            N+V ++ +CT      +V+                  E++P     + +Y     L+  
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLE-- 150
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSM 820
             +     VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +
Sbjct: 151 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 207
Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           ++      + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 208 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 262

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 108/235 (45%), Gaps = 47/235 (20%)
Query: 672 IGIGSYGSVYKGRFPDGIE-------VAIKVFHLQREGALNS----FDAECEILKTIRHR 720
           +G G++G V +     GI+       VA+K+    +EGA +S      +E +IL  I H 
Sbjct: 26  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 81
Query: 721 -NLVKIISSCTNHNFKALVL------------------EYMPKGSLEDCMYASNFNLDIF 761
            N+V ++ +CT      +V+                  E++P     + +Y     L+  
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE-- 139
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSM 820
             +     VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +
Sbjct: 140 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 196
Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           ++      + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 251

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 59/276 (21%), Positives = 119/276 (43%), Gaps = 39/276 (14%)
Query: 678 GSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRNLVKIISSCTN--HN 733
           G ++KGR+  G ++ +KV  ++      S  F+ EC  L+   H N++ ++ +C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 734 FKALVLEYMPKGSLEDCMY-ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV--HCDI 790
              L+  +MP GSL + ++  +NF +D  Q +   +D+A  + +LH     P++  H  +
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHA-L 139
Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR---EGQVSIKGD 847
              +V++D+ M A +S      +   + S +    +    ++APE  +   E       D
Sbjct: 140 NSRSVMIDEDMTARIS------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSAD 193
Query: 848 VYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQ 907
           ++++ ++L E+ T   P  +    E+ +K  +    P +                     
Sbjct: 194 MWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI-------------------PP 234
Query: 908 SCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
             +  V  L   C +E P  R     I+  L K++D
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 22/184 (11%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIE---VAIKVFHLQRE--GALNSFDAECEILKTIR 718
           D++     +G G+YG VYK    D +    VAIK   L+ E  G   +   E  +LK ++
Sbjct: 34  DRYRRITKLGEGTYGEVYKAI--DTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 719 HRNLVKIISSCTNHNFK-ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
           HRN+++ + S  +HN +  L+ EY    +  D     + N D+  R+ I   +   +  +
Sbjct: 92  HRNIIE-LKSVIHHNHRLHLIFEY----AENDLKKYMDKNPDVSMRV-IKSFLYQLINGV 145
Query: 778 HFGHSNPIVHCDIKPSNVLL-----DDSMVAHLSDFGIAKLLSEEDSMKQ-TQTLATIGY 831
           +F HS   +H D+KP N+LL      ++ V  + DFG+A+       ++Q T  + T+ Y
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG--IPIRQFTHEIITLWY 203
Query: 832 IAPE 835
             PE
Sbjct: 204 RPPE 207

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G+E A K    ++  A          + E  IL+ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  +      L DFG+A  +  ED ++      T  ++APE     
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP 217

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G++  V   R    G EVA+++    +    +L     E  I+K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
                   LV+EY   G + D + A     +   R      + SA++Y H      IVH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQVSIKGD 847
           D+K  N+LLD  M   ++DFG +   +  + +   +   +  Y APE +  +     + D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DEFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 848 VYNYGIMLMEVFTGMKP 864
           V++ G++L  + +G  P
Sbjct: 196 VWSLGVILYTLVSGSLP 212

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 56/284 (19%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 672 IGIGSYGSVYKGRFPDGI----EVAIKVFHLQREGALNS---FDAECEILKTIRHRNLVK 724
           +G GS+G VY+G   D I    E  + V  +    +L     F  E  ++K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD---------IFQRLGIMIDVASALE 775
           ++   +      +V+E M  G L+  + +     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT-QTLATIGYIAP 834
           YL+   +   VH D+   N ++       + DFG+ + + E D  ++  + L  + ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E  ++G  +   D++++G++L E+ +  +   +  + E  +K            +MD   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF-----------VMDGGY 250
Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           L + +        +C   V  L   C   +P+ R    EI++ L
Sbjct: 251 LDQPD--------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 672 IGIGSYGSVYKGRF-PDGIEVAIK--VFHLQREGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G++G V+K R    G +VA+K  +   ++EG   +   E +IL+ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 729 CTN-----HNFKA---LVLEYMP---KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
           C       +  KA   LV ++      G L + +    F L   +R+  M+     L  L
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQML-----LNGL 138
Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS---EEDSMKQTQTLATIGYIAP 834
           ++ H N I+H D+K +NVL+    V  L+DFG+A+  S        +    + T+ Y  P
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 835 EYGR-EGQVSIKGDVYNYGIMLMEVFT 860
           E    E       D++  G ++ E++T
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 28/78 (35%), Positives = 41/78 (52%)
Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H D+KP N+L+     A+L DFGIA   ++E   +   T+ T+ Y APE   E   + + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 847 DVYNYGIMLMEVFTGMKP 864
           D+Y    +L E  TG  P
Sbjct: 217 DIYALTCVLYECLTGSPP 234

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 78/172 (45%), Gaps = 26/172 (15%)
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTLAT 828
           VA  +E+L    S   +H D+   N+LL ++ V  + DFG+A+ +    D +++  T   
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVM 887
           + ++APE   +   S K DV++YG++L E+F+ G  P                   P V 
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP------------------YPGVQ 306
Query: 888 NIMDTNLLSEDEEHANV-AKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
             MD +  S   E   + A +     +  + ++C    P+ R    E++ +L
Sbjct: 307 --MDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G++  V   R    G EVA+K+    +    +L     E  I+K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
                   LV+EY   G + D + A     +   R      + SA++Y H      IVH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQVSIKGD 847
           D+K  N+LLD  M   ++DFG +   +  + +       +  Y APE +  +     + D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 848 VYNYGIMLMEVFTGMKP 864
           V++ G++L  + +G  P
Sbjct: 196 VWSLGVILYTLVSGSLP 212

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G++  V   R    G EVA+K+    +    +L     E  I+K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
                   LV+EY   G + D + A     +   R      + SA++Y H      IVH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQVSIKGD 847
           D+K  N+LLD  M   ++DFG +   +  + +       +  Y APE +  +     + D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 848 VYNYGIMLMEVFTGMKP 864
           V++ G++L  + +G  P
Sbjct: 196 VWSLGVILYTLVSGSLP 212

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 108/235 (45%), Gaps = 47/235 (20%)
Query: 672 IGIGSYGSVYKGRFPDGIE-------VAIKVFHLQREGALNS----FDAECEILKTIRHR 720
           +G G++G V +     GI+       VA+K+    +EGA +S      +E +IL  I H 
Sbjct: 72  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 127
Query: 721 -NLVKIISSCTNHNFKALVL------------------EYMPKGSLEDCMYASNFNLDIF 761
            N+V ++ +CT      +V+                  E++P     + +Y     L+  
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE-- 185
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSM 820
             +     VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +
Sbjct: 186 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 242
Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           ++      + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 243 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 13  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 72  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 14  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 73  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I K + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 108/235 (45%), Gaps = 47/235 (20%)
Query: 672 IGIGSYGSVYKGRFPDGIE-------VAIKVFHLQREGALNS----FDAECEILKTIRHR 720
           +G G++G V +     GI+       VA+K+    +EGA +S      +E +IL  I H 
Sbjct: 26  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 81
Query: 721 -NLVKIISSCTNHNFKALVL------------------EYMPKGSLEDCMYASNFNLDIF 761
            N+V ++ +CT      +V+                  E++P     + +Y     L+  
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE-- 139
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSM 820
             +     VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +
Sbjct: 140 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           ++      + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 251

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGI--EVAIKVFHLQREGALNS---------FDAECE 712
           D++     +G G+ G V K  F      +VAIK+   +R+ A+ S          + E E
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIE 67
Query: 713 ILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           ILK + H  ++KI +     ++  +VLE M  G L D +  +    +   +L     +  
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLL 125
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
           A++YLH    N I+H D+KP NVLL   ++  +  ++DFG +K+L E   M+      T 
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--TLCGTP 180
Query: 830 GYIAPE----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN 880
            Y+APE     G  G  +   D ++ G++L    +G  P +E  T ++S+K  I 
Sbjct: 181 TYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQIT 233

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G+E A K    ++  A          + E  IL+ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  +      L DFG+A  +  ED ++      T  ++APE     
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP 217

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 10/221 (4%)
Query: 663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL 722
           +D F  E+ +G G+   VY+ +   G +    +  L++         E  +L  + H N+
Sbjct: 52  SDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNI 110
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           +K+          +LVLE +  G L D +    +    +        V   LE + + H 
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGY----YSERDAADAVKQILEAVAYLHE 166
Query: 783 NPIVHCDIKPSNVLLDD---SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
           N IVH D+KP N+L           ++DFG++K++  +  MK      T GY APE  R 
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK--TVCGTPGYCAPEILRG 224
Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN 880
                + D+++ GI+   +  G +P  +    +   +R +N
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGI--EVAIKVFHLQREGALNS---------FDAECE 712
           D++     +G G+ G V K  F      +VAIK+   +R+ A+ S          + E E
Sbjct: 16  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIE 73
Query: 713 ILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           ILK + H  ++KI +     ++  +VLE M  G L D +  +    +   +L     +  
Sbjct: 74  ILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLL 131
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
           A++YLH    N I+H D+KP NVLL   ++  +  ++DFG +K+L E   M+      T 
Sbjct: 132 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--TLCGTP 186
Query: 830 GYIAPE----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN 880
            Y+APE     G  G  +   D ++ G++L    +G  P +E  T ++S+K  I 
Sbjct: 187 TYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQIT 239

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGI--EVAIKVFHLQREGALNS---------FDAECE 712
           D++     +G G+ G V K  F      +VAIK+   +R+ A+ S          + E E
Sbjct: 9   DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIE 66
Query: 713 ILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           ILK + H  ++KI +     ++  +VLE M  G L D +  +    +   +L     +  
Sbjct: 67  ILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLL 124
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
           A++YLH    N I+H D+KP NVLL   ++  +  ++DFG +K+L E   M+      T 
Sbjct: 125 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--TLCGTP 179
Query: 830 GYIAPE----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN 880
            Y+APE     G  G  +   D ++ G++L    +G  P +E  T ++S+K  I 
Sbjct: 180 TYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQIT 232

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGI--EVAIKVFHLQREGALNS---------FDAECE 712
           D++     +G G+ G V K  F      +VAIK+   +R+ A+ S          + E E
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIE 67
Query: 713 ILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           ILK + H  ++KI +     ++  +VLE M  G L D +  +    +   +L     +  
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLL 125
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
           A++YLH    N I+H D+KP NVLL   ++  +  ++DFG +K+L E   M+      T 
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--TLCGTP 180
Query: 830 GYIAPE----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN 880
            Y+APE     G  G  +   D ++ G++L    +G  P +E  T ++S+K  I 
Sbjct: 181 TYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQIT 233

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+++D      ++DFG+AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 25/223 (11%)
Query: 653 RYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQR-EGALNSFDAE 710
           R+   E +R  D +   +++G G++  V         + VAIK    +  EG   S + E
Sbjct: 9   RWKQAEDIR--DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 66
Query: 711 CEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------IFQRL 764
             +L  I+H N+V +     +     L+++ +  G L D +    F  +      IFQ  
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ-- 124
Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVL---LDDSMVAHLSDFGIAKLLSEEDSMK 821
                V  A++YL   H   IVH D+KP N+L   LD+     +SDFG++K+  E+    
Sbjct: 125 -----VLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSV 174
Query: 822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            +    T GY+APE   +   S   D ++ G++   +  G  P
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGI--EVAIKVFHLQREGALNS---------FDAECE 712
           D++     +G G+ G V K  F      +VAIK+   +R+ A+ S          + E E
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIE 67
Query: 713 ILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           ILK + H  ++KI +     ++  +VLE M  G L D +  +    +   +L     +  
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLL 125
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
           A++YLH    N I+H D+KP NVLL   ++  +  ++DFG +K+L E   M+      T 
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--TLCGTP 180
Query: 830 GYIAPE----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN 880
            Y+APE     G  G  +   D ++ G++L    +G  P +E  T ++S+K  I 
Sbjct: 181 TYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQIT 233

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 110/229 (48%), Gaps = 39/229 (17%)
Query: 672 IGIGSYGSVYKGRFPDGIE-------VAIKVFHLQREGALNS----FDAECEILKTIRHR 720
           +G G++G V +     GI+       VA+K+    +EGA +S      +E +IL  I H 
Sbjct: 35  LGRGAFGQVIEAD-AFGIDKTATXRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 90
Query: 721 -NLVKIISSCTNHNFKALVL-EYMPKGSLEDCMYASNFNL----DIFQRLGIM------- 767
            N+V ++ +CT      +V+ E+   G+L   + +         D+++    +       
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTL 826
             VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +++    
Sbjct: 151 FQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
             + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 256

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G+E A K    ++  A          + E  IL+ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  +      L DFG+A  +  ED ++      T  ++APE     
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP 217

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 672 IGIGSYGSVYKGRF-PDGIEVAIK--VFHLQREGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G++G V+K R    G +VA+K  +   ++EG   +   E +IL+ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 729 CT------NHNFKALVL-----EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
           C       N    ++ L     E+   G L + +    F L   +R+  M+     L  L
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQML-----LNGL 138
Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS---EEDSMKQTQTLATIGYIAP 834
           ++ H N I+H D+K +NVL+    V  L+DFG+A+  S        +    + T+ Y  P
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 835 E--YGREGQVSIKGDVYNYGIMLMEVFT 860
           E   G E       D++  G ++ E++T
Sbjct: 199 ELLLG-ERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 10/197 (5%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G++  V   R    G EVA+K+    +    +L     E  I+K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
                   LV+EY   G + D + A     +   R      + SA++Y H      IVH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQVSIKGD 847
           D+K  N+LLD  M   ++DFG +   +  + +          Y APE +  +     + D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DAFCGAPPYAAPELFQGKKYDGPEVD 195
Query: 848 VYNYGIMLMEVFTGMKP 864
           V++ G++L  + +G  P
Sbjct: 196 VWSLGVILYTLVSGSLP 212

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 23/243 (9%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G+E A K    ++  A          + E  IL+ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  +      L DFG+A  +  ED ++      T  ++APE     
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            + ++ D+++ G++   + +G  P    F G+   +   N  + AV    D    S+  E
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP----FLGDTKQETLAN--ITAVSYDFDEEFFSQTSE 247
Query: 901 HAN 903
            A 
Sbjct: 248 LAK 250

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 669 ENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKI 725
           +  IG G++  V   R    G EVA+K+    +    +L     E  I+K + H N+VK+
Sbjct: 20  QKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
                      LV+EY   G + D + A     +   R      + SA++Y H  +   I
Sbjct: 80  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY---I 135
Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQVSI 844
           VH D+K  N+LLD  M   ++DFG +   +  + +       +  Y APE +  +     
Sbjct: 136 VHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKL--DTFCGSPPYAAPELFQGKKYDGP 193
Query: 845 KGDVYNYGIMLMEVFTGMKP 864
           + DV++ G++L  + +G  P
Sbjct: 194 EVDVWSLGVILYTLVSGSLP 213

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 25/223 (11%)
Query: 653 RYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIE-VAIKVFHLQR-EGALNSFDAE 710
           R+   E +R  D +   +++G G++  V         + VAIK    +  EG   S + E
Sbjct: 9   RWKQAEDIR--DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 711 CEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------IFQRL 764
             +L  I+H N+V +     +     L+++ +  G L D +    F  +      IFQ  
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ-- 124
Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVL---LDDSMVAHLSDFGIAKLLSEEDSMK 821
                V  A++YL   H   IVH D+KP N+L   LD+     +SDFG++K+  E+    
Sbjct: 125 -----VLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSV 174
Query: 822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            +    T GY+APE   +   S   D ++ G++   +  G  P
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/302 (19%), Positives = 127/302 (42%), Gaps = 39/302 (12%)
Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGI----EVAIKVFHLQREGALNS--- 706
           Y  DE   + ++ +    +G GS+G VY+G   D I    E  + V  +    +L     
Sbjct: 8   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 67
Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------- 759
           F  E  ++K     ++V+++   +      +V+E M  G L+  + +     +       
Sbjct: 68  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 127
Query: 760 --IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
             + + + +  ++A  + YL+   +   VH ++   N ++       + DFG+ + + E 
Sbjct: 128 PTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYET 184
Query: 818 DSMKQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
           D  ++  + L  + ++APE  ++G  +   D++++G++L E+ +  +   +  + E  +K
Sbjct: 185 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 244
Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                       +MD   L + +        +C   V  L   C   +P  R    EI++
Sbjct: 245 -----------FVMDGGYLDQPD--------NCPERVTDLMRMCWQFNPNMRPTFLEIVN 285
Query: 937 RL 938
            L
Sbjct: 286 LL 287

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 110/229 (48%), Gaps = 39/229 (17%)
Query: 672 IGIGSYGSVYKGRFPDGIE-------VAIKVFHLQREGALNS----FDAECEILKTIRHR 720
           +G G++G V +     GI+       VA+K+    +EGA +S      +E +IL  I H 
Sbjct: 35  LGRGAFGQVIEAD-AFGIDKTATXRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 90
Query: 721 -NLVKIISSCTNHNFKALVL-EYMPKGSLEDCMYASNFNL----DIFQRLGIM------- 767
            N+V ++ +CT      +V+ E+   G+L   + +         D+++    +       
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTL 826
             VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +++    
Sbjct: 151 FQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 207
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
             + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 256

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  LA T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLAGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/302 (19%), Positives = 127/302 (42%), Gaps = 39/302 (12%)
Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGI----EVAIKVFHLQREGALNS--- 706
           Y  DE   + ++ +    +G GS+G VY+G   D I    E  + V  +    +L     
Sbjct: 7   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------- 759
           F  E  ++K     ++V+++   +      +V+E M  G L+  + +     +       
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 760 --IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
             + + + +  ++A  + YL+   +   VH ++   N ++       + DFG+ + + E 
Sbjct: 127 PTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYET 183
Query: 818 DSMKQT-QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
           D  ++  + L  + ++APE  ++G  +   D++++G++L E+ +  +   +  + E  +K
Sbjct: 184 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                       +MD   L + +        +C   V  L   C   +P  R    EI++
Sbjct: 244 -----------FVMDGGYLDQPD--------NCPERVTDLMRMCWQFNPNMRPTFLEIVN 284
Query: 937 RL 938
            L
Sbjct: 285 LL 286

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 670 NLIGIGSYGSVYKGRFPDGIEV----AIKVFH----LQREGALNSFDAECEILKTIRHRN 721
            ++G G+YG V+  R   G +     A+KV      +Q+         E ++L+ IR   
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 722 -LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
            LV +  +        L+L+Y+  G L    +      + F    + I V   +  L   
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIYVGEIVLALEHL 175
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I++ DIK  N+LLD +    L+DFG++K    +++ +      TI Y+AP+  R G
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 235
Query: 841 QVSIKG--DVYNYGIMLMEVFTGMKP 864
                   D ++ G+++ E+ TG  P
Sbjct: 236 DSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 177
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +        T TL  T  Y+APE   
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GATWTLCGTPEYLAPEIIL 232
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+++D      ++DFG+AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 51/189 (26%), Positives = 82/189 (43%), Gaps = 25/189 (13%)
Query: 691 VAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLED 749
           VA+K+  ++R      +   E  I K + H N+VK        N + L LEY   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-- 91
Query: 750 CMYASNFNLDIFQRL--GIMIDVASALEYLH-------FGHSNPIVHCDIKPSNVLLDDS 800
                      F R+   I +    A  + H       + H   I H DIKP N+LLD+ 
Sbjct: 92  -----------FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 140
Query: 801 MVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGREGQVSIKG-DVYNYGIMLMEV 858
               +SDFG+A +    +  +    +  T+ Y+APE  +  +   +  DV++ GI+L  +
Sbjct: 141 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200
Query: 859 FTGMKPTNE 867
             G  P ++
Sbjct: 201 LAGELPWDQ 209

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 57/235 (24%), Positives = 108/235 (45%), Gaps = 47/235 (20%)
Query: 672 IGIGSYGSVYKGRFPDGIE-------VAIKVFHLQREGALNS----FDAECEILKTI-RH 719
           +G G++G V +     GI+       VA+K+    +EGA +S      +E +IL  I  H
Sbjct: 35  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 90
Query: 720 RNLVKIISSCTNHNFKALVL------------------EYMPKGSLEDCMYASNFNLDIF 761
            N+V ++ +CT      +V+                  E++P     + +Y     L+  
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE-- 148
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSM 820
             +     VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXV 205
Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           ++      + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 57/235 (24%), Positives = 108/235 (45%), Gaps = 47/235 (20%)
Query: 672 IGIGSYGSVYKGRFPDGIE-------VAIKVFHLQREGALNS----FDAECEILKTI-RH 719
           +G G++G V +     GI+       VA+K+    +EGA +S      +E +IL  I  H
Sbjct: 35  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 90
Query: 720 RNLVKIISSCTNHNFKALVL------------------EYMPKGSLEDCMYASNFNLDIF 761
            N+V ++ +CT      +V+                  E++P     + +Y     L+  
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE-- 148
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSM 820
             +     VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           ++      + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY P G     M++    +  F         A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+++D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 212
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 672 IGIGSYGSVYKGRF-PDGIEVAIK--VFHLQREGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G++G V+K R    G +VA+K  +   ++EG   +   E +IL+ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 729 CT------NHNFKALVL-----EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
           C       N    ++ L     E+   G L + +    F L   +R+  M+     L  L
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQML-----LNGL 138
Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS---EEDSMKQTQTLATIGYIAP 834
           ++ H N I+H D+K +NVL+    V  L+DFG+A+  S        +    + T+ Y  P
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 835 EYGR-EGQVSIKGDVYNYGIMLMEVFT 860
           E    E       D++  G ++ E++T
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G++  V   R    G EVA+++    +    +L     E  I+K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
                   LV+EY   G + D + A     +   R      + SA++Y H      IVH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQVSIKGD 847
           D+K  N+LLD  M   ++DFG +   +  + +       +  Y APE +  +     + D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DTFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 848 VYNYGIMLMEVFTGMKP 864
           V++ G++L  + +G  P
Sbjct: 196 VWSLGVILYTLVSGSLP 212

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+++D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 39/219 (17%)
Query: 666 FSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDA---------ECEILK 715
           F  ++L+G G+YG V      P G  VAIK         +  FD          E +ILK
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIK--------KIEPFDKPLFALRTLREIKILK 64
Query: 716 TIRHRNLVKIIS-----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDV 770
             +H N++ I +     S  N N   ++ E M +  L   +     + D  Q       +
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYF-----I 118
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE------EDSMKQ-- 822
              L  +   H + ++H D+KPSN+L++ +    + DFG+A+++ E      E + +Q  
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 823 -TQTLATIGYIAPEYG-REGQVSIKGDVYNYGIMLMEVF 859
            T+ +AT  Y APE      + S   DV++ G +L E+F
Sbjct: 179 MTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 107/225 (47%), Gaps = 17/225 (7%)
Query: 672 IGIGSYGSVYKGRFPDGIE-VAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G+YG+V+K +  +  E VA+K   L    EG  +S   E  +LK ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
             +     LV E+  +  L+    + N +LD       +  +   L+ L F HS  ++H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL---LKGLGFCHSRNVLHR 125
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV-SIKGD 847
           D+KP N+L++ +    L+DFG+A+           + + T+ Y  P+     ++ S   D
Sbjct: 126 DLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSID 184
Query: 848 VYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           +++ G +  E+    +P    F G       ++D L  +  ++ T
Sbjct: 185 MWSAGCIFAELANAARP---LFPGND-----VDDQLKRIFRLLGT 221

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 143
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D+     ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 144 LHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 198
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGI--EVAIKVFHLQREGALNS---------FDAECE 712
           D++     +G G+ G V K  F      +VAI++   +R+ A+ S          + E E
Sbjct: 149 DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIE 206
Query: 713 ILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           ILK + H  ++KI +     ++  +VLE M  G L D +  +    +   +L     +  
Sbjct: 207 ILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLL 264
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
           A++YLH    N I+H D+KP NVLL   ++  +  ++DFG +K+L E   M+      T 
Sbjct: 265 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--TLCGTP 319
Query: 830 GYIAPE----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN 880
            Y+APE     G  G  +   D ++ G++L    +G  P +E  T ++S+K  I 
Sbjct: 320 TYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQIT 372

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 17/214 (7%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
               +   D +  G+++ E+  G  P   FF  E
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP---FFADE 242

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 672 IGIGSYGSVYKGRF-PDGIEVAIK--VFHLQREGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G++G V+K R    G +VA+K  +   ++EG   +   E +IL+ ++H N+V +I  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 729 CT------NHNFKALVL-----EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
           C       N    ++ L     E+   G L + +    F L   +R+  M+     L  L
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQML-----LNGL 137
Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS---EEDSMKQTQTLATIGYIAP 834
           ++ H N I+H D+K +NVL+    V  L+DFG+A+  S        +    + T+ Y  P
Sbjct: 138 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 835 EYGR-EGQVSIKGDVYNYGIMLMEVFT 860
           E    E       D++  G ++ E++T
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 110/231 (47%), Gaps = 41/231 (17%)
Query: 672 IGIGSYGSVYKGRFPDGIE-------VAIKVFHLQREGALNS----FDAECEILKTIRHR 720
           +G G++G V +     GI+       VA+K+    +EGA +S      +E +IL  I H 
Sbjct: 37  LGRGAFGQVIEAD-AFGIDKTATXRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 92
Query: 721 -NLVKIISSCTNHNFKALVL-EYMPKGSLEDCMYASNFNL------DIFQRLGIM----- 767
            N+V ++ +CT      +V+ E+   G+L   + +           D+++    +     
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 768 --IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQ 824
               VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +++  
Sbjct: 153 YSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
               + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 57/235 (24%), Positives = 108/235 (45%), Gaps = 47/235 (20%)
Query: 672 IGIGSYGSVYKGRFPDGIE-------VAIKVFHLQREGALNS----FDAECEILKTI-RH 719
           +G G++G V +     GI+       VA+K+    +EGA +S      +E +IL  I  H
Sbjct: 35  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 90
Query: 720 RNLVKIISSCTNHNFKALVL------------------EYMPKGSLEDCMYASNFNLDIF 761
            N+V ++ +CT      +V+                  E++P     + +Y     L+  
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE-- 148
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSM 820
             +     VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           ++      + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 57/235 (24%), Positives = 108/235 (45%), Gaps = 47/235 (20%)
Query: 672 IGIGSYGSVYKGRFPDGIE-------VAIKVFHLQREGALNS----FDAECEILKTI-RH 719
           +G G++G V +     GI+       VA+K+    +EGA +S      +E +IL  I  H
Sbjct: 26  LGRGAFGQVIEAD-AFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 81
Query: 720 RNLVKIISSCTNHNFKALVL------------------EYMPKGSLEDCMYASNFNLDIF 761
            N+V ++ +CT      +V+                  E++P     + +Y     L+  
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE-- 139
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSM 820
             +     VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +
Sbjct: 140 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           ++      + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 251

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 36/229 (15%)
Query: 661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHL-QREGALNSFDAECEILKTIR 718
           R    F     +G G +G V++ +   D    AIK   L  RE A      E + L  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 719 HRNLVKIISSCTNHN------------FKALVLEYMPKGSLEDCMYASNFNLDIFQR--- 763
           H  +V+  ++    N            +  + ++   K +L+D M   N    I +R   
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERS 118
Query: 764 --LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-- 819
             L I + +A A+E+LH   S  ++H D+KPSN+      V  + DFG+   + +++   
Sbjct: 119 VCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 820 ---------MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
                     + T  + T  Y++PE       S K D+++ G++L E+ 
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGI--EVAIKVFHLQREGALNS---------FDAECE 712
           D++     +G G+ G V K  F      +VAI++   +R+ A+ S          + E E
Sbjct: 135 DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIE 192
Query: 713 ILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           ILK + H  ++KI +     ++  +VLE M  G L D +  +    +   +L     +  
Sbjct: 193 ILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLL 250
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
           A++YLH    N I+H D+KP NVLL   ++  +  ++DFG +K+L E   M+      T 
Sbjct: 251 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--TLCGTP 305
Query: 830 GYIAPE----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN 880
            Y+APE     G  G  +   D ++ G++L    +G  P +E  T ++S+K  I 
Sbjct: 306 TYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQIT 358

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+++D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY P G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+++D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 39/219 (17%)
Query: 666 FSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDA---------ECEILK 715
           F  ++L+G G+YG V      P G  VAIK         +  FD          E +ILK
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIK--------KIEPFDKPLFALRTLREIKILK 64
Query: 716 TIRHRNLVKIIS-----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDV 770
             +H N++ I +     S  N N   ++ E M +  L   +     + D  Q       +
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYF-----I 118
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE------EDSMKQ-- 822
              L  +   H + ++H D+KPSN+L++ +    + DFG+A+++ E      E + +Q  
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 823 -TQTLATIGYIAPEYG-REGQVSIKGDVYNYGIMLMEVF 859
            T+ +AT  Y APE      + S   DV++ G +L E+F
Sbjct: 179 MTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 10/197 (5%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G++  V   R    G EVAIK+    +    +L     E  I+K + H N+VK+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
                   L++EY   G + D + A     +   R      + SA++Y H      IVH 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 135
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQVSIKGD 847
           D+K  N+LLD  M   ++DFG +   +     K      +  Y APE +  +     + D
Sbjct: 136 DLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDTFCGSPPYAAPELFQGKKYDGPEVD 193
Query: 848 VYNYGIMLMEVFTGMKP 864
           V++ G++L  + +G  P
Sbjct: 194 VWSLGVILYTLVSGSLP 210

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 108/235 (45%), Gaps = 35/235 (14%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G+YG V K R  P G  +A+K         +NS + +  ++        V    + T
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIR----ATVNSQEQKRLLMDLDISMRTVDCPFTVT 114
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR-------------LG-IMIDVASALEY 776
            +   AL  E    G +  CM   + +LD F +             LG I + +  ALE+
Sbjct: 115 FYG--ALFRE----GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 168
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
           LH   S  ++H D+KPSNVL++      + DFGI+  L   DS+ +T       Y+APE 
Sbjct: 169 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DSVAKTIDAGCKPYMAPER 224
Query: 837 -----GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV 886
                 ++G  S+K D+++ GI ++E+     P + + T    +K+ + +  P +
Sbjct: 225 INPELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 278

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  I + +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +VLEY P G     M++    +  F         A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 212
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 10/197 (5%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G++  V   R    G EVAIK+    +    +L     E  I+K + H N+VK+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
                   L++EY   G + D + A     +   R      + SA++Y H      IVH 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 138
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQVSIKGD 847
           D+K  N+LLD  M   ++DFG +   +     K         Y APE +  +     + D
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFCGAPPYAAPELFQGKKYDGPEVD 196
Query: 848 VYNYGIMLMEVFTGMKP 864
           V++ G++L  + +G  P
Sbjct: 197 VWSLGVILYTLVSGSLP 213

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/284 (19%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 672 IGIGSYGSVYKGRFPDGI----EVAIKVFHLQREGALNS---FDAECEILKTIRHRNLVK 724
           +G GS+G VY+G   D I    E  + V  +    +L     F  E  ++K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD---------IFQRLGIMIDVASALE 775
           ++   +      +V+E M  G L+  + +     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT-QTLATIGYIAP 834
           YL+   +   VH D+   N ++       + DFG+ + + E    ++  + L  + ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E  ++G  +   D++++G++L E+ +  +   +  + E  +K            +MD   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK-----------FVMDGGY 250
Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           L + +        +C   V  L   C   +P+ R    EI++ L
Sbjct: 251 LDQPD--------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 83/168 (49%), Gaps = 11/168 (6%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVKIIS 727
           +G GS+G V        G +VA+K+ +   L +       + E   L+ +RH +++K+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
              + +   +V+EY      +  +     +    +R      + SA+EY H    + IVH
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 135
Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            D+KP N+LLD+ +   ++DFG++ ++++ + +K   +  +  Y APE
Sbjct: 136 RDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK--TSCGSPNYAAPE 181

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 12/205 (5%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
            HS  +++ D+KP N+L+D      ++DFG AK +      +      T  Y+APE    
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILS 212
Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKP 864
              +   D +  G+++ E+  G  P
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 83/168 (49%), Gaps = 11/168 (6%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVKIIS 727
           +G GS+G V        G +VA+K+ +   L +       + E   L+ +RH +++K+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
              + +   +V+EY      +  +     +    +R      + SA+EY H    + IVH
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 136
Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            D+KP N+LLD+ +   ++DFG++ ++++ + +K   +  +  Y APE
Sbjct: 137 RDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK--TSCGSPNYAAPE 182

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFEY 177
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 232
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFEY 151
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 152 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 206
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 12/205 (5%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
            HS  +++ D+KP N+L+D      ++DFG AK +      +      T  Y+APE    
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLXGTPEYLAPEIILS 212
Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKP 864
              +   D +  G+++ E+  G  P
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 212
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 83/168 (49%), Gaps = 11/168 (6%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVKIIS 727
           +G GS+G V        G +VA+K+ +   L +       + E   L+ +RH +++K+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
              + +   +V+EY      +  +     +    +R      + SA+EY H    + IVH
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 126
Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            D+KP N+LLD+ +   ++DFG++ ++++ + +K   +  +  Y APE
Sbjct: 127 RDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK--TSCGSPNYAAPE 172

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFAEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISS 728
           +G G+YG V     R  +   VA+K+  ++R      +   E  I   + H N+VK    
Sbjct: 15  LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLH-------F 779
               N + L LEY   G L             F R+   I +    A  + H       +
Sbjct: 74  RREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            H   I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 839 EGQVSIKG-DVYNYGIMLMEVFTGMKPTNE 867
             +   +  DV++ GI+L  +  G  P ++
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 83/168 (49%), Gaps = 11/168 (6%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVKIIS 727
           +G GS+G V        G +VA+K+ +   L +       + E   L+ +RH +++K+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
              + +   +V+EY      +  +     +    +R      + SA+EY H    + IVH
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 130
Query: 788 CDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
            D+KP N+LLD+ +   ++DFG++ ++++ + +K   +  +  Y APE
Sbjct: 131 RDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK--TSCGSPNYAAPE 176

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 666 FSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA-----ECEILKTIRH 719
           F    L+G G++G V   R    G   A+K+  L++E  +   +      E  +L+  RH
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM-IDVASALEYLH 778
             L  +  +   H+    V+EY   G L    + S   +   +R      ++ SALEYLH
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 125
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAPEYG 837
              S  +V+ DIK  N++LD      ++DFG+ K  +S+  +MK      T  Y+APE  
Sbjct: 126 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVL 180
Query: 838 REGQVSIKGDVYNYGIMLMEVFTGMKP 864
            +       D +  G+++ E+  G  P
Sbjct: 181 EDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 666 FSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA-----ECEILKTIRH 719
           F    L+G G++G V   R    G   A+K+  L++E  +   +      E  +L+  RH
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM-IDVASALEYLH 778
             L  +  +   H+    V+EY   G L    + S   +   +R      ++ SALEYLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAPEYG 837
              S  +V+ DIK  N++LD      ++DFG+ K  +S+  +MK      T  Y+APE  
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVL 177
Query: 838 REGQVSIKGDVYNYGIMLMEVFTGMKP 864
            +       D +  G+++ E+  G  P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 666 FSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA-----ECEILKTIRH 719
           F    L+G G++G V   R    G   A+K+  L++E  +   +      E  +L+  RH
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM-IDVASALEYLH 778
             L  +  +   H+    V+EY   G L    + S   +   +R      ++ SALEYLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAPEYG 837
              S  +V+ DIK  N++LD      ++DFG+ K  +S+  +MK      T  Y+APE  
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--XFCGTPEYLAPEVL 177
Query: 838 REGQVSIKGDVYNYGIMLMEVFTGMKP 864
            +       D +  G+++ E+  G  P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 666 FSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           FS   +IG G +G VY  R  D G   A+K    +R         + E L  +  R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-----KQGETL-ALNERIMLS 244
Query: 725 IISS-------CTNHNFK-----ALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMID 769
           ++S+       C ++ F      + +L+ M  G L       +++L    +F    +   
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-------HYHLSQHGVFSEADMRFY 297
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
            A  +  L   H+  +V+ D+KP+N+LLD+     +SD G+A   S++   K   ++ T 
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTH 354
Query: 830 GYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           GY+APE  ++G       D ++ G ML ++  G  P  +  T +
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 666 FSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA-----ECEILKTIRH 719
           F    L+G G++G V   R    G   A+K+  L++E  +   +      E  +L+  RH
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM-IDVASALEYLH 778
             L  +  +   H+    V+EY   G L    + S   +   +R      ++ SALEYLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAPEYG 837
              S  +V+ DIK  N++LD      ++DFG+ K  +S+  +MK      T  Y+APE  
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--XFCGTPEYLAPEVL 177
Query: 838 REGQVSIKGDVYNYGIMLMEVFTGMKP 864
            +       D +  G+++ E+  G  P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 659 LLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEIL--KT 716
           ++  +D++     IG G++G     R     E+ + V +++R  A++  + + EI+  ++
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKEL-VAVKYIERGAAIDE-NVQREIINHRS 72
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLD----IFQRLGIMIDVA 771
           +RH N+V+           A+++EY   G L E    A  F+ D     FQ+L       
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------- 125
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS--DFGIAKLLSEEDSMKQTQTLATI 829
             L  + + HS  I H D+K  N LLD S    L   DFG +K      S+  +Q  +T+
Sbjct: 126 --LSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTV 178
Query: 830 G---YIAPEYGREGQVSIK-GDVYNYGIMLMEVFTGMKP 864
           G   YIAPE     +   K  DV++ G+ L  +  G  P
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 666 FSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           FS   +IG G +G VY  R  D G   A+K    +R         + E L  +  R ++ 
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-----KQGETL-ALNERIMLS 243
Query: 725 IISS-------CTNHNFK-----ALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMID 769
           ++S+       C ++ F      + +L+ M  G L       +++L    +F    +   
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-------HYHLSQHGVFSEADMRFY 296
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
            A  +  L   H+  +V+ D+KP+N+LLD+     +SD G+A   S++   K   ++ T 
Sbjct: 297 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTH 353
Query: 830 GYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           GY+APE  ++G       D ++ G ML ++  G  P  +  T +
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 397

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 670 NLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA-----ECEILKTIRHRNLV 723
            L+G G++G V   R    G   A+K+  L++E  +   +      E  +L+  RH  L 
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM-IDVASALEYLHFGHS 782
            +  +   H+    V+EY   G L    + S   +   +R      ++ SALEYLH   S
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH---S 123
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAPEYGREGQ 841
             +V+ DIK  N++LD      ++DFG+ K  +S+  +MK      T  Y+APE   +  
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--XFCGTPEYLAPEVLEDND 181
Query: 842 VSIKGDVYNYGIMLMEVFTGMKP 864
                D +  G+++ E+  G  P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 666 FSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           FS   +IG G +G VY  R  D G   A+K    +R         + E L  +  R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-----KQGETL-ALNERIMLS 244
Query: 725 IISS-------CTNHNFK-----ALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMID 769
           ++S+       C ++ F      + +L+ M  G L       +++L    +F    +   
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-------HYHLSQHGVFSEADMRFY 297
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
            A  +  L   H+  +V+ D+KP+N+LLD+     +SD G+A   S++   K   ++ T 
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTH 354
Query: 830 GYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           GY+APE  ++G       D ++ G ML ++  G  P  +  T +
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 666 FSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK 724
           FS   +IG G +G VY  R  D G   A+K    +R         + E L  +  R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-----KQGETL-ALNERIMLS 244
Query: 725 IISS-------CTNHNFK-----ALVLEYMPKGSLEDCMYASNFNLD---IFQRLGIMID 769
           ++S+       C ++ F      + +L+ M  G L       +++L    +F    +   
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-------HYHLSQHGVFSEADMRFY 297
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
            A  +  L   H+  +V+ D+KP+N+LLD+     +SD G+A   S++   K   ++ T 
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTH 354
Query: 830 GYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           GY+APE  ++G       D ++ G ML ++  G  P  +  T +
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 670 NLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA-----ECEILKTIRHRNLV 723
            L+G G++G V   R    G   A+K+  L++E  +   +      E  +L+  RH  L 
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 73
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM-IDVASALEYLHFGHS 782
            +  +   H+    V+EY   G L    + S   +   +R      ++ SALEYLH   S
Sbjct: 74  ALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH---S 128
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAPEYGREGQ 841
             +V+ DIK  N++LD      ++DFG+ K  +S+  +MK      T  Y+APE   +  
Sbjct: 129 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--XFCGTPEYLAPEVLEDND 186
Query: 842 VSIKGDVYNYGIMLMEVFTGMKP 864
                D +  G+++ E+  G  P
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G++ A K    +R  +          + E  ILK I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++APE     
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPAFVAPEIVNYE 192
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             L K+  S  +++   +V+EY P G     M++    +  F         A  +    +
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+++D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 212
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             L K+  S  +++   +V+EY P G     M++    +  F         A  +    +
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+++D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 212
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             L K+  S  +++   +V+EY P G     M++    +  F         A  +    +
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+++D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 212
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 39/219 (17%)
Query: 666 FSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDA---------ECEILK 715
           F  ++L+G G+YG V      P G  VAIK         +  FD          E +ILK
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIK--------KIEPFDKPLFALRTLREIKILK 64
Query: 716 TIRHRNLVKIIS-----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDV 770
             +H N++ I +     S  N N   ++ E M +  L   +     + D  Q       +
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYF-----I 118
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE------EDSMKQT- 823
              L  +   H + ++H D+KPSN+L++ +    + DFG+A+++ E      E + +Q+ 
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 824 --QTLATIGYIAPEYG-REGQVSIKGDVYNYGIMLMEVF 859
             + +AT  Y APE      + S   DV++ G +L E+F
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAEC-----EILKTI 717
           D F    ++G GS+G V   R  + G   A+KV  L+++  L   D EC      IL   
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLA 80
Query: 718 R-HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
           R H  L ++       +    V+E++  G L   +  S    D  +      ++ SAL +
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMF 139
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI----GYI 832
           LH      I++ D+K  NVLLD      L+DFG+ K     + +    T AT      YI
Sbjct: 140 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGTPDYI 191
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           APE  +E       D +  G++L E+  G  P
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 77/167 (46%), Gaps = 22/167 (13%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIM 767
           E  I   ++H ++V+++ + ++     +V E+M           ++   +I +R   G +
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMD---------GADLCFEIVKRADAGFV 126
Query: 768 IDVASA-------LEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEE 817
              A A       LE L + H N I+H D+KP NVLL   ++S    L DFG+A  L  E
Sbjct: 127 YSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG-E 185
Query: 818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             +     + T  ++APE  +        DV+  G++L  + +G  P
Sbjct: 186 SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 636 TEVSHIKAGMSPQ--VMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVA 692
            E +H  A ++ +   + +  S D      D++     IG G+YG V   R    G +VA
Sbjct: 25  AEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVA 84
Query: 693 IKVFHLQREGALNSFDA---------ECEILKTIRHRNLVKIIS----SCTNHNFKAL-- 737
           IK          N+FD          E +ILK  +H N++ I      +     FK++  
Sbjct: 85  IKKIP-------NAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 137
Query: 738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL 797
           VL+ M +  L   +++S   L +      +  +   L+Y+H   S  ++H D+KPSN+L+
Sbjct: 138 VLDLM-ESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLV 192
Query: 798 DDSMVAHLSDFGIAKLLSEEDSMKQ---TQTLATIGYIAPE 835
           +++    + DFG+A+ L    +  Q   T+ +AT  Y APE
Sbjct: 193 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ ++  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+++D      ++DFG AK +       +T  L  T  Y+APE   
Sbjct: 157 LHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIII 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 635 STEVSHIKAGMSPQ--VMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFP-DGIEV 691
             E +H  A ++ +   + +  S D      D++     IG G+YG V   R    G +V
Sbjct: 23  KAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQV 82
Query: 692 AIKVFHLQREGALNSFDA---------ECEILKTIRHRNLVKIIS----SCTNHNFKAL- 737
           AIK          N+FD          E +ILK  +H N++ I      +     FK++ 
Sbjct: 83  AIKKIP-------NAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135
Query: 738 -VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVL 796
            VL+ M +  L   +++S   L +      +  +   L+Y+H   S  ++H D+KPSN+L
Sbjct: 136 VVLDLM-ESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLL 190
Query: 797 LDDSMVAHLSDFGIAKLLSEEDSMKQ---TQTLATIGYIAPE 835
           ++++    + DFG+A+ L    +  Q   T+ +AT  Y APE
Sbjct: 191 VNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 670 NLIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEILKTIRHRNLVKI 725
            +IG G++G V   +  +  +V A+K+   + + +      F  E ++L     + +  +
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG--IMIDVASALEYLHFGHSN 783
             +  + N   LV++Y   G L   +  S F   + + +    + ++  A++ +H  H  
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAEMVIAIDSVHQLH-- 195
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY-----GR 838
             VH DIKP N+L+D +    L+DFG    L E+ +++ +  + T  YI+PE      G 
Sbjct: 196 -YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
           +G+   + D ++ G+ + E+  G  P
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 107/225 (47%), Gaps = 17/225 (7%)
Query: 672 IGIGSYGSVYKGRFPDGIE-VAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G+YG+V+K +  +  E VA+K   L    EG  +S   E  +LK ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
             +     LV E+  +  L+    + N +LD       +  +   L+ L F HS  ++H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL---LKGLGFCHSRNVLHR 125
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV-SIKGD 847
           D+KP N+L++ +    L++FG+A+           + + T+ Y  P+     ++ S   D
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSID 184
Query: 848 VYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           +++ G +  E+    +P    F G       ++D L  +  ++ T
Sbjct: 185 MWSAGCIFAELANAGRP---LFPGND-----VDDQLKRIFRLLGT 221

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 12/204 (5%)
Query: 665 QFSEENLIGIGSYGSVYKGR-FPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHRNL 722
           ++++   IG G+YG V           VAIK +   + +        E +IL   RH N+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---IMIDVASALEYLHF 779
           + I         +A+   Y+    ++D M    + L   Q+L    I   +   L  L +
Sbjct: 104 IGIRDILRASTLEAMRDVYI----VQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKY 159
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAPEYG 837
            HS  ++H D+KPSN+L++ +    + DFG+A++   E       T+ +AT  Y APE  
Sbjct: 160 IHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIM 219
Query: 838 REGQVSIKG-DVYNYGIMLMEVFT 860
              +   K  D+++ G +L E+ +
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G++ A K    +R  +          + E  ILK I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++APE     
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIVNYE 192
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G++ A K    +R  +          + E  ILK I+H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  + + + YLH   S  
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 133
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++APE     
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIVNYE 191
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 192 PLGLEADMWSIGVITYILLSGASP 215

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G++ A K    +R  +          + E  ILK I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++APE     
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIVNYE 192
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G++ A K    +R  +          + E  ILK I+H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  + + + YLH   S  
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 133
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++APE     
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIVNYE 191
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 192 PLGLEADMWSIGVITYILLSGASP 215

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
            HS  +++ D+KP N+L+D      ++DFG AK +       + +T    G   PEY   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------KGRTWXLCG--TPEYLAP 207
Query: 840 GQVSIKG-----DVYNYGIMLMEVFTGMKP 864
             +  KG     D +  G+++ E+  G  P
Sbjct: 208 AIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G++ A K    +R  +          + E  ILK I+H N++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++APE     
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIVNYE 192
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 39/229 (17%)
Query: 666 FSEENLIGIGSYGSVYKGRFPD---GIEVAIKVFHLQREGALNSFDAE----CEILKTIR 718
            + +  +G GS+G V+  R  D   G + A+K   L+       F  E    C  L + R
Sbjct: 60  MTHQPRVGRGSFGEVH--RMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPR 111
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID------VAS 772
              +V +  +     +  + +E +  GSL            + +++G + +      +  
Sbjct: 112 ---IVPLYGAVREGPWVNIFMELLEGGSLGQ----------LIKQMGCLPEDRALYYLGQ 158
Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLL-DDSMVAHLSDFGIAKLLSEEDSMKQTQT----LA 827
           ALE L + H+  I+H D+K  NVLL  D   A L DFG A  L  +   K   T      
Sbjct: 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
           T  ++APE         K D+++   M++ +  G  P  ++F G + +K
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G++ A K    +R  +          + E  ILK I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++APE     
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIVNYE 192
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 84/197 (42%), Gaps = 10/197 (5%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISS 728
           IG G++  V   R    G EVA+K+    +    +L     E  I K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 729 CTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHC 788
                   LV EY   G + D + A     +   R      + SA++Y H      IVH 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 789 DIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQVSIKGD 847
           D+K  N+LLD      ++DFG +   +  + +          Y APE +  +     + D
Sbjct: 138 DLKAENLLLDADXNIKIADFGFSNEFTFGNKL--DAFCGAPPYAAPELFQGKKYDGPEVD 195
Query: 848 VYNYGIMLMEVFTGMKP 864
           V++ G++L  + +G  P
Sbjct: 196 VWSLGVILYTLVSGSLP 212

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKT 716
           D +     +G G +  V K R    G++ A K    +R  +          + E  ILK 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
           I+H N++ +     N     L+LE +  G L D + A   +L   +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYI 832
           LH   S  I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFV 184
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           APE      + ++ D+++ G++   + +G  P
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 666 FSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAE----CEILKTIRHR 720
            + +  +G GS+G V++ +    G + A+K   L+       F  E    C  L + R  
Sbjct: 76  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPR-- 127
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID------VASAL 774
            +V +  +     +  + +E +  GSL            + +++G + +      +  AL
Sbjct: 128 -IVPLYGAVREGPWVNIFMELLEGGSLGQ----------LIKQMGCLPEDRALYYLGQAL 176
Query: 775 EYLHFGHSNPIVHCDIKPSNVLL-DDSMVAHLSDFGIAKLLSEEDSMKQTQT----LATI 829
           E L + H+  I+H D+K  NVLL  D   A L DFG A  L  +   K   T      T 
Sbjct: 177 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 236
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
            ++APE         K D+++   M++ +  G  P  ++F G + +K
Sbjct: 237 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G++ A K    +R  +          + E  ILK I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++APE     
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIVNYE 192
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G++ A K    +R  +          + E  ILK I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++APE     
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIVNYE 192
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G++ A K    +R  +          + E  ILK I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++APE     
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIVNYE 192
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 108/262 (41%), Gaps = 55/262 (20%)
Query: 672 IGIGSYGSV---YKGRFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKII 726
           +G G+YGSV   Y  R     +VA+K      +  +++     E  +LK ++H N++ ++
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 727 SSCTNHNFKALVLEYMPKGSLED---------CMYASNFNLDIFQRLG---IMIDVASAL 774
              T            P  S+ED          M A   N+   Q L    +   V   L
Sbjct: 86  DVFT------------PATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
             L + HS  I+H D+KPSNV +++     + DFG+A+   EE     T  +AT  Y AP
Sbjct: 134 RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE----MTGYVATRWYRAP 189
Query: 835 E----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM 890
           E    +    Q     D+++ G ++ E+  G       F G   I     D L  +M ++
Sbjct: 190 EIMLNWMHYNQTV---DIWSVGCIMAELLQG----KALFPGSDYI-----DQLKRIMEVV 237
Query: 891 DTN----LLSEDEEHANVAKQS 908
            T     L     EHA    QS
Sbjct: 238 GTPSPEVLAKISSEHARTYIQS 259

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 666 FSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAE----CEILKTIRHR 720
            + +  +G GS+G V++ +    G + A+K   L+       F  E    C  L + R  
Sbjct: 74  MTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPR-- 125
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID------VASAL 774
            +V +  +     +  + +E +  GSL            + +++G + +      +  AL
Sbjct: 126 -IVPLYGAVREGPWVNIFMELLEGGSLGQ----------LIKQMGCLPEDRALYYLGQAL 174
Query: 775 EYLHFGHSNPIVHCDIKPSNVLL-DDSMVAHLSDFGIAKLLSEEDSMKQTQT----LATI 829
           E L + H+  I+H D+K  NVLL  D   A L DFG A  L  +   K   T      T 
Sbjct: 175 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 234
Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
            ++APE         K D+++   M++ +  G  P  ++F G + +K
Sbjct: 235 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 92/179 (51%), Gaps = 17/179 (9%)
Query: 666 FSEENLIGIGSYGS-VYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILK-TIRHRNLV 723
           F  ++++G G+ G+ VY+G F D  +VA+K    +     +  D E ++L+ +  H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVI 81
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           +   +  +  F+ + +E +   +L++ +   +F     + + ++    S L +LH   S 
Sbjct: 82  RYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137
Query: 784 PIVHCDIKPSNVLLD-----DSMVAHLSDFGIAKLLS--EEDSMKQTQTLATIGYIAPE 835
            IVH D+KP N+L+        + A +SDFG+ K L+       +++    T G+IAPE
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G++ A K    +R  +          + E  ILK I+H N++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++APE     
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIVNYE 192
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID 769
           E +IL  +  R +V +  +        LV+  M  G +   +Y  + +   FQ    +  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT---L 826
            A  +  L   H   I++ D+KP NVLLDD     +SD G+A  L       QT+T    
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL----KAGQTKTKGYA 350
Query: 827 ATIGYIAPE--YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            T G++APE   G E   S+  D +  G+ L E+     P
Sbjct: 351 GTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFD-----AECEILKTI 717
           + F    L+G G++G V   R    G   A+K+  L++E  +   +      E  +L+  
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIM-IDVASALEY 776
           RH  L  +  +   H+    V+EY   G L    + S   +   +R      ++ SALEY
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAPE 835
           LH   S  +V+ DIK  N++LD      ++DFG+ K  +S+  +MK      T  Y+APE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPE 175
Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
              +       D +  G+++ E+  G  P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G++ A K    +R  +          + E  ILK I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+LE +  G L D + A   +L   +    +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++APE     
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIVNYE 192
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID 769
           E +IL  +  R +V +  +        LV+  M  G +   +Y  + +   FQ    +  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT---L 826
            A  +  L   H   I++ D+KP NVLLDD     +SD G+A  L       QT+T    
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL----KAGQTKTKGYA 350
Query: 827 ATIGYIAPE--YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            T G++APE   G E   S+  D +  G+ L E+     P
Sbjct: 351 GTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID 769
           E +IL  +  R +V +  +        LV+  M  G +   +Y  + +   FQ    +  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT---L 826
            A  +  L   H   I++ D+KP NVLLDD     +SD G+A  L       QT+T    
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL----KAGQTKTKGYA 350
Query: 827 ATIGYIAPE--YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            T G++APE   G E   S+  D +  G+ L E+     P
Sbjct: 351 GTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 58/107 (54%), Gaps = 11/107 (10%)
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTLAT 828
           VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +++      
Sbjct: 200 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 303

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 58/107 (54%), Gaps = 11/107 (10%)
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTLAT 828
           VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +++      
Sbjct: 202 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 108/262 (41%), Gaps = 55/262 (20%)
Query: 672 IGIGSYGSV---YKGRFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKII 726
           +G G+YGSV   Y  R     +VA+K      +  +++     E  +LK ++H N++ ++
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 727 SSCTNHNFKALVLEYMPKGSLED---------CMYASNFNLDIFQRLG---IMIDVASAL 774
              T            P  S+ED          M A   N+   Q L    +   V   L
Sbjct: 94  DVFT------------PATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLL 141
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
             L + HS  I+H D+KPSNV +++     + DFG+A+   EE     T  +AT  Y AP
Sbjct: 142 RGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----MTGYVATRWYRAP 197
Query: 835 E----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM 890
           E    +    Q     D+++ G ++ E+  G       F G   I     D L  +M ++
Sbjct: 198 EIMLNWMHYNQTV---DIWSVGCIMAELLQG----KALFPGSDYI-----DQLKRIMEVV 245
Query: 891 DTN----LLSEDEEHANVAKQS 908
            T     L     EHA    QS
Sbjct: 246 GTPSPEVLAKISSEHARTYIQS 267

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEI 713
           E+    D F    +IG G++  V   +     +V A+K+   + + + G ++ F  E ++
Sbjct: 55  EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114
Query: 714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG--IMIDVA 771
           L     R + ++  +  + N+  LV+EY   G L   +  S F   I   +    + ++ 
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEMARFYLAEIV 172
Query: 772 SALEYLH-FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG 830
            A++ +H  G+    VH DIKP N+LLD      L+DFG    L  + +++    + T  
Sbjct: 173 MAIDSVHRLGY----VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 831 YIAPE-------YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           Y++PE           G    + D +  G+   E+F G  P
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 108/262 (41%), Gaps = 55/262 (20%)
Query: 672 IGIGSYGSV---YKGRFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKII 726
           +G G+YGSV   Y  R     +VA+K      +  +++     E  +LK ++H N++ ++
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 727 SSCTNHNFKALVLEYMPKGSLED---------CMYASNFNLDIFQRLG---IMIDVASAL 774
              T            P  S+ED          M A   N+   Q L    +   V   L
Sbjct: 94  DVFT------------PATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
             L + HS  I+H D+KPSNV +++     + DFG+A+   EE     T  +AT  Y AP
Sbjct: 142 RGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----MTGYVATRWYRAP 197
Query: 835 E----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM 890
           E    +    Q     D+++ G ++ E+  G       F G   I     D L  +M ++
Sbjct: 198 EIMLNWMHYNQTV---DIWSVGCIMAELLQG----KALFPGSDYI-----DQLKRIMEVV 245
Query: 891 DTN----LLSEDEEHANVAKQS 908
            T     L     EHA    QS
Sbjct: 246 GTPSPEVLAKISSEHARTYIQS 267

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHRNL 722
           +++  + IG G+YG V       + + VAIK +   + +        E +IL   RH N+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 723 VKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEYLH 778
           + I     N   +A  +E M    + +D M    + L   Q L    I   +   L  L 
Sbjct: 86  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAPEY 836
           + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y APE 
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 837 GREGQVSIKG-DVYNYGIMLMEVFT 860
               +   K  D+++ G +L E+ +
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 659 LLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEIL--KT 716
           ++  +D++     IG G++G     R     E+ + V +++R   ++  + + EI+  ++
Sbjct: 14  IMHDSDRYELVKDIGAGNFGVARLMRDKQANEL-VAVKYIERGEKIDE-NVKREIINHRS 71
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLD----IFQRLGIMIDVA 771
           +RH N+V+           A+V+EY   G L E    A  F+ D     FQ+L       
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------- 124
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL--SDFGIAKLLSEEDSMKQTQTLATI 829
             +  + + H+  + H D+K  N LLD S    L  +DFG +K      S+  +Q  + +
Sbjct: 125 --ISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA-----SVLHSQPKSAV 177
Query: 830 G---YIAPEYGREGQVSIK-GDVYNYGIMLMEVFTGMKP 864
           G   YIAPE   + +   K  DV++ G+ L  +  G  P
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID 769
           E +IL  +  R +V +  +        LV+  M  G +   +Y  + +   FQ    +  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT---L 826
            A  +  L   H   I++ D+KP NVLLDD     +SD G+A  L       QT+T    
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL----KAGQTKTKGYA 350
Query: 827 ATIGYIAPE--YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            T G++APE   G E   S+  D +  G+ L E+     P
Sbjct: 351 GTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 7/157 (4%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID 769
           E  IL   RHRN++ +  S  +     ++ E++    + + +  S F L+  + +  +  
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDD--SMVAHLSDFGIAKLLSEEDSMKQTQTLA 827
           V  AL++L   HS+ I H DI+P N++     S    + +FG A+ L   D+ +   T  
Sbjct: 111 VCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167
Query: 828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
              Y APE  +   VS   D+++ G ++  + +G+ P
Sbjct: 168 E--YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 58/107 (54%), Gaps = 11/107 (10%)
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTLAT 828
           VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +++      
Sbjct: 209 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 312

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 699 QREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNL 758
           QRE        E  I +++ H+++V       +++F  +VLE   + SL + ++     L
Sbjct: 60  QRE----KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKAL 114
Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
              +    +  +    +YLH    N ++H D+K  N+ L++ +   + DFG+A  + E D
Sbjct: 115 TEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYD 170
Query: 819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
             ++     T  YIAPE   +   S + DV++ G ++  +  G  P       E  ++  
Sbjct: 171 GERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 230
Query: 879 IND-SLPAVMNIMDTNLLSE 897
            N+ S+P  +N +  +L+ +
Sbjct: 231 KNEYSIPKHINPVAASLIQK 250

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 699 QREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNL 758
           QRE        E  I +++ H+++V       +++F  +VLE   + SL + ++     L
Sbjct: 64  QRE----KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKAL 118
Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
              +    +  +    +YLH    N ++H D+K  N+ L++ +   + DFG+A  + E D
Sbjct: 119 TEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYD 174
Query: 819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
             ++     T  YIAPE   +   S + DV++ G ++  +  G  P       E  ++  
Sbjct: 175 GERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 234
Query: 879 IND-SLPAVMNIMDTNLLSE 897
            N+ S+P  +N +  +L+ +
Sbjct: 235 KNEYSIPKHINPVAASLIQK 254

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 58/107 (54%), Gaps = 11/107 (10%)
Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQTQTLAT 828
           VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  + D +++      
Sbjct: 207 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEF 868
           + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 310

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 699 QREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNL 758
           QRE        E  I +++ H+++V       +++F  +VLE   + SL + ++     L
Sbjct: 60  QRE----KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKAL 114
Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
              +    +  +    +YLH    N ++H D+K  N+ L++ +   + DFG+A  + E D
Sbjct: 115 TEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYD 170
Query: 819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
             ++     T  YIAPE   +   S + DV++ G ++  +  G  P       E  ++  
Sbjct: 171 GERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 230
Query: 879 IND-SLPAVMNIMDTNLLSE 897
            N+ S+P  +N +  +L+ +
Sbjct: 231 KNEYSIPKHINPVAASLIQK 250

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 13/206 (6%)
Query: 665 QFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALN--SFDAECEILKTIRHRN 721
           Q  EE  +G G++  V +  +   G E A K+ + ++  A +    + E  I + ++H N
Sbjct: 25  QLFEE--LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 82
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +V++  S +      L+ + +  G L + + A  +    +        +   LE +   H
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCH 138
Query: 782 SNPIVHCDIKPSNVLLDDSM---VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR 838
              +VH D+KP N+LL   +      L+DFG+A +  E +         T GY++PE  R
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEVLR 197
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
           +       D++  G++L  +  G  P
Sbjct: 198 KDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAIK +   + +        E +IL   RH 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 86  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRG 140
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y AP
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAIK +   + +        E +IL   RH 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHE 85
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 86  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y AP
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAIK +   + +        E +IL   RH 
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 86
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 87  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 141
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y AP
Sbjct: 142 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 201
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAIK +   + +        E +IL   RH 
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 87
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 88  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 142
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y AP
Sbjct: 143 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 202
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 203 EIMLNSKGYTKSIDIWSVGCILAEMLS 229

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAIK +   + +        E +IL   RH 
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 78
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 79  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 133
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y AP
Sbjct: 134 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 193
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 194 EIMLNSKGYTKSIDIWSVGCILAEMLS 220

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAIK +   + +        E +IL   RH 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 86  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y AP
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAI-KVFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAI K+   + +        E +IL   RH 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 86  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y AP
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHRNL 722
           +++  + IG G+YG V       + + VAIK +   + +        E +IL   RH N+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 723 VKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEYLH 778
           + I     N   +A  +E M    + +D M    + L   Q L    I   +   L  L 
Sbjct: 86  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAPEY 836
           + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y APE 
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 837 GREGQVSIKG-DVYNYGIMLMEVFT 860
               +   K  D+++ G +L E+ +
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAIK +   + +        E +IL   RH 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 86  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y AP
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAIK +   + +        E +IL   RH 
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 79
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 80  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 134
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y AP
Sbjct: 135 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 20/200 (10%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKII-- 726
           +G G+YGSV        G+++A+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 727 ----SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
               +S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 119 FTPATSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 172
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG-Q 841
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE       
Sbjct: 173 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 228
Query: 842 VSIKGDVYNYGIMLMEVFTG 861
            ++  D+++ G ++ E+ TG
Sbjct: 229 YNMTVDIWSVGCIMAELLTG 248

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHRNL 722
           +++  + IG G+YG V       + + VAIK +   + +        E +IL   RH N+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 723 VKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEYLH 778
           + I     N   +A  +E M    + +D M    + L   Q L    I   +   L  L 
Sbjct: 84  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAPEY 836
           + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y APE 
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 837 GREGQVSIKG-DVYNYGIMLMEVFT 860
               +   K  D+++ G +L E+ +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHRNL 722
           +++  + IG G+YG V       + + VAIK +   + +        E +IL   RH N+
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 723 VKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEYLH 778
           + I     N   +A  +E M    + +D M    + L   Q L    I   +   L  L 
Sbjct: 104 IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 158
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAPEY 836
           + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y APE 
Sbjct: 159 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 837 GREGQVSIKG-DVYNYGIMLMEVFT 860
               +   K  D+++ G +L E+ +
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHRNL 722
           +++  + IG G+YG V       + + VAIK +   + +        E +IL   RH N+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 723 VKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEYLH 778
           + I     N   +A  +E M    + +D M    + L   Q L    I   +   L  L 
Sbjct: 86  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 140
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAPEY 836
           + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y APE 
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 837 GREGQVSIKG-DVYNYGIMLMEVFT 860
               +   K  D+++ G +L E+ +
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHRNL 722
           +++  + IG G+YG V       + + VAIK +   + +        E +IL   RH N+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 723 VKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEYLH 778
           + I     N   +A  +E M    + +D M    + L   Q L    I   +   L  L 
Sbjct: 84  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAPEY 836
           + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y APE 
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 837 GREGQVSIKG-DVYNYGIMLMEVFT 860
               +   K  D+++ G +L E+ +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHRNL 722
           +++  + IG G+YG V       + + VAIK +   + +        E +IL   RH N+
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 723 VKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEYLH 778
           + I     N   +A  +E M    + +D M    + L   Q L    I   +   L  L 
Sbjct: 92  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 146
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAPEY 836
           + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y APE 
Sbjct: 147 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 837 GREGQVSIKG-DVYNYGIMLMEVFT 860
               +   K  D+++ G +L E+ +
Sbjct: 207 MLNSKGYTKSIDIWSVGCILAEMLS 231

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHRNL 722
           +++  + IG G+YG V       + + VAIK +   + +        E +IL   RH N+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 723 VKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEYLH 778
           + I     N   +A  +E M    + +D M    + L   Q L    I   +   L  L 
Sbjct: 84  IGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 138
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAPEY 836
           + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y APE 
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 837 GREGQVSIKG-DVYNYGIMLMEVFT 860
               +   K  D+++ G +L E+ +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 14/206 (6%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA---ECEILKTIRH 719
           DQF     +G GS+G V   +  + G   A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G     M++    +  F         A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPEYGR 838
            HS  +++ D+KP N+L+D      ++DFG AK +       +T  L  T   +APE   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEALAPEIIL 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               +   D +  G+++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAIK +   + +        E +IL   RH 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 81
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 82  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 136
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y AP
Sbjct: 137 LKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAIK +   + +        E +IL   RH 
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 79
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 80  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 134
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y AP
Sbjct: 135 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAIK +   + +        E +IL   RH 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 81
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 82  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 136
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y AP
Sbjct: 137 LKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 659 LLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEIL--KT 716
           ++  +D++     IG G++G     R     E+ + V +++R G   + + + EI+  ++
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNEL-VAVKYIER-GEKIAANVKREIINHRS 71
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLD----IFQRLGIMIDVA 771
           +RH N+V+           A+V+EY   G L E    A  F+ D     FQ+L       
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------- 124
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS--DFGIAKLLSEEDSMKQTQTLATI 829
             +  + + H+  + H D+K  N LLD S    L   DFG +K      S+  +Q  +T+
Sbjct: 125 --ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTV 177
Query: 830 G---YIAPEYGREGQVSIK-GDVYNYGIMLMEVFTGMKP 864
           G   YIAPE   + +   K  DV++ G+ L  +  G  P
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 699 QREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNL 758
           QRE        E  I +++ H+++V       +++F  +VLE   + SL + ++     L
Sbjct: 84  QRE----KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKAL 138
Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
              +    +  +    +YLH    N ++H D+K  N+ L++ +   + DFG+A  + E D
Sbjct: 139 TEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYD 194
Query: 819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
             ++     T  YIAPE   +   S + DV++ G ++  +  G  P       E  ++  
Sbjct: 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 254
Query: 879 IND-SLPAVMNIMDTNLLSE 897
            N+ S+P  +N +  +L+ +
Sbjct: 255 KNEYSIPKHINPVAASLIQK 274

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 699 QREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNL 758
           QRE        E  I +++ H+++V       +++F  +VLE   + SL + ++     L
Sbjct: 82  QRE----KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKAL 136
Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
              +    +  +    +YLH    N ++H D+K  N+ L++ +   + DFG+A  + E D
Sbjct: 137 TEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYD 192
Query: 819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
             ++     T  YIAPE   +   S + DV++ G ++  +  G  P       E  ++  
Sbjct: 193 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 252
Query: 879 IND-SLPAVMNIMDTNLLSE 897
            N+ S+P  +N +  +L+ +
Sbjct: 253 KNEYSIPKHINPVAASLIQK 272

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 28/233 (12%)
Query: 644 GMSPQ--VMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQR 700
           GMS +    +R+  +  +    +++   + +G G+YGSV        G+ VA+K      
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 70
Query: 701 EGALNSFDA--ECEILKTIRHRNLVKIIS------SCTNHNFKALVLEYMPKGSLEDCMY 752
           +  +++     E  +LK ++H N++ ++       S    N   LV   M    L + + 
Sbjct: 71  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK 129
Query: 753 ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK 812
                 D  Q L     +   L  L + HS  I+H D+KPSN+ +++     + DFG+A+
Sbjct: 130 CQKLTDDHVQFL-----IYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR 184
Query: 813 LLSEEDSMKQTQTLATIGYIAPE----YGREGQVSIKGDVYNYGIMLMEVFTG 861
              +E     T  +AT  Y APE    +    Q     D+++ G ++ E+ TG
Sbjct: 185 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTG 230

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 699 QREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNL 758
           QRE        E  I +++ H+++V       +++F  +VLE   + SL + ++     L
Sbjct: 58  QRE----KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKAL 112
Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
              +    +  +    +YLH    N ++H D+K  N+ L++ +   + DFG+A  + E D
Sbjct: 113 TEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYD 168
Query: 819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
             ++     T  YIAPE   +   S + DV++ G ++  +  G  P       E  ++  
Sbjct: 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 228
Query: 879 IND-SLPAVMNIMDTNLLSE 897
            N+ S+P  +N +  +L+ +
Sbjct: 229 KNEYSIPKHINPVAASLIQK 248

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
           M      ++YLH   +N ++H D+K  N+ L+D M   + DFG+A  + E D  ++    
Sbjct: 148 MRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLC 203
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND-SLPA 885
            T  YIAPE   +   S + D+++ G +L  +  G  P       E  I+   N+ S+P 
Sbjct: 204 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR 263
Query: 886 VMNIMDTNLL 895
            +N + + L+
Sbjct: 264 HINPVASALI 273

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
           M      ++YLH   +N ++H D+K  N+ L+D M   + DFG+A  + E D  ++    
Sbjct: 132 MRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLC 187
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND-SLPA 885
            T  YIAPE   +   S + D+++ G +L  +  G  P       E  I+   N+ S+P 
Sbjct: 188 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR 247
Query: 886 VMNIMDTNLL 895
            +N + + L+
Sbjct: 248 HINPVASALI 257

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 38/209 (18%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIISS 728
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 729 CTNHNFKALVLEYMPKGSLED---------CMYASNFNLDIFQRLG---IMIDVASALEY 776
            T            P  SLE+          M A   N+   Q+L    +   +   L  
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE- 835
           L + HS  I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRWYRAPEI 193
Query: 836 ---YGREGQVSIKGDVYNYGIMLMEVFTG 861
              +    Q     D+++ G ++ E+ TG
Sbjct: 194 MLNWMHYNQTV---DIWSVGCIMAELLTG 219

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
           M      ++YLH   +N ++H D+K  N+ L+D M   + DFG+A  + E D  ++    
Sbjct: 148 MRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKTLC 203
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND-SLPA 885
            T  YIAPE   +   S + D+++ G +L  +  G  P       E  I+   N+ S+P 
Sbjct: 204 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR 263
Query: 886 VMNIMDTNLL 895
            +N + + L+
Sbjct: 264 HINPVASALI 273

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 30/205 (14%)
Query: 672 IGIGSYGSV---YKGRFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKII 726
           +G G+YG+V     GR   G +VAIK  +   +  L +  A  E  +LK +RH N++ ++
Sbjct: 33  VGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 727 SSCTNH----NFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
              T      +F    LV+ +M    L   M       D  Q L     V   L+ L + 
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL-----VYQMLKGLRYI 144
Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----Y 836
           H+  I+H D+KP N+ +++     + DFG+A+    E        + T  Y APE    +
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MXGXVVTRWYRAPEVILNW 200
Query: 837 GREGQVSIKGDVYNYGIMLMEVFTG 861
            R  Q     D+++ G ++ E+ TG
Sbjct: 201 MRYTQTV---DIWSVGCIMAEMITG 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 28/233 (12%)
Query: 644 GMSPQ--VMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQR 700
           GMS +    +R+  +  +    +++   + +G G+YGSV        G+ VA+K      
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 70
Query: 701 EGALNSFDA--ECEILKTIRHRNLVKIIS------SCTNHNFKALVLEYMPKGSLEDCMY 752
           +  +++     E  +LK ++H N++ ++       S    N   LV   M    L + + 
Sbjct: 71  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK 129
Query: 753 ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK 812
                 D  Q L     +   L  L + HS  I+H D+KPSN+ +++     + DFG+A+
Sbjct: 130 CQKLTDDHVQFL-----IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 184
Query: 813 LLSEEDSMKQTQTLATIGYIAPE----YGREGQVSIKGDVYNYGIMLMEVFTG 861
              +E     T  +AT  Y APE    +    Q     D+++ G ++ E+ TG
Sbjct: 185 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTG 230

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
           M      ++YLH   +N ++H D+K  N+ L+D M   + DFG+A  + E D  ++    
Sbjct: 148 MRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKXLC 203
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND-SLPA 885
            T  YIAPE   +   S + D+++ G +L  +  G  P       E  I+   N+ S+P 
Sbjct: 204 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR 263
Query: 886 VMNIMDTNLL 895
            +N + + L+
Sbjct: 264 HINPVASALI 273

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           IG G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 95  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 148
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 204
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 205 YNQTV---DIWSVGCIMAELLTG 224

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 44/236 (18%)
Query: 688 GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN-HNFKA------LVLE 740
           G E A K    +R G     D   EIL  I    L K      N H          L+LE
Sbjct: 54  GQEYAAKFLKKRRRGQ----DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILE 109
Query: 741 YMPKGSLEDCMYASNFNLDIFQRLGIMID-------VASALEYLHFGHSNPIVHCDIKPS 793
           Y   G +        F+L     L  M+        +   LE +++ H N IVH D+KP 
Sbjct: 110 YAAGGEI--------FSL-CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQ 160
Query: 794 NVLLDDSMV---AHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYN 850
           N+LL          + DFG+++ +     ++  + + T  Y+APE      ++   D++N
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRKIGHACELR--EIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 851 YGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAK 906
            GI+   + T   P    F GE        D+    +NI   N+   +E  ++V++
Sbjct: 219 IGIIAYMLLTHTSP----FVGE--------DNQETYLNISQVNVDYSEETFSSVSQ 262

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 659 LLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEIL--KT 716
           ++  +D++     IG G++G     R     E+ + V +++R   ++  + + EI+  ++
Sbjct: 13  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNEL-VAVKYIERGEKIDE-NVKREIINHRS 70
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLD----IFQRLGIMIDVA 771
           +RH N+V+           A+V+EY   G L E    A  F+ D     FQ+L       
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------- 123
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS--DFGIAKLLSEEDSMKQTQTLATI 829
             +  + + H+  + H D+K  N LLD S    L   DFG +K      S+  +Q  +T+
Sbjct: 124 --ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTV 176
Query: 830 G---YIAPEYGREGQVSIK-GDVYNYGIMLMEVFTGMKP 864
           G   YIAPE   + +   K  DV++ G+ L  +  G  P
Sbjct: 177 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 10/144 (6%)
Query: 661 RATDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDAECEILKTI-- 717
           R T +F E   IG G +GSV+K  +  DG   AIK       G+++  +A  E+      
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 63
Query: 718 -RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL---GIMIDVASA 773
            +H ++V+  S+    +   +  EY   GSL D +  +   +  F+      +++ V   
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLL 797
           L Y+H   S  +VH DIKPSN+ +
Sbjct: 124 LRYIH---SMSLVHMDIKPSNIFI 144

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 10/144 (6%)
Query: 661 RATDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDAECEILKTI-- 717
           R T +F E   IG G +GSV+K  +  DG   AIK       G+++  +A  E+      
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 718 -RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL---GIMIDVASA 773
            +H ++V+  S+    +   +  EY   GSL D +  +   +  F+      +++ V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLL 797
           L Y+H   S  +VH DIKPSN+ +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFI 148

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 10/144 (6%)
Query: 661 RATDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDAECEILKTI-- 717
           R T +F E   IG G +GSV+K  +  DG   AIK       G+++  +A  E+      
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 718 -RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL---GIMIDVASA 773
            +H ++V+  S+    +   +  EY   GSL D +  +   +  F+      +++ V   
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLL 797
           L Y+H   S  +VH DIKPSN+ +
Sbjct: 126 LRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 38/209 (18%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIISS 728
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 729 CTNHNFKALVLEYMPKGSLED---------CMYASNFNLDIFQRLG---IMIDVASALEY 776
            T            P  SLE+          M A   N+   Q+L    +   +   L  
Sbjct: 97  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE- 835
           L + HS  I+H D+KPSN+ +++     + DFG+A+  ++E     T  +AT  Y APE 
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEI 200
Query: 836 ---YGREGQVSIKGDVYNYGIMLMEVFTG 861
              +    Q     D+++ G ++ E+ TG
Sbjct: 201 MLNWMHYNQTV---DIWSVGCIMAELLTG 226

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 10/144 (6%)
Query: 661 RATDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDAECEILKTI-- 717
           R T +F E   IG G +GSV+K  +  DG   AIK       G+++  +A  E+      
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 718 -RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL---GIMIDVASA 773
            +H ++V+  S+    +   +  EY   GSL D +  +   +  F+      +++ V   
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLL 797
           L Y+H   S  +VH DIKPSN+ +
Sbjct: 126 LRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 97  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 150
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+  ++E     T  +AT  Y APE    +  
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMH 206
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 207 YNQTV---DIWSVGCIMAELLTG 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGXVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/210 (21%), Positives = 93/210 (44%), Gaps = 11/210 (5%)
Query: 661 RATDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALN--SFDAECEILKTI 717
           R T+++     +G G++  V +  +   G E A  + + ++  A +    + E  I + +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
           +H N+V++  S +      L+ + +  G L + + A  +    +        +   LE +
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAV 123
Query: 778 HFGHSNPIVHCDIKPSNVLLDDSM---VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
              H   +VH ++KP N+LL   +      L+DFG+A +  E +         T GY++P
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSP 182
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           E  R+       D++  G++L  +  G  P
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV 842
             I+H D+KPSN+ +++     + DFG+A+   +E            GY+A  + R  ++
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVATRWYRAPEI 193
Query: 843 SIKG-------DVYNYGIMLMEVFTG 861
            +         D+++ G ++ E+ TG
Sbjct: 194 MLNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 38/209 (18%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIISS 728
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 729 CTNHNFKALVLEYMPKGSLED---------CMYASNFNLDIFQRLG---IMIDVASALEY 776
            T            P  SLE+          M A   N+   Q+L    +   +   L  
Sbjct: 97  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE- 835
           L + HS  I+H D+KPSN+ +++     + DFG+A+  ++E     T  +AT  Y APE 
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEI 200
Query: 836 ---YGREGQVSIKGDVYNYGIMLMEVFTG 861
              +    Q     D+++ G ++ E+ TG
Sbjct: 201 MLNWMHYNQTV---DIWSVGCIMAELLTG 226

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 38/209 (18%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIISS 728
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 729 CTNHNFKALVLEYMPKGSLED---------CMYASNFNLDIFQRLG---IMIDVASALEY 776
            T            P  SLE+          M A   N+   Q+L    +   +   L  
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE- 835
           L + HS  I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEI 193
Query: 836 ---YGREGQVSIKGDVYNYGIMLMEVFTG 861
              +    Q     D+++ G ++ E+ TG
Sbjct: 194 MLNWMHYNQTV---DIWSVGCIMAELLTG 219

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 95  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 148
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 204
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 205 YNQTV---DIWSVGCIMAELLTG 224

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT 730
           +G G+YG V K R  P G  +A+K    +    +NS + +  ++        V    + T
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVK----RIRATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 731 NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR-------------LG-IMIDVASALEY 776
            +   AL  E    G +  CM   + +LD F +             LG I + +  ALE+
Sbjct: 71  FYG--ALFRE----GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE---DSMKQTQTLATIGYIA 833
           LH   S  ++H D+KPSNVL++      + DFGI+  L ++   D     +       I 
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERIN 182
Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP 884
           PE  ++G  S+K D+++ GI ++E+     P + + T    +K+ + +  P
Sbjct: 183 PELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 232

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 664 DQFSEENLIGIGSYGSVY------KGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI 717
           ++F    L+G G++G V        GR+   +++  K   + ++   ++   E  +L+  
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYY-AMKILKKEVIVAKDEVAHTL-TENRVLQNS 205
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEY 776
           RH  L  +  S   H+    V+EY   G L   +     F+ D  +  G   ++ SAL+Y
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALDY 263
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI----GYI 832
           LH      +V+ D+K  N++LD      ++DFG+ K     + +K   T+ T      Y+
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYL 316
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           APE   +       D +  G+++ E+  G  P
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 102 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 155
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 212 YNQTV---DIWSVGCIMAELLTG 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 102 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 155
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 211
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 212 YNQTV---DIWSVGCIMAELLTG 231

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 88  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 141
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 142 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 197
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 198 YNQTV---DIWSVGCIMAELLTG 217

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 664 DQFSEENLIGIGSYGSVY------KGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI 717
           ++F    L+G G++G V        GR+   +++  K   + ++   ++   E  +L+  
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYY-AMKILKKEVIVAKDEVAHTL-TENRVLQNS 208
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEY 776
           RH  L  +  S   H+    V+EY   G L   +     F+ D  +  G   ++ SAL+Y
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALDY 266
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI----GYI 832
           LH      +V+ D+K  N++LD      ++DFG+ K     + +K   T+ T      Y+
Sbjct: 267 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYL 319
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           APE   +       D +  G+++ E+  G  P
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 92  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 145
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 201
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 202 YNQTV---DIWSVGCIMAELLTG 221

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 38/209 (18%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIK--------VFHLQREGALNSFDAECEILKTIRHRNL 722
           +G G+YGSV        G+ VA+K        + H +R         E  +LK ++H N+
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR------ELRLLKHMKHENV 95
Query: 723 VKIIS------SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
           + ++       S    N   LV   M    L + +       D  Q L     +   L  
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 149
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE- 835
           L + HS  I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE 
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEI 205
Query: 836 ---YGREGQVSIKGDVYNYGIMLMEVFTG 861
              +    Q     D+++ G ++ E+ TG
Sbjct: 206 MLNWMHYNQTV---DIWSVGCIMAELLTG 231

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 92  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 145
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 201
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 202 YNQTV---DIWSVGCIMAELLTG 221

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 87  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 140
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 196
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 197 YNQTV---DIWSVGCIMAELLTG 216

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 109 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 162
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 218
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 219 YNQTV---DIWSVGCIMAELLTG 238

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 110 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 163
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 219
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 220 YNQTV---DIWSVGCIMAELLTG 239

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 92  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 145
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 201
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 202 YNQTV---DIWSVGCIMAELLTG 221

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 87  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 140
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 196
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 197 YNQTV---DIWSVGCIMAELLTG 216

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 95  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 148
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 204
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 205 YNQTV---DIWSVGCIMAELLTG 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 89  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 142
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 143 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 198
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 199 YNQTV---DIWSVGCIMAELLTG 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 86  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 139
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 195
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 196 YNQTV---DIWSVGCIMAELLTG 215

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 92  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 145
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 146 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 201
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 202 YNQTV---DIWSVGCIMAELLTG 221

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 113 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 166
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 222
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 223 YNQTV---DIWSVGCIMAELLTG 242

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 96  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 149
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 205
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 206 YNQTV---DIWSVGCIMAELLTG 225

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 96  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 149
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 150 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 205
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 206 YNQTV---DIWSVGCIMAELLTG 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 95  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 148
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 204
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 205 YNQTV---DIWSVGCIMAELLTG 224

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 97  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 150
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 206
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 207 YNQTV---DIWSVGCIMAELLTG 226

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAIK +   + +        E +IL   RH 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 86  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +        + +AT  Y AP
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 200
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGA------LNSFDAECEILKTIRHRNLVK 724
           +G G +  V K R    G++ A K    +R  +          + E  ILK I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +     N     L+ E +  G L D + A   +L   +    +  + + + YLH   S  
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 785 IVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           I H D+KP N++L D  V      + DFG+A  +   +  K      T  ++APE     
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIVNYE 192
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
            + ++ D+++ G++   + +G  P
Sbjct: 193 PLGLEADMWSIGVITYILLSGASP 216

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 665 QFSEENLIGIGSYG---SVYKGRFPDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHR 720
           +++  + IG G+YG   S Y     + + VAIK +   + +        E +IL   RH 
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 86
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEY 776
           N++ I     N   +A  +E M    + +D M    + L   Q L    I   +   L  
Sbjct: 87  NIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 141
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAP 834
           L + HS  ++H D+KPSN+LL+ +    + DFG+A++   +        + +AT  Y AP
Sbjct: 142 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 201
Query: 835 EYGREGQVSIKG-DVYNYGIMLMEVFT 860
           E     +   K  D+++ G +L E+ +
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIK-VFHLQREGALNSFDAECEILKTIRHRNL 722
           +++  + IG G+YG V       + + VAIK +   + +        E +IL   RH N+
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 723 VKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLG---IMIDVASALEYLH 778
           + I     N   +A  +E M    L    M A  + L   Q L    I   +   L  L 
Sbjct: 104 IGI-----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 158
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIAPEY 836
           + HS  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +AT  Y APE 
Sbjct: 159 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 837 GREGQVSIKG-DVYNYGIMLMEVFT 860
               +   K  D+++ G +L E+ +
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 113 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 166
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV 842
             I+H D+KPSN+ +++     + DFG+A+   +E            GY+A  + R  ++
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MXGYVATRWYRAPEI 216
Query: 843 SIKG-------DVYNYGIMLMEVFTG 861
            +         D+++ G ++ E+ TG
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 38/209 (18%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIISS 728
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 729 CTNHNFKALVLEYMPKGSLED---------CMYASNFNLDIFQRL---GIMIDVASALEY 776
            T            P  SLE+          M A   N+   Q+L    +   +   L  
Sbjct: 96  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE- 835
           L + HS  I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE 
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEI 199
Query: 836 ---YGREGQVSIKGDVYNYGIMLMEVFTG 861
              +    Q     D+++ G ++ E+ TG
Sbjct: 200 MLNWMHYNQTV---DIWSVGCIMAELLTG 225

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 670 NLIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEILKTIRHRNLVKI 725
            +IG G++G V   +  +   + A+K+   + + +      F  E ++L     + +  +
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCM--YASNFNLDIFQ-RLGIMIDVASALEYLHFGHS 782
             +  + N   LV++Y   G L   +  +      D+ +  +G M+    ++  LH+   
Sbjct: 156 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY--- 212
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE--- 839
              VH DIKP NVLLD +    L+DFG    ++++ +++ +  + T  YI+PE  +    
Sbjct: 213 ---VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 840 --GQVSIKGDVYNYGIMLMEVFTGMKP 864
             G+   + D ++ G+ + E+  G  P
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 670 NLIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEILKTIRHRNLVKI 725
            +IG G++G V   +  +   + A+K+   + + +      F  E ++L     + +  +
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCM--YASNFNLDIFQ-RLGIMIDVASALEYLHFGHS 782
             +  + N   LV++Y   G L   +  +      D+ +  +G M+    ++  LH+   
Sbjct: 140 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY--- 196
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE--- 839
              VH DIKP NVLLD +    L+DFG    ++++ +++ +  + T  YI+PE  +    
Sbjct: 197 ---VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 840 --GQVSIKGDVYNYGIMLMEVFTGMKP 864
             G+   + D ++ G+ + E+  G  P
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 91/197 (46%), Gaps = 23/197 (11%)
Query: 674 IGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN 733
           +G YG +++       EV +KV          SF     ++  + H++LV     C   +
Sbjct: 32  VGDYGQLHE------TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85
Query: 734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPS 793
              LV E++  GSL+  +  +   ++I  +L +   +A+A   +HF   N ++H ++   
Sbjct: 86  ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFLEENTLIHGNVCAK 142
Query: 794 NVLL---DDSMVAH-----LSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQVSI 844
           N+LL   +D    +     LSD GI+  +  +D +++      I ++ PE       +++
Sbjct: 143 NILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-----RIPWVPPECIENPKNLNL 197
Query: 845 KGDVYNYGIMLMEVFTG 861
             D +++G  L E+ +G
Sbjct: 198 ATDKWSFGTTLWEICSG 214

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 60/129 (46%), Gaps = 21/129 (16%)
Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
           L I I +A A+E+LH   S  ++H D+KPSN+      V  + DFG+   + +++  +  
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 824 QT-----------LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
            T           + T  Y++PE       S K D+++ G++L E+          F+ +
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-------FSTQ 276
Query: 873 MSIKRWIND 881
           M   R I D
Sbjct: 277 MERVRIITD 285

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + + +     D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKSQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+ +   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 664 DQFSEENLIGIGSYGSVY------KGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI 717
           ++F    L+G G++G V        GR+   +++  K   + ++   ++   E  +L+  
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYY-AMKILKKEVIVAKDEVAHTL-TENRVLQNS 65
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEY 776
           RH  L  +  S   H+    V+EY   G L   +     F+ D  +  G   ++ SAL+Y
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALDY 123
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL----ATIGYI 832
           LH      +V+ D+K  N++LD      ++DFG+ K     + +K   T+     T  Y+
Sbjct: 124 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKXFCGTPEYL 176
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           APE   +       D +  G+++ E+  G  P
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 82/173 (47%), Gaps = 14/173 (8%)
Query: 701 EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL---EDCMYASNFN 757
           +   + F  E +I+  I++   +      TN++   ++ EYM   S+   ++  +  + N
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 758 LDIF---QRLGIMID-VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL 813
              F   Q +  +I  V ++  Y+H  +   I H D+KPSN+L+D +    LSDFG ++ 
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 814 LSEEDSMKQTQTLATIGYIAPEY--GREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           + ++   K   +  T  ++ PE+          K D+++ GI L  +F  + P
Sbjct: 202 MVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + D+G+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 664 DQFSEENLIGIGSYGSVY------KGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI 717
           ++F    L+G G++G V        GR+   +++  K   + ++   ++   E  +L+  
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYY-AMKILKKEVIVAKDEVAHTL-TENRVLQNS 66
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEY 776
           RH  L  +  S   H+    V+EY   G L   +     F+ D  +  G   ++ SAL+Y
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALDY 124
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL----ATIGYI 832
           LH      +V+ D+K  N++LD      ++DFG+ K     + +K   T+     T  Y+
Sbjct: 125 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKXFCGTPEYL 177
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           APE   +       D +  G+++ E+  G  P
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 664 DQFSEENLIGIGSYGSVY------KGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI 717
           ++F    L+G G++G V        GR+   +++  K   + ++   ++   E  +L+  
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYY-AMKILKKEVIVAKDEVAHTL-TENRVLQNS 67
Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEY 776
           RH  L  +  S   H+    V+EY   G L   +     F+ D  +  G   ++ SAL+Y
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALDY 125
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL----ATIGYI 832
           LH      +V+ D+K  N++LD      ++DFG+ K     + +K   T+     T  Y+
Sbjct: 126 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKXFCGTPEYL 178
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           APE   +       D +  G+++ E+  G  P
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G  VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +  +    D  Q L     +   L  L + HS
Sbjct: 86  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCAKLTDDHVQFL-----IYQILRGLKYIHS 139
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 195
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 196 YNQTV---DIWSVGCIMAELLTG 215

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 22/167 (13%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIM 767
           E  I   ++H ++V+++ + ++     +V E+M           ++   +I +R   G +
Sbjct: 78  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMD---------GADLCFEIVKRADAGFV 128
Query: 768 IDVASA-------LEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEE 817
              A A       LE L + H N I+H D+KP  VLL   ++S    L  FG+A  L  E
Sbjct: 129 YSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-E 187
Query: 818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             +     + T  ++APE  +        DV+  G++L  + +G  P
Sbjct: 188 SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G  VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 109 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 162
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 218
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 219 YNQTV---DIWSVGCIMAELLTG 238

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G  VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 110 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 163
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 219
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 220 YNQTV---DIWSVGCIMAELLTG 239

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 35/122 (28%), Positives = 61/122 (50%), Gaps = 6/122 (4%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE---DSMKQ 822
           I + +  ALE+LH   S  ++H D+KPSNVL++        DFGI+  L ++   D    
Sbjct: 141 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAG 198
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS 882
            +       I PE  ++G  S+K D+++ GI  +E+     P + + T    +K+ + + 
Sbjct: 199 CKPYXAPERINPELNQKG-YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEP 257
Query: 883 LP 884
            P
Sbjct: 258 SP 259

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G  VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 86  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 139
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 195
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 196 YNQTV---DIWSVGCIMAELLTG 215

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 18/209 (8%)
Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAEC-----EILKTIRHRNLVK 724
           ++G GS+G V         E+ AIK+  L+++  +   D EC      +L  +     + 
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKI--LKKDVVIQDDDVECTMVEKRVLALLDKPPFLT 83
Query: 725 IISSCTNHNFK-ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
            + SC     +   V+EY+  G   D MY     +  F+    +   A     L F H  
Sbjct: 84  QLHSCFQTVDRLYFVMEYVNGG---DLMYHIQ-QVGKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
            I++ D+K  NV+LD      ++DFG+ K     D +   +   T  YIAPE        
Sbjct: 140 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMMDGVTTREFCGTPDYIAPEIIAYQPYG 198
Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
              D + YG++L E+  G  P    F GE
Sbjct: 199 KSVDWWAYGVLLYEMLAGQPP----FDGE 223

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G  VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G  VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 100 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 153
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE    +  
Sbjct: 154 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 209
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 210 YNQTV---DIWSVGCIMAELLTG 229

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 22/167 (13%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIM 767
           E  I   ++H ++V+++ + ++     +V E+M           ++   +I +R   G +
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMD---------GADLCFEIVKRADAGFV 126
Query: 768 IDVASA-------LEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEE 817
              A A       LE L + H N I+H D+KP  VLL   ++S    L  FG+A  L  E
Sbjct: 127 YSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-E 185
Query: 818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             +     + T  ++APE  +        DV+  G++L  + +G  P
Sbjct: 186 SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 17  NASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKE 76
           N ++C   G  C    N+  S+  S   L   IPS++   +  + L L  N  S    K 
Sbjct: 1   NEALCKKDGGVCSCNNNK-NSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKA 56
Query: 77  IGNLTKLKELHLDYNKLQGEIPEELGXXXXXXXXXXXXXXXTGTIPASIFNLSFISTALD 136
              LTKL+ L+L+ NKLQ                         T+PA IF        L 
Sbjct: 57  FHRLTKLRLLYLNDNKLQ-------------------------TLPAGIFKELKNLETLW 91
Query: 137 FSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLP 196
            +DN L  + P  +   L  L  L +  NQ K   P       +L+ +SL YN+    LP
Sbjct: 92  VTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS-LP 149
Query: 197 RDLGNS-TKLKSLDLGFNNLNGEIPQ-EIGNLRNLEILGIDQSNLVGFVPDTIFN-ISTL 253
           + + +  T LK L L +NN    +P+     L  L+ L +D +N +  VP+  F+ +  L
Sbjct: 150 KGVFDKLTSLKELRL-YNNQLKRVPEGAFDKLTELKTLKLD-NNQLKRVPEGAFDSLEKL 207
Query: 254 KILSLFNN 261
           K+L L  N
Sbjct: 208 KMLQLQEN 215

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 26/158 (16%)
Query: 377 QGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDXXXXXXXXXXXXXXTS 436
           + LDLQ+NK      + F   ++L ++YLN NKL  ++P+                    
Sbjct: 40  KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPA-------------------- 78
Query: 437 VIPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRNNLSGNIPSTIIGLKN 495
                F  L+++     + N L  +LP+ + + L  + ++ L RN L    P     L  
Sbjct: 79  ---GIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTK 134
Query: 496 LQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGV 533
           L +LSL +N+LQ      F +L SL+ L L NN L  V
Sbjct: 135 LTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 659 LLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEIL--KT 716
           ++  +D++     IG G++G     R     E+ + V +++R   ++  + + EI+  ++
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNEL-VAVKYIERGEKIDE-NVKREIINHRS 71
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLD----IFQRLGIMIDVA 771
           +RH N+V+           A+V+EY   G L E    A  F+ D     FQ+L       
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------- 124
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS--DFGIAKLLSEEDSMKQTQTLATI 829
             +  + + H+  + H D+K  N LLD S    L    FG +K      S+  +Q  +T+
Sbjct: 125 --ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKSTV 177
Query: 830 G---YIAPEYGREGQVSIK-GDVYNYGIMLMEVFTGMKP 864
           G   YIAPE   + +   K  DV++ G+ L  +  G  P
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 108/246 (43%), Gaps = 31/246 (12%)
Query: 672 IGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI----- 725
           +G G  G V+     D    VAIK   L    ++     E +I++ + H N+VK+     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 726 ---------ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
                    + S T  N   +V EYM +  L + +      L+   RL  M  +   L+Y
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPL-LEEHARL-FMYQLLRGLKY 135
Query: 777 LHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQ--TQTLATIGYIA 833
           +H   S  ++H D+KP+N+ ++ + +V  + DFG+A+++    S K   ++ L T  Y +
Sbjct: 136 IH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192
Query: 834 PEYGREGQVSIKG-DVYNYGIMLMEVFTGMKPTNEFFTG--EMSIKRWINDSLPAVMNIM 890
           P          K  D++  G +  E+ TG       F G  E+   + I +S+P V    
Sbjct: 193 PRLLLSPNNYTKAIDMWAAGCIFAEMLTG----KTLFAGAHELEQMQLILESIPVVHEED 248
Query: 891 DTNLLS 896
              LLS
Sbjct: 249 RQELLS 254

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 11/103 (10%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQ 822
           IM D+ +A+++LH   S+ I H D+KP N+L    +   V  L+DFG AK    E +   
Sbjct: 114 IMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNA 166
Query: 823 TQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            QT   T  Y+APE     +     D+++ G+++  +  G  P
Sbjct: 167 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 209

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 90/197 (45%), Gaps = 23/197 (11%)
Query: 674 IGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN 733
           +G YG +++       EV +KV          SF     ++  + H++LV     C   +
Sbjct: 32  VGDYGQLHE------TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGD 85
Query: 734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPS 793
              LV E++  GSL+  +  +   ++I  +L +   +A A   +HF   N ++H ++   
Sbjct: 86  ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFLEENTLIHGNVCAK 142
Query: 794 NVLL---DDSMVAH-----LSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREGQVSI 844
           N+LL   +D    +     LSD GI+  +  +D +++      I ++ PE       +++
Sbjct: 143 NILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-----RIPWVPPECIENPKNLNL 197
Query: 845 KGDVYNYGIMLMEVFTG 861
             D +++G  L E+ +G
Sbjct: 198 ATDKWSFGTTLWEICSG 214

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 33/206 (16%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFH--LQREGALNSFDAECEILKTIRHRNLVKII-- 726
           +G G+YGSV        G +VAIK      Q E        E  +LK ++H N++ ++  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 727 ----SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
               SS  N     LV+ +M +  L+  M    F+ +  Q L     V   L+ L + HS
Sbjct: 110 FTPASSLRNFYDFYLVMPFM-QTDLQKIM-GMEFSEEKIQYL-----VYQMLKGLKYIHS 162
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV 842
             +VH D+KP N+ +++     + DFG+A+    E            GY+   + R  +V
Sbjct: 163 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----------MTGYVVTRWYRAPEV 212
Query: 843 SIKG-------DVYNYGIMLMEVFTG 861
            +         D+++ G ++ E+ TG
Sbjct: 213 ILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 38/209 (18%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIISS 728
           +G G+YGSV        G  VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 729 CTNHNFKALVLEYMPKGSLED---------CMYASNFNLDIFQRL---GIMIDVASALEY 776
            T            P  SLE+          M A   N+   Q+L    +   +   L  
Sbjct: 96  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE- 835
           L + HS  I+H D+KPSN+ +++     + DFG+A+   +E     T  +AT  Y APE 
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEI 199
Query: 836 ---YGREGQVSIKGDVYNYGIMLMEVFTG 861
              +    Q     D+++ G ++ E+ TG
Sbjct: 200 MLNWMHYNQTV---DIWSVGCIMAELLTG 225

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 33/206 (16%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFH--LQREGALNSFDAECEILKTIRHRNLVKII-- 726
           +G G+YGSV        G +VAIK      Q E        E  +LK ++H N++ ++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 727 ----SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
               SS  N     LV+ +M +  L+  M    F+ +  Q L     V   L+ L + HS
Sbjct: 92  FTPASSLRNFYDFYLVMPFM-QTDLQKIM-GLKFSEEKIQYL-----VYQMLKGLKYIHS 144
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV 842
             +VH D+KP N+ +++     + DFG+A+    E            GY+   + R  +V
Sbjct: 145 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----------MTGYVVTRWYRAPEV 194
Query: 843 SIKG-------DVYNYGIMLMEVFTG 861
            +         D+++ G ++ E+ TG
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTG 220

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 672 IGIGSYGSVYKG------RFPDGIEVAIKVF----HLQREGALNSFDAECEILKTI-RHR 720
           +G G++G V +       +    + VA+K+     HL    AL S   E ++L  +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKVLSYLGNHM 87
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-------EDCMYASNFNLDIFQRL--------- 764
           N+V ++ +CT      ++ EY   G L        D    S  +  I +           
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 765 -GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQ 822
                 VA  + +L    S   +H D+   N+LL    +  + DFG+A+ + ++ + + +
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
                 + ++APE       + + DV++YGI L E+F+
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 659 LLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEIL--KT 716
           ++  +D++     IG G++G     R     E+ + V +++R   ++  + + EI+  ++
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNEL-VAVKYIERGEKIDE-NVKREIINHRS 71
Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLD----IFQRLGIMIDVA 771
           +RH N+V+           A+V+EY   G L E    A  F+ D     FQ+L       
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------- 124
Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS--DFGIAKLLSEEDSMKQTQTLATI 829
             +  + + H+  + H D+K  N LLD S    L    FG +K  S     +   T+ T 
Sbjct: 125 --ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK--SSVLHSQPKDTVGTP 180
Query: 830 GYIAPEYGREGQVSIK-GDVYNYGIMLMEVFTGMKP 864
            YIAPE   + +   K  DV++ G+ L  +  G  P
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 672 IGIGSYGSVYKG------RFPDGIEVAIKVF----HLQREGALNSFDAECEILKTI-RHR 720
           +G G++G V +       +    + VA+K+     HL    AL S   E ++L  +  H 
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKVLSYLGNHM 103
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-------EDCMYASNFNLDIFQRL--------- 764
           N+V ++ +CT      ++ EY   G L        D    S  +  I +           
Sbjct: 104 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 765 -GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQ 822
                 VA  + +L    S   +H D+   N+LL    +  + DFG+A+ + ++ + + +
Sbjct: 164 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
                 + ++APE       + + DV++YGI L E+F+
Sbjct: 221 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     +  FG+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 11/103 (10%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQ 822
           IM D+ +A+++LH   S+ I H D+KP N+L    +   V  L+DFG AK    E +   
Sbjct: 133 IMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNA 185
Query: 823 TQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            QT   T  Y+APE     +     D+++ G+++  +  G  P
Sbjct: 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + D G+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 672 IGIGSYGSVYKG------RFPDGIEVAIKVF----HLQREGALNSFDAECEILKTI-RHR 720
           +G G++G V +       +    + VA+K+     HL    AL S   E ++L  +  H 
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKVLSYLGNHM 105
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-------EDCMYASNFNLDIFQRL--------- 764
           N+V ++ +CT      ++ EY   G L        D    S  +  I +           
Sbjct: 106 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 765 -GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQ 822
                 VA  + +L    S   +H D+   N+LL    +  + DFG+A+ + ++ + + +
Sbjct: 166 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 222
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
                 + ++APE       + + DV++YGI L E+F+
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 31/254 (12%)
Query: 662 ATDQFS---------EENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDAEC 711
           +TD FS         +E+++G G++  V          E A+K+   Q     +    E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 712 EILKTIR-HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDV 770
           E+L   + HRN++++I      +   LV E M  GS+   ++    + +  +   ++ DV
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDV 120
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIA---KLLSEEDSMKQTQ 824
           ASAL++LH   +  I H D+KP N+L +         + DFG+    KL  +   +   +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 825 TLATIG---YIAPE----YGREGQVSIK-GDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
            L   G   Y+APE    +  E  +  K  D+++ G++L  + +G  P       +    
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 877 RWINDSLPAVMNIM 890
           R   ++ PA  N++
Sbjct: 238 R--GEACPACQNML 249

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 20/225 (8%)
Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS----FDAECEILKTIRHRNLVKII- 726
           IG GS+ +VYKG       V +    LQ      S    F  E E LK ++H N+V+   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 727 ---SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL-GIMIDVASALEYLHFGHS 782
              S+        LV E    G+L+   Y   F +   + L      +   L++LH   +
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLK--TYLKRFKVXKIKVLRSWCRQILKGLQFLH-TRT 149
Query: 783 NPIVHCDIKPSNVLLDD-SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-YGREG 840
            PI+H D+K  N+ +   +    + D G+A L   + +      + T  + APE Y  + 
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAPEXYEEKY 206
Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA 885
             S+  DVY +G   +E  T   P +E        +R  +   PA
Sbjct: 207 DESV--DVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPA 249

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G  VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 110 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 163
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + DFG+A+   +E        +AT  Y APE    +  
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MXGXVATRWYRAPEIMLNWMH 219
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 220 YNQTV---DIWSVGCIMAELLTG 239

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 672 IGIGSYGSVYKG------RFPDGIEVAIKVF----HLQREGALNSFDAECEILKTI-RHR 720
           +G G++G V +       +    + VA+K+     HL    AL S   E ++L  +  H 
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKVLSYLGNHM 110
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-------EDCMYASNFNLDIFQRL--------- 764
           N+V ++ +CT      ++ EY   G L        D    S  +  I +           
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 765 -GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQ 822
                 VA  + +L    S   +H D+   N+LL    +  + DFG+A+ + ++ + + +
Sbjct: 171 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
                 + ++APE       + + DV++YGI L E+F+
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 672 IGIGSYGSVYKG------RFPDGIEVAIKVF----HLQREGALNSFDAECEILKTI-RHR 720
           +G G++G V +       +    + VA+K+     HL    AL S   E ++L  +  H 
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKVLSYLGNHM 110
Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-------EDCMYASNFNLDIFQRL--------- 764
           N+V ++ +CT      ++ EY   G L        D    S  +  I +           
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 765 -GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK-LLSEEDSMKQ 822
                 VA  + +L    S   +H D+   N+LL    +  + DFG+A+ + ++ + + +
Sbjct: 171 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT 860
                 + ++APE       + + DV++YGI L E+F+
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIE---VAIKVFHLQREGALNSFDAECEILKTI-RH 719
           D++  ++LIG GS+G V K    D +E   VAIK+    ++  LN    E  +L+ + +H
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAY--DRVEQEWVAIKIIK-NKKAFLNQAQIEVRLLELMNKH 110
Query: 720 RNLVKI-ISSCTNH----NFKALVLEYMPKGSLEDCMYASNF---NLDIFQRLGIMIDVA 771
              +K  I     H    N   LV E M   +L D +  +NF   +L++ ++    +   
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQM--C 167
Query: 772 SALEYLHFGHSNP---IVHCDIKPSNVLL--DDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
           +AL +L    + P   I+HCD+KP N+LL         + DFG +  L +    +  Q +
Sbjct: 168 TALLFL----ATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQ----RIYQXI 219
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTG 861
            +  Y +PE        +  D+++ G +L+E+ TG
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + D G+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G+ VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----YGR 838
             I+H D+KPSN+ +++     + D G+A+   +E     T  +AT  Y APE    +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE----MTGYVATRWYRAPEIMLNWMH 199
Query: 839 EGQVSIKGDVYNYGIMLMEVFTG 861
             Q     D+++ G ++ E+ TG
Sbjct: 200 YNQTV---DIWSVGCIMAELLTG 219

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQ 822
           IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK  +  +S+  
Sbjct: 120 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 174
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T+   T  Y+APE     +     D+++ G+++  +  G  P
Sbjct: 175 TEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 32/206 (15%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G  VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 86  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 139
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV 842
             I+H D+KPSN+ +++     + DFG+A+   +E            G++A  + R  ++
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MAGFVATRWYRAPEI 189
Query: 843 SIKG-------DVYNYGIMLMEVFTG 861
            +         D+++ G ++ E+ TG
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 32/206 (15%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G  VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV 842
             I+H D+KPSN+ +++     + DFG+A+   +E            G++A  + R  ++
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MAGFVATRWYRAPEI 193
Query: 843 SIKG-------DVYNYGIMLMEVFTG 861
            +         D+++ G ++ E+ TG
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIE---VAIKVFHLQREGALNSFDAECEILKTI-RH 719
           D++  ++LIG GS+G V K    D +E   VAIK+    ++  LN    E  +L+ + +H
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAY--DRVEQEWVAIKIIK-NKKAFLNQAQIEVRLLELMNKH 110
Query: 720 RNLVKI-ISSCTNH----NFKALVLEYMPKGSLEDCMYASNF---NLDIFQRLGIMIDVA 771
              +K  I     H    N   LV E M   +L D +  +NF   +L++ ++    +   
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQM--C 167
Query: 772 SALEYLHFGHSNP---IVHCDIKPSNVLLDDSMVAHLS--DFGIAKLLSEEDSMKQTQTL 826
           +AL +L    + P   I+HCD+KP N+LL +   + +   DFG +  L +    +  Q +
Sbjct: 168 TALLFL----ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ----RIYQXI 219
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTG 861
            +  Y +PE        +  D+++ G +L+E+ TG
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 32/206 (15%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIIS- 727
           +G G+YGSV        G  VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 728 -----SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
                S    N   LV   M    L + +       D  Q L     +   L  L + HS
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV 842
             I+H D+KPSN+ +++     + DFG+A+   +E            G++A  + R  ++
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MAGFVATRWYRAPEI 193
Query: 843 SIKG-------DVYNYGIMLMEVFTG 861
            +         D+++ G ++ E+ TG
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 97/258 (37%), Gaps = 55/258 (21%)
Query: 659 LLRATDQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAE-----CE 712
           LL    ++  +  IG GSYG V          + AIK+ +  +   +N  D E       
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 713 ILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLED----------------------- 749
           ++K + H N+ ++     +  +  LV+E    G L D                       
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 750 ------------CMYASNFNLDIFQRL----GIMIDVASALEYLHFGHSNPIVHCDIKPS 793
                        ++    +LD  QR      IM  + SAL YLH   +  I H DIKP 
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPE 197
Query: 794 NVLL--DDSMVAHLSDFGIAK---LLSEEDSMKQTQTLATIGYIAPEYGREGQVSI--KG 846
           N L   + S    L DFG++K    L+  +    T    T  ++APE       S   K 
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 847 DVYNYGIMLMEVFTGMKP 864
           D ++ G++L  +  G  P
Sbjct: 258 DAWSAGVLLHLLLMGAVP 275

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIE---VAIKVFHLQREGALNSFDAECEILKTI-RH 719
           D++  ++LIG GS+G V K    D +E   VAIK+    ++  LN    E  +L+ + +H
Sbjct: 35  DRYEIDSLIGKGSFGQVVKAY--DRVEQEWVAIKIIK-NKKAFLNQAQIEVRLLELMNKH 91
Query: 720 RNLVKI-ISSCTNH----NFKALVLEYMPKGSLEDCMYASNF---NLDIFQRLGIMIDVA 771
              +K  I     H    N   LV E M   +L D +  +NF   +L++ ++    +   
Sbjct: 92  DTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQM--C 148
Query: 772 SALEYLHFGHSNP---IVHCDIKPSNVLLDDSMVAHLS--DFGIAKLLSEEDSMKQTQTL 826
           +AL +L    + P   I+HCD+KP N+LL +   + +   DFG +  L +    +  Q +
Sbjct: 149 TALLFL----ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ----RIYQXI 200
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTG 861
            +  Y +PE        +  D+++ G +L+E+ TG
Sbjct: 201 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 235

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 42/224 (18%)
Query: 672 IGIGSYGSVYKG--RFPDGIEVAIKVFHLQREGALNSFDA-----ECEILKTIR-HRNLV 723
           +G G+YG V+K   R    +    K+F    +   NS DA     E  IL  +  H N+V
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIF----DAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 724 KIISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
            +++     N +   LV +YM +  L   + A+   L+   +  ++  +   ++YLH G 
Sbjct: 73  NLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI--LEPVHKQYVVYQLIKVIKYLHSG- 128
Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS--------------------EEDSMK 821
              ++H D+KPSN+LL+      ++DFG+++                       ++D   
Sbjct: 129 --GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 822 QTQTLATIGYIAPEYGREGQVSIKG-DVYNYGIMLMEVFTGMKP 864
            T  +AT  Y APE         KG D+++ G +L E+  G KP
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KP 229

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 36/212 (16%)
Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSC 729
           +IG GSY  V   R      + A++V  +++E  L + D + + ++T +H     +    
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKE--LVNDDEDIDWVQTEKH-----VFEQA 109
Query: 730 TNHNFKA-------------LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
           +NH F                V+EY+  G L   M       +   R     +++ AL Y
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNY 168
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI----GYI 832
           LH      I++ D+K  NVLLD      L+D+G+ K     + ++   T +T      YI
Sbjct: 169 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYI 220
Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           APE  R        D +  G+++ E+  G  P
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 30/210 (14%)
Query: 670 NLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISS 728
            +IG GSY  V   R      + A+KV  +++E  L + D + + ++T +H     +   
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKV--VKKE--LVNDDEDIDWVQTEKH-----VFEQ 76
Query: 729 CTNHNFKA-------------LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALE 775
            +NH F                V+EY+  G L   M       +   R     +++ AL 
Sbjct: 77  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALN 135
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAP 834
           YLH      I++ D+K  NVLLD      L+D+G+ K  L   D+   +    T  YIAP
Sbjct: 136 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--SXFCGTPNYIAP 190
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           E  R        D +  G+++ E+  G  P
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGRSP 220

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 661 RATDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRH 719
           +  D+F  E + G G++G+V  G+    G+ VAIK   +Q     N      + L  + H
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHH 78
Query: 720 RNLVKIIS-------SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDV-- 770
            N+V++ S             +  +V+EY+P  +L  C    N+         I+I V  
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRC--CRNYYRRQVAPPPILIKVFL 135
Query: 771 ---ASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-VAHLSDFGIAKLLSEEDSMKQTQTL 826
                ++  LH    N + H DIKP NVL++++     L DFG AK LS   S      +
Sbjct: 136 FQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP--SEPNVAYI 192
Query: 827 ATIGYIAPE--YGREGQVSIKGDVYNYGIMLMEVFTG 861
            +  Y APE  +G +   +   D+++ G +  E+  G
Sbjct: 193 CSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLG 228

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 670 NLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISS 728
            +IG GSY  V   R      + A+KV  +++E  L + D + + ++T +H     +   
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKV--VKKE--LVNDDEDIDWVQTEKH-----VFEQ 61
Query: 729 CTNHNFKA-------------LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALE 775
            +NH F                V+EY+  G L   M       +   R     +++ AL 
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALN 120
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAP 834
           YLH      I++ D+K  NVLLD      L+D+G+ K  L   D+   +    T  YIAP
Sbjct: 121 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--SXFCGTPNYIAP 175
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTN 866
           E  R        D +  G+++ E+  G  P +
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 57/276 (20%), Positives = 110/276 (39%), Gaps = 39/276 (14%)
Query: 678 GSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRNLVKIISSCTN--HN 733
           G ++KGR+  G ++ +KV  ++      S  F+ EC  L+   H N++ ++ +C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 734 FKALVLEYMPKGSLEDCMY-ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV--HCDI 790
              L+  + P GSL + ++  +NF +D  Q +   +D A    +LH     P++  H  +
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHA-L 139
Query: 791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR---EGQVSIKGD 847
              +V +D+   A +S   +      + S +         ++APE  +   E       D
Sbjct: 140 NSRSVXIDEDXTARISXADV------KFSFQSPGRXYAPAWVAPEALQKKPEDTNRRSAD 193
Query: 848 VYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQ 907
            +++ ++L E+ T   P  +    E+  K  +    P +                     
Sbjct: 194 XWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTI-------------------PP 234
Query: 908 SCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
             +  V  L   C +E P  R     I+  L K +D
Sbjct: 235 GISPHVSKLXKICXNEDPAKRPKFDXIVPILEKXQD 270

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 670 NLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISS 728
            +IG GSY  V   R      + A+KV  +++E  L + D + + ++T +H     +   
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKV--VKKE--LVNDDEDIDWVQTEKH-----VFEQ 65
Query: 729 CTNHNFKA-------------LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALE 775
            +NH F                V+EY+  G L   M       +   R     +++ AL 
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALN 124
Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL-LSEEDSMKQTQTLATIGYIAP 834
           YLH      I++ D+K  NVLLD      L+D+G+ K  L   D+   +    T  YIAP
Sbjct: 125 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--SXFCGTPNYIAP 179
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTN 866
           E  R        D +  G+++ E+  G  P +
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQ 822
           IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK  +  +S+  
Sbjct: 126 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 180
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T    T  Y+APE     +     D+++ G+++  +  G  P
Sbjct: 181 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQ 822
           IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK  +  +S+  
Sbjct: 128 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 182
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T    T  Y+APE     +     D+++ G+++  +  G  P
Sbjct: 183 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 224

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQ 822
           IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK  +  +S+  
Sbjct: 121 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 175
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T    T  Y+APE     +     D+++ G+++  +  G  P
Sbjct: 176 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 217

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQ 822
           IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK  +  +S+  
Sbjct: 127 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 181
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T    T  Y+APE     +     D+++ G+++  +  G  P
Sbjct: 182 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 223

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 76/182 (41%), Gaps = 14/182 (7%)
Query: 663 TDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQR--------EGALNSFDAECEI 713
           + ++S  + +G G++G V+     +   EV +K    ++        +  L     E  I
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
           L  + H N++K++    N  F  LV+E    G         +  LD      I   + SA
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           + YL       I+H DIK  N+++ +     L DFG A  L E   +  T    TI Y A
Sbjct: 143 VGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYT-FCGTIEYCA 197
Query: 834 PE 835
           PE
Sbjct: 198 PE 199

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQ 822
           IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK  +  +S+  
Sbjct: 120 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 174
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T    T  Y+APE     +     D+++ G+++  +  G  P
Sbjct: 175 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/63 (39%), Positives = 39/63 (61%), Gaps = 2/63 (3%)
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA-KLLSEEDSMKQTQTLATIGYI 832
           LE +H  H + IVH D+KP+N L+ D M+  L DFGIA ++  +  S+ +   + T+ Y+
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 833 APE 835
            PE
Sbjct: 176 PPE 178

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/63 (39%), Positives = 39/63 (61%), Gaps = 2/63 (3%)
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA-KLLSEEDSMKQTQTLATIGYI 832
           LE +H  H + IVH D+KP+N L+ D M+  L DFGIA ++  +  S+ +   + T+ Y+
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 833 APE 835
            PE
Sbjct: 180 PPE 182

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/63 (39%), Positives = 39/63 (61%), Gaps = 2/63 (3%)
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA-KLLSEEDSMKQTQTLATIGYI 832
           LE +H  H + IVH D+KP+N L+ D M+  L DFGIA ++  +  S+ +   + T+ Y+
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 833 APE 835
            PE
Sbjct: 177 PPE 179

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQ 822
           IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK  +  +S+  
Sbjct: 166 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 220
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T    T  Y+APE     +     D+++ G+++  +  G  P
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQ 822
           IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK  +  +S+  
Sbjct: 136 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 190
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T    T  Y+APE     +     D+++ G+++  +  G  P
Sbjct: 191 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 232

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQ 822
           IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK  +  +S+  
Sbjct: 122 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 176
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T    T  Y+APE     +     D+++ G+++  +  G  P
Sbjct: 177 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/63 (39%), Positives = 39/63 (61%), Gaps = 2/63 (3%)
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA-KLLSEEDSMKQTQTLATIGYI 832
           LE +H  H + IVH D+KP+N L+ D M+  L DFGIA ++  +  S+ +   + T+ Y+
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 833 APE 835
            PE
Sbjct: 196 PPE 198

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/63 (39%), Positives = 39/63 (61%), Gaps = 2/63 (3%)
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA-KLLSEEDSMKQTQTLATIGYI 832
           LE +H  H + IVH D+KP+N L+ D M+  L DFGIA ++  +  S+ +   + T+ Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 833 APE 835
            PE
Sbjct: 224 PPE 226

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQ 822
           IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK  +  +S+  
Sbjct: 122 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 176
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T    T  Y+APE     +     D+++ G+++  +  G  P
Sbjct: 177 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSMKQ 822
           IM  +  A++YLH   S  I H D+KP N+L        +  L+DFG AK  +  +S+  
Sbjct: 172 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 226
Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T    T  Y+APE     +     D+++ G+++  +  G  P
Sbjct: 227 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 268

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/63 (39%), Positives = 39/63 (61%), Gaps = 2/63 (3%)
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA-KLLSEEDSMKQTQTLATIGYI 832
           LE +H  H + IVH D+KP+N L+ D M+  L DFGIA ++  +  S+ +   + T+ Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 833 APE 835
            PE
Sbjct: 224 PPE 226

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 124/262 (47%), Gaps = 43/262 (16%)
Query: 669 ENLIGIGSYGSV-YKGRFPDGIEVAIKVFHLQR-EGALNSFDAECEIL-KTIRHRNLVKI 725
           E ++G GS G+V ++G F  G  VA+K   +   + AL     E ++L ++  H N+++ 
Sbjct: 20  EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIRY 74
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNF---NLDI---FQRLGIMIDVASALEYLHF 779
             S T   F  + LE +   +L+D + + N    NL +   +  + ++  +AS + +LH 
Sbjct: 75  YCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 132
Query: 780 GHSNPIVHCDIKPSNVLLDDS-------------MVAHLSDFGIAKLLSEEDSMKQT--- 823
             S  I+H D+KP N+L+  S             +   +SDFG+ K L    S  +T   
Sbjct: 133 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 824 QTLATIGYIAPEYGREG-------QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSI 875
               T G+ APE   E        +++   D+++ G +   + + G  P  + ++ E +I
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 876 KRWINDSLPAVMNIMDTNLLSE 897
            R I  SL  +  + D +L++E
Sbjct: 251 IRGIF-SLDEMKCLHDRSLIAE 271

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 38/209 (18%)
Query: 672 IGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDA--ECEILKTIRHRNLVKIISS 728
           +G G+YGSV        G  VA+K      +  +++     E  +LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 729 CTNHNFKALVLEYMPKGSLED---------CMYASNFNLDIFQRLG---IMIDVASALEY 776
            T            P  SLE+          M A   N+   Q+L    +   +   L  
Sbjct: 90  FT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE- 835
           L + HS  I+H D+KPSN+ +++     + DF +A+   +E     T  +AT  Y APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE----MTGYVATRWYRAPEI 193
Query: 836 ---YGREGQVSIKGDVYNYGIMLMEVFTG 861
              +    Q     D+++ G ++ E+ TG
Sbjct: 194 MLNWMHYNQTV---DIWSVGCIMAELLTG 219

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 11/202 (5%)
Query: 666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEI---LKTIRHRN 721
           F   + +G GSYG V+K R   DG   A+K       G  +      E+    K  +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
            V++  +        L  E +   SL+    A   +L   Q  G + D   AL +LH   
Sbjct: 119 CVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--- 174
Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQ 841
           S  +VH D+KP+N+ L       L DFG+   L    + +  +      Y+APE   +G 
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPEL-LQGS 231
Query: 842 VSIKGDVYNYGIMLMEVFTGMK 863
                DV++ G+ ++EV   M+
Sbjct: 232 YGTAADVFSLGLTILEVACNME 253

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 18/209 (8%)
Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEILKTI------RHRNLV 723
           ++G GS+G V         E+ A+K+  L+++  +   D EC +++        +   L 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++ S     +    V+EY+  G L   MY     +  F+    +   A     L F  S 
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
            I++ D+K  NV+LD      ++DFG+ K  +  D +       T  YIAPE        
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAYQPYG 520
Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
              D + +G++L E+  G  P    F GE
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAP----FEGE 545

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 26/64 (40%), Positives = 39/64 (60%), Gaps = 4/64 (6%)
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--MKQTQTLATIGY 831
           LE +H  H + IVH D+KP+N L+ D M+  L DFGIA  +  +    +K +Q + T+ Y
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQ-VGTVNY 194
Query: 832 IAPE 835
           + PE
Sbjct: 195 MPPE 198

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 18/209 (8%)
Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEILKTI------RHRNLV 723
           ++G GS+G V         E+ A+K+  L+++  +   D EC +++        +   L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++ S     +    V+EY+  G   D MY     +  F+    +   A     L F  S 
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGG---DLMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
            I++ D+K  NV+LD      ++DFG+ K  +  D +       T  YIAPE        
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAYQPYG 199
Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
              D + +G++L E+  G  P    F GE
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAP----FEGE 224

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 10/150 (6%)
Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSL-EDCMYASNFNLDIFQRLGIMIDVASALEYL 777
           H N+VK+     +     LV+E +  G L E      +F+    +   IM  + SA+ ++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET--EASYIMRKLVSAVSHM 122
Query: 778 HFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           H      +VH D+KP N+L    +D++   + DFG A+L   ++   +T    T+ Y AP
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAP 178
Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           E   +       D+++ G++L  + +G  P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIR 718
           LR  +++     IG GS+G +Y G     G EVAIK+  ++ +        E +I K ++
Sbjct: 5   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQ 62
Query: 719 HRNLVKIISSC-TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
               +  I  C    ++  +V+E +   SLED     +    +   L +   + S +EY+
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 778 HFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAK 812
           H   S   +H D+KP N L+       + ++ DFG+AK
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIR 718
           LR  +++     IG GS+G +Y G     G EVAIK+  ++ +        E +I K ++
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQ 60
Query: 719 HRNLVKIISSC-TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
               +  I  C    ++  +V+E +   SLED     +    +   L +   + S +EY+
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 778 HFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAK 812
           H   S   +H D+KP N L+       + ++ DFG+AK
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 31/254 (12%)
Query: 662 ATDQFS---------EENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDAEC 711
           +TD FS         +E+++G G++  V          E A+K+   Q     +    E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 712 EILKTIR-HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDV 770
           E+L   + HRN++++I      +   LV E M  GS+   ++    + +  +   ++ DV
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDV 120
Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIA---KLLSEEDSMKQTQ 824
           ASAL++LH   +  I H D+KP N+L +         + DF +    KL  +   +   +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 825 TLATIG---YIAPE----YGREGQVSIK-GDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
            L   G   Y+APE    +  E  +  K  D+++ G++L  + +G  P       +    
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 877 RWINDSLPAVMNIM 890
           R   ++ PA  N++
Sbjct: 238 R--GEACPACQNML 249

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/63 (38%), Positives = 38/63 (60%), Gaps = 2/63 (3%)
Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA-KLLSEEDSMKQTQTLATIGYI 832
           LE +H  H + IVH D+KP+N L+ D M+  L DFGIA ++  +  S+ +   +  + Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 833 APE 835
            PE
Sbjct: 224 PPE 226

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAE-CEILKTIRHR------NL 722
            +IG GS+G V K  +   +   + +  ++ E   +   AE   IL+ +R +      N+
Sbjct: 103 KVIGKGSFGQVVKA-YDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASN----FNLDIFQRLGIMIDVASALEYLH 778
           + ++ + T  N   +  E +     E  +   N    F+L + ++        S L+ L 
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYE--LIKKNKFQGFSLPLVRKF-----AHSILQCLD 214
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLS--DFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
             H N I+HCD+KP N+LL     + +   DFG     S  +  +    + +  Y APE 
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS----SCYEHQRVYTXIQSRFYRAPEV 270
Query: 837 GREGQVSIKGDVYNYGIMLMEVFTG 861
               +  +  D+++ G +L E+ TG
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 78/180 (43%), Gaps = 29/180 (16%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLED------CMYASNFNLDIFQR 763
           E  ++K + H+N++ +++  T            P+ SLE+       M   + NL    +
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFT------------PQKSLEEFQDVYIVMELMDANLSQVIQ 120
Query: 764 LGIMIDVASALEY-----LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
           + +  +  S L Y     +   HS  I+H D+KPSN+++       + DFG+A+  +   
Sbjct: 121 MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGT 178
Query: 819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
           S   T  + T  Y APE           D+++ G+++ E+  G       F G   I +W
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 719 HRNLVKIISSCTNH-NFKALVLEYMPKGSLED------CMYASNFNLDIFQRLGIMIDVA 771
           +R LV  +  C NH N   L+  + P+ SLE+       M   + NL    ++ +  +  
Sbjct: 71  YRELV--LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 772 SALEY-----LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
           S L Y     +   HS  I+H D+KPSN+++       + DFG+A+  +   S   T  +
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYV 186
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
            T  Y APE           D+++ G ++ E+  G       F G   I +W
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 122/258 (47%), Gaps = 39/258 (15%)
Query: 669 ENLIGIGSYGSV-YKGRFPDGIEVAIKVFHLQR-EGALNSFDAECEIL-KTIRHRNLVKI 725
           E ++G GS G+V ++G F  G  VA+K   +   + AL     E ++L ++  H N+++ 
Sbjct: 38  EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIRY 92
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNF---NLDI---FQRLGIMIDVASALEYLHF 779
             S T   F  + LE +   +L+D + + N    NL +   +  + ++  +AS + +LH 
Sbjct: 93  YCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 150
Query: 780 GHSNPIVHCDIKPSNVLLDDS-------------MVAHLSDFGIAKLLSEEDSMKQT--- 823
             S  I+H D+KP N+L+  S             +   +SDFG+ K L       +    
Sbjct: 151 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 824 QTLATIGYIAPEYGREG---QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWI 879
               T G+ APE   E    +++   D+++ G +   + + G  P  + ++ E +I R I
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 268
Query: 880 NDSLPAVMNIMDTNLLSE 897
             SL  +  + D +L++E
Sbjct: 269 F-SLDEMKCLHDRSLIAE 285

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAE-CEILKTIRHR------NL 722
            +IG GS+G V K  +   +   + +  ++ E   +   AE   IL+ +R +      N+
Sbjct: 103 KVIGKGSFGQVVKA-YDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASN----FNLDIFQRLGIMIDVASALEYLH 778
           + ++ + T  N   +  E +     E  +   N    F+L + ++        S L+ L 
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYE--LIKKNKFQGFSLPLVRKF-----AHSILQCLD 214
Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLS--DFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
             H N I+HCD+KP N+LL     + +   DFG     S  +  +    + +  Y APE 
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS----SCYEHQRVYTXIQSRFYRAPEV 270
Query: 837 GREGQVSIKGDVYNYGIMLMEVFTG 861
               +  +  D+++ G +L E+ TG
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 78/180 (43%), Gaps = 29/180 (16%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLED------CMYASNFNLDIFQR 763
           E  ++K + H+N++ +++  T            P+ SLE+       M   + NL    +
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFT------------PQKSLEEFQDVYIVMELMDANLSQVIQ 120
Query: 764 LGIMIDVASALEY-----LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
           + +  +  S L Y     +   HS  I+H D+KPSN+++       + DFG+A+  +   
Sbjct: 121 MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGT 178
Query: 819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
           S   T  + T  Y APE           D+++ G+++ E+  G       F G   I +W
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 21/199 (10%)
Query: 688 GIEVAIKVFH--LQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN----FK--ALVL 739
           GI VA+K      Q +        E  +LK + H+N++ +++  T       F+   LV+
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD 799
           E M     +      +  LD  +   ++  +   +++LH   S  I+H D+KPSN+++  
Sbjct: 107 ELMDANLCQ----VIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 159
Query: 800 SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
                + DFG+A+  S    M  T  + T  Y APE           D+++ G ++ E+ 
Sbjct: 160 DCTLKILDFGLARTASTNFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 217
Query: 860 TGMKPTNEFFTGEMSIKRW 878
            G    +  F G   I +W
Sbjct: 218 KG----SVIFQGTDHIDQW 232

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 122/258 (47%), Gaps = 39/258 (15%)
Query: 669 ENLIGIGSYGSV-YKGRFPDGIEVAIKVFHLQR-EGALNSFDAECEIL-KTIRHRNLVKI 725
           E ++G GS G+V ++G F  G  VA+K   +   + AL     E ++L ++  H N+++ 
Sbjct: 38  EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIRY 92
Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNF---NLDI---FQRLGIMIDVASALEYLHF 779
             S T   F  + LE +   +L+D + + N    NL +   +  + ++  +AS + +LH 
Sbjct: 93  YCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 150
Query: 780 GHSNPIVHCDIKPSNVLLDDS-------------MVAHLSDFGIAKLLSEEDSMKQT--- 823
             S  I+H D+KP N+L+  S             +   +SDFG+ K L       +    
Sbjct: 151 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 824 QTLATIGYIAPEYGREG---QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWI 879
               T G+ APE   E    +++   D+++ G +   + + G  P  + ++ E +I R I
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 268
Query: 880 NDSLPAVMNIMDTNLLSE 897
             SL  +  + D +L++E
Sbjct: 269 F-SLDEMKCLHDRSLIAE 285

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 671 LIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIISS 728
           L+G G+Y  V       +G E A+K+   Q   + +    E E L   + ++N++++I  
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEF 79
Query: 729 CTNHNFKALVLEYMPKGS-LEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
             +     LV E +  GS L       +FN     R  ++ DVA+AL++LH   +  I H
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASR--VVRDVAAALDFLH---TKGIAH 134
Query: 788 CDIKPSNVLLDDS---MVAHLSDFGIAKLLSEEDSM------KQTQTLATIGYIAPEYGR 838
            D+KP N+L +         + DF +   +   +S       + T    +  Y+APE   
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 839 --EGQVSI---KGDVYNYGIMLMEVFTGMKP 864
               Q +    + D+++ G++L  + +G  P
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 719 HRNLVKIISSCTNH-NFKALVLEYMPKGSLED------CMYASNFNLDIFQRLGIMIDVA 771
           +R LV  +  C NH N   L+  + P+ SLE+       M   + NL    ++ +  +  
Sbjct: 71  YRELV--LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 772 SALEY-----LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
           S L Y     +   HS  I+H D+KPSN+++       + DFG+A+  +   S   T  +
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 186
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
            T  Y APE           D+++ G ++ E+  G       F G   I +W
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/254 (22%), Positives = 113/254 (44%), Gaps = 21/254 (8%)
Query: 686 PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP 743
           P G  V ++  +L+      +     E  + K   H N+V   ++    N   +V  +M 
Sbjct: 34  PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 93
Query: 744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVA 803
            GS +D +  ++F +D    L I   +   L+ L + H    VH  +K S++L+      
Sbjct: 94  YGSAKD-LICTHF-MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 151
Query: 804 HLSDFGIAKLLSEEDSMKQTQ--------TLATIGYIAPEYGREG--QVSIKGDVYNYGI 853
           +LS  G+   LS     ++ +        ++  + +++PE  ++       K D+Y+ GI
Sbjct: 152 YLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 209
Query: 854 MLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSV 913
              E+  G  P  +    +M +++ +N ++P    ++DT+ +   EE      +S A+S 
Sbjct: 210 TACELANGHVPFKDMPATQMLLEK-LNGTVPC---LLDTSTIPA-EELTMSPSRSVANSG 264
Query: 914 LSLAMECTSESPEN 927
           LS ++  ++  P N
Sbjct: 265 LSDSLTTSTPRPSN 278

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 11/158 (6%)
Query: 660 LRATDQFSEENLIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFDAECEILKTIR 718
           LR  +++     IG GS+G +Y G     G EVAIK+  ++ +        E +  K ++
Sbjct: 5   LRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHP--QLHIESKFYKMMQ 62
Query: 719 HRNLVKIISSC-TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
               +  I  C    ++  +V+E +   SLED     +    +   L +   + S +EY+
Sbjct: 63  GGVGIPSIKWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 778 HFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAK 812
           H   S   +H D+KP N L+       + ++ DFG+AK
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/254 (22%), Positives = 113/254 (44%), Gaps = 21/254 (8%)
Query: 686 PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP 743
           P G  V ++  +L+      +     E  + K   H N+V   ++    N   +V  +M 
Sbjct: 50  PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109
Query: 744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVA 803
            GS +D +  ++F +D    L I   +   L+ L + H    VH  +K S++L+      
Sbjct: 110 YGSAKD-LICTHF-MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 167
Query: 804 HLSDFGIAKLLSEEDSMKQTQ--------TLATIGYIAPEYGREG--QVSIKGDVYNYGI 853
           +LS  G+   LS     ++ +        ++  + +++PE  ++       K D+Y+ GI
Sbjct: 168 YLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 225
Query: 854 MLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSV 913
              E+  G  P  +    +M +++ +N ++P    ++DT+ +   EE      +S A+S 
Sbjct: 226 TACELANGHVPFKDMPATQMLLEK-LNGTVPC---LLDTSTIPA-EELTMSPSRSVANSG 280
Query: 914 LSLAMECTSESPEN 927
           LS ++  ++  P N
Sbjct: 281 LSDSLTTSTPRPSN 294

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 72/281 (25%), Positives = 113/281 (40%), Gaps = 52/281 (18%)
Query: 671 LIGIGSYGSVYKG-RFPDGIEVAIKVFHLQREGALNSFD------AECEILKTIR----H 719
           L+G G +G+V+ G R  D ++VAIKV    R    +          E  +L  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 720 RNLVKIISSCTNHNFKALVLEY-MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
             +++++          LVLE  +P   L D +       +   R      V +A+++ H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC-FFGQVVAAIQHCH 156
Query: 779 FGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY- 836
              S  +VH DIK  N+L+D     A L DFG   LL +E     T    T  Y  PE+ 
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWI 210
Query: 837 GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
            R    ++   V++ GI+L ++  G  P                          D  +L 
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFER-----------------------DQEIL- 246
Query: 897 EDEEH--ANVAKQSCASSVLSLAMECTSESPENRVNTKEII 935
           E E H  A+V+   CA     L   C +  P +R + +EI+
Sbjct: 247 EAELHFPAHVSPDCCA-----LIRRCLAPKPSSRPSLEEIL 282

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 719 HRNLVKIISSCTNH-NFKALVLEYMPKGSLED------CMYASNFNLDIFQRLGIMIDVA 771
           +R LV  +  C NH N   L+  + P+ SLE+       M   + NL    ++ +  +  
Sbjct: 71  YRELV--LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 772 SALEY-----LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
           S L Y     +   HS  I+H D+KPSN+++       + DFG+A+  +   S   T  +
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEV 186
Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
            T  Y APE           D+++ G ++ E+  G       F G   I +W
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 108/258 (41%), Gaps = 52/258 (20%)
Query: 666 FSEENLIGIGSYGSVY--KGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLV 723
           F  E+ IG G++ SVY    +   G E  I + HL          AE + L     ++ V
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNV 82
Query: 724 KIISSCTNHNFKALV-LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH-FGH 781
             +  C   N   ++ + Y+   S  D + + +F     +    M+++  AL+ +H FG 
Sbjct: 83  MGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQ----EVREYMLNLFKALKRIHQFG- 137
Query: 782 SNPIVHCDIKPSNVLLDDSMVAH-LSDFGIAK------------LLSEEDSMKQTQTLAT 828
              IVH D+KPSN L +  +  + L DFG+A+            + SE    + +Q   +
Sbjct: 138 ---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCS 194
Query: 829 I-----GYIAPEYG----REGQVSIKG-------DVYNYGIMLMEVFTGMKPTNEFFTGE 872
           I       +AP  G    R  +V  K        D+++ G++ + + +G  P   F+   
Sbjct: 195 ICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP---FYKA- 250
Query: 873 MSIKRWINDSLPAVMNIM 890
                  +D L A+  IM
Sbjct: 251 -------SDDLTALAQIM 261

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 47/193 (24%), Positives = 84/193 (43%), Gaps = 23/193 (11%)
Query: 710 ECEILKTIRHRNLVKIISSCTNHNFKA----LVLEYMPKGSL----EDCMYASNFNLDIF 761
           E ++ +   H N++++++ C           L+L +  +G+L    E      NF L   
Sbjct: 76  EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTED 134
Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFG-IAKLLSEEDSM 820
           Q L +++ +   LE +H   +    H D+KP+N+LL D     L D G + +     +  
Sbjct: 135 QILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191
Query: 821 KQTQTL-------ATIGYIAPE-YGREGQVSI--KGDVYNYGIMLMEVFTGMKPTNEFFT 870
           +Q  TL        TI Y APE +  +    I  + DV++ G +L  +  G  P +  F 
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251
Query: 871 GEMSIKRWINDSL 883
              S+   + + L
Sbjct: 252 KGDSVALAVQNQL 264

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 86/199 (43%), Gaps = 21/199 (10%)
Query: 688 GIEVAIKVFH--LQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN----FK--ALVL 739
           GI VA+K      Q +        E  +LK + H+N++ +++  T       F+   LV+
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD 799
           E M     +      +  LD  +   ++  +   +++LH   S  I+H D+KPSN+++  
Sbjct: 109 ELMDANLCQ----VIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 161
Query: 800 SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
                + DFG+A+       M  T  + T  Y APE       +   D+++ G ++ E+ 
Sbjct: 162 DCTLKILDFGLARTACTNFMM--TPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELV 219
Query: 860 TGMKPTNEFFTGEMSIKRW 878
            G       F G   I +W
Sbjct: 220 KGCV----IFQGTDHIDQW 234

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	952
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-160
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-136
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-97
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-71
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-35
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-96
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-94
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-84
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-73
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-40
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-95
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-59
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-47
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-28
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-83
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-83
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-69
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-59
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-32
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-79
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-59
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-46
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-77
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-27
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-24
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-75
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-73
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-62
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-26
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-18
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-62
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-55
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-55
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-54
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-54
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-52
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-37
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-52
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-52
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-50
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-29
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-07
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-52
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-51
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-50
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-38
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-20
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-50
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-48
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-47
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-40
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-04
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-48
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-48
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-48
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-44
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-42
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-39
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-30
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-36
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-27
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-24
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-41
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-40
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-36
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-40
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-40
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-25
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-21
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-38
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-31
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-37
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-18
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-36
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-33
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-36
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-33
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-17
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-36
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-25
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-23
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-35
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-31
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-31
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-31
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-33
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-30
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-34
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-34
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-33
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-33
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-33
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-33
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-32
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-28
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-28
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-24
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-32
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-32
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-31
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-31
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-31
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-19
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-29
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-29
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-14
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-31
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-31
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-31
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-31
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-31
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-30
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-30
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-14
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-30
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-30
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-29
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-26
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-22
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-18
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-27
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-26
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-26
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-25
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-25
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-25
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-24
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-07
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-25
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-25
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-24
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-23
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-23
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-23
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-15
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-21
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-21
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-11
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-13
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-07
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-05
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-10
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-07
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-11
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-13
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-13
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	9e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	9e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	8e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	9e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	8e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	4e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	8e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	7e-05
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	9e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	4e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	6e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  487 bits (1257), Expect = e-160
 Identities = 171/572 (29%), Positives = 253/572 (44%), Gaps = 44/572 (7%)

Query: 36  TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQG 95
             L IS   L+G     +   + L+ L +S N F G IP     L  L+ L L  NK  G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTG 283

Query: 96  EIPEEL-GNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGL 154
           EIP+ L G    L  L L+ N   G +P    + S +  +L  S N+ +G  P D    +
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL-ESLALSSNNFSGELPMDTLLKM 342

Query: 155 PRLKGLYVSYNQFKGPIPNNLWHCK-ELSSVSLSYNQFTGRLPRDLGNSTK--LKSLDLG 211
             LK L +S+N+F G +P +L +    L ++ LS N F+G +  +L  + K  L+ L L 
Sbjct: 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402

Query: 212 FNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSK 271
            N   G+IP  + N   L  L +  + L G +P ++ ++S L+ L L+ N L G +P   
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE- 461

Query: 272 NLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLT--FSTS 329
            L+ +  LE L L  N+L+G IPS            L   +NL  + L  N LT      
Sbjct: 462 -LMYVKTLETLILDFNDLTGEIPS-----------GLSNCTNLNWISLSNNRLTGEIPKW 509

Query: 330 ELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGP 389
                           IG L NL  L L +N+ SG++P  LG  + L  LDL  N F G 
Sbjct: 510 ----------------IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT 553

Query: 390 IPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSN--ELTSVIPSTFWNLED 447
           IP      S      +  N ++G     + +    +    + N  E   +       L  
Sbjct: 554 IPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLST 609

Query: 448 ILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQ 507
               + +S    G      +N  +++ + +S N LSG IP  I  +  L  L+L HN + 
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669

Query: 508 GPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANF 567
           G IP+  G+L  L  LDLS+N L G IP ++  L  L  ++LS N L G IP  G F  F
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729

Query: 568 SAESFIGNDLLCGSPYLHVPLCKSSPHKKSRK 599
               F+ N  LCG P        +  +   ++
Sbjct: 730 PPAKFLNNPGLCGYPLPRCDPSNADGYAHHQR 761

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  426 bits (1098), Expect = e-136
 Identities = 158/568 (27%), Positives = 249/568 (43%), Gaps = 72/568 (12%)

Query: 5   NPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLA---GTIPSHLGNLSSLQT 61
              N+L  +W+SN + C++ G+TC    ++VTS+ +S   L      + S L +L+ L++
Sbjct: 25  PDKNLLP-DWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81

Query: 62  LVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTI 121
           L LS +  +G++         L  L L  N L G +                        
Sbjct: 82  LFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTT---------------------- 118

Query: 122 PASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLW---HC 178
             S+ + S +   L+ S N+L           L  L+ L +S N   G           C
Sbjct: 119 LTSLGSCSGLKF-LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGC 177

Query: 179 KELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSN 238
            EL  +++S N+ +G +   +     L+ LD+  NN +  IP  +G+   L+ L I  + 
Sbjct: 178 GELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNK 234

Query: 239 LVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFF 298
           L G     I   + LK+L++ +N   G +P       L +L+ L+L  N  +G IP F  
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPLP----LKSLQYLSLAENKFTGEIPDFLS 290

Query: 299 NASKLYALELGYNSNLKRLGLERNYLT--FSTSELMSLFSALVNCKSLKIGNLINLTTLS 356
                     G    L  L L  N+                         G+   L +L+
Sbjct: 291 ----------GACDTLTGLDLSGNHFYGAVPPF----------------FGSCSLLESLA 324

Query: 357 LGDNNLSGSLPI-TLGRLKKLQGLDLQNNKFEGPIPQEFCHFS-RLYVVYLNRNKLSGSI 414
           L  NN SG LP+ TL +++ L+ LDL  N+F G +P+   + S  L  + L+ N  SG I
Sbjct: 325 LSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPI 384

Query: 415 PSCLGD--LNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAV 472
              L     N+L+ L L +N  T  IP T  N  +++    S N L+G++P  + +L  +
Sbjct: 385 LPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKL 444

Query: 473 VDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSG 532
            D+ L  N L G IP  ++ +K L+ L L+ N L G IP       +L ++ LSNN L+G
Sbjct: 445 RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG 504

Query: 533 VIPASLEKLLYLKSLNLSFNKLVGEIPR 560
            IP  + +L  L  L LS N   G IP 
Sbjct: 505 EIPKWIGRLENLAILKLSNNSFSGNIPA 532

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  111 bits (279), Expect = 4e-25
 Identities = 40/113 (35%), Positives = 63/113 (55%), Gaps = 1/113 (0%)

Query: 35  VTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQ 94
                I+     G       N  S+  L +S N  SG IPKEIG++  L  L+L +N + 
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669

Query: 95  GEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFP 147
           G IP+E+G+L  L +L L++N L G IP ++  L+ ++  +D S+N+L+G  P
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE-IDLSNNNLSGPIP 721

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  318 bits (817), Expect = 3e-97
 Identities = 102/588 (17%), Positives = 187/588 (31%), Gaps = 83/588 (14%)

Query: 13  NWTSNASVCSWM---GITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWF 69
           NW  N  +  W    G++ +  G RVT L++   G +G +P  +G L+ L+ L L  +  
Sbjct: 59  NWNFNKELDMWGAQPGVSLNSNG-RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117

Query: 70  SG----TIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLA--ELEMLVLNNNLLTGTIPA 123
                   PK I      ++        Q    +        +L    +N++    +I  
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177

Query: 124 SIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSS 183
           S        T +    N++T      +   L +L+  Y+  + F          C+   +
Sbjct: 178 SSRITLKD-TQIGQLSNNIT-FVSKAVM-RLTKLRQFYMGNSPFVAENI-----CEAWEN 229

Query: 184 VSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEIL--------GID 235
            +  Y Q          N   L  +++       ++P  +  L  ++++          +
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289

Query: 236 QSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPS 295
           Q                ++I+ +  N L    P   +L  +  L  L    N L G +P+
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPA 348

Query: 296 FFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTL 355
           F            G    L  L L  N +T   +                 G    +  L
Sbjct: 349 F------------GSEIKLASLNLAYNQITEIPANF--------------CGFTEQVENL 382

Query: 356 SLGDNNLSGSLPITL--GRLKKLQGLDLQNNKFEG-------PIPQEFCHFSRLYVVYLN 406
           S   N L   +P       +  +  +D   N+          P+         +  + L+
Sbjct: 383 SFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441

Query: 407 RNKLSGSIPSCLGDLNSLRILSLSSNELTSV-------IPSTFWNLEDILGFDFSSNSLN 459
            N++S          + L  ++L  N LT +           F N   +   D   N L 
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT 501

Query: 460 GSLPLEIE--NLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEH------NKLQGPIP 511
             L  +     L  +V I LS N+ S   P+  +    L+   + +      N+     P
Sbjct: 502 -KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559

Query: 512 ESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIP 559
           E      SL  L + +ND+  V          +  L++  N  +    
Sbjct: 560 EGITLCPSLTQLQIGSNDIRKVNEKITPN---ISVLDIKDNPNISIDL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  247 bits (633), Expect = 3e-71
 Identities = 76/535 (14%), Positives = 152/535 (28%), Gaps = 136/535 (25%)

Query: 48  TIPSHLGNLSSLQTLVLSRNWFSG-------------------TIPKEIGNLTKLKELHL 88
            +   +  L+ L+   +  + F                     T   +  NL  L ++ +
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV 256

Query: 89  DYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPY 148
                  ++P  L  L E++++ +  N           +   ++                
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALAD--------------- 300

Query: 149 DMCPGLPRLKGLYVSYNQFK-GPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKS 207
              P   +++ +Y+ YN  K  P+  +L   K+L  +   YNQ  G      G+  KL S
Sbjct: 301 --APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLAS 357

Query: 208 LDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNL 267
           L+L +N +        G    +E                         LS  +N L   +
Sbjct: 358 LNLAYNQITEIPANFCGFTEQVE------------------------NLSFAHNKLKY-I 392

Query: 268 PSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFS 327
           P+  +   +  +  ++   N +       F                              
Sbjct: 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT------------------------ 428

Query: 328 TSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFE 387
                                 IN+++++L +N +S            L  ++L  N   
Sbjct: 429 ------------------PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470

Query: 388 G-------PIPQEFCHFSRLYVVYLNRNKLSGSIPS-CLGDLNSLRILSLSSNELTSVIP 439
                      + F +   L  + L  NKL+          L  L  + LS N  +   P
Sbjct: 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FP 529

Query: 440 STFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHL 499
           +   N   + GF   +                        N      P  I    +L  L
Sbjct: 530 TQPLNSSTLKGFGIRNQ------------------RDAQGNRTLREWPEGITLCPSLTQL 571

Query: 500 SLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
            +  N ++  + E      ++  LD+ +N    +  + +   +      L ++K 
Sbjct: 572 QIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  142 bits (361), Expect = 2e-35
 Identities = 30/229 (13%), Positives = 75/229 (32%), Gaps = 12/229 (5%)

Query: 346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGP----IPQEFCHFSRLY 401
           + +   +T LSL     SG +P  +G+L +L+ L L ++  +       P+         
Sbjct: 77  LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136

Query: 402 VVYLNRNKLSGSIPSCLGDLN--SLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLN 459
                R     +        +   L    ++S+     I  +             SN++ 
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI- 195

Query: 460 GSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVS 519
             +   +  L  +   Y+  +                ++ + E+ +        +  L  
Sbjct: 196 TFVSKAVMRLTKLRQFYMGNSPFVAENICEA-----WENENSEYAQQYKTEDLKWDNLKD 250

Query: 520 LEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFS 568
           L  +++ N      +P  L+ L  ++ +N++ N+ +        +   +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  316 bits (811), Expect = 7e-96
 Identities = 127/567 (22%), Positives = 213/567 (37%), Gaps = 48/567 (8%)

Query: 45  LAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNL 104
           L+          ++L  L L  N               L  L L +N L          L
Sbjct: 85  LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144

Query: 105 AELEMLVLNNNLLTGTIPASIFNLSFIS-TALDFSDNSLTGSFPYDMCPGLPRLKGLYVS 163
             L+ L+L+NN +       +   +  S   L+ S N +    P      + RL GL+++
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP-GCFHAIGRLFGLFLN 203

Query: 164 YNQFKGPIPNNL---WHCKELSSVSLSYNQFTGRLPRDLGN--STKLKSLDLGFNNLNGE 218
             Q    +   L        + ++SLS +Q +            T L  LDL +NNLN  
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263

Query: 219 IPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSK------- 271
                  L  LE   ++ +N+      ++  +  ++ L+L  +    ++  +        
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323

Query: 272 NLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSEL 331
           +   L  LE LN+  N++ G   + F               NLK L L  ++ +  T   
Sbjct: 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTG-----------LINLKYLSLSNSFTSLRTLTN 372

Query: 332 MSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIP 391
              F +L +           L  L+L  N +S         L  L+ LDL  N+    + 
Sbjct: 373 -ETFVSLAH---------SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422

Query: 392 -QEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSV--IPSTFWNLEDI 448
            QE+     ++ +YL+ NK      +    + SL+ L L    L +V   PS F  L ++
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482

Query: 449 LGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLS--------GNIPSTIIGLKNLQHLS 500
              D S+N++       +E L+ +  + L  NNL+        G     + GL +L  L+
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542

Query: 501 LEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR 560
           LE N       E F +L  L+ +DL  N+L+ +  +     + LKSLNL  N +     +
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602

Query: 561 --GGAFANFSAESFIGNDLLCGSPYLH 585
             G AF N +      N   C    + 
Sbjct: 603 VFGPAFRNLTELDMRFNPFDCTCESIA 629

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  311 bits (799), Expect = 3e-94
 Identities = 118/547 (21%), Positives = 186/547 (34%), Gaps = 42/547 (7%)

Query: 35  VTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQ 94
           +T L ++   L     ++    S L +L +  N  S   P+    L  LK L+L +N+L 
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86

Query: 95  GEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGL 154
               +       L  L L +N +             + T LD S N L+ S        L
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT-LDLSHNGLS-STKLGTQVQL 144

Query: 155 PRLKGLYVSYNQFKGPIPNNL--WHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGF 212
             L+ L +S N+ +      L  +    L  + LS NQ     P       +L  L L  
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204

Query: 213 NNLNGEIPQEIG---NLRNLEILGIDQSNLVGFVPDTIFN--ISTLKILSLFNNTLSGNL 267
             L   + +++       ++  L +  S L      T      + L +L L  N L+   
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264

Query: 268 PSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFS 327
             S     LP LE   L  NN+             +  L L    +  +  +    L   
Sbjct: 265 NDS--FAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL--KRSFTKQSISLASLPKI 320

Query: 328 TSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFE 387
                                L  L  L++ DN++ G        L  L+ L L N+   
Sbjct: 321 DDFS--------------FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366

Query: 388 GPIPQE----FCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIP-STF 442
                         S L+++ L +NK+S         L  L +L L  NE+   +    +
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEW 426

Query: 443 WNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSG--NIPSTIIGLKNLQHLS 500
             LE+I     S N            + ++  + L R  L    + PS    L+NL  L 
Sbjct: 427 RGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486

Query: 501 LEHNKLQGPIPESFGELVSLEFLDLSNNDLS--------GVIPASLEKLLYLKSLNLSFN 552
           L +N +     +    L  LE LDL +N+L+        G     L+ L +L  LNL  N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546

Query: 553 KLVGEIP 559
                  
Sbjct: 547 GFDEIPV 553

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  285 bits (732), Expect = 1e-84
 Identities = 107/550 (19%), Positives = 189/550 (34%), Gaps = 51/550 (9%)

Query: 36  TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIG--NLTKLKELHLDYNKL 93
            +L +S  GL+ T       L +LQ L+LS N       +E+     + LK+L L  N++
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183

Query: 94  QGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIS--TALDFSDNSLTGSFPYDMC 151
           +   P     +  L  L LNN  L  ++   +      +    L  S++ L+ +      
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243

Query: 152 P-GLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDL 210
                 L  L +SYN       ++     +L    L YN         L     ++ L+L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303

Query: 211 G---------FNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNN 261
                       +L          L+ LE L ++ +++ G   +    +  LK LSL N+
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363

Query: 262 TLSGNLPSSKNLIGLPN--LEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGL 319
             S    +++  + L +  L  LNL  N +S      F               +L+ L L
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW-----------LGHLEVLDL 412

Query: 320 ERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGL 379
             N +    +                   L N+  + L  N        +   +  LQ L
Sbjct: 413 GLNEIGQELTGQE-------------WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459

Query: 380 DLQNNKFEG--PIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSV 437
            L+    +     P  F     L ++ L+ N ++      L  L  L IL L  N L  +
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519

Query: 438 --------IPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPST 489
                          L  +   +  SN  +       ++L  +  I L  NNL+    S 
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579

Query: 490 IIGLKNLQHLSLEHNKLQGPIPESFGE-LVSLEFLDLSNNDLSGVIPASLEKLLYLKSLN 548
                +L+ L+L+ N +     + FG    +L  LD+  N       +    + ++   +
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETH 639

Query: 549 LSFNKLVGEI 558
            +  +L    
Sbjct: 640 TNIPELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  254 bits (650), Expect = 4e-73
 Identities = 95/480 (19%), Positives = 161/480 (33%), Gaps = 47/480 (9%)

Query: 106 ELEMLVLNNNLLTGTIPASIF-NLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSY 164
             E+   ++  LT  +P  +  N+    T L+ + N L      +      +L  L V +
Sbjct: 5   SHEVADCSHLKLT-QVPDDLPTNI----TVLNLTHNQLRRLPAANF-TRYSQLTSLDVGF 58

Query: 165 NQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIG 224
           N      P        L  ++L +N+ +    +     T L  L L  N++         
Sbjct: 59  NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118

Query: 225 NLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNL 284
             +NL  L +  + L      T   +  L+ L L NN +        ++    +L+ L L
Sbjct: 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178

Query: 285 GLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSL 344
             N +    P  F    +L+ L L                    S    L   L      
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQ-------------LGPSLTEKLCLEL------ 219

Query: 345 KIGNLINLTTLSLGDNNLSGSLPITLGRLK--KLQGLDLQNNKFEGPIPQEFCHFSRLYV 402
                 ++  LSL ++ LS +   T   LK   L  LDL  N         F    +L  
Sbjct: 220 ---ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEY 276

Query: 403 VYLNRNKLSGSIPSCLGDLNSLRILSLSSN---------ELTSVIPSTFWNLEDILGFDF 453
            +L  N +       L  L ++R L+L  +          L  +   +F  L+ +   + 
Sbjct: 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336

Query: 454 SSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTII----GLKNLQHLSLEHNKLQGP 509
             N + G        L  +  + LS +  S    +           L  L+L  NK+   
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKI 396

Query: 510 IPESFGELVSLEFLDLSNNDLSGVIPAS-LEKLLYLKSLNLSFNKLVGEIPRGGAFANFS 568
             ++F  L  LE LDL  N++   +       L  +  + LS+NK +       +FA   
Sbjct: 397 ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR--NSFALVP 454

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  159 bits (403), Expect = 1e-40
 Identities = 52/214 (24%), Positives = 88/214 (41%), Gaps = 5/214 (2%)

Query: 350 INLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNK 409
           ++          L+  +P  L     +  L+L +N+        F  +S+L  + +  N 
Sbjct: 4   VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 410 LSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENL 469
           +S   P     L  L++L+L  NEL+ +   TF    ++      SNS+           
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 470 KAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFG--ELVSLEFLDLSN 527
           K ++ + LS N LS     T + L+NLQ L L +NK+Q    E        SL+ L+LS+
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 528 NDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG 561
           N +    P     +  L  L L+  +L   +   
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 93.1 bits (232), Expect = 1e-19
 Identities = 35/187 (18%), Positives = 62/187 (33%), Gaps = 14/187 (7%)

Query: 36  TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRN--------WFSGTIPKEIGNLTKLKELH 87
           T L +S+  +A      L  L  L+ L L  N           G     +  L+ L  L+
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542

Query: 88  LDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFP 147
           L+ N       E   +L EL+++ L  N L     +   N   +  +L+   N +T    
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSL-KSLNLQKNLITSVEK 601

Query: 148 YDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSY----NQFTGRLPRDLGNST 203
               P    L  L + +N F     +  W    ++    +     + +    P       
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHG-F 660

Query: 204 KLKSLDL 210
            ++  D 
Sbjct: 661 PVRLFDT 667

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 67.7 bits (166), Expect = 1e-11
 Identities = 21/131 (16%), Positives = 42/131 (32%), Gaps = 5/131 (3%)

Query: 34  RVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKL 93
            +  L +   G          +L  L+ + L  N  +        N   LK L+L  N +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596

Query: 94  QGEIPEELG-NLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCP 152
                +  G     L  L +  N    T      ++++    ++ +  ++     + +C 
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCE----SIAWFVNWINETHTNIPELSSHYLCN 652

Query: 153 GLPRLKGLYVS 163
             P   G  V 
Sbjct: 653 TPPHYHGFPVR 663

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  311 bits (798), Expect = 8e-95
 Identities = 111/545 (20%), Positives = 183/545 (33%), Gaps = 30/545 (5%)

Query: 33  NRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNK 92
               +L +S   L         +   LQ L LSR            +L+ L  L L  N 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 93  LQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCP 152
           +Q         L+ L+ LV     L       I +L  +   L+ + N +      +   
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE-LNVAHNLIQSFKLPEYFS 146

Query: 153 GLPRLKGLYVSYNQFKGPIPNNLWHCKELS----SVSLSYNQFTGRLPRDLGNSTKLKSL 208
            L  L+ L +S N+ +     +L    ++     S+ LS N     +        +L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKL 205

Query: 209 DLGFNNLNGEIPQE-IGNLRNLEILGI------DQSNLVGFVPDTIFNISTLKILSLFNN 261
            L  N  +  + +  I  L  LE+  +      ++ NL  F    +  +  L I      
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 262 TLSGNLPSSKNLI-GLPNLEGLNLGLNNLSGSIP-SFFFNASKLYALELGYNSNLKRLGL 319
            L   L    +L   L N+   +L    +      S+ F    L  +   +         
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325

Query: 320 ERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLS--GSLPITLGRLKKLQ 377
               LTF++++  + FS           +L +L  L L  N LS  G    +      L+
Sbjct: 326 SLKRLTFTSNKGGNAFS---------EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376

Query: 378 GLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIP-SCLGDLNSLRILSLSSNELTS 436
            LDL  N     +   F    +L  +    + L      S    L +L  L +S      
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435

Query: 437 VIPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRNNLSGNIPSTIIGLKN 495
                F  L  +     + NS   +   +I   L+ +  + LS+  L    P+    L +
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495

Query: 496 LQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLY-LKSLNLSFNKL 554
           LQ L++ HN         +  L SL+ LD S N +       L+     L  LNL+ N  
Sbjct: 496 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555

Query: 555 VGEIP 559
                
Sbjct: 556 ACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  213 bits (544), Expect = 3e-59
 Identities = 83/456 (18%), Positives = 156/456 (34%), Gaps = 46/456 (10%)

Query: 136 DFSDNSLTGSFPYDMCPGLPR-LKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGR 194
              + +     P      LP   K L +S+N  +     + +   EL  + LS  +    
Sbjct: 13  QCMELNFY-KIP----DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67

Query: 195 LPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLK 254
                 + + L +L L  N +          L +L+ L   ++NL       I ++ TLK
Sbjct: 68  EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127

Query: 255 ILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKL----YALELGY 310
            L++ +N +       +    L NLE L+L  N +     +      ++     +L+L  
Sbjct: 128 ELNVAHNLIQS-FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 311 NS------------NLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLG 358
           N              L +L L  N+ + +  +  +    L   +  ++            
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMK--TCIQGLAGLEVHRLVLGEF-----RN 239

Query: 359 DNNLSGSLPITLGRLKKLQGLDLQ---NNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIP 415
           + NL       L  L  L   + +    + +   I   F   + +    L    +     
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299

Query: 416 SCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDI 475
                    + L L + +          +L+ +    F+SN    +      +L ++  +
Sbjct: 300 --FSYNFGWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNAFSE--VDLPSLEFL 352

Query: 476 YLSRNNLS--GNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGV 533
            LSRN LS  G    +  G  +L++L L  N +   +  +F  L  LE LD  +++L  +
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM 411

Query: 534 IPAS-LEKLLYLKSLNLSFNKLVGEIPRGGAFANFS 568
              S    L  L  L++S           G F   S
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFN--GIFNGLS 445

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  178 bits (453), Expect = 2e-47
 Identities = 78/436 (17%), Positives = 131/436 (30%), Gaps = 55/436 (12%)

Query: 48  TIPSHLGNLSSLQTLVLSRNWFSGTIPKE-IGNLTKLKELHLDYNKLQGE------IPEE 100
            I         L  L L  N+ S  + K  I  L  L+   L   + + E          
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 101 LGNLAELEMLVLN---NNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRL 157
           L  L  L +        +     I      L+ +S+       ++     +         
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS-FSLVSVTIERVKDF---SYNFGW 306

Query: 158 KGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLN- 216
           + L +   +F       L   K      L++    G       +   L+ LDL  N L+ 
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLK-----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361

Query: 217 -GEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIG 275
            G   Q      +L+ L +   N V  +      +  L+ L   ++ L      S   + 
Sbjct: 362 KGCCSQSDFGTTSLKYLDL-SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFS-VFLS 419

Query: 276 LPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN--------------SNLKRLGLER 321
           L NL  L++   +   +    F   S L  L++  N               NL  L L +
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479

Query: 322 NYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDL 381
             L   +                   +L +L  L++  NN           L  LQ LD 
Sbjct: 480 CQLEQLSPTA--------------FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 525

Query: 382 QNNKFEGPIPQEFCH-FSRLYVVYLNRNKLSGSIPSC--LGDLNSLRILSLSSNELTSVI 438
             N       QE  H  S L  + L +N  + +      L  +   R L +    +    
Sbjct: 526 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECAT 585

Query: 439 PSTFWNLEDILGFDFS 454
           PS    +  +L  + +
Sbjct: 586 PSDKQGM-PVLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  118 bits (299), Expect = 7e-28
 Identities = 34/159 (21%), Positives = 60/159 (37%), Gaps = 4/159 (2%)

Query: 402 VVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGS 461
                       IP  L    S + L LS N L  +   +F++  ++   D S   +   
Sbjct: 11  TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67

Query: 462 LPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLE 521
                ++L  +  + L+ N +         GL +LQ L      L        G L +L+
Sbjct: 68  EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127

Query: 522 FLDLSNNDLSGV-IPASLEKLLYLKSLNLSFNKLVGEIP 559
            L++++N +    +P     L  L+ L+LS NK+     
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 81.6 bits (202), Expect = 5e-16
 Identities = 22/157 (14%), Positives = 54/157 (34%), Gaps = 6/157 (3%)

Query: 36  TSLTISDLG---LAGTIPSH-LGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYN 91
           +SL +  +                L +L  L LS+       P    +L+ L+ L++ +N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504

Query: 92  KLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFP-YDM 150
                       L  L++L  + N +  +    + +       L+ + N    +      
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 564

Query: 151 CPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLS 187
              +   + L V   + +   P++      + S++++
Sbjct: 565 LQWIKDQRQLLVEVERMECATPSDKQG-MPVLSLNIT 600

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  287 bits (735), Expect = 2e-83
 Identities = 96/617 (15%), Positives = 192/617 (31%), Gaps = 84/617 (13%)

Query: 13  NWTSNASVCSWMGITCDVYGN--RVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFS 70
           NW  N  +  W         N  RVT L+++  G  G +P  +G L+ L+ L    +  +
Sbjct: 301 NWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSET 360

Query: 71  GTIPKEIGNLTKLKELHLDYNKLQGEIPEE-LGNLAELEMLVLNNNLLT-----GTIPAS 124
            +                  ++++    +  L     L +  L  + +        I   
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420

Query: 125 IFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSV 184
              +S   T +    N +T      +   L +L+ +Y + + F            +    
Sbjct: 421 SR-ISLKDTQIGNLTNRIT-FISKAIQ-RLTKLQIIYFANSPFTYDNI-----AVDWEDA 472

Query: 185 SLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGF-- 242
           +  Y +          N   L  ++L       ++P  + +L  L+ L I  +  +    
Sbjct: 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532

Query: 243 -------VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPS 295
                  + D       ++I  +  N L    P+S +L  +  L  L+   N +   + +
Sbjct: 533 LKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HLEA 590

Query: 296 FFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTL 355
           F            G N  L  L L+ N +     +  +                  +  L
Sbjct: 591 F------------GTNVKLTDLKLDYNQIEEIPEDFCA--------------FTDQVEGL 624

Query: 356 SLGDNNLSGSLP--ITLGRLKKLQGLDLQNNKFEGPIPQEFC-----HFSRLYVVYLNRN 408
               N L   +P       +  +  +D   NK         C            V L+ N
Sbjct: 625 GFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683

Query: 409 KLSGSIPSCLGDLNSLRILSLSSNELTSV-------IPSTFWNLEDILGFDFSSNSLNGS 461
           ++           + +  + LS+N +TS+           + N   +   D   N L  S
Sbjct: 684 EIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-S 742

Query: 462 LPLEIE--NLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEH------NKLQGPIPES 513
           L  +     L  + ++ +S N  S   P+  +    L+   + H      N++    P  
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801

Query: 514 FGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL-VGEIPRGGAFANFSAESF 572
                SL  L + +ND+  V      +   L  L+++ N     ++     +        
Sbjct: 802 ITTCPSLIQLQIGSNDIRKVDEKLTPQ---LYILDIADNPNISIDVTSVCPYIEAGMYVL 858

Query: 573 IGND--LLCGSPYLHVP 587
           + +    + G   L + 
Sbjct: 859 LYDKTQDIRGCDALGIE 875

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  270 bits (694), Expect = 2e-83
 Identities = 78/239 (32%), Positives = 115/239 (48%), Gaps = 4/239 (1%)

Query: 346 IGNLINLTTLSLGD-NNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVY 404
           + NL  L  L +G  NNL G +P  + +L +L  L + +    G IP        L  + 
Sbjct: 72  LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131

Query: 405 LNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDIL-GFDFSSNSLNGSLP 463
            + N LSG++P  +  L +L  ++   N ++  IP ++ +   +      S N L G +P
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191

Query: 464 LEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFL 523
               NL  +  + LSRN L G+        KN Q + L  N L   +    G   +L  L
Sbjct: 192 PTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGL 249

Query: 524 DLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSP 582
           DL NN + G +P  L +L +L SLN+SFN L GEIP+GG    F   ++  N  LCGSP
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  230 bits (590), Expect = 7e-69
 Identities = 72/287 (25%), Positives = 114/287 (39%), Gaps = 33/287 (11%)

Query: 4   DNPNNILAQNWTSNASVCSWMGITCDVYGN--RVTSLTISDLGLAGT------------- 48
            NP  + +   T++    +W+G+ CD      RV +L +S L L                
Sbjct: 19  GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78

Query: 49  --------------IPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQ 94
                         IP  +  L+ L  L ++    SG IP  +  +  L  L   YN L 
Sbjct: 79  NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS 138

Query: 95  GEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGL 154
           G +P  + +L  L  +  + N ++G IP S  + S + T++  S N LTG  P       
Sbjct: 139 GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF--AN 196

Query: 155 PRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNN 214
             L  + +S N  +G         K    + L+ N     L   +G S  L  LDL  N 
Sbjct: 197 LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNR 255

Query: 215 LNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNN 261
           + G +PQ +  L+ L  L +  +NL G +P    N+    + +  NN
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  204 bits (522), Expect = 2e-59
 Identities = 74/351 (21%), Positives = 124/351 (35%), Gaps = 62/351 (17%)

Query: 121 IPASIFNLSFIS---TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG--PIPNNL 175
           I   + N + +S      D  + +  G    D      R+  L +S        PIP++L
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLC-DTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 176 WHCKELSSVSLS-YNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGI 234
            +   L+ + +   N   G +P  +   T+L  L +   N++G IP  +  ++ L  L  
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 235 DQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNL-EGLNLGLNNLSGSI 293
             + L G +P +I ++  L  ++   N +SG +P S        L   + +  N L+G I
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS--YGSFSKLFTSMTISRNRLTGKI 190

Query: 294 PSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLT 353
           P                                                     NL NL 
Sbjct: 191 PPT-------------------------------------------------FANL-NLA 200

Query: 354 TLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGS 413
            + L  N L G   +  G  K  Q + L  N     +  +      L  + L  N++ G+
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGT 259

Query: 414 IPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPL 464
           +P  L  L  L  L++S N L   IP    NL+      +++N      PL
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCGSPL 309

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  125 bits (317), Expect = 8e-32
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 7/155 (4%)

Query: 413 SIPSCLGDLNSLR----ILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGS--LPLEI 466
            I   LG+  +L          +     V+  T      +   D S  +L     +P  +
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 467 ENLKAVVDIYLS-RNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDL 525
            NL  +  +Y+   NNL G IP  I  L  L +L + H  + G IP+   ++ +L  LD 
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 526 SNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR 560
           S N LSG +P S+  L  L  +    N++ G IP 
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  267 bits (685), Expect = 9e-79
 Identities = 108/585 (18%), Positives = 192/585 (32%), Gaps = 57/585 (9%)

Query: 20  VCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGN 79
           +   +  T +     +             IP  L   +S + L  S N            
Sbjct: 9   IEKEVNKTYNCENLGLNE-----------IPGTL--PNSTECLEFSFNVLPTIQNTTFSR 55

Query: 80  LTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSD 139
           L  L  L L   ++     +   +   L+ LVL  N L      ++     +   L F  
Sbjct: 56  LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKH-LFFIQ 114

Query: 140 NSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDL 199
             ++ S  +        L+ LY+  N          +  ++L  +    N        D+
Sbjct: 115 TGIS-SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173

Query: 200 GNSTKLKSLDLGFNNLN-GEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFN--ISTLKIL 256
            +  +  +L L  N  +   I     +    + L    +  +  +   + N  I +L + 
Sbjct: 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233

Query: 257 SLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN----- 311
           +  +       P+    +   ++E +NL  +       + F   S L  L+L        
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL 293

Query: 312 -------SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSG 364
                  S LK+L L  N                         N  +LT LS+  N    
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQIS--------------ASNFPSLTHLSIKGNTKRL 339

Query: 365 SL-PITLGRLKKLQGLDLQNNKFE--GPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDL 421
            L    L  L+ L+ LDL ++  E       +  + S L  + L+ N+          + 
Sbjct: 340 ELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC 399

Query: 422 NSLRILSLSSNELTSVIP-STFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRN 480
             L +L L+   L      S F NL  +   + S + L+ S     + L A+  + L  N
Sbjct: 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN 459

Query: 481 NLSGNI---PSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPAS 537
           +         +++  L  L+ L L    L      +F  L  +  +DLS+N L+     +
Sbjct: 460 HFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519

Query: 538 LEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFI---GNDLLC 579
           L  L  +  LNL+ N +   +P        S +  I    N L C
Sbjct: 520 LSHLKGIY-LNLASNHISIILP--SLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  213 bits (545), Expect = 2e-59
 Identities = 84/450 (18%), Positives = 146/450 (32%), Gaps = 39/450 (8%)

Query: 34  RVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKL 93
            + SL +    ++            L+ L    N       +++ +L +   L L+ N  
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189

Query: 94  Q-GEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIS-TALDFSDNSLTGSFPYDMC 151
               I     + A  + L          I   + N +  S     F D          + 
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE-DISPAVF 248

Query: 152 PGLPR--LKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLD 209
            GL    ++ + +  + F     N       L  + L+    +  LP  L   + LK L 
Sbjct: 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLV 307

Query: 210 LGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIF-NISTLKILSLFNNTLSGNLP 268
           L  N           N  +L  L I  +     +      N+  L+ L L ++ +  +  
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC 367

Query: 269 SSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN--------------SNL 314
            +  L  L +L+ LNL  N         F    +L  L+L +                 L
Sbjct: 368 CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427

Query: 315 KRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPI---TLG 371
           K L L  + L  S+ +L                 L  L  L+L  N+          +L 
Sbjct: 428 KVLNLSHSLLDISSEQL--------------FDGLPALQHLNLQGNHFPKGNIQKTNSLQ 473

Query: 372 RLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSS 431
            L +L+ L L            F     +  V L+ N+L+ S    L  L  +  L+L+S
Sbjct: 474 TLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLAS 532

Query: 432 NELTSVIPSTFWNLEDILGFDFSSNSLNGS 461
           N ++ ++PS    L      +   N L+ +
Sbjct: 533 NHISIILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  175 bits (446), Expect = 2e-46
 Identities = 81/436 (18%), Positives = 141/436 (32%), Gaps = 40/436 (9%)

Query: 32  GNRVTSLTISDLGLAGTIPSHLGN--LSSLQTLVLSRNWFSGTIPKEIGNLTK--LKELH 87
                SL          I   L N  + SL              P     L +  ++ ++
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260

Query: 88  LDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFP 147
           L  +             + L+ L L    L+  +P+ +  LS +   L  S N       
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKK-LVLSANKFEN-LC 317

Query: 148 YDMCPGLPRLKGLYVSYNQFKGPIPNN-LWHCKELSSVSLSYNQFT--GRLPRDLGNSTK 204
                  P L  L +  N  +  +    L + + L  + LS++           L N + 
Sbjct: 318 QISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSH 377

Query: 205 LKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIF-NISTLKILSLFNNTL 263
           L+SL+L +N       +       LE+L +  + L      + F N+  LK+L+L ++ L
Sbjct: 378 LQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437

Query: 264 SGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNY 323
             +        GLP L+ LNL  N+          +   L          L+ L L    
Sbjct: 438 DISSEQL--FDGLPALQHLNLQGNHFPKGNIQKTNSLQTL--------GRLEILVLSFCD 487

Query: 324 LTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQN 383
           L+                      +L  +  + L  N L+ S    L  LK +  L+L +
Sbjct: 488 LSSIDQHA--------------FTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLAS 532

Query: 384 NKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFW 443
           N     +P      S+   + L +N L  +          L     +  +L     +   
Sbjct: 533 NHISIILPSLLPILSQQRTINLRQNPLDCTCS--NIYF--LEWYKENMQKLEDTEDTLCE 588

Query: 444 NLEDILGFDFSSNSLN 459
           N   + G   S  +L+
Sbjct: 589 NPPLLRGVRLSDVTLS 604

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  264 bits (677), Expect = 1e-77
 Identities = 112/535 (20%), Positives = 168/535 (31%), Gaps = 46/535 (8%)

Query: 45  LAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNL 104
           L         N S LQ L LSR        K    L  L  L L  N +Q   P     L
Sbjct: 44  LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL 103

Query: 105 AELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSY 164
             LE LV     L       I  L  +   L+ + N +           L  L  + +SY
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKK-LNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162

Query: 165 NQFKGPIPNNLWHCKELSSV----SLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIP 220
           N  +    N+L   +E   V     +S N     +        KL  L L  N  +  I 
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIM 221

Query: 221 QE-IGNLRNLEILGIDQSNLVGFVPDTIFNIST---LKILSLFNNTLSGNLPSSKNLI-- 274
           +  + NL  L +  +            IF  S    L  +++    L+     S +++  
Sbjct: 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF 281

Query: 275 -GLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN----------SNLKRLGLERNY 323
             L N+  ++L   ++   +     +  K  +L +               LK L L  N 
Sbjct: 282 HCLANVSAMSLAGVSIK-YLEDVPKH-FKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNK 339

Query: 324 LTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLK--KLQGLDL 381
            + S                     L +L+ L L  N LS S   +   L    L+ LDL
Sbjct: 340 GSISFK----------------KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383

Query: 382 QNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIP-SCLGDLNSLRILSLSSNELTSVIPS 440
             N     +   F     L  +    + L      S    L  L  L +S          
Sbjct: 384 SFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442

Query: 441 TFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHL 499
            F  L  +     + NS   +    +  N   +  + LS+  L          L  LQ L
Sbjct: 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502

Query: 500 SLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
           ++ HN L       + +L SL  LD S N +             L   NL+ N +
Sbjct: 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  117 bits (296), Expect = 2e-27
 Identities = 47/221 (21%), Positives = 79/221 (35%), Gaps = 34/221 (15%)

Query: 353 TTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSG 412
            T    D  LS  +P  +      + +DL  N  +      F +FS L  + L+R ++  
Sbjct: 14  ITYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70

Query: 413 SIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAV 472
                   L+ L  L L+ N + S  P +F  L                      +L+  
Sbjct: 71  IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLT---------------------SLE-- 107

Query: 473 VDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQG-PIPESFGELVSLEFLDLSNNDLS 531
            ++      L+      I  L  L+ L++ HN +    +P  F  L +L  +DLS N + 
Sbjct: 108 -NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166

Query: 532 GVIPASLEKL----LYLKSLNLSFNKLVGEIPRGGAFANFS 568
            +    L+ L        SL++S N +        AF    
Sbjct: 167 TITVNDLQFLRENPQVNLSLDMSLNPIDFIQD--QAFQGIK 205

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  108 bits (272), Expect = 2e-24
 Identities = 38/157 (24%), Positives = 64/157 (40%), Gaps = 5/157 (3%)

Query: 412 GSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKA 471
           GS+  C+  + ++        +L+ V      + ++I   D S N L         N   
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLSKVPDDIPSSTKNI---DLSFNPLKILKSYSFSNFSE 57

Query: 472 VVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLS 531
           +  + LSR  +         GL +L +L L  N +Q   P SF  L SLE L      L+
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 532 GVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFS 568
            +    + +L+ LK LN++ N +         F+N +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLT 153

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  249 bits (637), Expect = 2e-75
 Identities = 93/297 (31%), Positives = 148/297 (49%), Gaps = 23/297 (7%)

Query: 652 RRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAEC 711
            R    +L  AT+ F  + LIG G +G VYKG   DG +VA+K    +    +  F+ E 
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 712 EILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFN---LDIFQRLGIMI 768
           E L   RH +LV +I  C   N   L+ +YM  G+L+  +Y S+     +   QRL I I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED----SMKQTQ 824
             A  L YL   H+  I+H D+K  N+LLD++ V  ++DFGI+K  +E D    S   T 
Sbjct: 147 GAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS---TV 200

Query: 825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNE-FFTGEMSIKRWINDSL 883
              T+GYI PEY  +G+++ K DVY++G++L EV        +      +++  W  +S 
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260

Query: 884 PA--VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
               +  I+D NL  +        +          A++C + S E+R +  +++ +L
Sbjct: 261 NNGQLEQIVDPNLADK-------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  244 bits (624), Expect = 2e-73
 Identities = 99/290 (34%), Positives = 150/290 (51%), Gaps = 22/290 (7%)

Query: 651 WRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE---GALNSF 707
            +R+S  EL  A+D FS +N++G G +G VYKGR  DG  VA+K   L+ E   G    F
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR--LKEERTQGGELQF 74

Query: 708 DAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY---ASNFNLDIFQRL 764
             E E++    HRNL+++   C     + LV  YM  GS+  C+     S   LD  +R 
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134

Query: 765 GIMIDVASALEYLHFGHSNP-IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
            I +  A  L YLH  H +P I+H D+K +N+LLD+   A + DFG+AKL+  +D+   T
Sbjct: 135 RIALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193

Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTN-EFFTGEMSIK--RWIN 880
               TIG+IAPEY   G+ S K DV+ YG+ML+E+ TG +  +      +  +    W+ 
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253

Query: 881 DSLP--AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR 928
             L    +  ++D +L    ++            ++ +A+ CT  SP  R
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEE-------VEQLIQVALLCTQSSPMER 296

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  221 bits (566), Expect = 1e-62
 Identities = 124/550 (22%), Positives = 203/550 (36%), Gaps = 68/550 (12%)

Query: 41  SDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEE 100
            +L     IP +L    S + L LS N           +  +L+ L L   ++Q      
Sbjct: 15  MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71

Query: 101 LGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGL 160
             +L+ L  L+L  N +  ++    F+                         GL  L+ L
Sbjct: 72  YQSLSHLSTLILTGNPIQ-SLALGAFS-------------------------GLSSLQKL 105

Query: 161 YVSYNQFKGPIPNNLWHCKELSSVSLSYNQFT-GRLPRDLGNSTKLKSLDLGFNNLNGEI 219
                         + H K L  +++++N     +LP    N T L+ LDL  N +    
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165

Query: 220 PQEIGNLRNLEILGID---QSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGL 276
             ++  L  + +L +      N + F+    F    L  L+L NN  S N+     + GL
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVM-KTCIQGL 224

Query: 277 PNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLER---NYLTFSTSELMS 333
             LE   L L          F N   L   +      L  L +E     YL +   +++ 
Sbjct: 225 AGLEVHRLVLGE--------FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276

Query: 334 LFSALVNCKSLKIGNL-----------INLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQ 382
           LF+ L N  S  + ++                L L +            +LK L+ L   
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ---FPTLKLKSLKRLTFT 333

Query: 383 NNKFEGPIPQEFCHFSRLYVVYLNRNKLS--GSIPSCLGDLNSLRILSLSSNELTSVIPS 440
           +NK              L  + L+RN LS  G          SL+ L LS N + + + S
Sbjct: 334 SNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSS 390

Query: 441 TFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHL 499
            F  LE +   DF  ++L       +  +L+ ++ + +S  +          GL +L+ L
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450

Query: 500 SLEHNKLQGPI-PESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEI 558
            +  N  Q    P+ F EL +L FLDLS   L  + P +   L  L+ LN++ N+L   +
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SV 509

Query: 559 PRGGAFANFS 568
           P  G F   +
Sbjct: 510 PD-GIFDRLT 518

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  160 bits (406), Expect = 2e-41
 Identities = 82/446 (18%), Positives = 157/446 (35%), Gaps = 46/446 (10%)

Query: 133 TALDFSDNSLTGSFPYDMCPGLPR-LKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQF 191
                 + +     P      LP   K L +S+N  +     + +   EL  + LS  + 
Sbjct: 10  ITYQCMELNFY-KIP----DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI 64

Query: 192 TGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNIS 251
                    + + L +L L  N +          L +L+ L   ++NL       I ++ 
Sbjct: 65  QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124

Query: 252 TLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKL----YALE 307
           TLK L++ +N +  +    +    L NLE L+L  N +     +      ++     +L+
Sbjct: 125 TLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183

Query: 308 LGYNS------------NLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTL 355
           L  N              L +L L  N+ + +  +  +    L     L++  L+     
Sbjct: 184 LSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMK--TCIQGL---AGLEVHRLVLGEFR 238

Query: 356 SLGDNNLSGSLPITLGRLKKLQGLDL---QNNKFEGPIPQEFCHFSRLYVVYLNRNKLSG 412
           +  + NL       L  L  L   +      + +   I   F   + +    L    +  
Sbjct: 239 N--EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296

Query: 413 SIP-SCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKA 471
               S       L +++    +  ++   +   L       F+SN    +      +L +
Sbjct: 297 VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL------TFTSNKGGNAFSE--VDLPS 348

Query: 472 VVDIYLSRNNLS--GNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNND 529
           +  + LSRN LS  G    +  G  +L++L L  N +   +  +F  L  LE LD  +++
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSN 407

Query: 530 LSGVIPAS-LEKLLYLKSLNLSFNKL 554
           L  +   S    L  L  L++S    
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHT 433

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  113 bits (284), Expect = 4e-26
 Identities = 47/237 (19%), Positives = 79/237 (33%), Gaps = 11/237 (4%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
           +   L L  N L      +     +LQ LDL   + +      +   S L  + L  N +
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 411 SGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLN-GSLPLEIENL 469
                     L+SL+ L      L S+      +L+ +   + + N +    LP    NL
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148

Query: 470 KAVVDIYLSRNNLSGNIPSTIIGLKNLQ----HLSLEHNKLQGPIPESFGELVSLEFLDL 525
             +  + LS N +     + +  L  +      L L  N +    P +F E+  L  L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTL 207

Query: 526 SNNDLSGVIPA-SLEKLLYLKSLNLSFNKLVG----EIPRGGAFANFSAESFIGNDL 577
            NN  S  +    ++ L  L+   L   +       E     A       +     L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 87.8 bits (218), Expect = 5e-18
 Identities = 27/140 (19%), Positives = 51/140 (36%), Gaps = 4/140 (2%)

Query: 429 LSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPS 488
                   +  +  ++ +++   D S N L         +   +  + LSR  +      
Sbjct: 14  CMELNFYKIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 489 TIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLN 548
               L +L  L L  N +Q     +F  L SL+ L     +L+ +    +  L  LK LN
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 549 LSFNKLVGEIPRGGAFANFS 568
           ++ N +         F+N +
Sbjct: 131 VAHNLIQ-SFKLPEYFSNLT 149

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  212 bits (542), Expect = 4e-62
 Identities = 79/305 (25%), Positives = 142/305 (46%), Gaps = 34/305 (11%)

Query: 652 RRYSHDELLRATDQFSEE------NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN 705
             +S  EL   T+ F E       N +G G +G VYKG   +   VA+K   L     + 
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK--LAAMVDIT 69

Query: 706 S------FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN--FN 757
           +      FD E +++   +H NLV+++   ++ +   LV  YMP GSL D +   +    
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 758 LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
           L    R  I    A+ + +LH    N  +H DIK +N+LLD++  A +SDFG+A+   + 
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 818 D-SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
             ++  ++ + T  Y+APE  R G+++ K D+Y++G++L+E+ TG+   +        + 
Sbjct: 187 AQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD-EHREPQLLL 244

Query: 877 RWINDSLP---AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKE 933
               +       + + +D  +   D             ++ S+A +C  E    R + K+
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADST--------SVEAMYSVASQCLHEKKNKRPDIKK 296

Query: 934 IISRL 938
           +   L
Sbjct: 297 VQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  197 bits (503), Expect = 1e-56
 Identities = 66/310 (21%), Positives = 120/310 (38%), Gaps = 29/310 (9%)

Query: 657 DELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEI--L 714
           + L   +       +   G +G V+K +      VA+K+F +Q +    S+  E E+  L
Sbjct: 17  ENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK---QSWQNEYEVYSL 72

Query: 715 KTIRHRNLVKIISSCTNHNFKA----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDV 770
             ++H N+++ I +            L+  +  KGSL D  +     +   +   I   +
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD--FLKANVVSWNELCHIAETM 130

Query: 771 ASALEYLH------FGHSNP-IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
           A  L YLH           P I H DIK  NVLL +++ A ++DFG+A       S   T
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190

Query: 824 QTLA-TIGYIAPEYGREG-----QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM---S 874
                T  Y+APE             ++ D+Y  G++L E+ +     +      M    
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

Query: 875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
            +   + SL  +  ++               K +  + +     EC     E R++   +
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKK-RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 935 ISRLIKIRDL 944
             R+ +++ L
Sbjct: 310 GERITQMQRL 319

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  193 bits (492), Expect = 1e-55
 Identities = 73/304 (24%), Positives = 137/304 (45%), Gaps = 27/304 (8%)

Query: 641 IKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR 700
           +K G        R + D+      Q +    IG GS+G+VYKG++    +VA+K+ ++  
Sbjct: 1   MKKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTA 58

Query: 701 --EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNL 758
                L +F  E  +L+  RH N++  +   T     A+V ++    SL   ++AS    
Sbjct: 59  PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKF 117

Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE-E 817
           ++ + + I    A  ++YLH   +  I+H D+K +N+ L +     + DFG+A   S   
Sbjct: 118 EMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174

Query: 818 DSMKQTQTLATIGYIAPE---YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS 874
            S +  Q   +I ++APE          S + DVY +GI+L E+ TG  P    ++  ++
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSN-IN 229

Query: 875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
                  +   ++ ++    LS D       + +C   +  L  EC  +  + R +   I
Sbjct: 230 -------NRDQIIEMVGRGSLSPDLS---KVRSNCPKRMKRLMAECLKKKRDERPSFPRI 279

Query: 935 ISRL 938
           ++ +
Sbjct: 280 LAEI 283

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  192 bits (491), Expect = 3e-55
 Identities = 70/282 (24%), Positives = 121/282 (42%), Gaps = 32/282 (11%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLV 723
            +   E ++G G++G V K ++    +VAIK    + E    +F  E   L  + H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASN--FNLDIFQRLGIMIDVASALEYLHFGH 781
           K+  +C N     LV+EY   GSL + ++ +           +   +  +  + YLH   
Sbjct: 65  KLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 782 SNPIVHCDIKPSNVLLDDSM-VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
              ++H D+KP N+LL     V  + DFG A  +     M  T    +  ++APE     
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HM--TNNKGSAAWMAPEVFEGS 178

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL-PAVMNIMDTNLLSEDE 899
             S K DV+++GI+L EV T  KP +E       I   +++   P ++            
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI------------ 226

Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                  ++    + SL   C S+ P  R + +EI+  +  +
Sbjct: 227 -------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  191 bits (487), Expect = 1e-54
 Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 32/285 (11%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRN 721
              + +  IG GS+G+V++  +  G +VA+K+   Q      +N F  E  I+K +RH N
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN--FNLDIFQRLGIMIDVASALEYLHF 779
           +V  + + T     ++V EY+ +GSL   ++ S     LD  +RL +  DVA  + YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
             + PIVH ++K  N+L+D      + DFG+++L +      ++    T  ++APE  R+
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRD 213

Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL---LS 896
              + K DVY++G++L E+ T  +P                +    V  +        + 
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNL------------NPAQVVAAVGFKCKRLEIP 261

Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            +              V ++   C +  P  R +   I+  L  +
Sbjct: 262 RN----------LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  190 bits (484), Expect = 2e-54
 Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 49/298 (16%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGA-------LNSFDAECEILK 715
           ++   E  IG G +G V+KGR   D   VAIK   L               F  E  I+ 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALE 775
            + H N+VK+     N     +V+E++P G L   +      +    +L +M+D+A  +E
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDS-----MVAHLSDFGIAKLLSEEDSMKQTQTLATIG 830
           Y+    + PIVH D++  N+ L        + A ++DFG+++      S+  +  L    
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--SVHSV--SGLLGNFQ 191

Query: 831 YIAPE--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND-----SL 883
           ++APE     E   + K D Y++ ++L  + TG  P +E+  G++     I +     ++
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251

Query: 884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
           P                      + C   + ++   C S  P+ R +   I+  L ++
Sbjct: 252 P----------------------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  202 bits (515), Expect = 3e-54
 Identities = 110/522 (21%), Positives = 182/522 (34%), Gaps = 71/522 (13%)

Query: 79  NLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIF-NLSFISTALDF 137
            L   + L L +N ++         L +L++L L +     TI    F NL  +   LD 
Sbjct: 22  VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRI-LDL 80

Query: 138 SDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPI--PNNLWHCKELSSVSLSYNQFTG-R 194
             + +      D   GL  L  L + +      +       + K L+ + LS NQ     
Sbjct: 81  GSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139

Query: 195 LPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLK 254
           L    G    LKS+D   N +      E+  L+   +                F+++   
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLS--------------FFSLAANS 185

Query: 255 ILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNA-SKLYALELGYNSN 313
           + S  +      +   +N+     LE L++  N  +  I   F NA SK  A  L    +
Sbjct: 186 LYSRVSVDWGKCMNPFRNM----VLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241

Query: 314 LKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRL 373
           +   G   + +        + F+ L            ++  L L    +          L
Sbjct: 242 IMGAGFGFHNIKDPDQ---NTFAGLAR---------SSVRHLDLSHGFVFSLNSRVFETL 289

Query: 374 KKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNE 433
           K L+ L+L  NK      + F     L V+ L+ N L     S    L  +  + L  N 
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349

Query: 434 LTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSG--------- 484
           +  +   TF  LE +   D   N+L       I  + ++ DI+LS N L           
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTAN 404

Query: 485 ------------NIPSTIIGLKNLQHLSLEHNKLQG-PIPESFGELVSLEFLDLSNNDLS 531
                       +I   ++ + +LQ L L  N+       ++  E  SLE L L  N L 
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464

Query: 532 GVIPASLEK-----LLYLKSLNLSFNKLVGEIPRGGAFANFS 568
                 L       L +L+ L L+ N L   +P  G F++ +
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLN-SLP-PGVFSHLT 504

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  195 bits (497), Expect = 6e-52
 Identities = 122/605 (20%), Positives = 206/605 (34%), Gaps = 91/605 (15%)

Query: 21  CSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNL 80
           CS+ G         +T            +P     L++ + L+LS N+           L
Sbjct: 2   CSFDGRIAFYRFCNLTQ-----------VPQ---VLNTTERLLLSFNYIRTVTASSFPFL 47

Query: 81  TKLKELHLDYNKLQGEIPEE-LGNLAELEMLVLNNNLLTGTIPASIF-NLSFISTALDFS 138
            +L+ L L        I +E   NL  L +L L ++ +   +    F  L  +   L   
Sbjct: 48  EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFE-LRLY 105

Query: 139 DNSLTGSF-PYDMCPGLPRLKGLYVSYNQFKG-PIPNNLWHCKELSSVSLSYNQFTGRLP 196
              L+ +         L  L  L +S NQ +   +  +      L S+  S NQ      
Sbjct: 106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCE 165

Query: 197 RDLGN--STKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLK 254
            +L       L    L  N+L   +  + G   N     + +        D   N  T+ 
Sbjct: 166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEIL------DVSGNGWTVD 219

Query: 255 ILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNL 314
           I   F+N +S +   S  LI   ++ G   G +N+     + F   +          S++
Sbjct: 220 ITGNFSNAISKSQAFS--LILAHHIMGAGFGFHNIKDPDQNTFAGLA---------RSSV 268

Query: 315 KRLGLERNYLTFSTSELMSLFSALVNCKSLKIGN-------------LINLTTLSLGDNN 361
           + L L   ++    S    +F  L + K L +               L NL  L+L  N 
Sbjct: 269 RHLDLSHGFVFSLNS---RVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325

Query: 362 LSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDL 421
           L          L K+  +DLQ N       Q F    +L  + L  N L+      +  +
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFI 380

Query: 422 NSLRILSLSSNELTSV---------------------IPSTFWNLEDILGFDFSSNSLNG 460
            S+  + LS N+L ++                     I      +  +     + N  + 
Sbjct: 381 PSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSS 440

Query: 461 SLPLEI-ENLKAVVDIYLSRNNLSGNIPSTI-----IGLKNLQHLSLEHNKLQGPIPESF 514
               +      ++  ++L  N L     + +      GL +LQ L L HN L    P  F
Sbjct: 441 CSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVF 500

Query: 515 GELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIG 574
             L +L  L L++N L+ +    L     L+ L++S N+L    P    F + S      
Sbjct: 501 SHLTALRGLSLNSNRLTVLSHNDLPAN--LEILDISRNQL--LAPNPDVFVSLSVLDITH 556

Query: 575 NDLLC 579
           N  +C
Sbjct: 557 NKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  149 bits (378), Expect = 4e-37
 Identities = 118/620 (19%), Positives = 191/620 (30%), Gaps = 134/620 (21%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLT--KLKEL 86
           D+  N++ SL +             G L+SL+++  S N        E+  L    L   
Sbjct: 129 DLSKNQIRSLYLHPS---------FGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFF 179

Query: 87  HLDYNKLQGEIPEELGNLAE------LEMLVLNNNLLTGTIPASIFNLSFISTALDFSDN 140
            L  N L   +  + G          LE+L ++ N  T  I  +  N    S A      
Sbjct: 180 SLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLI-- 237

Query: 141 SLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELS--SVSLSYNQFTGRLPRD 198
                           + G    ++  K P  N        S   + LS+        R 
Sbjct: 238 ------------LAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRV 285

Query: 199 LGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSL 258
                 LK L+L +N +N    +    L NL++L                N+S   +  L
Sbjct: 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVL----------------NLSYNLLGEL 329

Query: 259 FNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLG 318
           +++             GLP +  ++L  N+++      F                L+ L 
Sbjct: 330 YSSNFY----------GLPKVAYIDLQKNHIAIIQDQTFKFL-----------EKLQTLD 368

Query: 319 LERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQG 378
           L  N LT                    I  + ++  + L  N L     I L        
Sbjct: 369 LRDNALTT-------------------IHFIPSIPDIFLSGNKLVTLPKINL----TANL 405

Query: 379 LDLQNNKFEG-PIPQEFCHFSRLYVVYLNRNKLSGSIPSCL-GDLNSLRILSLSSNELTS 436
           + L  N+ E   I         L ++ LN+N+ S         +  SL  L L  N L  
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465

Query: 437 VIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNL 496
              +                          E L  +  +YL+ N L+   P     L  L
Sbjct: 466 AWETEL-------------------CWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL 506

Query: 497 QHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVG 556
           + LSL  N+L            +LE LD+S N L    P        L  L+++ NK + 
Sbjct: 507 RGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFIC 561

Query: 557 EIPRGGAFANFSAESFIG-----NDLLCGSP---------YLHVPLCKSSPHKKSRKQVI 602
           E      F N+   + +       D+ C  P          L    C      KS K  +
Sbjct: 562 ECEL-STFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSL 620

Query: 603 LLGVVLPLSTVFIVTVILVL 622
            +   + L+   +  + +  
Sbjct: 621 FIVCTVTLTLFLMTILTVTK 640

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  189 bits (482), Expect = 3e-52
 Identities = 101/504 (20%), Positives = 170/504 (33%), Gaps = 88/504 (17%)

Query: 51  SHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEML 110
                L+     VL +   + T+     +L ++  L  D   ++    + +  L  L  +
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73

Query: 111 VLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGP 170
             +NN LT   P  + NL+ +   +  ++N +    P      L  L GL +  NQ    
Sbjct: 74  NFSNNQLTDITP--LKNLTKL-VDILMNNNQIADITPLA---NLTNLTGLTLFNNQITDI 127

Query: 171 IPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLE 230
            P  L +   L+ + LS N  +      L   T L+ L  G N +    P  + NL  LE
Sbjct: 128 DP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLE 180

Query: 231 ILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLS 290
            L I  + +       +  ++ L+ L   NN +S        L  L NL+ L+L  N L 
Sbjct: 181 RLDISSNKVSD--ISVLAKLTNLESLIATNNQIS----DITPLGILTNLDELSLNGNQLK 234

Query: 291 GSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLI 350
             I +                +NL  L L  N ++                    +  L 
Sbjct: 235 -DIGTL------------ASLTNLTDLDLANNQISNLAP----------------LSGLT 265

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
            LT L LG N +S   P  L  L  L  L+L  N+ E   P    +   L  + L  N +
Sbjct: 266 KLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNI 321

Query: 411 SGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLK 470
           S   P  +  L  L+ L   +N+++ V                            + NL 
Sbjct: 322 SDISP--VSSLTKLQRLFFYNNKVSDVSS--------------------------LANLT 353

Query: 471 AVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDL 530
            +  +    N +S   P  +  L  +  L L               +     +      L
Sbjct: 354 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411

Query: 531 SGVIPASLEKLLYLKSLNLSFNKL 554
             + PA++         ++++N  
Sbjct: 412 --IAPATISDGGSYTEPDITWNLP 433

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  182 bits (464), Expect = 8e-50
 Identities = 100/452 (22%), Positives = 173/452 (38%), Gaps = 68/452 (15%)

Query: 110 LVLNNNLLTGTIPASIFNLSFIS--TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQF 167
            +  +  +       IF  + ++          ++T +        L ++  L       
Sbjct: 7   TITQDTPIN-----QIFTDTALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGI 58

Query: 168 KGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLR 227
           K    + + +   L+ ++ S NQ T   P  L N TKL  + +  N +    P  + NL 
Sbjct: 59  K--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLT 112

Query: 228 NLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLN 287
           NL  L +  + +     D + N++ L  L L +NT+S        L GL +L+ L+ G N
Sbjct: 113 NLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTIS----DISALSGLTSLQQLSFG-N 165

Query: 288 NLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIG 347
            ++   P             L   + L+RL +  N ++  +                 + 
Sbjct: 166 QVTDLKP-------------LANLTTLERLDISSNKVSDISV----------------LA 196

Query: 348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNR 407
            L NL +L   +N +S   P  LG L  L  L L  N+ +          + L  + L  
Sbjct: 197 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLAN 252

Query: 408 NKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIE 467
           N++S   P  L  L  L  L L +N+++++ P     L  +   + + N L    P  I 
Sbjct: 253 NQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--IS 306

Query: 468 NLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSN 527
           NLK +  + L  NN+S   P  +  L  LQ L   +NK+      S   L ++ +L   +
Sbjct: 307 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGH 362

Query: 528 NDLSGVIPASLEKLLYLKSLNLSFNKLVGEIP 559
           N +S + P  L  L  +  L L+         
Sbjct: 363 NQISDLTP--LANLTRITQLGLNDQAWTNAPV 392

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  121 bits (305), Expect = 4e-29
 Identities = 64/306 (20%), Positives = 118/306 (38%), Gaps = 50/306 (16%)

Query: 257 SLFNNTLSGNLPSSK--NLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNL 314
            L + T++ + P ++      L       LG  N++ ++                    +
Sbjct: 2   PLGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS-------------QTDLDQV 48

Query: 315 KRLGLERNYLTFSTSELMSLFSALVNCKSLK-IGNLINLTTLSLGDNNLSGSLPITLGRL 373
             L  +R  +                  S+  +  L NLT ++  +N L+   P  L  L
Sbjct: 49  TTLQADRLGIK-----------------SIDGVEYLNNLTQINFSNNQLTDITP--LKNL 89

Query: 374 KKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNE 433
            KL  + + NN+     P    + + L  + L  N+++   P  L +L +L  L LSSN 
Sbjct: 90  TKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNT 145

Query: 434 LTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGL 493
           ++ +       L  +    F +   +      + NL  +  + +S N +S    S +  L
Sbjct: 146 ISDISA--LSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKL 198

Query: 494 KNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNK 553
            NL+ L   +N++    P   G L +L+ L L+ N L  +    L  L  L  L+L+ N+
Sbjct: 199 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQ 254

Query: 554 LVGEIP 559
           +    P
Sbjct: 255 ISNLAP 260

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 81.2 bits (201), Expect = 5e-16
 Identities = 38/192 (19%), Positives = 70/192 (36%), Gaps = 13/192 (6%)

Query: 53  LGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVL 112
           L  L++L  L L+ N      P  I NL  L  L L +N +    P  + +L +L+ L  
Sbjct: 283 LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338

Query: 113 NNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIP 172
            NN ++    +S+ NL+ I+  L    N ++   P      L R+  L ++   +     
Sbjct: 339 YNNKVSD--VSSLANLTNINW-LSAGHNQISDLTPLA---NLTRITQLGLNDQAWTNAPV 392

Query: 173 NNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEIL 232
           N   +    ++V           P  + +       D+ +N  +    +          +
Sbjct: 393 NYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTI 449

Query: 233 GIDQSNLVGFVP 244
           G   +   G V 
Sbjct: 450 GKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 53.8 bits (130), Expect = 2e-07
 Identities = 21/96 (21%), Positives = 37/96 (38%), Gaps = 5/96 (5%)

Query: 48  TIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAEL 107
           +  S L NL+++  L    N  S   P  + NLT++ +L L+             N++  
Sbjct: 344 SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIP 401

Query: 108 EMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLT 143
             +      L    PA+I +     T  D + N  +
Sbjct: 402 NTVKNVTGAL--IAPATISDGGSY-TEPDITWNLPS 434

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  182 bits (464), Expect = 5e-52
 Identities = 63/290 (21%), Positives = 114/290 (39%), Gaps = 37/290 (12%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE----GALNSFDAECEILKTIRH 719
            + + E +IGIG +G VY+  +  G EVA+K      +      + +   E ++   ++H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
            N++ +   C       LV+E+   G L      S   +     +   + +A  + YLH 
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNR--VLSGKRIPPDILVNWAVQIARGMNYLHD 123

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAH--------LSDFGIAKLLSEEDSMKQTQTLATIGY 831
               PI+H D+K SN+L+   +           ++DFG+A+       M          +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA---GAYAW 180

Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
           +APE  R    S   DV++YG++L E+ TG  P        ++    +N     +     
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP---- 236

Query: 892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                           +C      L  +C +  P +R +   I+ +L  I
Sbjct: 237 ---------------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  182 bits (464), Expect = 7e-52
 Identities = 57/291 (19%), Positives = 115/291 (39%), Gaps = 41/291 (14%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRN 721
            Q +    +     G ++KGR+  G ++ +KV  ++         F+ EC  L+   H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 722 LVKIISSCTNHNFK--ALVLEYMPKGSLEDCMY-ASNFNLDIFQRLGIMIDVASALEYLH 778
           ++ ++ +C +       L+  +MP GSL + ++  +NF +D  Q +   +D+A  + +LH
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE--- 835
                 I    +   +V++D+ M A +S   +        S +    +    ++APE   
Sbjct: 129 -TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQ 181

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL- 894
              E       D++++ ++L E+ T   P  +              ++   M +    L 
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADL------------SNMEIGMKVALEGLR 229

Query: 895 --LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
             +              +  V  L   C +E P  R     I+  L K++D
Sbjct: 230 PTIPPG----------ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  182 bits (465), Expect = 1e-51
 Identities = 60/290 (20%), Positives = 115/290 (39%), Gaps = 40/290 (13%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRN 721
           +Q     LIG G +G VY GR+    EVAI++  ++R  E  L +F  E    +  RH N
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +V  + +C +    A++       +L   +  +   LD+ +   I  ++   + YL   H
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---H 147

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA----TIGYIAPE-- 835
           +  I+H D+K  NV  D+  V  ++DFG+  +     + ++   L      + ++APE  
Sbjct: 148 AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 836 -------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMN 888
                     +   S   DV+  G +  E+     P             +      A++ 
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP-------------FKTQPAEAIIW 253

Query: 889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
            M T +         +++      +  + + C +   E R    +++  L
Sbjct: 254 QMGTGMKPN------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  186 bits (473), Expect = 2e-50
 Identities = 101/533 (18%), Positives = 182/533 (34%), Gaps = 60/533 (11%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELH 87
           D+  N++T +   DL             ++LQ L+L  +  + TI  +   +L  L+ L 
Sbjct: 32  DLSFNKITYIGHGDLR----------ACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLD 80

Query: 88  LDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFP 147
           L  N L        G L+ L+ L L  N        S+F        L   +        
Sbjct: 81  LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140

Query: 148 YDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKS 207
                GL  L  L +     +     +L   +++  ++L  ++    L       + ++ 
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200

Query: 208 LDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNL 267
           L+L   NL                     S L      +       +   L + + +  L
Sbjct: 201 LELRDTNLA----------------RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL 244

Query: 268 PSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFS 327
              + ++ L  +E  +  LN L    PS     S+L  +E      ++RL + + YL + 
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET---VTIRRLHIPQFYLFYD 301

Query: 328 TSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFE 387
            S + S               L  +  +++ ++ +          LK L+ LDL  N   
Sbjct: 302 LSTVYS--------------LLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347

Query: 388 GPIPQEFCHF---SRLYVVYLNRNKLS--GSIPSCLGDLNSLRILSLSSNELTSVIPSTF 442
               +          L  + L++N L         L  L +L  L +S N     +P + 
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSC 406

Query: 443 WNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLE 502
              E +   + SS  +   +   I   + +  + +S NNL  +       L  LQ L + 
Sbjct: 407 QWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSL---FLPRLQELYIS 459

Query: 503 HNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLV 555
            NKL+     S      L  + +S N L  V     ++L  L+ + L  N   
Sbjct: 460 RNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  149 bits (379), Expect = 3e-38
 Identities = 77/413 (18%), Positives = 145/413 (35%), Gaps = 51/413 (12%)

Query: 178 CKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQS 237
           C            FT  +P  L  +  +KSLDL FN +      ++    NL++L +  S
Sbjct: 4   CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60

Query: 238 NLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSG-SIPSF 296
            +     D  +++ +L+ L L +N LS +L SS     L +L+ LNL  N      + S 
Sbjct: 61  RINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSS-WFGPLSSLKYLNLMGNPYQTLGVTSL 118

Query: 297 FFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLS 356
           F N + L  L +G       +                        + +    L +L  L 
Sbjct: 119 FPNLTNLQTLRIGNVETFSEI------------------------RRIDFAGLTSLNELE 154

Query: 357 LGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPS 416
           +   +L      +L  ++ +  L L  ++    +       S +  + L    L+    S
Sbjct: 155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS 214

Query: 417 CLGDLNSLRILSLSSNELTSV-------IPSTFWNLEDILGFDFSSNSLNGSLPLEIENL 469
            L        +   +   + +       +      + ++   +F   +LNG         
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSES 274

Query: 470 KAVVDI-----------YLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELV 518
             V ++           ++ +  L  ++ +    L+ ++ +++E++K+          L 
Sbjct: 275 DVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLK 334

Query: 519 SLEFLDLSNNDLSGVI---PASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFS 568
           SLEFLDLS N +        A       L++L LS N L      G       
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 94.4 bits (235), Expect = 4e-20
 Identities = 52/274 (18%), Positives = 100/274 (36%), Gaps = 19/274 (6%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHL 88
           D   N +     S+  +   +        +++ L + + +    +      L K+K + +
Sbjct: 260 DCTLNGLGDFNPSESDVVSELGKV--ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317

Query: 89  DYNKLQGEIPEELGNLAELEMLVLNNNLLTGTI---PASIFNLSFISTALDFSDNSLTG- 144
           + +K+         +L  LE L L+ NL+        A       + T L  S N L   
Sbjct: 318 ENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT-LVLSQNHLRSM 376

Query: 145 SFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTK 204
               ++   L  L  L +S N F  P+P++    +++  ++LS       +   +     
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQT 432

Query: 205 LKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLS 264
           L+ LD+  NNL+      +  L+ L I      N +  +PD       L ++ +  N L 
Sbjct: 433 LEVLDVSNNNLD-SFSLFLPRLQELYI----SRNKLKTLPDASL-FPVLLVMKISRNQLK 486

Query: 265 GNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFF 298
                      L +L+ + L  N    S P   +
Sbjct: 487 --SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 518

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  179 bits (455), Expect = 5e-50
 Identities = 74/331 (22%), Positives = 116/331 (35%), Gaps = 54/331 (16%)

Query: 655 SHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEIL 714
           +  E     D      LIG G YG+VYKG   D   VA+KVF         +F  E  I 
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIY 59

Query: 715 KT--IRHRNLVKIISSCTNHNFKA-----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIM 767
           +   + H N+ + I               LV+EY P GSL    Y S    D      + 
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRLA 117

Query: 768 IDVASALEYLH-----FGHSNP-IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK 821
             V   L YLH       H  P I H D+   NVL+ +     +SDFG++  L+    ++
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 822 QTQTLA-------TIGYIAPEYGRE-------GQVSIKGDVYNYGIMLMEVFTGMKPTNE 867
             +          TI Y+APE                + D+Y  G++  E+F     T+ 
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TDL 235

Query: 868 FFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAK-------------QSCASSVL 914
           F    +       +   A    +  +   ED +     +                  S+ 
Sbjct: 236 FPGESV------PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289

Query: 915 SLAMECTSESPENRVNTKEIISRLIKIRDLL 945
               +C  +  E R+  +    R+ ++  + 
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIW 320

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  178 bits (454), Expect = 1e-48
 Identities = 99/517 (19%), Positives = 185/517 (35%), Gaps = 90/517 (17%)

Query: 55  NLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNN 114
           + + LQ  +   +  +  +P E  N+    E +  +++ +   P   G   E+ +  L +
Sbjct: 9   SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67

Query: 115 NLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNN 174
            L               +  L+ ++  L+ S P       P L+ L  S N     +P  
Sbjct: 68  CLDRQ------------AHELELNNLGLS-SLP----ELPPHLESLVASCNSLT-ELPEL 109

Query: 175 LWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGI 234
               K L   + +    +   P        L+ L +  N L  ++P E+ N   L+I+ +
Sbjct: 110 PQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDV 160

Query: 235 DQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIP 294
           D +N +  +PD   +   L+ ++  NN L   LP    L  LP L  +    N+L   +P
Sbjct: 161 D-NNSLKKLPDLPPS---LEFIAAGNNQLE-ELP---ELQNLPFLTAIYADNNSLK-KLP 211

Query: 295 SFFFNASKLYAL--------ELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKI 346
               +   + A         EL     L  +  + N L        +L     + ++L +
Sbjct: 212 DLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-------TLPDLPPSLEALNV 264

Query: 347 GN---------LINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHF 397
            +           +LT L + +N  S  L      L     L+  +N+    +       
Sbjct: 265 RDNYLTDLPELPQSLTFLDVSENIFS-GLSELPPNLYY---LNASSNEIRS-LCDL---P 316

Query: 398 SRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNS 457
             L  + ++ NKL   +P+       L  L  S N L   +P    NL+ +       N 
Sbjct: 317 PSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLAE-VPELPQNLKQL---HVEYNP 368

Query: 458 LNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGEL 517
           L    P   E+++      L  N+    +P      +NL+ L +E N L+   P+     
Sbjct: 369 LR-EFPDIPESVE-----DLRMNSHLAEVPELP---QNLKQLHVETNPLRE-FPD---IP 415

Query: 518 VSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
            S+E L +++  +      + E    L+      +  
Sbjct: 416 ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  173 bits (441), Expect = 7e-47
 Identities = 106/499 (21%), Positives = 183/499 (36%), Gaps = 85/499 (17%)

Query: 48  TIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNL-------------TKLKELHLDYNKLQ 94
            +P    N+ S      + + +    P   G                +  EL L+   L 
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84

Query: 95  GEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGL 154
             +PE   +   LE LV + N LT  +P    +L  +    + +  +L+           
Sbjct: 85  -SLPELPPH---LESLVASCNSLT-ELPELPQSLKSL-LVDNNNLKALSDL--------P 130

Query: 155 PRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNN 214
           P L+ L VS NQ +  +P  L +   L  + +  N    +LP    +   L+ +  G N 
Sbjct: 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQ 184

Query: 215 LNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLI 274
           L  E+P E+ NL  L  +  D +N +  +PD   +   L+ +   NN L   LP    L 
Sbjct: 185 LE-ELP-ELQNLPFLTAIYAD-NNSLKKLPDLPLS---LESIVAGNNILE-ELPE---LQ 234

Query: 275 GLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSL 334
            LP L  +    N L  ++P                  +L+ L +  NYLT       SL
Sbjct: 235 NLPFLTTIYADNNLLK-TLPDLP--------------PSLEALNVRDNYLTDLPELPQSL 279

Query: 335 FS-ALVNCKSLKIGNLI-NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQ 392
               +       +  L  NL  L+   N +  SL         L+ L++ NNK    +P 
Sbjct: 280 TFLDVSENIFSGLSELPPNLYYLNASSNEIR-SLC---DLPPSLEELNVSNNKLIE-LPA 334

Query: 393 EFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFD 452
                 RL  +  + N L+  +P       +L+ L +  N L    P    ++ED+    
Sbjct: 335 LPP---RLERLIASFNHLA-EVPELPQ---NLKQLHVEYNPLRE-FPDIPESVEDLR--- 383

Query: 453 FSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPE 512
             ++ L   +P   +NLK    +++  N L    P      ++++ L +   ++  P   
Sbjct: 384 -MNSHLA-EVPELPQNLKQ---LHVETNPLR-EFPDIP---ESVEDLRMNSERVVDPYEF 434

Query: 513 SFGELVSLEFLDLSNNDLS 531
           +      LE     ++   
Sbjct: 435 AHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  154 bits (391), Expect = 2e-40
 Identities = 97/496 (19%), Positives = 183/496 (36%), Gaps = 108/496 (21%)

Query: 97  IPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPR 156
           I     +   L+  + +++ LT  +P    N+    T    + +    + P    PG   
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSK-TEYYNAWSEWERNAP----PGNGE 56

Query: 157 LKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLN 216
            + + VS       + + L   ++   + L+    +  LP    +   L+SL    N+L 
Sbjct: 57  QREMAVSR------LRDCL--DRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT 104

Query: 217 GEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGL 276
            E+P+   +L++L +   +   L             L+ L + NN L   LP    L   
Sbjct: 105 -ELPELPQSLKSLLVDNNNLKALSDL-------PPLLEYLGVSNNQLE-KLPE---LQNS 152

Query: 277 PNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN-----------SNLKRLGLERNYLT 325
             L+ +++  N+L   +P    +   L  +  G N             L  +  + N L 
Sbjct: 153 SFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK 208

Query: 326 FSTSELMSLFSALVNCKSL-----------KIGNLINLTTLSLGDNNLSGSLPITLGRLK 374
                   L    ++ +S+           ++ NL  LTT+   +N L  +LP     L+
Sbjct: 209 -------KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE 260

Query: 375 KLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNEL 434
            L   D         +P+     + L V     + LS   P       +L  L+ SSNE+
Sbjct: 261 ALNVRDNYLTD----LPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEI 309

Query: 435 TSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLK 494
            S +     +LE++   + S+N L   LP     L+    +  S N+L+  +P      +
Sbjct: 310 RS-LCDLPPSLEEL---NVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELP---Q 357

Query: 495 NLQHLSLEHNKLQGPIPESFGELV----------------SLEFLDLSNNDLSGVIPASL 538
           NL+ L +E+N L+   P+    +                 +L+ L +  N L    P   
Sbjct: 358 NLKQLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIP 415

Query: 539 EKLLYLKSLNLSFNKL 554
           E    ++ L ++  ++
Sbjct: 416 ES---VEDLRMNSERV 428

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 43.8 bits (104), Expect = 2e-04
 Identities = 12/95 (12%), Positives = 30/95 (31%), Gaps = 9/95 (9%)

Query: 29  DVYGNRVTSL-----TISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKL 83
            V  N +        ++ DL +   +        +L+ L +  N      P    ++   
Sbjct: 363 HVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVE-- 419

Query: 84  KELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLT 118
            +L ++  ++            +LE  V  ++   
Sbjct: 420 -DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  173 bits (441), Expect = 2e-48
 Identities = 57/295 (19%), Positives = 110/295 (37%), Gaps = 39/295 (13%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL 722
                  ++G G +G   K      G  + +K      E    +F  E ++++ + H N+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           +K I           + EY+  G+L   + + +      QR+    D+AS + YL   HS
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HS 126

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-------------TI 829
             I+H D+   N L+ ++    ++DFG+A+L+ +E +  +                    
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEF--FTGEMSIKRWINDSLPAVM 887
            ++APE         K DV+++GI+L E+   +    ++   T +  +            
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246

Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR 942
           N                    C  S   + + C    PE R +  ++   L  +R
Sbjct: 247 N--------------------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  172 bits (438), Expect = 4e-48
 Identities = 72/305 (23%), Positives = 116/305 (38%), Gaps = 49/305 (16%)

Query: 669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKII 726
              +G G YG V++G +  G  VA+K+F  + E    S+  E E+  T+  RH N++  I
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68

Query: 727 SSCTNHNFKA----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH---- 778
           +S       +    L+  Y   GSL D  Y     LD    L I++ +AS L +LH    
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 779 -FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAP 834
                  I H D+K  N+L+  +    ++D G+A + S+  +         +G   Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 835 E------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEF------FTGEMSIKRWINDS 882
           E               + D++ +G++L EV   M            F   +       D 
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 883 LPAVMN------IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
              V        I +                   +S+  L  EC  ++P  R+    I  
Sbjct: 247 RKVVCVDQQRPNIPN-----------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

Query: 937 RLIKI 941
            L KI
Sbjct: 296 TLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  172 bits (439), Expect = 8e-48
 Identities = 68/303 (22%), Positives = 115/303 (37%), Gaps = 31/303 (10%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKT--IRHRN 721
            Q      IG G YG V+ G++  G +VA+KVF    E    S+  E EI +T  +RH N
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHEN 92

Query: 722 LVKIISSCTNHNFK----ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
           ++  I++            L+ +Y   GSL D  Y  +  LD    L +     S L +L
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYD--YLKSTTLDAKSMLKLAYSSVSGLCHL 150

Query: 778 H-----FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG-- 830
           H           I H D+K  N+L+  +    ++D G+A     + +         +G  
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 831 -YIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL 883
            Y+ PE           Q  I  D+Y++G++L EV             ++     +    
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP--S 268

Query: 884 PAVMNIMDTNLLSED---EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK 940
                 M   +  +          +   C   +  L  EC + +P +R+    +   L K
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

Query: 941 IRD 943
           + +
Sbjct: 329 MSE 331

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  170 bits (432), Expect = 9e-47
 Identities = 75/399 (18%), Positives = 141/399 (35%), Gaps = 55/399 (13%)

Query: 133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFT 192
             L      +   FP      L       +        +       + ++ + ++  +  
Sbjct: 3   ATLATLPAPINQIFP---DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 193 GRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNIST 252
               + +   T L+ L+L  N +    P  + NL  L  L I  + +       + N++ 
Sbjct: 58  S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTN 111

Query: 253 LKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNS 312
           L+ L L  + +S        L  L  +  LNLG N+    +              L   +
Sbjct: 112 LRELYLNEDNIS----DISPLANLTKMYSLNLGANHNLSDLS------------PLSNMT 155

Query: 313 NLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGR 372
            L  L +  + +   T                 I NL +L +LSL  N +    P  L  
Sbjct: 156 GLNYLTVTESKVKDVTP----------------IANLTDLYSLSLNYNQIEDISP--LAS 197

Query: 373 LKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSN 432
           L  L       N+     P    + +RL  + +  NK++   P  L +L+ L  L + +N
Sbjct: 198 LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253

Query: 433 ELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIG 492
           +++ +  +   +L  +   +  SN ++  +   + NL  +  ++L+ N L       I G
Sbjct: 254 QISDI--NAVKDLTKLKMLNVGSNQIS-DIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGG 309

Query: 493 LKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLS 531
           L NL  L L  N +    P     L  ++  D +N  + 
Sbjct: 310 LTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  168 bits (427), Expect = 5e-46
 Identities = 75/400 (18%), Positives = 147/400 (36%), Gaps = 56/400 (14%)

Query: 36  TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQG 95
            +L      +    P    +L+     VL +   +  +      L  + +L +   K+  
Sbjct: 3   ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS 58

Query: 96  EIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLP 155
              + +  L  LE L LN N +T   P  + NL  + T L    N +T          L 
Sbjct: 59  --IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKL-TNLYIGTNKITDISALQ---NLT 110

Query: 156 RLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNL 215
            L+ LY++ +      P  L +  ++ S++L  N         L N T L  L +  + +
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKV 167

Query: 216 NGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIG 275
               P  I NL +L  L ++ + +    P  + ++++L   + + N ++        +  
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT----DITPVAN 219

Query: 276 LPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLF 335
           +  L  L +G N ++   P             L   S L  L +  N ++   +      
Sbjct: 220 MTRLNSLKIGNNKITDLSP-------------LANLSQLTWLEIGTNQISDINA------ 260

Query: 336 SALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFC 395
                     + +L  L  L++G N +S      L  L +L  L L NN+      +   
Sbjct: 261 ----------VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIG 308

Query: 396 HFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELT 435
             + L  ++L++N ++   P  L  L+ +     ++  + 
Sbjct: 309 GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  159 bits (404), Expect = 5e-43
 Identities = 77/366 (21%), Positives = 137/366 (37%), Gaps = 50/366 (13%)

Query: 205 LKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLS 264
             +L      +N   P    +L       + ++++      T   + ++  L +      
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGE--- 54

Query: 265 GNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN-----------SN 313
             + S + +  L NLE LNL  N ++   P    N  KL  L +G N           +N
Sbjct: 55  -KVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQNLTN 111

Query: 314 LKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRL 373
           L+ L L  + ++                    + NL  + +L+LG N+   S    L  +
Sbjct: 112 LRELYLNEDNIS----------------DISPLANLTKMYSLNLGANHNL-SDLSPLSNM 154

Query: 374 KKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNE 433
             L  L +  +K +   P    + + LY + LN N++    P  L  L SL   +   N+
Sbjct: 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQ 210

Query: 434 LTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGL 493
           +T + P    N+  +      +N +    PL   NL  +  + +  N +S    + +  L
Sbjct: 211 ITDITP--VANMTRLNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQISD--INAVKDL 264

Query: 494 KNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNK 553
             L+ L++  N++          L  L  L L+NN L       +  L  L +L LS N 
Sbjct: 265 TKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322

Query: 554 LVGEIP 559
           +    P
Sbjct: 323 ITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  121 bits (306), Expect = 4e-30
 Identities = 52/262 (19%), Positives = 104/262 (39%), Gaps = 31/262 (11%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHL 88
            +  + ++ +            S L NL+ + +L L  N    +    + N+T L  L +
Sbjct: 116 YLNEDNISDI------------SPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTV 162

Query: 89  DYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPY 148
             +K++      + NL +L  L LN N +    P  + +L+ +        N +T   P 
Sbjct: 163 TESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSL-HYFTAYVNQITDITPV 217

Query: 149 DMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSL 208
                + RL  L +  N+     P  L +  +L+ + +  NQ +      + + TKLK L
Sbjct: 218 A---NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270

Query: 209 DLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLP 268
           ++G N ++      + NL  L  L ++ + L     + I  ++ L  L L  N ++    
Sbjct: 271 NVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT---- 324

Query: 269 SSKNLIGLPNLEGLNLGLNNLS 290
             + L  L  ++  +     + 
Sbjct: 325 DIRPLASLSKMDSADFANQVIK 346

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  161 bits (409), Expect = 8e-44
 Identities = 63/306 (20%), Positives = 115/306 (37%), Gaps = 51/306 (16%)

Query: 669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEI--LKTIRHRNLVKII 726
           +  IG G +G V++G++  G EVA+K+F  + E    S+  E EI     +RH N++  I
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102

Query: 727 SSCTNHNFKA----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH---- 778
           ++    N       LV +Y   GSL D  Y + + + +   + + +  AS L +LH    
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 779 -FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAP 834
                  I H D+K  N+L+  +    ++D G+A                 +G   Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 835 E------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMN 888
           E        +  +   + D+Y  G++  E+                    I++       
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG------------GIHEDYQLPYY 268

Query: 889 IMDTNLLSEDEEHANVAKQ-------------SCASSVLSLAMECTSESPENRVNTKEII 935
            +  +  S +E    V +Q                  +  +  EC   +   R+    I 
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

Query: 936 SRLIKI 941
             L ++
Sbjct: 329 KTLSQL 334

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  161 bits (408), Expect = 4e-42
 Identities = 97/547 (17%), Positives = 182/547 (33%), Gaps = 85/547 (15%)

Query: 26  ITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKE 85
              D   N +             +P  L        L +S+N+ S     +I +L+KL+ 
Sbjct: 3   FLVDRSKNGLIH-----------VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRI 49

Query: 86  LHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGS 145
           L + +N++Q           ELE L L++N L          +S                
Sbjct: 50  LIISHNRIQYLDISVFKFNQELEYLDLSHNKLV--------KISCHP------------- 88

Query: 146 FPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKL 205
                      LK L +S+N F                 +L   +  G +       ++L
Sbjct: 89  --------TVNLKHLDLSFNAFD----------------ALPICKEFGNM-------SQL 117

Query: 206 KSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSG 265
           K L L   +L       I +L   ++L +                   + L +   T   
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK- 176

Query: 266 NLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLT 325
                  ++ +      NL L+N+   +     +       +L  N  L  L L     T
Sbjct: 177 ---EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233

Query: 326 FSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNK 385
           +++      F  ++           +++ + L           +   LK L    + ++ 
Sbjct: 234 WNS------FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287

Query: 386 FEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNL 445
           F  P    +  FS + +     +        C   ++    L  S+N LT  +     +L
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347

Query: 446 EDILGFDFSSNSLNGSLPLEIE---NLKAVVDIYLSRNNLSGNIPSTII-GLKNLQHLSL 501
            ++       N L   L    E    +K++  + +S+N++S +         K+L  L++
Sbjct: 348 TELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406

Query: 502 EHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG 561
             N L   I         ++ LDL +N +   IP  + KL  L+ LN++ N+L   +P  
Sbjct: 407 SSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL-KSVPD- 461

Query: 562 GAFANFS 568
           G F   +
Sbjct: 462 GIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  152 bits (385), Expect = 4e-39
 Identities = 87/499 (17%), Positives = 176/499 (35%), Gaps = 54/499 (10%)

Query: 73  IPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIS 132
           +PK++    K   L++  N +      ++ +L++L +L++++N +   +  S+F      
Sbjct: 15  VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFK----- 66

Query: 133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFT 192
                                   L+ L +S+N+      +   + K L    LS+N F 
Sbjct: 67  --------------------FNQELEYLDLSHNKLVKISCHPTVNLKHLD---LSFNAFD 103

Query: 193 GRLPRD--LGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFV-PDTIFN 249
             LP     GN ++LK L L   +L       I +L   ++L +          P+ + +
Sbjct: 104 -ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQD 162

Query: 250 ISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELG 309
            +T  +  +F      +     ++  + NLE  N+           F    +KL      
Sbjct: 163 FNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKL 222

Query: 310 YNSNLKRLGLERNYLT-------------FSTSELMSLFSALVNCKSLKIGNLINLTTLS 356
            N  L  +    N                FS S +                +L  L+   
Sbjct: 223 SNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQ 282

Query: 357 LGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPS 416
           +  +               +   +   +             S    +  + N L+ ++  
Sbjct: 283 VVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFE 342

Query: 417 CLGDLNSLRILSLSSNELTSV--IPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVV 473
             G L  L  L L  N+L  +  I      ++ +   D S NS++           K+++
Sbjct: 343 NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402

Query: 474 DIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGV 533
            + +S N L+  I   +     ++ L L  NK++  IP+   +L +L+ L++++N L  V
Sbjct: 403 SLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSV 459

Query: 534 IPASLEKLLYLKSLNLSFN 552
                ++L  L+ + L  N
Sbjct: 460 PDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  125 bits (316), Expect = 3e-30
 Identities = 81/437 (18%), Positives = 143/437 (32%), Gaps = 54/437 (12%)

Query: 55  NLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQG-EIPEELGNLAELEMLVLN 113
               L+ L LS N     I         LK L L +N      I +E GN+++L+ L L+
Sbjct: 67  FNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123

Query: 114 NNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPN 173
              L  +    I +L+     L   +       P     GL       +          +
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE----GLQDFNTESLHIVFPTNKEFH 179

Query: 174 NLWHCKELSSVSLSYNQFTGRLPRDLGNS-----------TKLKSLDLGFNNLNGEIPQE 222
            +      +  +L  +     L  +  +             KL +L L            
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR 239

Query: 223 IGNL---RNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGN---LPSSKNLIGL 276
           I  L     +    I    L G +    F+ S   + +L  + +  +    P S      
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF 299

Query: 277 PNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNS-------------NLKRLGLERNY 323
            N+   N  ++             S    L+   N               L+ L L+ N 
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359

Query: 324 LTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLP-ITLGRLKKLQGLDLQ 382
           L    S++  + +            + +L  L +  N++S           K L  L++ 
Sbjct: 360 LK-ELSKIAEMTT-----------QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407

Query: 383 NNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTF 442
           +N     I +  C   R+ V+ L+ NK+  SIP  +  L +L+ L+++SN+L SV    F
Sbjct: 408 SNILTDTIFR--CLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIF 464

Query: 443 WNLEDILGFDFSSNSLN 459
             L  +      +N  +
Sbjct: 465 DRLTSLQKIWLHTNPWD 481

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  156 bits (397), Expect = 1e-41
 Identities = 79/426 (18%), Positives = 139/426 (32%), Gaps = 52/426 (12%)

Query: 171 IPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEI-GNLRNL 229
           I +NL +      V +           +       K +    + +  ++P  +  + R +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 230 EILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNL 289
           E+L ++   +            T++ L +  N +   LP       +P L  L L  N+L
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV-FQNVPLLTVLVLERNDL 129

Query: 290 SGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNL 349
           S S+P   F               L  L +  N L     +                   
Sbjct: 130 S-SLPRGIF----------HNTPKLTTLSMSNNNLERIEDDTFQ--------------AT 164

Query: 350 INLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNK 409
            +L  L L  N L+    + L  +  L   ++  N               +  +  + N 
Sbjct: 165 TSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNS 216

Query: 410 LSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEI-EN 468
           ++  +         L IL L  N LT    +   N   ++  D S N L   +       
Sbjct: 217 IN-VVRG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVK 270

Query: 469 LKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN 528
           ++ +  +Y+S N L   +      +  L+ L L HN L   +  +  +   LE L L +N
Sbjct: 271 MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHN 328

Query: 529 DLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPY--LHV 586
            +  +  ++      LK+L LS N           F N +  +    D  C   Y   H 
Sbjct: 329 SIVTLKLSTHHT---LKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHG 384

Query: 587 PLCKSS 592
             CK S
Sbjct: 385 LCCKES 390

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  139 bits (353), Expect = 6e-36
 Identities = 73/414 (17%), Positives = 140/414 (33%), Gaps = 75/414 (18%)

Query: 48  TIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAEL 107
            I S+L        + +           E   L   K +    + ++      L +  ++
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 108 EMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQF 167
           E+L LN+  +   I    F                              ++ LY+ +N  
Sbjct: 72  ELLNLNDLQIE-EIDTYAFA-------------------------YAHTIQKLYMGFNAI 105

Query: 168 KGPIPNNLWHCKELSSVSLSYNQFTGRLPRDL-GNSTKLKSLDLGFNNLNGEIPQEI-GN 225
           +   P+   +   L+ + L  N  +  LPR +  N+ KL +L +  NNL   I  +    
Sbjct: 106 RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQA 163

Query: 226 LRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLG 285
             +L+ L +  SN +  V  ++    +L   ++  N LS        L     +E L+  
Sbjct: 164 TTSLQNLQL-SSNRLTHVDLSLI--PSLFHANVSYNLLS-------TLAIPIAVEELDAS 213

Query: 286 LNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLK 345
            N+++  +                    L  L L+ N LT +                  
Sbjct: 214 HNSIN-VVRGPVN-------------VELTILKLQHNNLTDTAW---------------- 243

Query: 346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYL 405
           + N   L  + L  N L   +     ++++L+ L + NN+    +         L V+ L
Sbjct: 244 LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 302

Query: 406 NRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLN 459
           + N L   +       + L  L L  N + ++  ST   L+++     S N  +
Sbjct: 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL---TLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  138 bits (349), Expect = 2e-35
 Identities = 70/408 (17%), Positives = 136/408 (33%), Gaps = 55/408 (13%)

Query: 38  LTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYNKLQGE 96
           + I               L++ + +    +     +P  +  +  +++ L+L+  +++ E
Sbjct: 26  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 83

Query: 97  IPEE-LGNLAELEMLVLNNNLLTGTIPASIF-NLSFISTALDFSDNSLTGSFPYDMCPGL 154
           I          ++ L +  N +   +P  +F N+  + T L    N L+ S P  +    
Sbjct: 84  IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLL-TVLVLERNDLS-SLPRGIFHNT 140

Query: 155 PRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNN 214
           P+L  L +S N  +    +       L ++ LS N+ T  +   L     L   ++ +N 
Sbjct: 141 PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNL 197

Query: 215 LNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLI 274
           L       +     +E L     N +  V   +     L IL L +N L+     +  L+
Sbjct: 198 L-----STLAIPIAVEELDAS-HNSINVVRGPVN--VELTILKLQHNNLT----DTAWLL 245

Query: 275 GLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSL 334
             P L  ++L  N L   I    F               L+RL +  N L      L   
Sbjct: 246 NYPGLVEVDLSYNELE-KIMYHPFVK----------MQRLERLYISNNRLV----ALNLY 290

Query: 335 FSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEF 394
                         +  L  L L  N+L   +     +  +L+ L L +N     +    
Sbjct: 291 GQ-----------PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS- 336

Query: 395 CHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTF 442
                L  + L+ N    +    L    ++   ++   +    I    
Sbjct: 337 -THHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQL 381

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  114 bits (288), Expect = 2e-27
 Identities = 73/352 (20%), Positives = 122/352 (34%), Gaps = 51/352 (14%)

Query: 34  RVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYNK 92
           +V  L ++DL +            ++Q L +  N     +P  +  N+  L  L L+ N 
Sbjct: 70  QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 128

Query: 93  LQGEIPEEL-GNLAELEMLVLNNNLLTGTIPASIF-NLSFISTALDFSDNSLTGSFPYDM 150
           L   +P  +  N  +L  L ++NN L   I    F   + +   L  S N LT       
Sbjct: 129 LS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQN-LQLSSNRLT-HVDLS- 183

Query: 151 CPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDL 210
              +P L    VSYN         L     +  +  S+N     +   +  + +L  L L
Sbjct: 184 --LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKL 233

Query: 211 GFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSS 270
             NNL  +    + N   L  + +  + L   +      +  L+ L + NN L   L   
Sbjct: 234 QHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLY 290

Query: 271 KNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN----------SNLKRLGLE 320
                +P L+ L+L  N+L   +        +L  L L +N            LK L L 
Sbjct: 291 --GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLS 347

Query: 321 RNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGR 372
            N      + L +LF               N+   ++ D +    +   L  
Sbjct: 348 HNDWDC--NSLRALFR--------------NVARPAVDDADQHCKIDYQLEH 383

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  103 bits (260), Expect = 7e-24
 Identities = 39/216 (18%), Positives = 78/216 (36%), Gaps = 10/216 (4%)

Query: 340 NCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSR 399
            C    +        + +               L   + +  +N+            F +
Sbjct: 11  KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70

Query: 400 LYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLN 459
           + ++ LN  ++           ++++ L +  N +  + P  F N+  +       N L+
Sbjct: 71  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 460 GSLPLEI-ENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELV 518
            SLP  I  N   +  + +S NNL      T     +LQ+L L  N+L   +      + 
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIP 186

Query: 519 SLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
           SL   ++S N LS     +L   + ++ L+ S N +
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSI 217

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 13/109 (11%), Positives = 39/109 (35%), Gaps = 2/109 (1%)

Query: 461 SLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSL 520
            +   ++      D+++             I L N + ++ +++ ++            +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 521 EFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSA 569
           E L+L++  +  +   +      ++ L + FN +   +P    F N   
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPP-HVFQNVPL 118

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  153 bits (388), Expect = 4e-41
 Identities = 59/363 (16%), Positives = 113/363 (31%), Gaps = 52/363 (14%)

Query: 193 GRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNIST 252
           G       +S+  ++L    +         +   +       ++ +          N + 
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57

Query: 253 LKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNS 312
            +I +     L             P    L L    L    P   F  S L  + +    
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 313 NLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGR 372
                             LM L           +     L TL+L  N L  +LP ++  
Sbjct: 116 ------------------LMEL--------PDTMQQFAGLETLTLARNPLR-ALPASIAS 148

Query: 373 LKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSN 432
           L +L+ L ++       +P+                  S         L +L+ L L   
Sbjct: 149 LNRLRELSIRACPELTELPEPLA---------------STDASGEHQGLVNLQSLRLEWT 193

Query: 433 ELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIG 492
            + S +P++  NL+++      ++ L+ +L   I +L  + ++ L       N P    G
Sbjct: 194 GIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251

Query: 493 LKNLQHLSLEH-NKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSF 551
              L+ L L+  + L   +P     L  LE LDL        +P+ + +L     + +  
Sbjct: 252 RAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310

Query: 552 NKL 554
           +  
Sbjct: 311 HLQ 313

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  150 bits (381), Expect = 4e-40
 Identities = 55/388 (14%), Positives = 108/388 (27%), Gaps = 76/388 (19%)

Query: 52  HLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLV 111
           H  + S  + L    +         +    +      +             N    ++  
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIET 62

Query: 112 LNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPI 171
                L       + + +                         P    L +         
Sbjct: 63  RTGRALK-ATADLLEDAT------------------------QPGRVALELRSVPLPQ-F 96

Query: 172 PNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEI 231
           P+  +    L  +++        LP  +     L++L L  N L   +P  I +L  L  
Sbjct: 97  PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRE 154

Query: 232 LGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSG 291
           L I     +  +P+ +                  +  +S    GL NL+ L L    +  
Sbjct: 155 LSIRACPELTELPEPL-----------------ASTDASGEHQGLVNLQSLRLEWTGIR- 196

Query: 292 SIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLIN 351
           S+P+   N   L +L++  +  L  LG                           I +L  
Sbjct: 197 SLPASIANLQNLKSLKIRNSP-LSALGPA-------------------------IHHLPK 230

Query: 352 LTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLS 411
           L  L L       + P   G    L+ L L++      +P +    ++L  + L      
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290

Query: 412 GSIPSCLGDLNSLRILSLSSNELTSVIP 439
             +PS +  L +  I+ +  +    +  
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  143 bits (363), Expect = 9e-38
 Identities = 62/360 (17%), Positives = 110/360 (30%), Gaps = 74/360 (20%)

Query: 36  TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQG 95
            +L              L           +R            N    +        L+ 
Sbjct: 15  ENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRTGRALK- 69

Query: 96  EIPEELGNLAE--LEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPG 153
              + L +  +     L L +  L    P   F LS                        
Sbjct: 70  ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS------------------------ 104

Query: 154 LPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFN 213
              L+ + +        +P+ +     L +++L+ N     LP  + +  +L+ L +   
Sbjct: 105 --HLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRAC 160

Query: 214 NLNGEIPQEIGN---------LRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLS 264
               E+P+ + +         L NL+ L ++ + +   +P +I N+  LK L + N+ LS
Sbjct: 161 PELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219

Query: 265 GNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYL 324
             L  +  +  LP LE L+L       + P  F   + L  L L   SNL  L L+    
Sbjct: 220 A-LGPA--IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD---- 272

Query: 325 TFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNN 384
                                I  L  L  L L        LP  + +L     + +  +
Sbjct: 273 ---------------------IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  139 bits (353), Expect = 2e-36
 Identities = 45/246 (18%), Positives = 82/246 (33%), Gaps = 17/246 (6%)

Query: 36  TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQG 95
            +L +  + L    P     LS LQ + +        +P  +     L+ L L  N L+ 
Sbjct: 84  VALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR- 140

Query: 96  EIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIS--------TALDFSDNSLTGSFP 147
            +P  + +L  L  L +        +P  + +              +L      +  S P
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLP 199

Query: 148 YDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKS 207
             +   L  LK L +  +     +   + H  +L  + L         P   G    LK 
Sbjct: 200 ASIA-NLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257

Query: 208 LDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNN---TLS 264
           L L   +    +P +I  L  LE L +     +  +P  I  +    I+ +  +    L 
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317

Query: 265 GNLPSS 270
            + P +
Sbjct: 318 QHRPVA 323

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  135 bits (343), Expect = 4e-35
 Identities = 54/285 (18%), Positives = 93/285 (32%), Gaps = 26/285 (9%)

Query: 276 LPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLF 335
               E L    +              + Y  +     +  R     N     T    +L 
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-NSNNPQIETRTGRALK 69

Query: 336 SALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFC 395
           +       L+         L L    L    P    RL  LQ + +        +P    
Sbjct: 70  ATA---DLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQ 124

Query: 396 HFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSS 455
            F+ L  + L RN L  ++P+ +  LN LR LS+ +    + +P    +           
Sbjct: 125 QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST---------- 173

Query: 456 NSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFG 515
                    E + L  +  + L    +  ++P++I  L+NL+ L + ++ L   +  +  
Sbjct: 174 -----DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIH 226

Query: 516 ELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLS-FNKLVGEIP 559
            L  LE LDL         P        LK L L   + L+  +P
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLP 270

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  156 bits (395), Expect = 1e-40
 Identities = 66/458 (14%), Positives = 143/458 (31%), Gaps = 25/458 (5%)

Query: 54  GNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLN 113
            N +  +   ++ +     +     +   +KEL L  N L      +L    +LE+L L+
Sbjct: 7   QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 114 NNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPN 173
           +N+L       + +LS +   LD ++N +            P ++ L+ + N       +
Sbjct: 67  SNVLYE--TLDLESLSTL-RTLDLNNNYVQ------ELLVGPSIETLHAANNNISRVSCS 117

Query: 174 NLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNG-EIPQEIGNLRNLEIL 232
                K +    L+ N+ T     D G  ++++ LDL  N ++     +   +   LE L
Sbjct: 118 RGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 233 GIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGS 292
            + Q N +  V   +   + LK L L +N L+  +           +  ++L  N L   
Sbjct: 175 NL-QYNFIYDVKGQVV-FAKLKTLDLSSNKLA-FMGP--EFQSAAGVTWISLRNNKLV-L 228

Query: 293 IPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINL 352
           I      +  L   +L  N       L   +      + ++    +              
Sbjct: 229 IEKALRFSQNLEHFDLRGN-GFHCGTLRDFFSKNQRVQTVAK-QTVKKLTGQNEEECTVP 286

Query: 353 TTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEG----PIPQEFCHFSRLYVVYLNRN 408
           T    G             RL  L+  +      +G     +  E  + +R   +   + 
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346

Query: 409 KLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIEN 468
           +    I        +   L      L   + +      ++ G    +           E 
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQ 406

Query: 469 LKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKL 506
               +   + +      +    +    ++   +  +K 
Sbjct: 407 SPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  154 bits (390), Expect = 5e-40
 Identities = 70/487 (14%), Positives = 143/487 (29%), Gaps = 74/487 (15%)

Query: 73  IPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIS 132
           I +   N  + K   +  + L+  +     +   ++ L L+ N L+  I A+        
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLA----- 55

Query: 133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFT 192
                                  +L+ L +S N     +   L     L ++ L+ N   
Sbjct: 56  --------------------PFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93

Query: 193 GRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNIST 252
                +L     +++L    NN++  +       +  + + +  + +           S 
Sbjct: 94  -----ELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSR 145

Query: 253 LKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNS 312
           ++ L L  N +   +  ++       LE LNL  N +   +                  +
Sbjct: 146 VQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV------------FA 191

Query: 313 NLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGR 372
            LK L L  N L F   E                 +   +T +SL +N L   +   L  
Sbjct: 192 KLKTLDLSSNKLAFMGPE---------------FQSAAGVTWISLRNNKLV-LIEKALRF 235

Query: 373 LKKLQGLDLQNNKFE-GPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSS 431
            + L+  DL+ N F  G +   F    R+    + +  +         +     +    +
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ--TVAKQTVKKLTGQNEEECTVPTLGHYGA 293

Query: 432 NELTSVIPSTFWNLEDILGFDFSSNSLNGS----LPLEIENLKAVVDIYLSRNNLSGNIP 487
                +       L  +   + +  S  GS    L  E EN     +I   +      I 
Sbjct: 294 YCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVID 353

Query: 488 STIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSL 547
              +  +    L  +   L   +         L+            +  + E+   L+ L
Sbjct: 354 QVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLL 412

Query: 548 NLSFNKL 554
                + 
Sbjct: 413 RAIVKRY 419

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  111 bits (278), Expect = 1e-25
 Identities = 39/340 (11%), Positives = 91/340 (26%), Gaps = 19/340 (5%)

Query: 53  LGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQG-EIPEELGNLAELEMLV 111
                  + + L+ N  +     + G  ++++ L L  N++      E   +   LE L 
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 112 LNNNLLTGTIPASIF--NLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG 169
           L  N +   +   +    L      LD S N L      +       +  + +  N+   
Sbjct: 176 LQYNFIY-DVKGQVVFAKL----KTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRNNKLVL 228

Query: 170 PIPNNLWHCKELSSVSLSYNQFTGRLPRDL-GNSTKLKSLDLGFNNLNGEIPQEIGNLRN 228
            I   L   + L    L  N F     RD    + +++++      +     Q       
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTV 285

Query: 229 LEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSS--KNLIGLPNLEGLNLGL 286
             +                  +  LK       +  G+                 ++   
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345

Query: 287 NNLSGSIPSFFFNASKLYALELGYNS-NLKRLGLERNYLTFSTSELMSLFSALVNCKSLK 345
                 I            LE    + + +     R +     +   ++    +   + +
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405

Query: 346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNK 385
              L  L   ++        +     +   ++  D+  +K
Sbjct: 406 QSPLQLLR--AIVKRYEEMYVEQQSVQNNAIRDWDMYQHK 443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 97.2 bits (242), Expect = 3e-21
 Identities = 27/177 (15%), Positives = 70/177 (39%), Gaps = 11/177 (6%)

Query: 390 IPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDIL 449
           I +   + +R  +  +  + L  ++ S      +++ L LS N L+ +  +       + 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 450 GFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGP 509
             + SSN L     L++E+L  +  + L+ N +       ++   +++ L   +N +   
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114

Query: 510 IPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFAN 566
                      + + L+NN ++ +          ++ L+L  N++   +      A+
Sbjct: 115 SCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 70.6 bits (173), Expect = 1e-12
 Identities = 24/101 (23%), Positives = 43/101 (42%), Gaps = 3/101 (2%)

Query: 461 SLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSL 520
           ++    +N        ++ ++L   + S      N++ L L  N L             L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 521 EFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG 561
           E L+LS+N L   +   LE L  L++L+L+ N +  E+  G
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-QELLVG 98

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  148 bits (375), Expect = 4e-38
 Identities = 82/377 (21%), Positives = 138/377 (36%), Gaps = 56/377 (14%)

Query: 180 ELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNL 239
           +  +V     +F   +P  +   T+ + LDLG N +      E  +  +LE L ++++ +
Sbjct: 12  QDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68

Query: 240 VGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFN 299
               P    N+  L+ L L +N L   +P      GL NL  L++  N +   +  + F 
Sbjct: 69  SAVEPGAFNNLFNLRTLGLRSNRLK-LIPL-GVFTGLSNLTKLDISENKIV-ILLDYMFQ 125

Query: 300 ASKLYALELGYNSNLKRLGLERNYLTFSTSELMS-LFSALVNCKSLKIGNLINLTTLSLG 358
                        NLK L +  N L      +    FS            L +L  L+L 
Sbjct: 126 D----------LYNLKSLEVGDNDLV----YISHRAFS-----------GLNSLEQLTLE 160

Query: 359 DNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCL 418
             NL+      L  L  L  L L++          F    RL V+ ++      ++    
Sbjct: 161 KCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNC 220

Query: 419 GDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLS 478
               +L  LS++   LT+V      +L                       L+    + LS
Sbjct: 221 LYGLNLTSLSITHCNLTAVPYLAVRHL---------------------VYLR---FLNLS 256

Query: 479 RNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASL 538
            N +S    S +  L  LQ + L   +L    P +F  L  L  L++S N L+ +  +  
Sbjct: 257 YNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVF 316

Query: 539 EKLLYLKSLNLSFNKLV 555
             +  L++L L  N L 
Sbjct: 317 HSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  126 bits (318), Expect = 8e-31
 Identities = 48/258 (18%), Positives = 100/258 (38%), Gaps = 16/258 (6%)

Query: 311 NSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITL 370
            +  + L L +N +     +  +              +  +L  L L +N +S   P   
Sbjct: 31  PTETRLLDLGKNRIKTLNQDEFA--------------SFPHLEELELNENIVSAVEPGAF 76

Query: 371 GRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLS 430
             L  L+ L L++N+ +      F   S L  + ++ NK+   +     DL +L+ L + 
Sbjct: 77  NNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136

Query: 431 SNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTI 490
            N+L  +    F  L  +        +L       + +L  ++ + L   N++     + 
Sbjct: 137 DNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSF 196

Query: 491 IGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLS 550
             L  L+ L + H      +  +    ++L  L +++ +L+ V   ++  L+YL+ LNLS
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLS 256

Query: 551 FNKLVGEIPRGGAFANFS 568
           +N +   I          
Sbjct: 257 YNPIS-TIEG-SMLHELL 272

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  124 bits (314), Expect = 3e-30
 Identities = 72/357 (20%), Positives = 120/357 (33%), Gaps = 44/357 (12%)

Query: 20  VCSWMGITCDVYGNRVTSL------TISDLGLAG----TIPSH-LGNLSSLQTLVLSRNW 68
            CS        +  R  ++          L L      T+      +   L+ L L+ N 
Sbjct: 8   ECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67

Query: 69  FSGTIPKEIGNLTKLKELHLDYNKLQGEIPEE-LGNLAELEMLVLNNNLLTGTIPASIF- 126
            S   P    NL  L+ L L  N+L+  IP      L+ L  L ++ N +   +   +F 
Sbjct: 68  VSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQ 125

Query: 127 NLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSL 186
           +L  +  +L+  DN L     +    GL  L+ L +            L H   L  + L
Sbjct: 126 DLYNL-KSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRL 183

Query: 187 SYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDT 246
            +               +LK L++        +        NL  L I   NL       
Sbjct: 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLA 243

Query: 247 IFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYAL 306
           + ++  L+ L+L  N +S  +  S  L  L  L+ + L    L+  +  + F        
Sbjct: 244 VRHLVYLRFLNLSYNPIS-TIEGS-MLHELLRLQEIQLVGGQLA-VVEPYAFRG------ 294

Query: 307 ELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLS 363
                + L+ L +  N LT     +                ++ NL TL L  N L+
Sbjct: 295 ----LNYLRVLNVSGNQLTTLEESVFH--------------SVGNLETLILDSNPLA 333

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  143 bits (363), Expect = 1e-36
 Identities = 85/403 (21%), Positives = 132/403 (32%), Gaps = 39/403 (9%)

Query: 186 LSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGIDQSNLVGFVP 244
           LS N               L+ L +        I       L +L IL +   N    + 
Sbjct: 37  LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL-DYNQFLQLE 95

Query: 245 DTIF-NISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKL 303
              F  ++ L++L+L    L G + S      L +LE L L  NN+    P+ FF     
Sbjct: 96  TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN--- 152

Query: 304 YALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLS 363
                        L L  N +    S            K   +  L ++T   + +  L 
Sbjct: 153 -------MRRFHVLDLTFNKVK---SICEEDLLNFQG-KHFTLLRLSSITLQDMNEYWLG 201

Query: 364 GSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNS 423
                   +   +  LDL  N F+  + + F                   I S +   + 
Sbjct: 202 WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG-----------TKIQSLILSNSY 250

Query: 424 LRILSLSSNELTSVIPSTFWNLE--DILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRN 480
               S            TF  LE   +   D S + +  +L   +  +   +  + L++N
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQN 309

Query: 481 NLSGNIPSTI-IGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLE 539
            ++  I      GL +L  L+L  N L       F  L  LE LDLS N +  +   S  
Sbjct: 310 EIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL 368

Query: 540 KLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFI---GNDLLC 579
            L  LK L L  N+L   +P  G F   ++   I    N   C
Sbjct: 369 GLPNLKELALDTNQLK-SVPD-GIFDRLTSLQKIWLHTNPWDC 409

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  132 bits (334), Expect = 6e-33
 Identities = 93/510 (18%), Positives = 159/510 (31%), Gaps = 119/510 (23%)

Query: 27  TCDVYGNRVTSLTISDLGLAG--TIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLK 84
            C V G         + GL     +P+H+        + LS N  +         L  L+
Sbjct: 7   ECSVIGYNAI---CINRGLHQVPELPAHV------NYVDLSLNSIAELNETSFSRLQDLQ 57

Query: 85  ELHLDYNKLQGEIPEEL-GNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLT 143
            L ++       I       L+ L +L L+ N     +    FN                
Sbjct: 58  FLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFN---------------- 100

Query: 144 GSFPYDMCPGLPRLKGLYVSYNQFKG-PIPNNLWHC-KELSSVSLSYNQFTGRLPRDL-G 200
                    GL  L+ L ++     G  +  N +     L  + L  N      P     
Sbjct: 101 ---------GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151

Query: 201 NSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFN 260
           N  +   LDL FN +     +++ N +                  T+  +S++ +  +  
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHF--------------TLLRLSSITLQDMNE 197

Query: 261 NTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLE 320
             L        N     ++  L+L  N    S+   FF+A           + ++ L L 
Sbjct: 198 YWLGWEKCG--NPFKNTSITTLDLSGNGFKESMAKRFFDAIAG--------TKIQSLILS 247

Query: 321 RNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITL-GRLKKLQGL 379
            +Y   S S   + F    N     +     + T  L  + +  +L  ++      L+ L
Sbjct: 248 NSYNMGS-SFGHTNFKDPDNFTFKGLEAS-GVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304

Query: 380 DLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPS-CLGDLNSLRILSLSSNELTSVI 438
            L  N+                            I       L  L  L+LS N L S+ 
Sbjct: 305 TLAQNEIN-------------------------KIDDNAFWGLTHLLKLNLSQNFLGSID 339

Query: 439 PSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQH 498
              F NL                     + L+    + LS N++      + +GL NL+ 
Sbjct: 340 SRMFENL---------------------DKLE---VLDLSYNHIRALGDQSFLGLPNLKE 375

Query: 499 LSLEHNKLQGPIPESFGELVSLEFLDLSNN 528
           L+L+ N+L+      F  L SL+ + L  N
Sbjct: 376 LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  145 bits (367), Expect = 1e-36
 Identities = 94/507 (18%), Positives = 177/507 (34%), Gaps = 66/507 (13%)

Query: 73  IPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIS 132
           +PK++    + K L L  N +      ++  L+EL +L L++N +  ++   +F      
Sbjct: 46  VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFL----- 97

Query: 133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFT 192
                                   L+ L VS+N+ +      +   + L    LS+N F 
Sbjct: 98  --------------------FNQDLEYLDVSHNRLQNISCCPMASLRHLD---LSFNDFD 134

Query: 193 GRLPR--DLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNI 250
             LP   + GN TKL  L L            + +L    IL    S  +         I
Sbjct: 135 -VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQI 193

Query: 251 STLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGY 310
               +L L  +    +L S +  + +  L  L L    L+        N  +L       
Sbjct: 194 PNTTVLHLVFHPN--SLFSVQVNMSVNALGHLQLSNIKLN------DENCQRLMTFLSEL 245

Query: 311 NSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSG-----S 365
                 L +   ++  +    + LF                +  L++ +  ++       
Sbjct: 246 TRGPTLLNVTLQHIETTWKCSVKLFQFF---------WPRPVEYLNIYNLTITERIDREE 296

Query: 366 LPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR 425
              +   LK L    ++N  F       +  F+ + +  L+ +        C    +S  
Sbjct: 297 FTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356

Query: 426 ILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLP---LEIENLKAVVDIYLSRNNL 482
            L+ + N  T  +      L+ +       N L  +     L  +N+ ++  + +S N+L
Sbjct: 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSL 415

Query: 483 -SGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKL 541
            S     T    +++  L+L  N L G +         ++ LDL NN +   IP  +  L
Sbjct: 416 NSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHL 472

Query: 542 LYLKSLNLSFNKLVGEIPRGGAFANFS 568
             L+ LN++ N+L   +P  G F   +
Sbjct: 473 QALQELNVASNQLK-SVPD-GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  136 bits (344), Expect = 1e-33
 Identities = 88/498 (17%), Positives = 163/498 (32%), Gaps = 54/498 (10%)

Query: 49  IPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEEL-GNLAEL 107
           +P         + L LS+N  S     +I  L++L+ L L +N+++  +   +     +L
Sbjct: 46  VPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102

Query: 108 EMLVLNNNLLTGTIPASIF-NLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQ 166
           E L +++N L   I      +L      LD S N             L +L  L +S  +
Sbjct: 103 EYLDVSHNRLQ-NISCCPMASL----RHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAK 157

Query: 167 FKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLN--------GE 218
           F+      + H      +    +        +         L L F+  +          
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217

Query: 219 IPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPN 278
                  L N+++   +   L+ F+ +     + L +      T                
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277

Query: 279 LEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSAL 338
           +E LN+    ++  I    F  S+          +L    ++     FS   L S+F+  
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETA------LKSLMIEHVKNQVFLFSKEALYSVFA-- 329

Query: 339 VNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFS 398
                        +    L  ++      +          L+   N F   + Q      
Sbjct: 330 ------------EMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLK 377

Query: 399 RLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILG----FDFS 454
           RL  + L RN L  +         ++  L      L S+    +             + S
Sbjct: 378 RLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436

Query: 455 SNSLNG----SLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPI 510
           SN L G     LP +++ L       L  N +  +IP  +  L+ LQ L++  N+L+   
Sbjct: 437 SNMLTGSVFRCLPPKVKVL------DLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVP 489

Query: 511 PESFGELVSLEFLDLSNN 528
              F  L SL+++ L +N
Sbjct: 490 DGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 84.5 bits (209), Expect = 5e-17
 Identities = 70/399 (17%), Positives = 128/399 (32%), Gaps = 73/399 (18%)

Query: 54  GNLSSLQTLVLSRN-WFSGTIPKEIGNLTKLKELHLDYNKLQ------------------ 94
             ++SL+ L LS N +    + KE GNLTKL  L L   K +                  
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD 177

Query: 95  ----GEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTA-LDFSDNSLT----GS 145
                    E  +L      VL+      ++ +   N+S  +   L  S+  L       
Sbjct: 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR 237

Query: 146 FPYDMCPGLPRLKGLYVSYNQFKGP------IPNNLWHCKELSSVSLSYNQFTGRLPRDL 199
               +         L V+    +        +    W  + +  +++     T R+ R+ 
Sbjct: 238 LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP-RPVEYLNIYNLTITERIDREE 296

Query: 200 GNSTKLKSLDLGFNNLNGEIPQEIGN-----LRNLEILGIDQSNLVGFVPDTIFNISTLK 254
              ++     L   ++  ++              + I  +  S+          + S+  
Sbjct: 297 FTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356

Query: 255 ILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNS-- 312
            L+   N  + ++   +    L  L+ L L  N L  +          + +LE    S  
Sbjct: 357 FLNFTQNVFTDSVF--QGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLN 413

Query: 313 ---------------NLKRLGLERNYLTFS-----TSELMSLFSALVNCK--SLKIG--N 348
                          ++  L L  N LT S       ++  L   L N +  S+     +
Sbjct: 414 SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLD--LHNNRIMSIPKDVTH 471

Query: 349 LINLTTLSLGDNNLSGSLPI-TLGRLKKLQGLDLQNNKF 386
           L  L  L++  N L  S+P     RL  LQ + L +N +
Sbjct: 472 LQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  140 bits (354), Expect = 4e-36
 Identities = 74/310 (23%), Positives = 123/310 (39%), Gaps = 45/310 (14%)

Query: 646 SPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGA- 703
           S  V+ R    D+ +   +       IG G++G V+ GR   D   VA+K     RE   
Sbjct: 96  SGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC---RETLP 152

Query: 704 ---LNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDI 760
                 F  E  ILK   H N+V++I  CT      +V+E +  G     +      L +
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV 212

Query: 761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED-S 819
              L ++ D A+ +EYL    S   +H D+   N L+ +  V  +SDFG+++  ++   +
Sbjct: 213 KTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269

Query: 820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMS 874
                    + + APE    G+ S + DV+++GI+L E F+ G  P    +N+       
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ------- 322

Query: 875 IKRWINDSLPAVMN--IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTK 932
                  +   V     +                + C  +V  L  +C +  P  R +  
Sbjct: 323 ------QTREFVEKGGRLP-------------CPELCPDAVFRLMEQCWAYEPGQRPSFS 363

Query: 933 EIISRLIKIR 942
            I   L  IR
Sbjct: 364 TIYQELQSIR 373

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  136 bits (346), Expect = 8e-36
 Identities = 80/294 (27%), Positives = 129/294 (43%), Gaps = 39/294 (13%)

Query: 671 LIGIGSYGSVYKGRFPDGI---EVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVK 724
            +G G   +VY     D I   +VAIK   +     E  L  F+ E      + H+N+V 
Sbjct: 18  KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           +I      +   LV+EY+   +L + +  S+  L +   +     +   +++    H   
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKH---AHDMR 131

Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGREGQVS 843
           IVH DIKP N+L+D +    + DFGIAK LSE  S+ QT   L T+ Y +PE  +     
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEFFTGE--MSI--KRWINDSLPAVMNIMDTNLLSEDE 899
              D+Y+ GI+L E+  G  P    F GE  +SI  K  I DS+P V   +  ++     
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDVRKDI----- 240

Query: 900 EHANVAKQSCASSVLSLAMECTSESPENR-VNTKEIISRLIKIRDLLFANIEMV 952
                       S+ ++ +  T +   NR    +E+   L  +     AN ++ 
Sbjct: 241 ----------PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVY 284

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  142 bits (359), Expect = 3e-35
 Identities = 93/482 (19%), Positives = 150/482 (31%), Gaps = 83/482 (17%)

Query: 80  LTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSD 139
                 L++  + L   +P+ L     +  LV+ +N LT ++PA    L      L+ S 
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPEL----RTLEVSG 90

Query: 140 NSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDL 199
           N LT S P     GL  L                       L  + +  NQ T  LP   
Sbjct: 91  NQLT-SLPVLPP-GLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT-SLPVLP 140

Query: 200 GNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLF 259
                L+ L +  N L   +P     L  L        N +  +P        L+ LS+ 
Sbjct: 141 PG---LQELSVSDNQLA-SLPALPSELCKLWAYN----NQLTSLPMLPSG---LQELSVS 189

Query: 260 NNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN-------- 311
           +N L+ +LP+      L  L   N  L +L             L  L +  N        
Sbjct: 190 DNQLA-SLPTL--PSELYKLWAYNNRLTSLPALPSG-------LKELIVSGNRLTSLPVL 239

Query: 312 -SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITL 370
            S LK L +  N LT S   L S                  L +LS+  N L+  LP +L
Sbjct: 240 PSELKELMVSGNRLT-SLPMLPS-----------------GLLSLSVYRNQLT-RLPESL 280

Query: 371 GRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILS-- 428
             L     ++L+ N       Q     +          +   +  S   +  +L + +  
Sbjct: 281 IHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAAD 340

Query: 429 -LSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIP 487
            L         P+  W++       F       +  L ++ L    + ++        I 
Sbjct: 341 WLVPAREGEPAPADRWHM-------FGQEDNADAFSLFLDRLSETEN-FIKDAGFKAQIS 392

Query: 488 STIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDL-----SGVIPASLEKLL 542
           S +  L   + L      +      S  + V+     + N  L      G     L  L+
Sbjct: 393 SWLAQLAEDEALRANTFAMATEATSSCEDRVTFFLHQMKNVQLVHNAEKGQYDNDLAALV 452

Query: 543 YL 544
             
Sbjct: 453 AT 454

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  138 bits (350), Expect = 3e-34
 Identities = 83/397 (20%), Positives = 142/397 (35%), Gaps = 73/397 (18%)

Query: 176 WHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGID 235
                 + +++  +  T  LP  L     + +L +  NNL   +P     LR LE+ G  
Sbjct: 37  CLNNGNAVLNVGESGLT-TLPDCLPAH--ITTLVIPDNNLT-SLPALPPELRTLEVSG-- 90

Query: 236 QSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPS 295
             N +  +P     +  L I S     L   LPS         L  L +  N L+ S+P 
Sbjct: 91  --NQLTSLPVLPPGLLELSIFSNPLTHLP-ALPS--------GLCKLWIFGNQLT-SLPV 138

Query: 296 FFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTL 355
                             L+ L +  N L    +                      L  L
Sbjct: 139 LP--------------PGLQELSVSDNQLASLPALPS------------------ELCKL 166

Query: 356 SLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIP 415
              +N L+ SLP+    L++L    + +N+    +P       +L+      N+L+ S+P
Sbjct: 167 WAYNNQLT-SLPMLPSGLQEL---SVSDNQLAS-LPTLPSELYKLW---AYNNRLT-SLP 217

Query: 416 SCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDI 475
           +       L+ L +S N LTS +P     L+++     S N L  SLP+    L     +
Sbjct: 218 ALPS---GLKELIVSGNRLTS-LPVLPSELKEL---MVSGNRLT-SLPMLPSGLL---SL 266

Query: 476 YLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIP 535
            + RN L+  +P ++I L +   ++LE N L     ++  E+ S                
Sbjct: 267 SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGA 325

Query: 536 A--SLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAE 570
           +     + L+L + +       GE      +  F  E
Sbjct: 326 SAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQE 362

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  131 bits (332), Expect = 6e-32
 Identities = 79/363 (21%), Positives = 123/363 (33%), Gaps = 53/363 (14%)

Query: 32  GNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYN 91
              +T+L I D  L  ++P+    L   +TL +S N  + ++P     L +L        
Sbjct: 60  PAHITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT 114

Query: 92  KLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMC 151
            L    P     L +L    +  N LT ++P     L      L  SDN L  S P    
Sbjct: 115 HL----PALPSGLCKLW---IFGNQLT-SLPVLPPGL----QELSVSDNQLA-SLP---- 157

Query: 152 PGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLG 211
                L  L+   NQ    +P      +EL   S+S NQ    LP        L  L   
Sbjct: 158 ALPSELCKLWAYNNQLTS-LPMLPSGLQEL---SVSDNQLA-SLPTLPSE---LYKLWAY 209

Query: 212 FNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSK 271
            N L   +P     L+ L + G    N +  +P      S LK L +  N L+ +LP   
Sbjct: 210 NNRLT-SLPALPSGLKELIVSG----NRLTSLPVL---PSELKELMVSGNRLT-SLPML- 259

Query: 272 NLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN-------SNLKRLGLERNYL 324
                  L  L++  N L+  +P    + S    + L  N         L+ +     Y 
Sbjct: 260 ----PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYS 314

Query: 325 TFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNN 384
                  M+  SA    ++L +     L     G+   +       G+        L  +
Sbjct: 315 GPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWH-MFGQEDNADAFSLFLD 373

Query: 385 KFE 387
           +  
Sbjct: 374 RLS 376

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  111 bits (279), Expect = 2e-25
 Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 35/259 (13%)

Query: 299 NASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALV--NCKSLKIGNLI-NLTTL 355
            A+ +  +    N+    L +  + LT     L +  + LV  +     +  L   L TL
Sbjct: 27  RAAVVQKMRACLNNGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPALPPELRTL 86

Query: 356 SLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIP 415
            +  N L+ SLP+    L +L             +P       +L   ++  N+L+ S+P
Sbjct: 87  EVSGNQLT-SLPVLPPGLLELSIFSNPLTH----LPALPSGLCKL---WIFGNQLT-SLP 137

Query: 416 SCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDI 475
                   L+ LS+S N+L S +P+    L  +      +N L  SLP+    L+   ++
Sbjct: 138 VLPP---GLQELSVSDNQLAS-LPALPSELCKL---WAYNNQLT-SLPMLPSGLQ---EL 186

Query: 476 YLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIP 535
            +S N L+ ++P+       L  L   +N+L   +P        L+ L +S N L+  +P
Sbjct: 187 SVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPALPS---GLKELIVSGNRLTS-LP 237

Query: 536 ASLEKLLYLKSLNLSFNKL 554
               +   LK L +S N+L
Sbjct: 238 VLPSE---LKELMVSGNRL 253

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  103 bits (257), Expect = 8e-23
 Identities = 45/218 (20%), Positives = 85/218 (38%), Gaps = 28/218 (12%)

Query: 342 KSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLY 401
           + ++         L++G++ L+ +LP  L     +  L + +N     +P        L 
Sbjct: 32  QKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPALPPELRTL- 86

Query: 402 VVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGS 461
              ++ N+L+ S+P     L  L I S     L ++       L  +       N L  S
Sbjct: 87  --EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS----GLCKL---WIFGNQLT-S 135

Query: 462 LPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLE 521
           LP+    L+   ++ +S N L+ ++P+       L  L   +N+L   +P        L+
Sbjct: 136 LPVLPPGLQ---ELSVSDNQLA-SLPA---LPSELCKLWAYNNQLTS-LPMLPS---GLQ 184

Query: 522 FLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIP 559
            L +S+N L+  +P    +L  L + N     L     
Sbjct: 185 ELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPS 221

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  134 bits (339), Expect = 3e-35
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 9/199 (4%)

Query: 669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRNLVKII 726
              IG G +G V+ G + +  +VAIK     REGA++   F  E E++  + H  LV++ 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLY 69

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIV 786
             C       LV E+M  G L D +            LG+ +DV   + YL       ++
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126

Query: 787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKG 846
           H D+   N L+ ++ V  +SDFG+ + + ++     T T   + + +PE     + S K 
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186

Query: 847 DVYNYGIMLMEVFT-GMKP 864
           DV+++G+++ EVF+ G  P
Sbjct: 187 DVWSFGVLMWEVFSEGKIP 205

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  138 bits (349), Expect = 5e-35
 Identities = 72/284 (25%), Positives = 129/284 (45%), Gaps = 35/284 (12%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRN 721
           +    E  +G G +G V+ G +     VAIK     + G ++   F  E +++K +RH  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 240

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFG 780
           LV++ +  +      +V EYM KGSL D +       L + Q + +   +AS + Y+   
Sbjct: 241 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 297

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
                VH D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + APE    G
Sbjct: 298 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356

Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMN--IMDTNLLSE 897
           + +IK DV+++GI+L E+ T G  P    + G M  +    + L  V     M       
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVP----YPG-MVNR----EVLDQVERGYRMP------ 401

Query: 898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                      C  S+  L  +C  + PE R   + + + L   
Sbjct: 402 -------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  139 bits (351), Expect = 7e-35
 Identities = 68/304 (22%), Positives = 130/304 (42%), Gaps = 39/304 (12%)

Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGA-- 703
           P +     ++D+        + ++ +G G YG VY+G +    + VA+K     +E    
Sbjct: 203 PTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTME 259

Query: 704 LNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY---ASNFNLDI 760
           +  F  E  ++K I+H NLV+++  CT      ++ E+M  G+L D  Y    +   +  
Sbjct: 260 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSA 317

Query: 761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM 820
              L +   ++SA+EYL        +H ++   N L+ ++ +  ++DFG+++L++ +   
Sbjct: 318 VVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374

Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWI 879
                   I + APE     + SIK DV+ +G++L E+ T GM P    + G + +    
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YPG-IDLS--- 426

Query: 880 NDSLPAVMN--IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR 937
                 +     M+               + C   V  L   C   +P +R +  EI   
Sbjct: 427 -QVYELLEKDYRME-------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 472

Query: 938 LIKI 941
              +
Sbjct: 473 FETM 476

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  134 bits (339), Expect = 1e-34
 Identities = 55/356 (15%), Positives = 114/356 (32%), Gaps = 67/356 (18%)

Query: 195 LPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLK 254
           +     N  + K   +  ++L   +     +  N++ L +  + L       +   + L+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 255 ILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNL 314
           +L+L +N     L  + +L  L  L  L+L  N +                 EL    ++
Sbjct: 62  LLNLSSN----VLYETLDLESLSTLRTLDLNNNYVQ----------------ELLVGPSI 101

Query: 315 KRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLK 374
           + L    N ++                  +          + L +N ++    +  G   
Sbjct: 102 ETLHAANNNIS-----------------RVSCSRGQGKKNIYLANNKITMLRDLDEGCRS 144

Query: 375 KLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNEL 434
           ++Q LDL+ N+ +                       + +        ++L  L+L  N +
Sbjct: 145 RVQYLDLKLNEID-----------------------TVNFAELAASSDTLEHLNLQYNFI 181

Query: 435 TSVIPSTFW-NLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGL 493
             V     +  L+ +   D SSN L   +  E ++   V  I L  N L   I   +   
Sbjct: 182 YDVKGQVVFAKLKTL---DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236

Query: 494 KNLQHLSLEHNKLQ-GPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLN 548
           +NL+H  L  N    G + + F +   ++ +                 +  L    
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  125 bits (317), Expect = 8e-32
 Identities = 55/354 (15%), Positives = 112/354 (31%), Gaps = 69/354 (19%)

Query: 49  IPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELE 108
           I     N +  +   ++ +     +     +   +KEL L  N L      +L    +LE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 109 MLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFK 168
           +L L++N+L         +L                         L  L+ L ++ N  +
Sbjct: 62  LLNLSSNVLY-----ETLDLE-----------------------SLSTLRTLDLNNNYVQ 93

Query: 169 GPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRN 228
                 L     + ++  + N  + R+    G     K++ L  N +      + G    
Sbjct: 94  -----ELLVGPSIETLHAANNNIS-RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSR 145

Query: 229 LEILGIDQSNLVGFVPDTIF-NISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLN 287
           ++ L +  + +       +  +  TL+ L+L  N +  ++      +    L+ L+L  N
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG---QVVFAKLKTLDLSSN 201

Query: 288 NLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIG 347
            L+  +             E    + +  + L  N L                     + 
Sbjct: 202 KLA-FMGP-----------EFQSAAGVTWISLRNNKLVLIEKA---------------LR 234

Query: 348 NLINLTTLSLGDNNLS-GSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRL 400
              NL    L  N    G+L     + +++Q +  Q  K      +E C    L
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  124 bits (314), Expect = 2e-31
 Identities = 44/210 (20%), Positives = 89/210 (42%), Gaps = 13/210 (6%)

Query: 346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYL 405
             N        + D++L  +L         ++ LDL  N        +   F++L ++ L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 406 NRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLE 465
           + N L       L  L++LR L L++N +  ++     ++E +     ++N+++    + 
Sbjct: 66  SSNVLY-ETLD-LESLSTLRTLDLNNNYVQELLVGP--SIETL---HAANNNISR---VS 115

Query: 466 IENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQG-PIPESFGELVSLEFLD 524
               +   +IYL+ N ++            +Q+L L+ N++      E      +LE L+
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 525 LSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
           L  N +   +   +     LK+L+LS NKL
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKL 203

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  123 bits (312), Expect = 4e-31
 Identities = 59/284 (20%), Positives = 113/284 (39%), Gaps = 20/284 (7%)

Query: 33  NRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNK 92
           NR     ++D  L   + S   +  +++ L LS N  S     ++   TKL+ L+L  N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 93  LQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCP 152
           L  E   +L +L+ L  L LNNN +       +     I   L  ++N+++         
Sbjct: 70  LY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSI-ETLHAANNNIS-RVSCSR-- 118

Query: 153 GLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTG-RLPRDLGNSTKLKSLDLG 211
                K +Y++ N+       +      +  + L  N+           +S  L+ L+L 
Sbjct: 119 -GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 212 FNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSK 271
           +N +  ++  ++     L+ L +  SN + F+     + + +  +SL NN L   +  + 
Sbjct: 178 YNFIY-DVKGQV-VFAKLKTLDLS-SNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKA- 232

Query: 272 NLIGLPNLEGLNLGLNNLS-GSIPSFFFNASKLYALELGYNSNL 314
            L    NLE  +L  N    G++  FF    ++  +       L
Sbjct: 233 -LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  123 bits (312), Expect = 4e-31
 Identities = 49/244 (20%), Positives = 89/244 (36%), Gaps = 28/244 (11%)

Query: 312 SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLG 371
           +  K   +  + L  + + L                +  N+  L L  N LS      L 
Sbjct: 10  NRYKIEKVTDSSLKQALASL--------------RQSAWNVKELDLSGNPLSQISAADLA 55

Query: 372 RLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSS 431
              KL+ L+L +N        +    S L  + LN N +       L    S+  L  ++
Sbjct: 56  PFTKLELLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAAN 108

Query: 432 NELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSG-NIPSTI 490
           N ++ V  S     ++I     ++N +     L+      V  + L  N +   N     
Sbjct: 109 NNISRVSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165

Query: 491 IGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLS 550
                L+HL+L++N +     +       L+ LDLS+N L+  +    +    +  ++L 
Sbjct: 166 ASSDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222

Query: 551 FNKL 554
            NKL
Sbjct: 223 NNKL 226

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 24/101 (23%), Positives = 43/101 (42%), Gaps = 3/101 (2%)

Query: 461 SLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSL 520
           ++    +N        ++ ++L   + S      N++ L L  N L             L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 521 EFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG 561
           E L+LS+N L   +   LE L  L++L+L+ N +  E+  G
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-QELLVG 98

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  139 bits (352), Expect = 1e-34
 Identities = 89/533 (16%), Positives = 173/533 (32%), Gaps = 68/533 (12%)

Query: 38  LTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYNKLQGE 96
           + I               L++ + +    +     +P  +  +  +++ L+L+  +++ E
Sbjct: 32  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 89

Query: 97  IPEE-LGNLAELEMLVLNNNLLTGTIPASIF-NLSFISTALDFSDNSLTGSFPYDMCPGL 154
           I          ++ L +  N +   +P  +F N+  + T L    N L+ S P  +    
Sbjct: 90  IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLL-TVLVLERNDLS-SLPRGIFHNT 146

Query: 155 PRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNN 214
           P+L  L +S N  +    +       L ++ LS N+ T  +   L     L   ++ +N 
Sbjct: 147 PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNL 203

Query: 215 LNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLI 274
           L       +     +E L     N +  V   +     L IL L +N    NL  +  L+
Sbjct: 204 L-----STLAIPIAVEELDAS-HNSINVVRGPVN--VELTILKLQHN----NLTDTAWLL 251

Query: 275 GLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSL 334
             P L  ++L  N L   I    F               L+RL +  N L      L   
Sbjct: 252 NYPGLVEVDLSYNELE-KIMYHPFVK----------MQRLERLYISNNRLV----ALNLY 296

Query: 335 FSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEF 394
                         +  L  L L  N+L   +     +  +L+ L L +N     +    
Sbjct: 297 GQ-----------PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS- 342

Query: 395 CHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWN---------- 444
                L  + L+ N    +  S      ++   ++   +    I     +          
Sbjct: 343 -THHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKP 399

Query: 445 LEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHN 504
             D L    +  S+   +        A   I   ++          + L+  + L  E N
Sbjct: 400 YLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVN 459

Query: 505 KLQGPIPESFGELVSLE--FLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLV 555
           +L+  + +   E +  E     L     + +    L K   L   + + NK+ 
Sbjct: 460 ELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPK-DGLARSSDNLNKVF 511

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  136 bits (344), Expect = 1e-33
 Identities = 84/514 (16%), Positives = 165/514 (32%), Gaps = 77/514 (14%)

Query: 48  TIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAEL 107
            I S+L        + +           E   L   K +    + ++      L +  ++
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 108 EMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQF 167
           E+L LN+  +   I    F                              ++ LY+ +N  
Sbjct: 78  ELLNLNDLQIE-EIDTYAFA-------------------------YAHTIQKLYMGFNAI 111

Query: 168 KGPIPNNLWHCKELSSVSLSYNQFTGRLPRDL-GNSTKLKSLDLGFNNLNGEIPQEI-GN 225
           +   P+   +   L+ + L  N  +  LPR +  N+ KL +L +  NNL   I  +    
Sbjct: 112 RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQA 169

Query: 226 LRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLG 285
             +L+ L +  SN +  V  ++    +L   ++  N LS        L     +E L+  
Sbjct: 170 TTSLQNLQL-SSNRLTHVDLSLI--PSLFHANVSYNLLS-------TLAIPIAVEELDAS 219

Query: 286 LNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLK 345
            N+++  +                    L  L L+ N LT +                  
Sbjct: 220 HNSIN-VVRGPVN-------------VELTILKLQHNNLTDTAW---------------- 249

Query: 346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYL 405
           + N   L  + L  N L   +     ++++L+ L + NN+    +         L V+ L
Sbjct: 250 LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 308

Query: 406 NRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLE--DILGFDFSSNSLNGSLP 463
           + N L   +       + L  L L  N + ++  ST   L+   +   D+  NSL     
Sbjct: 309 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFR 367

Query: 464 LEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPI---PESFGELVSL 520
                     D +   +    +        K      L++  L   +     + G   + 
Sbjct: 368 NVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSAT 427

Query: 521 EFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
           + ++   +    +       L   + L    N+L
Sbjct: 428 DTINSVQSLSHYITQQGGVPLQGNEQLEAEVNEL 461

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  126 bits (317), Expect = 4e-30
 Identities = 74/344 (21%), Positives = 136/344 (39%), Gaps = 42/344 (12%)

Query: 218 EIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLP 277
            I   +        + ID      +       ++  KI++  N+T+   LP++  L    
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAA-LLDSFR 75

Query: 278 NLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSA 337
            +E LNL    +   I ++ F           Y   +++L +  N + +    +      
Sbjct: 76  QVELLNLNDLQIE-EIDTYAF----------AYAHTIQKLYMGFNAIRYLPPHVFQ---- 120

Query: 338 LVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHF 397
                     N+  LT L L  N+LS           KL  L + NN  E      F   
Sbjct: 121 ----------NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 170

Query: 398 SRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNS 457
           + L  + L+ N+L+  +   L  + SL   ++S N L+++       +E++   D S NS
Sbjct: 171 TSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLSTLAIPI--AVEEL---DASHNS 222

Query: 458 LNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGEL 517
           +N    +       +  + L  NNL+    + ++    L  + L +N+L+  +   F ++
Sbjct: 223 INV---VRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKM 277

Query: 518 VSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG 561
             LE L +SNN L   +    + +  LK L+LS N L+  + R 
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERN 319

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  132 bits (335), Expect = 2e-34
 Identities = 51/214 (23%), Positives = 100/214 (46%), Gaps = 9/214 (4%)

Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAEC 711
             +          +    +G G +G V  G++    +VAIK+    +EG+++   F  E 
Sbjct: 14  LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEA 70

Query: 712 EILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA 771
           +++  + H  LV++   CT      ++ EYM  G L + +          Q L +  DV 
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 130

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY 831
            A+EYL    S   +H D+   N L++D  V  +SDFG+++ + +++      +   + +
Sbjct: 131 EAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 187

Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
             PE     + S K D++ +G+++ E+++ G  P
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (349), Expect = 2e-34
 Identities = 76/303 (25%), Positives = 134/303 (44%), Gaps = 37/303 (12%)

Query: 645 MSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGAL 704
             PQ         E+ R  +    E  +G G +G V+ G +     VAIK     + G +
Sbjct: 250 SKPQTQGLAKDAWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTM 304

Query: 705 NS--FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFN-LDIF 761
           +   F  E +++K +RH  LV++ +  +      +V EYM KGSL D +       L + 
Sbjct: 305 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLP 363

Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK 821
           Q + +   +AS + Y+        VH D++ +N+L+ +++V  ++DFG+A+L+ + +   
Sbjct: 364 QLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420

Query: 822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIN 880
           +      I + APE    G+ +IK DV+++GI+L E+ T G  P    + G M  +    
Sbjct: 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YPG-MVNR---- 471

Query: 881 DSLPAVMN--IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           + L  V     M                  C  S+  L  +C  + PE R   + + + L
Sbjct: 472 EVLDQVERGYRMP-------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518

Query: 939 IKI 941
              
Sbjct: 519 EDY 521

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  131 bits (333), Expect = 2e-34
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 9/204 (4%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRN 721
           ++ +    +G G +G V  G++    +VA+K+    +EG+++   F  E + +  + H  
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPK 64

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           LVK    C+      +V EY+  G L + + +    L+  Q L +  DV   + +L    
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---E 121

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQ 841
           S+  +H D+   N L+D  +   +SDFG+ + + ++  +    T   + + APE     +
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK 181

Query: 842 VSIKGDVYNYGIMLMEVFT-GMKP 864
            S K DV+ +GI++ EVF+ G  P
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMP 205

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  133 bits (337), Expect = 2e-34
 Identities = 76/301 (25%), Positives = 125/301 (41%), Gaps = 26/301 (8%)

Query: 655 SHDELLRATDQ--FSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREG 702
            H +L    D   F E +L     +G G++GSV   R+       G  VA+K        
Sbjct: 7   HHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD 66

Query: 703 ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDI 760
               F  E +ILK +    +VK          ++  LV+EY+P G L D +      LD 
Sbjct: 67  QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA 126

Query: 761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS- 819
            + L     +   +EYL    S   VH D+   N+L++      ++DFG+AKLL  +   
Sbjct: 127 SRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183

Query: 820 -MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKR 877
            + +    + I + APE   +   S + DV+++G++L E+FT   K      +      R
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLR 239

Query: 878 WINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR 937
            +              LL E +     A  +C + V  L   C + SP++R +   +  +
Sbjct: 240 MMGCERDVPALSRLLELLEEGQRLP--APPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297

Query: 938 L 938
           L
Sbjct: 298 L 298

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  136 bits (344), Expect = 3e-34
 Identities = 55/223 (24%), Positives = 109/223 (48%), Gaps = 11/223 (4%)

Query: 646 SPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA-- 703
                 + +  D      +    E  +G G +G V+   +    +VA+K     + G+  
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMS 226

Query: 704 LNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYAS-NFNLDIFQ 762
           + +F AE  ++KT++H  LVK+ +  T      ++ E+M KGSL D + +       + +
Sbjct: 227 VEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPK 285

Query: 763 RLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ 822
            +     +A  + ++        +H D++ +N+L+  S+V  ++DFG+A+++ + +   +
Sbjct: 286 LIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342

Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
                 I + APE    G  +IK DV+++GI+LME+ T G  P
Sbjct: 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  131 bits (333), Expect = 3e-34
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 20/209 (9%)

Query: 669 ENLIGIGSYGSVYKGRF--PDG--IEVAIKVFHLQREGALNS------FDAECEILKTIR 718
              +G GS+G V +G +  P G  + VA+K     +   L+       F  E   + ++ 
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL---KPDVLSQPEAMDDFIREVNAMHSLD 79

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           HRNL+++         K +V E  P GSL D +     +  +       + VA  + YL 
Sbjct: 80  HRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL- 137

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEY 836
              S   +H D+   N+LL    +  + DFG+ + L + D     Q        + APE 
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 837 GREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
            +    S   D + +G+ L E+FT G +P
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  130 bits (330), Expect = 9e-34
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 23/210 (10%)

Query: 668 EENLIGIGSYGSVYKGRFPDG---IEVAIKVFHLQREGALNS----FDAECEILKTIRHR 720
            +  +G G++GSV +G +      I+VAIKV    ++G   +       E +I+  + + 
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNP 70

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL--- 777
            +V++I  C       LV+E    G L   +      + +     ++  V+  ++YL   
Sbjct: 71  YIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 129

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPE 835
           +F      VH D+   NVLL +   A +SDFG++K L  +DS    ++     + + APE
Sbjct: 130 NF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
                + S + DV++YG+ + E  + G KP
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  137 bits (347), Expect = 1e-33
 Identities = 50/253 (19%), Positives = 91/253 (35%), Gaps = 46/253 (18%)

Query: 631 CKRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGR--FPDG 688
           C    + +  +  G    ++  +Y   E+            I  G  G +Y       +G
Sbjct: 62  CGSPYSFLPQLNPG---DIVAGQY---EVKG---------CIAHGGLGWIYLALDRNVNG 106

Query: 689 IEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKII-----SSCTNHNFKALVLEYM 742
             V +K         A     AE + L  + H ++V+I      +         +V+EY+
Sbjct: 107 RPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV 166

Query: 743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV 802
              SL+         L + + +  ++++  AL YLH   S  +V+ D+KP N++L +  +
Sbjct: 167 GGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQL 220

Query: 803 AHLSDFGIAKLLSEEDSMKQTQT---LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
             L D G    +                T G+ APE  R    ++  D+Y  G  L  + 
Sbjct: 221 K-LIDLGAVSRI--------NSFGYLYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALT 270

Query: 860 TGMKPTNEFFTGE 872
             +        G 
Sbjct: 271 LDLPT----RNGR 279

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  129 bits (326), Expect = 3e-33
 Identities = 55/207 (26%), Positives = 107/207 (51%), Gaps = 15/207 (7%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--FDAECEILKTIRHRN 721
           +       +G G +G V+ G +    +VA+K     ++G+++   F AE  ++K ++H+ 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 69

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMY---ASNFNLDIFQRLGIMIDVASALEYLH 778
           LV++ +  T      ++ EYM  GSL D  +    S   L I + L +   +A  + ++ 
Sbjct: 70  LVRLYAVVTQEPI-YIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR 838
                  +H D++ +N+L+ D++   ++DFG+A+L+ + +   +      I + APE   
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 839 EGQVSIKGDVYNYGIMLMEVFT-GMKP 864
            G  +IK DV+++GI+L E+ T G  P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIP 210

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  129 bits (326), Expect = 3e-33
 Identities = 73/296 (24%), Positives = 134/296 (45%), Gaps = 27/296 (9%)

Query: 665 QFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAECEIL 714
           QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E EIL
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65

Query: 715 KTIRHRNLVKIISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           K+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--MKQTQTLATIG 830
            +EYL    +   +H D+   N+L+++     + DFG+ K+L ++      +    + I 
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFT---GMKPTNEFFTGEMSIKRWINDSLPAVM 887
           + APE   E + S+  DV+++G++L E+FT     K     F   +   +     +  ++
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242

Query: 888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
            ++  N               C   +  +  EC + +   R + +++  R+ +IRD
Sbjct: 243 ELLKNNGRLP-------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  135 bits (341), Expect = 3e-33
 Identities = 74/327 (22%), Positives = 126/327 (38%), Gaps = 30/327 (9%)

Query: 558 IPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSRKQVILLGVVLPLSTVFIVT 617
           IP G  F               G  Y     C +S    +           P +      
Sbjct: 223 IPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQR 282

Query: 618 VILVLTFGLITRCCKRRSTEVSHIKAGMSPQVMWRRYSH-DELLRATDQFSEENL----- 671
            I  L     T    R ++        M   V    +S  +EL         +NL     
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI 342

Query: 672 -IGIGSYGSVYKGRFPDG---IEVAIKVFHLQREGALNS----FDAECEILKTIRHRNLV 723
            +G G++GSV +G +      I+VAIKV    ++G   +       E +I+  + +  +V
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL---HFG 780
           ++I  C       LV+E    G L   +      + +     ++  V+  ++YL   +F 
Sbjct: 400 RLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF- 457

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGR 838
                VH ++   NVLL +   A +SDFG++K L  +DS    ++     + + APE   
Sbjct: 458 -----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512

Query: 839 EGQVSIKGDVYNYGIMLMEVFT-GMKP 864
             + S + DV++YG+ + E  + G KP
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKP 539

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  130 bits (328), Expect = 3e-33
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 18/212 (8%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDG----IEVAIKVFHLQREGALNS----FDAECEIL 714
            +F +  ++G G++G+VYKG + P+G    I VAIK     RE            E  ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVM 71

Query: 715 KTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
            ++ + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  +
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT-IGYIA 833
            YL       +VH D+   NVL+       ++DFG+AKLL  E+     +     I ++A
Sbjct: 131 NYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
            E       + + DV++YG+ + E+ T G KP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  128 bits (325), Expect = 4e-33
 Identities = 55/211 (26%), Positives = 104/211 (49%), Gaps = 25/211 (11%)

Query: 668 EENLIGIGSYGSVYKGRFPDG---IEVAIKVFHLQREGAL-----NSFDAECEILKTIRH 719
           E+  +G G++G+V KG +        VA+K+    +  A      +   AE  +++ + +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL---KNEANDPALKDELLAEANVMQQLDN 77

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL-- 777
             +V++I  C   ++  LV+E    G L   +   N ++     + ++  V+  ++YL  
Sbjct: 78  PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE 135

Query: 778 -HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAP 834
            +F      VH D+   NVLL     A +SDFG++K L  +++  + QT     + + AP
Sbjct: 136 SNF------VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189

Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           E     + S K DV+++G+++ E F+ G KP
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  128 bits (324), Expect = 5e-33
 Identities = 64/288 (22%), Positives = 115/288 (39%), Gaps = 48/288 (16%)

Query: 669 ENLIGIGSYGSVYKGRFPDG----IEVAIKVFHLQREGA----LNSFDAECEILKTIRHR 720
              IG G +G V++G +       + VAIK     +          F  E   ++   H 
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHP 76

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
           ++VK+I   T +    +++E    G L   +    ++LD+   +     +++AL YL   
Sbjct: 77  HIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE-- 133

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
            S   VH DI   NVL+  +    L DFG+++ + +    K ++    I ++APE     
Sbjct: 134 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192

Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMSIKRWINDS--LPAVMNIMDTN 893
           + +   DV+ +G+ + E+   G+KP     N        +   I +   LP   N     
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERLPMPPN----- 241

Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                          C  ++ SL  +C +  P  R    E+ ++L  I
Sbjct: 242 ---------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  128 bits (324), Expect = 5e-33
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 11/215 (5%)

Query: 655 SHDELLRATDQFSEENLIGIGSYGSVYKGRFPDG-IEVAIKVFHLQREGALNS--FDAEC 711
           ++D+        + ++ +G G YG VY+G +    + VA+K     +E  +    F  E 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEA 60

Query: 712 EILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDV 770
            ++K I+H NLV+++  CT      ++ E+M  G+L D +   N   +     L +   +
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120

Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG 830
           +SA+EYL        +H D+   N L+ ++ +  ++DFG+++L++ +           I 
Sbjct: 121 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           + APE     + SIK DV+ +G++L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  128 bits (323), Expect = 6e-33
 Identities = 54/242 (22%), Positives = 93/242 (38%), Gaps = 30/242 (12%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRH 719
           R    F E  LIG G +G V+K +   DG    IK      E A      E + L  + H
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDH 63

Query: 720 RNLVKIISSCTNHNFKA----------------LVLEYMPKGSLEDCM-YASNFNLDIFQ 762
            N+V         ++                  + +E+  KG+LE  +       LD   
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 763 RLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ 822
            L +   +   ++Y+H   S  +++ D+KPSN+ L D+    + DFG+   L  +     
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178

Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS 882
           T++  T+ Y++PE         + D+Y  G++L E+          F          +  
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---AFETSKFFTDLRDGI 235

Query: 883 LP 884
           + 
Sbjct: 236 IS 237

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  128 bits (324), Expect = 1e-32
 Identities = 73/293 (24%), Positives = 134/293 (45%), Gaps = 21/293 (7%)

Query: 665 QFSEENL-----IGIGSYGSVYKGRFP-----DGIEVAIKVFHLQREGALNSFDAECEIL 714
           QF E +L     +G G++GSV   R+       G  VA+K      E  L  F+ E EIL
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96

Query: 715 KTIRHRNLVKIISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           K+++H N+VK    C +   +   L++EY+P GSL D +      +D  + L     +  
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--MKQTQTLATIG 830
            +EYL    +   +H D+   N+L+++     + DFG+ K+L ++      +    + I 
Sbjct: 157 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM 890
           + APE   E + S+  DV+++G++L E+FT ++ +       M +          ++   
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ--GQMIVFH 271

Query: 891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
              LL  +          C   +  +  EC + +   R + +++  R+ +IRD
Sbjct: 272 LIELLKNNGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  128 bits (323), Expect = 1e-32
 Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 18/211 (8%)

Query: 669 ENLIGIGSYGSVYKGRFPDGI---EVAIKVFHLQR---EGALNSFDAECEILKTIRHRNL 722
             L+G G  G VY+    D +    VA+K+                 E      ++  ++
Sbjct: 39  RRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           V I           + +  +    L   M      L   + + I+  + SAL+     H+
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAA-MLRRQGPLAPPRAVAIVRQIGSALDA---AHA 152

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT-LATIGYIAPEYGREGQ 841
               H D+KP N+L+     A+L DFGIA   ++E  + Q    + T+ Y+APE   E  
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDE-KLTQLGNTVGTLYYMAPERFSESH 211

Query: 842 VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
            + + D+Y    +L E  TG  P    + G+
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP----YQGD 238

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  128 bits (323), Expect = 1e-32
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 28/217 (12%)

Query: 671 LIGIGSYGSVYKGRFPDGI---EVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVK 724
           ++G G    V+  R  D     +VA+KV              F  E +    + H  +V 
Sbjct: 19  ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 725 I------ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           +       +      +  +V+EY+   +L D +  +   +   + + ++ D   AL +  
Sbjct: 77  VYDTGEAETPAGPLPY--IVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNF-- 131

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPE 835
             H N I+H D+KP+N+++  +    + DFGIA+ +++  +   TQT A IG   Y++PE
Sbjct: 132 -SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS-VTQTAAVIGTAQYLSPE 189

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
             R   V  + DVY+ G +L EV TG  P    FTG+
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  127 bits (322), Expect = 1e-32
 Identities = 63/291 (21%), Positives = 117/291 (40%), Gaps = 24/291 (8%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFP-----DGIEVAIKVFHLQR---EGALNSFDAECEILK 715
                   +G G +G V   R+       G +VA+K   L+       +     E EIL+
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILR 78

Query: 716 TIRHRNLVKIISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
            + H N+VK    CT        L++E++P GSL++ +  +   +++ Q+L   + +   
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--MKQTQTLATIGY 831
           ++YL    S   VH D+   NVL++      + DFG+ K +  +      +    + + +
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195

Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIM 890
            APE   + +  I  DV+++G+ L E+ T     ++        I          +    
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH----GQMTVTR 251

Query: 891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
             N L E +        +C   V  L  +C    P NR + + +I     +
Sbjct: 252 LVNTLKEGKRLP--CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  126 bits (320), Expect = 1e-32
 Identities = 48/208 (23%), Positives = 95/208 (45%), Gaps = 22/208 (10%)

Query: 669 ENLIGIGSYGSVYKGRF----PDGIEVAIKVFHLQREGALNS----FDAECEILKTIRHR 720
             ++G G +G VY+G +     + I VA+K     ++         F +E  I+K + H 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTC---KKDCTLDNKEKFMSEAVIMKNLDHP 73

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL--- 777
           ++VK+I          +++E  P G L   +  +  +L +   +   + +  A+ YL   
Sbjct: 74  HIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYG 837
           +       VH DI   N+L+       L DFG+++ + +ED  K + T   I +++PE  
Sbjct: 133 NC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 186

Query: 838 REGQVSIKGDVYNYGIMLMEVFT-GMKP 864
              + +   DV+ + + + E+ + G +P
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQP 214

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  128 bits (323), Expect = 2e-32
 Identities = 62/321 (19%), Positives = 116/321 (36%), Gaps = 46/321 (14%)

Query: 243 VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASK 302
           VP  +       +L L NN ++  +    +   L NL  L L  N +S  I    F  + 
Sbjct: 46  VPKDLP--PDTALLDLQNNKIT-EIKDG-DFKNLKNLHTLILINNKIS-KISPGAF--AP 98

Query: 303 LYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNL 362
           L          L+RL L +N L                   L       L  L + +N +
Sbjct: 99  L--------VKLERLYLSKNQLK-----------------ELPEKMPKTLQELRVHENEI 133

Query: 363 SGSLPITLGRLKKLQGLDLQNNKF-EGPIPQE-FCHFSRLYVVYLNRNKLSGSIPSCLGD 420
           +         L ++  ++L  N      I    F    +L  + +    ++ +IP   G 
Sbjct: 134 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GL 190

Query: 421 LNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRN 480
             SL  L L  N++T V  ++   L ++     S NS++      + N   + +++L+ N
Sbjct: 191 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 250

Query: 481 NLSGNIPSTIIGLKNLQHLSLEHNKLQG------PIPESFGELVSLEFLDLSNNDL--SG 532
            L   +P  +   K +Q + L +N +          P    +  S   + L +N +    
Sbjct: 251 KLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309

Query: 533 VIPASLEKLLYLKSLNLSFNK 553
           + P++   +    ++ L   K
Sbjct: 310 IQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  116 bits (293), Expect = 2e-28
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 9/213 (4%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
           +   L L +N ++         LK L  L L NNK     P  F    +L  +YL++N+L
Sbjct: 53  DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112

Query: 411 SGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSL-NGSLPLEI-EN 468
              +P  +    +L+ L +  NE+T V  S F  L  ++  +  +N L +  +     + 
Sbjct: 113 K-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169

Query: 469 LKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN 528
           +K +  I ++  N++  IP  +    +L  L L+ NK+      S   L +L  L LS N
Sbjct: 170 MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 226

Query: 529 DLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG 561
            +S V   SL    +L+ L+L+ NKLV ++P G
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  114 bits (288), Expect = 6e-28
 Identities = 71/377 (18%), Positives = 123/377 (32%), Gaps = 84/377 (22%)

Query: 133 TALDFSDNSLTGSFPYDMCPGLPR-LKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQF 191
             +  SD  L    P      LP     L +  N+       +  + K L ++ L  N+ 
Sbjct: 34  RVVQCSDLGLE-KVP----KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 192 TGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNIS 251
           +   P       KL+ L L  N L  E+P+++   + L+ L +   N +  V  ++FN  
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVH-ENEITKVRKSVFN-- 142

Query: 252 TLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNL-SGSIPSFFFNASKLYALELGY 310
                                  GL  +  + LG N L S  I +  F   K        
Sbjct: 143 -----------------------GLNQMIVVELGTNPLKSSGIENGAFQGMK-------- 171

Query: 311 NSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITL 370
              L  + +    +T                 ++  G   +LT L L  N ++     +L
Sbjct: 172 --KLSYIRIADTNIT-----------------TIPQGLPPSLTELHLDGNKITKVDAASL 212

Query: 371 GRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLS 430
             L  L  L L  N           +   L  ++LN NKL   +P  L D   ++++ L 
Sbjct: 213 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271

Query: 431 SNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNI--PS 488
           +N ++++  + F                    P       +   + L  N +      PS
Sbjct: 272 NNNISAIGSNDF------------------CPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313

Query: 489 TIIGLKNLQHLSLEHNK 505
           T   +     + L + K
Sbjct: 314 TFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  112 bits (281), Expect = 6e-27
 Identities = 64/270 (23%), Positives = 113/270 (41%), Gaps = 17/270 (6%)

Query: 50  PSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEM 109
                NL +L TL+L  N  S   P     L KL+ L+L  N+L+ E+PE++     L+ 
Sbjct: 69  DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQE 125

Query: 110 LVLNNNLLTGTIPASIF-NLSFISTALDFSDNSLTGSF-PYDMCPGLPRLKGLYVSYNQF 167
           L ++ N +T  +  S+F  L+ +   ++   N L  S        G+ +L  + ++    
Sbjct: 126 LRVHENEIT-KVRKSVFNGLNQM-IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183

Query: 168 KGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLR 227
              IP  L     L+ + L  N+ T      L     L  L L FN+++      + N  
Sbjct: 184 TT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 240

Query: 228 NLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLS----GNLPSSKNLIGLPNLEGLN 283
           +L  L ++ + LV  VP  + +   ++++ L NN +S     +           +  G++
Sbjct: 241 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVS 299

Query: 284 LGLNNLSGSI--PSFFFNASKLYALELGYN 311
           L  N +      PS F       A++LG  
Sbjct: 300 LFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  107 bits (268), Expect = 3e-25
 Identities = 69/344 (20%), Positives = 120/344 (34%), Gaps = 61/344 (17%)

Query: 58  SLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLL 117
            L+ +  S       +PK++   T    L L  NK+      +  NL  L  L+L NN +
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPPDTA--LLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 118 TGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWH 177
           +  I    F                           L +L+ LY+S NQ K  +P  +  
Sbjct: 89  S-KISPGAFA-------------------------PLVKLERLYLSKNQLKE-LPEKMP- 120

Query: 178 CKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNL-NGEIPQEI-GNLRNLEILGID 235
            K L  + +  N+ T           ++  ++LG N L +  I       ++ L  + I 
Sbjct: 121 -KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179

Query: 236 QSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPS 295
            +N+   +P  +    +L  L L  N ++  + ++ +L GL NL  L L  N++S     
Sbjct: 180 DTNITT-IPQGLP--PSLTELHLDGNKIT-KVDAA-SLKGLNNLAKLGLSFNSISAVDNG 234

Query: 296 FFFNASKLYALELGYNS------------NLKRLGLERNYLTFSTSELMSLFSALVNCKS 343
              N   L  L L  N              ++ + L  N ++           +   C  
Sbjct: 235 SLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA--------IGSNDFCPP 286

Query: 344 LKIGNLINLTTLSLGDNNLSGSL--PITLGRLKKLQGLDLQNNK 385
                  + + +SL  N +      P T   +     + L N K
Sbjct: 287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  103 bits (260), Expect = 3e-24
 Identities = 59/218 (27%), Positives = 89/218 (40%), Gaps = 13/218 (5%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
           +L  +   D  L   +P  L        LDLQNNK       +F +   L+ + L  NK+
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 411 SGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLK 470
           S   P     L  L  L LS N+L  +       L+++       N +          L 
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL---RVHENEITKVRKSVFNGLN 145

Query: 471 AVVDIYLSRNNL-SGNIPS-TIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN 528
            ++ + L  N L S  I +    G+K L ++ +    +   IP+  G   SL  L L  N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQ--GLPPSLTELHLDGN 202

Query: 529 DLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFAN 566
            ++ V  ASL+ L  L  L LSFN +   +   G+ AN
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSI-SAVDN-GSLAN 238

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  125 bits (317), Expect = 4e-32
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 22/210 (10%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVFHL--QREGALNSFDAECEILKTIRHRNLVKIIS 727
            IG GS+ +VYKG      +EVA          +     F  E E+LK ++H N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 728 SCTNHNFKA----LVLEYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           S  +         LV E M  G+L+  +       + + +       +   L++LH   +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS--WCRQILKGLQFLH-TRT 149

Query: 783 NPIVHCDIKPSNVLLDDSM-VAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPEYGR 838
            PI+H D+K  N+ +        + D G+A L         +   A IG   ++APE   
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR------ASFAKAVIGTPEFMAPEMYE 203

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKPTNEF 868
           E       DVY +G+ ++E+ T   P +E 
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSEYPYSEC 232

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  126 bits (318), Expect = 5e-32
 Identities = 67/294 (22%), Positives = 121/294 (41%), Gaps = 28/294 (9%)

Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIK---VFHLQREGALNSFDAECEILKTIRH 719
             F  E  IG G +  VY+     DG+ VA+K   +F L    A      E ++LK + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIF---QRLGIMIDVASALEY 776
            N++K  +S    N   +VLE    G L   +        +          + + SALE+
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
           +H   S  ++H DIKP+NV +  + V  L D G+ +  S + +   +    T  Y++PE 
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207

Query: 837 GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
             E   + K D+++ G +L E+     P    F G+         +L ++   +      
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP----FYGD-------KMNLYSLCKKI------ 250

Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIE 950
           E  ++  +     +  +  L   C +  PE R +   +     ++     +++E
Sbjct: 251 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  125 bits (317), Expect = 6e-32
 Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 19/220 (8%)

Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDG----IEVAIKVFHLQREGA----LNSFDA 709
            +         + +IG G +G VY G + D     I+ AIK             + +F  
Sbjct: 15  LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL---SRITEMQQVEAFLR 71

Query: 710 ECEILKTIRHRNLVKIISSCTNHN-FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
           E  +++ + H N++ +I           ++L YM  G L   + +   N  +   +   +
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED---SMKQTQT 825
            VA  +EYL        VH D+   N +LD+S    ++DFG+A+ + + +     +    
Sbjct: 132 QVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188

Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
              + + A E  +  + + K DV+++G++L E+ T G  P
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  127 bits (320), Expect = 6e-32
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)

Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHL------QREGALNSFDAECEILKT 716
           +++     IG GS+G     +   DG +  IK  ++      +RE +      E  +L  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR----EVAVLAN 79

Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALE 775
           ++H N+V+   S   +    +V++Y   G L   + A         Q L   + +  AL+
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           ++H      I+H DIK  N+ L       L DFGIA++L+    + +     T  Y++PE
Sbjct: 140 HVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPE 195

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
                  + K D++  G +L E+ T    
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHA 224

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  126 bits (318), Expect = 6e-32
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 669 ENLIGIGSYGSVYKGRFPDG-----IEVAIKVFHLQREGA----LNSFDAECEILKTIRH 719
             ++G G +G+V+KG +        I V IKV     + +      +       + ++ H
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI---EDKSGRQSFQAVTDHMLAIGSLDH 74

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
            ++V+++  C   + + LV +Y+P GSL D +      L     L   + +A  + YL  
Sbjct: 75  AHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL-- 131

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQTQTLATIGYIAPEYGR 838
              + +VH ++   NVLL       ++DFG+A LL  +D  +  ++    I ++A E   
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 839 EGQVSIKGDVYNYGIMLMEVFT-GMKP 864
            G+ + + DV++YG+ + E+ T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  124 bits (313), Expect = 1e-31
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 23/223 (10%)

Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHL------QREGALNSFDAECEILKT 716
           + +     IG GSYG   K R   DG  +  K          +++  ++    E  +L+ 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS----EVNLLRE 61

Query: 717 IRHRNLVKIISSCTNHNFKAL--VLEYMPKGSLEDCMYASNFNLDIF---QRLGIMIDVA 771
           ++H N+V+      +     L  V+EY   G L   +               L +M  + 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121

Query: 772 SALEYLHFGH--SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
            AL+  H      + ++H D+KP+NV LD      L DFG+A++L+ + S  +T  + T 
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTP 180

Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
            Y++PE       + K D+++ G +L E+   M P    FT  
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF 219

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  125 bits (316), Expect = 1e-31
 Identities = 62/251 (24%), Positives = 105/251 (41%), Gaps = 20/251 (7%)

Query: 625 GLITRCCKRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGR 684
            L  +         +       P    R ++  E+  +     +   IG G  G V  GR
Sbjct: 13  NLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTR-EIEASRIHIEKI--IGSGDSGEVCYGR 69

Query: 685 FPDG----IEVAIKVFHLQREGALNS----FDAECEILKTIRHRNLVKIISSCTNHNFKA 736
                   + VAIK     + G        F +E  I+    H N++++    T      
Sbjct: 70  LRVPGQRDVPVAIKAL---KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126

Query: 737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVL 796
           +V EYM  GSL+  +   +    I Q +G++  V + + YL        VH D+   NVL
Sbjct: 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVL 183

Query: 797 LDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT--IGYIAPEYGREGQVSIKGDVYNYGIM 854
           +D ++V  +SDFG++++L ++     T T     I + APE       S   DV+++G++
Sbjct: 184 VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243

Query: 855 LMEVFT-GMKP 864
           + EV   G +P
Sbjct: 244 MWEVLAYGERP 254

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  124 bits (314), Expect = 2e-31
 Identities = 60/252 (23%), Positives = 90/252 (35%), Gaps = 26/252 (10%)

Query: 632 KRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGR-FPDGIE 690
           + +   VS                          F   + +G GSYG V+K R   DG  
Sbjct: 25  QLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRL 84

Query: 691 VAIKVFHLQREGALNSFDAECEI---LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL 747
            A+K       G  +      E+    K  +H   V++  +        L  E     SL
Sbjct: 85  YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSL 143

Query: 748 EDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSD 807
           +    A   +L   Q  G + D   AL +LH   S  +VH D+KP+N+ L       L D
Sbjct: 144 QQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGD 200

Query: 808 FGIAKLLSEEDSMKQTQTLA-TIGYIAPE-----YGREGQVSIKGDVYNYGIMLMEVFTG 861
           FG+   L    +    +       Y+APE     YG         DV++ G+ ++EV   
Sbjct: 201 FGLLVELG---TAGAGEVQEGDPRYMAPELLQGSYGT------AADVFSLGLTILEVACN 251

Query: 862 MKPTNEFFTGEM 873
           M+       GE 
Sbjct: 252 MEL---PHGGEG 260

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  124 bits (313), Expect = 2e-31
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 10/200 (5%)

Query: 671 LIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSC 729
           ++G G+YG VY GR     + +AIK    +          E  + K ++H+N+V+ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--GIMIDVASALEYLHFGHSNPIVH 787
           + + F  + +E +P GSL   + +    L   ++        +   L+YL   H N IVH
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL---HDNQIVH 145

Query: 788 CDIKPSNVLLDDSM-VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE--YGREGQVSI 844
            DIK  NVL++    V  +SDFG +K L+  +   +T T  T+ Y+APE           
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGYGK 204

Query: 845 KGDVYNYGIMLMEVFTGMKP 864
             D+++ G  ++E+ TG  P
Sbjct: 205 AADIWSLGCTIIEMATGKPP 224

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  124 bits (314), Expect = 2e-31
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 9/222 (4%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNK--FEGPIPQEFCHFSRLYVVYLNRN 408
           + T L L  N L         +L +L  L L +N   F+G   Q     + L  + L+ N
Sbjct: 29  SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88

Query: 409 KLSGSIPSCLGDLNSLRILSLSSNELTSVIP-STFWNLEDILGFDFSSNSLNGSLPLEI- 466
            +  ++ S    L  L  L    + L  +   S F +L +++  D S           I 
Sbjct: 89  GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIF 146

Query: 467 ENLKAVVDIYLSRNNLSGNIPSTI-IGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDL 525
             L ++  + ++ N+   N    I   L+NL  L L   +L+   P +F  L SL+ L++
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206

Query: 526 SNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANF 567
           S+N+   +     + L  L+ L+ S N ++    +     +F
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKK-QELQHF 246

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  111 bits (279), Expect = 6e-27
 Identities = 65/328 (19%), Positives = 114/328 (34%), Gaps = 78/328 (23%)

Query: 206 KSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIF-NISTLKILSLFNNTLS 264
             +      L   +P  I    +   L + +SN +  +P  +F  ++ L  LSL +N LS
Sbjct: 10  TEIRCNSKGLT-SVPTGI--PSSATRLEL-ESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65

Query: 265 GNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYL 324
                S++  G  +L+ L+L  N +  ++ S F    +L  L+  ++ NLK++       
Sbjct: 66  FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS-NLKQMSEF---- 119

Query: 325 TFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNN 384
                   S+F            +L NL  L +   +   +       L  L+ L +  N
Sbjct: 120 --------SVFL-----------SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160

Query: 385 KFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWN 444
            F                           +P    +L +L  L LS  +L  + P+ F +
Sbjct: 161 SF-----------------------QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197

Query: 445 LEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHN 504
           L                      +L+    + +S NN           L +LQ L    N
Sbjct: 198 L---------------------SSLQ---VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233

Query: 505 KLQGPIPESFGELV-SLEFLDLSNNDLS 531
            +     +       SL FL+L+ ND +
Sbjct: 234 HIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  105 bits (263), Expect = 8e-25
 Identities = 52/259 (20%), Positives = 97/259 (37%), Gaps = 11/259 (4%)

Query: 36  TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKL-- 93
           T +  +  GL  ++P+ +   SS   L L  N            LT+L +L L  N L  
Sbjct: 10  TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66

Query: 94  QGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPG 153
           +G   +       L+ L L+ N +  T+ ++   L  +   LDF  ++L     + +   
Sbjct: 67  KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQL-EHLDFQHSNLKQMSEFSVFLS 124

Query: 154 LPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRD-LGNSTKLKSLDLGF 212
           L  L  L +S+   +            L  + ++ N F      D       L  LDL  
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184

Query: 213 NNLNGEIPQEI-GNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSK 271
             L  ++      +L +L++L +  +N           +++L++L    N +       +
Sbjct: 185 CQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQE 242

Query: 272 NLIGLPNLEGLNLGLNNLS 290
                 +L  LNL  N+ +
Sbjct: 243 LQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 40/215 (18%), Positives = 74/215 (34%), Gaps = 24/215 (11%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHL 88
            +  N ++                    +SL+ L LS N    T+      L +L+ L  
Sbjct: 58  SLSSNGLSFKGCC--------SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 108

Query: 89  DYNKLQGEIPEE--LGNLAELEMLVLNNNLLTGTIPASIF----NLSFISTALDFSDNSL 142
            ++ L+ ++ E     +L  L  L +++          IF    +L      L  + NS 
Sbjct: 109 QHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSL----EVLKMAGNSF 162

Query: 143 TGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNS 202
             +F  D+   L  L  L +S  Q +   P        L  +++S+N F           
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 222

Query: 203 TKLKSLDLGFNNLNGEIPQEI--GNLRNLEILGID 235
             L+ LD   N++     ++       +L  L + 
Sbjct: 223 NSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLT 256

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  128 bits (323), Expect = 2e-31
 Identities = 78/465 (16%), Positives = 155/465 (33%), Gaps = 67/465 (14%)

Query: 37  SLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGE 96
           S   +   +  T       L++L +L    +  +      I  LT L +L    N +   
Sbjct: 22  SEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT-T 78

Query: 97  IPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPR 156
           +   L     L  L  ++N LT      +  L    T L+   N LT           P 
Sbjct: 79  LD--LSQNTNLTYLACDSNKLTNLDVTPLTKL----TYLNCDTNKLT-KLDVS---QNPL 128

Query: 157 LKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLN 216
           L  L  + N        ++ H  +L+ +    N+   +L  D+   T+L +LD  FN + 
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT 183

Query: 217 GEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGL 276
                ++   + L  L  D +N+      T  +++    L+  +   S N  +  ++  L
Sbjct: 184 EL---DVSQNKLLNRLNCDTNNI------TKLDLNQNIQLTFLD--CSSNKLTEIDVTPL 232

Query: 277 PNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLT-----FSTSEL 331
             L   +  +N L+               L++   S L  L   +  L       +T  +
Sbjct: 233 TQLTYFDCSVNPLT--------------ELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLI 278

Query: 332 MSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIP 391
                     K L + +   L  L      ++    + L +  KL  L L N +    + 
Sbjct: 279 YFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELTE-LD 334

Query: 392 QEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGF 451
               H ++L  +      +     S +G + +L     +  +  ++   T          
Sbjct: 335 --VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKET---------- 380

Query: 452 DFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNL 496
             ++NSL  ++  ++ +           +    +  +  I  +NL
Sbjct: 381 -LTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENL 424

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  122 bits (308), Expect = 1e-29
 Identities = 66/379 (17%), Positives = 121/379 (31%), Gaps = 52/379 (13%)

Query: 181 LSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLV 240
            +S   +  +              L SLD   +++  ++   I  L  L  L    +N+ 
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77

Query: 241 GFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNA 300
                 +   + L  L+  +N L+     + ++  L  L  LN   N L+          
Sbjct: 78  TL---DLSQNTNLTYLACDSNKLT-----NLDVTPLTKLTYLNCDTNKLT---------- 119

Query: 301 SKLYALELGYNSNLKRLGLERNYLT-FSTSELMSL----FSALVNCKSLKIGNLINLTTL 355
                L++  N  L  L   RN LT    S    L             L +     LTTL
Sbjct: 120 ----KLDVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTL 175

Query: 356 SLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIP 415
               N ++    + + + K L  L+   N        +     +L  +  + NKL+  I 
Sbjct: 176 DCSFNKITE---LDVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EID 228

Query: 416 SCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDI 475
             +  L  L     S N LT +  ST   L  +         L     +++ +   ++  
Sbjct: 229 --VTPLTQLTYFDCSVNPLTELDVSTLSKLTTL---HCIQTDLLE---IDLTHNTQLIYF 280

Query: 476 YLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIP 535
                     +   +     L  L  +   +         +   L +L L+N +L+ +  
Sbjct: 281 QAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELTEL-- 333

Query: 536 ASLEKLLYLKSLNLSFNKL 554
             +     LKSL+     +
Sbjct: 334 -DVSHNTKLKSLSCVNAHI 351

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  122 bits (307), Expect = 2e-29
 Identities = 67/446 (15%), Positives = 137/446 (30%), Gaps = 54/446 (12%)

Query: 59  LQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLT 118
             + V +      T       L  L  L    + +  ++   +  L  L  L+  +N +T
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77

Query: 119 GTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHC 178
               +   NL    T L    N LT +        L +L  L    N+       ++   
Sbjct: 78  TLDLSQNTNL----TYLACDSNKLT-NLDVT---PLTKLTYLNCDTNKLT---KLDVSQN 126

Query: 179 KELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSN 238
             L+ ++ + N  T     D+ ++T+L  LD   N    ++   +     L  L    + 
Sbjct: 127 PLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181

Query: 239 LVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFF 298
           +       +     L  L+   N +     +  +L     L  L+   N L+        
Sbjct: 182 ITEL---DVSQNKLLNRLNCDTNNI-----TKLDLNQNIQLTFLDCSSNKLT-------- 225

Query: 299 NASKLYALELGYNSNLKRLGLERNYLT----FSTSELMSLFSALVNCKSLKIGNLINLTT 354
                  +++   + L       N LT     + S+L +L     +   + + +   L  
Sbjct: 226 ------EIDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIY 279

Query: 355 LSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSI 414
                      L +T     +L  LD Q          +     +L  +YLN  +L+  +
Sbjct: 280 FQAEGCRKIKELDVT--HNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-EL 333

Query: 415 PSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVD 474
              +     L+ LS  +  +     S+   +  +     +           + N    + 
Sbjct: 334 D--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIA 389

Query: 475 IYLSRNNLSGNIPSTIIGLKNLQHLS 500
           +     +  GN  +   G   +   +
Sbjct: 390 VSPDLLDQFGNPMNIEPGDGGVYDQA 415

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 81.7 bits (202), Expect = 3e-16
 Identities = 37/219 (16%), Positives = 76/219 (34%), Gaps = 28/219 (12%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
           N  +       +  +  I+  +L  L  LD  N+     +       + L  +    N +
Sbjct: 19  NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNI 76

Query: 411 SGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLED-------ILGFDFSSNSLNGSL- 462
           + ++   L    +L  L+  SN+LT++  +    L         +   D S N L   L 
Sbjct: 77  T-TLD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLN 133

Query: 463 -------PLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFG 515
                   +++ +   + ++    N     +   +     L  L    NK+         
Sbjct: 134 CARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVS 188

Query: 516 ELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
           +   L  L+   N+++ +    L + + L  L+ S NKL
Sbjct: 189 QNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKL 224

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 75.9 bits (187), Expect = 2e-14
 Identities = 50/285 (17%), Positives = 88/285 (30%), Gaps = 34/285 (11%)

Query: 29  DVYGNRVTSLTISD------LGLAG----TIPSHLGNLSSLQTLVLSRNWFSGTIPKEIG 78
           D   N++T L +S       L         +   L     L  L  S N  +  I   + 
Sbjct: 176 DCSFNKITELDVSQNKLLNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLT-EID--VT 230

Query: 79  NLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFS 138
            LT+L       N L  E+   +  L++L  L      L   I  +              
Sbjct: 231 PLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EIDLTHNT---QLIYFQAE 283

Query: 139 DNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRD 198
                            +L  L             +L    +L  + L+  + T  L  D
Sbjct: 284 GCRKIKELDV---THNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-EL--D 334

Query: 199 LGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSL 258
           + ++TKLKSL     ++  +    +G +  L      +   +    +T+ N S    +S 
Sbjct: 335 VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSP 392

Query: 259 FNNTLSGN-LPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASK 302
                 GN +       G+ +     +   NLS   P+  +  + 
Sbjct: 393 DLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTS 437

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  127 bits (322), Expect = 2e-31
 Identities = 68/224 (30%), Positives = 103/224 (45%), Gaps = 17/224 (7%)

Query: 646 SPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALN 705
                   +          +      IG G +G V  G +  G +VA+K   ++ +    
Sbjct: 175 GTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQ 231

Query: 706 SFDAECEILKTIRHRNLVKIISSCTNHNFKA-LVLEYMPKGSLEDCMY---ASNFNLDIF 761
           +F AE  ++  +RH NLV+++           +V EYM KGSL D  Y        L   
Sbjct: 232 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGD 289

Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK 821
             L   +DV  A+EYL     N  VH D+   NVL+ +  VA +SDFG    L++E S  
Sbjct: 290 CLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFG----LTKEASST 342

Query: 822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           Q      + + APE  RE + S K DV+++GI+L E+++ G  P
Sbjct: 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  125 bits (315), Expect = 2e-31
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 18/212 (8%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDG-----IEVAIKVFHLQREGALNS----FDAECEIL 714
            +F +  ++G G++G+VYKG +        I VAIK     RE            E  ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVM 71

Query: 715 KTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
            ++ + ++ +++  C     + L+ + MP G L D +     N+     L   + +A  +
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT-IGYIA 833
            YL       +VH D+   NVL+       ++DFG+AKLL  E+     +     I ++A
Sbjct: 131 NYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
            E       + + DV++YG+ + E+ T G KP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  130 bits (328), Expect = 2e-31
 Identities = 65/288 (22%), Positives = 115/288 (39%), Gaps = 48/288 (16%)

Query: 669 ENLIGIGSYGSVYKGRFPDG----IEVAIKVFHLQREGA----LNSFDAECEILKTIRHR 720
              IG G +G V++G +       + VAIK     +          F  E   ++   H 
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHP 451

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
           ++VK+I   T +    +++E    G L   +    F+LD+   +     +++AL YL   
Sbjct: 452 HIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE-- 508

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
            S   VH DI   NVL+  +    L DFG+++ + +    K ++    I ++APE     
Sbjct: 509 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567

Query: 841 QVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMSIKRWIND--SLPAVMNIMDTN 893
           + +   DV+ +G+ + E+   G+KP     N        +   I +   LP   N     
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERLPMPPN----- 616

Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                          C  ++ SL  +C +  P  R    E+ ++L  I
Sbjct: 617 ---------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  124 bits (313), Expect = 3e-31
 Identities = 66/298 (22%), Positives = 118/298 (39%), Gaps = 33/298 (11%)

Query: 665 QFSEENL-----IGIGSYGSVYKGRF-----PDGIEVAIKVFHLQREGALNS---FDAEC 711
            F +  L     +G G +G V    +       G  VA+K   L+ +        +  E 
Sbjct: 27  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEI 84

Query: 712 EILKTIRHRNLVKIISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID 769
           +IL+T+ H +++K    C +    +  LV+EY+P GSL D  Y    ++ + Q L     
Sbjct: 85  DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQ 142

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--MKQTQTLA 827
           +   + YLH   +   +H D+   NVLLD+  +  + DFG+AK + E       +    +
Sbjct: 143 ICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199

Query: 828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAV 886
            + + APE  +E +     DV+++G+ L E+ T      +            I  +   +
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP----PTKFLELIGIAQGQM 255

Query: 887 MNIMDTNLLSEDEEHANVAK-QSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
                  L    E    + +   C + V  L   C       R   + +I  L  + +
Sbjct: 256 TV---LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  126 bits (319), Expect = 3e-31
 Identities = 58/285 (20%), Positives = 119/285 (41%), Gaps = 43/285 (15%)

Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLV 723
            F  ++++G G+ G++      D  +VA+K    +     +  D E ++L+    H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           +   +  +  F+ + +E     +L++ +   +F     + + ++    S L +LH   S 
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137

Query: 784 PIVHCDIKPSNVLL-----DDSMVAHLSDFGIAKLLSEED-SMKQTQTLA-TIGYIAPEY 836
            IVH D+KP N+L+        + A +SDFG+ K L+    S  +   +  T G+IAPE 
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 837 ---GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM--- 890
                +   +   D+++ G +   V +        F            SL    NI+   
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSH---PF----------GKSLQRQANILLGA 244

Query: 891 -DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
              + L  ++    +A++        L  +  +  P+ R + K +
Sbjct: 245 CSLDCLHPEKHEDVIARE--------LIEKMIAMDPQKRPSAKHV 281

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  123 bits (311), Expect = 4e-31
 Identities = 63/297 (21%), Positives = 113/297 (38%), Gaps = 51/297 (17%)

Query: 669 ENLIGIGSYGSVYKGRFPDG----IEVAIKVFHLQREGA----LNSFDAECEILKTIRHR 720
             +IG G +G VY G   D     I  A+K             ++ F  E  I+K   H 
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHP 86

Query: 721 NLVKIISSCTNHNFKAL-VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
           N++ ++  C       L VL YM  G L + +     N  +   +G  + VA  ++YL  
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-- 144

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT---IGYIAPEY 836
             S   VH D+   N +LD+     ++DFG+A+ + +++             + ++A E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203

Query: 837 GREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMSIKRWINDS--LPAVMNI 889
            +  + + K DV+++G++L E+ T G  P              I  ++     L      
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRLLQPEY- 256

Query: 890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF 946
                              C   +  + ++C     E R +  E++SR+  I     
Sbjct: 257 -------------------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  124 bits (313), Expect = 4e-31
 Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 17/209 (8%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
               + +  +G GS+G V++ +    G + A+K   L+          E      +    
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPR 111

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFG 780
           +V +  +     +  + +E +  GSL   +        D       +      LEYLH  
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY--YLGQALEGLEYLH-- 167

Query: 781 HSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLAT-IG---YIAPE 835
            +  I+H D+K  NVLL  D   A L DFG A  L  +   K   T     G   ++APE
Sbjct: 168 -TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
                    K D+++   M++ +  G  P
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  123 bits (311), Expect = 5e-31
 Identities = 57/283 (20%), Positives = 112/283 (39%), Gaps = 40/283 (14%)

Query: 670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNL--VKI 725
             IG G    V++         AIK  +L+      L+S+  E   L  ++  +   +++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
                   +  +V+E      L   +     ++D ++R     ++  A+  +H    + I
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPE--------- 835
           VH D+KP+N L+ D M+  L DFGIA  +  + +     +   T+ Y+ PE         
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

Query: 836 --YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
                + ++S K DV++ G +L  +  G  P    F         I + +  +  I+D N
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQ-------IINQISKLHAIIDPN 256

Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
              E  +            +  +   C    P+ R++  E+++
Sbjct: 257 HEIEFPDIPE-------KDLQDVLKCCLKRDPKQRISIPELLA 292

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  123 bits (310), Expect = 5e-31
 Identities = 59/248 (23%), Positives = 100/248 (40%), Gaps = 50/248 (20%)

Query: 660 LRATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIR 718
           LR    F E  ++G G++G V K R   D    AIK      E  L++  +E  +L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLN 60

Query: 719 HRNLVKIISSCTNHNFKA-------------LVLEYMPKGSLEDCMYASNFNLDIFQRLG 765
           H+ +V+  ++                     + +EY   G+L D +++ N N    +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT 825
           +   +  AL Y+H   S  I+H D+KP N+ +D+S    + DFG+AK +     + +  +
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 826 LATIG-------------YIAPE-------YGREGQVSIKGDVYNYGIMLMEVFTGMKPT 865
               G             Y+A E       Y        K D+Y+ GI+  E+       
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE------KIDMYSLGIIFFEMIYP---- 227

Query: 866 NEFFTGEM 873
             F TG  
Sbjct: 228 --FSTGME 233

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  126 bits (318), Expect = 6e-31
 Identities = 57/234 (24%), Positives = 90/234 (38%), Gaps = 10/234 (4%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
           N   L+L +NN+      T   L  L+ L L  N         F   + L  + L  N L
Sbjct: 76  NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135

Query: 411 SGSIPS-CLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEI-EN 468
           +  IPS     L+ LR L L +N + S+    F  +  ++  D         +     E 
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194

Query: 469 LKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN 528
           L  +  + L   N+  ++P  +  L  L+ L +  N      P SF  L SL+ L + N+
Sbjct: 195 LFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252

Query: 529 DLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFI---GNDLLC 579
            +S +   + + L  L  LNL+ N L   +P    F        +    N   C
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLS-SLP-HDLFTPLRYLVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  118 bits (298), Expect = 2e-28
 Identities = 69/282 (24%), Positives = 115/282 (40%), Gaps = 35/282 (12%)

Query: 180 ELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNL 239
           + S V  +    +  +P+ +   +  + L+L  NN+         +L +LE+L +   N 
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQL-GRNS 110

Query: 240 VGFVPDTIF-NISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFF 298
           +  +    F  +++L  L LF+N L+  +PS      L  L  L L  N +  SIPS+ F
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLT-VIPSG-AFEYLSKLRELWLRNNPIE-SIPSYAF 167

Query: 299 NA-SKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSL 357
           N    L  L+LG    L+ +        F                      L NL  L+L
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEG----AFE--------------------GLFNLKYLNL 203

Query: 358 GDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSC 417
           G  N+   +P  L  L  L+ L++  N F    P  F   S L  +++  +++S    + 
Sbjct: 204 GMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNA 261

Query: 418 LGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLN 459
              L SL  L+L+ N L+S+    F  L  ++      N  N
Sbjct: 262 FDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  112 bits (283), Expect = 2e-26
 Identities = 59/244 (24%), Positives = 103/244 (42%), Gaps = 21/244 (8%)

Query: 312 SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLG 371
           SN + L L  N +    +     F            +L +L  L LG N++         
Sbjct: 75  SNTRYLNLMENNIQMIQA---DTFR-----------HLHHLEVLQLGRNSIRQIEVGAFN 120

Query: 372 RLKKLQGLDLQNNKFEGPIPQE-FCHFSRLYVVYLNRNKLSGSIPS-CLGDLNSLRILSL 429
            L  L  L+L +N     IP   F + S+L  ++L  N +  SIPS     + SL  L L
Sbjct: 121 GLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDL 178

Query: 430 SS-NELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPS 488
               +L  +    F  L ++   +    ++   +P  +  L  + ++ +S N+     P 
Sbjct: 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPG 236

Query: 489 TIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLN 548
           +  GL +L+ L + ++++      +F  L SL  L+L++N+LS +       L YL  L+
Sbjct: 237 SFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELH 296

Query: 549 LSFN 552
           L  N
Sbjct: 297 LHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  101 bits (253), Expect = 1e-22
 Identities = 61/267 (22%), Positives = 105/267 (39%), Gaps = 19/267 (7%)

Query: 27  TCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKEL 86
           +C    N+ + +  +  GL+  +P  +   S+ + L L  N           +L  L+ L
Sbjct: 51  SCS---NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVL 104

Query: 87  HLDYNKLQGEIPEE-LGNLAELEMLVLNNNLLTGTIPASIF-NLSFISTALDFSDNSLTG 144
            L  N ++ +I       LA L  L L +N LT  IP+  F  LS +   L   +N +  
Sbjct: 105 QLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKL-RELWLRNNPIE- 160

Query: 145 SFPYDMCPGLPRLKGLYVS-YNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNST 203
           S P      +P L  L +    + +            L  ++L        +P +L    
Sbjct: 161 SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLV 218

Query: 204 KLKSLDLGFNNLNGEIPQE-IGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNT 262
            L+ L++  N+   EI       L +L+ L +  S +     +    +++L  L+L +N 
Sbjct: 219 GLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN 277

Query: 263 LSGNLPSSKNLIGLPNLEGLNLGLNNL 289
           LS +LP       L  L  L+L  N  
Sbjct: 278 LS-SLPHD-LFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 74.8 bits (184), Expect = 4e-14
 Identities = 45/192 (23%), Positives = 68/192 (35%), Gaps = 21/192 (10%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELH 87
           +++ N +T +                 LS L+ L L  N    +IP      +  L  L 
Sbjct: 129 ELFDNWLTVIP----------SGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLD 177

Query: 88  L-DYNKLQGEIPEE-LGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGS 145
           L +  KL+  I E     L  L+ L L    +   +P  +  L  +   L+ S N     
Sbjct: 178 LGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEE-LEMSGNHFP-E 232

Query: 146 FPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRD-LGNSTK 204
                  GL  LK L+V  +Q      N       L  ++L++N  +  LP D       
Sbjct: 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRY 291

Query: 205 LKSLDLGFNNLN 216
           L  L L  N  N
Sbjct: 292 LVELHLHHNPWN 303

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  124 bits (312), Expect = 1e-30
 Identities = 72/388 (18%), Positives = 145/388 (37%), Gaps = 63/388 (16%)

Query: 587 PLCKSSPHKKSRKQVILLGVVLPLSTVFIVTVILVLTFGLITRCCKRRSTEVSHIKAGMS 646
           P+     H   R+  +  G+++P  +  +     + +   ++    +++   +    G +
Sbjct: 6   PMGHHHHHHGRRRASVAAGILVPRGSPGL---DGICSIEELSTSLYKKAGSENLYFQGAN 62

Query: 647 PQVMWRRYSHDELLRATDQFSEE---------NLIGIGSYGSVYKGRFPDG----IEVAI 693
              +     + EL++A                 +IG G +G VY G   D     I  A+
Sbjct: 63  TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122

Query: 694 KVFHLQREGA----LNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL-VLEYMPKGSLE 748
           K             ++ F  E  I+K   H N++ ++  C       L VL YM  G L 
Sbjct: 123 KSL---NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179

Query: 749 DCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDF 808
           + +     N  +   +G  + VA  +++L    S   VH D+   N +LD+     ++DF
Sbjct: 180 NFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADF 236

Query: 809 GIAKLLSEEDSM---KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           G+A+ + +++      +T     + ++A E  +  + + K DV+++G++L E+ T G  P
Sbjct: 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

Query: 865 ----TNEFFTGEMSIKRWINDS--LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAM 918
                         I  ++     L                         C   +  + +
Sbjct: 297 YPDVNTF------DITVYLLQGRRLLQPEY--------------------CPDPLYEVML 330

Query: 919 ECTSESPENRVNTKEIISRLIKIRDLLF 946
           +C     E R +  E++SR+  I     
Sbjct: 331 KCWHPKAEMRPSFSELVSRISAIFSTFI 358

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  125 bits (315), Expect = 1e-30
 Identities = 54/234 (23%), Positives = 89/234 (38%), Gaps = 10/234 (4%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
           N   L+L +N +      +   L+ L+ L L  N         F   + L  + L  N+L
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124

Query: 411 SGSIPS-CLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEI-EN 468
           + +IP+     L+ L+ L L +N + S+    F  +  +   D         +     E 
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183

Query: 469 LKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN 528
           L  +  + L+  NL   IP  +  L  L  L L  N L    P SF  L+ L+ L +  +
Sbjct: 184 LSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241

Query: 529 DLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFI---GNDLLC 579
            +  +   + + L  L  +NL+ N L   +P    F        I    N   C
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLT-LLPH-DLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  111 bits (280), Expect = 4e-26
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 7/208 (3%)

Query: 348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE-FCHFSRLYVVYLN 406
           +L +L  L L  N++          L  L  L+L +N+    IP   F + S+L  ++L 
Sbjct: 86  HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLR 144

Query: 407 RNKLSGSIPS-CLGDLNSLRILSLSS-NELTSVIPSTFWNLEDILGFDFSSNSLNGSLPL 464
            N +  SIPS     + SLR L L     L+ +    F  L ++   + +  +L   +P 
Sbjct: 145 NNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP- 201

Query: 465 EIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLD 524
            +  L  + ++ LS N+LS   P +  GL +LQ L +  +++Q     +F  L SL  ++
Sbjct: 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261

Query: 525 LSNNDLSGVIPASLEKLLYLKSLNLSFN 552
           L++N+L+ +       L +L+ ++L  N
Sbjct: 262 LAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 98.3 bits (245), Expect = 9e-22
 Identities = 65/329 (19%), Positives = 100/329 (30%), Gaps = 82/329 (24%)

Query: 132 STALDFSDNSLTGSFPYDMCPGLP-RLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQ 190
            + +     +L    P     G+    + L +  NQ +    N+  H + L  + LS N 
Sbjct: 45  FSKVICVRKNLR-EVP----DGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 191 FTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNI 250
                         L +L+L  N L   IP                             +
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIP-----------------------NGAFVYL 135

Query: 251 STLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGY 310
           S LK L L NN +  ++PS      +P+L  L+LG       I    F            
Sbjct: 136 SKLKELWLRNNPIE-SIPSY-AFNRIPSLRRLDLGELKRLSYISEGAFE----------- 182

Query: 311 NSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITL 370
                                                 L NL  L+L   NL   +P  L
Sbjct: 183 -------------------------------------GLSNLRYLNLAMCNLR-EIP-NL 203

Query: 371 GRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLS 430
             L KL  LDL  N      P  F     L  +++ ++++     +   +L SL  ++L+
Sbjct: 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263

Query: 431 SNELTSVIPSTFWNLEDILGFDFSSNSLN 459
            N LT +    F  L  +       N  N
Sbjct: 264 HNNLTLLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 96.4 bits (240), Expect = 5e-21
 Identities = 60/259 (23%), Positives = 109/259 (42%), Gaps = 16/259 (6%)

Query: 57  SSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNL 116
           +    ++  R      +P  I   T  + L+L  N++Q        +L  LE+L L+ N 
Sbjct: 43  NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 117 LTGTIPASIF-NLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNL 175
           +  TI    F  L+ ++T L+  DN LT + P      L +LK L++  N  +  IP+  
Sbjct: 100 IR-TIEIGAFNGLANLNT-LELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYA 155

Query: 176 WH-CKELSSVSLS-YNQFTGRLPRD-LGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEIL 232
           ++    L  + L    + +  +        + L+ L+L   NL  EIP  +  L  L+ L
Sbjct: 156 FNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDEL 212

Query: 233 GIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGS 292
            +  ++L    P +   +  L+ L +  + +   +  +     L +L  +NL  NNL+  
Sbjct: 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERN-AFDNLQSLVEINLAHNNLTLL 270

Query: 293 IPSFFFNASKLYALELGYN 311
               F     L  + L +N
Sbjct: 271 PHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 85.2 bits (211), Expect = 2e-17
 Identities = 53/235 (22%), Positives = 87/235 (37%), Gaps = 45/235 (19%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELH 87
           +++ N++  +            +   +L  L+ L LSRN    TI       L  L  L 
Sbjct: 70  NLHENQIQIIK----------VNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLE 118

Query: 88  LDYNKLQGEIPEE-LGNLAELEMLVLNNNLLTGTIPASIFN---------------LSFI 131
           L  N+L   IP      L++L+ L L NN +  +IP+  FN               LS+I
Sbjct: 119 LFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYI 176

Query: 132 S----------TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKEL 181
           S            L+ +  +L    P      L +L  L +S N      P +      L
Sbjct: 177 SEGAFEGLSNLRYLNLAMCNLR-EIPNL--TPLIKLDELDLSGNHLSAIRPGSFQGLMHL 233

Query: 182 SSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGID 235
             + +  +Q          N   L  ++L  NNL   +P ++   L +LE + + 
Sbjct: 234 QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLH 287

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 76.3 bits (188), Expect = 1e-14
 Identities = 48/192 (25%), Positives = 78/192 (40%), Gaps = 21/192 (10%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELH 87
           +++ NR+T++                 LS L+ L L  N    +IP      +  L+ L 
Sbjct: 118 ELFDNRLTTIP----------NGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLD 166

Query: 88  L-DYNKLQGEIPEE-LGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGS 145
           L +  +L   I E     L+ L  L L    L   IP  +  L  +   LD S N L+ +
Sbjct: 167 LGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDE-LDLSGNHLS-A 221

Query: 146 FPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNS-TK 204
                  GL  L+ L++  +Q +    N   + + L  ++L++N  T  LP DL      
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHH 280

Query: 205 LKSLDLGFNNLN 216
           L+ + L  N  N
Sbjct: 281 LERIHLHHNPWN 292

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  122 bits (307), Expect = 2e-30
 Identities = 37/187 (19%), Positives = 68/187 (36%), Gaps = 19/187 (10%)

Query: 665 QFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLV 723
            +     +G G +  V       DG   A+K      +        E ++ +   H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 724 KIISSCTNHNFKA----LVLEYMPKGSLEDCMYASNFNLDIF---QRLGIMIDVASALEY 776
           ++++ C           L+L +  +G+L + +       +     Q L +++ +   LE 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA--------T 828
           +H   +    H D+KP+N+LL D     L D G            +             T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 829 IGYIAPE 835
           I Y APE
Sbjct: 207 ISYRAPE 213

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  122 bits (308), Expect = 2e-30
 Identities = 56/233 (24%), Positives = 111/233 (47%), Gaps = 21/233 (9%)

Query: 644 GMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-----PDGIEVAIKVFHL 698
           G  P     +++  E+       + + +IG G +G VYKG          + VAIK    
Sbjct: 27  GSDPNQAVLKFTT-EIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-- 81

Query: 699 QREGALNS----FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYAS 754
            + G        F  E  I+    H N++++    + +    ++ EYM  G+L+  +   
Sbjct: 82  -KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK 140

Query: 755 NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL 814
           +    + Q +G++  +A+ ++YL    +   VH D+   N+L++ ++V  +SDFG++++L
Sbjct: 141 DGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197

Query: 815 SEEDSMKQTQTLAT--IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
            ++     T +     I + APE     + +   DV+++GI++ EV T G +P
Sbjct: 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  123 bits (310), Expect = 2e-30
 Identities = 57/286 (19%), Positives = 111/286 (38%), Gaps = 40/286 (13%)

Query: 665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNL 722
            +S    IG G    V++         AIK  +L+      L+S+  E   L  ++  + 
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 723 --VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
             +++        +  +V+E      L   +     ++D ++R     ++  A+  +H  
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH-- 172

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPE---- 835
             + IVH D+KP+N L+ D M+  L DFGIA  +  + +     +    + Y+ PE    
Sbjct: 173 -QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 836 -------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMN 888
                     + ++S K DV++ G +L  +  G  P    F         I + +  +  
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQ-------IINQISKLHA 279

Query: 889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
           I+D N   E  +            +  +   C    P+ R++  E+
Sbjct: 280 IIDPNHEIEFPDIPE-------KDLQDVLKCCLKRDPKQRISIPEL 318

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  122 bits (307), Expect = 3e-30
 Identities = 57/281 (20%), Positives = 110/281 (39%), Gaps = 40/281 (14%)

Query: 670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNL--VKI 725
             IG G    V++         AIK  +L+      L+S+  E   L  ++  +   +++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI 785
                   +  +V+E      L   +     ++D ++R     ++  A+  +H    + I
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPE--------- 835
           VH D+KP+N L+ D M+  L DFGIA  +  + +     +   T+ Y+ PE         
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 836 --YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
                + ++S K DV++ G +L  +  G  P    F         I + +  +  I+D N
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQ-------IINQISKLHAIIDPN 237

Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
              E  +            +  +   C    P+ R++  E+
Sbjct: 238 HEIEFPDIPE-------KDLQDVLKCCLKRDPKQRISIPEL 271

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  120 bits (302), Expect = 4e-30
 Identities = 46/222 (20%), Positives = 93/222 (41%), Gaps = 42/222 (18%)

Query: 669 ENLIGIGSYGSVYKGRF--------PDGIEVAIKVFHLQREGALN---SFDAECEILKTI 717
              +G G++  ++KG              EV +KV     +   N   SF     ++  +
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAASMMSKL 69

Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
            H++LV     C   +   LV E++  GSL+  +  +   ++I  +L +   +A+A+ +L
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129

Query: 778 ---HFGHSNPIVHCDIKPSNVLLD--------DSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
                      +H ++   N+LL         +     LSD GI+  +  +D ++     
Sbjct: 130 EENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ----- 178

Query: 827 ATIGYIAPE---YGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
             I ++ PE     +   +++  D +++G  L E+ + G KP
Sbjct: 179 ERIPWVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKP 218

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  121 bits (306), Expect = 7e-30
 Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 20/229 (8%)

Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQREG 702
           P      ++  EL       S + ++G G +G V  GR        I VAIK     + G
Sbjct: 31  PTQTVHEFAK-ELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVG 84

Query: 703 ALNS----FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNL 758
                   F  E  I+    H N++++    T      +V EYM  GSL+  +   +   
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF 144

Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            + Q +G++  +AS ++YL        VH D+   N+L++ ++V  +SDFG+ ++L ++ 
Sbjct: 145 TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201

Query: 819 SMKQTQTLAT--IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
               T       I + +PE     + +   DV++YGI+L EV + G +P
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  118 bits (299), Expect = 7e-30
 Identities = 69/217 (31%), Positives = 102/217 (47%), Gaps = 19/217 (8%)

Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA-LNSFDAECE 712
           +          +      IG G +G V  G +  G +VA+K     +  A   +F AE  
Sbjct: 11  FYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI---KNDATAQAFLAEAS 66

Query: 713 ILKTIRHRNLVKIISSCTNHNFKA-LVLEYMPKGSLEDCMY---ASNFNLDIFQRLGIMI 768
           ++  +RH NLV+++           +V EYM KGSL D  Y        L     L   +
Sbjct: 67  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSL 124

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           DV  A+EYL     N  VH D+   NVL+ +  VA +SDFG    L++E S  Q      
Sbjct: 125 DVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLP 177

Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           + + APE  RE + S K DV+++GI+L E+++ G  P
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  119 bits (301), Expect = 1e-29
 Identities = 49/216 (22%), Positives = 99/216 (45%), Gaps = 25/216 (11%)

Query: 669 ENLIGIGSYGSVYKGRFPDG----IEVAIKVFHLQREGA----LNSFDAECEILKTIRHR 720
             ++G G +GSV +G         ++VA+K   ++ + +    +  F +E   +K   H 
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 721 NLVKIISSCTNHNFKA-----LVLEYMPKGSLED-----CMYASNFNLDIFQRLGIMIDV 770
           N+++++  C   + +      ++L +M  G L        +     ++ +   L  M+D+
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQTQTLATI 829
           A  +EYL    +   +H D+   N +L D M   ++DFG++K +   D   +       +
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213

Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
            +IA E   +   + K DV+ +G+ + E+ T GM P
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  119 bits (301), Expect = 2e-29
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 10/204 (4%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHL-QREGALNSFDAECEILKTIRHRN 721
           D F + + +G G+ G V+K    P G+ +A K+ HL  +    N    E ++L       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCM-YASNFNLDIFQRLGIMIDVASALEYLHFG 780
           +V    +  +    ++ +E+M  GSL+  +  A      I  +  + I V   L YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--VSIAVIKGLTYLREK 150

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           H   I+H D+KPSN+L++      L DFG++  L   DSM  +  + T  Y++PE  +  
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQGT 205

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP 864
             S++ D+++ G+ L+E+  G  P
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYP 229

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  118 bits (298), Expect = 3e-29
 Identities = 62/307 (20%), Positives = 125/307 (40%), Gaps = 57/307 (18%)

Query: 672 IGIGSYGSVYKGRFPDGIE------VAIKVFHLQREGA----LNSFDAECEILKTIRHRN 721
           +G GS+G VY+G     ++      VAIK      E A       F  E  ++K     +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 89

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSL---------EDCMYASNFNLDIFQRLGIMIDVAS 772
           +V+++   +      +++E M +G L                     + + + +  ++A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQTQTLATIGY 831
            + YL+   +N  VH D+   N ++ +     + DFG+ + + E D   K  + L  + +
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206

Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMSIKRWINDSLPAV 886
           ++PE  ++G  +   DV+++G++L E+ T   +P    +NE                  V
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----------------QV 249

Query: 887 MN-IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL 945
           +  +M+  LL + +         C   +  L   C   +P+ R +  EIIS + +  +  
Sbjct: 250 LRFVMEGGLLDKPDN--------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301

Query: 946 FANIEMV 952
           F  +   
Sbjct: 302 FREVSFY 308

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (296), Expect = 4e-29
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 16/211 (7%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
            + +     +G G++G VYK +    G   A KV   + E  L  +  E EIL T  H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +VK++ +  +     +++E+ P G+++  M   +  L   Q   +   +  AL +LH   
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--- 134

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPE--- 835
           S  I+H D+K  NVL+       L+DFG++    +    + +     IG   ++APE   
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS----FIGTPYWMAPEVVM 190

Query: 836 --YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
               ++     K D+++ GI L+E+     P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  118 bits (297), Expect = 5e-29
 Identities = 66/328 (20%), Positives = 118/328 (35%), Gaps = 36/328 (10%)

Query: 36  TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQG 95
             +  SDLGL   +P  +        L L  N  S     +   L  L  L L  NK+  
Sbjct: 36  RVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92

Query: 96  EIPEELGNLAELEMLVLNNNLLTGTIPASIF-NLSFISTALDFSDNSLTGSFPYDMCPGL 154
              +    L +L+ L ++ N L   IP ++  +L      L   DN +    P  +  GL
Sbjct: 93  IHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSL----VELRIHDNRIR-KVPKGVFSGL 146

Query: 155 PRLKGLYVSYNQFK-GPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFN 213
             +  + +  N  +        +   +L+ + +S  + T  +P+DL     L  L L  N
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHN 203

Query: 214 NLNGEIPQEI-GNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKN 272
            +   I  E       L  LG+  + +      ++  + TL+ L L NN LS  +P+   
Sbjct: 204 KIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA--G 259

Query: 273 LIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELM 332
           L  L  L+ + L  NN++  +    F             +    + L  N + +   +  
Sbjct: 260 LPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVK----RAYYNGISLFNNPVPYWEVQ-P 313

Query: 333 SLFSALVNCKSLKIGNLINLTTLSLGDN 360
           + F             + +   +  G+ 
Sbjct: 314 ATFR-----------CVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  117 bits (296), Expect = 5e-29
 Identities = 61/320 (19%), Positives = 109/320 (34%), Gaps = 45/320 (14%)

Query: 243 VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASK 302
           VP  I       +L L NN +S  L    +  GL +L  L L  N +S  I    F  S 
Sbjct: 48  VPKEIS--PDTTLLDLQNNDIS-ELRKD-DFKGLQHLYALVLVNNKIS-KIHEKAF--SP 100

Query: 303 LYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNL 362
           L          L++L + +N+L                   +      +L  L + DN +
Sbjct: 101 L--------RKLQKLYISKNHLV-----------------EIPPNLPSSLVELRIHDNRI 135

Query: 363 SGSLPITLGRLKKLQGLDLQNNKF-EGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDL 421
                     L+ +  +++  N               +L  + ++  KL+  IP  L   
Sbjct: 136 RKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--P 192

Query: 422 NSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNN 481
            +L  L L  N++ ++          +       N +       +  L  + +++L  N 
Sbjct: 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK 252

Query: 482 LSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESF------GELVSLEFLDLSNNDLS--GV 533
           LS  +P+ +  LK LQ + L  N +       F       +      + L NN +    V
Sbjct: 253 LS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV 311

Query: 534 IPASLEKLLYLKSLNLSFNK 553
            PA+   +    ++     K
Sbjct: 312 QPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  112 bits (281), Expect = 6e-27
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 8/212 (3%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
           + T L L +N++S         L+ L  L L NNK      + F    +L  +Y+++N L
Sbjct: 55  DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114

Query: 411 SGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSL-NGSLPLEIENL 469
              IP  L   +SL  L +  N +  V    F  L ++   +   N L N        + 
Sbjct: 115 V-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171

Query: 470 KAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNND 529
             +  + +S   L+  IP  +   + L  L L+HNK+Q    E       L  L L +N 
Sbjct: 172 LKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQ 228

Query: 530 LSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG 561
           +  +   SL  L  L+ L+L  NKL   +P G
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  108 bits (273), Expect = 6e-26
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 15/218 (6%)

Query: 348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNR 407
            L +L  L L +N +S         L+KLQ L +  N     IP      S L  + ++ 
Sbjct: 76  GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHD 132

Query: 408 NKLSGSIPSCLGDLNSLRILSLSSNELTSVI--PSTFWNLEDILGFDFSSNSLNGSLPLE 465
           N++          L ++  + +  N L +    P  F  L+ +     S   L   +P +
Sbjct: 133 NRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLT-GIPKD 190

Query: 466 I-ENLKAVVDIYLSRNNLSGNIPS-TIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFL 523
           + E L     ++L  N +   I    ++    L  L L HN+++     S   L +L  L
Sbjct: 191 LPETLNE---LHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLREL 246

Query: 524 DLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG 561
            L NN LS  +PA L  L  L+ + L  N +  ++   
Sbjct: 247 HLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVN 282

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 96.6 bits (241), Expect = 8e-22
 Identities = 46/217 (21%), Positives = 78/217 (35%), Gaps = 12/217 (5%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
           +L  +   D  L  ++P  +        LDLQNN        +F     LY + L  NK+
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 411 SGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLK 470
           S         L  L+ L +S N L  + P+   +L ++       N +          L+
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVEL---RIHDNRIRKVPKGVFSGLR 147

Query: 471 AVVDIYLSRNNL-SGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNND 529
            +  I +  N L +            L +L +   KL G   +      +L  L L +N 
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPE---TLNELHLDHNK 204

Query: 530 LSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFAN 566
           +  +    L +   L  L L  N++   I   G+ + 
Sbjct: 205 IQAIELEDLLRYSKLYRLGLGHNQI-RMIEN-GSLSF 239

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  117 bits (294), Expect = 5e-29
 Identities = 53/251 (21%), Positives = 97/251 (38%), Gaps = 44/251 (17%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHL-----QREGALNSFDAECEIL 714
           R    F     +G G +G V++ +   D    AIK   L      RE  +     E + L
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR----EVKAL 57

Query: 715 KTIRHRNLVKIISSCTNHNFKA------------LVLEYMPKGSLEDCMYASNFN--LDI 760
             + H  +V+  ++    N               + ++   K +L+D M         + 
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117

Query: 761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM 820
              L I + +A A+E+LH   S  ++H D+KPSN+      V  + DFG+   + +++  
Sbjct: 118 SVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

Query: 821 KQTQTLATIG-----------YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFF 869
           +   T                Y++PE       S K D+++ G++L E+     P   F 
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P---FS 228

Query: 870 TGEMSIKRWIN 880
           T    ++   +
Sbjct: 229 TQMERVRTLTD 239

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  117 bits (296), Expect = 5e-29
 Identities = 60/294 (20%), Positives = 116/294 (39%), Gaps = 52/294 (17%)

Query: 672 IGIGSYGSVYKGRFPDG----IEVAIKVFH--LQREGALNSFDAECEILKTIRHRNLVKI 725
           +G G +GSV + +        ++VA+K+    +     +  F  E   +K   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 726 ISSCTNHNFKA------LVLEYMPKGSLED-----CMYASNFNLDIFQRLGIMIDVASAL 774
           +        K       ++L +M  G L        +  + FNL +   +  M+D+A  +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQTQTLATIGYIA 833
           EYL    S   +H D+   N +L + M   ++DFG+++ +   D   +   +   + ++A
Sbjct: 151 EYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207

Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMSIKRWINDSLPAVMN 888
            E   +   ++  DV+ +G+ + E+ T G  P     N                   + N
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-----------------EIYN 250

Query: 889 -IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            ++  N L +  E        C   V  L  +C S  P+ R +   +   L  I
Sbjct: 251 YLIGGNRLKQPPE--------CMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  116 bits (293), Expect = 7e-29
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 23/224 (10%)

Query: 655 SHDELLRA----------TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGA 703
           S +E+L              +++    IG G+ G+VY       G EVAI+  +LQ++  
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60

Query: 704 LNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR 763
                 E  +++  ++ N+V  + S    +   +V+EY+  GSL D +  +   +D  Q 
Sbjct: 61  KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQI 118

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
             +  +   ALE+LH   SN ++H DIK  N+LL       L+DFG    ++ E S + T
Sbjct: 119 AAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175

Query: 824 QTLATIG---YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
                +G   ++APE         K D+++ GIM +E+  G  P
Sbjct: 176 ----MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  117 bits (294), Expect = 1e-28
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 13/206 (6%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
                    IG GS G V   R    G +VA+K+  L+++        E  I++  +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +V++  S        +++E++  G+L D +  S   L+  Q   +   V  AL YLH   
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH--- 158

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPEYGR 838
           +  ++H DIK  ++LL       LSDFG    +S++   +++     +G   ++APE   
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS----LVGTPYWMAPEVIS 214

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
               + + D+++ GIM++E+  G  P
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPP 240

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (293), Expect = 1e-28
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 27/221 (12%)

Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRN 721
             +   +++G G+  +V++GR    G   AIKVF+       ++    E E+LK + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 722 LVK---IISSCTNHNFKALVLEYMPKGSLEDCMYA--SNFNLDIFQRLGIMIDVASALEY 776
           +VK   I    T  +   L++E+ P GSL   +    + + L   + L ++ DV   + +
Sbjct: 69  IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 777 LHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGY 831
           L     N IVH +IKP N++     D   V  L+DFG A+ L +++      +L  T  Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEY 181

Query: 832 IAPE-YGREGQVSIKGDVYNY-------GIMLMEVFTGMKP 864
           + P+ Y R          Y         G+      TG  P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  114 bits (288), Expect = 5e-28
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 13/206 (6%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
            + F     +G GSYGSVYK      G  VAIK   ++ +  L     E  I++     +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +VK   S   +    +V+EY   GS+ D +   N  L   +   I+      LEYLH   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH--- 142

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPEYGR 838
               +H DIK  N+LL+    A L+DFG+A  L++  + + T     IG   ++APE  +
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT----VIGTPFWMAPEVIQ 198

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
           E   +   D+++ GI  +E+  G  P
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPP 224

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  113 bits (285), Expect = 9e-28
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHL-QREGALNSFDAECEILKTIRHR 720
            + F++   IG GS+G V+KG        VAIK+  L + E  +     E  +L      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
            + K   S        +++EY+  GS  D +     +        I+ ++   L+YLH  
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT--ILREILKGLDYLH-- 136

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPEYG 837
            S   +H DIK +NVLL +     L+DFG+A  L++    + T     +G   ++APE  
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT----FVGTPFWMAPEVI 191

Query: 838 REGQVSIKGDVYNYGIMLMEVFTGMKP 864
           ++     K D+++ GI  +E+  G  P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  114 bits (288), Expect = 2e-27
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 27/221 (12%)

Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRN 721
             +   +++G G+  +V++GR    G   AIKVF+       ++    E E+LK + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 722 LVK---IISSCTNHNFKALVLEYMPKGSLEDCMYA--SNFNLDIFQRLGIMIDVASALEY 776
           +VK   I    T  +   L++E+ P GSL   +    + + L   + L ++ DV   + +
Sbjct: 69  IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 777 LHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGY 831
           L     N IVH +IKP N++     D   V  L+DFG A+ L +++      +L  T  Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEY 181

Query: 832 IAPE-YGREGQVSIKGDVYNY-------GIMLMEVFTGMKP 864
           + P+ Y R          Y         G+      TG  P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  115 bits (289), Expect = 2e-27
 Identities = 49/211 (23%), Positives = 84/211 (39%), Gaps = 30/211 (14%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEIL-KTIRHRNL 722
           +    E ++G GS G+V       G  VA+K   +      +    E ++L ++  H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNV 71

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG------IMIDVASALEY 776
           ++   S T   F  + LE     +L+D + + N + +  +         ++  +AS + +
Sbjct: 72  IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAH-------------LSDFGIAKLLSEEDSMKQT 823
           LH   S  I+H D+KP N+L+  S                 +SDFG+ K L    S  +T
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 824 QTLA---TIGYIAPEYGREGQVSIKGDVYNY 851
                  T G+ APE   E            
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTR 218

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  111 bits (280), Expect = 3e-27
 Identities = 54/234 (23%), Positives = 79/234 (33%), Gaps = 32/234 (13%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
               + L  N +S     +    + L  L L +N         F   + L  + L+ N  
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 411 SGSIPS-CLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENL 469
             S+       L  L  L L    L  + P  F  L                       L
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA---------------------AL 131

Query: 470 KAVVDIYLSRNNLSGNIPSTI-IGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN 528
           +    +YL  N L   +P      L NL HL L  N++      +F  L SL+ L L  N
Sbjct: 132 Q---YLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187

Query: 529 DLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFI---GNDLLC 579
            ++ V P +   L  L +L L  N L   +P   A A   A  ++    N  +C
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLS-ALPT-EALAPLRALQYLRLNDNPWVC 239

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 50/278 (17%), Positives = 83/278 (29%), Gaps = 55/278 (19%)

Query: 183 SVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGF 242
           + S         +P  +      + + L  N ++          RNL IL +  + L   
Sbjct: 15  TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 243 VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASK 302
                  ++ L+ L L +N    ++  +    GL  L  L+L    L   +    F    
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPAT-FHGLGRLHTLHLDRCGLQ-ELGPGLFR--- 126

Query: 303 LYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNL 362
                                                         L  L  L L DN L
Sbjct: 127 ---------------------------------------------GLAALQYLYLQDNAL 141

Query: 363 SGSLPI-TLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDL 421
             +LP  T   L  L  L L  N+      + F     L  + L++N+++   P    DL
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200

Query: 422 NSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLN 459
             L  L L +N L+++       L  +     + N   
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 95.8 bits (239), Expect = 8e-22
 Identities = 50/239 (20%), Positives = 85/239 (35%), Gaps = 14/239 (5%)

Query: 28  CDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELH 87
           C  Y     + +    GL   +P  +   ++ Q + L  N  S            L  L 
Sbjct: 6   CVCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILW 62

Query: 88  LDYNKLQGEIPEE-LGNLAELEMLVLNNNLLTGTIPASIF-NLSFISTALDFSDNSLTGS 145
           L  N L   I       LA LE L L++N    ++  + F  L  +   L      L   
Sbjct: 63  LHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRL-HTLHLDRCGLQ-E 119

Query: 146 FPYDMCPGLPRLKGLYVSYNQFKGPIPNNLW-HCKELSSVSLSYNQFTGRLPRDLGNSTK 204
               +  GL  L+ LY+  N  +  +P++ +     L+ + L  N+ +    R       
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178

Query: 205 LKSLDLGFNNLNGEIPQEI-GNLRNLEILGIDQSNLVGFVPDTIF-NISTLKILSLFNN 261
           L  L L  N +   +      +L  L  L +  +N +  +P      +  L+ L L +N
Sbjct: 179 LDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLF-ANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 60/251 (23%), Positives = 90/251 (35%), Gaps = 38/251 (15%)

Query: 138 SDNSLTGSFPYDMCPGLPR-LKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLP 196
               L  + P     G+P   + +++  N+       +   C+ L+ + L  N       
Sbjct: 19  PQQGLQ-AVP----VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73

Query: 197 RDLGNSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGIDQSNLVGFVPDTIF-NISTLK 254
                   L+ LDL  N     +       L  L  L +D    +  +   +F  ++ L+
Sbjct: 74  AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD-RCGLQELGPGLFRGLAALQ 132

Query: 255 ILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNL 314
            L L +N L   LP       L NL  L L  N +S S+P   F    L         +L
Sbjct: 133 YLYLQDNALQ-ALPDDT-FRDLGNLTHLFLHGNRIS-SVPERAF--RGL--------HSL 179

Query: 315 KRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPI-TLGRL 373
            RL L +N +                       +L  L TL L  NNLS +LP   L  L
Sbjct: 180 DRLLLHQNRVAHVHPHAFR--------------DLGRLMTLYLFANNLS-ALPTEALAPL 224

Query: 374 KKLQGLDLQNN 384
           + LQ L L +N
Sbjct: 225 RALQYLRLNDN 235

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  112 bits (281), Expect = 5e-27
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 20/214 (9%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHL-QREGALNSFDAECEI-LKTIRHR 720
           +   +   IG G+YGSV K    P G  +A+K       E        + ++ +++    
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG------IMIDVASAL 774
            +V+   +        + +E M   S +           +   +       I +    AL
Sbjct: 82  YIVQFYGALFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKITLATVKAL 138

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
            +L       I+H DIKPSN+LLD S    L DFGI+  L   DS+ +T+      Y+AP
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAP 194

Query: 835 E----YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           E            ++ DV++ GI L E+ TG  P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  111 bits (279), Expect = 6e-27
 Identities = 68/299 (22%), Positives = 119/299 (39%), Gaps = 54/299 (18%)

Query: 672 IGIGSYGSVYKGR------FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI 725
           +G G++G V+           D + VA+K        A   F  E E+L  ++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 726 ISSCTNHNFKALVLEYMPKGSL---------------EDCMYASNFNLDIFQRLGIMIDV 770
              C + +   +V EYM  G L               +     +   L + Q L I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQTQTLATI 829
           AS + YL    S   VH D+   N L+  +++  + DFG+++ +   D       T+  I
Sbjct: 143 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMSIKRWINDSLP 884
            ++ PE     + + + DV+++G++L E+FT G +P    +N     E            
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----E------------ 243

Query: 885 AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
            +  I    +L           + C   V  + + C    P+ R+N KEI   L  +  
Sbjct: 244 VIECITQGRVLE--------RPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  111 bits (279), Expect = 1e-26
 Identities = 65/296 (21%), Positives = 117/296 (39%), Gaps = 57/296 (19%)

Query: 672 IGIGSYGSVYKGR------FPDGIEVAIKVFHLQREGA----LNSFDAECEILKTIRHRN 721
           +G G++G VY+G+       P  ++VA+K      E         F  E  I+    H+N
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALIISKFNHQN 94

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLED------CMYASNFNLDIFQRLGIMIDVASALE 775
           +V+ I        + +++E M  G L+          +   +L +   L +  D+A   +
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 776 YLHFGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGY 831
           YL     N  +H DI   N LL       VA + DFG+A+ +       K    +  + +
Sbjct: 155 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMSIKRWINDSLPAV 886
           + PE   EG  + K D +++G++L E+F+ G  P    +N+                  V
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----------------EV 254

Query: 887 MN-IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
           +  +     +           ++C   V  +  +C    PE+R N   I+ R+   
Sbjct: 255 LEFVTSGGRMD--------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  109 bits (275), Expect = 1e-26
 Identities = 51/240 (21%), Positives = 92/240 (38%), Gaps = 38/240 (15%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA--ECEILKTI 717
           R T +F E   IG G +GSV+K     DG   AIK       G+++  +A  E      +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 718 -RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIF---QRLGIMIDVASA 773
            +H ++V+  S+    +   +  EY   GSL D +  +   +  F   +   +++ V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLD-------------------DSMVAHLSDFGIAKLL 814
           L Y+H   S  +VH DIKPSN+ +                    + ++  + D G    +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 815 SEEDSMKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM 873
           S     +         ++A E  +E      K D++   + ++              G+ 
Sbjct: 185 SSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL---PRNGDQ 236

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  109 bits (275), Expect = 2e-26
 Identities = 72/305 (23%), Positives = 121/305 (39%), Gaps = 69/305 (22%)

Query: 669 ENLIGIGSYGSVYKGRFPDG------IEVAIKVFHLQREGA----LNSFDAECEILKTIR 718
              +G   +G VYKG             VAIK     ++ A       F  E  +   ++
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKAEGPLREEFRHEAMLRARLQ 70

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSL---------------EDCMYASNFNLDIFQR 763
           H N+V ++   T     +++  Y   G L                D        L+    
Sbjct: 71  HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130

Query: 764 LGIMIDVASALEYL---HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS- 819
           + ++  +A+ +EYL   H       VH D+   NVL+ D +   +SD G+ + +   D  
Sbjct: 131 VHLVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY 184

Query: 820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMS 874
                +L  I ++APE    G+ SI  D+++YG++L EVF+ G++P    +N+       
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------- 237

Query: 875 IKRWINDSLPAVMN-IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKE 933
                      V+  I +  +L             C + V +L +EC +E P  R   K+
Sbjct: 238 ----------DVVEMIRNRQVLP--------CPDDCPAWVYALMIECWNEFPSRRPRFKD 279

Query: 934 IISRL 938
           I SRL
Sbjct: 280 IHSRL 284

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  109 bits (274), Expect = 2e-26
 Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 15/211 (7%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGA-LNSFDAECEI-LKTIRHR 720
           D       +G G+YG V K R  P G  +A+K                + +I ++T+   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIF--QRLG-IMIDVASALEYL 777
             V    +        + +E M   SL+                 LG I + +  ALE+L
Sbjct: 67  FTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-- 835
           H   S  ++H D+KPSNVL++      + DFGI+  L   D + +        Y+APE  
Sbjct: 126 HSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPERI 181

Query: 836 --YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
                +   S+K D+++ GI ++E+     P
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  111 bits (279), Expect = 2e-26
 Identities = 43/216 (19%), Positives = 80/216 (37%), Gaps = 17/216 (7%)

Query: 663 TDQFSEENLIGIG--SYGSVYKGRF-PDGIEVAIKVFHL--QREGALNSFDAECEILKTI 717
              +    +IG G     +V   R+ P G  V ++  +L       +     E  + K  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEY 776
            H N+V   ++    N   +V  +M  GS +D +     + ++      I+  V  AL+Y
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYI---- 832
           +H       VH  +K S++L+      +LS       +      ++         +    
Sbjct: 144 IH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200

Query: 833 --APEYGREGQV--SIKGDVYNYGIMLMEVFTGMKP 864
             +PE  ++       K D+Y+ GI   E+  G  P
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  110 bits (276), Expect = 3e-26
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 22/212 (10%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFD---AECEILKTIR 718
              FS+   IG GS+G+VY  R   +   VAIK      + +   +     E   L+ +R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           H N ++        +   LV+EY   GS  D +      L   +   +       L YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG---YIAPE 835
              S+ ++H D+K  N+LL +  +  L DFG A +++  +S         +G   ++APE
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF--------VGTPYWMAPE 220

Query: 836 ---YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
                 EGQ   K DV++ GI  +E+     P
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  109 bits (274), Expect = 5e-26
 Identities = 64/299 (21%), Positives = 119/299 (39%), Gaps = 55/299 (18%)

Query: 672 IGIGSYGSVYKGRFPDGIE------VAIKVFHLQREGALNSFDAECEILKTIRHRNLVKI 725
           +G G++G V+     + +       VA+K      E A   F  E E+L  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 726 ISSCTNHNFKALVLEYMPKGSL--------------EDCMYASNFNLDIFQRLGIMIDVA 771
              CT      +V EYM  G L                    +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQTQTLATIG 830
           + + YL        VH D+   N L+   +V  + DFG+++ +   D      +T+  I 
Sbjct: 169 AGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMSIKRWINDSLPA 885
           ++ PE     + + + DV+++G++L E+FT G +P    +N                   
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-----------------E 268

Query: 886 VMN-IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
            ++ I     L           ++C   V ++   C    P+ R + K++ +RL  +  
Sbjct: 269 AIDCITQGRELE--------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  108 bits (272), Expect = 6e-26
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 13/209 (6%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEIL-KTIRHR 720
           +       +G G+ G V+K RF   G  +A+K       +        + +++ K+    
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
            +V+   +   +    + +E M     E         +       + + +  AL YL   
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----- 835
           H   ++H D+KPSN+LLD+     L DFGI+  L   D   + ++     Y+APE     
Sbjct: 144 HG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAAYMAPERIDPP 199

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
              +    I+ DV++ GI L+E+ TG  P
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFP 228

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  108 bits (272), Expect = 7e-26
 Identities = 51/228 (22%), Positives = 99/228 (43%), Gaps = 41/228 (17%)

Query: 672 IGIGSYGSVYKGRFPDG------IEVAIKVFHLQREGA----LNSFDAECEILKTIRHRN 721
           +G G +G V K              VA+K+    +E A    L    +E  +LK + H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENASPSELRDLLSEFNVLKQVNHPH 87

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSL-----------------------EDCMYASNFNL 758
           ++K+  +C+      L++EY   GSL                           +     L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            +   +     ++  ++YL       +VH D+   N+L+ +     +SDFG+++ + EED
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 819 S-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           S +K++Q    + ++A E   +   + + DV+++G++L E+ T G  P
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  109 bits (275), Expect = 7e-26
 Identities = 65/298 (21%), Positives = 116/298 (38%), Gaps = 57/298 (19%)

Query: 672 IGIGSYGSVYKGRFPDG------IEVAIKVFHLQREGA----LNSFDAECEILKTIRHRN 721
           +G G++G VY+G+          ++VA+K      E         F  E  I+    H+N
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALIISKFNHQN 135

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLED------CMYASNFNLDIFQRLGIMIDVASALE 775
           +V+ I        + ++LE M  G L+          +   +L +   L +  D+A   +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 776 YLHFGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGY 831
           YL     N  +H DI   N LL       VA + DFG+A+ +       K    +  + +
Sbjct: 196 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMSIKRWINDSLPAV 886
           + PE   EG  + K D +++G++L E+F+ G  P    +N+                  V
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----------------EV 295

Query: 887 MN-IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
           +  +     +           ++C   V  +  +C    PE+R N   I+ R+     
Sbjct: 296 LEFVTSGGRMD--------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  113 bits (283), Expect = 7e-26
 Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 18/217 (8%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQR-EGALNSFDAECEILKTIR 718
           +    +  +  +G G +G V +      G +VAIK    +        +  E +I+K + 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 719 HRNLVKII------SSCTNHNFKALVLEYMPKGSLED--CMYASNFNLDIFQRLGIMIDV 770
           H N+V              ++   L +EY   G L      + +   L       ++ D+
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130

Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEEDSMKQTQTLA 827
           +SAL YLH    N I+H D+KP N++L      ++  + D G AK L ++  +     + 
Sbjct: 131 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEF-VG 185

Query: 828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T+ Y+APE   + + ++  D +++G +  E  TG +P
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  108 bits (272), Expect = 9e-26
 Identities = 51/230 (22%), Positives = 86/230 (37%), Gaps = 36/230 (15%)

Query: 665 QFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNL 722
           +     ++  G +  VY+ +    G E A+K      E    +   E   +K +  H N+
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 723 VKIISSCT-------NHNFKALVLEYMPKGSLEDCMYASNFN--LDIFQRLGIMIDVASA 773
           V+  S+ +           + L+L  + KG L + +        L     L I      A
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS---------------EED 818
           ++++H     PI+H D+K  N+LL +     L DFG A  +S               EE+
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 819 SMKQTQTLATIGYIAPE----YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             + T    T  Y  PE    Y     +  K D++  G +L  +     P
Sbjct: 208 ITRNT----TPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP 252

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  108 bits (273), Expect = 1e-25
 Identities = 62/306 (20%), Positives = 126/306 (41%), Gaps = 68/306 (22%)

Query: 672 IGIGSYGSVYKG--------RFPDGIEVAIKVFHLQREGA----LNSFDAECEILKTI-R 718
           +G G +G V           +  + + VA+K+    ++ A    L+   +E E++K I +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 145

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSL---------------EDCMYASNFNLDIFQR 763
           H+N++ ++ +CT      +++EY  KG+L                D        +     
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQ 822
           +     +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D   K 
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGEMSIKR 877
           T     + ++APE   +   + + DV+++G+++ E+FT G  P      E          
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------- 312

Query: 878 WINDSLPAVM--NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII 935
              +    +   + MD                +C + +  +  +C    P  R   K+++
Sbjct: 313 ---ELFKLLKEGHRMD-------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356

Query: 936 SRLIKI 941
             L +I
Sbjct: 357 EDLDRI 362

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  107 bits (269), Expect = 1e-25
 Identities = 52/215 (24%), Positives = 101/215 (46%), Gaps = 17/215 (7%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRN 721
           D +  + +IG G+   V      P   +VAIK  +L++ + +++    E + +    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL-------GIMIDVASAL 774
           +V   +S    +   LV++ +  GS+ D +       +    +        I+ +V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT-IG--- 830
           EYLH    N  +H D+K  N+LL +     ++DFG++  L+    + + +   T +G   
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 831 YIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKP 864
           ++APE   + +    K D++++GI  +E+ TG  P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  107 bits (270), Expect = 1e-25
 Identities = 50/234 (21%), Positives = 97/234 (41%), Gaps = 42/234 (17%)

Query: 672 IGIGSYGSVYKG------RFPDGIEVAIKVFHLQREGA----LNSFDAECEILKTI-RHR 720
           +G G++G V +       +    + VA+K+    +  A      +  +E ++L  +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSAHLTEREALMSELKVLSYLGNHM 87

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL-----------------EDCMYASNFNLDIFQR 763
           N+V ++ +CT      ++ EY   G L                    M      LD+   
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQ 822
           L     VA  + +L    S   +H D+   N+LL    +  + DFG+A+ +  + + + +
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFF 869
                 + ++APE       + + DV++YGI L E+F+       GM   ++F+
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  109 bits (273), Expect = 1e-25
 Identities = 30/252 (11%), Positives = 74/252 (29%), Gaps = 50/252 (19%)

Query: 671 LIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNS----------------------- 706
           ++G     +  +      G    + V +       N+                       
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 707 -----FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM-PKGSLEDCM------YAS 754
                F    +++K  + + ++++     +    +    Y   + +L+          ++
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 755 NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL 814
           + +L    RL + + V   L  LH      +VH  ++P +++LD      L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 815 SEEDSMKQTQTLATIGYIAPE-----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFF 869
                    +  A     A             ++   D +  G+ +  ++    P     
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----N 317

Query: 870 TGE--MSIKRWI 879
           T +  +    WI
Sbjct: 318 TDDAALGGSEWI 329

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  107 bits (269), Expect = 2e-25
 Identities = 53/233 (22%), Positives = 102/233 (43%), Gaps = 41/233 (17%)

Query: 672 IGIGSYGSVYKGR------FPDGIEVAIKVFHLQREGA----LNSFDAECEILKTI-RHR 720
           +G G++G V +              VA+K+    +EGA      +  +E +IL  I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91

Query: 721 NLVKIISSCTNHNFKALV-LEYMPKGSL---------------EDCMYASNFNLDIFQRL 764
           N+V ++ +CT      +V +E+   G+L                         L +   +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQT 823
                VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ + ++   +++ 
Sbjct: 152 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208

Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFF 869
                + ++APE   +   +I+ DV+++G++L E+F+       G+K   EF 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  107 bits (269), Expect = 2e-25
 Identities = 52/223 (23%), Positives = 105/223 (47%), Gaps = 36/223 (16%)

Query: 672 IGIGSYGSVYKG--------RFPDGIEVAIKVFHLQREGA----LNSFDAECEILKTI-R 718
           +G G++G V           +  + + VA+K+    ++ A    L+   +E E++K I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 99

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSL---------------EDCMYASNFNLDIFQR 763
           H+N++ ++ +CT      +++EY  KG+L                D        +     
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQ 822
           +     +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  D   K 
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           T     + ++APE   +   + + DV+++G+++ E+FT G  P
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  106 bits (266), Expect = 2e-25
 Identities = 43/209 (20%), Positives = 85/209 (40%), Gaps = 31/209 (14%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRHRNLVKII 726
            +G G +   ++          A K+     L +         E  I +++ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDVASALEYL 777
               +++F  +VLE   + SL          L++ +R            +  +    +YL
Sbjct: 82  GFFEDNDFVFVVLELCRRRSL----------LELHKRRKALTEPEARYYLRQIVLGCQYL 131

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ--TLATIGYIAPE 835
           H    N ++H D+K  N+ L++ +   + DFG+A  +  +   K+    T     YIAPE
Sbjct: 132 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAPE 185

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
              +   S + DV++ G ++  +  G  P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  107 bits (268), Expect = 3e-25
 Identities = 43/209 (20%), Positives = 85/209 (40%), Gaps = 31/209 (14%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVKII 726
            +G G +   ++          A K+     L +         E  I +++ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG---------IMIDVASALEYL 777
               +++F  +VLE   + SL          L++ +R            +  +    +YL
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL----------LELHKRRKALTEPEARYYLRQIVLGCQYL 157

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ--TLATIGYIAPE 835
           H    N ++H D+K  N+ L++ +   + DFG+A  +  +   K+    T     YIAPE
Sbjct: 158 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAPE 211

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
              +   S + DV++ G ++  +  G  P
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  107 bits (268), Expect = 3e-25
 Identities = 61/332 (18%), Positives = 113/332 (34%), Gaps = 49/332 (14%)

Query: 178 CKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQS 237
           C        S       +P  L  +  +KSLDL  N +      ++    NL+ L +  +
Sbjct: 30  CDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86

Query: 238 NLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIP--S 295
            +     D+  ++ +L+ L L  N LS NL SS     L +L  LNL  N    ++   S
Sbjct: 87  GINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSW-FKPLSSLTFLNLLGNPYK-TLGETS 143

Query: 296 FFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTL 355
            F + +KL  L +G      ++  +     F+                     L  L  L
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRK----DFA--------------------GLTFLEEL 179

Query: 356 SLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIP 415
            +  ++L    P +L  ++ +  L L   +    +       S +  + L    L     
Sbjct: 180 EIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD---- 235

Query: 416 SCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDI 475
                       +   +EL++   ++            +  SL   +   +  +  ++++
Sbjct: 236 ------------TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLEL 282

Query: 476 YLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQ 507
             SRN L          L +LQ + L  N   
Sbjct: 283 EFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  105 bits (265), Expect = 8e-25
 Identities = 62/315 (19%), Positives = 115/315 (36%), Gaps = 50/315 (15%)

Query: 243 VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASK 302
           +P  +     +K L L NN ++  + +S +L    NL+ L L  N ++ +I    F  S 
Sbjct: 46  IPSGLT--EAVKSLDLSNNRIT-YISNS-DLQRCVNLQALVLTSNGIN-TIEEDSF--SS 98

Query: 303 LYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNL 362
           L         +L+ L L  NYL+  +S   S F             L +LT L+L  N  
Sbjct: 99  L--------GSLEHLDLSYNYLSNLSS---SWFK-----------PLSSLTFLNLLGNPY 136

Query: 363 SGSLP--ITLGRLKKLQGLDLQNNKFEGPIPQE-FCHFSRLYVVYLNRNKLSGSIPSCLG 419
             +L        L KLQ L + N      I ++ F   + L  + ++ + L    P  L 
Sbjct: 137 K-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLK 195

Query: 420 DLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSR 479
            + ++  L L   +   ++         +   +     L+                    
Sbjct: 196 SIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT----------------FHF 239

Query: 480 NNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLE 539
           + LS    +++I     +++ +    L   + +   ++  L  L+ S N L  V     +
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFD 298

Query: 540 KLLYLKSLNLSFNKL 554
           +L  L+ + L  N  
Sbjct: 299 RLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 97.1 bits (242), Expect = 9e-22
 Identities = 57/271 (21%), Positives = 98/271 (36%), Gaps = 25/271 (9%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELH 87
           D+  NR+T ++           S L    +LQ LVL+ N  + TI ++   +L  L+ L 
Sbjct: 58  DLSNNRITYIS----------NSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLD 106

Query: 88  LDYNKLQGEIPEEL-GNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSF 146
           L YN L   +       L+ L  L L  N        S+F+       L   +       
Sbjct: 107 LSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI 165

Query: 147 PYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLK 206
                 GL  L+ L +  +  +   P +L   + +S + L   Q    L   +  ++ ++
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225

Query: 207 SLDLGFNNLNGEIPQEI--------GNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSL 258
            L+L   +L+     E+                + I   +L   V   +  IS L  L  
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEF 284

Query: 259 FNNTLSGNLPSSKNLIGLPNLEGLNLGLNNL 289
             N L  ++P       L +L+ + L  N  
Sbjct: 285 SRNQLK-SVPDG-IFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 34/197 (17%), Positives = 69/197 (35%), Gaps = 21/197 (10%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELH 87
           ++ GN   +L  + L           +L+ LQ L +        I ++    LT L+EL 
Sbjct: 130 NLLGNPYKTLGETSL---------FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180

Query: 88  LDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTG--- 144
           +D + LQ   P+ L ++  +  L+L+       +     +++     L+  D  L     
Sbjct: 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHF 239

Query: 145 ----SFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRD-L 199
               +   +        + + ++       +   L     L  +  S NQ    +P    
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIF 297

Query: 200 GNSTKLKSLDLGFNNLN 216
              T L+ + L  N  +
Sbjct: 298 DRLTSLQKIWLHTNPWD 314

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  110 bits (275), Expect = 4e-25
 Identities = 55/313 (17%), Positives = 96/313 (30%), Gaps = 61/313 (19%)

Query: 251 STLKILSLFNNTLSGNLPS-----SKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYA 305
                 SL  N+    +                        N     +     N      
Sbjct: 6   PINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN------ 59

Query: 306 LELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGS 365
                      L L R  L+     L                    +T L +  N L  S
Sbjct: 60  -------QFSELQLNRLNLSSLPDNLPP-----------------QITVLEITQNALI-S 94

Query: 366 LPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR 425
           LP     L+ L   D  +N+    +P+       L    ++ N+L+  +P        L 
Sbjct: 95  LPELPASLEYL---DACDNRLST-LPELPASLKHLD---VDNNQLT-MLPELPA---LLE 143

Query: 426 ILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGN 485
            ++  +N+LT  +P    +LE +      +N L   LP   E+L+    + +S N L  +
Sbjct: 144 YINADNNQLTM-LPELPTSLEVL---SVRNNQLT-FLPELPESLE---ALDVSTNLLE-S 194

Query: 486 IPSTIIGLKNLQ----HLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKL 541
           +P+  +   + +          N++   IPE+   L     + L +N LS  I  SL + 
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253

Query: 542 LYLKSLNLSFNKL 554
                 +      
Sbjct: 254 TAQPDYHGPRIYF 266

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  109 bits (274), Expect = 6e-25
 Identities = 68/318 (21%), Positives = 107/318 (33%), Gaps = 58/318 (18%)

Query: 219 IPQEIGNLRNLEILGIDQSNLVGFVPDTIFNI-STLKILSLFNNTLSGNLPSSKNLIGLP 277
           I   I N  +L        N +       F+     +  +L          S      + 
Sbjct: 3   IMLPINNNFSLSQN--SFYNTISGTYADYFSAWDKWEKQALPGE-NRNEAVSLLKECLIN 59

Query: 278 NLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSA 337
               L L   NLS S+P                   +  L + +N L      L  L + 
Sbjct: 60  QFSELQLNRLNLS-SLPDNLP-------------PQITVLEITQNALI----SLPELPA- 100

Query: 338 LVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHF 397
                        +L  L   DN LS +LP     LK L   D+ NN+    +P+     
Sbjct: 101 -------------SLEYLDACDNRLS-TLPELPASLKHL---DVDNNQLTM-LPELPALL 142

Query: 398 SRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNS 457
             +     + N+L+  +P       SL +LS+ +N+LT  +P    +LE +   D S+N 
Sbjct: 143 EYIN---ADNNQLT-MLPELPT---SLEVLSVRNNQLTF-LPELPESLEAL---DVSTNL 191

Query: 458 LNGSLPLEIENL----KAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPES 513
           L  SLP          +  +      N ++ +IP  I+ L     + LE N L   I ES
Sbjct: 192 LE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRES 249

Query: 514 FGELVSLEFLDLSNNDLS 531
             +  +           S
Sbjct: 250 LSQQTAQPDYHGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  107 bits (269), Expect = 3e-24
 Identities = 78/482 (16%), Positives = 144/482 (29%), Gaps = 94/482 (19%)

Query: 72  TIPKEIGNLTKLKELHLDYNKLQG---EIPEELGNLAELEMLVLNNNLLTGTIPASIF-N 127
           +I   I N   L +    YN + G   +         +  +   N N     +   +   
Sbjct: 2   SIMLPINNNFSLSQN-SFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60

Query: 128 LSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLS 187
                + L  +  +L+ S P ++ P   ++  L ++ N     +P        L  +   
Sbjct: 61  F----SELQLNRLNLS-SLPDNLPP---QITVLEITQNALI-SLPELP---ASLEYLDAC 108

Query: 188 YNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTI 247
            N+ +  LP    +   LK LD+  N L   +P+    L  +       +N +  +P+  
Sbjct: 109 DNRLS-TLPELPAS---LKHLDVDNNQLT-MLPELPALLEYINA----DNNQLTMLPELP 159

Query: 248 FNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALE 307
            +   L++LS+ NN L+  LP         +LE L++  N L  S+P+            
Sbjct: 160 TS---LEVLSVRNNQLTF-LPEL-----PESLEALDVSTNLLE-SLPAVPVRNHHS---- 205

Query: 308 LGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLP 367
                         N +T                    I +L    T+ L DN LS  + 
Sbjct: 206 ---EETEIFFRCRENRITHIPEN---------------ILSLDPTCTIILEDNPLSSRIR 247

Query: 368 ITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRIL 427
            +L +             F     Q+      L                           
Sbjct: 248 ESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLA-------------------DAVTAWF 288

Query: 428 SLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIP 487
             +     S I   F + E    F    + L+ ++               + +     + 
Sbjct: 289 PENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVS------------ARNTSGFREQVA 336

Query: 488 STIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDL-----SGVIPASLEKLL 542
           + +  L     L  +   +     ES  + V+L + +L    L      G+       LL
Sbjct: 337 AWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALL 396

Query: 543 YL 544
            L
Sbjct: 397 SL 398

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 51.9 bits (124), Expect = 8e-07
 Identities = 15/87 (17%), Positives = 27/87 (31%), Gaps = 6/87 (6%)

Query: 36  TSLTISDLGLAGTIPSHLGNLSSLQT----LVLSRNWFSGTIPKEIGNLTKLKELHLDYN 91
            +L +S   L  ++P+        +          N  +  IP+ I +L     + L+ N
Sbjct: 183 EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN 240

Query: 92  KLQGEIPEELGNLAELEMLVLNNNLLT 118
            L   I E L                +
Sbjct: 241 PLSSRIRESLSQQTAQPDYHGPRIYFS 267

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  107 bits (268), Expect = 4e-25
 Identities = 39/237 (16%), Positives = 72/237 (30%), Gaps = 25/237 (10%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRFPD------GIEVAIKVFHLQREGALNSFDAECEILKT 716
           +      +L+G G++  VY+    D        +  +KV                E LK 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCM----YASNFNLDIFQRLGIMIDVAS 772
                 +K  S+    N   LV E    G+L + +          +     +   + +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH-----------LSDFGIAKLLSEEDSMK 821
            +E +H      I+H DIKP N +L +  +             L D G +  +       
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 822 QTQTLA-TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
                  T G+   E       + + D +     +  +  G     +   GE   + 
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  107 bits (269), Expect = 4e-25
 Identities = 54/223 (24%), Positives = 101/223 (45%), Gaps = 36/223 (16%)

Query: 672 IGIGSYGSVYKGRFPD--------GIEVAIKVFHLQREGA----LNSFDAECEILKTI-R 718
           +G G++G V                 +VA+K+    +  A    L+   +E E++K I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDATEKDLSDLISEMEMMKMIGK 133

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSL---------------EDCMYASNFNLDIFQR 763
           H+N++ ++ +CT      +++EY  KG+L                +  +     L     
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQ 822
           +     VA  +EYL    S   +H D+   NVL+ +  V  ++DFG+A+ +   D   K 
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
           T     + ++APE   +   + + DV+++G++L E+FT G  P
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  104 bits (262), Expect = 6e-25
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 32/210 (15%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVKII 726
           L+G GS+  VY+      G+EVAIK+     + + G +     E +I   ++H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------IFQRLGIMIDVASALEYLHFG 780
           +   + N+  LVLE    G +   +                 ++       + + YLH  
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLYLH-- 129

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----- 835
            S+ I+H D+  SN+LL  +M   ++DFG+A  L        T    T  YI+PE     
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRS 187

Query: 836 -YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            +G E       DV++ G M   +  G  P
Sbjct: 188 AHGLE------SDVWSLGCMFYTLLIGRPP 211

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (265), Expect = 6e-25
 Identities = 65/240 (27%), Positives = 98/240 (40%), Gaps = 28/240 (11%)

Query: 645 MSPQVMWRRYSHDELLRATD---QFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQR 700
           M+     R     +L    D    F    L+G G+YG VYKGR    G   AIKV  +  
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61

Query: 701 EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKA------LVLEYMPKGSLEDCMYA 753
           +        E  +LK    HRN+     +    N         LV+E+   GS+ D +  
Sbjct: 62  D-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120

Query: 754 SNFN-LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK 812
           +  N L       I  ++   L +LH    + ++H DIK  NVLL ++    L DFG++ 
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177

Query: 813 LLSEEDSMKQTQTLATIG---YIAPE-----YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            L      + T     IG   ++APE        +     K D+++ GI  +E+  G  P
Sbjct: 178 QLDRTVGRRNT----FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  105 bits (265), Expect = 7e-25
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 32/220 (14%)

Query: 669 ENLIGIGSYGSVYKGRFPDG---IEVAIKVFHLQREGA----LNSFDAECEILKTI-RHR 720
           +++IG G++G V K R       ++ AIK     +E A       F  E E+L  +  H 
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLGHHP 86

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLED---------------CMYASNFNLDIFQRLG 765
           N++ ++ +C +  +  L +EY P G+L D                  ++   L   Q L 
Sbjct: 87  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146

Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT 825
              DVA  ++YL        +H D+   N+L+ ++ VA ++DFG+++   +E  +K+T  
Sbjct: 147 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 201

Query: 826 LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
              + ++A E       +   DV++YG++L E+ + G  P
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  105 bits (265), Expect = 8e-25
 Identities = 50/222 (22%), Positives = 101/222 (45%), Gaps = 32/222 (14%)

Query: 669 ENLIGIGSYGSVYKG------RFPDGIEVAIKVFHLQREGA----LNSFDAECEILKTI- 717
              +G G++G V +       +    ++VA+K+    +  A      +  +E +I+  + 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSHLG 107

Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-------------EDCMYASNFNLDIFQRL 764
           +H N+V ++ +CT+     ++ EY   G L             +     +N        L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQT 823
                VA  + +L    S   +H D+   NVLL +  VA + DFG+A+ +  + + + + 
Sbjct: 168 HFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224

Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP 864
                + ++APE   +   +++ DV++YGI+L E+F+ G+ P
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  105 bits (264), Expect = 1e-24
 Identities = 27/244 (11%), Positives = 56/244 (22%), Gaps = 44/244 (18%)

Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFH---LQREGALNSFDAECEI 713
            L +   +      + +G    V+  R  +   + A+KVF          L         
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 714 LKTIRHRNLVKIISSCTNHNFKA--------------------------LVLEYM----- 742
              +   +  +                                      L++        
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175

Query: 743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV 802
              S  D +Y    +  I     +   +      L    S  +VH    P N+ +     
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGR 232

Query: 803 AHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY--GREGQVSIKGDVYNYGIMLMEVFT 860
             L D      +              + Y   E+        +   + +  G+ +  V+ 
Sbjct: 233 LMLGDVSALWKVGTRGPASSV----PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288

Query: 861 GMKP 864
              P
Sbjct: 289 LFLP 292

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  104 bits (261), Expect = 3e-24
 Identities = 68/320 (21%), Positives = 124/320 (38%), Gaps = 71/320 (22%)

Query: 672 IGIGSYGSVYKGRFPDGIE------VAIKVFHLQREGA----LNSFDAECEILKTIRHRN 721
           IG G++G V++ R P  +       VA+K+    +E A       F  E  ++    + N
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDNPN 111

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSL-----------------------EDCMYASNFNL 758
           +VK++  C       L+ EYM  G L                                 L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
              ++L I   VA+ + YL        VH D+   N L+ ++MV  ++DFG+++ +   D
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 819 S-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKP----TNEFFTGE 872
                      I ++ PE     + + + DV+ YG++L E+F+ G++P     +E     
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE----- 283

Query: 873 MSIKRWINDSLPAVMN-IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNT 931
                        V+  + D N+L+  E         C   + +L   C S+ P +R + 
Sbjct: 284 ------------EVIYYVRDGNILACPEN--------CPLELYNLMRLCWSKLPADRPSF 323

Query: 932 KEIISRLIKIRDLLFANIEM 951
             I   L ++ +     + +
Sbjct: 324 CSIHRILQRMCERAEGTVGV 343

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  103 bits (258), Expect = 3e-24
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 33/192 (17%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDA---------ECE 712
            + +  + ++G G    V +    P   E A+K+  +   G+ ++ +          E +
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 713 ILKTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR-------- 763
           IL+ +  H N++++  +   + F  LV + M KG L D          + ++        
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD---------YLTEKVTLSEKET 126

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
             IM  +   +  LH      IVH D+KP N+LLDD M   L+DFG +  L   + ++  
Sbjct: 127 RKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR-- 181

Query: 824 QTLATIGYIAPE 835
           +   T  Y+APE
Sbjct: 182 EVCGTPSYLAPE 193

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  103 bits (259), Expect = 5e-24
 Identities = 56/239 (23%), Positives = 97/239 (40%), Gaps = 47/239 (19%)

Query: 672 IGIGSYGSVYKGR------FPDGIEVAIKVFHLQREGA----LNSFDAECEILKTI-RHR 720
           +G G++G V              I+VA+K+    +E A      +  +E +++  +  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQLGSHE 109

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSL----------------------EDCMYASNFNL 758
           N+V ++ +CT      L+ EY   G L                                L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
                L     VA  +E+L F      VH D+   NVL+    V  + DFG+A+ +  + 
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 819 S-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-------GMKPTNEFF 869
           + + +      + ++APE   EG  +IK DV++YGI+L E+F+       G+     F+
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 285

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  101 bits (255), Expect = 8e-24
 Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 37/197 (18%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
              F    ++G G++  V+  +    G   A+K          +S + E  +LK I+H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR--------LGIMIDVASA 773
           +V +     +     LV++ +  G L D          I +R          ++  V SA
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFD---------RILERGVYTEKDASLVIQQVLSA 118

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-T 828
           ++YL   H N IVH D+KP N+L     ++S +  ++DFG++K+           T   T
Sbjct: 119 VKYL---HENGIVHRDLKPENLLYLTPEENSKIM-ITDFGLSKMEQNG----IMSTACGT 170

Query: 829 IGYIAPE------YGRE 839
            GY+APE      Y + 
Sbjct: 171 PGYVAPEVLAQKPYSKA 187

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =   99 bits (250), Expect = 2e-23
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 25/206 (12%)

Query: 670 NLIGIGSYGSVYKGR-FPDGIEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVKI 725
             +G G +G+VY  R       +A+KV     L++ G  +    E EI   +RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 726 ISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNP 784
                +     L+LEY P G++   +   + F+         + ++A+AL Y H   S  
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--YITELANALSYCH---SKR 129

Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE------YGR 838
           ++H DIKP N+LL  +    ++DFG +       S ++T    T+ Y+ PE      +  
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLDYLPPEMIEGRMHDE 186

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
                 K D+++ G++  E   G  P
Sbjct: 187 ------KVDLWSLGVLCYEFLVGKPP 206

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  101 bits (253), Expect = 4e-23
 Identities = 32/258 (12%), Positives = 79/258 (30%), Gaps = 61/258 (23%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNS----------------------- 706
           ++G     +  +      G    + V +       N+                       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 707 -----FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM-PKGSLEDC------MYAS 754
                F    +++K  + + ++++     +    +    Y   + +L+          ++
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 755 NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL 814
           + +L    RL + + V   L  LH      +VH  ++P +++LD      L+ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 815 SEEDSMKQTQTLATIGYIAPEY-----------GREGQVSIKGDVYNYGIMLMEVFTGMK 863
                     +  + G+  PE             R   ++   D +  G+++  ++    
Sbjct: 257 GAR-----VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

Query: 864 PTNEFFTGE--MSIKRWI 879
           P     T +  +    WI
Sbjct: 312 P----ITKDAALGGSEWI 325

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  100 bits (252), Expect = 4e-23
 Identities = 49/232 (21%), Positives = 90/232 (38%), Gaps = 38/232 (16%)

Query: 672 IGIGSYGSVYKGRFPDGIEVAIKVFH-----------------LQREGALNSFDAECEIL 714
           +  G +  +      D    A+K +                  +  +   + F  E +I+
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 715 KTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA--- 771
             I++   +      TN++   ++ EYM   S+        F LD      I I V    
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTCFIPIQVIKCI 156

Query: 772 -----SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
                ++  Y+H  +   I H D+KPSN+L+D +    LSDFG ++     D   +  + 
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKKIKG-SR 211

Query: 827 ATIGYIAPE--YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
            T  ++ PE           K D+++ GI L  +F  + P    F+ ++S+ 
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLV 259

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 36/198 (18%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGA--LNSFDAECEILKTIRH 719
           +D +  +  +G G++  V +      G+E A K+ + ++  A      + E  I + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR--------LGIMIDVA 771
            N+V++  S    +F  LV + +  G L +         DI  R           +  + 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFE---------DIVAREFYSEADASHCIQQIL 115

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLA 827
            ++ Y H   SN IVH ++KP N+LL      + V  L+DFG+A  +++ ++        
Sbjct: 116 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVK-LADFGLAIEVNDSEAWH--GFAG 169

Query: 828 TIGYIAPE------YGRE 839
           T GY++PE      Y + 
Sbjct: 170 TPGYLSPEVLKKDPYSKP 187

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 35/197 (17%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRH 719
            ++++   ++G GS+G V K +      E A+KV +         ++   E E+LK + H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR--------LGIMIDVA 771
            N++K+     + +   +V E    G L D         +I +R          I+  V 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFD---------EIIKRKRFSEHDAARIIKQVF 131

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLA 827
           S + Y+   H + IVH D+KP N+LL     D  +  + DFG++    +   M     + 
Sbjct: 132 SGITYM---HKHNIVHRDLKPENILLESKEKDCDIK-IIDFGLSTCFQQNTKM--KDRIG 185

Query: 828 TIGYIAPE-----YGRE 839
           T  YIAPE     Y  +
Sbjct: 186 TAYYIAPEVLRGTYDEK 202

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 98.0 bits (244), Expect = 2e-22
 Identities = 51/309 (16%), Positives = 97/309 (31%), Gaps = 28/309 (9%)

Query: 262 TLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLER 321
             S   P   +         + L     S              A    +   +K L L+R
Sbjct: 16  NFSDPKPDWSSAFNCLGAADVELYGGGRSLEY---LLKRVDTEADLGQFTDIIKSLSLKR 72

Query: 322 NYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRL--KKLQGL 379
             +        +   + +   +L++  +  L  L+L +  ++G+ P  L       L  L
Sbjct: 73  LTVR------AARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126

Query: 380 DLQNNKFEGPIPQ----EFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELT 435
           +L+N  +          +      L V+ + +          +    +L  L LS N   
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186

Query: 436 -------SVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPS 488
                  ++ P  F  L+ +   +    + +G           +  + LS N+L     +
Sbjct: 187 GERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246

Query: 489 TI-IGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSL 547
                   L  L+L    L+            L  LDLS N L      S ++L  + +L
Sbjct: 247 PSCDWPSQLNSLNLSFTGLKQVPKGLP---AKLSVLDLSYNRLDRN--PSPDELPQVGNL 301

Query: 548 NLSFNKLVG 556
           +L  N  + 
Sbjct: 302 SLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 97.7 bits (243), Expect = 3e-22
 Identities = 66/313 (21%), Positives = 105/313 (33%), Gaps = 58/313 (18%)

Query: 205 LKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLS 264
           LK +D   +        +  +L+ L +      + + F    +  IS L+ L+L N  ++
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 265 GNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYL 324
           G  P        P+L  LN  L N+S +    +     L  L+      LK L + + + 
Sbjct: 109 GTAPPPLLEATGPDLNILN--LRNVSWATRDAW-----LAELQQWLKPGLKVLSIAQAHS 161

Query: 325 TFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPIT----LGRLKKLQGLD 380
              + E + +F                L+TL L DN   G   +       +   LQ L 
Sbjct: 162 LNFSCEQVRVFP--------------ALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207

Query: 381 LQNNKFE---GPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLSSNELTS 436
           L+N   E   G          +L  + L+ N L  +  +   D  + L  L+LS   L  
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ 267

Query: 437 VIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNL 496
           V       L            L+                 LS N L    PS    L  +
Sbjct: 268 VPKGLPAKLS----------VLD-----------------LSYNRLDR-NPS-PDELPQV 298

Query: 497 QHLSLEHNKLQGP 509
            +LSL+ N     
Sbjct: 299 GNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.2 bits (208), Expect = 1e-17
 Identities = 53/273 (19%), Positives = 83/273 (30%), Gaps = 24/273 (8%)

Query: 36  TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPK---EIGNLTKLKELHLDYNK 92
             L   D        + +    SL+ L +        I      +  ++ L+EL L+  +
Sbjct: 47  YLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLE 106

Query: 93  LQGEIPEELGNLA--ELEMLVLNNNLLTG--TIPASIFNLSFIS-TALDFSDNSLTGSFP 147
           + G  P  L      +L +L L N          A +          L  +      +F 
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NFS 165

Query: 148 YDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKE----LSSVSLSYNQFT---GRLPRDLG 200
            +     P L  L +S N   G        C      L  ++L         G       
Sbjct: 166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA 225

Query: 201 NSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLF 259
              +L+ LDL  N+L              L  L +     +  VP  +   + L +L L 
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL-SFTGLKQVPKGLP--AKLSVLDLS 282

Query: 260 NNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGS 292
            N L    PS      LP +  L+L  N    S
Sbjct: 283 YNRLDR-NPS---PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 52/304 (17%), Positives = 91/304 (29%), Gaps = 42/304 (13%)

Query: 99  EELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDM--CPGLPR 156
           E  G    LE L+   +        +    S     L      +     +      G+  
Sbjct: 37  ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96

Query: 157 LKGLYVSYNQFKGPIPNNL--WHCKELSSVSLSYNQFTGRLPR--DLGN--STKLKSLDL 210
           L+ L +   +  G  P  L      +L+ ++L    +  R     +L       LK L +
Sbjct: 97  LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156

Query: 211 GFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTI----FNISTLKILSLFNNTLSGN 266
              +      +++     L  L +  +  +G              TL++L+L N  +   
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216

Query: 267 LPSSKNLI-GLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLT 325
                 L      L+GL+L  N+L  +  +   +          + S L  L L    L 
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD----------WPSQLNSLNLSFTGLK 266

Query: 326 FSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNK 385
                L +                  L+ L L  N L    P     L ++  L L+ N 
Sbjct: 267 QVPKGLPA-----------------KLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNP 307

Query: 386 FEGP 389
           F   
Sbjct: 308 FLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 44/222 (19%), Positives = 86/222 (38%), Gaps = 17/222 (7%)

Query: 32  GNRVTSLTISDLGLAGTIPSHLGNLS--SLQTLVLSRNWFSG--TIPKEIGNL--TKLKE 85
            + +  LT+ +L + GT P  L   +   L  L L    ++       E+       LK 
Sbjct: 94  ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKV 153

Query: 86  LHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTG--TIPASIFNLSFIS-TALDFSDNSL 142
           L +          E++     L  L L++N   G   + +++  L F +   L   +  +
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213

Query: 143 T--GSFPYDMCPGLPRLKGLYVSYNQFKG-PIPNNLWHCKELSSVSLSYNQFTGRLPRDL 199
                    +     +L+GL +S+N  +      +     +L+S++LS+     ++P+ L
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272

Query: 200 GNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVG 241
               KL  LDL +N L+   P     L  +  L +  +  + 
Sbjct: 273 --PAKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 51/195 (26%), Positives = 80/195 (41%), Gaps = 33/195 (16%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
              ++ EN IG GS+G V         I  A K         ++ F  E EI+K++ H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR--------LGIMIDVASA 773
           ++++  +  ++    LV+E    G L +          +  +          IM DV SA
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFE---------RVVHKRVFRESDAARIMKDVLSA 118

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
           + Y    H   + H D+KP N L      DS +  L DFG+A        M+    + T 
Sbjct: 119 VAYC---HKLNVAHRDLKPENFLFLTDSPDSPLK-LIDFGLAARFKPGKMMR--TKVGTP 172

Query: 830 GYIAPE-----YGRE 839
            Y++P+     YG E
Sbjct: 173 YYVSPQVLEGLYGPE 187

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 99.0 bits (247), Expect = 3e-22
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 34/192 (17%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--------EGALNSFDAECEI 713
             ++  +++IG G    V +      G E A+K+  +          E    +   E  I
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 714 LKTIR-HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL-------- 764
           L+ +  H +++ +I S  + +F  LV + M KG L D          + +++        
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD---------YLTEKVALSEKETR 203

Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ 824
            IM  +  A+ +LH   +N IVH D+KP N+LLDD+M   LSDFG +  L   + ++   
Sbjct: 204 SIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR--- 257

Query: 825 TLA-TIGYIAPE 835
            L  T GY+APE
Sbjct: 258 ELCGTPGYLAPE 269

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (250), Expect = 4e-22
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 36/226 (15%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVF---HLQREGALNSFDAECEILKTIR 718
           +D++  + ++G GS+G V   +    G E A+KV     ++++    S   E ++LK + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR--------LGIMIDV 770
           H N++K+     +  +  LV E    G L D         +I  R          I+  V
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFD---------EIISRKRFSEVDAARIIRQV 135

Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
            S + Y+H    N IVH D+KP N+LL     D+ +  + DFG++        M     +
Sbjct: 136 LSGITYMH---KNKIVHRDLKPENLLLESKSKDANIR-IIDFGLSTHFEASKKM--KDKI 189

Query: 827 ATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
            T  YIAPE    G    K DV++ G++L  + +G  P    F G 
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP----FNGA 230

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 97.3 bits (243), Expect = 4e-22
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 47/225 (20%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSL-----------EDCM--YASNFNLDIFQRLGI 766
              VK+  +  +       L Y   G L           E C   Y +            
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------------ 137

Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
             ++ SALEYLH      I+H D+KP N+LL++ M   ++DFG AK+LS E    +  + 
Sbjct: 138 --EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192

Query: 827 -ATIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             T  Y++PE        +        D++  G ++ ++  G+ P
Sbjct: 193 VGTAQYVSPELLTEKSACKS------SDLWALGCIIYQLVAGLPP 231

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 96.1 bits (240), Expect = 6e-22
 Identities = 48/191 (25%), Positives = 86/191 (45%), Gaps = 20/191 (10%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHR 720
            D F  +  +G G++G V+       G+E  IK  +  R +  +   +AE E+LK++ H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIF---QRLGIMIDVASALEYL 777
           N++KI     +++   +V+E    G L + + ++              +M  + +AL Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 778 HFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
              HS  +VH D+KP N+L       S +  + DFG+A+L   ++         T  Y+A
Sbjct: 141 ---HSQHVVHKDLKPENILFQDTSPHSPIK-IIDFGLAELFKSDEHST--NAAGTALYMA 194

Query: 834 PE-----YGRE 839
           PE        +
Sbjct: 195 PEVFKRDVTFK 205

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 99.4 bits (248), Expect = 7e-22
 Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 35/225 (15%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRH 719
           ++ +     +G G+YG V   R     +E AIK+         + +    E  +LK + H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR--------LGIMIDVA 771
            N++K+     +     LV+E    G L D         +I  R          I+  V 
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFD---------EIIHRMKFNEVDAAVIIKQVL 146

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLA 827
           S + YLH    + IVH D+KP N+LL     D+++  + DFG++ +   +  M   + L 
Sbjct: 147 SGVTYLH---KHNIVHRDLKPENLLLESKEKDALIK-IVDFGLSAVFENQKKM--KERLG 200

Query: 828 TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           T  YIAPE  R  +   K DV++ G++L  +  G  P    F G+
Sbjct: 201 TAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP----FGGQ 240

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 95.7 bits (239), Expect = 8e-22
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 39/212 (18%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRHRNLVKII 726
            +G G +G+VY  R   +   +A+KV     L++EG  +    E EI   +RH N++++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLG------IMIDVASALEYLHF 779
           +   +     L+LE+ P+G L        +  L    R         M ++A AL Y H 
Sbjct: 81  NYFHDRKRIYLMLEFAPRGEL--------YKELQKHGRFDEQRSATFMEELADALHYCH- 131

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPE--- 835
                ++H DIKP N+L+       ++DFG     S      + +T+  T+ Y+ PE   
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRTMCGTLDYLPPEMIE 185

Query: 836 ---YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
              +        K D++  G++  E   GM P
Sbjct: 186 GKTHDE------KVDLWCAGVLCYEFLVGMPP 211

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 97.9 bits (244), Expect = 9e-22
 Identities = 45/213 (21%), Positives = 91/213 (42%), Gaps = 12/213 (5%)

Query: 650 MWRRYSHDELLRATDQFSE----ENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGAL 704
           +W++Y    +        +       +G G++G V++      G     K  +       
Sbjct: 33  IWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK 92

Query: 705 NSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL 764
            +   E  I+  + H  L+ +  +  +     L+LE++  G L D + A ++ +   + +
Sbjct: 93  YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI 152

Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL--SDFGIAKLLSEEDSMKQ 822
             M      L+++   H + IVH DIKP N++ +    + +   DFG+A  L+ ++ +K 
Sbjct: 153 NYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK- 208

Query: 823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIML 855
             T AT  + APE      V    D++  G++ 
Sbjct: 209 -VTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 97.1 bits (242), Expect = 1e-21
 Identities = 51/227 (22%), Positives = 99/227 (43%), Gaps = 8/227 (3%)

Query: 632 KRRSTEVSHIKAGMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIE 690
           KR S     I A  +P       +    + +    S+  ++G G +G V+K      G++
Sbjct: 57  KRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLK 116

Query: 691 VAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDC 750
           +A K+   +          E  ++  + H NL+++  +  + N   LV+EY+  G L D 
Sbjct: 117 LAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR 176

Query: 751 MYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL--SDF 808
           +   ++NL     +  M  +   + ++H      I+H D+KP N+L  +     +   DF
Sbjct: 177 IIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDF 233

Query: 809 GIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIML 855
           G+A+     + +K      T  ++APE      VS   D+++ G++ 
Sbjct: 234 GLARRYKPREKLK--VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 48/210 (22%), Positives = 82/210 (39%), Gaps = 49/210 (23%)

Query: 658 ELLRATDQFSEE----NLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECE 712
           +L R + QF++       IG+GSY    +       +E A+K+    +         E E
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIE 67

Query: 713 IL-KTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL------- 764
           IL +  +H N++ +     +  +  +V E M  G L               ++       
Sbjct: 68  ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFS 114

Query: 765 -----GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLS 815
                 ++  +   +EYLH   +  +VH D+KPSN+L      +     + DFG AK L 
Sbjct: 115 EREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171

Query: 816 EEDSMKQTQTLATIGYIAPE------YGRE 839
            E+ +  T    T  ++APE      Y   
Sbjct: 172 AENGLLMT-PCYTANFVAPEVLERQGYDAA 200

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 95.8 bits (239), Expect = 2e-21
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 56/212 (26%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFH--------LQREGALNSFDAECEI 713
            D++     +G G+ G V          +VAIK+           +      + + E EI
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--------- 764
           LK + H  ++KI +     ++  +VLE M  G L             F ++         
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL-------------FDKVVGNKRLKEA 114

Query: 765 ---GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEE 817
                   +  A++YLH    N I+H D+KP NVLL    +D ++  ++DFG +K+L E 
Sbjct: 115 TCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIK-ITDFGHSKILGET 170

Query: 818 DSMKQTQTLA-TIGYIAPE---------YGRE 839
             M+   TL  T  Y+APE         Y R 
Sbjct: 171 SLMR---TLCGTPTYLAPEVLVSVGTAGYNRA 199

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 96.2 bits (240), Expect = 2e-21
 Identities = 46/198 (23%), Positives = 87/198 (43%), Gaps = 36/198 (18%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRH 719
           +D +  +  +G G++  V +      G+E A K+ + ++         + E  I + ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR--------LGIMIDVA 771
            N+V++  S    +F  LV + +  G L +         DI  R           +  + 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFE---------DIVAREFYSEADASHCIQQIL 138

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLA 827
            ++ Y H   SN IVH ++KP N+LL      + V  L+DFG+A  +++ ++        
Sbjct: 139 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVK-LADFGLAIEVNDSEAW--HGFAG 192

Query: 828 TIGYIAPE------YGRE 839
           T GY++PE      Y + 
Sbjct: 193 TPGYLSPEVLKKDPYSKP 210

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 95.8 bits (239), Expect = 2e-21
 Identities = 48/220 (21%), Positives = 81/220 (36%), Gaps = 42/220 (19%)

Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKV-----FHLQR 700
              +      D L     +  E   IG G +  V +      G + A+K+     F    
Sbjct: 9   GGGILDMADDDVLFEDVYELCEV--IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP 66

Query: 701 EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDI 760
             +      E  I   ++H ++V+++ + ++     +V E+M    L           +I
Sbjct: 67  GLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF---------EI 117

Query: 761 FQRL------------GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHL 805
            +R               M  +  AL Y H    N I+H D+KP  VLL   ++S    L
Sbjct: 118 VKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKL 174

Query: 806 SDFGIAKLLSEEDSMKQTQTLATIGYIAPE------YGRE 839
             FG+A  L E   +     + T  ++APE      YG+ 
Sbjct: 175 GGFGVAIQLGESGLVAGG-RVGTPHFMAPEVVKREPYGKP 213

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 97.0 bits (242), Expect = 3e-21
 Identities = 44/201 (21%), Positives = 83/201 (41%), Gaps = 41/201 (20%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDA-----ECEILKT 716
           T+++     +G G++  V +      G E A  + + ++   L++ D      E  I + 
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK---LSARDHQKLEREARICRL 66

Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR--------LGIMI 768
           ++H N+V++  S +      L+ + +  G L +         DI  R           + 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE---------DIVAREYYSEADASHCIQ 117

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQ 824
            +  A+ + H      +VH ++KP N+LL      + V  L+DFG+A  +  E       
Sbjct: 118 QILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVK-LADFGLAIEVEGEQQAWFG- 172

Query: 825 TLATIGYIAPE------YGRE 839
              T GY++PE      YG+ 
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKP 193

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 96.3 bits (240), Expect = 3e-21
 Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 54/211 (25%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFH--------LQREGALNSFDAECEI 713
            D++     +G G+ G V          +VAI++           +      + + E EI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL--------- 764
           LK + H  ++KI +     ++  +VLE M  G L             F ++         
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL-------------FDKVVGNKRLKEA 239

Query: 765 ---GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEED 818
                   +  A++YLH    N I+H D+KP NVLL   ++  +  ++DFG +K+L E  
Sbjct: 240 TCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296

Query: 819 SMKQTQTLA-TIGYIAPE---------YGRE 839
            M+   TL  T  Y+APE         Y R 
Sbjct: 297 LMR---TLCGTPTYLAPEVLVSVGTAGYNRA 324

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 97.1 bits (242), Expect = 3e-21
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 45/230 (19%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRH 719
            ++++   ++G GS+G V K +      E A+KV +         ++   E E+LK + H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR--------LGIMIDVA 771
            N++K+     + +   +V E    G L D         +I +R          I+  V 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFD---------EIIKRKRFSEHDAARIIKQVF 131

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLA 827
           S + Y+H    + IVH D+KP N+LL     D  +  + DFG++    +   M     + 
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIK-IIDFGLSTCFQQNTKM--KDRIG 185

Query: 828 TIGYIAPE-----YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           T  YIAPE     Y        K DV++ G++L  + +G  P    F G+
Sbjct: 186 TAYYIAPEVLRGTYDE------KCDVWSAGVILYILLSGTPP----FYGK 225

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 50/201 (24%), Positives = 78/201 (38%), Gaps = 49/201 (24%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDA----------------- 709
            IG GSYG V       D    A+KV     L R+                         
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 710 ------ECEILKTIRHRNLVK---IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD- 759
                 E  ILK + H N+VK   ++      +   +V E + +G + +    +   L  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVME--VPTLKPLSE 136

Query: 760 -----IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL 814
                 FQ      D+   +EYLH      I+H DIKPSN+L+ +     ++DFG++   
Sbjct: 137 DQARFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 815 SEEDSMKQTQTLATIGYIAPE 835
              D++    T+ T  ++APE
Sbjct: 188 KGSDALLSN-TVGTPAFMAPE 207

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 15/214 (7%)

Query: 376 LQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPS-CLGDLNSLRILSLSSNEL 434
            + LDL  N         F  F  L V+ L+R ++  +I       L+ L  L L+ N +
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88

Query: 435 TSVIPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRNNL-SGNIPSTIIG 492
            S+    F  L  +        +L  SL      +LK + ++ ++ N + S  +P     
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 493 LKNLQHLSLEHNKLQGPIPESFGELVSLEF----LDLSNNDLSGVIPASLEKLLYLKSLN 548
           L NL+HL L  NK+Q         L  +      LDLS N ++  I     K + LK L 
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELA 206

Query: 549 LSFNKLVGEIPRGGAFANFSAESFI---GNDLLC 579
           L  N+L   +P  G F   ++   I    N   C
Sbjct: 207 LDTNQLK-SVPD-GIFDRLTSLQKIWLHTNPWDC 238

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 57/271 (21%), Positives = 92/271 (33%), Gaps = 62/271 (22%)

Query: 269 SSKNL----IGLP-NLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNY 323
              N       LP + + L+L  N L   + S+ F               L+ L L R  
Sbjct: 15  MELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSF--FSF--------PELQVLDLSRCE 63

Query: 324 LTFSTSELMSLFSALVNCKSLKIG---NLINLTTLSLGDNNLSGSLPI-TLGRLKKLQGL 379
           +                  +++ G   +L +L+TL L  N +  SL +     L  LQ L
Sbjct: 64  IQ-----------------TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKL 105

Query: 380 DLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPS--CLGDLNSLRILSLSSNELTSV 437
                           H   L  + +  N +  S        +L +L  L LSSN++ S+
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSI 164

Query: 438 IPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ 497
             +    L                +PL   +L       LS N ++  I         L+
Sbjct: 165 YCTDLRVLH--------------QMPLLNLSL------DLSLNPMN-FIQPGAFKEIRLK 203

Query: 498 HLSLEHNKLQGPIPESFGELVSLEFLDLSNN 528
            L+L+ N+L+      F  L SL+ + L  N
Sbjct: 204 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 48/210 (22%), Positives = 80/210 (38%), Gaps = 12/210 (5%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
           +   L L  N L      +     +LQ LDL   + +      +   S L  + L  N +
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 411 SGSIPS-CLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLE--IE 467
             S+       L+SL+ L      L S+      +L+ +   + + N +  S  L     
Sbjct: 89  Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFS 146

Query: 468 NLKAVVDIYLSRNNLSGNIPSTII-GLKNLQ----HLSLEHNKLQGPIPESFGELVSLEF 522
           NL  +  + LS N +  +I  T +  L  +      L L  N +    P +F E+  L+ 
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKE 204

Query: 523 LDLSNNDLSGVIPASLEKLLYLKSLNLSFN 552
           L L  N L  V     ++L  L+ + L  N
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 46/216 (21%), Positives = 75/216 (34%), Gaps = 32/216 (14%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELH 87
           D+  N +  L                +   LQ L LSR     TI      +L+ L  L 
Sbjct: 34  DLSFNPLRHLG----------SYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82

Query: 88  LDYNKLQGEIPEEL-GNLAELEMLVLNNNLLTGTIPASIF----NLSFISTALDFSDNSL 142
           L  N +Q  +       L+ L+ LV     L  ++          L      L+ + N +
Sbjct: 83  LTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTL----KELNVAHNLI 136

Query: 143 TGSFPY-DMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSV----SLSYNQFTGRLPR 197
             SF   +    L  L+ L +S N+ +     +L    ++  +     LS N     +  
Sbjct: 137 Q-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194

Query: 198 DLGNSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEIL 232
                 +LK L L  N L   +P  I   L +L+ +
Sbjct: 195 GAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKI 229

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 53/250 (21%), Positives = 88/250 (35%), Gaps = 33/250 (13%)

Query: 138 SDNSLTGSFPYDMCPGLP-RLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLP 196
            + +     P      LP   K L +S+N  +     + +   EL  + LS  +    + 
Sbjct: 15  MELNFY-KIP----DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIE 68

Query: 197 RDL-GNSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGIDQSNLVGFVPDTIFNISTLK 254
                + + L +L L  N +   +       L +L+ L   ++NL       I ++ TLK
Sbjct: 69  DGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127

Query: 255 ILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNL 314
            L++ +N +  +    +    L NLE L+L  N +  SI         L+ + L      
Sbjct: 128 ELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDL--RVLHQMPLLNL--- 180

Query: 315 KRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLK 374
             L L  N + F        F  +             L  L+L  N L         RL 
Sbjct: 181 -SLDLSLNPMNFIQP---GAFKEI------------RLKELALDTNQLKSVPDGIFDRLT 224

Query: 375 KLQGLDLQNN 384
            LQ + L  N
Sbjct: 225 SLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 20/167 (11%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELH 87
            + GN + SL       A    S    LSSLQ LV      + ++     G+L  LKEL+
Sbjct: 82  ILTGNPIQSL-------ALGAFS---GLSSLQKLVAVETNLA-SLENFPIGHLKTLKELN 130

Query: 88  LDYNKLQG-EIPEELGNLAELEMLVLNNNLLTGTIPASIF----NLSFISTALDFSDNSL 142
           + +N +Q  ++PE   NL  LE L L++N +  +I  +       +  ++ +LD S N +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM 189

Query: 143 TGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYN 189
                      + RLK L +  NQ K            L  + L  N
Sbjct: 190 N-FIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 33/165 (20%), Positives = 52/165 (31%), Gaps = 30/165 (18%)

Query: 403 VYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSL 462
                      IP       S + L LS N L  +   +F                    
Sbjct: 12  YQCMELNFY-KIPD--NLPFSTKNLDLSFNPLRHLGSYSF-------------------- 48

Query: 463 PLEIENLKAVVDIYLSRNNLSGNIPSTI-IGLKNLQHLSLEHNKLQGPIPESFGELVSLE 521
                +   +  + LSR  +   I       L +L  L L  N +Q     +F  L SL+
Sbjct: 49  ----FSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ 103

Query: 522 FLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFAN 566
            L     +L+ +    +  L  LK LN++ N +         F+N
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSN 147

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 96.8 bits (241), Expect = 7e-21
 Identities = 45/196 (22%), Positives = 81/196 (41%), Gaps = 8/196 (4%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
            D +     +G G++G V++      G   A K      E    +   E + +  +RH  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           LV +  +  + N   ++ E+M  G L + +   +  +   + +  M  V   L ++H   
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH--- 272

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHL--SDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
            N  VH D+KP N++        L   DFG+   L  + S+K   T  T  + APE    
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK--VTTGTAEFAAPEVAEG 330

Query: 840 GQVSIKGDVYNYGIML 855
             V    D+++ G++ 
Sbjct: 331 KPVGYYTDMWSVGVLS 346

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 93.8 bits (233), Expect = 8e-21
 Identities = 37/176 (21%), Positives = 74/176 (42%), Gaps = 16/176 (9%)

Query: 705 NSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNF--NLDIFQ 762
           ++   +   +     +N V  +   +   +  + ++   K +L+D M       + +   
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165

Query: 763 RLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ 822
            L I I +A A+E+LH   S  ++H D+KPSN+      V  + DFG+   + +++  + 
Sbjct: 166 CLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222

Query: 823 TQTLA-----------TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNE 867
             T             T  Y++PE       S K D+++ G++L E+        E
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 93.9 bits (234), Expect = 9e-21
 Identities = 53/197 (26%), Positives = 85/197 (43%), Gaps = 38/197 (19%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
           +D F  E+ +G G+   VY+ +        A+KV    +         E  +L  + H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPN 109

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR--------LGIMIDVASA 773
           ++K+          +LVLE +  G L D          I ++           +  +  A
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFD---------RIVEKGYYSERDAADAVKQILEA 160

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-T 828
           + YLH    N IVH D+KP N+L      D+ +  ++DFG++K++  +  MK   T+  T
Sbjct: 161 VAYLH---ENGIVHRDLKPENLLYATPAPDAPLK-IADFGLSKIVEHQVLMK---TVCGT 213

Query: 829 IGYIAPE------YGRE 839
            GY APE      YG E
Sbjct: 214 PGYCAPEILRGCAYGPE 230

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 93.7 bits (233), Expect = 1e-20
 Identities = 61/303 (20%), Positives = 107/303 (35%), Gaps = 20/303 (6%)

Query: 58  SLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEE-LGNLAELEMLVLNNNL 116
           S +  +   +  +  IP ++       EL     KL+  I +       +LE + ++ N 
Sbjct: 10  SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQND 65

Query: 117 LTGTIPASIF-NLSFISTALDFSD-NSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNN 174
           +   I A +F NL  +   +     N+L      +    LP L+ L +S    K     +
Sbjct: 66  VLEVIEADVFSNLPKLHE-IRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVH 123

Query: 175 LWHCKELSSVSLSYNQFTGRLPRDL--GNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEIL 232
             H  +   + +  N     + R+   G S +   L L  N +  EI     N   L+ L
Sbjct: 124 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDEL 182

Query: 233 GIDQSNLVGFVPDTIF-NISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSG 291
            +  +N +  +P+ +F   S   IL +    +  +LPS   L  L  L   +    NL  
Sbjct: 183 NLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG-LENLKKLRARS--TYNLK- 237

Query: 292 SIPSFFFNASKLYALELGYNSNLKR-LGLERNYLTFSTSELMSLFSALVNCKSLKIGNLI 350
            +P+       L    L Y S+        R           S+    V+  +   G   
Sbjct: 238 KLPT-LEKLVALMEASLTYPSHCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRS 296

Query: 351 NLT 353
           +L 
Sbjct: 297 SLA 299

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 90.3 bits (224), Expect = 2e-19
 Identities = 34/207 (16%), Positives = 72/207 (34%), Gaps = 4/207 (1%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE-FCHFSRLYVVYL-NRN 408
           N   L      L             L+ +++  N     I  + F +  +L+ + +   N
Sbjct: 31  NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 409 KLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLE-IE 467
            L    P    +L +L+ L +S+  +  +      +    +  D   N    ++      
Sbjct: 91  NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150

Query: 468 NLKA-VVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLS 526
            L    V ++L++N +     S   G +  +    ++N L+    + F        LD+S
Sbjct: 151 GLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210

Query: 527 NNDLSGVIPASLEKLLYLKSLNLSFNK 553
              +  +    LE L  L++ +    K
Sbjct: 211 RTRIHSLPSYGLENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 84.5 bits (209), Expect = 1e-17
 Identities = 48/256 (18%), Positives = 83/256 (32%), Gaps = 33/256 (12%)

Query: 277 PNLEGLNLGLNNLSGSIPSF-FFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLF 335
            N   L   L  L   I    F     L  +E+  N  L+ +                +F
Sbjct: 30  RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEA-------------DVF 75

Query: 336 SALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFC 395
           S L     ++I    NL  ++                L  LQ L + N   +        
Sbjct: 76  SNLPKLHEIRIEKANNLLYINPE----------AFQNLPNLQYLLISNTGIKHLPDVHKI 125

Query: 396 HFSRLYVVYLNRNKLSGSIPSCL--GDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDF 453
           H  +  ++ +  N    +I      G      IL L+ N +  +  S F   +       
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185

Query: 454 SSNSLNGSLPLEI-ENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPE 512
            +N+L   LP ++       V + +SR  +       +  LK L+  S  + K    +P 
Sbjct: 186 DNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKK---LP- 240

Query: 513 SFGELVSLEFLDLSNN 528
           +  +LV+L    L+  
Sbjct: 241 TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 83.0 bits (205), Expect = 4e-17
 Identities = 52/283 (18%), Positives = 90/283 (31%), Gaps = 49/283 (17%)

Query: 18  ASVCSWMGITCDVYGNRVTSL------TISDLGLAG----TIPSH-LGNLSSLQTLVLSR 66
             +C           ++VT +         +L         I          L+ + +S+
Sbjct: 4   HRICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 63

Query: 67  NWFSGTIPKEI-GNLTKLKELHL-DYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPAS 124
           N     I  ++  NL KL E+ +   N L    PE   NL  L+ L+++N  +       
Sbjct: 64  NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK------ 117

Query: 125 IFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNL--WHCKELS 182
                                 P        +   L +  N     I  N       E  
Sbjct: 118 --------------------HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESV 157

Query: 183 SVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGIDQSNLVG 241
            + L+ N     +     N T+L  L+L  NN   E+P ++        IL I ++ +  
Sbjct: 158 ILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 216

Query: 242 FVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNL 284
                + N+  L+  S +N      LP+ +    L  L   +L
Sbjct: 217 LPSYGLENLKKLRARSTYNLK---KLPTLEK---LVALMEASL 253

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.4 bits (201), Expect = 1e-16
 Identities = 36/216 (16%), Positives = 73/216 (33%), Gaps = 8/216 (3%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
           +       ++ ++  +P  L   +    L     K        F  F  L  + +++N +
Sbjct: 10  SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 411 SGSIPS-CLGDLNSLRILSLS-SNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIEN 468
              I +    +L  L  + +  +N L  + P  F NL ++     S+  +     +   +
Sbjct: 67  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126

Query: 469 LKAVVDIYLSRNNLSGNIPS-TIIGL-KNLQHLSLEHNKLQGPIPESFGELVSLEFLDLS 526
               V + +  N     I   + +GL      L L  N +Q     +F      E     
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSD 186

Query: 527 NNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGG 562
           NN+L  +             L++S  ++   +P  G
Sbjct: 187 NNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG 221

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 95.2 bits (237), Expect = 2e-20
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 46/236 (19%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKV-------------FHLQREGALNSFD 708
            + + +   +G G+YG V   +      E AIKV              +   E       
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 709 AECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQR----- 763
            E  +LK++ H N++K+     +  +  LV E+   G L +          I  R     
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE---------QIINRHKFDE 145

Query: 764 ---LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSE 816
                IM  + S + YLH    + IVH DIKP N+LL        +  + DFG++   S+
Sbjct: 146 CDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK-IVDFGLSSFFSK 201

Query: 817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           +  +     L T  YIAPE  +  + + K DV++ G+++  +  G  P    F G+
Sbjct: 202 DYKL--RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP----FGGQ 250

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 46/192 (23%), Positives = 73/192 (38%), Gaps = 45/192 (23%)

Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIISSC 729
           +G GS+    K          A+K+   + E        E   LK    H N+VK+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL------------GIMIDVASALEYL 777
            +     LV+E +  G L             F+R+             IM  + SA+ ++
Sbjct: 76  HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 778 HFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           H      +VH D+KP N+L     D+  +  + DFG A+L   ++   +T    T+ Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIK-IIDFGFARLKPPDNQPLKT-PCFTLHYAA 177

Query: 834 PE------YGRE 839
           PE      Y   
Sbjct: 178 PELLNQNGYDES 189

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 13/197 (6%)

Query: 339 VNCKSLKIGNL-----INLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE 393
           VNC    +  L      + T L L +N L      TL    +L  L+L   +      Q 
Sbjct: 15  VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQV 72

Query: 394 FCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDF 453
                 L  + L+ N+L  S+P     L +L +L +S N LTS+       L ++     
Sbjct: 73  DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131

Query: 454 SSNSLNGSLPLEI-ENLKAVVDIYLSRNNLSGNIPSTII-GLKNLQHLSLEHNKLQGPIP 511
             N L  +LP  +      +  + L+ NNL+  +P+ ++ GL+NL  L L+ N L   IP
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IP 188

Query: 512 ESFGELVSLEFLDLSNN 528
           + F     L F  L  N
Sbjct: 189 KGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 90.6 bits (225), Expect = 6e-20
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 10/194 (5%)

Query: 376 LQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELT 435
              ++         +P +        +++L+ N L     + L     L  L+L   ELT
Sbjct: 12  HLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68

Query: 436 SVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTII-GLK 494
            +       L  +   D S N L  SLPL  + L A+  + +S N L+ ++P   + GL 
Sbjct: 69  KL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124

Query: 495 NLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
            LQ L L+ N+L+   P        LE L L+NN+L+ +    L  L  L +L L  N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184

Query: 555 VGEIPRGGAFANFS 568
              IP+ G F +  
Sbjct: 185 YT-IPK-GFFGSHL 196

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 46/195 (23%), Positives = 73/195 (37%), Gaps = 22/195 (11%)

Query: 312 SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLG 371
            +   L L  N L   +    +                  LT L+L    L+  L    G
Sbjct: 31  KDTTILHLSENLLYTFSL---ATLM-----------PYTRLTQLNLDRAELT-KLQ-VDG 74

Query: 372 RLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLS 430
            L  L  LDL +N+ +  +P        L V+ ++ N+L+ S+P      L  L+ L L 
Sbjct: 75  TLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLK 132

Query: 431 SNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRNNLSGNIPST 489
            NEL ++ P        +     ++N+L   LP  +   L+ +  + L  N+L   IP  
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKG 190

Query: 490 IIGLKNLQHLSLEHN 504
             G   L    L  N
Sbjct: 191 FFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 56/243 (23%), Positives = 85/243 (34%), Gaps = 47/243 (19%)

Query: 21  CSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNL 80
                +  +     +T+           +P  L        L LS N         +   
Sbjct: 8   KVASHLEVNCDKRNLTA-----------LPPDL--PKDTTILHLSENLLYTFSLATLMPY 54

Query: 81  TKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDN 140
           T+L +L+LD  +L  ++  + G L  L  L L++N L  ++P                  
Sbjct: 55  TRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLG--------------- 96

Query: 141 SLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDL- 199
                        LP L  L VS+N+        L    EL  + L  N+    LP  L 
Sbjct: 97  -----------QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLL 144

Query: 200 GNSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSL 258
             + KL+ L L  NNL  E+P  +   L NL+ L + Q N +  +P   F    L    L
Sbjct: 145 TPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLL-QENSLYTIPKGFFGSHLLPFAFL 202

Query: 259 FNN 261
             N
Sbjct: 203 HGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 50/202 (24%), Positives = 72/202 (35%), Gaps = 37/202 (18%)

Query: 186 LSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPD 245
           LS N         L   T+L  L+L    L  ++    G L  L  L +   N +  +P 
Sbjct: 38  LSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLS-HNQLQSLPL 94

Query: 246 TIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYA 305
               +  L +L +  N L+ +LP    L GL  L+ L L  N L  ++P      +    
Sbjct: 95  LGQTLPALTVLDVSFNRLT-SLPLGA-LRGLGELQELYLKGNELK-TLPPGLL--TPT-- 147

Query: 306 LELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIG---NLINLTTLSLGDNNL 362
                   L++L L  N LT                  L  G    L NL TL L +N+L
Sbjct: 148 ------PKLEKLSLANNNLT-----------------ELPAGLLNGLENLDTLLLQENSL 184

Query: 363 SGSLPITLGRLKKLQGLDLQNN 384
             ++P        L    L  N
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGN 205

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 92.2 bits (229), Expect = 3e-20
 Identities = 50/240 (20%), Positives = 81/240 (33%), Gaps = 60/240 (25%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDA-----ECEILKT 716
             ++  +  IG GSYG V            AIK+ +  +   +N  D      E  ++K 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG----------- 765
           + H N+ ++     +  +  LV+E    G L D +     +      +            
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 766 ----------------------------IMIDVASALEYLHFGHSNPIVHCDIKPSNVLL 797
                                       IM  + SAL YLH   +  I H DIKP N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLF 201

Query: 798 DDSMVAHL--SDFGIAKLL---SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYG 852
             +    +   DFG++K     +  +    T    T  ++APE      V +     +YG
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE------V-LNTTNESYG 254

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 47/191 (24%), Positives = 75/191 (39%), Gaps = 41/191 (21%)

Query: 669 ENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKII 726
           E+++G G++  V          E A+K+   Q     +    E E+L   + HRN++++I
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL------------GIMIDVASAL 774
                 +   LV E M  GS+                +             ++ DVASAL
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASAL 124

Query: 775 EYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMK--QTQTLAT 828
           ++LH   +  I H D+KP N+L       S V  + DF +   +          T  L T
Sbjct: 125 DFLH---NKGIAHRDLKPENILCEHPNQVSPVK-ICDFDLGSGIKLNGDCSPISTPELLT 180

Query: 829 I----GYIAPE 835
                 Y+APE
Sbjct: 181 PCGSAEYMAPE 191

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 91.1 bits (227), Expect = 4e-20
 Identities = 47/177 (26%), Positives = 82/177 (46%), Gaps = 7/177 (3%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQ--REGALNSFDAECEILKTIR 718
              +++ +   +G G+YG VYK +   G  VA+K   L    EG  ++   E  +LK + 
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           H N+V +I    +     LV E+M K  L+  +  +   L   Q    +  +   + + H
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
               + I+H D+KP N+L++      L+DFG+A+          T  + T+ Y AP+
Sbjct: 137 ---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPD 189

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 23/209 (11%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA----ECEILKTIRHRNLVK- 724
           L+G GSYG V +          A+K+   ++   + + +A    E ++L+ +RH+N+++ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 725 --IISSCT-NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
             ++ +      +  +V+EY   G  E           + Q  G    +   LEYLH   
Sbjct: 72  VDVLYNEEKQKMY--MVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH--- 126

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI----GYIAPE-- 835
           S  IVH DIKP N+LL       +S  G+A+ L          T  T      +  PE  
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL---HPFAADDTCRTSQGSPAFQPPEIA 183

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
            G +     K D+++ G+ L  + TG+ P
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 47/285 (16%), Positives = 100/285 (35%), Gaps = 45/285 (15%)

Query: 272 NLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSEL 331
               L N   +  G +N++ ++                    +  L      +T      
Sbjct: 14  PDPALANAIKIAAGKSNVTDTVT-------------QADLDGITTLSAFGTGVT------ 54

Query: 332 MSLFSALVNCKSLK-IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPI 390
                      +++ +  L NL  L L DN ++   P  L  L K+  L+L  N  +   
Sbjct: 55  -----------TIEGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVS 101

Query: 391 PQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILG 450
                    +  + L   +++   P  L  L++L++L L  N++T++ P     L ++  
Sbjct: 102 A--IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQY 155

Query: 451 FDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPI 510
               +  ++   PL   NL  +  +    N +S +I   +  L NL  + L++N++    
Sbjct: 156 LSIGNAQVSDLTPLA--NLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV- 210

Query: 511 PESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLV 555
                   +L  + L+N  ++         L+    +       +
Sbjct: 211 -SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI 254

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 55/307 (17%), Positives = 107/307 (34%), Gaps = 27/307 (8%)

Query: 53  LGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVL 112
              L++   +   ++  + T+     +L  +  L      +     E +  L  L  L L
Sbjct: 15  DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLEL 70

Query: 113 NNNLLTGTIPASIFNLSFIS--TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGP 170
            +N +T      +  L  ++  T L+ S N L          GL  +K L ++  Q    
Sbjct: 71  KDNQIT-----DLAPLKNLTKITELELSGNPLKNVSAIA---GLQSIKTLDLTSTQITD- 121

Query: 171 IPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLE 230
               L     L  + L  NQ T   P  L   T L+ L +G   ++   P  + NL  L 
Sbjct: 122 -VTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLT 176

Query: 231 ILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLS 290
            L  D + +    P  + ++  L  + L NN +S        L    NL  + L    ++
Sbjct: 177 TLKADDNKISDISP--LASLPNLIEVHLKNNQIS----DVSPLANTSNLFIVTLTNQTIT 230

Query: 291 GSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLI 350
                +  N      ++    + +    +  +  T+++  L    ++ +N  S      +
Sbjct: 231 NQPVFYNNNLVVPNVVKGPSGAPIAPATIS-DNGTYASPNLTWNLTSFINNVSYTFNQSV 289

Query: 351 NLTTLSL 357
                ++
Sbjct: 290 TFKNTTV 296

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 64/345 (18%), Positives = 125/345 (36%), Gaps = 63/345 (18%)

Query: 225 NLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNL 284
            L N   +   +SN+   V     ++  +  LS F   ++    + + +  L NL GL L
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT----TIEGVQYLNNLIGLEL 70

Query: 285 GLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSL 344
             N ++  +              L   + +  L L  N L        ++ +        
Sbjct: 71  KDNQIT-DLA------------PLKNLTKITELELSGNPLK-------NVSA-------- 102

Query: 345 KIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVY 404
            I  L ++ TL L    ++   P  L  L  LQ L L  N+     P      + L  + 
Sbjct: 103 -IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLS 157

Query: 405 LNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPL 464
           +   ++S   P  L +L+ L  L    N+++ +  S   +L +++     +N ++   PL
Sbjct: 158 IGNAQVSDLTP--LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSPL 213

Query: 465 EIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPI-PESFGELVSLEFL 523
              N   +  + L+   ++ N P       NL   ++       PI P +  +  +    
Sbjct: 214 A--NTSNLFIVTLTNQTIT-NQPVFY--NNNLVVPNVVKGPSGAPIAPATISDNGTYASP 268

Query: 524 DLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFS 568
           +L+ N  S           ++ +++ +FN+ V           FS
Sbjct: 269 NLTWNLTS-----------FINNVSYTFNQSVTF---KNTTVPFS 299

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 59/253 (23%), Positives = 102/253 (40%), Gaps = 42/253 (16%)

Query: 33  NRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNK 92
           + +T+L+    G+  T    +  L++L  L L  N  +   P  + NLTK+ EL L  N 
Sbjct: 41  DGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96

Query: 93  LQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCP 152
           L  +    +  L  ++ L L +  +T      +  L+                       
Sbjct: 97  L--KNVSAIAGLQSIKTLDLTSTQIT-----DVTPLA----------------------- 126

Query: 153 GLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGF 212
           GL  L+ LY+  NQ    I   L     L  +S+   Q +   P  L N +KL +L    
Sbjct: 127 GLSNLQVLYLDLNQITN-IS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182

Query: 213 NNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKN 272
           N ++ +I   + +L NL  + +  + +    P  + N S L I++L N T++       N
Sbjct: 183 NKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238

Query: 273 LIGLPNLEGLNLG 285
            + +PN+     G
Sbjct: 239 NLVVPNVVKGPSG 251

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 33/168 (19%), Positives = 64/168 (38%), Gaps = 16/168 (9%)

Query: 51  SHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEML 110
           + L  LS+LQ L L  N  +   P  +  LT L+ L +   ++    P  L NL++L  L
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178

Query: 111 VLNNNLLTGTIP-ASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG 169
             ++N ++   P AS+ NL      +   +N ++   P         L  + ++      
Sbjct: 179 KADDNKISDISPLASLPNL----IEVHLKNNQISDVSPLA---NTSNLFIVTLTNQTITN 231

Query: 170 PIPNNLWHCKELSSVSLSYNQFTGRL-PRDLGNSTKLKSLDLGFNNLN 216
                      L   ++        + P  + ++    S +L +N  +
Sbjct: 232 QPVFYN---NNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 88.7 bits (221), Expect = 2e-19
 Identities = 45/174 (25%), Positives = 82/174 (47%), Gaps = 7/174 (4%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRN 721
           +++     IG G+YG VYK +   G   A+K   L+   EG  ++   E  ILK ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +VK+           LV E++ +  L+  +      L+       ++ + + + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
              ++H D+KP N+L++      ++DFG+A+        K T  + T+ Y AP+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPD 170

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 89.2 bits (222), Expect = 3e-19
 Identities = 46/216 (21%), Positives = 80/216 (37%), Gaps = 41/216 (18%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDA------ECEILK 715
            D +     +G G +  V K R    G+E A K    ++  A     +      E  IL+
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL----------- 764
            + H N++ +     N     L+LE +  G L             F  L           
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEA 117

Query: 765 -GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDS 819
              +  +   + YLH   +  I H D+KP N++L           L DFG+A  + +   
Sbjct: 118 TSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIML 855
            K      T  ++APE      + ++ D+++ G++ 
Sbjct: 175 FK--NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 32/264 (12%), Positives = 65/264 (24%), Gaps = 56/264 (21%)

Query: 671 LIGIGSYGSVYKGRFPDGI---EVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVK 724
             G       ++    D     +VA+     Q    +  L    +    L  I    + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 725 IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP 784
           ++          +V E++  GSL++    S         +  M  +A+A +  H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSI 844
           +      PS V +           G                LA    +     ++     
Sbjct: 150 VALSIDHPSRVRVSID--------GDVV-------------LAYPATMPDANPQD----- 183

Query: 845 KGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANV 904
             D+   G  L  +     P                  L           +   +   ++
Sbjct: 184 --DIRGIGASLYALLVNRWP----LPEAGVR-----SGLAPAERDTAGQPIEPADIDRDI 232

Query: 905 AKQSCASSVLSLAMECTSESPENR 928
             Q     + ++A          R
Sbjct: 233 PFQ-----ISAVAARSVQGDGGIR 251

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 88.0 bits (219), Expect = 4e-19
 Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 24/219 (10%)

Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHR 720
            ++ +   IG G+YG+V+K +       VA+K   L    EG  +S   E  +LK ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
           N+V++     +     LV E+  +  L+    + N +LD       +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-- 118

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE----- 835
            S  ++H D+KP N+L++ +    L++FG+A+          +  + T+ Y  P+     
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGA 176

Query: 836 --YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
             Y      SI  D+++ G +  E+    +P    F G 
Sbjct: 177 KLYS----TSI--DMWSAGCIFAELANAGRP---LFPGN 206

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 89.0 bits (221), Expect = 4e-19
 Identities = 49/180 (27%), Positives = 74/180 (41%), Gaps = 28/180 (15%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDA-----ECEILKTIRHRNL 722
           +G G++G V+         EV +K      +  +  +          E  IL  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 723 VKIISSCTNHNFKALVLEYMPKGS-LEDCMYASNFNLD------IFQRLGIMIDVASALE 775
           +K++    N  F  LV+E    G  L   +   +  LD      IF++L       SA+ 
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFI-DRHPRLDEPLASYIFRQL------VSAVG 144

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           YL       I+H DIK  N+++ +     L DFG A  L E   +  T    TI Y APE
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYT-FCGTIEYCAPE 199

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 88.1 bits (219), Expect = 5e-19
 Identities = 43/197 (21%), Positives = 85/197 (43%), Gaps = 11/197 (5%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
            +++     +G G +G V++            K   + +         E  IL   RHRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           ++ +  S  +     ++ E++    + + +  S F L+  + +  +  V  AL++LH   
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH--- 119

Query: 782 SNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR 838
           S+ I H DI+P N++      S +  + +FG A+ L   D+ +         Y APE  +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIK-IIEFGQARQLKPGDNFR--LLFTAPEYYAPEVHQ 176

Query: 839 EGQVSIKGDVYNYGIML 855
              VS   D+++ G ++
Sbjct: 177 HDVVSTATDMWSLGTLV 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 85.0 bits (211), Expect = 5e-19
 Identities = 32/186 (17%), Positives = 66/186 (35%), Gaps = 10/186 (5%)

Query: 348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNR 407
                    LG ++ +    IT  ++  L  + L N            +   +  + +N 
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 408 NKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIE 467
              +   P  +  L++L  L +   ++TS        L  +   D S ++ + S+  +I 
Sbjct: 76  IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 468 NLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSN 527
            L  V  I LS N    +I   +  L  L+ L+++ + +         +   L  L   +
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190

Query: 528 NDLSGV 533
             + G 
Sbjct: 191 QTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.8 bits (187), Expect = 8e-16
 Identities = 35/211 (16%), Positives = 69/211 (32%), Gaps = 36/211 (17%)

Query: 55  NLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNN 114
              +    +L ++    T       +  L  + L    +  ++   +     ++ L +NN
Sbjct: 21  TFKAYLNGLLGQS---STANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75

Query: 115 NLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNN 174
              T        N + IS                    GL  L+ L +           N
Sbjct: 76  IHAT--------NYNPIS--------------------GLSNLERLRIMGKDVTSDKIPN 107

Query: 175 LWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGI 234
           L     L+ + +S++     +   +    K+ S+DL +N    +I   +  L  L+ L I
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNI 166

Query: 235 DQSNLVGFVPDTIFNISTLKILSLFNNTLSG 265
               +  +    I +   L  L  F+ T+ G
Sbjct: 167 QFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 23/138 (16%), Positives = 56/138 (40%), Gaps = 7/138 (5%)

Query: 421 LNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRN 480
             +     L  +   ++  +    +  +     ++ ++     +E      + D+ ++  
Sbjct: 22  FKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNI 76

Query: 481 NLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEK 540
           + + N  + I GL NL+ L +    +      +   L SL  LD+S++     I   +  
Sbjct: 77  HAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134

Query: 541 LLYLKSLNLSFNKLVGEI 558
           L  + S++LS+N  + +I
Sbjct: 135 LPKVNSIDLSYNGAITDI 152

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 30/204 (14%), Positives = 65/204 (31%), Gaps = 32/204 (15%)

Query: 257 SLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKR 316
           +  N  L  +  ++     + +L  + L   N++                 + Y  N+K 
Sbjct: 24  AYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-------------IEYAHNIKD 70

Query: 317 LGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKL 376
           L +   + T                    I  L NL  L +   +++      L  L  L
Sbjct: 71  LTINNIHATNYNP----------------ISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114

Query: 377 QGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTS 436
             LD+ ++  +  I  +     ++  + L+ N     I   L  L  L+ L++  + +  
Sbjct: 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD 173

Query: 437 VIPSTFWNLEDILGFDFSSNSLNG 460
                  +   +      S ++ G
Sbjct: 174 YRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.7 bits (166), Expect = 5e-13
 Identities = 31/186 (16%), Positives = 70/186 (37%), Gaps = 33/186 (17%)

Query: 33  NRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNK 92
           N +T +T++++ +  T  + +    +++ L ++    +   P  I  L+ L+ L +    
Sbjct: 44  NSLTYITLANINV--TDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99

Query: 93  LQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCP 152
           +  +    L  L  L +L ++++    +I   I  L                        
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL------------------------ 135

Query: 153 GLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGF 212
             P++  + +SYN     I   L    EL S+++ ++       R + +  KL  L    
Sbjct: 136 --PKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFS 190

Query: 213 NNLNGE 218
             + G+
Sbjct: 191 QTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.3 bits (165), Expect = 7e-13
 Identities = 22/158 (13%), Positives = 54/158 (34%), Gaps = 9/158 (5%)

Query: 154 LPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFN 213
           +  L  + ++           + +   +  ++++    T   P  +   + L+ L +   
Sbjct: 43  MNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGK 98

Query: 214 NLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNL 273
           ++  +    +  L +L +L I  S     +   I  +  +  + L  N    ++     L
Sbjct: 99  DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI---MPL 155

Query: 274 IGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN 311
             LP L+ LN+  + +         +  KL  L     
Sbjct: 156 KTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 12/93 (12%), Positives = 36/93 (38%), Gaps = 7/93 (7%)

Query: 467 ENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLS 526
              KA ++  L +++ +     T   + +L +++L +  +            +++ L ++
Sbjct: 20  STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTIN 74

Query: 527 NNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIP 559
           N   +   P  +  L  L+ L +    +  +  
Sbjct: 75  NIHATNYNP--ISGLSNLERLRIMGKDVTSDKI 105

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 88.6 bits (220), Expect = 7e-19
 Identities = 46/216 (21%), Positives = 79/216 (36%), Gaps = 41/216 (18%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDA------ECEILK 715
            D +     +G G +  V K R    G+E A K    ++  A            E  IL+
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL----------- 764
            + H N++ +     N     L+LE +  G L             F  L           
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEA 117

Query: 765 -GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDS 819
              +  +   + YLH   +  I H D+KP N++L           L DFG+A  + +   
Sbjct: 118 TSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIML 855
            K      T  ++APE      + ++ D+++ G++ 
Sbjct: 175 FK--NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 86.8 bits (216), Expect = 7e-19
 Identities = 50/217 (23%), Positives = 82/217 (37%), Gaps = 43/217 (19%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFH------LQREGALNSFDAECEILK 715
            D +     +G G +  V K R    G E A K          +R  +    + E  IL+
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL----------- 764
            IRH N++ +     N     L+LE +  G L             F  L           
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGEL-------------FDFLAEKESLTEDEA 110

Query: 765 -GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL-----DDSMVAHLSDFGIAKLLSEED 818
              +  +   + YLH   S  I H D+KP N++L      +  +  L DFGIA  +   +
Sbjct: 111 TQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIK-LIDFGIAHKIEAGN 166

Query: 819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIML 855
             K      T  ++APE      + ++ D+++ G++ 
Sbjct: 167 EFK--NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 88.9 bits (221), Expect = 7e-19
 Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 63/233 (27%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVF---HLQREGALNSFDAECEILKTIRH 719
           D F     IG GS+G V   +  D  ++ A+K            + +   E +I++ + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 720 RNLVKIISSCTNHNFKA-----LVLEYMPKGSL-----------ED--CMYASNFNLDIF 761
             LV +  S     F+      +V++ +  G L           E+   ++         
Sbjct: 75  PFLVNLWYS-----FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC------- 122

Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK 821
                  ++  AL+YL    +  I+H D+KP N+LLD+    H++DF IA +L  E    
Sbjct: 123 -------ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-- 170

Query: 822 QTQTLA-TIGYIAPE---------YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
              T+A T  Y+APE         Y     V    D ++ G+   E+  G +P
Sbjct: 171 -ITTMAGTKPYMAPEMFSSRKGAGYSFA--V----DWWSLGVTAYELLRGRRP 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 88.0 bits (219), Expect = 7e-19
 Identities = 56/178 (31%), Positives = 86/178 (48%), Gaps = 8/178 (4%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA--ECEILKTI 717
           ++ +++    L+G GSYG V K R  D G  VAIK F    +  +    A  E ++LK +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81

Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
           RH NLV ++  C       LV E++   ++ D +      LD       +  + + + + 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           H   S+ I+H DIKP N+L+  S V  L DFG A+ L+          +AT  Y APE
Sbjct: 141 H---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDDEVATRWYRAPE 194

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 87.3 bits (217), Expect = 1e-18
 Identities = 47/216 (21%), Positives = 82/216 (37%), Gaps = 41/216 (18%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDA------ECEILK 715
            D +     +G G +  V K R    G++ A K    +R  +     +      E  ILK
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRL----------- 764
            I+H N++ +     N     L+LE +  G L             F  L           
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGEL-------------FDFLAEKESLTEEEA 116

Query: 765 -GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDS 819
              +  + + + YL   HS  I H D+KP N++L           + DFG+A  +   + 
Sbjct: 117 TEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

Query: 820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIML 855
            K      T  ++APE      + ++ D+++ G++ 
Sbjct: 174 FK--NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 88.7 bits (220), Expect = 1e-18
 Identities = 44/197 (22%), Positives = 79/197 (40%), Gaps = 30/197 (15%)

Query: 661 RATDQFSEENL-IGIGSYGSVYKGRFPD---GIEVAIKVFHLQREGALNSFDAECEILKT 716
           R  D F  E   +G G+YG VYK +  D     + A+K       G   S   E  +L+ 
Sbjct: 17  RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRE 74

Query: 717 IRHRNLVKIISSCTNHNFKA--LVLEYMP---KGSLEDCMYASNFN----LDIFQRLGIM 767
           ++H N++ +     +H  +   L+ +Y        ++    +        L       ++
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134

Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH----LSDFGIAKLLSEEDSMKQT 823
             +   + YLH   +N ++H D+KP+N+L+           ++D G A+L +   S  + 
Sbjct: 135 YQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN---SPLKP 188

Query: 824 QTLA-----TIGYIAPE 835
                    T  Y APE
Sbjct: 189 LADLDPVVVTFWYRAPE 205

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 88.6 bits (220), Expect = 1e-18
 Identities = 53/232 (22%), Positives = 92/232 (39%), Gaps = 42/232 (18%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEILKTIRH 719
           D F    +IG G++  V   +     +V A+K+   + + + G ++ F  E ++L     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID---------- 769
           R + ++  +  + N+  LV+EY   G L          L    + G  I           
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDL--------LTL--LSKFGERIPAEMARFYLAE 170

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH--LSDFGIAKLLSEEDSMKQTQTLA 827
           +  A++ +H       VH DIKP N+LLD     H  L+DFG    L  + +++    + 
Sbjct: 171 IVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVG 225

Query: 828 TIGYIAPEYGREGQVSIKGDVYN-------YGIMLMEVFTGMKPTNEFFTGE 872
           T  Y++PE  +          Y         G+   E+F G  P    F  +
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP----FYAD 273

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.8 bits (222), Expect = 1e-18
 Identities = 45/244 (18%), Positives = 92/244 (37%), Gaps = 32/244 (13%)

Query: 312 SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLG 371
           +   +  L++  +T                 ++    L ++  +   ++++  S+   + 
Sbjct: 21  AETIKDNLKKKSVT----------------DAVTQNELNSIDQIIANNSDIK-SVQ-GIQ 62

Query: 372 RLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSS 431
            L  +  L L  NK     P    +   L  ++L+ NK+   + S L DL  L+ LSL  
Sbjct: 63  YLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEH 118

Query: 432 NELTSVIP-STFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTI 490
           N ++ +        LE +      +N +     L    L  +  + L  N +S +I   +
Sbjct: 119 NGISDINGLVHLPQLESL---YLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVP-L 171

Query: 491 IGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLS 550
            GL  LQ+L L  N +      +   L +L+ L+L + +           L+   ++  +
Sbjct: 172 AGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 229

Query: 551 FNKL 554
              L
Sbjct: 230 DGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 86.3 bits (213), Expect = 2e-17
 Identities = 51/278 (18%), Positives = 103/278 (37%), Gaps = 32/278 (11%)

Query: 51  SHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEML 110
                 +      L +   +  +      L  + ++  + + ++  + + +  L  +  L
Sbjct: 15  FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 70

Query: 111 VLNNNLLTGTIPASIFNLSFIS--TALDFSDNSLTGSFPYDMCP--GLPRLKGLYVSYNQ 166
            LN N LT      I  L+ +     L   +N +      D+     L +LK L + +N 
Sbjct: 71  FLNGNKLT-----DIKPLTNLKNLGWLFLDENKIK-----DLSSLKDLKKLKSLSLEHNG 120

Query: 167 FKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNL 226
                 N L H  +L S+ L  N+ T      L   TKL +L L  N ++ +I   +  L
Sbjct: 121 IS--DINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGL 174

Query: 227 RNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGL 286
             L+ L + ++++       +  +  L +L LF+         +K +    NL   N  +
Sbjct: 175 TKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQEC-----LNKPINHQSNLVVPNT-V 226

Query: 287 NNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYL 324
            N  GS+ +    +      +     +L     E +++
Sbjct: 227 KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFI 264

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 84.0 bits (207), Expect = 9e-17
 Identities = 61/314 (19%), Positives = 113/314 (35%), Gaps = 51/314 (16%)

Query: 199 LGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSL 258
                +    +L   ++   + Q    L +++ +  + S++       I  +  +  L L
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 72

Query: 259 FNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLG 318
             N     L   K L  L NL  L L  N +   + S            L     LK L 
Sbjct: 73  NGN----KLTDIKPLTNLKNLGWLFLDENKIK-DLSS------------LKDLKKLKSLS 115

Query: 319 LERNYLTFSTSELMSLFSALVNCKSLK-IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQ 377
           LE N ++                  +  + +L  L +L LG+N ++      L RL KL 
Sbjct: 116 LEHNGIS-----------------DINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLD 156

Query: 378 GLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSV 437
            L L++N+    +P      ++L  +YL++N +S  +   L  L +L +L L S E  + 
Sbjct: 157 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNK 212

Query: 438 IPSTF------WNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTII 491
             +          +++  G   +   ++     E  N+K  +  + +  +     P TI 
Sbjct: 213 PINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIG 272

Query: 492 GLKNLQHLSLEHNK 505
             K   H  +    
Sbjct: 273 KAKARFHGRVTQPL 286

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 83.2 bits (205), Expect = 1e-16
 Identities = 60/307 (19%), Positives = 110/307 (35%), Gaps = 68/307 (22%)

Query: 247 IFNISTLKILSLFNNTLSGNLPSS-KNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYA 305
           IF            + L     +       L +++ +    +++  S+            
Sbjct: 14  IFPDDAFA--ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQ----------- 59

Query: 306 LELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGS 365
             + Y  N+ +L L  N LT        +           + NL NL  L L +N +   
Sbjct: 60  -GIQYLPNVTKLFLNGNKLT-------DIKP---------LTNLKNLGWLFLDENKIK-D 101

Query: 366 LPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR 425
           L  +L  LKKL+ L L++N           H  +L  +YL  NK++    + L  L  L 
Sbjct: 102 LS-SLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT--DITVLSRLTKLD 156

Query: 426 ILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGN 485
            LSL  N+++ ++P                          +  L  + ++YLS+N++S +
Sbjct: 157 TLSLEDNQISDIVP--------------------------LAGLTKLQNLYLSKNHIS-D 189

Query: 486 IPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLK 545
           +   + GLKNL  L L   +           LV    +  ++  L    P  +      +
Sbjct: 190 L-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYE 246

Query: 546 SLNLSFN 552
             N+ ++
Sbjct: 247 KPNVKWH 253

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 78.2 bits (192), Expect = 6e-15
 Identities = 61/406 (15%), Positives = 122/406 (30%), Gaps = 76/406 (18%)

Query: 83  LKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSL 142
           + E       ++ +I       AE     L    +T  +  +   L+ I   +  +++ +
Sbjct: 1   MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVTQN--ELNSI-DQIIANNSDI 55

Query: 143 TGSFPYDMCP--GLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLG 200
                  +     LP +  L+++ N+    I   L + K L  + L  N+    L   L 
Sbjct: 56  K-----SVQGIQYLPNVTKLFLNGNKLTD-IKP-LTNLKNLGWLFLDENKIK-DLS-SLK 106

Query: 201 NSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFN 260
           +  KLKSL L  N ++     +I  L +L                       L+ L L N
Sbjct: 107 DLKKLKSLSLEHNGIS-----DINGLVHL---------------------PQLESLYLGN 140

Query: 261 NTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLE 320
           N ++        L  L  L+ L+L  N +S  I              L   + L+ L L 
Sbjct: 141 NKIT----DITVLSRLTKLDTLSLEDNQIS-DIVP------------LAGLTKLQNLYLS 183

Query: 321 RNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLD 380
           +N+++              + ++L    L NL  L L               L     + 
Sbjct: 184 KNHIS--------------DLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 227

Query: 381 LQNNKFEGPIP-QEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIP 439
             +     P    +   + +  V +      +         +   +  +     +T  + 
Sbjct: 228 NTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLK 287

Query: 440 STFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGN 485
             +    D+ G    +    G+     +       ++         
Sbjct: 288 EVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNG 333

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 77.5 bits (190), Expect = 8e-15
 Identities = 48/278 (17%), Positives = 92/278 (33%), Gaps = 36/278 (12%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHL 88
               + + S+              +  L ++  L L+ N  +   P  + NL  L  L L
Sbjct: 49  IANNSDIKSV------------QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94

Query: 89  DYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIS--TALDFSDNSLTGSF 146
           D NK++ ++   L +L +L+ L L +N ++      I  L  +    +L   +N +T   
Sbjct: 95  DENKIK-DL-SSLKDLKKLKSLSLEHNGIS-----DINGLVHLPQLESLYLGNNKIT--- 144

Query: 147 PYDMCP--GLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTK 204
             D+     L +L  L +  NQ    I   L    +L ++ LS N  +    R L     
Sbjct: 145 --DITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD--LRALAGLKN 198

Query: 205 LKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLS 264
           L  L+L       +      NL     +    ++     P+ I +    +  ++  +   
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTV--KNTDGSLVTPEIISDDGDYEKPNVKWHLPE 256

Query: 265 GNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASK 302
                S        +       +          +  S 
Sbjct: 257 FTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSY 294

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 7/174 (4%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRN 721
           + + + + +G G+Y +VYKG+       VA+K   L+  EGA  +   E  +LK ++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +V +           LV EY+ K  L+  +      +++      +  +   L Y H   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--- 117

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
              ++H D+KP N+L+++     L+DFG+A+  S          + T+ Y  P+
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYDNEVVTLWYRPPD 170

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 35/196 (17%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGR--FPDGIEVAIKVFHLQ--REG----ALNSFDAECE 712
           RA  Q+     IG G+YG V+K R     G  VA+K   +Q   EG     +       E
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------E 61

Query: 713 I-----LKTIRHRNLVKIISSCTNHNFKA-----LVLEYMP---KGSLEDCMYASNFNLD 759
           +     L+T  H N+V++   CT           LV E++       L+         + 
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVP 118

Query: 760 IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS 819
                 +M  +   L++LH   S+ +VH D+KP N+L+  S    L+DFG+A++ S +  
Sbjct: 119 TETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173

Query: 820 MKQTQTLATIGYIAPE 835
           M  T  + T+ Y APE
Sbjct: 174 MALTSVVVTLWYRAPE 189

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 87.8 bits (218), Expect = 2e-18
 Identities = 53/183 (28%), Positives = 82/183 (44%), Gaps = 20/183 (10%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL 722
              ++   +IG GS+G V++ +  +  EVAIK     +         E +I++ ++H N+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94

Query: 723 VK----IISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGI---MIDVASA 773
           V       S+    +     LVLEY+P+ ++                L I   M  +  +
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYI 832
           L Y+   HS  I H DIKP N+LLD  S V  L DFG AK+L   +       + +  Y 
Sbjct: 154 LAYI---HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--VSYICSRYYR 208

Query: 833 APE 835
           APE
Sbjct: 209 APE 211

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 86.5 bits (215), Expect = 2e-18
 Identities = 51/176 (28%), Positives = 77/176 (43%), Gaps = 10/176 (5%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDA--ECEILKTIRHR 720
           +++ +   IG GSYG V+K R  D G  VAIK F    +  +    A  E  +LK ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
           NLV ++          LV EY    ++   +      +       I      A+ + H  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL-SEEDSMKQTQTLATIGYIAPE 835
             +  +H D+KP N+L+    V  L DFG A+LL    D       +AT  Y +PE
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPE 172

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 55/173 (31%), Positives = 88/173 (50%), Gaps = 8/173 (4%)

Query: 404 YLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLP 463
            L  NKLS         L  LR+L L+ N+L ++    F  L+++     + N L  +LP
Sbjct: 43  DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALP 101

Query: 464 LEI-ENLKAVVDIYLSRNNLSGNIPSTI-IGLKNLQHLSLEHNKLQGPIPE-SFGELVSL 520
           + + + L  + ++ L RN L  ++P  +   L  L +LSL +N+LQ  +P+  F +L SL
Sbjct: 102 IGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSL 159

Query: 521 EFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFI 573
           + L L NN L  V   + +KL  LK+L L  N+L   +P  GAF +      +
Sbjct: 160 KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPE-GAFDSLEKLKML 210

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 53/180 (29%), Positives = 91/180 (50%), Gaps = 6/180 (3%)

Query: 376 LQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCL-GDLNSLRILSLSSNEL 434
            + LDLQ+NK      + F   ++L ++YLN NKL  ++P+ +  +L +L  L ++ N+L
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97

Query: 435 TSVIPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRNNLSGNIPSTII-G 492
            ++    F  L ++       N L  SLP  + ++L  +  + L  N L  ++P  +   
Sbjct: 98  QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155

Query: 493 LKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFN 552
           L +L+ L L +N+L+     +F +L  L+ L L NN L  V   + + L  LK L L  N
Sbjct: 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 60/189 (31%), Positives = 89/189 (47%), Gaps = 18/189 (9%)

Query: 81  TKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIF----NLSFISTALD 136
              K+L L  NKL     +    L +L +L LN+N L  T+PA IF    NL      L 
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL----ETLW 91

Query: 137 FSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHC-KELSSVSLSYNQFTGRL 195
            +DN L  + P  +   L  L  L +  NQ K  +P  ++    +L+ +SL YN+    L
Sbjct: 92  VTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SL 148

Query: 196 PRDLGNS-TKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGIDQSNLVGFVPDTIF-NIST 252
           P+ + +  T LK L L  N L   +P+     L  L+ L +D + L   VP+  F ++  
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEK 206

Query: 253 LKILSLFNN 261
           LK+L L  N
Sbjct: 207 LKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 50/166 (30%), Positives = 69/166 (41%), Gaps = 16/166 (9%)

Query: 55  NLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYNKLQGEIPEEL-GNLAELEMLVL 112
            L+ L+ L L+ N    T+P  I   L  L+ L +  NKLQ  +P  +   L  L  L L
Sbjct: 59  RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116

Query: 113 NNNLLTGTIPASIF----NLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFK 168
           + N L  ++P  +F     L    T L    N L  S P  +   L  LK L +  NQ K
Sbjct: 117 DRNQLK-SLPPRVFDSLTKL----TYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK 170

Query: 169 GPIPNNLWHC-KELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFN 213
             +P   +    EL ++ L  NQ          +  KLK L L  N
Sbjct: 171 R-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 16/162 (9%)

Query: 409 KLSGSIPSCLGDLNSLRILSLSSNELTSV---IPSTFWNLEDILGFDFSSNSLNGSLPLE 465
           K  G + SC  + NS+     SS +LT++   IP+    L      D  SN L+      
Sbjct: 6   KKDGGVCSCNNNKNSV---DCSSKKLTAIPSNIPADTKKL------DLQSNKLSSLPSKA 56

Query: 466 IENLKAVVDIYLSRNNLSGNIPSTI-IGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLD 524
              L  +  +YL+ N L   +P+ I   LKNL+ L +  NKLQ      F +LV+L  L 
Sbjct: 57  FHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELR 115

Query: 525 LSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFAN 566
           L  N L  + P   + L  L  L+L +N+L   +P+ G F  
Sbjct: 116 LDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPK-GVFDK 155

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 38/126 (30%), Positives = 53/126 (42%), Gaps = 15/126 (11%)

Query: 55  NLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYNKLQGEIPEEL-GNLAELEMLVL 112
            L +L  L L RN    ++P  +  +LTKL  L L YN+LQ  +P+ +   L  L+ L L
Sbjct: 107 QLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRL 164

Query: 113 NNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIP 172
            NN L   +P   F+       L   +N L    P      L +LK L +          
Sbjct: 165 YNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQ--------- 213

Query: 173 NNLWHC 178
            N W C
Sbjct: 214 ENPWDC 219

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 13/178 (7%)

Query: 664 DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L    EG  ++   E  +LK + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62

Query: 721 NLVKIISSCTNHNFKALVLEYMP---KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
           N+VK++      N   LV E++    K  ++     +   + +      +  +   L + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFC 119

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           H   S+ ++H D+KP N+L++      L+DFG+A+          T  + T+ Y APE
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPE 173

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 85.7 bits (213), Expect = 3e-18
 Identities = 53/192 (27%), Positives = 84/192 (43%), Gaps = 25/192 (13%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQRE-GALNSFDAEC--EI--- 713
            AT ++     IG+G+YG+VYK R    G  VA+K   +    G           E+   
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 714 --LKTIRHRNLVKIISSCTNHNFKA-----LVLEYMP---KGSLEDCMYASNFNLDIFQR 763
             L+   H N+V+++  C            LV E++    +  L+         L     
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAETI 122

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
             +M      L++LH   +N IVH D+KP N+L+       L+DFG+A++ S +  M  T
Sbjct: 123 KDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALT 177

Query: 824 QTLATIGYIAPE 835
             + T+ Y APE
Sbjct: 178 PVVVTLWYRAPE 189

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 50/178 (28%), Positives = 77/178 (43%), Gaps = 27/178 (15%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA---ECEILKTIRHRNLVKII 726
            +G G+YG V           VA+K+  +  + A++  +    E  I K + H N+VK  
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKI--VDMKRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA--------SALEYLH 778
                 N + L LEY   G L        F+  I   +G+    A        + + YLH
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL--------FDR-IEPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPE 835
                 I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 85.3 bits (212), Expect = 5e-18
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 12/183 (6%)

Query: 660 LRATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA--ECEILKT 716
           + ++ QF +   +G G+Y +VYKG     G+ VA+K   L  E    S  A  E  ++K 
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS-TAIREISLMKE 59

Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMP---KGSLEDCMYASNFN-LDIFQRLGIMIDVAS 772
           ++H N+V++       N   LV E+M    K  ++     +    L++         +  
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYI 832
            L + H    N I+H D+KP N+L++      L DFG+A+      +   +  + T+ Y 
Sbjct: 120 GLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVVTLWYR 175

Query: 833 APE 835
           AP+
Sbjct: 176 APD 178

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 85.4 bits (212), Expect = 6e-18
 Identities = 43/202 (21%), Positives = 78/202 (38%), Gaps = 33/202 (16%)

Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGA--LNSFDAECEILKTIRHR-NLVKIIS 727
           +G G +  V +      G E A K    +R G         E  +L+  +    ++ +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG----------IMIDVASALEYL 777
              N +   L+LEY   G +                L           ++  +   + YL
Sbjct: 97  VYENTSEIILILEYAAGGEIFS---------LCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 778 HFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           H    N IVH D+KP N+LL        +  + DFG+++ +     ++  + + T  Y+A
Sbjct: 148 H---QNNIVHLDLKPQNILLSSIYPLGDIK-IVDFGMSRKIGHACELR--EIMGTPEYLA 201

Query: 834 PEYGREGQVSIKGDVYNYGIML 855
           PE      ++   D++N GI+ 
Sbjct: 202 PEILNYDPITTATDMWNIGIIA 223

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 86.7 bits (215), Expect = 6e-18
 Identities = 51/231 (22%), Positives = 91/231 (39%), Gaps = 42/231 (18%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEILKTIRH 719
           + F    +IG G++G V   +  +  +V A+K+   + + +      F  E ++L     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID---------- 769
           + +  +  +  + N   LV++Y   G L          L    +    +           
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDL--------LTL--LSKFEDRLPEEMARFYLAE 183

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH--LSDFGIAKLLSEEDSMKQTQTL- 826
           +  A++ +H       VH DIKP N+L+D +   H  L+DFG    L  ED   Q+    
Sbjct: 184 MVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLM-EDGTVQSSVAV 237

Query: 827 ATIGYIAPEYGREGQVSIKG-----DVYNYGIMLMEVFTGMKPTNEFFTGE 872
            T  YI+PE  +  +          D ++ G+ + E+  G  P    F  E
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP----FYAE 284

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 85.8 bits (213), Expect = 6e-18
 Identities = 48/209 (22%), Positives = 74/209 (35%), Gaps = 23/209 (11%)

Query: 644 GMSPQVMWRRYS-HDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIK--VFHLQR 700
           GM  +          EL      ++ +  I  GSYG+V  G   +GI VAIK     +  
Sbjct: 1   GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60

Query: 701 EGALNSFDA---------ECEILKTIRHRNLVK---IISSCTNHNFKA--LVLEYMPKGS 746
              +N             E  +L    H N++    I             LV E M    
Sbjct: 61  GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-D 119

Query: 747 LEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS 806
           L   ++     +        M  +   L  LH      +VH D+ P N+LL D+    + 
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITIC 176

Query: 807 DFGIAKLLSEEDSMKQTQTLATIGYIAPE 835
           DF +A+  + + +   T  +    Y APE
Sbjct: 177 DFNLAREDTADANK--THYVTHRWYRAPE 203

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 84.9 bits (211), Expect = 8e-18
 Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 13/185 (7%)

Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNS---FDA--EC 711
           ++     ++ + + +G G + +VYK R       VAIK   L             A  E 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 712 EILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA 771
           ++L+ + H N++ ++ +  + +  +LV ++M    LE  +  ++  L        M+   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ-TQTLATIG 830
             LEYLH    + I+H D+KP+N+LLD++ V  L+DFG+AK        +  T  + T  
Sbjct: 123 QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRW 177

Query: 831 YIAPE 835
           Y APE
Sbjct: 178 YRAPE 182

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 85.0 bits (211), Expect = 9e-18
 Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 49/240 (20%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIK--VFHLQREG----ALNSFDAECEI 713
               ++ +   IG G++G V+K R    G +VA+K  +   ++EG    AL     E +I
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKI 69

Query: 714 LKTIRHRNLVKIISSCTNHNFKA--------LVLEYMP---KGSLEDCMYASNFNLDIFQ 762
           L+ ++H N+V +I  C               LV ++      G L +          + +
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSE 125

Query: 763 RLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ 822
              +M  + + L Y+H    N I+H D+K +NVL+    V  L+DFG+A+  S   + + 
Sbjct: 126 IKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182

Query: 823 ---TQTLATIGYIAPE-------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
              T  + T+ Y  PE       YG      I  D++  G ++ E++T   P      G 
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYG----PPI--DLWGAGCIMAEMWTR-SP---IMQGN 232

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.1 bits (211), Expect = 1e-17
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 51/234 (21%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKV---FHLQREGALNSFDAECEILKTIRH 719
           + +    +IG G++G V   R     +V A+K+   F + +      F  E +I+     
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA-------- 771
             +V++  +  +  +  +V+EYMP G L         NL       +    A        
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL--------VNL--MSNYDVPEKWARFYTAEVV 178

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH--LSDFGIAKLLSEEDSMKQTQTL-AT 828
            AL+ +H   S   +H D+KP N+LLD S   H  L+DFG    +++E  ++   T   T
Sbjct: 179 LALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVR-CDTAVGT 232

Query: 829 IGYIAPE----------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
             YI+PE          YGRE       D ++ G+ L E+  G  P    F  +
Sbjct: 233 PDYISPEVLKSQGGDGYYGRE--C----DWWSVGVFLYEMLVGDTP----FYAD 276

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 83.8 bits (208), Expect = 2e-17
 Identities = 45/186 (24%), Positives = 85/186 (45%), Gaps = 20/186 (10%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQ--REGALNSFDAECEILKTI 717
            + D++     +G G+YG VYK         VAIK   L+   EG   +   E  +LK +
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL 90

Query: 718 RHRNLVKIISSCTNHNFKALVLEYMP---KGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
           +HRN++++ S   +++   L+ EY     K  ++      + ++ + +    +  + + +
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN---PDVSMRVIKSF--LYQLINGV 145

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAH-----LSDFGIAKLLSEEDSMKQTQTLATI 829
            + H   S   +H D+KP N+LL  S  +      + DFG+A+        + T  + T+
Sbjct: 146 NFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITL 201

Query: 830 GYIAPE 835
            Y  PE
Sbjct: 202 WYRPPE 207

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 50/178 (28%), Positives = 77/178 (43%), Gaps = 27/178 (15%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA---ECEILKTIRHRNLVKII 726
            +G G+YG V           VA+K+  +  + A++  +    E  I K + H N+VK  
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKI--VDMKRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 727 SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA--------SALEYLH 778
                 N + L LEY   G L        F+  I   +G+    A        + + YLH
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL--------FDR-IEPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPE 835
                 I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 84.4 bits (209), Expect = 2e-17
 Identities = 44/197 (22%), Positives = 76/197 (38%), Gaps = 46/197 (23%)

Query: 669 ENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKII 726
             ++G+G  G V +        + A+K+       A      E E+     +  ++V+I+
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIV 121

Query: 727 ----SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG----------IMIDVAS 772
               +         +V+E +  G L            I  R            IM  +  
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFS---------RIQDRGDQAFTEREASEIMKSIGE 172

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
           A++YLH   S  I H D+KP N+L      ++++  L+DFG AK  +  +S+       T
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILK-LTDFGFAKETTSHNSLT--TPCYT 226

Query: 829 IGYIAPE------YGRE 839
             Y+APE      Y + 
Sbjct: 227 PYYVAPEVLGPEKYDKS 243

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 84.0 bits (208), Expect = 4e-17
 Identities = 54/196 (27%), Positives = 82/196 (41%), Gaps = 45/196 (22%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
              +++  +IG GS+G VY+ +    G  VAIK     +         E +I++ + H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108

Query: 722 LVK----IISSCTNHNFKAL--VLEYMPK--GSLEDCMYASNFNLD-------IFQRLGI 766
           +V+      SS    +   L  VL+Y+P+    +      +   L        ++Q    
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF-- 166

Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQT 825
                 +L Y+   HS  I H DIKP N+LLD D+ V  L DFG AK L   +       
Sbjct: 167 -----RSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN----- 213

Query: 826 LATIGYI------APE 835
              + YI      APE
Sbjct: 214 ---VSYICSRYYRAPE 226

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 36/206 (17%), Positives = 75/206 (36%), Gaps = 8/206 (3%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE-FCHFSRLYVVYLNRNK 409
           +  TL L + +L          L  +  + +  +     +    F + S++  + +   +
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 410 LSGSIPS-CLGDLNSLRILSLSSNELTSVIPSTFW-NLEDILGFDFSSNSLNGSLPLEI- 466
               I    L +L  L+ L + +  L      T   + +     + + N    S+P+   
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151

Query: 467 ENLKAV-VDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPE-SFGELVS-LEFL 523
           + L    + + L  N  + ++         L  + L  NK    I + +FG + S    L
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210

Query: 524 DLSNNDLSGVIPASLEKLLYLKSLNL 549
           D+S   ++ +    LE L  L + N 
Sbjct: 211 DVSQTSVTALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 73.9 bits (182), Expect = 9e-15
 Identities = 45/234 (19%), Positives = 83/234 (35%), Gaps = 18/234 (7%)

Query: 36  TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYNKLQ 94
               ++   +   IPS      S QTL L       TIP     NL  +  +++  +   
Sbjct: 14  EDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTL 68

Query: 95  GEIPEEL-GNLAELEMLVL-NNNLLTGTIPASIF-NLSFISTALDFSDNSLTGSFPYDMC 151
            ++      NL+++  + + N   LT  I       L  +   L   +  L         
Sbjct: 69  QQLESHSFYNLSKVTHIEIRNTRNLT-YIDPDALKELPLL-KFLGIFNTGLKMFPDLTKV 126

Query: 152 PGLPRLKGLYVSYNQFKGPIPNNLWH--CKELSSVSLSYNQFTGRLPRDLGNSTKLKSLD 209
                   L ++ N +   IP N +   C E  ++ L  N FT  +     N TKL ++ 
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVY 185

Query: 210 LGFNNLNGEIPQEI--GNLRNLEILGIDQSNLVGFVPDTIF-NISTLKILSLFN 260
           L  N     I ++   G      +L + Q+++   +P     ++  L   + + 
Sbjct: 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 42/205 (20%), Positives = 83/205 (40%), Gaps = 10/205 (4%)

Query: 35  VTSLTISDLGLAGTIPSH-LGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYNK 92
             +L + +  L  TIPSH   NL ++  + +S +     +      NL+K+  + +   +
Sbjct: 33  TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 93  LQGEIPEE-LGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMC 151
               I  + L  L  L+ L + N  L      +    + I   L+ +DN    S P +  
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151

Query: 152 PGLPR-LKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDL--GNSTKLKSL 208
            GL      L +  N F   +    ++  +L +V L+ N++   + +D   G  +    L
Sbjct: 152 QGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210

Query: 209 DLGFNNLNGEIPQEI-GNLRNLEIL 232
           D+   ++   +P +   +L+ L   
Sbjct: 211 DVSQTSVT-ALPSKGLEHLKELIAR 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 30/224 (13%), Positives = 71/224 (31%), Gaps = 16/224 (7%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
                 +   ++   +P         Q L L            F +   +  +Y++ +  
Sbjct: 12  QEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67

Query: 411 SGSIPS-CLGDLNSLRILSLSSN-ELTSVIPSTFWNLEDILGFDFSSNSLNGSLP--LEI 466
              + S    +L+ +  + + +   LT + P     L  +      +  L    P   ++
Sbjct: 68  LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKV 126

Query: 467 ENLKAVVDIYLSRNNLSGNIPS-TIIGLKN-LQHLSLEHNKLQGPIPESFGELVSLEFLD 524
            +      + ++ N    +IP     GL N    L L +N     +         L+ + 
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVY 185

Query: 525 LS-NNDLSGVIPASLEKLL-YLKSLNLSFNKLVGEIPRGGAFAN 566
           L+ N  L+ +   +   +      L++S   +   +P      +
Sbjct: 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALP-SKGLEH 227

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 45/258 (17%), Positives = 90/258 (34%), Gaps = 39/258 (15%)

Query: 132 STALDFSDNSLTGSFPYDMCPGLPR-LKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQ 190
                 +   +         P LP   + L +     +    +   +   +S + +S + 
Sbjct: 13  EEDFRVTCKDIQR------IPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66

Query: 191 FTGRLPRDL-GNSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGIDQSNLVGFVPDT-I 247
              +L      N +K+  +++        I  +    L  L+ LGI  + L  F   T +
Sbjct: 67  TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKV 126

Query: 248 FNISTLKILSLFNNTLSGNLPSSKNLIGLPN-LEGLNLGLNNLSGSIPSFFFNASKLYAL 306
           ++     IL + +N    ++P +    GL N    L L  N  + S+  + FN +KL A+
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNA-FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184

Query: 307 ELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSL 366
            L  N  L  +                 F  + +            + L +   +++ +L
Sbjct: 185 YLNKNKYLTVID-------------KDAFGGVYS----------GPSLLDVSQTSVT-AL 220

Query: 367 PITLGRLKKLQGLDLQNN 384
           P     L+ L+ L  +N 
Sbjct: 221 PSKG--LEHLKELIARNT 236

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 81.5 bits (202), Expect = 5e-17
 Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 46/187 (24%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRHRNLVK-- 724
            +G+G++G V  G     G +VA+K+     ++    +     E + LK  RH +++K  
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 725 -IISSCTNHNFKALVLEYMPKGSLEDCMY-----------ASNFNLDIFQRLGIMIDVAS 772
            +IS+     F  +V+EY+  G L D  Y           A       FQ++       S
Sbjct: 78  QVIST-PTDFF--MVMEYVSGGELFD--YICKHGRVEEMEARRL----FQQI------LS 122

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI--- 829
           A++Y H    + +VH D+KP NVLLD  M A ++DFG++ +      M   + L T    
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM------MSDGEFLRTSCGS 173

Query: 830 -GYIAPE 835
             Y APE
Sbjct: 174 PNYAAPE 180

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 84.4 bits (209), Expect = 5e-17
 Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 29/223 (13%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVF---HLQREGALNSFDAECEILKTIRH 719
           D F +  ++G G +G V+  +     ++ A K      L++         E +IL  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIF--QRLGIMI-DVASALEY 776
           R +V +  +        LV+  M  G +   +Y  + +   F   R       + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPE 835
           LH      I++ D+KP NVLLDD     +SD G+A  L       +T+  A T G++APE
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPE 359

Query: 836 ------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
                 Y      S+  D +  G+ L E+     P    F   
Sbjct: 360 LLLGEEYDF----SV--DYFALGVTLYEMIAARGP----FRAR 392

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 84.6 bits (209), Expect = 6e-17
 Identities = 56/242 (23%), Positives = 95/242 (39%), Gaps = 59/242 (24%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVF---HLQREGALNSFDAECEIL---KT 716
           + FS   +IG G +G VY  R  D  ++ A+K      ++ +        E  +L    T
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-----------ED--CMYASNFNLDIFQR 763
                +V +  +    +  + +L+ M  G L           E     YA+         
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA--------- 299

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
                ++   LE++H   +  +V+ D+KP+N+LLD+     +SD G+A     + S K+ 
Sbjct: 300 -----EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKP 347

Query: 824 QTLA-TIGYIAPEYGREGQVSIKGDVYN-------YGIMLMEVFTGMKPTNEFFTGEMSI 875
                T GY+APE      V  KG  Y+        G ML ++  G  P    F    + 
Sbjct: 348 HASVGTHGYMAPE------VLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTK 397

Query: 876 KR 877
            +
Sbjct: 398 DK 399

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 82.4 bits (204), Expect = 7e-17
 Identities = 50/183 (27%), Positives = 72/183 (39%), Gaps = 40/183 (21%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVF--------HLQREGALNSFDAECEILKTIRHRN 721
            IG G++G     R       VA+K          ++QRE             +++RH N
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE---------IINHRSLRHPN 77

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMY-ASNFNLD------IFQRLGIMIDVASAL 774
           +V+           A+++EY   G L +     +            FQ+L       S +
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYE--RICNAGRFSEDEARFFFQQL------LSGV 129

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHL--SDFGIAKLLSEEDSMKQTQTLATIGYI 832
            Y H   S  I H D+K  N LLD S    L   DFG +K  S   S  ++ T+ T  YI
Sbjct: 130 SYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKS-TVGTPAYI 184

Query: 833 APE 835
           APE
Sbjct: 185 APE 187

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 82.0 bits (203), Expect = 9e-17
 Identities = 48/201 (23%), Positives = 84/201 (41%), Gaps = 48/201 (23%)

Query: 665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNL 722
           Q S++ L G+G  G V +      G + A+K+ +     A      E +         ++
Sbjct: 31  QLSKQVL-GLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHI 84

Query: 723 VKIISSCTNHNFKA----LVLEYMPKGSLEDCMYASNFNLDIFQRL----------GIMI 768
           V I+    N +       +++E M  G L            I +R            IM 
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFS---------RIQERGDQAFTEREAAEIMR 135

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAKLLSEEDSMKQTQ 824
           D+ +A+++LH   S+ I H D+KP N+L      D+++  L+DFG AK    +++++   
Sbjct: 136 DIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLK-LTDFGFAKET-TQNALQ--T 188

Query: 825 TLATIGYIAPE------YGRE 839
              T  Y+APE      Y + 
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKS 209

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 83.7 bits (207), Expect = 9e-17
 Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 34/224 (15%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVF---HLQREGALNSFDAECEILKTIRH 719
           + F +  ++G G +G V   +     ++ A K      +++         E +IL+ +  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY-ASNFNLDIF--QRLGIMI-DVASALE 775
           R +V +  +    +   LVL  M  G L    +   +     F   R      ++   LE
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDL---KFHIYHMGQAGFPEARAVFYAAEICCGLE 300

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAP 834
            LH      IV+ D+KP N+LLDD     +SD G+A  + E  +    +    T+GY+AP
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAP 354

Query: 835 E------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           E      Y      S   D +  G +L E+  G  P    F   
Sbjct: 355 EVVKNERYTF----SP--DWWALGCLLYEMIAGQSP----FQQR 388

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 82.9 bits (205), Expect = 1e-16
 Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 46/187 (24%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVK-- 724
            +G+G++G V  G+    G +VA+K+ +   ++    +     E + LK  RH +++K  
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 725 -IISSCTNHNFKALVLEYMPKGSLEDCMY-----------ASNFNLDIFQRLGIMIDVAS 772
            +IS+  +  F  +V+EY+  G L D  Y           +       FQ++       S
Sbjct: 83  QVIST-PSDIF--MVMEYVSGGELFD--YICKNGRLDEKESRRL----FQQI------LS 127

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI--- 829
            ++Y H    + +VH D+KP NVLLD  M A ++DFG++ +      M   + L T    
Sbjct: 128 GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM------MSDGEFLRTSCGS 178

Query: 830 -GYIAPE 835
             Y APE
Sbjct: 179 PNYAAPE 185

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 47/197 (23%), Positives = 79/197 (40%), Gaps = 41/197 (20%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIK-VFHLQREGALNSFDA-----ECEILK 715
            D+F  E + G G++G+V  G+    G+ VAIK V         +           + L 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-------QDPRFRNRELQIMQDLA 74

Query: 716 TIRHRNLVK---IISSCTNHNFK----ALVLEYMP---------KGSLEDCMYASNFNLD 759
            + H N+V+      +    + +     +V+EY+P             +         + 
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134

Query: 760 IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-VAHLSDFGIAKLLSEED 818
           +FQ +        ++  LH   S  + H DIKP NVL++++     L DFG AK LS  +
Sbjct: 135 LFQLI-------RSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186

Query: 819 SMKQTQTLATIGYIAPE 835
                  + +  Y APE
Sbjct: 187 PN--VAYICSRYYRAPE 201

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 49/183 (26%), Positives = 77/183 (42%), Gaps = 41/183 (22%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA-----ECEILKTIRHRNLVK- 724
           IG G++  V   R    G EVAIK+  + +   LN         E  I+K + H N+VK 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKI--IDKT-QLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 725 --IISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD------IFQRLGIMIDVASALEY 776
             +I +     +  L++EY   G + D +  ++  +        F+++       SA++Y
Sbjct: 80  FEVIET-EKTLY--LIMEYASGGEVFDYL-VAHGRMKEKEARSKFRQI------VSAVQY 129

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI----GYI 832
            H      IVH D+K  N+LLD  M   ++DFG +              L        Y 
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE------FTVGGKLDAFCGAPPYA 180

Query: 833 APE 835
           APE
Sbjct: 181 APE 183

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 46/178 (25%), Positives = 73/178 (41%), Gaps = 20/178 (11%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDA---ECEILKTIRHR--N 721
           L+G G +GSVY G    D + VAIK      +   G L +      E  +LK +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 722 LVKIISSCTNHNFKALVLEY-MPKGSLEDCMY-ASNFNLDIFQRLGIMIDVASALEYLHF 779
           +++++      +   L+LE   P   L D  +      L           V  A+ + H 
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFD--FITERGALQEELARSFFWQVLEAVRHCH- 166

Query: 780 GHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
             +  ++H DIK  N+L+D +     L DFG   LL  +D++       T  Y  PE+
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTD-FDGTRVYSPPEW 219

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 43/210 (20%), Positives = 84/210 (40%), Gaps = 14/210 (6%)

Query: 346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYL 405
              L ++  +   ++++  S+   +  L  +  L L  NK     P    +   L  ++L
Sbjct: 42  QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL 97

Query: 406 NRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLE 465
           + NK+   + S L DL  L+ LSL  N ++ +      +L  +      +N +     L 
Sbjct: 98  DENKVK-DL-SSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKITDITVLS 153

Query: 466 IENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDL 525
              L  +  + L  N +S +I   + GL  LQ+L L  N +      +   L +L+ L+L
Sbjct: 154 --RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLEL 207

Query: 526 SNNDLSGVIPASLEKLLYLKSLNLSFNKLV 555
            + +           L+   ++  +   LV
Sbjct: 208 FSQECLNKPINHQSNLVVPNTVKNTDGSLV 237

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 62/314 (19%), Positives = 113/314 (35%), Gaps = 67/314 (21%)

Query: 243 VPDTIFNISTLKILS-LFNNTLSGNLPSS-KNLIGLPNLEGLNLGLNNLSGSIPSFFFNA 300
           VP  I  I +    +    + L     +       L +++ +    +++  S+       
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQ------ 62

Query: 301 SKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDN 360
                  + Y  N+ +L L  N LT        +           + NL NL  L L +N
Sbjct: 63  ------GIQYLPNVTKLFLNGNKLT-------DIKP---------LANLKNLGWLFLDEN 100

Query: 361 NLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD 420
            +       L  LKKL+ L L++N           H  +L  +YL  NK++    + L  
Sbjct: 101 KVKDLSS--LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKITD--ITVLSR 154

Query: 421 LNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRN 480
           L  L  LSL  N+++ ++P                          +  L  + ++YLS+N
Sbjct: 155 LTKLDTLSLEDNQISDIVP--------------------------LAGLTKLQNLYLSKN 188

Query: 481 NLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEK 540
           ++S ++   + GLKNL  L L   +           LV    +  ++  L  V P  +  
Sbjct: 189 HIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISD 244

Query: 541 LLYLKSLNLSFNKL 554
               +  N+ ++  
Sbjct: 245 DGDYEKPNVKWHLP 258

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 44/236 (18%), Positives = 90/236 (38%), Gaps = 27/236 (11%)

Query: 53  LGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVL 112
               +      L +   +  +      L  + ++  + + ++  + + +  L  +  L L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75

Query: 113 NNNLLTGTIPASIFNLSFIS--TALDFSDNSLTGSFPYDMCP--GLPRLKGLYVSYNQFK 168
           N N LT      I  L+ +     L   +N +      D+     L +LK L + +N   
Sbjct: 76  NGNKLT-----DIKPLANLKNLGWLFLDENKVK-----DLSSLKDLKKLKSLSLEHNGIS 125

Query: 169 GPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRN 228
               N L H  +L S+ L  N+ T      L   TKL +L L  N ++ +I   +  L  
Sbjct: 126 --DINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTK 179

Query: 229 LEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSS-KNLIGLPNLEGLN 283
           L+ L + ++++       +  +  L +L LF+        +   NL+    ++  +
Sbjct: 180 LQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 233

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 51/250 (20%), Positives = 92/250 (36%), Gaps = 41/250 (16%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHL 88
               + + S+              +  L ++  L L+ N  +   P  + NL  L  L L
Sbjct: 52  IANNSDIKSV------------QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL 97

Query: 89  DYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIS--TALDFSDNSLTGSF 146
           D NK++ ++   L +L +L+ L L +N ++      I  L  +    +L   +N +T   
Sbjct: 98  DENKVK-DL-SSLKDLKKLKSLSLEHNGIS-----DINGLVHLPQLESLYLGNNKIT--- 147

Query: 147 PYDMCP--GLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTK 204
             D+     L +L  L +  NQ    +P  L    +L ++ LS N  +    R L     
Sbjct: 148 --DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKN 201

Query: 205 LKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLS 264
           L  L+L       +      NL     +     +LV   P+ I +    +        + 
Sbjct: 202 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYE-----KPNVK 254

Query: 265 GNLPSSKNLI 274
            +LP   N +
Sbjct: 255 WHLPEFTNEV 264

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 80.0 bits (198), Expect = 9e-16
 Identities = 94/484 (19%), Positives = 155/484 (32%), Gaps = 112/484 (23%)

Query: 133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFT 192
            +LD     L+ +   ++ P L + + + +               CK++SS         
Sbjct: 6   QSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA------RCKDISSA-------- 51

Query: 193 GRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNIST 252
                 L  +  L  L+L  N L       +         G+   +              
Sbjct: 52  ------LRVNPALAELNLRSNELGDVGVHCVLQ-------GLQTPS------------CK 86

Query: 253 LKILSLFNNTLS--GNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGY 310
           ++ LSL N  L+  G    S  L  LP L+ L+L  N L  +          L    L  
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA------GLQLLCEGLLDP 140

Query: 311 NSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLK--------IG-------------NL 349
              L++L LE   L+ ++ E   L S L      K        I              + 
Sbjct: 141 QCRLEKLQLEYCSLSAASCE--PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP 198

Query: 350 INLTTLSLGDNNLS----GSLPITLGRLKKLQGLDLQNNKFEGPIPQEFC-----HFSRL 400
             L  L L    ++      L   +     L+ L L +NK       E C       SRL
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 258

Query: 401 YVVYLNRNKLS----GSIPSCLGDLNSLRILSLSSNE--------LTSVIPSTFWNLEDI 448
             +++    ++    G +   L    SL+ LSL+ NE        L   +      LE +
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 318

Query: 449 LGFDFSSNSLNG----SLPLEIENLKAVVDIYLSRNNLSGNIPSTI-IGLKN----LQHL 499
                 S S            +   + ++++ +S N L       +  GL      L+ L
Sbjct: 319 ---WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375

Query: 500 SLEHNKLQ----GPIPESFGELVSLEFLDLSNNDL--SGV--IPASLEKLLY-LKSLNLS 550
            L    +       +  +     SL  LDLSNN L  +G+  +  S+ +    L+ L L 
Sbjct: 376 WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLY 435

Query: 551 FNKL 554
               
Sbjct: 436 DIYW 439

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 77.3 bits (191), Expect = 7e-15
 Identities = 85/535 (15%), Positives = 164/535 (30%), Gaps = 119/535 (22%)

Query: 57  SSLQTLVLSRNWFSGTIPKEIG-NLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNN 115
             +Q+L +     S     E+   L + + + LD   L         +++    L +N  
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT---EARCKDIS--SALRVNPA 57

Query: 116 LLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGL----PRLKGLYVSYNQFK--- 168
           L                  L+   N L     + +  GL     +++ L +         
Sbjct: 58  L----------------AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 101

Query: 169 -GPIPNNLWHCKELSSVSLSYNQFTGRLPRDLG-----NSTKLKSLDLGFNNLNGEIPQE 222
            G + + L     L  + LS N       + L         +L+ L L + +L+    + 
Sbjct: 102 CGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161

Query: 223 IG----NLRNLEILGIDQSNL----VGFVPDTI-FNISTLKILSLFNNTLS--GNLPSSK 271
           +        + + L +  +++    V  +   +  +   L+ L L +  ++         
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221

Query: 272 NLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSEL 331
            +    +L  L LG N L           ++L    L  +S L+ L +    +T      
Sbjct: 222 IVASKASLRELALGSNKLGDV------GMAELCPGLLHPSSRLRTLWIWECGIT--AKGC 273

Query: 332 MSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRL-----KKLQGLDLQNNKF 386
             L   L   +S        L  LSL  N L       L         +L+ L +++   
Sbjct: 274 GDLCRVLRAKES--------LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCS- 324

Query: 387 EGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLE 446
                   C                    S L     L  L +S+N L            
Sbjct: 325 ---FTAACCS----------------HFSSVLAQNRFLLELQISNNRLEDA--------- 356

Query: 447 DILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLS----GNIPSTIIGLKNLQHLSLE 502
              G       L        +    +  ++L+  ++S     ++ +T++   +L+ L L 
Sbjct: 357 ---GVRELCQGL-------GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 406

Query: 503 HNKLQGPIPESFGELV-----SLEFLDLSNNDLSGVIPASLEKLL----YLKSLN 548
           +N L         E V      LE L L +   S  +   L+ L      L+ ++
Sbjct: 407 NNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 70.0 bits (172), Expect = 1e-12
 Identities = 69/392 (17%), Positives = 131/392 (33%), Gaps = 79/392 (20%)

Query: 202 STKLKSLDLGFNNLNGEIPQEIG-NLRNLEILGIDQSNL----VGFVPDTIFNISTLKIL 256
           S  ++SLD+    L+     E+   L+  +++ +D   L       +   +     L  L
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 257 SLFNNTLSGN--------LPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALEL 308
           +L +N L           L +         ++ L+L    L+G+          + +  L
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSC-----KIQKLSLQNCCLTGA-------GCGVLSSTL 109

Query: 309 GYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLS----G 364
                L+ L L  N L    + L  L   L++ +         L  L L   +LS     
Sbjct: 110 RTLPTLQELHLSDNLL--GDAGLQLLCEGLLDPQC-------RLEKLQLEYCSLSAASCE 160

Query: 365 SLPITLGRLKKLQGLDLQNNKFEGPIPQEFC-----HFSRLYVVYLNRNKLS----GSIP 415
            L   L      + L + NN       +  C        +L  + L    ++      + 
Sbjct: 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 220

Query: 416 SCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDI 475
             +    SLR L+L SN+L                 D     L   L   +     +  +
Sbjct: 221 GIVASKASLRELALGSNKLG----------------DVGMAELCPGL---LHPSSRLRTL 261

Query: 476 YLSRNNLS----GNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELV-----SLEFLDLS 526
           ++    ++    G++   +   ++L+ LSL  N+L         E +      LE L + 
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321

Query: 527 NNDLSGV----IPASLEKLLYLKSLNLSFNKL 554
           +   +        + L +  +L  L +S N+L
Sbjct: 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRL 353

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 63.1 bits (154), Expect = 2e-10
 Identities = 65/357 (18%), Positives = 113/357 (31%), Gaps = 55/357 (15%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIG----NLTKLK 84
            +  N      + D GL       L     L+ L L     S    + +          K
Sbjct: 119 HLSDNL-----LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFK 173

Query: 85  ELHLDYNKLQGEIPEELG-----NLAELEMLVLNNNLLTGTIPASIFNLSFIS------T 133
           EL +  N +       L      +  +LE L L +  +T     +  +L  I        
Sbjct: 174 ELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT---SDNCRDLCGIVASKASLR 230

Query: 134 ALDFSDNSLTGSFPYDMCPGL----PRLKGLYVSYNQFKGP----IPNNLWHCKELSSVS 185
            L    N L      ++CPGL     RL+ L++            +   L   + L  +S
Sbjct: 231 ELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELS 290

Query: 186 LSYNQFTGRLPRDLG-----NSTKLKSLDLGFNNLNGEIPQEIGNL----RNLEILGIDQ 236
           L+ N+      R L         +L+SL +   +          ++    R L  L I  
Sbjct: 291 LAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISN 350

Query: 237 SNL-----VGFVPDTIFNISTLKILSLFNNTLS--GNLPSSKNLIGLPNLEGLNLGLNNL 289
           + L                S L++L L +  +S       +  L+   +L  L+L  N L
Sbjct: 351 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410

Query: 290 SGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKI 346
             +         +L          L++L L   Y +    +   L +   +  SL++
Sbjct: 411 GDAG------ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR--LQALEKDKPSLRV 459

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 43.0 bits (102), Expect = 4e-04
 Identities = 45/227 (19%), Positives = 78/227 (34%), Gaps = 39/227 (17%)

Query: 40  ISDLGLAGTIPSHLGNLSSLQTLVLSRNWFS----GTIPKEIGNLTKLKELHLDYNKLQG 95
           + D+G+A   P  L   S L+TL +     +    G + + +     LKEL L  N+L  
Sbjct: 239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD 298

Query: 96  EIPEELGNLAE-----LEMLVLNNNLLTGTIPASIFNLSFISTA---LDFSDNSLTGSFP 147
           E    L          LE L + +   T    +   ++   +     L  S+N L  +  
Sbjct: 299 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 358

Query: 148 YDMCPGL----PRLKGLYVSYNQFK----GPIPNNLWHCKELSSVSLSYNQFTGRLPRDL 199
            ++C GL      L+ L+++           +   L     L  + LS N        D 
Sbjct: 359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG-----DA 413

Query: 200 G----------NSTKLKSLDLGFNNLNGEIPQEIGNL----RNLEIL 232
           G              L+ L L     + E+   +  L     +L ++
Sbjct: 414 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 60/229 (26%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAEC-----EILKTI 717
             F     +G GS+G V+  R        A+KV  L++E  +     E       +L  +
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIV 63

Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-----------ED--CMYASNFNLDIFQRL 764
            H  ++++  +  +     ++++Y+  G L                 YA+          
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---------- 113

Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH--LSDFGIAKLLSEEDSMKQ 822
               +V  ALEYLH   S  I++ D+KP N+LLD +   H  ++DFG AK + +      
Sbjct: 114 ----EVCLALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVPD-----V 159

Query: 823 TQTL-ATIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
           T TL  T  YIAPE      Y +   +    D +++GI++ E+  G  P
Sbjct: 160 TYTLCGTPDYIAPEVVSTKPYNKS--I----DWWSFGILIYEMLAGYTP 202

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 79.4 bits (196), Expect = 1e-15
 Identities = 55/233 (23%), Positives = 94/233 (40%), Gaps = 52/233 (22%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVF---HLQREGALNSFDAECEILKTIRH 719
           ++F    L+G G++G V   +        A+K+     +  +  +     E  +L+  RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSL-----------ED--CMYASNFNLDIFQRLGI 766
             L  +  S   H+    V+EY   G L           ED    Y +            
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA------------ 255

Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
             ++ SAL+YLH   +  +V+ D+K  N++LD      ++DFG+ K   ++      +T 
Sbjct: 256 --EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTF 309

Query: 827 -ATIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
             T  Y+APE      YGR   V    D +  G+++ E+  G  P    F  +
Sbjct: 310 CGTPEYLAPEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLP----FYNQ 352

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.3 bits (193), Expect = 2e-15
 Identities = 42/189 (22%), Positives = 66/189 (34%), Gaps = 39/189 (20%)

Query: 402 VVYLNRNKLSGSIPS--CLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLN 459
           ++ L+ N LS  + +      L +L  L LS N L  +    F                 
Sbjct: 43  LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF----------------- 84

Query: 460 GSLPLEIENLKAVVDIYLSRNNLSGNIPS-TIIGLKNLQHLSLEHNKLQGPIPESFGELV 518
                    +  +  + LS N+L   +       L+ L+ L L +N +      +F ++ 
Sbjct: 85  -------VPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMA 136

Query: 519 SLEFLDLSNNDLSGVIP---ASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFI-- 573
            L+ L LS N +S           KL  L  L+LS NKL  ++P         A      
Sbjct: 137 QLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL-KKLPL-TDLQKLPAWVKNGL 194

Query: 574 ---GNDLLC 579
               N L C
Sbjct: 195 YLHNNPLEC 203

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 16/153 (10%)

Query: 423 SLRILSLSSNELTSV---IPSTFWNLEDILGFDFSSNSLNGSLPLEI--ENLKAVVDIYL 477
           +  ILS S  +L +V   +PS    L      D S N+L   L  E     L  +  + L
Sbjct: 19  ASNILSCSKQQLPNVPQSLPSYTALL------DLSHNNL-SRLRAEWTPTRLTNLHSLLL 71

Query: 478 SRNNLSGNIPS-TIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPA 536
           S N+L+  I S   + + NL++L L  N L       F +L +LE L L NN +  V   
Sbjct: 72  SHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRN 130

Query: 537 SLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSA 569
           + E +  L+ L LS N++    P      + + 
Sbjct: 131 AFEDMAQLQKLYLSQNQIS-RFPV-ELIKDGNK 161

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 36/139 (25%), Positives = 62/139 (44%), Gaps = 11/139 (7%)

Query: 55  NLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYNKLQGEIPEE-LGNLAELEMLVL 112
            L++L +L+LS N  +  I  E    +  L+ L L  N L   + E    +L  LE+L+L
Sbjct: 62  RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119

Query: 113 NNNLLTGTIPASIF-NLSFISTALDFSDNSLTGSFPYDM---CPGLPRLKGLYVSYNQFK 168
            NN +   +  + F +++ +   L  S N ++  FP ++      LP+L  L +S N+ K
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQK-LYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176

Query: 169 GPIPNNLWHCKELSSVSLS 187
                +L          L 
Sbjct: 177 KLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 64.9 bits (158), Expect = 4e-11
 Identities = 40/183 (21%), Positives = 70/183 (38%), Gaps = 17/183 (9%)

Query: 113 NNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIP 172
           +   L   +P S+ + +     LD S N+L+          L  L  L +S+N     I 
Sbjct: 26  SKQQLP-NVPQSLPSYT---ALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-IS 80

Query: 173 NNLW-HCKELSSVSLSYNQFTGRLPRD-LGNSTKLKSLDLGFNNLNGEIPQEI-GNLRNL 229
           +  +     L  + LS N     L      +   L+ L L  N++   + +    ++  L
Sbjct: 81  SEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQL 138

Query: 230 EILGIDQSNLVGFVPDTIF----NISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLG 285
           + L +   N +   P  +      +  L +L L +N L   LP + +L  LP      L 
Sbjct: 139 QKLYLS-QNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLT-DLQKLPAWVKNGLY 195

Query: 286 LNN 288
           L+N
Sbjct: 196 LHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 45/186 (24%), Positives = 65/186 (34%), Gaps = 39/186 (20%)

Query: 243 VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPS-FFFNAS 301
           VP ++   S   +L L +N LS  L +      L NL  L L  N+L+  I S  F    
Sbjct: 33  VPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 302 KLYALELGYN-------------SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGN 348
            L  L+L  N               L+ L L  N++          F            +
Sbjct: 89  NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNA---FE-----------D 134

Query: 349 LINLTTLSLGDNNLSGSLP----ITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYV-- 402
           +  L  L L  N +S   P        +L KL  LDL +NK +     +           
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193

Query: 403 VYLNRN 408
           +YL+ N
Sbjct: 194 LYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 24/122 (19%), Positives = 51/122 (41%), Gaps = 20/122 (16%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELH 87
           D+  N + +L                +L +L+ L+L  N     + +    ++ +L++L+
Sbjct: 94  DLSSNHLHTLD----------EFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLY 142

Query: 88  LDYNKLQGEIPEE----LGNLAELEMLVLNNNLLTGTIPASIFNL--SFISTALDFSDNS 141
           L  N++    P E       L +L +L L++N L   +P +      +++   L   +N 
Sbjct: 143 LSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNP 200

Query: 142 LT 143
           L 
Sbjct: 201 LE 202

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 48/185 (25%), Positives = 81/185 (43%), Gaps = 43/185 (23%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKVFH---LQREGALNSFDAECEILKTIRHRNLVK-- 724
            +G GS+G V     +    +VA+K      L++       + E   LK +RH +++K  
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 725 -IISSCTNHNFKALVLEY---------MPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
            +I++        +V+EY         + K  + +      F    FQ++        A+
Sbjct: 76  DVITT-PTDIV--MVIEYAGGELFDYIVEKKRMTEDE-GRRF----FQQI------ICAI 121

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI----G 830
           EY H    + IVH D+KP N+LLDD++   ++DFG++ +      M     L T      
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI------MTDGNFLKTSCGSPN 172

Query: 831 YIAPE 835
           Y APE
Sbjct: 173 YAAPE 177

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 53/239 (22%), Positives = 90/239 (37%), Gaps = 50/239 (20%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIK----VFHLQREGALNSFDA-----ECE 712
             ++     IG G+ G V           VAIK     F        N   A     E  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-------NQTHAKRAYRELV 76

Query: 713 ILKTIRHRNLVKI----ISSCTNHNFKA--LVLEYMP-------KGSLEDCMYASNFNLD 759
           ++K + H+N++ +        +   F+   +V+E M        +  L+     S     
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM-SYL--- 132

Query: 760 IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS 819
           ++Q L         +++LH   S  I+H D+KPSN+++       + DFG+A+       
Sbjct: 133 LYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182

Query: 820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
           M  T  + T  Y APE           D+++ G ++ E+  G       F G   I +W
Sbjct: 183 M--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GV---LFPGTDHIDQW 235

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 79.0 bits (194), Expect = 3e-15
 Identities = 53/252 (21%), Positives = 77/252 (30%), Gaps = 52/252 (20%)

Query: 307 ELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNL--SG 364
           +   +  L R  L     T   SEL S        + L+  N   L T+ L    L    
Sbjct: 344 DSATDEQLFRCELSVEKSTVLQSELESC----KELQELEPENKWCLLTIILLMRALDPLL 399

Query: 365 SLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSL 424
               TL     L+ +D                  R   +   R+K          +   +
Sbjct: 400 YEKETLQYFSTLKAVD----------------PMRAAYLDDLRSKFLLENSVLKMEYADV 443

Query: 425 RILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSG 484
           R+L L+  +LT +                            +E L  V  + LS N L  
Sbjct: 444 RVLHLAHKDLTVLC--------------------------HLEQLLLVTHLDLSHNRLR- 476

Query: 485 NIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGV-IPASLEKLLY 543
            +P  +  L+ L+ L    N L+    +    L  L+ L L NN L        L     
Sbjct: 477 ALPPALAALRCLEVLQASDNALE--NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534

Query: 544 LKSLNLSFNKLV 555
           L  LNL  N L 
Sbjct: 535 LVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 74.0 bits (181), Expect = 1e-13
 Identities = 45/283 (15%), Positives = 89/283 (31%), Gaps = 40/283 (14%)

Query: 156 RLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNL 215
            L    ++    +                 L  ++      RD     +L   +L     
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC-WCRDSATDEQLFRCELSVEKS 361

Query: 216 NGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIG 275
              +  E+ + + L+ L           P+  + + T+ +L    + L     + +    
Sbjct: 362 T-VLQSELESCKELQEL----------EPENKWCLLTIILLMRALDPLLYEKETLQYFST 410

Query: 276 LPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLF 335
           L  ++ +     +   S            ++     ++++ L L    LT          
Sbjct: 411 LKAVDPMRAAYLDDLRS------KFLLENSVLKMEYADVRVLHLAHKDLT---------- 454

Query: 336 SALVNCKSLK-IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEF 394
                   L  +  L+ +T L L  N L  +LP  L  L+ L+ L   +N  E  +    
Sbjct: 455 -------VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GV 504

Query: 395 CHFSRLYVVYLNRNKLSG-SIPSCLGDLNSLRILSLSSNELTS 436
            +  RL  + L  N+L   +    L     L +L+L  N L  
Sbjct: 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.5 bits (177), Expect = 3e-13
 Identities = 59/345 (17%), Positives = 97/345 (28%), Gaps = 59/345 (17%)

Query: 8   NILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSH------LGNLSSLQT 61
             L            W         + V    +    L   +P H       G+ S  + 
Sbjct: 272 GTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKEC 331

Query: 62  LVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTI 121
           ++L          ++     +L    L   K    +  EL +  EL+ L   N     TI
Sbjct: 332 VLLKDRPECW--CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI 388

Query: 122 PASIFNLSFISTALDFSD--NSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCK 179
              +  L  +    +     ++L    P        R   L    ++F            
Sbjct: 389 ILLMRALDPLLYEKETLQYFSTLKAVDP-------MRAAYLDDLRSKFLLENSVLKMEYA 441

Query: 180 ELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNL 239
           ++  + L++   T  L   L     +  LDL  N L   +P  +  LR L          
Sbjct: 442 DVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCL---------- 488

Query: 240 VGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFN 299
                         ++L   +N L  N+     +  LP L+ L L  N L     +    
Sbjct: 489 --------------EVLQASDNALE-NVD---GVANLPRLQELLLCNNRLQ-QSAAI--- 526

Query: 300 ASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSL 344
                   L     L  L L+ N L         L   L +  S+
Sbjct: 527 ------QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 71.7 bits (175), Expect = 6e-13
 Identities = 34/190 (17%), Positives = 64/190 (33%), Gaps = 9/190 (4%)

Query: 365 SLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSL 424
                    ++L   +L   K    +  E      L  +         +I   +  L+ L
Sbjct: 340 CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL 398

Query: 425 RILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSG 484
                +    +++              D   +       +       V  ++L+  +L+ 
Sbjct: 399 LYEKETLQYFSTLKAVDPMRAAY---LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT- 454

Query: 485 NIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYL 544
            +   +  L  + HL L HN+L+  +P +   L  LE L  S+N L  V    +  L  L
Sbjct: 455 VLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV--DGVANLPRL 510

Query: 545 KSLNLSFNKL 554
           + L L  N+L
Sbjct: 511 QELLLCNNRL 520

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 66.7 bits (162), Expect = 2e-11
 Identities = 39/240 (16%), Positives = 72/240 (30%), Gaps = 37/240 (15%)

Query: 270 SKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTS 329
            ++      L    L +   +  + S   +  +L  LE      L  + L    L     
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 330 ELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGP 389
           E       L    +LK  + +    L    +       +       ++ L L +      
Sbjct: 401 EK----ETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL 456

Query: 390 IPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDIL 449
              E      +  + L+ N+L  ++P  L  L  L +L  S N L +V            
Sbjct: 457 CHLE--QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV------------ 501

Query: 450 GFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPS--TIIGLKNLQHLSLEHNKLQ 507
                           + NL  + ++ L  N L     +   ++    L  L+L+ N L 
Sbjct: 502 --------------DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 48/186 (25%), Positives = 73/186 (39%), Gaps = 34/186 (18%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIK------VFHLQREGALNSFDAECEILKTIR----H 719
           L+G G +G+V+ G    D ++VAIK      V          +   E  +L  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 720 RNLVKIISSCTNHNFKALVLEY-MPKGSLEDCMY-ASNFNLD------IFQRLGIMIDVA 771
             +++++          LVLE  +P   L D  Y      L        F ++       
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFD--YITEKGPLGEGPSRCFFGQV------V 149

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIG 830
           +A+++ H   S  +VH DIK  N+L+D     A L DFG   LL   D         T  
Sbjct: 150 AAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTD-FDGTRV 203

Query: 831 YIAPEY 836
           Y  PE+
Sbjct: 204 YSPPEW 209

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 76.6 bits (189), Expect = 5e-15
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 52/225 (23%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFD---AECEILKTIRH 719
           DQF     +G GS+G V   +  +     A+K+   Q+   L   +    E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSL-----------ED--CMYASNFNLDIFQRLGI 766
             LVK+  S  +++   +V+EY+  G +           E     YA+            
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA------------ 148

Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
              +    EYLH   S  +++ D+KP N+L+D      ++DFG AK +       +T TL
Sbjct: 149 --QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTL 198

Query: 827 -ATIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
             T   +APE      Y +   V    D +  G+++ E+  G  P
Sbjct: 199 CGTPEALAPEIILSKGYNK--AV----DWWALGVLIYEMAAGYPP 237

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 58/235 (24%), Positives = 94/235 (40%), Gaps = 57/235 (24%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAEC-----EILKTI 717
           + F    L+G G++G V   R        A+K+  L++E  +   +         +L+  
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSL-----------ED--CMYASNFNLDIFQRL 764
           RH  L  +  +   H+    V+EY   G L           E+    Y +          
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA---------- 112

Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ 824
               ++ SALEYLH   S  +V+ DIK  N++LD      ++DFG+ K    +      +
Sbjct: 113 ----EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 163

Query: 825 TL-ATIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           T   T  Y+APE      YGR   V    D +  G+++ E+  G  P    F  +
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLP----FYNQ 208

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 74.9 bits (185), Expect = 2e-14
 Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 61/239 (25%)

Query: 664 DQFSEENLIGIGSYGSVY---KGRFPDGIEV-AIKVFH----LQREGALNSFDAECEILK 715
           + F    ++G G YG V+   K    +  ++ A+KV      ++         AE  IL+
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 716 TIRHRNLVKIISSCTNHNFKALVLEYMPKGSL-----------ED--CMYASNFNLDIFQ 762
            ++H  +V +I +        L+LEY+  G L           ED  C Y +        
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-------- 128

Query: 763 RLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH--LSDFGIAKLLSEEDSM 820
                 +++ AL +LH      I++ D+KP N++L+     H  L+DFG+ K    + ++
Sbjct: 129 ------EISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV 177

Query: 821 KQTQTLA-TIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
             T T   TI Y+APE      + R   V    D ++ G ++ ++ TG  P    FTGE
Sbjct: 178 --THTFCGTIEYMAPEILMRSGHNRA--V----DWWSLGALMYDMLTGAPP----FTGE 224

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 75.3 bits (185), Expect = 3e-14
 Identities = 56/254 (22%), Positives = 96/254 (37%), Gaps = 52/254 (20%)

Query: 645 MSPQVMWRRYSHDELLRAT----DQFSEENLIGIGSYGSVYKGR-FPDGIEVAIK----V 695
           MS   +  ++   E+  +T     ++     IG G+ G V           VAIK     
Sbjct: 39  MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 98

Query: 696 FHLQREGALNSFDA-----ECEILKTIRHRNLVKII----SSCTNHNFKA--LVLEYMPK 744
           F        N   A     E  ++K + H+N++ ++       T   F+   LV+E M  
Sbjct: 99  FQ-------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD- 150

Query: 745 GSLEDCMYASNFNLDIFQRLG------IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD 798
                    +N    I   L       ++  +   +++LH   S  I+H D+KPSN+++ 
Sbjct: 151 ---------ANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVK 198

Query: 799 DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEV 858
                 + DFG+A+       M  T  + T  Y APE           D+++ G ++ E+
Sbjct: 199 SDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256

Query: 859 FTGMKPTNEFFTGE 872
               K     F G 
Sbjct: 257 VRH-KI---LFPGR 266

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.4 bits (183), Expect = 4e-14
 Identities = 53/256 (20%), Positives = 87/256 (33%), Gaps = 62/256 (24%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
           + ++S    +G GS+G V +      G   A+K               E +I+K + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 722 LVKIIS---SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY-- 776
           ++K++    +  +   K                  +N +  +         +   +EY  
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 777 --------------------------------LHFGHSNPIVHCDIKPSNVLLD-DSMVA 803
                                           + F HS  I H DIKP N+L++      
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181

Query: 804 HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPE-------YGREGQVSIKGDVYNYGIMLM 856
            L DFG AK L   +       + +  Y APE       Y      SI  D+++ G +  
Sbjct: 182 KLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYT----PSI--DLWSIGCVFG 233

Query: 857 EVFTGMKPTNEFFTGE 872
           E+  G KP    F+GE
Sbjct: 234 ELILG-KP---LFSGE 245

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.4 bits (181), Expect = 4e-14
 Identities = 60/240 (25%), Positives = 108/240 (45%), Gaps = 65/240 (27%)

Query: 664 DQFSEENLIGIGSYGSVY---KGRFPDGIEV-AIKVFHLQREGALNSFD-----AECEIL 714
            QF    ++G GS+G V+   K    D  ++ A+KV    ++  L   D      E +IL
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL---KKATLKVRDRVRTKMERDIL 80

Query: 715 KTIRHRNLVKIISSCTNHNFKALVLEYMPKGSL-----------ED--CMYASNFNLDIF 761
             + H  +VK+  +        L+L+++  G L           E+    Y +       
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA------- 133

Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH--LSDFGIAKLLSEEDS 819
                  ++A AL++LH   S  I++ D+KP N+LLD+    H  L+DFG++K   + + 
Sbjct: 134 -------ELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHE- 180

Query: 820 MKQTQTL-ATIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
            K+  +   T+ Y+APE      + +        D +++G+++ E+ TG  P    F G+
Sbjct: 181 -KKAYSFCGTVEYMAPEVVNRRGHTQS--A----DWWSFGVLMFEMLTGTLP----FQGK 229

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.1 bits (180), Expect = 8e-14
 Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 29/189 (15%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIK---VFHLQREGALNSFDA-----ECEI 713
             +++  + IG G+YG V       + + VAIK    F        +         E +I
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-------HQTYCQRTLREIKI 78

Query: 714 LKTIRHRNLVK---IISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
           L   RH N++    II + T    K   +V + M    L   +   + + D       + 
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICY--FLY 135

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ--TQTL 826
            +   L+Y+H   S  ++H D+KPSN+LL+ +    + DFG+A++   +       T+ +
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 827 ATIGYIAPE 835
           AT  Y APE
Sbjct: 193 ATRWYRAPE 201

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 70.4 bits (173), Expect = 9e-14
 Identities = 33/150 (22%), Positives = 63/150 (42%), Gaps = 26/150 (17%)

Query: 404 YLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLP 463
            L +N +    P        LR + LS+N+++ + P  F  L                  
Sbjct: 38  RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL------------------ 79

Query: 464 LEIENLKAVVDIYLSRNNLSGNIPSTII-GLKNLQHLSLEHNKLQGPIPESFGELVSLEF 522
               +L     + L  N ++  +P ++  GL +LQ L L  NK+     ++F +L +L  
Sbjct: 80  ---RSLN---SLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNL 132

Query: 523 LDLSNNDLSGVIPASLEKLLYLKSLNLSFN 552
           L L +N L  +   +   L  +++++L+ N
Sbjct: 133 LSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 38/147 (25%), Positives = 59/147 (40%), Gaps = 11/147 (7%)

Query: 430 SSNELTSV---IPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNI 486
               LT +   +P T   +          N++    P      K +  I LS N +S   
Sbjct: 19  RGKGLTEIPTNLPETITEI------RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELA 72

Query: 487 PSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKS 546
           P    GL++L  L L  NK+       F  L SL+ L L+ N ++ +   + + L  L  
Sbjct: 73  PDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNL 132

Query: 547 LNLSFNKLVGEIPRGGAFANFSAESFI 573
           L+L  NKL   I + G F+   A   +
Sbjct: 133 LSLYDNKL-QTIAK-GTFSPLRAIQTM 157

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 34/153 (22%), Positives = 60/153 (39%), Gaps = 9/153 (5%)

Query: 41  SDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEE 100
              GL   IP++L    ++  + L +N      P       KL+ + L  N++  E+  +
Sbjct: 19  RGKGLT-EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPD 74

Query: 101 L-GNLAELEMLVLNNNLLTGTIPASIF-NLSFISTALDFSDNSLTGSFPYDMCPGLPRLK 158
               L  L  LVL  N +T  +P S+F  L  +   L  + N +      D    L  L 
Sbjct: 75  AFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSL-QLLLLNANKIN-CLRVDAFQDLHNLN 131

Query: 159 GLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQF 191
            L +  N+ +          + + ++ L+ N F
Sbjct: 132 LLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 29/146 (19%), Positives = 56/146 (38%), Gaps = 18/146 (12%)

Query: 121 IPASIFNLSFISTALDFSDNSLT----GSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLW 176
           +P +I       T +    N++     G+F         +L+ + +S NQ     P+   
Sbjct: 30  LPETI-------TEIRLEQNTIKVIPPGAFS-----PYKKLRRIDLSNNQISELAPDAFQ 77

Query: 177 HCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGID 235
             + L+S+ L  N+ T            L+ L L  N +N  +  +   +L NL +L + 
Sbjct: 78  GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136

Query: 236 QSNLVGFVPDTIFNISTLKILSLFNN 261
            + L      T   +  ++ + L  N
Sbjct: 137 DNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 45/213 (21%), Positives = 72/213 (33%), Gaps = 49/213 (23%)

Query: 243 VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPS-FFFNAS 301
           +P  +    T+  + L  NT+   +P          L  ++L  N +S  +    F    
Sbjct: 26  IPTNLP--ETITEIRLEQNTIK-VIPP-GAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80

Query: 302 KLYALELGYN-------------SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIG- 347
            L +L L  N              +L+ L L  N +                   L++  
Sbjct: 81  SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKI-----------------NCLRVDA 123

Query: 348 --NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVV-Y 404
             +L NL  LSL DN L      T   L+ +Q + L  N F        C     ++  Y
Sbjct: 124 FQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI-------CDCHLKWLADY 176

Query: 405 LNRNKLSGSIPSCLG--DLNSLRILSLSSNELT 435
           L+ N +  S   C     L + RI  + S +  
Sbjct: 177 LHTNPIETSGARCTSPRRLANKRIGQIKSKKFR 209

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 12/88 (13%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELH 87
            +YGN++T L            S    L SLQ L+L+ N  +  +  +   +L  L  L 
Sbjct: 86  VLYGNKITELP----------KSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLS 134

Query: 88  LDYNKLQGEIPEELGNLAELEMLVLNNN 115
           L  NKLQ         L  ++ + L  N
Sbjct: 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 37/165 (22%), Positives = 64/165 (38%), Gaps = 46/165 (27%)

Query: 672 IGIGSYGSVYKGRF-PDGIEVAIKVFH----LQREGALNSFDAECEILKTI-RHRNLVKI 725
           +G+G  G V +        + A+K+       +RE          E+     +  ++V+I
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE---------VELHWRASQCPHIVRI 76

Query: 726 I----SSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLG----------IMIDVA 771
           +    +         +V+E +  G L            I  R            IM  + 
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGELFS---------RIQDRGDQAFTEREASEIMKSIG 127

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAK 812
            A++YLH   S  I H D+KP N+L      ++++  L+DFG AK
Sbjct: 128 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILK-LTDFGFAK 168

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.5 bits (178), Expect = 2e-13
 Identities = 43/204 (21%), Positives = 80/204 (39%), Gaps = 27/204 (13%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIK----VFHLQREGALNSFDA-----ECE 712
            D++   +LIG GSYG V +     +   VAIK    VF        +  D      E  
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-------DLIDCKRILREIA 104

Query: 713 ILKTIRHRNLVK---IISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIM 767
           IL  + H ++VK   I+       F    +VLE       +     +   L       ++
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR-TPVYLTELHIKTLL 162

Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA 827
            ++   ++Y+H   S  I+H D+KP+N L++      + DFG+A+ +   ++      ++
Sbjct: 163 YNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219

Query: 828 TIGYIAPEYGREGQVSIKGDVYNY 851
                          ++K  +  +
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGH 243

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.9 bits (176), Expect = 2e-13
 Identities = 29/126 (23%), Positives = 59/126 (46%), Gaps = 5/126 (3%)

Query: 741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS 800
                  E         L +   +     VA  +E+L    S   +H D+   N+LL + 
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 229

Query: 801 MVAHLSDFGIAKLLSEEDS-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF 859
            V  + DFG+A+ + ++   +++      + ++APE   +   +I+ DV+++G++L E+F
Sbjct: 230 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

Query: 860 T-GMKP 864
           + G  P
Sbjct: 290 SLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 25/101 (24%), Positives = 45/101 (44%), Gaps = 20/101 (19%)

Query: 666 FSEENL-----IGIGSYGSVYKG------RFPDGIEVAIKVFHLQREGA----LNSFDAE 710
           F  + L     +G G++G V +       +      VA+K+    +EGA      +  +E
Sbjct: 19  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSE 75

Query: 711 CEILKTI-RHRNLVKIISSCTNHNFKALV-LEYMPKGSLED 749
            +IL  I  H N+V ++ +CT      +V +E+   G+L  
Sbjct: 76  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 39/151 (25%), Positives = 65/151 (43%), Gaps = 19/151 (12%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRH-RNLVKIISSC 729
           IG G++G +  G+       VAIK+     +        E    K +     + ++    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEP--MKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASN--FNLDIFQRLGI-MIDVASALEYLHFGHSNPIV 786
               + A+VLE +   SLED     +  F+L     + I +I   S +EY+H   S  ++
Sbjct: 75  PCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLI---SRMEYVH---SKNLI 127

Query: 787 HCDIKPSNVLL-----DDSMVAHLSDFGIAK 812
           + D+KP N L+         V H+ DF +AK
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 41/199 (20%), Positives = 78/199 (39%), Gaps = 40/199 (20%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIK--VFHLQREGALNSFDA-----ECEIL 714
             ++ +   +G G  G V+          VAIK  V         +         E +I+
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-------DPQSVKHALREIKII 62

Query: 715 KTIRHRNLVKII------------SSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDI 760
           + + H N+VK+                +     +  +V EYM    L + +       + 
Sbjct: 63  RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEH 121

Query: 761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS--DFGIAKLLSEED 818
            +    M  +   L+Y+H   S  ++H D+KP+N+ + ++    L   DFG+A+++    
Sbjct: 122 ARL--FMYQLLRGLKYIH---SANVLHRDLKPANLFI-NTEDLVLKIGDFGLARIMDPHY 175

Query: 819 SMKQ--TQTLATIGYIAPE 835
           S K   ++ L T  Y +P 
Sbjct: 176 SHKGHLSEGLVTKWYRSPR 194

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.2 bits (175), Expect = 3e-13
 Identities = 47/189 (24%), Positives = 83/189 (43%), Gaps = 33/189 (17%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIK----VFHLQREGALNSFDA-----ECE 712
            +++   + +G G+YGSV        G+ VA+K     F        +   A     E  
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-------SIIHAKRTYRELR 80

Query: 713 ILKTIRHRNLVKI----ISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGI 766
           +LK ++H N++ +      + +   F    LV   M    L + +       D  Q   +
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQF--L 137

Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
           +  +   L+Y+H   S  I+H D+KPSN+ +++     + DFG+A+  ++E     T  +
Sbjct: 138 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYV 190

Query: 827 ATIGYIAPE 835
           AT  Y APE
Sbjct: 191 ATRWYRAPE 199

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 71.2 bits (175), Expect = 3e-13
 Identities = 59/240 (24%), Positives = 103/240 (42%), Gaps = 59/240 (24%)

Query: 664 DQFSEENLIGIGSYGSVY---KGRFPDGIEV-AIKVFH----LQREGALNSFDAECEILK 715
           + F    ++G G+YG V+   K    D  ++ A+KV      +Q+         E ++L+
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 716 TIRHRN-LVKIISSCTNHNFKALVLEYMPKGSL-----------ED--CMYASNFNLDIF 761
            IR    LV +  +        L+L+Y+  G L           E    +Y         
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG------- 166

Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH--LSDFGIAKLLSEEDS 819
                  ++  ALE+LH      I++ DIK  N+LLD +   H  L+DFG++K    +++
Sbjct: 167 -------EIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADET 214

Query: 820 MKQTQTLA-TIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
            ++      TI Y+AP+       G +  V    D ++ G+++ E+ TG  P    FT +
Sbjct: 215 -ERAYDFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP----FTVD 265

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.1 bits (175), Expect = 4e-13
 Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 56/206 (27%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIK---VFHLQREGALNSFDA-----ECEI 713
           +  F  ++L+G G+YG V      P G  VAIK    F            A     E +I
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-------KPLFALRTLREIKI 62

Query: 714 LKTIRHRNLVK---IISSCTNHNFKA--LVLEYMP--------KGSLED--CMYASNFNL 758
           LK  +H N++    I    +  NF    ++ E M            L D    Y   F  
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY---F-- 117

Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
            I+Q L        A++ LH    + ++H D+KPSN+L++ +    + DFG+A+++ E  
Sbjct: 118 -IYQTL-------RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166

Query: 819 SMKQ---------TQTLATIGYIAPE 835
           +             + +AT  Y APE
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPE 192

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 70.4 bits (173), Expect = 4e-13
 Identities = 48/232 (20%), Positives = 90/232 (38%), Gaps = 53/232 (22%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDA-----ECEILKT 716
            D +     +G G Y  V++     +  +V +K+        L          E +IL+ 
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--------LKPVKKKKIKREIKILEN 86

Query: 717 IR-HRNLVKIISSCTNHNFK--ALVLEY---------MPKGSLEDCMYASNFNLDIFQRL 764
           +R   N++ +     +   +  ALV E+             +  D  +   +   +++ L
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF---Y---MYEIL 140

Query: 765 GIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQT 823
                   AL+Y H   S  I+H D+KP NV++D +     L D+G+A+           
Sbjct: 141 -------KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--N 188

Query: 824 QTLATIGYIAPE---YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
             +A+  +  PE     +    S+  D+++ G ML  +    +P   FF G 
Sbjct: 189 VRVASRYFKGPELLVDYQMYDYSL--DMWSLGCMLASMIFRKEP---FFHGH 235

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.0 bits (176), Expect = 5e-13
 Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 58/236 (24%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAEC-----EILKTI 717
             F+   ++G GS+G V         E+ A+K+  L+++  +   D EC      +L   
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALP 398

Query: 718 -RHRNLVKIISSCTNHNFKALVLEYMPKGSL-----------ED--CMYASNFNLDIFQR 763
            +   L ++ S     +    V+EY+  G L           E     YA+         
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------- 449

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
                ++A  L +L    S  I++ D+K  NV+LD      ++DFG+ K    +     T
Sbjct: 450 -----EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTT 499

Query: 824 QTLA-TIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           +T   T  YIAPE      YG+   V    D + +G++L E+  G  P    F GE
Sbjct: 500 KTFCGTPDYIAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAP----FEGE 545

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.8 bits (174), Expect = 6e-13
 Identities = 70/238 (29%), Positives = 98/238 (41%), Gaps = 62/238 (26%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAEC-----EIL-KT 716
             F    +IG GS+G V   R        A+KV  LQ++  L   + +       +L K 
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKN 95

Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-----------ED--CMYASNFNLDIFQR 763
           ++H  LV +  S    +    VL+Y+  G L           E     YA+         
Sbjct: 96  VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA--------- 146

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH--LSDFGIAKLLSEEDSMK 821
                ++ASAL YLH   S  IV+ D+KP N+LLD     H  L+DFG+ K   E +S  
Sbjct: 147 -----EIASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST- 195

Query: 822 QTQTL-ATIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
            T T   T  Y+APE      Y R   V    D +  G +L E+  G+ P    F   
Sbjct: 196 -TSTFCGTPEYLAPEVLHKQPYDRT--V----DWWCLGAVLYEMLYGLPP----FYSR 242

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 53/235 (22%), Positives = 86/235 (36%), Gaps = 37/235 (15%)

Query: 339 VNC--KSLK---IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE 393
           +       +             +L   +++     T   L  +  +   N+  +      
Sbjct: 3   ITVSTPIKQIFPDDAFAETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQG-- 58

Query: 394 FCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDF 453
             +   +  + L  NKL   I + L +L +L  L L+ N+L S+    F  L ++     
Sbjct: 59  IQYLPNVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116

Query: 454 SSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPES 513
             N L  SLP  + +                        L NL +L+L HN+LQ      
Sbjct: 117 VENQLQ-SLPDGVFD-----------------------KLTNLTYLNLAHNQLQSLPKGV 152

Query: 514 FGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFS 568
           F +L +L  LDLS N L  +     +KL  LK L L  N+L   +P  G F   +
Sbjct: 153 FDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS-VPD-GVFDRLT 205

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 14/199 (7%)

Query: 315 KRLGLERNYLTF--STSELMSLFSALVNCKSLK----IGNLINLTTLSLGDNNLSGSLPI 368
            +  L++  +T   + +EL S+   + N   +K    I  L N+  L+LG N L   +  
Sbjct: 22  IKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-DISA 80

Query: 369 TLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRIL 427
            L  L  L  L L  N+ +      F   + L  + L  N+L  S+P  + D L +L  L
Sbjct: 81  -LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYL 138

Query: 428 SLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRNNLSGNI 486
           +L+ N+L S+    F  L ++   D S N L  SLP  + + L  + D+ L +N L  ++
Sbjct: 139 NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SV 196

Query: 487 PSTII-GLKNLQHLSLEHN 504
           P  +   L +LQ++ L  N
Sbjct: 197 PDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 49/213 (23%), Positives = 78/213 (36%), Gaps = 29/213 (13%)

Query: 19  SVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGN----------LSSLQTLVLSRNW 68
                  I  ++    VT     +   +        +          L +++ L L  N 
Sbjct: 15  DDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNK 74

Query: 69  FSGTIPKEIG---NLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASI 125
                  +I     LT L  L L  N+LQ         L  L+ LVL  N L  ++P  +
Sbjct: 75  L-----HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGV 128

Query: 126 FNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLW-HCKELSSV 184
           F+     T L+ + N L  S P  +   L  L  L +SYNQ +  +P  ++    +L  +
Sbjct: 129 FDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDL 186

Query: 185 SLSYNQFTGRLPR---DLGNSTKLKSLDLGFNN 214
            L  NQ    +P    D    T L+ + L  +N
Sbjct: 187 RLYQNQLK-SVPDGVFD--RLTSLQYIWL-HDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 61/238 (25%), Positives = 100/238 (42%), Gaps = 47/238 (19%)

Query: 202 STKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNIST-LKILSLFN 260
             +    +L   ++  +   +   L +++ +  + S++              ++ L+L  
Sbjct: 18  FAETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQG---IQYLPNVRYLALGG 72

Query: 261 NTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLE 320
           N L  ++ + K L    NL  L L  N L  S+P+  F+  KL        +NLK L L 
Sbjct: 73  NKLH-DISALKELT---NLTYLILTGNQLQ-SLPNGVFD--KL--------TNLKELVLV 117

Query: 321 RNYLTFSTSELMSLFSALVNCKSLKIG---NLINLTTLSLGDNNLSGSLPITL-GRLKKL 376
            N L                  SL  G    L NLT L+L  N L  SLP  +  +L  L
Sbjct: 118 ENQLQ-----------------SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNL 159

Query: 377 QGLDLQNNKFEGPIPQE-FCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLSSN 432
             LDL  N+ +  +P+  F   ++L  + L +N+L  S+P  + D L SL+ + L  N
Sbjct: 160 TELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 69.6 bits (171), Expect = 1e-12
 Identities = 65/255 (25%), Positives = 100/255 (39%), Gaps = 63/255 (24%)

Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALN 705
           P++   R S    L+  D F    ++G GS+G V+   F    +  AIK   L+++  L 
Sbjct: 1   PELNKERPSLQIKLKIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLM 57

Query: 706 SFDAEC-----EILKT-IRHRNLVKIISSCTNHNFKALVLEYMPKGSL-----------E 748
             D EC      +L     H  L  +  +         V+EY+  G L            
Sbjct: 58  DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL 117

Query: 749 D--CMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH-- 804
                YA+              ++   L++LH   S  IV+ D+K  N+LLD     H  
Sbjct: 118 SRATFYAA--------------EIILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIK 158

Query: 805 LSDFGIAKLLSEEDSMKQTQTL-ATIGYIAPE------YGREGQVSIKGDVYNYGIMLME 857
           ++DFG+ K     D+   T T   T  YIAPE      Y          D +++G++L E
Sbjct: 159 IADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHS------VDWWSFGVLLYE 210

Query: 858 VFTGMKPTNEFFTGE 872
           +  G  P    F G+
Sbjct: 211 MLIGQSP----FHGQ 221

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 62/229 (27%), Positives = 91/229 (39%), Gaps = 58/229 (25%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAEC-----EILKTI-RHRNLV 723
           ++G GS+G V   R  +  ++ A+KV  L+++  L   D EC      IL     H  L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 724 KIISSCTNHNFKALVLEYMPKGSL-----------ED--CMYASNFNLDIFQRLGIMIDV 770
           ++       +    V+E++  G L           E     YA+              ++
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--------------EI 133

Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL-ATI 829
            SAL +LH      I++ D+K  NVLLD      L+DFG+ K          T T   T 
Sbjct: 134 ISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTP 188

Query: 830 GYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
            YIAPE      YG    V    D +  G++L E+  G  P    F  E
Sbjct: 189 DYIAPEILQEMLYGPA--V----DWWAMGVLLYEMLCGHAP----FEAE 227

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 47/198 (23%), Positives = 78/198 (39%), Gaps = 52/198 (26%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIK----VFHLQREGALNSFDA-----ECE 712
              +     +G G+YGSV        G +VAIK     F        +   A     E  
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-------SEIFAKRAYRELL 75

Query: 713 ILKTIRHRNLVKI----ISSCTNHNFKA--LVLEYMP-------KGSLED--CMYASNFN 757
           +LK ++H N++ +      + +  NF    LV+ +M             +    Y     
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY---L- 131

Query: 758 LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
             ++Q L         L+Y+H   S  +VH D+KP N+ +++     + DFG+A+    +
Sbjct: 132 --VYQML-------KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HAD 177

Query: 818 DSMKQTQTLATIGYIAPE 835
             M  T  + T  Y APE
Sbjct: 178 AEM--TGYVVTRWYRAPE 193

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 31/141 (21%), Positives = 55/141 (39%), Gaps = 12/141 (8%)

Query: 430 SSNELTSV---IPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRNNLSGN 485
           S+ +L  +   IP     L        ++N         I + L  +  I  S N ++  
Sbjct: 19  SNQKLNKIPEHIPQYTAEL------RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDI 72

Query: 486 IPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLK 545
                 G   +  + L  N+L+    + F  L SL+ L L +N ++ V   S   L  ++
Sbjct: 73  EEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR 132

Query: 546 SLNLSFNKLVGEIPRGGAFAN 566
            L+L  N++   +   GAF  
Sbjct: 133 LLSLYDNQIT-TVAP-GAFDT 151

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 38/152 (25%), Positives = 65/152 (42%), Gaps = 29/152 (19%)

Query: 404 YLNRNKLSGSIPS--CLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGS 461
            LN N+ +  + +      L  LR ++ S+N++T +    F                   
Sbjct: 38  RLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAF------------------- 77

Query: 462 LPLEIENLKAVVDIYLSRNNLSGNIPSTII-GLKNLQHLSLEHNKLQGPIPESFGELVSL 520
                E    V +I L+ N L  N+   +  GL++L+ L L  N++     +SF  L S+
Sbjct: 78  -----EGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSV 131

Query: 521 EFLDLSNNDLSGVIPASLEKLLYLKSLNLSFN 552
             L L +N ++ V P + + L  L +LNL  N
Sbjct: 132 RLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 36/153 (23%), Positives = 59/153 (38%), Gaps = 25/153 (16%)

Query: 377 QGLDLQNNKFEG-PIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELT 435
             L L NN+F        F    +L  +  + NK++          + +  + L+SN L 
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94

Query: 436 SVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKN 495
           +V    F  L                     E+LK    + L  N ++     + IGL +
Sbjct: 95  NVQHKMFKGL---------------------ESLK---TLMLRSNRITCVGNDSFIGLSS 130

Query: 496 LQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN 528
           ++ LSL  N++    P +F  L SL  L+L  N
Sbjct: 131 VRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 32/157 (20%), Positives = 58/157 (36%), Gaps = 27/157 (17%)

Query: 41  SDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYNKLQGEIPE 99
           S+  L   IP H+        L L+ N F+      I   L +L++++   NK+  +I E
Sbjct: 19  SNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEE 74

Query: 100 E-LGNLAELEMLVLNNNLLTGTIPASIF-NLSFISTALDFSDNSLTGSFPYDMCPGLPRL 157
                 + +  ++L +N L   +   +F  L  +   L    N +T     D   GL  +
Sbjct: 75  GAFEGASGVNEILLTSNRLE-NVQHKMFKGLESL-KTLMLRSNRIT-CVGNDSFIGLSSV 131

Query: 158 KGLYVSYNQFKGPIP----------------NNLWHC 178
           + L +  NQ    +                  N ++C
Sbjct: 132 RLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFNC 167

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 42/213 (19%), Positives = 73/213 (34%), Gaps = 48/213 (22%)

Query: 243 VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASK 302
           +P+ I        L L NN  +  L ++     LP L  +N   N ++      F  AS 
Sbjct: 26  IPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82

Query: 303 LYALELGYN-------------SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIG-- 347
           +  + L  N              +LK L L  N +T                  +     
Sbjct: 83  VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-----------------CVGNDSF 125

Query: 348 -NLINLTTLSLGDNNLSGSLPI-TLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVV-Y 404
             L ++  LSL DN ++ ++       L  L  L+L  N F        C+    ++  +
Sbjct: 126 IGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN-------CNCYLAWLGEW 177

Query: 405 LNRNKLSGSIPSCLG--DLNSLRILSLSSNELT 435
           L + ++    P C     L  + I  ++  + T
Sbjct: 178 LRKKRIVTGNPRCQKPYFLKEIPIQDVAIQDFT 210

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 23/131 (17%), Positives = 49/131 (37%), Gaps = 4/131 (3%)

Query: 133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFT 192
             L  ++N  T      +   LP+L+ +  S N+              ++ + L+ N+  
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94

Query: 193 GRLPRDLGNSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGIDQSNLVGFVPDTIF-NI 250
               +       LK+L L  N +   +  +    L ++ +L +  + +   V    F  +
Sbjct: 95  NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTL 152

Query: 251 STLKILSLFNN 261
            +L  L+L  N
Sbjct: 153 HSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.2 bits (97), Expect = 7e-04
 Identities = 26/131 (19%), Positives = 56/131 (42%), Gaps = 9/131 (6%)

Query: 185 SLSYNQFTGRLPRDL-GNSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGIDQSNLVGF 242
            L+ N+FT      +     +L+ ++   N +  +I +        +  + +   N +  
Sbjct: 38  RLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS-NRLEN 95

Query: 243 VPDTIF-NISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNA- 300
           V   +F  + +LK L L +N ++  + +    IGL ++  L+L  N ++ ++    F+  
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRIT-CVGNDS-FIGLSSVRLLSLYDNQIT-TVAPGAFDTL 152

Query: 301 SKLYALELGYN 311
             L  L L  N
Sbjct: 153 HSLSTLNLLAN 163

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 60/348 (17%), Positives = 115/348 (33%), Gaps = 69/348 (19%)

Query: 53  LGNLSSLQTLVLSRNWFSG----TIPKEIGNLTKLKELHLDYNKLQGE----IPEELGNL 104
           +   S ++   L  +  +     ++   +     +KE+ L  N +  E    + E + + 
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 105 AELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSY 164
            +LE+   ++             L  +  AL                   P+L  + +S 
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQAL----------------LKCPKLHTVRLSD 103

Query: 165 NQF--KG--PIPNNLWHCKELSSVSLSYNQFT-------------GRLPRDLGNSTKLKS 207
           N F      P+ + L     L  + L  N                  + +   N+  L+S
Sbjct: 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS 163

Query: 208 LDLGFNNLNGE----IPQEIGNLRNLEILGIDQSNL-----VGFVPDTIFNISTLKILSL 258
           +  G N L         +   + R L  + + Q+ +        + + +     LK+L L
Sbjct: 164 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDL 223

Query: 259 FNNTLS--GNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKL-YALELGYNSNLK 315
            +NT +  G+   +  L   PNL  L L    LS         A+ +  A     N  L+
Sbjct: 224 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR------GAAAVVDAFSKLENIGLQ 277

Query: 316 RLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLS 363
            L L+ N +      + +L + +          + +L  L L  N  S
Sbjct: 278 TLRLQYNEIE--LDAVRTLKTVIDE-------KMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 65.1 bits (159), Expect = 4e-11
 Identities = 55/347 (15%), Positives = 108/347 (31%), Gaps = 76/347 (21%)

Query: 250 ISTLKILSLFNNTLS--GNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALE 307
             +++  SL  + ++          L+   +++ + L  N +          A++  +  
Sbjct: 3   RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTE-------AARWLSEN 55

Query: 308 LGYNSNLKRLGLERNYLTFSTSE----LMSLFSALVNCKSLKIGNLINLTTLSLGDNNLS 363
           +    +L+       +      E    L  L  AL+ C          L T+ L DN   
Sbjct: 56  IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCP--------KLHTVRLSDNAFG 107

Query: 364 --GSLPIT--LGRLKKLQGLDLQNNKF-------------EGPIPQEFCHFSRLYVVYLN 406
                P+   L +   L+ L L NN               E  + ++  +   L  +   
Sbjct: 108 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 167

Query: 407 RNKLSG----SIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSL 462
           RN+L                 L  + +  N +          +E +L    +        
Sbjct: 168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE------GIEHLLLEGLAYCQ----- 216

Query: 463 PLEIENLKAVVDIYLSRNNLSGN----IPSTIIGLKNLQHLSLEHNKLQGP----IPESF 514
                 LK    + L  N  +      +   +    NL+ L L    L       + ++F
Sbjct: 217 -----ELK---VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF 268

Query: 515 GELV--SLEFLDLSNNDLSG----VIPASL-EKLLYLKSLNLSFNKL 554
            +L    L+ L L  N++       +   + EK+  L  L L+ N+ 
Sbjct: 269 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 60.5 bits (147), Expect = 9e-10
 Identities = 46/278 (16%), Positives = 85/278 (30%), Gaps = 47/278 (16%)

Query: 181 LSSVSLSYNQFTGR----LPRDLGNSTKLKSLDLGFNNLNGE----IPQEIGNLRNLEIL 232
           +   SL  +  T      +   L     +K + L  N +  E    + + I + ++LEI 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 233 GIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGS 292
                             S +    + +          + L+  P L  + L  N    +
Sbjct: 66  ----------------EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 109

Query: 293 IPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLK-IGNLIN 351
                 +        L  ++ L+ L L  N L         +  AL      K   N   
Sbjct: 110 AQEPLIDF-------LSKHTPLEHLYLHNNGL--GPQAGAKIARALQELAVNKKAKNAPP 160

Query: 352 LTTLSLGDNNLSG----SLPITLGRLKKLQGLDLQNNKF-----EGPIPQEFCHFSRLYV 402
           L ++  G N L          T    + L  + +  N       E  + +   +   L V
Sbjct: 161 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKV 220

Query: 403 VYLNRNKLSG----SIPSCLGDLNSLRILSLSSNELTS 436
           + L  N  +     ++   L    +LR L L+   L++
Sbjct: 221 LDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 258

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 51.6 bits (124), Expect = 6e-07
 Identities = 43/275 (15%), Positives = 76/275 (27%), Gaps = 50/275 (18%)

Query: 39  TISDLGLAGTIPSHLGNLSSLQTLVLSRNWFS----------GTIPKEIGNLTKLKELHL 88
           TI     A  +  ++ +   L+    S  +              + + +    KL  + L
Sbjct: 43  TIGTEA-ARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRL 101

Query: 89  DYNKLQGE----IPEELGNLAELEMLVLNNN------------LLTGTIPASIFNLSFIS 132
             N         + + L     LE L L+NN             L           +   
Sbjct: 102 SDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL 161

Query: 133 TALDFSDNSLTGSFPYDMCPGL---PRLKGLYVSYNQF-----KGPIPNNLWHCKELSSV 184
            ++    N L      +          L  + +  N       +  +   L +C+EL  +
Sbjct: 162 RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVL 221

Query: 185 SLSYNQFTGR----LPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNL------RNLEIL-- 232
            L  N FT      L   L +   L+ L L    L+      + +         L+ L  
Sbjct: 222 DLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 281

Query: 233 ---GIDQSNLVGFVPDTIFNISTLKILSLFNNTLS 264
               I+   +          +  L  L L  N  S
Sbjct: 282 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 11/146 (7%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRH-RNLVKIISSC 729
           IG GS+G +Y G     G EVAIK+  ++ +        E +I K ++    +  I    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD 789
              ++  +V+E +   SLED     +    +   L +   + S +EY+H   S   +H D
Sbjct: 75  AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 130

Query: 790 IKPSNVLL---DDSMVAHLSDFGIAK 812
           +KP N L+       + ++ DFG+AK
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 67.6 bits (166), Expect = 4e-12
 Identities = 58/245 (23%), Positives = 90/245 (36%), Gaps = 71/245 (28%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSC 729
           +IG GSY  V   R      + A+KV  +++E   +  D +         ++   +    
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDW----VQTEKH---VFEQA 66

Query: 730 TNHNF----KA---------LVLEYMPKGSL-----------ED--CMYASNFNLDIFQR 763
           +NH F     +          V+EY+  G L           E+    Y++         
Sbjct: 67  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------- 117

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
                +++ AL YLH      I++ D+K  NVLLD      L+D+G+ K          T
Sbjct: 118 -----EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--T 167

Query: 824 QTL-ATIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
            T   T  YIAPE      YG    V    D +  G+++ E+  G  P   F     S  
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFS--V----DWWALGVLMFEMMAGRSP---FDIVGSSDN 218

Query: 877 RWIND 881
              N 
Sbjct: 219 PDQNT 223

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 68.2 bits (167), Expect = 5e-12
 Identities = 43/194 (22%), Positives = 74/194 (38%), Gaps = 27/194 (13%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIK----VFHLQREGALNSFDA-----ECE 712
            D +  ++LIG GSYG VY          VAIK    +F        +  D      E  
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-------DLIDCKRILREIT 77

Query: 713 ILKTIRHRNLVK---IISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIM 767
           IL  ++   +++   +I       F    +VLE      L+       F  +   +  I+
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-IL 135

Query: 768 IDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA 827
            ++     ++   H + I+H D+KP+N LL+      + DFG+A+ ++ E        L 
Sbjct: 136 YNLLLGENFI---HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192

Query: 828 TIGYIAPEYGREGQ 841
                 P      +
Sbjct: 193 ENEEPGPHNKNLKK 206

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 62/231 (26%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAEC-----EILKTI-RHRNLV 723
           ++G GS+G V         E+ A+K+  L+++  +   D EC      +L    +   L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 724 KIISSCTNHNFKALVLEYMPKGSL-----------ED--CMYASNFNLDIFQRLGIMIDV 770
           ++ S     +    V+EY+  G L           E     YA+              ++
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 130

Query: 771 ASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH--LSDFGIAKLLSEEDSMKQTQTL-A 827
           A  L +L    S  I++ D+K  NV+LD     H  ++DFG+ K    +     T+T   
Sbjct: 131 AIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVT--TKTFCG 183

Query: 828 TIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           T  YIAPE      YG+   V    D + +G++L E+  G  P    F GE
Sbjct: 184 TPDYIAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAP----FEGE 224

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)

Query: 427 LSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRNNLSGN 485
           L L S  L ++  +TF  L  +   +   N L  +L   + ++L  +  + L+ N L+ +
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA-S 97

Query: 486 IPSTI-IGLKNLQHLSLEHNKLQGPIPES-FGELVSLEFLDLSNNDLSGVIPASLEKLLY 543
           +P  +   L  L  L L  N+L+  +P   F  L  L+ L L+ N L  +   + +KL  
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156

Query: 544 LKSLNLSFNKLVGEIPRGGAFANFSAESFI 573
           L++L+LS N+L   +P  GAF        I
Sbjct: 157 LQTLSLSTNQLQS-VPH-GAFDRLGKLQTI 184

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 28/178 (15%)

Query: 377 QGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLSSNELT 435
           + LDLQ+          F   ++L  + L+ N+L  ++ + + D L  L  L L++N+L 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 436 SVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKN 495
           S+    F +L  +       N L  SLP        V D                  L  
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLK-SLP------SGVFD-----------------RLTK 132

Query: 496 LQHLSLEHNKLQGPIPES-FGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFN 552
           L+ L L  N+LQ  IP   F +L +L+ L LS N L  V   + ++L  L+++ L  N
Sbjct: 133 LKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 56/197 (28%), Positives = 79/197 (40%), Gaps = 33/197 (16%)

Query: 339 VNC--KSLK---IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE 393
           V+C  KSL     G   +   L L    L+     T   L KL  L+L  N+ +      
Sbjct: 19  VDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV 78

Query: 394 FCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLSSNELTSVIPSTFWNLEDILGFD 452
           F   + L  + L  N+L+ S+P  + D L  L  L L  N+L S+    F    D L   
Sbjct: 79  FDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVF----DRLT-- 131

Query: 453 FSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTII-GLKNLQHLSLEHNKLQGPIP 511
                           LK   ++ L+ N L  +IP+     L NLQ LSL  N+LQ    
Sbjct: 132 ---------------KLK---ELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPH 172

Query: 512 ESFGELVSLEFLDLSNN 528
            +F  L  L+ + L  N
Sbjct: 173 GAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 54/192 (28%), Positives = 75/192 (39%), Gaps = 32/192 (16%)

Query: 72  TIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFI 131
           ++P  I   T+  +L L    L          L +L  L L+ N L  T+ A +F+    
Sbjct: 28  SVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84

Query: 132 STALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQF 191
              L  ++N L  S P  +   L +L  LY+  NQ K                SL    F
Sbjct: 85  LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK----------------SLPSGVF 127

Query: 192 TGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGIDQSNLVGFVPDTIF-N 249
             RL       TKLK L L  N L   IP      L NL+ L +  + L   VP   F  
Sbjct: 128 D-RL-------TKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDR 177

Query: 250 ISTLKILSLFNN 261
           +  L+ ++LF N
Sbjct: 178 LGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 55/191 (28%), Positives = 79/191 (41%), Gaps = 11/191 (5%)

Query: 25  GITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLK 84
           G TC+     V         L  ++PS  G  +  + L L     +         LTKL 
Sbjct: 9   GCTCNEGKKEVDC---QGKSLD-SVPS--GIPADTEKLDLQSTGLATLSDATFRGLTKLT 62

Query: 85  ELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTG 144
            L+LDYN+LQ        +L EL  L L NN L  ++P  +F+       L    N L  
Sbjct: 63  WLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK- 120

Query: 145 SFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLW-HCKELSSVSLSYNQFTGRLPRDLGNST 203
           S P  +   L +LK L ++ NQ +  IP   +     L ++SLS NQ             
Sbjct: 121 SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLG 179

Query: 204 KLKSLDLGFNN 214
           KL+++ L F N
Sbjct: 180 KLQTITL-FGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 4/156 (2%)

Query: 327 STSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPI-TLGRLKKLQGLDLQNNK 385
            T +L    + L          L  LT L+L  N L  +L       L +L  L L NN+
Sbjct: 36  DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQ 94

Query: 386 FEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLSSNELTSVIPSTFWN 444
                   F H ++L  +YL  N+L  S+PS + D L  L+ L L++N+L S+    F  
Sbjct: 95  LASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDK 153

Query: 445 LEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRN 480
           L ++     S+N L        + L  +  I L  N
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 54/183 (29%), Positives = 71/183 (38%), Gaps = 35/183 (19%)

Query: 206 KSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFN-ISTLKILSLFNNTLS 264
           + LDL    L          L  L  L +D  N +  +   +F+ ++ L  L L NN L+
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLD-YNQLQTLSAGVFDDLTELGTLGLANNQLA 96

Query: 265 GNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYL 324
            +LP       L  L+ L LG N L  S+PS  F+  +L        + LK L L  N L
Sbjct: 97  -SLPLGV-FDHLTQLDKLYLGGNQLK-SLPSGVFD--RL--------TKLKELRLNTNQL 143

Query: 325 TFSTSELMSLFSALVNCKSLKIG---NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDL 381
                             S+  G    L NL TLSL  N L         RL KLQ + L
Sbjct: 144 Q-----------------SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL 186

Query: 382 QNN 384
             N
Sbjct: 187 FGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 43/162 (26%), Positives = 68/162 (41%), Gaps = 14/162 (8%)

Query: 36  TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYNKLQ 94
             L +   GLA    +    L+ L  L L  N    T+   +  +LT+L  L L  N+L 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 95  GEIPEEL-GNLAELEMLVLNNNLLTGTIPASIF----NLSFISTALDFSDNSLTGSFPYD 149
             +P  +  +L +L+ L L  N L  ++P+ +F     L      L  + N L  S P  
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKL----KELRLNTNQLQ-SIPAG 149

Query: 150 MCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQF 191
               L  L+ L +S NQ +           +L +++L  NQF
Sbjct: 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 43/172 (25%), Positives = 59/172 (34%), Gaps = 36/172 (20%)

Query: 269 SSKNLIGLP-----NLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNS----------- 312
             K+L  +P     + E L+L    L+    + F   +KL  L L YN            
Sbjct: 22  QGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD 81

Query: 313 --NLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGN-------------LINLTTLSL 357
              L  LGL  N L    S  + +F  L     L +G              L  L  L L
Sbjct: 82  LTELGTLGLANNQLA---SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRL 138

Query: 358 GDNNLSGSLPI-TLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRN 408
             N L  S+P     +L  LQ L L  N+ +      F    +L  + L  N
Sbjct: 139 NTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.0 bits (164), Expect = 9e-12
 Identities = 57/245 (23%), Positives = 90/245 (36%), Gaps = 71/245 (28%)

Query: 671 LIGIGSYGSVYKGRFPDGIEV-AIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSC 729
           +IG GSY  V   R      + A++V  +++E   +  D +         ++   +    
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDW----VQTEKH---VFEQA 109

Query: 730 TNHNF----KA---------LVLEYMPKGSL-----------ED--CMYASNFNLDIFQR 763
           +NH F     +          V+EY+  G L           E+    Y++         
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------- 160

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
                +++ AL YLH      I++ D+K  NVLLD      L+D+G+ K          T
Sbjct: 161 -----EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--T 210

Query: 824 QTL-ATIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
            T   T  YIAPE      YG    V    D +  G+++ E+  G  P   F     S  
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFS--V----DWWALGVLMFEMMAGRSP---FDIVGSSDN 261

Query: 877 RWIND 881
              N 
Sbjct: 262 PDQNT 266

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 68.3 bits (166), Expect = 1e-11
 Identities = 102/665 (15%), Positives = 192/665 (28%), Gaps = 233/665 (35%)

Query: 87  HLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSF 146
           H+D+         E G     E      ++L+    A + N        D   + L+   
Sbjct: 6   HMDF---------ETG-----EHQYQYKDILSVFEDAFVDNFDCKDV-QDMPKSILS-KE 49

Query: 147 PYDMCPGLP-RLKGLYV-----------SYNQFKGPI--PNNLW-------HCKELSSVS 185
             D        + G                 +F   +   N  +         ++ S ++
Sbjct: 50  EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMT 109

Query: 186 LSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRN-LEIL------------ 232
             Y +   RL  D  N          F   N    Q    LR  L  L            
Sbjct: 110 RMYIEQRDRLYND--NQV--------FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159

Query: 233 GIDQSNLVGFV----------PDTIF--NI-------STLKILSLFNNTLSGNLPS-SKN 272
           G  ++ +   V             IF  N+       + L++L      +  N  S S +
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219

Query: 273 LIGLP-NLEGLNLGLNNL------------------SGSIPSFFFNASKL-------YAL 306
              +   +  +   L  L                  + +  +F  +   L          
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279

Query: 307 ELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNL------INLTTLSLGDN 360
            L   +    + L+ + +T +  E+ SL    ++C   +  +L       N   LS+   
Sbjct: 280 FLS-AATTTHISLDHHSMTLTPDEVKSLLLKYLDC---RPQDLPREVLTTNPRRLSI--- 332

Query: 361 NLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD 420
                    +    +           +G        +      ++N +KL+  I S L  
Sbjct: 333 ---------IAESIR-----------DGL-----ATWD--NWKHVNCDKLTTIIESSLNV 365

Query: 421 LN---------SLRILSLSSNELTSVIP----STFWN------LEDILGFDFSSNSLNG- 460
           L           L +   S++     IP    S  W       +  ++      + +   
Sbjct: 366 LEPAEYRKMFDRLSVFPPSAH-----IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420

Query: 461 ------SLP-------LEIENLKA----VVDIYLSRNNLSGN--IPSTI-------IGLK 494
                 S+P       +++EN  A    +VD Y        +  IP  +       IG  
Sbjct: 421 PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG-- 478

Query: 495 NLQHLS-LEHNKLQGPIPESFGELVSLEFLD--LSNNDLSGVIPASLEKLL-----YLKS 546
              HL  +EH +        F   +   FL+  + ++  +     S+   L     Y   
Sbjct: 479 --HHLKNIEHPERMTLFRMVF---LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPY 533

Query: 547 LNLS---FNKLVGEIPRGGAFANFSAESFIGNDLLCGSPY---LHVPLCKSSPHK----K 596
           +  +   + +LV  I       +F  +  I  +L+C S Y   L + L   +  +    +
Sbjct: 534 ICDNDPKYERLVNAI------LDFLPK--IEENLIC-SKYTDLLRIAL--MAEDEAIFEE 582

Query: 597 SRKQV 601
           + KQV
Sbjct: 583 AHKQV 587

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.9 bits (139), Expect = 1e-08
 Identities = 79/518 (15%), Positives = 162/518 (31%), Gaps = 147/518 (28%)

Query: 497 QHLSLEHNKLQ---GPIPESFGE--LVSLEFLD--------LSNNDLSGVI--PASLEKL 541
            H+  E  + Q     I   F +  + + +  D        LS  ++  +I    ++   
Sbjct: 5   HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT 64

Query: 542 LYL-----------------KSLNLSFNKLVGEI------PRGGAFANFSAESFIGNDLL 578
           L L                 + L +++  L+  I      P             + ND  
Sbjct: 65  LRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124

Query: 579 CGSPYLHVPLCKSSPHKKSRKQVILLGVVLPLSTVFIVTVILVLTFG---LITRCCKRRS 635
             + Y +V   +  P+ K R+       +L L     V +  VL  G   +    C   S
Sbjct: 125 VFAKY-NVS--RLQPYLKLRQ------ALLELRPAKNVLIDGVLGSGKTWVALDVC--LS 173

Query: 636 TEVSHIKAGMSPQVMW----RRYSHDELLRATDQFS---EENLIGIGSYGSVYKGRFPDG 688
            +V   +  M  ++ W       S + +L    +     + N      + S  K R    
Sbjct: 174 YKV---QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS- 229

Query: 689 IEVAIKVF--------------HLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNF 734
           I+  ++                ++Q   A N+F+  C+IL T R + +   +S+ T    
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT--- 286

Query: 735 KALVLEYMPKGSLEDCMYASNFNLDIFQR-LGIMIDVASALEYLHFGHSNPIVHCDIKPS 793
             + L++       D          +  + L         L         P       P 
Sbjct: 287 THISLDHHSMTLTPD------EVKSLLLKYLDCRPQ---DL---------PREVLTTNP- 327

Query: 794 NVLLDDSMVAHLSDFGIAKLLSEE----------DSMKQTQTL-ATIGYIAPEYGREGQV 842
                 S+        IA+ + +           +  K T  + +++  + P   R+   
Sbjct: 328 ---RRLSI--------IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK--- 373

Query: 843 SIKGDVYNYGIMLMEVFTGMKPTNEFFTGE-MSIKRWINDSLPAVMNIMDTNLLSEDEEH 901
                +++     + VF    P +       +S+  W +     VM +++     +  ++
Sbjct: 374 -----MFDR----LSVF----PPSAHIPTILLSL-IWFDVIKSDVMVVVN-----KLHKY 414

Query: 902 ANVAKQSCAS--SVLSLAMECTSESPENRVNTKEIISR 937
           + V KQ   S  S+ S+ +E   +        + I+  
Sbjct: 415 SLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH 452

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.8 bits (136), Expect = 4e-08
 Identities = 103/728 (14%), Positives = 199/728 (27%), Gaps = 234/728 (32%)

Query: 176 WHCKELSSVSLSYNQFTGRLP-RDLGNSTK--LKSLDLGFNNLNGEIPQEIGNLRNLEIL 232
           +  K++ SV    + F      +D+ +  K  L   +   +++        G LR    L
Sbjct: 16  YQYKDILSVFE--DAFVDNFDCKDVQDMPKSILSKEE--IDHIIMSKDAVSGTLRLFWTL 71

Query: 233 GIDQSNLVG-FV-----PDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGL 286
              Q  +V  FV      +  F +S +K             PS                 
Sbjct: 72  LSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ--------RQPS-------MMTRMYIEQR 116

Query: 287 NNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKI 346
           + L      F    +K          N+ RL              + L  AL     L+ 
Sbjct: 117 DRLYNDNQVF----AKY---------NVSRL-----------QPYLKLRQAL---LELRP 149

Query: 347 GNLINL--------TTL---SLGDNNLSGSLP-----ITLGRLKKLQG-LDLQNNKFEGP 389
              + +        T +         +   +      + L      +  L++        
Sbjct: 150 AKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQK----- 204

Query: 390 IPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNS--LRILSLSSNELTSVIPSTFWNLED 447
                 +  ++   + +R+  S +I   +  + +   R+L     E   ++     N + 
Sbjct: 205 ----LLY--QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA 258

Query: 448 ILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQ 507
              F+ S               K ++    +R      + +  +      H+SL+H+   
Sbjct: 259 WNAFNLSC--------------KILL---TTRFK---QV-TDFLSAATTTHISLDHHS-- 295

Query: 508 GPIPESFGELVSLE----FLDLSNNDLS-----------GVIPASLEKLL----YLKSLN 548
                +            +LD    DL             +I  S+   L      K +N
Sbjct: 296 ----MTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351

Query: 549 LSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPHKKSRKQVILLGVVL 608
              +KL   I           ES + N L    P  +            RK    L  V 
Sbjct: 352 --CDKLTTII-----------ESSL-NVL---EPAEY------------RKMFDRL-SVF 381

Query: 609 PLSTVFIVTVIL-VLTFGLITRC-------CKRRSTEVSHIKAGMSPQVMWRRYS-HDEL 659
           P S   I T++L ++ F +I            + S      K            S     
Sbjct: 382 PPS-AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES--------TISIPSIY 432

Query: 660 LRATDQFSEE----NLIGIGSYGSVYKGRFPDGIEVAIK--------VFHLQREGALNSF 707
           L    +   E      I +  Y ++ K    D +               HL+        
Sbjct: 433 LELKVKLENEYALHRSI-VDHY-NIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERM 490

Query: 708 DAECEI---LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---NLDIF 761
                +    + +      KI    T  N    +L      +L+   +   +   N   +
Sbjct: 491 TLFRMVFLDFRFLE----QKIRHDSTAWNASGSILN-----TLQQLKFYKPYICDNDPKY 541

Query: 762 QRLGIMIDVASALEYLHF--GHSNPIV---HCDIKPSNVLLDDSMVAHLSDFGIAKLLSE 816
           +R   +++       L F       ++   + D+    ++ +D  +              
Sbjct: 542 ER---LVN-----AILDFLPKIEENLICSKYTDLLRIALMAEDEAIF------------- 580

Query: 817 EDSMKQTQ 824
           E++ KQ Q
Sbjct: 581 EEAHKQVQ 588

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.3 bits (114), Expect = 1e-05
 Identities = 63/388 (16%), Positives = 122/388 (31%), Gaps = 129/388 (33%)

Query: 60  QTLVLSRN-----WFSGTIPKEI------GNLTK--LKELHLDY-NKLQGEIPEELGNLA 105
           + L+ +R      + S      I        LT   +K L L Y +    ++P E     
Sbjct: 267 KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE----- 321

Query: 106 ELEMLVLNNNLLTGTIPASI------------FNLSFISTALDFSDNSLTGSFPYDMCPG 153
               ++  N      I  SI             N   ++T ++ S N L    P +    
Sbjct: 322 ----VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE---PAEY--- 371

Query: 154 LPRLKGLYVSYNQF-KG-PIPNN----LWHCKELSSVSLSYNQFTGR--LPRDLGNST-K 204
               + ++   + F     IP      +W     S V +  N+      + +    ST  
Sbjct: 372 ----RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427

Query: 205 LKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLS 264
           + S+ L       E+  ++ N   L    +D  N+                 +  ++ L 
Sbjct: 428 IPSIYL-------ELKVKLENEYALHRSIVDHYNI---------------PKTFDSDDLI 465

Query: 265 GNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYL 324
                       P L+               +F++    +   +G+  +LK +       
Sbjct: 466 -----------PPYLDQ--------------YFYS----H---IGH--HLKNIEH----- 486

Query: 325 TFSTSELMSLFSAL-VNCKSLK-IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQG-LDL 381
                E M+LF  + ++    + +   I   + +    N SGS+  TL +LK  +  +  
Sbjct: 487 ----PERMTLFRMVFLD---FRFLEQKIRHDSTAW---NASGSILNTLQQLKFYKPYICD 536

Query: 382 QNNKFEGPIPQEFCHFSRLYVVYLNRNK 409
            + K+E  +      F       L  +K
Sbjct: 537 NDPKYERLV-NAILDFLPKIEENLICSK 563

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 32/151 (21%), Positives = 63/151 (41%), Gaps = 19/151 (12%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRH-RNLVKIISSC 729
           IG GS+G +++G    +  +VAIK    + +        E    K +     +  +    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASN--FNLDIFQRLGI-MIDVASALEYLHFGHSNPIV 786
                  LV++ +   SLED +      F++         M+   + ++ +H      +V
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQML---ARVQSIH---EKSLV 128

Query: 787 HCDIKPSNVLL-----DDSMVAHLSDFGIAK 812
           + DIKP N L+      ++ + ++ DFG+ K
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 33/189 (17%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIK----VFHLQREGALNSFDA-----ECE 712
              + +   +G G+YG+V        G +VAIK     F        +   A     E  
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-------SELFAKRAYRELR 76

Query: 713 ILKTIRHRNLVKII----SSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGI 766
           +LK +RH N++ ++       T  +F    LV+ +M    L   M       D  Q   +
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF--L 133

Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTL 826
           +  +   L Y+H   +  I+H D+KP N+ +++     + DFG+A+    +  M  T  +
Sbjct: 134 VYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEM--TGYV 186

Query: 827 ATIGYIAPE 835
            T  Y APE
Sbjct: 187 VTRWYRAPE 195

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 66.3 bits (162), Expect = 2e-11
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 35/209 (16%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKV------FHLQREGALNSFDAECEILKTIRHR--- 720
           +IG GS+G V K         VA+K+      FH Q   A      E  IL+ +R +   
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ---AAE----EIRILEHLRKQDKD 156

Query: 721 ---NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---NLDIFQRLGIMIDVASAL 774
              N++ ++ + T  N   +  E +   +L + +  + F   +L + ++      +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK--FAHSILQCL 213

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAH--LSDFGIAKLLSEEDSMKQTQTLATIGYI 832
           + LH    N I+HCD+KP N+LL     +   + DFG +    +    +    + +  Y 
Sbjct: 214 DALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ----RVYTYIQSRFYR 266

Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTG 861
           APE     +  +  D+++ G +L E+ TG
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTG 295

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 28/173 (16%), Positives = 60/173 (34%), Gaps = 39/173 (22%)

Query: 669 ENLIGIGSYGSVYKGR---------FPDGIEVAIKVFH-----------LQREGALNSFD 708
           ++     + G +Y+            P   + ++K+              QR       +
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 709 AECEILKTIRHRNLVKIISS---CTNHNFKALVLEYMPKGSLEDCMYASN---FNLDIFQ 762
              + L +     +   +        + F  LVL  + + SL+  +  S     +     
Sbjct: 107 KWKK-LYSTPLLAIPTCMGFGVHQDKYRF--LVLPSLGR-SLQSALDVSPKHVLSERSVL 162

Query: 763 RLGI-MIDVASALEYLHFGHSNPIVHCDIKPSNVLL--DDSMVAHLSDFGIAK 812
           ++   ++D   ALE+LH    N  VH ++   N+ +  +D     L+ +G A 
Sbjct: 163 QVACRLLD---ALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 21/102 (20%), Positives = 43/102 (42%), Gaps = 2/102 (1%)

Query: 455 SNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPS-TIIGLKNLQHLSLEHNKLQGPIPES 513
           +          +   + + ++Y+       ++    + GL  L++L++  + L+   P++
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 514 FGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLV 555
           F     L  L+LS N L   +     + L L+ L LS N L 
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 24/109 (22%), Positives = 39/109 (35%), Gaps = 15/109 (13%)

Query: 72  TIPKEIGNLTKLKELHLDYNKLQGEIPEE-LGNLAELEMLVLNNNLLTGTIPASIF-NLS 129
                +     L EL+++  +    +    L  L EL  L +  + L   +    F    
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 130 FISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHC 178
            +S  L+ S N+L  S  +    GL  L+ L +S          N  HC
Sbjct: 81  RLSR-LNLSFNALE-SLSWKTVQGLS-LQELVLS---------GNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 5e-07
 Identities = 24/91 (26%), Positives = 35/91 (38%), Gaps = 2/91 (2%)

Query: 346 IGNLINLTTLSLGDNNLSGSLP-ITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVY 404
           +    NLT L + +      L    L  L +L+ L +  +      P  F    RL  + 
Sbjct: 27  LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86

Query: 405 LNRNKLSGSIPSCLGDLNSLRILSLSSNELT 435
           L+ N L  S+        SL+ L LS N L 
Sbjct: 87  LSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.0 bits (116), Expect = 4e-06
 Identities = 21/119 (17%), Positives = 34/119 (28%), Gaps = 26/119 (21%)

Query: 390 IPQEFCHFSRLYVVYLNRNKLSGSIPS-CLGDLNSLRILSLSSNELTSVIPSTFWNLEDI 448
                     L  +Y+   +    +    L  L  LR L++  + L  V P  F      
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF------ 76

Query: 449 LGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQ 507
                                  +  + LS N L  ++    +   +LQ L L  N L 
Sbjct: 77  ------------------HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.3 bits (109), Expect = 3e-05
 Identities = 20/101 (19%), Positives = 33/101 (32%), Gaps = 4/101 (3%)

Query: 213 NNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIF-NISTLKILSLFNNTLSGNLPSSK 271
            +   +    +    NL  L I+    +  +       +  L+ L++  + L    P + 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA- 75

Query: 272 NLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNS 312
                P L  LNL  N L  S+         L  L L  N 
Sbjct: 76  -FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNP 114

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 23/114 (20%), Positives = 36/114 (31%), Gaps = 5/114 (4%)

Query: 177 HCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQE-IGNLRNLEILGID 235
                S +  + +         L  +  L  L +        +    +  L  L  L I 
Sbjct: 6   CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 236 QSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNL 289
           +S L    PD       L  L+L  N L  +L      +   +L+ L L  N L
Sbjct: 65  KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLS--WKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 43.6 bits (102), Expect = 2e-04
 Identities = 18/87 (20%), Positives = 35/87 (40%), Gaps = 4/87 (4%)

Query: 34  RVTSLTISDLGLAGTIPSH-LGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYN 91
            +T L I +      +    L  L  L+ L + ++     +  +      +L  L+L +N
Sbjct: 32  NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFN 90

Query: 92  KLQGEIPEELGNLAELEMLVLNNNLLT 118
            L+  +  +      L+ LVL+ N L 
Sbjct: 91  ALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 43.2 bits (101), Expect = 3e-04
 Identities = 18/106 (16%), Positives = 32/106 (30%), Gaps = 2/106 (1%)

Query: 111 VLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGP 170
           +             +     + T L   +             GL  L+ L +  +  +  
Sbjct: 13  LRCTRDGALDSLHHLPGAENL-TELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71

Query: 171 IPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLN 216
            P+       LS ++LS+N     L         L+ L L  N L+
Sbjct: 72  APDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.3 bits (157), Expect = 6e-11
 Identities = 41/228 (17%), Positives = 84/228 (36%), Gaps = 59/228 (25%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKV------FHLQREGALNSFDAECEILKTIR----- 718
            +G G + +V+  +   +   VA+K+      +    E        E ++L+ +      
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE-------DEIKLLQRVNDADNT 78

Query: 719 ------HRNLVKIISSCTNHNFKA----LVLEYMPKGSLEDCMYASN---FNLDIFQRLG 765
                   +++K++    +         +V E +   +L   +         L   ++  
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ-- 135

Query: 766 IMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH------LSDFGIAKLLSEEDS 819
           I   +   L+Y+H      I+H DIKP NVL++            ++D G A    E   
Sbjct: 136 ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-- 191

Query: 820 MKQTQTLATIGYIAPE------YGREGQVSIKGDVYNYGIMLMEVFTG 861
              T ++ T  Y +PE      +G         D+++   ++ E+ TG
Sbjct: 192 --YTNSIQTREYRSPEVLLGAPWG----CGA--DIWSTACLIFELITG 231

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.3 bits (156), Expect = 9e-11
 Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 17/149 (11%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLV-KIISSC 729
           IG GS+G +Y G       EVAIK+ +++ +        E +I + ++    +  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 730 TNHNFKALVLEYMPKGSLEDCMYASN--FNLDIFQRLGI-MIDVASALEYLHFGHSNPIV 786
              ++  LV++ +   SLED     +   +L     L   MI   + +E++H   S   +
Sbjct: 73  VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMI---NRVEFVH---SKSFL 125

Query: 787 HCDIKPSNVLL---DDSMVAHLSDFGIAK 812
           H DIKP N L+     +   ++ DFG+AK
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.4 bits (153), Expect = 9e-11
 Identities = 44/265 (16%), Positives = 74/265 (27%), Gaps = 70/265 (26%)

Query: 660 LRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNS--------FDAEC 711
              T++      IG G +G V++    D   VAIK+  ++    +N            E 
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 712 EILKTI---------RHRNLVKIISSC------------------------------TNH 732
            I K +         R    + + S                                   
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 733 NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKP 792
           +   +VLE+   G   + M     +L       I+  + ++L            H D+  
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLA--TAKSILHQLTASLAVAEASLR--FEHRDLHW 190

Query: 793 SNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYG 852
            NVLL  + +  L      K  +      Q      I Y      R+G V          
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVS---IIDYTLSRLERDGIV---------- 237

Query: 853 IMLMEVFTGMKPTNEFFTGEMSIKR 877
                VF  +    + FTG+   + 
Sbjct: 238 -----VFCDVSMDEDLFTGDGDYQF 257

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 45/192 (23%), Positives = 78/192 (40%), Gaps = 26/192 (13%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIK----VFHLQREGALNSFDA-----ECE 712
             ++     +G G+YG V+K      G  VA+K     F        NS DA     E  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-------NSTDAQRTFREIM 60

Query: 713 ILKTIR-HRNLVKIISSCTNHNFKA--LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID 769
           IL  +  H N+V +++     N +   LV +YM    L   + A+       Q   ++  
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQY--VVYQ 117

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATI 829
           +   ++YLH   S  ++H D+KPSN+LL+      ++DFG+++       +     L+  
Sbjct: 118 LIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 830 GYIAPEYGREGQ 841
                    +  
Sbjct: 175 ENTENFDDDQPI 186

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 35/224 (15%), Positives = 75/224 (33%), Gaps = 21/224 (9%)

Query: 51  SHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEML 110
                L++     L +   S T       L+ ++  + D + +Q  +   +     L+ L
Sbjct: 13  FPDPGLANAVKQNLGKQ--SVTDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68

Query: 111 VLNNNLLTGTIPASIFNLSFIS--TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFK 168
            L++N ++      +  L  ++    L  + N L              L  L++  N+ +
Sbjct: 69  HLSHNQIS-----DLSPLKDLTKLEELSVNRNRLKNLNGIP----SACLSRLFLDNNELR 119

Query: 169 GPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRN 228
               ++L H K L  +S+  N+        LG  +KL+ LDL  N +       +  L+ 
Sbjct: 120 D--TDSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGG--LTRLKK 173

Query: 229 LEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKN 272
           +  + +     V         +     +   +         S  
Sbjct: 174 VNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNG 217

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 53/322 (16%), Positives = 93/322 (28%), Gaps = 86/322 (26%)

Query: 249 NISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALEL 308
            ++     +L   +++       +   L  ++  N   +N+  S+              +
Sbjct: 17  GLANAVKQNLGKQSVT----DLVSQKELSGVQNFNGDNSNIQ-SLAG------------M 59

Query: 309 GYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLK-IGNLINLTTLSLGDNNLSGSLP 367
            + +NLK L L  N ++                  L  + +L  L  LS+  N L     
Sbjct: 60  QFFTNLKELHLSHNQIS-----------------DLSPLKDLTKLEELSVNRNRLKN--- 99

Query: 368 ITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRIL 427
           +       L  L L NN+          H   L ++ +  NKL  SI   LG L+ L +L
Sbjct: 100 LNGIPSACLSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVL 155

Query: 428 SLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIP 487
            L  NE+T+                             +  LK V  I L+         
Sbjct: 156 DLHGNEITNTGG--------------------------LTRLKKVNWIDLTGQKCVNE-- 187

Query: 488 STIIGLKNLQHLSLEHNKLQGPI-PESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKS 546
             +     L   +   +     I P       S     +                 Y   
Sbjct: 188 -PVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPV-----------YTDE 235

Query: 547 LNLSFNKLVGEIPRGGAFANFS 568
           ++  F++ +     G   A F 
Sbjct: 236 VSYKFSEYINV---GETEAIFD 254

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 46/262 (17%), Positives = 85/262 (32%), Gaps = 56/262 (21%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHL 88
           +   + + SL            + +   ++L+ L LS N  S   P  + +LTKL+EL +
Sbjct: 47  NGDNSNIQSL------------AGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92

Query: 89  DYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPY 148
           + N+L  +    + +   L  L L+NN L         +   +                 
Sbjct: 93  NRNRL--KNLNGIPSAC-LSRLFLDNNELR--------DTDSLI---------------- 125

Query: 149 DMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSL 208
                L  L+ L +  N+ K      L    +L  + L  N+ T      L    K+  +
Sbjct: 126 ----HLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWI 177

Query: 209 DLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLP 268
           DL       E  +    L     +       +     + + IS        +  +   LP
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWI-----SPYYISNGGSYV--DGCVLWELP 230

Query: 269 SSKNLIGLPNLEGLNLGLNNLS 290
              + +     E +N+G     
Sbjct: 231 VYTDEVSYKFSEYINVGETEAI 252

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 50/233 (21%)

Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKV------FHLQREGALNS 706
            + ++     D++  ++LIG GS+G V K     +   VAIK+      F  Q   A   
Sbjct: 47  KNGEKW---MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ---AQI- 99

Query: 707 FDAECEILKTIRHR------NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---N 757
              E  +L+ +          +V +       N   LV E +   +L D +  +NF   +
Sbjct: 100 ---EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVS 155

Query: 758 LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH--LSDFGIAKLLS 815
           L++ ++      + +AL +L     + I+HCD+KP N+LL +   +   + DFG +  L 
Sbjct: 156 LNLTRK--FAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212

Query: 816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGI-------MLMEVFTG 861
           +    +  Q + +  Y +PE        + G  Y+  I       +L+E+ TG
Sbjct: 213 Q----RIYQYIQSRFYRSPEV-------LLGMPYDLAIDMWSLGCILVEMHTG 254

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 37/168 (22%), Positives = 66/168 (39%), Gaps = 33/168 (19%)

Query: 671 LIGIGSYGSVYKGRFPDG------IEVAIKVFH-----LQREGAL-NSFDAECEILKTIR 718
            IG G +G +Y                 +KV       L  E           +I K IR
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 719 HRNLVKI---------ISSCTNHNFKALVLEYMPKGSLEDCMYASN--FNLDIFQRLGI- 766
            R L  +         +      +++ ++++      L+    A+   F+     +L + 
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQLSLR 160

Query: 767 MIDVASALEYLHFGHSNPIVHCDIKPSNVLLD--DSMVAHLSDFGIAK 812
           ++D+   LEY+H    +  VH DIK SN+LL+  +    +L D+G+A 
Sbjct: 161 ILDI---LEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 58.8 bits (143), Expect = 6e-10
 Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 3/91 (3%)

Query: 476 YLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIP 535
           YL  N  +  +P  +   K+L  + L +N++     +SF  +  L  L LS N L  + P
Sbjct: 37  YLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPP 95

Query: 536 ASLEKLLYLKSLNLSFNKLVGEIPRGGAFAN 566
            + + L  L+ L+L  N +   +P  GAF +
Sbjct: 96  RTFDGLKSLRLLSLHGNDI-SVVPE-GAFND 124

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 8/116 (6%)

Query: 339 VNC--KSLK---IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE 393
           V C  K LK    G   ++T L L  N  +  +P  L   K L  +DL NN+      Q 
Sbjct: 15  VRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQS 73

Query: 394 FCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLSSNELTSVIPSTFWNLEDI 448
           F + ++L  + L+ N+L   IP    D L SLR+LSL  N+++ V    F +L  +
Sbjct: 74  FSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSAL 128

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.4 bits (134), Expect = 9e-09
 Identities = 32/126 (25%), Positives = 56/126 (44%), Gaps = 27/126 (21%)

Query: 404 YLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLP 463
           YL+ N+ +  +P  L +   L ++ LS+N ++++   +F N+  +L    S N L   +P
Sbjct: 37  YLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIP 94

Query: 464 LEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPE-SFGELVSLEF 522
                     D                 GLK+L+ LSL  N +   +PE +F +L +L  
Sbjct: 95  ------PRTFD-----------------GLKSLRLLSLHGNDISV-VPEGAFNDLSALSH 130

Query: 523 LDLSNN 528
           L +  N
Sbjct: 131 LAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 33/123 (26%), Positives = 51/123 (41%), Gaps = 24/123 (19%)

Query: 73  IPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIF-NLSFI 131
           +PK I       EL+LD N+    +P+EL N   L ++ L+NN ++ T+    F N++ +
Sbjct: 25  LPKGIPRDVT--ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80

Query: 132 STALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIP----------------NNL 175
            T L  S N L    P     GL  L+ L +  N     +P                 N 
Sbjct: 81  LT-LILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGANP 137

Query: 176 WHC 178
            +C
Sbjct: 138 LYC 140

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 31/105 (29%), Positives = 55/105 (52%), Gaps = 7/105 (6%)

Query: 160 LYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNS-TKLKSLDLGFNNLNGE 218
           LY+  NQF   +P  L + K L+ + LS N+ +  L     ++ T+L +L L +N L   
Sbjct: 36  LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92

Query: 219 IPQEI-GNLRNLEILGIDQSNLVGFVPDTIF-NISTLKILSLFNN 261
           IP      L++L +L +  +++   VP+  F ++S L  L++  N
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 29/89 (32%), Positives = 44/89 (49%), Gaps = 6/89 (6%)

Query: 48  TIPSHLGNLSSLQTLVLSRNWFSGTIPKEI-GNLTKLKELHLDYNKLQGEIPEEL-GNLA 105
            +P  L N   L  + LS N  S T+  +   N+T+L  L L YN+L+  IP      L 
Sbjct: 45  LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLK 102

Query: 106 ELEMLVLNNNLLTGTIPASIF-NLSFIST 133
            L +L L+ N ++  +P   F +LS +S 
Sbjct: 103 SLRLLSLHGNDIS-VVPEGAFNDLSALSH 130

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 39/165 (23%), Positives = 66/165 (40%), Gaps = 30/165 (18%)

Query: 671 LIGIGSYGSVYKG-RFPDGIEVAIKVF--------HLQREGA-LNSFDAECEILKTIRHR 720
            IG G +G +Y         + A  V          L  E         +  I K I  +
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 721 NLVKI---------ISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGI-MID 769
            L  +         ++     +++ +V+E +    L+     +  F      +LGI M+D
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLD 162

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLD--DSMVAHLSDFGIAK 812
           V   LEY+H    N  VH DIK +N+LL   +    +L+D+G++ 
Sbjct: 163 V---LEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 41/143 (28%), Positives = 59/143 (41%), Gaps = 14/143 (9%)

Query: 430 SSNELTSV---IPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNI 486
            S    SV   IP+    L          N +    P   ++L  + ++YL  N L   +
Sbjct: 27  RSKRHASVPAGIPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-AL 79

Query: 487 PSTII-GLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLK 545
           P  +   L  L  L L  N+L       F  LV L+ L +  N L+  +P  +E+L +L 
Sbjct: 80  PVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLT 138

Query: 546 SLNLSFNKLVGEIPRGGAFANFS 568
            L L  N+L   IP  GAF   S
Sbjct: 139 HLALDQNQL-KSIPH-GAFDRLS 159

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 36/126 (28%), Positives = 63/126 (50%), Gaps = 3/126 (2%)

Query: 404 YLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLP 463
           YL+ N+++   P     L +L+ L L SN+L ++    F +L  +   D  +N L   LP
Sbjct: 46  YLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLP 104

Query: 464 LEI-ENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEF 522
             + + L  + ++++  N L+  +P  I  L +L HL+L+ N+L+     +F  L SL  
Sbjct: 105 SAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163

Query: 523 LDLSNN 528
             L  N
Sbjct: 164 AYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 39/142 (27%), Positives = 67/142 (47%), Gaps = 7/142 (4%)

Query: 413 SIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKA 471
           S+P+  G   + +IL L  N++T + P  F +L ++      SN L  +LP+ + ++L  
Sbjct: 33  SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89

Query: 472 VVDIYLSRNNLSGNIPSTIIG-LKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDL 530
           +  + L  N L+  +PS +   L +L+ L +  NKL   +P     L  L  L L  N L
Sbjct: 90  LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147

Query: 531 SGVIPASLEKLLYLKSLNLSFN 552
             +   + ++L  L    L  N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 40/149 (26%), Positives = 62/149 (41%), Gaps = 10/149 (6%)

Query: 339 VNC--KSLK---IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE 393
           V+C  K       G   N   L L DN ++   P     L  L+ L L +N+        
Sbjct: 24  VDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV 83

Query: 394 FCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLSSNELTSVIPSTFWNLEDILGFD 452
           F   ++L V+ L  N+L+  +PS + D L  L+ L +  N+LT  +P     L  +    
Sbjct: 84  FDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLA 141

Query: 453 FSSNSLNGSLPLEI-ENLKAVVDIYLSRN 480
              N L  S+P    + L ++   YL  N
Sbjct: 142 LDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 40/161 (24%), Positives = 53/161 (32%), Gaps = 39/161 (24%)

Query: 269 SSKNLIGLP-----NLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN------------ 311
            SK    +P     N + L L  N ++   P  F +   L  L LG N            
Sbjct: 27  RSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS 86

Query: 312 -SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIG---NLINLTTLSLGDNNLSGSLP 367
            + L  L L  N LT                  L       L++L  L +  N L+  LP
Sbjct: 87  LTQLTVLDLGTNQLT-----------------VLPSAVFDRLVHLKELFMCCNKLT-ELP 128

Query: 368 ITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRN 408
             + RL  L  L L  N+ +      F   S L   YL  N
Sbjct: 129 RGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 46/196 (23%), Positives = 71/196 (36%), Gaps = 41/196 (20%)

Query: 19  SVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIG 78
           S CS  G T D    R  S           +P+  G  ++ Q L L  N  +   P    
Sbjct: 15  SQCSCSGTTVDCRSKRHAS-----------VPA--GIPTNAQILYLHDNQITKLEPGVFD 61

Query: 79  NLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFS 138
           +L  LKEL+L  N+L         +L +L +L L  N LT  +P+++F            
Sbjct: 62  SLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVF------------ 108

Query: 139 DNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRD 198
            + L              LK L++  N+    +P  +     L+ ++L  NQ        
Sbjct: 109 -DRLV------------HLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGA 154

Query: 199 LGNSTKLKSLDLGFNN 214
               + L    L F N
Sbjct: 155 FDRLSSLTHAYL-FGN 169

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 42/143 (29%), Positives = 64/143 (44%), Gaps = 13/143 (9%)

Query: 430 SSNELTSV---IPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNI 486
            S   TSV   IP+    L      D  +NSL        + L ++  +YL  N L  ++
Sbjct: 15  YSQGRTSVPTGIPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SL 67

Query: 487 PSTII-GLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLK 545
           P+ +   L +L +L+L  N+LQ      F +L  L+ L L+ N L  +     +KL  LK
Sbjct: 68  PNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLK 127

Query: 546 SLNLSFNKLVGEIPRGGAFANFS 568
            L L  N+L   +P  G F   +
Sbjct: 128 DLRLYQNQLKS-VPD-GVFDRLT 148

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 4/121 (3%)

Query: 327 STSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITL-GRLKKLQGLDLQNNK 385
            T+ L    ++L +  +     L +LT L LG N L  SLP  +  +L  L  L+L  N+
Sbjct: 29  QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQ 87

Query: 386 FEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLSSNELTSVIPSTFWN 444
            +      F   ++L  + LN N+L  S+P  + D L  L+ L L  N+L SV    F  
Sbjct: 88  LQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDR 146

Query: 445 L 445
           L
Sbjct: 147 L 147

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 8/149 (5%)

Query: 407 RNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEI 466
            ++   S+P+  G       L L +N L S+    F  L  +       N L  SLP  +
Sbjct: 15  YSQGRTSVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGV 71

Query: 467 -ENLKAVVDIYLSRNNLSGNIPSTII-GLKNLQHLSLEHNKLQGPIPE-SFGELVSLEFL 523
              L ++  + LS N L  ++P+ +   L  L+ L+L  N+LQ  +P+  F +L  L+ L
Sbjct: 72  FNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDL 129

Query: 524 DLSNNDLSGVIPASLEKLLYLKSLNLSFN 552
            L  N L  V     ++L  L+ + L  N
Sbjct: 130 RLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 28/154 (18%)

Query: 377 QGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLSSNELT 435
             LDL+ N  +      F   + L  +YL  NKL  S+P+ + + L SL  L+LS+N+L 
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89

Query: 436 SVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKN 495
           S+    F  L  +     ++N L  SLP        V D                  L  
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQLQ-SLP------DGVFD-----------------KLTQ 125

Query: 496 LQHLSLEHNKLQGPIPE-SFGELVSLEFLDLSNN 528
           L+ L L  N+L+  +P+  F  L SL+++ L +N
Sbjct: 126 LKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 39/149 (26%), Positives = 62/149 (41%), Gaps = 9/149 (6%)

Query: 339 VNC--KSLK---IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE 393
           V C  +       G     T L L  N+L          L  L  L L  NK +      
Sbjct: 12  VECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV 71

Query: 394 FCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLSSNELTSVIPSTFWNLEDILGFD 452
           F   + L  + L+ N+L  S+P+ + D L  L+ L+L++N+L S+    F  L  +    
Sbjct: 72  FNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130

Query: 453 FSSNSLNGSLPLEI-ENLKAVVDIYLSRN 480
              N L  S+P  + + L ++  I+L  N
Sbjct: 131 LYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 37/142 (26%), Positives = 50/142 (35%), Gaps = 27/142 (19%)

Query: 57  SSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNL 116
           +    L L  N            LT L +L+L  NKLQ         L  L  L L+ N 
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87

Query: 117 LTGTIPASIF----NLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIP 172
           L  ++P  +F     L      L  + N L  S P  +   L +LK L +  NQ K  +P
Sbjct: 88  LQ-SLPNGVFDKLTQL----KELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VP 140

Query: 173 ----------------NNLWHC 178
                           +N W C
Sbjct: 141 DGVFDRLTSLQYIWLHDNPWDC 162

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 47/171 (27%), Positives = 66/171 (38%), Gaps = 39/171 (22%)

Query: 243 VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASK 302
           VP  I   +    L L  N+L      +     L +L  L LG N L  S+P+  FN  K
Sbjct: 22  VPTGIP--AQTTYLDLETNSLKS--LPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFN--K 74

Query: 303 LYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIG---NLINLTTLSLGD 359
           L        ++L  L L  N L                  SL  G    L  L  L+L  
Sbjct: 75  L--------TSLTYLNLSTNQLQ-----------------SLPNGVFDKLTQLKELALNT 109

Query: 360 NNLSGSLPI-TLGRLKKLQGLDLQNNKFEGPIPQE-FCHFSRLYVVYLNRN 408
           N L  SLP     +L +L+ L L  N+ +  +P   F   + L  ++L+ N
Sbjct: 110 NQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 5/94 (5%)

Query: 475 IYLSRNNLSGNIPSTII--GLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSG 532
           + L+ N L   I S  +   L +L  L L+ N+L G  P +F     ++ L L  N +  
Sbjct: 34  LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE 92

Query: 533 VIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFAN 566
           +       L  LK+LNL  N++   +   G+F +
Sbjct: 93  ISNKMFLGLHQLKTLNLYDNQISC-VMP-GSFEH 124

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 38/129 (29%), Positives = 55/129 (42%), Gaps = 14/129 (10%)

Query: 430 SSNELTSV---IPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRNNLSGN 485
           +   L  +   IP     L        + N L       +   L  +V + L RN L+  
Sbjct: 16  TGRGLKEIPRDIPLHTTEL------LLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-G 68

Query: 486 IPSTII-GLKNLQHLSLEHNKLQGPIPE-SFGELVSLEFLDLSNNDLSGVIPASLEKLLY 543
           I      G  ++Q L L  NK++  I    F  L  L+ L+L +N +S V+P S E L  
Sbjct: 69  IEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 544 LKSLNLSFN 552
           L SLNL+ N
Sbjct: 128 LTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 32/128 (25%), Positives = 50/128 (39%), Gaps = 29/128 (22%)

Query: 404 YLNRNKLSGSIPSCLGD-LNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSL 462
            LN N+L       L   L  L  L L  N+LT + P+ F                    
Sbjct: 35  LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF-------------------- 74

Query: 463 PLEIENLKAVVDIYLSRNNLSGNIPSTII-GLKNLQHLSLEHNKLQGPIPE-SFGELVSL 520
               E    + ++ L  N +   I + +  GL  L+ L+L  N++   +   SF  L SL
Sbjct: 75  ----EGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSL 128

Query: 521 EFLDLSNN 528
             L+L++N
Sbjct: 129 TSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 22/81 (27%), Positives = 41/81 (50%), Gaps = 4/81 (4%)

Query: 55  NLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEEL-GNLAELEMLVLN 113
            L  L  L L RN  +G  P      + ++EL L  NK++ EI  ++   L +L+ L L 
Sbjct: 52  RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLY 110

Query: 114 NNLLTGTIPASIF-NLSFIST 133
           +N ++  +    F +L+ +++
Sbjct: 111 DNQIS-CVMPGSFEHLNSLTS 130

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 34/145 (23%), Positives = 50/145 (34%), Gaps = 34/145 (23%)

Query: 243 VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASK 302
           +P  I        L L +N L   + S      LP+L  L L  N L+  I    F    
Sbjct: 23  IPRDIP--LHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFE--G 76

Query: 303 LYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIG---NLINLTTLSLGD 359
                    S+++ L L  N +                   +       L  L TL+L D
Sbjct: 77  A--------SHIQELQLGENKIK-----------------EISNKMFLGLHQLKTLNLYD 111

Query: 360 NNLSGSLPITLGRLKKLQGLDLQNN 384
           N +S  +P +   L  L  L+L +N
Sbjct: 112 NQISCVMPGSFEHLNSLTSLNLASN 136

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 54.2 bits (129), Expect = 1e-07
 Identities = 31/162 (19%), Positives = 64/162 (39%), Gaps = 17/162 (10%)

Query: 412 GSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLE--DILGFDFSSNSLNGSLPLEIENL 469
             +   L  +  L  L +      S+      NL+  +I+      + +   L  ++ NL
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221

Query: 470 KAVVDIYLSRNNLSGNIPSTII-------GLKNLQHLSLEHNKLQGPIPESFGE---LVS 519
           +  + +Y+   +   +    +           NL+ L +   + Q  + E F E   L  
Sbjct: 222 E-KLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280

Query: 520 LEFLDLSNNDLSGV----IPASLEKLLYLKSLNLSFNKLVGE 557
           LE +D+S   L+      +   ++K+ +LK +N+ +N L  E
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.8 bits (115), Expect = 5e-06
 Identities = 28/194 (14%), Positives = 58/194 (29%), Gaps = 25/194 (12%)

Query: 135 LDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGR 194
           +DF +  ++     D+ P L  +  L     +    +         L S+ +        
Sbjct: 149 IDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDS 208

Query: 195 LPRDLGNS--TKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNIST 252
           +  D+  S    L+ L L     +     ++   R L                       
Sbjct: 209 VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKD---------------RFPN 253

Query: 253 LKILSLFNNTLSGNLPSS-KNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN 311
           LK L + +      +         LP LE +++    L+        +        +   
Sbjct: 254 LKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDH-------VDKI 306

Query: 312 SNLKRLGLERNYLT 325
            +LK + ++ NYL+
Sbjct: 307 KHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 47.6 bits (112), Expect = 1e-05
 Identities = 29/178 (16%), Positives = 57/178 (32%), Gaps = 26/178 (14%)

Query: 216 NGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIG 275
             ++   +  +  L  L I  +N +            LK L + +  L  ++        
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGK---KPRPNLKSLEIISGGLPDSVVEDILGSD 217

Query: 276 LPNLEGLNL--GLNNLSGSIPSFFFNASKLYA-LELGYNSNLKRLGLERNYLTFSTSELM 332
           LPNLE L L  G+ +          + +            NLK LG+             
Sbjct: 218 LPNLEKLVLYVGVEDYGFDG-----DMNVFRPLFSKDRFPNLKWLGIVDAEEQN------ 266

Query: 333 SLFSALVNCKSLKIGNLINLTTLSLGDNNLSGS----LPITLGRLKKLQGLDLQNNKF 386
            +    +    L       L T+ +    L+      L   + ++K L+ ++++ N  
Sbjct: 267 VVVEMFLESDILP-----QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.3 bits (106), Expect = 7e-05
 Identities = 20/140 (14%), Positives = 48/140 (34%), Gaps = 18/140 (12%)

Query: 421 LNSLRILSLSSNE-----LTSVIPSTFWNLEDI-LGFDFSSNSLNGSLP-----LEIENL 469
             +L+ L + S       +  ++ S   NLE + L         +G +         +  
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251

Query: 470 KAVVDIYLSRNNLSGNIPSTIIG---LKNLQHLSLEHNKLQG----PIPESFGELVSLEF 522
             +  + +        +    +    L  L+ + +    L       + +   ++  L+F
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311

Query: 523 LDLSNNDLSGVIPASLEKLL 542
           +++  N LS  +   L+K L
Sbjct: 312 INMKYNYLSDEMKKELQKSL 331

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.9 bits (105), Expect = 8e-05
 Identities = 28/189 (14%), Positives = 57/189 (30%), Gaps = 35/189 (18%)

Query: 47  GTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELG---- 102
             +   L  +  L  L +        +         LK L +    L   + E++     
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 103 -NLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLY 161
            NL +L + V   +                       D  +    P       P LK L 
Sbjct: 219 PNLEKLVLYVGVEDYG--------------------FDGDMNVFRPLFSKDRFPNLKWLG 258

Query: 162 VSYNQFKGPIPNNLWHC---KELSSVSLSYNQFTGR----LPRDLGNSTKLKSLDLGFNN 214
           +   + +  +           +L ++ +S    T      L   +     LK +++ +N 
Sbjct: 259 IVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318

Query: 215 LNGEIPQEI 223
           L+ E+ +E+
Sbjct: 319 LSDEMKKEL 327

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 41.5 bits (96), Expect = 9e-04
 Identities = 44/261 (16%), Positives = 80/261 (30%), Gaps = 49/261 (18%)

Query: 114 NNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFK----- 168
           + +L      S+  ++      +  D S       +        +GL+     F+     
Sbjct: 98  DKILKDKKLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEIS 157

Query: 169 ----GPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIG 224
                 +   L     L+++ +     T  L         LKSL++    L   + ++I 
Sbjct: 158 WIEQVDLSPVLDAMPLLNNLKIK---GTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDIL 214

Query: 225 --NLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGL 282
             +L NLE L      L   V D  F+        LF+                PNL+ L
Sbjct: 215 GSDLPNLEKL-----VLYVGVEDYGFDGDMNVFRPLFSKD------------RFPNLKWL 257

Query: 283 NLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCK 342
            +        +   F  +  L          L+ + +    LT   + L  L   +   K
Sbjct: 258 GIVDAEEQNVVVEMFLESDIL--------PQLETMDISAGVLTDEGARL--LLDHVDKIK 307

Query: 343 SLKIGNLINLTTLSLGDNNLS 363
                   +L  +++  N LS
Sbjct: 308 --------HLKFINMKYNYLS 320

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 28/166 (16%), Positives = 59/166 (35%), Gaps = 35/166 (21%)

Query: 404 YLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLP 463
           +     +   + + L  L + + L+LS+N +  +                          
Sbjct: 31  HGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS------------------------ 65

Query: 464 LEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFL 523
             +  ++ +  + L RN +   I +       L+ L + +N++         +LV+L  L
Sbjct: 66  --LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVL 120

Query: 524 DLSNN---DLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFAN 566
            +SNN   +   +    L  L  L+ L L+ N L  +     A + 
Sbjct: 121 YMSNNKITNWGEIDK--LAALDKLEDLLLAGNPLYNDYKENNATSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 49.3 bits (118), Expect = 9e-07
 Identities = 33/160 (20%), Positives = 55/160 (34%), Gaps = 36/160 (22%)

Query: 75  KEIGNLTKLK--ELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIS 132
           ++    T+ +  ELH     ++ ++   L  L   + L L+ N +       I +LS   
Sbjct: 17  RKSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-----KISSLS--- 67

Query: 133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFT 192
                               G+  L+ L +  N  K  I N       L  + +SYNQ  
Sbjct: 68  --------------------GMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA 106

Query: 193 GRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEIL 232
             L   +     L+ L +  N +      EI  L  L+ L
Sbjct: 107 -SL-SGIEKLVNLRVLYMSNNKITN--WGEIDKLAALDKL 142

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 20/98 (20%), Positives = 45/98 (45%), Gaps = 10/98 (10%)

Query: 458 LNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGEL 517
               +  E E +    +++     +   + +T+  LK  +HL+L  N ++  I  S   +
Sbjct: 17  RKSVVATEAEKV----ELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGM 69

Query: 518 VSLEFLDLSNNDLSGVIPASLEKLL-YLKSLNLSFNKL 554
            +L  L L  N +  +   +L+ +   L+ L +S+N++
Sbjct: 70  ENLRILSLGRNLIKKI--ENLDAVADTLEELWISYNQI 105

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 36/177 (20%), Positives = 63/177 (35%), Gaps = 31/177 (17%)

Query: 379 LDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVI 438
           L       E  +            + L+ N +   I S L  + +LRILSL  N      
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRN------ 80

Query: 439 PSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQH 498
                 ++ I   D  +++L               ++++S N ++ ++ S I  L NL+ 
Sbjct: 81  -----LIKKIENLDAVADTLE--------------ELWISYNQIA-SL-SGIEKLVNLRV 119

Query: 499 LSLEHNKLQGPIP-ESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
           L + +NK+      +    L  LE L L+ N L      +     Y   +      L
Sbjct: 120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 26/121 (21%), Positives = 48/121 (39%), Gaps = 10/121 (8%)

Query: 49  IPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELE 108
           + + L  L + + L LS N     I   +  +  L+ L L  N ++ +I         LE
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 109 MLVLNNNLLTGTIPASIFNLSFIS--TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQ 166
            L ++ N +      S+  +  +     L  S+N +T     D    L +L+ L ++ N 
Sbjct: 97  ELWISYNQIA-----SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151

Query: 167 F 167
            
Sbjct: 152 L 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 39/183 (21%), Positives = 62/183 (33%), Gaps = 45/183 (24%)

Query: 225 NLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNL 284
           +     I  +D +         +  +   K L+L  N +        +L G+ NL  L+L
Sbjct: 31  HGMIPPIEKMDAT---------LSTLKACKHLALSTNNIE----KISSLSGMENLRILSL 77

Query: 285 GLNNLSGSIPSFFFNASKLYALELGYNSNLKRL-GLERNYLTFSTSELMSLFSALVNCKS 343
           G N +   I +    A  L  L + YN  +  L G+E                       
Sbjct: 78  GRNLIK-KIENLDAVADTLEELWISYN-QIASLSGIE----------------------- 112

Query: 344 LKIGNLINLTTLSLGDNNLSGSLPI-TLGRLKKLQGLDLQNNKFEGPIPQEFCHFS-RLY 401
                L+NL  L + +N ++    I  L  L KL+ L L  N       +       R+ 
Sbjct: 113 ----KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168

Query: 402 VVY 404
           VV 
Sbjct: 169 VVK 171

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 64/388 (16%), Positives = 116/388 (29%), Gaps = 85/388 (21%)

Query: 79  NLTKLKELHLDYNKLQGEIPEELG-----NLAELEMLVLNNNLLTGTIPASIFN-LSFIS 132
               +  L L  N L      EL        A +  L L+ N L       +   L+ I 
Sbjct: 20  IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79

Query: 133 ---TALDFSDNSLTGSFPYDMCPGLP----RLKGLYVSYNQFKG----PIPNNLWHC-KE 180
              T+L+ S N L+     ++   L      +  L + +N F             +    
Sbjct: 80  ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139

Query: 181 LSSVSLSYNQFTGRLPRDLG-----NSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGID 235
           ++S++L  N    +   +L          + SL+L  NNL  +   E+          + 
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAK-------FLA 192

Query: 236 QSNLVGFVPDTIFNISTLKILSLFNNTL--SGNLPSSKNLIGLPN-LEGLNLGLNNLSGS 292
                          +++  L L  N L        +     +PN +  LNL LN L G 
Sbjct: 193 SIP------------ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240

Query: 293 IPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSE-LMSLFSALVNCKSLKIGNLIN 351
                  + +   L      +L+ + L+ + +   + E   +L +A  N +         
Sbjct: 241 -------SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQ--------K 285

Query: 352 LTTLSLGDNNLSGSLPITLGRL-----KKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLN 406
           +  +      +  S  I +  L      K     L N                ++     
Sbjct: 286 IILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ-------------CLIFAQKHQ 332

Query: 407 RNKLSGSIPSCLGDLNSLRILSLSSNEL 434
            N    +IP  L +         +   L
Sbjct: 333 TNIEDLNIPDELRESI------QTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 62/353 (17%), Positives = 116/353 (32%), Gaps = 59/353 (16%)

Query: 199 LGNSTKLKSLDLGFNNLNGEIPQEIG-----NLRNLEILGIDQSNL-----VGFVPDTIF 248
                 + SLDL  NNL      E+         ++  L +  ++L        V     
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 249 NISTLKILSLFNNTLS--GNLPSSKNLIGLP-NLEGLNLGLNNLSGSIPSFFFNASKLYA 305
             + +  L+L  N LS   +    K L  +P  +  L+LG N+ S        ++S+   
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSK------SSSEFKQ 131

Query: 306 LELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGS 365
                 +++  L L  N L   +S+   L   L    +       N+ +L+L  NNL+  
Sbjct: 132 AFSNLPASITSLNLRGNDLGIKSSD--ELIQILAAIPA-------NVNSLNLRGNNLASK 182

Query: 366 LPITLGRL-----KKLQGLDLQNNKFEGPIPQEFCHF-----SRLYVVYLNRNKLSGS-- 413
               L +        +  LDL  N        E  +      + +  + L  N L G   
Sbjct: 183 NCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242

Query: 414 --IPSCLGDLNSLRILSLSSNELTSV-------IPSTFWNLEDILGFDFSSNSLNGSLPL 464
             +      L  L+ + L  + + ++       + + F N++ I+  D +   ++ S  +
Sbjct: 243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI 302

Query: 465 EIENLKAVVDIYLSRNNLSGNIPSTIIGLKN----------LQHLSLEHNKLQ 507
            I NL   +       +L           +           L+        L 
Sbjct: 303 PISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.8 bits (114), Expect = 9e-06
 Identities = 46/327 (14%), Positives = 98/327 (29%), Gaps = 48/327 (14%)

Query: 40  ISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIG-----NLTKLKELHLDYNKLQ 94
           +  +     I +     +S+ +L LS N        E+          +  L+L  N L 
Sbjct: 34  LYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLS 93

Query: 95  GEIPEELGNL-----AELEMLVLNNNLLTGT----IPASIFNLSFISTALDFSDNSLTGS 145
            +  +EL          + +L L  N  +         +  NL    T+L+   N L   
Sbjct: 94  YKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK 153

Query: 146 FPYDMCPGLPR----LKGLYVSYNQFKGP--------IPNNLWHCKELSSVSLSYNQFTG 193
              ++   L      +  L +  N             + +       ++S+ LS N    
Sbjct: 154 SSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASI---PASVTSLDLSANLLGL 210

Query: 194 RLPRDLG-----NSTKLKSLDLGFNNLNGEIPQEIGNL----RNLEILGIDQSNLVGFVP 244
           +   +L          + SL+L  N L+G   + +  L    ++L+ + +D   +     
Sbjct: 211 KSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSK 270

Query: 245 DTIFNI-------STLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFF 297
           +    +         + ++      +  +   S  +  L         + +L       F
Sbjct: 271 EQCKALGAAFPNIQKIILVDKNGKEIHPS--HSIPISNLIRELSGKADVPSLLNQC-LIF 327

Query: 298 FNASKLYALELGYNSNLKRLGLERNYL 324
               +    +L     L+        L
Sbjct: 328 AQKHQTNIEDLNIPDELRESIQTCKPL 354

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 51.9 bits (125), Expect = 5e-07
 Identities = 35/145 (24%), Positives = 63/145 (43%), Gaps = 28/145 (19%)

Query: 671 LIGIGSYGSVYKGR-FPDGIEVAIKV------FHLQREGALNSFDAECEILKTIRHR--- 720
            +G G++G V   +   +    A+KV      +      A      E +ILK I++    
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRS---AKI----EADILKKIQNDDIN 94

Query: 721 --NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---NLDIFQRLGIMIDVASALE 775
             N+VK       ++   L+ E +   SL + +  +N+   +++  +     I++  AL 
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKL--YCIEILKALN 151

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDS 800
           YL       + H D+KP N+LLDD 
Sbjct: 152 YLR---KMSLTHTDLKPENILLDDP 173

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 28/93 (30%), Positives = 36/93 (38%), Gaps = 2/93 (2%)

Query: 476 YLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIP 535
            L  N L          L  L  LSL  N++Q      F +L  L  L L  N L  +  
Sbjct: 34  ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPN 93

Query: 536 ASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFS 568
              +KL  LK L L  N+L   +P  G F   +
Sbjct: 94  GVFDKLTQLKELALDTNQL-KSVPD-GIFDRLT 124

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 34/114 (29%), Positives = 52/114 (45%), Gaps = 7/114 (6%)

Query: 339 VNC--KSLK---IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE 393
           + C  K L     G   + T L L  N L         +L +L  L L  N+ +      
Sbjct: 12  IRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV 71

Query: 394 FCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLSSNELTSVIPSTFWNLE 446
           F   ++L ++YL+ NKL  S+P+ + D L  L+ L+L +N+L SV    F  L 
Sbjct: 72  FDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLT 124

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 27/77 (35%), Positives = 33/77 (42%), Gaps = 7/77 (9%)

Query: 485 NIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYL 544
            IPS+         L LE NKLQ      F +L  L  L LS N +  +     +KL  L
Sbjct: 25  GIPSS------ATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78

Query: 545 KSLNLSFNKLVGEIPRG 561
             L L  NKL   +P G
Sbjct: 79  TILYLHENKL-QSLPNG 94

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 4/106 (3%)

Query: 377 QGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLSSNELT 435
             L+L++NK +      F   ++L  + L++N++  S+P  + D L  L IL L  N+L 
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89

Query: 436 SVIPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRN 480
           S+    F  L  +      +N L  S+P  I + L ++  I+L  N
Sbjct: 90  SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 38/128 (29%), Positives = 56/128 (43%), Gaps = 13/128 (10%)

Query: 430 SSNELTSV---IPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNI 486
           +S  LTSV   IPS+   L      +  SN L        + L  +  + LS+N +  ++
Sbjct: 15  NSKGLTSVPTGIPSSATRL------ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SL 67

Query: 487 PSTII-GLKNLQHLSLEHNKLQGPIPES-FGELVSLEFLDLSNNDLSGVIPASLEKLLYL 544
           P  +   L  L  L L  NKLQ  +P   F +L  L+ L L  N L  V     ++L  L
Sbjct: 68  PDGVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSL 126

Query: 545 KSLNLSFN 552
           + + L  N
Sbjct: 127 QKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 35/118 (29%), Positives = 57/118 (48%), Gaps = 6/118 (5%)

Query: 413 SIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEI-ENLKA 471
           S+P+  G  +S   L L SN+L S+    F  L  +     S N +  SLP  + + L  
Sbjct: 21  SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77

Query: 472 VVDIYLSRNNLSGNIPSTII-GLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN 528
           +  +YL  N L  ++P+ +   L  L+ L+L+ N+L+      F  L SL+ + L  N
Sbjct: 78  LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 31/123 (25%), Positives = 48/123 (39%), Gaps = 13/123 (10%)

Query: 57  SSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNL 116
           SS   L L  N            LT+L +L L  N++Q         L +L +L L+ N 
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87

Query: 117 LTGTIPASIF-NLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNL 175
           L  ++P  +F  L+ +   L    N L  S P  +   L  L+ +++           N 
Sbjct: 88  LQ-SLPNGVFDKLTQL-KELALDTNQLK-SVPDGIFDRLTSLQKIWLH---------TNP 135

Query: 176 WHC 178
           W C
Sbjct: 136 WDC 138

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 6/105 (5%)

Query: 160 LYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNS-TKLKSLDLGFNNLNGE 218
           L +  N+ +           +L+ +SLS NQ    LP  + +  TKL  L L  N L   
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90

Query: 219 IPQEI-GNLRNLEILGIDQSNLVGFVPDTIF-NISTLKILSLFNN 261
           +P  +   L  L+ L +D  N +  VPD IF  +++L+ + L  N
Sbjct: 91  LPNGVFDKLTQLKELALDT-NQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 40/145 (27%), Positives = 51/145 (35%), Gaps = 35/145 (24%)

Query: 243 VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASK 302
           VP  I   S+   L L +N L  +LP       L  L  L+L  N +  S+P   F+  K
Sbjct: 22  VPTGIP--SSATRLELESNKLQ-SLPH-GVFDKLTQLTKLSLSQNQIQ-SLPDGVFD--K 74

Query: 303 LYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIG---NLINLTTLSLGD 359
           L        + L  L L  N L                 +SL  G    L  L  L+L  
Sbjct: 75  L--------TKLTILYLHENKL-----------------QSLPNGVFDKLTQLKELALDT 109

Query: 360 NNLSGSLPITLGRLKKLQGLDLQNN 384
           N L         RL  LQ + L  N
Sbjct: 110 NQLKSVPDGIFDRLTSLQKIWLHTN 134

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 30/147 (20%), Positives = 55/147 (37%), Gaps = 30/147 (20%)

Query: 671 LIGIGSYGSVYKG--RFPDGIEVAIKV------FHLQREGALNSFDAECEILKTIRHR-- 720
            +G G++G V +         +VA+K+      +      A      E  +LK I+ +  
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA---AR----LEINVLKKIKEKDK 78

Query: 721 ----NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---NLDIFQRLGIMIDVASA 773
                 V +      H    +  E + K +  + +  +NF    L   + +   +     
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQL----- 132

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDS 800
              L F H N + H D+KP N+L  +S
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNS 159

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 29/105 (27%), Positives = 41/105 (39%), Gaps = 15/105 (14%)

Query: 457 SLNGSLPLEIENLKAVVD----IYLSRNNLS--GNIPSTIIGLKNLQHLSLEHNKLQGPI 510
            L G     IENL A +D    I  S N +      P     L+ L+ L + +N++    
Sbjct: 25  DLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPL----LRRLKTLLVNNNRICRIG 80

Query: 511 PESFGELVSLEFLDLSNN---DLSGVIPASLEKLLYLKSLNLSFN 552
                 L  L  L L+NN   +L  + P  L  L  L  L +  N
Sbjct: 81  EGLDQALPDLTELILTNNSLVELGDLDP--LASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 17/90 (18%), Positives = 35/90 (38%), Gaps = 3/90 (3%)

Query: 465 EIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLD 524
           +  N     ++ L    +   I +    L     +    N+++  + + F  L  L+ L 
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70

Query: 525 LSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
           ++NN +  +     + L  L  L L+ N L
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSL 100

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.1 bits (102), Expect = 8e-05
 Identities = 24/138 (17%), Positives = 42/138 (30%), Gaps = 34/138 (24%)

Query: 79  NLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFS 138
           N  + +EL L   K+   I      L + + +  ++N +       +             
Sbjct: 17  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-----KLDGF---------- 60

Query: 139 DNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRD 198
                        P L RLK L V+ N+             +L+ + L+ N        D
Sbjct: 61  -------------PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGD 105

Query: 199 ---LGNSTKLKSLDLGFN 213
              L +   L  L +  N
Sbjct: 106 LDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 21/135 (15%), Positives = 45/135 (33%), Gaps = 26/135 (19%)

Query: 370 LGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSL 429
                + + LDL+  K    I        +   +  + N++   +      L  L+ L +
Sbjct: 15  YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLV 71

Query: 430 SSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPST 489
           ++N +  +       L D+     ++NSL      +++ L                    
Sbjct: 72  NNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLA------------------- 110

Query: 490 IIGLKNLQHLSLEHN 504
              LK+L +L +  N
Sbjct: 111 --SLKSLTYLCILRN 123

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 31/82 (37%), Positives = 40/82 (48%), Gaps = 8/82 (9%)

Query: 485 NIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYL 544
            IP+T       Q L L  N++    P  F  L  L  LDL NN L+ +     +KL  L
Sbjct: 27  GIPTT------TQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQL 80

Query: 545 KSLNLSFNKLVGEIPRGGAFAN 566
             L+L+ N+L   IPR GAF N
Sbjct: 81  TQLSLNDNQLKS-IPR-GAFDN 100

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 41.4 bits (98), Expect = 4e-04
 Identities = 36/113 (31%), Positives = 49/113 (43%), Gaps = 17/113 (15%)

Query: 19  SVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIG 78
           S CS  G T D  G  + S           +P+  G  ++ Q L L  N  +   P    
Sbjct: 5   SQCSCSGTTVDCSGKSLAS-----------VPT--GIPTTTQVLYLYDNQITKLEPGVFD 51

Query: 79  NLTKLKELHLDYNKLQGEIPEEL-GNLAELEMLVLNNNLLTGTIPASIF-NLS 129
            LT+L  L LD N+L   +P  +   L +L  L LN+N L  +IP   F NL 
Sbjct: 52  RLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLK 102

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 53/261 (20%), Positives = 88/261 (33%), Gaps = 87/261 (33%)

Query: 672 IGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKTIRH-------R 720
           +G G + +V+          VA+KV        E AL+    E  +LK++R+       R
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----EIRLLKSVRNSDPNDPNR 100

Query: 721 NLV-------KIISSCTNHNFKALVLEYMPKG-SLEDCMYASN---FNLDIFQRLGIMID 769
            +V       KI      H    +V E +  G  L   +  SN     L   ++  I+  
Sbjct: 101 EMVVQLLDDFKISGVNGTH--ICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKK--IIQQ 154

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLL--DDSMVAH----------------------- 804
           V   L+YLH      I+H DIKP N+LL  ++  +                         
Sbjct: 155 VLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212

Query: 805 ------------------------LSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
                                   ++D G A  + +      T+ + T  Y + E     
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIGS 268

Query: 841 QVSIKGDVYNYGIMLMEVFTG 861
             +   D+++   M  E+ TG
Sbjct: 269 GYNTPADIWSTACMAFELATG 289

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 8/82 (9%)

Query: 485 NIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYL 544
            IP+        Q L L +N++    P  F  LV+L+ L  ++N L+ +     +KL  L
Sbjct: 30  GIPTD------KQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQL 83

Query: 545 KSLNLSFNKLVGEIPRGGAFAN 566
             L+L+ N L   IPR GAF N
Sbjct: 84  TQLDLNDNHLKS-IPR-GAFDN 103

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 27/70 (38%), Positives = 35/70 (50%), Gaps = 2/70 (2%)

Query: 377 QGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLSSNELT 435
           Q L L NN+     P  F H   L  +Y N NKL+ +IP+ + D L  L  L L+ N L 
Sbjct: 36  QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK 94

Query: 436 SVIPSTFWNL 445
           S+    F NL
Sbjct: 95  SIPRGAFDNL 104

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 30/92 (32%), Positives = 41/92 (44%), Gaps = 3/92 (3%)

Query: 464 LEIENLKAVVDIYLS-RNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEF 522
           L      AV ++ L    +  G I        NL+ LSL +  L      +  +L  L+ 
Sbjct: 18  LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKK 75

Query: 523 LDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
           L+LS N + G +    EKL  L  LNLS NKL
Sbjct: 76  LELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.7 bits (111), Expect = 5e-06
 Identities = 32/105 (30%), Positives = 46/105 (43%), Gaps = 15/105 (14%)

Query: 457 SLNGSLPLEIENLKAVVD----IYLSRNNLS--GNIPSTIIGLKNLQHLSLEHNKLQGPI 510
               S   +IE L A       + L    L    N+P     L  L+ L L  N++ G +
Sbjct: 32  DNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPK----LPKLKKLELSENRIFGGL 87

Query: 511 PESFGELVSLEFLDLSNN---DLSGVIPASLEKLLYLKSLNLSFN 552
                +L +L  L+LS N   D+S + P  L+KL  LKSL+L   
Sbjct: 88  DMLAEKLPNLTHLNLSGNKLKDISTLEP--LKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 31/124 (25%), Positives = 43/124 (34%), Gaps = 27/124 (21%)

Query: 406 NRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLE 465
           N     G I     +  +L  LSL +  L SV                            
Sbjct: 33  NCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN-------------------------- 66

Query: 466 IENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGP-IPESFGELVSLEFLD 524
           +  L  +  + LS N + G +      L NL HL+L  NKL+     E   +L  L+ LD
Sbjct: 67  LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126

Query: 525 LSNN 528
           L N 
Sbjct: 127 LFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 36/139 (25%), Positives = 48/139 (34%), Gaps = 34/139 (24%)

Query: 79  NLTKLKELHLDYNKLQ-GEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDF 137
               ++EL LD  K   G+I         LE L L N  L      S+ NL         
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNL--------- 67

Query: 138 SDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPR 197
                         P LP+LK L +S N+  G +         L+ ++LS N+       
Sbjct: 68  --------------PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--IS 111

Query: 198 D---LGNSTKLKSLDLGFN 213
               L     LKSLDL   
Sbjct: 112 TLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 9/99 (9%)

Query: 343 SLKIGNLINLTTLSL-GDNNLSGSLPITLGRLKKLQGLDLQNN---KFEGPIPQEFCHFS 398
            L+      +  L L    +  G +         L+ L L N                  
Sbjct: 17  ELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN-----LPKLP 71

Query: 399 RLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSV 437
           +L  + L+ N++ G +      L +L  L+LS N+L  +
Sbjct: 72  KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI 110

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 31/147 (21%), Positives = 61/147 (41%), Gaps = 30/147 (20%)

Query: 671 LIGIGSYGSVYKG--RFPDGIEVAIKV------FHLQREGALNSFDAECEILKTIRHR-- 720
            +G G++G V +       G  VA+K+      +      A +    E ++L+ +     
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA---ARS----EIQVLEHLNTTDP 73

Query: 721 ----NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNF---NLDIFQRLGIMIDVASA 773
                 V+++    +H    +V E +   S  D +  + F    LD  ++  +   +  +
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRK--MAYQICKS 130

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDS 800
           + +LH   SN + H D+KP N+L   S
Sbjct: 131 VNFLH---SNKLTHTDLKPENILFVQS 154

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 26/92 (28%), Positives = 42/92 (45%), Gaps = 11/92 (11%)

Query: 466 IENLKAVVDIYLSRNNLS--GNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFL 523
            +  + +  +      L+   N+P     L  L+ L L  N++ G +     +  +L  L
Sbjct: 38  TDEFEELEFLSTINVGLTSIANLPK----LNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93

Query: 524 DLSNN---DLSGVIPASLEKLLYLKSLNLSFN 552
           +LS N   DLS + P  L+KL  LKSL+L   
Sbjct: 94  NLSGNKIKDLSTIEP--LKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.8 bits (109), Expect = 8e-06
 Identities = 25/92 (27%), Positives = 40/92 (43%), Gaps = 3/92 (3%)

Query: 464 LEIENLKAVVDIYLS-RNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEF 522
           L       V ++ L    +  G +       + L+ LS  +  L      +  +L  L+ 
Sbjct: 11  LRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKK 68

Query: 523 LDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
           L+LS+N +SG +    EK   L  LNLS NK+
Sbjct: 69  LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 37/137 (27%), Positives = 51/137 (37%), Gaps = 30/137 (21%)

Query: 79  NLTKLKELHLDYNKLQ-GEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDF 137
             + +KEL LD ++   G++        ELE L   N  LT     SI NL         
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANL--------- 60

Query: 138 SDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTG-RLP 196
                         P L +LK L +S N+  G +      C  L+ ++LS N+       
Sbjct: 61  --------------PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI 106

Query: 197 RDLGNSTKLKSLDLGFN 213
             L     LKSLDL   
Sbjct: 107 EPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 31/135 (22%), Positives = 46/135 (34%), Gaps = 36/135 (26%)

Query: 312 SNLKRLGLERNYLTFSTSELMSLFSALVNCKSL--------KIGNL---INLTTLSLGDN 360
           S++K L L+ +       +L  L       + L         I NL     L  L L DN
Sbjct: 17  SDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDN 74

Query: 361 NLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD 420
            +SG L +   +   L  L+L  NK +                         S    L  
Sbjct: 75  RVSGGLEVLAEKCPNLTHLNLSGNKIKDL-----------------------STIEPLKK 111

Query: 421 LNSLRILSLSSNELT 435
           L +L+ L L + E+T
Sbjct: 112 LENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 19/99 (19%), Positives = 39/99 (39%), Gaps = 11/99 (11%)

Query: 344 LKIGNLINLTTLSLGDNNLSGSLPIT--LGRLKKLQGLDLQNN---KFEGPIPQEFCHFS 398
           L+     ++  L L DN+ S    +       ++L+ L   N                 +
Sbjct: 11  LRNRTPSDVKELVL-DNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN-----LPKLN 64

Query: 399 RLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSV 437
           +L  + L+ N++SG +        +L  L+LS N++  +
Sbjct: 65  KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL 103

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.0 bits (94), Expect = 8e-04
 Identities = 29/134 (21%), Positives = 48/134 (35%), Gaps = 26/134 (19%)

Query: 372 RLKKLQGLDLQNNKF-EGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLS 430
               ++ L L N++  EG +      F  L  +      L+ SI + L  LN L+ L LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 431 SNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTI 490
            N ++  +        ++   + S N +       IE LK                    
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLK-------------------- 110

Query: 491 IGLKNLQHLSLEHN 504
             L+NL+ L L + 
Sbjct: 111 -KLENLKSLDLFNC 123

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 54/332 (16%), Positives = 99/332 (29%), Gaps = 78/332 (23%)

Query: 80  LTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSD 139
           L+ L++L+L   ++    P +   +A   +L    + L                 ++ + 
Sbjct: 71  LSSLRQLNLAGVRMT---PVKCTVVAA--VLGSGRHALD---------------EVNLAS 110

Query: 140 NSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSV-----------SLSY 188
             L  +    + P   R + L +  N            CK+L  +            LS 
Sbjct: 111 CQLDPAGLRTLLPVFLRARKLGLQLNSLGPE------ACKDLRDLLLHDQCQITTLRLSN 164

Query: 189 NQFTGR----LPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVP 244
           N  T      L   L  +T +  L L    L  E  + +        L     N      
Sbjct: 165 NPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA-----AQL---DRN------ 210

Query: 245 DTIFNISTLKILSLFNNTL--SGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASK 302
                   L+ L++  N    +  L  ++     P+LE L+L  N LS           +
Sbjct: 211 ------RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE-------GRQ 257

Query: 303 LYALELGYNSNLKRLGLERNYLTFSTSELMSLFS-ALVNCKSLKIGNL---INLTTLSLG 358
           +     G      R+ +     T  +     + S    N  S     +   + L    L 
Sbjct: 258 VLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLE 317

Query: 359 DNNLSGSLPITLGRLKK----LQGLDLQNNKF 386
           D+  +   P    +L +    ++ L  Q    
Sbjct: 318 DSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 45.1 bits (107), Expect = 7e-05
 Identities = 43/288 (14%), Positives = 85/288 (29%), Gaps = 59/288 (20%)

Query: 55  NLSSLQTLVLSRNWFSGTIPKEIGN-LTKLKELHLDYNKLQGEIPEELGNLAELEMLVLN 113
              +L  + L+         + +     + ++L L  N L  E  ++L      ++L+ +
Sbjct: 99  GRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLR-----DLLLHD 153

Query: 114 NNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGL---PRLKGLYVSYNQFKGP 170
              +T                L  S+N LT +    +  GL     +  L + +      
Sbjct: 154 QCQIT---------------TLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDE 198

Query: 171 ----IPNNLWHCKELSSVSLSYNQFTGR----LPRDLGNSTKLKSLDLGFNNLNGEIPQE 222
               +   L   ++L  ++++YN         L R       L+ L L FN L+ E  Q 
Sbjct: 199 GLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQV 258

Query: 223 IGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNT--------LSGNLPSSKNLI 274
           +      ++ G  +                + +               LS    +  +  
Sbjct: 259 LR-----DLGGAAEGGA------------RVVVSLTEGTAVSEYWSVILSEVQRNLNSWD 301

Query: 275 GLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERN 322
                  L L L +L  S            A  L     ++ L  +  
Sbjct: 302 RARVQRHLELLLRDLEDS--RGATLNPWRKAQLLRVEGEVRALLEQLG 347

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267

 Score = 44.2 bits (104), Expect = 9e-05
 Identities = 25/112 (22%), Positives = 45/112 (40%), Gaps = 12/112 (10%)

Query: 423 SLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNL 482
           S + L L                ++I       + +  +L +  EN+  ++ + LS N L
Sbjct: 128 SQQALDLKGLRSD-----PDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRL 182

Query: 483 SG--NIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSG 532
               ++ S +    NL+ L+L  N+L+     S  EL  ++ L L    L G
Sbjct: 183 YRLDDMSSIVQKAPNLKILNLSGNELK-----SERELDKIKGLKLEELWLDG 229

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 54/397 (13%), Positives = 128/397 (32%), Gaps = 58/397 (14%)

Query: 34  RVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKL 93
           R+  + ++D  L   I     N   L  L     + +  +         LKEL L  + +
Sbjct: 111 RLKRMVVTDDCLE-LIAKSFKNFKVL-VLSSCEGFSTDGLAAIAATCRNLKELDLRESDV 168

Query: 94  QGEIPEELGNLAE----LEMLVLNN--NLLTGTIPASIFNLSFISTAL---DFSDNSLTG 144
                  L +  +    L  L ++   + ++    +++  L      L     +      
Sbjct: 169 DDVSGHWLSHFPDTYTSLVSLNISCLASEVSF---SALERLVTRCPNLKSLKLNRAVPLE 225

Query: 145 SFPYDMCPGLPRLKGLYVSY------NQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRD 198
                +    P+L+ L                +   L  CKEL  +S  ++     LP  
Sbjct: 226 KL-ATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAV 284

Query: 199 LGNSTKLKSLDLGFNNLNGE-IPQEIGNLRNLEILGIDQSNLVGFVPDT-IFNIST---- 252
               ++L +L+L +  +    + + +     L+ L      ++ ++ D  +  +++    
Sbjct: 285 YSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRL-----WVLDYIEDAGLEVLASTCKD 339

Query: 253 LKILSLFNNTLSGNLPSSKN--------LIGLPNLEGLNLGLNNLSG-SIPSFFFNASKL 303
           L+ L +F +      P+            +G P LE +      ++  ++ +   N   +
Sbjct: 340 LRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNM 399

Query: 304 YALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLI------------- 350
               L     ++    +   L        ++     + + L +  L+             
Sbjct: 400 TRFRL---CIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAK 456

Query: 351 NLTTLSLGDNNLSG-SLPITLGRLKKLQGLDLQNNKF 386
            +  LS+     S   +   L     L+ L++++  F
Sbjct: 457 KMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 42.6 bits (100), Expect = 6e-04
 Identities = 50/282 (17%), Positives = 96/282 (34%), Gaps = 34/282 (12%)

Query: 272 NLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSEL 331
            L G P+    NL  +   G +  +    S          + L+ + L+R  +T     L
Sbjct: 72  ELKGKPHFADFNLVPDGWGGYVYPWIEAMSS-------SYTWLEEIRLKRMVVT--DDCL 122

Query: 332 MSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIP 391
             +  +  N K L + +    +T  L    ++ +          L+ LDL+ +  +    
Sbjct: 123 ELIAKSFKNFKVLVLSSCEGFSTDGL--AAIAATCR-------NLKELDLRESDVDDVSG 173

Query: 392 QEFCHFSRLYV--VYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDIL 449
               HF   Y   V LN + L+  +       ++L  L      L S+       L   +
Sbjct: 174 HWLSHFPDTYTSLVSLNISCLASEV-----SFSALERLVTRCPNLKSL------KLNRAV 222

Query: 450 GFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGP 509
             +  +  L  +  LE             R ++   +   + G K L+ LS   + +   
Sbjct: 223 PLEKLATLLQRAPQLEELGTGGYTAE--VRPDVYSGLSVALSGCKELRCLSGFWDAVPAY 280

Query: 510 IPESFGELVSLEFLDLSNNDLSGV-IPASLEKLLYLKSLNLS 550
           +P  +     L  L+LS   +    +   L +   L+ L + 
Sbjct: 281 LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	952
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.94
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.88
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.86
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.86
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.86
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.85
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.84
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.83
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.8
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.8
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.8
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.79
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.79
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.78
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.76
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.76
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.76
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.74
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.74
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.73
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.73
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.73
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.71
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.71
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.67
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.66
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.66
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.62
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.62
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.61
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.61
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.57
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.55
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.54
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.53
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.52
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.5
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.45
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.43
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.43
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.42
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.33
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.32
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.32
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.28
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.13
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.12
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.12
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.88
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.87
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.84
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.84
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.73
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.5
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.45
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.44
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.41
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.38
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.37
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.36
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.22
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.16
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.98
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.94
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.86
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.84
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.78
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.76
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.68
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.33
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.33
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.2
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.2
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.19
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.18
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.13
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.01
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.95
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.95
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.8
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.78
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.59
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.51
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.03
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.5
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.29

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=8.8e-73  Score=694.20  Aligned_cols=575  Identities=33%  Similarity=0.500  Sum_probs=431.0

Q ss_pred             CCCCccccccCCCCCCCCCceEEEeCCCCeEEEEEecCCCCccc---CC-----------------------ccccCCcc
Q 002214            5 NPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGT---IP-----------------------SHLGNLSS   58 (952)
Q Consensus         5 ~~~~~~~~~~~~~~~~c~w~~v~c~~~~~~~~~l~l~~~~~~~~---~p-----------------------~~l~~l~~   58 (952)
                      ||. .++ +|..++|||.|.||+|+  .++|++|+++++++.|.   +|                       +.++.+++
T Consensus        26 ~~~-~l~-~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~~l~~~~~~l~~  101 (768)
T 3rgz_A           26 DKN-LLP-DWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSAS  101 (768)
T ss_dssp             CTT-SST-TCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEEECCCCCCCCTT
T ss_pred             Ccc-ccc-CCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcCCCchhhccCCC
Confidence            787 666 88777899999999999  57999999999999886   55                       46667777


Q ss_pred             cCeeeccccccccccCC--CcCCcCCCcEEeCcCCcccccCChhh-cCCCCCCeEeecCccCccccCcc---cccccccc
Q 002214           59 LQTLVLSRNWFSGTIPK--EIGNLTKLKELHLDYNKLQGEIPEEL-GNLAELEMLVLNNNLLTGTIPAS---IFNLSFIS  132 (952)
Q Consensus        59 L~~L~L~~n~l~~~~p~--~l~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~---~~~l~~l~  132 (952)
                      |++|+|++|.+++.+|.  .++.+++|++|+|++|.+.+..|..+ .++++|++|+|++|.+++..|..   +.++..+ 
T Consensus       102 L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L-  180 (768)
T 3rgz_A          102 LTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGEL-  180 (768)
T ss_dssp             CCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTC-
T ss_pred             CCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCC-
Confidence            77777777777777776  77777777777777777776666554 66777777777777776555544   3333332 


Q ss_pred             cceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccc-----------
Q 002214          133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGN-----------  201 (952)
Q Consensus       133 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-----------  201 (952)
                      +.|++++|.+++..|.   ..+++|++|+|++|++++.+|. +..+++|++|+|++|++++.+|..|+.           
T Consensus       181 ~~L~Ls~n~l~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~  256 (768)
T 3rgz_A          181 KHLAISGNKISGDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS  256 (768)
T ss_dssp             CEEECCSSEEESCCBC---TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCS
T ss_pred             CEEECCCCcccccCCc---ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCC
Confidence            4444444444433332   2344444444444444443333 444444444444444444444444444           


Q ss_pred             -----------cCCccEEEeeCCcCCccCchhhhcc-CCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCC
Q 002214          202 -----------STKLKSLDLGFNNLNGEIPQEIGNL-RNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPS  269 (952)
Q Consensus       202 -----------l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  269 (952)
                                 +++|++|+|++|++++.+|..+..+ ++|+.|+|++|++.+..|..+.++++|++|++++|.+.+.+|.
T Consensus       257 n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~  336 (768)
T 3rgz_A          257 NQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM  336 (768)
T ss_dssp             SCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCH
T ss_pred             CcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCH
Confidence                       4444555555555544556555554 7777777777777777777777777777777777777655442


Q ss_pred             CcccCCCCCcceEEcccCcCCCCCCcccccch-hhhhhhcccc---------------CccccccccCcceee-chhhHH
Q 002214          270 SKNLIGLPNLEGLNLGLNNLSGSIPSFFFNAS-KLYALELGYN---------------SNLKRLGLERNYLTF-STSELM  332 (952)
Q Consensus       270 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~-~L~~l~l~~~---------------~~L~~L~L~~n~l~~-~~~~~~  332 (952)
                       ..+..+++|++|++++|++++.+|..+..++ +|+.|+++.|               .+|+.|++++|.++. .+..+.
T Consensus       337 -~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~  415 (768)
T 3rgz_A          337 -DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS  415 (768)
T ss_dssp             -HHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGG
T ss_pred             -HHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHh
Confidence             1256677788888888887777777777776 7777777654               357777777777763 232211


Q ss_pred             HHHHHhhc----------cccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceE
Q 002214          333 SLFSALVN----------CKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYV  402 (952)
Q Consensus       333 ~~~~~~~~----------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  402 (952)
                      . ...+..          .....++.+++|+.|++++|.+++.+|..+..+++|++|++++|++++..|..|..+++|++
T Consensus       416 ~-l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  494 (768)
T 3rgz_A          416 N-CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW  494 (768)
T ss_dssp             G-CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred             c-CCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCE
Confidence            1 111111          11123567788999999999998888888999999999999999998888999999999999


Q ss_pred             EEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhh---------------
Q 002214          403 VYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIE---------------  467 (952)
Q Consensus       403 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---------------  467 (952)
                      |+|++|++++.+|..++.+++|++|++++|++++.+|..+..+++|+.|++++|++++.+|..+.               
T Consensus       495 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~  574 (768)
T 3rgz_A          495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKR  574 (768)
T ss_dssp             EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCE
T ss_pred             EEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccc
Confidence            99999999989999999999999999999999989999999999999999999999877775442               


Q ss_pred             -------------------------------------------------------cccccceeecCCcccCCCCcccccC
Q 002214          468 -------------------------------------------------------NLKAVVDIYLSRNNLSGNIPSTIIG  492 (952)
Q Consensus       468 -------------------------------------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~  492 (952)
                                                                             .+++|+.|+|++|++++.+|..|+.
T Consensus       575 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~  654 (768)
T 3rgz_A          575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS  654 (768)
T ss_dssp             EEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGG
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhc
Confidence                                                                   3467889999999999999999999


Q ss_pred             CCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCCCccccccccc
Q 002214          493 LKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESF  572 (952)
Q Consensus       493 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~  572 (952)
                      +++|+.|+|++|+++|.+|..|+.+++|+.|||++|++++.+|..+..+++|+.|++++|+++|.+|..++|.++...+|
T Consensus       655 l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~  734 (768)
T 3rgz_A          655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKF  734 (768)
T ss_dssp             CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGG
T ss_pred             cccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCccCCCCCccCCCCCCCCC
Q 002214          573 IGNDLLCGSPYLHVPLCKSSP  593 (952)
Q Consensus       573 ~~n~~~c~~p~~~lp~c~~~~  593 (952)
                      .|||++||.|.   +.|....
T Consensus       735 ~gN~~Lcg~~l---~~C~~~~  752 (768)
T 3rgz_A          735 LNNPGLCGYPL---PRCDPSN  752 (768)
T ss_dssp             CSCTEEESTTS---CCCCSCC
T ss_pred             cCCchhcCCCC---cCCCCCc
Confidence            99999999984   4686543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.5e-59  Score=576.81  Aligned_cols=503  Identities=31%  Similarity=0.465  Sum_probs=412.9

Q ss_pred             EEEEEecCCCCcccCCcc---ccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEe
Q 002214           35 VTSLTISDLGLAGTIPSH---LGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLV  111 (952)
Q Consensus        35 ~~~l~l~~~~~~~~~p~~---l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  111 (952)
                      +++|+++++.+++..|..   +.++++|++|++++|.+++.+|  +..+++|++|+|++|++.+.+|. ++++++|++|+
T Consensus       153 L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~  229 (768)
T 3rgz_A          153 LEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLD  229 (768)
T ss_dssp             CSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEE
T ss_pred             CCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEE
Confidence            344444444444443333   4444555555555555544333  26677777777777777766666 88888888888


Q ss_pred             ecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCC-CCCcEEEccCCc
Q 002214          112 LNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHC-KELSSVSLSYNQ  190 (952)
Q Consensus       112 L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~L~L~~N~  190 (952)
                      |++|.+++.+|..+.+++.+ +.|++++|++++.+|..   .+++|++|+|++|++++.+|..+... ++|++|+|++|+
T Consensus       230 Ls~n~l~~~~~~~l~~l~~L-~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~  305 (768)
T 3rgz_A          230 ISGNKLSGDFSRAISTCTEL-KLLNISSNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH  305 (768)
T ss_dssp             CCSSCCCSCHHHHTTTCSSC-CEEECCSSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSE
T ss_pred             CcCCcCCCcccHHHhcCCCC-CEEECCCCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCc
Confidence            88888887788888777765 78888888888777764   67788888888888888888888765 888888888888


Q ss_pred             ccccCCccccccCCccEEEeeCCcCCccCchh-hhccCCCcEeeeccccccccCCccccCCC-CccEEEeeCccccccCC
Q 002214          191 FTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQE-IGNLRNLEILGIDQSNLVGFVPDTIFNIS-TLKILSLFNNTLSGNLP  268 (952)
Q Consensus       191 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~n~~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~  268 (952)
                      +++.+|..|+++++|++|+|++|++++.+|.. |..+++|+.|++++|++.+.+|..+.+++ +|++|++++|++++.++
T Consensus       306 l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~  385 (768)
T 3rgz_A          306 FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL  385 (768)
T ss_dssp             EEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECC
T ss_pred             CCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcC
Confidence            88888888888888889999888888677765 88888888999888888888888888887 88888888888887766


Q ss_pred             CCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhcccc-------------CccccccccCcceeechhhHHHHH
Q 002214          269 SSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYN-------------SNLKRLGLERNYLTFSTSELMSLF  335 (952)
Q Consensus       269 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~-------------~~L~~L~L~~n~l~~~~~~~~~~~  335 (952)
                      .......+++|++|++++|++++.+|..|..+++|+.|++++|             ++|+.|++++|.+......     
T Consensus       386 ~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~-----  460 (768)
T 3rgz_A          386 PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ-----  460 (768)
T ss_dssp             TTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCG-----
T ss_pred             hhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCH-----
Confidence            6544334778888899888888888888888888888887766             4678888888887632221     


Q ss_pred             HHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCC
Q 002214          336 SALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIP  415 (952)
Q Consensus       336 ~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  415 (952)
                               .++.+++|++|++++|++++.+|..+..+++|++|+|++|++++..|.+|..+++|++|+|++|++++.+|
T Consensus       461 ---------~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  531 (768)
T 3rgz_A          461 ---------ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP  531 (768)
T ss_dssp             ---------GGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECC
T ss_pred             ---------HHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCC
Confidence                     36778999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccCCCCCCcEEeccccccCCcCCcc------------------------------------------------------
Q 002214          416 SCLGDLNSLRILSLSSNELTSVIPST------------------------------------------------------  441 (952)
Q Consensus       416 ~~~~~l~~L~~L~L~~N~l~~~~~~~------------------------------------------------------  441 (952)
                      ..+..+++|+.|++++|++++.+|..                                                      
T Consensus       532 ~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  611 (768)
T 3rgz_A          532 AELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN  611 (768)
T ss_dssp             GGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTC
T ss_pred             HHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcccccc
Confidence            99999999999999999998766643                                                      


Q ss_pred             ----------------ccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcc
Q 002214          442 ----------------FWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNK  505 (952)
Q Consensus       442 ----------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  505 (952)
                                      |..+++|+.|||++|++++.+|..++.++.|+.|+|++|++++.+|..|+.+++|+.|||++|+
T Consensus       612 ~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~  691 (768)
T 3rgz_A          612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK  691 (768)
T ss_dssp             CSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred             ccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence                            3345789999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCC
Q 002214          506 LQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIP  559 (952)
Q Consensus       506 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  559 (952)
                      ++|.+|..+..+++|++|||++|+|+|.+|.. ..+..+....+.+|+.-|-.|
T Consensus       692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~~  744 (768)
T 3rgz_A          692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGYP  744 (768)
T ss_dssp             CEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEESTT
T ss_pred             ccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCCC
Confidence            99999999999999999999999999999964 456677778889998666544

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=6.6e-58  Score=557.46  Aligned_cols=526  Identities=23%  Similarity=0.242  Sum_probs=351.0

Q ss_pred             CeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEee
Q 002214           33 NRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVL  112 (952)
Q Consensus        33 ~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  112 (952)
                      .+++.|+++++.+++..|..++++++|++|+|++|.+++..|..++.+++|++|+|++|++.+..+.+|+++++|++|+|
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  104 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL  104 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence            57899999999999777778999999999999999999888888999999999999999998555557999999999999


Q ss_pred             cCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCcccc--CCCCCcEEEccCCc
Q 002214          113 NNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLW--HCKELSSVSLSYNQ  190 (952)
Q Consensus       113 ~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~--~l~~L~~L~L~~N~  190 (952)
                      ++|++++..|..+.++..+ +.|++++|.+++..| ..+..+++|++|++++|++++..+..+.  .+++|+.|++++|+
T Consensus       105 ~~n~l~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~  182 (680)
T 1ziw_A          105 MSNSIQKIKNNPFVKQKNL-ITLDLSHNGLSSTKL-GTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ  182 (680)
T ss_dssp             CSSCCCCCCSCTTTTCTTC-CEEECCSSCCSCCCC-CSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCC
T ss_pred             CCCccCccChhHccccCCC-CEEECCCCcccccCc-hhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCc
Confidence            9999986666778888776 899999999986544 4456788999999999998876665544  45788888888888


Q ss_pred             ccccCCccccccC---------------------------CccEEEeeCCcCCccCchhhhccCC--CcEeeeccccccc
Q 002214          191 FTGRLPRDLGNST---------------------------KLKSLDLGFNNLNGEIPQEIGNLRN--LEILGIDQSNLVG  241 (952)
Q Consensus       191 l~~~~~~~~~~l~---------------------------~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L~~n~~~~  241 (952)
                      +++..|..|..++                           +|++|++++|.+++..|..|..++.  |+.|++++|++.+
T Consensus       183 l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~  262 (680)
T 1ziw_A          183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV  262 (680)
T ss_dssp             CCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCE
T ss_pred             ccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCc
Confidence            8877777665543                           3445555555555555555555543  5555555555555


Q ss_pred             cCCccccCCCCccEEEeeCccccccCCCC-------------------------------cccCCCCCcceEEcccCcCC
Q 002214          242 FVPDTIFNISTLKILSLFNNTLSGNLPSS-------------------------------KNLIGLPNLEGLNLGLNNLS  290 (952)
Q Consensus       242 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-------------------------------~~l~~l~~L~~L~L~~N~l~  290 (952)
                      ..+..+..+++|++|++++|.+.+..+..                               ..+..+++|++|++++|++.
T Consensus       263 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~  342 (680)
T 1ziw_A          263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP  342 (680)
T ss_dssp             ECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBC
T ss_pred             cCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccC
Confidence            55555555555555555555555443321                               01233334444444444444


Q ss_pred             CCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccC--CCcccEEEccCCCCCCCCCc
Q 002214          291 GSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGN--LINLTTLSLGDNNLSGSLPI  368 (952)
Q Consensus       291 ~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~--l~~L~~L~L~~n~l~~~~~~  368 (952)
                      +..+..|..+++|+.++++           +|.+...            .+....+..  .++|+.|++++|+++++.|.
T Consensus       343 ~~~~~~~~~l~~L~~L~Ls-----------~n~~~~~------------~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~  399 (680)
T 1ziw_A          343 GIKSNMFTGLINLKYLSLS-----------NSFTSLR------------TLTNETFVSLAHSPLHILNLTKNKISKIESD  399 (680)
T ss_dssp             CCCTTTTTTCTTCCEEECT-----------TCBSCCC------------EECTTTTGGGTTSCCCEEECTTSCCCEECTT
T ss_pred             CCChhHhccccCCcEEECC-----------CCchhhh------------hcchhhhcccccCcCceEECCCCCCCeEChh
Confidence            4433333333333333333           3221100            000001111  24677777777777766677


Q ss_pred             ccccCCCCcEEEccCccccCCCC-ccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccC--CcCCccccCC
Q 002214          369 TLGRLKKLQGLDLQNNKFEGPIP-QEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELT--SVIPSTFWNL  445 (952)
Q Consensus       369 ~l~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l  445 (952)
                      +|..+++|++|++++|.+.+..| ..|.++++|+.|++++|++.+..+..|..+++|+.|++++|.++  +..|..|..+
T Consensus       400 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l  479 (680)
T 1ziw_A          400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPL  479 (680)
T ss_dssp             TTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTC
T ss_pred             hhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccC
Confidence            77777777777777777764333 56677777777777777777666667777777777777777765  3456667777


Q ss_pred             CCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCc--------ccccCCCCCceEEccCccccCccccccccc
Q 002214          446 EDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIP--------STIIGLKNLQHLSLEHNKLQGPIPESFGEL  517 (952)
Q Consensus       446 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  517 (952)
                      ++|+.|++++|++++..+..|.++++|++|+|++|++++..+        ..|.++++|+.|+|++|+++.+.+..|.++
T Consensus       480 ~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l  559 (680)
T 1ziw_A          480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL  559 (680)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             CCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccc
Confidence            777777777777776666667777777777777777764321        235667777777777777775444567777


Q ss_pred             ccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCC--CcccccccccccCccCCCCCc
Q 002214          518 VSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGG--AFANFSAESFIGNDLLCGSPY  583 (952)
Q Consensus       518 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~p~  583 (952)
                      ++|+.|+|++|+|++.++..|..+++|+.|++++|++++..|...  .+.++....+.+|||.|+|+.
T Consensus       560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            777777777777776666666777777777777777776554321  345566666677777777763

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.6e-57  Score=554.02  Aligned_cols=520  Identities=22%  Similarity=0.236  Sum_probs=448.1

Q ss_pred             EEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCc
Q 002214           36 TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNN  115 (952)
Q Consensus        36 ~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n  115 (952)
                      +.+|.++++++ .+|..+.  +++++|+|++|.+++..+..|..+++|++|+|++|.+.+..|.+|+++++|++|+|++|
T Consensus         7 ~~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n   83 (680)
T 1ziw_A            7 EVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN   83 (680)
T ss_dssp             SEEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred             CeeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence            35778888887 6887775  79999999999999777778999999999999999999888999999999999999999


Q ss_pred             cCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccC
Q 002214          116 LLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRL  195 (952)
Q Consensus       116 ~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  195 (952)
                      .+++..+..+.++..+ ++|++++|+++ .++...+.++++|++|+|++|++++..|..+..+++|++|++++|.+++..
T Consensus        84 ~l~~l~~~~~~~l~~L-~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  161 (680)
T 1ziw_A           84 ELSQLSDKTFAFCTNL-TELHLMSNSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK  161 (680)
T ss_dssp             CCCCCCTTTTTTCTTC-SEEECCSSCCC-CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred             ccCccChhhhccCCCC-CEEECCCCccC-ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence            9994444468888766 99999999998 566677789999999999999999888999999999999999999999877


Q ss_pred             Ccccc--ccCCccEEEeeCCcCCccCchhhhcc---------------------------CCCcEeeeccccccccCCcc
Q 002214          196 PRDLG--NSTKLKSLDLGFNNLNGEIPQEIGNL---------------------------RNLEILGIDQSNLVGFVPDT  246 (952)
Q Consensus       196 ~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l---------------------------~~L~~L~L~~n~~~~~~~~~  246 (952)
                      +..++  .+++|++|++++|.+++..|..|..+                           ++|+.|++++|++.+..|..
T Consensus       162 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~  241 (680)
T 1ziw_A          162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT  241 (680)
T ss_dssp             HHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTT
T ss_pred             HHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhH
Confidence            77665  45899999999999998888877765                           45778888888888888999


Q ss_pred             ccCCCC--ccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccc--------------
Q 002214          247 IFNIST--LKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGY--------------  310 (952)
Q Consensus       247 ~~~l~~--L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~--------------  310 (952)
                      +..++.  |+.|++++|++++..+.  .+..+++|++|++++|++.+..|..|.++++|+.++++.              
T Consensus       242 ~~~l~~~~L~~L~Ls~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~  319 (680)
T 1ziw_A          242 FLGLKWTNLTMLDLSYNNLNVVGND--SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK  319 (680)
T ss_dssp             TGGGGGSCCCEEECTTSCCCEECTT--TTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCE
T ss_pred             hhccCcCCCCEEECCCCCcCccCcc--cccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccc
Confidence            988765  99999999999877554  378899999999999999999999999999998887753              


Q ss_pred             --------cCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCC--CCCCcccccC--CCCcE
Q 002214          311 --------NSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLS--GSLPITLGRL--KKLQG  378 (952)
Q Consensus       311 --------~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~l~~l--~~L~~  378 (952)
                              +++|+.|++++|.++..+..              .+.++++|++|++++|.+.  ......|..+  ++|+.
T Consensus       320 i~~~~~~~l~~L~~L~l~~n~l~~~~~~--------------~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~  385 (680)
T 1ziw_A          320 IDDFSFQWLKCLEHLNMEDNDIPGIKSN--------------MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI  385 (680)
T ss_dssp             ECTTTTTTCTTCCEEECCSCCBCCCCTT--------------TTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCE
T ss_pred             cChhhcccCCCCCEEECCCCccCCCChh--------------HhccccCCcEEECCCCchhhhhcchhhhcccccCcCce
Confidence                    46788888888887755433              3677888999999888754  2333444443  58999


Q ss_pred             EEccCccccCCCCccccCCCcceEEEeccccccccCC-CccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCc
Q 002214          379 LDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIP-SCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNS  457 (952)
Q Consensus       379 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  457 (952)
                      |++++|+++++.|..|..+++|+.|+|++|++++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.
T Consensus       386 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~  465 (680)
T 1ziw_A          386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA  465 (680)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSC
T ss_pred             EECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccc
Confidence            9999999999999999999999999999999987665 689999999999999999999999999999999999999999


Q ss_pred             cC--CCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCccc--------ccccccccccEEeCCC
Q 002214          458 LN--GSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIP--------ESFGELVSLEFLDLSN  527 (952)
Q Consensus       458 l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------~~~~~l~~L~~L~Ls~  527 (952)
                      ++  +..|..|..+++|+.|+|++|+++++.+..|.++++|++|+|++|++++..+        ..|..+++|+.|+|++
T Consensus       466 l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~  545 (680)
T 1ziw_A          466 LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLES  545 (680)
T ss_dssp             CBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCS
T ss_pred             ccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCC
Confidence            87  5688999999999999999999999888899999999999999999986432        2478999999999999


Q ss_pred             CcccccCccchhcccccccccccccccccCCCCC-CCcccccccccccCc
Q 002214          528 NDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG-GAFANFSAESFIGND  576 (952)
Q Consensus       528 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~  576 (952)
                      |+|+.+.+..|.++++|+.|+|++|++++..+.. ..+..+....+.+|.
T Consensus       546 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~  595 (680)
T 1ziw_A          546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL  595 (680)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             CCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCc
Confidence            9999766678999999999999999999655542 345666666677774

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2.6e-56  Score=535.98  Aligned_cols=497  Identities=22%  Similarity=0.214  Sum_probs=413.6

Q ss_pred             CeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEee
Q 002214           33 NRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVL  112 (952)
Q Consensus        33 ~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  112 (952)
                      ..+++|+++++.+++..|..|+++++|++|+|++|.+++..|+.|.++++|++|+|++|++.+..|.+|+++++|++|+|
T Consensus        33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  112 (606)
T 3t6q_A           33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF  112 (606)
T ss_dssp             TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred             CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence            57899999999999888889999999999999999999888889999999999999999999888899999999999999


Q ss_pred             cCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCc--EEEccCCc
Q 002214          113 NNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELS--SVSLSYNQ  190 (952)
Q Consensus       113 ~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~--~L~L~~N~  190 (952)
                      ++|++++..|..+.++..+ +.|++++|++++.-+..+ .++++|++|++++|++++..|..|..+++|+  .|++++|+
T Consensus       113 ~~n~i~~l~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~  190 (606)
T 3t6q_A          113 IQTGISSIDFIPLHNQKTL-ESLYLGSNHISSIKLPKG-FPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND  190 (606)
T ss_dssp             TTSCCSCGGGSCCTTCTTC-CEEECCSSCCCCCCCCTT-CCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCC
T ss_pred             cccCcccCCcchhccCCcc-cEEECCCCcccccCcccc-cCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCc
Confidence            9999996667778777775 899999999985222222 3489999999999999987788889999998  89999999


Q ss_pred             ccccCCccccccCCccEEEeeCCcCC--------------------------ccCchhhhccC--CCcEeeecccccccc
Q 002214          191 FTGRLPRDLGNSTKLKSLDLGFNNLN--------------------------GEIPQEIGNLR--NLEILGIDQSNLVGF  242 (952)
Q Consensus       191 l~~~~~~~~~~l~~L~~L~L~~N~l~--------------------------~~~p~~~~~l~--~L~~L~L~~n~~~~~  242 (952)
                      +++..|..|.. .+|++|++++|...                          ...+..|..+.  +|+.|++++|++.++
T Consensus       191 l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~  269 (606)
T 3t6q_A          191 IAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI  269 (606)
T ss_dssp             CCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSC
T ss_pred             cCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCcc
Confidence            99887777654 67889998887511                          11223333333  788999999999988


Q ss_pred             CCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCc
Q 002214          243 VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERN  322 (952)
Q Consensus       243 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n  322 (952)
                      .+..|..+++|++|++++|+++ .+|..  +..+++|++|++++|++.+..|..+..+++|+.|+++           +|
T Consensus       270 ~~~~~~~l~~L~~L~l~~n~l~-~lp~~--l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~-----------~n  335 (606)
T 3t6q_A          270 SSNTFHCFSGLQELDLTATHLS-ELPSG--LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK-----------GN  335 (606)
T ss_dssp             CTTTTTTCTTCSEEECTTSCCS-CCCSS--CCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC-----------SC
T ss_pred             CHHHhccccCCCEEeccCCccC-CCChh--hcccccCCEEECccCCcCcCchhhhhccCcCCEEECC-----------CC
Confidence            8888999999999999999988 44543  6788899999999999988777777666555555444           44


Q ss_pred             cee-echhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCC--CcccccCCCCcEEEccCccccCCCCccccCCCc
Q 002214          323 YLT-FSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSL--PITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSR  399 (952)
Q Consensus       323 ~l~-~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  399 (952)
                      .+. ..+              ...++.+++|++|++++|.+++..  +..+..+++|++|++++|.+.+..|..|..+++
T Consensus       336 ~~~~~~~--------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  401 (606)
T 3t6q_A          336 TKRLELG--------------TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ  401 (606)
T ss_dssp             SSCCBCC--------------SSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTT
T ss_pred             Ccccccc--------------hhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCcc
Confidence            332 111              123678889999999999998665  778889999999999999998888899999999


Q ss_pred             ceEEEeccccccccCCC-ccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCC---Cchhhhccccccee
Q 002214          400 LYVVYLNRNKLSGSIPS-CLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGS---LPLEIENLKAVVDI  475 (952)
Q Consensus       400 L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L  475 (952)
                      |+.|++++|++.+..+. .+..+++|++|++++|++++..+..|..+++|+.|++++|++++.   .+..+..+++|+.|
T Consensus       402 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L  481 (606)
T 3t6q_A          402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL  481 (606)
T ss_dssp             CSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEE
T ss_pred             CCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEE
Confidence            99999999999876654 488899999999999999988888999999999999999998762   33678889999999


Q ss_pred             ecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccc
Q 002214          476 YLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLV  555 (952)
Q Consensus       476 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  555 (952)
                      +|++|++++..|..|..+++|+.|+|++|++++..|..|..+++| .|+|++|++++.+|..+..+++|+.|++++|+|.
T Consensus       482 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  560 (606)
T 3t6q_A          482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD  560 (606)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEE
T ss_pred             ECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcc
Confidence            999999998888999999999999999999998888999999999 9999999999888888999999999999999999


Q ss_pred             cCCCCC
Q 002214          556 GEIPRG  561 (952)
Q Consensus       556 ~~~p~~  561 (952)
                      |.++..
T Consensus       561 c~c~~~  566 (606)
T 3t6q_A          561 CTCSNI  566 (606)
T ss_dssp             CSGGGH
T ss_pred             ccCCcH
Confidence            988753

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2.9e-55  Score=526.89  Aligned_cols=512  Identities=21%  Similarity=0.228  Sum_probs=439.5

Q ss_pred             EEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCcc
Q 002214           37 SLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNL  116 (952)
Q Consensus        37 ~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~  116 (952)
                      .++.++.+++ .+|..+..  ++++|+|++|.|++..|..|..+++|++|+|++|++.+..|.+|+++++|++|+|++|+
T Consensus        16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~   92 (606)
T 3t6q_A           16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP   92 (606)
T ss_dssp             EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence            5677777877 67877764  79999999999998889999999999999999999998889999999999999999999


Q ss_pred             CccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCC
Q 002214          117 LTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLP  196 (952)
Q Consensus       117 l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  196 (952)
                      +++..|..+.++..+ +.|++++|++++ ++...+.++++|++|+|++|++++..+..+..+++|+.|++++|++++..|
T Consensus        93 l~~~~~~~~~~l~~L-~~L~L~~n~i~~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  170 (606)
T 3t6q_A           93 LIFMAETALSGPKAL-KHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK  170 (606)
T ss_dssp             CSEECTTTTSSCTTC-CEEECTTSCCSC-GGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECH
T ss_pred             ccccChhhhcccccc-cEeeccccCccc-CCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccCh
Confidence            998888899888876 999999999984 544556889999999999999997554556669999999999999998889


Q ss_pred             ccccccCCcc--EEEeeCCcCCccCchhhhccCCCcEeeecccccc--------------------------ccCCcccc
Q 002214          197 RDLGNSTKLK--SLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLV--------------------------GFVPDTIF  248 (952)
Q Consensus       197 ~~~~~l~~L~--~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~--------------------------~~~~~~~~  248 (952)
                      ..|+.+++|+  +|++++|.+++..|..+.. .+|+.|++++|...                          .+.+..+.
T Consensus       171 ~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~  249 (606)
T 3t6q_A          171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE  249 (606)
T ss_dssp             HHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGG
T ss_pred             hhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhc
Confidence            9999999999  9999999999777766654 68999998876411                          12223333


Q ss_pred             CCC--CccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceee
Q 002214          249 NIS--TLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTF  326 (952)
Q Consensus       249 ~l~--~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~  326 (952)
                      .+.  +|+.|++++|.+++..+.  .+..+++|++|++++|+++ .+|..+..+           ++|+.|++++|.++.
T Consensus       250 ~l~~~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~-~lp~~l~~l-----------~~L~~L~l~~n~l~~  315 (606)
T 3t6q_A          250 GLCEMSVESINLQKHYFFNISSN--TFHCFSGLQELDLTATHLS-ELPSGLVGL-----------STLKKLVLSANKFEN  315 (606)
T ss_dssp             GGGGSEEEEEECTTCCCSSCCTT--TTTTCTTCSEEECTTSCCS-CCCSSCCSC-----------TTCCEEECTTCCCSB
T ss_pred             hhhcCceeEEEeecCccCccCHH--HhccccCCCEEeccCCccC-CCChhhccc-----------ccCCEEECccCCcCc
Confidence            333  799999999999876443  4788999999999999998 556655554           456666666666654


Q ss_pred             chhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCC-CcccccCCCCcEEEccCccccCCC--CccccCCCcceEE
Q 002214          327 STSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSL-PITLGRLKKLQGLDLQNNKFEGPI--PQEFCHFSRLYVV  403 (952)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L  403 (952)
                      .+..              .++.+++|++|++++|.+.+.. +..+..+++|++|++++|.+++..  +..+..+++|+.|
T Consensus       316 ~~~~--------------~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L  381 (606)
T 3t6q_A          316 LCQI--------------SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL  381 (606)
T ss_dssp             GGGG--------------CGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEE
T ss_pred             Cchh--------------hhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEE
Confidence            4332              4678999999999999998555 456999999999999999998776  7889999999999


Q ss_pred             EeccccccccCCCccCCCCCCcEEeccccccCCcCCc-cccCCCCCceeEecCCccCCCCchhhhcccccceeecCCccc
Q 002214          404 YLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPS-TFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNL  482 (952)
Q Consensus       404 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  482 (952)
                      ++++|++.+..|..|..+++|++|++++|++++..+. .|..+++|+.|++++|.+++..|..+..+++|++|+|++|++
T Consensus       382 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  461 (606)
T 3t6q_A          382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF  461 (606)
T ss_dssp             ECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBC
T ss_pred             ECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCC
Confidence            9999999999999999999999999999999987654 489999999999999999998999999999999999999999


Q ss_pred             CCC---CcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCC
Q 002214          483 SGN---IPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIP  559 (952)
Q Consensus       483 ~~~---~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  559 (952)
                      ++.   .+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+..++.| .|++++|++++.+|
T Consensus       462 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~  540 (606)
T 3t6q_A          462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP  540 (606)
T ss_dssp             GGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCG
T ss_pred             CccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCH
Confidence            862   34679999999999999999998889999999999999999999999999999999999 99999999998777


Q ss_pred             CC-CCcccccccccccCccCCCCCc
Q 002214          560 RG-GAFANFSAESFIGNDLLCGSPY  583 (952)
Q Consensus       560 ~~-~~~~~~~~~~~~~n~~~c~~p~  583 (952)
                      .. ..+.++....+.+||+.|+|+.
T Consensus       541 ~~~~~l~~L~~L~l~~N~~~c~c~~  565 (606)
T 3t6q_A          541 SLLPILSQQRTINLRQNPLDCTCSN  565 (606)
T ss_dssp             GGHHHHHTSSEEECTTCCEECSGGG
T ss_pred             hhcccCCCCCEEeCCCCCccccCCc
Confidence            53 3456777888999999999884

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=6.8e-55  Score=523.70  Aligned_cols=489  Identities=22%  Similarity=0.187  Sum_probs=399.2

Q ss_pred             CeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEee
Q 002214           33 NRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVL  112 (952)
Q Consensus        33 ~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  112 (952)
                      .++++|+++++.+++..|..++++++|++|+|++|.+++..|..|.++++|++|+|++|++.+..|.+|+++++|++|+|
T Consensus        32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  111 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA  111 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred             CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence            56888888888888777778888888888888888888777778888888888888888888777888888888888888


Q ss_pred             cCccCccccCcccccccccccceeeccccccc-cCCCCCCCCCCccceEEcccCcccccCCccccCCCCCc----EEEcc
Q 002214          113 NNNLLTGTIPASIFNLSFISTALDFSDNSLTG-SFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELS----SVSLS  187 (952)
Q Consensus       113 ~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~----~L~L~  187 (952)
                      ++|.+++..|..++++..+ +.|++++|.+++ .+|.. +.++++|++|++++|++++..|..|..+.+|+    .|+++
T Consensus       112 ~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~lp~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~  189 (606)
T 3vq2_A          112 VETKLASLESFPIGQLITL-KKLNVAHNFIHSCKLPAY-FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS  189 (606)
T ss_dssp             TTSCCCCSSSSCCTTCTTC-CEEECCSSCCCCCCCCGG-GGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECT
T ss_pred             cCCccccccccccCCCCCC-CEEeCCCCcccceechHh-HhhcCCCCEEEccCCcceecChhhhhhhhccccccceeecc
Confidence            8888885555777777765 888888888875 45543 45788888888888888877777777766655    78888


Q ss_pred             CCcccccCCccccccCCccEEEeeCCcCC-ccCchhhhccCCCcEeee--------------------------------
Q 002214          188 YNQFTGRLPRDLGNSTKLKSLDLGFNNLN-GEIPQEIGNLRNLEILGI--------------------------------  234 (952)
Q Consensus       188 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L--------------------------------  234 (952)
                      +|.+++..+..+... +|++|++++|.+. +..|..++.+++|+.+.+                                
T Consensus       190 ~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l  268 (606)
T 3vq2_A          190 LNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL  268 (606)
T ss_dssp             TCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEE
T ss_pred             CCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheec
Confidence            888886666666554 7888888888876 456777777877777666                                


Q ss_pred             -ccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCc
Q 002214          235 -DQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSN  313 (952)
Q Consensus       235 -~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~  313 (952)
                       ..|.+.+..|. +..+++|+.|++++|.+.. ++   .+..+++|++|++++|++ +.+|. + .+++|+.++++.|..
T Consensus       269 ~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~---~l~~~~~L~~L~l~~n~l-~~lp~-~-~l~~L~~L~l~~n~~  340 (606)
T 3vq2_A          269 TYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE---DVPKHFKWQSLSIIRCQL-KQFPT-L-DLPFLKSLTLTMNKG  340 (606)
T ss_dssp             CCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC---CCCTTCCCSEEEEESCCC-SSCCC-C-CCSSCCEEEEESCSS
T ss_pred             cccccccccccc-cccCCCCCEEEecCccchh-hh---hccccccCCEEEcccccC-ccccc-C-CCCccceeeccCCcC
Confidence             44455555555 7788899999999998864 33   477788899999999998 45553 3 555555555544432


Q ss_pred             cccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCC--CCcccccCCCCcEEEccCccccCCCC
Q 002214          314 LKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGS--LPITLGRLKKLQGLDLQNNKFEGPIP  391 (952)
Q Consensus       314 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~l~~L~~L~L~~N~i~~~~~  391 (952)
                      +..                           ..++.+++|++|++++|++++.  .+..+..+++|++|++++|.+.+ .|
T Consensus       341 ~~~---------------------------~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~  392 (606)
T 3vq2_A          341 SIS---------------------------FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MS  392 (606)
T ss_dssp             CEE---------------------------CCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-EC
T ss_pred             ccc---------------------------hhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-ch
Confidence            211                           1356788999999999999865  37888999999999999999985 55


Q ss_pred             ccccCCCcceEEEeccccccccCC-CccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCC-CCchhhhcc
Q 002214          392 QEFCHFSRLYVVYLNRNKLSGSIP-SCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNG-SLPLEIENL  469 (952)
Q Consensus       392 ~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l  469 (952)
                      ..|..+++|+.|++++|++.+..| ..+..+++|++|++++|++++..|..|..+++|+.|++++|++++ ..|..+..+
T Consensus       393 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l  472 (606)
T 3vq2_A          393 ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANT  472 (606)
T ss_dssp             CCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTC
T ss_pred             hhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccC
Confidence            888999999999999999998777 688999999999999999999899999999999999999999987 478889999


Q ss_pred             cccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhccc-cccccc
Q 002214          470 KAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLL-YLKSLN  548 (952)
Q Consensus       470 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~  548 (952)
                      ++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|+|+ .+|..+..++ +|+.|+
T Consensus       473 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~  551 (606)
T 3vq2_A          473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFN  551 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEE
T ss_pred             CCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEE
Confidence            99999999999999888999999999999999999999888999999999999999999998 5666688887 599999


Q ss_pred             ccccccccCCCCC
Q 002214          549 LSFNKLVGEIPRG  561 (952)
Q Consensus       549 l~~N~l~~~~p~~  561 (952)
                      +++|+|.|.++..
T Consensus       552 l~~N~~~c~c~~~  564 (606)
T 3vq2_A          552 LTNNSVACICEHQ  564 (606)
T ss_dssp             CCSCCCCCSSTTH
T ss_pred             ccCCCcccCCccH
Confidence            9999999988864

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-54  Score=537.80  Aligned_cols=520  Identities=24%  Similarity=0.246  Sum_probs=304.7

Q ss_pred             CCCCceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeecccccccccc-CCCcCCcCCCcEEeCcCCcccccCC
Q 002214           20 VCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTI-PKEIGNLTKLKELHLDYNKLQGEIP   98 (952)
Q Consensus        20 ~c~w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~p   98 (952)
                      .|.|.+|-+  ...++++|||++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++.+..|
T Consensus        13 ~~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p   90 (844)
T 3j0a_A           13 FCNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP   90 (844)
T ss_dssp             CCCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT
T ss_pred             CCCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH
Confidence            466777766  4568899999999998888889999999999999999666566 7789999999999999999998889


Q ss_pred             hhhcCCCCCCeEeecCccCccccCcc--cccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCcccc
Q 002214           99 EELGNLAELEMLVLNNNLLTGTIPAS--IFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLW  176 (952)
Q Consensus        99 ~~l~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~  176 (952)
                      .+|+++++|++|+|++|.+++.+|..  +.+++.+ +.|++++|.+++..+...+.++++|++|+|++|.+++..+..+.
T Consensus        91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L-~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~  169 (844)
T 3j0a_A           91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL-TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE  169 (844)
T ss_dssp             TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSC-CEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGH
T ss_pred             hHccCCcccCEeeCcCCCCCcccccCccccccCCC-CEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcc
Confidence            99999999999999999998766665  7777765 88999999998766666778899999999999999888888888


Q ss_pred             CC--CCCcEEEccCCcccccCCccccccCC------ccEEEeeCCcCCccCchhhhcc---CCCcEeeecc---------
Q 002214          177 HC--KELSSVSLSYNQFTGRLPRDLGNSTK------LKSLDLGFNNLNGEIPQEIGNL---RNLEILGIDQ---------  236 (952)
Q Consensus       177 ~l--~~L~~L~L~~N~l~~~~~~~~~~l~~------L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~---------  236 (952)
                      .+  ++|+.|++++|.+.+..|..++.+.+      |++|+|++|.+++..|..+...   .+++.|.++.         
T Consensus       170 ~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~  249 (844)
T 3j0a_A          170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGF  249 (844)
T ss_dssp             HHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSC
T ss_pred             cccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccc
Confidence            77  88999999999998888877776665      8999999998877666665543   2333333331         


Q ss_pred             ccccccCCccccCC--CCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCcc
Q 002214          237 SNLVGFVPDTIFNI--STLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNL  314 (952)
Q Consensus       237 n~~~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L  314 (952)
                      +++....+..|..+  ++|+.|++++|.+.+..+.  .+..+++|+.|+|++|++++..+..|.++++|           
T Consensus       250 ~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~--~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L-----------  316 (844)
T 3j0a_A          250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR--VFETLKDLKVLNLAYNKINKIADEAFYGLDNL-----------  316 (844)
T ss_dssp             SSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSC--CSSSCCCCCEEEEESCCCCEECTTTTTTCSSC-----------
T ss_pred             cccCCCChhhhhccccCCccEEECCCCcccccChh--hhhcCCCCCEEECCCCcCCCCChHHhcCCCCC-----------
Confidence            11222222222222  3455555555555443222  24445555555555555554444444333322           


Q ss_pred             ccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccc
Q 002214          315 KRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEF  394 (952)
Q Consensus       315 ~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~  394 (952)
                      +.|++++|.++....              ..++.+++|+.|++++|+++.+.+..|..+++|++|+|++|.++++.    
T Consensus       317 ~~L~Ls~N~l~~~~~--------------~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~----  378 (844)
T 3j0a_A          317 QVLNLSYNLLGELYS--------------SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH----  378 (844)
T ss_dssp             CEEEEESCCCSCCCS--------------CSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS----
T ss_pred             CEEECCCCCCCccCH--------------HHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc----
Confidence            222223332221111              12344555555555555555444444555555555555555554211    


Q ss_pred             cCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCc-cccCCCCCceeEecCCccCCCCch-hhhccccc
Q 002214          395 CHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPS-TFWNLEDILGFDFSSNSLNGSLPL-EIENLKAV  472 (952)
Q Consensus       395 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L  472 (952)
                       .+++|+.|++++|+++ .+|..   ..+++.|++++|++++.... .+..+++|+.|+|++|++++..+. .+..+++|
T Consensus       379 -~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L  453 (844)
T 3j0a_A          379 -FIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL  453 (844)
T ss_dssp             -SCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTC
T ss_pred             -CCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCcc
Confidence             1444555555555554 22221   23444444444444433211 123444444444444444432221 23334444


Q ss_pred             ceeecCCcccC-----CCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccc
Q 002214          473 VDIYLSRNNLS-----GNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSL  547 (952)
Q Consensus       473 ~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  547 (952)
                      +.|+|++|.++     +..+..|.++++|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++.+|..+.  ++|+.|
T Consensus       454 ~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L  531 (844)
T 3j0a_A          454 EQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEIL  531 (844)
T ss_dssp             CBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEE
T ss_pred             ccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEE
Confidence            44444444443     22223344444444444444444444444444444444444444444444333333  444444


Q ss_pred             cccccccccCCCCCCCcccccccccccCccCCCCC
Q 002214          548 NLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSP  582 (952)
Q Consensus       548 ~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p  582 (952)
                      +|++|++++.+|.  .|..+....+.+|||.|+|+
T Consensus       532 ~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          532 DISRNQLLAPNPD--VFVSLSVLDITHNKFICECE  564 (844)
T ss_dssp             EEEEECCCCCCSC--CCSSCCEEEEEEECCCCSSS
T ss_pred             ECCCCcCCCCChh--HhCCcCEEEecCCCcccccc
Confidence            4444444444442  23344444444444444444

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=4.9e-54  Score=516.24  Aligned_cols=507  Identities=21%  Similarity=0.206  Sum_probs=434.0

Q ss_pred             EEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCc
Q 002214           36 TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNN  115 (952)
Q Consensus        36 ~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n  115 (952)
                      +.++.++.+++ .+|..+.  +++++|+|++|.+++..+..|.++++|++|+|++|++.+..|.+|+++++|++|+|++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n   90 (606)
T 3vq2_A           14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN   90 (606)
T ss_dssp             TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence            46788899987 7887765  79999999999999888889999999999999999999888999999999999999999


Q ss_pred             cCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccc-cCCccccCCCCCcEEEccCCccccc
Q 002214          116 LLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG-PIPNNLWHCKELSSVSLSYNQFTGR  194 (952)
Q Consensus       116 ~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~  194 (952)
                      ++++..|..+.++..+ ++|++++|+++ .++...+.++++|++|++++|++++ .+|..|+++++|++|++++|++++.
T Consensus        91 ~l~~~~p~~~~~l~~L-~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~  168 (606)
T 3vq2_A           91 PIQSFSPGSFSGLTSL-ENLVAVETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI  168 (606)
T ss_dssp             CCCCCCTTSSTTCTTC-CEEECTTSCCC-CSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEE
T ss_pred             cccccChhhcCCcccC-CEEEccCCccc-cccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceec
Confidence            9997779999999876 99999999998 4555557899999999999999986 5799999999999999999999999


Q ss_pred             CCccccccCCcc----EEEeeCCcCCccCchhhhccCCCcEeeecccccc-ccCCccccCCCCccEEEee----------
Q 002214          195 LPRDLGNSTKLK----SLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLV-GFVPDTIFNISTLKILSLF----------  259 (952)
Q Consensus       195 ~~~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~-~~~~~~~~~l~~L~~L~Ls----------  259 (952)
                      .|..|+.+++|+    +|++++|.+++..+..+... +|+.|++++|.+. ...|..+.++++|+.+++.          
T Consensus       169 ~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l  247 (606)
T 3vq2_A          169 TVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL  247 (606)
T ss_dssp             CTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCC
T ss_pred             ChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcc
Confidence            899999888776    89999999996666666555 9999999999886 4566777788888877774          


Q ss_pred             -----------------------CccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCcccc
Q 002214          260 -----------------------NNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKR  316 (952)
Q Consensus       260 -----------------------~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~  316 (952)
                                             .|.+.+..+.   +..+++|+.|++++|.+... | .+..           +.+|+.
T Consensus       248 ~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~---~~~l~~L~~L~l~~~~~~~l-~-~l~~-----------~~~L~~  311 (606)
T 3vq2_A          248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK---FHCLANVSAMSLAGVSIKYL-E-DVPK-----------HFKWQS  311 (606)
T ss_dssp             SCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS---CGGGTTCSEEEEESCCCCCC-C-CCCT-----------TCCCSE
T ss_pred             cccChHHhhhhhhccHhheeccccccccccccc---cccCCCCCEEEecCccchhh-h-hccc-----------cccCCE
Confidence                                   3444444332   55667777788887777643 3 3333           345666


Q ss_pred             ccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCC--CCccc
Q 002214          317 LGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGP--IPQEF  394 (952)
Q Consensus       317 L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~--~~~~~  394 (952)
                      |++++|.+...+                .+ .+++|++|++++|...+..  .+..+++|++|++++|.+++.  .+..+
T Consensus       312 L~l~~n~l~~lp----------------~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~  372 (606)
T 3vq2_A          312 LSIIRCQLKQFP----------------TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSD  372 (606)
T ss_dssp             EEEESCCCSSCC----------------CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHH
T ss_pred             EEcccccCcccc----------------cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhh
Confidence            777777664433                14 7889999999999665433  678999999999999999866  38889


Q ss_pred             cCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCC-ccccCCCCCceeEecCCccCCCCchhhhcccccc
Q 002214          395 CHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIP-STFWNLEDILGFDFSSNSLNGSLPLEIENLKAVV  473 (952)
Q Consensus       395 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  473 (952)
                      ..+++|+.|++++|.+++ +|..+..+++|+.|++++|++++..+ ..|..+++|+.|++++|.+.+..|..+..+++|+
T Consensus       373 ~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  451 (606)
T 3vq2_A          373 LGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN  451 (606)
T ss_dssp             HCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred             ccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCC
Confidence            999999999999999994 66889999999999999999999887 7899999999999999999999999999999999


Q ss_pred             eeecCCcccCC-CCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhccccccccccccc
Q 002214          474 DIYLSRNNLSG-NIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFN  552 (952)
Q Consensus       474 ~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  552 (952)
                      +|++++|++++ .+|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++.+|..|..+++|+.|++++|
T Consensus       452 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  531 (606)
T 3vq2_A          452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN  531 (606)
T ss_dssp             EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTS
T ss_pred             EEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCC
Confidence            99999999997 47889999999999999999999988999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC-CCcc-cccccccccCccCCCCCccC
Q 002214          553 KLVGEIPRG-GAFA-NFSAESFIGNDLLCGSPYLH  585 (952)
Q Consensus       553 ~l~~~~p~~-~~~~-~~~~~~~~~n~~~c~~p~~~  585 (952)
                      +++ .+|.. ..+. ++....+.+||+.|+|+..+
T Consensus       532 ~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~  565 (606)
T 3vq2_A          532 RIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQK  565 (606)
T ss_dssp             CCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTHH
T ss_pred             cCc-ccCHhHhhhcccCcEEEccCCCcccCCccHH
Confidence            999 45543 2232 46677889999999999643

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.9e-55  Score=526.14  Aligned_cols=476  Identities=21%  Similarity=0.316  Sum_probs=351.1

Q ss_pred             ccCCCCCCCCC---ceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeeccccccc------c------ccCCCc
Q 002214           13 NWTSNASVCSW---MGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFS------G------TIPKEI   77 (952)
Q Consensus        13 ~~~~~~~~c~w---~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~------~------~~p~~l   77 (952)
                      +|..+++||.|   .||+|+.. ++|++|+|+++++.|.+|+.|+++++|++|+|++|.+.      +      .+|...
T Consensus        59 ~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~  137 (636)
T 4eco_A           59 NWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ  137 (636)
T ss_dssp             CCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH
T ss_pred             CCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH
Confidence            89878999999   99999865 69999999999999999999999999999999999872      2      334333


Q ss_pred             CCcCCCcEEeCcCCcccccCChhhcC-CCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCc
Q 002214           78 GNLTKLKELHLDYNKLQGEIPEELGN-LAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPR  156 (952)
Q Consensus        78 ~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~  156 (952)
                        +..|+ +++++|.+.+..|..++. +..+..+++....+...   ....+..  ..+...+|+++| +|.. +..+++
T Consensus       138 --~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~---~~~~l~~--l~l~~~~n~l~~-ip~~-l~~l~~  207 (636)
T 4eco_A          138 --KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS---SRITLKD--TQIGQLSNNITF-VSKA-VMRLTK  207 (636)
T ss_dssp             --HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCC---CCCCCCT--TTTTCCSCEEEE-ECGG-GGGCTT
T ss_pred             --HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccc---cccchhh--hhhccccCCCcc-CCHH-HhcccC
Confidence              55677 788888877777666552 12222233322221100   0000000  122233566776 6654 456778


Q ss_pred             cceEEcccCccccc-----------------CCcccc--CCCCCcEEEccCCcccccCCccccccCCccEEEeeCCc-CC
Q 002214          157 LKGLYVSYNQFKGP-----------------IPNNLW--HCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNN-LN  216 (952)
Q Consensus       157 L~~L~L~~n~l~~~-----------------~~~~l~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~  216 (952)
                      |++|+|++|++++.                 +|..+.  ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++
T Consensus       208 L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~  287 (636)
T 4eco_A          208 LRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS  287 (636)
T ss_dssp             CCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSC
T ss_pred             CCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCc
Confidence            88888888888864                 788888  88888888888888888888888888888888888887 87


Q ss_pred             c-cCchhhhcc------CCCcEeeeccccccccCCc--cccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccC
Q 002214          217 G-EIPQEIGNL------RNLEILGIDQSNLVGFVPD--TIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLN  287 (952)
Q Consensus       217 ~-~~p~~~~~l------~~L~~L~L~~n~~~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N  287 (952)
                      + .+|..++.+      ++|+.|++++|++. .+|.  .+.++++|++|++++|++++.+|   .+..+++|++|++++|
T Consensus       288 ~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip---~~~~l~~L~~L~L~~N  363 (636)
T 4eco_A          288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP---AFGSEIKLASLNLAYN  363 (636)
T ss_dssp             HHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC---CCEEEEEESEEECCSS
T ss_pred             cccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh---hhCCCCCCCEEECCCC
Confidence            7 788888776      88888888888887 5666  78888888888888888876666   3666777888888888


Q ss_pred             cCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCc-ccEEEccCCCCCCCC
Q 002214          288 NLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLIN-LTTLSLGDNNLSGSL  366 (952)
Q Consensus       288 ~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~-L~~L~L~~n~l~~~~  366 (952)
                      +++ .+|..                                                 ++.+++ |++|++++|+++ .+
T Consensus       364 ~l~-~lp~~-------------------------------------------------l~~l~~~L~~L~Ls~N~l~-~l  392 (636)
T 4eco_A          364 QIT-EIPAN-------------------------------------------------FCGFTEQVENLSFAHNKLK-YI  392 (636)
T ss_dssp             EEE-ECCTT-------------------------------------------------SEEECTTCCEEECCSSCCS-SC
T ss_pred             ccc-cccHh-------------------------------------------------hhhhcccCcEEEccCCcCc-cc
Confidence            777 44433                                                 234556 777777777777 56


Q ss_pred             CcccccCC--CCcEEEccCccccCCCCcccc-------CCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCc
Q 002214          367 PITLGRLK--KLQGLDLQNNKFEGPIPQEFC-------HFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSV  437 (952)
Q Consensus       367 ~~~l~~l~--~L~~L~L~~N~i~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  437 (952)
                      |..+..++  +|++|++++|.+.+..|..|.       .+++|+.|+|++|++++..+..+..+++|++|+|++|+++.+
T Consensus       393 p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i  472 (636)
T 4eco_A          393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI  472 (636)
T ss_dssp             CSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBC
T ss_pred             chhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCc
Confidence            66666544  788888888888777777777       667788888888888744444455678888888888888765


Q ss_pred             CCccccCCC-------CCceeEecCCccCCCCchhhh--cccccceeecCCcccCCCCcccccCCCCCceEEc------c
Q 002214          438 IPSTFWNLE-------DILGFDFSSNSLNGSLPLEIE--NLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSL------E  502 (952)
Q Consensus       438 ~~~~~~~l~-------~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L------~  502 (952)
                      ++..+....       +|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|      +
T Consensus       473 ~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls  550 (636)
T 4eco_A          473 PKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQ  550 (636)
T ss_dssp             CSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTT
T ss_pred             CHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccc
Confidence            555555443       7888888888888 5676665  78888888888888886 6777888888888888      5


Q ss_pred             CccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCC
Q 002214          503 HNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIP  559 (952)
Q Consensus       503 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  559 (952)
                      +|++.+.+|..+..+++|+.|+|++|+|+ .+|..+.  ++|+.|++++|++.+..+
T Consensus       551 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~~~  604 (636)
T 4eco_A          551 GNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKDNPNISIDL  604 (636)
T ss_dssp             CCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--TTCCEEECCSCTTCEEEC
T ss_pred             cCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh--CcCCEEECcCCCCccccH
Confidence            67778888888888999999999999984 6676655  788999999998876443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-53  Score=524.43  Aligned_cols=504  Identities=23%  Similarity=0.204  Sum_probs=422.6

Q ss_pred             EEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccC-ChhhcCCCCCCeEeecC
Q 002214           36 TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEI-PEELGNLAELEMLVLNN  114 (952)
Q Consensus        36 ~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~  114 (952)
                      ...|.++++++ .+|.   ..++|++|+|++|.|++..|..|..+++|++|+|++|...+.+ |.+|+++++|++|+|++
T Consensus         7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~   82 (844)
T 3j0a_A            7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS   82 (844)
T ss_dssp             EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred             eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence            56777888888 6776   5589999999999999888999999999999999999655455 88999999999999999


Q ss_pred             ccCccccCcccccccccccceeeccccccccCCC-CCCCCCCccceEEcccCcccccCC-ccccCCCCCcEEEccCCccc
Q 002214          115 NLLTGTIPASIFNLSFISTALDFSDNSLTGSFPY-DMCPGLPRLKGLYVSYNQFKGPIP-NNLWHCKELSSVSLSYNQFT  192 (952)
Q Consensus       115 n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~  192 (952)
                      |.+++..|..+.++..+ +.|++++|.+++.+|. ..+..+++|++|+|++|++++..+ ..|+++++|+.|+|++|.++
T Consensus        83 N~l~~~~p~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~  161 (844)
T 3j0a_A           83 SKIYFLHPDAFQGLFHL-FELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF  161 (844)
T ss_dssp             CCCCEECTTSSCSCSSC-CCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred             CcCcccCHhHccCCccc-CEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence            99998889999998876 9999999999986654 457899999999999999987654 57999999999999999999


Q ss_pred             ccCCcccccc--CCccEEEeeCCcCCccCchhhhccCC------CcEeeeccccccccCCccccCC---CCccEEEeeCc
Q 002214          193 GRLPRDLGNS--TKLKSLDLGFNNLNGEIPQEIGNLRN------LEILGIDQSNLVGFVPDTIFNI---STLKILSLFNN  261 (952)
Q Consensus       193 ~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~------L~~L~L~~n~~~~~~~~~~~~l---~~L~~L~Ls~N  261 (952)
                      +..+..++.+  ++|+.|+|++|.+.+..|..++.+.+      |+.|++++|++.+..+..+...   .+++.|.++.+
T Consensus       162 ~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~  241 (844)
T 3j0a_A          162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH  241 (844)
T ss_dssp             CCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSS
T ss_pred             eeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccc
Confidence            9999999988  89999999999999888888777766      9999999999988877777643   67888988754


Q ss_pred             cccccC-------CCCcccCCC--CCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHH
Q 002214          262 TLSGNL-------PSSKNLIGL--PNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELM  332 (952)
Q Consensus       262 ~l~~~~-------~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~  332 (952)
                      .+....       +....+.++  ++|+.|++++|.+.+..+..|..+++           |+.|++++|.++..+..  
T Consensus       242 ~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~-----------L~~L~L~~n~i~~~~~~--  308 (844)
T 3j0a_A          242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD-----------LKVLNLAYNKINKIADE--  308 (844)
T ss_dssp             CCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCC-----------CCEEEEESCCCCEECTT--
T ss_pred             cccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCC-----------CCEEECCCCcCCCCChH--
Confidence            332111       011223443  78999999999999888888766654           55566666666544332  


Q ss_pred             HHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccc
Q 002214          333 SLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSG  412 (952)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  412 (952)
                                  .|+++++|++|+|++|++++..+..|..+++|++|++++|.|..+.+..|..+++|+.|+|++|.+++
T Consensus       309 ------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~  376 (844)
T 3j0a_A          309 ------------AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT  376 (844)
T ss_dssp             ------------TTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC
T ss_pred             ------------HhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc
Confidence                        46789999999999999998889999999999999999999998889999999999999999999984


Q ss_pred             cCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCC-chhhhcccccceeecCCcccCCCCcc-cc
Q 002214          413 SIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSL-PLEIENLKAVVDIYLSRNNLSGNIPS-TI  490 (952)
Q Consensus       413 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~  490 (952)
                      .     ..+++|+.|++++|+++.++. .   ..+++.|++++|++++.. +..+..+++|+.|+|++|++++..+. .+
T Consensus       377 i-----~~~~~L~~L~l~~N~l~~l~~-~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  447 (844)
T 3j0a_A          377 I-----HFIPSIPDIFLSGNKLVTLPK-I---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTP  447 (844)
T ss_dssp             C-----SSCCSCSEEEEESCCCCCCCC-C---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSS
T ss_pred             c-----cCCCCcchhccCCCCcccccc-c---ccccceeecccCccccCchhhhhhcCCccceeeCCCCccccccccccc
Confidence            3     338899999999999996533 2   568999999999999643 33456899999999999999976544 46


Q ss_pred             cCCCCCceEEccCcccc-----CcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCCCcc
Q 002214          491 IGLKNLQHLSLEHNKLQ-----GPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFA  565 (952)
Q Consensus       491 ~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~  565 (952)
                      ..+++|+.|+|++|.++     +..+..|..+++|+.|+|++|+|++.+|..|..+++|+.|+|++|++++..|.... .
T Consensus       448 ~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~  526 (844)
T 3j0a_A          448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-A  526 (844)
T ss_dssp             CSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-S
T ss_pred             ccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-c
Confidence            67899999999999997     44456799999999999999999999999999999999999999999986665433 6


Q ss_pred             cccccccccCccCC
Q 002214          566 NFSAESFIGNDLLC  579 (952)
Q Consensus       566 ~~~~~~~~~n~~~c  579 (952)
                      ++....+.+|....
T Consensus       527 ~L~~L~Ls~N~l~~  540 (844)
T 3j0a_A          527 NLEILDISRNQLLA  540 (844)
T ss_dssp             CCCEEEEEEECCCC
T ss_pred             cccEEECCCCcCCC
Confidence            66667777775543

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=5.4e-53  Score=513.20  Aligned_cols=481  Identities=20%  Similarity=0.280  Sum_probs=349.3

Q ss_pred             cCCCCccccccCCCCCC--CCC------------ceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeec-cccc
Q 002214            4 DNPNNILAQNWTSNASV--CSW------------MGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVL-SRNW   68 (952)
Q Consensus         4 ~~~~~~~~~~~~~~~~~--c~w------------~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L-~~n~   68 (952)
                      .||+|.-+.+|.+ .++  |.|            .||+|+. .++|+.|+|+++++.|.+|+.|++|++|++|+| ++|.
T Consensus       282 ~~~~W~~~~~~~~-~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~  359 (876)
T 4ecn_A          282 DGKNWRYYSGTIN-NTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSE  359 (876)
T ss_dssp             TGGGCCCCCSSCS-SCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTH
T ss_pred             CCCCCCcCCCccc-ccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCchHHhccccceEeeeccccc
Confidence            3565555544532 244  999            9999997 579999999999999999999999999999999 8898


Q ss_pred             cccccCCCc---------------------------------------------------CCcCCCcEEeCcC--Ccccc
Q 002214           69 FSGTIPKEI---------------------------------------------------GNLTKLKELHLDY--NKLQG   95 (952)
Q Consensus        69 l~~~~p~~l---------------------------------------------------~~l~~L~~L~L~~--n~l~~   95 (952)
                      ++|..|-..                                                   .....++.+.+..  |++.+
T Consensus       360 lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~  439 (876)
T 4ecn_A          360 TVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF  439 (876)
T ss_dssp             HHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE
T ss_pred             ccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccc
Confidence            877643221                                                   1122344444443  77876


Q ss_pred             cCChhhcCCCCCCeEeecCccCcc-ccCcccccccccccceeeccccccccCCCCC-CCCCCccceEEcccCcccccCCc
Q 002214           96 EIPEELGNLAELEMLVLNNNLLTG-TIPASIFNLSFISTALDFSDNSLTGSFPYDM-CPGLPRLKGLYVSYNQFKGPIPN  173 (952)
Q Consensus        96 ~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~  173 (952)
                       +|..|+++++|++|+|++|++++ .+|..+.         ..+.|.++|.+|..+ |.++++|++|+|++|++.+.+|.
T Consensus       440 -IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~---------~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~  509 (876)
T 4ecn_A          440 -ISKAIQRLTKLQIIYFANSPFTYDNIAVDWE---------DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPD  509 (876)
T ss_dssp             -ECGGGGGCTTCCEEEEESCCCCGGGBSSSCS---------CTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCG
T ss_pred             -hhHHHhcCCCCCEEECcCCcCCCCccccccc---------ccccccccccCChhhhhccCCCCCEEECcCCCCCccChH
Confidence             78888888888888888888886 2333222         122345555677766 34788888888888888888888


Q ss_pred             cccCCCCCcEEEccCCc-ccc-cCCccccccC-------CccEEEeeCCcCCccCch--hhhccCCCcEeeecccccccc
Q 002214          174 NLWHCKELSSVSLSYNQ-FTG-RLPRDLGNST-------KLKSLDLGFNNLNGEIPQ--EIGNLRNLEILGIDQSNLVGF  242 (952)
Q Consensus       174 ~l~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~n~~~~~  242 (952)
                      .|.++++|+.|+|++|+ +++ .+|..++.++       +|++|+|++|+++ .+|.  .|+.+++|+.|+|++|++. .
T Consensus       510 ~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~  587 (876)
T 4ecn_A          510 FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-H  587 (876)
T ss_dssp             GGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-B
T ss_pred             HHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-c
Confidence            88888888888888887 887 6787777666       8888999988888 7777  8888888899999888888 5


Q ss_pred             CCccccCCCCccEEEeeCccccccCCCCcccCCCCC-cceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccC
Q 002214          243 VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPN-LEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLER  321 (952)
Q Consensus       243 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~  321 (952)
                      +| .+..+++|+.|+|++|+++ .+|..  +..+++ |++|+|++|+++ .+|..+...                     
T Consensus       588 lp-~~~~L~~L~~L~Ls~N~l~-~lp~~--l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~---------------------  641 (876)
T 4ecn_A          588 LE-AFGTNVKLTDLKLDYNQIE-EIPED--FCAFTDQVEGLGFSHNKLK-YIPNIFNAK---------------------  641 (876)
T ss_dssp             CC-CCCTTSEESEEECCSSCCS-CCCTT--SCEECTTCCEEECCSSCCC-SCCSCCCTT---------------------
T ss_pred             ch-hhcCCCcceEEECcCCccc-cchHH--HhhccccCCEEECcCCCCC-cCchhhhcc---------------------
Confidence            55 7888888889999888887 55543  677787 888999988888 455443221                     


Q ss_pred             cceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCccc---c--cCCCCcEEEccCccccCCCCccccC
Q 002214          322 NYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITL---G--RLKKLQGLDLQNNKFEGPIPQEFCH  396 (952)
Q Consensus       322 n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l---~--~l~~L~~L~L~~N~i~~~~~~~~~~  396 (952)
                                                ..++|+.|+|++|++++.+|...   .  .+++|+.|+|++|.|+.+.+..+..
T Consensus       642 --------------------------~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~  695 (876)
T 4ecn_A          642 --------------------------SVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFAT  695 (876)
T ss_dssp             --------------------------CSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHT
T ss_pred             --------------------------ccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHcc
Confidence                                      12346666666666665444221   1  2346666666666666443334446


Q ss_pred             CCcceEEEeccccccccCCCccCC--------CCCCcEEeccccccCCcCCcccc--CCCCCceeEecCCccCCCCchhh
Q 002214          397 FSRLYVVYLNRNKLSGSIPSCLGD--------LNSLRILSLSSNELTSVIPSTFW--NLEDILGFDFSSNSLNGSLPLEI  466 (952)
Q Consensus       397 l~~L~~L~L~~N~l~~~~~~~~~~--------l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~  466 (952)
                      +++|+.|+|++|+|+ .+|..+..        +++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|++++ +|..+
T Consensus       696 l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l  772 (876)
T 4ecn_A          696 GSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQP  772 (876)
T ss_dssp             TCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGG
T ss_pred             CCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhh
Confidence            666666666666666 33333222        226777777777777 3455554  67777777777777775 56677


Q ss_pred             hcccccceeecCC------cccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhc
Q 002214          467 ENLKAVVDIYLSR------NNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEK  540 (952)
Q Consensus       467 ~~l~~L~~L~Ls~------N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  540 (952)
                      ..+++|+.|+|++      |++.+.+|..|..+++|+.|+|++|+|+ .+|..+.  ++|+.|||++|++..+.+..+..
T Consensus       773 ~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L~-~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~  849 (876)
T 4ecn_A          773 LNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLT--PQLYILDIADNPNISIDVTSVCP  849 (876)
T ss_dssp             GGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--SSSCEEECCSCTTCEEECGGGHH
T ss_pred             hcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCCC-ccCHhhc--CCCCEEECCCCCCCccChHHccc
Confidence            7777777777765      8888889999999999999999999994 6777665  68999999999998777777877


Q ss_pred             cccccccccccccccc
Q 002214          541 LLYLKSLNLSFNKLVG  556 (952)
Q Consensus       541 l~~L~~L~l~~N~l~~  556 (952)
                      ...+..+.|.+|++..
T Consensus       850 ~~~~~~~~L~~n~~~~  865 (876)
T 4ecn_A          850 YIEAGMYVLLYDKTQD  865 (876)
T ss_dssp             HHHTTCCEEECCTTSE
T ss_pred             cccchheeecCCCccc
Confidence            7777888888887653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.9e-53  Score=451.53  Aligned_cols=265  Identities=25%  Similarity=0.440  Sum_probs=219.0

Q ss_pred             hccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      .++|.+.+.||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            357888999999999999999863      47889999998766666788999999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEE
Q 002214          737 LVLEYMPKGSLEDCMYASN------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH  804 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~k  804 (952)
                      +|||||++|+|.+++...+            ..++|.++..++.|||+||+||   |+++|+||||||+|||+++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccCHhhEEECCCCcEE
Confidence            9999999999999997532            3699999999999999999999   689999999999999999999999


Q ss_pred             EeccccccccCCcCcccc-cccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccc
Q 002214          805 LSDFGIAKLLSEEDSMKQ-TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDS  882 (952)
Q Consensus       805 l~Dfgla~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  882 (952)
                      |+|||+|+.....+.... ....||+.|||||++.++.++.++|||||||++|||+| |+.||......+          
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~----------  238 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----------  238 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----------
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----------
Confidence            999999987655443322 23568999999999999999999999999999999999 899986532111          


Q ss_pred             hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhhcc
Q 002214          883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIE  950 (952)
Q Consensus       883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~  950 (952)
                         +...+....       ....|..|++++.++|.+||+.||++||||+||.+.|+++.+....-++
T Consensus       239 ---~~~~i~~~~-------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~~ld  296 (299)
T 4asz_A          239 ---VIECITQGR-------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLD  296 (299)
T ss_dssp             ---HHHHHHHTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCCCSC
T ss_pred             ---HHHHHHcCC-------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCcccc
Confidence               111111000       0112456788999999999999999999999999999998765433333

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.3e-52  Score=451.04  Aligned_cols=258  Identities=24%  Similarity=0.443  Sum_probs=209.5

Q ss_pred             ccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..|+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46778899999999999999863      478999999987666667889999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcE
Q 002214          738 VLEYMPKGSLEDCMYASN--------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVA  803 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~  803 (952)
                      |||||++|+|.+++....              .+++|.+++.|+.|||+||+||   |+++||||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHhhEEECCCCcE
Confidence            999999999999987532              3589999999999999999999   68999999999999999999999


Q ss_pred             EEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhcc
Q 002214          804 HLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIND  881 (952)
Q Consensus       804 kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  881 (952)
                      ||+|||+|+.....+.. ......||+.|||||++.+..++.++|||||||++|||+| |+.||......+  .      
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~------  269 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--A------  269 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--H------
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--H------
Confidence            99999999976544332 2234679999999999999999999999999999999999 899986532111  0      


Q ss_pred             chhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          882 SLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                           ...+....       ....|..|++++.+||.+||+.||++||||+||+++|+.+.+.
T Consensus       270 -----~~~i~~g~-------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          270 -----IDCITQGR-------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             -----HHHHHHTC-------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -----HHHHHcCC-------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                 01110000       0112456788999999999999999999999999999998764

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=482.13  Aligned_cols=510  Identities=20%  Similarity=0.203  Sum_probs=344.1

Q ss_pred             eEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeec
Q 002214           34 RVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLN  113 (952)
Q Consensus        34 ~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~  113 (952)
                      .++.|+++++.+++..+..+..+++|++|+|++|++++..|..|.++++|++|+|++|++.+..|.+|+++++|++|+++
T Consensus        29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  108 (570)
T 2z63_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (570)
T ss_dssp             SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence            45555555555554444555555555555555555554444455555555555555555554444555555555555555


Q ss_pred             CccCccccCcccccccccccceeeccccccc-cCCCCCCCCCCccceEEcccCcccccCCccccCCCCC----cEEEccC
Q 002214          114 NNLLTGTIPASIFNLSFISTALDFSDNSLTG-SFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKEL----SSVSLSY  188 (952)
Q Consensus       114 ~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L----~~L~L~~  188 (952)
                      +|++++..+..++++..+ +.|++++|.+++ .+|.. +.++++|++|++++|++++..+..+..+++|    +.|++++
T Consensus       109 ~n~l~~l~~~~~~~l~~L-~~L~L~~n~l~~~~lp~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~  186 (570)
T 2z63_A          109 ETNLASLENFPIGHLKTL-KELNVAHNLIQSFKLPEY-FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  186 (570)
T ss_dssp             TSCCCCSTTCSCTTCTTC-CEEECCSSCCCCCCCCGG-GGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred             ccccccCCCccccccccc-cEEecCCCccceecChhh-hcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence            555552222234444433 455555555443 23322 2344555555555555544444444444444    4555555


Q ss_pred             CcccccCCccccccCCccEEEeeCCcCC-ccCchhhhccCCCcEeeecccc------ccccCCccccCCC--CccEEEee
Q 002214          189 NQFTGRLPRDLGNSTKLKSLDLGFNNLN-GEIPQEIGNLRNLEILGIDQSN------LVGFVPDTIFNIS--TLKILSLF  259 (952)
Q Consensus       189 N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~n~------~~~~~~~~~~~l~--~L~~L~Ls  259 (952)
                      |.+++..|..|... +|+.|++++|... ...+..+..+++++.+.+....      +..+....+..+.  +++.++++
T Consensus       187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~  265 (570)
T 2z63_A          187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA  265 (570)
T ss_dssp             CCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred             CCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence            55554444444433 4555555554322 1233344444444444332211      1122222333332  24566777


Q ss_pred             Cc-cccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHh
Q 002214          260 NN-TLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSAL  338 (952)
Q Consensus       260 ~N-~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~  338 (952)
                      +| .+.+..+.  .+..+++|++|++++|.+.+ +|..+..+            +|+.|++++|.+...+          
T Consensus       266 ~~~~~~~~~~~--~~~~l~~L~~L~l~~~~l~~-l~~~~~~~------------~L~~L~l~~n~~~~l~----------  320 (570)
T 2z63_A          266 YLDYYLDDIID--LFNCLTNVSSFSLVSVTIER-VKDFSYNF------------GWQHLELVNCKFGQFP----------  320 (570)
T ss_dssp             ETTEEESCSTT--TTGGGTTCSEEEEESCEECS-CCBCCSCC------------CCSEEEEESCBCSSCC----------
T ss_pred             cchhhhhhchh--hhcCcCcccEEEecCccchh-hhhhhccC------------CccEEeeccCcccccC----------
Confidence            66 55555444  36778899999999999884 56555443            4555556666554332          


Q ss_pred             hccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCC--CccccCCCcceEEEeccccccccCCC
Q 002214          339 VNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPI--PQEFCHFSRLYVVYLNRNKLSGSIPS  416 (952)
Q Consensus       339 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~  416 (952)
                             ...+++|+.|++++|.+.+..+.  ..+++|++|++++|.+++..  +..+..+++|+.|++++|.+.+..+.
T Consensus       321 -------~~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  391 (570)
T 2z63_A          321 -------TLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN  391 (570)
T ss_dssp             -------BCBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE
T ss_pred             -------cccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc
Confidence                   24678999999999999866554  78999999999999998654  67888999999999999999965555


Q ss_pred             ccCCCCCCcEEeccccccCCcCC-ccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccC-CCCcccccCCC
Q 002214          417 CLGDLNSLRILSLSSNELTSVIP-STFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLS-GNIPSTIIGLK  494 (952)
Q Consensus       417 ~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~  494 (952)
                       +..+++|++|++++|++++..+ ..|..+++|+.|++++|.+.+..|..+.++++|+.|+|++|+++ +.+|..|..++
T Consensus       392 -~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~  470 (570)
T 2z63_A          392 -FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR  470 (570)
T ss_dssp             -EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCT
T ss_pred             -ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhccc
Confidence             8999999999999999998766 57899999999999999999989999999999999999999998 57889999999


Q ss_pred             CCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCCCc-ccccc--cc
Q 002214          495 NLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAF-ANFSA--ES  571 (952)
Q Consensus       495 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~~~~--~~  571 (952)
                      +|+.|+|++|++++..|..|..+++|+.|+|++|++++.+|..|..+++|+.|++++|+++|.+|....+ .++..  ..
T Consensus       471 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~  550 (570)
T 2z63_A          471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQK  550 (570)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGG
T ss_pred             CCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhcccc
Confidence            9999999999999888999999999999999999999988889999999999999999999999975443 33332  22


Q ss_pred             cccCccCCCCC
Q 002214          572 FIGNDLLCGSP  582 (952)
Q Consensus       572 ~~~n~~~c~~p  582 (952)
                      +.+.+ .|..|
T Consensus       551 ~~~~~-~C~~~  560 (570)
T 2z63_A          551 EQGSA-KCSGS  560 (570)
T ss_dssp             EESCC-BBTTT
T ss_pred             CCCch-hhCCC
Confidence            34444 66655

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-51  Score=439.58  Aligned_cols=262  Identities=26%  Similarity=0.472  Sum_probs=208.3

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ..+++.+.++||+|+||+||+|++++  .||||+++...  ....+.|.+|++++++++|||||+++|++.+ +..++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            45678899999999999999998743  69999986443  3445789999999999999999999998865 4689999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |||++|+|.+++...+..+++.++..|+.|||+||+||   |+++||||||||+|||+++++.+||+|||+|+.......
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yL---H~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL---HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999999988777899999999999999999999   688999999999999999999999999999987654322


Q ss_pred             -ccccccccccccccccccCc---CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          820 -MKQTQTLATIGYIAPEYGRE---GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       820 -~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                       ......+||+.|||||++.+   +.|+.++|||||||++|||+||+.||........ ....+..      ....+.. 
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~~~------~~~~p~~-  259 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMVGR------GYASPDL-  259 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHT------TCCCCCS-
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHHhc------CCCCCCc-
Confidence             22344679999999998853   4689999999999999999999999965322111 1111000      0000000 


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                             ...+..|++++.++|.+||+.||++||||+||+++|+.++..
T Consensus       260 -------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          260 -------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             -------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             -------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence                   012346788999999999999999999999999999988654

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2e-50  Score=479.02  Aligned_cols=502  Identities=19%  Similarity=0.185  Sum_probs=382.1

Q ss_pred             CCCCceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCCh
Q 002214           20 VCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPE   99 (952)
Q Consensus        20 ~c~w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~   99 (952)
                      .|.|.|+ |+.          ++++++ .+|+.+.  ++|++|+|++|.+++..|..+..+++|++|+|++|++.+..|.
T Consensus         3 ~C~~~~~-c~~----------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~   68 (549)
T 2z81_A            3 SCDASGV-CDG----------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD   68 (549)
T ss_dssp             EECTTSE-EEC----------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred             cCCCCce-EEC----------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence            5999998 865          344554 5676654  6888888888888877778888888888888888888877778


Q ss_pred             hhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcc-cccCCccccCC
Q 002214          100 ELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQF-KGPIPNNLWHC  178 (952)
Q Consensus       100 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l-~~~~~~~l~~l  178 (952)
                      +|+++++|++|+|++|++++..|..+.++..+ +.|++++|.+++.-....+.++++|++|++++|++ ....+..|..+
T Consensus        69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l  147 (549)
T 2z81_A           69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSL-KYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL  147 (549)
T ss_dssp             TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTC-CEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred             hccccccCCEEECCCCccCccCHHHhccCCCC-cEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence            88888888888888888886555667777665 88888888887522224567888999999999984 43334678889


Q ss_pred             CCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccC--C-ccccCCCCccE
Q 002214          179 KELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFV--P-DTIFNISTLKI  255 (952)
Q Consensus       179 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~--~-~~~~~l~~L~~  255 (952)
                      ++|++|++++|++++..|..++.+++|++|++++|.+....+..+..+++|+.|++++|++.+..  + .....+++|+.
T Consensus       148 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~  227 (549)
T 2z81_A          148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK  227 (549)
T ss_dssp             CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCE
T ss_pred             cccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccc
Confidence            99999999999998888888999999999999999887433333467889999999998888752  2 22345788999


Q ss_pred             EEeeCccccccCCCC--cccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHH
Q 002214          256 LSLFNNTLSGNLPSS--KNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMS  333 (952)
Q Consensus       256 L~Ls~N~l~~~~~~~--~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~  333 (952)
                      |++++|.+++..+..  ..+..+++|+.+++++|.+.+...-.     ....-.+....+++.+.+.++.+.....-   
T Consensus       228 L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~-----~~~~~~~~~l~~L~~L~l~~~~i~~~~~~---  299 (549)
T 2z81_A          228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN-----PSESDVVSELGKVETVTIRRLHIPQFYLF---  299 (549)
T ss_dssp             EEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCC-----CCTTTCCCCCTTCCEEEEESCBCSCGGGS---
T ss_pred             eeccccccchhHHHHHHHHhhhhcccccccccccccccccccc-----ccchhhhhhhcccccccccccccchhhhc---
Confidence            999998876432211  12345678889999998887532211     00011123344555666655554321100   


Q ss_pred             HHHHhhccccccccCCCcccEEEccCCCCCCCCCccc-ccCCCCcEEEccCccccCCCC---ccccCCCcceEEEecccc
Q 002214          334 LFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITL-GRLKKLQGLDLQNNKFEGPIP---QEFCHFSRLYVVYLNRNK  409 (952)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l-~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~~N~  409 (952)
                           ..+.. .+...++|+.|++++|+++ .+|..+ ..+++|++|++++|++.+..|   ..+..+++|+.|+|++|+
T Consensus       300 -----~~l~~-~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~  372 (549)
T 2z81_A          300 -----YDLST-VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH  372 (549)
T ss_dssp             -----CCCCH-HHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSC
T ss_pred             -----ccchh-hhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCc
Confidence                 00000 0123568999999999998 455544 689999999999999987653   347889999999999999


Q ss_pred             ccccCC--CccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCc
Q 002214          410 LSGSIP--SCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIP  487 (952)
Q Consensus       410 l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  487 (952)
                      +++..+  ..+..+++|++|++++|++++ +|..+..+++|+.|++++|+++. +|..+  .++|+.|+|++|++++.. 
T Consensus       373 l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~-  447 (549)
T 2z81_A          373 LRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS-  447 (549)
T ss_dssp             CCCHHHHHHHGGGCTTCCEEECTTCCCCC-CCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC-
T ss_pred             ccccccchhhhhcCCCCCEEECCCCCCcc-CChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc-
Confidence            986543  568899999999999999984 67788899999999999999984 44433  268999999999999653 


Q ss_pred             ccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCC
Q 002214          488 STIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG  561 (952)
Q Consensus       488 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  561 (952)
                         ..+++|++|+|++|+|+ .+|. ...+++|+.|+|++|+|++.+|..+..+++|+.|++++|++.|.+|..
T Consensus       448 ---~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  516 (549)
T 2z81_A          448 ---LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  516 (549)
T ss_dssp             ---CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHH
T ss_pred             ---ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccH
Confidence               57899999999999999 5665 567899999999999999999999999999999999999999999853

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-51  Score=444.03  Aligned_cols=255  Identities=26%  Similarity=0.450  Sum_probs=210.8

Q ss_pred             ccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      .++++.+.||+|+||+||+|++      .+++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            4567788999999999999986      2578999999965433 34578999999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC
Q 002214          737 LVLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM  801 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~  801 (952)
                      +|||||++|+|.+++....               ..++|.++..|+.|||+||+||   |+++||||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCccccceEECCCC
Confidence            9999999999999996432               3589999999999999999999   789999999999999999999


Q ss_pred             cEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhh
Q 002214          802 VAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWI  879 (952)
Q Consensus       802 ~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~  879 (952)
                      .+||+|||+|+.....+.. ..+...||++|||||++.++.++.++|||||||++|||+| |+.||......  .+    
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~----  256 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DV----  256 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HH----
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HH----
Confidence            9999999999876544332 2334679999999999999999999999999999999999 89998653211  11    


Q ss_pred             ccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          880 NDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       880 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                             ...+.....       ...|..|++++.++|.+||+.||++||||+||+++|+.+
T Consensus       257 -------~~~i~~~~~-------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          257 -------VEMIRNRQV-------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -------HHHHHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -------HHHHHcCCC-------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                   111111110       112456888999999999999999999999999999753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.7e-50  Score=436.03  Aligned_cols=250  Identities=23%  Similarity=0.322  Sum_probs=210.8

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      ..|++.++||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999984 79999999997666556677899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      +||+|.+++...  .+++.++..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+.+..... ..
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~  227 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR  227 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence            999999998764  599999999999999999999   789999999999999999999999999999997754332 23


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...+||+.|||||++.+..|+.++||||+||++|||++|+.||.....  ......       +.+......        
T Consensus       228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~-------i~~~~~~~~--------  290 (346)
T 4fih_A          228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKM-------IRDNLPPRL--------  290 (346)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHH-------HHHSSCCCC--------
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHH-------HHcCCCCCC--------
Confidence            456899999999999999999999999999999999999999865211  111000       000000000        


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ..+..+++++.+|+.+||..||++|||++|+++|
T Consensus       291 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          291 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             0123467889999999999999999999999874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-50  Score=438.94  Aligned_cols=251  Identities=22%  Similarity=0.323  Sum_probs=204.3

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++....  ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            36899999999999999999987 469999999997543  344578999999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          740 EYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+||+|.+++...+ ..+++.+++.++.||+.||+||   |++|||||||||+|||+++++.+||+|||+|+......
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999997644 3579999999999999999999   78999999999999999999999999999999764322


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                       ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...... ..+.+           +......   
T Consensus       180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~-----------i~~~~~~---  243 (350)
T 4b9d_A          180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-NLVLK-----------IISGSFP---  243 (350)
T ss_dssp             -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHH-----------HHHTCCC---
T ss_pred             -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHH-----------HHcCCCC---
Confidence             1223467999999999999999999999999999999999999999652111 01111           1111100   


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..+..+++++.+|+.+||+.||++|||++|++++
T Consensus       244 -----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          244 -----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 1123467889999999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.1e-50  Score=431.56  Aligned_cols=257  Identities=22%  Similarity=0.285  Sum_probs=211.7

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .+.|.+.++||+|+||+||+|++ .+|+.||||+++.+..     ..+|+.++++++|||||++++++.+++..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            35688889999999999999998 4699999999975432     24799999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC-cEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-VAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+||+|.+++...+ .+++.++..++.||+.||+||   |+++||||||||+|||++.++ .+||+|||+|+.+......
T Consensus       132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYL---HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999999997654 699999999999999999999   799999999999999999988 6999999999977543221


Q ss_pred             ----cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          821 ----KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       821 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                          .....+||+.|||||++.+..|+.++|||||||++|||+||+.||......+. ..+......+            
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~~------------  274 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEPPP------------  274 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSCCG------------
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCCCC------------
Confidence                12235799999999999999999999999999999999999999976432221 1111111000            


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHh
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~  946 (952)
                           ....+..+++++.+++.+||+.||++|||+.|+++++....+...
T Consensus       275 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          275 -----IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             -----GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             -----chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence                 001234578889999999999999999999999999988876653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.3e-50  Score=441.47  Aligned_cols=269  Identities=21%  Similarity=0.364  Sum_probs=220.9

Q ss_pred             cCHHHHHHHhccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCC-Ccccee
Q 002214          654 YSHDELLRATDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRH-RNLVKI  725 (952)
Q Consensus       654 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l  725 (952)
                      ++.++++...++|++.+.||+|+||+||+|++.      .++.||||+++.... ...+.|.+|++++++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            455667777889999999999999999999863      246899999875443 345679999999999965 999999


Q ss_pred             eeEeecC-CeeEEEEEccCCCChhHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCC
Q 002214          726 ISSCTNH-NFKALVLEYMPKGSLEDCMYAS---------------NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCD  789 (952)
Q Consensus       726 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~D  789 (952)
                      +|+|.++ +..++|||||++|+|.++++..               ...+++.++..++.|||+||+||   |+++|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL---H~~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH---hhCCeecCc
Confidence            9999764 5689999999999999999753               23589999999999999999999   789999999


Q ss_pred             CCCCCeeeCCCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCc
Q 002214          790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNE  867 (952)
Q Consensus       790 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~  867 (952)
                      |||+|||+++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999976544332 3344679999999999999999999999999999999998 9999966


Q ss_pred             cccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          868 FFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      ....+. +.+           .+....       ....|..+++++.++|.+||+.||++||||+||+++|+++.+.
T Consensus       291 ~~~~~~-~~~-----------~i~~g~-------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          291 VKIDEE-FCR-----------RLKEGT-------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCCSHH-HHH-----------HHHHTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHH-HHH-----------HHHcCC-------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            322211 111           111111       0112345788899999999999999999999999999998764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.3e-49  Score=427.79  Aligned_cols=275  Identities=21%  Similarity=0.307  Sum_probs=206.8

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCC----eeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN----FKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  739 (952)
                      .+|.+.+.||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||++++++.+++    ..|+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4577889999999999999998 6899999998654332 123345666667889999999999997653    579999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG-----HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-----h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      |||++|+|.+++...  .+++..+.+++.|+++||+|||..     |+++|+||||||+|||+++++.+||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999999765  489999999999999999999732     3569999999999999999999999999999876


Q ss_pred             CCcCcc---cccccccccccccccccCcC------CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc--ch
Q 002214          815 SEEDSM---KQTQTLATIGYIAPEYGREG------QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND--SL  883 (952)
Q Consensus       815 ~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--~~  883 (952)
                      ......   .....+||+.|||||++.+.      .++.++|||||||++|||+||+.||.........+..+...  ..
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            543322   22235799999999998654      46789999999999999999998876543333222222111  11


Q ss_pred             hhhhh-hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          884 PAVMN-IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       884 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      ..... +.........+.  ......+++.+.++|.+||+.||++||||.||++.|+++.++
T Consensus       239 ~~~~~~~~~~~~rp~~p~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPN--RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCG--GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhcccCCCCCCc--cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            11111 111111111111  111234677899999999999999999999999999998765

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.6e-48  Score=462.56  Aligned_cols=496  Identities=19%  Similarity=0.213  Sum_probs=403.9

Q ss_pred             CcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccce
Q 002214           56 LSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTAL  135 (952)
Q Consensus        56 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L  135 (952)
                      |+...+.+.+++.++ .+|..+.  ++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..+.++..+ +.|
T Consensus         4 C~~~~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L-~~L   79 (549)
T 2z81_A            4 CDASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL-EHL   79 (549)
T ss_dssp             ECTTSEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTC-CEE
T ss_pred             CCCCceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccC-CEE
Confidence            344455788899998 8888765  799999999999998888999999999999999999997777888888876 999


Q ss_pred             eeccccccccCCCCCCCCCCccceEEcccCcccc-cCCccccCCCCCcEEEccCCc-ccccCCccccccCCccEEEeeCC
Q 002214          136 DFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG-PIPNNLWHCKELSSVSLSYNQ-FTGRLPRDLGNSTKLKSLDLGFN  213 (952)
Q Consensus       136 ~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N  213 (952)
                      ++++|++++ ++...+.++++|++|+|++|++++ ..|..+..+++|+.|++++|+ +....+..|+++++|++|++++|
T Consensus        80 ~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n  158 (549)
T 2z81_A           80 DLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL  158 (549)
T ss_dssp             ECTTSCCCS-CCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred             ECCCCccCc-cCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCC
Confidence            999999994 555556789999999999999986 357789999999999999998 55555578999999999999999


Q ss_pred             cCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCC-CCcccCCCCCcceEEcccCcCCCC
Q 002214          214 NLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLP-SSKNLIGLPNLEGLNLGLNNLSGS  292 (952)
Q Consensus       214 ~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~l~~L~~L~L~~N~l~~~  292 (952)
                      .+++..|..++.+++|+.|+++.|.+.......+..+++|++|++++|++++... .......+++|+.|++++|.+++.
T Consensus       159 ~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~  238 (549)
T 2z81_A          159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE  238 (549)
T ss_dssp             TCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHH
T ss_pred             cccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchh
Confidence            9999999999999999999999998866544445679999999999999986421 112234578999999999998765


Q ss_pred             CCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCC-----CC
Q 002214          293 IPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGS-----LP  367 (952)
Q Consensus       293 ~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~-----~~  367 (952)
                      .+..+..       .+....+|+.+++++|.+...+.-        .......+..+++|+.|++.++.+...     .+
T Consensus       239 ~~~~l~~-------~~~~~~~L~~l~l~~~~~~~~~~~--------~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~  303 (549)
T 2z81_A          239 SFNELLK-------LLRYILELSEVEFDDCTLNGLGDF--------NPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS  303 (549)
T ss_dssp             HHHHHHG-------GGGGCTTCCEEEEESCEEECCSCC--------CCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCC
T ss_pred             HHHHHHH-------Hhhhhccccccccccccccccccc--------cccchhhhhhhcccccccccccccchhhhcccch
Confidence            4433221       134456777888887776543210        001112356788999999999988642     12


Q ss_pred             cccccCCCCcEEEccCccccCCCCccc-cCCCcceEEEeccccccccCC---CccCCCCCCcEEeccccccCCcCC--cc
Q 002214          368 ITLGRLKKLQGLDLQNNKFEGPIPQEF-CHFSRLYVVYLNRNKLSGSIP---SCLGDLNSLRILSLSSNELTSVIP--ST  441 (952)
Q Consensus       368 ~~l~~l~~L~~L~L~~N~i~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~  441 (952)
                      ..+...++|++|++++|.+.. .|..+ .++++|++|+|++|++++.+|   ..++.+++|++|++++|+++++.+  ..
T Consensus       304 ~~~~~~~~L~~L~l~~n~l~~-ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  382 (549)
T 2z81_A          304 TVYSLLEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI  382 (549)
T ss_dssp             HHHHHSTTCCEEEEESSCCCC-CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHH
T ss_pred             hhhhhcccceEEEeccCcccc-CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhh
Confidence            234456799999999999984 55554 689999999999999997663   457889999999999999997754  56


Q ss_pred             ccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCccccccccccccc
Q 002214          442 FWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLE  521 (952)
Q Consensus       442 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  521 (952)
                      +..+++|+.|++++|+++ .+|..+..+++|++|++++|+++. +|..+  .++|+.|+|++|+|++.+    ..+++|+
T Consensus       383 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~  454 (549)
T 2z81_A          383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQ  454 (549)
T ss_dssp             GGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCC
T ss_pred             hhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhc
Confidence            899999999999999999 688889999999999999999984 44433  268999999999999643    5789999


Q ss_pred             EEeCCCCcccccCccchhcccccccccccccccccCCCC-CCCcccccccccccCccCCCCC
Q 002214          522 FLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR-GGAFANFSAESFIGNDLLCGSP  582 (952)
Q Consensus       522 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~~p  582 (952)
                      +|+|++|+|+ .+|. ...+++|+.|+|++|++++.+|. -..+..+....+.+|++.|+||
T Consensus       455 ~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          455 ELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             EEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             EEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            9999999998 5565 46799999999999999987775 2456777788899999999988

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.2e-49  Score=419.60  Aligned_cols=246  Identities=23%  Similarity=0.379  Sum_probs=198.4

Q ss_pred             CCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeec----CCeeEEE
Q 002214          666 FSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTN----HNFKALV  738 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  738 (952)
                      |++.+.||+|+||+||+|.+ .+++.||+|++....  ....+.|.+|++++++++|||||++++++.+    ++..|+|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            36677899999999999987 468999999986442  3345679999999999999999999999864    3568999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCeeeC-CCCcEEEeccccccccC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP--IVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~--ivH~Dlk~~Nill~-~~~~~kl~Dfgla~~~~  815 (952)
                      ||||++|+|.+++.... .+++..+..++.||+.||+||   |+++  |+||||||+|||++ .++.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~yl---H~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999997654 699999999999999999999   5666  99999999999998 47999999999998643


Q ss_pred             CcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ..   .....+||+.|||||++.+ .++.++|||||||++|||+||+.||............            +.....
T Consensus       184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~------------i~~~~~  247 (290)
T 3fpq_A          184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR------------VTSGVK  247 (290)
T ss_dssp             TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH------------HTTTCC
T ss_pred             CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH------------HHcCCC
Confidence            22   2334679999999998865 6999999999999999999999999652211111111            111100


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .      ...+..+++++.+++.+||+.||++|||++|+++|
T Consensus       248 ~------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          248 P------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             C------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             C------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0      01123456789999999999999999999999874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.8e-50  Score=427.36  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=209.0

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++...   .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999987 57999999999643   2334577999999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||++||+|.+++...+ .+++.++..++.||+.||+||   |++||+||||||+|||+++++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999997654 699999999999999999999   789999999999999999999999999999998754332


Q ss_pred             -ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 -MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                       ......+||+.|||||++.+..|+.++||||+||++|||+||+.||..... ...+.+           +.....    
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~-----------i~~~~~----  251 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-GLIFAK-----------IIKLEY----  251 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH-----------HHHTCC----
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH-----------HHcCCC----
Confidence             233456899999999999999999999999999999999999999965211 001111           111110    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                           ..+..+++++.+|+.+||..||++|||+.|+.+
T Consensus       252 -----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          252 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             -----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence                 012345778999999999999999999998754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.1e-49  Score=437.33  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=211.0

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      +.|++.+.||+|+||.||+|++ .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            5699999999999999999998 469999999998766666678999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      +||+|.+++...  .+++.++..++.||+.||+||   |++|||||||||+|||++.+|.+||+|||+|+.+..... ..
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~yl---H~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~  304 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR  304 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CB
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cc
Confidence            999999998754  499999999999999999999   789999999999999999999999999999997754332 33


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...+||+.|||||++.+..|+.++|||||||++|||++|+.||.....  ......+       ........        
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i-------~~~~~~~~--------  367 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMI-------RDNLPPRL--------  367 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHH-------HHSCCCCC--------
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHH-------HcCCCCCC--------
Confidence            456899999999999999999999999999999999999999865211  1111100       00000000        


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ..+..+++++.+|+.+||..||++|||++|+++|
T Consensus       368 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          368 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             -SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             0123457789999999999999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.3e-49  Score=415.57  Aligned_cols=246  Identities=22%  Similarity=0.371  Sum_probs=192.6

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++...   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999987 469999999986442   233567999999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+ +|+|.+++...+ .+++.++..++.||+.||+||   |++||+||||||+|||+++++.+||+|||+|+...... 
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYC---HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            999 679999887654 799999999999999999999   78999999999999999999999999999998764332 


Q ss_pred             ccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                       .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||....     ......       .+....     
T Consensus       167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~-------~i~~~~-----  228 (275)
T 3hyh_A          167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFK-------NISNGV-----  228 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH-------HHHHTC-----
T ss_pred             -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHH-------HHHcCC-----
Confidence             2234679999999999988775 579999999999999999999996521     111110       000000     


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ...+..+++++.+++.+||+.||++|||++|++++
T Consensus       229 ----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          229 ----YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                01123467789999999999999999999999874

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=457.38  Aligned_cols=466  Identities=20%  Similarity=0.190  Sum_probs=381.2

Q ss_pred             CeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEee
Q 002214           33 NRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVL  112 (952)
Q Consensus        33 ~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  112 (952)
                      .++++|+++++.+++..|..++++++|++|+|++|.+++..|..|+.+++|++|++++|++.+..+..++++++|++|+|
T Consensus        52 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  131 (570)
T 2z63_A           52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV  131 (570)
T ss_dssp             SSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEEC
T ss_pred             CCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEec
Confidence            57899999999999877888999999999999999999877889999999999999999999655557999999999999


Q ss_pred             cCccCcc-ccCcccccccccccceeeccccccccCCCCCCCCCCcc----ceEEcccCcccccCCccccCCCCCcEEEcc
Q 002214          113 NNNLLTG-TIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRL----KGLYVSYNQFKGPIPNNLWHCKELSSVSLS  187 (952)
Q Consensus       113 ~~n~l~~-~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L----~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~  187 (952)
                      ++|.+++ .+|..+.+++.+ +.|++++|++++ ++...+..+++|    ++|++++|.+++..|..+..+ +|+.|+++
T Consensus       132 ~~n~l~~~~lp~~~~~l~~L-~~L~l~~n~l~~-~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~  208 (570)
T 2z63_A          132 AHNLIQSFKLPEYFSNLTNL-EHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLR  208 (570)
T ss_dssp             CSSCCCCCCCCGGGGGCTTC-CEEECTTSCCCE-ECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEE
T ss_pred             CCCccceecChhhhcccCCC-CEEeCcCCccce-ecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecc
Confidence            9999996 479999998876 999999999984 444445567777    899999999998888877766 89999999


Q ss_pred             CCccc-ccCCccccccCCccEEEeeCCcC------CccCchhhhccCC--CcEeeeccc-cccccCCccccCCCCccEEE
Q 002214          188 YNQFT-GRLPRDLGNSTKLKSLDLGFNNL------NGEIPQEIGNLRN--LEILGIDQS-NLVGFVPDTIFNISTLKILS  257 (952)
Q Consensus       188 ~N~l~-~~~~~~~~~l~~L~~L~L~~N~l------~~~~p~~~~~l~~--L~~L~L~~n-~~~~~~~~~~~~l~~L~~L~  257 (952)
                      +|... ...+..+.+++.++.+.+..+.+      .......+..+.+  ++.++++++ .+.+..++.+..+++|+.|+
T Consensus       209 ~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~  288 (570)
T 2z63_A          209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS  288 (570)
T ss_dssp             SCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEE
T ss_pred             cccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEE
Confidence            98543 23455667777777766654322      2222333444443  456666666 66677777788888888888


Q ss_pred             eeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHH
Q 002214          258 LFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSA  337 (952)
Q Consensus       258 Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~  337 (952)
                      +++|.+.+ +|..  +..+ +|++|++++|.+.. +|.  ..+           .+|+.|++++|.+....         
T Consensus       289 l~~~~l~~-l~~~--~~~~-~L~~L~l~~n~~~~-l~~--~~l-----------~~L~~L~l~~n~~~~~~---------  341 (570)
T 2z63_A          289 LVSVTIER-VKDF--SYNF-GWQHLELVNCKFGQ-FPT--LKL-----------KSLKRLTFTSNKGGNAF---------  341 (570)
T ss_dssp             EESCEECS-CCBC--CSCC-CCSEEEEESCBCSS-CCB--CBC-----------SSCCEEEEESCBSCCBC---------
T ss_pred             ecCccchh-hhhh--hccC-CccEEeeccCcccc-cCc--ccc-----------cccCEEeCcCCcccccc---------
Confidence            88888874 3332  4455 88888888888873 332  122           34555555555443211         


Q ss_pred             hhccccccccCCCcccEEEccCCCCCCCC--CcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCC
Q 002214          338 LVNCKSLKIGNLINLTTLSLGDNNLSGSL--PITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIP  415 (952)
Q Consensus       338 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  415 (952)
                             ....+++|++|++++|++++..  +..+..+++|++|++++|.+.+..+. |..+++|+.|++++|.+.+..+
T Consensus       342 -------~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~  413 (570)
T 2z63_A          342 -------SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSE  413 (570)
T ss_dssp             -------CCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTT
T ss_pred             -------ccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccc
Confidence                   1257889999999999998654  67889999999999999999866555 9999999999999999997766


Q ss_pred             -CccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccC-CCCchhhhcccccceeecCCcccCCCCcccccCC
Q 002214          416 -SCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLN-GSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGL  493 (952)
Q Consensus       416 -~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  493 (952)
                       ..+..+++|++|++++|++++..+..|..+++|+.|++++|.++ +.+|..+..+++|+.|+|++|++++..|..|..+
T Consensus       414 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  493 (570)
T 2z63_A          414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL  493 (570)
T ss_dssp             SCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             hhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcc
Confidence             57899999999999999999999999999999999999999997 5788999999999999999999999889999999


Q ss_pred             CCCceEEccCccccCcccccccccccccEEeCCCCcccccCcc
Q 002214          494 KNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPA  536 (952)
Q Consensus       494 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  536 (952)
                      ++|++|+|++|++++.+|..|..+++|+.|++++|++++..|.
T Consensus       494 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          494 SSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             cCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            9999999999999988888899999999999999999987664

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=3.7e-48  Score=464.53  Aligned_cols=457  Identities=18%  Similarity=0.233  Sum_probs=383.5

Q ss_pred             cccCeeeccccccccccCCCcCCcCCCcEEeCcCCccc------c------cCChhhcCCCCCCeEeecCccCccccCcc
Q 002214           57 SSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQ------G------EIPEELGNLAELEMLVLNNNLLTGTIPAS  124 (952)
Q Consensus        57 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~------~------~~p~~l~~l~~L~~L~L~~n~l~~~~p~~  124 (952)
                      ..++.|+|++|.++|.+|++++.|++|++|+|++|.+.      +      .+|...  +..|+ +++++|.+.+.+|..
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~  157 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED  157 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence            36788999999999999999999999999999999872      2      345444  56677 888888888888877


Q ss_pred             cccccccccceeeccccccccCCCCCCCCCCccceEEcc--cCcccccCCccccCCCCCcEEEccCCccccc--------
Q 002214          125 IFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVS--YNQFKGPIPNNLWHCKELSSVSLSYNQFTGR--------  194 (952)
Q Consensus       125 ~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~--~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--------  194 (952)
                      +..+...+..+++....+..       .....++.+.+.  +|++++ +|..|+++++|++|+|++|++++.        
T Consensus       158 ~~~~~~~l~~~~l~~~~~~~-------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~  229 (636)
T 4eco_A          158 FSDLIKDCINSDPQQKSIKK-------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN  229 (636)
T ss_dssp             SCHHHHHHHHHCTTSCCCCC-------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC
T ss_pred             HHHHHHHHhhcCcccccccc-------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccc
Confidence            76543322333433333221       122344544444  588998 899999999999999999999985        


Q ss_pred             ---------CCcccc--ccCCccEEEeeCCcCCccCchhhhccCCCcEeeecccc-ccc-cCCccccCC------CCccE
Q 002214          195 ---------LPRDLG--NSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSN-LVG-FVPDTIFNI------STLKI  255 (952)
Q Consensus       195 ---------~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~-~~~-~~~~~~~~l------~~L~~  255 (952)
                               +|..++  ++++|++|+|++|.+.+.+|..|+++++|+.|++++|+ +.+ .+|..+..+      ++|++
T Consensus       230 ~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~  309 (636)
T 4eco_A          230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI  309 (636)
T ss_dssp             TTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCE
T ss_pred             cccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCE
Confidence                     899999  99999999999999999999999999999999999998 887 788888876      99999


Q ss_pred             EEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHH
Q 002214          256 LSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLF  335 (952)
Q Consensus       256 L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~  335 (952)
                      |++++|+++ .+|....+..+++|++|++++|++++.+| .|                                      
T Consensus       310 L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~--------------------------------------  349 (636)
T 4eco_A          310 IYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AF--------------------------------------  349 (636)
T ss_dssp             EECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CC--------------------------------------
T ss_pred             EECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hh--------------------------------------
Confidence            999999998 66652247889999999999999987666 33                                      


Q ss_pred             HHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCC-CcEEEccCccccCCCCccccCCC--cceEEEeccccccc
Q 002214          336 SALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKK-LQGLDLQNNKFEGPIPQEFCHFS--RLYVVYLNRNKLSG  412 (952)
Q Consensus       336 ~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~-L~~L~L~~N~i~~~~~~~~~~l~--~L~~L~L~~N~l~~  412 (952)
                                 +.+++|++|++++|+++ .+|..+..+++ |++|++++|.++ ..|..+..+.  +|+.|++++|++++
T Consensus       350 -----------~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~  416 (636)
T 4eco_A          350 -----------GSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGS  416 (636)
T ss_dssp             -----------EEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTT
T ss_pred             -----------CCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCC
Confidence                       45668899999999999 77888999999 999999999999 6788887765  99999999999999


Q ss_pred             cCCCccC-------CCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcc-------cccceeecC
Q 002214          413 SIPSCLG-------DLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENL-------KAVVDIYLS  478 (952)
Q Consensus       413 ~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-------~~L~~L~Ls  478 (952)
                      ..|..+.       .+++|++|++++|+++++++..|..+++|+.|+|++|+++...+..+...       ++|+.|+|+
T Consensus       417 ~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls  496 (636)
T 4eco_A          417 VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR  496 (636)
T ss_dssp             TTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECC
T ss_pred             cchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECc
Confidence            9999888       88899999999999998777778889999999999999994433444433       399999999


Q ss_pred             CcccCCCCccccc--CCCCCceEEccCccccCcccccccccccccEEeC------CCCcccccCccchhccccccccccc
Q 002214          479 RNNLSGNIPSTII--GLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDL------SNNDLSGVIPASLEKLLYLKSLNLS  550 (952)
Q Consensus       479 ~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L------s~N~l~~~~~~~~~~l~~L~~L~l~  550 (952)
                      +|+++ .+|..+.  .+++|+.|+|++|+|++ +|..+..+++|+.|+|      ++|++.+.+|..+..+++|+.|+|+
T Consensus       497 ~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls  574 (636)
T 4eco_A          497 FNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG  574 (636)
T ss_dssp             SSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECC
T ss_pred             CCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECC
Confidence            99999 6777776  99999999999999997 8899999999999999      5688888999999999999999999


Q ss_pred             ccccccCCCCCCCcccccccccccCccCCCC
Q 002214          551 FNKLVGEIPRGGAFANFSAESFIGNDLLCGS  581 (952)
Q Consensus       551 ~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~  581 (952)
                      +|++ +.+|.. .+..+....+.+|++.|-.
T Consensus       575 ~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~~  603 (636)
T 4eco_A          575 SNDI-RKVNEK-ITPNISVLDIKDNPNISID  603 (636)
T ss_dssp             SSCC-CBCCSC-CCTTCCEEECCSCTTCEEE
T ss_pred             CCcC-CccCHh-HhCcCCEEECcCCCCcccc
Confidence            9999 788875 4477888888999887743

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.3e-48  Score=452.54  Aligned_cols=463  Identities=19%  Similarity=0.217  Sum_probs=331.6

Q ss_pred             EEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCc
Q 002214           36 TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNN  115 (952)
Q Consensus        36 ~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n  115 (952)
                      ++||+++++++ .+|..+.  ++|++|+|++|.+++..|..|..+++|++|+|++|++.+..|.+|+++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            57888888888 6787776  88899999999888766678888889999999999888777888888899999999888


Q ss_pred             cCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccc-cCCccccCCCCCcEEEccCCccccc
Q 002214          116 LLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG-PIPNNLWHCKELSSVSLSYNQFTGR  194 (952)
Q Consensus       116 ~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~  194 (952)
                      +++ .+|..                            .+++|++|+|++|++++ .+|..|+.+++|++|++++|++++ 
T Consensus        80 ~l~-~lp~~----------------------------~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~-  129 (520)
T 2z7x_B           80 KLV-KISCH----------------------------PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK-  129 (520)
T ss_dssp             CCC-EEECC----------------------------CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG-
T ss_pred             cee-ecCcc----------------------------ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch-
Confidence            887 44443                            34567777777777665 356667777777777777777664 


Q ss_pred             CCccccccCCc--cEEEeeCCcC--CccCchhhhccC-CCcEeeeccccccccCC-ccccCCCCccEEEeeCcc------
Q 002214          195 LPRDLGNSTKL--KSLDLGFNNL--NGEIPQEIGNLR-NLEILGIDQSNLVGFVP-DTIFNISTLKILSLFNNT------  262 (952)
Q Consensus       195 ~~~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~l~-~L~~L~L~~n~~~~~~~-~~~~~l~~L~~L~Ls~N~------  262 (952)
                        ..++.+++|  ++|++++|.+  .+..|..+..+. +...+++++|++.+..+ ..+..+++|+.|++++|.      
T Consensus       130 --~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~  207 (520)
T 2z7x_B          130 --SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS  207 (520)
T ss_dssp             --GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTH
T ss_pred             --hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccc
Confidence              345666666  7777777776  556666666655 23344556666555433 345566777777777765      


Q ss_pred             -ccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCccee-echhhHHHHHHHhhc
Q 002214          263 -LSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLT-FSTSELMSLFSALVN  340 (952)
Q Consensus       263 -l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~-~~~~~~~~~~~~~~~  340 (952)
                       +.+.++   .+..+++|+.|++++|.+++..+..+..        .....+|+.|++++|.++ ..+..++        
T Consensus       208 ~~~~~~~---~l~~l~~L~~L~l~~~~l~~~~~~~~~~--------~~~~~~L~~L~l~~n~l~~~~p~~~~--------  268 (520)
T 2z7x_B          208 YFLSILA---KLQTNPKLSNLTLNNIETTWNSFIRILQ--------LVWHTTVWYFSISNVKLQGQLDFRDF--------  268 (520)
T ss_dssp             HHHHHHH---GGGGCTTCCEEEEEEEEEEHHHHHHHHH--------HHHTSSCSEEEEEEEEEESCCCCCCC--------
T ss_pred             eeecchh---hhccccchhhccccccccCHHHHHHHHH--------HhhhCcccEEEeecccccCccccchh--------
Confidence             443333   2555666777777666665322111100        001235566666666555 3332210        


Q ss_pred             cccccccCCCcccEEEccCCCCCCCCCcccccC---CCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCc
Q 002214          341 CKSLKIGNLINLTTLSLGDNNLSGSLPITLGRL---KKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSC  417 (952)
Q Consensus       341 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l---~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  417 (952)
                        ....+.+++|+.+++++|.+ ..+...+..+   ++|+.|++++|.+....  .+..+++|++|++++|++++..|..
T Consensus       269 --~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~  343 (520)
T 2z7x_B          269 --DYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFEN  343 (520)
T ss_dssp             --CCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTT
T ss_pred             --hcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhh
Confidence              00126788888889988888 3333555554   67899999998876432  2367888999999999998888888


Q ss_pred             cCCCCCCcEEeccccccCC--cCCccccCCCCCceeEecCCccCCCCch-hhhcccccceeecCCcccCCCCcccccCCC
Q 002214          418 LGDLNSLRILSLSSNELTS--VIPSTFWNLEDILGFDFSSNSLNGSLPL-EIENLKAVVDIYLSRNNLSGNIPSTIIGLK  494 (952)
Q Consensus       418 ~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  494 (952)
                      +..+++|++|++++|++++  ..|..|..+++|+.|++++|++++.+|. .+..+++|++|++++|++++..|..+.  +
T Consensus       344 ~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~  421 (520)
T 2z7x_B          344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--P  421 (520)
T ss_dssp             CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--T
T ss_pred             hccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--c
Confidence            8889999999999999986  3456788899999999999999874554 478888999999999999877766654  7


Q ss_pred             CCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          495 NLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       495 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      +|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+++.+..+..+++|++|++++|+++|.++.
T Consensus       422 ~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             cCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence            8999999999998 6777777899999999999999854444588899999999999999988774

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.4e-49  Score=420.40  Aligned_cols=248  Identities=25%  Similarity=0.319  Sum_probs=198.4

Q ss_pred             ccCCccceecCccceEEEEEEe----CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF----PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ++|++.+.||+|+||+||+|+.    .+++.||||+++...  .....++.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999986    257899999986432  2234578899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      |||||+||+|.+++...+ .+++.++..++.|++.||+||   |++||+||||||+|||+++++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999997655 699999999999999999999   7899999999999999999999999999999865433


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      .. .....+||+.|||||++.+..++.++||||+||++|||+||+.||...... ..+..           +.....   
T Consensus       180 ~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~-----------i~~~~~---  243 (304)
T 3ubd_A          180 EK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-ETMTM-----------ILKAKL---  243 (304)
T ss_dssp             -C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH-----------HHHCCC---
T ss_pred             Cc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-HHHHH-----------HHcCCC---
Confidence            22 233467999999999999999999999999999999999999999652111 00111           111100   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNT-----KEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~~  937 (952)
                            ..+..+++++.+++.+||+.||++|||+     +|+++|
T Consensus       244 ------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          244 ------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             ------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                  1134467889999999999999999985     566653

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.5e-46  Score=454.39  Aligned_cols=490  Identities=22%  Similarity=0.163  Sum_probs=303.5

Q ss_pred             eEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeec
Q 002214           34 RVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLN  113 (952)
Q Consensus        34 ~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~  113 (952)
                      .+++|||++|.+++..|.+|..+++|++|+|++|+|++..|.+|.++++|++|+|++|++++..+.+|+++++|++|+|+
T Consensus        53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls  132 (635)
T 4g8a_A           53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  132 (635)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred             CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence            34555555555554334445555555555555555554334445555555555555555554333445555555555555


Q ss_pred             CccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCC----cEEEccCC
Q 002214          114 NNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKEL----SSVSLSYN  189 (952)
Q Consensus       114 ~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L----~~L~L~~N  189 (952)
                      +|++++..+..+.+++.+ +.|++++|++++.-....+..+++|++|+|++|++++..+..|..+.++    ..++++.|
T Consensus       133 ~N~l~~l~~~~~~~L~~L-~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n  211 (635)
T 4g8a_A          133 ETNLASLENFPIGHLKTL-KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  211 (635)
T ss_dssp             TSCCCCSTTCCCTTCTTC-CEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred             CCcCCCCChhhhhcCccc-CeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence            555553333334444433 4555555555432222233344555555555555554444444433322    23445555


Q ss_pred             cccccCCccccccCCccEEEeeCCcCCc-cCchhhhccCCCcEeeecccc------ccccCCcc----------------
Q 002214          190 QFTGRLPRDLGNSTKLKSLDLGFNNLNG-EIPQEIGNLRNLEILGIDQSN------LVGFVPDT----------------  246 (952)
Q Consensus       190 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n~------~~~~~~~~----------------  246 (952)
                      .++...+..+. ...++.|++++|.... ..+..+..+..++...+..+.      +.......                
T Consensus       212 ~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~  290 (635)
T 4g8a_A          212 PMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY  290 (635)
T ss_dssp             CCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred             cccccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence            55433333222 2234455555554331 223344555555554443211      11111222                


Q ss_pred             -----------ccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccc
Q 002214          247 -----------IFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLK  315 (952)
Q Consensus       247 -----------~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~  315 (952)
                                 +..+.+++.+++.+|.+...    ..+....+|+.|++.+|.+....+..+              ..|+
T Consensus       291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~----~~~~~~~~L~~L~l~~~~~~~~~~~~l--------------~~L~  352 (635)
T 4g8a_A          291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERV----KDFSYNFGWQHLELVNCKFGQFPTLKL--------------KSLK  352 (635)
T ss_dssp             CCSCEEECTTTTGGGTTCSEEEEESCEEEEC----GGGGSCCCCSEEEEESCEESSCCCCBC--------------TTCC
T ss_pred             hcccccchhhhhhhhcccccccccccccccc----cccccchhhhhhhcccccccCcCcccc--------------hhhh
Confidence                       23344455555555555422    123344556666666666654433222              2344


Q ss_pred             cccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCC--CCCcccccCCCCcEEEccCccccCCCCcc
Q 002214          316 RLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSG--SLPITLGRLKKLQGLDLQNNKFEGPIPQE  393 (952)
Q Consensus       316 ~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~l~~L~~L~L~~N~i~~~~~~~  393 (952)
                      .+.+..|.+....                ....+++|+.|++++|.+..  ..+..+..+.+|+.|+++.|.+.. .+..
T Consensus       353 ~l~l~~n~~~~~~----------------~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~  415 (635)
T 4g8a_A          353 RLTFTSNKGGNAF----------------SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSN  415 (635)
T ss_dssp             EEEEESCCSCCBC----------------CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSC
T ss_pred             hcccccccCCCCc----------------ccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-cccc
Confidence            4444444433221                23467888999999988863  345566778889999999888874 4566


Q ss_pred             ccCCCcceEEEeccccccccCC-CccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccC-CCCchhhhcccc
Q 002214          394 FCHFSRLYVVYLNRNKLSGSIP-SCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLN-GSLPLEIENLKA  471 (952)
Q Consensus       394 ~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~  471 (952)
                      |..+++|+.+++..|......+ ..|..+++++.+++++|++.+..+..+..++.|+.|++++|.+. ...|..|..+++
T Consensus       416 ~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~  495 (635)
T 4g8a_A          416 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN  495 (635)
T ss_dssp             CTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred             ccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccc
Confidence            7888999999998887765443 56788889999999999998888888889999999999998754 456778888999


Q ss_pred             cceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcc-ccccccccc
Q 002214          472 VVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKL-LYLKSLNLS  550 (952)
Q Consensus       472 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~l~  550 (952)
                      |+.|+|++|+|+++.|..|.++++|++|+|++|+|++..|..|..+++|++|||++|+|++..|..|..+ ++|+.|+|+
T Consensus       496 L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~  575 (635)
T 4g8a_A          496 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT  575 (635)
T ss_dssp             CCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECT
T ss_pred             cCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEee
Confidence            9999999999998888889999999999999999998888889999999999999999998888888887 579999999


Q ss_pred             ccccccCCCC
Q 002214          551 FNKLVGEIPR  560 (952)
Q Consensus       551 ~N~l~~~~p~  560 (952)
                      +|+|.|.|..
T Consensus       576 ~Np~~C~C~~  585 (635)
T 4g8a_A          576 QNDFACTCEH  585 (635)
T ss_dssp             TCCBCCSGGG
T ss_pred             CCCCcccCCc
Confidence            9999988864

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.6e-45  Score=445.20  Aligned_cols=534  Identities=21%  Similarity=0.211  Sum_probs=406.2

Q ss_pred             CCceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhh
Q 002214           22 SWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEEL  101 (952)
Q Consensus        22 ~w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l  101 (952)
                      .|..-.|....   ...+=++.+++ .+|..+.  +++++|||++|+|++..|.+|.++++|++|+|++|+|++..|++|
T Consensus        23 ~~~~c~~~~~~---~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f   96 (635)
T 4g8a_A           23 SWEPCVEVVPN---ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY   96 (635)
T ss_dssp             --CCSEEEETT---TEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTT
T ss_pred             CCCCccccCCC---CEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHh
Confidence            45544444333   23355666776 6787664  489999999999997667789999999999999999998778899


Q ss_pred             cCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccc-cCCccccCCCC
Q 002214          102 GNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG-PIPNNLWHCKE  180 (952)
Q Consensus       102 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~  180 (952)
                      +++++|++|+|++|++++..+..|.+++.+ +.|++++|+++ .+|...+.++++|++|+|++|+++. ..|..+..+++
T Consensus        97 ~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L-~~L~Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~  174 (635)
T 4g8a_A           97 QSLSHLSTLILTGNPIQSLALGAFSGLSSL-QKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN  174 (635)
T ss_dssp             TTCTTCCEEECTTCCCCEECGGGGTTCTTC-CEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTT
T ss_pred             cCCCCCCEEEccCCcCCCCCHHHhcCCCCC-CEEECCCCcCC-CCChhhhhcCcccCeeccccCccccCCCchhhccchh
Confidence            999999999999999995444566777765 88999999988 5777778889999999999999875 45778888999


Q ss_pred             CcEEEccCCcccccCCccccccCCcc----EEEeeCCcCCccCchhhhccCCCcEeeeccccccc-cCCccccCCCCccE
Q 002214          181 LSSVSLSYNQFTGRLPRDLGNSTKLK----SLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVG-FVPDTIFNISTLKI  255 (952)
Q Consensus       181 L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~-~~~~~~~~l~~L~~  255 (952)
                      |++|+|++|++++..+..|..+.+++    .++++.|.+....+.. .....++.|++.+|.... ..+..+..+..++.
T Consensus       175 L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~-~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~  253 (635)
T 4g8a_A          175 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA-FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEV  253 (635)
T ss_dssp             CCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTT-TTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEE
T ss_pred             hhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCccc-ccchhhhhhhhhcccccccccchhhcCCccccc
Confidence            99999999999988888887776554    6888999988554444 444567778888765442 34455667777777


Q ss_pred             EEeeCccccccC----CCCcccCCCCCcceEEcccCcCCC---CCCcccccchhhhhhh-----------ccccCccccc
Q 002214          256 LSLFNNTLSGNL----PSSKNLIGLPNLEGLNLGLNNLSG---SIPSFFFNASKLYALE-----------LGYNSNLKRL  317 (952)
Q Consensus       256 L~Ls~N~l~~~~----~~~~~l~~l~~L~~L~L~~N~l~~---~~~~~~~~~~~L~~l~-----------l~~~~~L~~L  317 (952)
                      ..+..+......    .....+..+..+...++..+....   .....+....++..+.           +.....++.|
T Consensus       254 ~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L  333 (635)
T 4g8a_A          254 HRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL  333 (635)
T ss_dssp             EEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEE
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhh
Confidence            776544332110    011123333344444444433221   1122222233333222           2333456666


Q ss_pred             cccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccC--CCCcccc
Q 002214          318 GLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEG--PIPQEFC  395 (952)
Q Consensus       318 ~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~--~~~~~~~  395 (952)
                      ++..|.+...+                 ...+..|+.+++.+|.+...  .....+++|+.|++++|.+..  ..+..+.
T Consensus       334 ~l~~~~~~~~~-----------------~~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~  394 (635)
T 4g8a_A          334 ELVNCKFGQFP-----------------TLKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDF  394 (635)
T ss_dssp             EEESCEESSCC-----------------CCBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHH
T ss_pred             hcccccccCcC-----------------cccchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchh
Confidence            66666554322                 23567888899998887743  345678999999999999853  4566777


Q ss_pred             CCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcC-CccccCCCCCceeEecCCccCCCCchhhhcccccce
Q 002214          396 HFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVI-PSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVD  474 (952)
Q Consensus       396 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  474 (952)
                      .+.+|+.+++..|.+. ..+..+..+++|+.+++++|+..... ...|..+++++.++++.|.+.+..+..+..++.|+.
T Consensus       395 ~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~  473 (635)
T 4g8a_A          395 GTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV  473 (635)
T ss_dssp             SCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred             hhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhh
Confidence            8899999999999988 45667889999999999998877654 457899999999999999999999999999999999


Q ss_pred             eecCCcccC-CCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccc
Q 002214          475 IYLSRNNLS-GNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNK  553 (952)
Q Consensus       475 L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  553 (952)
                      |+|++|++. ...|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++.+|..|.++++|+.|+|++|+
T Consensus       474 L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~  553 (635)
T 4g8a_A          474 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH  553 (635)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSC
T ss_pred             hhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCc
Confidence            999999854 4678899999999999999999999889999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCC-Cc-ccccccccccCccCCCCCcc
Q 002214          554 LVGEIPRGG-AF-ANFSAESFIGNDLLCGSPYL  584 (952)
Q Consensus       554 l~~~~p~~~-~~-~~~~~~~~~~n~~~c~~p~~  584 (952)
                      +++..|..- .+ .++....+.+|||.|+|...
T Consensus       554 l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~  586 (635)
T 4g8a_A          554 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ  586 (635)
T ss_dssp             CCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGH
T ss_pred             CCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcH
Confidence            999888642 22 56777889999999999843

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.2e-47  Score=408.47  Aligned_cols=249  Identities=22%  Similarity=0.380  Sum_probs=189.3

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCC--------
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHN--------  733 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  733 (952)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4699999999999999999987 4799999999875543 34567899999999999999999999986543        


Q ss_pred             ----eeEEEEEccCCCChhHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEec
Q 002214          734 ----FKALVLEYMPKGSLEDCMYASNF--NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSD  807 (952)
Q Consensus       734 ----~~~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~D  807 (952)
                          ..|+||||+++|+|.+++.....  ..++..++.++.||++||+||   |++||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yl---H~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHH---HHCcCccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976542  356677899999999999999   789999999999999999999999999


Q ss_pred             cccccccCCcCcc-----------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchh
Q 002214          808 FGIAKLLSEEDSM-----------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK  876 (952)
Q Consensus       808 fgla~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  876 (952)
                      ||+|+........           ..+..+||+.|||||++.+..|+.++|||||||++|||++   ||......   ..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~---~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER---VR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---HH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH---HH
Confidence            9999876543221           1223579999999999999999999999999999999996   76431100   00


Q ss_pred             hhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                              ..........        +......+++..+++.+||+.||++|||+.|++++
T Consensus       236 --------~~~~~~~~~~--------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          236 --------TLTDVRNLKF--------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             --------HHHHHHTTCC--------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --------HHHHHhcCCC--------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                    0111111000        00112234567889999999999999999999873

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.9e-46  Score=437.21  Aligned_cols=458  Identities=19%  Similarity=0.220  Sum_probs=379.9

Q ss_pred             CeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeecc
Q 002214           60 QTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSD  139 (952)
Q Consensus        60 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~  139 (952)
                      ++||+++|.++ .+|..+.  ++|++|+|++|++.+..|.+|+++++|++|+|++|++++..|..+.             
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-------------   66 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK-------------   66 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGT-------------
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhh-------------
Confidence            57999999999 7888776  8999999999999977778999999999999999999955555543             


Q ss_pred             ccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccc-cCCccccccCCccEEEeeCCcCCcc
Q 002214          140 NSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTG-RLPRDLGNSTKLKSLDLGFNNLNGE  218 (952)
Q Consensus       140 n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~  218 (952)
                                   ++++|++|+|++|+++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|+|++|.+++ 
T Consensus        67 -------------~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~-  129 (520)
T 2z7x_B           67 -------------FNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK-  129 (520)
T ss_dssp             -------------TCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG-
T ss_pred             -------------cccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch-
Confidence                         5678999999999998 46665  89999999999999997 468999999999999999999985 


Q ss_pred             CchhhhccCCC--cEeeeccccc--cccCCccccCCC-CccEEEeeCccccccCCCCcccCCCCCcceEEcccCc-----
Q 002214          219 IPQEIGNLRNL--EILGIDQSNL--VGFVPDTIFNIS-TLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNN-----  288 (952)
Q Consensus       219 ~p~~~~~l~~L--~~L~L~~n~~--~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~-----  288 (952)
                        ..+..+++|  +.|++++|++  .+..|..+..++ +...+++++|.+.+.++. ..+..+++|+.|++++|.     
T Consensus       130 --~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~-~~~~~l~~L~~L~l~~n~~~~~~  206 (520)
T 2z7x_B          130 --SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILD-VSVKTVANLELSNIKCVLEDNKC  206 (520)
T ss_dssp             --GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCC-CCCTTCSEEEECCEEECCSTTTT
T ss_pred             --hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhh-hhhhcccceeecccccccccccc
Confidence              467888888  9999999999  788888888766 455678889998876554 357789999999999997     


Q ss_pred             --CCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCC
Q 002214          289 --LSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSL  366 (952)
Q Consensus       289 --l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~  366 (952)
                        +.+.++            .+....+|+.|+++.|.+......  .....         ...++|++|++++|++++.+
T Consensus       207 ~~~~~~~~------------~l~~l~~L~~L~l~~~~l~~~~~~--~~~~~---------~~~~~L~~L~l~~n~l~~~~  263 (520)
T 2z7x_B          207 SYFLSILA------------KLQTNPKLSNLTLNNIETTWNSFI--RILQL---------VWHTTVWYFSISNVKLQGQL  263 (520)
T ss_dssp             HHHHHHHH------------GGGGCTTCCEEEEEEEEEEHHHHH--HHHHH---------HHTSSCSEEEEEEEEEESCC
T ss_pred             ceeecchh------------hhccccchhhccccccccCHHHHH--HHHHH---------hhhCcccEEEeecccccCcc
Confidence              333222            344556777777777776532211  11110         12458999999999999888


Q ss_pred             Cccc-----ccCCCCcEEEccCccccCCCCccccCC---CcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcC
Q 002214          367 PITL-----GRLKKLQGLDLQNNKFEGPIPQEFCHF---SRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVI  438 (952)
Q Consensus       367 ~~~l-----~~l~~L~~L~L~~N~i~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  438 (952)
                      |..+     ..+++|+.+++++|.+ ......+..+   .+|+.|++++|.+....  .+..+++|++|++++|++++..
T Consensus       264 p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~  340 (520)
T 2z7x_B          264 DFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTV  340 (520)
T ss_dssp             CCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTT
T ss_pred             ccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhh
Confidence            8888     8999999999999999 3433555555   67999999999987432  2368999999999999999989


Q ss_pred             CccccCCCCCceeEecCCccCC--CCchhhhcccccceeecCCcccCCCCc-ccccCCCCCceEEccCccccCccccccc
Q 002214          439 PSTFWNLEDILGFDFSSNSLNG--SLPLEIENLKAVVDIYLSRNNLSGNIP-STIIGLKNLQHLSLEHNKLQGPIPESFG  515 (952)
Q Consensus       439 ~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~  515 (952)
                      |..+..+++|+.|++++|++++  ..|..+..+++|++|+|++|++++.+| ..+..+++|++|+|++|++++..|..+.
T Consensus       341 ~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~  420 (520)
T 2z7x_B          341 FENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP  420 (520)
T ss_dssp             TTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC
T ss_pred             hhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc
Confidence            9999999999999999999996  456789999999999999999998455 4589999999999999999887777664


Q ss_pred             ccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCC--CCcccccccccccCccCCCCCc
Q 002214          516 ELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG--GAFANFSAESFIGNDLLCGSPY  583 (952)
Q Consensus       516 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~~~~~~~~~~n~~~c~~p~  583 (952)
                        ++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++. +|..  ..+.++....+.+|++.|+|+.
T Consensus       421 --~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          421 --PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             --TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             --ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccCCc
Confidence              79999999999999 678777799999999999999995 5543  4456677788999999998874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=5.8e-46  Score=451.50  Aligned_cols=463  Identities=19%  Similarity=0.212  Sum_probs=353.6

Q ss_pred             cccCeeeccccccccccCCCcCCcCCCcEEeC-cCCcccccCChhhcCC-CCCCeEe---e------------cCccCcc
Q 002214           57 SSLQTLVLSRNWFSGTIPKEIGNLTKLKELHL-DYNKLQGEIPEELGNL-AELEMLV---L------------NNNLLTG  119 (952)
Q Consensus        57 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L-~~n~l~~~~p~~l~~l-~~L~~L~---L------------~~n~l~~  119 (952)
                      ..++.|+|++|.+.|.+|++|+.|++|++|+| ++|.+.|..|-..... ..+....   +            ....+.+
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            46788999999999999999999999999999 8888876533221111 0000000   0            0000000


Q ss_pred             ccCccc-----------ccccccccceee--ccccccccCCCCCCCCCCccceEEcccCcccc-----------------
Q 002214          120 TIPASI-----------FNLSFISTALDF--SDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG-----------------  169 (952)
Q Consensus       120 ~~p~~~-----------~~l~~l~~~L~l--~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~-----------------  169 (952)
                      .++..+           .+... ++.+.+  .+|++++ +|.. +.++++|++|+|++|++++                 
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~-l~~l~l~~~~N~L~~-IP~~-l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g  479 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRIS-LKDTQIGNLTNRITF-ISKA-IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQ  479 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCC-CCTTTTTCCSCEEEE-ECGG-GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHH
T ss_pred             HHHHHhhhCccccccccccccc-hhhceeccccCcccc-hhHH-HhcCCCCCEEECcCCcCCCCcccccccccccccccc
Confidence            000000           00000 122222  3477776 7765 4578888888888888887                 


Q ss_pred             cCCcccc--CCCCCcEEEccCCcccccCCccccccCCccEEEeeCCc-CCc-cCchhhhccC-------CCcEeeecccc
Q 002214          170 PIPNNLW--HCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNN-LNG-EIPQEIGNLR-------NLEILGIDQSN  238 (952)
Q Consensus       170 ~~~~~l~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~L~~n~  238 (952)
                      .+|..++  ++++|+.|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..++.++       +|+.|+|++|+
T Consensus       480 ~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~  559 (876)
T 4ecn_A          480 YENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN  559 (876)
T ss_dssp             HTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSC
T ss_pred             cCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCc
Confidence            3888887  99999999999999999999999999999999999998 887 7888888776       99999999999


Q ss_pred             ccccCCc--cccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCcccc
Q 002214          239 LVGFVPD--TIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKR  316 (952)
Q Consensus       239 ~~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~  316 (952)
                      +. .+|.  .+.++++|+.|+|++|+++ .+|   .+..+++|++|+|++|++. .+|..                    
T Consensus       560 L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp---~~~~L~~L~~L~Ls~N~l~-~lp~~--------------------  613 (876)
T 4ecn_A          560 LE-EFPASASLQKMVKLGLLDCVHNKVR-HLE---AFGTNVKLTDLKLDYNQIE-EIPED--------------------  613 (876)
T ss_dssp             CC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC---CCCTTSEESEEECCSSCCS-CCCTT--------------------
T ss_pred             CC-ccCChhhhhcCCCCCEEECCCCCcc-cch---hhcCCCcceEEECcCCccc-cchHH--------------------
Confidence            98 6677  8899999999999999998 556   4788899999999999988 45543                    


Q ss_pred             ccccCcceeechhhHHHHHHHhhccccccccCCCc-ccEEEccCCCCCCCCCcccccCCC--CcEEEccCccccCCCCcc
Q 002214          317 LGLERNYLTFSTSELMSLFSALVNCKSLKIGNLIN-LTTLSLGDNNLSGSLPITLGRLKK--LQGLDLQNNKFEGPIPQE  393 (952)
Q Consensus       317 L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~l~~l~~--L~~L~L~~N~i~~~~~~~  393 (952)
                                                   +..+++ |+.|+|++|+++ .+|..+..++.  |+.|+|++|++.+..|..
T Consensus       614 -----------------------------l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l  663 (876)
T 4ecn_A          614 -----------------------------FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNI  663 (876)
T ss_dssp             -----------------------------SCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSC
T ss_pred             -----------------------------HhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccc
Confidence                                         345667 999999999999 67888877654  999999999998766643


Q ss_pred             cc-----CCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCC-------CCCceeEecCCccCCC
Q 002214          394 FC-----HFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNL-------EDILGFDFSSNSLNGS  461 (952)
Q Consensus       394 ~~-----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-------~~L~~L~Ls~N~l~~~  461 (952)
                      .+     .+++|+.|+|++|+++...+..+..+++|+.|+|++|+|+.+++..+...       ++|+.|+|++|+|+ .
T Consensus       664 ~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~  742 (876)
T 4ecn_A          664 SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-S  742 (876)
T ss_dssp             SSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-C
T ss_pred             hhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-c
Confidence            32     34589999999999994444445589999999999999996666555543       39999999999999 6


Q ss_pred             Cchhhh--cccccceeecCCcccCCCCcccccCCCCCceEEccC------ccccCcccccccccccccEEeCCCCccccc
Q 002214          462 LPLEIE--NLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEH------NKLQGPIPESFGELVSLEFLDLSNNDLSGV  533 (952)
Q Consensus       462 ~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~------N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  533 (952)
                      +|..+.  .+++|+.|+|++|+|++ +|..+..+++|+.|+|++      |++.+.+|..|..+++|+.|+|++|+| +.
T Consensus       743 lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~  820 (876)
T 4ecn_A          743 LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RK  820 (876)
T ss_dssp             CCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CB
T ss_pred             chHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-Cc
Confidence            888887  99999999999999997 788899999999999977      888889999999999999999999999 57


Q ss_pred             CccchhcccccccccccccccccCCCCCCC-cccccccccccCccCC--CCCc
Q 002214          534 IPASLEKLLYLKSLNLSFNKLVGEIPRGGA-FANFSAESFIGNDLLC--GSPY  583 (952)
Q Consensus       534 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~~~c--~~p~  583 (952)
                      +|..+.  ++|+.|+|++|++....+.... ........+.+|+..+  +||.
T Consensus       821 Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~~  871 (876)
T 4ecn_A          821 VDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA  871 (876)
T ss_dssp             CCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCGG
T ss_pred             cCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCCC
Confidence            777765  6999999999999765443110 0112233345555544  6663

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=5.9e-45  Score=432.25  Aligned_cols=462  Identities=20%  Similarity=0.202  Sum_probs=304.4

Q ss_pred             EEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCc
Q 002214           36 TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNN  115 (952)
Q Consensus        36 ~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n  115 (952)
                      +.+|+++++++ .+|..+.  ++|++|+|++|.+++..|..|..+++|++|+|++|++++..|++|+++++|++|+|++|
T Consensus        34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            78999999998 4887765  89999999999999777789999999999999999999888999999999999999999


Q ss_pred             cCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccc-cCCccccCCCCCcEEEccCCccccc
Q 002214          116 LLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG-PIPNNLWHCKELSSVSLSYNQFTGR  194 (952)
Q Consensus       116 ~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~  194 (952)
                      +++ .+|..  .                          +++|++|+|++|++++ ..|..|.++++|++|+|++|++++ 
T Consensus       111 ~l~-~lp~~--~--------------------------l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~-  160 (562)
T 3a79_B          111 RLQ-NISCC--P--------------------------MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ-  160 (562)
T ss_dssp             CCC-EECSC--C--------------------------CTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT-
T ss_pred             cCC-ccCcc--c--------------------------cccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc-
Confidence            998 55554  3                          3455555555555543 223455555555555555555543 


Q ss_pred             CCccccccCCc--cEEEeeCCcC--CccCchhhhccC--CCcEeeeccccccccCCc-cccCCCCccEEEeeCccc----
Q 002214          195 LPRDLGNSTKL--KSLDLGFNNL--NGEIPQEIGNLR--NLEILGIDQSNLVGFVPD-TIFNISTLKILSLFNNTL----  263 (952)
Q Consensus       195 ~~~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~l~--~L~~L~L~~n~~~~~~~~-~~~~l~~L~~L~Ls~N~l----  263 (952)
                        ..+..+++|  ++|+|++|.+  ++..|..|..+.  .| .+++++|.+.+..++ .+..+++|+.|++++|+.    
T Consensus       161 --~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~  237 (562)
T 3a79_B          161 --LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR  237 (562)
T ss_dssp             --TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHH
T ss_pred             --CchhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccch
Confidence              223333333  5555555555  444444444433  22 234444444443322 233455555555555431    


Q ss_pred             -cccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCccee-echhhHHHHHHHhhcc
Q 002214          264 -SGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLT-FSTSELMSLFSALVNC  341 (952)
Q Consensus       264 -~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~-~~~~~~~~~~~~~~~~  341 (952)
                       .+.+   ..+.++++|+.|+++++.+.+.....   ..     ......+|+.|++++|.++ ..+...+.        
T Consensus       238 l~~~~---~~l~~l~~L~~L~L~~~~l~~~~~~~---~~-----~~~~~~~L~~L~l~~n~l~~~ip~~~~~--------  298 (562)
T 3a79_B          238 LMTFL---SELTRGPTLLNVTLQHIETTWKCSVK---LF-----QFFWPRPVEYLNIYNLTITERIDREEFT--------  298 (562)
T ss_dssp             HHHHH---HHHHSCSSCEEEEEEEEEECHHHHHH---HH-----HHHTTSSEEEEEEEEEEECSCCCCCCCC--------
T ss_pred             HHHHH---HHHhccCcceEEEecCCcCcHHHHHH---HH-----HhhhcccccEEEEeccEeeccccchhhh--------
Confidence             1110   11333444455555444443211000   00     0001123444444444433 22211000        


Q ss_pred             ccccccCCCcccEEEccCCCCCCCCCcccccC---CCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCcc
Q 002214          342 KSLKIGNLINLTTLSLGDNNLSGSLPITLGRL---KKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCL  418 (952)
Q Consensus       342 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l---~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  418 (952)
                        ...+.+++|+.+++..|.+ ......+..+   .+|++|++++|.+....  .+..+++|++|++++|++++..|..+
T Consensus       299 --~~~~~L~~L~~~~~~~~~~-~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~  373 (562)
T 3a79_B          299 --YSETALKSLMIEHVKNQVF-LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGC  373 (562)
T ss_dssp             --CCSCSCCEEEEEEEEECCC-SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTC
T ss_pred             --cccccchheehhhccccee-ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhh
Confidence              0014566777777777777 2332333332   67899999999875322  22678889999999999988888888


Q ss_pred             CCCCCCcEEeccccccCCcC--CccccCCCCCceeEecCCccCCCCc-hhhhcccccceeecCCcccCCCCcccccCCCC
Q 002214          419 GDLNSLRILSLSSNELTSVI--PSTFWNLEDILGFDFSSNSLNGSLP-LEIENLKAVVDIYLSRNNLSGNIPSTIIGLKN  495 (952)
Q Consensus       419 ~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  495 (952)
                      ..+++|++|++++|+++++.  |..|..+++|+.|++++|++++.+| ..+..+++|++|+|++|++++..|..+.  ++
T Consensus       374 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~  451 (562)
T 3a79_B          374 STLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PK  451 (562)
T ss_dssp             CSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TT
T ss_pred             cccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--Cc
Confidence            89999999999999998754  4568888999999999999987444 4578888999999999998876665544  68


Q ss_pred             CceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          496 LQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       496 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      |+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+++++..+..+++|+.|++++|+|.|.||.
T Consensus       452 L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  515 (562)
T 3a79_B          452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG  515 (562)
T ss_dssp             CSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred             CCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence            999999999998 5666666889999999999999854444488889999999999999988874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-45  Score=404.22  Aligned_cols=269  Identities=23%  Similarity=0.275  Sum_probs=202.3

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeec------CC
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTN------HN  733 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  733 (952)
                      .++|++.+.||+|+||+||+|++ .+|+.||||+++...  ....+.+.+|+++|++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            35799999999999999999997 479999999986443  2345678899999999999999999998753      35


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ..|+|||||+ |+|.+++...+ .+++.++..++.||+.||+||   |++|||||||||+|||++.++.+||+|||+|+.
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYM---HSAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            7899999995 67999887644 799999999999999999999   799999999999999999999999999999987


Q ss_pred             cCCcC---cccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhhh
Q 002214          814 LSEED---SMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPAV  886 (952)
Q Consensus       814 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~  886 (952)
                      +....   .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+.....   ......
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChHH
Confidence            64322   1223346899999999987764 5689999999999999999999999652111 11111110   000000


Q ss_pred             hhhcc--------ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 MNIMD--------TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...+.        .................+++++.+|+.+||..||++|||+.|+++|
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000        0000000000011123456789999999999999999999999874

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2e-44  Score=397.67  Aligned_cols=268  Identities=19%  Similarity=0.276  Sum_probs=200.9

Q ss_pred             HHhccCCccceecCccceEEEEEEeC----CCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCee
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  735 (952)
                      ...++|++.+.||+|+||+||+|+.+    +++.||||++.....  ..++.+|+++++++ +|||||++++++.+.+..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            35678999999999999999999763    478899998865433  35688999999998 699999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC-CcEEEecccccccc
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS-MVAHLSDFGIAKLL  814 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgla~~~  814 (952)
                      |+||||+++|+|.+++.    .+++.++..++.|++.||+||   |++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~yl---H~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRI---HQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999999999884    489999999999999999999   79999999999999999876 79999999999865


Q ss_pred             CCcCc---------------------------ccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCC
Q 002214          815 SEEDS---------------------------MKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTN  866 (952)
Q Consensus       815 ~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~  866 (952)
                      .....                           ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            43211                           111235799999999988765 58999999999999999999999985


Q ss_pred             ccccCccchhhhhccch-h---hhhhhc-------------------------ccc---ccchhh--HHHHHhhhhhHHH
Q 002214          867 EFFTGEMSIKRWINDSL-P---AVMNIM-------------------------DTN---LLSEDE--EHANVAKQSCASS  912 (952)
Q Consensus       867 ~~~~~~~~~~~~~~~~~-~---~~~~~~-------------------------~~~---~~~~~~--~~~~~~~~~~~~~  912 (952)
                      ........+.......- +   ......                         +..   ......  ..........+++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            42221111111110000 0   000000                         000   000000  0000112345678


Q ss_pred             HHHHHhhccccCCCCCCCHHHHHHH
Q 002214          913 VLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       913 l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +.+|+.+||..||++|||++|+++|
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcC
Confidence            9999999999999999999999864

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3.4e-43  Score=417.07  Aligned_cols=442  Identities=21%  Similarity=0.206  Sum_probs=325.6

Q ss_pred             CeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEee
Q 002214           33 NRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVL  112 (952)
Q Consensus        33 ~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  112 (952)
                      .++++|+++++.+++..|..++.+++|++|+|++|++++..|+.|..+++|++|+|++|+++ .+|..  .+++|++|+|
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L  128 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL  128 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence            57899999999999877889999999999999999999888999999999999999999999 67776  8999999999


Q ss_pred             cCccCcc-ccCcccccccccccceeeccccccccCCCCCCCCCCcc--ceEEcccCcc--cccCCccccCCC--CCcEEE
Q 002214          113 NNNLLTG-TIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRL--KGLYVSYNQF--KGPIPNNLWHCK--ELSSVS  185 (952)
Q Consensus       113 ~~n~l~~-~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~~~~l~~l~--~L~~L~  185 (952)
                      ++|++++ .+|..+.+++.+ +.|++++|++++.    .+..+++|  ++|++++|++  ++..|..+..+.  .+ .++
T Consensus       129 s~N~l~~l~~p~~~~~l~~L-~~L~L~~n~l~~~----~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~  202 (562)
T 3a79_B          129 SFNDFDVLPVCKEFGNLTKL-TFLGLSAAKFRQL----DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLV  202 (562)
T ss_dssp             CSSCCSBCCCCGGGGGCTTC-CEEEEECSBCCTT----TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEE
T ss_pred             CCCCccccCchHhhcccCcc-cEEecCCCccccC----chhhhhhceeeEEEeecccccccccCcccccccCcceE-EEE
Confidence            9999995 345777777655 7777777777641    22334444  7777777777  666666666554  22 456


Q ss_pred             ccCCcccccCCc-cccccCCccEEEeeCCcCC----ccCchhhhccCCCcEeeeccccccccCCcc---ccCCCCccEEE
Q 002214          186 LSYNQFTGRLPR-DLGNSTKLKSLDLGFNNLN----GEIPQEIGNLRNLEILGIDQSNLVGFVPDT---IFNISTLKILS  257 (952)
Q Consensus       186 L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~---~~~l~~L~~L~  257 (952)
                      +++|.+.+.++. .+..+++|+.|++++|+..    ...+..+..+++|+.|+++++.+.+.....   ....++|++|+
T Consensus       203 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~  282 (562)
T 3a79_B          203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLN  282 (562)
T ss_dssp             ECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEE
T ss_pred             ecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEE
Confidence            667766654433 3456677777777776421    112334666666666666655544321110   11223666666


Q ss_pred             eeCccccccCCCCccc---CCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHH
Q 002214          258 LFNNTLSGNLPSSKNL---IGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSL  334 (952)
Q Consensus       258 Ls~N~l~~~~~~~~~l---~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~  334 (952)
                      +++|.+++.+|....-   ..++.|+.++++.|.+  .+|.                                 ..+...
T Consensus       283 l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~---------------------------------~~~~~~  327 (562)
T 3a79_B          283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSK---------------------------------EALYSV  327 (562)
T ss_dssp             EEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCH---------------------------------HHHHHH
T ss_pred             EeccEeeccccchhhhcccccchheehhhccccee--ecCh---------------------------------hhhhhh
Confidence            6666666554433100   2333333333333333  1110                                 111110


Q ss_pred             HHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEecccccccc-
Q 002214          335 FSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGS-  413 (952)
Q Consensus       335 ~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-  413 (952)
                                  -...+|++|++++|.+....  ....+++|++|++++|.+++..|..|.++++|+.|+|++|++++. 
T Consensus       328 ------------~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  393 (562)
T 3a79_B          328 ------------FAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFF  393 (562)
T ss_dssp             ------------HHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTT
T ss_pred             ------------hccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcc
Confidence                        11257999999999987432  237889999999999999998999999999999999999999963 


Q ss_pred             -CCCccCCCCCCcEEeccccccCC-cCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCccccc
Q 002214          414 -IPSCLGDLNSLRILSLSSNELTS-VIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTII  491 (952)
Q Consensus       414 -~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  491 (952)
                       +|..+..+++|++|++++|++++ +++..|..+++|+.|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+.
T Consensus       394 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~  470 (562)
T 3a79_B          394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVT  470 (562)
T ss_dssp             HHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTT
T ss_pred             cchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhc
Confidence             35678999999999999999998 6666799999999999999999876665554  79999999999999 5666666


Q ss_pred             CCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCc
Q 002214          492 GLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIP  535 (952)
Q Consensus       492 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  535 (952)
                      .+++|+.|+|++|+|+++.+..|..+++|+.|+|++|++.+..+
T Consensus       471 ~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          471 HLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             SSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             CCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            99999999999999995444449999999999999999986544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.5e-43  Score=412.92  Aligned_cols=253  Identities=20%  Similarity=0.323  Sum_probs=212.5

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|++........+.+.+|+++|+.++|||||++++++.+++..|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            46899999999999999999988 47999999999776666667899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC--CcEEEeccccccccCCcCc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS--MVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~--~~~kl~Dfgla~~~~~~~~  819 (952)
                      |+||+|.+++......+++.++..++.||+.||+||   |+++|+||||||+|||++.+  +.+||+|||+|+.+.....
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            999999999976666799999999999999999999   78999999999999999854  8999999999998754432


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        ....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+ .+..           +........  
T Consensus       313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~~-----------i~~~~~~~~--  376 (573)
T 3uto_A          313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRN-----------VKSCDWNMD--  376 (573)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHH-----------HHTTCCCCC--
T ss_pred             --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHH-----------HHhCCCCCC--
Confidence              234679999999999999999999999999999999999999996521110 1111           111000000  


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ...+..+++++.+|+.+||..||++|||+.|+++|
T Consensus       377 ---~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          377 ---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             ---SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               01123467789999999999999999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.6e-43  Score=409.39  Aligned_cols=250  Identities=21%  Similarity=0.274  Sum_probs=201.7

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHH---HHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFD---AECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++....   ......+.   .++.+++.++|||||++++++.+++..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            36799999999999999999988 469999999986432   11122333   446677778999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      |+||||++||+|.+++...+ .+++..+..++.||+.||+||   |++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yL---H~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999997654 699999999999999999999   79999999999999999999999999999998765


Q ss_pred             CcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ...   ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||......+  ......       ...... 
T Consensus       344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~-------~i~~~~-  410 (689)
T 3v5w_A          344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDR-------MTLTMA-  410 (689)
T ss_dssp             SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHH-------HHHHCC-
T ss_pred             CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH-------hhcCCC-
Confidence            432   234689999999999864 579999999999999999999999996532221  111000       000000 


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN-----TKEIISR  937 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~  937 (952)
                              ...+..+++++.+|+.+||..||++|++     ++||.+|
T Consensus       411 --------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          411 --------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             --------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                    0123446788999999999999999998     6887654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=379.88  Aligned_cols=265  Identities=22%  Similarity=0.380  Sum_probs=222.1

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|.+.+.||+|+||+||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            45789999999999999999998 46899999998766666678899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++|+|.+++......+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            999999999988777899999999999999999999   78999999999999999999999999999998765433211


Q ss_pred             c-------------cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhh
Q 002214          822 Q-------------TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMN  888 (952)
Q Consensus       822 ~-------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  888 (952)
                      .             ....||+.|+|||++.+..++.++||||||+++|||++|..|+................       
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~-------  238 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG-------  238 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH-------
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc-------
Confidence            1             13569999999999999999999999999999999999999986543322211111000       


Q ss_pred             hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 002214          889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFAN  948 (952)
Q Consensus       889 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~  948 (952)
                                 ......+..+++++.+++.+||+.||++|||+.|+++.|+++++.+...
T Consensus       239 -----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~  287 (310)
T 3s95_A          239 -----------FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH  287 (310)
T ss_dssp             -----------HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred             -----------cccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence                       0011123456778999999999999999999999999999999887654

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=4.1e-42  Score=397.49  Aligned_cols=405  Identities=21%  Similarity=0.224  Sum_probs=240.7

Q ss_pred             CCCCCCCceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCccccc
Q 002214           17 NASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGE   96 (952)
Q Consensus        17 ~~~~c~w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~   96 (952)
                      +.+.|.|.+.          .++.++.+++ .+|. +  .++|++|+|++|.+++..|..++.+++|++|+|++|.+.+.
T Consensus         4 ~~~~c~~~~~----------~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~   69 (455)
T 3v47_A            4 GTSECSVIGY----------NAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV   69 (455)
T ss_dssp             ---CCEEETT----------EEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCE
T ss_pred             ccceeEEEcc----------ccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccce
Confidence            4456776542          2333444454 4555 2  26778888888888766677777777777777777777533


Q ss_pred             C-ChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCcc-
Q 002214           97 I-PEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNN-  174 (952)
Q Consensus        97 ~-p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-  174 (952)
                      + |..|+++++|++|+|++|++++..|..+                          .++++|++|+|++|++++..+.. 
T Consensus        70 i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~--------------------------~~l~~L~~L~L~~n~l~~~~~~~~  123 (455)
T 3v47_A           70 IRNNTFRGLSSLIILKLDYNQFLQLETGAF--------------------------NGLANLEVLTLTQCNLDGAVLSGN  123 (455)
T ss_dssp             ECTTTTTTCTTCCEEECTTCTTCEECTTTT--------------------------TTCTTCCEEECTTSCCBTHHHHSS
T ss_pred             ECcccccccccCCEEeCCCCccCccChhhc--------------------------cCcccCCEEeCCCCCCCccccCcc
Confidence            3 4567777777777777776663333322                          23445566666666555432222 


Q ss_pred             -ccCCCCCcEEEccCCcccccCCcc-ccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCC
Q 002214          175 -LWHCKELSSVSLSYNQFTGRLPRD-LGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNIST  252 (952)
Q Consensus       175 -l~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~  252 (952)
                       |..+++|++|+|++|++++..|.. |+++++|++|+|++|++++..|..+..+.                      ..+
T Consensus       124 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~----------------------~~~  181 (455)
T 3v47_A          124 FFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQ----------------------GKH  181 (455)
T ss_dssp             TTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGT----------------------TCE
T ss_pred             cccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccc----------------------ccc
Confidence             444555555555555554443433 44444444444444444443333333320                      134


Q ss_pred             ccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHH
Q 002214          253 LKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELM  332 (952)
Q Consensus       253 L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~  332 (952)
                      |+.|++++|.+.+..+.                          .+... .                              
T Consensus       182 L~~L~l~~n~l~~~~~~--------------------------~~~~~-~------------------------------  204 (455)
T 3v47_A          182 FTLLRLSSITLQDMNEY--------------------------WLGWE-K------------------------------  204 (455)
T ss_dssp             EEEEECTTCBCTTCSTT--------------------------CTTHH-H------------------------------
T ss_pred             ccccccccCcccccchh--------------------------hcccc-c------------------------------
Confidence            45555555554432111                          10000 0                              


Q ss_pred             HHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccC---CCCcEEEccCccccCCCCccccCCCcceEEEecccc
Q 002214          333 SLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRL---KKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNK  409 (952)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l---~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~  409 (952)
                                ...+..+++|++|++++|++++..|..+...   ++|+.|++++|.+.+...              ..+.
T Consensus       205 ----------~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~--------------~~~~  260 (455)
T 3v47_A          205 ----------CGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF--------------GHTN  260 (455)
T ss_dssp             ----------HCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT--------------TCCS
T ss_pred             ----------cccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc--------------chhh
Confidence                      0001123344444444444444333333322   445555555544332110              0111


Q ss_pred             ccccCCCccCC--CCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCc
Q 002214          410 LSGSIPSCLGD--LNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIP  487 (952)
Q Consensus       410 l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  487 (952)
                      +....+..+..  .++|+.|++++|++++..|..|..+++|+.|++++|++++..|..|.++++|++|+|++|++++..|
T Consensus       261 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  340 (455)
T 3v47_A          261 FKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDS  340 (455)
T ss_dssp             SCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECG
T ss_pred             hccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcCh
Confidence            11111222222  3567777777777777777777777777777777777777677777888888888888888887778


Q ss_pred             ccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCCCc
Q 002214          488 STIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAF  564 (952)
Q Consensus       488 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  564 (952)
                      ..|..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|++++|+++|.+|....+
T Consensus       341 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~l  417 (455)
T 3v47_A          341 RMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL  417 (455)
T ss_dssp             GGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHH
T ss_pred             hHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcchHH
Confidence            88888999999999999998877888999999999999999999877778889999999999999999999864433

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.4e-42  Score=379.38  Aligned_cols=283  Identities=35%  Similarity=0.580  Sum_probs=229.7

Q ss_pred             ccccCHHHHHHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEe
Q 002214          651 WRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSC  729 (952)
Q Consensus       651 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~  729 (952)
                      ...++..++....++|.+.+.||+|+||.||+|+..+|+.||||++..... .....+.+|++++++++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            356888999999999999999999999999999988899999999865432 2234789999999999999999999999


Q ss_pred             ecCCeeEEEEEccCCCChhHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEe
Q 002214          730 TNHNFKALVLEYMPKGSLEDCMYASN---FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS  806 (952)
Q Consensus       730 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~  806 (952)
                      ...+..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||..+..||+||||||+||+++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999997643   249999999999999999999964444499999999999999999999999


Q ss_pred             ccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccc---cCccchhhhhccch
Q 002214          807 DFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFF---TGEMSIKRWINDSL  883 (952)
Q Consensus       807 Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~---~~~~~~~~~~~~~~  883 (952)
                      |||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||....   ........|.....
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            999999776544444445669999999999988889999999999999999999999996321   22223333433322


Q ss_pred             hh--hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          884 PA--VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       884 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                      ..  .....+......       .+..++.++.+++.+||+.||++|||+.||+++|+.
T Consensus       257 ~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          257 KEKKLEALVDVDLQGN-------YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             SSCCSTTSSCTTCTTS-------CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hchhhhhhcChhhccc-------cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            21  112222222111       224457889999999999999999999999999974

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.4e-42  Score=377.45  Aligned_cols=279  Identities=33%  Similarity=0.553  Sum_probs=227.0

Q ss_pred             HHHHHHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          656 HDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       656 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      ..++...+++|++.+.||+|+||.||+|++++|+.||||++........+.+.+|++++++++||||+++++++.+.+..
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            34445577899999999999999999999988999999998776666678899999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          736 ALVLEYMPKGSLEDCMYASN---FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                      ++||||+++|+|.+++....   ..+++..++.++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHh---cCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99999999999999987543   2589999999999999999999   68999999999999999999999999999998


Q ss_pred             ccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCc-cchhhhhccch--hhhhh
Q 002214          813 LLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE-MSIKRWINDSL--PAVMN  888 (952)
Q Consensus       813 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~--~~~~~  888 (952)
                      ........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .....|.....  .....
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            65432221 2233458999999999988899999999999999999999999987644332 12222221111  01112


Q ss_pred             hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       889 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      .+++....       ..+..++.++.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus       268 ~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          268 IVDPNLAD-------KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             SSSSSCTT-------CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hcChhhcc-------ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            22222211       12345688899999999999999999999999999988764

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=5.5e-41  Score=387.98  Aligned_cols=383  Identities=21%  Similarity=0.214  Sum_probs=261.5

Q ss_pred             CCCCCCceEEEeC-CCCeEEEEEecCCCCcccCCccccCCcccCeeecccccccccc-CCCcCCcCCCcEEeCcCCcccc
Q 002214           18 ASVCSWMGITCDV-YGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTI-PKEIGNLTKLKELHLDYNKLQG   95 (952)
Q Consensus        18 ~~~c~w~~v~c~~-~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~n~l~~   95 (952)
                      .-.|.+.|.+... ...++++|+++++.+++..|..++++++|++|+|++|.+.+.+ |..|..+++|++|+|++|++.+
T Consensus        14 ~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~   93 (455)
T 3v47_A           14 NAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ   93 (455)
T ss_dssp             EEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCE
T ss_pred             ccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCc
Confidence            3467777766543 3467999999999999888999999999999999999998665 5679999999999999999998


Q ss_pred             cCChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCcc-
Q 002214           96 EIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNN-  174 (952)
Q Consensus        96 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-  174 (952)
                      ..|..|+++++|++|+|++|.+++.+|..                        ..+..+++|++|+|++|++++..|.. 
T Consensus        94 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~------------------------~~~~~l~~L~~L~L~~n~l~~~~~~~~  149 (455)
T 3v47_A           94 LETGAFNGLANLEVLTLTQCNLDGAVLSG------------------------NFFKPLTSLEMLVLRDNNIKKIQPASF  149 (455)
T ss_dssp             ECTTTTTTCTTCCEEECTTSCCBTHHHHS------------------------STTTTCTTCCEEECCSSBCCSCCCCGG
T ss_pred             cChhhccCcccCCEEeCCCCCCCccccCc------------------------ccccCcccCCEEECCCCccCccCcccc
Confidence            88999999999999999999998544332                        22346778999999999988776766 


Q ss_pred             ccCCCCCcEEEccCCcccccCCcccccc--CCccEEEeeCCcCCccCchhh--------hccCCCcEeeeccccccccCC
Q 002214          175 LWHCKELSSVSLSYNQFTGRLPRDLGNS--TKLKSLDLGFNNLNGEIPQEI--------GNLRNLEILGIDQSNLVGFVP  244 (952)
Q Consensus       175 l~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~--------~~l~~L~~L~L~~n~~~~~~~  244 (952)
                      +..+++|+.|++++|++++..|..+..+  .+|+.|++++|.+.+..+..+        ..+++|+.|++++|++.+..|
T Consensus       150 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~  229 (455)
T 3v47_A          150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA  229 (455)
T ss_dssp             GGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHH
T ss_pred             cCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccch
Confidence            7888999999999999988888888776  688899999998885544332        244556666666666655555


Q ss_pred             ccccCC---CCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccC
Q 002214          245 DTIFNI---STLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLER  321 (952)
Q Consensus       245 ~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~  321 (952)
                      ..+...   ++|+.|++++|.+.+...                ..+.+.+..+..+.                       
T Consensus       230 ~~~~~~~~~~~L~~L~l~~~~~~~~~~----------------~~~~~~~~~~~~~~-----------------------  270 (455)
T 3v47_A          230 KRFFDAIAGTKIQSLILSNSYNMGSSF----------------GHTNFKDPDNFTFK-----------------------  270 (455)
T ss_dssp             HHHHHHTTTCCEEEEECTTCTTTSCCT----------------TCCSSCCCCTTTTG-----------------------
T ss_pred             hhhhccccccceeeEeecccccccccc----------------chhhhccCcccccc-----------------------
Confidence            444332   445555555444332100                00111100000000                       


Q ss_pred             cceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcce
Q 002214          322 NYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLY  401 (952)
Q Consensus       322 n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  401 (952)
                                              -...++|+.|++++|.+++..|..+..+++|++|+|++|.                
T Consensus       271 ------------------------~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~----------------  310 (455)
T 3v47_A          271 ------------------------GLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNE----------------  310 (455)
T ss_dssp             ------------------------GGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSC----------------
T ss_pred             ------------------------cccccCceEEEecCccccccchhhcccCCCCCEEECCCCc----------------
Confidence                                    0012345555555555554444444444555555555444                


Q ss_pred             EEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcc
Q 002214          402 VVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNN  481 (952)
Q Consensus       402 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  481 (952)
                              +++..|..|.++++|++|++++|+++++.+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|+
T Consensus       311 --------l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  382 (455)
T 3v47_A          311 --------INKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQ  382 (455)
T ss_dssp             --------CCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             --------ccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCc
Confidence                    444445555556666666666666665556666666666666666666665566667777777777777777


Q ss_pred             cCCCCcccccCCCCCceEEccCccccCccc
Q 002214          482 LSGNIPSTIIGLKNLQHLSLEHNKLQGPIP  511 (952)
Q Consensus       482 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  511 (952)
                      +++..+..|..+++|++|+|++|++++..|
T Consensus       383 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          383 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             cccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            776666677888888888888888886555

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.5e-41  Score=368.35  Aligned_cols=251  Identities=26%  Similarity=0.363  Sum_probs=210.1

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999987 57999999999776665567889999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++|+|.+++...  .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|........ .
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  172 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence            9999999998765  489999999999999999999   788999999999999999999999999999987654332 2


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......        .....       
T Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~--------~~~~~-------  236 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATN--------GTPEL-------  236 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHH--------CSCCC-------
T ss_pred             cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhC--------CCCCC-------
Confidence            3346799999999999999999999999999999999999999865211110 0000000        00000       


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                        ..+..+++.+.+++.+||+.||++|||+.|++++
T Consensus       237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          237 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              0123467789999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-41  Score=364.19  Aligned_cols=258  Identities=24%  Similarity=0.420  Sum_probs=217.2

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .++|++.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            467999999999999999999998899999999975443 2367899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      ++++|.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||+++..........
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  164 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHH---HhCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence            99999999987777799999999999999999999   789999999999999999999999999999987755443344


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      ....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......+ ....            +.....      
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-~~~~------------~~~~~~------  225 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVED------------ISTGFR------  225 (269)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHH------------HHTTCC------
T ss_pred             cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-HHHH------------HhcCcc------
Confidence            44567889999999988899999999999999999999 999986521110 0000            000000      


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                       ...+..+++++.+++.+||+.||++||++.|++++|+++.+.
T Consensus       226 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          226 -LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence             011233567899999999999999999999999999998763

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.1e-40  Score=381.81  Aligned_cols=402  Identities=27%  Similarity=0.345  Sum_probs=156.9

Q ss_pred             CcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccce
Q 002214           56 LSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTAL  135 (952)
Q Consensus        56 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L  135 (952)
                      .++|+.|++++|.+ +.+|++|+++++|++|++++|++.+.+|..++++++|+.++++.|...            .++.|
T Consensus        10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~------------~l~~L   76 (454)
T 1jl5_A           10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR------------QAHEL   76 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHH------------TCSEE
T ss_pred             cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhcc------------CCCEE
Confidence            45555555555555 355555555555555666555555555555555555533333333210            01334


Q ss_pred             eeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcC
Q 002214          136 DFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNL  215 (952)
Q Consensus       136 ~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  215 (952)
                      ++++|.+++ +|.    ..++|++|++++|++++ +|..   +++|+.|++++|++++ +|..   .++|++|++++|++
T Consensus        77 ~l~~~~l~~-lp~----~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l  143 (454)
T 1jl5_A           77 ELNNLGLSS-LPE----LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQL  143 (454)
T ss_dssp             ECTTSCCSC-CCS----CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCC
T ss_pred             EecCCcccc-CCC----CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCC
Confidence            444444331 222    11345555555555543 3322   2445555555555542 1211   13455555555555


Q ss_pred             CccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCc
Q 002214          216 NGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPS  295 (952)
Q Consensus       216 ~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  295 (952)
                      ++ +| .|+.+++|++|++++|++.++ |..   ..+|++|++++|++++ +|   .+..+++|++|++++|++++ +|.
T Consensus       144 ~~-lp-~~~~l~~L~~L~l~~N~l~~l-p~~---~~~L~~L~L~~n~l~~-l~---~~~~l~~L~~L~l~~N~l~~-l~~  212 (454)
T 1jl5_A          144 EK-LP-ELQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEE-LP---ELQNLPFLTAIYADNNSLKK-LPD  212 (454)
T ss_dssp             SS-CC-CCTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSS-CC---CCTTCTTCCEEECCSSCCSS-CCC
T ss_pred             CC-Cc-ccCCCCCCCEEECCCCcCccc-CCC---cccccEEECcCCcCCc-Cc---cccCCCCCCEEECCCCcCCc-CCC
Confidence            43 33 355555555555555554442 222   1355555555555543 22   14455555555555555543 111


Q ss_pred             ccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCC
Q 002214          296 FFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKK  375 (952)
Q Consensus       296 ~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~  375 (952)
                      ..              .+|+.|++++|.++..+                .++.+++|++|++++|++++ +|..   +++
T Consensus       213 ~~--------------~~L~~L~l~~n~l~~lp----------------~~~~l~~L~~L~l~~N~l~~-l~~~---~~~  258 (454)
T 1jl5_A          213 LP--------------LSLESIVAGNNILEELP----------------ELQNLPFLTTIYADNNLLKT-LPDL---PPS  258 (454)
T ss_dssp             CC--------------TTCCEEECCSSCCSSCC----------------CCTTCTTCCEEECCSSCCSS-CCSC---CTT
T ss_pred             Cc--------------CcccEEECcCCcCCccc----------------ccCCCCCCCEEECCCCcCCc-cccc---ccc
Confidence            10              12222222222222111                02344555555555555553 2221   245


Q ss_pred             CcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCC-CCCceeEec
Q 002214          376 LQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNL-EDILGFDFS  454 (952)
Q Consensus       376 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls  454 (952)
                      |++|++++|++++ .|..   .++|+.|++++|++++. |..   .++|++|++++|+++++.     .+ ++|+.|+++
T Consensus       259 L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i~-----~~~~~L~~L~Ls  325 (454)
T 1jl5_A          259 LEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSLC-----DLPPSLEELNVS  325 (454)
T ss_dssp             CCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEEC-----CCCTTCCEEECC
T ss_pred             cCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCccc-----CCcCcCCEEECC
Confidence            5555555555553 2222   24555555555555531 111   145555666666555421     12 355555555


Q ss_pred             CCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccC--cccccccccccccEEeCCCCcccc
Q 002214          455 SNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQG--PIPESFGELVSLEFLDLSNNDLSG  532 (952)
Q Consensus       455 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~  532 (952)
                      +|++++ +|..   +++|+.|++++|+++. +|.   .+++|++|+|++|++++  .+|..+..+        +.|.+.+
T Consensus       326 ~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~  389 (454)
T 1jl5_A          326 NNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLA  389 (454)
T ss_dssp             SSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC---
T ss_pred             CCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhccccc
Confidence            555553 3322   3455555555555553 333   24555566666665554  334333322        1233333


Q ss_pred             cCccchhccccccccccccccccc--CCCC
Q 002214          533 VIPASLEKLLYLKSLNLSFNKLVG--EIPR  560 (952)
Q Consensus       533 ~~~~~~~~l~~L~~L~l~~N~l~~--~~p~  560 (952)
                      .+|..   +++|+.|++++|++++  .+|.
T Consensus       390 ~i~~~---~~~L~~L~ls~N~l~~~~~iP~  416 (454)
T 1jl5_A          390 EVPEL---PQNLKQLHVETNPLREFPDIPE  416 (454)
T ss_dssp             ------------------------------
T ss_pred             ccccc---cCcCCEEECCCCcCCccccchh
Confidence            33332   2677777777777776  5553

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.7e-41  Score=376.54  Aligned_cols=261  Identities=24%  Similarity=0.445  Sum_probs=215.1

Q ss_pred             hccCCccceecCccceEEEEEEe--------CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeecC
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF--------PDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNH  732 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  732 (952)
                      .++|.+.+.||+|+||.||+|++        .++..||||+++... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            46899999999999999999985        245689999997553 33456799999999999 899999999999999


Q ss_pred             CeeEEEEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee
Q 002214          733 NFKALVLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL  797 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill  797 (952)
                      +..|+||||+++|+|.+++....               ..+++.+++.++.||++||+||   |++||+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchhhEEE
Confidence            99999999999999999997643               2489999999999999999999   78999999999999999


Q ss_pred             CCCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccch
Q 002214          798 DDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSI  875 (952)
Q Consensus       798 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~  875 (952)
                      +.++.+||+|||+|+........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+  .
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence            99999999999999876543322 2233457889999999998899999999999999999999 999986532111  1


Q ss_pred             hhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHh
Q 002214          876 KRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~  946 (952)
                      .           ..+.....       ...+..++.++.+++.+||+.||++||++.|+++.|+++.....
T Consensus       315 ~-----------~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          315 F-----------KLLKEGHR-------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             H-----------HHHHTTCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             H-----------HHHhcCCC-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            1           00110000       01234567889999999999999999999999999999987653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-41  Score=372.64  Aligned_cols=274  Identities=23%  Similarity=0.313  Sum_probs=211.7

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCC----eeEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN----FKAL  737 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l  737 (952)
                      ..++|++.+.||+|+||+||+|++. ++.||||+++.... ......+|+.++++++||||+++++++....    ..++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3468999999999999999999984 89999999865433 2345667999999999999999999998754    3699


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeEeCCCCCCCeeeCCCCcEEEec
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN----------PIVHCDIKPSNVLLDDSMVAHLSD  807 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~----------~ivH~Dlk~~Nill~~~~~~kl~D  807 (952)
                      ||||+++|+|.+++...  .+++..+..++.|+++||+||   |+.          ||+||||||+||+++.++.+||+|
T Consensus       100 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~L---H~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYL---HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHH---TCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            99999999999999764  499999999999999999999   677          999999999999999999999999


Q ss_pred             cccccccCCcCcc-cccccccccccccccccCc-----CCcCcccchHhHHHHHHHHHhCCCCCCccccCcc-chhhhhc
Q 002214          808 FGIAKLLSEEDSM-KQTQTLATIGYIAPEYGRE-----GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM-SIKRWIN  880 (952)
Q Consensus       808 fgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~  880 (952)
                      ||+|+........ ......||+.|+|||++.+     ..++.++|||||||++|||+||+.||........ .+.....
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            9999876543322 2233579999999998876     3567789999999999999999999876432221 1111100


Q ss_pred             --cchhhhhhhcc-ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          881 --DSLPAVMNIMD-TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       881 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                        .........+. ........  .......+++++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          255 QHPSLEDMQEVVVHKKKRPVLR--DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCC--GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCchhhhhhhhhcccCCCCcc--ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence              01111111111 11111110  0112234577899999999999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9e-42  Score=364.76  Aligned_cols=258  Identities=23%  Similarity=0.422  Sum_probs=216.3

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .++|++.+.||+|+||.||+|+++++..||||+++.... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            468999999999999999999998888999999975543 2367899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      ++++|.+++......+++.+++.++.|++.|++||   |++||+||||||+||+++.++.+||+|||++...........
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  162 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS  162 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence            99999999987766799999999999999999999   789999999999999999999999999999987765544444


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...           ......       
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~-----------~~~~~~-------  223 (268)
T 3sxs_A          163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-VLK-----------VSQGHR-------  223 (268)
T ss_dssp             CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHH-----------HHTTCC-------
T ss_pred             cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-HHH-----------HHcCCC-------
Confidence            44567788999999988889999999999999999999 9999865321110 000           000000       


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                       ...+..+++++.+++.+||+.||++|||+.|++++|++++++
T Consensus       224 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          224 -LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             -CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             -CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence             001233467799999999999999999999999999988655

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=372.28  Aligned_cols=259  Identities=25%  Similarity=0.444  Sum_probs=212.3

Q ss_pred             hccCCccceecCccceEEEEEEeC----CCcEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|++.+.||+|+||.||+|++.    .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            357899999999999999999884    3556999999754 33345679999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|+|.+++......+++.+++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            9999999999999987767899999999999999999999   7899999999999999999999999999999877543


Q ss_pred             Ccc--cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          818 DSM--KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       818 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ...  ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+  .           ...+....
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~-----------~~~~~~~~  271 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--V-----------ISSVEEGY  271 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--H-----------HHHHHTTC
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--H-----------HHHHHcCC
Confidence            222  1222446788999999998899999999999999999999 999986532111  0           00010000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      .       ...+..+++++.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus       272 ~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          272 R-------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             C-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             C-------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            0       011245678899999999999999999999999999998764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9e-42  Score=383.01  Aligned_cols=260  Identities=25%  Similarity=0.406  Sum_probs=215.6

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ..++|.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3568899999999999999999985 789999999875432 33457889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++...+..+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+.......
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            99999999999987666799999999999999999999   789999999999999999999999999999986543322


Q ss_pred             ccc-cccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          820 MKQ-TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       820 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      ... ....+++.|+|||.+.++.++.++|||||||++|||+| |..||......+             ..+.+.....  
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------------~~~~~~~~~~--  333 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------------TREFVEKGGR--  333 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------------HHHHHHTTCC--
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------------HHHHHHcCCC--
Confidence            211 12346788999999988899999999999999999999 999986532110             1111111100  


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                           ...+..+++++.+++.+||+.||++|||+.++++.|++++++
T Consensus       334 -----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          334 -----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                 012345678899999999999999999999999999999875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.3e-41  Score=368.63  Aligned_cols=265  Identities=26%  Similarity=0.407  Sum_probs=206.5

Q ss_pred             HHHHHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCe
Q 002214          657 DELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNF  734 (952)
Q Consensus       657 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  734 (952)
                      +++....++|++.+.||+|+||+||+|++ +|+.||||++....  ....+.+.+|++++++++||||+++++++...+.
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            33444567899999999999999999987 68899999986543  3345678999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCeeeCCCCcEEEecccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNF--NLDIFQRLGIMIDVASALEYLHFGHSNP--IVHCDIKPSNVLLDDSMVAHLSDFGI  810 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~ia~~l~~Lh~~h~~~--ivH~Dlk~~Nill~~~~~~kl~Dfgl  810 (952)
                      .++||||+++|+|.+++.....  .+++..++.++.|+++||+||   |++|  |+||||||+||+++.++.+||+|||+
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL---HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHH---HTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH---HcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            9999999999999999876442  389999999999999999999   6888  99999999999999999999999999


Q ss_pred             ccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          811 AKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       811 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      ++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+  .....          .
T Consensus       186 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~----------~  252 (309)
T 3p86_A          186 SRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAV----------G  252 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHH----------H
T ss_pred             Ccccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH----------H
Confidence            9865332 222334579999999999999999999999999999999999999986532111  00000          0


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                      ....       ....+..+++++.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus       253 ~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          253 FKCK-------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             HSCC-------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             hcCC-------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            0000       00112446778999999999999999999999999999987654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.6e-42  Score=371.35  Aligned_cols=270  Identities=26%  Similarity=0.455  Sum_probs=213.2

Q ss_pred             hccCCccceecCccceEEEEEEe-----CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecC--Cee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-----PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNH--NFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  735 (952)
                      .++|++.+.||+|+||+||+|++     .+++.||||++........+.+.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46899999999999999999984     36899999999876666667899999999999999999999998653  568


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||+++|+|.+++......+++..++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            999999999999999987766799999999999999999999   78999999999999999999999999999998765


Q ss_pred             CcCcc--cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccc-h-----hhhh
Q 002214          816 EEDSM--KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS-L-----PAVM  887 (952)
Q Consensus       816 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~-----~~~~  887 (952)
                      .....  ......++..|+|||.+.+..++.++||||||+++|||++|..|+......   ........ .     ....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHH
Confidence            43221  122345778899999999889999999999999999999999997653211   11110000 0     0011


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                      +.+....       ....+..+++++.+++.+||+.||++|||+.|+++.|+++++.+
T Consensus       243 ~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          243 ELLKNNG-------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHTTC-------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHhccC-------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            1111110       01123467889999999999999999999999999999998865

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.7e-41  Score=363.15  Aligned_cols=259  Identities=23%  Similarity=0.433  Sum_probs=214.6

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..++|++.+.||+|+||.||+|.+.++..||||+++..... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            45689999999999999999999988899999999755432 36789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++++|.+++......+++.+++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.........
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  177 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  177 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence            999999999987666799999999999999999999   78999999999999999999999999999998775544333


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......+ ....            +.....     
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-~~~~------------~~~~~~-----  239 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TAEH------------IAQGLR-----  239 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHH------------HHTTCC-----
T ss_pred             ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-HHHH------------HhcccC-----
Confidence            344557889999999988889999999999999999998 999986532111 0000            000000     


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                        ...+..+++++.+++.+||+.||++|||+.|++++|+++.++
T Consensus       240 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          240 --LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence              001233467899999999999999999999999999998764

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=6.3e-40  Score=375.67  Aligned_cols=403  Identities=26%  Similarity=0.301  Sum_probs=270.0

Q ss_pred             CCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCC
Q 002214           74 PKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPG  153 (952)
Q Consensus        74 p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~  153 (952)
                      |+.+ ..+.|++|++++|.+ +.+|.+++++++|++|++++|.+++.+|.+++++..+ +.+++++|..           
T Consensus         5 p~~~-~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L-~~l~l~~c~~-----------   70 (454)
T 1jl5_A            5 PRNV-SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM-AVSRLRDCLD-----------   70 (454)
T ss_dssp             -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHH-HHHHHHHHHH-----------
T ss_pred             cccc-ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhc-chhhhhhhhc-----------
Confidence            4444 468999999999999 5999999999999999999999999999999988765 5677777764           


Q ss_pred             CCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEee
Q 002214          154 LPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILG  233 (952)
Q Consensus       154 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  233 (952)
                       .++++|++++|++++ +|..   .++|+.|++++|++++ +|..   .++|++|++++|++++ +|..   .++|++|+
T Consensus        71 -~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~  137 (454)
T 1jl5_A           71 -RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLG  137 (454)
T ss_dssp             -HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEE
T ss_pred             -cCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEE
Confidence             378999999999985 5552   4789999999999996 6654   4789999999999985 3322   27999999


Q ss_pred             eccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCc
Q 002214          234 IDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSN  313 (952)
Q Consensus       234 L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~  313 (952)
                      +++|++.+ +| .+.++++|++|++++|++++ +|..     .++|++|++++|++++ +| .+..+           ++
T Consensus       138 L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~-----~~~L~~L~L~~n~l~~-l~-~~~~l-----------~~  196 (454)
T 1jl5_A          138 VSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL-----PPSLEFIAAGNNQLEE-LP-ELQNL-----------PF  196 (454)
T ss_dssp             CCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC-----CTTCCEEECCSSCCSS-CC-CCTTC-----------TT
T ss_pred             CcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC-----cccccEEECcCCcCCc-Cc-cccCC-----------CC
Confidence            99999998 45 59999999999999999985 3432     3599999999999997 44 34444           44


Q ss_pred             cccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCcc
Q 002214          314 LKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE  393 (952)
Q Consensus       314 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~  393 (952)
                      |+.|++++|.++..+.                  ..++|++|++++|+++ .+| .+..+++|++|++++|++++ .|..
T Consensus       197 L~~L~l~~N~l~~l~~------------------~~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~  255 (454)
T 1jl5_A          197 LTAIYADNNSLKKLPD------------------LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL  255 (454)
T ss_dssp             CCEEECCSSCCSSCCC------------------CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC
T ss_pred             CCEEECCCCcCCcCCC------------------CcCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc
Confidence            5556666665553332                  1247899999999988 555 48889999999999999885 3432


Q ss_pred             ccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcc-ccc
Q 002214          394 FCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENL-KAV  472 (952)
Q Consensus       394 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L  472 (952)
                         +++|+.|++++|++++ +|..   +++|++|++++|+++++..    -.++|+.|++++|++++ ++    .+ ++|
T Consensus       256 ---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~----~~~~L~~L~l~~N~l~~-i~----~~~~~L  319 (454)
T 1jl5_A          256 ---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRS-LC----DLPPSL  319 (454)
T ss_dssp             ---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSE-EC----CCCTTC
T ss_pred             ---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccC----cCCcCCEEECcCCcCCc-cc----CCcCcC
Confidence               4788999999999885 4543   3788999999999886432    12688899999998885 22    23 478


Q ss_pred             ceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccc--cCccchhccccccccccc
Q 002214          473 VDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSG--VIPASLEKLLYLKSLNLS  550 (952)
Q Consensus       473 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~l~  550 (952)
                      +.|++++|++++ +|..   +++|+.|++++|++++ +|.   .+++|++|++++|++++  .+|..+..        ++
T Consensus       320 ~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~  383 (454)
T 1jl5_A          320 EELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LR  383 (454)
T ss_dssp             CEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EE
T ss_pred             CEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hh
Confidence            899999999986 4443   5789999999999884 555   46889999999999987  55665543        34


Q ss_pred             ccccccCCCCCCCcccccccccccCccCC
Q 002214          551 FNKLVGEIPRGGAFANFSAESFIGNDLLC  579 (952)
Q Consensus       551 ~N~l~~~~p~~~~~~~~~~~~~~~n~~~c  579 (952)
                      .|.+.+.+|.  ...++....+.+|+...
T Consensus       384 ~n~~~~~i~~--~~~~L~~L~ls~N~l~~  410 (454)
T 1jl5_A          384 MNSHLAEVPE--LPQNLKQLHVETNPLRE  410 (454)
T ss_dssp             CCC--------------------------
T ss_pred             hccccccccc--ccCcCCEEECCCCcCCc
Confidence            5777787776  34667777777886554

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.3e-41  Score=369.82  Aligned_cols=248  Identities=23%  Similarity=0.333  Sum_probs=206.9

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++...  .....+.+.+|++++++++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46799999999999999999998 57999999998654  2334567889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++...+ .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+...... 
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYC---HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            9999999999987654 699999999999999999999   78999999999999999999999999999998765432 


Q ss_pred             ccccccccccccccccccCcCCcC-cccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVS-IKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                       .....+||+.|+|||++.+..+. .++||||+||++|||++|+.||.....     ....       ..+.....    
T Consensus       169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~-------~~i~~~~~----  231 (328)
T 3fe3_A          169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KELR-------ERVLRGKY----  231 (328)
T ss_dssp             -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-------HHHHHCCC----
T ss_pred             -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HHHH-------HHHHhCCC----
Confidence             23446799999999998877764 789999999999999999999865211     1100       00000000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..+..+++++.+++.+||..||.+|||+.|++++
T Consensus       232 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 -----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 0123356789999999999999999999999865

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6e-41  Score=363.11  Aligned_cols=261  Identities=25%  Similarity=0.398  Sum_probs=208.5

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            45799999999999999999987 468999999985432   33456789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHA---HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999987654 689999999999999999999   78999999999999999999999999999998765444


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      ........||+.|+|||.+.+..++.++||||+|+++|||++|+.||......+...            ..+....    
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------------~~~~~~~----  229 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI------------KHIQDSV----  229 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH------------HHHSSCC----
T ss_pred             ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH------------HHhhccC----
Confidence            333444679999999999999899999999999999999999999986532111100            0011100    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRV-NTKEIISRLIKIRD  943 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~~i~~  943 (952)
                      +......+..+++.+.+++.+||+.||++|| +++++.+.|+.+..
T Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            0011112345678899999999999999999 89999998887643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.6e-40  Score=364.28  Aligned_cols=262  Identities=23%  Similarity=0.316  Sum_probs=215.1

Q ss_pred             cccCHHHHHHHhcc----------CCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCC
Q 002214          652 RRYSHDELLRATDQ----------FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHR  720 (952)
Q Consensus       652 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  720 (952)
                      ..++.+++..+++.          |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            35677777777653          777789999999999999985 7999999999876666667899999999999999


Q ss_pred             ccceeeeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC
Q 002214          721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS  800 (952)
Q Consensus       721 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~  800 (952)
                      ||+++++++...+..++||||+++|+|.+++...  .+++..+..++.|+++||+||   |++||+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYL---HAQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999988653  589999999999999999999   68899999999999999999


Q ss_pred             CcEEEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc
Q 002214          801 MVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN  880 (952)
Q Consensus       801 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~  880 (952)
                      +.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......  ....   
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~---  251 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMK---  251 (321)
T ss_dssp             CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH---
T ss_pred             CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH---
Confidence            9999999999987654322 233457999999999999989999999999999999999999998642110  0000   


Q ss_pred             cchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          881 DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          .......+..         ..+..+++++.+++.+||+.||++|||+.|++++
T Consensus       252 ----~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          252 ----RLRDSPPPKL---------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             ----HHHHSSCCCC---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ----HHhcCCCCCc---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0001000000         0122356789999999999999999999999874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.1e-41  Score=360.39  Aligned_cols=262  Identities=24%  Similarity=0.386  Sum_probs=203.9

Q ss_pred             HhccCCccceecCccceEEEEEEeC----CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      ..++|++.+.||+|+||.||+|.+.    .+..||+|+.+... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            3568999999999999999999874    25679999986543 334567899999999999999999999985 45689


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            99999999999999987776799999999999999999999   789999999999999999999999999999987755


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ..........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+  ....          +..... 
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~----------i~~~~~-  235 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR----------IENGER-  235 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----------HHTTCC-
T ss_pred             ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHH----------HHcCCC-
Confidence            44333334557889999999988889999999999999999997 999986532211  1100          000000 


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                             ...+..+++++.+++.+||+.||++|||+.|++++|+++.++-.+
T Consensus       236 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  280 (281)
T 1mp8_A          236 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA  280 (281)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhcc
Confidence                   001235678899999999999999999999999999999887654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.7e-41  Score=375.83  Aligned_cols=259  Identities=26%  Similarity=0.473  Sum_probs=202.9

Q ss_pred             hccCCccceecCccceEEEEEEeC----CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|.+.+.||+|+||.||+|++.    ++..||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999874    57789999987543 3345679999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|+|.+++......+++.+++.++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            9999999999999987777899999999999999999999   7889999999999999999999999999999876543


Q ss_pred             Cccc--ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          818 DSMK--QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       818 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ....  .....+++.|+|||++.+..++.++|||||||++||+++ |+.||......             +....+....
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-------------~~~~~i~~~~  267 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-------------DVIKAVDEGY  267 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-------------HHHHHHHTTE
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------------HHHHHHHcCC
Confidence            2211  122345778999999998899999999999999999998 99998653211             0111111110


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      .       ...+..++.++.+++.+||+.||++||++.||++.|+++.+.
T Consensus       268 ~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          268 R-------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             E-------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C-------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            0       011234678899999999999999999999999999998764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-39  Score=356.14  Aligned_cols=279  Identities=29%  Similarity=0.490  Sum_probs=224.6

Q ss_pred             ccccCHHHHHHHhccCCcc------ceecCccceEEEEEEeCCCcEEEEEEeeccC----chhhHHHHHHHHHHHhCCCC
Q 002214          651 WRRYSHDELLRATDQFSEE------NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR----EGALNSFDAECEILKTIRHR  720 (952)
Q Consensus       651 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~  720 (952)
                      ...++..++..+++.|...      +.||+|+||.||+|.. +++.||||++....    ....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3568889999999998877      8999999999999997 68899999986432    33457789999999999999


Q ss_pred             ccceeeeEeecCCeeEEEEEccCCCChhHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC
Q 002214          721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYAS--NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD  798 (952)
Q Consensus       721 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~  798 (952)
                      ||+++++++.+.+..++||||+++|+|.+++...  ...+++..+..++.|++.||+||   |++||+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL---HENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999988643  34689999999999999999999   789999999999999999


Q ss_pred             CCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhh
Q 002214          799 DSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR  877 (952)
Q Consensus       799 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~  877 (952)
                      .++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||....... ....
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~  245 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLD  245 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHH
Confidence            9999999999999876543222 2233568999999998765 58899999999999999999999987643222 1222


Q ss_pred             hhc---cchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          878 WIN---DSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       878 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                      +..   .........++..+..        .+..++.++.+++.+||+.||++|||+.|++++|+++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKMND--------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSCSC--------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHhhhhhhhhhhhccccccc--------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            211   1111122222222211        124467889999999999999999999999999998864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.6e-40  Score=360.98  Aligned_cols=270  Identities=21%  Similarity=0.318  Sum_probs=207.7

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ..++|++.+.||+|+||+||+|++.+|+.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            346899999999999999999999889999999986543  233467889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++ +|.+.+......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+...... 
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  173 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC---HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-  173 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence            99974 88888877776799999999999999999999   78999999999999999999999999999998764332 


Q ss_pred             ccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhh-hh------h
Q 002214          820 MKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPA-VM------N  888 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~-~~------~  888 (952)
                      .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ......   ...+. ..      .
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCChHHhhhhhccch
Confidence            22334568999999998876 5689999999999999999999999976433221 111110   00000 00      0


Q ss_pred             hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          889 IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       889 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..+.................+++++.+++.+||+.||++|||++|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0000000000000111234467789999999999999999999999874

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.6e-41  Score=374.01  Aligned_cols=271  Identities=21%  Similarity=0.369  Sum_probs=218.7

Q ss_pred             ccCHHHHHHHhccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhC-CCCccce
Q 002214          653 RYSHDELLRATDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQRE-GALNSFDAECEILKTI-RHRNLVK  724 (952)
Q Consensus       653 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~  724 (952)
                      .+....+....++|.+.+.||+|+||.||+|++      .+++.||||+++.... ...+.+.+|+++++++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            355666677788999999999999999999973      3568999999975433 3456789999999999 7999999


Q ss_pred             eeeEeecCC-eeEEEEEccCCCChhHHhhhcCC-----------------------------------------------
Q 002214          725 IISSCTNHN-FKALVLEYMPKGSLEDCMYASNF-----------------------------------------------  756 (952)
Q Consensus       725 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------  756 (952)
                      +++++.+.+ ..++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999988754 48999999999999999876432                                               


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          757 ------------------NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       757 ------------------~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                                        .+++..++.++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                              189999999999999999999   78999999999999999999999999999998764433


Q ss_pred             c-ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          819 S-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       819 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      . .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+.....            +..... 
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~------------~~~~~~-  314 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------------LKEGTR-  314 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH------------HHHTCC-
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH------------HHcCCC-
Confidence            2 22334568899999999988899999999999999999998 99998653222111111            000000 


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                            ...+..+++++.+++.+||+.||++|||+.|++++|+++.+..
T Consensus       315 ------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          315 ------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence                  0012345678999999999999999999999999999988654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.4e-40  Score=358.56  Aligned_cols=266  Identities=16%  Similarity=0.189  Sum_probs=216.8

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++.....  .+.+.+|+.+++++ +|++++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            45799999999999999999997 5799999999864432  35678999999999 79999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc-----EEEeccccccccC
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV-----AHLSDFGIAKLLS  815 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~-----~kl~Dfgla~~~~  815 (952)
                      |+ +++|.+++...+..+++..+..++.|+++||+||   |++||+||||||+||+++.++.     +||+|||+|+...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 9999999987776799999999999999999999   7899999999999999987776     9999999998765


Q ss_pred             CcCcc------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhh
Q 002214          816 EEDSM------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNI  889 (952)
Q Consensus       816 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  889 (952)
                      .....      ......||+.|+|||++.+..++.++||||||+++|||++|+.||........  .....       .+
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~-------~~  233 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQKYE-------RI  233 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHHHH-------HH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--HHHHH-------HH
Confidence            43221      12345699999999999998999999999999999999999999976322211  00000       00


Q ss_pred             ccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       890 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                      ....    ...........+++++.+++.+||+.||++||++++|++.|+++.++...
T Consensus       234 ~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          234 GEKK----QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             HHHH----HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             Hhhc----cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence            0000    00001112235678899999999999999999999999999999887654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2e-40  Score=365.61  Aligned_cols=264  Identities=19%  Similarity=0.225  Sum_probs=214.2

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.....  .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999997 5799999999865433  35688999999999 99999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc-----EEEeccccccccC
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV-----AHLSDFGIAKLLS  815 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~-----~kl~Dfgla~~~~  815 (952)
                      |+ +++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.     +||+|||+|+...
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYV---HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 9999999987666899999999999999999999   7889999999999999998887     9999999998764


Q ss_pred             CcCcc------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhh
Q 002214          816 EEDSM------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNI  889 (952)
Q Consensus       816 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  889 (952)
                      .....      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ...........    
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~~~----  235 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQKIGDT----  235 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHHHHHHH----
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHHHHHhh----
Confidence            43221      1234679999999999999999999999999999999999999997642211  11100000000    


Q ss_pred             ccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHh
Q 002214          890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       890 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~  946 (952)
                         .    ...........++ ++.+++..||+.||.+||++.+|.+.|+++.++..
T Consensus       236 ---~----~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          236 ---K----RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             ---H----HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ---h----ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence               0    0000011122356 89999999999999999999999999999987753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-40  Score=364.14  Aligned_cols=252  Identities=20%  Similarity=0.321  Sum_probs=209.5

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|.+.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999884 68999999986543 3346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC--CCcEEEeccccccccCCcCc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD--SMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~  819 (952)
                      +++|+|.+++......+++.++..++.|+++||+||   |++||+||||||+||+++.  ++.+||+|||+++.......
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            999999999987766799999999999999999999   7899999999999999987  78999999999987754332


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        .....||+.|+|||++.+..++.++|||||||++|||++|..||......     ..       ...+........  
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~-------~~~i~~~~~~~~--  223 (321)
T 1tki_A          160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QI-------IENIMNAEYTFD--  223 (321)
T ss_dssp             --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HH-------HHHHHHTCCCCC--
T ss_pred             --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----HH-------HHHHHcCCCCCC--
Confidence              23456899999999999888999999999999999999999998652111     00       011111111000  


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ......++.++.+++.+||..||++|||+.|++++
T Consensus       224 ---~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          224 ---EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence               11123467889999999999999999999999885

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.4e-40  Score=359.06  Aligned_cols=264  Identities=26%  Similarity=0.383  Sum_probs=203.8

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHh--CCCCccceeeeEeec----CCeeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKT--IRHRNLVKIISSCTN----HNFKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~  736 (952)
                      .++|++.+.||+|+||+||+|++ +|+.||||++....   ...+.+|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            56899999999999999999998 78999999986543   3456677777776  799999999998654    34688


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEeCCCCCCCeeeCCCCcEEEeccccc
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF-----GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA  811 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~-----~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  811 (952)
                      +||||+++|+|.+++...  .+++..++.++.|++.||+|||.     .++++|+||||||+||+++.++.+||+|||+|
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999643  59999999999999999999941     11899999999999999999999999999999


Q ss_pred             cccCCcCccc---ccccccccccccccccCcC------CcCcccchHhHHHHHHHHHhC----------CCCCCccccCc
Q 002214          812 KLLSEEDSMK---QTQTLATIGYIAPEYGREG------QVSIKGDVYNYGIMLMEVFTG----------MKPTNEFFTGE  872 (952)
Q Consensus       812 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg----------~~p~~~~~~~~  872 (952)
                      +.........   .....||+.|+|||++.+.      .++.++|||||||++|||++|          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            8654332221   2234799999999998776      556799999999999999999          66665543333


Q ss_pred             cchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          873 MSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      ...........       ........+  ....+..+++++.+++.+||+.||++|||+.||++.|+++
T Consensus       241 ~~~~~~~~~~~-------~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSFEDMRKVVC-------VDQQRPNIP--NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCHHHHHHHHT-------TSCCCCCCC--GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhhhhHHHh-------ccCCCCCCC--hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            22222111000       000000000  0112344678899999999999999999999999999876

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.6e-40  Score=371.56  Aligned_cols=271  Identities=17%  Similarity=0.193  Sum_probs=210.6

Q ss_pred             HhccCCccceecCccceEEEEEEeCC------CcEEEEEEeeccCchh-----------hHHHHHHHHHHHhCCCCccce
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPD------GIEVAIKVFHLQREGA-----------LNSFDAECEILKTIRHRNLVK  724 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~  724 (952)
                      ..++|++.+.||+|+||.||+|.+.+      ++.||||++.......           ...+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999998854      4789999986543211           112345666677788999999


Q ss_pred             eeeEeecC----CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC--
Q 002214          725 IISSCTNH----NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD--  798 (952)
Q Consensus       725 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~--  798 (952)
                      +++++...    ...++||||+ +++|.+++......+++..++.++.|++.||+||   |++||+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~l---H~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYI---HEHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeEEecCCHHHEEEecC
Confidence            99998764    4589999999 9999999988767899999999999999999999   788999999999999999  


Q ss_pred             CCCcEEEeccccccccCCcCccc------ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCc
Q 002214          799 DSMVAHLSDFGIAKLLSEEDSMK------QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE  872 (952)
Q Consensus       799 ~~~~~kl~Dfgla~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  872 (952)
                      .++.+||+|||+|+.+.......      .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            89999999999998765432211      123459999999999999899999999999999999999999997533221


Q ss_pred             cchhhhhccc-hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          873 MSIKRWINDS-LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       873 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                      . ........ .+.....++..+          ....+++++.+++..||+.||++||++.++++.|+++.+....
T Consensus       269 ~-~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          269 K-YVRDSKIRYRENIASLMDKCF----------PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             H-HHHHHHHHHHHCHHHHHHHHS----------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             H-HHHHHHHHhhhhHHHHHHHhc----------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            1 11111111 111111111110          1134578899999999999999999999999999999887543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.9e-40  Score=352.90  Aligned_cols=258  Identities=24%  Similarity=0.404  Sum_probs=216.1

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .++|++.+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            4679999999999999999999988999999999755433 367899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      ++++|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++..........
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence            99999999987766799999999999999999999   789999999999999999999999999999987654333333


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......     ...        ..+.....      
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~--------~~i~~~~~------  223 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVV--------EDISTGFR------  223 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH--------HHHHTTCC------
T ss_pred             ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-----HHH--------HHHhcCCc------
Confidence            34567889999999988889999999999999999999 89998652111     000        00000000      


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                       ...+..++.++.+++.+||+.||++||++.|++++|+++.++
T Consensus       224 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          224 -LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence             001233567899999999999999999999999999998763

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.5e-40  Score=363.69  Aligned_cols=249  Identities=23%  Similarity=0.315  Sum_probs=206.9

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|+++..   .......+.+|++++++++||||+++++++...+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999884 6999999999654   223456788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++|+|.+++...+ .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|+......
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999999999887654 689999999999999999999   78999999999999999999999999999998643322


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....       ..+.....    
T Consensus       160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~-------~~i~~~~~----  222 (337)
T 1o6l_A          160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLF-------ELILMEEI----  222 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-------HHHHHCCC----
T ss_pred             -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHH-------HHHHcCCC----
Confidence             223346799999999999999999999999999999999999999864211     0000       00000000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                           ..+..+++++.+++.+||+.||++||     ++.|++++
T Consensus       223 -----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                 01234577899999999999999999     89999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.3e-40  Score=366.11  Aligned_cols=253  Identities=20%  Similarity=0.321  Sum_probs=207.8

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCch------hhHHHHHHHHHHHhCCCCccceeeeEeecCCe
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREG------ALNSFDAECEILKTIRHRNLVKIISSCTNHNF  734 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  734 (952)
                      ..++|.+.+.||+|+||.||+|+.. +|+.||+|+++.....      ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3467999999999999999999884 6999999998754321      24678999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC----cEEEecccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM----VAHLSDFGI  810 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgl  810 (952)
                      .++||||+++|+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+||+++.++    .+||+|||+
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            999999999999999987543 699999999999999999999   789999999999999998877    799999999


Q ss_pred             ccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          811 AKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       811 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      ++......  ......||+.|+|||++.+..++.++||||+||++|+|++|..||...... ..+.           .+.
T Consensus       166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-~~~~-----------~i~  231 (361)
T 2yab_A          166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLA-----------NIT  231 (361)
T ss_dssp             CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHH-----------HHH
T ss_pred             ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHH-----------HHH
Confidence            98765432  223457999999999999889999999999999999999999998652111 0011           111


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ......     ....+..+++++.+++.+||..||++|||+.|++++
T Consensus       232 ~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          232 AVSYDF-----DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             TTCCCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hcCCCC-----CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            100000     011223467789999999999999999999999863

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.5e-40  Score=361.16  Aligned_cols=266  Identities=21%  Similarity=0.371  Sum_probs=217.3

Q ss_pred             HhccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhC-CCCccceeeeEeecCC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQRE-GALNSFDAECEILKTI-RHRNLVKIISSCTNHN  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  733 (952)
                      ..++|++.+.||+|+||.||+|++      .+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++..++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            456899999999999999999985      3578999999975543 3457789999999999 9999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCee
Q 002214          734 FKALVLEYMPKGSLEDCMYASNF-----------------NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVL  796 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nil  796 (952)
                      ..++||||+++|+|.+++.....                 .+++..++.++.|+++||+||   |++||+||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEE
Confidence            99999999999999999876543                 489999999999999999999   7889999999999999


Q ss_pred             eCCCCcEEEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccc
Q 002214          797 LDDSMVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS  874 (952)
Q Consensus       797 l~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~  874 (952)
                      ++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||........ 
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  256 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-  256 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence            9999999999999998765443321 223457889999999988899999999999999999999 9999865322111 


Q ss_pred             hhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhhc
Q 002214          875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANI  949 (952)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~  949 (952)
                      ....           +......       ..+..+++++.+++.+||+.||++|||+.|++++|+++.+...++|
T Consensus       257 ~~~~-----------~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~i  313 (313)
T 1t46_A          257 FYKM-----------IKEGFRM-------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI  313 (313)
T ss_dssp             HHHH-----------HHHTCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC--
T ss_pred             HHHH-----------hccCCCC-------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhcCC
Confidence            1110           1100000       0123457789999999999999999999999999999988765543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-40  Score=368.62  Aligned_cols=261  Identities=25%  Similarity=0.435  Sum_probs=214.7

Q ss_pred             HhccCCccceecCccceEEEEEEe--------CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeec
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF--------PDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTN  731 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  731 (952)
                      ..++|.+.+.||+|+||+||+|++        .+++.||||+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            346899999999999999999985        234689999987553 33457789999999999 99999999999999


Q ss_pred             CCeeEEEEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCee
Q 002214          732 HNFKALVLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVL  796 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nil  796 (952)
                      ++..++||||+++|+|.+++....               ..+++.+++.++.|++.||+||   |++||+||||||+||+
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCcceEE
Confidence            999999999999999999997654               3589999999999999999999   7889999999999999


Q ss_pred             eCCCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccc
Q 002214          797 LDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS  874 (952)
Q Consensus       797 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~  874 (952)
                      ++.++.+||+|||+|+........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......   
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---  300 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---  300 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence            999999999999999876543322 2233457889999999999999999999999999999999 99998652111   


Q ss_pred             hhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                        .        ....+......       ..+..+++++.+++.+||+.||++|||+.||+++|+++....
T Consensus       301 --~--------~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          301 --E--------LFKLLKEGHRM-------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             --H--------HHHHHHTTCCC-------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             --H--------HHHHHHcCCCC-------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence              1        11111111000       012346778999999999999999999999999999998654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-40  Score=383.04  Aligned_cols=258  Identities=25%  Similarity=0.459  Sum_probs=213.7

Q ss_pred             HHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ...++|.+.+.||+|+||.||+|.+.+++.||||+++.... ..+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            34568999999999999999999998899999999975443 4578999999999999999999999987 567899999


Q ss_pred             ccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          741 YMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |+++|+|.+++.... ..+++..+..++.|++.||+||   |+++|+||||||+|||++.++.+||+|||+|+.......
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence            999999999997543 3588999999999999999999   788999999999999999999999999999987654333


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      .......+++.|+|||++....++.++|||||||++|||+| |+.||......+             ....+.....   
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-------------~~~~i~~~~~---  403 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------------VIRALERGYR---  403 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------------HHHHHHHTCC---
T ss_pred             eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-------------HHHHHHcCCC---
Confidence            33334457889999999988899999999999999999999 999986532110             0011111100   


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                          ...+..+++++.++|.+||+.||++|||+.+|++.|+++..
T Consensus       404 ----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          404 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                01134578889999999999999999999999999987754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.2e-40  Score=363.77  Aligned_cols=247  Identities=24%  Similarity=0.387  Sum_probs=204.4

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|.+.+.||+|+||.||+|.+ .+|+.||||++....   ......+.+|+.+++.++||||+++++++..++..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999997 578999999986432   22345789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+ +|+|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYC---HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 788988887654 699999999999999999999   78899999999999999999999999999998765433


Q ss_pred             cccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      .  ....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||........ ...            +....   
T Consensus       163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~------------i~~~~---  224 (336)
T 3h4j_B          163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-FKK------------VNSCV---  224 (336)
T ss_dssp             T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-BCC------------CCSSC---
T ss_pred             c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-HHH------------HHcCC---
Confidence            2  234579999999999988775 7899999999999999999999965322110 000            00000   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ...+..+++++.+++.+||+.||.+|||++|++++
T Consensus       225 -----~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          225 -----YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             -----CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             -----CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                 00123356789999999999999999999999865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-40  Score=368.76  Aligned_cols=266  Identities=24%  Similarity=0.427  Sum_probs=214.1

Q ss_pred             HHhccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCC
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHN  733 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  733 (952)
                      ...++|.+.+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34578999999999999999999874      35899999997553 334567999999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 002214          734 FKALVLEYMPKGSLEDCMYASN-----------------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI  790 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dl  790 (952)
                      ..++||||+++|+|.+++....                       ..+++.+++.++.|+++||+||   |++||+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCC
Confidence            9999999999999999997642                       4689999999999999999999   7889999999


Q ss_pred             CCCCeeeCCCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCcc
Q 002214          791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEF  868 (952)
Q Consensus       791 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~  868 (952)
                      ||+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            999999999999999999999876443321 2233568899999999988889999999999999999999 99998652


Q ss_pred             ccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 002214          869 FTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFAN  948 (952)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~  948 (952)
                      ...+  ...          .+.+....        ..+..+++++.+++.+||+.||++||++.|++++|+++.++....
T Consensus       281 ~~~~--~~~----------~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~  340 (343)
T 1luf_A          281 AHEE--VIY----------YVRDGNIL--------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGT  340 (343)
T ss_dssp             CHHH--HHH----------HHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-----
T ss_pred             ChHH--HHH----------HHhCCCcC--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhh
Confidence            2110  000          01111110        112356778999999999999999999999999999998776654


Q ss_pred             c
Q 002214          949 I  949 (952)
Q Consensus       949 ~  949 (952)
                      +
T Consensus       341 ~  341 (343)
T 1luf_A          341 V  341 (343)
T ss_dssp             -
T ss_pred             c
Confidence            4

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.1e-40  Score=375.99  Aligned_cols=253  Identities=29%  Similarity=0.455  Sum_probs=209.8

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCC-eeEEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN-FKALVLE  740 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  740 (952)
                      ..++|++.+.||+|+||.||+|.+ .|+.||||+++...  ..+.+.+|++++++++||||+++++++.+.+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            356789999999999999999998 47899999987543  4578999999999999999999999987654 7899999


Q ss_pred             ccCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          741 YMPKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |+++|+|.+++...+. .+++..++.++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++...... 
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            9999999999987654 379999999999999999999   78999999999999999999999999999998543221 


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                         ....+++.|+|||.+.+..++.++|||||||++|||+| |+.||......+. ...            +....    
T Consensus       344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-~~~------------i~~~~----  403 (450)
T 1k9a_A          344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPR------------VEKGY----  403 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-HHH------------HHTTC----
T ss_pred             ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHH------------HHcCC----
Confidence               22357889999999999999999999999999999999 9999875422210 100            00000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                         ....+..+++++.++|.+||+.||++|||+.|+++.|+++...
T Consensus       404 ---~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          404 ---KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ---CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence               0112345788999999999999999999999999999988753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.9e-40  Score=362.43  Aligned_cols=253  Identities=25%  Similarity=0.351  Sum_probs=205.3

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|++.+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999885 789999999865432 234568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc-
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-  819 (952)
                      |+++|+|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.+..... 
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999886543 689999999999999999999   789999999999999999999999999999986543222 


Q ss_pred             ccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.........+..+......              
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------  227 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------  227 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------------
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------------
Confidence            12234579999999999877665 788999999999999999999997643332222222211100              


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ......++.++.+++.+||+.||++|||+.|++++
T Consensus       228 ----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                00113456778999999999999999999999764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=371.05  Aligned_cols=260  Identities=24%  Similarity=0.401  Sum_probs=211.0

Q ss_pred             hccCCccceecCccceEEEEEEeC------CCcEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      .++|++.+.||+|+||+||+|++.      +++.||||+++.. .......+.+|+.++++++||||+++++++...+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            457899999999999999999852      4678999998644 233456788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC---cEEEe
Q 002214          736 ALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM---VAHLS  806 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~---~~kl~  806 (952)
                      ++||||+++|+|.+++....      ..+++.+++.++.|+++||+||   |++||+||||||+||+++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997643      3589999999999999999999   789999999999999999555   59999


Q ss_pred             ccccccccCCcCc-ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchh
Q 002214          807 DFGIAKLLSEEDS-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLP  884 (952)
Q Consensus       807 Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  884 (952)
                      |||+|+....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......  ..         
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~---------  295 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EV---------  295 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH---------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HH---------
Confidence            9999986533222 22233567899999999988899999999999999999998 99998652111  01         


Q ss_pred             hhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          885 AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                        ...+.....       ...+..++.++.+++.+||+.||++||++.||+++|+.+.+..
T Consensus       296 --~~~i~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          296 --LEFVTSGGR-------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             --HHHHHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             --HHHHHcCCC-------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence              111111000       0112346778999999999999999999999999999887653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.3e-40  Score=377.40  Aligned_cols=262  Identities=18%  Similarity=0.256  Sum_probs=211.5

Q ss_pred             HHHHHHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecC
Q 002214          657 DELLRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNH  732 (952)
Q Consensus       657 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  732 (952)
                      .++....++|++.++||+|+||+||+|++. +++.||||+++...   ......+.+|..++..++||||+++++++.++
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            344455689999999999999999999985 58899999986432   22234588999999999999999999999999


Q ss_pred             CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          733 NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                      +..|+||||+++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+|||++.++.+||+|||+|+
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILl~~~g~vkL~DFGla~  223 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSCL  223 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence            999999999999999999987666799999999999999999999   78999999999999999999999999999998


Q ss_pred             ccCCcCcccccccccccccccccccC-----cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhh
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGR-----EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM  887 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  887 (952)
                      .............+||+.|+|||++.     .+.++.++|||||||++|||++|+.||...... ..+.+.....    .
T Consensus       224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~----~  298 (437)
T 4aw2_A          224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHK----E  298 (437)
T ss_dssp             ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHH----H
T ss_pred             hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhhcc----c
Confidence            77554444444568999999999886     567899999999999999999999998652111 1111111000    0


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPEN--RVNTKEIISR  937 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~  937 (952)
                      ..   ..        +.....+++++.+++++|+..+|++  ||++.|++++
T Consensus       299 ~~---~~--------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          299 RF---QF--------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HC---CC--------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             cc---cC--------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            00   00        0001235778999999999988888  9999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-40  Score=365.83  Aligned_cols=266  Identities=21%  Similarity=0.341  Sum_probs=211.5

Q ss_pred             HHhccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeecC
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTNH  732 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  732 (952)
                      ...++|.+.+.||+|+||.||+|++      .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            4567899999999999999999986      246789999986542 33457889999999999 899999999999999


Q ss_pred             CeeEEEEEccCCCChhHHhhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 002214          733 NFKALVLEYMPKGSLEDCMYASNF----------------------NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI  790 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dl  790 (952)
                      +..++||||+++|+|.+++.....                      .+++..++.++.|+++||+||   |++||+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH---HHTTEEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCC
Confidence            999999999999999999976542                      378999999999999999999   7899999999


Q ss_pred             CCCCeeeCCCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCcc
Q 002214          791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEF  868 (952)
Q Consensus       791 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~  868 (952)
                      ||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            999999999999999999999866443322 2233457889999999988899999999999999999998 99998663


Q ss_pred             ccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 002214          869 FTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFAN  948 (952)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~  948 (952)
                      .... .....           +......       ..+..+++++.+++.+||+.||++|||+.|++++|+.+.+...+.
T Consensus       279 ~~~~-~~~~~-----------~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  339 (344)
T 1rjb_A          279 PVDA-NFYKL-----------IQNGFKM-------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA  339 (344)
T ss_dssp             CCSH-HHHHH-----------HHTTCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred             CcHH-HHHHH-----------HhcCCCC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence            2211 11111           1111000       012345778999999999999999999999999999987765543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.3e-40  Score=359.05  Aligned_cols=252  Identities=21%  Similarity=0.338  Sum_probs=207.0

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCch------hhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREG------ALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|++......      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            457999999999999999999984 6899999998654321      346789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC----cEEEeccccc
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM----VAHLSDFGIA  811 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgla  811 (952)
                      ++||||+++|+|.+++... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++    .+||+|||++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHH---HHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            9999999999999998754 3699999999999999999999   789999999999999999887    8999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      +.......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ...           .+..
T Consensus       166 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~-----------~~~~  231 (326)
T 2y0a_A          166 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA-----------NVSA  231 (326)
T ss_dssp             EECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH-----------HHHH
T ss_pred             eECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHH-----------HHHh
Confidence            87653322  234569999999999998899999999999999999999999985421110 000           0000


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .....     .......++.++.+++.+||..||++|||+.|++++
T Consensus       232 ~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          232 VNYEF-----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             TCCCC-----CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cCCCc-----CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00000     011123457789999999999999999999999974

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.4e-40  Score=366.86  Aligned_cols=252  Identities=22%  Similarity=0.289  Sum_probs=201.3

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  736 (952)
                      ..++|++.+.||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|..++.++ +||||+++++++.+.+..|
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3468999999999999999999974 68899999997542   23345688999999887 8999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+++|+|..++...+ .+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+....
T Consensus       130 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            9999999999999887654 699999999999999999999   789999999999999999999999999999986332


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhh-hcccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMN-IMDTNLL  895 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  895 (952)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.....    ....... +....  
T Consensus       206 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~----~~~~~~~~i~~~~--  278 (396)
T 4dc2_A          206 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN----TEDYLFQVILEKQ--  278 (396)
T ss_dssp             TT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C----CHHHHHHHHHHCC--
T ss_pred             CC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh----hHHHHHHHHhccc--
Confidence            22 2234467999999999999999999999999999999999999999643222111000    0000000 00000  


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNT  931 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  931 (952)
                             ...+..++.++.+++.+||+.||++||++
T Consensus       279 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 -------IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                   01233467789999999999999999996

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.8e-40  Score=362.61  Aligned_cols=258  Identities=24%  Similarity=0.410  Sum_probs=205.4

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCc----EEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGI----EVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      .++|++.+.||+|+||+||+|++. +++    +||+|.++... ....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            357999999999999999999863 444    46888775432 344578999999999999999999999998765 78


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +|+||+++|+|.+++......+++..++.++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999999999988777899999999999999999999   788999999999999999999999999999987654


Q ss_pred             cCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          817 EDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       817 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      .... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+  ....           +....
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~-----------~~~~~  236 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI-----------LEKGE  236 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH-----------HHTTC
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHH-----------HHcCC
Confidence            3322 2223457889999999999999999999999999999999 999986532211  1111           11110


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      ..       ..+..++.++.+++.+||+.||++||++.|++++|+++.+.
T Consensus       237 ~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          237 RL-------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CC-------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CC-------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            00       01234577899999999999999999999999999988654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=372.64  Aligned_cols=261  Identities=21%  Similarity=0.313  Sum_probs=209.7

Q ss_pred             HHHHHHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecC
Q 002214          657 DELLRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNH  732 (952)
Q Consensus       657 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  732 (952)
                      .+.....++|++.+.||+|+||+||+|+.+ +|+.||||+++...   ....+.+.+|..++.+++||||+++++++.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            344455688999999999999999999984 79999999986432   22345688999999999999999999999999


Q ss_pred             CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          733 NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                      +..|+||||+++|+|.+++...+..+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILld~~g~vkL~DFGla~  210 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV---HRLGYVHRDIKPDNILLDRCGHIRLADFGSCL  210 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence            999999999999999999987666799999999999999999999   78999999999999999999999999999998


Q ss_pred             ccCCcCcccccccccccccccccccC-------cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhh
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGR-------EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA  885 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  885 (952)
                      .............+||+.|+|||++.       ...++.++|||||||++|||++|+.||...... ..+.+.....   
T Consensus       211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~---  286 (412)
T 2vd5_A          211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-ETYGKIVHYK---  286 (412)
T ss_dssp             ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHH---
T ss_pred             eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcc---
Confidence            77554443334467999999999886       457899999999999999999999998652111 0111111000   


Q ss_pred             hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCC---CCHHHHHHH
Q 002214          886 VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR---VNTKEIISR  937 (952)
Q Consensus       886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ev~~~  937 (952)
                        .    ...      ....+..+++++.+++.+||. +|++|   |+++|+.+|
T Consensus       287 --~----~~~------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          287 --E----HLS------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             --H----HCC------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             --c----CcC------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence              0    000      000123467889999999999 99998   589998764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.2e-40  Score=358.17  Aligned_cols=272  Identities=22%  Similarity=0.371  Sum_probs=214.3

Q ss_pred             CCccceecCccceEEEEEEeC-----CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecC--CeeEE
Q 002214          666 FSEENLIGIGSYGSVYKGRFP-----DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNH--NFKAL  737 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  737 (952)
                      |++.+.||+|+||+||+|.+.     +++.||||+++... ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            489999999999999998652     68899999997653 23456789999999999999999999999874  67899


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|+|.+++....  +++..++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~L---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYL---HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999997654  89999999999999999999   7899999999999999999999999999999877543


Q ss_pred             Ccc--cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccch--hhhhhhcccc
Q 002214          818 DSM--KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL--PAVMNIMDTN  893 (952)
Q Consensus       818 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  893 (952)
                      ...  ......+|+.|+|||++.+..++.++||||||+++|||++|+.||............+.....  ....+.+...
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            321  122345888999999999888999999999999999999999998653211111111110000  0111111111


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhhc
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANI  949 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~  949 (952)
                      ...       ..+..+++++.+++.+||+.||++|||+.|+++.|+++.+++..+.
T Consensus       268 ~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~  316 (318)
T 3lxp_A          268 ERL-------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA  316 (318)
T ss_dssp             CCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred             cCC-------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence            110       1234567889999999999999999999999999999999887654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.9e-40  Score=381.55  Aligned_cols=256  Identities=25%  Similarity=0.456  Sum_probs=214.3

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ..++|.+.+.||+|+||.||+|++. +++.||||+++.... ..+.|.+|+.++++++||||+++++++...+..++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            3457889999999999999999985 488999999975433 35789999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          741 YMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |+++|+|.+++.... ..+++..++.++.|+++||+||   |+++|+||||||+|||++.++.+||+|||+++.......
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            999999999998643 4689999999999999999999   789999999999999999999999999999997754443


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      .......+++.|+|||++....++.++|||||||++|||++ |..||......  ...           +.+.....   
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~-----------~~~~~~~~---  437 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY-----------ELLEKDYR---  437 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH-----------HHHHTTCC---
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHH-----------HHHHcCCC---
Confidence            33344557889999999998899999999999999999999 99998653211  111           11111110   


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                          ...+..+++++.++|.+||+.||++|||+.||++.|+.+
T Consensus       438 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          438 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence                012345788899999999999999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.7e-40  Score=356.07  Aligned_cols=268  Identities=22%  Similarity=0.353  Sum_probs=203.8

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ++|++.+.||+|+||+||+|+..+|+.||+|++.....  ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57899999999999999999998899999999865432  2346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +++ +|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++...... ..
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  156 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK  156 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-cc
Confidence            975 99998887767899999999999999999999   78999999999999999999999999999998764322 12


Q ss_pred             ccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cc----hhhhhh--hcc
Q 002214          822 QTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DS----LPAVMN--IMD  891 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~----~~~~~~--~~~  891 (952)
                      .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ...+...   ..    .+....  .++
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhcccccc
Confidence            233568999999998865 458999999999999999999999986532111 1111100   00    000000  000


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .......+.........+++++.+++.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000000000001123457789999999999999999999999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.9e-40  Score=355.88  Aligned_cols=256  Identities=26%  Similarity=0.404  Sum_probs=202.5

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .++|++.+.||+|+||+||+|++ .++.||||++...  ...+.+.+|++++++++||||+++++++.+  ..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            35788999999999999999998 5789999998643  345788999999999999999999998874  478999999


Q ss_pred             CCCChhHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc-EEEeccccccccCCcCc
Q 002214          743 PKGSLEDCMYASNF--NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV-AHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       743 ~~g~L~~~l~~~~~--~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~-~kl~Dfgla~~~~~~~~  819 (952)
                      ++|+|.+++.....  .+++..++.++.|+++||+|||..|.+||+||||||+||+++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999976543  4789999999999999999997555589999999999999998886 799999999865322  


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        .....||+.|+|||++.+..++.++||||||+++|||++|+.||.............          ... ...    
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----------~~~-~~~----  222 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA----------VHN-GTR----  222 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH----------HHT-TCC----
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH----------Hhc-CCC----
Confidence              123458999999999998899999999999999999999999987532221110000          000 000    


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                         ...+..++.++.+++.+||+.||++|||+.|+++.|+++.+.+
T Consensus       223 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          223 ---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             ---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             ---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence               0012345778999999999999999999999999999987654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.8e-40  Score=351.55  Aligned_cols=260  Identities=22%  Similarity=0.390  Sum_probs=209.2

Q ss_pred             HhccCCccceecCccceEEEEEEeCC----CcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPD----GIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      ..++|.+.+.||+|+||+||+|++.+    +..||+|++.... ....+.+.+|+.++++++||||+++++++.++ ..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            35689999999999999999998632    3469999987553 33457789999999999999999999998754 568


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+++++|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||++.....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            99999999999999988777799999999999999999999   789999999999999999999999999999987655


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+           .....
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~-----------~~~~~  232 (281)
T 3cc6_A          166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVL-----------EKGDR  232 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHH-----------HHTCC
T ss_pred             ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHH-----------hcCCC
Confidence            44333344567889999999988889999999999999999998 999986422211  11100           00000


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                             ...+..+++++.+++.+||+.||++||++.|++++|+++.+.-
T Consensus       233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          233 -------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence                   0012345778999999999999999999999999999987653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.3e-40  Score=352.70  Aligned_cols=262  Identities=24%  Similarity=0.444  Sum_probs=214.2

Q ss_pred             HHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ...++|++.+.||+|+||.||+|...+++.||||+++.... ..+.+.+|++++++++||||+++++++.. +..++|||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   87 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence            34578999999999999999999998888999999865433 34678999999999999999999999874 45899999


Q ss_pred             ccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          741 YMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |+++++|.+++.... ..+++..+..++.|+++||+||   |++||+||||||+||++++++.+||+|||++........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            999999999987542 2589999999999999999999   789999999999999999999999999999987755443


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+  ..           ..+.....   
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~-----------~~~~~~~~---  228 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VI-----------QNLERGYR---  228 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH-----------HHHHTTCC---
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HH-----------HHHhcccC---
Confidence            33344557889999999988889999999999999999999 899986521110  00           00000000   


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                          ...+..+++++.+++.+||+.||++|||+.++++.|+++......
T Consensus       229 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             ----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence                001234577899999999999999999999999999999876543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-39  Score=352.52  Aligned_cols=253  Identities=26%  Similarity=0.470  Sum_probs=205.7

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCch-------hhHHHHHHHHHHHhCCCCccceeeeEeecCCe
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREG-------ALNSFDAECEILKTIRHRNLVKIISSCTNHNF  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  734 (952)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++......       ..+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46799999999999999999988 57899999998644321       1267899999999999999999999997665 


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCeeeCCCCc-----EEEec
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP--IVHCDIKPSNVLLDDSMV-----AHLSD  807 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~--ivH~Dlk~~Nill~~~~~-----~kl~D  807 (952)
                       ++||||+++|+|.+.+......+++..++.++.|++.|++||   |++|  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM---QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHH---HhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             699999999999998887777899999999999999999999   6778  999999999999988776     99999


Q ss_pred             cccccccCCcCccccccccccccccccccc--CcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhh
Q 002214          808 FGIAKLLSEEDSMKQTQTLATIGYIAPEYG--REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA  885 (952)
Q Consensus       808 fgla~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  885 (952)
                      ||+++....    ......||+.|+|||++  ....++.++|||||||++|||++|+.||..............      
T Consensus       173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~------  242 (287)
T 4f0f_A          173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI------  242 (287)
T ss_dssp             CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH------
T ss_pred             CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH------
Confidence            999985432    22345699999999988  445678999999999999999999999976433221111110      


Q ss_pred             hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          886 VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                          ......       ...+..+++++.+++.+||+.||++|||+.|+++.|+++
T Consensus       243 ----~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 ----REEGLR-------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ----HHSCCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ----hccCCC-------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                000000       011245678899999999999999999999999999753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=366.19  Aligned_cols=250  Identities=24%  Similarity=0.308  Sum_probs=201.5

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  736 (952)
                      ..++|++.+.||+|+||+||+|+.. +|+.||||+++..   .....+.+.+|..+++.+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            4578999999999999999999874 6899999999754   223446688999999998 7999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+++|+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+|||++.++.+||+|||+|+....
T Consensus       101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999999987654 699999999999999999999   789999999999999999999999999999986432


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      .. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+..           +.....  
T Consensus       177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~-----------i~~~~~--  241 (353)
T 3txo_A          177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-DLFEA-----------ILNDEV--  241 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH-----------HHHCCC--
T ss_pred             CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-HHHHH-----------HHcCCC--
Confidence            22 2233467999999999999888999999999999999999999998652111 00111           111111  


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCH------HHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNT------KEIISR  937 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ev~~~  937 (952)
                             ..+..+++++.+++.+||..||++||++      .|+++|
T Consensus       242 -------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          242 -------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             -------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                   0123356779999999999999999998      777653

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.2e-39  Score=373.51  Aligned_cols=347  Identities=21%  Similarity=0.227  Sum_probs=198.1

Q ss_pred             eEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeecccc
Q 002214          159 GLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSN  238 (952)
Q Consensus       159 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~  238 (952)
                      .++.++++++ .+|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|+.|+|++|+
T Consensus        15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~   91 (477)
T 2id5_A           15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR   91 (477)
T ss_dssp             EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence            3444444444 3343332  345555555555554445555555555555555555554445555555555555555555


Q ss_pred             ccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCcccccc
Q 002214          239 LVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLG  318 (952)
Q Consensus       239 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~  318 (952)
                      +..+.+..|.++++|++|+|++|++.+..+.  .+..                                           
T Consensus        92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~--~~~~-------------------------------------------  126 (477)
T 2id5_A           92 LKLIPLGVFTGLSNLTKLDISENKIVILLDY--MFQD-------------------------------------------  126 (477)
T ss_dssp             CCSCCTTSSTTCTTCCEEECTTSCCCEECTT--TTTT-------------------------------------------
T ss_pred             CCccCcccccCCCCCCEEECCCCccccCChh--Hccc-------------------------------------------
Confidence            4444444444444444444444444433221  1233                                           


Q ss_pred             ccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCC
Q 002214          319 LERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFS  398 (952)
Q Consensus       319 L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~  398 (952)
                                                    +++|++|++++|.+++..+..|..+++|++|++++|.+++..+..|.+++
T Consensus       127 ------------------------------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~  176 (477)
T 2id5_A          127 ------------------------------LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLH  176 (477)
T ss_dssp             ------------------------------CTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCT
T ss_pred             ------------------------------cccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccC
Confidence                                          33444444444444444444455555555555555555544444455555


Q ss_pred             cceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecC
Q 002214          399 RLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLS  478 (952)
Q Consensus       399 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  478 (952)
                      +|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+..+.......+|+.|++++|+++...+..|..+++|+.|+|+
T Consensus       177 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls  256 (477)
T 2id5_A          177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLS  256 (477)
T ss_dssp             TCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECC
T ss_pred             CCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECC
Confidence            55555555555554445555555566666666555544444444444566666666666665444566777777777777


Q ss_pred             CcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCC
Q 002214          479 RNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEI  558 (952)
Q Consensus       479 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  558 (952)
                      +|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|+|.|.+
T Consensus       257 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c  336 (477)
T 2id5_A          257 YNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDC  336 (477)
T ss_dssp             SSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred             CCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCcc
Confidence            77777666677777777777777777777777777777777777777777777766667777777777777777777776


Q ss_pred             CCCCCcccccccccccCccCCCCCc
Q 002214          559 PRGGAFANFSAESFIGNDLLCGSPY  583 (952)
Q Consensus       559 p~~~~~~~~~~~~~~~n~~~c~~p~  583 (952)
                      +....+.+.....+.++...|+.|.
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          337 RLLWVFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             GGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred             chHhHHhhhhccccCccCceeCCch
Confidence            5432222333344566667776663

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=364.44  Aligned_cols=253  Identities=19%  Similarity=0.307  Sum_probs=209.5

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999884 6899999999766555556889999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC--CCcEEEeccccccccCCcCc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD--SMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~  819 (952)
                      +++|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.  ++.+||+|||+|+.......
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            999999999987766799999999999999999999   7899999999999999974  57899999999987654332


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......           .......  
T Consensus       207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~-----------~~~~~~~--  270 (387)
T 1kob_A          207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVK-----------RCDWEFD--  270 (387)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHH-----------HCCCCCC--
T ss_pred             --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHH-----------hCCCCCC--
Confidence              22346999999999999989999999999999999999999998652110 0001000           0000000  


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ......+++++.+++.+||..||++|||+.|++++
T Consensus       271 ---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          271 ---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence               00113457789999999999999999999999875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=371.49  Aligned_cols=255  Identities=19%  Similarity=0.273  Sum_probs=206.6

Q ss_pred             HHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ...++|++.+.||+|+||+||+|.. .+|+.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            3467899999999999999999987 478999999987553  2334678999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC---CCCcEEEecccccccc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLL  814 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgla~~~  814 (952)
                      ||||+++|+|.+.+.... .+++..+..++.|++.||+||   |++||+||||||+||+++   .++.+||+|||+|+..
T Consensus        88 v~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~l---H~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHC---HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            999999999999887654 699999999999999999999   789999999999999998   5688999999999876


Q ss_pred             CCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ..... ......||+.|+|||++.+..++.++||||+||++|+|++|..||...... ..+...           .....
T Consensus       164 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~~~~i-----------~~~~~  230 (444)
T 3soa_A          164 EGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RLYQQI-----------KAGAY  230 (444)
T ss_dssp             CTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH-----------HHTCC
T ss_pred             cCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HHHHHH-----------HhCCC
Confidence            54322 223467999999999999989999999999999999999999998552110 001110           00000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....     .....+++++.+++.+||+.||++|||+.|++++
T Consensus       231 ~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 DFPS-----PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CCCT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCc-----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0000     0113457789999999999999999999999874

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=356.32  Aligned_cols=274  Identities=22%  Similarity=0.315  Sum_probs=210.0

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCC--eeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHN--FKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  738 (952)
                      .++|.+.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            357999999999999999999985 58999999986543 233567889999999999999999999987654  77999


Q ss_pred             EEccCCCChhHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee----CCCCcEEEecccccc
Q 002214          739 LEYMPKGSLEDCMYASNF--NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAK  812 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill----~~~~~~kl~Dfgla~  812 (952)
                      |||+++|+|.+++.....  .+++.+++.++.|++.||+||   |++||+||||||+||++    +.++.+||+|||+|+
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976432  489999999999999999999   78999999999999999    888899999999998


Q ss_pred             ccCCcCcccccccccccccccccccC--------cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccch---hhhhcc
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGR--------EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI---KRWIND  881 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~---~~~~~~  881 (952)
                      .......  .....||+.|+|||++.        +..++.++|||||||++|||++|+.||..........   .+....
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            7654332  23456999999999875        5678999999999999999999999996533222111   111111


Q ss_pred             chhhhhhhccc----cccc-hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          882 SLPAVMNIMDT----NLLS-EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       882 ~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      ..+.....+..    .... ............+++.+.+++.+||+.||++|||++|++++..+.
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            00000000000    0000 000000012345678899999999999999999999999998753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-39  Score=361.45  Aligned_cols=253  Identities=21%  Similarity=0.311  Sum_probs=205.5

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-----chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-----EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++....     ....+.+.+|+.++++++||||+++++++.+++..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46799999999999999999987 468999999986432     113567899999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc---EEEecccc
Q 002214          737 LVLEYMPKGSLEDCMYAS---NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV---AHLSDFGI  810 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgl  810 (952)
                      +||||+++|+|.+.+...   ...+++..+..++.|+++||+||   |++||+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC---HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998877543   23589999999999999999999   7899999999999999986654   99999999


Q ss_pred             ccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          811 AKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       811 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      ++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....  +.....           +.
T Consensus       180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~-----------i~  245 (351)
T 3c0i_A          180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEG-----------II  245 (351)
T ss_dssp             CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHH-----------HH
T ss_pred             eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHH-----------HH
Confidence            987654322 2334579999999999998899999999999999999999999986521  100111           11


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .......     ......+++++.+++.+||+.||++|||+.|++++
T Consensus       246 ~~~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          246 KGKYKMN-----PRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HTCCCCC-----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCCCCC-----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1111000     01123457789999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.9e-40  Score=356.81  Aligned_cols=267  Identities=23%  Similarity=0.415  Sum_probs=210.9

Q ss_pred             hccCCccceecCccceEEEEEEe-----CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecC--Ce
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-----PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNH--NF  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  734 (952)
                      .+.|++.+.||+|+||.||+|++     .+++.||||+++... ....+.+.+|++++++++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            34689999999999999999983     468999999987543 33457789999999999999999999999876  66


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .++||||+++|+|.+++......+++..++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++..
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHh---hcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            8999999999999999977777899999999999999999999   7899999999999999999999999999999877


Q ss_pred             CCcCc--ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccc-----hhhhh
Q 002214          815 SEEDS--MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS-----LPAVM  887 (952)
Q Consensus       815 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~  887 (952)
                      .....  .......+|..|+|||.+.+..++.++||||+|+++|||++|+.|+......   ........     .....
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCCGGGHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCCcccccCHHHHH
Confidence            54432  2223356888999999998888999999999999999999999986432110   00000000     00011


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                      ..+....       ....+..+++++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       254 ~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          254 NTLKEGK-------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHTTC-------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhccC-------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1111100       00123456788999999999999999999999999999875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.4e-40  Score=372.43  Aligned_cols=258  Identities=22%  Similarity=0.290  Sum_probs=208.9

Q ss_pred             HHHHHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCC
Q 002214          658 ELLRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHN  733 (952)
Q Consensus       658 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  733 (952)
                      ++....++|.+.+.||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            34455678999999999999999999985 58999999986432   222355889999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ..|+||||+++|+|.+++...  .+++..+..++.|++.||+||   |++||+||||||+|||++.++.+||+|||+|+.
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            999999999999999988764  589999999999999999999   789999999999999999999999999999987


Q ss_pred             cCCcCcccccccccccccccccccCcCC----cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhh
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGREGQ----VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNI  889 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  889 (952)
                      ............+||+.|+|||++.+..    ++.++|||||||++|||++|+.||..... ...+.++.....    . 
T Consensus       218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~----~-  291 (410)
T 3v8s_A          218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNHKN----S-  291 (410)
T ss_dssp             CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTHHH----H-
T ss_pred             eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-hhHHHHHHhccc----c-
Confidence            7654443444578999999999887654    78999999999999999999999864211 001111110000    0 


Q ss_pred             ccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 002214          890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPEN--RVNTKEIISR  937 (952)
Q Consensus       890 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~  937 (952)
                          ..  .     .....+++++.+++.+||..+|.+  ||++.||++|
T Consensus       292 ----~~--~-----p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          292 ----LT--F-----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ----CC--C-----CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ----cc--C-----CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                00  0     001235778999999999999998  9999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-39  Score=355.70  Aligned_cols=279  Identities=24%  Similarity=0.357  Sum_probs=205.7

Q ss_pred             HHHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhC--CCCccceeeeEeecC----
Q 002214          659 LLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI--RHRNLVKIISSCTNH----  732 (952)
Q Consensus       659 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----  732 (952)
                      .....++|++.+.||+|+||.||+|++ .|+.||||++.....   ..+.+|.+++...  +||||+++++++...    
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            344567899999999999999999998 489999999864432   4455666666655  899999999999876    


Q ss_pred             CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCCeeeCCCCcEEEec
Q 002214          733 NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG-----HSNPIVHCDIKPSNVLLDDSMVAHLSD  807 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-----h~~~ivH~Dlk~~Nill~~~~~~kl~D  807 (952)
                      ...++||||+++|+|.+++...  .+++..++.++.|++.||+|||..     |..||+||||||+||+++.++.+||+|
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            6889999999999999999764  589999999999999999999521     123999999999999999999999999


Q ss_pred             cccccccCCcCccc---ccccccccccccccccCcCCcCcc------cchHhHHHHHHHHHhCCCCCCccccCccchhhh
Q 002214          808 FGIAKLLSEEDSMK---QTQTLATIGYIAPEYGREGQVSIK------GDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW  878 (952)
Q Consensus       808 fgla~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~  878 (952)
                      ||+|+.........   .....||+.|+|||++.+...+.+      +|||||||++|||+||..|+.........+...
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            99998765433221   123579999999999887766555      999999999999999955443222111111111


Q ss_pred             hccc--hhhhhhhcc-ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          879 INDS--LPAVMNIMD-TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       879 ~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                      ....  .......+. .......+  .......+++++.+++.+||+.||++|||+.||+++|+++.+..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIKKLRPSFP--NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCC--GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cCCCCchhhhHHHHhhhccCcccc--ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            1000  001111111 01111110  11123467889999999999999999999999999999998763

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-39  Score=357.40  Aligned_cols=260  Identities=23%  Similarity=0.394  Sum_probs=214.0

Q ss_pred             HhccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCe
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNF  734 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  734 (952)
                      ..++|.+.+.||+|+||.||+|.+      .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            356899999999999999999986      245899999987543 3445778999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 002214          735 KALVLEYMPKGSLEDCMYASN-----------------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIK  791 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk  791 (952)
                      .++||||+++|+|.+++....                       ..+++.+++.++.|+++||+||   |++||+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHH---HHTTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHH---HHCCCcccccc
Confidence            999999999999999997643                       2388999999999999999999   78999999999


Q ss_pred             CCCeeeCCCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccc
Q 002214          792 PSNVLLDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFF  869 (952)
Q Consensus       792 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~  869 (952)
                      |+||++++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999876543322 2233457889999999988889999999999999999999 999986532


Q ss_pred             cCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          870 TGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      ...  ...           .+......       ..+..+++++.+++.+||+.||++||++.|++++|+++.++
T Consensus       258 ~~~--~~~-----------~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          258 PER--LFN-----------LLKTGHRM-------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GGG--HHH-----------HHHTTCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHH--HHH-----------HhhcCCcC-------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            111  111           11110000       01234677899999999999999999999999999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-39  Score=348.54  Aligned_cols=263  Identities=23%  Similarity=0.394  Sum_probs=215.0

Q ss_pred             hccCCccc-eecCccceEEEEEEeC---CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEEN-LIGIGSYGSVYKGRFP---DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|.+.+ .||+|+||.||+|.+.   +++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            34666666 9999999999999863   67889999997643 33457789999999999999999999999 4556899


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++++|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            9999999999999987766799999999999999999999   7889999999999999999999999999999877543


Q ss_pred             Cccc--ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          818 DSMK--QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       818 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ....  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......  .....           +....
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~-----------i~~~~  230 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAF-----------IEQGK  230 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHH-----------HHTTC
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHH-----------HhcCC
Confidence            3221  222456889999999988889999999999999999999 99998653211  11111           10000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhhc
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANI  949 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~  949 (952)
                      .       ...+..+++++.+++.+||+.||++||++.|++++|+++..+....-
T Consensus       231 ~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  278 (287)
T 1u59_A          231 R-------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  278 (287)
T ss_dssp             C-------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             c-------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence            0       01124567889999999999999999999999999999988876543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9.2e-40  Score=349.81  Aligned_cols=252  Identities=21%  Similarity=0.390  Sum_probs=207.0

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecC--CeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNH--NFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  738 (952)
                      .++|.+.+.||+|+||.||+|++ +++.||||+++...  ....+.+.+|+.++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            45799999999999999999998 58999999987553  33456799999999999999999999999877  788999


Q ss_pred             EEccCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          739 LEYMPKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNP--IVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~--ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      |||+++|+|.+++..... .+++..++.++.|+++||+||   |+++  |+||||||+||+++.++.++++|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL---HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHH---TTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH---hcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999987553 589999999999999999999   7888  9999999999999999999999999886432


Q ss_pred             CcCcccccccccccccccccccCcCCcCc---ccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQVSI---KGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                      .      ....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||......+...            .....
T Consensus       165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------------~~~~~  226 (271)
T 3kmu_A          165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------------KVALE  226 (271)
T ss_dssp             C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH------------HHHHS
T ss_pred             c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH------------HHHhc
Confidence            2      2345899999999987765544   7999999999999999999986532111100            00000


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                      ...       ...+..+++++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       227 ~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          227 GLR-------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCC-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            000       01123467789999999999999999999999999998864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1e-39  Score=358.97  Aligned_cols=261  Identities=24%  Similarity=0.452  Sum_probs=197.0

Q ss_pred             HhccCCccceecCccceEEEEEEeCC-C---cEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPD-G---IEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      ..++|++.+.||+|+||.||+|++.. +   ..||||+++..  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45689999999999999999998753 2   37999998654  344567899999999999999999999999876654


Q ss_pred             ------EEEEEccCCCChhHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEE
Q 002214          736 ------ALVLEYMPKGSLEDCMYASN-----FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH  804 (952)
Q Consensus       736 ------~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~k  804 (952)
                            ++||||+++|+|.+++....     ..+++.+++.++.|+++||+||   |++||+||||||+||++++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHH---HcCCcccCCCCcceEEEcCCCCEE
Confidence                  99999999999999886432     2589999999999999999999   789999999999999999999999


Q ss_pred             EeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccc
Q 002214          805 LSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDS  882 (952)
Q Consensus       805 l~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  882 (952)
                      |+|||+|+......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ .....    
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~~~----  252 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IYNYL----  252 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHH----
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-HHHHH----
Confidence            99999998765433222 223457889999999998899999999999999999999 899986532211 11110    


Q ss_pred             hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                             ......        ..+..+++++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       253 -------~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          253 -------IGGNRL--------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             -------HTTCCC--------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             -------hcCCCC--------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                   000000        012345778999999999999999999999999999987654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.5e-40  Score=351.00  Aligned_cols=251  Identities=24%  Similarity=0.453  Sum_probs=195.3

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCc----hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE----GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|++.+.||+|+||.||+|++ .|+.||||+++....    ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            45789999999999999999998 589999999865432    2346789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---eEeCCCCCCCeeeCC--------CCcEEEec
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP---IVHCDIKPSNVLLDD--------SMVAHLSD  807 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~---ivH~Dlk~~Nill~~--------~~~~kl~D  807 (952)
                      |||+++++|.+++..  ..+++..++.++.|+++|++||   |++|   |+||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~l---H~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYL---HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHH---HHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHH---HhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999998864  3689999999999999999999   5666   999999999999986        77899999


Q ss_pred             cccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhh
Q 002214          808 FGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM  887 (952)
Q Consensus       808 fgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  887 (952)
                      ||+++......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..........            
T Consensus       160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------------  224 (271)
T 3dtc_A          160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------------  224 (271)
T ss_dssp             CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------------
T ss_pred             CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence            99998654332   223568999999999988889999999999999999999999986532111000            


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      .........       ..+..+++++.+++.+||+.||++|||+.|++++|+++
T Consensus       225 ~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          225 GVAMNKLAL-------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHHTSCCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             hhhcCCCCC-------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            000000000       01234677899999999999999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.7e-39  Score=351.08  Aligned_cols=261  Identities=25%  Similarity=0.436  Sum_probs=218.1

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4678999999999999999999985 48899999986543 345778999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          741 YMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |+++++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++........
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHH---HHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHH---HHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            999999999997643 4689999999999999999999   788999999999999999999999999999997765544


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......  ....           .+......  
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~-----------~~~~~~~~--  231 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYE-----------LLEKDYRM--  231 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHH-----------HHHTTCCC--
T ss_pred             ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH-----------HHhccCCC--
Confidence            44444567889999999988899999999999999999999 99998653211  1111           11111000  


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHh
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~  946 (952)
                           ..+..+++++.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus       232 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          232 -----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                 1123467789999999999999999999999999999877643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-39  Score=363.28  Aligned_cols=253  Identities=21%  Similarity=0.353  Sum_probs=206.5

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4568999999999999999999874 68999999997543  23456788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC---CcEEEeccccccccC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLLS  815 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgla~~~~  815 (952)
                      |||+++|+|.+.+.... .+++..+..++.|+++||+||   |++||+||||||+||+++.+   +.+||+|||+++...
T Consensus       107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            99999999999887544 689999999999999999999   78899999999999999865   459999999998765


Q ss_pred             CcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|..||.....  .....          .+......
T Consensus       183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~----------~i~~~~~~  248 (362)
T 2bdw_A          183 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYA----------QIKAGAYD  248 (362)
T ss_dssp             TCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----------HHHHTCCC
T ss_pred             CCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHH----------HHHhCCCC
Confidence            332  22345799999999999988999999999999999999999999865211  00000          00000000


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...     .....+++++.+++.+||+.||++||++.|++++
T Consensus       249 ~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 YPS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CCT-----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000     0123457789999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.5e-39  Score=351.26  Aligned_cols=267  Identities=21%  Similarity=0.287  Sum_probs=210.6

Q ss_pred             HHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEe-ecCCeeEEE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSC-TNHNFKALV  738 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv  738 (952)
                      ...++|++.+.||+|+||.||+|++ .+++.||||+......  ...+.+|+.++++++|++++..++++ ...+..++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3457899999999999999999997 5789999998754433  24578999999999988877766655 667788999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee---CCCCcEEEeccccccccC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgla~~~~  815 (952)
                      |||+ +++|.+++......+++..+..++.|++.||+||   |++||+||||||+||++   +.++.+||+|||+|+...
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999 9999999987666899999999999999999999   78999999999999999   789999999999998765


Q ss_pred             CcCcc------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccc--hhhhhccchhhhh
Q 002214          816 EEDSM------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS--IKRWINDSLPAVM  887 (952)
Q Consensus       816 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~  887 (952)
                      .....      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........  .........+   
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---  236 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---  236 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH---
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc---
Confidence            43321      122457999999999999999999999999999999999999999764322111  1110000000   


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFAN  948 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~  948 (952)
                                  .........+++++.+++.+||+.||++|||+.|+++.|+++.++....
T Consensus       237 ------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~  285 (296)
T 4hgt_A          237 ------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             ------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             ------------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence                        0011112345788999999999999999999999999999998876543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.7e-40  Score=361.60  Aligned_cols=273  Identities=24%  Similarity=0.355  Sum_probs=214.8

Q ss_pred             hccCCccceecCccceEEEEEEe-----CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEee--cCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-----PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT--NHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  735 (952)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            35799999999999999999984     468999999998776666678999999999999999999999886  45678


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||+++++|.+++......+++..++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            999999999999999987665799999999999999999999   78999999999999999999999999999998765


Q ss_pred             CcCcc--cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc--cchhhhhhhcc
Q 002214          816 EEDSM--KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN--DSLPAVMNIMD  891 (952)
Q Consensus       816 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~  891 (952)
                      .....  ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||............+..  .........+.
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            43321  223356888899999998888999999999999999999999997542211000000000  00001111111


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                      ....       ...+..+++++.+++.+||+.||++|||+.|++++|+++....
T Consensus       259 ~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          259 EGQR-------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             TTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             cccC-------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            1110       0123456788999999999999999999999999999886654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.5e-40  Score=377.84  Aligned_cols=257  Identities=26%  Similarity=0.460  Sum_probs=206.6

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            4567899999999999999999998888999999975443 34679999999999999999999999876 678999999


Q ss_pred             cCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++|+|.+++... ...+++.++..++.|+++||+||   |+++|+||||||+||++++++.+||+|||+++........
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  336 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  336 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence            9999999999753 23589999999999999999999   7899999999999999999999999999999876543333


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                      ......+++.|+|||.+.++.++.++|||||||++|||++ |+.||......+             ....+.....    
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------------~~~~i~~~~~----  399 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------------VLDQVERGYR----  399 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------------HHHHHHTTCC----
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------------HHHHHHcCCC----
Confidence            3334557889999999988899999999999999999999 999986532111             0000100100    


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                         ...+..+++++.++|.+||+.||++|||+.++++.|+++..
T Consensus       400 ---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          400 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence               01234578889999999999999999999999999987754

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=362.10  Aligned_cols=249  Identities=21%  Similarity=0.349  Sum_probs=200.9

Q ss_pred             CccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCCC
Q 002214          667 SEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKG  745 (952)
Q Consensus       667 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  745 (952)
                      ...+.||+|+||.||+|.. .+|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            3357899999999999987 469999999998766556678999999999999999999999999999999999999999


Q ss_pred             ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee--CCCCcEEEeccccccccCCcCccccc
Q 002214          746 SLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL--DDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       746 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill--~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +|.+++......+++..+..++.|+++||+||   |++||+||||||+||++  +.++.+||+|||+++.......  ..
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~  246 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHM---HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK  246 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence            99998877666799999999999999999999   78999999999999999  6778999999999987654332  23


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN  903 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (952)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+           .........     
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i-----------~~~~~~~~~-----  309 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNI-----------LACRWDLED-----  309 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHH-----------HHTCCCSCS-----
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH-----------HhccCCCCh-----
Confidence            356999999999999889999999999999999999999998652111 011111           111000000     


Q ss_pred             HhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          904 VAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       904 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .....+++++.+++.+||+.||++|||+.|++++
T Consensus       310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0123457789999999999999999999999983

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=362.73  Aligned_cols=250  Identities=23%  Similarity=0.341  Sum_probs=204.1

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999874 68999999986432   23456788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+......
T Consensus        94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYL---QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999999987643 699999999999999999999   78999999999999999999999999999998764332


Q ss_pred             cccccccccccccccccccCc---CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          819 SMKQTQTLATIGYIAPEYGRE---GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                        ......||+.|+|||++..   ..++.++|||||||++|||++|+.||.......  .....        ..+.... 
T Consensus       170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~--------~~~~~~~-  236 (384)
T 4fr4_A          170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIV--------HTFETTV-  236 (384)
T ss_dssp             --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHH--------HHHHHCC-
T ss_pred             --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHH--------HHHhhcc-
Confidence              2344679999999998863   458999999999999999999999986422111  11110        0000000 


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCC-HHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVN-TKEIIS  936 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~  936 (952)
                             ...+..+++++.+++.+||+.||++||+ +.++.+
T Consensus       237 -------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 -------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                   0012345778999999999999999998 666654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2e-39  Score=358.26  Aligned_cols=257  Identities=23%  Similarity=0.294  Sum_probs=204.9

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|+++...   ....+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            357999999999999999999984 68999999997542   23456688999999988 89999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+.....
T Consensus        88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999987654 689999999999999999999   7899999999999999999999999999999864322


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhh-hhccccccc
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM-NIMDTNLLS  896 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  896 (952)
                      . ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+.....    ...... .+.....  
T Consensus       164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----~~~~~~~~i~~~~~--  236 (345)
T 3a8x_A          164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN----TEDYLFQVILEKQI--  236 (345)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----------CHHHHHHHHHHCCC--
T ss_pred             C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc----cHHHHHHHHHcCCC--
Confidence            2 2233467999999999999989999999999999999999999999653221110000    000000 0000000  


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCH------HHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNT------KEIISR  937 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ev~~~  937 (952)
                             ..+..++.++.+++.+||+.||++||++      .|+++|
T Consensus       237 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          237 -------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             -------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                   1123457789999999999999999996      566543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=354.78  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=205.8

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+.+|..+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467999999999999999999884 69999999986542   23346788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+..... 
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            99999999999997654 689999999999999999999   7999999999999999999999999999999875432 


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                         ....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+           ..+......   
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~-----------~~i~~~~~~---  221 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTY-----------EKILNAELR---  221 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHH-----------HHHHHCCCC---
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHH-----------HHHHhCCCC---
Confidence               23357999999999999999999999999999999999999998652110 001           111111110   


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                            .+..+++++.+++.+|+..||++||     ++.|++++
T Consensus       222 ------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          222 ------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                  1234567899999999999999999     88888764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.5e-39  Score=352.24  Aligned_cols=269  Identities=20%  Similarity=0.285  Sum_probs=204.4

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....  ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999984 68999999987543  2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+++ ++.+.+......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+...... .
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R  156 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-S
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-c
Confidence            9975 66666666566899999999999999999999   78899999999999999999999999999998764332 2


Q ss_pred             cccccccccccccccccCcCC-cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc---chh----hhhhhccc
Q 002214          821 KQTQTLATIGYIAPEYGREGQ-VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND---SLP----AVMNIMDT  892 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~~~----~~~~~~~~  892 (952)
                      ......+|+.|+|||++.+.. ++.++||||+||++|||++|..||................   ..+    ......+.
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            233456899999999887665 7999999999999999999988864322111111111110   000    00000000


Q ss_pred             cccc--hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          893 NLLS--EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       893 ~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....  ............+++++.+++.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000  00000001123457789999999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=361.26  Aligned_cols=252  Identities=23%  Similarity=0.308  Sum_probs=191.4

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ..++|.+.+.||+|+||.||+|++. +++.||||+++...  ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3567999999999999999999985 58899999987543  23668899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC---CCcEEEeccccccccCCc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD---SMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgla~~~~~~  817 (952)
                      |+++|+|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.   ++.+||+|||+++.....
T Consensus       129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYL---HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999999887644 689999999999999999999   7889999999999999975   899999999999866432


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+......           .....
T Consensus       205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~-----------~~~~~  271 (349)
T 2w4o_A          205 V--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC-----------EYYFI  271 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTT-----------CCCCC
T ss_pred             c--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhC-----------CCccC
Confidence            2  2233568999999999999899999999999999999999999986532211111111110           00000


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .     .....++.++.+++.+||+.||++|||+.|++++
T Consensus       272 ~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          272 S-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             T-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             C-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0     0113456789999999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=355.71  Aligned_cols=271  Identities=25%  Similarity=0.453  Sum_probs=217.4

Q ss_pred             hccCCccceecCccceEEEEEEe-----CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCC--ee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-----PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN--FK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  735 (952)
                      .++|++.+.||+|+||.||+|++     .+|+.||||++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45789999999999999999984     468999999997766666778999999999999999999999986653  78


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||+++++|.+++......+++..++.++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            999999999999999988777799999999999999999999   78999999999999999999999999999998775


Q ss_pred             CcCccc--ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccc------hhhhh
Q 002214          816 EEDSMK--QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS------LPAVM  887 (952)
Q Consensus       816 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~------~~~~~  887 (952)
                      ......  .....++..|+|||.+.+..++.++||||||+++|||+||..|+.....   .+.+.....      .....
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---HHHHHHCTTCCTHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---HHHHhhccccchhhhHHHHH
Confidence            443221  2234577889999999888899999999999999999999998754210   000100000      00011


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHh
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~  946 (952)
                      +.+.....       ...+..+++++.+++.+||+.||++|||+.|+++.|+++++++.
T Consensus       274 ~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          274 ELLKNNGR-------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHHHTTCC-------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHhhcCCC-------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            11111100       01134567889999999999999999999999999999998864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.2e-39  Score=348.17  Aligned_cols=264  Identities=21%  Similarity=0.283  Sum_probs=213.7

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEe-ecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSC-TNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  740 (952)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++.....  .+.+.+|+.++++++|++++..++++ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            56899999999999999999997 5799999999865443  35688999999999988877666655 56678899999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee---CCCCcEEEeccccccccCCc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgla~~~~~~  817 (952)
                      |+ +++|.+++......+++..+..++.|++.||+||   |++||+||||||+||++   +.++.+||+|||+++.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 9999999987666899999999999999999999   78999999999999999   48899999999999876543


Q ss_pred             Ccc------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCcc--chhhhhccchhhhhhh
Q 002214          818 DSM------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM--SIKRWINDSLPAVMNI  889 (952)
Q Consensus       818 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~  889 (952)
                      ...      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........  .+.........     
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  236 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-----  236 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-----
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-----
Confidence            321      12345799999999999998999999999999999999999999976432211  11111100000     


Q ss_pred             ccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       890 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                                .........+++++.+++.+||+.||++|||+.|+++.|+++......
T Consensus       237 ----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          237 ----------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             ----------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             ----------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence                      001112245678899999999999999999999999999999887654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=351.71  Aligned_cols=250  Identities=26%  Similarity=0.343  Sum_probs=197.3

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc--------------------------hhhHHHHHHHHHHH
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE--------------------------GALNSFDAECEILK  715 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  715 (952)
                      .++|++.+.||+|+||.||+|++ .+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46899999999999999999987 4689999999864421                          12356889999999


Q ss_pred             hCCCCccceeeeEeec--CCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 002214          716 TIRHRNLVKIISSCTN--HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPS  793 (952)
Q Consensus       716 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~  793 (952)
                      +++||||+++++++.+  .+..++||||+++++|.+++..  ..+++.++..++.|+++||+||   |++||+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYL---HYQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHH
Confidence            9999999999999986  5688999999999999886543  3699999999999999999999   7889999999999


Q ss_pred             CeeeCCCCcEEEeccccccccCCcCcccccccccccccccccccCcCC---cCcccchHhHHHHHHHHHhCCCCCCcccc
Q 002214          794 NVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQ---VSIKGDVYNYGIMLMEVFTGMKPTNEFFT  870 (952)
Q Consensus       794 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~  870 (952)
                      ||+++.++.+||+|||+++....... ......||+.|+|||.+.+..   ++.++|||||||++|||++|+.||.....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99999999999999999987654322 223457999999999987654   47889999999999999999999864211


Q ss_pred             CccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          871 GEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..+..    .   .........       ....+++++.+++.+||+.||++|||+.|++++
T Consensus       246 -----~~~~~----~---~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          246 -----MCLHS----K---IKSQALEFP-------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             -----HHHHH----H---HHHCCCCCC-------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             -----HHHHH----H---HhcccCCCC-------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence                 11000    0   000000000       012356789999999999999999999999764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.9e-40  Score=362.36  Aligned_cols=251  Identities=23%  Similarity=0.313  Sum_probs=204.7

Q ss_pred             HHHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCe
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNF  734 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  734 (952)
                      ....++|.+.+.||+|+||.||+|+.+ +|+.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999984 68999999997542   23346678899999887 99999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .|+||||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+..
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            999999999999999987654 689999999999999999999   7889999999999999999999999999999864


Q ss_pred             CCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      .... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+..           +.....
T Consensus       169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~-----------i~~~~~  235 (345)
T 1xjd_A          169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHS-----------IRMDNP  235 (345)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH-----------HHHCCC
T ss_pred             ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-HHHHH-----------HHhCCC
Confidence            3222 2234467999999999999989999999999999999999999998652110 00000           000000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTK-EIIS  936 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~~  936 (952)
                               ..+..+++++.+++.+||..||++||++. |+.+
T Consensus       236 ---------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          236 ---------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                     01234567899999999999999999997 6653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4e-39  Score=355.85  Aligned_cols=262  Identities=23%  Similarity=0.441  Sum_probs=213.7

Q ss_pred             HhccCCccceecCccceEEEEEEeC--------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceeeeEeec
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP--------DGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKIISSCTN  731 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  731 (952)
                      ..++|.+.+.||+|+||.||+|++.        +++.||||+++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3578999999999999999999862        46789999997543 33456789999999999 89999999999999


Q ss_pred             CCeeEEEEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCee
Q 002214          732 HNFKALVLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVL  796 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nil  796 (952)
                      .+..++||||+++|+|.+++....               ..+++.+++.++.|+++||+||   |++||+||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCccceEE
Confidence            999999999999999999997643               2489999999999999999999   7899999999999999


Q ss_pred             eCCCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccc
Q 002214          797 LDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS  874 (952)
Q Consensus       797 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~  874 (952)
                      ++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......   
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---  266 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---  266 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence            999999999999999876543322 2223457889999999988889999999999999999999 99998652111   


Q ss_pred             hhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHh
Q 002214          875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~  946 (952)
                        ..        ...+.....       ...+..++.++.+++.+||+.||++||++.|++++|+++.....
T Consensus       267 --~~--------~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          267 --EL--------FKLLKEGHR-------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             --HH--------HHHHHHTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             --HH--------HHHHhcCCC-------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence              10        000000000       01123467789999999999999999999999999999987654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.3e-39  Score=352.09  Aligned_cols=260  Identities=27%  Similarity=0.466  Sum_probs=197.5

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ..++|++.+.||+|+||+||+|++.  ..||||+++...  ....+.+.+|+.++++++||||+++++++. ....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence            4568999999999999999999864  359999986543  334577899999999999999999999654 45689999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC-
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED-  818 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-  818 (952)
                      ||+++++|.+++......+++.+++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999999987777899999999999999999999   78999999999999999999999999999998654322 


Q ss_pred             cccccccccccccccccccC---cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          819 SMKQTQTLATIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ........||+.|+|||.+.   +..++.++||||||+++|||++|+.||......+. ....           +.....
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~-----------~~~~~~  243 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEM-----------VGRGSL  243 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHHH-----------HHHTSC
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHHH-----------hccccc
Confidence            12223356899999999886   56788899999999999999999999965322111 1110           000000


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                      ...   .......+++++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       244 ~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          244 SPD---LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CCC---TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             Ccc---hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            000   00012356788999999999999999999999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.6e-39  Score=351.46  Aligned_cols=261  Identities=24%  Similarity=0.432  Sum_probs=208.4

Q ss_pred             hccCCccceecCccceEEEEEEeCC----CcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEee-cCCeeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD----GIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCT-NHNFKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~  736 (952)
                      ..+|++.+.||+|+||.||+|++.+    +..||+|.+.... ....+.+.+|+.++++++||||+++++++. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3568889999999999999998632    3368999886543 344577899999999999999999999864 556889


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+++|+|.+++......+++..++.++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999987777799999999999999999999   789999999999999999999999999999987654


Q ss_pred             cCcc---cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhC-CCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          817 EDSM---KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTG-MKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       817 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                      ....   ......+|+.|+|||.+.+..++.++||||+|+++|||++| ..||......+ .........          
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-~~~~~~~~~----------  249 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR----------  249 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-HHHHHHTTC----------
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-HHHHHhcCC----------
Confidence            3321   12335578899999999888999999999999999999995 55554321111 111110000          


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHh
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~  946 (952)
                               ....+..+++++.+++.+||+.||++|||+.|+++.|+++.+.+.
T Consensus       250 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          250 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                     000123456789999999999999999999999999999987654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.9e-39  Score=358.48  Aligned_cols=251  Identities=23%  Similarity=0.361  Sum_probs=199.3

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCC------
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHN------  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  733 (952)
                      ..++|++.+.||+|+||.||+|++. +|+.||||+++... +...+.+.+|++++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3568999999999999999999985 79999999997543 334578999999999999999999999885543      


Q ss_pred             ---------------------------------------------------eeEEEEEccCCCChhHHhhhcCC--CCCH
Q 002214          734 ---------------------------------------------------FKALVLEYMPKGSLEDCMYASNF--NLDI  760 (952)
Q Consensus       734 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~l~~  760 (952)
                                                                         ..++||||+++|+|.+++.....  ..++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               37999999999999999976542  3567


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc-----------cccccccccc
Q 002214          761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-----------MKQTQTLATI  829 (952)
Q Consensus       761 ~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~~~~  829 (952)
                      ..++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......           .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHH---HhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            77899999999999999   789999999999999999999999999999987754321           1223356999


Q ss_pred             ccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhh
Q 002214          830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSC  909 (952)
Q Consensus       830 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (952)
                      .|+|||++.+..++.++|||||||++|||++|..|+....       .       ........ .       ........
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------~-------~~~~~~~~-~-------~~~~~~~~  298 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------R-------IITDVRNL-K-------FPLLFTQK  298 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------H-------HHHHHHTT-C-------CCHHHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------H-------HHHHhhcc-C-------CCcccccC
Confidence            9999999998899999999999999999999877642210       0       00000000 0       00112334


Q ss_pred             HHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          910 ASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       910 ~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ++++.+++.+||+.||++|||+.|++++
T Consensus       299 ~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          299 YPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             CHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             ChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            5678999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.1e-40  Score=355.43  Aligned_cols=253  Identities=21%  Similarity=0.361  Sum_probs=205.9

Q ss_pred             hccCCccceecCccceEEEEEEeCC-C-------cEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCe
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD-G-------IEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNF  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  734 (952)
                      .++|.+.+.||+|+||+||+|++.. +       +.||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4579999999999999999998742 3       5799999976666667889999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc--------EEEe
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV--------AHLS  806 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~--------~kl~  806 (952)
                      .++||||+++|+|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---hhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            9999999999999999987766699999999999999999999   7899999999999999998887        9999


Q ss_pred             ccccccccCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhh
Q 002214          807 DFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA  885 (952)
Q Consensus       807 Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  885 (952)
                      |||++......     ....+++.|+|||++.+ ..++.++||||||+++|||++|..|+.......... ..       
T Consensus       164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~-------  230 (289)
T 4fvq_A          164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QF-------  230 (289)
T ss_dssp             CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HH-------
T ss_pred             cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HH-------
Confidence            99999755322     22457889999998877 678999999999999999999655543211111000 00       


Q ss_pred             hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          886 VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                          ....         ...+..+++++.+++.+||+.||++|||+.|++++|+++...
T Consensus       231 ----~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          231 ----YEDR---------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             ----HHTT---------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             ----hhcc---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence                0000         001122355689999999999999999999999999987543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.6e-39  Score=356.48  Aligned_cols=270  Identities=21%  Similarity=0.368  Sum_probs=217.4

Q ss_pred             cCHHHHHHHhccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhC-CCCcccee
Q 002214          654 YSHDELLRATDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQRE-GALNSFDAECEILKTI-RHRNLVKI  725 (952)
Q Consensus       654 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l  725 (952)
                      +....+....++|++.+.||+|+||+||+|++      .+++.||||+++.... ...+.+.+|+.+++++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34455556678999999999999999999974      3578999999875433 3446789999999999 79999999


Q ss_pred             eeEeecC-CeeEEEEEccCCCChhHHhhhcCCC---------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCC
Q 002214          726 ISSCTNH-NFKALVLEYMPKGSLEDCMYASNFN---------------LDIFQRLGIMIDVASALEYLHFGHSNPIVHCD  789 (952)
Q Consensus       726 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~---------------l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~D  789 (952)
                      ++++... ...++||||+++|+|.+++......               +++..++.++.|+++||+||   |++||+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH---HHTTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH---HhCCccccc
Confidence            9998765 4589999999999999999765432               88999999999999999999   788999999


Q ss_pred             CCCCCeeeCCCCcEEEeccccccccCCcCc-ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCc
Q 002214          790 IKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNE  867 (952)
Q Consensus       790 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~  867 (952)
                      |||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||+| |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987654332 22233567899999999988899999999999999999998 9999865


Q ss_pred             cccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          868 FFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                      ....+.......            ....       ...+..+++++.+++.+||+.||++|||+.|++++|+++.+..
T Consensus       254 ~~~~~~~~~~~~------------~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          254 VKIDEEFCRRLK------------EGTR-------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCCSHHHHHHHH------------HTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cchhHHHHHHhc------------cCcc-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            322211111100            0000       0012335678999999999999999999999999999998764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-39  Score=364.55  Aligned_cols=261  Identities=25%  Similarity=0.451  Sum_probs=201.3

Q ss_pred             ccCCccceecCccceEEEEEEeC--CC--cEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeec-CCeeEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP--DG--IEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTN-HNFKAL  737 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  737 (952)
                      ..|.+.+.||+|+||+||+|++.  ++  ..||||.++.. .....+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            35777899999999999999863  32  46899988643 33456789999999999999999999998754 567899


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|+|.+++......+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            9999999999999987777789999999999999999999   7899999999999999999999999999999866433


Q ss_pred             Ccc---cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          818 DSM---KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       818 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      ...   ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||......+  ....+.          ...
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~----------~~~  313 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLL----------QGR  313 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHH----------TTC
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHH----------cCC
Confidence            221   1223457889999999998899999999999999999999 667775432211  111100          000


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                      .        ...+..++.++.+++.+||+.||++||++.|+++.|+++.+.+..
T Consensus       314 ~--------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          314 R--------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             C--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            0        011234677899999999999999999999999999999876543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-39  Score=358.88  Aligned_cols=258  Identities=23%  Similarity=0.397  Sum_probs=205.4

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcE----EEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIE----VAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      .++|++.+.||+|+||+||+|++. +++.    ||+|.+.... ......+.+|+.++++++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            357899999999999999999874 4443    7888774332 233456788999999999999999999986 45688


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+++|+|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHH---HHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHH---HhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999999999987666799999999999999999999   788999999999999999999999999999997754


Q ss_pred             cCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          817 EDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       817 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      .... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+  ....           +....
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~-----------~~~~~  234 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDL-----------LEKGE  234 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHH-----------HHTTC
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHH-----------HHcCC
Confidence            4322 2233567889999999998899999999999999999999 999987532211  1111           00000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      .       ...+..++.++.+++.+||+.||++||++.|++++|+++.+.
T Consensus       235 ~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          235 R-------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             B-------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             C-------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            0       001223566789999999999999999999999999987543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.4e-39  Score=351.06  Aligned_cols=268  Identities=24%  Similarity=0.347  Sum_probs=204.1

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||+++..   .......+.+|+.++++++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            446799999999999999999987 57999999998653   23345678999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          738 VLEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      ||||+++++|.+++..   ....+++..++.++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++..
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999998864   344689999999999999999999   7899999999999999999999999999999866


Q ss_pred             CCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ..... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.............+           ....
T Consensus       187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------~~~~  254 (310)
T 2wqm_A          187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-----------EQCD  254 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH-----------HTTC
T ss_pred             cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh-----------hccc
Confidence            43322 22335689999999999988999999999999999999999999864321111111100           0000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhhcc
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIE  950 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~  950 (952)
                      ...      .....+++++.+++.+||+.||++|||+.||++.|++++...+...+
T Consensus       255 ~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~  304 (310)
T 2wqm_A          255 YPP------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE  304 (310)
T ss_dssp             SCC------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred             CCC------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence            000      01134577899999999999999999999999999999988765443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.2e-39  Score=358.40  Aligned_cols=246  Identities=22%  Similarity=0.265  Sum_probs=206.1

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            368999999999999999999984 69999999986542   23456788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+..... 
T Consensus       120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            99999999999997654 689999999999999999999   7899999999999999999999999999999876432 


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                         ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.           .+.....    
T Consensus       195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~-----------~i~~~~~----  255 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYE-----------KIVSGKV----  255 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH-----------HHHHCCC----
T ss_pred             ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHH-----------HHHcCCC----
Confidence               23356999999999999889999999999999999999999998642110 0011           1111110    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVN-----TKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~  937 (952)
                           ..+..++.++.+++.+||+.||++||+     +.||.++
T Consensus       256 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                 012345778999999999999999998     8888764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.9e-39  Score=351.45  Aligned_cols=270  Identities=24%  Similarity=0.377  Sum_probs=191.9

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ..++|++.+.||+|+||+||+|... +|+.||+|+++.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3468999999999999999999874 689999999875432 33467889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          740 EYMPKGSLEDCMYASN-----FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      ||++ |+|.+++....     ..+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC---HENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9997 59998886532     3589999999999999999999   7899999999999999999999999999999876


Q ss_pred             CCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cch----hhh
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSL----PAV  886 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~----~~~  886 (952)
                      ..... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .......   ...    +..
T Consensus       159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGGG
T ss_pred             CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhh
Confidence            43322 2234568999999998876 468999999999999999999999996532111 1111100   000    000


Q ss_pred             hhh--cccccc----ch-hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 MNI--MDTNLL----SE-DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 ~~~--~~~~~~----~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...  ......    .. ........+..++.++.+++.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            000  000000    00 0000111123457789999999999999999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=352.61  Aligned_cols=246  Identities=24%  Similarity=0.260  Sum_probs=197.5

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|++.++||+|+||+||+|++. +|+.||||++.....  .....+..|+..+.++ +||||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367999999999999999999985 799999998854332  2334455666666555 899999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+ +++|.+++...+..+++..+..++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++......
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL---HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            9999 7799998888777899999999999999999999   68899999999999999999999999999998764332


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                        ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...    .....+..           ...    
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~-----------~~~----  269 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQ-----------GYL----  269 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTT-----------TCC----
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhc-----------cCC----
Confidence              2233569999999998875 7899999999999999999997765331    11111110           000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ....+..+++++.+++.+||+.||++|||+.|++++
T Consensus       270 ---~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          270 ---PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence               011234567889999999999999999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-38  Score=353.43  Aligned_cols=276  Identities=22%  Similarity=0.330  Sum_probs=214.6

Q ss_pred             CHHHHHHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHh--CCCCccceeeeEeecC
Q 002214          655 SHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKT--IRHRNLVKIISSCTNH  732 (952)
Q Consensus       655 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~  732 (952)
                      +........++|.+.+.||+|+||.||+|++ +|+.||||++....   ...+.+|++++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3344455668899999999999999999998 68999999986432   3567889999988  7899999999999877


Q ss_pred             C----eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEeCCCCCCCeeeCCCCcE
Q 002214          733 N----FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF-----GHSNPIVHCDIKPSNVLLDDSMVA  803 (952)
Q Consensus       733 ~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~-----~h~~~ivH~Dlk~~Nill~~~~~~  803 (952)
                      .    ..++||||+++|+|.+++...  .+++.+++.++.|++.||+|||.     .|+++|+||||||+||+++.++.+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence            5    789999999999999999764  58999999999999999999941     118899999999999999999999


Q ss_pred             EEeccccccccCCcCcc---cccccccccccccccccCcC------CcCcccchHhHHHHHHHHHhC----------CCC
Q 002214          804 HLSDFGIAKLLSEEDSM---KQTQTLATIGYIAPEYGREG------QVSIKGDVYNYGIMLMEVFTG----------MKP  864 (952)
Q Consensus       804 kl~Dfgla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg----------~~p  864 (952)
                      ||+|||+++........   ......||+.|+|||++.+.      .++.++|||||||++|||++|          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            99999999876543322   22345699999999988765      344789999999999999999          667


Q ss_pred             CCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          865 TNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      |............+....       .........+.  ......+++.+.+++.+||+.||++|||+.||+++|+++.++
T Consensus       267 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVV-------CEQKLRPNIPN--RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHH-------TTSCCCCCCCG--GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccccCcCcccHHHHHHHH-------HHHHhCCCCcc--cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            655433322222221111       11111111110  011235678899999999999999999999999999999876


Q ss_pred             H
Q 002214          945 L  945 (952)
Q Consensus       945 ~  945 (952)
                      .
T Consensus       338 ~  338 (342)
T 1b6c_B          338 E  338 (342)
T ss_dssp             T
T ss_pred             h
Confidence            3

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.5e-40  Score=357.79  Aligned_cols=258  Identities=22%  Similarity=0.417  Sum_probs=198.3

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCe----
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNF----  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  734 (952)
                      .++|++.+.||+|+||.||+|++ .+++.||||+++...   ......+.+|+.++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999997 578999999997543   2334678899999999999999999999876543    


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .|+||||+++++|.+++.... .+++.+++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++..
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            499999999999999997654 689999999999999999999   7889999999999999999999999999999876


Q ss_pred             CCcCc--ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          815 SEEDS--MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       815 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                      .....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....            ....
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~------------~~~~  234 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ------------HVRE  234 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------------HHHC
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH------------HhcC
Confidence            54322  122335689999999999988999999999999999999999999865321111000            0000


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHH-HHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII-SRLIKI  941 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~-~~L~~i  941 (952)
                      ....     .......+++++.+++.+||+.||++||++.+++ +.+.++
T Consensus       235 ~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          235 DPIP-----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCCC-----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCC-----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            0000     0111234678899999999999999999766655 444433

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-39  Score=348.44  Aligned_cols=261  Identities=21%  Similarity=0.386  Sum_probs=209.5

Q ss_pred             cCCccceecCccceEEEEEEeC-C---CcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCee-EEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRFP-D---GIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFK-ALV  738 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  738 (952)
                      .|...+.||+|+||+||+|++. +   +..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            5667799999999999999862 2   33799999865433 3457789999999999999999999999766554 999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+.+|+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999987677899999999999999999999   78899999999999999999999999999998664432


Q ss_pred             c---ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          819 S---MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       819 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      .   .......+++.|+|||.+.+..++.++||||||+++|||++|..|+....... ......           .....
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~~~~-----------~~~~~  246 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLTHFL-----------AQGRR  246 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHHHHH-----------HTTCC
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHHHHh-----------hcCCC
Confidence            2   12223567899999999999999999999999999999999666643321111 111110           00000


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                             ...+..+++++.+++.+||+.||++|||+.|+++.|+++.+.+..
T Consensus       247 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          247 -------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             -------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence                   001234567899999999999999999999999999999887654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.2e-39  Score=361.67  Aligned_cols=272  Identities=18%  Similarity=0.300  Sum_probs=206.6

Q ss_pred             HhccCCccceecCc--cceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          662 ATDQFSEENLIGIG--SYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       662 ~~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      ..++|++.+.||+|  +||+||+|++. +|+.||||++....  ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            35689999999999  99999999985 69999999997553  334567889999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          737 LVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||.+....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999999987652 4699999999999999999999   78999999999999999999999999999987543


Q ss_pred             CcCc------ccccccccccccccccccCc--CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhh
Q 002214          816 EEDS------MKQTQTLATIGYIAPEYGRE--GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM  887 (952)
Q Consensus       816 ~~~~------~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  887 (952)
                      ....      .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||........ .........+...
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~  258 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLL  258 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH-HHHC---------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHhcCCCCccc
Confidence            2211      11122468999999999887  5789999999999999999999999976432221 1111111111000


Q ss_pred             hh--------------------ccccccc------hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          888 NI--------------------MDTNLLS------EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       888 ~~--------------------~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..                    .......      .........+..+++++.+++.+||+.||++|||+.|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            00                    0000000      00000011234567889999999999999999999999876

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-39  Score=355.19  Aligned_cols=259  Identities=25%  Similarity=0.462  Sum_probs=205.7

Q ss_pred             ccCCccceecCccceEEEEEEeCC-----CcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPD-----GIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .+|...+.||+|+||.||+|.+..     +..||||+++... ......+.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467788999999999999998632     3469999987543 3345678999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|+|.+++......+++.+++.++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            9999999999999987767899999999999999999999   7889999999999999999999999999999876543


Q ss_pred             Ccc--cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          818 DSM--KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       818 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ...  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......             +....+....
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------------~~~~~~~~~~  267 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------------EVMKAINDGF  267 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------------HHHHHHHTTC
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-------------HHHHHHHCCC
Confidence            221  1222346789999999988899999999999999999999 99998652211             0001110000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                      .       ...+..++.++.+++.+||+.||++||++.|++++|+++.+..
T Consensus       268 ~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          268 R-------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             C-------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             c-------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            0       0012346778999999999999999999999999999987654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=353.26  Aligned_cols=261  Identities=20%  Similarity=0.270  Sum_probs=208.4

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEee----cCCeeE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT----NHNFKA  736 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~  736 (952)
                      ..++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.++++++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            346899999999999999999997 579999999987766666778999999999999999999999986    335789


Q ss_pred             EEEEccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          737 LVLEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      +||||+++|+|.+++..   ....+++.+++.++.|+++||+||   |++||+||||||+||+++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI---HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999998876   345799999999999999999999   788999999999999999999999999999986


Q ss_pred             cCCcCcc--------cccccccccccccccccCcCC---cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccc
Q 002214          814 LSEEDSM--------KQTQTLATIGYIAPEYGREGQ---VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS  882 (952)
Q Consensus       814 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  882 (952)
                      .......        ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||................ 
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-  262 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-  262 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-
Confidence            5422111        011235799999999887543   6889999999999999999999986532221111111100 


Q ss_pred             hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                                ...       ...+..++.++.+++.+||+.||.+|||+.|++++|+++..
T Consensus       263 ----------~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          263 ----------QLS-------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             ----------C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             ----------cCC-------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                      000       00113456789999999999999999999999999988643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.9e-39  Score=355.30  Aligned_cols=249  Identities=22%  Similarity=0.308  Sum_probs=195.6

Q ss_pred             hccCCccceecCccceEEEEEEe----CCCcEEEEEEeeccC----chhhHHHHHHHHHHHhCCCCccceeeeEeecCCe
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF----PDGIEVAIKVFHLQR----EGALNSFDAECEILKTIRHRNLVKIISSCTNHNF  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  734 (952)
                      .++|++.+.||+|+||.||+|+.    .+|+.||+|+++...    ......+.+|+.++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999987    478999999986542    2234567899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .|+||||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHL---HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHH---HhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999987654 689999999999999999999   7889999999999999999999999999999864


Q ss_pred             CCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ...           .+.....
T Consensus       172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~-----------~i~~~~~  238 (327)
T 3a62_A          172 IHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TID-----------KILKCKL  238 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHH-----------HHHHTCC
T ss_pred             ccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHH-----------HHHhCCC
Confidence            33221 2234569999999999998889999999999999999999999986521110 000           0110000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                               ..+..+++++.+++.+||..||++||     ++.|++++
T Consensus       239 ---------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          239 ---------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ---------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                     01234567899999999999999999     77788764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.9e-39  Score=352.47  Aligned_cols=267  Identities=19%  Similarity=0.269  Sum_probs=202.2

Q ss_pred             hccCCcc-ceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEE
Q 002214          663 TDQFSEE-NLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       663 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .+.|.+. +.||+|+||+||+|+. .+++.||||++........+.+.+|++++.++ +||||+++++++.+++..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567774 7899999999999987 47899999999766555567899999999995 7999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc---EEEeccccccccCC
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV---AHLSDFGIAKLLSE  816 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgla~~~~~  816 (952)
                      ||+++|+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.   +||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFL---HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999997654 689999999999999999999   7889999999999999998776   99999999986542


Q ss_pred             cCc------ccccccccccccccccccCc-----CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc--cch
Q 002214          817 EDS------MKQTQTLATIGYIAPEYGRE-----GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN--DSL  883 (952)
Q Consensus       817 ~~~------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~  883 (952)
                      ...      .......||+.|+|||++..     ..++.++|||||||++|||++|+.||......+..+.....  ...
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            221      11123459999999998864     56889999999999999999999999764433221111000  000


Q ss_pred             hhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ......+........    ......++.++.+++.+||+.||++|||+.|++++
T Consensus       247 ~~~~~~i~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          247 NMLFESIQEGKYEFP----DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHCCCCCC----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHhccCcccC----chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            001111111100000    01123467789999999999999999999999874

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.2e-39  Score=358.41  Aligned_cols=250  Identities=20%  Similarity=0.272  Sum_probs=204.9

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  736 (952)
                      ..++|++.+.||+|+||.||+|+.. +|+.||||+++...   ....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4578999999999999999999985 48899999987542   23456788999999988 8999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+++|+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999987654 699999999999999999999   789999999999999999999999999999986432


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.           .+.....  
T Consensus       174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~-----------~i~~~~~--  238 (353)
T 2i0e_A          174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQ-----------SIMEHNV--  238 (353)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH-----------HHHHCCC--
T ss_pred             CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-HHHH-----------HHHhCCC--
Confidence            22 2233467999999999999999999999999999999999999998652110 0011           1111111  


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVN-----TKEIISR  937 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~  937 (952)
                             ..+..++.++.+++.+||..||++||+     +.|+.++
T Consensus       239 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          239 -------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             -------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                   012345778999999999999999995     5777654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.5e-39  Score=350.94  Aligned_cols=263  Identities=22%  Similarity=0.412  Sum_probs=202.3

Q ss_pred             HHHhccCCccceecCccceEEEEEEeC----CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCC
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHN  733 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  733 (952)
                      ....++|.+.+.||+|+||.||+|+..    +++.||||+++...  ....+.+.+|+.++++++||||+++++++.+.+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            345678999999999999999999763    35689999986543  334567899999999999999999999997754


Q ss_pred             -----eeEEEEEccCCCChhHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcE
Q 002214          734 -----FKALVLEYMPKGSLEDCMYA-----SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVA  803 (952)
Q Consensus       734 -----~~~lv~e~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~  803 (952)
                           ..++||||+++|+|.+++..     ....+++..++.++.|+++||+||   |++||+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCcE
Confidence                 35999999999999998853     234699999999999999999999   78999999999999999999999


Q ss_pred             EEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhcc
Q 002214          804 HLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIND  881 (952)
Q Consensus       804 kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  881 (952)
                      ||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ .....   
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~---  262 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-MYDYL---  262 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHH---
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHH---
Confidence            999999998765433222 223457889999999998899999999999999999999 888886532111 00000   


Q ss_pred             chhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          882 SLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                              .....        ...+..+++++.+++.+||+.||++|||+.|++++|+++.+++
T Consensus       263 --------~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          263 --------LHGHR--------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             --------HTTCC--------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --------HcCCC--------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                    00000        0112346778999999999999999999999999999998765

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=360.84  Aligned_cols=266  Identities=14%  Similarity=0.153  Sum_probs=209.9

Q ss_pred             hccCCccceecCccceEEEEEEeCC---------CcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccce---------
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD---------GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK---------  724 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  724 (952)
                      .++|.+.+.||+|+||.||+|++..         ++.||||++...     +.+.+|++++++++|||+++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999998853         789999998643     45789999999999999998         


Q ss_pred             ------eeeEeec-CCeeEEEEEccCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCee
Q 002214          725 ------IISSCTN-HNFKALVLEYMPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVL  796 (952)
Q Consensus       725 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nil  796 (952)
                            +++++.. ++..++||||+ +++|.+++... ...+++.+++.++.|++.||+||   |++||+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL---HENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHHHEE
Confidence                  5667665 67889999999 99999999865 34799999999999999999999   7889999999999999


Q ss_pred             eCCCC--cEEEeccccccccCCcCcc------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCcc
Q 002214          797 LDDSM--VAHLSDFGIAKLLSEEDSM------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEF  868 (952)
Q Consensus       797 l~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  868 (952)
                      ++.++  .+||+|||+|+.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999876543221      112347999999999999989999999999999999999999999764


Q ss_pred             ccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          869 FTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                      ......................+...          ....+++++.+++.+||+.||++||++.|+++.|+++.++...
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCG----------HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTS----------CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhcc----------ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            32222222111110000000000000          0123467899999999999999999999999999999887643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=357.69  Aligned_cols=274  Identities=24%  Similarity=0.344  Sum_probs=200.6

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHH--HHhCCCCccceeeeEeec-----CCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEI--LKTIRHRNLVKIISSCTN-----HNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~  735 (952)
                      .++|++.+.||+|+||.||+|+. +++.||||++.....   ..+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46899999999999999999987 789999999865432   334445555  445899999999985532     3366


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeEeCCCCCCCeeeCCCCcEEEe
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN---------PIVHCDIKPSNVLLDDSMVAHLS  806 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~---------~ivH~Dlk~~Nill~~~~~~kl~  806 (952)
                      ++||||+++|+|.+++....  .++..+..++.|+++||+||   |+.         ||+||||||+||+++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~L---H~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYL---HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHH---HCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHH---HhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999997654  58999999999999999999   566         99999999999999999999999


Q ss_pred             ccccccccCCcCc-------ccccccccccccccccccCc-------CCcCcccchHhHHHHHHHHHhCCCCCCccccCc
Q 002214          807 DFGIAKLLSEEDS-------MKQTQTLATIGYIAPEYGRE-------GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE  872 (952)
Q Consensus       807 Dfgla~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  872 (952)
                      |||+|+.+.....       .......||+.|+|||++.+       ..++.++|||||||++|||++|..||.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            9999987653321       11223569999999998876       456788999999999999999988764322211


Q ss_pred             cchhhhh---c--cchhhhhhhccccc-cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHh
Q 002214          873 MSIKRWI---N--DSLPAVMNIMDTNL-LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       873 ~~~~~~~---~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~  946 (952)
                      .....+.   .  .........+.... ....+. .......+++++.+++.+||+.||++|||++|+++.|+++.+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE-AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT-TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCc-ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            1111100   0  00001111111000 000000 000123367789999999999999999999999999999987654

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=6.1e-38  Score=359.50  Aligned_cols=363  Identities=19%  Similarity=0.205  Sum_probs=249.3

Q ss_pred             cccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCccc
Q 002214           46 AGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASI  125 (952)
Q Consensus        46 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~  125 (952)
                      .+..+..++.+++|++|++++|.+++ +| .++.+++|++|+|++|++++ +|  ++++++|++|+|++|++++ +|   
T Consensus        31 ~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~---  101 (457)
T 3bz5_A           31 QATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD---  101 (457)
T ss_dssp             CTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC---
T ss_pred             CcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee---
Confidence            33445566777777777777777774 45 57777777777777777774 33  6777777777777777662 11   


Q ss_pred             ccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCc
Q 002214          126 FNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKL  205 (952)
Q Consensus       126 ~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  205 (952)
                                               +..+++|++|++++|++++ +|  +..+++|+.|++++|++++. +  ++.+++|
T Consensus       102 -------------------------~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L  150 (457)
T 3bz5_A          102 -------------------------VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQL  150 (457)
T ss_dssp             -------------------------CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTC
T ss_pred             -------------------------cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcC
Confidence                                     2345667777777777664 33  66667777777777777653 2  6666777


Q ss_pred             cEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcc
Q 002214          206 KSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLG  285 (952)
Q Consensus       206 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~  285 (952)
                      ++|++++|...+.+  .++.+++|+.|++++|++.++ |  +..+++|+.|++++|++++.     .+..+++|++|+++
T Consensus       151 ~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~-----~l~~l~~L~~L~Ls  220 (457)
T 3bz5_A          151 TELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL-----DLNQNIQLTFLDCS  220 (457)
T ss_dssp             CEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC-----CCTTCTTCSEEECC
T ss_pred             CEEECCCCCccccc--ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee-----ccccCCCCCEEECc
Confidence            77777777443333  356666666666666666664 2  55666667777777666643     25556666666666


Q ss_pred             cCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCC
Q 002214          286 LNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGS  365 (952)
Q Consensus       286 ~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~  365 (952)
                      +|+++++ |                                                   ++.+++|+.|++++|++++.
T Consensus       221 ~N~l~~i-p---------------------------------------------------~~~l~~L~~L~l~~N~l~~~  248 (457)
T 3bz5_A          221 SNKLTEI-D---------------------------------------------------VTPLTQLTYFDCSVNPLTEL  248 (457)
T ss_dssp             SSCCSCC-C---------------------------------------------------CTTCTTCSEEECCSSCCSCC
T ss_pred             CCccccc-C---------------------------------------------------ccccCCCCEEEeeCCcCCCc
Confidence            6666642 2                                                   23455677777777777754


Q ss_pred             CCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCC
Q 002214          366 LPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNL  445 (952)
Q Consensus       366 ~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  445 (952)
                      .   +..+++|+.|++++|.              |+.|++++|.+.+.+|  ++.+++|+.|++++|.+.+.+|.   ..
T Consensus       249 ~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~  306 (457)
T 3bz5_A          249 D---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QA  306 (457)
T ss_dssp             C---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TT
T ss_pred             C---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CC
Confidence            3   3456667777776654              3456677777666665  46778888888888887766553   34


Q ss_pred             CCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeC
Q 002214          446 EDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDL  525 (952)
Q Consensus       446 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  525 (952)
                      ++|+.|++++|             ++|+.|++++|++++.   .+..+++|+.|++++|+|++        ++.|..|++
T Consensus       307 ~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l  362 (457)
T 3bz5_A          307 AGITELDLSQN-------------PKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPA  362 (457)
T ss_dssp             CCCSCCCCTTC-------------TTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSG
T ss_pred             CcceEechhhc-------------ccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccc
Confidence            56666666555             6789999999999974   38899999999999999985        256777889


Q ss_pred             CCCcccccCccchhcccccccccccccccccCCCCC
Q 002214          526 SNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG  561 (952)
Q Consensus       526 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  561 (952)
                      ++|.+++.     ..+..|..+++++|+++|.+|..
T Consensus       363 ~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          363 LNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             GGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             cCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence            99999875     35678889999999999999963

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.6e-39  Score=357.60  Aligned_cols=253  Identities=23%  Similarity=0.287  Sum_probs=195.2

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|++.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999985 789999999865432 236788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc--EEEeccccccccCCcCc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV--AHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgla~~~~~~~~  819 (952)
                      +++|+|.+++...+ .+++..+..++.|+++||+||   |++||+||||||+||+++.++.  +||+|||+|+...... 
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~L---H~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-  172 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYC---HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  172 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence            99999999887654 699999999999999999999   7899999999999999987765  9999999998543222 


Q ss_pred             ccccccccccccccccccCcCCcCcc-cchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIK-GDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                       ......||+.|+|||++.+..++.+ +||||+||++|||++|+.||....... .+.....       .......... 
T Consensus       173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~-------~~~~~~~~~~-  242 (361)
T 3uc3_A          173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQ-------RILSVKYSIP-  242 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHH-------HHHTTCCCCC-
T ss_pred             -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHH-------HHhcCCCCCC-
Confidence             2233569999999999887777555 899999999999999999996532211 1111111       0010000000 


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                            ....+++++.+++.+||+.||++|||+.|++++
T Consensus       243 ------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          243 ------DDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                  011346789999999999999999999999876

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.4e-39  Score=345.20  Aligned_cols=250  Identities=23%  Similarity=0.395  Sum_probs=187.3

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|.+.+.||+|+||.||+|+. .+|+.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46799999999999999999987 579999999986442   22346789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++++|.+++......+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL---HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            999999999999987766799999999999999999999   78899999999999999999999999999998764332


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      . ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||....... .....           .....    
T Consensus       167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~-----------~~~~~----  229 (278)
T 3cok_A          167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-TLNKV-----------VLADY----  229 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------C-----------CSSCC----
T ss_pred             C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-HHHHH-----------hhccc----
Confidence            2 2223568999999999998889999999999999999999999986532111 00000           00000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..+..++.++.+++.+||+.||++|||+.|++++
T Consensus       230 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          230 -----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                 0122356779999999999999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.2e-40  Score=360.67  Aligned_cols=271  Identities=23%  Similarity=0.406  Sum_probs=217.4

Q ss_pred             cCHHHHHHHhccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceee
Q 002214          654 YSHDELLRATDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKII  726 (952)
Q Consensus       654 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~  726 (952)
                      +..+++....++|++.+.||+|+||.||+|++.      +++.||||++..... .....+.+|+.++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            344455566789999999999999999999764      378899999865433 3345788999999999999999999


Q ss_pred             eEeecCCeeEEEEEccCCCChhHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee
Q 002214          727 SSCTNHNFKALVLEYMPKGSLEDCMYASN---------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL  797 (952)
Q Consensus       727 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill  797 (952)
                      +++.+.+..++||||+++|+|.+++....         ..+++..++.++.|++.||+||   |++||+||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCCccCCCccceEEE
Confidence            99999999999999999999999987532         3578999999999999999999   78899999999999999


Q ss_pred             CCCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccch
Q 002214          798 DDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSI  875 (952)
Q Consensus       798 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~  875 (952)
                      +.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......  ..
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~  249 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QV  249 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HH
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HH
Confidence            99999999999999866443322 2223457889999999988889999999999999999999 88888652111  00


Q ss_pred             hhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          876 KRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                      ..          ........        ..+..++.++.+++.+||+.||++|||+.|++++|+++.+....
T Consensus       250 ~~----------~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~  303 (322)
T 1p4o_A          250 LR----------FVMEGGLL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  303 (322)
T ss_dssp             HH----------HHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             HH----------HHHcCCcC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCc
Confidence            00          00111110        01234677899999999999999999999999999887554433

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1e-38  Score=342.92  Aligned_cols=252  Identities=23%  Similarity=0.312  Sum_probs=207.4

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3467999999999999999999884 578999999977655556789999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee---CCCCcEEEeccccccccCCc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgla~~~~~~  817 (952)
                      |+++++|.+++.... .+++..+..++.|++.|++||   |++||+||||||+||++   +.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           87 LCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYC---HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             ccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            999999999887654 589999999999999999999   78999999999999999   78899999999999876543


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      ..  .....+|+.|+|||.+.+ .++.++||||||+++|||++|+.||......+ ....           .........
T Consensus       163 ~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~-----------~~~~~~~~~  227 (277)
T 3f3z_A          163 KM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLK-----------IREGTFTFP  227 (277)
T ss_dssp             SC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH-----------HHHCCCCCC
T ss_pred             cc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHH-----------HHhCCCCCC
Confidence            32  233569999999998865 48999999999999999999999986532111 0000           111111000


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .     .....+++++.+++.+||+.||++|||+.|++++
T Consensus       228 ~-----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          228 E-----KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             H-----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             c-----hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0     0112457789999999999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=360.53  Aligned_cols=264  Identities=17%  Similarity=0.182  Sum_probs=201.8

Q ss_pred             hccCCccceecCccceEEEEEEeC----CCcEEEEEEeeccCch-----------hhHHHHHHHHHHHhCCCCccceeee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQREG-----------ALNSFDAECEILKTIRHRNLVKIIS  727 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  727 (952)
                      .++|.+.+.||+|+||.||+|.+.    ++..||||+.......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467999999999999999999985    5788999998754321           1234668889999999999999999


Q ss_pred             Eeec----CCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC--
Q 002214          728 SCTN----HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM--  801 (952)
Q Consensus       728 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~--  801 (952)
                      ++..    ....++||||+ +++|.+++...+ .+++.+++.++.|++.||+||   |++||+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYI---HENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCcCHHHEEEccCCCC
Confidence            9887    67899999999 999999987665 799999999999999999999   788999999999999998887  


Q ss_pred             cEEEeccccccccCCcCcc------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccch
Q 002214          802 VAHLSDFGIAKLLSEEDSM------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI  875 (952)
Q Consensus       802 ~~kl~Dfgla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  875 (952)
                      .+||+|||+|+.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999876533211      1133569999999999998889999999999999999999999996532222211


Q ss_pred             hhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          876 KRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      ........+.....        ..  .......+++++.+++.+||+.||++||++.+|++.|+++
T Consensus       271 ~~~~~~~~~~~~~~--------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          271 QTAKTNLLDELPQS--------VL--KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHTTTHH--------HH--HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHhhcccccHH--------HH--hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            11111111000000        00  0000115678899999999999999999999999999764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-38  Score=347.98  Aligned_cols=261  Identities=19%  Similarity=0.251  Sum_probs=201.9

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+.++++++||||+++++++..++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999974 68999999986542   2234678999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++++|.+++.... .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||++......
T Consensus       112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAA---HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999999987654 689999999999999999999   7889999999999999999999999999999876544


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      .........+++.|+|||.+.+..++.++||||||+++|||++|+.||......  ....           .+...... 
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~-----------~~~~~~~~-  253 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGA-----------HINQAIPR-  253 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHH-----------HHHSCCCC-
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHH-----------HhccCCCC-
Confidence            333334467999999999999889999999999999999999999998652111  0000           00000000 


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRV-NTKEIISRLIKIRDL  944 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~~i~~~  944 (952)
                          ....+..++.++.+++.+||+.||++|| +++++++.|++..+.
T Consensus       254 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          254 ----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             ----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             ----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence                0012345677899999999999999999 999999999876443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4e-39  Score=369.05  Aligned_cols=248  Identities=26%  Similarity=0.428  Sum_probs=206.3

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            357999999999999999999985 79999999986542   22346789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++|+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999987543 699999999999999999999   78999999999999999999999999999998765432


Q ss_pred             cccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      .  ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... ....           .+.+...   
T Consensus       171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~-----------~i~~~~~---  233 (476)
T 2y94_A          171 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-TLFK-----------KICDGIF---  233 (476)
T ss_dssp             C--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-HHHH-----------HHHTTCC---
T ss_pred             c--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-HHHH-----------HHhcCCc---
Confidence            2  234579999999999887765 68999999999999999999998652111 0001           1111110   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                            ..+..+++++.+++.+||..||++|||+.|++++
T Consensus       234 ------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          234 ------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                  0123356789999999999999999999999874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=354.57  Aligned_cols=258  Identities=24%  Similarity=0.406  Sum_probs=203.5

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcE----EEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIE----VAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      .++|++.+.||+|+||+||+|++. +++.    ||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            357999999999999999999873 4543    577766433 3344578999999999999999999999998765 78


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +|+||+++|+|.+++......+++..++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            99999999999999988777899999999999999999999   788999999999999999999999999999987654


Q ss_pred             cCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          817 EDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       817 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      .... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+  ....           +....
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~-----------~~~~~  236 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI-----------LEKGE  236 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH-----------HHTTC
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHH-----------HHcCC
Confidence            3221 2223457889999999999999999999999999999999 999986532211  1111           11110


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      .       ...+..++.++.+++.+||+.||++||++.|+++.|+++.+.
T Consensus       237 ~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          237 R-------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             C-------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             C-------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            0       001234577899999999999999999999999999998754

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.9e-39  Score=356.05  Aligned_cols=266  Identities=21%  Similarity=0.358  Sum_probs=214.7

Q ss_pred             HHHhccCCccceecCccceEEEEEEeCC------CcEEEEEEeeccCc-hhhHHHHHHHHHHHhC-CCCccceeeeEeec
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRFPD------GIEVAIKVFHLQRE-GALNSFDAECEILKTI-RHRNLVKIISSCTN  731 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  731 (952)
                      ....++|.+.+.||+|+||.||+|.+..      ++.||+|++..... ...+.+.+|+.+++++ +||||+++++++..
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3446789999999999999999998732      34899999875532 3456789999999999 89999999999999


Q ss_pred             CCeeEEEEEccCCCChhHHhhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC
Q 002214          732 HNFKALVLEYMPKGSLEDCMYAS-------------NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD  798 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~  798 (952)
                      .+..++||||+++|+|.+++...             ...+++..++.++.|++.||+||   |++||+||||||+||+++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCcccceEEEC
Confidence            99999999999999999998653             23579999999999999999999   788999999999999999


Q ss_pred             CCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchh
Q 002214          799 DSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIK  876 (952)
Q Consensus       799 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~  876 (952)
                      .++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||........ ..
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~  277 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FY  277 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HH
Confidence            9999999999999865433222 2223457889999999988899999999999999999999 8999865322111 11


Q ss_pred             hhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                      ..           +......       ..+..+++++.+++.+||+.||++|||+.|++++|+++......
T Consensus       278 ~~-----------~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  330 (333)
T 2i1m_A          278 KL-----------VKDGYQM-------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR  330 (333)
T ss_dssp             HH-----------HHHTCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             HH-----------HhcCCCC-------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence            11           0000000       01233567899999999999999999999999999998776544

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.2e-39  Score=350.85  Aligned_cols=252  Identities=21%  Similarity=0.329  Sum_probs=207.1

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCch------hhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREG------ALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      .++|++.+.||+|+||.||+|++. +|+.||||++......      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999985 6899999998654321      356789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC----cEEEeccccc
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM----VAHLSDFGIA  811 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgla  811 (952)
                      ++||||+++++|.+++... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~l---H~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            9999999999999998754 3689999999999999999999   788999999999999999888    7999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      +.......  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ...           .+..
T Consensus       167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~-----------~i~~  232 (321)
T 2a2a_A          167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA-----------NITS  232 (321)
T ss_dssp             EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH-----------HHHT
T ss_pred             eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-HHH-----------HHHh
Confidence            87654322  234569999999999998899999999999999999999999986521110 000           0000


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ... ..    .......++.++.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~-~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          233 VSY-DF----DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             TCC-CC----CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ccc-cc----ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000 00    011123457789999999999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=354.98  Aligned_cols=243  Identities=23%  Similarity=0.333  Sum_probs=204.0

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc--------hhhHHHHHHHHHHHhCCCCccceeeeEeecC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE--------GALNSFDAECEILKTIRHRNLVKIISSCTNH  732 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  732 (952)
                      ..++|++.+.||+|+||.||+|++ .+++.||||+++....        .....+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999986 5689999999875431        1234677899999999999999999999999


Q ss_pred             CeeEEEEEccCCC-ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccc
Q 002214          733 NFKALVLEYMPKG-SLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA  811 (952)
Q Consensus       733 ~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  811 (952)
                      +..++||||+.+| +|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYL---RLKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999887654 699999999999999999999   7889999999999999999999999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      +.......  .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......                  .
T Consensus       178 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------~  237 (335)
T 3dls_A          178 AYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------V  237 (335)
T ss_dssp             EECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------T
T ss_pred             eECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------H
Confidence            87654332  233569999999999887776 88999999999999999999998652110                  0


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....         ..+..+++++.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~---------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 EAAI---------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             TTCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hhcc---------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000         0112246779999999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-39  Score=381.62  Aligned_cols=260  Identities=23%  Similarity=0.389  Sum_probs=208.4

Q ss_pred             cCCccc-eecCccceEEEEEEeC---CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          665 QFSEEN-LIGIGSYGSVYKGRFP---DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       665 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++|||||++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999763   56789999997543 3346789999999999999999999999976 5689999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++......+++..+..++.||+.||+||   |+++|+||||||+|||++.++.+||+|||+|+.......
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            99999999999987777799999999999999999999   789999999999999999999999999999987654332


Q ss_pred             cc--ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          820 MK--QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       820 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      ..  .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+  ..           ..+....  
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~-----------~~i~~~~--  556 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM-----------AFIEQGK--  556 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HH-----------HHHHTTC--
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HH-----------HHHHcCC--
Confidence            21  122346789999999998899999999999999999998 999986532211  11           1111110  


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFAN  948 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~  948 (952)
                           ....+..+++++.++|.+||+.||++||++.+|++.|+.+.......
T Consensus       557 -----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~  603 (613)
T 2ozo_A          557 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  603 (613)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred             -----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence                 01123457889999999999999999999999999999998776543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=355.40  Aligned_cols=254  Identities=16%  Similarity=0.144  Sum_probs=207.3

Q ss_pred             HhccCCccceecCccceEEEEEE------eCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC---CCccceeeeEeecC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGR------FPDGIEVAIKVFHLQREGALNSFDAECEILKTIR---HRNLVKIISSCTNH  732 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  732 (952)
                      ..++|.+.+.||+|+||+||+|.      ..+++.||||+++...   ...+.+|++++++++   |+|++++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35679999999999999999994      3468999999986543   356788888888887   99999999999999


Q ss_pred             CeeEEEEEccCCCChhHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC---------
Q 002214          733 NFKALVLEYMPKGSLEDCMYA----SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD---------  799 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~---------  799 (952)
                      +..++||||+++|+|.+++..    ....+++..++.++.|+++||+||   |++||+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV---HDCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999975    344699999999999999999999   7899999999999999998         


Q ss_pred             --CCcEEEeccccccccCCc-CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchh
Q 002214          800 --SMVAHLSDFGIAKLLSEE-DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK  876 (952)
Q Consensus       800 --~~~~kl~Dfgla~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  876 (952)
                        ++.+||+|||+|+.+... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.....+.....
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  296 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE  296 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEEC
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeec
Confidence              899999999999765321 22233446799999999999999999999999999999999999999855322211100


Q ss_pred             hhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCC-CCHHHHHHHHHHHHHHHh
Q 002214          877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENR-VNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~ev~~~L~~i~~~~~  946 (952)
                      .               .. ..         ...++.+.+++..|++.+|.+| |+++++.+.|+++.....
T Consensus       297 ~---------------~~-~~---------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~  342 (365)
T 3e7e_A          297 G---------------LF-RR---------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY  342 (365)
T ss_dssp             S---------------CC-TT---------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             h---------------hc-cc---------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence            0               00 00         0124567889999999999998 578888888888766643

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.2e-37  Score=358.07  Aligned_cols=300  Identities=30%  Similarity=0.444  Sum_probs=133.1

Q ss_pred             CCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEee
Q 002214          154 LPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILG  233 (952)
Q Consensus       154 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  233 (952)
                      +++|++|++++|++++..+  +..+++|++|++++|++++..+  +..+++|++|++++|.+.+ ++ .+..+++|+.|+
T Consensus        89 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~  162 (466)
T 1o6v_A           89 LTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLS  162 (466)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEE
T ss_pred             cccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEee
Confidence            3445555555555543222  5555555555555555553322  5555555555555555553 22 355555555555


Q ss_pred             eccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCc
Q 002214          234 IDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSN  313 (952)
Q Consensus       234 L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~  313 (952)
                      ++ |++....+  +.++++|++|++++|.+.+.    ..+..+++|++|++++|.+.+..+                   
T Consensus       163 l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~~----~~l~~l~~L~~L~l~~n~l~~~~~-------------------  216 (466)
T 1o6v_A          163 FG-NQVTDLKP--LANLTTLERLDISSNKVSDI----SVLAKLTNLESLIATNNQISDITP-------------------  216 (466)
T ss_dssp             EE-ESCCCCGG--GTTCTTCCEEECCSSCCCCC----GGGGGCTTCSEEECCSSCCCCCGG-------------------
T ss_pred             cC-CcccCchh--hccCCCCCEEECcCCcCCCC----hhhccCCCCCEEEecCCccccccc-------------------
Confidence            54 23332211  44455555555555554421    113344444444444444442211                   


Q ss_pred             cccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCcc
Q 002214          314 LKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE  393 (952)
Q Consensus       314 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~  393 (952)
                                                      ++.+++|++|++++|++++.  ..+..+++|++|++++|.+.+..+  
T Consensus       217 --------------------------------~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--  260 (466)
T 1o6v_A          217 --------------------------------LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--  260 (466)
T ss_dssp             --------------------------------GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred             --------------------------------ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--
Confidence                                            12233444555555554432  234444555555555555443322  


Q ss_pred             ccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccc
Q 002214          394 FCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVV  473 (952)
Q Consensus       394 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  473 (952)
                      +..+++|+.|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|+.|++++|++++..|  +..+++|+
T Consensus       261 ~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~  334 (466)
T 1o6v_A          261 LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQ  334 (466)
T ss_dssp             GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCC
T ss_pred             hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCC
Confidence            4444444444444444443222  3444444444444444443322  3444444444444444443322  33444444


Q ss_pred             eeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCccc
Q 002214          474 DIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLS  531 (952)
Q Consensus       474 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  531 (952)
                      .|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|+++
T Consensus       335 ~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~  388 (466)
T 1o6v_A          335 RLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT  388 (466)
T ss_dssp             EEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred             EeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence            444444444432  234444444444444444443333  444444444444444444

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-39  Score=349.25  Aligned_cols=269  Identities=23%  Similarity=0.329  Sum_probs=202.0

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc-----hhhHHHHHHHHHHHhCC---CCccceeeeEeecC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE-----GALNSFDAECEILKTIR---HRNLVKIISSCTNH  732 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  732 (952)
                      ..++|++.+.||+|+||+||+|++ .+|+.||||++.....     .....+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999997 5789999999864331     12346778888887774   99999999999765


Q ss_pred             C-----eeEEEEEccCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEe
Q 002214          733 N-----FKALVLEYMPKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLS  806 (952)
Q Consensus       733 ~-----~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~  806 (952)
                      .     ..++||||++ |+|.+++..... .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5789999996 599998876543 489999999999999999999   78999999999999999999999999


Q ss_pred             ccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc---ch
Q 002214          807 DFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND---SL  883 (952)
Q Consensus       807 Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~~  883 (952)
                      |||+|+......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ...+....   ..
T Consensus       163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~  239 (308)
T 3g33_A          163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPP  239 (308)
T ss_dssp             SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred             eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence            999998764332  2234578999999999988899999999999999999999999986532111 11111100   00


Q ss_pred             h-hhh---hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          884 P-AVM---NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       884 ~-~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      + ...   .....................+++++.+++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            0 000   00000000000000111234567889999999999999999999999875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=357.85  Aligned_cols=251  Identities=22%  Similarity=0.365  Sum_probs=198.3

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCC--CccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRH--RNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|+.++++++|  |||+++++++..++..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            45799999999999999999999889999999986543  3345678999999999976  9999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      ||+ .+++|.+++.... .+++.++..++.|+++||+||   |++||+||||||+||+++ ++.+||+|||+|+......
T Consensus        88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            995 5889999997654 689999999999999999999   788999999999999997 6789999999998765433


Q ss_pred             cc-cccccccccccccccccCc-----------CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhh
Q 002214          819 SM-KQTQTLATIGYIAPEYGRE-----------GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV  886 (952)
Q Consensus       819 ~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  886 (952)
                      .. ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........           .
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----------~  230 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----------L  230 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----------H
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-----------H
Confidence            22 2234579999999998754           67889999999999999999999998653221111           1


Q ss_pred             hhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...++......       .+..++.++.+++.+||+.||++|||+.|++++
T Consensus       231 ~~~~~~~~~~~-------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          231 HAIIDPNHEIE-------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHCTTSCCC-------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhcCCcccC-------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            11111111111       112335678999999999999999999999876

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-39  Score=356.35  Aligned_cols=260  Identities=23%  Similarity=0.332  Sum_probs=203.4

Q ss_pred             HHHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc-----CchhhHHHHHHHHHHHhCCCCccceeeeEeec
Q 002214          658 ELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-----REGALNSFDAECEILKTIRHRNLVKIISSCTN  731 (952)
Q Consensus       658 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  731 (952)
                      ++....++|++.+.||+|+||+||+|.+ .+++.||+|++...     .....+.+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3456778999999999999999999987 46889999998643     23445789999999999999999999999999


Q ss_pred             CCeeEEEEEccCCCChhHHhhhc---------------------------------------CCCCCHHHHHHHHHHHHH
Q 002214          732 HNFKALVLEYMPKGSLEDCMYAS---------------------------------------NFNLDIFQRLGIMIDVAS  772 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~  772 (952)
                      .+..++||||+++|+|.+++...                                       ...+++..+..++.|+++
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999988521                                       112356778899999999


Q ss_pred             HHHHHHhcCCCCeEeCCCCCCCeeeCCCC--cEEEeccccccccCCcC---cccccccccccccccccccCc--CCcCcc
Q 002214          773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSM--VAHLSDFGIAKLLSEED---SMKQTQTLATIGYIAPEYGRE--GQVSIK  845 (952)
Q Consensus       773 ~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~--~~kl~Dfgla~~~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~  845 (952)
                      ||+||   |++||+||||||+||+++.++  .+||+|||+|+.+....   ........||+.|+|||++.+  ..++.+
T Consensus       180 ~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYL---HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHH---HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHH---HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999   788999999999999998776  89999999998654322   122334679999999998865  678899


Q ss_pred             cchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCC
Q 002214          846 GDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESP  925 (952)
Q Consensus       846 ~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  925 (952)
                      +|||||||++|||++|+.||......+ ..           ............+     ....+++++.+++.+||+.||
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~-~~-----------~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDAD-TI-----------SQVLNKKLCFENP-----NYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHH-HH-----------HHHHHCCCCTTSG-----GGGGSCHHHHHHHHHHSCSCT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHH-HH-----------HHHHhcccccCCc-----ccccCCHHHHHHHHHHcCCCh
Confidence            999999999999999999986532111 11           1111111111110     112357789999999999999


Q ss_pred             CCCCCHHHHHHH
Q 002214          926 ENRVNTKEIISR  937 (952)
Q Consensus       926 ~~RPs~~ev~~~  937 (952)
                      ++||++.|++++
T Consensus       320 ~~Rps~~~~l~h  331 (345)
T 3hko_A          320 DERFDAMRALQH  331 (345)
T ss_dssp             TTSCCHHHHHHS
T ss_pred             hHCCCHHHHhcC
Confidence            999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.3e-39  Score=345.42  Aligned_cols=248  Identities=24%  Similarity=0.393  Sum_probs=202.7

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      +.++|++.+.||+|+||+||+|.+. +++.||||++....   ......+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3568999999999999999999874 57899999986432   2234678899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|+|.+++.... .+++..+..++.|++.|++||   |++||+||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            999999999999887654 689999999999999999999   7899999999999999999999999999998754322


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                         ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+ ....        ... ..      
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~--------~~~-~~------  223 (279)
T 3fdn_A          163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKR--------ISR-VE------  223 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH--------HHH-TC------
T ss_pred             ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-HHHH--------HHh-CC------
Confidence               2233568999999999998899999999999999999999999986421110 0000        000 00      


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ...+..+++++.+++.+||+.||++|||+.|++++
T Consensus       224 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 -----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 00123356789999999999999999999999986

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.6e-37  Score=357.52  Aligned_cols=348  Identities=27%  Similarity=0.389  Sum_probs=263.2

Q ss_pred             cCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCccccccccccc
Q 002214           54 GNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIST  133 (952)
Q Consensus        54 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~  133 (952)
                      ..+++++.|++++|.+. .+|. +..+++|++|+|++|.+.+ +|. ++++++|++|++++|.+++..|           
T Consensus        43 ~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~-----------  107 (466)
T 1o6v_A           43 TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITP-----------  107 (466)
T ss_dssp             HHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-----------
T ss_pred             hHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCC-chh-hhccccCCEEECCCCccccChh-----------
Confidence            34667778888888777 4553 7777888888888888774 343 7778888888888877762221           


Q ss_pred             ceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCC
Q 002214          134 ALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFN  213 (952)
Q Consensus       134 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  213 (952)
                                       +..+++|++|++++|++++.. . +..+++|++|++++|.+++ ++ .++.+++|++|+++ |
T Consensus       108 -----------------~~~l~~L~~L~L~~n~l~~~~-~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~  165 (466)
T 1o6v_A          108 -----------------LANLTNLTGLTLFNNQITDID-P-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-N  165 (466)
T ss_dssp             -----------------GTTCTTCCEEECCSSCCCCCG-G-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-E
T ss_pred             -----------------hcCCCCCCEEECCCCCCCCCh-H-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-C
Confidence                             235667777788777777432 2 7777888888888888774 33 47778888888886 4


Q ss_pred             cCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCC
Q 002214          214 NLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSI  293 (952)
Q Consensus       214 ~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~  293 (952)
                      .+.+..  .+..+++|+.|++++|++...  ..+..+++|++|++++|.+.+..+    +..+++|++|++++|++.+. 
T Consensus       166 ~~~~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~----~~~l~~L~~L~l~~n~l~~~-  236 (466)
T 1o6v_A          166 QVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP----LGILTNLDELSLNGNQLKDI-  236 (466)
T ss_dssp             SCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG----GGGCTTCCEEECCSSCCCCC-
T ss_pred             cccCch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc----ccccCCCCEEECCCCCcccc-
Confidence            444332  377888888888888877665  347778888888888888875533    55678888888888887642 


Q ss_pred             CcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccC
Q 002214          294 PSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRL  373 (952)
Q Consensus       294 ~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l  373 (952)
                      +                                                  .+..+++|+.|++++|.+++..+  +..+
T Consensus       237 ~--------------------------------------------------~l~~l~~L~~L~l~~n~l~~~~~--~~~l  264 (466)
T 1o6v_A          237 G--------------------------------------------------TLASLTNLTDLDLANNQISNLAP--LSGL  264 (466)
T ss_dssp             G--------------------------------------------------GGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred             h--------------------------------------------------hhhcCCCCCEEECCCCccccchh--hhcC
Confidence            1                                                  13456778888888888886544  7788


Q ss_pred             CCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEe
Q 002214          374 KKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDF  453 (952)
Q Consensus       374 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  453 (952)
                      ++|++|++++|.+++..+  +..+++|+.|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|+.|++
T Consensus       265 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l  338 (466)
T 1o6v_A          265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF  338 (466)
T ss_dssp             TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEEC
T ss_pred             CCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeEC
Confidence            888888888888876544  7788888888888888886544  7788899999999999987766  778899999999


Q ss_pred             cCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCc
Q 002214          454 SSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGP  509 (952)
Q Consensus       454 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  509 (952)
                      ++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|++++.
T Consensus       339 ~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~  390 (466)
T 1o6v_A          339 YNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA  390 (466)
T ss_dssp             CSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred             CCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence            99998864  478889999999999999997766  88899999999999999863

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-38  Score=360.08  Aligned_cols=270  Identities=23%  Similarity=0.304  Sum_probs=195.1

Q ss_pred             HHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCC-CCccceeeeEeecCC--e
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIR-HRNLVKIISSCTNHN--F  734 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  734 (952)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||||++...  .....+.+.+|+.+++++. ||||+++++++..++  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3567899999999999999999987 46999999998543  3344567889999999997 999999999997543  6


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .|+||||++ |+|.+++...  .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+..
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYL---HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            899999997 5899888764  589999999999999999999   7899999999999999999999999999999865


Q ss_pred             CCcC--------------------cccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCcc
Q 002214          815 SEED--------------------SMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM  873 (952)
Q Consensus       815 ~~~~--------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  873 (952)
                      ....                    .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~  238 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM-N  238 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence            3211                    111233579999999998876 67899999999999999999999998653211 1


Q ss_pred             chhhhhc---cchhhhhhhcc-------------------ccccchhhHHHH-----HhhhhhHHHHHHHHhhccccCCC
Q 002214          874 SIKRWIN---DSLPAVMNIMD-------------------TNLLSEDEEHAN-----VAKQSCASSVLSLAMECTSESPE  926 (952)
Q Consensus       874 ~~~~~~~---~~~~~~~~~~~-------------------~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~  926 (952)
                      .+.....   ...++....+.                   ............     ..+..+++++.+++.+||..||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            1111110   00000000000                   000000000000     01125678899999999999999


Q ss_pred             CCCCHHHHHHH
Q 002214          927 NRVNTKEIISR  937 (952)
Q Consensus       927 ~RPs~~ev~~~  937 (952)
                      +|||+.|+++|
T Consensus       319 ~R~t~~e~l~H  329 (388)
T 3oz6_A          319 KRISANDALKH  329 (388)
T ss_dssp             GSCCHHHHTTS
T ss_pred             cCCCHHHHhCC
Confidence            99999999876

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.7e-39  Score=355.37  Aligned_cols=246  Identities=25%  Similarity=0.362  Sum_probs=202.1

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      +.|...+.||+|+||+||+|+. .+|+.||||++....   ....+.+.+|++++++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4688999999999999999987 579999999986543   223467889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||++ |++.+.+......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.....  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 688888876666899999999999999999999   7889999999999999999999999999999865432  


Q ss_pred             ccccccccccccccccccC---cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          820 MKQTQTLATIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                         ....||+.|+|||++.   .+.++.++|||||||++|||++|+.||....... .........        .+..  
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~--------~~~~--  273 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNE--------SPAL--  273 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSC--------CCCC--
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcC--------CCCC--
Confidence               2356999999999873   5678999999999999999999999985421110 000000000        0000  


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                              .+..+++.+.+++.+||+.||++|||+.|++++
T Consensus       274 --------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          274 --------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                    112356779999999999999999999999865

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.1e-39  Score=351.64  Aligned_cols=250  Identities=22%  Similarity=0.298  Sum_probs=181.4

Q ss_pred             cceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEEEEccCCCC
Q 002214          669 ENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALVLEYMPKGS  746 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  746 (952)
                      .+.||+|+||+||+|.+. +|+.||||++...   ....+.+|+.++++++ ||||+++++++.+++..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999984 6899999998643   2356789999999997 9999999999999999999999999999


Q ss_pred             hhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC---cEEEeccccccccCCcCccccc
Q 002214          747 LEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM---VAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       747 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      |.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++   .+||+|||+++...... ....
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~  167 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHM---HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLK  167 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccc
Confidence            999997654 699999999999999999999   789999999999999997665   89999999998664332 2233


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhh-hhccccccchhhHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM-NIMDTNLLSEDEEHA  902 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  902 (952)
                      ...+|+.|+|||++.+..++.++|||||||++|||++|+.||.........      ....+.. .+.........    
T Consensus       168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~~i~~~~~~~~~----  237 (325)
T 3kn6_A          168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC------TSAVEIMKKIKKGDFSFEG----  237 (325)
T ss_dssp             ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C------CCHHHHHHHHTTTCCCCCS----
T ss_pred             ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc------ccHHHHHHHHHcCCCCCCc----
Confidence            456899999999999999999999999999999999999999753221100      0000111 11111111010    


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ..+..+++++.+++.+||+.||++|||+.|++++
T Consensus       238 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          238 -EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             -HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             -ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence             1123467889999999999999999999988743

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-38  Score=341.37  Aligned_cols=254  Identities=25%  Similarity=0.362  Sum_probs=208.0

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3568999999999999999999985 68999999986543 334577899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++++|.+++... ..+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||.+........
T Consensus        85 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            999999999988654 3689999999999999999999   789999999999999999999999999999986543221


Q ss_pred             -ccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          820 -MKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       820 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                       .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.........+..+.....          ..  
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~--  228 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----------YL--  228 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT----------TS--
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc----------cc--
Confidence             11234568999999999887665 78899999999999999999999764333222222221100          00  


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                            .....+++++.+++.+||+.||++|||+.|++++
T Consensus       229 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          229 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                  0113456789999999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.2e-39  Score=379.58  Aligned_cols=258  Identities=26%  Similarity=0.455  Sum_probs=212.8

Q ss_pred             HHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ...++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            34567999999999999999999998888999999975443 34679999999999999999999999876 67899999


Q ss_pred             ccCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          741 YMPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |+++|+|.+++... ...+++.+++.++.||++||+||   |+++|+||||||+|||+++++.+||+|||+++.......
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            99999999999753 23589999999999999999999   789999999999999999999999999999987654332


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      .......++..|+|||++....++.++|||||||++|||++ |+.||......+             ....+.....   
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------------~~~~i~~~~~---  482 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------------VLDQVERGYR---  482 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------------HHHHHHTTCC---
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------------HHHHHHcCCC---
Confidence            23333457889999999988899999999999999999999 899986532111             0011111100   


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                          ...+..++.++.++|.+||+.||++|||+.+|++.|+++..
T Consensus       483 ----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          483 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                01134567889999999999999999999999999987644

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.9e-39  Score=345.51  Aligned_cols=260  Identities=23%  Similarity=0.371  Sum_probs=209.4

Q ss_pred             HhccCCccc-eecCccceEEEEEEe---CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          662 ATDQFSEEN-LIGIGSYGSVYKGRF---PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       662 ~~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      ..++|.+.+ .||+|+||+||+|.+   .+++.||||+++...  ....+.+.+|++++++++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            456788888 999999999999964   347899999986543  23357799999999999999999999999 55678


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||+++++|.+++.... .+++..++.++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHH---HhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            99999999999999997654 689999999999999999999   78899999999999999999999999999998765


Q ss_pred             CcCccc--ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          816 EEDSMK--QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       816 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                      ......  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......  ....           .+..
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~-----------~~~~  235 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTA-----------MLEK  235 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH-----------HHHT
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH-----------HHHc
Confidence            443321  122346789999999988889999999999999999999 99998653211  1111           0100


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHh
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~  946 (952)
                      ...       ...+..+++++.+++.+||+.||++||++.|+++.|+++.....
T Consensus       236 ~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          236 GER-------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             TCC-------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CCC-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            000       00123467889999999999999999999999999999987754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-38  Score=344.12  Aligned_cols=252  Identities=21%  Similarity=0.347  Sum_probs=205.8

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++....  ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            568999999999999999999874 68999999986543  334567889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc---EEEeccccccccCC
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV---AHLSDFGIAKLLSE  816 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgla~~~~~  816 (952)
                      ||+++++|.+.+.... .+++..+..++.|++.|++||   |++||+||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999988887654 689999999999999999999   7899999999999999986655   99999999987654


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      ...  .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||....... .....           .......
T Consensus       161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~-----------~~~~~~~  226 (284)
T 3kk8_A          161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQI-----------KAGAYDY  226 (284)
T ss_dssp             SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH-----------HHTCCCC
T ss_pred             Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHH-----------HhccccC
Confidence            332  233569999999999999999999999999999999999999985521110 00000           0000000


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..     .....+++++.+++.+||+.||++|||+.|++++
T Consensus       227 ~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          227 PS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             CT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             Cc-----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            00     0113456789999999999999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.7e-38  Score=355.29  Aligned_cols=276  Identities=20%  Similarity=0.261  Sum_probs=204.6

Q ss_pred             CHHHHHHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCc-----------hhhHHHHHHHHHHHhCCCCccc
Q 002214          655 SHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE-----------GALNSFDAECEILKTIRHRNLV  723 (952)
Q Consensus       655 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv  723 (952)
                      ...++....++|.+.+.||+|+||.||+|.+.+|+.||||++.....           ...+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            35677788899999999999999999999998899999999854321           1236789999999999999999


Q ss_pred             eeeeEeec-----CCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC
Q 002214          724 KIISSCTN-----HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD  798 (952)
Q Consensus       724 ~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~  798 (952)
                      ++++++..     ....++||||++ |+|.+.+......+++..+..++.|++.||+||   |++||+||||||+||+++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL---HEAGVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCcCEecCCChHHEEEc
Confidence            99999843     346799999997 688888877766899999999999999999999   788999999999999999


Q ss_pred             CCCcEEEeccccccccCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhh
Q 002214          799 DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR  877 (952)
Q Consensus       799 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~  877 (952)
                      .++.+||+|||+++......  ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ....
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~  245 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLNK  245 (362)
T ss_dssp             TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH
T ss_pred             CCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence            99999999999998543322  2334568999999998876 678999999999999999999999986532111 1111


Q ss_pred             hhc---c---------chhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          878 WIN---D---------SLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       878 ~~~---~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...   .         ..+...+.+..................+++.+.+++.+||+.||++|||+.|++++
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            100   0         00001111111111111111112234557789999999999999999999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.8e-39  Score=360.15  Aligned_cols=250  Identities=21%  Similarity=0.363  Sum_probs=198.7

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCC--CCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIR--HRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .+|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|+.++++++  ||||+++++++..++..|+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4699999999999999999999889999999986543  334577899999999996  599999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      | +.+++|.+++.... .+++.++..++.||+.||+||   |++||+||||||+|||++ ++.+||+|||+|+.+.....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 56889999987654 789999999999999999999   789999999999999995 58999999999987654322


Q ss_pred             c-cccccccccccccccccCc-----------CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhh
Q 002214          820 M-KQTQTLATIGYIAPEYGRE-----------GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM  887 (952)
Q Consensus       820 ~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  887 (952)
                      . ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........           ..
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-----------~~  278 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----------LH  278 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-----------HH
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH-----------HH
Confidence            1 2234579999999998764           46889999999999999999999999653211111           11


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .+++......       .+..++.++.+++.+||+.||++|||+.|++++
T Consensus       279 ~~~~~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          279 AIIDPNHEIE-------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHCTTSCCC-------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhCccccCC-------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1122111111       112235678999999999999999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.5e-38  Score=361.55  Aligned_cols=254  Identities=24%  Similarity=0.314  Sum_probs=195.2

Q ss_pred             HHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--------chhhHHHHHHHHHHHhCCCCccceeeeEeec
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--------EGALNSFDAECEILKTIRHRNLVKIISSCTN  731 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  731 (952)
                      ...++|.+.+.||+|+||+||+|.+ .+++.||||++....        ......+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3567899999999999999999987 468999999986532        1122357899999999999999999999865


Q ss_pred             CCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC---cEEEecc
Q 002214          732 HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM---VAHLSDF  808 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~---~~kl~Df  808 (952)
                       +..++||||+++|+|.+++.... .+++.++..++.|++.||+||   |++||+||||||+||+++.++   .+||+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCCCcceEEEeec
Confidence             45799999999999999886544 699999999999999999999   688999999999999997544   5999999


Q ss_pred             ccccccCCcCcccccccccccccccccccC---cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhh
Q 002214          809 GIAKLLSEEDSMKQTQTLATIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA  885 (952)
Q Consensus       809 gla~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  885 (952)
                      |+|+......  ......||+.|+|||++.   ...++.++|||||||++|||++|+.||.................   
T Consensus       287 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~---  361 (419)
T 3i6u_A          287 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK---  361 (419)
T ss_dssp             STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC---
T ss_pred             ccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC---
Confidence            9998764332  223457999999999875   35678899999999999999999999975322221111111100   


Q ss_pred             hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                               ....    ......+++++.+++.+||+.||++|||++|++++
T Consensus       362 ---------~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          362 ---------YNFI----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             ---------CCCC----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---------CCCC----chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                     0000    11123457789999999999999999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.4e-38  Score=365.46  Aligned_cols=265  Identities=20%  Similarity=0.218  Sum_probs=196.1

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecC------C
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNH------N  733 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  733 (952)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++...  .....+++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            56899999999999999999987 46899999998654  334456788999999999999999999999654      3


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ..|+||||++++ +.+.+..   .+++..+..++.|+++||+||   |++||+||||||+|||++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~---~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCCC-HHHHHhh---cCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            579999999764 6555543   489999999999999999999   788999999999999999999999999999987


Q ss_pred             cCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhh-----
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPA-----  885 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~-----  885 (952)
                      ....  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+....   ....++     
T Consensus       214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHTTS
T ss_pred             cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHHc
Confidence            6432  2234467999999999999999999999999999999999999999653211 1111111   011111     


Q ss_pred             ---hhhhccccccchhhHHH-----------HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 ---VMNIMDTNLLSEDEEHA-----------NVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ---~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ....+............           .......++++.+|+.+||..||++|||++|+++|
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               11111100000000000           00112236789999999999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.3e-39  Score=344.60  Aligned_cols=252  Identities=29%  Similarity=0.437  Sum_probs=201.2

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecC-CeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNH-NFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  741 (952)
                      .++|++.+.||+|+||.||+|+. +|+.||||+++...  ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            56899999999999999999988 58999999986543  347789999999999999999999987554 578999999


Q ss_pred             cCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASNF-NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++++|.+++..... .+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||++.......  
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHH---HhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            999999999876432 378999999999999999999   78999999999999999999999999999998654322  


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+  ...       .    +.....    
T Consensus       172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~-------~----~~~~~~----  232 (278)
T 1byg_A          172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP-------R----VEKGYK----  232 (278)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHH-------H----HTTTCC----
T ss_pred             --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH-------H----HhcCCC----
Confidence              22357889999999988889999999999999999998 999986532111  100       0    000000    


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                         ...+..+++++.+++.+||+.||++||++.|+++.|++++..
T Consensus       233 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          233 ---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence               011234677899999999999999999999999999998764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.6e-38  Score=349.98  Aligned_cols=260  Identities=25%  Similarity=0.440  Sum_probs=208.0

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcE--EEEEEeecc-CchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIE--VAIKVFHLQ-REGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|.+.+.||+|+||.||+|++. +|..  ||+|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            357999999999999999999874 5664  499988643 233456789999999999 89999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc
Q 002214          738 VLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV  802 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~  802 (952)
                      ||||+++|+|.+++....               ..+++..++.++.|+++||+||   |++||+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCccceEEEcCCCe
Confidence            999999999999987643               3689999999999999999999   7899999999999999999999


Q ss_pred             EEEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhcc
Q 002214          803 AHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWIND  881 (952)
Q Consensus       803 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  881 (952)
                      +||+|||+++.....  .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......     .    
T Consensus       181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~----  249 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----E----  249 (327)
T ss_dssp             EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----H----
T ss_pred             EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----H----
Confidence            999999999754321  12223457889999999988889999999999999999998 99998653211     0    


Q ss_pred             chhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          882 SLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                          ....+......       ..+..+++++.+++.+||+.||++|||+.|++++|+++.+....
T Consensus       250 ----~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          250 ----LYEKLPQGYRL-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             ----HHHHGGGTCCC-------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             ----HHHHhhcCCCC-------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence                00111111000       01234577899999999999999999999999999998876543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-38  Score=345.84  Aligned_cols=269  Identities=24%  Similarity=0.339  Sum_probs=201.3

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57999999999999999999984 599999998854432  234678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+++++|.+++... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFC---HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence            99999998877654 3689999999999999999999   789999999999999999999999999999987653322 


Q ss_pred             cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccc--hhhhhccchhhhhhhcc------
Q 002214          821 KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS--IKRWINDSLPAVMNIMD------  891 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~------  891 (952)
                      ......+|+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+..  .........+.....+.      
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            2234568999999998865 56899999999999999999999998653221110  01111111111000000      


Q ss_pred             ccccch--hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSE--DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ......  ...........++.++.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000  0000011123467789999999999999999999999865

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-38  Score=367.74  Aligned_cols=253  Identities=23%  Similarity=0.340  Sum_probs=207.7

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999884 79999999986532   23346688999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          739 LEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      |||+++|+|.+++.... ..+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yL---H~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL---HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999887644 3599999999999999999999   7889999999999999999999999999999876543


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      ..  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...        ....+....   
T Consensus       340 ~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~--------i~~~i~~~~---  405 (576)
T 2acx_A          340 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REE--------VERLVKEVP---  405 (576)
T ss_dssp             CC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHH--------HHHHHHHCC---
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHH--------HHHHhhccc---
Confidence            22  2335799999999999998999999999999999999999999975322110 000        000000000   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                           ...+..+++++.+++.+||..||++||     ++.||++|
T Consensus       406 -----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          406 -----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                 001234577899999999999999999     78888765

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.3e-39  Score=361.41  Aligned_cols=277  Identities=22%  Similarity=0.305  Sum_probs=212.0

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCC--eeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHN--FKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  738 (952)
                      .++|.+.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            457999999999999999999985 58999999986543 233567889999999999999999999988754  77999


Q ss_pred             EEccCCCChhHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee----CCCCcEEEecccccc
Q 002214          739 LEYMPKGSLEDCMYASNF--NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHLSDFGIAK  812 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill----~~~~~~kl~Dfgla~  812 (952)
                      |||+++|+|.+++.....  .+++..++.++.|++.||+||   |++||+||||||+||++    +.++.+||+|||+|+
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999876432  489999999999999999999   78999999999999999    788889999999998


Q ss_pred             ccCCcCcccccccccccccccccccCc--------CCcCcccchHhHHHHHHHHHhCCCCCCccccCccch---hhhhcc
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGRE--------GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI---KRWIND  881 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~---~~~~~~  881 (952)
                      .......  .....||+.|+|||++.+        ..++.++|||||||++|||++|+.||..........   .+....
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            7654332  234569999999998764        567889999999999999999999997543222111   111111


Q ss_pred             chhhhhhhccccccch-----hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          882 SLPAVMNIMDTNLLSE-----DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       882 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      ..+.....+.......     ...........++..+.+++.+||..||++||++.|+++.++++.++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            1000000000000000     00000012245678899999999999999999999999999887654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.2e-38  Score=339.20  Aligned_cols=258  Identities=23%  Similarity=0.352  Sum_probs=207.0

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc------hhhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE------GALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++....      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357999999999999999999985 689999999865431      1356789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC----cEEEeccccc
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM----VAHLSDFGIA  811 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgla  811 (952)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++    .+||+|||++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYL---HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999987644 689999999999999999999   789999999999999998877    8999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      ........  .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+ ....           ...
T Consensus       160 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~-----------~~~  225 (283)
T 3bhy_A          160 HKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTN-----------ISA  225 (283)
T ss_dssp             EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH-----------HHT
T ss_pred             eeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHH-----------hHh
Confidence            87644322  233568999999999998899999999999999999999999986522110 0000           000


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR--LIKIRD  943 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~i~~  943 (952)
                      ... ..    .......++..+.+++.+||+.||++||++.|++++  ++++++
T Consensus       226 ~~~-~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          226 VNY-DF----DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             TCC-CC----CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             ccc-CC----cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            000 00    011123457789999999999999999999999984  555543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.7e-39  Score=360.57  Aligned_cols=253  Identities=15%  Similarity=0.183  Sum_probs=198.6

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHH---HHHhCCCCccceee-------eE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECE---ILKTIRHRNLVKII-------SS  728 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~  728 (952)
                      .++|.+.+.||+|+||+||+|++ .+|+.||||++...   .....+.+.+|+.   ++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46799999999999999999997 56999999998743   3345578899994   55555899999998       55


Q ss_pred             eecCC-----------------eeEEEEEccCCCChhHHhhhcCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 002214          729 CTNHN-----------------FKALVLEYMPKGSLEDCMYASNF------NLDIFQRLGIMIDVASALEYLHFGHSNPI  785 (952)
Q Consensus       729 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~l~~~~~~~i~~~ia~~l~~Lh~~h~~~i  785 (952)
                      +..++                 ..|+||||+ +|+|.+++.....      .+++..++.++.|++.||+||   |++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH---HHTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH---HhCCe
Confidence            55443                 278999999 6899999875431      233588889999999999999   78899


Q ss_pred             EeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccccccccccccccccCcC-----------CcCcccchHhHHHH
Q 002214          786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG-----------QVSIKGDVYNYGIM  854 (952)
Q Consensus       786 vH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~slG~~  854 (952)
                      +||||||+|||++.++.+||+|||+|+....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986432    2233557 999999998877           89999999999999


Q ss_pred             HHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHH
Q 002214          855 LMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI  934 (952)
Q Consensus       855 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  934 (952)
                      +|||++|+.||........ ....           ..             ....+++++.+++.+||+.||++|||+.|+
T Consensus       303 l~elltg~~Pf~~~~~~~~-~~~~-----------~~-------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  357 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGG-SEWI-----------FR-------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQA  357 (377)
T ss_dssp             HHHHHHSSCCC------CC-SGGG-----------GS-------------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred             HHHHHHCCCCCcccccccc-hhhh-----------hh-------------hccCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence            9999999999865321110 0000           00             012346789999999999999999999999


Q ss_pred             HH--HHHHHHHHHhhhc
Q 002214          935 IS--RLIKIRDLLFANI  949 (952)
Q Consensus       935 ~~--~L~~i~~~~~~~~  949 (952)
                      ++  .++++++...+..
T Consensus       358 l~hp~f~~~~~~~~~~l  374 (377)
T 3byv_A          358 METPEYEQLRTELSAAL  374 (377)
T ss_dssp             HTSHHHHHHHHHHHHHG
T ss_pred             hhChHHHHHHHHHHHhh
Confidence            97  6777777665543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.6e-39  Score=352.81  Aligned_cols=268  Identities=21%  Similarity=0.293  Sum_probs=198.9

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCch-hhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREG-ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ++|.+.+.||+|+||+||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999985 7899999998654322 223456799999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      ++ |+|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++....... .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~  156 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC---HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T  156 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence            97 589998888777799999999999999999999   789999999999999999999999999999986543322 2


Q ss_pred             ccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhh-hhhhccc----
Q 002214          822 QTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPA-VMNIMDT----  892 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~-~~~~~~~----  892 (952)
                      .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ......   ....+. .......    
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHhchhhhcchhhc
Confidence            233568999999998876 568999999999999999999999996532111 111100   000000 0000000    


Q ss_pred             --cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          893 --NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       893 --~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                        ................+++++.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence              000000000111234567889999999999999999999999873

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-38  Score=342.95  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=198.5

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|.+.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            36799999999999999999987 468999999987554 3345788999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee---CCCCcEEEecccccccc
Q 002214          741 YMPKGSLEDCMYAS---NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       741 ~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgla~~~  814 (952)
                      |+++|+|.+.+...   ...+++..+..++.|+++||+||   |++||+||||||+||++   +.++.+||+|||+++..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF---HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988543   35799999999999999999999   78999999999999999   45688999999999866


Q ss_pred             CCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ....  ......+|+.|+|||.+. +.++.++||||||+++|||++|+.||......+  .....        .......
T Consensus       178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~--------~~~~~~~  244 (285)
T 3is5_A          178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKA--------TYKEPNY  244 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH--------HHCCCCC
T ss_pred             CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhh--------ccCCccc
Confidence            4332  223456899999999876 468899999999999999999999986532111  00000        0000000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..        ....+++++.+++.+||+.||++|||+.|++++
T Consensus       245 ~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          245 AV--------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CC----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cc--------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00        011246678999999999999999999999863

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=360.53  Aligned_cols=347  Identities=21%  Similarity=0.160  Sum_probs=253.5

Q ss_pred             ceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCC
Q 002214          134 ALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFN  213 (952)
Q Consensus       134 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  213 (952)
                      .++.+++.++ .+|..+.   ++++.|+|++|++++..+..|..+++|+.|+|++|.+++..|.+|+++++|++|+|++|
T Consensus        15 ~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           15 AVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             EEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            4555666665 5666543   58899999999999888899999999999999999999888999999999999999999


Q ss_pred             cCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCC
Q 002214          214 NLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSI  293 (952)
Q Consensus       214 ~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~  293 (952)
                      +++...+..|.++++|+.|+|++|++.+..+..|..+++|++|+|++|.+.+..+.  .+.++++|++|++++|+++   
T Consensus        91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~---  165 (477)
T 2id5_A           91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR--AFSGLNSLEQLTLEKCNLT---  165 (477)
T ss_dssp             CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTT--SSTTCTTCCEEEEESCCCS---
T ss_pred             cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChh--hccCCCCCCEEECCCCcCc---
Confidence            99977777899999999999999999999999999999999999999998755332  2445555555555555544   


Q ss_pred             CcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccC
Q 002214          294 PSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRL  373 (952)
Q Consensus       294 ~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l  373 (952)
                                                                                            +..+..|..+
T Consensus       166 ----------------------------------------------------------------------~~~~~~l~~l  175 (477)
T 2id5_A          166 ----------------------------------------------------------------------SIPTEALSHL  175 (477)
T ss_dssp             ----------------------------------------------------------------------SCCHHHHTTC
T ss_pred             ----------------------------------------------------------------------ccChhHhccc
Confidence                                                                                  3333344444


Q ss_pred             CCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEe
Q 002214          374 KKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDF  453 (952)
Q Consensus       374 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  453 (952)
                      ++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|.......+|++|++++|+++++++..|..+++|+.|+|
T Consensus       176 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  255 (477)
T 2id5_A          176 HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNL  255 (477)
T ss_dssp             TTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEEC
T ss_pred             CCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeEC
Confidence            55555555555554444445555555555555555544444444444556777777777776655566777777777777


Q ss_pred             cCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCccccc
Q 002214          454 SSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGV  533 (952)
Q Consensus       454 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  533 (952)
                      ++|.+++..+..|..+++|+.|+|++|+++++.|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus       256 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~  335 (477)
T 2id5_A          256 SYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACD  335 (477)
T ss_dssp             CSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred             CCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCc
Confidence            77777766666777777888888888888877788888888888888888888877777788888888888888888743


Q ss_pred             CccchhcccccccccccccccccCCCC
Q 002214          534 IPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       534 ~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      -+ ...-...+..+++.++...|..|.
T Consensus       336 c~-~~~~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          336 CR-LLWVFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             GG-GHHHHTTTTSSCCTTCCCBEEESG
T ss_pred             cc-hHhHHhhhhccccCccCceeCCch
Confidence            22 222223344566777777777665

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.5e-38  Score=361.03  Aligned_cols=264  Identities=20%  Similarity=0.274  Sum_probs=212.3

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCC-CccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRH-RNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|++.+.||+|+||.||+|++ .+++.||||++......  ..+.+|+++++.++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999997 57999999987654432  457899999999987 556666667777888999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee---CCCCcEEEeccccccccCCc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgla~~~~~~  817 (952)
                      |+ +++|.+++......+++.+++.++.||+.||+||   |++||+||||||+|||+   +.++.+||+|||+|+.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV---HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 9999999987667899999999999999999999   78999999999999999   68899999999999876543


Q ss_pred             Ccc------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          818 DSM------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       818 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      ...      ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ...+.       .+..
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~-------~i~~  230 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQKYE-------KISE  230 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHHHH-------HHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHHHH-------HHhh
Confidence            321      12245799999999999999999999999999999999999999976432211  00000       0000


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                      ...    ..........+++++.+++..||+.||++||++.+|++.|+++....
T Consensus       231 ~~~----~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          231 KKV----ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHH----HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccc----cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            000    00011123456889999999999999999999999999999997754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.1e-39  Score=369.95  Aligned_cols=250  Identities=22%  Similarity=0.301  Sum_probs=196.9

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ..++|++.+.||+|+||.||+|+. .+|+.||||++...   .......+.+|+.++++++||||+++++++...+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            346899999999999999999987 46899999998753   23334667889999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS-NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~-~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+||   |+ +||+||||||+|||++.++.+||+|||+|+....
T Consensus       226 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---hhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            999999999999887654 689999999999999999999   66 8999999999999999999999999999986433


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ....          .+.....  
T Consensus       302 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~----------~i~~~~~--  366 (446)
T 4ejn_A          302 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFE----------LILMEEI--  366 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----------HHHHCCC--
T ss_pred             CC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHH----------HHHhCCC--
Confidence            22 2233467999999999999999999999999999999999999998652110  0000          0000000  


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                             ..+..+++++.+++.+||+.||++||     ++.|++++
T Consensus       367 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          367 -------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                   01234567899999999999999999     99999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.8e-38  Score=349.20  Aligned_cols=271  Identities=22%  Similarity=0.328  Sum_probs=203.0

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeec--------
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTN--------  731 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  731 (952)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++....  ......+.+|+.++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46899999999999999999998 579999999986543  2234578899999999999999999999876        


Q ss_pred             CCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccc
Q 002214          732 HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA  811 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  811 (952)
                      .+..++||||+++ ++.+.+......+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            3468999999975 78787777666799999999999999999999   7899999999999999999999999999999


Q ss_pred             cccCCcCc---ccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCcc--chhhhhccchhh
Q 002214          812 KLLSEEDS---MKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM--SIKRWINDSLPA  885 (952)
Q Consensus       812 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~  885 (952)
                      +.+.....   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.  ...+......+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            87653221   22234568999999998875 4579999999999999999999999875321110  000000000000


Q ss_pred             hh---------hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 VM---------NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..         ..+...................++++.+++.+||+.||++|||++|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00         00000000000000111112235678999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.4e-38  Score=343.06  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=207.2

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeec--------
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN--------  731 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  731 (952)
                      ...++|++.+.||+|+||.||+|++. +|+.||+|++....    +.+.+|++++++++||||+++++++..        
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            34568999999999999999999985 79999999987543    346789999999999999999998854        


Q ss_pred             --------CCeeEEEEEccCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc
Q 002214          732 --------HNFKALVLEYMPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV  802 (952)
Q Consensus       732 --------~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~  802 (952)
                              ....++||||+++|+|.+++... ...+++..++.++.|++.||+||   |++||+||||||+||+++.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYI---HSKKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHEEEcCCCC
Confidence                    34579999999999999999754 34689999999999999999999   7889999999999999999999


Q ss_pred             EEEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccc
Q 002214          803 AHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS  882 (952)
Q Consensus       803 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  882 (952)
                      +||+|||++.......  ......+++.|+|||.+.+..++.++||||||+++|||++|..|+....       .+.   
T Consensus       161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~~---  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KFF---  228 (284)
T ss_dssp             EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------HHH---
T ss_pred             EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------HHH---
Confidence            9999999998765432  2233568999999999988889999999999999999999998863210       000   


Q ss_pred             hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 002214          883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFAN  948 (952)
Q Consensus       883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~  948 (952)
                          .......           .+..++.++.+++.+||+.||++|||+.|++++|+.+++....+
T Consensus       229 ----~~~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          229 ----TDLRDGI-----------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             ----HHHHTTC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             ----HHhhccc-----------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence                0000000           11234667899999999999999999999999999988766544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.2e-38  Score=352.77  Aligned_cols=276  Identities=23%  Similarity=0.275  Sum_probs=209.4

Q ss_pred             cccCHHHHHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-----CCcccee
Q 002214          652 RRYSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIR-----HRNLVKI  725 (952)
Q Consensus       652 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l  725 (952)
                      ..++..+.....++|.+.+.||+|+||+||+|++ .+++.||||+++.. ......+..|+.++++++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            3445555555678999999999999999999998 57899999998643 233466788999999996     9999999


Q ss_pred             eeEeecCCeeEEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-----
Q 002214          726 ISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-----  799 (952)
Q Consensus       726 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-----  799 (952)
                      ++++...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.     
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYL---RKMSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCTTCCE
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCcccEEEccccccc
Confidence            99999999999999999 999999987654 3589999999999999999999   7899999999999999975     


Q ss_pred             --------------------CCcEEEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHH
Q 002214          800 --------------------SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVF  859 (952)
Q Consensus       800 --------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~  859 (952)
                                          ++.+||+|||+|+.....    .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                                889999999999865432    23456899999999999999999999999999999999


Q ss_pred             hCCCCCCccccCccchhhhhc--cchhh-h---------hhhccccc-c-------chhhH------HHHHhhhhhHHHH
Q 002214          860 TGMKPTNEFFTGEMSIKRWIN--DSLPA-V---------MNIMDTNL-L-------SEDEE------HANVAKQSCASSV  913 (952)
Q Consensus       860 tg~~p~~~~~~~~~~~~~~~~--~~~~~-~---------~~~~~~~~-~-------~~~~~------~~~~~~~~~~~~l  913 (952)
                      +|+.||......+ .......  ...+. .         ...++... .       .....      .....+...++.+
T Consensus       254 ~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          254 TGSLLFRTHEHME-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HSSCSCCCSSHHH-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HCCCCCCCCcHHH-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            9999996532111 0100000  00000 0         00000000 0       00000      0000111223678


Q ss_pred             HHHHhhccccCCCCCCCHHHHHHH
Q 002214          914 LSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       914 ~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .+++.+||+.||++|||++|++++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHhcCChhhCCCHHHHhcC
Confidence            899999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7e-39  Score=356.82  Aligned_cols=247  Identities=27%  Similarity=0.317  Sum_probs=193.6

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHH-HHhCCCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEI-LKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|++.+.||+|+||.||+|+.+ +++.||||+++...   ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999985 58899999996543   2233456677776 567899999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|+|.+++...+ .+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999987654 689999999999999999999   7899999999999999999999999999999864322


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      . ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+.           .++....   
T Consensus       193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~-----------~i~~~~~---  256 (373)
T 2r5t_A          193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYD-----------NILNKPL---  256 (373)
T ss_dssp             C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-HHHH-----------HHHHSCC---
T ss_pred             C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HHHH-----------HHHhccc---
Confidence            2 2233467999999999999999999999999999999999999998642110 0011           1111110   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII  935 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  935 (952)
                            ..+..++.++.+++.+||+.||++||++.+.+
T Consensus       257 ------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          257 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             ------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                  01234567899999999999999999986433

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.4e-38  Score=348.56  Aligned_cols=260  Identities=24%  Similarity=0.407  Sum_probs=206.6

Q ss_pred             hccCCccceecCccceEEEEEEe------CCCcEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      .++|++.+.||+|+||.||+|++      .+++.||||++... .......+.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46899999999999999999984      35778999998644 234456789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC---CCcEEEe
Q 002214          736 ALVLEYMPKGSLEDCMYASN------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD---SMVAHLS  806 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~---~~~~kl~  806 (952)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||+||   |++||+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998654      3589999999999999999999   7889999999999999984   4569999


Q ss_pred             ccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchh
Q 002214          807 DFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLP  884 (952)
Q Consensus       807 Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  884 (952)
                      |||+++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |..||......  ...        
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~--------  255 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL--------  255 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH--------
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHH--------
Confidence            99999865332221 2223467899999999988889999999999999999998 89998652111  111        


Q ss_pred             hhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          885 AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                         ..+.....       ...+..++.++.+++.+||+.||++||++.|++++|+.+.+.-
T Consensus       256 ---~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          256 ---EFVTSGGR-------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             ---HHHHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             ---HHHhcCCC-------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence               00100000       0012345778999999999999999999999999999887643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4e-38  Score=359.67  Aligned_cols=271  Identities=21%  Similarity=0.281  Sum_probs=200.0

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecC-----C
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNH-----N  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  733 (952)
                      ..++|.+.+.||+|+||.||+|++ .+|+.||||++...  .....+++.+|++++++++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            356899999999999999999987 46899999998643  233456889999999999999999999999766     5


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ..|+||||++ |+|.+++... ..+++..+..++.||++||+||   |++||+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~L---H~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFI---HESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            6899999996 5999988754 3699999999999999999999   789999999999999999999999999999997


Q ss_pred             cCCcCcc---------------------ccccccccccccccccc-CcCCcCcccchHhHHHHHHHHHhCCCCCCccccC
Q 002214          814 LSEEDSM---------------------KQTQTLATIGYIAPEYG-REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTG  871 (952)
Q Consensus       814 ~~~~~~~---------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  871 (952)
                      .......                     .....+||+.|+|||++ ....++.++||||+||++|||++|..||.....+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            6543211                     12446799999999975 5667999999999999999999977666432211


Q ss_pred             ccchh---------------hhh----ccchhhhhhhccccc-------------------cchhhHHHHHhhhhhHHHH
Q 002214          872 EMSIK---------------RWI----NDSLPAVMNIMDTNL-------------------LSEDEEHANVAKQSCASSV  913 (952)
Q Consensus       872 ~~~~~---------------~~~----~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l  913 (952)
                      ...+.               .+.    ......+.+.+....                   ..............+++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence            11000               000    000000000000000                   0000000001113467889


Q ss_pred             HHHHhhccccCCCCCCCHHHHHHH
Q 002214          914 LSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       914 ~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .+|+.+||..||++|||+.|++++
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~H  362 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDH  362 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcC
Confidence            999999999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.9e-38  Score=345.42  Aligned_cols=253  Identities=23%  Similarity=0.352  Sum_probs=202.3

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++..++..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3568999999999999999999985 589999999976666666889999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+++++|.+++......+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++...... ..
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  172 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL---HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ  172 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence            9999999999887666799999999999999999999   7889999999999999999999999999998643211 11


Q ss_pred             ccccccccccccccccc-----CcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          821 KQTQTLATIGYIAPEYG-----REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ......|++.|+|||++     .+..++.++||||||+++|||++|+.||....... .........        .... 
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~--------~~~~-  242 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSD--------PPTL-  242 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSC--------CCCC-
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccC--------Cccc-
Confidence            12235689999999987     46678899999999999999999999986532110 000000000        0000 


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                              ..+..++.++.+++.+||+.||++|||+.|+++
T Consensus       243 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 --------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                    112345778999999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.8e-38  Score=350.26  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=201.3

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ..++|.+.+.||+|+||.||+|.++ +|+.||||++.....    ...+|++++.++ +||||+++++++.+++..|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4568999999999999999999884 689999999865433    235688888888 7999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC----CcEEEeccccccccC
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS----MVAHLSDFGIAKLLS  815 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgla~~~~  815 (952)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||++..+    +.+||+|||+++...
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~l---H~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYL---HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999887654 689999999999999999999   78999999999999998533    359999999998764


Q ss_pred             CcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      .... ......+|+.|+|||++.+..++.++|||||||++|||++|..||......  .......       .+......
T Consensus       172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~-------~i~~~~~~  241 (342)
T 2qr7_A          172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILA-------RIGSGKFS  241 (342)
T ss_dssp             CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHH-------HHHHCCCC
T ss_pred             CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHH-------HHccCCcc
Confidence            3322 223457899999999998888999999999999999999999999652211  1111110       00000000


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...     ..+..+++++.+++.+||..||++||++.|++++
T Consensus       242 ~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          242 LSG-----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             CCS-----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cCc-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000     0123457789999999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7e-38  Score=338.70  Aligned_cols=248  Identities=23%  Similarity=0.363  Sum_probs=199.7

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeec----CCeeE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTN----HNFKA  736 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  736 (952)
                      ..|.+.+.||+|+||.||+|.+ .++..||+|++....  ....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            4578889999999999999987 468899999986542  3345778999999999999999999998865    35689


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCeeeC-CCCcEEEeccccccc
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP--IVHCDIKPSNVLLD-DSMVAHLSDFGIAKL  813 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~--ivH~Dlk~~Nill~-~~~~~kl~Dfgla~~  813 (952)
                      +||||+++|+|.+++.... .+++..+..++.|++.||+||   |+.+  |+||||||+||+++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHH---HcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999997654 689999999999999999999   6777  99999999999998 889999999999976


Q ss_pred             cCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      .....   .....||+.|+|||.+.+ .++.++||||+|+++|+|++|+.||................            
T Consensus       182 ~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------------  245 (290)
T 1t4h_A          182 KRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG------------  245 (290)
T ss_dssp             CCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT------------
T ss_pred             ccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc------------
Confidence            53322   233568999999998764 58999999999999999999999986532221111111100            


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...      ...+..+++++.+++.+||+.||++|||+.|++++
T Consensus       246 ~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          246 VKP------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             CCC------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCc------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            000      01123345679999999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.7e-38  Score=340.80  Aligned_cols=247  Identities=24%  Similarity=0.384  Sum_probs=205.6

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367999999999999999999885 68899999986432   22346789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++|+|.+++...+ .+++..+..++.|+++|++||   |++||+||||||+||+++.++.+||+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYC---HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            99999999999987654 689999999999999999999   7899999999999999999999999999999765432 


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                        ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ..           ..+.....    
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~-----------~~~~~~~~----  229 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-TH-----------RRIVNVDL----  229 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HH-----------HHHHTTCC----
T ss_pred             --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-HH-----------HHHhcccc----
Confidence              2233568999999999999899999999999999999999999986521110 00           00111000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..+..++.++.+++.+||+.||++||++.|++++
T Consensus       230 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          230 -----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             -----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                 0123356789999999999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-39  Score=356.03  Aligned_cols=255  Identities=24%  Similarity=0.319  Sum_probs=205.2

Q ss_pred             hccCCccceecCccceEEEEEEe----CCCcEEEEEEeeccC----chhhHHHHHHHHHHHhC-CCCccceeeeEeecCC
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF----PDGIEVAIKVFHLQR----EGALNSFDAECEILKTI-RHRNLVKIISSCTNHN  733 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  733 (952)
                      .++|++.+.||+|+||.||+|+.    .+|+.||||+++...    ....+.+.+|+++++++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999987    478999999986432    22345677899999999 6999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ..++||||+++|+|.+++.... .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999987654 689999999999999999999   788999999999999999999999999999987


Q ss_pred             cCCcCcccccccccccccccccccCc--CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGRE--GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      .............||+.|+|||++.+  ..++.++|||||||++|||++|+.||....... ....+...       ...
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~-------~~~  280 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRR-------ILK  280 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHH-------HHH
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHH-------Hhc
Confidence            65444434445679999999999875  347889999999999999999999986532211 11111100       000


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISRL  938 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~L  938 (952)
                      ..         ...+..++..+.+++.+||..||++||     ++.|++++.
T Consensus       281 ~~---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          281 SE---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             cC---------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            00         001234567799999999999999999     999998764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.5e-38  Score=346.39  Aligned_cols=263  Identities=19%  Similarity=0.266  Sum_probs=202.8

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCccceeeeEeec--CCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIISSCTN--HNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  738 (952)
                      .++|++.+.||+|+||+||+|++ .+++.||||+++...   .+.+.+|+.++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36799999999999999999987 578999999986433   367899999999997 9999999999987  5678999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC-cEEEeccccccccCCc
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-VAHLSDFGIAKLLSEE  817 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~~~~  817 (952)
                      |||+++++|.+++.    .+++.++..++.|++.||+||   |++||+||||||+||+++.++ .+||+|||+|+.....
T Consensus       112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            99999999999875    388999999999999999999   789999999999999999776 8999999999876543


Q ss_pred             CcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccch-hhhhhhccccc-
Q 002214          818 DSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL-PAVMNIMDTNL-  894 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-  894 (952)
                      ..  .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.................. +...+.++... 
T Consensus       185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            32  234568999999998876 67899999999999999999999998543222211111111000 01111111000 


Q ss_pred             --------------cchhhH-HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          895 --------------LSEDEE-HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       895 --------------~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                                    ...... .....+..+++++.+++.+||+.||++|||++|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                          000000 0001123367889999999999999999999999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.1e-38  Score=350.60  Aligned_cols=257  Identities=26%  Similarity=0.388  Sum_probs=207.5

Q ss_pred             HHHHHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--------hhhHHHHHHHHHHHhC-CCCccceeee
Q 002214          658 ELLRATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--------GALNSFDAECEILKTI-RHRNLVKIIS  727 (952)
Q Consensus       658 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~  727 (952)
                      ......++|.+.+.||+|+||.||+|++. +|+.||||+++....        ...+.+.+|+.+++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34455678999999999999999999985 799999999865431        1245688999999999 7999999999


Q ss_pred             EeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEec
Q 002214          728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSD  807 (952)
Q Consensus       728 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~D  807 (952)
                      ++...+..++||||+++++|.+++.... .+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFL---HANNIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEEEe
Confidence            9999999999999999999999987643 689999999999999999999   788999999999999999999999999


Q ss_pred             cccccccCCcCcccccccccccccccccccCc------CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc
Q 002214          808 FGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE------GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND  881 (952)
Q Consensus       808 fgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~  881 (952)
                      ||++........  .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||.....  ....     
T Consensus       244 fG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~-----  314 (365)
T 2y7j_A          244 FGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILML-----  314 (365)
T ss_dssp             CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH-----
T ss_pred             cCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHH-----
Confidence            999987654332  234579999999998753      3588899999999999999999999865211  0000     


Q ss_pred             chhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          882 SLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..+.........     ..+..++.++.+++.+||+.||++|||+.|++++
T Consensus       315 -----~~i~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          315 -----RMIMEGQYQFSS-----PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             -----HHHHHTCCCCCH-----HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -----HHHHhCCCCCCC-----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 000000000000     1123456789999999999999999999999874

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.2e-38  Score=377.00  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=202.2

Q ss_pred             ceecCccceEEEEEEe---CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRF---PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      +.||+|+||.||+|.+   .+++.||||+++...  ....+.+.+|++++++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999965   346889999997543  2345789999999999999999999999975 457899999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc--cc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM--KQ  822 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~  822 (952)
                      |+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+.+......  ..
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yL---H~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997544 689999999999999999999   7899999999999999999999999999999877543321  22


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+             ....+.....      
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------------~~~~i~~~~~------  590 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------------VTAMLEKGER------  590 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------------HHHHHHTTCC------
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------------HHHHHHcCCC------
Confidence            23457889999999998899999999999999999998 999986532111             1111111100      


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                       ...+..+++++.++|..||+.||++||++.+|++.|+++..++
T Consensus       591 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          591 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence             0123457888999999999999999999999999999987765

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.8e-38  Score=349.56  Aligned_cols=271  Identities=21%  Similarity=0.310  Sum_probs=196.9

Q ss_pred             HHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      ....++|++.+.||+|+||+||+|++ .+++.||||+++....  ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            34567899999999999999999987 4789999999865432  23456789999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee-----CCCCcEEEeccccc
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL-----DDSMVAHLSDFGIA  811 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill-----~~~~~~kl~Dfgla  811 (952)
                      +||||++ |+|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||++     +.++.+||+|||+|
T Consensus       110 lv~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFC---HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            9999997 59999887654 689999999999999999999   78899999999999999     45566999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc---ch----
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND---SL----  883 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~~----  883 (952)
                      +....... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+ ........   ..    
T Consensus       185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTS
T ss_pred             cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCchhhh
Confidence            87643322 22345689999999988764 58999999999999999999999986532111 11111000   00    


Q ss_pred             hhhhhh--ccccc-cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          884 PAVMNI--MDTNL-LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       884 ~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +.....  ..... ...........+..+++++.+++.+||+.||++|||+.|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            000000  00000 0000011122334467889999999999999999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.1e-38  Score=355.31  Aligned_cols=252  Identities=21%  Similarity=0.274  Sum_probs=192.7

Q ss_pred             hccCCcc-ceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHh-CCCCccceeeeEeec----CCee
Q 002214          663 TDQFSEE-NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKT-IRHRNLVKIISSCTN----HNFK  735 (952)
Q Consensus       663 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~  735 (952)
                      .++|.+. +.||+|+||+||+|.+. +|+.||||++...     ..+.+|+.++.+ .+||||+++++++..    .+..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3456665 68999999999999884 6899999998522     456788888754 589999999998865    5678


Q ss_pred             EEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC---CCcEEEeccccc
Q 002214          736 ALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD---SMVAHLSDFGIA  811 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgla  811 (952)
                      |+||||+++|+|.+++.... ..+++..+..++.||+.||+||   |++||+||||||+||+++.   ++.+||+|||+|
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999997653 3699999999999999999999   6899999999999999997   789999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      +......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... .    ....   ..
T Consensus       212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~----~~~i---~~  281 (400)
T 1nxk_A          212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-M----KTRI---RM  281 (400)
T ss_dssp             EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-H----HHHH---HH
T ss_pred             cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-H----HHHH---Hc
Confidence            8764322  22345789999999999999999999999999999999999999965332211000 0    0000   00


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .......     .....++.++.+++.+||+.||++|||+.|++++
T Consensus       282 ~~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          282 GQYEFPN-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TCCCCCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CcccCCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0000000     0113467789999999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.6e-38  Score=342.79  Aligned_cols=250  Identities=19%  Similarity=0.290  Sum_probs=207.0

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            3467999999999999999999985 58899999986542   3345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++++|.+++.... .+++.++..++.|+++|++||   |++||+||||||+||+++.++.+||+|||++......
T Consensus        93 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            999999999999887644 689999999999999999999   7889999999999999999999999999999876432


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      .. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ...           .......   
T Consensus       169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~-----------~~~~~~~---  232 (294)
T 2rku_A          169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYL-----------RIKKNEY---  232 (294)
T ss_dssp             TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHH-----------HHHTTCC---
T ss_pred             cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-----------HHhhccC---
Confidence            22 2233568999999999998889999999999999999999999986532110 000           0000000   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                            ..+..++.++.+++.+||+.||++|||+.|++++
T Consensus       233 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                  0123356779999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.9e-38  Score=362.67  Aligned_cols=195  Identities=24%  Similarity=0.355  Sum_probs=155.1

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecC-----Ce
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNH-----NF  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  734 (952)
                      .++|++.+.||+|+||+||+|++. +|+.||||++...  .....+++.+|++++++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999874 6899999998643  233457789999999999999999999998433     56


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .|+||||+ +|+|.+++... ..+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~L---H~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYV---HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHH---HhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 57898888654 3699999999999999999999   7889999999999999999999999999999876


Q ss_pred             CCcCc--------------------------cccccccccccccccccc-CcCCcCcccchHhHHHHHHHHHhCC
Q 002214          815 SEEDS--------------------------MKQTQTLATIGYIAPEYG-REGQVSIKGDVYNYGIMLMEVFTGM  862 (952)
Q Consensus       815 ~~~~~--------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~  862 (952)
                      .....                          ......+||+.|+|||++ ....++.++|||||||++|||++|.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            43221                          112335789999999975 5667999999999999999999943

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5e-38  Score=342.30  Aligned_cols=252  Identities=22%  Similarity=0.318  Sum_probs=203.7

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ..++|.+.+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3467999999999999999999984 799999999976554445678899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee---CCCCcEEEeccccccccCCc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgla~~~~~~  817 (952)
                      |+++++|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+||++   +.++.+||+|||+++.....
T Consensus        87 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           87 LVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYL---HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             cCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            999999999887654 689999999999999999999   78899999999999999   78899999999999764332


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                         ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||....... .....           ........
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i-----------~~~~~~~~  227 (304)
T 2jam_A          163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKI-----------KEGYYEFE  227 (304)
T ss_dssp             ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHH-----------HHCCCCCC
T ss_pred             ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHH-----------HcCCCCCC
Confidence               1223468999999999999899999999999999999999999986521110 00000           00000000


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ...+..+++++.+++.+||..||++|||+.|++++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          228 -----SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             -----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             -----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 00123457789999999999999999999999874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=347.62  Aligned_cols=256  Identities=21%  Similarity=0.256  Sum_probs=192.3

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCccceeeeEee--------cC
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIISSCT--------NH  732 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~  732 (952)
                      ..+|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|+.+++++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            45899999999999999999997 478999999987666666678899999999996 999999999983        34


Q ss_pred             CeeEEEEEccCCCChhHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCeeeCCCCcEEEecc
Q 002214          733 NFKALVLEYMPKGSLEDCMYA--SNFNLDIFQRLGIMIDVASALEYLHFGHSNP--IVHCDIKPSNVLLDDSMVAHLSDF  808 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~--~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~--ivH~Dlk~~Nill~~~~~~kl~Df  808 (952)
                      ...++||||++ |+|.+++..  ....+++.+++.++.|++.||+||   |+.|  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM---HRQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            46799999995 789888865  344699999999999999999999   6778  999999999999999999999999


Q ss_pred             ccccccCCcCccc-----------cccccccccccccccc---CcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccc
Q 002214          809 GIAKLLSEEDSMK-----------QTQTLATIGYIAPEYG---REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS  874 (952)
Q Consensus       809 gla~~~~~~~~~~-----------~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  874 (952)
                      |+++.........           .....+|+.|+|||++   .+..++.++|||||||++|||++|+.||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            9998765432211           1134589999999988   56678999999999999999999999986421110  


Q ss_pred             hhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                         ...           ......       .+..++..+.+++.+||+.||++|||+.|++++|+++....
T Consensus       261 ---~~~-----------~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          261 ---IVN-----------GKYSIP-------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             -------------------CCCC-------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ---hhc-----------CcccCC-------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence               000           000000       01223455889999999999999999999999999997754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3e-38  Score=365.46  Aligned_cols=253  Identities=22%  Similarity=0.310  Sum_probs=206.1

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|++++++++||||+++++++...+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999984 69999999986442   23346788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          739 LEYMPKGSLEDCMYASN---FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      |||++||+|.+++....   ..+++..+..++.||+.||+||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL---HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHH---HHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999887543   3699999999999999999999   78999999999999999999999999999998765


Q ss_pred             CcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      .... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..       .+..... 
T Consensus       341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~-------~i~~~~~-  410 (543)
T 3c4z_A          341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQ-------RVLEQAV-  410 (543)
T ss_dssp             TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHH-------HHHHCCC-
T ss_pred             CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHH-------HHhhccc-
Confidence            4322 2233579999999999999999999999999999999999999996532111 1111100       0010000 


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNT-----KEIIS  936 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~  936 (952)
                              ..+..++.++.+++.+||..||++||++     .|+.+
T Consensus       411 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          411 --------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             --------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             --------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                    0123457789999999999999999975     66654

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=7.4e-38  Score=341.40  Aligned_cols=276  Identities=29%  Similarity=0.488  Sum_probs=205.5

Q ss_pred             CCCCccccccCCCCCCCC--CceEEEeCCC--CeEEEEEecCCCCcc--cCCccccCCcccCeeeccc-cccccccCCCc
Q 002214            5 NPNNILAQNWTSNASVCS--WMGITCDVYG--NRVTSLTISDLGLAG--TIPSHLGNLSSLQTLVLSR-NWFSGTIPKEI   77 (952)
Q Consensus         5 ~~~~~~~~~~~~~~~~c~--w~~v~c~~~~--~~~~~l~l~~~~~~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~l   77 (952)
                      ||. .++ +|..++|||.  |.||+|+...  .+|++|+++++++++  .+|+.++++++|++|+|++ |.+.+.+|..|
T Consensus        20 ~~~-~l~-~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l   97 (313)
T 1ogq_A           20 NPT-TLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI   97 (313)
T ss_dssp             CCG-GGT-TCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGG
T ss_pred             Ccc-ccc-CCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhH
Confidence            565 454 7877789999  9999998654  799999999999999  8999999999999999995 99999999999


Q ss_pred             CCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCcc
Q 002214           78 GNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRL  157 (952)
Q Consensus        78 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L  157 (952)
                      +.+++|++|+|++|++.+.+|..|+++++|++|+|++|.+++.+|..+.++..+ +.|++++|++++.+|..+..-.++|
T Consensus        98 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~~L  176 (313)
T 1ogq_A           98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL-VGITFDGNRISGAIPDSYGSFSKLF  176 (313)
T ss_dssp             GGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTC-CEEECCSSCCEEECCGGGGCCCTTC
T ss_pred             hcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCC-CeEECcCCcccCcCCHHHhhhhhcC
Confidence            999999999999999999999999999999999999999998888888776654 6666666666666665543222266


Q ss_pred             ceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccc
Q 002214          158 KGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQS  237 (952)
Q Consensus       158 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n  237 (952)
                      ++|++++|++++.+|..+..+. |+.|+|++|++++..|..|+.+++|++|+|++|.+++.+|. +..+++|++|+|++|
T Consensus       177 ~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N  254 (313)
T 1ogq_A          177 TSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNN  254 (313)
T ss_dssp             CEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSS
T ss_pred             cEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCC
Confidence            6666666666666666666665 66666666666666666666666666666666666544443 556666666666666


Q ss_pred             cccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCc
Q 002214          238 NLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNN  288 (952)
Q Consensus       238 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~  288 (952)
                      ++.+.+|..+..+++|++|+|++|++++.+|..   ..+++|+.|++++|+
T Consensus       255 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~---~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG---GNLQRFDVSAYANNK  302 (313)
T ss_dssp             CCEECCCGGGGGCTTCCEEECCSSEEEEECCCS---TTGGGSCGGGTCSSS
T ss_pred             cccCcCChHHhcCcCCCEEECcCCcccccCCCC---ccccccChHHhcCCC
Confidence            666666666666666666666666666555542   345555666666655

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-38  Score=352.74  Aligned_cols=271  Identities=23%  Similarity=0.316  Sum_probs=200.8

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-----hhhHHHHHHHHHHHhCCCCccceeeeEeecCCe
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-----GALNSFDAECEILKTIRHRNLVKIISSCTNHNF  734 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  734 (952)
                      ...++|.+.+.||+|+||.||+|++. +|+.||||++.....     ...+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999984 689999999864322     123568899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .++||||+++ +|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+..
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999976 89888887766789999999999999999999   7899999999999999999999999999999876


Q ss_pred             CCcCcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc---ch----hhh
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND---SL----PAV  886 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~~----~~~  886 (952)
                      .... .......+|+.|+|||++.+. .++.++|||||||++|||++|..||......+ .+.+....   ..    +..
T Consensus       163 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~  240 (346)
T 1ua2_A          163 GSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDM  240 (346)
T ss_dssp             TSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSST
T ss_pred             cCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhhhhh
Confidence            4332 223345789999999988654 58899999999999999999999986532111 11111110   00    000


Q ss_pred             hhhccccccchhh-HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 MNIMDTNLLSEDE-EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....+.......+ .........+++++.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000000000000 00011124457889999999999999999999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-38  Score=351.38  Aligned_cols=264  Identities=21%  Similarity=0.282  Sum_probs=197.1

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCC------
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHN------  733 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  733 (952)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++...  .....+++.+|++++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999998 57999999998543  2334567899999999999999999999997653      


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ..|+||||+ +++|.+++...  .+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 88999988763  589999999999999999999   789999999999999999999999999999987


Q ss_pred             cCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhhhhhh
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPAVMNI  889 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~  889 (952)
                      ....    .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+....   .....+....
T Consensus       178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHT
T ss_pred             cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHH
Confidence            5432    234578999999998876 678999999999999999999999986532111 111111   0000111000


Q ss_pred             ccc--------cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          890 MDT--------NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       890 ~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +..        .+..............+++++.+++.+||..||++|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            000        000000000001123457789999999999999999999999884

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.9e-38  Score=348.91  Aligned_cols=249  Identities=19%  Similarity=0.295  Sum_probs=206.5

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|.+.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467999999999999999999984 58899999986542   33456788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++++|.+++.... .+++.++..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999887643 689999999999999999999   78899999999999999999999999999998764332


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      . ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+ .+..           ......    
T Consensus       196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~-----------~~~~~~----  258 (335)
T 2owb_A          196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLR-----------IKKNEY----  258 (335)
T ss_dssp             C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH-----------HHHTCC----
T ss_pred             c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHH-----------HhcCCC----
Confidence            2 2234568999999999988889999999999999999999999986521110 0000           000000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..+..++.++.+++.+||+.||++||++.|++++
T Consensus       259 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 -----SIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 0123456778999999999999999999999874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.1e-38  Score=342.93  Aligned_cols=253  Identities=26%  Similarity=0.363  Sum_probs=202.9

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ...++|.+.+.||+|+||.||+|.+. +|+.||||++....  ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34568999999999999999999885 58999999987543  2467899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++++|.+++......+++..+..++.|++.||+||   |+.||+||||||+||+++.++.+||+|||++....... 
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL---HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-  179 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence            99999999999986666899999999999999999999   78999999999999999999999999999998764322 


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......    ...     ..........     
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~-----~~~~~~~~~~-----  245 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR----AIF-----MIPTNPPPTF-----  245 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHH-----HHHHSCCCCC-----
T ss_pred             cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH----HHH-----HHhcCCCccc-----
Confidence            22234568999999999998899999999999999999999999986532110    000     0000000000     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ..+..++.++.+++.+||+.||++|||+.|++++
T Consensus       246 ----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          246 ----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             ----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                0123457789999999999999999999999874

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.2e-38  Score=341.23  Aligned_cols=245  Identities=22%  Similarity=0.277  Sum_probs=200.4

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  737 (952)
                      ..++|++.+.||+|+||+||+|++. +++.||||++....  ......+.+|+..+.++ +||||+++++++.+++..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999985 79999999987542  33456788999999999 99999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC--------------
Q 002214          738 VLEYMPKGSLEDCMYASN---FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS--------------  800 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~--------------  800 (952)
                      ||||+++++|.+++....   ..+++..+..++.|+++||+||   |++||+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999987642   4689999999999999999999   78999999999999999844              


Q ss_pred             -----CcEEEeccccccccCCcCcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccc
Q 002214          801 -----MVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS  874 (952)
Q Consensus       801 -----~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  874 (952)
                           ..+||+|||.+.......     ...+|+.|+|||.+.+. .++.++|||||||++|||++|..|+...    ..
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQ  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HH
T ss_pred             ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hH
Confidence                 479999999998764332     23589999999998765 5668999999999999999998775331    11


Q ss_pred             hhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .........+                   ..+..+++++.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 WHEIRQGRLP-------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHHHHTTCCC-------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHHHcCCCC-------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            1111111000                   0123457789999999999999999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5e-38  Score=340.89  Aligned_cols=251  Identities=25%  Similarity=0.398  Sum_probs=199.9

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      +|.....||+|+||.||+|.+ .+++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            455556999999999999997 5689999999977666666789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-CCcEEEeccccccccCCcCcc
Q 002214          744 KGSLEDCMYASNF--NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-SMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       744 ~g~L~~~l~~~~~--~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++|.+++.....  .+++..+..++.|++.||+||   |++||+||||||+||+++. ++.+||+|||++........ 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL---HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHH---HhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            9999999976533  467889999999999999999   7889999999999999987 89999999999987643222 


Q ss_pred             cccccccccccccccccCcCC--cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          821 KQTQTLATIGYIAPEYGREGQ--VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      ......|++.|+|||++.+..  ++.++||||||+++|||++|+.||............       .......       
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------~~~~~~~-------  244 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-------VGMFKVH-------  244 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-------HHHHCCC-------
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-------hcccccc-------
Confidence            223356899999999887643  789999999999999999999998653211100000       0000000       


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ...+..+++++.+++.+||+.||++||++.|++++
T Consensus       245 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          245 ----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                01123457789999999999999999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.7e-38  Score=343.89  Aligned_cols=259  Identities=23%  Similarity=0.388  Sum_probs=200.0

Q ss_pred             hccCCccceecCccceEEEEEEeC--CCc--EEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP--DGI--EVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      .++|++.+.||+|+||+||+|++.  +++  .||||+++..   .....+.+.+|++++++++||||+++++++..+. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            457999999999999999999852  333  6899988654   2344578899999999999999999999998765 7


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||+++++|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+++...
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            899999999999999987666799999999999999999999   78899999999999999999999999999998765


Q ss_pred             CcCcc--cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          816 EEDSM--KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       816 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                      .....  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......     ...       ......
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~-------~~~~~~  240 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QIL-------HKIDKE  240 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH-------HHHHTS
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HHH-------HHHHcc
Confidence            43322  1223457889999999988889999999999999999999 99998653211     000       000000


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      ....       ..+..++.++.+++.+||+.||++|||+.+++++|+++...
T Consensus       241 ~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          241 GERL-------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             CCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CCCC-------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            0000       01234677899999999999999999999999999987543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.6e-38  Score=375.63  Aligned_cols=260  Identities=24%  Similarity=0.395  Sum_probs=210.0

Q ss_pred             HhccCCccceecCccceEEEEEEeC----CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      ..++|.+.+.||+|+||.||+|.+.    .+..||||+++... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            4568999999999999999999873    25679999986543 3345678999999999999999999999854 5689


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+++|+|.+++......+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+....
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            99999999999999987776799999999999999999999   788999999999999999999999999999987755


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ..........+|+.|+|||++.+..++.++|||||||++|||++ |..||......+  ...          .+..... 
T Consensus       544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~----------~i~~~~~-  610 (656)
T 2j0j_A          544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIG----------RIENGER-  610 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----------HHHHTCC-
T ss_pred             CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHH----------HHHcCCC-
Confidence            44433344567889999999988899999999999999999997 999986532111  000          0000000 


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                             ...+..+++++.+++.+||+.||++|||+.|+++.|+++.+.-
T Consensus       611 -------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          611 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                   0123456788999999999999999999999999999997664

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.8e-38  Score=338.25  Aligned_cols=248  Identities=24%  Similarity=0.422  Sum_probs=197.5

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            467999999999999999999985 79999999986542   22346789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999987654 689999999999999999999   78899999999999999999999999999998765432


Q ss_pred             cccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      .  .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.....     ...        ...+.....  
T Consensus       166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~--------~~~~~~~~~--  228 (276)
T 2h6d_A          166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTL--------FKKIRGGVF--  228 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH--------HHHHHHCCC--
T ss_pred             c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHH--------HHHhhcCcc--
Confidence            2  223568999999999887765 6899999999999999999999865211     000        000000000  


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                            ..+..++.++.+++.+||+.||++|||+.|++++
T Consensus       229 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 ------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                  0123356779999999999999999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.8e-38  Score=342.34  Aligned_cols=250  Identities=27%  Similarity=0.410  Sum_probs=207.2

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .+.|.+.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            35699999999999999999987 468999999987553 3345789999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+++++|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++....... .
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  174 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I  174 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence            99999999988653  589999999999999999999   78899999999999999999999999999998764332 2


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      ......+++.|+|||++.+..++.++||||||+++|||++|+.||.......  ....+       ..    ...     
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~-------~~----~~~-----  236 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLI-------PK----NNP-----  236 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHH-------HH----SCC-----
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHh-------hc----CCC-----
Confidence            2334568999999999998899999999999999999999999986532110  00000       00    000     


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                        ...+..++.++.+++.+||+.||++|||+.|++++.
T Consensus       237 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          237 --PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             --CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             --CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence              001224567799999999999999999999998763

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.2e-38  Score=355.06  Aligned_cols=264  Identities=13%  Similarity=0.123  Sum_probs=190.1

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc---hhhHHHHHHHHHHHhC--CCCccceee-------eEe
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE---GALNSFDAECEILKTI--RHRNLVKII-------SSC  729 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  729 (952)
                      ...|.+.+.||+|+||+||+|++. +|+.||||++.....   ...+.+.+|+.+++.+  +|||+++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345899999999999999999974 789999999976542   3345677886555544  699987754       444


Q ss_pred             ecC-----------------CeeEEEEEccCCCChhHHhhhcCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeE
Q 002214          730 TNH-----------------NFKALVLEYMPKGSLEDCMYASNFNLDIFQR------LGIMIDVASALEYLHFGHSNPIV  786 (952)
Q Consensus       730 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~------~~i~~~ia~~l~~Lh~~h~~~iv  786 (952)
                      ..+                 ...++||||++ |+|.+++...+..+++..+      ..++.|+++||+||   |++||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L---H~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL---QSKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH---HHTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH---HHCCCc
Confidence            332                 33799999998 8999999875444566666      78889999999999   789999


Q ss_pred             eCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccccccccccccccccCc--CCcCcccchHhHHHHHHHHHhCCCC
Q 002214          787 HCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE--GQVSIKGDVYNYGIMLMEVFTGMKP  864 (952)
Q Consensus       787 H~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p  864 (952)
                      ||||||+|||++.++.+||+|||+|+......    ....+|+.|+|||++.+  ..++.++|||||||++|||++|+.|
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999998764321    13457799999999987  6789999999999999999999999


Q ss_pred             CCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH--HHHHHH
Q 002214          865 TNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS--RLIKIR  942 (952)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~--~L~~i~  942 (952)
                      |.........  .+.......   .......       ......+++++.+++.+||+.||++|||+.|+++  .++++.
T Consensus       293 f~~~~~~~~~--~~~~~~~~~---~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          293 FGLVTPGIKG--SWKRPSLRV---PGTDSLA-------FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             TTBCCTTCTT--CCCBCCTTS---CCCCSCC-------CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             CCCcCccccc--chhhhhhhh---ccccccc-------hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            9765332111  110000000   0000000       0011345778999999999999999999999986  455555


Q ss_pred             HHHh
Q 002214          943 DLLF  946 (952)
Q Consensus       943 ~~~~  946 (952)
                      +...
T Consensus       361 ~~~~  364 (371)
T 3q60_A          361 NEIS  364 (371)
T ss_dssp             HHHH
T ss_pred             HHHh
Confidence            5443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.7e-38  Score=342.00  Aligned_cols=251  Identities=22%  Similarity=0.287  Sum_probs=188.2

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .++|++.+.||+|+||+||+|++ .+|+.||||+++....  ...+.+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46899999999999999999997 5799999999865432  22334455556678889999999999999999999999


Q ss_pred             EccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          740 EYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGHSN-PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       740 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~-~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ||++ |+|.+++..   ....+++..+..++.|++.||+||   |++ ||+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL---HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 588777654   445799999999999999999999   676 99999999999999999999999999998764


Q ss_pred             CcCccccccccccccccccccc----CcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYG----REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      ...  ......||+.|+|||++    .+..++.++||||+|+++|||++|+.||..............           .
T Consensus       162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------~  228 (290)
T 3fme_A          162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV-----------E  228 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH-----------H
T ss_pred             ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh-----------c
Confidence            432  22334699999999985    566789999999999999999999999865322111111111           1


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ......       .+..+++++.+++.+||+.||++|||+.|++++
T Consensus       229 ~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          229 EPSPQL-------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             SCCCCC-------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cCCCCc-------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            110000       112356789999999999999999999999883

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-37  Score=360.64  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=204.1

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ..++|++.+.||+|+||+||+|++. +++.||||++....  ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3568999999999999999999984 78999999986432  23457789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC---CCCcEEEeccccccccC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgla~~~~  815 (952)
                      |||+++|+|.+.+.... .+++..+..++.|++.||+||   |++||+||||||+||+++   .++.+||+|||+|+...
T Consensus       100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999999999887654 689999999999999999999   789999999999999995   55679999999998764


Q ss_pred             CcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ...  ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+ ....           +......
T Consensus       176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~-----------i~~~~~~  240 (486)
T 3mwu_A          176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKR-----------VETGKYA  240 (486)
T ss_dssp             CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH-----------HHHTCCC
T ss_pred             CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-----------HHhCCCC
Confidence            432  2334579999999999875 58999999999999999999999986521110 0011           0000000


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...     ..+..+++++.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          241 FDL-----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             SCS-----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCC-----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000     1123467789999999999999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.7e-38  Score=345.97  Aligned_cols=264  Identities=23%  Similarity=0.371  Sum_probs=188.3

Q ss_pred             HHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ....++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            34567899999999999999999987 468999999886543 2345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccc
Q 002214          738 VLEYMPKGSLEDCMYA-------SNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGI  810 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  810 (952)
                      ||||+++++|.+++..       ....+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL---HKNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999998864       234689999999999999999999   788999999999999999999999999999


Q ss_pred             ccccCCcCcc----cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhh
Q 002214          811 AKLLSEEDSM----KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA  885 (952)
Q Consensus       811 a~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  885 (952)
                      +.........    ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... .......+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~  246 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-LTLQNDPPS  246 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-HHHTSSCCC
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-HHhccCCCc
Confidence            9876533211    1223468999999998865 468899999999999999999999987632221110 000000000


Q ss_pred             hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..        ...  ........++.++.+++.+||+.||++||++.|++++
T Consensus       247 ~~--------~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          247 LE--------TGV--QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             TT--------C-------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cc--------ccc--ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00        000  0000123456789999999999999999999999873

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.2e-37  Score=360.20  Aligned_cols=256  Identities=23%  Similarity=0.372  Sum_probs=202.4

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .++|++.+.||+|+||+||+|++. +++.||+|+++...  ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999985 68999999986543  233567899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC---CCcEEEeccccccccCC
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD---SMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgla~~~~~  816 (952)
                      ||+++|+|.+.+.... .+++..+..++.|+++||+||   |++||+||||||+||+++.   ++.+||+|||+|+....
T Consensus       116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYL---HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999998886654 689999999999999999999   7899999999999999976   45599999999987643


Q ss_pred             cCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          817 EDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       817 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      ..  ......||+.|+|||++. +.++.++||||+||++|+|++|..||......+ .....           .......
T Consensus       192 ~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i-----------~~~~~~~  256 (494)
T 3lij_A          192 QK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-ILRKV-----------EKGKYTF  256 (494)
T ss_dssp             TB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH-----------HHTCCCC
T ss_pred             Cc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-----------HhCCCCC
Confidence            32  233467999999999886 468999999999999999999999986532110 00100           0000000


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR--LIKIR  942 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~i~  942 (952)
                      ..     .....+++++.+++.+||+.||++|||+.|++++  +++..
T Consensus       257 ~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          257 DS-----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             CS-----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             Cc-----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence            00     0123457789999999999999999999999975  44443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.9e-38  Score=346.65  Aligned_cols=267  Identities=26%  Similarity=0.364  Sum_probs=202.0

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc--hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE--GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            468999999999999999999985 589999999865432  23456789999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++++|.++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.......
T Consensus       104 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFC---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHH---HHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            999999888876543 3699999999999999999999   789999999999999999999999999999987644322


Q ss_pred             ccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhhhhhh------
Q 002214          820 MKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPAVMNI------  889 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~------  889 (952)
                       ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+. .....   ....+.....      
T Consensus       180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhccc
Confidence             22345689999999988765 689999999999999999999999865322111 11110   0000110000      


Q ss_pred             ----ccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          890 ----MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       890 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ..+......  ........+++++.+++.+||+.||++|||++|++++
T Consensus       258 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          258 FAGVRLPEIKERE--PLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GTTCCCCCCSSCC--CHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccccCccccccc--hhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                000000000  0111223567889999999999999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.6e-38  Score=351.31  Aligned_cols=266  Identities=22%  Similarity=0.335  Sum_probs=204.7

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357999999999999999999985 68999999987653 3345678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN-PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~-~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      |+++++|.+++.... .+++..+..++.|++.||+||   |++ ||+||||||+||+++.++.+||+|||++......  
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~l---h~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999997654 689999999999999999999   554 8999999999999999999999999999765322  


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhh--------------
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA--------------  885 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------------  885 (952)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+  ...........              
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE--LELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH--HHHHHC-------------------
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccCCCCCCCcccCCC
Confidence             1233568999999999999999999999999999999999999986532111  00000000000              


Q ss_pred             hhhh--ccccccchhhHHH---------HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 VMNI--MDTNLLSEDEEHA---------NVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ~~~~--~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....  .+...........         ......++.++.+++.+||+.||++|||++|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            0000  0000000000000         00112357789999999999999999999999876

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8e-38  Score=352.00  Aligned_cols=273  Identities=21%  Similarity=0.307  Sum_probs=203.4

Q ss_pred             HHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeec-------
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN-------  731 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  731 (952)
                      ....++|++.+.||+|+||+||+|++ .+|+.||||++......    ..+|+++++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999987 57999999998644322    2479999999999999999999843       


Q ss_pred             -------------------------------CCeeEEEEEccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHH
Q 002214          732 -------------------------------HNFKALVLEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYL  777 (952)
Q Consensus       732 -------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~L  777 (952)
                                                     ....++||||++ |+|.+.+..   ....+++..+..++.|+++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334789999997 587777653   345799999999999999999999


Q ss_pred             HhcCCCCeEeCCCCCCCeeeC-CCCcEEEeccccccccCCcCcccccccccccccccccccCcC-CcCcccchHhHHHHH
Q 002214          778 HFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIML  855 (952)
Q Consensus       778 h~~h~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l  855 (952)
                         |++||+||||||+||+++ .++.+||+|||+|+.......  .....+|+.|+|||.+.+. .++.++||||+||++
T Consensus       158 ---H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          158 ---HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             ---HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             ---HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence               799999999999999997 689999999999987644332  2345689999999987764 489999999999999


Q ss_pred             HHHHhCCCCCCccccCccchhhhh---ccchhhhhhhccccc------cchhhHHHHHhhhhhHHHHHHHHhhccccCCC
Q 002214          856 MEVFTGMKPTNEFFTGEMSIKRWI---NDSLPAVMNIMDTNL------LSEDEEHANVAKQSCASSVLSLAMECTSESPE  926 (952)
Q Consensus       856 ~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  926 (952)
                      |||++|+.||......+ .+.+.+   .....+....+....      ...........+..+++++.+++.+||+.||+
T Consensus       233 ~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          233 GELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            99999999986532111 111111   111111000000000      00011122334455788899999999999999


Q ss_pred             CCCCHHHHHHH--HHHHHH
Q 002214          927 NRVNTKEIISR--LIKIRD  943 (952)
Q Consensus       927 ~RPs~~ev~~~--L~~i~~  943 (952)
                      +|||+.|++++  ++++++
T Consensus       312 ~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          312 LRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             GSCCHHHHHTSGGGHHHHH
T ss_pred             hCCCHHHHhcCHHHHHHHh
Confidence            99999999864  566554

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.4e-38  Score=349.25  Aligned_cols=267  Identities=18%  Similarity=0.261  Sum_probs=205.6

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchh-----------------hHHHHHHHHHHHhCCCCcccee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGA-----------------LNSFDAECEILKTIRHRNLVKI  725 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  725 (952)
                      .++|.+.+.||+|+||.||+|.. +|+.||||++.......                 .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 99999999986442111                 1789999999999999999999


Q ss_pred             eeEeecCCeeEEEEEccCCCChhHH------hhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCeee
Q 002214          726 ISSCTNHNFKALVLEYMPKGSLEDC------MYAS-NFNLDIFQRLGIMIDVASALEYLHFGHS-NPIVHCDIKPSNVLL  797 (952)
Q Consensus       726 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~-~~ivH~Dlk~~Nill  797 (952)
                      ++++.+.+..++||||+++|+|.++      +... ...+++..+..++.|++.||+||   |+ +||+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI---HNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH---hccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5542 45799999999999999999999   66 999999999999999


Q ss_pred             CCCCcEEEeccccccccCCcCcccccccccccccccccccCcC-CcCc-ccchHhHHHHHHHHHhCCCCCCccccCccch
Q 002214          798 DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG-QVSI-KGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI  875 (952)
Q Consensus       798 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  875 (952)
                      +.++.+||+|||.+......   ......+++.|+|||.+.+. .++. ++||||||+++|||++|+.||..........
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            99999999999999876432   23345699999999998877 5665 9999999999999999999997543221111


Q ss_pred             hhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          876 KRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ........ ........................++.++.+++.+||+.||++|||+.|++++
T Consensus       263 ~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          263 NNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11111100 00000000000000000011124467889999999999999999999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1e-37  Score=342.86  Aligned_cols=253  Identities=25%  Similarity=0.321  Sum_probs=198.9

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--------chhhHHHHHHHHHHHhCCCCccceeeeEeecC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--------EGALNSFDAECEILKTIRHRNLVKIISSCTNH  732 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  732 (952)
                      ..++|.+.+.||+|+||.||+|++. +++.||||++....        ......+.+|++++++++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4568999999999999999999874 68999999986432        11234578999999999999999999998766


Q ss_pred             CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc---EEEeccc
Q 002214          733 NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV---AHLSDFG  809 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~---~kl~Dfg  809 (952)
                      + .++||||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.   +||+|||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            5 799999999999999886543 689999999999999999999   7899999999999999987664   9999999


Q ss_pred             cccccCCcCcccccccccccccccccccC---cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhh
Q 002214          810 IAKLLSEEDSMKQTQTLATIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV  886 (952)
Q Consensus       810 la~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  886 (952)
                      +++......  ......||+.|+|||++.   ...++.++|||||||++|||++|..||................     
T Consensus       163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----  235 (322)
T 2ycf_A          163 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG-----  235 (322)
T ss_dssp             TCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT-----
T ss_pred             cceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC-----
Confidence            998764322  122346899999999863   5678899999999999999999999997533221111111000     


Q ss_pred             hhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                             ....    ....+..+++++.+++.+||+.||++||++.|++++
T Consensus       236 -------~~~~----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          236 -------KYNF----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             -------CCCC----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -------cccc----CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence                   0000    011123457789999999999999999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-37  Score=362.96  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=202.9

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-------------hhhHHHHHHHHHHHhCCCCccceeee
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-------------GALNSFDAECEILKTIRHRNLVKIIS  727 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  727 (952)
                      ..++|.+.+.||+|+||+||+|+.. +++.||||++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999984 688999999864321             23467899999999999999999999


Q ss_pred             EeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC---cEE
Q 002214          728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM---VAH  804 (952)
Q Consensus       728 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~---~~k  804 (952)
                      ++.+.+..++||||+++|+|.+.+.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYL---HKHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999999887654 699999999999999999999   789999999999999998776   699


Q ss_pred             EeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchh
Q 002214          805 LSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP  884 (952)
Q Consensus       805 l~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  884 (952)
                      |+|||+|+......  ......||+.|+|||++. +.++.++||||+||++|+|++|..||......  ...        
T Consensus       190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~--------  256 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DII--------  256 (504)
T ss_dssp             ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH--------
T ss_pred             EEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHH--------
Confidence            99999998765432  233467999999999887 46899999999999999999999998652211  000        


Q ss_pred             hhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          885 AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                        ..+.........     ..+..+++++.+++.+||..||.+|||+.|++++
T Consensus       257 --~~i~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          257 --KKVEKGKYYFDF-----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             --HHHHHCCCCCCH-----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HHHHcCCCCCCc-----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence              001111110000     1123467889999999999999999999999865

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.1e-37  Score=345.47  Aligned_cols=265  Identities=20%  Similarity=0.217  Sum_probs=193.3

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCC------
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHN------  733 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  733 (952)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999874 6899999998653  2334567889999999999999999999997654      


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ..++||||+++ +|.+.+..   .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            78999999975 78777752   489999999999999999999   788999999999999999999999999999986


Q ss_pred             cCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhhhh---
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPAVM---  887 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~---  887 (952)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.....   ...++..   
T Consensus       177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC-CCCCCHHHHTTS
T ss_pred             ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHHh
Confidence            54321  223457899999999999889999999999999999999999998653211 11111111   0001100   


Q ss_pred             -----hhcccccc-c-h-hhH--------HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          888 -----NIMDTNLL-S-E-DEE--------HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       888 -----~~~~~~~~-~-~-~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..+..... . . ...        .........+.++.+++.+||..||++|||++|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                 00000000 0 0 000        0000122347789999999999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-37  Score=362.55  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=205.8

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999985 79999999986442   33457789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee---CCCCcEEEeccccccccC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL---DDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgla~~~~  815 (952)
                      |||+++|+|.+.+.... .+++..+..++.|++.||+||   |++||+||||||+||++   +.++.+||+|||+|+...
T Consensus       105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYM---HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999887654 699999999999999999999   78899999999999999   567899999999998765


Q ss_pred             CcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ....  .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||......  ....          .+......
T Consensus       181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~----------~i~~~~~~  245 (484)
T 3nyv_A          181 ASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILK----------KVEKGKYT  245 (484)
T ss_dssp             CCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----------HHHHCCCC
T ss_pred             cccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHH----------HHHcCCCC
Confidence            4332  233569999999998865 6899999999999999999999998652111  1100          01111100


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...     ..+..+++++.+++.+||+.||++|||+.|++++
T Consensus       246 ~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          246 FEL-----PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             CCS-----GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            000     1123467889999999999999999999999874

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.5e-38  Score=340.28  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=201.9

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEee--cCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCT--NHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  737 (952)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999884 68999999987543  334567899999999999999999999874  4578899


Q ss_pred             EEEccCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeCCCCCCCeeeCCCCcEEEeccc
Q 002214          738 VLEYMPKGSLEDCMYAS---NFNLDIFQRLGIMIDVASALEYLHFGHSNP-----IVHCDIKPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~-----ivH~Dlk~~Nill~~~~~~kl~Dfg  809 (952)
                      ||||+++++|.+++...   ...+++..++.++.|++.||+||   |+.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC---HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH---hcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998753   23589999999999999999999   5666     9999999999999999999999999


Q ss_pred             cccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhh
Q 002214          810 IAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNI  889 (952)
Q Consensus       810 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  889 (952)
                      +++....... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......  ....           .
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~-----------~  227 (279)
T 2w5a_A          162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAG-----------K  227 (279)
T ss_dssp             HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH-----------H
T ss_pred             hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHH-----------H
Confidence            9987643322 122346899999999998888999999999999999999999998653211  0000           0


Q ss_pred             ccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 002214          890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL  938 (952)
Q Consensus       890 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  938 (952)
                      +......       ..+..++.++.+++.+||+.||++||++.|+++++
T Consensus       228 i~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          228 IREGKFR-------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHTCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             Hhhcccc-------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            0000000       01234577899999999999999999999999765

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.6e-38  Score=348.79  Aligned_cols=264  Identities=20%  Similarity=0.270  Sum_probs=185.6

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecC------C
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNH------N  733 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  733 (952)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++...  .....+.+.+|++++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999987 56899999998643  233456788999999999999999999998654      5


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ..++||||+ +++|.+++..  ..+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||+|+.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 7899988865  3699999999999999999999   789999999999999999999999999999986


Q ss_pred             cCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhh---hccchhhhhhh
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW---INDSLPAVMNI  889 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~  889 (952)
                      ....    .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+...   .....++....
T Consensus       182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHTT
T ss_pred             cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHH
Confidence            5432    234578999999998876 67899999999999999999999998653211 111111   11111110000


Q ss_pred             ccc--------cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          890 MDT--------NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       890 ~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +..        .+..............+++++.+|+.+||..||++|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            000        000000000011123456789999999999999999999999875

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.2e-36  Score=348.71  Aligned_cols=353  Identities=20%  Similarity=0.258  Sum_probs=246.0

Q ss_pred             CeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEee
Q 002214           33 NRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVL  112 (952)
Q Consensus        33 ~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  112 (952)
                      .++++|+++++.+++ +| .++.+++|++|+|++|++++ +|  ++.+++|++|+|++|++.+ +|  ++++++|++|++
T Consensus        42 ~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L  113 (457)
T 3bz5_A           42 ATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNC  113 (457)
T ss_dssp             TTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred             CCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEEC
Confidence            578999999999996 46 79999999999999999995 45  8999999999999999995 44  899999999999


Q ss_pred             cCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCccc
Q 002214          113 NNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFT  192 (952)
Q Consensus       113 ~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~  192 (952)
                      ++|++++ +|  +                          ..+++|++|++++|++++.   .++.+++|+.|++++|+..
T Consensus       114 ~~N~l~~-l~--~--------------------------~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~  161 (457)
T 3bz5_A          114 DTNKLTK-LD--V--------------------------SQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKI  161 (457)
T ss_dssp             CSSCCSC-CC--C--------------------------TTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCC
T ss_pred             CCCcCCe-ec--C--------------------------CCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCcc
Confidence            9999883 32  2                          3456788888888888753   2777888888888888544


Q ss_pred             ccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcc
Q 002214          193 GRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKN  272 (952)
Q Consensus       193 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  272 (952)
                      +.+  .++.+++|++|++++|++++ +|  ++.+++|+.|++++|++.+.   .+..+++|++|++++|++++ +|    
T Consensus       162 ~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip----  228 (457)
T 3bz5_A          162 TKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID----  228 (457)
T ss_dssp             CCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC----
T ss_pred             ccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC----
Confidence            344  47778888888888888875 44  77888888888888888776   37778888888888888886 33    


Q ss_pred             cCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcc
Q 002214          273 LIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINL  352 (952)
Q Consensus       273 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L  352 (952)
                      +..+++|+.|++++|++++..+.                                                    .+++|
T Consensus       229 ~~~l~~L~~L~l~~N~l~~~~~~----------------------------------------------------~l~~L  256 (457)
T 3bz5_A          229 VTPLTQLTYFDCSVNPLTELDVS----------------------------------------------------TLSKL  256 (457)
T ss_dssp             CTTCTTCSEEECCSSCCSCCCCT----------------------------------------------------TCTTC
T ss_pred             ccccCCCCEEEeeCCcCCCcCHH----------------------------------------------------HCCCC
Confidence            66788888899988888865332                                                    22233


Q ss_pred             cEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEecccc
Q 002214          353 TTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSN  432 (952)
Q Consensus       353 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  432 (952)
                      +.|++++|              +|+.|++++|.+.+..|  +..+++|+.|++++|...+.+|.   ..++|+.|++++|
T Consensus       257 ~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~  317 (457)
T 3bz5_A          257 TTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN  317 (457)
T ss_dssp             CEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC
T ss_pred             CEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc
Confidence            33443332              12333444444333222  23344444444444444333332   2234444444433


Q ss_pred             ccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccc
Q 002214          433 ELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPE  512 (952)
Q Consensus       433 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  512 (952)
                                   ++|+.|++++|++++. +  +..+++|+.|++++|++++        ++.|..|++++|++.|.   
T Consensus       318 -------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~---  370 (457)
T 3bz5_A          318 -------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE---  370 (457)
T ss_dssp             -------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE---
T ss_pred             -------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec---
Confidence                         4566666666666653 2  6666777777777777764        24566677777877754   


Q ss_pred             cccccccccEEeCCCCcccccCccch
Q 002214          513 SFGELVSLEFLDLSNNDLSGVIPASL  538 (952)
Q Consensus       513 ~~~~l~~L~~L~Ls~N~l~~~~~~~~  538 (952)
                        ..+..|+.+++++|+++|.+|..+
T Consensus       371 --~~~~~l~~l~l~~N~l~g~ip~~~  394 (457)
T 3bz5_A          371 --GQTITMPKETLTNNSLTIAVSPDL  394 (457)
T ss_dssp             --EEEEECCCBCCBTTBEEEECCTTC
T ss_pred             --ceeeecCccccccCcEEEEcChhH
Confidence              345667778888888888777654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.4e-37  Score=345.72  Aligned_cols=269  Identities=21%  Similarity=0.279  Sum_probs=203.4

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecC-----Ce
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNH-----NF  734 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  734 (952)
                      ..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3468999999999999999999874 68899999986543 33447789999999999999999999998654     46


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .++||||++ |+|.+++...  .+++.++..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++..
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            899999996 5899988764  489999999999999999999   7899999999999999999999999999999876


Q ss_pred             CCcCccc--ccccccccccccccccC-cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhhhhh
Q 002214          815 SEEDSMK--QTQTLATIGYIAPEYGR-EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPAVMN  888 (952)
Q Consensus       815 ~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~  888 (952)
                      .......  .....||+.|+|||++. ...++.++||||+||++|||++|+.||......+ ......   .....+...
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH
Confidence            5433221  23357999999999764 4458999999999999999999999986532211 111111   111000000


Q ss_pred             -hcc-------ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          889 -IMD-------TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       889 -~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ..+       .................++.++.+++.+||+.||++|||+.|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             000       0000000000011123457789999999999999999999999874

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.9e-37  Score=341.18  Aligned_cols=256  Identities=19%  Similarity=0.261  Sum_probs=203.2

Q ss_pred             HHHhccCCcc-ceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCe
Q 002214          660 LRATDQFSEE-NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNF  734 (952)
Q Consensus       660 ~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  734 (952)
                      ....++|.+. +.||+|+||.||+|... +|+.||+|++....  ......+.+|+.+++++ +||||+++++++.+.+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            4456678877 89999999999999885 69999999986543  23356789999999999 56999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC---CCcEEEecccc
Q 002214          735 KALVLEYMPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD---SMVAHLSDFGI  810 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgl  810 (952)
                      .++||||+++|+|.+++... ...+++.++..++.|++.||+||   |++||+||||||+||+++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~L---H~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL---HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            99999999999999988643 34689999999999999999999   7899999999999999998   78999999999


Q ss_pred             ccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          811 AKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       811 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      ++.......  .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .....        ... 
T Consensus       181 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i--------~~~-  248 (327)
T 3lm5_A          181 SRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-TYLNI--------SQV-  248 (327)
T ss_dssp             CEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH--------HHT-
T ss_pred             ccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHH--------Hhc-
Confidence            987643322  233569999999999999999999999999999999999999986522111 00000        000 


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .....       ......+++.+.+++.+||+.||++|||++|++++
T Consensus       249 ~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          249 NVDYS-------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             CCCCC-------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ccccC-------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            00000       00123457789999999999999999999999865

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=353.62  Aligned_cols=268  Identities=20%  Similarity=0.276  Sum_probs=182.9

Q ss_pred             ccCCc-cceecCccceEEEEEEeC---CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEee--cCCeeEE
Q 002214          664 DQFSE-ENLIGIGSYGSVYKGRFP---DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT--NHNFKAL  737 (952)
Q Consensus       664 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  737 (952)
                      +.|.+ +++||+|+||+||+|+..   +++.||||++.....  ...+.+|+.++++++||||+++++++.  .....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            45665 568999999999999964   578999999864432  357889999999999999999999995  4678999


Q ss_pred             EEEccCCCChhHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee----CCCCcEEE
Q 002214          738 VLEYMPKGSLEDCMYAS--------NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL----DDSMVAHL  805 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill----~~~~~~kl  805 (952)
                      ||||++ |+|.+++...        ...+++..+..++.|++.||+||   |++||+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999996 4787776532        12489999999999999999999   78999999999999999    77899999


Q ss_pred             eccccccccCCcCc--ccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccc
Q 002214          806 SDFGIAKLLSEEDS--MKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS  882 (952)
Q Consensus       806 ~Dfgla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  882 (952)
                      +|||+|+.......  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............+....
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987653221  22234678999999998876 4589999999999999999999999965322110000000000


Q ss_pred             hhhhhhhc------------------------cccccchh--hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          883 LPAVMNIM------------------------DTNLLSED--EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       883 ~~~~~~~~------------------------~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                      ...+.+.+                        ........  ...........++++.+|+.+||..||++|||++|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000                        00000000  00000001112567899999999999999999999987


Q ss_pred             H
Q 002214          937 R  937 (952)
Q Consensus       937 ~  937 (952)
                      +
T Consensus       334 h  334 (405)
T 3rgf_A          334 D  334 (405)
T ss_dssp             S
T ss_pred             C
Confidence            5

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-38  Score=345.98  Aligned_cols=260  Identities=24%  Similarity=0.370  Sum_probs=200.3

Q ss_pred             cCHHHHHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeec
Q 002214          654 YSHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTN  731 (952)
Q Consensus       654 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  731 (952)
                      ++..++....++|++.+.||+|+||.||+|++ .+|+.||||++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            33344445678899999999999999999998 5789999999865433 346789999999999 89999999999876


Q ss_pred             ------CCeeEEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEE
Q 002214          732 ------HNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAH  804 (952)
Q Consensus       732 ------~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~k  804 (952)
                            .+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTCCEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCcHHHEEEcCCCCEE
Confidence                  467899999999999999987643 4689999999999999999999   788999999999999999999999


Q ss_pred             EeccccccccCCcCcccccccccccccccccccC-----cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh
Q 002214          805 LSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR-----EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI  879 (952)
Q Consensus       805 l~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~  879 (952)
                      |+|||++....... .......+++.|+|||++.     +..++.++|||||||++|||++|+.||....... ......
T Consensus       170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~  247 (326)
T 2x7f_A          170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALFLIP  247 (326)
T ss_dssp             ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHH
T ss_pred             EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhh
Confidence            99999998664322 1223356899999999886     5678899999999999999999999986532110 000000


Q ss_pred             ccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          880 NDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       880 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...        ....          .+..++.++.+++.+||..||++||++.|++++
T Consensus       248 ~~~--------~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          248 RNP--------APRL----------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HSC--------CCCC----------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cCc--------cccC----------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000        0000          112356789999999999999999999999874

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.6e-37  Score=352.33  Aligned_cols=266  Identities=20%  Similarity=0.228  Sum_probs=200.1

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC--------CCccceeeeEee---
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIR--------HRNLVKIISSCT---  730 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  730 (952)
                      .++|++.+.||+|+||+||+|++ .+++.||||+++.. ....+.+.+|++++++++        ||||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            46899999999999999999987 46899999998643 334567889999999985        788999999987   


Q ss_pred             -cCCeeEEEEEccCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCeeeCCCC------
Q 002214          731 -NHNFKALVLEYMPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSN-PIVHCDIKPSNVLLDDSM------  801 (952)
Q Consensus       731 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~-~ivH~Dlk~~Nill~~~~------  801 (952)
                       .....++||||+ ++++.+.+... ...+++..+..++.|++.||+||   |++ ||+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL---HTKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCCCHHHeeEeccchhhhhh
Confidence             556889999999 55666655443 35799999999999999999999   677 999999999999999775      


Q ss_pred             -------------------------------------------cEEEeccccccccCCcCcccccccccccccccccccC
Q 002214          802 -------------------------------------------VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR  838 (952)
Q Consensus       802 -------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~  838 (952)
                                                                 .+||+|||+|+.....    .....||+.|+|||++.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence                                                       7999999999876432    23356899999999999


Q ss_pred             cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccch-----hhh---hccchhhh-------hhhcccc----------
Q 002214          839 EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI-----KRW---INDSLPAV-------MNIMDTN----------  893 (952)
Q Consensus       839 ~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-----~~~---~~~~~~~~-------~~~~~~~----------  893 (952)
                      +..++.++|||||||++|||++|+.||......+...     ...   ....-...       ...+...          
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            8889999999999999999999999997543222110     000   00000000       0000000          


Q ss_pred             ccchhh--HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDE--EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ......  ......+...++++.+|+.+||+.||++|||++|++++
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            000000  00001134567889999999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.7e-37  Score=333.69  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=204.5

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---------chhhHHHHHHHHHHHhCC-CCccceeeeEe
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---------EGALNSFDAECEILKTIR-HRNLVKIISSC  729 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  729 (952)
                      ...++|.+.+.||+|+||.||+|.+. +|+.||||++....         ....+.+.+|++++++++ ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999984 68999999986543         122456889999999995 99999999999


Q ss_pred             ecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccc
Q 002214          730 TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       730 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  809 (952)
                      ...+..++||||+++++|.+++.... .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            99999999999999999999987653 689999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCcCcccccccccccccccccccC------cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccch
Q 002214          810 IAKLLSEEDSMKQTQTLATIGYIAPEYGR------EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL  883 (952)
Q Consensus       810 la~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  883 (952)
                      ++........  .....+++.|+|||++.      ...++.++||||||+++|||++|+.||......  ...       
T Consensus       170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~-------  238 (298)
T 1phk_A          170 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LML-------  238 (298)
T ss_dssp             TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH-------
T ss_pred             chhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--HHH-------
Confidence            9987654322  23356899999999874      456889999999999999999999998542110  000       


Q ss_pred             hhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                         ............     .....++.++.+++.+||+.||++|||+.|+++
T Consensus       239 ---~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          239 ---RMIMSGNYQFGS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             ---HHHHHTCCCCCT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ---HHHhcCCcccCc-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence               000010000000     011345778999999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.9e-37  Score=353.27  Aligned_cols=265  Identities=21%  Similarity=0.286  Sum_probs=203.0

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhC------CCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTI------RHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  735 (952)
                      ..+|++.+.||+|+||+||+|.+. +++.||||+++... .....+.+|+++++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999874 58999999986432 2345677888888887      577999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc--EEEecccccc
Q 002214          736 ALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV--AHLSDFGIAK  812 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgla~  812 (952)
                      ++||||+. ++|.+++.... ..+++..+..++.|+++||+||   |++||+||||||+|||++.++.  +||+|||+|+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL---HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999995 68988887654 3589999999999999999999   6889999999999999999887  9999999997


Q ss_pred             ccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhhh---
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPAV---  886 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~---  886 (952)
                      .....    .....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..+..   ...+..   
T Consensus       251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~-~l~~i~~~~~~p~~~~~~~  325 (429)
T 3kvw_A          251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD-QLACMIELLGMPSQKLLDA  325 (429)
T ss_dssp             ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHT
T ss_pred             ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHh
Confidence            65332    223568999999999999899999999999999999999999986532211 1111110   000000   


Q ss_pred             ----hhhccccc-----------------------------cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHH
Q 002214          887 ----MNIMDTNL-----------------------------LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKE  933 (952)
Q Consensus       887 ----~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  933 (952)
                          ...++..-                             ...........+...++++.+|+.+||+.||++|||++|
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e  405 (429)
T 3kvw_A          326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ  405 (429)
T ss_dssp             BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence                00000000                             000011111222334678999999999999999999999


Q ss_pred             HHHH
Q 002214          934 IISR  937 (952)
Q Consensus       934 v~~~  937 (952)
                      ++++
T Consensus       406 ~L~H  409 (429)
T 3kvw_A          406 ALRH  409 (429)
T ss_dssp             HHTS
T ss_pred             HhCC
Confidence            9874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-37  Score=373.05  Aligned_cols=250  Identities=20%  Similarity=0.276  Sum_probs=205.9

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCee
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  735 (952)
                      ...++|.+.+.||+|+||.||+|+.. +++.||||+++..   .....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            34578999999999999999999874 6889999998743   233456788999999988 799999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      |+||||+++|+|.+++...+ .+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+...
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999999999999998654 699999999999999999999   78999999999999999999999999999998643


Q ss_pred             CcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+.           .++.... 
T Consensus       494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-~~~~~-----------~i~~~~~-  559 (674)
T 3pfq_A          494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ-----------SIMEHNV-  559 (674)
T ss_dssp             CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH-----------HHHSSCC-
T ss_pred             cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-HHHHH-----------HHHhCCC-
Confidence            322 223446799999999999999999999999999999999999999865211 10111           1111111 


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNT-----KEIIS  936 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~  936 (952)
                              ..+..+++++.+|+.+||+.||++||++     .||.+
T Consensus       560 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                    0123457789999999999999999997     66654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.7e-37  Score=338.23  Aligned_cols=267  Identities=20%  Similarity=0.298  Sum_probs=196.5

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEee-----------
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCT-----------  730 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  730 (952)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467999999999999999999985 58999999998776666788999999999999999999999873           


Q ss_pred             ---cCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC-CCCcEEEe
Q 002214          731 ---NHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLS  806 (952)
Q Consensus       731 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~-~~~~~kl~  806 (952)
                         +....++||||++ |+|.+++..  ..+++..+..++.|+++||+||   |++||+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYI---HSANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               3467899999997 699998865  3589999999999999999999   789999999999999997 67799999


Q ss_pred             ccccccccCCcCc--ccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccc-
Q 002214          807 DFGIAKLLSEEDS--MKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDS-  882 (952)
Q Consensus       807 Dfgla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-  882 (952)
                      |||+++.......  .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ......... 
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~  242 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILESIP  242 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHSC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence            9999987643221  11223457899999997754 678999999999999999999999986532111 111111000 


Q ss_pred             ------hhhhhhhc----cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          883 ------LPAVMNIM----DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       883 ------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                            .++....+    ........ .........++.++.+++.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPH-KPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCC-CCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCchhhhhhhhhcCcccccccccCCC-CChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence                  00000000    00000000 00011223567889999999999999999999999874

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.5e-37  Score=345.04  Aligned_cols=263  Identities=20%  Similarity=0.262  Sum_probs=197.9

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCee----
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFK----  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  735 (952)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999874 68999999986542  33356788999999999999999999999877654    


Q ss_pred             --EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          736 --ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       736 --~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                        ++||||++ ++|.+.+.   ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999996 68877763   3489999999999999999999   788999999999999999999999999999986


Q ss_pred             cCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhhhhhh
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPAVMNI  889 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~  889 (952)
                      ....    .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .......   ....+....
T Consensus       194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHTT
T ss_pred             cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHHHHHH
Confidence            5432    234568999999998876 678999999999999999999999996532111 1111100   000000000


Q ss_pred             cc--------ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          890 MD--------TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       890 ~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +.        .................+++++.+++.+||+.||++|||++|++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00        0000000000111223467889999999999999999999999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.8e-37  Score=348.18  Aligned_cols=265  Identities=24%  Similarity=0.346  Sum_probs=196.9

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCC------eeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN------FKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  736 (952)
                      ..+|++.+.||+|+||+||+|++..+..||+|++......    ..+|+++++.++||||+++++++...+      ..+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3579999999999999999999977777999988543322    237999999999999999999985433      378


Q ss_pred             EEEEccCCCChhHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC-CCCcEEEeccccccc
Q 002214          737 LVLEYMPKGSLEDCMY--ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKL  813 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~--~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgla~~  813 (952)
                      +||||++++.+.....  .....+++..+..++.|+++||+||   |++||+||||||+||+++ .++.+||+|||+|+.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI---HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999998754443322  2345799999999999999999999   789999999999999999 899999999999987


Q ss_pred             cCCcCcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhhhhhh
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPAVMNI  889 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~  889 (952)
                      ......  .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+....   .....+....
T Consensus       192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHh
Confidence            644332  2345689999999988664 58999999999999999999999986532111 111111   1111111111


Q ss_pred             cccccc-----c-hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          890 MDTNLL-----S-EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       890 ~~~~~~-----~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +.....     . .........+..+++++.+++.+||..||++|||+.|++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            111000     0 00011112233467889999999999999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.5e-37  Score=335.94  Aligned_cols=251  Identities=22%  Similarity=0.349  Sum_probs=197.8

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC----chhhHHHHHHHHHHHhCCCCccceeeeEee--cCCe
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR----EGALNSFDAECEILKTIRHRNLVKIISSCT--NHNF  734 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~  734 (952)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++....    ....+.+.+|++++++++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            346899999999999999999998 468999999986542    234577899999999999999999999984  4567


Q ss_pred             eEEEEEccCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      .++||||++++ +.+++... ...+++..+..++.|+++||+||   |++||+||||||+||+++.++.+||+|||.+..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL---HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999876 66666543 34689999999999999999999   788999999999999999999999999999987


Q ss_pred             cCCcCc-ccccccccccccccccccCcCC--cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          814 LSEEDS-MKQTQTLATIGYIAPEYGREGQ--VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       814 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      ...... .......+++.|+|||++.+..  ++.++||||||+++|||++|+.||.....     ....        ..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~--------~~i  225 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YKLF--------ENI  225 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHH--------HHH
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHH--------HHH
Confidence            643221 1223356899999999887643  47899999999999999999999865211     1100        000


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....        ...+..+++++.+++.+||+.||++|||+.|++++
T Consensus       226 ~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          226 GKGS--------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHCC--------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             hcCC--------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000        00123457789999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.4e-37  Score=336.85  Aligned_cols=253  Identities=23%  Similarity=0.348  Sum_probs=194.9

Q ss_pred             HhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeec---------
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN---------  731 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  731 (952)
                      ..++|++.+.||+|+||.||+|+. .+|+.||||++... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            456899999999999999999997 47999999998643 3345778999999999999999999998754         


Q ss_pred             ----CCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEec
Q 002214          732 ----HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSD  807 (952)
Q Consensus       732 ----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~D  807 (952)
                          .+..++||||+++|+|.+++......+++..++.++.|+++||+||   |++||+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI---HSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHH---HhCCeecccCCHHhEEEcCCCCEEEee
Confidence                3568999999999999999987766788999999999999999999   788999999999999999999999999


Q ss_pred             cccccccCCcC-------------cccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCcc
Q 002214          808 FGIAKLLSEED-------------SMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM  873 (952)
Q Consensus       808 fgla~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  873 (952)
                      ||+++......             ........|++.|+|||++.+. .++.++|||||||++|||++   ||........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            99998764321             1112335689999999988754 68999999999999999998   5432111000


Q ss_pred             chhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          874 SIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .....        .. ......       ...+..++..+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~--------~~-~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          237 ILKKL--------RS-VSIEFP-------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHH--------HS-TTCCCC-------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHhc--------cc-cccccC-------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            00000        00 000000       00123346678999999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.3e-37  Score=338.64  Aligned_cols=269  Identities=23%  Similarity=0.323  Sum_probs=202.9

Q ss_pred             HhccCCccceecCccceEEEEEEe--CCCcEEEEEEeeccCc--hhhHHHHHHHHHHHhC---CCCccceeeeEee----
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQRE--GALNSFDAECEILKTI---RHRNLVKIISSCT----  730 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----  730 (952)
                      ..++|++.+.||+|+||.||+|++  .+|+.||+|+++....  .....+.+|+.+++++   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999998  4688999999865432  2234567788877776   8999999999987    


Q ss_pred             -cCCeeEEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecc
Q 002214          731 -NHNFKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDF  808 (952)
Q Consensus       731 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Df  808 (952)
                       .....++||||++ |+|.+++.... ..+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5567899999997 69999987654 3589999999999999999999   7889999999999999999999999999


Q ss_pred             ccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc---c-hh
Q 002214          809 GIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND---S-LP  884 (952)
Q Consensus       809 gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~-~~  884 (952)
                      |+++......  ......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+ ........   . ..
T Consensus       165 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          165 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEE  241 (326)
T ss_dssp             CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGG
T ss_pred             cccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCcc
Confidence            9998764322  2334568999999999998899999999999999999999999986532111 11111100   0 00


Q ss_pred             hhhhhc---cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          885 AVMNIM---DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       885 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ......   ..................++.++.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000   00000000000011223467889999999999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.4e-38  Score=343.18  Aligned_cols=260  Identities=24%  Similarity=0.353  Sum_probs=202.0

Q ss_pred             HHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ...++|++.+.||+|+||.||+|++.+  .||+|+++...  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            346789999999999999999999843  49999986542  22345678899999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++++|.+++...+..+++..+..++.|+++||+||   |++||+||||||+||+++ ++.+||+|||+++......
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHH---HHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            999999999999987776799999999999999999999   788999999999999998 6799999999987653211


Q ss_pred             ----cccccccccccccccccccCc---------CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhh
Q 002214          819 ----SMKQTQTLATIGYIAPEYGRE---------GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA  885 (952)
Q Consensus       819 ----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  885 (952)
                          ........|++.|+|||++..         ..++.++||||||+++|||++|+.||....... .....       
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~-------  255 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-IIWQM-------  255 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-HHHHH-------
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHh-------
Confidence                112223458999999998764         357889999999999999999999986532111 00000       


Q ss_pred             hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          886 VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                       ........          .+..++.++.+++.+||+.||++|||+.|+++.|+++.++.
T Consensus       256 -~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          256 -GTGMKPNL----------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             -HTTCCCCC----------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             -ccCCCCCC----------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence             00000000          01134567899999999999999999999999999887664

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.7e-37  Score=340.65  Aligned_cols=267  Identities=22%  Similarity=0.255  Sum_probs=200.7

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecC-----Cee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNH-----NFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  735 (952)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++.... ......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999984 68999999986443 33456788999999999999999999988654     678


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      ++||||++ |+|.+++...  .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+|+...
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVL---HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999996 6899988763  589999999999999999999   78899999999999999999999999999998765


Q ss_pred             CcCcc---------cccccccccccccccccC-cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccc
Q 002214          816 EEDSM---------KQTQTLATIGYIAPEYGR-EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDS  882 (952)
Q Consensus       816 ~~~~~---------~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~  882 (952)
                      .....         ......||+.|+|||++. +..++.++|||||||++|||++|+.||......+ ......   ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~  242 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGTP  242 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Confidence            32211         112246899999999765 4678999999999999999999999986532110 000000   000


Q ss_pred             ----------hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          883 ----------LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       883 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                                .+...+.+...... ...........+++++.+++.+||+.||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMY-PAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCC-CCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             chhccccccccchhhHHhhcccCC-CCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                      00000000000000 0000111224567889999999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.8e-37  Score=338.31  Aligned_cols=254  Identities=24%  Similarity=0.318  Sum_probs=180.0

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCc-hhhHHHHHHHH-HHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-GALNSFDAECE-ILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++.... .....+..|+. +++.++||||+++++++..++..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            468999999999999999999984 799999999975532 33345556665 677789999999999999999999999


Q ss_pred             EccCCCChhHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          740 EYMPKGSLEDCMYA----SNFNLDIFQRLGIMIDVASALEYLHFGHSN-PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       740 e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~-~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      ||+++ +|.+++..    ....+++..+..++.|+++|++||   |+. ||+||||||+||+++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL---KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHH---HHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHH---hccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 78777653    245789999999999999999999   567 9999999999999999999999999999876


Q ss_pred             CCcCccccccccccccccccccc----CcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYG----REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      ....  ......||+.|+|||++    .+..++.++||||||+++|||++|+.||..................+.     
T Consensus       177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----  249 (327)
T 3aln_A          177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ-----  249 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC-----
T ss_pred             cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC-----
Confidence            4332  22234689999999988    456789999999999999999999999865322111111111111000     


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         +.       ......+++++.+++.+||+.||++||++.|++++
T Consensus       250 ---~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          250 ---LS-------NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             ---CC-------CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ---CC-------CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence               00       00112356789999999999999999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.6e-36  Score=339.08  Aligned_cols=275  Identities=21%  Similarity=0.271  Sum_probs=192.9

Q ss_pred             HHHHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCC--
Q 002214          657 DELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN--  733 (952)
Q Consensus       657 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  733 (952)
                      .......++|++.+.||+|+||.||+|++ .+|+.||||++.... .....+.+|++.++.++||||+++++++...+  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            45567788999999999999999999998 468999999885443 23356678888899999999999999986533  


Q ss_pred             -----eeEEEEEccCCCChhHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-CCcEE
Q 002214          734 -----FKALVLEYMPKGSLEDCMY---ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-SMVAH  804 (952)
Q Consensus       734 -----~~~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-~~~~k  804 (952)
                           ..++||||+++ ++...+.   .....+++..+..++.|++.|++||| .|++||+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                 27899999976 5544433   23446899999999999999999993 13999999999999999996 89999


Q ss_pred             EeccccccccCCcCcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---
Q 002214          805 LSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---  880 (952)
Q Consensus       805 l~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---  880 (952)
                      |+|||+|+.......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+..   
T Consensus       173 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~  249 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVLG  249 (360)
T ss_dssp             ECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred             EeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHcC
Confidence            999999987654332  2345689999999988654 4899999999999999999999998653211 11111111   


Q ss_pred             cchhhhhhhccccccch---------hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          881 DSLPAVMNIMDTNLLSE---------DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       881 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....+....++......         ...........+++++.+++.+||+.||++|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            11111111111100000         0000011112357889999999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.7e-37  Score=336.93  Aligned_cols=253  Identities=22%  Similarity=0.362  Sum_probs=198.4

Q ss_pred             HHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCC--CCccceeeeEeecCCeeE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIR--HRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~  736 (952)
                      ...++|++.+.||+|+||.||+|.+.+++.||||++....  ....+.+.+|++++++++  ||||+++++++..++..+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            3456899999999999999999999889999999986543  334577899999999997  599999999999999999


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||| +.+++|.+++.... .+++..+..++.|+++||+||   |++||+||||||+||++++ +.+||+|||+++....
T Consensus       105 lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred             EEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence            9999 55889999987654 689999999999999999999   7889999999999999964 8999999999987654


Q ss_pred             cCcc-cccccccccccccccccCc-----------CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchh
Q 002214          817 EDSM-KQTQTLATIGYIAPEYGRE-----------GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP  884 (952)
Q Consensus       817 ~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  884 (952)
                      .... ......|++.|+|||.+.+           ..++.++||||||+++|||++|+.||.........          
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----------  248 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----------  248 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----------
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH----------
Confidence            3221 1223568999999998765           46888999999999999999999998653221111          


Q ss_pred             hhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          885 AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ....++......       .+..++.++.+++.+||+.||++||++.|++++
T Consensus       249 -~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          249 -LHAIIDPNHEIE-------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -HHHHHCTTSCCC-------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHhcccccC-------CcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence             111111111100       112335679999999999999999999999875

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=4.8e-36  Score=357.50  Aligned_cols=136  Identities=24%  Similarity=0.295  Sum_probs=87.8

Q ss_pred             ccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCccccccccccccc
Q 002214          442 FWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLE  521 (952)
Q Consensus       442 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  521 (952)
                      +..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+
T Consensus       250 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~  327 (597)
T 3oja_B          250 LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE  327 (597)
T ss_dssp             GGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCS
T ss_pred             hccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCC
Confidence            3333444444444444443444444445555555555555553 3445566777888888888877 4666677788888


Q ss_pred             EEeCCCCcccccCccchhcccccccccccccccccCCCCCCCcccccccccccCccCCCCCc
Q 002214          522 FLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPY  583 (952)
Q Consensus       522 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~  583 (952)
                      .|+|++|.|++..   +..+++|+.|++++|+|.|.++. ..+..+....+.+++..|+.+.
T Consensus       328 ~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~~  385 (597)
T 3oja_B          328 NLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDY  385 (597)
T ss_dssp             EEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTTC
T ss_pred             EEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcch
Confidence            8888888887542   55677888888888888887643 3456666677788888998763

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=5e-36  Score=338.66  Aligned_cols=337  Identities=21%  Similarity=0.221  Sum_probs=217.9

Q ss_pred             CCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEee
Q 002214          154 LPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILG  233 (952)
Q Consensus       154 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  233 (952)
                      +++++.|++++|.++...+..|..+++|+.|+|++|.+++..+..|+.+++|++|+|++|.+++..|..|+.+++|++|+
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  123 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence            45666666666666643333355666666666666666655555666666666666666666655555566666666666


Q ss_pred             eccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCc
Q 002214          234 IDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSN  313 (952)
Q Consensus       234 L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~  313 (952)
                      +++|++..+.+..|.++++|++|++++|.+++..+.  .+..+++|++|++++|+++                       
T Consensus       124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~-----------------------  178 (390)
T 3o6n_A          124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD--TFQATTSLQNLQLSSNRLT-----------------------  178 (390)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTT--TTSSCTTCCEEECCSSCCS-----------------------
T ss_pred             CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChh--hccCCCCCCEEECCCCcCC-----------------------
Confidence            666666555444455555566666655555543222  2344444555555544443                       


Q ss_pred             cccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCcc
Q 002214          314 LKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE  393 (952)
Q Consensus       314 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~  393 (952)
                                                                        +.   .+..+++|+.|++++|.+++     
T Consensus       179 --------------------------------------------------~~---~~~~l~~L~~L~l~~n~l~~-----  200 (390)
T 3o6n_A          179 --------------------------------------------------HV---DLSLIPSLFHANVSYNLLST-----  200 (390)
T ss_dssp             --------------------------------------------------BC---CGGGCTTCSEEECCSSCCSE-----
T ss_pred             --------------------------------------------------cc---ccccccccceeecccccccc-----
Confidence                                                              22   12333444444444444432     


Q ss_pred             ccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccc
Q 002214          394 FCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVV  473 (952)
Q Consensus       394 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  473 (952)
                      +...++|+.|++++|.+... |.  ...++|+.|++++|++++.  ..+..+++|+.|++++|.+++..|..|..+++|+
T Consensus       201 ~~~~~~L~~L~l~~n~l~~~-~~--~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  275 (390)
T 3o6n_A          201 LAIPIAVEELDASHNSINVV-RG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE  275 (390)
T ss_dssp             EECCSSCSEEECCSSCCCEE-EC--CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCC
T ss_pred             cCCCCcceEEECCCCeeeec-cc--cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCC
Confidence            11223455555555555532 22  1235677777777777653  4677777788888888877777777788888888


Q ss_pred             eeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccc
Q 002214          474 DIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNK  553 (952)
Q Consensus       474 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  553 (952)
                      .|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|+.. |  +..+++|+.|++++|+
T Consensus       276 ~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~  350 (390)
T 3o6n_A          276 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHND  350 (390)
T ss_dssp             EEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSC
T ss_pred             EEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCC
Confidence            88888888874 4666678899999999999998 4666788889999999999999855 3  6778899999999999


Q ss_pred             cccCCCCCCCcccccccccccCccCCCCCcc
Q 002214          554 LVGEIPRGGAFANFSAESFIGNDLLCGSPYL  584 (952)
Q Consensus       554 l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~~  584 (952)
                      |.|.+.. ..+..+....+.+++..|+++..
T Consensus       351 ~~~~~~~-~~~~~~~~~~~~~~~~~c~~~~~  380 (390)
T 3o6n_A          351 WDCNSLR-ALFRNVARPAVDDADQHCKIDYQ  380 (390)
T ss_dssp             EEHHHHH-HHTTTCCTTTBCCCCSCCCTTCE
T ss_pred             ccchhHH-HHHHHHHhhcccccCceeccccc
Confidence            9987543 34566666777888888987743

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.2e-37  Score=346.85  Aligned_cols=264  Identities=24%  Similarity=0.334  Sum_probs=195.8

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecC------Cee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNH------NFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  735 (952)
                      ..+|.+.+.||+|+||.||+|++. +|+.||||++.....    ...+|++++++++||||+++++++...      ...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            346899999999999999999984 699999999864432    234799999999999999999988532      246


Q ss_pred             EEEEEccCCCChhHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC-CcEEEeccccc
Q 002214          736 ALVLEYMPKGSLEDCMY---ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS-MVAHLSDFGIA  811 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgla  811 (952)
                      ++||||+++ ++.+.+.   .....+++..+..++.|+++||+||   |++||+||||||+|||++.+ +.+||+|||+|
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999975 5655554   2345799999999999999999999   78999999999999999965 67899999999


Q ss_pred             cccCCcCcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhhhh
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPAVM  887 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~  887 (952)
                      +.......  .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+++.   ....+..
T Consensus       205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred             hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            87644322  2345789999999988664 7899999999999999999999998653211 11111111   1111100


Q ss_pred             hhcccccc----c--hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          888 NIMDTNLL----S--EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       888 ~~~~~~~~----~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..+.....    .  ....+....+..+++++.+|+.+||..||++||++.|++++
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            00111000    0  00001112233457889999999999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.3e-36  Score=328.28  Aligned_cols=253  Identities=23%  Similarity=0.332  Sum_probs=204.0

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34578999999999999999999985 78999999986543  2345778999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC---CcEEEecccccccc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS---MVAHLSDFGIAKLL  814 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgla~~~  814 (952)
                      ||||+++++|.+.+.... .+++.++..++.|++.||+||   |++||+||||||+||+++.+   +.+||+|||++...
T Consensus        99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            999999999998887554 689999999999999999999   78899999999999999754   47999999999876


Q ss_pred             CCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      .....  .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......  ...+          .+.....
T Consensus       175 ~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~----------~~~~~~~  239 (287)
T 2wei_A          175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILK----------RVETGKY  239 (287)
T ss_dssp             CCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----------HHHHCCC
T ss_pred             cCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHH----------HHHcCCC
Confidence            44322  223458999999998875 4889999999999999999999998652111  1100          0000000


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....     .....+++++.+++.+||+.||++|||+.|++++
T Consensus       240 ~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          240 AFDL-----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CCCS-----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCCc-----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            0000     0113457789999999999999999999999974

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.6e-36  Score=334.37  Aligned_cols=265  Identities=19%  Similarity=0.293  Sum_probs=202.2

Q ss_pred             hccCCccceecCccceEEEEEEe--CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCC------ccceeeeEeecCCe
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHR------NLVKIISSCTNHNF  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~  734 (952)
                      .++|++.+.||+|+||+||+|.+  .+++.||||+++.. ....+.+.+|+++++.++|+      +++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            45899999999999999999987  36899999998643 23456788999999998765      49999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC--------------
Q 002214          735 KALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD--------------  799 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~--------------  799 (952)
                      .++||||+ +++|.+++.... ..+++..+..++.|+++||+||   |++||+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL---HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999887654 3689999999999999999999   7889999999999999987              


Q ss_pred             -----CCcEEEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccc
Q 002214          800 -----SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS  874 (952)
Q Consensus       800 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  874 (952)
                           ++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~  242 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-H  242 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-H
T ss_pred             cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-H
Confidence                 678999999999865332    233568999999999998899999999999999999999999986532111 0


Q ss_pred             hhhhh--ccchhh-hhhh------ccc---cccchhhH------------HHHHhhhhhHHHHHHHHhhccccCCCCCCC
Q 002214          875 IKRWI--NDSLPA-VMNI------MDT---NLLSEDEE------------HANVAKQSCASSVLSLAMECTSESPENRVN  930 (952)
Q Consensus       875 ~~~~~--~~~~~~-~~~~------~~~---~~~~~~~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  930 (952)
                      .....  ....+. ....      +..   ........            ........+++++.+++.+||+.||++|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            00000  000000 0000      000   00000000            000012345788999999999999999999


Q ss_pred             HHHHHHH
Q 002214          931 TKEIISR  937 (952)
Q Consensus       931 ~~ev~~~  937 (952)
                      +.|++++
T Consensus       323 ~~ell~h  329 (339)
T 1z57_A          323 LREALKH  329 (339)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999865

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=339.13  Aligned_cols=263  Identities=20%  Similarity=0.256  Sum_probs=196.7

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCe-----
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNF-----  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  734 (952)
                      .++|.+.+.||+|+||.||+|.+ .+|+.||||++....  ....+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            45799999999999999999987 469999999986542  3335678899999999999999999999987653     


Q ss_pred             -eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          735 -KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       735 -~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                       .++||||++ ++|.+++..   .+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 588877643   489999999999999999999   788999999999999999999999999999986


Q ss_pred             cCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhhhhhh
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPAVMNI  889 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~  889 (952)
                      ....    .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+.....   ....+....
T Consensus       176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHHTT
T ss_pred             CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHH
Confidence            5322    233568999999998876 678999999999999999999999986532111 1111100   000000000


Q ss_pred             ccc--------cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          890 MDT--------NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       890 ~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      +..        ................+++++.+++.+||+.||++|||++|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000        000000000001123457889999999999999999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.7e-37  Score=336.82  Aligned_cols=244  Identities=25%  Similarity=0.314  Sum_probs=201.0

Q ss_pred             HHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCch------hhHHHHHHHHHHHhCC--CCccceeeeEee
Q 002214          660 LRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREG------ALNSFDAECEILKTIR--HRNLVKIISSCT  730 (952)
Q Consensus       660 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~  730 (952)
                      ....++|++.+.||+|+||.||+|++ .+++.||||++......      ..+.+.+|+.++++++  |||++++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34567899999999999999999987 57899999998654321      2245678999999996  599999999999


Q ss_pred             cCCeeEEEEEccCC-CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC-CCCcEEEecc
Q 002214          731 NHNFKALVLEYMPK-GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDF  808 (952)
Q Consensus       731 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~-~~~~~kl~Df  808 (952)
                      .++..++|||++.+ ++|.+++.... .+++..+..++.|+++||+||   |++||+||||||+||+++ .++.+||+||
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            99999999999976 89999987644 689999999999999999999   789999999999999999 7899999999


Q ss_pred             ccccccCCcCcccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhh
Q 002214          809 GIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVM  887 (952)
Q Consensus       809 gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  887 (952)
                      |+++......   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....       ....       
T Consensus       195 g~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~-------  257 (320)
T 3a99_A          195 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIR-------  257 (320)
T ss_dssp             TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH-------
T ss_pred             cccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhc-------
Confidence            9998765332   233568999999998876665 688999999999999999999985421       0000       


Q ss_pred             hhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          888 NIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ...         ..+..+++++.+++.+||+.||++|||+.|++++
T Consensus       258 ----~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          258 ----GQV---------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ----CCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----ccc---------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                000         0112356789999999999999999999999874

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.7e-35  Score=334.19  Aligned_cols=347  Identities=16%  Similarity=0.198  Sum_probs=193.0

Q ss_pred             cccCCCCCCCC-CceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCC-CcCCcCCCcEEeCc
Q 002214           12 QNWTSNASVCS-WMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPK-EIGNLTKLKELHLD   89 (952)
Q Consensus        12 ~~~~~~~~~c~-w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~   89 (952)
                      ++|.++.+||. |.+..|...+..+   +-.....  .....-..+++++.|++++|.++ .+|. .+..+++|++|+|+
T Consensus         4 ~~~~~~~~C~~~~~~~~c~~~~~~i---~~~~~~~--~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~   77 (390)
T 3o6n_A            4 KPRQPEYKCIDSNLQYDCVFYDVHI---DMQTQDV--YFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLN   77 (390)
T ss_dssp             ---CCEECBCC------EEEESCEE---CSSCCCC--EESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECT
T ss_pred             CCCCCccceehhhhhhccceeeeee---ecccccc--cccccccccCCceEEEecCCchh-hCChhHhcccccCcEEECC
Confidence            47987778887 4444454322111   1122222  11222234678888999888888 4554 46788888889998


Q ss_pred             CCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccc
Q 002214           90 YNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG  169 (952)
Q Consensus        90 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  169 (952)
                      +|.+.+..+.+|+++++|++|+|++|.+++..|.                          .+.++++|++|+|++|+++.
T Consensus        78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--------------------------~~~~l~~L~~L~L~~n~l~~  131 (390)
T 3o6n_A           78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH--------------------------VFQNVPLLTVLVLERNDLSS  131 (390)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT--------------------------TTTTCTTCCEEECCSSCCCC
T ss_pred             CCcccccChhhccCCCCcCEEECCCCCCCcCCHH--------------------------HhcCCCCCCEEECCCCccCc
Confidence            8888876677888888888888888887733333                          23455677777777777774


Q ss_pred             cCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccC
Q 002214          170 PIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFN  249 (952)
Q Consensus       170 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~  249 (952)
                      ..+..|..+++|++|++++|++++..|..|+.+++|++|++++|++++.   .+..+++|+.|++++|.+.+.     ..
T Consensus       132 l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~  203 (390)
T 3o6n_A          132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AI  203 (390)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----EC
T ss_pred             CCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc-----CC
Confidence            3334456677777777777777766666677777777777777777643   244555555565555544432     12


Q ss_pred             CCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechh
Q 002214          250 ISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTS  329 (952)
Q Consensus       250 l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~  329 (952)
                      .++|+.|++++|.+... +.    ...++|                                                  
T Consensus       204 ~~~L~~L~l~~n~l~~~-~~----~~~~~L--------------------------------------------------  228 (390)
T 3o6n_A          204 PIAVEELDASHNSINVV-RG----PVNVEL--------------------------------------------------  228 (390)
T ss_dssp             CSSCSEEECCSSCCCEE-EC----CCCSSC--------------------------------------------------
T ss_pred             CCcceEEECCCCeeeec-cc----cccccc--------------------------------------------------
Confidence            23455555555554422 11    112344                                                  


Q ss_pred             hHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEecccc
Q 002214          330 ELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNK  409 (952)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~  409 (952)
                                             +.|++++|.+++.  ..+..+++|++|++++|.+++..|..|..+++|+.|+|++|+
T Consensus       229 -----------------------~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  283 (390)
T 3o6n_A          229 -----------------------TILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR  283 (390)
T ss_dssp             -----------------------CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSC
T ss_pred             -----------------------cEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCc
Confidence                                   4444444444422  234444445555555554444444444445555555555555


Q ss_pred             ccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccC
Q 002214          410 LSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLS  483 (952)
Q Consensus       410 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  483 (952)
                      +++ +|..+..+++|++|++++|++++ .|..+..+++|+.|++++|+++.. +  +..+++|+.|++++|++.
T Consensus       284 l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~  352 (390)
T 3o6n_A          284 LVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWD  352 (390)
T ss_dssp             CCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEE
T ss_pred             Ccc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCcc
Confidence            442 33334455555555555555553 233345555555555555555532 1  445555666666666655

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.4e-36  Score=336.33  Aligned_cols=199  Identities=26%  Similarity=0.352  Sum_probs=171.4

Q ss_pred             HhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CC-----ccceeeeEeecCCe
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIR-HR-----NLVKIISSCTNHNF  734 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~  734 (952)
                      ..++|++.+.||+|+||+||+|++. +++.||||+++.. ......+..|+++++.++ |+     +++++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4578999999999999999999874 6889999998643 233467788999998885 55     49999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC--CCCcEEEeccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD--DSMVAHLSDFGIA  811 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~--~~~~~kl~Dfgla  811 (952)
                      .++||||++ |+|.+++.... ..+++..+..++.|++.||+|||. |+.||+||||||+||+++  .++.+||+|||+|
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999995 59999887654 468999999999999999999952 378999999999999994  5788999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNE  867 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  867 (952)
                      +.....    .....+|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            876432    2335689999999999998999999999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.6e-36  Score=334.85  Aligned_cols=253  Identities=20%  Similarity=0.277  Sum_probs=175.0

Q ss_pred             HhccCCccc-eecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeec----CCee
Q 002214          662 ATDQFSEEN-LIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN----HNFK  735 (952)
Q Consensus       662 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  735 (952)
                      ..++|.+.+ .||+|+||+||+|++. +|+.||||++....    ....+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            456888855 6999999999999985 69999999986432    112223334566799999999999876    4568


Q ss_pred             EEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC---CCcEEEeccccc
Q 002214          736 ALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD---SMVAHLSDFGIA  811 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgla  811 (952)
                      ++||||+++|+|.+++.... ..+++.+++.++.|++.||+||   |++||+||||||+||+++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~L---H~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL---HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998654 3699999999999999999999   7889999999999999976   455999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      +......   .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||........... ...    ..   ..
T Consensus       179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~----~~---~~  247 (336)
T 3fhr_A          179 KETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MKR----RI---RL  247 (336)
T ss_dssp             EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             eeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HHH----hh---hc
Confidence            8654322   2335689999999999888899999999999999999999999865322211000 000    00   00


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .....     .......+++++.+++.+||+.||++|||+.|++++
T Consensus       248 ~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          248 GQYGF-----PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ---CC-----CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccccc-----CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00000     000113457789999999999999999999999974

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=333.80  Aligned_cols=252  Identities=21%  Similarity=0.318  Sum_probs=183.4

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCch--hhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREG--ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .++|++.+.||+|+||.||+|++. +|+.||||++......  ..+.+.++..+++.++||||+++++++.+++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467899999999999999999984 7999999999755332  2234455556788889999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN-PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~-~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      ||+ ++.+..+.......+++..+..++.|+++||+||   |++ ||+||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL---KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 5666666655556799999999999999999999   564 99999999999999999999999999998664332


Q ss_pred             cccccccccccccccccccC-----cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          819 SMKQTQTLATIGYIAPEYGR-----EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                        ......+++.|+|||++.     ...++.++||||||+++|||++|+.||..................        ..
T Consensus       180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------~~  249 (318)
T 2dyl_A          180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP--------PL  249 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC--------CC
T ss_pred             --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC--------CC
Confidence              223356899999999884     456888999999999999999999998653221111111111000        00


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      . .        ....++.++.+++.+||+.||++||++.|++++
T Consensus       250 ~-~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          250 L-P--------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             C-C--------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             C-C--------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0 0        012356789999999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.6e-36  Score=340.87  Aligned_cols=266  Identities=17%  Similarity=0.283  Sum_probs=199.0

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-----------CCccceeeeEee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIR-----------HRNLVKIISSCT  730 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  730 (952)
                      .++|.+.+.||+|+||+||+|++ .+++.||||++.... ...+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            45799999999999999999997 578999999986432 33467889999999886           899999999987


Q ss_pred             cCC----eeEEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCeeeC------
Q 002214          731 NHN----FKALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSN-PIVHCDIKPSNVLLD------  798 (952)
Q Consensus       731 ~~~----~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~-~ivH~Dlk~~Nill~------  798 (952)
                      ..+    ..++||||+ +++|.+++.... ..+++..+..++.|++.||+||   |++ ||+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM---HRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHH---HhcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 889999987643 3599999999999999999999   677 999999999999994      


Q ss_pred             CCCcEEEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCcc-----
Q 002214          799 DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM-----  873 (952)
Q Consensus       799 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-----  873 (952)
                      ..+.+||+|||+|+.....    .....+|+.|+|||++.+..++.++|||||||++|||++|+.||........     
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            4458999999999876432    2335689999999999988999999999999999999999999975332111     


Q ss_pred             chhhhhc--cchhh-h-------hhhccc-cc--------cc---hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCH
Q 002214          874 SIKRWIN--DSLPA-V-------MNIMDT-NL--------LS---EDEEHANVAKQSCASSVLSLAMECTSESPENRVNT  931 (952)
Q Consensus       874 ~~~~~~~--~~~~~-~-------~~~~~~-~~--------~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  931 (952)
                      ...+...  +..+. .       ...+.. ..        ..   .........+..+++++.+++.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            0111000  00000 0       000000 00        00   00000011234678899999999999999999999


Q ss_pred             HHHHHH
Q 002214          932 KEIISR  937 (952)
Q Consensus       932 ~ev~~~  937 (952)
                      +|++++
T Consensus       329 ~ell~h  334 (373)
T 1q8y_A          329 GGLVNH  334 (373)
T ss_dssp             HHHHTC
T ss_pred             HHHhhC
Confidence            999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.6e-36  Score=346.44  Aligned_cols=251  Identities=24%  Similarity=0.361  Sum_probs=187.4

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEcc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      +.|...+.||+|+||+||.+...+|+.||||++..+.   .+.+.+|+.+++++ +||||+++++++.+++..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            3456678899999999987766789999999986543   35678999999886 8999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCC------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC-------------CcE
Q 002214          743 PKGSLEDCMYASNFN------LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS-------------MVA  803 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~------l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~-------------~~~  803 (952)
                      + |+|.+++......      .++..++.++.||+.||+||   |++||+||||||+||+++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 6999998765421      12334578999999999999   78899999999999999754             489


Q ss_pred             EEeccccccccCCcCcc---cccccccccccccccccCc-------CCcCcccchHhHHHHHHHHHh-CCCCCCccccCc
Q 002214          804 HLSDFGIAKLLSEEDSM---KQTQTLATIGYIAPEYGRE-------GQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGE  872 (952)
Q Consensus       804 kl~Dfgla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~  872 (952)
                      ||+|||+|+........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||......+
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999977543321   1223579999999998865       578999999999999999999 999986532211


Q ss_pred             cchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          873 MSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .   .+...       .......      ....+..+++++.+++.+||+.||++|||+.||+++
T Consensus       248 ~---~i~~~-------~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 S---NIIRG-------IFSLDEM------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             H---HHHHT-------CCCCCCC------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             H---HHhcC-------CCCcccc------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            1   11100       0000000      000123457889999999999999999999999863

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.8e-37  Score=333.86  Aligned_cols=245  Identities=26%  Similarity=0.359  Sum_probs=192.7

Q ss_pred             HHHHhccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc------hhhHHHHHHHHHHHhC----CCCccceeee
Q 002214          659 LLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE------GALNSFDAECEILKTI----RHRNLVKIIS  727 (952)
Q Consensus       659 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~  727 (952)
                      .....++|++.+.||+|+||.||+|++ .+++.||||++.....      .....+.+|+.+++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            345567899999999999999999987 4689999999865432      1223456799999998    8999999999


Q ss_pred             EeecCCeeEEEEEc-cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC-CCCcEEE
Q 002214          728 SCTNHNFKALVLEY-MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHL  805 (952)
Q Consensus       728 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~-~~~~~kl  805 (952)
                      ++...+..++|||| +.+++|.+++.... .+++..++.++.|+++||+||   |++||+||||||+||+++ .++.+||
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHC---HSRGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChhhEEEeCCCCeEEE
Confidence            99999999999999 78999999997654 689999999999999999999   688999999999999999 8999999


Q ss_pred             eccccccccCCcCcccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchh
Q 002214          806 SDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLP  884 (952)
Q Consensus       806 ~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  884 (952)
                      +|||+++......   .....+++.|+|||++.+..+ +.++||||||+++|||++|+.||....       ..      
T Consensus       182 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~------  245 (312)
T 2iwi_A          182 IDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EI------  245 (312)
T ss_dssp             CCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH------
T ss_pred             EEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HH------
Confidence            9999998765432   234568999999998876665 458999999999999999999985421       00      


Q ss_pred             hhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          885 AVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           .....         ..+..++.++.+++.+||+.||++|||+.|++++
T Consensus       246 -----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          246 -----LEAEL---------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -----HHTCC---------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----hhhcc---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00000         0123356779999999999999999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-36  Score=344.69  Aligned_cols=250  Identities=21%  Similarity=0.351  Sum_probs=189.5

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..+|...+.||+|+||+||.....+|+.||||++.....   ..+.+|+++++++ +||||+++++++.+....|+||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            356889999999999997655556899999999865432   3356899999999 799999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-----CCcEEEeccccccccCC
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-----SMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfgla~~~~~  816 (952)
                      ++ |+|.+++........+.++..++.||++||+||   |++||+||||||+||+++.     ...+||+|||+|+....
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL---HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHH---HHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHH---HHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            96 699999987766666667789999999999999   7899999999999999953     34688999999987653


Q ss_pred             cCc--ccccccccccccccccccC---cCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhc
Q 002214          817 EDS--MKQTQTLATIGYIAPEYGR---EGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIM  890 (952)
Q Consensus       817 ~~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (952)
                      ...  .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.......  .......        .
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--~~~~~~~--------~  245 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--ANILLGA--------C  245 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--HHHHTTC--------C
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--HHHHhcc--------C
Confidence            321  2233467999999999987   4567889999999999999999 899985421111  0000000        0


Q ss_pred             cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ......        .+...+..+.+++.+||+.||++|||+.||+++
T Consensus       246 ~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          246 SLDCLH--------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             CCTTSC--------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CccccC--------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            000000        112345668899999999999999999999853

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9.5e-36  Score=332.15  Aligned_cols=265  Identities=20%  Similarity=0.275  Sum_probs=198.8

Q ss_pred             hccCCccceecCccceEEEEEEeC-CC-cEEEEEEeeccCchhhHHHHHHHHHHHhCCCCc------cceeeeEeecCCe
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DG-IEVAIKVFHLQREGALNSFDAECEILKTIRHRN------LVKIISSCTNHNF  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  734 (952)
                      .++|++.+.||+|+||+||+|.+. ++ +.||+|+++.. ....+.+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999874 34 78999998643 234567889999999997665      8999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeee----------------
Q 002214          735 KALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLL----------------  797 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill----------------  797 (952)
                      .++||||+ ++++.+.+.... ..+++.++..++.|++.||+||   |++||+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL---HENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 566666665543 4699999999999999999999   78999999999999999                


Q ss_pred             ---CCCCcEEEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccc
Q 002214          798 ---DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMS  874 (952)
Q Consensus       798 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  874 (952)
                         +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~  247 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-H  247 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H
T ss_pred             ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence               56789999999999865332    233568999999999998899999999999999999999999997532211 0


Q ss_pred             hhhhh--ccchhh-hhhh-------ccccc--cchhhHHH------------HHhhhhhHHHHHHHHhhccccCCCCCCC
Q 002214          875 IKRWI--NDSLPA-VMNI-------MDTNL--LSEDEEHA------------NVAKQSCASSVLSLAMECTSESPENRVN  930 (952)
Q Consensus       875 ~~~~~--~~~~~~-~~~~-------~~~~~--~~~~~~~~------------~~~~~~~~~~l~~li~~cl~~dP~~RPs  930 (952)
                      .....  ....+. ....       .....  ........            .......+.++.+++.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            00000  000000 0000       00000  00000000            0011234668999999999999999999


Q ss_pred             HHHHHHH
Q 002214          931 TKEIISR  937 (952)
Q Consensus       931 ~~ev~~~  937 (952)
                      +.|++++
T Consensus       328 ~~e~l~h  334 (355)
T 2eu9_A          328 LAEALLH  334 (355)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999854

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2e-36  Score=353.58  Aligned_cols=264  Identities=22%  Similarity=0.304  Sum_probs=198.5

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeec------CCe
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTN------HNF  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  734 (952)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||+++.. .....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            47899999999999999999987 46899999998654 33345678999999999999999999998765      677


Q ss_pred             eEEEEEccCCCChhHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCc---EEEeccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNF--NLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMV---AHLSDFG  809 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~---~kl~Dfg  809 (952)
                      .++||||+++|+|.+++.....  .+++..++.++.|++.||+||   |+.||+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yL---Hs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL---HENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHH---HHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976442  588999999999999999999   7899999999999999997665   9999999


Q ss_pred             cccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhh----
Q 002214          810 IAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPA----  885 (952)
Q Consensus       810 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----  885 (952)
                      .++.......  .....||+.|+|||.+.+..++.++|||||||++|||++|..||.....    ...|.......    
T Consensus       170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSNEH  243 (676)
T ss_dssp             CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC------
T ss_pred             cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccchh
Confidence            9987654332  2345799999999999999999999999999999999999999865211    11111111000    


Q ss_pred             --hhhhccccccc-hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHH
Q 002214          886 --VMNIMDTNLLS-EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII  935 (952)
Q Consensus       886 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  935 (952)
                        ..+........ ............+++++.+++..||..||++|||+.|++
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence              00000000000 000000112244688899999999999999999998843

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=5e-34  Score=317.00  Aligned_cols=194  Identities=23%  Similarity=0.369  Sum_probs=127.8

Q ss_pred             CCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEE
Q 002214          348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRIL  427 (952)
Q Consensus       348 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  427 (952)
                      .+++|++|++++|.+.+..+  +..+++|++|++++|.+.+..+  +..+++|+.|++++|.+.+..+  +..+++|++|
T Consensus       153 ~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L  226 (347)
T 4fmz_A          153 NMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSL  226 (347)
T ss_dssp             TCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred             hCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEE
Confidence            44555566666665553332  5556666666666666653322  5566666666666666664333  5666667777


Q ss_pred             eccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcccc
Q 002214          428 SLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQ  507 (952)
Q Consensus       428 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  507 (952)
                      ++++|++++..+  +..+++|+.|++++|.+++.  ..+..+++|+.|++++|++++.  ..+..+++|+.|+|++|+++
T Consensus       227 ~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~  300 (347)
T 4fmz_A          227 KIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLG  300 (347)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred             EccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCC
Confidence            777777665544  66667777777777776642  3566777777777777777754  35777788888888888887


Q ss_pred             CcccccccccccccEEeCCCCcccccCccchhcccccccccccccccc
Q 002214          508 GPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLV  555 (952)
Q Consensus       508 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  555 (952)
                      +..+..|..+++|+.|+|++|++++..|  +..+++|+.|++++|+++
T Consensus       301 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          301 NEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             GGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            7777777788888888888888876655  777788888888888764

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-35  Score=334.75  Aligned_cols=251  Identities=15%  Similarity=0.176  Sum_probs=188.8

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc---hhhHHHHHHHHHHHhCCC-Ccccee---------e--
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE---GALNSFDAECEILKTIRH-RNLVKI---------I--  726 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l---------~--  726 (952)
                      ...|...+.||+|+||+||+|++ .+|+.||||+++....   ...+.+.+|+.+++.++| ++....         .  
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34577889999999999999996 5799999999874332   235789999999999987 322111         1  


Q ss_pred             ----------eEeec-----CCeeEEEEEccCCCChhHHhh------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 002214          727 ----------SSCTN-----HNFKALVLEYMPKGSLEDCMY------ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPI  785 (952)
Q Consensus       727 ----------~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~i  785 (952)
                                .++..     ....+++|+++ +++|.+++.      .....+++..++.++.|+++||+||   |++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH---HHTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH---HhCCc
Confidence                      11111     12356777776 689998884      2233578889999999999999999   78999


Q ss_pred             EeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccccccccccccccccc----------CcCCcCcccchHhHHHHH
Q 002214          786 VHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYG----------REGQVSIKGDVYNYGIML  855 (952)
Q Consensus       786 vH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Dv~slG~~l  855 (952)
                      +||||||+|||++.++.+||+|||+|+.....    .....| +.|+|||++          ....++.++|||||||++
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            99999999999999999999999999865432    233567 999999988          556688999999999999


Q ss_pred             HHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHH
Q 002214          856 MEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII  935 (952)
Q Consensus       856 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  935 (952)
                      |||++|+.||......+. ..           ..+.             ....+++++.+++.+||+.||++||++.|++
T Consensus       308 ~elltg~~Pf~~~~~~~~-~~-----------~~~~-------------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG-SE-----------WIFR-------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC-SG-----------GGGS-------------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhhh-HH-----------HHHh-------------hcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999865321110 00           0000             0113467799999999999999999999998


Q ss_pred             HH--HHHHHHHHhh
Q 002214          936 SR--LIKIRDLLFA  947 (952)
Q Consensus       936 ~~--L~~i~~~~~~  947 (952)
                      ++  ++++.+.+.+
T Consensus       363 ~~~~~~~~~~~~~~  376 (413)
T 3dzo_A          363 ETPEYEQLRTELSA  376 (413)
T ss_dssp             TSHHHHHHHHHHHH
T ss_pred             hCHHHHHHHHHHHH
Confidence            76  6666655543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-34  Score=311.34  Aligned_cols=233  Identities=12%  Similarity=0.081  Sum_probs=186.9

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|++.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            357999999999999999999985 58999999997553   23346789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++++|.+++...   ....++..++.|++.||+||   |++||+||||||+||+++.++.+||+++|         
T Consensus       110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~l---H~~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAA---HRAGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHH---HHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            9999999999998542   46678899999999999999   78999999999999999999999998543         


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                                  |++       .++.++|||||||++|||+||+.||......+. .......        +.....   
T Consensus       175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~~~~~~--------~~~~~~---  223 (286)
T 3uqc_A          175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LAPAERD--------TAGQPI---  223 (286)
T ss_dssp             ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SEECCBC--------TTSCBC---
T ss_pred             ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hHHHHHH--------hccCCC---
Confidence                        333       367899999999999999999999976432211 0000000        000000   


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                        ........+++++.+++.+||+.||++| |+.|+++.|+++...
T Consensus       224 --~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          224 --EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             --CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             --ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence              0011234567889999999999999999 999999999987654

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.3e-33  Score=313.56  Aligned_cols=305  Identities=26%  Similarity=0.381  Sum_probs=246.1

Q ss_pred             CCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEe
Q 002214          153 GLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEIL  232 (952)
Q Consensus       153 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  232 (952)
                      .+++|++|++++|.+.. ++ .+..+++|++|++++|++++..+  +..+++|++|++++|.+++ +| .+..+++|++|
T Consensus        42 ~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L  115 (347)
T 4fmz_A           42 ELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLREL  115 (347)
T ss_dssp             HHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred             hcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEE
Confidence            46788888888888873 44 47788888888888888885433  8888888888888888874 33 58888888888


Q ss_pred             eeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccC
Q 002214          233 GIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNS  312 (952)
Q Consensus       233 ~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~  312 (952)
                      ++++|++.+..+  +..+++|++|++++|.....++   .+..+++|++|++++|.+.+..+                  
T Consensus       116 ~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~---~~~~l~~L~~L~l~~~~~~~~~~------------------  172 (347)
T 4fmz_A          116 YLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS---PLSNMTGLNYLTVTESKVKDVTP------------------  172 (347)
T ss_dssp             ECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG---GGTTCTTCCEEECCSSCCCCCGG------------------
T ss_pred             ECcCCcccCchh--hccCCceeEEECCCCCCccccc---chhhCCCCcEEEecCCCcCCchh------------------
Confidence            888888777644  7788888888888885543332   26777888888888887764222                  


Q ss_pred             ccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCc
Q 002214          313 NLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQ  392 (952)
Q Consensus       313 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~  392 (952)
                                                       ++.+++|++|++++|.+++..+  +..+++|+.|++++|.+.+..+ 
T Consensus       173 ---------------------------------~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-  216 (347)
T 4fmz_A          173 ---------------------------------IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP-  216 (347)
T ss_dssp             ---------------------------------GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-
T ss_pred             ---------------------------------hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch-
Confidence                                             3456788899999999885443  8888999999999999886544 


Q ss_pred             cccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhccccc
Q 002214          393 EFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAV  472 (952)
Q Consensus       393 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  472 (952)
                       +..+++|+.|++++|++++..+  +..+++|++|++++|+++++  ..+..+++|+.|++++|++++.  ..+..+++|
T Consensus       217 -~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L  289 (347)
T 4fmz_A          217 -VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQL  289 (347)
T ss_dssp             -GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTC
T ss_pred             -hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCC
Confidence             8888999999999999985544  88899999999999999875  4688999999999999999864  468899999


Q ss_pred             ceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCccc
Q 002214          473 VDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLS  531 (952)
Q Consensus       473 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  531 (952)
                      +.|++++|++++..+..|..+++|++|+|++|++++..|  +..+++|+.|++++|+|+
T Consensus       290 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             SEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            999999999998888999999999999999999997666  889999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.5e-35  Score=353.10  Aligned_cols=243  Identities=23%  Similarity=0.344  Sum_probs=196.5

Q ss_pred             hccCCccceecCccceEEEEEEeC--CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCe-----
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP--DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNF-----  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  734 (952)
                      .++|++.+.||+|+||+||+|.+.  +|+.||||++.... ......+.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999985  68999999986443 3345678899999999999999999999987655     


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .|+||||+++++|.+++..   .+++.+++.++.||++||+||   |++||+||||||+||+++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~l---H~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYL---HSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHH---HHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            6999999999999887654   689999999999999999999   78999999999999999986 8999999999876


Q ss_pred             CCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ...     ....||+.|+|||++.++. +.++|||||||++|||++|..||........          +          
T Consensus       232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~----------  285 (681)
T 2pzi_A          232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P----------  285 (681)
T ss_dssp             TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C----------
T ss_pred             ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------c----------
Confidence            432     3356999999999887654 8899999999999999999888754211100          0          


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRV-NTKEIISRLIKIRDLL  945 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~~i~~~~  945 (952)
                       ...      .....++.+.+++.+||+.||++|| +++++.+.+..+.+..
T Consensus       286 -~~~------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~  330 (681)
T 2pzi_A          286 -EDD------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV  330 (681)
T ss_dssp             -TTC------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred             -ccc------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence             000      0112356789999999999999999 5666777777765543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.5e-34  Score=312.05  Aligned_cols=231  Identities=21%  Similarity=0.307  Sum_probs=180.8

Q ss_pred             hccCCcc-ceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHH-HhCCCCccceeeeEeec----CCee
Q 002214          663 TDQFSEE-NLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEIL-KTIRHRNLVKIISSCTN----HNFK  735 (952)
Q Consensus       663 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~  735 (952)
                      .++|.+. +.||+|+||.||+|.. .+++.||+|+++..     ..+.+|+.++ +..+||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3567776 7899999999999987 57899999998532     4567888888 55699999999999876    6778


Q ss_pred             EEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC---CCcEEEeccccc
Q 002214          736 ALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD---SMVAHLSDFGIA  811 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgla  811 (952)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.||+||   |++||+||||||+||+++.   ++.+||+|||+|
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998754 3699999999999999999999   7899999999999999998   789999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      ....                       +..++.++|||||||++|||++|+.||.......... ...            
T Consensus       168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~------------  211 (299)
T 3m2w_A          168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMK------------  211 (299)
T ss_dssp             EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-CSC------------
T ss_pred             cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-HHH------------
Confidence            7542                       1346778999999999999999999986532211100 000            


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .................+++++.+++.+||+.||++|||+.|++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0000000000011124467889999999999999999999999975

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=4e-34  Score=311.89  Aligned_cols=236  Identities=33%  Similarity=0.560  Sum_probs=223.6

Q ss_pred             ccCCCcccEEEccC-CCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCC
Q 002214          346 IGNLINLTTLSLGD-NNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSL  424 (952)
Q Consensus       346 ~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  424 (952)
                      ++.+++|++|++++ |.+.+.+|..|..+++|++|+|++|.+++..|..|..+++|++|+|++|++++.+|..+..+++|
T Consensus        72 l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  151 (313)
T 1ogq_A           72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL  151 (313)
T ss_dssp             GGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTC
T ss_pred             HhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCC
Confidence            45678899999995 99998999999999999999999999998999999999999999999999999999999999999


Q ss_pred             cEEeccccccCCcCCccccCCC-CCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccC
Q 002214          425 RILSLSSNELTSVIPSTFWNLE-DILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEH  503 (952)
Q Consensus       425 ~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  503 (952)
                      ++|++++|++++..|..+..++ +|+.|++++|++++..|..+..++ |+.|+|++|++++..|..|..+++|+.|+|++
T Consensus       152 ~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  230 (313)
T 1ogq_A          152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK  230 (313)
T ss_dssp             CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCS
T ss_pred             CeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCC
Confidence            9999999999989999999998 999999999999999999999998 99999999999999999999999999999999


Q ss_pred             ccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCCCcccccccccccCccCCCCCc
Q 002214          504 NKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPY  583 (952)
Q Consensus       504 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~  583 (952)
                      |++++.+|. +..+++|++|+|++|+|++.+|..+..+++|+.|++++|+++|.+|....+.++....+.+|+++||.|.
T Consensus       231 N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          231 NSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             SEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             CceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCC
Confidence            999976665 8899999999999999999999999999999999999999999999988899999999999999999884

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9.1e-35  Score=321.21  Aligned_cols=244  Identities=16%  Similarity=0.188  Sum_probs=185.6

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccC--------chhhHHHHHHHHHHHhCC---------CCcccee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--------EGALNSFDAECEILKTIR---------HRNLVKI  725 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  725 (952)
                      .++|++.+.||+|+||+||+|++ +|+.||||+++...        ....+.+.+|+.++++++         |||++++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46799999999999999999998 78999999997553        223467889999999886         6666665


Q ss_pred             eeE-----------------eec-------------CCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 002214          726 ISS-----------------CTN-------------HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALE  775 (952)
Q Consensus       726 ~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~  775 (952)
                      .++                 +.+             .+..|+||||+++|++.+.+..  ..+++..+..++.|++.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            554                 332             6789999999999976666643  35899999999999999999


Q ss_pred             HHHhcC-CCCeEeCCCCCCCeeeCCCC--------------------cEEEeccccccccCCcCcccccccccccccccc
Q 002214          776 YLHFGH-SNPIVHCDIKPSNVLLDDSM--------------------VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP  834 (952)
Q Consensus       776 ~Lh~~h-~~~ivH~Dlk~~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aP  834 (952)
                      ||   | ++||+||||||+|||++.++                    .+||+|||+|+.....      ...||+.|+||
T Consensus       176 ~l---H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VA---EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE  246 (336)
T ss_dssp             HH---HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred             HH---HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence            99   6 89999999999999999887                    9999999999866422      34699999999


Q ss_pred             cccCcCCcCcccchHhHHHH-HHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHH
Q 002214          835 EYGREGQVSIKGDVYNYGIM-LMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSV  913 (952)
Q Consensus       835 E~~~~~~~~~~~Dv~slG~~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  913 (952)
                      |++.+.. +.++||||+|++ .+++++|..||...        .|..................     ....+..+++++
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~  312 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLTDKMLKQMTFKTKC-----NTPAMKQIKRKI  312 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHHHHHHHTCCCSSCC-----CSHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHHHhhhhhhccCccc-----chhhhhhcCHHH
Confidence            9998766 889999998777 78888999997431        11111111111100000000     011234578899


Q ss_pred             HHHHhhccccCCCCCCCHHHHH-HH
Q 002214          914 LSLAMECTSESPENRVNTKEII-SR  937 (952)
Q Consensus       914 ~~li~~cl~~dP~~RPs~~ev~-~~  937 (952)
                      .+|+.+||+.|     |++|++ ++
T Consensus       313 ~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHhccC-----CHHHHHhcC
Confidence            99999999976     999988 53

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=5.9e-33  Score=330.79  Aligned_cols=314  Identities=21%  Similarity=0.196  Sum_probs=224.1

Q ss_pred             CCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEE
Q 002214          178 CKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILS  257 (952)
Q Consensus       178 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~  257 (952)
                      +.+++.|++++|.++...+..|+.+++|++|+|++|.+++..|..|+.+++|+.|+|++|.+.+..|..|.+        
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--------  121 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN--------  121 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTT--------
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcC--------
Confidence            345555555555555444444455555555555555555444445555555555555555554444444444        


Q ss_pred             eeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHH
Q 002214          258 LFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSA  337 (952)
Q Consensus       258 Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~  337 (952)
                                        +++|++|+|++|.+++.++..                                         
T Consensus       122 ------------------l~~L~~L~L~~n~l~~l~~~~-----------------------------------------  142 (597)
T 3oja_B          122 ------------------VPLLTVLVLERNDLSSLPRGI-----------------------------------------  142 (597)
T ss_dssp             ------------------CTTCCEEECCSSCCCCCCTTT-----------------------------------------
T ss_pred             ------------------CCCCCEEEeeCCCCCCCCHHH-----------------------------------------
Confidence                              455555555555554333322                                         


Q ss_pred             hhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCc
Q 002214          338 LVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSC  417 (952)
Q Consensus       338 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  417 (952)
                              |+++++|++|+|++|.+++..|..|..+++|++|+|++|.+++..   +..+++|+.|++++|.+++.    
T Consensus       143 --------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l----  207 (597)
T 3oja_B          143 --------FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL----  207 (597)
T ss_dssp             --------TTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE----
T ss_pred             --------hccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc----
Confidence                    234556666777777776666666777777777777777776542   44556777777777777632    


Q ss_pred             cCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCc
Q 002214          418 LGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ  497 (952)
Q Consensus       418 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  497 (952)
                       ...++|+.|++++|.++.+.+..   .++|+.|+|++|.+++  +..+..+++|+.|+|++|.+++..|..|..+++|+
T Consensus       208 -~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  281 (597)
T 3oja_B          208 -AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE  281 (597)
T ss_dssp             -ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCC
T ss_pred             -cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCC
Confidence             34467888999999888665433   2689999999999985  47899999999999999999999999999999999


Q ss_pred             eEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCCCcccccccccccCcc
Q 002214          498 HLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDL  577 (952)
Q Consensus       498 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~  577 (952)
                      .|+|++|++++ +|..+..+++|+.|+|++|.|+ .+|..+..+++|+.|+|++|++++..  ...+..+....+.+|++
T Consensus       282 ~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~L~~L~l~~N~~  357 (597)
T 3oja_B          282 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDW  357 (597)
T ss_dssp             EEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCE
T ss_pred             EEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hhhcCCCCEEEeeCCCC
Confidence            99999999995 6777888999999999999999 57788899999999999999998753  34677888888999999


Q ss_pred             CCCCCc
Q 002214          578 LCGSPY  583 (952)
Q Consensus       578 ~c~~p~  583 (952)
                      .|.+..
T Consensus       358 ~~~~~~  363 (597)
T 3oja_B          358 DCNSLR  363 (597)
T ss_dssp             EHHHHH
T ss_pred             CChhHH
Confidence            998753

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=4e-32  Score=299.40  Aligned_cols=288  Identities=20%  Similarity=0.284  Sum_probs=192.4

Q ss_pred             CCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEee
Q 002214          180 ELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLF  259 (952)
Q Consensus       180 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls  259 (952)
                      +++.+++++|.++ .+|..+.  ++|++|+|++|.+++..|..|..+++|+.|++++|++.+..|..+.++++|++|+++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            5777888888777 5565553  577788888888776666777777777777777777777777777777777777777


Q ss_pred             CccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhh
Q 002214          260 NNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALV  339 (952)
Q Consensus       260 ~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~  339 (952)
                      +|+++. +|..  +  .++|++|++                                                       
T Consensus       111 ~n~l~~-l~~~--~--~~~L~~L~l-------------------------------------------------------  130 (332)
T 2ft3_A          111 KNHLVE-IPPN--L--PSSLVELRI-------------------------------------------------------  130 (332)
T ss_dssp             SSCCCS-CCSS--C--CTTCCEEEC-------------------------------------------------------
T ss_pred             CCcCCc-cCcc--c--cccCCEEEC-------------------------------------------------------
Confidence            777652 2221  1  134444444                                                       


Q ss_pred             ccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCcccc--CCCCccccCCCcceEEEeccccccccCCCc
Q 002214          340 NCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFE--GPIPQEFCHFSRLYVVYLNRNKLSGSIPSC  417 (952)
Q Consensus       340 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  417 (952)
                                        ++|++++..+..|..+++|++|++++|.++  +..+..|..+ +|+.|++++|++++ +|..
T Consensus       131 ------------------~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~  190 (332)
T 2ft3_A          131 ------------------HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKD  190 (332)
T ss_dssp             ------------------CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSS
T ss_pred             ------------------CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcc
Confidence                              444444444444555555555555555553  2444455544 55555555555553 3333


Q ss_pred             cCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCc
Q 002214          418 LGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ  497 (952)
Q Consensus       418 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  497 (952)
                      +.  ++|++|++++|++++..+..|..+++|+.|++++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|+
T Consensus       191 ~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~  267 (332)
T 2ft3_A          191 LP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQ  267 (332)
T ss_dssp             SC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCC
T ss_pred             cc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCC
Confidence            32  56777777777777777777777777777777777777766667777788888888888887 5666777888888


Q ss_pred             eEEccCccccCccccccccc------ccccEEeCCCCccc--ccCccchhcccccccccccccc
Q 002214          498 HLSLEHNKLQGPIPESFGEL------VSLEFLDLSNNDLS--GVIPASLEKLLYLKSLNLSFNK  553 (952)
Q Consensus       498 ~L~L~~N~l~~~~~~~~~~l------~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~l~~N~  553 (952)
                      .|+|++|+|++..+..|...      ++|+.|++++|++.  +..|..|..+++|+.+++++|+
T Consensus       268 ~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          268 VVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             EEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             EEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            88888888887666666543      56888888888887  5677788888888888888874

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.2e-31  Score=295.52  Aligned_cols=290  Identities=21%  Similarity=0.271  Sum_probs=183.4

Q ss_pred             CCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEe
Q 002214          179 KELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSL  258 (952)
Q Consensus       179 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L  258 (952)
                      .+++.++++++.++ .+|..+.  ++|++|+|++|++++..+..|+.+++|++|+|++|++.+..|..+.++++|++|++
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL  107 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence            36788888888887 5565554  57888888888888766667888888888888888888777777777778888888


Q ss_pred             eCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHh
Q 002214          259 FNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSAL  338 (952)
Q Consensus       259 s~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~  338 (952)
                      ++|+++. +|..  +  .++|++|++++|+++                                                
T Consensus       108 s~n~l~~-l~~~--~--~~~L~~L~l~~n~l~------------------------------------------------  134 (330)
T 1xku_A          108 SKNQLKE-LPEK--M--PKTLQELRVHENEIT------------------------------------------------  134 (330)
T ss_dssp             CSSCCSB-CCSS--C--CTTCCEEECCSSCCC------------------------------------------------
T ss_pred             CCCcCCc-cChh--h--cccccEEECCCCccc------------------------------------------------
Confidence            7777763 2221  1  145555555555544                                                


Q ss_pred             hccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccC--CCCccccCCCcceEEEeccccccccCCC
Q 002214          339 VNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEG--PIPQEFCHFSRLYVVYLNRNKLSGSIPS  416 (952)
Q Consensus       339 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~  416 (952)
                                               +..+..|..+++|++|++++|.+..  ..+..|..+++|+.|++++|+++. +|.
T Consensus       135 -------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~  188 (330)
T 1xku_A          135 -------------------------KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQ  188 (330)
T ss_dssp             -------------------------BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCS
T ss_pred             -------------------------ccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCc
Confidence                                     3333334444444444444444421  334444444445555555554442 233


Q ss_pred             ccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCC
Q 002214          417 CLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNL  496 (952)
Q Consensus       417 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  496 (952)
                      .+.  ++|++|++++|++++..+..|..+++|+.|++++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|
T Consensus       189 ~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L  265 (330)
T 1xku_A          189 GLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI  265 (330)
T ss_dssp             SCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSC
T ss_pred             ccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCc
Confidence            222  55666666666666665666666666666666666666555556666667777777777776 556666777777


Q ss_pred             ceEEccCccccCcccccccc------cccccEEeCCCCcccc--cCccchhcccccccccccccc
Q 002214          497 QHLSLEHNKLQGPIPESFGE------LVSLEFLDLSNNDLSG--VIPASLEKLLYLKSLNLSFNK  553 (952)
Q Consensus       497 ~~L~L~~N~l~~~~~~~~~~------l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~l~~N~  553 (952)
                      ++|+|++|+|++..+..|..      .+.|+.|++++|++..  +.|..|..+..++.++|++|+
T Consensus       266 ~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          266 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             CEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             CEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            77777777777665555543      3677788888887753  556777788888888888774

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=8.7e-32  Score=296.69  Aligned_cols=301  Identities=22%  Similarity=0.272  Sum_probs=211.4

Q ss_pred             cCCCCCCCCC-----CccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccC
Q 002214          145 SFPYDMCPGL-----PRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEI  219 (952)
Q Consensus       145 ~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  219 (952)
                      ++|..+...+     .+++.+++++|.++ .+|..+.  ++|+.|+|++|.+++..|..|+++++|++|+|++|++++..
T Consensus        18 ~lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~   94 (332)
T 2ft3_A           18 SLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH   94 (332)
T ss_dssp             -------CCCCSSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             cCCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccC
Confidence            5665544433     37999999999998 6777664  68999999999999888889999999999999999999888


Q ss_pred             chhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCccccc
Q 002214          220 PQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFN  299 (952)
Q Consensus       220 p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  299 (952)
                      |..|+.+++|++|++++|++..+.+..+   ++|++|++++|++++..+  ..+..+++|++|++++|.++..       
T Consensus        95 ~~~~~~l~~L~~L~L~~n~l~~l~~~~~---~~L~~L~l~~n~i~~~~~--~~~~~l~~L~~L~l~~n~l~~~-------  162 (332)
T 2ft3_A           95 EKAFSPLRKLQKLYISKNHLVEIPPNLP---SSLVELRIHDNRIRKVPK--GVFSGLRNMNCIEMGGNPLENS-------  162 (332)
T ss_dssp             GGGSTTCTTCCEEECCSSCCCSCCSSCC---TTCCEEECCSSCCCCCCS--GGGSSCSSCCEEECCSCCCBGG-------
T ss_pred             HhHhhCcCCCCEEECCCCcCCccCcccc---ccCCEEECCCCccCccCH--hHhCCCccCCEEECCCCccccC-------
Confidence            9999999999999999999986644433   899999999999985422  2355566666666666665420       


Q ss_pred             chhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEE
Q 002214          300 ASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGL  379 (952)
Q Consensus       300 ~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  379 (952)
                                                                                      +..+..+..+ +|++|
T Consensus       163 ----------------------------------------------------------------~~~~~~~~~l-~L~~L  177 (332)
T 2ft3_A          163 ----------------------------------------------------------------GFEPGAFDGL-KLNYL  177 (332)
T ss_dssp             ----------------------------------------------------------------GSCTTSSCSC-CCSCC
T ss_pred             ----------------------------------------------------------------CCCcccccCC-ccCEE
Confidence                                                                            1223333333 44444


Q ss_pred             EccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccC
Q 002214          380 DLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLN  459 (952)
Q Consensus       380 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  459 (952)
                      ++++|.+++ .|..+.  ++|+.|++++|++++..+..|..+++|+.|++++|++++..+..|..+++|+.|++++|+++
T Consensus       178 ~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  254 (332)
T 2ft3_A          178 RISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS  254 (332)
T ss_dssp             BCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred             ECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence            444444443 222221  45555555555555555556666677777777777777666666777777777777777776


Q ss_pred             CCCchhhhcccccceeecCCcccCCCCcccccC------CCCCceEEccCcccc--CcccccccccccccEEeCCCCc
Q 002214          460 GSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIG------LKNLQHLSLEHNKLQ--GPIPESFGELVSLEFLDLSNND  529 (952)
Q Consensus       460 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~  529 (952)
                       .+|..+..+++|+.|++++|++++..+..|..      .++|+.|++++|.+.  +..|..|..+++|+.|++++|+
T Consensus       255 -~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          255 -RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             -BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             -ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence             56666777777777888888777666666654      366888999999887  5677888889999999998885

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.9e-31  Score=293.87  Aligned_cols=291  Identities=22%  Similarity=0.242  Sum_probs=197.5

Q ss_pred             CCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEee
Q 002214          154 LPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILG  233 (952)
Q Consensus       154 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  233 (952)
                      ..+++.++++++.++ .+|..+.  ++|+.|+|++|++++..+..|+++++|++|+|++|.+++..|..|+.+++|++|+
T Consensus        30 ~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           30 QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             EEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             cCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            348999999999998 5777664  6899999999999988888999999999999999999988899999999999999


Q ss_pred             eccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCC--CCCcccccchhhhhhhcccc
Q 002214          234 IDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSG--SIPSFFFNASKLYALELGYN  311 (952)
Q Consensus       234 L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~~~~L~~l~l~~~  311 (952)
                      +++|++..+... +.  ++|++|++++|++++..+  ..+..+++|++|++++|.+..  ..+.                
T Consensus       107 Ls~n~l~~l~~~-~~--~~L~~L~l~~n~l~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~~~~----------------  165 (330)
T 1xku_A          107 LSKNQLKELPEK-MP--KTLQELRVHENEITKVRK--SVFNGLNQMIVVELGTNPLKSSGIENG----------------  165 (330)
T ss_dssp             CCSSCCSBCCSS-CC--TTCCEEECCSSCCCBBCH--HHHTTCTTCCEEECCSSCCCGGGBCTT----------------
T ss_pred             CCCCcCCccChh-hc--ccccEEECCCCcccccCH--hHhcCCccccEEECCCCcCCccCcChh----------------
Confidence            999998865443 33  799999999999986533  236677778888887777752  1111                


Q ss_pred             CccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCC
Q 002214          312 SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIP  391 (952)
Q Consensus       312 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~  391 (952)
                                                       .++.+++|++|++++|.++. +|..+.  ++|++|++++|.+++..+
T Consensus       166 ---------------------------------~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~  209 (330)
T 1xku_A          166 ---------------------------------AFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDA  209 (330)
T ss_dssp             ---------------------------------GGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECT
T ss_pred             ---------------------------------hccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCH
Confidence                                             13445566666666666663 232222  455555555555554444


Q ss_pred             ccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccc
Q 002214          392 QEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKA  471 (952)
Q Consensus       392 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  471 (952)
                      ..|..++                        +|++|++++|++++..+..|..+++|+.|++++|+++ .+|..+..+++
T Consensus       210 ~~~~~l~------------------------~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~  264 (330)
T 1xku_A          210 ASLKGLN------------------------NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY  264 (330)
T ss_dssp             GGGTTCT------------------------TCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSS
T ss_pred             HHhcCCC------------------------CCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCC
Confidence            4554444                        4555555555554444444555555555555555555 34555555556


Q ss_pred             cceeecCCcccCCCCcccccC------CCCCceEEccCccccC--cccccccccccccEEeCCCCc
Q 002214          472 VVDIYLSRNNLSGNIPSTIIG------LKNLQHLSLEHNKLQG--PIPESFGELVSLEFLDLSNND  529 (952)
Q Consensus       472 L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~  529 (952)
                      |++|+|++|+|+++.+..|..      .+.|+.|++++|.+..  +.|..|..+++|+.++|++|+
T Consensus       265 L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          265 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             CCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             cCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            666666666666555555533      3667778888887753  556777778888888888774

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=8.1e-35  Score=336.94  Aligned_cols=398  Identities=18%  Similarity=0.145  Sum_probs=218.3

Q ss_pred             cccCeeeccccccccccCCC-cCCcCCCcEEeCcCCcccc----cCChhhcCCCCCCeEeecCccCccccCccccccccc
Q 002214           57 SSLQTLVLSRNWFSGTIPKE-IGNLTKLKELHLDYNKLQG----EIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFI  131 (952)
Q Consensus        57 ~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l  131 (952)
                      ++|+.|+|++|++++..... +..+++|++|+|++|.+..    .++..+..+++|++|+|++|.+++..+..++...  
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l--   80 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGL--   80 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTT--
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHH--
Confidence            46677777777776443333 5667777777777777763    3466677777777777777777643333332110  


Q ss_pred             ccceeeccccccccCCCCCCCCCCccceEEcccCcccc----cCCccccCCCCCcEEEccCCcccccCCccccc-----c
Q 002214          132 STALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG----PIPNNLWHCKELSSVSLSYNQFTGRLPRDLGN-----S  202 (952)
Q Consensus       132 ~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-----l  202 (952)
                                     +    ...++|++|+|++|+++.    .++..+..+++|++|+|++|.+++..+..+..     .
T Consensus        81 ---------------~----~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~  141 (461)
T 1z7x_W           81 ---------------Q----TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ  141 (461)
T ss_dssp             ---------------C----STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred             ---------------h----hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCC
Confidence                           0    011257777777777763    34666777777777777777776443433322     4


Q ss_pred             CCccEEEeeCCcCCccC----chhhhccCCCcEeeeccccccccCCcccc-----CCCCccEEEeeCccccccCC--CCc
Q 002214          203 TKLKSLDLGFNNLNGEI----PQEIGNLRNLEILGIDQSNLVGFVPDTIF-----NISTLKILSLFNNTLSGNLP--SSK  271 (952)
Q Consensus       203 ~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~n~~~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~~--~~~  271 (952)
                      ++|++|+|++|++++..    +..+..+++|+.|++++|.+....+..+.     ..++|++|++++|.+++...  -..
T Consensus       142 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~  221 (461)
T 1z7x_W          142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG  221 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred             CcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHH
Confidence            46777777777776533    45556667777777777666554333332     13456666666665542100  001


Q ss_pred             ccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCc
Q 002214          272 NLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLIN  351 (952)
Q Consensus       272 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~  351 (952)
                      .+..+++|++|++++|++++.....                                     +...       .+..+++
T Consensus       222 ~l~~~~~L~~L~Ls~n~l~~~~~~~-------------------------------------l~~~-------~~~~~~~  257 (461)
T 1z7x_W          222 IVASKASLRELALGSNKLGDVGMAE-------------------------------------LCPG-------LLHPSSR  257 (461)
T ss_dssp             HHHHCTTCCEEECCSSBCHHHHHHH-------------------------------------HHHH-------HTSTTCC
T ss_pred             HHHhCCCccEEeccCCcCChHHHHH-------------------------------------HHHH-------HhcCCCC
Confidence            1223444444555444443210000                                     0000       0123556


Q ss_pred             ccEEEccCCCCCCC----CCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEE
Q 002214          352 LTTLSLGDNNLSGS----LPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRIL  427 (952)
Q Consensus       352 L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  427 (952)
                      |++|++++|.++..    ++..+..+++|++|++++|.+.+..+..+...                   .....++|++|
T Consensus       258 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~-------------------l~~~~~~L~~L  318 (461)
T 1z7x_W          258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET-------------------LLEPGCQLESL  318 (461)
T ss_dssp             CCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH-------------------HTSTTCCCCEE
T ss_pred             ceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHH-------------------hccCCccceee
Confidence            66666666666632    34455556666666666666653333222211                   00112355555


Q ss_pred             eccccccCCc----CCccccCCCCCceeEecCCccCCCCchhhhc-----ccccceeecCCcccCC----CCcccccCCC
Q 002214          428 SLSSNELTSV----IPSTFWNLEDILGFDFSSNSLNGSLPLEIEN-----LKAVVDIYLSRNNLSG----NIPSTIIGLK  494 (952)
Q Consensus       428 ~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~  494 (952)
                      ++++|.+++.    .+..+..+++|+.|++++|.+++..+..+..     .++|++|+|++|++++    .+|..+..++
T Consensus       319 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~  398 (461)
T 1z7x_W          319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH  398 (461)
T ss_dssp             ECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCC
T ss_pred             EcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCC
Confidence            5555555433    2333444556666666666655433333332     4577777777777764    5566677777


Q ss_pred             CCceEEccCccccCccccccc-----ccccccEEeCCCCcccccCccch
Q 002214          495 NLQHLSLEHNKLQGPIPESFG-----ELVSLEFLDLSNNDLSGVIPASL  538 (952)
Q Consensus       495 ~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~~~~~  538 (952)
                      +|++|+|++|++++.....+.     ...+|+.|++.+|.+....+..+
T Consensus       399 ~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~l  447 (461)
T 1z7x_W          399 SLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL  447 (461)
T ss_dssp             CCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred             CccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHHH
Confidence            888888888877643222221     23457777777777664444433

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=1.1e-31  Score=294.32  Aligned_cols=264  Identities=19%  Similarity=0.267  Sum_probs=218.2

Q ss_pred             ccCCCCcccccc----CCCCCCCCCceEEEeC--------CCCeEEEEEecCCCCcccCCccccCCcccCeeeccccccc
Q 002214            3 NDNPNNILAQNW----TSNASVCSWMGITCDV--------YGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFS   70 (952)
Q Consensus         3 ~~~~~~~~~~~~----~~~~~~c~w~~v~c~~--------~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~   70 (952)
                      ..||.+.++ +|    ....++|.|.|+.|..        ...++++|++++++++ .+|+.++++++|++|+|++|.++
T Consensus        40 ~~~~~~~~~-~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~  117 (328)
T 4fcg_A           40 NADRNRWHS-AWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM  117 (328)
T ss_dssp             HHCCTTHHH-HHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC
T ss_pred             cCCchhhhh-hhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc
Confidence            357777775 77    4567999999999952        3468999999999998 89999999999999999999999


Q ss_pred             cccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCC
Q 002214           71 GTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDM  150 (952)
Q Consensus        71 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~  150 (952)
                       .+|..++.+++|++|+|++|++. .+|..++++++|++|+|++|.+.+.+|..+....            +.     ..
T Consensus       118 -~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~------------~~-----~~  178 (328)
T 4fcg_A          118 -ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD------------AS-----GE  178 (328)
T ss_dssp             -CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-------------C-----CC
T ss_pred             -chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhcc------------ch-----hh
Confidence             89999999999999999999999 8899999999999999999998888998776421            00     12


Q ss_pred             CCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCc
Q 002214          151 CPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLE  230 (952)
Q Consensus       151 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  230 (952)
                      +.++++|++|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..++.+++|++|+|++|++.+.+|..|+.+++|+
T Consensus       179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~  256 (328)
T 4fcg_A          179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK  256 (328)
T ss_dssp             EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred             hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence            345778888888888887 67777888888888888888888 4566788888888888888888778888888888888


Q ss_pred             EeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCC
Q 002214          231 ILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSG  291 (952)
Q Consensus       231 ~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~  291 (952)
                      .|+|++|++.+.+|..+.++++|++|+|++|.+.+.+|..  +..+++|+.+++..+.+..
T Consensus       257 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~--l~~L~~L~~l~l~~~~~~~  315 (328)
T 4fcg_A          257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL--IAQLPANCIILVPPHLQAQ  315 (328)
T ss_dssp             EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGG--GGGSCTTCEEECCGGGSCC
T ss_pred             EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHH--HhhccCceEEeCCHHHHHH
Confidence            8888888888888888888888888888888887777754  7778888888888776653

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=3.9e-34  Score=331.17  Aligned_cols=363  Identities=20%  Similarity=0.177  Sum_probs=210.1

Q ss_pred             CccceEEcccCcccccCCcc-ccCCCCCcEEEccCCcccc----cCCccccccCCccEEEeeCCcCCccCchhhh-ccC-
Q 002214          155 PRLKGLYVSYNQFKGPIPNN-LWHCKELSSVSLSYNQFTG----RLPRDLGNSTKLKSLDLGFNNLNGEIPQEIG-NLR-  227 (952)
Q Consensus       155 ~~L~~L~L~~n~l~~~~~~~-l~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~-  227 (952)
                      ++|++|+|++|+++...... +..+++|+.|+|++|+++.    .++..+..+++|++|+|++|.+++..+..+. .++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            35566666666655322222 4556666666666666653    2344555556666666666666543333332 244 


Q ss_pred             ---CCcEeeeccccccc----cCCccccCCCCccEEEeeCccccccCCCC---cccCCCCCcceEEcccCcCCCCCCccc
Q 002214          228 ---NLEILGIDQSNLVG----FVPDTIFNISTLKILSLFNNTLSGNLPSS---KNLIGLPNLEGLNLGLNNLSGSIPSFF  297 (952)
Q Consensus       228 ---~L~~L~L~~n~~~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~l~~l~~L~~L~L~~N~l~~~~~~~~  297 (952)
                         +|++|+|++|++..    .++..+..+++|++|+|++|.+++..+..   ......++|++|++++|++++.....+
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence               46666666666653    33555666666666666666664321110   001224467777777776664322211


Q ss_pred             ccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCC----CCcccccC
Q 002214          298 FNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGS----LPITLGRL  373 (952)
Q Consensus       298 ~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l  373 (952)
                      ..       .+..+++|+.|++++|.+.......+  ...+.       ...++|++|++++|.++..    ++..+..+
T Consensus       163 ~~-------~l~~~~~L~~L~L~~n~i~~~~~~~l--~~~l~-------~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~  226 (461)
T 1z7x_W          163 AS-------VLRAKPDFKELTVSNNDINEAGVRVL--CQGLK-------DSPCQLEALKLESCGVTSDNCRDLCGIVASK  226 (461)
T ss_dssp             HH-------HHHHCTTCCEEECCSSBCHHHHHHHH--HHHHH-------HSCCCCCEEECTTSCCBTTHHHHHHHHHHHC
T ss_pred             HH-------HHhhCCCCCEEECcCCCcchHHHHHH--HHHHh-------cCCCCceEEEccCCCCcHHHHHHHHHHHHhC
Confidence            11       12234455555555555443222111  01110       1345788888888888753    45667777


Q ss_pred             CCCcEEEccCccccCCC-----CccccCCCcceEEEecccccccc----CCCccCCCCCCcEEeccccccCCcCCccccC
Q 002214          374 KKLQGLDLQNNKFEGPI-----PQEFCHFSRLYVVYLNRNKLSGS----IPSCLGDLNSLRILSLSSNELTSVIPSTFWN  444 (952)
Q Consensus       374 ~~L~~L~L~~N~i~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  444 (952)
                      ++|++|++++|.+.+..     +..+..+++|+.|++++|.++..    ++..+..+++|++|++++|++++..+..+..
T Consensus       227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~  306 (461)
T 1z7x_W          227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE  306 (461)
T ss_dssp             TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred             CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence            88888888888776432     22233467777788877777743    4555666777777777777776544333332


Q ss_pred             -----CCCCceeEecCCccCCC----CchhhhcccccceeecCCcccCCCCcccccC-----CCCCceEEccCccccC--
Q 002214          445 -----LEDILGFDFSSNSLNGS----LPLEIENLKAVVDIYLSRNNLSGNIPSTIIG-----LKNLQHLSLEHNKLQG--  508 (952)
Q Consensus       445 -----l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~--  508 (952)
                           .++|+.|++++|.+++.    ++..+..+++|++|+|++|++++..+..+..     .++|++|+|++|++++  
T Consensus       307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~  386 (461)
T 1z7x_W          307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS  386 (461)
T ss_dssp             HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred             HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhh
Confidence                 25777777777777654    3455566677777777777776544433332     5677777777777764  


Q ss_pred             --cccccccccccccEEeCCCCccccc
Q 002214          509 --PIPESFGELVSLEFLDLSNNDLSGV  533 (952)
Q Consensus       509 --~~~~~~~~l~~L~~L~Ls~N~l~~~  533 (952)
                        .+|..+..+++|++|+|++|++++.
T Consensus       387 ~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          387 CSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             HHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             HHHHHHHHHhCCCccEEECCCCCCCHH
Confidence              5566666677777777777777643

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=1e-32  Score=330.02  Aligned_cols=451  Identities=18%  Similarity=0.124  Sum_probs=249.0

Q ss_pred             CC-CCceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeecccccc---ccccCCCcC------------CcCCC
Q 002214           20 VC-SWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWF---SGTIPKEIG------------NLTKL   83 (952)
Q Consensus        20 ~c-~w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l---~~~~p~~l~------------~l~~L   83 (952)
                      +| +|.++.+...    ..+.+..+ +...++..+..+++|+.|+|+++..   .+.+|..++            .+++|
T Consensus        40 vck~W~~~~~~~~----~~l~~~~~-~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L  114 (592)
T 3ogk_B           40 VCRRWFKIDSETR----EHVTMALC-YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL  114 (592)
T ss_dssp             SCHHHHHHHHHHC----CEEEESCG-GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred             HhHHHHHhhhccc----cEEEEeec-cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCC
Confidence            45 8998854321    23333332 2233455567889999999988643   134454444            56667


Q ss_pred             cEEeCcCCcccccCChhhcCC--CCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEE
Q 002214           84 KELHLDYNKLQGEIPEELGNL--AELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLY  161 (952)
Q Consensus        84 ~~L~L~~n~l~~~~p~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~  161 (952)
                      ++|+|++|.+.+..+..+...  .+|++|+|++|.-.  .+..+..                      +..++++|++|+
T Consensus       115 ~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~--~~~~l~~----------------------~~~~~~~L~~L~  170 (592)
T 3ogk_B          115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGF--TTDGLLS----------------------IVTHCRKIKTLL  170 (592)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEE--EHHHHHH----------------------HHHHCTTCSEEE
T ss_pred             CeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCc--CHHHHHH----------------------HHhhCCCCCEEE
Confidence            777777776665555555543  33777777666411  1111110                      112456777888


Q ss_pred             cccCccccc----CCccccCCCCCcEEEccCCccc----ccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEee
Q 002214          162 VSYNQFKGP----IPNNLWHCKELSSVSLSYNQFT----GRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILG  233 (952)
Q Consensus       162 L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  233 (952)
                      |++|.+++.    ++..+..+++|+.|++++|.++    +.++..+.++++|++|+|++|.+.+ +|..+..+++|+.|+
T Consensus       171 L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~  249 (592)
T 3ogk_B          171 MEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFC  249 (592)
T ss_dssp             CTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEE
T ss_pred             CccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhc
Confidence            887776644    2233455677777777777775    2334445567777777777777763 667777777777777


Q ss_pred             ecccccc---ccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccc
Q 002214          234 IDQSNLV---GFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGY  310 (952)
Q Consensus       234 L~~n~~~---~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~  310 (952)
                      ++.....   ...+..+..+++|+.|+++++... .++.  .+..+++|++|+|++|.+++.....              
T Consensus       250 l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~--~~~~~~~L~~L~Ls~~~l~~~~~~~--------------  312 (592)
T 3ogk_B          250 GGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPI--LFPFAAQIRKLDLLYALLETEDHCT--------------  312 (592)
T ss_dssp             ECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGG--GGGGGGGCCEEEETTCCCCHHHHHH--------------
T ss_pred             ccccccccchHHHHHHhhccccccccCccccchh-HHHH--HHhhcCCCcEEecCCCcCCHHHHHH--------------
Confidence            7643222   123344555666666666654322 1121  1334555666666665543211100              


Q ss_pred             cCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCC-CCCCcccccCCCCcEEEccC------
Q 002214          311 NSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLS-GSLPITLGRLKKLQGLDLQN------  383 (952)
Q Consensus       311 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~------  383 (952)
                                                        .+..+++|++|+++ +.+. ..++..+..+++|++|++++      
T Consensus       313 ----------------------------------~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~  357 (592)
T 3ogk_B          313 ----------------------------------LIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQG  357 (592)
T ss_dssp             ----------------------------------HHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSST
T ss_pred             ----------------------------------HHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccc
Confidence                                              02345555666665 3332 12222334456666666662      


Q ss_pred             -----ccccCCC-CccccCCCcceEEEeccccccccCCCccCC-CCCCcEEecc----ccccCCc-----CCccccCCCC
Q 002214          384 -----NKFEGPI-PQEFCHFSRLYVVYLNRNKLSGSIPSCLGD-LNSLRILSLS----SNELTSV-----IPSTFWNLED  447 (952)
Q Consensus       384 -----N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~~~~l~~  447 (952)
                           |.++... +..+..+++|+.|+++.|.+++..+..+.. +++|+.|+++    .|++++.     .+..+.++++
T Consensus       358 ~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~  437 (592)
T 3ogk_B          358 MEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKK  437 (592)
T ss_dssp             TSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTT
T ss_pred             cccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCC
Confidence                 3443221 111234566666666666665444444443 6667777764    5566543     2223555677


Q ss_pred             CceeEecCCc--cCCCCchhhh-cccccceeecCCcccCCC-CcccccCCCCCceEEccCccccCc-ccccccccccccE
Q 002214          448 ILGFDFSSNS--LNGSLPLEIE-NLKAVVDIYLSRNNLSGN-IPSTIIGLKNLQHLSLEHNKLQGP-IPESFGELVSLEF  522 (952)
Q Consensus       448 L~~L~Ls~N~--l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~  522 (952)
                      |+.|++++|.  +++..+..+. .+++|++|+|++|++++. .+..+.++++|+.|+|++|.+++. ++.....+++|+.
T Consensus       438 L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~  517 (592)
T 3ogk_B          438 LRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRY  517 (592)
T ss_dssp             CCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCE
T ss_pred             CCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCe
Confidence            7777776433  4443333333 367777777777777642 334456677788888888877643 2333456777888


Q ss_pred             EeCCCCcccccCccch-hccccccccccccc
Q 002214          523 LDLSNNDLSGVIPASL-EKLLYLKSLNLSFN  552 (952)
Q Consensus       523 L~Ls~N~l~~~~~~~~-~~l~~L~~L~l~~N  552 (952)
                      |+|++|+++......+ ..++.+....+..+
T Consensus       518 L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          518 LWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             EEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             eECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            8888887765432222 34555555544444

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=8.7e-30  Score=283.24  Aligned_cols=190  Identities=19%  Similarity=0.201  Sum_probs=115.7

Q ss_pred             cCCCcccEEEccCCCCCCCCC-cccccCCCCcEEEccCc-cccCCCCccccCCCcceEEEeccccccccCCCccCCCCCC
Q 002214          347 GNLINLTTLSLGDNNLSGSLP-ITLGRLKKLQGLDLQNN-KFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSL  424 (952)
Q Consensus       347 ~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  424 (952)
                      +.+++|++|++++|++++..+ ..+..+++|++|++++| .+....+..|.++++|+.|++++|++++..|..+..+++|
T Consensus       121 ~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L  200 (353)
T 2z80_A          121 KPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNV  200 (353)
T ss_dssp             TTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEE
T ss_pred             CCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccC
Confidence            345566666666666664433 35666666666666666 3554445555555555555555555555555555555555


Q ss_pred             cEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCccccc---CCCCCceEEc
Q 002214          425 RILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTII---GLKNLQHLSL  501 (952)
Q Consensus       425 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~L  501 (952)
                      ++|++++|+++.+.+..                        +..+++|+.|++++|++++..+..+.   ..+.++.++|
T Consensus       201 ~~L~l~~n~l~~~~~~~------------------------~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L  256 (353)
T 2z80_A          201 SHLILHMKQHILLLEIF------------------------VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF  256 (353)
T ss_dssp             EEEEEECSCSTTHHHHH------------------------HHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEE
T ss_pred             CeecCCCCccccchhhh------------------------hhhcccccEEECCCCccccccccccccccccchhhcccc
Confidence            55555555554333222                        33445555555555555544333222   3456777777


Q ss_pred             cCccccC----cccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          502 EHNKLQG----PIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       502 ~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      ++|.+++    .+|..+..+++|+.|+|++|+|+.+.+..|..+++|++|++++|++.|.+|.
T Consensus       257 ~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          257 RNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             ESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             ccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence            7777664    3567788888888888888888854444468888888888888888888773

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=7.5e-30  Score=283.76  Aligned_cols=213  Identities=22%  Similarity=0.262  Sum_probs=153.8

Q ss_pred             ccCCCCCCCCCceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCc
Q 002214           13 NWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNK   92 (952)
Q Consensus        13 ~~~~~~~~c~w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~   92 (952)
                      .|......|.|.|+ |+.          ++++++ .+|..+.  ++|++|++++|.+++..+..+..+++|++|+|++|+
T Consensus        22 ~~~~~~~~C~~~~~-c~~----------~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~   87 (353)
T 2z80_A           22 SSNQASLSCDRNGI-CKG----------SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG   87 (353)
T ss_dssp             -----CCEECTTSE-EEC----------CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             CCCccCCCCCCCeE-eeC----------CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCc
Confidence            44445678999987 764          556665 6777665  589999999999996666689999999999999999


Q ss_pred             ccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCC
Q 002214           93 LQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIP  172 (952)
Q Consensus        93 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  172 (952)
                      +.+..|.+|+++++|++|+|++|+++ .+|..                         .+.++++|++|+|++|+++...+
T Consensus        88 l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~-------------------------~~~~l~~L~~L~L~~n~l~~l~~  141 (353)
T 2z80_A           88 INTIEEDSFSSLGSLEHLDLSYNYLS-NLSSS-------------------------WFKPLSSLTFLNLLGNPYKTLGE  141 (353)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCS-SCCHH-------------------------HHTTCTTCSEEECTTCCCSSSCS
T ss_pred             cCccCHhhcCCCCCCCEEECCCCcCC-cCCHh-------------------------HhCCCccCCEEECCCCCCcccCc
Confidence            99877888999999999999999988 34333                         12345677777777777774322


Q ss_pred             -ccccCCCCCcEEEccCC-cccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCC
Q 002214          173 -NNLWHCKELSSVSLSYN-QFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNI  250 (952)
Q Consensus       173 -~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l  250 (952)
                       ..+..+++|+.|++++| .++...+..|+++++|++|++++|.+++..|..|+.+++|++|++++|++....+..+..+
T Consensus       142 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~  221 (353)
T 2z80_A          142 TSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT  221 (353)
T ss_dssp             SCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHT
T ss_pred             hhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhc
Confidence             36677777777777777 4665666677777777777777777776667777777777777777777655444444456


Q ss_pred             CCccEEEeeCccccc
Q 002214          251 STLKILSLFNNTLSG  265 (952)
Q Consensus       251 ~~L~~L~Ls~N~l~~  265 (952)
                      ++|+.|++++|.+++
T Consensus       222 ~~L~~L~L~~n~l~~  236 (353)
T 2z80_A          222 SSVECLELRDTDLDT  236 (353)
T ss_dssp             TTEEEEEEESCBCTT
T ss_pred             ccccEEECCCCcccc
Confidence            777777777777664

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=1.3e-29  Score=272.82  Aligned_cols=236  Identities=22%  Similarity=0.232  Sum_probs=213.7

Q ss_pred             CCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEecccc-ccccCCCccCCCCCCcE
Q 002214          348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNK-LSGSIPSCLGDLNSLRI  426 (952)
Q Consensus       348 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~  426 (952)
                      ..++|++|++++|.+++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|+ +....|..|..+++|++
T Consensus        30 ~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~  109 (285)
T 1ozn_A           30 IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHT  109 (285)
T ss_dssp             CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCE
T ss_pred             CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCE
Confidence            35689999999999998888899999999999999999998889999999999999999997 88777889999999999


Q ss_pred             EeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccc
Q 002214          427 LSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKL  506 (952)
Q Consensus       427 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  506 (952)
                      |++++|++++..+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++
T Consensus       110 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  189 (285)
T 1ozn_A          110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV  189 (285)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcc
Confidence            99999999999899999999999999999999987777899999999999999999987778899999999999999999


Q ss_pred             cCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCCCcccccccccccCccCCCCCc
Q 002214          507 QGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPY  583 (952)
Q Consensus       507 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~  583 (952)
                      ++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++.|.++....+.++.......+...|..|.
T Consensus       190 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~  266 (285)
T 1ozn_A          190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ  266 (285)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESG
T ss_pred             cccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCch
Confidence            98889999999999999999999998888889999999999999999999888655555666666666777777663

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=2.4e-29  Score=273.87  Aligned_cols=183  Identities=21%  Similarity=0.311  Sum_probs=98.0

Q ss_pred             CCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCC-ccccCCCcceEEEeccccccccCCCccCCCCCCcE
Q 002214          348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIP-QEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRI  426 (952)
Q Consensus       348 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  426 (952)
                      .+++|++|++++|.++ .+|..+..+++|++|++++|.+++..+ ..|..+++|++|++++|.+.+..+..+..+++|++
T Consensus        76 ~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  154 (306)
T 2z66_A           76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV  154 (306)
T ss_dssp             SCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCE
T ss_pred             cccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCE
Confidence            3455666666666665 344445566666666666666654443 45555555555555555555555555555555555


Q ss_pred             EeccccccCC-cCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcc
Q 002214          427 LSLSSNELTS-VIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNK  505 (952)
Q Consensus       427 L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  505 (952)
                      |++++|++++ ..|..|..+++|+.|++++|++++..|..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus       155 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  234 (306)
T 2z66_A          155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH  234 (306)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSC
T ss_pred             EECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCC
Confidence            5555555554 344555555555555555555554444455555555555555555554444444445555555555555


Q ss_pred             ccCcccccccccc-cccEEeCCCCccc
Q 002214          506 LQGPIPESFGELV-SLEFLDLSNNDLS  531 (952)
Q Consensus       506 l~~~~~~~~~~l~-~L~~L~Ls~N~l~  531 (952)
                      +++..|..+..++ +|+.|+|++|+++
T Consensus       235 l~~~~~~~~~~~~~~L~~L~L~~N~~~  261 (306)
T 2z66_A          235 IMTSKKQELQHFPSSLAFLNLTQNDFA  261 (306)
T ss_dssp             CCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred             CcccCHHHHHhhhccCCEEEccCCCee
Confidence            5544444444442 4555555555544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=5.8e-29  Score=270.84  Aligned_cols=194  Identities=18%  Similarity=0.209  Sum_probs=138.2

Q ss_pred             cCCCcccEEEccCCCCCCCCC-cccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccc-cCCCccCCCCCC
Q 002214          347 GNLINLTTLSLGDNNLSGSLP-ITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSG-SIPSCLGDLNSL  424 (952)
Q Consensus       347 ~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L  424 (952)
                      ..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+..+..|..+++|++|++++|.+++ ..|..+..+++|
T Consensus        98 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L  177 (306)
T 2z66_A           98 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL  177 (306)
T ss_dssp             ETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred             CCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCC
Confidence            345566777777777765544 567777888888888888877777778888888888888888875 567778888888


Q ss_pred             cEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCC-CCceEEccC
Q 002214          425 RILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLK-NLQHLSLEH  503 (952)
Q Consensus       425 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~  503 (952)
                      ++|++++|++++..|..|..+++|+.|++++|++++..+..+..+++|+.|+|++|++++..|..+..++ +|++|+|++
T Consensus       178 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~  257 (306)
T 2z66_A          178 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ  257 (306)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTT
T ss_pred             CEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccC
Confidence            8888888888877778888888888888888888876666778888888888888888877777777774 788888888


Q ss_pred             ccccCccc--ccccccccccEEeCCCCcccccCccchhc
Q 002214          504 NKLQGPIP--ESFGELVSLEFLDLSNNDLSGVIPASLEK  540 (952)
Q Consensus       504 N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  540 (952)
                      |++++..+  .....+..++.+.+..+.+....|..+.+
T Consensus       258 N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g  296 (306)
T 2z66_A          258 NDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG  296 (306)
T ss_dssp             CCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred             CCeecccChHHHHHHHHhhhhhhccccccccCCchhhCC
Confidence            88875322  11122333334444444444444444433

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=1.8e-28  Score=282.12  Aligned_cols=213  Identities=22%  Similarity=0.276  Sum_probs=179.4

Q ss_pred             ccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCc
Q 002214          346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR  425 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  425 (952)
                      |+++++|++|+|++|+|+++.+..|.++++|++|+|++|.|+.+.+..|..+++|++|+|++|++++..+..|..+++|+
T Consensus        95 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  174 (452)
T 3zyi_A           95 FRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLM  174 (452)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCC
T ss_pred             cCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCccc
Confidence            34567788888888888877778888888888888888888877777788888888888888888877777888888888


Q ss_pred             EEeccc-cccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCc
Q 002214          426 ILSLSS-NELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHN  504 (952)
Q Consensus       426 ~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  504 (952)
                      .|++++ |.+..+.+..|.++++|+.|+|++|++++. | .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|
T Consensus       175 ~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n  252 (452)
T 3zyi_A          175 RLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS  252 (452)
T ss_dssp             EEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTS
T ss_pred             EEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCC
Confidence            888888 556666666788888888888888888853 3 4778889999999999999888889999999999999999


Q ss_pred             cccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          505 KLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       505 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      ++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.+..
T Consensus       253 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~  308 (452)
T 3zyi_A          253 QVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI  308 (452)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred             cCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence            99988888899999999999999999988888888899999999999999988764

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=1.9e-28  Score=280.86  Aligned_cols=213  Identities=23%  Similarity=0.295  Sum_probs=184.4

Q ss_pred             ccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCc
Q 002214          346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR  425 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  425 (952)
                      |.++++|++|+|++|+++++.+..|.++++|++|+|++|+|+.+.+..|..+++|++|+|++|+|+...+..|..+++|+
T Consensus        84 ~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  163 (440)
T 3zyj_A           84 FKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLR  163 (440)
T ss_dssp             TSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCC
T ss_pred             hhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccC
Confidence            45667788888888888877778888888888888888888877777888888888888888888877777888888999


Q ss_pred             EEeccc-cccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCc
Q 002214          426 ILSLSS-NELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHN  504 (952)
Q Consensus       426 ~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  504 (952)
                      +|++++ |.+..+.+..|.++++|+.|++++|+++. +| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|
T Consensus       164 ~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n  241 (440)
T 3zyj_A          164 RLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS  241 (440)
T ss_dssp             EEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             EeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCC
Confidence            999988 55666666688889999999999998884 44 4788899999999999999888999999999999999999


Q ss_pred             cccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          505 KLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       505 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      +|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.+..
T Consensus       242 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l  297 (440)
T 3zyj_A          242 QIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI  297 (440)
T ss_dssp             CCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred             ceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence            99988888999999999999999999988888889999999999999999998864

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=2.3e-28  Score=287.92  Aligned_cols=289  Identities=27%  Similarity=0.320  Sum_probs=172.3

Q ss_pred             ccCCCCCCCCCceEEEe------CCCCeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEE
Q 002214           13 NWTSNASVCSWMGITCD------VYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKEL   86 (952)
Q Consensus        13 ~~~~~~~~c~w~~v~c~------~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L   86 (952)
                      .|...+++|+|.|..|.      ....++++|++++++++ .+|..+.  ++|+.|+|++|.|+ .+|.   .+++|++|
T Consensus        14 ~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L   86 (622)
T 3g06_A           14 AWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTL   86 (622)
T ss_dssp             HHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEE
T ss_pred             HHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEE
Confidence            68766789999876532      22345777888888877 6776665  67788888888777 5665   45777777


Q ss_pred             eCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCc
Q 002214           87 HLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQ  166 (952)
Q Consensus        87 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~  166 (952)
                      +|++|+++ .+|.   .+++|++|+|++|.++ .+|.                             .+++|+.|++++|+
T Consensus        87 ~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~-----------------------------~l~~L~~L~L~~N~  132 (622)
T 3g06_A           87 EVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA-----------------------------LPSGLCKLWIFGNQ  132 (622)
T ss_dssp             EECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC-----------------------------CCTTCCEEECCSSC
T ss_pred             EcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC-----------------------------CCCCcCEEECCCCC
Confidence            77777777 4554   5677777777777766 2222                             13456666666666


Q ss_pred             ccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCcc
Q 002214          167 FKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDT  246 (952)
Q Consensus       167 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~  246 (952)
                      ++. +|..   +++|++|+|++|++++ +|.   ..++|+.|++++|.+++ +|   ..+                    
T Consensus       133 l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~--------------------  180 (622)
T 3g06_A          133 LTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLP--------------------  180 (622)
T ss_dssp             CSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCC--------------------
T ss_pred             CCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccC--------------------
Confidence            553 3332   2555555555555553 232   22445555555555552 33   223                    


Q ss_pred             ccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceee
Q 002214          247 IFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTF  326 (952)
Q Consensus       247 ~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~  326 (952)
                          ++|+.|++++|+|++. |.     .+++|+.|++++|.++.+ |.                               
T Consensus       181 ----~~L~~L~Ls~N~l~~l-~~-----~~~~L~~L~L~~N~l~~l-~~-------------------------------  218 (622)
T 3g06_A          181 ----SGLQELSVSDNQLASL-PT-----LPSELYKLWAYNNRLTSL-PA-------------------------------  218 (622)
T ss_dssp             ----TTCCEEECCSSCCSCC-CC-----CCTTCCEEECCSSCCSSC-CC-------------------------------
T ss_pred             ----CCCcEEECCCCCCCCC-CC-----ccchhhEEECcCCccccc-CC-------------------------------
Confidence                4444455555544421 11     124555555555555421 11                               


Q ss_pred             chhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEec
Q 002214          327 STSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLN  406 (952)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  406 (952)
                                           .+++|+.|+|++|+|++ +|   ..+++|++|+|++|.|+. +|.   .+++|+.|+|+
T Consensus       219 ---------------------~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls  269 (622)
T 3g06_A          219 ---------------------LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVY  269 (622)
T ss_dssp             ---------------------CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred             ---------------------CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCC
Confidence                                 12345666666666664 23   344667777777777663 333   45667777777


Q ss_pred             cccccccCCCccCCCCCCcEEeccccccCCcCCccccCCC
Q 002214          407 RNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLE  446 (952)
Q Consensus       407 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  446 (952)
                      +|+|+ .+|..+..+++|+.|+|++|.+++..+..+..++
T Consensus       270 ~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          270 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             SSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             CCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            77777 5566777778888888888888777666665544

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=1.2e-27  Score=257.43  Aligned_cols=253  Identities=23%  Similarity=0.225  Sum_probs=209.8

Q ss_pred             cEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHH
Q 002214          254 KILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMS  333 (952)
Q Consensus       254 ~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~  333 (952)
                      +.++++++.++.. |.    ...++|++|++++|++++..+..                                     
T Consensus        14 ~~~~c~~~~l~~i-p~----~~~~~l~~L~l~~n~i~~~~~~~-------------------------------------   51 (285)
T 1ozn_A           14 VTTSCPQQGLQAV-PV----GIPAASQRIFLHGNRISHVPAAS-------------------------------------   51 (285)
T ss_dssp             CEEECCSSCCSSC-CT----TCCTTCSEEECTTSCCCEECTTT-------------------------------------
T ss_pred             eEEEcCcCCcccC-Cc----CCCCCceEEEeeCCcCCccCHHH-------------------------------------
Confidence            5677777777633 32    12357788888888777554433                                     


Q ss_pred             HHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCcc-ccCCCCccccCCCcceEEEeccccccc
Q 002214          334 LFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNK-FEGPIPQEFCHFSRLYVVYLNRNKLSG  412 (952)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~N~l~~  412 (952)
                                  ++.+++|++|++++|.+++..+..|..+++|++|++++|. +....+..|..+++|++|++++|++++
T Consensus        52 ------------~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~  119 (285)
T 1ozn_A           52 ------------FRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE  119 (285)
T ss_dssp             ------------TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCC
T ss_pred             ------------cccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCE
Confidence                        3566788889999999988878889999999999999997 887778889999999999999999998


Q ss_pred             cCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccC
Q 002214          413 SIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIG  492 (952)
Q Consensus       413 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  492 (952)
                      ..+..|..+++|++|++++|+++++.+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..|..|..
T Consensus       120 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  199 (285)
T 1ozn_A          120 LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD  199 (285)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred             ECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccC
Confidence            88888999999999999999999888888999999999999999999777777999999999999999999888999999


Q ss_pred             CCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCC
Q 002214          493 LKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG  561 (952)
Q Consensus       493 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  561 (952)
                      +++|+.|+|++|++++..+..+..+++|+.|+|++|++....+. ..-+..++.+..+.|.+.|..|..
T Consensus       200 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             CTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGG
T ss_pred             cccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchH
Confidence            99999999999999987777899999999999999999854332 233455777888899999988863

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=9.3e-28  Score=276.21  Aligned_cols=234  Identities=23%  Similarity=0.214  Sum_probs=214.5

Q ss_pred             CCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEe
Q 002214          349 LINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILS  428 (952)
Q Consensus       349 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  428 (952)
                      .+++++|+|++|+|+++.+..|.++++|++|+|++|.|+++.+..|.++++|++|+|++|++++..+..|..+++|++|+
T Consensus        74 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  153 (452)
T 3zyi_A           74 PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW  153 (452)
T ss_dssp             CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEE
T ss_pred             CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEE
Confidence            36899999999999999999999999999999999999999999999999999999999999988888899999999999


Q ss_pred             ccccccCCcCCccccCCCCCceeEecC-CccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcccc
Q 002214          429 LSSNELTSVIPSTFWNLEDILGFDFSS-NSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQ  507 (952)
Q Consensus       429 L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  507 (952)
                      |++|+++++.+..|..+++|+.|++++ |.+....+..|.++++|++|+|++|++++. | .+..+++|+.|+|++|+|+
T Consensus       154 L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~  231 (452)
T 3zyi_A          154 LRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFP  231 (452)
T ss_dssp             CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCS
T ss_pred             CCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCc
Confidence            999999999899999999999999999 556655566799999999999999999964 4 5889999999999999999


Q ss_pred             CcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCC-CCcccccccccccCccCCCCCcc
Q 002214          508 GPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG-GAFANFSAESFIGNDLLCGSPYL  584 (952)
Q Consensus       508 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~p~~  584 (952)
                      +..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+.. ..+.++....+.+|||.|+|...
T Consensus       232 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~  309 (452)
T 3zyi_A          232 EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDIL  309 (452)
T ss_dssp             EECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTH
T ss_pred             ccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCch
Confidence            988999999999999999999999999999999999999999999999766543 34667777889999999999854

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=1e-27  Score=274.92  Aligned_cols=234  Identities=22%  Similarity=0.224  Sum_probs=214.0

Q ss_pred             CCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEe
Q 002214          349 LINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILS  428 (952)
Q Consensus       349 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  428 (952)
                      .++++.|+|++|+++++.+..|.++++|++|+|++|.|+++.+..|.++++|++|+|++|+|++..+..|..+++|++|+
T Consensus        63 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  142 (440)
T 3zyj_A           63 STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW  142 (440)
T ss_dssp             CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEE
T ss_pred             CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceee
Confidence            36899999999999988889999999999999999999999999999999999999999999988788899999999999


Q ss_pred             ccccccCCcCCccccCCCCCceeEecCC-ccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcccc
Q 002214          429 LSSNELTSVIPSTFWNLEDILGFDFSSN-SLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQ  507 (952)
Q Consensus       429 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  507 (952)
                      |++|+++++.+..|..+++|+.|++++| .+....+..|.++++|++|+|++|+++. +| .+..+++|+.|+|++|+|+
T Consensus       143 L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~  220 (440)
T 3zyj_A          143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLS  220 (440)
T ss_dssp             CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCC
T ss_pred             CCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccC
Confidence            9999999999999999999999999994 5665556689999999999999999995 44 4889999999999999999


Q ss_pred             CcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCC-CCcccccccccccCccCCCCCcc
Q 002214          508 GPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG-GAFANFSAESFIGNDLLCGSPYL  584 (952)
Q Consensus       508 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~p~~  584 (952)
                      +..|..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..+.. ..+.++....+.+|||.|+|...
T Consensus       221 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~  298 (440)
T 3zyj_A          221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDIL  298 (440)
T ss_dssp             EECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTH
T ss_pred             ccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCch
Confidence            888999999999999999999999999999999999999999999999766543 34567777889999999999754

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=3.7e-30  Score=307.84  Aligned_cols=350  Identities=14%  Similarity=0.089  Sum_probs=240.4

Q ss_pred             cceEEcccCc-ccc-cCCccccCCCCCcEEEccCCccccc----CCccccccCCccEEEeeCCcCC----ccCchhhhcc
Q 002214          157 LKGLYVSYNQ-FKG-PIPNNLWHCKELSSVSLSYNQFTGR----LPRDLGNSTKLKSLDLGFNNLN----GEIPQEIGNL  226 (952)
Q Consensus       157 L~~L~L~~n~-l~~-~~~~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l  226 (952)
                      |++|+|++|. +.. .++.....+++|++|+|++|.+++.    ++..+..+++|++|+|++|.++    +.++..+..+
T Consensus       140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~  219 (592)
T 3ogk_B          140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC  219 (592)
T ss_dssp             CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred             CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence            7777777765 211 1122223667788888888777644    2234456677788888777776    2344455667


Q ss_pred             CCCcEeeeccccccccCCccccCCCCccEEEeeCcccc-ccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhh
Q 002214          227 RNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLS-GNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYA  305 (952)
Q Consensus       227 ~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~  305 (952)
                      ++|+.|++++|.+.+ ++..+..+++|++|+++.+... ...+....+..+++|+.|+++++... ..|.          
T Consensus       220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~----------  287 (592)
T 3ogk_B          220 RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPI----------  287 (592)
T ss_dssp             TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGG----------
T ss_pred             CCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHH----------
Confidence            777777777777665 3466677777777777753221 00111223445556666666553221 1111          


Q ss_pred             hhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCC-cccccCCCCcEEEccCc
Q 002214          306 LELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLP-ITLGRLKKLQGLDLQNN  384 (952)
Q Consensus       306 l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N  384 (952)
                                                             .+..+++|++|+|++|.+++... ..+..+++|++|+++++
T Consensus       288 ---------------------------------------~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~  328 (592)
T 3ogk_B          288 ---------------------------------------LFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNV  328 (592)
T ss_dssp             ---------------------------------------GGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGG
T ss_pred             ---------------------------------------HHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCc
Confidence                                                   13467789999999999874433 44688999999999944


Q ss_pred             cccCCCCccccCCCcceEEEec-----------ccccccc-CCCccCCCCCCcEEeccccccCCcCCccccC-CCCCcee
Q 002214          385 KFEGPIPQEFCHFSRLYVVYLN-----------RNKLSGS-IPSCLGDLNSLRILSLSSNELTSVIPSTFWN-LEDILGF  451 (952)
Q Consensus       385 ~i~~~~~~~~~~l~~L~~L~L~-----------~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L  451 (952)
                      ......+..+..+++|+.|+++           .|.++.. ++..+..+++|++|+++.|++++..+..+.. +++|+.|
T Consensus       329 ~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L  408 (592)
T 3ogk_B          329 IGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDF  408 (592)
T ss_dssp             GHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEE
T ss_pred             cCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEE
Confidence            3333334445678999999999           3666643 2233456899999999999998776666665 8999999


Q ss_pred             Eec----CCccCCC-----CchhhhcccccceeecCCc--ccCCCCccccc-CCCCCceEEccCccccC-cccccccccc
Q 002214          452 DFS----SNSLNGS-----LPLEIENLKAVVDIYLSRN--NLSGNIPSTII-GLKNLQHLSLEHNKLQG-PIPESFGELV  518 (952)
Q Consensus       452 ~Ls----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N--~l~~~~~~~~~-~l~~L~~L~L~~N~l~~-~~~~~~~~l~  518 (952)
                      +++    .|.+++.     ++..+.++++|++|+|++|  .+++..+..+. .+++|++|+|++|++++ .++..+..++
T Consensus       409 ~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~  488 (592)
T 3ogk_B          409 RLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCP  488 (592)
T ss_dssp             EEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCT
T ss_pred             EEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCc
Confidence            996    7788864     3445778999999999854  36654444443 48999999999999986 3455668899


Q ss_pred             cccEEeCCCCccccc-CccchhcccccccccccccccccC
Q 002214          519 SLEFLDLSNNDLSGV-IPASLEKLLYLKSLNLSFNKLVGE  557 (952)
Q Consensus       519 ~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~  557 (952)
                      +|+.|+|++|.+++. ++..+..+++|+.|++++|+++..
T Consensus       489 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          489 NLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             TCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             ccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            999999999998754 445557899999999999998754

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=1.5e-28  Score=268.52  Aligned_cols=267  Identities=22%  Similarity=0.200  Sum_probs=163.5

Q ss_pred             CcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeC
Q 002214          181 LSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFN  260 (952)
Q Consensus       181 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~  260 (952)
                      ++.++++.+.+...+...+..+++|++|+|++|.+++..|..|..+++|+.|+|++|++.+..+  +..+++|++|++++
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~   89 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN   89 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence            3445666666665555555566677777777777776666677777777777777666655443  55556666666666


Q ss_pred             ccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhc
Q 002214          261 NTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVN  340 (952)
Q Consensus       261 N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~  340 (952)
                      |++++..       ..++                                                              
T Consensus        90 n~l~~l~-------~~~~--------------------------------------------------------------  100 (317)
T 3o53_A           90 NYVQELL-------VGPS--------------------------------------------------------------  100 (317)
T ss_dssp             SEEEEEE-------ECTT--------------------------------------------------------------
T ss_pred             Ccccccc-------CCCC--------------------------------------------------------------
Confidence            6554221       1133                                                              


Q ss_pred             cccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCcc-C
Q 002214          341 CKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCL-G  419 (952)
Q Consensus       341 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~  419 (952)
                                 |++|++++|++++..+..   +++|++|++++|++++..+..|..+++|++|+|++|++++..+..+ .
T Consensus       101 -----------L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  166 (317)
T 3o53_A          101 -----------IETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA  166 (317)
T ss_dssp             -----------CCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGG
T ss_pred             -----------cCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhh
Confidence                       444444444444322221   3445555555555554444444444445555555554444333333 2


Q ss_pred             CCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceE
Q 002214          420 DLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHL  499 (952)
Q Consensus       420 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  499 (952)
                      .+++|++|++++|+++++.+                          ...+++|++|+|++|++++. |..|..+++|+.|
T Consensus       167 ~l~~L~~L~L~~N~l~~~~~--------------------------~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L  219 (317)
T 3o53_A          167 SSDTLEHLNLQYNFIYDVKG--------------------------QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWI  219 (317)
T ss_dssp             GTTTCCEEECTTSCCCEEEC--------------------------CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEE
T ss_pred             ccCcCCEEECCCCcCccccc--------------------------ccccccCCEEECCCCcCCcc-hhhhcccCcccEE
Confidence            45556666666666554311                          11245566666666666644 3347778888888


Q ss_pred             EccCccccCcccccccccccccEEeCCCCccc-ccCccchhccccccccccc-ccccccCCCC
Q 002214          500 SLEHNKLQGPIPESFGELVSLEFLDLSNNDLS-GVIPASLEKLLYLKSLNLS-FNKLVGEIPR  560 (952)
Q Consensus       500 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~-~N~l~~~~p~  560 (952)
                      +|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+++ .+.+.|..|.
T Consensus       220 ~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             ECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             ECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            88888888 46778888999999999999998 6788889999999999999 4556665543

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=2.2e-26  Score=270.99  Aligned_cols=167  Identities=28%  Similarity=0.308  Sum_probs=99.4

Q ss_pred             cccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEecc
Q 002214          351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLS  430 (952)
Q Consensus       351 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  430 (952)
                      +|++|+|++|+++++ |.   .+++|+.|++++|.|++ .|   ..+++|+.|++++|+|++ +|.   .+++|+.|+++
T Consensus       142 ~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~  209 (622)
T 3g06_A          142 GLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPT---LPSELYKLWAY  209 (622)
T ss_dssp             TCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred             CCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCC---ccchhhEEECc
Confidence            344444444444422 21   12445555555555543 22   223455555555555552 222   13556666666


Q ss_pred             ccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcc
Q 002214          431 SNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPI  510 (952)
Q Consensus       431 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  510 (952)
                      +|.++.++.    .+++|+.|++++|+|++ +|   ..+++|+.|+|++|+|+. +|.   .+++|+.|+|++|+|+ .+
T Consensus       210 ~N~l~~l~~----~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~l  276 (622)
T 3g06_A          210 NNRLTSLPA----LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RL  276 (622)
T ss_dssp             SSCCSSCCC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SC
T ss_pred             CCcccccCC----CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cC
Confidence            666664332    23566666666666664 33   345667777777777774 343   5677888888888888 56


Q ss_pred             cccccccccccEEeCCCCcccccCccchhccc
Q 002214          511 PESFGELVSLEFLDLSNNDLSGVIPASLEKLL  542 (952)
Q Consensus       511 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  542 (952)
                      |..+..+++|+.|+|++|++++..|..+..++
T Consensus       277 p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          277 PESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             CGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             CHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            77788888888888888888877777766655

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=6.3e-27  Score=256.45  Aligned_cols=205  Identities=20%  Similarity=0.260  Sum_probs=182.4

Q ss_pred             cCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCC------
Q 002214          347 GNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD------  420 (952)
Q Consensus       347 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------  420 (952)
                      +.+++|++|+|++|.++ .+|..+..+++|++|+|++|.++ ..|..|..+++|++|+|++|++.+.+|..+..      
T Consensus       101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~  178 (328)
T 4fcg_A          101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE  178 (328)
T ss_dssp             GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred             hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence            45678888999999988 77888888999999999999988 66888889999999999998888788877654      


Q ss_pred             ---CCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCc
Q 002214          421 ---LNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ  497 (952)
Q Consensus       421 ---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  497 (952)
                         +++|++|++++|+++ .+|..+..+++|+.|++++|++++ +|..+..+++|++|+|++|++.+.+|..|..+++|+
T Consensus       179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~  256 (328)
T 4fcg_A          179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK  256 (328)
T ss_dssp             EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred             hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence               999999999999998 567789999999999999999995 666799999999999999999999999999999999


Q ss_pred             eEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccc
Q 002214          498 HLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLV  555 (952)
Q Consensus       498 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  555 (952)
                      .|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+.++++|+.+++..|.+.
T Consensus       257 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            9999999998899999999999999999999999999999999999999999887664

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=9.4e-29  Score=270.18  Aligned_cols=125  Identities=21%  Similarity=0.176  Sum_probs=101.2

Q ss_pred             ccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeec
Q 002214          156 RLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGID  235 (952)
Q Consensus       156 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  235 (952)
                      +++.++++.+.+.......+..+++|+.|+|++|++++..|..|+.+++|++|+|++|.+++..+  +..+++|++|+++
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls   88 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN   88 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence            46677888888876555666778899999999999998888899999999999999999986555  9999999999999


Q ss_pred             cccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCC
Q 002214          236 QSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGS  292 (952)
Q Consensus       236 ~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~  292 (952)
                      +|++.++.     ..++|++|++++|++++..+.     .+++|++|++++|++++.
T Consensus        89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~-----~~~~L~~L~l~~N~l~~~  135 (317)
T 3o53_A           89 NNYVQELL-----VGPSIETLHAANNNISRVSCS-----RGQGKKNIYLANNKITML  135 (317)
T ss_dssp             SSEEEEEE-----ECTTCCEEECCSSCCSEEEEC-----CCSSCEEEECCSSCCCSG
T ss_pred             CCcccccc-----CCCCcCEEECCCCccCCcCcc-----ccCCCCEEECCCCCCCCc
Confidence            99988764     348999999999999754322     245666666666666543

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=4.8e-28  Score=279.95  Aligned_cols=222  Identities=23%  Similarity=0.187  Sum_probs=166.8

Q ss_pred             CCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEE
Q 002214          348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRIL  427 (952)
Q Consensus       348 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  427 (952)
                      .+++|++|+|++|.+++..|..|..+++|++|+|++|.|++..|  |..+++|++|+|++|.|++..+     .++|++|
T Consensus        32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L  104 (487)
T 3oja_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL  104 (487)
T ss_dssp             TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred             cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence            44578888888888887777788888888888888888876554  7788888888888888874432     2778888


Q ss_pred             eccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCccccc-CCCCCceEEccCccc
Q 002214          428 SLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTII-GLKNLQHLSLEHNKL  506 (952)
Q Consensus       428 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l  506 (952)
                      ++++|+++++.+..   +++|+.|+|++|.+++..|..+..+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.|
T Consensus       105 ~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l  181 (487)
T 3oja_A          105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI  181 (487)
T ss_dssp             ECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred             ECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence            88888888766543   46788888888888877777788888888888888888877777775 678888888888888


Q ss_pred             cCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCCCcccccccccccCccCCCCC
Q 002214          507 QGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSP  582 (952)
Q Consensus       507 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p  582 (952)
                      ++..+  +..+++|+.|+|++|.|++.+| .+..+++|+.|+|++|++++..+....+..+....+.+|++.|+++
T Consensus       182 ~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~~  254 (487)
T 3oja_A          182 YDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTL  254 (487)
T ss_dssp             CEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHHH
T ss_pred             ccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcch
Confidence            75532  3457888888888888886444 4778888888888888888644434455666677777888777654

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=6.7e-27  Score=249.24  Aligned_cols=217  Identities=28%  Similarity=0.318  Sum_probs=160.6

Q ss_pred             CCCCCCceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcccccC
Q 002214           18 ASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEI   97 (952)
Q Consensus        18 ~~~c~w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~   97 (952)
                      .++|.|+|+.|...+ +.+.+++++++++ .+|..+.  ++|+.|+|++|.+++..+..|..+++|++|+|++|++....
T Consensus         2 ~~~C~~~~~~C~c~~-~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~   77 (270)
T 2o6q_A            2 EALCKKDGGVCSCNN-NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP   77 (270)
T ss_dssp             CCCBGGGTCSBEEET-TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred             CccCCCCCCCCEeCC-CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence            489999999998643 4578999999988 5777665  68899999999998666668888899999999999888555


Q ss_pred             ChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccC
Q 002214           98 PEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWH  177 (952)
Q Consensus        98 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~  177 (952)
                      +..|.++++|++|+|++|+++                          .+|...+.++++|++|+|++|++++..+..|..
T Consensus        78 ~~~~~~l~~L~~L~l~~n~l~--------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  131 (270)
T 2o6q_A           78 AGIFKELKNLETLWVTDNKLQ--------------------------ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDS  131 (270)
T ss_dssp             TTTTSSCTTCCEEECCSSCCC--------------------------CCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTT
T ss_pred             hhhhcCCCCCCEEECCCCcCC--------------------------cCCHhHcccccCCCEEECCCCccCeeCHHHhCc
Confidence            566788888888888888877                          233334456677888888888877666666777


Q ss_pred             CCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEE
Q 002214          178 CKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILS  257 (952)
Q Consensus       178 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~  257 (952)
                      +++|+.|+|++|++++..+..|+.+++|++|+|++|++++..+..|..+++|+.|+|++|++.++.+..+..+++|+.|+
T Consensus       132 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  211 (270)
T 2o6q_A          132 LTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQ  211 (270)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred             CcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEE
Confidence            77777777777777766666677777777777777777765555666777777777777666666555566666666666


Q ss_pred             eeCcccc
Q 002214          258 LFNNTLS  264 (952)
Q Consensus       258 Ls~N~l~  264 (952)
                      |++|.+.
T Consensus       212 l~~N~~~  218 (270)
T 2o6q_A          212 LQENPWD  218 (270)
T ss_dssp             CCSSCBC
T ss_pred             ecCCCee
Confidence            6666554

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.94  E-value=1.1e-28  Score=268.84  Aligned_cols=249  Identities=21%  Similarity=0.178  Sum_probs=149.0

Q ss_pred             ccCCCCCCCCCceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeeccccccc-cccCCCcC-------CcCCCc
Q 002214           13 NWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFS-GTIPKEIG-------NLTKLK   84 (952)
Q Consensus        13 ~~~~~~~~c~w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~-~~~p~~l~-------~l~~L~   84 (952)
                      +|....+|+.|..+.......+++.|+++++.+  .+|..+...  |+.|+|++|.++ ..+|..+.       .+++|+
T Consensus        23 ~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~   98 (312)
T 1wwl_A           23 DWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ   98 (312)
T ss_dssp             CGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCC
T ss_pred             chHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCcc
Confidence            455445666666665544445667777777777  566666554  777777777773 34555554       577777


Q ss_pred             EEeCcCCcccccCChhh--cCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEc
Q 002214           85 ELHLDYNKLQGEIPEEL--GNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYV  162 (952)
Q Consensus        85 ~L~L~~n~l~~~~p~~l--~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L  162 (952)
                      +|+|++|++.+.+|..+  +.+++|++|+|++|++++. |..+..+...                     .+++|++|+|
T Consensus        99 ~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~---------------------~~~~L~~L~L  156 (312)
T 1wwl_A           99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQW---------------------LKPGLKVLSI  156 (312)
T ss_dssp             EEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTT---------------------CCTTCCEEEE
T ss_pred             EEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHh---------------------hcCCCcEEEe
Confidence            77777777776677665  7777777777777777744 6555544200                     1246666666


Q ss_pred             ccCcccccCCccccCCCCCcEEEccCCccccc--CCccc--cccCCccEEEeeCCcCCc---cCchhhhccCCCcEeeec
Q 002214          163 SYNQFKGPIPNNLWHCKELSSVSLSYNQFTGR--LPRDL--GNSTKLKSLDLGFNNLNG---EIPQEIGNLRNLEILGID  235 (952)
Q Consensus       163 ~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~~~~~--~~l~~L~~L~L~~N~l~~---~~p~~~~~l~~L~~L~L~  235 (952)
                      ++|++++..|..|..+++|+.|+|++|++.+.  .|..+  +.+++|++|+|++|++++   .....+..+++|+.|+++
T Consensus       157 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls  236 (312)
T 1wwl_A          157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS  236 (312)
T ss_dssp             ESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECT
T ss_pred             eCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECC
Confidence            66666655556666666666666666665433  12222  556666666666666652   112233455666666666


Q ss_pred             cccccccCC-ccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCC
Q 002214          236 QSNLVGFVP-DTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGS  292 (952)
Q Consensus       236 ~n~~~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~  292 (952)
                      +|++.+..| ..+..+++|++|+|++|+|+ .+|..  +.  ++|++|+|++|++++.
T Consensus       237 ~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~--~~--~~L~~L~Ls~N~l~~~  289 (312)
T 1wwl_A          237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG--LP--AKLSVLDLSYNRLDRN  289 (312)
T ss_dssp             TSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS--CC--SEEEEEECCSSCCCSC
T ss_pred             CCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh--cc--CCceEEECCCCCCCCC
Confidence            666666553 34445666666666666665 33332  11  5666666666666654

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.94  E-value=5.2e-28  Score=263.65  Aligned_cols=85  Identities=25%  Similarity=0.302  Sum_probs=51.3

Q ss_pred             hcccccceeecCCcccCCCCc-ccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccc
Q 002214          467 ENLKAVVDIYLSRNNLSGNIP-STIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLK  545 (952)
Q Consensus       467 ~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  545 (952)
                      ..+++|++|+|++|++++..| ..+..+++|++|+|++|+|+ .+|..+.  ++|+.|||++|+|++. |. +..+++|+
T Consensus       225 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~  299 (312)
T 1wwl_A          225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVG  299 (312)
T ss_dssp             HTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEE
T ss_pred             hcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCC
Confidence            344555666666666655443 34455666666666666666 4454444  6666666666666654 44 66666667


Q ss_pred             ccccccccccc
Q 002214          546 SLNLSFNKLVG  556 (952)
Q Consensus       546 ~L~l~~N~l~~  556 (952)
                      +|++++|++++
T Consensus       300 ~L~L~~N~l~~  310 (312)
T 1wwl_A          300 NLSLKGNPFLD  310 (312)
T ss_dssp             EEECTTCTTTC
T ss_pred             EEeccCCCCCC
Confidence            77777776654

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=3.8e-30  Score=307.96  Aligned_cols=450  Identities=16%  Similarity=0.108  Sum_probs=231.8

Q ss_pred             CCCCceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeecccccccc---ccCCC------------cCCcCCCc
Q 002214           20 VCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSG---TIPKE------------IGNLTKLK   84 (952)
Q Consensus        20 ~c~w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~---~~p~~------------l~~l~~L~   84 (952)
                      |++|.++..    .....++++++... ..+..+..+++|+.|++++|....   ..|..            ...+++|+
T Consensus        34 ck~W~~~~~----~~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~  108 (594)
T 2p1m_B           34 CKSWYEIER----WCRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE  108 (594)
T ss_dssp             CHHHHHHHH----HHCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             HHHHHHhhh----hhceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCC
Confidence            557888821    12346677665543 223456788999999999975321   22222            23567888


Q ss_pred             EEeCcCCcccccCChhhc-CCCCCCeEeecCc-cCccc-cCcccccccccccceeeccccccccCCCCCCCCCCccceEE
Q 002214           85 ELHLDYNKLQGEIPEELG-NLAELEMLVLNNN-LLTGT-IPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLY  161 (952)
Q Consensus        85 ~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~  161 (952)
                      +|+|++|.+.+..+..+. .+++|++|+|++| .++.. ++..+.                          .+++|++|+
T Consensus       109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~--------------------------~~~~L~~L~  162 (594)
T 2p1m_B          109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAA--------------------------TCRNLKELD  162 (594)
T ss_dssp             EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHH--------------------------HCTTCCEEE
T ss_pred             eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHH--------------------------hCCCCCEEe
Confidence            888888888766666665 6788888888887 44421 222111                          245666666


Q ss_pred             cccCcccccCCcccc----CCCCCcEEEccCCc--ccc-cCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeee
Q 002214          162 VSYNQFKGPIPNNLW----HCKELSSVSLSYNQ--FTG-RLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGI  234 (952)
Q Consensus       162 L~~n~l~~~~~~~l~----~l~~L~~L~L~~N~--l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  234 (952)
                      |++|.+++..+..+.    .+++|+.|++++|.  ++. .++..+..+++|++|+|++|...+.+|..+..+++|+.|++
T Consensus       163 L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l  242 (594)
T 2p1m_B          163 LRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGT  242 (594)
T ss_dssp             CTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEEC
T ss_pred             CcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEccc
Confidence            666665543333222    44566666666665  210 11111233466666666666222235556666666666664


Q ss_pred             cccc-------ccccCCccccCCCCccEE-EeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhh
Q 002214          235 DQSN-------LVGFVPDTIFNISTLKIL-SLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYAL  306 (952)
Q Consensus       235 ~~n~-------~~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l  306 (952)
                      +.+.       +.+ ++..+.++++|+.| .+.+.... .++.  .+..+++|++|++++|.+++.....          
T Consensus       243 ~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~-~l~~--~~~~~~~L~~L~L~~~~l~~~~l~~----------  308 (594)
T 2p1m_B          243 GGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVPA-YLPA--VYSVCSRLTTLNLSYATVQSYDLVK----------  308 (594)
T ss_dssp             SBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG-GGGG--GHHHHTTCCEEECTTCCCCHHHHHH----------
T ss_pred             ccccCccchhhHHH-HHHHHhcCCCcccccCCcccchh-hHHH--HHHhhCCCCEEEccCCCCCHHHHHH----------
Confidence            4332       222 12244555555555 22222111 1111  0113455555565555543211000          


Q ss_pred             hccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCC-CCcccccCCCCcEEEcc---
Q 002214          307 ELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGS-LPITLGRLKKLQGLDLQ---  382 (952)
Q Consensus       307 ~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~---  382 (952)
                                                            .+..+++|++|++++| ++.. ++.....+++|++|+++   
T Consensus       309 --------------------------------------~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~  349 (594)
T 2p1m_B          309 --------------------------------------LLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSE  349 (594)
T ss_dssp             --------------------------------------HHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSC
T ss_pred             --------------------------------------HHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCc
Confidence                                                  0123334444444444 2211 11111224444444442   


Q ss_pred             ------CccccCCCCcccc-CCCcceEEEeccccccccCCCccC-CCCCCcEEecc--c----cccCCcCC-----cccc
Q 002214          383 ------NNKFEGPIPQEFC-HFSRLYVVYLNRNKLSGSIPSCLG-DLNSLRILSLS--S----NELTSVIP-----STFW  443 (952)
Q Consensus       383 ------~N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~~~-----~~~~  443 (952)
                            .+.+++.....+. .+++|+.|.++.|.+++.....+. .+++|+.|+++  +    |.+++...     ..+.
T Consensus       350 ~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~  429 (594)
T 2p1m_B          350 PFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVE  429 (594)
T ss_dssp             TTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHH
T ss_pred             ccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHh
Confidence                  2223221111121 245555555555555433333332 35566666666  2    44442211     1245


Q ss_pred             CCCCCceeEecCCccCCCCchhhhc-ccccceeecCCcccCCCCcccc-cCCCCCceEEccCccccCcccc-cccccccc
Q 002214          444 NLEDILGFDFSSNSLNGSLPLEIEN-LKAVVDIYLSRNNLSGNIPSTI-IGLKNLQHLSLEHNKLQGPIPE-SFGELVSL  520 (952)
Q Consensus       444 ~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L  520 (952)
                      .+++|+.|++++ .+++..+..+.. +++|+.|+|++|.+++.....+ .++++|+.|+|++|++++.... ....+++|
T Consensus       430 ~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L  508 (594)
T 2p1m_B          430 HCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETM  508 (594)
T ss_dssp             HCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGS
T ss_pred             hCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCC
Confidence            566777777766 555444444444 6778888888887765444444 5578888888888888643333 34457888


Q ss_pred             cEEeCCCCcccccCccch-hccccccccccccccc
Q 002214          521 EFLDLSNNDLSGVIPASL-EKLLYLKSLNLSFNKL  554 (952)
Q Consensus       521 ~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~l~~N~l  554 (952)
                      +.|++++|+++......+ ..+++|+...+..+.-
T Consensus       509 ~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          509 RSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             SEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred             CEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence            888888888753333333 4566666655555543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=2.2e-28  Score=286.46  Aligned_cols=185  Identities=19%  Similarity=0.127  Sum_probs=131.2

Q ss_pred             ecCccceEEEEEEe-CCCcEEEEEEeeccC----------chhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEEE
Q 002214          672 IGIGSYGSVYKGRF-PDGIEVAIKVFHLQR----------EGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       672 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .+.|++|.+..++. -.|+.||||++....          +...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            45666665555432 358899999986442          12345799999999999 7999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||++|++|.+.+...+ .++..   .|+.||+.||+|+   |++|||||||||+|||++++|.+||+|||+|+...... 
T Consensus       322 Eyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~yl---H~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAAL---EKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-  393 (569)
T ss_dssp             ECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHH---HHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred             ecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHH---HHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence            9999999999997654 56654   5899999999999   79999999999999999999999999999998765432 


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCC
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPT  865 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~  865 (952)
                      ......+||+.|+|||++.+ .+..++|+||+|++.+++.++..|+
T Consensus       394 ~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          394 SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            22344679999999999875 4667899999999999887765553

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=3.4e-26  Score=244.88  Aligned_cols=212  Identities=22%  Similarity=0.239  Sum_probs=195.0

Q ss_pred             CcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEec
Q 002214          350 INLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSL  429 (952)
Q Consensus       350 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  429 (952)
                      ++|++|++++|++++..+..|..+++|++|++++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|++
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            47999999999999888889999999999999999999888889999999999999999999888899999999999999


Q ss_pred             cccccCCcCCccccCCCCCceeEecCCccCCC-CchhhhcccccceeecCCcccCCCCcccccCCCCCc----eEEccCc
Q 002214          430 SSNELTSVIPSTFWNLEDILGFDFSSNSLNGS-LPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ----HLSLEHN  504 (952)
Q Consensus       430 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~L~~N  504 (952)
                      ++|++++..+..|..+++|+.|++++|++++. +|..+..+++|++|+|++|++++..+..|..+++|+    .|++++|
T Consensus       108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n  187 (276)
T 2z62_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  187 (276)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred             CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence            99999998888899999999999999999874 589999999999999999999988888888888887    8999999


Q ss_pred             cccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCC
Q 002214          505 KLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGG  562 (952)
Q Consensus       505 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~  562 (952)
                      ++++..+..+.. .+|+.|+|++|+|++..+..|..+++|+.|++++|+|+|.+|...
T Consensus       188 ~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~  244 (276)
T 2z62_A          188 PMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  244 (276)
T ss_dssp             CCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTH
T ss_pred             cccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCchH
Confidence            999766655554 589999999999998878888999999999999999999998643

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=1e-25  Score=240.00  Aligned_cols=208  Identities=25%  Similarity=0.331  Sum_probs=190.1

Q ss_pred             CcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEec
Q 002214          350 INLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSL  429 (952)
Q Consensus       350 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  429 (952)
                      .+.+.+++++++++. +|..+.  ++|++|++++|.|++..+..|.++++|++|+|++|++++..+..|..+++|++|++
T Consensus        16 ~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l   92 (270)
T 2o6q_A           16 NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV   92 (270)
T ss_dssp             TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred             CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence            357899999999994 555443  68999999999999888889999999999999999999777777899999999999


Q ss_pred             cccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCc
Q 002214          430 SSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGP  509 (952)
Q Consensus       430 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  509 (952)
                      ++|+++++.+..|..+++|+.|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++.
T Consensus        93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  172 (270)
T 2o6q_A           93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV  172 (270)
T ss_dssp             CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence            99999998888999999999999999999988888899999999999999999988778899999999999999999988


Q ss_pred             ccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          510 IPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       510 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      .+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|+|.|.++.
T Consensus       173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  223 (270)
T 2o6q_A          173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG  223 (270)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred             ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence            788899999999999999999988888899999999999999999998864

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=1.9e-26  Score=266.65  Aligned_cols=170  Identities=22%  Similarity=0.173  Sum_probs=106.0

Q ss_pred             cccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccC-CCCCCcEEec
Q 002214          351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLG-DLNSLRILSL  429 (952)
Q Consensus       351 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L  429 (952)
                      +|++|++++|.+++..+.   .+++|+.|+|++|.|++..|..|..+++|+.|+|++|.+++..|..+. .+++|++|+|
T Consensus       100 ~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~L  176 (487)
T 3oja_A          100 SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL  176 (487)
T ss_dssp             TCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred             CcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEec
Confidence            455555555555543332   234555555555555555455555555555555555555544444443 4555555555


Q ss_pred             cccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCc
Q 002214          430 SSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGP  509 (952)
Q Consensus       430 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  509 (952)
                      ++|.|++..+                          +..+++|+.|+|++|+|++.+| .|..+++|+.|+|++|+|++ 
T Consensus       177 s~N~l~~~~~--------------------------~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-  228 (487)
T 3oja_A          177 QYNFIYDVKG--------------------------QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-  228 (487)
T ss_dssp             TTSCCCEEEC--------------------------CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-
T ss_pred             CCCccccccc--------------------------cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-
Confidence            5555554321                          1235566666666666665444 37777888888888888884 


Q ss_pred             ccccccccccccEEeCCCCccc-ccCccchhcccccccccccc
Q 002214          510 IPESFGELVSLEFLDLSNNDLS-GVIPASLEKLLYLKSLNLSF  551 (952)
Q Consensus       510 ~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~~  551 (952)
                      +|..+..+++|+.|++++|++. +.+|..+..++.|+.++++.
T Consensus       229 lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~  271 (487)
T 3oja_A          229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT  271 (487)
T ss_dssp             ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHH
T ss_pred             cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccc
Confidence            6777888888999999999887 56778888888999888873

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=4.2e-25  Score=237.26  Aligned_cols=207  Identities=25%  Similarity=0.255  Sum_probs=185.5

Q ss_pred             ccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCc
Q 002214          346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR  425 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  425 (952)
                      ++.+++++++++++|.++. +|..+.  ++++.|+|++|.|++..+..|..+++|+.|+|++|.|++..+.  ..+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            5788899999999999995 444443  6899999999999988899999999999999999999965443  7899999


Q ss_pred             EEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcc
Q 002214          426 ILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNK  505 (952)
Q Consensus       426 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  505 (952)
                      +|++++|+++. +|..+..+++|+.|++++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCCc-CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            99999999984 56788999999999999999998888899999999999999999998888889999999999999999


Q ss_pred             ccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCC
Q 002214          506 LQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIP  559 (952)
Q Consensus       506 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  559 (952)
                      |++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|.|.+.
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~  212 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence            99777778899999999999999998 677778888899999999999998763

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=6.2e-25  Score=235.00  Aligned_cols=225  Identities=24%  Similarity=0.283  Sum_probs=199.1

Q ss_pred             EEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccc
Q 002214          354 TLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNE  433 (952)
Q Consensus       354 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  433 (952)
                      .++..+..++ .+|..+.  ++|++|++++|.|++..+..|.++++|++|++++|++++..+..|..+++|++|++++|+
T Consensus        11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~   87 (276)
T 2z62_A           11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (276)
T ss_dssp             EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence            4666777777 4555443  589999999999998888899999999999999999998888899999999999999999


Q ss_pred             cCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCC-CcccccCCCCCceEEccCccccCcccc
Q 002214          434 LTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGN-IPSTIIGLKNLQHLSLEHNKLQGPIPE  512 (952)
Q Consensus       434 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~  512 (952)
                      +++..+..|..+++|+.|++++|++++..+..+..+++|++|++++|++++. +|..|..+++|++|+|++|++++..+.
T Consensus        88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~  167 (276)
T 2z62_A           88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  167 (276)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred             cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence            9999999999999999999999999987777899999999999999999975 589999999999999999999988888


Q ss_pred             ccccccccc----EEeCCCCcccccCccchhcccccccccccccccccCCCCC-CCcccccccccccCccCCCCC
Q 002214          513 SFGELVSLE----FLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG-GAFANFSAESFIGNDLLCGSP  582 (952)
Q Consensus       513 ~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~p  582 (952)
                      .|..+++|+    .|++++|++++..+..+.. .+|+.|++++|++++..+.. ..+.++....+.+|++.|+||
T Consensus       168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             GGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             HhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            888888888    9999999999766665554 58999999999999765543 456777788899999999997

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=2.1e-28  Score=292.71  Aligned_cols=422  Identities=14%  Similarity=0.097  Sum_probs=267.7

Q ss_pred             CeEEEEEecCCCCccc---CC------------ccccCCcccCeeeccccccccccCCCcC-CcCCCcEEeCcCC-cccc
Q 002214           33 NRVTSLTISDLGLAGT---IP------------SHLGNLSSLQTLVLSRNWFSGTIPKEIG-NLTKLKELHLDYN-KLQG   95 (952)
Q Consensus        33 ~~~~~l~l~~~~~~~~---~p------------~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n-~l~~   95 (952)
                      ++++.|+++++.....   .|            .....+++|+.|+|++|.+++..+..+. .+++|++|+|++| .+..
T Consensus        66 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~  145 (594)
T 2p1m_B           66 PKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFST  145 (594)
T ss_dssp             TTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEH
T ss_pred             CCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCH
Confidence            4689999999764321   22            1235788999999999999987777776 6899999999999 5553


Q ss_pred             c-CChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCc--ccc-cC
Q 002214           96 E-IPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQ--FKG-PI  171 (952)
Q Consensus        96 ~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~--l~~-~~  171 (952)
                      . ++..+.++++|++|+|++|.+++..+..+..                      +...+++|++|++++|.  +.. .+
T Consensus       146 ~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~----------------------~~~~~~~L~~L~l~~~~~~~~~~~l  203 (594)
T 2p1m_B          146 DGLAAIAATCRNLKELDLRESDVDDVSGHWLSH----------------------FPDTYTSLVSLNISCLASEVSFSAL  203 (594)
T ss_dssp             HHHHHHHHHCTTCCEEECTTCEEECCCGGGGGG----------------------SCTTCCCCCEEECTTCCSCCCHHHH
T ss_pred             HHHHHHHHhCCCCCEEeCcCCccCCcchHHHHH----------------------HhhcCCcCcEEEecccCCcCCHHHH
Confidence            2 5555668999999999999987544443332                      22356789999999887  221 11


Q ss_pred             CccccCCCCCcEEEccCC-cccccCCccccccCCccEEEeeCCc-------CCccCchhhhccCCCcEe-eecccccccc
Q 002214          172 PNNLWHCKELSSVSLSYN-QFTGRLPRDLGNSTKLKSLDLGFNN-------LNGEIPQEIGNLRNLEIL-GIDQSNLVGF  242 (952)
Q Consensus       172 ~~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~-------l~~~~p~~~~~l~~L~~L-~L~~n~~~~~  242 (952)
                      +..+..+++|+.|+|++| .+++ ++..+..+++|++|+++.+.       +. .++..+.++++|+.| .+.+.. ...
T Consensus       204 ~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~-~l~~~l~~~~~L~~Ls~~~~~~-~~~  280 (594)
T 2p1m_B          204 ERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYS-GLSVALSGCKELRCLSGFWDAV-PAY  280 (594)
T ss_dssp             HHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHH-HHHHHHHTCTTCCEEECCBTCC-GGG
T ss_pred             HHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHH-HHHHHHhcCCCcccccCCcccc-hhh
Confidence            122345689999999998 5554 77788889999999966553       33 345578899999998 444322 233


Q ss_pred             CCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCc
Q 002214          243 VPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERN  322 (952)
Q Consensus       243 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n  322 (952)
                      ++..+..+++|+.|+|++|.+++... ...+..+++|++|++++| ++......+                         
T Consensus       281 l~~~~~~~~~L~~L~L~~~~l~~~~l-~~~~~~~~~L~~L~l~~~-~~~~~l~~l-------------------------  333 (594)
T 2p1m_B          281 LPAVYSVCSRLTTLNLSYATVQSYDL-VKLLCQCPKLQRLWVLDY-IEDAGLEVL-------------------------  333 (594)
T ss_dssp             GGGGHHHHTTCCEEECTTCCCCHHHH-HHHHTTCTTCCEEEEEGG-GHHHHHHHH-------------------------
T ss_pred             HHHHHHhhCCCCEEEccCCCCCHHHH-HHHHhcCCCcCEEeCcCc-cCHHHHHHH-------------------------
Confidence            45555578899999999998753211 112456789999999887 431100000                         


Q ss_pred             ceeechhhHHHHHHHhhccccccccCCCcccEEEcc---------CCCCCCCCCccc-ccCCCCcEEEccCccccCCCCc
Q 002214          323 YLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLG---------DNNLSGSLPITL-GRLKKLQGLDLQNNKFEGPIPQ  392 (952)
Q Consensus       323 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~---------~n~l~~~~~~~l-~~l~~L~~L~L~~N~i~~~~~~  392 (952)
                                             ...+++|++|++.         .+.+++.....+ ..+++|+.|+++.|.+++....
T Consensus       334 -----------------------~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~  390 (594)
T 2p1m_B          334 -----------------------ASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALI  390 (594)
T ss_dssp             -----------------------HHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHH
T ss_pred             -----------------------HHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHH
Confidence                                   0123344444442         223332111112 1245555555555555433333


Q ss_pred             ccc-CCCcceEEEec--c----ccccc-----cCCCccCCCCCCcEEeccccccCCcCCccccC-CCCCceeEecCCccC
Q 002214          393 EFC-HFSRLYVVYLN--R----NKLSG-----SIPSCLGDLNSLRILSLSSNELTSVIPSTFWN-LEDILGFDFSSNSLN  459 (952)
Q Consensus       393 ~~~-~l~~L~~L~L~--~----N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~  459 (952)
                      .+. .+++|+.|+++  +    |.++.     .++..+..+++|+.|++++ .+++.....+.. +++|+.|+|++|.++
T Consensus       391 ~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~  469 (594)
T 2p1m_B          391 TIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDS  469 (594)
T ss_dssp             HHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSS
T ss_pred             HHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCc
Confidence            332 34555555555  2    33331     1112245667888888866 565544444444 778888888888876


Q ss_pred             CCCchhh-hcccccceeecCCcccCCCCcc-cccCCCCCceEEccCccccCcccccc-cccccccEEeCCCCcc
Q 002214          460 GSLPLEI-ENLKAVVDIYLSRNNLSGNIPS-TIIGLKNLQHLSLEHNKLQGPIPESF-GELVSLEFLDLSNNDL  530 (952)
Q Consensus       460 ~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l  530 (952)
                      +..+..+ ..+++|+.|+|++|.+++.... ....+++|+.|++++|+++......+ ..+++|+...+..+.-
T Consensus       470 ~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          470 DLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             HHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred             HHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence            5444444 6688899999999988643333 34458899999999998864433444 5568887777776643

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=1.9e-24  Score=232.14  Aligned_cols=209  Identities=25%  Similarity=0.230  Sum_probs=185.9

Q ss_pred             ccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCC
Q 002214          369 TLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDI  448 (952)
Q Consensus       369 ~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  448 (952)
                      .+..+++++++++++|.++.+ |..+.  ++++.|+|++|++++..+..|..+++|++|+|++|+|+++.+.  ..+++|
T Consensus         5 ~~~~l~~l~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L   79 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL   79 (290)
T ss_dssp             EEECSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred             cccccCCccEEECCCCCCCcC-CCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence            477889999999999999854 44443  6899999999999988889999999999999999999977554  789999


Q ss_pred             ceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCC
Q 002214          449 LGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN  528 (952)
Q Consensus       449 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  528 (952)
                      +.|++++|+++ .+|..+..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  158 (290)
T 1p9a_G           80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN  158 (290)
T ss_dssp             CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence            99999999999 67888999999999999999999888899999999999999999999888888999999999999999


Q ss_pred             cccccCccchhcccccccccccccccccCCCCCCCcccccccccccCccCCCCCc
Q 002214          529 DLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPY  583 (952)
Q Consensus       529 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~  583 (952)
                      +|++..+..|..+++|+.|+|++|+++...+.......+....+.+|||.|+|..
T Consensus       159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~~  213 (290)
T 1p9a_G          159 NLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEI  213 (290)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred             cCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCcc
Confidence            9998777888999999999999999995443344445677778899999998864

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=3.2e-24  Score=228.63  Aligned_cols=205  Identities=20%  Similarity=0.253  Sum_probs=186.6

Q ss_pred             ccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCc
Q 002214          346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR  425 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  425 (952)
                      ...+++|+.|++++|.++..  ..+..+++|++|++++|.+++.  ..+..+++|++|+|++|.+++..+..|..+++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  112 (272)
T 3rfs_A           37 QNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK  112 (272)
T ss_dssp             HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             cccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence            45678999999999999843  3588999999999999999863  4789999999999999999988888899999999


Q ss_pred             EEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcc
Q 002214          426 ILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNK  505 (952)
Q Consensus       426 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  505 (952)
                      +|++++|+++++.+..|..+++|+.|++++|++++..+..|..+++|+.|++++|++++..+..|..+++|++|+|++|+
T Consensus       113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  192 (272)
T 3rfs_A          113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ  192 (272)
T ss_dssp             EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence            99999999999989899999999999999999998888888999999999999999998888889999999999999999


Q ss_pred             ccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCC
Q 002214          506 LQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRG  561 (952)
Q Consensus       506 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  561 (952)
                      +++..+..|..+++|+.|+|++|++.+.       +++|+.|++..|.++|.+|..
T Consensus       193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~  241 (272)
T 3rfs_A          193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS  241 (272)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred             CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence            9988888899999999999999998754       457899999999999999963

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=2.1e-25  Score=259.78  Aligned_cols=185  Identities=18%  Similarity=0.189  Sum_probs=146.6

Q ss_pred             CccceecCccceEEEEEEeCCCcEEEEEEeeccCc--------hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          667 SEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE--------GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       667 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ...+.||+|+||+||+|.. .++.+|+|+......        ...+++.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999965 678899998643321        1235589999999999999999666666677778999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++++|.+++..         +..++.|+++||+||   |+++|+||||||+|||++.  .+||+|||+|+......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~L---H~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKL---HKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHH---HHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHH---HHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999998875         568999999999999   7899999999999999999  99999999999875533


Q ss_pred             ccc------ccccccccccccccccCc--CCcCcccchHhHHHHHHHHHhCCCCCC
Q 002214          819 SMK------QTQTLATIGYIAPEYGRE--GQVSIKGDVYNYGIMLMEVFTGMKPTN  866 (952)
Q Consensus       819 ~~~------~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~  866 (952)
                      ...      .....||+.|+|||++..  ..|+..+|+|+.++-..+-+.++.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            221      124579999999999876  567888999999999999888877763

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.91  E-value=6.4e-24  Score=231.12  Aligned_cols=203  Identities=19%  Similarity=0.202  Sum_probs=175.5

Q ss_pred             CCCcccEEEccCCCCCCCCCccc--ccCCCCcEEEccCccccCCCC----ccccCCCcceEEEeccccccccCCCccCCC
Q 002214          348 NLINLTTLSLGDNNLSGSLPITL--GRLKKLQGLDLQNNKFEGPIP----QEFCHFSRLYVVYLNRNKLSGSIPSCLGDL  421 (952)
Q Consensus       348 ~l~~L~~L~L~~n~l~~~~~~~l--~~l~~L~~L~L~~N~i~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  421 (952)
                      .+++|++|++++|.+++..|..+  ..+++|++|+|++|.+++..+    ..+..+++|++|+|++|++.+..+..|..+
T Consensus        89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l  168 (310)
T 4glp_A           89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF  168 (310)
T ss_dssp             HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred             ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence            34679999999999999999888  899999999999999987555    445679999999999999998888999999


Q ss_pred             CCCcEEeccccccCC---cC-CccccCCCCCceeEecCCccCCCCch----hhhcccccceeecCCcccCCCCcccccCC
Q 002214          422 NSLRILSLSSNELTS---VI-PSTFWNLEDILGFDFSSNSLNGSLPL----EIENLKAVVDIYLSRNNLSGNIPSTIIGL  493 (952)
Q Consensus       422 ~~L~~L~L~~N~l~~---~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  493 (952)
                      ++|++|+|++|++.+   .. +..+..+++|++|+|++|+++. ++.    .+..+++|++|+|++|++++..|..+..+
T Consensus       169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~  247 (310)
T 4glp_A          169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC  247 (310)
T ss_dssp             TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred             CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence            999999999999875   22 2345789999999999999973 343    35788999999999999998878887776


Q ss_pred             ---CCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhccccccccccccccccc
Q 002214          494 ---KNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVG  556 (952)
Q Consensus       494 ---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  556 (952)
                         ++|++|+|++|+|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|+.|++++|+|+.
T Consensus       248 ~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          248 MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence               69999999999999 5676664  8999999999999965 43 7889999999999999974

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=2.1e-24  Score=230.08  Aligned_cols=186  Identities=25%  Similarity=0.274  Sum_probs=115.1

Q ss_pred             CCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEe
Q 002214          349 LINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILS  428 (952)
Q Consensus       349 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  428 (952)
                      +++|++|++++|.+++.  ..+..+++|++|++++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+
T Consensus        62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  139 (272)
T 3rfs_A           62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN  139 (272)
T ss_dssp             CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence            33444444444444431  2444555555555555555544444455555555555555555545555556666666666


Q ss_pred             ccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccC
Q 002214          429 LSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQG  508 (952)
Q Consensus       429 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  508 (952)
                      +++|+++++.+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.+
T Consensus       140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  219 (272)
T 3rfs_A          140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC  219 (272)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence            66666666555556666666666666666665555556667777777777777776666667777777777777777764


Q ss_pred             cccccccccccccEEeCCCCcccccCccchhcccc
Q 002214          509 PIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLY  543 (952)
Q Consensus       509 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  543 (952)
                      .       +++|+.|+++.|.++|.+|..++.++.
T Consensus       220 ~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          220 T-------CPGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             C-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             c-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence            3       346777788888888888877766554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=6.6e-23  Score=215.70  Aligned_cols=181  Identities=24%  Similarity=0.280  Sum_probs=132.8

Q ss_pred             CcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEec
Q 002214          350 INLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSL  429 (952)
Q Consensus       350 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  429 (952)
                      .+.++++++++.++ .+|..+.  ++++.|+|++|.+++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            35678888888888 4444443  57888888888888877778888888888888888888777777788888888888


Q ss_pred             cccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCc
Q 002214          430 SSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGP  509 (952)
Q Consensus       430 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  509 (952)
                      ++|+++++.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+++.+..|..+++|+.|+|++|+|++.
T Consensus        91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  170 (251)
T 3m19_A           91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV  170 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence            88888877777777777777777777777765555566677777777777777766555666677777777777777665


Q ss_pred             ccccccccccccEEeCCCCccccc
Q 002214          510 IPESFGELVSLEFLDLSNNDLSGV  533 (952)
Q Consensus       510 ~~~~~~~l~~L~~L~Ls~N~l~~~  533 (952)
                      .+..|..+++|+.|+|++|+++..
T Consensus       171 ~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          171 PHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CHHHHhCCCCCCEEEeeCCceeCC
Confidence            555666666777777777766643

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=1.5e-23  Score=218.93  Aligned_cols=196  Identities=17%  Similarity=0.209  Sum_probs=144.6

Q ss_pred             cccEEEccCCCCCCCCCcccccCCCCcEEEccCcc-ccCCCCccccCCCcceEEEecc-ccccccCCCccCCCCCCcEEe
Q 002214          351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNK-FEGPIPQEFCHFSRLYVVYLNR-NKLSGSIPSCLGDLNSLRILS  428 (952)
Q Consensus       351 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~  428 (952)
                      +|++|++++|+++++.+..|..+++|++|++++|. ++.+.+..|.++++|++|++++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            67788888888887777778888888888888886 7767777788888888888887 788766667777888888888


Q ss_pred             ccccccCCcCCccccCCCCCc---eeEecCC-ccCCCCchhhhcccccc-eeecCCcccCCCCcccccCCCCCceEEccC
Q 002214          429 LSSNELTSVIPSTFWNLEDIL---GFDFSSN-SLNGSLPLEIENLKAVV-DIYLSRNNLSGNIPSTIIGLKNLQHLSLEH  503 (952)
Q Consensus       429 L~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  503 (952)
                      +++|+++++ |. |..+++|+   .|++++| ++++..+..|.++++|+ .|++++|+++.+.+..|.. ++|+.|+|++
T Consensus       112 l~~n~l~~l-p~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~  188 (239)
T 2xwt_C          112 IFNTGLKMF-PD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK  188 (239)
T ss_dssp             EEEECCCSC-CC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred             CCCCCCccc-cc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence            888888764 33 77777777   7888887 77766666677777777 7888777777544445555 6777788887


Q ss_pred             cc-ccCccccccccc-ccccEEeCCCCcccccCccchhccccccccccccc
Q 002214          504 NK-LQGPIPESFGEL-VSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFN  552 (952)
Q Consensus       504 N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  552 (952)
                      |+ +++..+..|..+ ++|+.|+|++|+|++..+.   .+++|+.|+++++
T Consensus       189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            74 776666677777 7778888888777754333   4566677777665

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=6e-23  Score=216.01  Aligned_cols=184  Identities=22%  Similarity=0.276  Sum_probs=170.1

Q ss_pred             CCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEe
Q 002214          374 KKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDF  453 (952)
Q Consensus       374 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  453 (952)
                      ...++++++++.++. .|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|+|+++.+..|..+++|+.|+|
T Consensus        14 ~~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            457899999999984 555553  68999999999999988989999999999999999999999999999999999999


Q ss_pred             cCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCccccc
Q 002214          454 SSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGV  533 (952)
Q Consensus       454 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  533 (952)
                      ++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++.
T Consensus        91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  170 (251)
T 3m19_A           91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV  170 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence            99999988888999999999999999999988888899999999999999999987777899999999999999999988


Q ss_pred             CccchhcccccccccccccccccCCCC
Q 002214          534 IPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       534 ~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      .+..|..+++|+.|++++|+|+|....
T Consensus       171 ~~~~~~~l~~L~~L~l~~N~~~c~~~~  197 (251)
T 3m19_A          171 PHGAFDRLGKLQTITLFGNQFDCSRCE  197 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCTTSTT
T ss_pred             CHHHHhCCCCCCEEEeeCCceeCCccc
Confidence            888999999999999999999987543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=9.1e-23  Score=221.34  Aligned_cols=196  Identities=23%  Similarity=0.371  Sum_probs=173.5

Q ss_pred             ccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCc
Q 002214          346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR  425 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  425 (952)
                      ...+++|++|++++|.++. ++ .+..+++|++|++++|.+++..+  +..+++|++|+|++|++++. + .+..+++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~  110 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIK  110 (308)
T ss_dssp             HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCC
T ss_pred             HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCC
Confidence            4467899999999999985 44 68899999999999999986555  99999999999999999854 3 689999999


Q ss_pred             EEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcc
Q 002214          426 ILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNK  505 (952)
Q Consensus       426 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  505 (952)
                      +|++++|+++++.+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|++++..+  +..+++|+.|+|++|+
T Consensus       111 ~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~  184 (308)
T 1h6u_A          111 TLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK  184 (308)
T ss_dssp             EEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             EEECCCCCCCCchh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCc
Confidence            99999999997643  8999999999999999996544  8899999999999999996544  8999999999999999


Q ss_pred             ccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccC
Q 002214          506 LQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGE  557 (952)
Q Consensus       506 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  557 (952)
                      +++..+  +..+++|+.|+|++|++++..+  +..+++|+.|++++|++++.
T Consensus       185 l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~  232 (308)
T 1h6u_A          185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ  232 (308)
T ss_dssp             CCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred             cCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence            996554  8999999999999999997653  89999999999999999863

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.88  E-value=2.5e-22  Score=209.65  Aligned_cols=203  Identities=21%  Similarity=0.223  Sum_probs=157.1

Q ss_pred             cCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCc-ccccCChhhcCCCCCCeEeecC-ccCccccCccc
Q 002214           48 TIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNK-LQGEIPEELGNLAELEMLVLNN-NLLTGTIPASI  125 (952)
Q Consensus        48 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~~  125 (952)
                      .+|. +.  ++|+.|++++|++++..+..+..+++|++|+|++|+ ++...+.+|+++++|++|+|++ |++++..+..+
T Consensus        25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f  101 (239)
T 2xwt_C           25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL  101 (239)
T ss_dssp             SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred             ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence            5676 43  389999999999997666689999999999999997 8866667899999999999998 99883322333


Q ss_pred             ccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCc---EEEccCC-cccccCCccccc
Q 002214          126 FNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELS---SVSLSYN-QFTGRLPRDLGN  201 (952)
Q Consensus       126 ~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~---~L~L~~N-~l~~~~~~~~~~  201 (952)
                                                .++++|++|++++|++++ +|. |..+++|+   .|++++| ++++..+..|.+
T Consensus       102 --------------------------~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~  153 (239)
T 2xwt_C          102 --------------------------KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQG  153 (239)
T ss_dssp             --------------------------ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTT
T ss_pred             --------------------------CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccc
Confidence                                      356678888888888774 555 77777777   8888888 888777777888


Q ss_pred             cCCcc-EEEeeCCcCCccCchhhhccCCCcEeeecccc-ccccCCccccCC-CCccEEEeeCccccccCCCCcccCCCCC
Q 002214          202 STKLK-SLDLGFNNLNGEIPQEIGNLRNLEILGIDQSN-LVGFVPDTIFNI-STLKILSLFNNTLSGNLPSSKNLIGLPN  278 (952)
Q Consensus       202 l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~-~~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~l~~l~~  278 (952)
                      +++|+ +|++++|+++...+..|.. ++|+.|++++|. +..+.+..|..+ ++|+.|++++|++++. |..    .+++
T Consensus       154 l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~----~~~~  227 (239)
T 2xwt_C          154 LCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK----GLEH  227 (239)
T ss_dssp             TBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT----TCTT
T ss_pred             hhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh----Hhcc
Confidence            88888 8888888887444444444 788888888884 877777788888 8888888888888743 321    5678


Q ss_pred             cceEEcccC
Q 002214          279 LEGLNLGLN  287 (952)
Q Consensus       279 L~~L~L~~N  287 (952)
                      |+.|+++++
T Consensus       228 L~~L~l~~~  236 (239)
T 2xwt_C          228 LKELIARNT  236 (239)
T ss_dssp             CSEEECTTC
T ss_pred             CceeeccCc
Confidence            888888776

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=8.4e-25  Score=246.17  Aligned_cols=203  Identities=19%  Similarity=0.246  Sum_probs=119.7

Q ss_pred             cCCCcccEEEccCCCCCC----CCCcccccCCCCcEEEccCccccCCCCccccC----C---------CcceEEEecccc
Q 002214          347 GNLINLTTLSLGDNNLSG----SLPITLGRLKKLQGLDLQNNKFEGPIPQEFCH----F---------SRLYVVYLNRNK  409 (952)
Q Consensus       347 ~~l~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~----l---------~~L~~L~L~~N~  409 (952)
                      ..+++|++|+|++|.++.    .++..+..+++|++|+|++|.|....+..+..    +         ++|++|+|++|+
T Consensus        91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~  170 (386)
T 2ca6_A           91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR  170 (386)
T ss_dssp             TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred             hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence            345566666666666664    24555666666666666666665333333322    2         566666666666


Q ss_pred             cc-ccCC---CccCCCCCCcEEeccccccCC-----cCCccccCCCCCceeEecCCccC----CCCchhhhcccccceee
Q 002214          410 LS-GSIP---SCLGDLNSLRILSLSSNELTS-----VIPSTFWNLEDILGFDFSSNSLN----GSLPLEIENLKAVVDIY  476 (952)
Q Consensus       410 l~-~~~~---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~  476 (952)
                      ++ ..++   ..+..+++|++|++++|+++.     ..+..+..+++|+.|+|++|.++    ..+|..+..+++|+.|+
T Consensus       171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~  250 (386)
T 2ca6_A          171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG  250 (386)
T ss_dssp             CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred             CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence            65 2233   345566677777777777652     23335666666777777777664    34566666667777777


Q ss_pred             cCCcccCCC----Cccccc--CCCCCceEEccCccccC----cccccc-cccccccEEeCCCCcccccCc--cch-hccc
Q 002214          477 LSRNNLSGN----IPSTII--GLKNLQHLSLEHNKLQG----PIPESF-GELVSLEFLDLSNNDLSGVIP--ASL-EKLL  542 (952)
Q Consensus       477 Ls~N~l~~~----~~~~~~--~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~Ls~N~l~~~~~--~~~-~~l~  542 (952)
                      |++|++++.    ++..+.  .+++|+.|+|++|+|++    .+|..+ .++++|+.|+|++|++++..+  ..+ ..++
T Consensus       251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l~  330 (386)
T 2ca6_A          251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFS  330 (386)
T ss_dssp             CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHHHH
T ss_pred             CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHHHHHHHhh
Confidence            777776643    344442  36777777777777775    355555 556777777777777775543  222 2344


Q ss_pred             ccccccc
Q 002214          543 YLKSLNL  549 (952)
Q Consensus       543 ~L~~L~l  549 (952)
                      .++.+++
T Consensus       331 ~~~~~~l  337 (386)
T 2ca6_A          331 TRGRGEL  337 (386)
T ss_dssp             HHTCCEE
T ss_pred             hcCcchh
Confidence            4544444

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=1.4e-24  Score=239.53  Aligned_cols=268  Identities=18%  Similarity=0.224  Sum_probs=201.8

Q ss_pred             CCCCCceEEEeCCCCeEEEEEecCCCCcccCCccccCC--cccCeeeccccccccccCCCcCCcCCCcEEeCcCCccccc
Q 002214           19 SVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNL--SSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGE   96 (952)
Q Consensus        19 ~~c~w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~   96 (952)
                      -|.+|.++.|+  +...+.+|++++.+.   |..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.+.+.
T Consensus        35 vc~~W~~~~~~--~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~  108 (336)
T 2ast_B           35 VCKRWYRLASD--ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS  108 (336)
T ss_dssp             SCHHHHHHHTC--STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH
T ss_pred             HHHHHHHHhcC--chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH
Confidence            46679988876  335789999998886   5667777  8999999999999976665 67899999999999999865


Q ss_pred             -CChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccc-cccccCCCCCCCCCCccceEEcccC-ccccc-CC
Q 002214           97 -IPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDN-SLTGSFPYDMCPGLPRLKGLYVSYN-QFKGP-IP  172 (952)
Q Consensus        97 -~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n-~l~~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~  172 (952)
                       +|..+.++++|++|+|++|.+++..|..+.++..+ +.|++++| .+++......+.++++|++|++++| ++++. ++
T Consensus       109 ~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L-~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~  187 (336)
T 2ast_B          109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNL-VRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ  187 (336)
T ss_dssp             HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTC-SEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHH
T ss_pred             HHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCC-CEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHH
Confidence             88899999999999999999998888888776654 88888888 5664322233456788888888888 77743 46


Q ss_pred             ccccCCC-CCcEEEccCC--ccc-ccCCccccccCCccEEEeeCCc-CCccCchhhhccCCCcEeeecccc-ccccCCcc
Q 002214          173 NNLWHCK-ELSSVSLSYN--QFT-GRLPRDLGNSTKLKSLDLGFNN-LNGEIPQEIGNLRNLEILGIDQSN-LVGFVPDT  246 (952)
Q Consensus       173 ~~l~~l~-~L~~L~L~~N--~l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~n~-~~~~~~~~  246 (952)
                      ..+..++ +|++|+|++|  .++ +.+|..+..+++|++|+|++|. +++..+..+..+++|+.|++++|. +.......
T Consensus       188 ~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~  267 (336)
T 2ast_B          188 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLE  267 (336)
T ss_dssp             HHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGG
T ss_pred             HHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHH
Confidence            6677788 8888888888  444 3456667778888888888888 666777788888888888888875 22222235


Q ss_pred             ccCCCCccEEEeeCccccccCCCCcccCCC-CCcceEEcccCcCCCCCCccccc
Q 002214          247 IFNISTLKILSLFNNTLSGNLPSSKNLIGL-PNLEGLNLGLNNLSGSIPSFFFN  299 (952)
Q Consensus       247 ~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~  299 (952)
                      +.++++|+.|++++| +...     .+..+ .+|..|++++|++++..|..+..
T Consensus       268 l~~~~~L~~L~l~~~-i~~~-----~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          268 LGEIPTLKTLQVFGI-VPDG-----TLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             GGGCTTCCEEECTTS-SCTT-----CHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             HhcCCCCCEEeccCc-cCHH-----HHHHHHhhCcceEEecccCccccCCcccc
Confidence            677888888888888 4321     12223 23667778888888877776543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.88  E-value=1.3e-23  Score=233.88  Aligned_cols=170  Identities=20%  Similarity=0.264  Sum_probs=100.0

Q ss_pred             CcccEEEccCCCCCCCCCccccc-----CCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCC-C
Q 002214          350 INLTTLSLGDNNLSGSLPITLGR-----LKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLN-S  423 (952)
Q Consensus       350 ~~L~~L~L~~n~l~~~~~~~l~~-----l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~  423 (952)
                      ++|++|+|++|++++..+..+..     .++|++|+|++|.|++..+..+                    +..+..++ +
T Consensus       109 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l--------------------~~~l~~~~~~  168 (362)
T 3goz_A          109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL--------------------IQILAAIPAN  168 (362)
T ss_dssp             TTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH--------------------HHHHHTSCTT
T ss_pred             CCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH--------------------HHHHhcCCcc
Confidence            45666666666666444433322     2456666666665553322222                    22223333 5


Q ss_pred             CcEEeccccccCCcCCcccc----CC-CCCceeEecCCccCCC----Cchhhhc-ccccceeecCCcccCCCCc----cc
Q 002214          424 LRILSLSSNELTSVIPSTFW----NL-EDILGFDFSSNSLNGS----LPLEIEN-LKAVVDIYLSRNNLSGNIP----ST  489 (952)
Q Consensus       424 L~~L~L~~N~l~~~~~~~~~----~l-~~L~~L~Ls~N~l~~~----~~~~~~~-l~~L~~L~Ls~N~l~~~~~----~~  489 (952)
                      |++|+|++|++++..+..+.    .. ++|+.|+|++|.|+..    ++..+.. .++|++|+|++|++++..+    ..
T Consensus       169 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  248 (362)
T 3goz_A          169 VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLL  248 (362)
T ss_dssp             CCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHT
T ss_pred             ccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHH
Confidence            66666666666555443332    23 4666666666666642    3444444 3478888888888876544    33


Q ss_pred             ccCCCCCceEEccCccccCc-------ccccccccccccEEeCCCCcccccCccchh
Q 002214          490 IIGLKNLQHLSLEHNKLQGP-------IPESFGELVSLEFLDLSNNDLSGVIPASLE  539 (952)
Q Consensus       490 ~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  539 (952)
                      +..+++|+.|+|++|.+.+.       ++..+..+++|+.||+++|++....+..+.
T Consensus       249 ~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~~  305 (362)
T 3goz_A          249 KDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPIS  305 (362)
T ss_dssp             TTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHHH
T ss_pred             HhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHHH
Confidence            46678888888888885433       334677788888899999988766454443

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.87  E-value=1.2e-23  Score=234.36  Aligned_cols=105  Identities=21%  Similarity=0.215  Sum_probs=57.3

Q ss_pred             EEcccCcccccCCccccCCCCCcEEEccCCcccccCC----ccccccC-CccEEEeeCCcCCccCchhhhcc-----CCC
Q 002214          160 LYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLP----RDLGNST-KLKSLDLGFNNLNGEIPQEIGNL-----RNL  229 (952)
Q Consensus       160 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L  229 (952)
                      +.+++|++++.+|..+...++|++|+|++|.+++..+    ..|..++ +|++|+|++|.+++..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            3455555555555544444556666666666654444    4555555 56666666666665555555554     556


Q ss_pred             cEeeeccccccccCCccccC----C-CCccEEEeeCcccc
Q 002214          230 EILGIDQSNLVGFVPDTIFN----I-STLKILSLFNNTLS  264 (952)
Q Consensus       230 ~~L~L~~n~~~~~~~~~~~~----l-~~L~~L~Ls~N~l~  264 (952)
                      ++|+|++|++.+..+..+..    + ++|++|+|++|+++
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~  122 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS  122 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGG
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCC
Confidence            66666665555554443322    2 45555555555554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=1.8e-22  Score=215.15  Aligned_cols=150  Identities=17%  Similarity=0.106  Sum_probs=120.6

Q ss_pred             HHHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCc------------------hhhHHHHHHHHHHHhCCCC
Q 002214          659 LLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE------------------GALNSFDAECEILKTIRHR  720 (952)
Q Consensus       659 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~  720 (952)
                      +......|.+.+.||+|+||.||+|.+.+|+.||||+++....                  .....+.+|+.++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3444556778899999999999999997899999999864321                  12456889999999999  


Q ss_pred             ccceeeeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC
Q 002214          721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS  800 (952)
Q Consensus       721 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~  800 (952)
                      | +++.+++.. +..++||||+++|+|.+ +..       .....++.|+++|++||   |++||+||||||+|||++ +
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~l---H~~giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEE-T
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHH---HHCCCEeCCCCHHHEEEE-C
Confidence            4 666665543 45699999999999988 422       23457999999999999   799999999999999999 9


Q ss_pred             CcEEEeccccccccCCcCcccccccccccccccccccC
Q 002214          801 MVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR  838 (952)
Q Consensus       801 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~  838 (952)
                      +.+||+|||+|+.              +..|.|||++.
T Consensus       229 ~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          229 EGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             TEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             CcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            9999999999973              33467888764

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.87  E-value=4.4e-22  Score=216.51  Aligned_cols=181  Identities=19%  Similarity=0.199  Sum_probs=141.3

Q ss_pred             cCCCcccEEEccCCCCCCCCC----cccccCCCCcEEEccCccccCCCCccccCCCcceEEEecccccccc---C-CCcc
Q 002214          347 GNLINLTTLSLGDNNLSGSLP----ITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGS---I-PSCL  418 (952)
Q Consensus       347 ~~l~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~---~-~~~~  418 (952)
                      +.+++|++|+|++|.+++..+    ..+..+++|++|+|++|.|.+..+..|..+++|++|+|++|++.+.   . +..+
T Consensus       114 ~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  193 (310)
T 4glp_A          114 ATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCP  193 (310)
T ss_dssp             CCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCT
T ss_pred             ccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhh
Confidence            345667777777777775443    3345678888888888888877778888888888888888887532   1 3345


Q ss_pred             CCCCCCcEEeccccccCCcCCc---cccCCCCCceeEecCCccCCCCchhhhcc---cccceeecCCcccCCCCcccccC
Q 002214          419 GDLNSLRILSLSSNELTSVIPS---TFWNLEDILGFDFSSNSLNGSLPLEIENL---KAVVDIYLSRNNLSGNIPSTIIG  492 (952)
Q Consensus       419 ~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~  492 (952)
                      ..+++|++|+|++|+++...+.   .+..+++|+.|+|++|++++..|..+..+   ++|++|+|++|+|+ .+|..+. 
T Consensus       194 ~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~-  271 (310)
T 4glp_A          194 HKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP-  271 (310)
T ss_dssp             TSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC-
T ss_pred             hcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc-
Confidence            7888999999999999744322   35778999999999999998778777776   69999999999999 5566664 


Q ss_pred             CCCCceEEccCccccCcccccccccccccEEeCCCCcccc
Q 002214          493 LKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSG  532 (952)
Q Consensus       493 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  532 (952)
                       ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus       272 -~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          272 -AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             -SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             -CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence             7999999999999964 43 7888999999999999973

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.86  E-value=1.4e-21  Score=212.10  Aligned_cols=173  Identities=23%  Similarity=0.394  Sum_probs=148.7

Q ss_pred             cCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcE
Q 002214          347 GNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRI  426 (952)
Q Consensus       347 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  426 (952)
                      ..+++|++|++++|++++..+  +..+++|++|++++|.+++.  ..+..+++|+.|++++|++++. +. +..+++|++
T Consensus        60 ~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~  133 (308)
T 1h6u_A           60 QYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQV  133 (308)
T ss_dssp             GGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCE
T ss_pred             hccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCE
Confidence            457789999999999986554  88999999999999999854  3688899999999999999854 33 889999999


Q ss_pred             EeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccc
Q 002214          427 LSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKL  506 (952)
Q Consensus       427 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  506 (952)
                      |++++|+++++.+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|++++..+  +..+++|++|+|++|++
T Consensus       134 L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l  207 (308)
T 1h6u_A          134 LYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQI  207 (308)
T ss_dssp             EECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCC
T ss_pred             EECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCcc
Confidence            9999999987655  8899999999999999986444  8899999999999999996544  88999999999999999


Q ss_pred             cCcccccccccccccEEeCCCCccccc
Q 002214          507 QGPIPESFGELVSLEFLDLSNNDLSGV  533 (952)
Q Consensus       507 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~  533 (952)
                      ++..+  +..+++|+.|+|++|++++.
T Consensus       208 ~~~~~--l~~l~~L~~L~l~~N~i~~~  232 (308)
T 1h6u_A          208 SDVSP--LANTSNLFIVTLTNQTITNQ  232 (308)
T ss_dssp             CBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred             Ccccc--ccCCCCCCEEEccCCeeecC
Confidence            96553  89999999999999999853

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.86  E-value=5.6e-24  Score=239.43  Aligned_cols=214  Identities=21%  Similarity=0.266  Sum_probs=171.7

Q ss_pred             ccCCCcccEEEccCCCC---CCCCCcc-------cccCCCCcEEEccCccccC----CCCccccCCCcceEEEecccccc
Q 002214          346 IGNLINLTTLSLGDNNL---SGSLPIT-------LGRLKKLQGLDLQNNKFEG----PIPQEFCHFSRLYVVYLNRNKLS  411 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l---~~~~~~~-------l~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~  411 (952)
                      +..+++|++|+|++|.+   ++.+|..       +..+++|++|+|++|.|..    ..+..+..+++|++|+|++|.++
T Consensus        56 l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~  135 (386)
T 2ca6_A           56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG  135 (386)
T ss_dssp             TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred             HHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCC
Confidence            34566677777777533   3333433       4788999999999999986    36778889999999999999997


Q ss_pred             ccCCCccC----CC---------CCCcEEeccccccCC-cCC---ccccCCCCCceeEecCCccCC-----CCchhhhcc
Q 002214          412 GSIPSCLG----DL---------NSLRILSLSSNELTS-VIP---STFWNLEDILGFDFSSNSLNG-----SLPLEIENL  469 (952)
Q Consensus       412 ~~~~~~~~----~l---------~~L~~L~L~~N~l~~-~~~---~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l  469 (952)
                      ...+..+.    .+         ++|++|++++|+++. ..+   ..+..+++|+.|++++|+++.     ..+..+..+
T Consensus       136 ~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~  215 (386)
T 2ca6_A          136 PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC  215 (386)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGC
T ss_pred             HHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcC
Confidence            54443333    33         899999999999973 334   467789999999999999983     344478899


Q ss_pred             cccceeecCCcccC----CCCcccccCCCCCceEEccCccccCc----ccccc--cccccccEEeCCCCcccc----cCc
Q 002214          470 KAVVDIYLSRNNLS----GNIPSTIIGLKNLQHLSLEHNKLQGP----IPESF--GELVSLEFLDLSNNDLSG----VIP  535 (952)
Q Consensus       470 ~~L~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~--~~l~~L~~L~Ls~N~l~~----~~~  535 (952)
                      ++|+.|+|++|.++    ..+|..+..+++|+.|+|++|+|++.    ++..+  +.+++|+.|+|++|.|++    .+|
T Consensus       216 ~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~  295 (386)
T 2ca6_A          216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK  295 (386)
T ss_dssp             TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred             CCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHH
Confidence            99999999999996    56788899999999999999999865    45666  448999999999999997    477


Q ss_pred             cch-hcccccccccccccccccCCC
Q 002214          536 ASL-EKLLYLKSLNLSFNKLVGEIP  559 (952)
Q Consensus       536 ~~~-~~l~~L~~L~l~~N~l~~~~p  559 (952)
                      ..+ .++++|+.|++++|++++..|
T Consensus       296 ~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          296 TVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             HHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             HHHHhcCCCceEEEccCCcCCcchh
Confidence            777 668999999999999986554

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=2.6e-21  Score=214.23  Aligned_cols=128  Identities=18%  Similarity=0.094  Sum_probs=60.5

Q ss_pred             EEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEecc-ccccccCCCccCCCC-CCcEEecccc
Q 002214          355 LSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNR-NKLSGSIPSCLGDLN-SLRILSLSSN  432 (952)
Q Consensus       355 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~N  432 (952)
                      +.+++|+++.+.|.+|..+++|++|++++|+|+...+..+....++..|++.+ |++....+..|..+. .++.|+|++|
T Consensus        85 l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N  164 (350)
T 4ay9_X           85 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN  164 (350)
T ss_dssp             EEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred             hcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccc
Confidence            34444555555555666666666666666666555555555555555555543 344434444444443 3555555555


Q ss_pred             ccCCcCCccccCCCCCceeEecC-CccCCCCchhhhcccccceeecCCcccC
Q 002214          433 ELTSVIPSTFWNLEDILGFDFSS-NSLNGSLPLEIENLKAVVDIYLSRNNLS  483 (952)
Q Consensus       433 ~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  483 (952)
                      +|+.+.+..|. ..+|+.|++++ |.++.+.++.|.++++|+.|+|++|+|+
T Consensus       165 ~i~~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~  215 (350)
T 4ay9_X          165 GIQEIHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH  215 (350)
T ss_dssp             CCCEECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred             cccCCChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence            55544333332 22344444432 3333222233344444444444444444

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.86  E-value=5.5e-23  Score=226.84  Aligned_cols=208  Identities=21%  Similarity=0.254  Sum_probs=139.6

Q ss_pred             CCcccEEEccCCCCCCC-CCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccc-cccc-cCCCccCCCCCCc
Q 002214          349 LINLTTLSLGDNNLSGS-LPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRN-KLSG-SIPSCLGDLNSLR  425 (952)
Q Consensus       349 l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~-~~~~~~~~l~~L~  425 (952)
                      +++|++|++++|.+++. ++..+..+++|++|++++|.+++..+..+..+++|++|+|++| .+++ .++..+..+++|+
T Consensus        92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~  171 (336)
T 2ast_B           92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD  171 (336)
T ss_dssp             CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred             CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence            34455555555554432 4444555555555555555555444555555555555555555 4443 2444556677777


Q ss_pred             EEecccc-ccCCc-CCccccCCC-CCceeEecCCc--cC-CCCchhhhcccccceeecCCcc-cCCCCcccccCCCCCce
Q 002214          426 ILSLSSN-ELTSV-IPSTFWNLE-DILGFDFSSNS--LN-GSLPLEIENLKAVVDIYLSRNN-LSGNIPSTIIGLKNLQH  498 (952)
Q Consensus       426 ~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~Ls~N~--l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~  498 (952)
                      +|++++| .+++. .+..+..++ +|+.|++++|.  ++ +.++..+..+++|+.|++++|. +++..+..+..+++|++
T Consensus       172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~  251 (336)
T 2ast_B          172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH  251 (336)
T ss_dssp             EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred             EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCE
Confidence            7777777 66643 355566777 78888888773  44 3456777888999999999998 77677778889999999


Q ss_pred             EEccCcc-ccCcccccccccccccEEeCCCCcccccCccchhccc-ccccccccccccccCCCC
Q 002214          499 LSLEHNK-LQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLL-YLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       499 L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~  560 (952)
                      |+|++|. +.......+..+++|+.|++++| ++   ...+..+. .|..|++++|++++..|.
T Consensus       252 L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~  311 (336)
T 2ast_B          252 LSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARP  311 (336)
T ss_dssp             EECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred             eeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCC
Confidence            9999995 33222236888999999999999 33   34555553 488888999999998886

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=8.9e-22  Score=217.92  Aligned_cols=227  Identities=16%  Similarity=0.153  Sum_probs=178.3

Q ss_pred             CcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccC-CCCccccCCCcceE-EEeccccccccCCCccCCCCCCcEE
Q 002214          350 INLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEG-PIPQEFCHFSRLYV-VYLNRNKLSGSIPSCLGDLNSLRIL  427 (952)
Q Consensus       350 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L  427 (952)
                      +++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+ +.+.+|.+++++.. +.++.|+++...|..|..+++|++|
T Consensus        30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L  109 (350)
T 4ay9_X           30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  109 (350)
T ss_dssp             TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred             CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence            578999999999997777889999999999999999855 45567888888764 6777899998888999999999999


Q ss_pred             eccccccCCcCCccccCCCCCceeEecC-CccCCCCchhhhccc-ccceeecCCcccCCCCcccccCCCCCceEEccC-c
Q 002214          428 SLSSNELTSVIPSTFWNLEDILGFDFSS-NSLNGSLPLEIENLK-AVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEH-N  504 (952)
Q Consensus       428 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N  504 (952)
                      ++++|+++...+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+.+.+..| ...+|+.|++++ |
T Consensus       110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n  188 (350)
T 4ay9_X          110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNN  188 (350)
T ss_dssp             EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCT
T ss_pred             cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCC
Confidence            9999999988888888888889999866 567766666777765 68889999999996555555 457899999974 7


Q ss_pred             cccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCCCcccccccccccCccCCCC
Q 002214          505 KLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGS  581 (952)
Q Consensus       505 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~  581 (952)
                      .++.+.+..|..+++|+.|||++|+|+.+++..|.++++|+.+++.+   ...+|....+.++....+ .+++.|.+
T Consensus       189 ~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~~---l~~lP~l~~l~~L~~l~l-~~~~~c~~  261 (350)
T 4ay9_X          189 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN---LKKLPTLEKLVALMEASL-TYPSHCCA  261 (350)
T ss_dssp             TCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCTT---CCCCCCTTTCCSCCEEEC-SCHHHHHH
T ss_pred             cccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCCC---cCcCCCchhCcChhhCcC-CCCccccc
Confidence            78766667889999999999999999977676777777666665533   335665555666655443 46677744

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.85  E-value=1.3e-21  Score=200.98  Aligned_cols=156  Identities=27%  Similarity=0.336  Sum_probs=110.7

Q ss_pred             EEEeccccccccCCCccCCCCCCcEEeccccccCCcCC-ccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCc
Q 002214          402 VVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIP-STFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRN  480 (952)
Q Consensus       402 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  480 (952)
                      .+++++|.++ .+|..+.  +.+++|+|++|+|+++.+ ..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus        15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   91 (220)
T 2v70_A           15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN   91 (220)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence            4444444444 2333222  234566666666665533 34666666677777777666666666777777777777777


Q ss_pred             ccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          481 NLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       481 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      +|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|.|.++.
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  171 (220)
T 2v70_A           92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL  171 (220)
T ss_dssp             CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred             ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence            77777777788888888888888888877777888888888888888888877788888888888888888888887764

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.85  E-value=1.5e-21  Score=200.40  Aligned_cols=138  Identities=22%  Similarity=0.350  Sum_probs=97.4

Q ss_pred             CCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEc
Q 002214          422 NSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSL  501 (952)
Q Consensus       422 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  501 (952)
                      ++|+.|++++|+|+++.+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|+.+.+..|.++++|++|+|
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L  111 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL  111 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence            45666666666666555556666666666666666666555666666677777777777777665666777777777777


Q ss_pred             cCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCC
Q 002214          502 EHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIP  559 (952)
Q Consensus       502 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  559 (952)
                      ++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.+.
T Consensus       112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B          112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence            7777777767777777777777777777777666677777777778888887777665

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=1.3e-21  Score=227.54  Aligned_cols=204  Identities=24%  Similarity=0.330  Sum_probs=131.0

Q ss_pred             ccCCCCCCC-----CCceE-EEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEE
Q 002214           13 NWTSNASVC-----SWMGI-TCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKEL   86 (952)
Q Consensus        13 ~~~~~~~~c-----~w~~v-~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L   86 (952)
                      +|..+.+.|     .|.|+ .|..  .+++.|+++++++++ +|..+.  ++|+.|+|++|.|+ .+|   ..+++|++|
T Consensus        35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L  105 (571)
T 3cvr_A           35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYL  105 (571)
T ss_dssp             HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEE
T ss_pred             HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEE
Confidence            576667788     69999 7863  478999999999986 887764  78999999999998 777   457899999


Q ss_pred             eCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCc
Q 002214           87 HLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQ  166 (952)
Q Consensus        87 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~  166 (952)
                      +|++|++++ +|. +.+  +|++|+|++|++++ +|.   .+. .++.|++++|++++ +|.    .+++|++|+|++|+
T Consensus       106 ~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~-~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~  171 (571)
T 3cvr_A          106 DACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPA-LLEYINADNNQLTM-LPE----LPTSLEVLSVRNNQ  171 (571)
T ss_dssp             ECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCT-TCCEEECCSSCCSC-CCC----CCTTCCEEECCSSC
T ss_pred             EccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCc-cccEEeCCCCccCc-CCC----cCCCcCEEECCCCC
Confidence            999999985 777 665  89999999999884 555   222 22555555555553 443    34455555555555


Q ss_pred             ccccCCccccCCCCCcEEEccCCcccccCCccccccCCc-------cEEEeeCCcCCccCchhhhccCCCcEeeeccccc
Q 002214          167 FKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKL-------KSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNL  239 (952)
Q Consensus       167 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~  239 (952)
                      +++ +|. |.  ++|+.|+|++|+|+ .+|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|++
T Consensus       172 L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l  242 (571)
T 3cvr_A          172 LTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL  242 (571)
T ss_dssp             CSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSC
T ss_pred             CCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcC
Confidence            553 444 33  55555555555555 3333 332  44       55555555555 3444444455555555555555


Q ss_pred             cccCCcccc
Q 002214          240 VGFVPDTIF  248 (952)
Q Consensus       240 ~~~~~~~~~  248 (952)
                      .+..|..+.
T Consensus       243 ~~~~p~~l~  251 (571)
T 3cvr_A          243 SSRIRESLS  251 (571)
T ss_dssp             CHHHHHHHH
T ss_pred             CCcCHHHHH
Confidence            444444443

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=1.1e-20  Score=192.46  Aligned_cols=174  Identities=23%  Similarity=0.262  Sum_probs=105.6

Q ss_pred             cEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEecccc
Q 002214          353 TTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSN  432 (952)
Q Consensus       353 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  432 (952)
                      +.++.+++.++. +|..+  .++|++|++++|.+++..+..|..++                        +|++|++++|
T Consensus        10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~------------------------~L~~L~l~~n   62 (208)
T 2o6s_A           10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELT------------------------SLTQLYLGGN   62 (208)
T ss_dssp             TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCT------------------------TCSEEECCSS
T ss_pred             CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccc------------------------cCcEEECCCC
Confidence            455666666653 23222  24566666666666544444444444                        4444444444


Q ss_pred             ccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccc
Q 002214          433 ELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPE  512 (952)
Q Consensus       433 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  512 (952)
                      +++++.+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+.
T Consensus        63 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  142 (208)
T 2o6s_A           63 KLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG  142 (208)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             ccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH
Confidence            44444444445555555555555555544444455666666666666666655566667777777777777777766666


Q ss_pred             cccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          513 SFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       513 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      .|..+++|+.|+|++|.+.+       .+++|++|+++.|.++|.+|.
T Consensus       143 ~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~  183 (208)
T 2o6s_A          143 VFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRN  183 (208)
T ss_dssp             TTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBC
T ss_pred             HhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeec
Confidence            67777777777777777654       345677788888888887775

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.84  E-value=7.8e-21  Score=211.22  Aligned_cols=180  Identities=26%  Similarity=0.256  Sum_probs=105.1

Q ss_pred             cEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCcccc-CCCcceEEEeccccccccCCCccCCCCCCcEEeccc
Q 002214          353 TTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFC-HFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSS  431 (952)
Q Consensus       353 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  431 (952)
                      +.+++++|+++. +|..+.  +.++.|+|++|.|++..+..|. .+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            466666666663 333332  3456666666666655555554 455555555555555544444444555555555555


Q ss_pred             cccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCccc
Q 002214          432 NELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIP  511 (952)
Q Consensus       432 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  511 (952)
                      |+|+++                        .+..|.++++|+.|+|++|+|+++.+..|.++++|+.|+|++|+|++..+
T Consensus        98 N~l~~~------------------------~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~  153 (361)
T 2xot_A           98 NHLHTL------------------------DEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPV  153 (361)
T ss_dssp             SCCCEE------------------------CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCG
T ss_pred             CcCCcC------------------------CHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCH
Confidence            554444                        44445555555556666666655556666666666666666666665444


Q ss_pred             ccc---cccccccEEeCCCCcccccCccchhcccc--cccccccccccccCCC
Q 002214          512 ESF---GELVSLEFLDLSNNDLSGVIPASLEKLLY--LKSLNLSFNKLVGEIP  559 (952)
Q Consensus       512 ~~~---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~l~~N~l~~~~p  559 (952)
                      ..|   ..+++|+.|+|++|+|+++.+..+..++.  |+.|+|++|+|.|.+.
T Consensus       154 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             GGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred             HHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence            444   45677777777777777666666666666  3677777777777654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.83  E-value=2e-20  Score=190.64  Aligned_cols=165  Identities=23%  Similarity=0.240  Sum_probs=127.4

Q ss_pred             CCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEE
Q 002214          348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRIL  427 (952)
Q Consensus       348 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  427 (952)
                      -.++|++|++++|++++..+..|..+++|++|++++|+++++.+..|..+++|++|+|++|++++..+..|..+++|++|
T Consensus        26 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  105 (208)
T 2o6s_A           26 IPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKEL  105 (208)
T ss_dssp             CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEE
Confidence            35689999999999998888889999999999999999998777778888888888888888887766777888888888


Q ss_pred             eccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcccc
Q 002214          428 SLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQ  507 (952)
Q Consensus       428 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  507 (952)
                      ++++|+++++.+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|.+.+       .+++|++|+++.|+++
T Consensus       106 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~  178 (208)
T 2o6s_A          106 ALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHS  178 (208)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCT
T ss_pred             EcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCC
Confidence            888888887777777777777777777777776555556666667777777666552       3455666666666666


Q ss_pred             Cccccccccccc
Q 002214          508 GPIPESFGELVS  519 (952)
Q Consensus       508 ~~~~~~~~~l~~  519 (952)
                      |.+|..++.++.
T Consensus       179 g~ip~~~~~l~~  190 (208)
T 2o6s_A          179 GVVRNSAGSVAP  190 (208)
T ss_dssp             TTBBCTTSSBCT
T ss_pred             ceeeccCccccC
Confidence            666666555543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.82  E-value=9.7e-20  Score=211.70  Aligned_cols=182  Identities=24%  Similarity=0.289  Sum_probs=141.5

Q ss_pred             cccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEecc
Q 002214          351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLS  430 (952)
Q Consensus       351 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  430 (952)
                      +|+.|+|++|++++ +|..+  +++|++|+|++|.|+ .+|   ..+++|+.|+|++|+|++ +|. +..  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            78889999988886 45444  378899999999888 445   446888899999998886 566 555  88999999


Q ss_pred             ccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcc
Q 002214          431 SNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPI  510 (952)
Q Consensus       431 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  510 (952)
                      +|+|+++++    .+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .+
T Consensus       129 ~N~l~~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l  195 (571)
T 3cvr_A          129 NNQLTMLPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL  195 (571)
T ss_dssp             SSCCSCCCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred             CCcCCCCCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence            999887443    57888999999999886 554   57788899999999886 555 65  88999999999888 45


Q ss_pred             cccccccccc-------cEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          511 PESFGELVSL-------EFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       511 ~~~~~~l~~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      |. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|.
T Consensus       196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            55 554  67       88999999988 4677777788999999999998887764

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.81  E-value=1.2e-19  Score=187.43  Aligned_cols=137  Identities=24%  Similarity=0.266  Sum_probs=91.3

Q ss_pred             CCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEc
Q 002214          422 NSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSL  501 (952)
Q Consensus       422 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  501 (952)
                      ++|++|+|++|+|+++.+..|..+++|+.|+|++|+|+...+..|..+++|+.|+|++|+|+++.+..|..+++|+.|+|
T Consensus        40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L  119 (229)
T 3e6j_A           40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM  119 (229)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence            45556666666665555555666666666666666665444455566666666666666666666666677777777777


Q ss_pred             cCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCC
Q 002214          502 EHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIP  559 (952)
Q Consensus       502 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  559 (952)
                      ++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.|.++
T Consensus       120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            777777 556667777777777777777776666667777777777777777777665

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=1.3e-19  Score=194.71  Aligned_cols=172  Identities=23%  Similarity=0.373  Sum_probs=113.5

Q ss_pred             ccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCce
Q 002214          371 GRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILG  450 (952)
Q Consensus       371 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  450 (952)
                      ..+++|+.|++++|.+... + .+..+++|+.|+|++|++++..+  +..+++|++|++++|++++..  .+..+++|+.
T Consensus        43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~  116 (291)
T 1h6t_A           43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLS--SLKDLKKLKS  116 (291)
T ss_dssp             HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGG--GGTTCTTCCE
T ss_pred             hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCCh--hhccCCCCCE
Confidence            4455566666666665533 2 35556666666666666654333  566666666666666666532  3666667777


Q ss_pred             eEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcc
Q 002214          451 FDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDL  530 (952)
Q Consensus       451 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  530 (952)
                      |++++|++++.  ..+..+++|+.|++++|++++.  ..+..+++|+.|+|++|++++..+  +..+++|+.|+|++|.|
T Consensus       117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i  190 (291)
T 1h6t_A          117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  190 (291)
T ss_dssp             EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence            77777776643  3566777777777777777754  567777778888888887776544  77777888888888877


Q ss_pred             cccCccchhccccccccccccccccc
Q 002214          531 SGVIPASLEKLLYLKSLNLSFNKLVG  556 (952)
Q Consensus       531 ~~~~~~~~~~l~~L~~L~l~~N~l~~  556 (952)
                      ++. | .+..+++|+.|++++|+++.
T Consensus       191 ~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          191 SDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             CCC-h-hhccCCCCCEEECcCCcccC
Confidence            753 3 37777788888888887765

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=1.1e-19  Score=195.29  Aligned_cols=181  Identities=20%  Similarity=0.341  Sum_probs=157.7

Q ss_pred             ccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCc
Q 002214          346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR  425 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  425 (952)
                      +..+++|+.|++++|.++.. + .+..+++|++|++++|++++..+  +..+++|+.|++++|++++ ++ .+..+++|+
T Consensus        42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~  115 (291)
T 1h6t_A           42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK  115 (291)
T ss_dssp             HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred             hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence            45678899999999999855 3 48899999999999999997655  9999999999999999985 33 489999999


Q ss_pred             EEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcc
Q 002214          426 ILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNK  505 (952)
Q Consensus       426 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  505 (952)
                      +|++++|+++++  ..+..+++|+.|++++|++++.  ..+..+++|+.|+|++|++++..+  +..+++|+.|+|++|+
T Consensus       116 ~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~  189 (291)
T 1h6t_A          116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH  189 (291)
T ss_dssp             EEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             EEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence            999999999975  5688999999999999999965  679999999999999999997655  9999999999999999


Q ss_pred             ccCcccccccccccccEEeCCCCcccccCccchhc
Q 002214          506 LQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEK  540 (952)
Q Consensus       506 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  540 (952)
                      |++. + .+..+++|+.|++++|+++......+..
T Consensus       190 i~~l-~-~l~~l~~L~~L~l~~n~i~~~~~~~~~~  222 (291)
T 1h6t_A          190 ISDL-R-ALAGLKNLDVLELFSQECLNKPINHQSN  222 (291)
T ss_dssp             CCBC-G-GGTTCTTCSEEEEEEEEEECCCEECCSE
T ss_pred             CCCC-h-hhccCCCCCEEECcCCcccCCccccccc
Confidence            9964 4 4999999999999999998644443333

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.80  E-value=1.1e-19  Score=201.83  Aligned_cols=180  Identities=24%  Similarity=0.185  Sum_probs=139.5

Q ss_pred             cccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccc-cCCCCcEEEccCccccCCCCc
Q 002214          314 LKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLG-RLKKLQGLDLQNNKFEGPIPQ  392 (952)
Q Consensus       314 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~L~~N~i~~~~~~  392 (952)
                      -+.++++++.++.+|..                 -...++.|+|++|+|++..+..|. .+++|++|+|++|+|+++.+.
T Consensus        20 ~~~l~c~~~~l~~iP~~-----------------~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~   82 (361)
T 2xot_A           20 SNILSCSKQQLPNVPQS-----------------LPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSE   82 (361)
T ss_dssp             TTEEECCSSCCSSCCSS-----------------CCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTT
T ss_pred             CCEEEeCCCCcCccCcc-----------------CCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChh
Confidence            47889999988877753                 234689999999999988888888 999999999999999999999


Q ss_pred             cccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhccccc
Q 002214          393 EFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAV  472 (952)
Q Consensus       393 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  472 (952)
                      .|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|+++.+..|..+++|+.|+|++|+|+...+..|..    
T Consensus        83 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~----  158 (361)
T 2xot_A           83 AFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKD----  158 (361)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC-----
T ss_pred             hccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcC----
Confidence            9999999999999999999888888999999999999999999888888888888888877777777533333311    


Q ss_pred             ceeecCCcccCCCCcccccCCCCCceEEccCccccCccccccccccc--ccEEeCCCCccc
Q 002214          473 VDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVS--LEFLDLSNNDLS  531 (952)
Q Consensus       473 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~Ls~N~l~  531 (952)
                                       +..+++|+.|+|++|+|++..+..|..++.  |+.|+|++|++.
T Consensus       159 -----------------~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          159 -----------------GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             --------------------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             -----------------cccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence                             033555555555555555444445555554  356666666665

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.80  E-value=3.2e-19  Score=183.02  Aligned_cols=153  Identities=24%  Similarity=0.328  Sum_probs=90.6

Q ss_pred             cEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEecccc
Q 002214          353 TTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSN  432 (952)
Q Consensus       353 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  432 (952)
                      +.++++++.++. +|..+.  ++|+.|++++|.|+++.+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            456666666663 333332  45666666666666555555555555555555555555444455555555555555555


Q ss_pred             ccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccc
Q 002214          433 ELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPE  512 (952)
Q Consensus       433 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  512 (952)
                      +|++++                        +..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+.
T Consensus        91 ~l~~l~------------------------~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  146 (220)
T 2v9t_B           91 KITELP------------------------KSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG  146 (220)
T ss_dssp             CCCCCC------------------------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             cCCccC------------------------HhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHH
Confidence            554443                        44455555566666666666656666666677777777777777766666


Q ss_pred             cccccccccEEeCCCCcccc
Q 002214          513 SFGELVSLEFLDLSNNDLSG  532 (952)
Q Consensus       513 ~~~~l~~L~~L~Ls~N~l~~  532 (952)
                      .|..+++|+.|+|++|++..
T Consensus       147 ~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          147 TFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             TTTTCTTCCEEECCSSCEEC
T ss_pred             HHhCCCCCCEEEeCCCCcCC
Confidence            67777777777777777653

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.80  E-value=3.7e-19  Score=183.89  Aligned_cols=163  Identities=25%  Similarity=0.299  Sum_probs=132.4

Q ss_pred             cCCCCCCCCCceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCcc
Q 002214           14 WTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKL   93 (952)
Q Consensus        14 ~~~~~~~c~w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l   93 (952)
                      |...+..|.|.+|.|..            ++++ .+|..+.  ++|++|+|++|.|++..|..+..+++|++|+|++|++
T Consensus        12 ~~~~~~~Cs~~~v~c~~------------~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l   76 (229)
T 3e6j_A           12 ACPSQCSCSGTTVDCRS------------KRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL   76 (229)
T ss_dssp             CCCTTCEEETTEEECTT------------SCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             cCCCCCEEeCCEeEccC------------CCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCC
Confidence            44457899998888863            3343 5676554  8999999999999988888999999999999999999


Q ss_pred             cccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCc
Q 002214           94 QGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPN  173 (952)
Q Consensus        94 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  173 (952)
                      ....+..|.++++|++|+|++|+++                          .++...+..+++|++|+|++|+++ .+|.
T Consensus        77 ~~i~~~~~~~l~~L~~L~Ls~N~l~--------------------------~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~  129 (229)
T 3e6j_A           77 GALPVGVFDSLTQLTVLDLGTNQLT--------------------------VLPSAVFDRLVHLKELFMCCNKLT-ELPR  129 (229)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCC--------------------------CCCTTTTTTCTTCCEEECCSSCCC-SCCT
T ss_pred             CCcChhhcccCCCcCEEECCCCcCC--------------------------ccChhHhCcchhhCeEeccCCccc-ccCc
Confidence            8655677899999999999999887                          233344456788999999999988 6788


Q ss_pred             cccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCcc
Q 002214          174 NLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGE  218 (952)
Q Consensus       174 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  218 (952)
                      .+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+...
T Consensus       130 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  174 (229)
T 3e6j_A          130 GIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE  174 (229)
T ss_dssp             TGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred             ccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence            888888899999999988877777788888888888888888743

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.79  E-value=4.5e-19  Score=181.91  Aligned_cols=133  Identities=23%  Similarity=0.298  Sum_probs=89.1

Q ss_pred             eEEEeccccccccCC-CccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCC
Q 002214          401 YVVYLNRNKLSGSIP-SCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSR  479 (952)
Q Consensus       401 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  479 (952)
                      +.|+|++|+|++..+ ..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|++++..+..|..+++|++|+|++
T Consensus        35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  114 (220)
T 2v70_A           35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS  114 (220)
T ss_dssp             SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTT
T ss_pred             CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCC
Confidence            334444444443322 2345555666666666666655555666666666666666666655666667777777777777


Q ss_pred             cccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCccccc
Q 002214          480 NNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGV  533 (952)
Q Consensus       480 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  533 (952)
                      |+|+++.|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++...
T Consensus       115 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A          115 NRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN  168 (220)
T ss_dssp             SCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred             CcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence            777777777778888888888888888877777888888888888888888754

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.79  E-value=2.1e-19  Score=211.53  Aligned_cols=172  Identities=24%  Similarity=0.380  Sum_probs=78.0

Q ss_pred             ccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCce
Q 002214          371 GRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILG  450 (952)
Q Consensus       371 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  450 (952)
                      ..+++|+.|++++|.|... + .|..+++|+.|+|++|+|++..+  +..+++|+.|+|++|+|+++  ..+..+++|+.
T Consensus        40 ~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~  113 (605)
T 1m9s_A           40 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKS  113 (605)
T ss_dssp             HHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCE
T ss_pred             hcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCCE
Confidence            3344444444444444322 1 24444444444444444443322  44444444444444444432  13444444444


Q ss_pred             eEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcc
Q 002214          451 FDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDL  530 (952)
Q Consensus       451 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  530 (952)
                      |+|++|++++.  ..+..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|+|++..|  +..+++|+.|+|++|+|
T Consensus       114 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i  187 (605)
T 1m9s_A          114 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  187 (605)
T ss_dssp             EECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCC
Confidence            44444444431  2344444555555555554432  344445555555555555544333  44455555555555555


Q ss_pred             cccCccchhccccccccccccccccc
Q 002214          531 SGVIPASLEKLLYLKSLNLSFNKLVG  556 (952)
Q Consensus       531 ~~~~~~~~~~l~~L~~L~l~~N~l~~  556 (952)
                      ++.  ..+..+++|+.|+|++|++++
T Consensus       188 ~~l--~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          188 SDL--RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             CBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred             CCC--hHHccCCCCCEEEccCCcCcC
Confidence            432  234445555555555555443

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.78  E-value=5.2e-19  Score=208.09  Aligned_cols=188  Identities=20%  Similarity=0.342  Sum_probs=162.1

Q ss_pred             ccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCc
Q 002214          346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR  425 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  425 (952)
                      +..+++|+.|++++|.+... + .+..+++|+.|+|++|.|.+..+  +..+++|+.|+|++|+|++ ++ .+..+++|+
T Consensus        39 ~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~  112 (605)
T 1m9s_A           39 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLK  112 (605)
T ss_dssp             HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCC
T ss_pred             hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCC
Confidence            35678899999999999854 3 58999999999999999987655  8999999999999999985 33 689999999


Q ss_pred             EEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcc
Q 002214          426 ILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNK  505 (952)
Q Consensus       426 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  505 (952)
                      .|+|++|+|+++  ..+..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|+|++..|  +..+++|+.|+|++|+
T Consensus       113 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~  186 (605)
T 1m9s_A          113 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH  186 (605)
T ss_dssp             EEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             EEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence            999999999975  4688999999999999999965  678999999999999999997766  8999999999999999


Q ss_pred             ccCcccccccccccccEEeCCCCcccccCccchhcccccccc
Q 002214          506 LQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSL  547 (952)
Q Consensus       506 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  547 (952)
                      |++.  ..+..+++|+.|+|++|++++.....+..+..+..+
T Consensus       187 i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~~~l  226 (605)
T 1m9s_A          187 ISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV  226 (605)
T ss_dssp             CCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCEEECCC
T ss_pred             CCCC--hHHccCCCCCEEEccCCcCcCCcccccccEEecccc
Confidence            9964  469999999999999999987655555555555444

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=3e-21  Score=225.89  Aligned_cols=207  Identities=18%  Similarity=0.166  Sum_probs=152.8

Q ss_pred             ccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCc-------------ccccCChhhcCCCCCCeEe-ecCccCc
Q 002214           53 LGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNK-------------LQGEIPEELGNLAELEMLV-LNNNLLT  118 (952)
Q Consensus        53 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~-------------l~~~~p~~l~~l~~L~~L~-L~~n~l~  118 (952)
                      +..+++|+.|+|++|+++ .+|++|+.+++|++|++++|.             +.+..|..++++++|+.|+ ++.|.+.
T Consensus       345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~  423 (567)
T 1dce_A          345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD  423 (567)
T ss_dssp             CSTTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred             cccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc
Confidence            367888999999999997 889999999999999987775             4456677778888888887 6666554


Q ss_pred             cccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCcc
Q 002214          119 GTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRD  198 (952)
Q Consensus       119 ~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~  198 (952)
                       .           +..+.+++|.++. +|.      ..|+.|+|++|++++ +|. |..+++|+.|+|++|+|+ .+|..
T Consensus       424 -~-----------L~~l~l~~n~i~~-l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~  481 (567)
T 1dce_A          424 -D-----------LRSKFLLENSVLK-MEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPA  481 (567)
T ss_dssp             -H-----------HHHHHHHHHHHHH-HHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGG
T ss_pred             -h-----------hhhhhhhcccccc-cCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchh
Confidence             1           1345566666652 221      247788888888875 565 888888888888888888 67778


Q ss_pred             ccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccC-CccccCCCCccEEEeeCccccccCCCCcc-cCCC
Q 002214          199 LGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFV-PDTIFNISTLKILSLFNNTLSGNLPSSKN-LIGL  276 (952)
Q Consensus       199 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-l~~l  276 (952)
                      |+++++|++|+|++|+|++ +| .|+.+++|+.|+|++|++.+.. |..+..+++|+.|+|++|++++..+.... +..+
T Consensus       482 ~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~l  559 (567)
T 1dce_A          482 LAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML  559 (567)
T ss_dssp             GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHC
T ss_pred             hhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHC
Confidence            8888888888888888875 56 7888888888888888888776 77888888888888888888765543322 2236


Q ss_pred             CCcceEEc
Q 002214          277 PNLEGLNL  284 (952)
Q Consensus       277 ~~L~~L~L  284 (952)
                      ++|+.|++
T Consensus       560 p~L~~L~l  567 (567)
T 1dce_A          560 PSVSSILT  567 (567)
T ss_dssp             TTCSEEEC
T ss_pred             cccCccCC
Confidence            66766653

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.76  E-value=5e-19  Score=177.45  Aligned_cols=129  Identities=26%  Similarity=0.356  Sum_probs=72.7

Q ss_pred             eEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCc-cccCCCCCceeEecCCccCCCCchhhhcccccceeecCC
Q 002214          401 YVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPS-TFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSR  479 (952)
Q Consensus       401 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  479 (952)
                      +.+++++|.++ .+|..+..  +|++|++++|+|+++.+. .|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            45666666665 44443322  566666666666655543 355556666666666655555555555555555555555


Q ss_pred             cccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccc
Q 002214          480 NNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSG  532 (952)
Q Consensus       480 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  532 (952)
                      |+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            55555555555555555555555555555555555555555555555555554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=1.1e-20  Score=220.95  Aligned_cols=204  Identities=23%  Similarity=0.223  Sum_probs=137.5

Q ss_pred             cccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCC-------------CCCCCCcccccCCC
Q 002214          309 GYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNN-------------LSGSLPITLGRLKK  375 (952)
Q Consensus       309 ~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~-------------l~~~~~~~l~~l~~  375 (952)
                      ..+++|+.|+|+.|.++.+|.+               ++.+++|+.|++++|.             +.+..|..+..+++
T Consensus       346 ~~~~~L~~L~Ls~n~L~~Lp~~---------------i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~  410 (567)
T 1dce_A          346 ATDEQLFRCELSVEKSTVLQSE---------------LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST  410 (567)
T ss_dssp             STTTTSSSCCCCHHHHHHHHHH---------------HHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHHhhHHH---------------HHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHh
Confidence            3445555566666655554443               2334445555554432             34456667777777


Q ss_pred             CcEEE-ccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEec
Q 002214          376 LQGLD-LQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFS  454 (952)
Q Consensus       376 L~~L~-L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  454 (952)
                      |+.|+ ++.|.+.           +|..+.+++|.++...+      ..|+.|+|++|+|+++ |. |..+++|+.|+|+
T Consensus       411 L~~L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls  471 (567)
T 1dce_A          411 LKAVDPMRAAYLD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLS  471 (567)
T ss_dssp             HHHHCGGGHHHHH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGGTTCCEEECC
T ss_pred             cccCcchhhcccc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-ccccccCcEeecC
Confidence            77777 6666542           34555666777764322      2478888888888764 44 7888888888888


Q ss_pred             CCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcc-cccccccccccEEeCCCCccccc
Q 002214          455 SNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPI-PESFGELVSLEFLDLSNNDLSGV  533 (952)
Q Consensus       455 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~  533 (952)
                      +|+|+ .+|..+..+++|+.|+|++|+|++ +| .|+.+++|+.|+|++|+|++.. |..++.+++|+.|+|++|+|++.
T Consensus       472 ~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~  548 (567)
T 1dce_A          472 HNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  548 (567)
T ss_dssp             SSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             ccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence            88888 677788888888888888888885 45 7788888888888888888765 77888888888888888888765


Q ss_pred             Cccc---hhcccccccccc
Q 002214          534 IPAS---LEKLLYLKSLNL  549 (952)
Q Consensus       534 ~~~~---~~~l~~L~~L~l  549 (952)
                      +|..   +..+++|+.|++
T Consensus       549 ~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          549 EGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             SSCTTHHHHHCTTCSEEEC
T ss_pred             ccHHHHHHHHCcccCccCC
Confidence            5432   334677777753

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.76  E-value=5.7e-19  Score=186.46  Aligned_cols=170  Identities=28%  Similarity=0.381  Sum_probs=98.6

Q ss_pred             CCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEe
Q 002214          349 LINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILS  428 (952)
Q Consensus       349 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  428 (952)
                      +.++..+++++|.+++..  .+..+++|++|++++|.|+.. + .+..+++|+.|+|++|+|++..+  +..+++|++|+
T Consensus        18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~   91 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS   91 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence            445666777777777433  567778888888888887743 3 56677777777777777774443  66777777777


Q ss_pred             ccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccC
Q 002214          429 LSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQG  508 (952)
Q Consensus       429 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  508 (952)
                      +++|+++++.+...   ++|+.|++++|++++                        .  ..+..+++|+.|+|++|+|++
T Consensus        92 L~~N~l~~l~~~~~---~~L~~L~L~~N~l~~------------------------~--~~l~~l~~L~~L~Ls~N~i~~  142 (263)
T 1xeu_A           92 VNRNRLKNLNGIPS---ACLSRLFLDNNELRD------------------------T--DSLIHLKNLEILSIRNNKLKS  142 (263)
T ss_dssp             CCSSCCSCCTTCCC---SSCCEEECCSSCCSB------------------------S--GGGTTCTTCCEEECTTSCCCB
T ss_pred             CCCCccCCcCcccc---CcccEEEccCCccCC------------------------C--hhhcCcccccEEECCCCcCCC
Confidence            77777765432211   455555555555543                        2  124445555555555555543


Q ss_pred             cccccccccccccEEeCCCCcccccCccchhcccccccccccccccccC
Q 002214          509 PIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGE  557 (952)
Q Consensus       509 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  557 (952)
                      . + .+..+++|+.|+|++|+|++.  ..+..+++|+.|++++|++++.
T Consensus       143 ~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          143 I-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             C-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             C-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            2 2 344555555555555555543  3445555555555555555543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.76  E-value=3.9e-19  Score=187.20  Aligned_cols=137  Identities=20%  Similarity=0.266  Sum_probs=107.3

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcE--EEEEEeeccCch------------------------hhHHHHHHHHHHHhC
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIE--VAIKVFHLQREG------------------------ALNSFDAECEILKTI  717 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  717 (952)
                      -|.+.+.||+|+||.||+|.+ .+|+.  ||||+++.....                        ....+.+|+.++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999998 68989  999987543111                        113678999999999


Q ss_pred             CCCcc--ceeeeEeecCCeeEEEEEccCC-C----ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEeCC
Q 002214          718 RHRNL--VKIISSCTNHNFKALVLEYMPK-G----SLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH-SNPIVHCD  789 (952)
Q Consensus       718 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h-~~~ivH~D  789 (952)
                      +|+++  ..++++    +..++||||+.+ |    +|.+....    .++..+..++.|++.|++||   | +.||+|||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~l---H~~~givHrD  196 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRL---YQEAELVHAD  196 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHH---HHTSCEECSS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHH---HHHCCEEeCC
Confidence            88764  333432    356899999942 4    66665432    23456788999999999999   7 89999999


Q ss_pred             CCCCCeeeCCCCcEEEecccccccc
Q 002214          790 IKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       790 lk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      |||+|||++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999999864

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.74  E-value=4.2e-18  Score=179.82  Aligned_cols=152  Identities=19%  Similarity=0.281  Sum_probs=129.8

Q ss_pred             ccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCc
Q 002214          346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR  425 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  425 (952)
                      +..+++|+.|++++|+++. ++ .+..+++|++|+|++|+|++..+  |..+++|+.|+|++|++++ +|.. .. ++|+
T Consensus        37 ~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~  109 (263)
T 1xeu_A           37 QKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLS  109 (263)
T ss_dssp             HHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCC
T ss_pred             hhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-Cccc
Confidence            4567899999999999995 44 78999999999999999997655  9999999999999999995 4433 33 9999


Q ss_pred             EEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcc
Q 002214          426 ILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNK  505 (952)
Q Consensus       426 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  505 (952)
                      +|++++|+++++  ..+..+++|+.|++++|++++. + .+..+++|+.|+|++|++++.  ..+..+++|+.|++++|+
T Consensus       110 ~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~  183 (263)
T 1xeu_A          110 RLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQK  183 (263)
T ss_dssp             EEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEE
T ss_pred             EEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCc
Confidence            999999999975  3588999999999999999864 3 688889999999999999865  678888899999999998


Q ss_pred             ccCcc
Q 002214          506 LQGPI  510 (952)
Q Consensus       506 l~~~~  510 (952)
                      +++..
T Consensus       184 ~~~~~  188 (263)
T 1xeu_A          184 CVNEP  188 (263)
T ss_dssp             EECCC
T ss_pred             ccCCc
Confidence            88553

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=5.6e-18  Score=170.67  Aligned_cols=153  Identities=17%  Similarity=0.219  Sum_probs=77.2

Q ss_pred             ccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCce
Q 002214          371 GRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILG  450 (952)
Q Consensus       371 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  450 (952)
                      ..+++|++|++++|.|+ ..| .+..+++|++|++++|.++ . +..+..+++|++|++++|++++..+..|..+++|+.
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            44555555555555555 222 3555555555555555443 1 124455555666666666555544555555555555


Q ss_pred             eEecCCccCCCCchhhhcccccceeecCCcc-cCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCc
Q 002214          451 FDFSSNSLNGSLPLEIENLKAVVDIYLSRNN-LSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNND  529 (952)
Q Consensus       451 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  529 (952)
                      |++++|++++..|..+..+++|++|+|++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|+
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence            5555555554444555555555555555554 33 222 34555555555555555553 22 44555555555555555


Q ss_pred             cc
Q 002214          530 LS  531 (952)
Q Consensus       530 l~  531 (952)
                      |.
T Consensus       193 i~  194 (197)
T 4ezg_A          193 IG  194 (197)
T ss_dssp             --
T ss_pred             cC
Confidence            43

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.74  E-value=1.3e-17  Score=167.19  Aligned_cols=155  Identities=26%  Similarity=0.303  Sum_probs=107.2

Q ss_pred             cEEeccccccCCcCCccccCCCCCceeEecCCccCCCCch-hhhcccccceeecCCcccCCCCcccccCCCCCceEEccC
Q 002214          425 RILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPL-EIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEH  503 (952)
Q Consensus       425 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  503 (952)
                      +.+++++|+++.++ ..+.  .+|+.|++++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~~ip-~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLKEIP-RDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCSSCC-SCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcCcCc-cCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            67777777776543 3332  2777777777777765553 377777777777777777777777777777777777777


Q ss_pred             ccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCCCcccccccccccCccCCCCC
Q 002214          504 NKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSP  582 (952)
Q Consensus       504 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p  582 (952)
                      |+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|.|.++......++....+.++...|+.|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            7777766667777777777777777777777777777777777777777777776643222233333445555666665

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=7.7e-18  Score=169.67  Aligned_cols=155  Identities=16%  Similarity=0.226  Sum_probs=136.6

Q ss_pred             ccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCc
Q 002214          346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR  425 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  425 (952)
                      .+.+++|+.|++++|.++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|++++..+..+..+++|+
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            456789999999999999 445 6899999999999999876  345889999999999999999988899999999999


Q ss_pred             EEeccccccCCcCCccccCCCCCceeEecCCc-cCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCc
Q 002214          426 ILSLSSNELTSVIPSTFWNLEDILGFDFSSNS-LNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHN  504 (952)
Q Consensus       426 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  504 (952)
                      +|++++|++++..+..|..+++|+.|++++|+ ++ .+| .+..+++|+.|++++|++++. + .+..+++|+.|++++|
T Consensus       116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N  191 (197)
T 4ezg_A          116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQ  191 (197)
T ss_dssp             EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC
T ss_pred             EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCc
Confidence            99999999998888999999999999999998 66 455 799999999999999999964 3 7899999999999999


Q ss_pred             cccC
Q 002214          505 KLQG  508 (952)
Q Consensus       505 ~l~~  508 (952)
                      +|.+
T Consensus       192 ~i~~  195 (197)
T 4ezg_A          192 TIGG  195 (197)
T ss_dssp             ----
T ss_pred             ccCC
Confidence            9874

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.73  E-value=4.9e-18  Score=186.12  Aligned_cols=200  Identities=12%  Similarity=0.037  Sum_probs=114.0

Q ss_pred             ccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCcc----ccCCCCccccCCCcce-EEEecccc-ccccCCCccC
Q 002214          346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNK----FEGPIPQEFCHFSRLY-VVYLNRNK-LSGSIPSCLG  419 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~----i~~~~~~~~~~l~~L~-~L~L~~N~-l~~~~~~~~~  419 (952)
                      |.++++|+.|++.+|.+..+.+.+|.++.++..+.+..+.    ........|.++..|+ .+.+.... +.........
T Consensus       120 F~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~  199 (329)
T 3sb4_A          120 FKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGL  199 (329)
T ss_dssp             TTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTC
T ss_pred             hhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhccc
Confidence            4455666666666666665666666666666655555422    2223344555555555 33333211 0000001111


Q ss_pred             CCCCCcEEeccccccCCcCCccc-cCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCc-
Q 002214          420 DLNSLRILSLSSNELTSVIPSTF-WNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ-  497 (952)
Q Consensus       420 ~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-  497 (952)
                      ...+++.+.+.++-.. .....+ ..+++|+.|+|++|+++.+.+..|.++++|+.|+|++| ++.+.+.+|.++++|+ 
T Consensus       200 ~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~  277 (329)
T 3sb4_A          200 QPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAG  277 (329)
T ss_dssp             CGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCE
T ss_pred             CccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccE
Confidence            2344455555443211 111111 12566777777776666555666777777777777776 6656667777777777 


Q ss_pred             eEEccCccccCcccccccccccccEEeCCCCcccccCccchhccccccccc
Q 002214          498 HLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLN  548 (952)
Q Consensus       498 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  548 (952)
                      .|++.+ .++.+.+.+|.++++|+.|++++|.++.+.+..|.++++|+.++
T Consensus       278 ~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          278 TLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             EEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             EEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence            777776 56656667777777777777777777766666777777777665

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.73  E-value=2.4e-18  Score=188.63  Aligned_cols=123  Identities=15%  Similarity=0.062  Sum_probs=64.5

Q ss_pred             CCccceEEcccCcccccCCccccC-CCCCcEEEccCCccc--ccCCccccccCCccEEEeeCCcCCccCchhhhc-----
Q 002214          154 LPRLKGLYVSYNQFKGPIPNNLWH-CKELSSVSLSYNQFT--GRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGN-----  225 (952)
Q Consensus       154 l~~L~~L~L~~n~l~~~~~~~l~~-l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----  225 (952)
                      ++++++|.++++- .......+.. +++|+.|+|++|+|.  ...+..+   +.++.+.+..|.   +.+.+|.+     
T Consensus        24 ~~~l~~L~l~g~i-~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~---I~~~aF~~~~~~~   96 (329)
T 3sb4_A           24 ANSITHLTLTGKL-NAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANF---VPAYAFSNVVNGV   96 (329)
T ss_dssp             HHHCSEEEEEEEE-CHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTE---ECTTTTEEEETTE
T ss_pred             hCceeEEEEeccc-cHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccc---cCHHHhccccccc
Confidence            3456666666531 1111112222 566777777777666  2222222   224455555553   23345555     


Q ss_pred             ---cCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEccc
Q 002214          226 ---LRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGL  286 (952)
Q Consensus       226 ---l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~  286 (952)
                         +++|+.|+|.+ ++..+.+.+|.++++|+.|++++|.+....+  ..|.++.++..+.+..
T Consensus        97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~--~aF~~~~~l~~l~~~~  157 (329)
T 3sb4_A           97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLP--EALADSVTAIFIPLGS  157 (329)
T ss_dssp             EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECT--TSSCTTTCEEEECTTC
T ss_pred             ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccch--hhhcCCCceEEecCcc
Confidence               67777777766 6666666666667777777776666653322  2355555555555444

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.73  E-value=5.1e-18  Score=169.92  Aligned_cols=132  Identities=26%  Similarity=0.319  Sum_probs=109.1

Q ss_pred             cEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCc
Q 002214          425 RILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHN  504 (952)
Q Consensus       425 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  504 (952)
                      +.+++++|+++.++.. +  .++|+.|++++|+|+ .+|..|..+++|+.|+|++|+|+++.+..|.++++|++|+|++|
T Consensus        13 ~~l~~~~~~l~~ip~~-~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLKVLPKG-I--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCSSCCSC-C--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCCcCCCC-C--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            4677777777654332 2  246778888888887 56678888888999999999998888888999999999999999


Q ss_pred             cccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          505 KLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       505 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      +|+++.|..|..+++|+.|+|++|+|+.+.+..|..+++|+.|++++|+|.|.+..
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l  144 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM  144 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence            99988888899999999999999999977777889999999999999999987763

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.71  E-value=3.4e-18  Score=206.49  Aligned_cols=213  Identities=19%  Similarity=0.147  Sum_probs=107.5

Q ss_pred             ccccccC-CCCCCCCCceEEEeCCCCeEEEEEecCCCCcccCCccccCCcccCee-----eccccccccccCCCcCCcCC
Q 002214            9 ILAQNWT-SNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTL-----VLSRNWFSGTIPKEIGNLTK   82 (952)
Q Consensus         9 ~~~~~~~-~~~~~c~w~~v~c~~~~~~~~~l~l~~~~~~~~~p~~l~~l~~L~~L-----~L~~n~l~~~~p~~l~~l~~   82 (952)
                      .-..+|. .++..+.|.++.+..  .+++.|+|.++++.. +|..+....+|..+     +++.|.+. ..|+.+..+++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~  225 (727)
T 4b8c_D          150 AKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQL  225 (727)
T ss_dssp             TC--------------------------------------------------------------------------CCCC
T ss_pred             cccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCC
Confidence            3344563 456789999988885  678999999998875 44443333333322     22233333 45667777788


Q ss_pred             CcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEc
Q 002214           83 LKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYV  162 (952)
Q Consensus        83 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L  162 (952)
                      |++|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..++                          ++++|++|+|
T Consensus       226 L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~--------------------------~l~~L~~L~L  277 (727)
T 4b8c_D          226 WHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIK--------------------------NLSNLRVLDL  277 (727)
T ss_dssp             CCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGG--------------------------GGTTCCEEEC
T ss_pred             CcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhh--------------------------CCCCCCEEeC
Confidence            888888888877 67777777778888888877777 6665554                          4557888888


Q ss_pred             ccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCC-CcEeeeccccccc
Q 002214          163 SYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRN-LEILGIDQSNLVG  241 (952)
Q Consensus       163 ~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~n~~~~  241 (952)
                      ++|+|+ .+|..|..+++|++|+|++|.|+ .+|..|+.+++|++|+|++|.+++.+|..+..+.. +..|+|++|.+.+
T Consensus       278 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~  355 (727)
T 4b8c_D          278 SHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI  355 (727)
T ss_dssp             TTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred             cCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccC
Confidence            888888 67888888888888888888887 66777888888888888888888888887766533 2346788888877


Q ss_pred             cCCccccCCCCccEEEeeCc
Q 002214          242 FVPDTIFNISTLKILSLFNN  261 (952)
Q Consensus       242 ~~~~~~~~l~~L~~L~Ls~N  261 (952)
                      .+|.      .|+.|+++.|
T Consensus       356 ~~p~------~l~~l~l~~n  369 (727)
T 4b8c_D          356 PLPH------ERRFIEINTD  369 (727)
T ss_dssp             CCCC------C---------
T ss_pred             cCcc------ccceeEeecc
Confidence            7665      4556666666

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.71  E-value=1.6e-18  Score=209.31  Aligned_cols=138  Identities=22%  Similarity=0.283  Sum_probs=76.0

Q ss_pred             ccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCc
Q 002214          346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR  425 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  425 (952)
                      +..+++|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|+|+ .+|..|+.+++|+
T Consensus       220 ~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~  296 (727)
T 4b8c_D          220 KYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLK  296 (727)
T ss_dssp             --CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCS
T ss_pred             hccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCC
Confidence            445556666666666665 34444445666666666666665 45555566666666666666665 4455566666666


Q ss_pred             EEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccc-cceeecCCcccCCCCc
Q 002214          426 ILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKA-VVDIYLSRNNLSGNIP  487 (952)
Q Consensus       426 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~  487 (952)
                      +|+|++|.|+. +|..|..+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|
T Consensus       297 ~L~L~~N~l~~-lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p  358 (727)
T 4b8c_D          297 YFYFFDNMVTT-LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP  358 (727)
T ss_dssp             EEECCSSCCCC-CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred             EEECCCCCCCc-cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence            66666666653 3444556666666666666665555555544322 1234555555554444

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.67  E-value=1.4e-15  Score=170.14  Aligned_cols=178  Identities=10%  Similarity=0.086  Sum_probs=84.5

Q ss_pred             cccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEecc
Q 002214          351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLS  430 (952)
Q Consensus       351 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  430 (952)
                      +|+.+.|.+ .++.+...+|.++++|+.+++.+| ++.+...+|.+ .+|+.+.+ .+.++.....+|.++++|+.+.+.
T Consensus       204 ~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~  279 (401)
T 4fdw_A          204 GIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTY  279 (401)
T ss_dssp             CCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEE
T ss_pred             ccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeC
Confidence            344444432 244344445555555555555443 33344444444 34444444 222333334444444444444444


Q ss_pred             ccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcc
Q 002214          431 SNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPI  510 (952)
Q Consensus       431 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  510 (952)
                      +|.+..                   +.+..+.+..|.++++|+.++|. |.++.+...+|.++++|+.++|..| ++.+.
T Consensus       280 ~~~~~~-------------------~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~  338 (401)
T 4fdw_A          280 GSTFND-------------------DPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQIN  338 (401)
T ss_dssp             SSCCCC-------------------CTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEEC
T ss_pred             CccccC-------------------CcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEc
Confidence            443320                   00002334445555555555555 2354455555666666666666443 44444


Q ss_pred             cccccccccccEEeCCCCcccccCccchhccc-cccccccccccc
Q 002214          511 PESFGELVSLEFLDLSNNDLSGVIPASLEKLL-YLKSLNLSFNKL  554 (952)
Q Consensus       511 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~l~~N~l  554 (952)
                      +.+|.++ +|+.|++++|.+..+.+..|.+++ .++.|++..|.+
T Consensus       339 ~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          339 FSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             TTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             HHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            5556665 666666666665555555555553 455555555543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.66  E-value=2.8e-16  Score=155.28  Aligned_cols=132  Identities=25%  Similarity=0.252  Sum_probs=77.8

Q ss_pred             cEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCc
Q 002214          425 RILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHN  504 (952)
Q Consensus       425 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  504 (952)
                      +.+++++|+++.++...   .++|+.|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        10 ~~l~~~~~~l~~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A           10 TEIRCNSKGLTSVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TEEECCSSCCSSCCTTC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCCccCCCCC---CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            44455555554332211   134555555555555444445555566666666666666555555666666666666666


Q ss_pred             cccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCC
Q 002214          505 KLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIP  559 (952)
Q Consensus       505 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  559 (952)
                      +|++..+..|..+++|++|+|++|+|++..+..+..+++|+.|++++|++.|.+|
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            6665555556666666666666666665555555666666777777776666655

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.66  E-value=2.8e-16  Score=153.86  Aligned_cols=112  Identities=25%  Similarity=0.292  Sum_probs=50.0

Q ss_pred             cCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCc-ccccCCCCC
Q 002214          418 LGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIP-STIIGLKNL  496 (952)
Q Consensus       418 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L  496 (952)
                      +..+++|++|++++|++++.  ..|..+++|+.|++++|++++.+|..+..+++|+.|+|++|++++... ..+..+++|
T Consensus        45 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L  122 (168)
T 2ell_A           45 TAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECL  122 (168)
T ss_dssp             CGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCC
T ss_pred             HHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCC
Confidence            33344444444444444433  334444444444444444443344444444445555555554443211 344445555


Q ss_pred             ceEEccCccccCccc---ccccccccccEEeCCCCccc
Q 002214          497 QHLSLEHNKLQGPIP---ESFGELVSLEFLDLSNNDLS  531 (952)
Q Consensus       497 ~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~  531 (952)
                      +.|++++|++++..+   ..+..+++|+.|++++|.+.
T Consensus       123 ~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          123 KSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             CEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             CEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            555555555543322   24444455555555555444

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.66  E-value=2.2e-15  Score=168.48  Aligned_cols=196  Identities=11%  Similarity=0.113  Sum_probs=132.5

Q ss_pred             ccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccc
Q 002214          352 LTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSS  431 (952)
Q Consensus       352 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  431 (952)
                      |+.+.+.+ .++.+.+.+|.++++|+.+++++|.++.+....|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..
T Consensus       159 L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~  235 (401)
T 4fdw_A          159 VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE  235 (401)
T ss_dssp             CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred             ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence            44444433 44444445555555555555555555555555554 355555555533 4445555666666666666665


Q ss_pred             cccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccC-----CCCcccccCCCCCceEEccCccc
Q 002214          432 NELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLS-----GNIPSTIIGLKNLQHLSLEHNKL  506 (952)
Q Consensus       432 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l  506 (952)
                      | ++.+...+|.+ .+|+.+.+ .|.++.+....|.++++|+.+++.+|.+.     .+.+.+|.++++|+.++|. |.+
T Consensus       236 ~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i  311 (401)
T 4fdw_A          236 N-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESI  311 (401)
T ss_dssp             T-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTC
T ss_pred             C-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-Cce
Confidence            3 45555566666 56666666 34455455666667777777777666654     5678899999999999999 458


Q ss_pred             cCcccccccccccccEEeCCCCcccccCccchhccccccccccccccccc
Q 002214          507 QGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVG  556 (952)
Q Consensus       507 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  556 (952)
                      +.+...+|.++++|+.++|.+| ++.+.+..|.++ +|+.+++++|.+..
T Consensus       312 ~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~  359 (401)
T 4fdw_A          312 RILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQ  359 (401)
T ss_dssp             CEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCB
T ss_pred             EEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcc
Confidence            8777889999999999999666 777888999999 99999999997754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=5.9e-17  Score=176.14  Aligned_cols=139  Identities=13%  Similarity=0.170  Sum_probs=101.8

Q ss_pred             cCCccceecCccceEEEEEEeCCCcEEEEEEeeccCc--------------hhhH--------HHHHHHHHHHhCCCCcc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE--------------GALN--------SFDAECEILKTIRHRNL  722 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h~ni  722 (952)
                      -|++.+.||+|+||.||+|...+|+.||||+++....              ....        ...+|...+.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4899999999999999999999999999998753210              0001        12356666666654443


Q ss_pred             ceeeeEeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC-
Q 002214          723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-  801 (952)
Q Consensus       723 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~-  801 (952)
                      ....-+...  ..++||||++|++|.++...       .....++.|++.++.||   |+.|||||||||.|||+++++ 
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~l---H~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRL---AKHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEEEEEC
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEEEeCCCC
Confidence            222111111  23799999999888765432       23456889999999999   688999999999999998776 


Q ss_pred             ---------cEEEeccccccccC
Q 002214          802 ---------VAHLSDFGIAKLLS  815 (952)
Q Consensus       802 ---------~~kl~Dfgla~~~~  815 (952)
                               .+.|+||+-+....
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccccceEEEEeCCcccCC
Confidence                     48999999887543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=3.2e-16  Score=153.37  Aligned_cols=135  Identities=21%  Similarity=0.192  Sum_probs=121.7

Q ss_pred             CCCCCcEEeccccccC-CcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCce
Q 002214          420 DLNSLRILSLSSNELT-SVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQH  498 (952)
Q Consensus       420 ~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  498 (952)
                      ..++|++|++++|+++ +.+|..+..+++|+.|++++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|++
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   99 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH   99 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence            3478999999999998 56788899999999999999999965  78899999999999999999878888888999999


Q ss_pred             EEccCccccCccc-ccccccccccEEeCCCCcccccCc---cchhccccccccccccccccc
Q 002214          499 LSLEHNKLQGPIP-ESFGELVSLEFLDLSNNDLSGVIP---ASLEKLLYLKSLNLSFNKLVG  556 (952)
Q Consensus       499 L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~~  556 (952)
                      |+|++|+|++..+ ..+..+++|+.|++++|++++..+   ..+..+++|+.|++++|++..
T Consensus       100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~  161 (168)
T 2ell_A          100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE  161 (168)
T ss_dssp             EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred             EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence            9999999996532 789999999999999999997665   589999999999999999864

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.63  E-value=4.1e-16  Score=149.24  Aligned_cols=127  Identities=21%  Similarity=0.233  Sum_probs=69.4

Q ss_pred             CCCcEEeccccccC-CcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEE
Q 002214          422 NSLRILSLSSNELT-SVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLS  500 (952)
Q Consensus       422 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  500 (952)
                      ++|+.|++++|.++ +..|..+..+++|+.|++++|.+++.  ..+..+++|+.|+|++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            34444444444444 33334444444444444444444433  4445555555555555555544555555566666666


Q ss_pred             ccCccccCc-ccccccccccccEEeCCCCcccccCc---cchhccccccccccc
Q 002214          501 LEHNKLQGP-IPESFGELVSLEFLDLSNNDLSGVIP---ASLEKLLYLKSLNLS  550 (952)
Q Consensus       501 L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l~  550 (952)
                      +++|++++. .+..+..+++|+.|++++|++++..+   ..+..+++|+.|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            666666642 23556666666666666666665544   456666666666665

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.63  E-value=5.3e-16  Score=148.45  Aligned_cols=128  Identities=22%  Similarity=0.303  Sum_probs=93.8

Q ss_pred             CcceEEEecccccc-ccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceee
Q 002214          398 SRLYVVYLNRNKLS-GSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIY  476 (952)
Q Consensus       398 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  476 (952)
                      ++|+.|++++|.++ +.+|..+..+++|++|++++|++++.  ..|..+++|+.|++++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            44555555555555 45555666677777777777777655  5667777777777777777766777777788888888


Q ss_pred             cCCcccCCC-CcccccCCCCCceEEccCccccCccc---ccccccccccEEeCCC
Q 002214          477 LSRNNLSGN-IPSTIIGLKNLQHLSLEHNKLQGPIP---ESFGELVSLEFLDLSN  527 (952)
Q Consensus       477 Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~  527 (952)
                      +++|++++. .+..+..+++|++|++++|++++..+   ..+..+++|+.||+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            888888754 34778888888888888888886555   4788888898888864

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.62  E-value=1.7e-14  Score=162.03  Aligned_cols=332  Identities=15%  Similarity=0.107  Sum_probs=174.3

Q ss_pred             cCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhh
Q 002214          145 SFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIG  224 (952)
Q Consensus       145 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~  224 (952)
                      ++....|.++.+|+.+.+..+ ++.+...+|.++.+|+.+++..+ ++.+...+|.++++|+.+.+..+ +......+|.
T Consensus        61 sIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~  137 (394)
T 4fs7_A           61 SIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFK  137 (394)
T ss_dssp             EECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTT
T ss_pred             EhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeee
Confidence            566777778888888888643 66566677888888888888755 55566777888888887777654 3435566677


Q ss_pred             ccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhh
Q 002214          225 NLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLY  304 (952)
Q Consensus       225 ~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~  304 (952)
                      .+..+......  ....+...+|.++++|+.+.+.++... .  ....|.++.+|+.+++..| +..+...+|.+...|+
T Consensus       138 ~~~~~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~~~-I--~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~  211 (394)
T 4fs7_A          138 GCDFKEITIPE--GVTVIGDEAFATCESLEYVSLPDSMET-L--HNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLE  211 (394)
T ss_dssp             TCCCSEEECCT--TCCEECTTTTTTCTTCCEEECCTTCCE-E--CTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCC
T ss_pred             cccccccccCc--cccccchhhhcccCCCcEEecCCccce-e--ccccccCCCCceEEEcCCC-ceEeCchhhccccccc
Confidence            66554443332  333444566777777777777655322 1  2234666777777777655 4444444554443333


Q ss_pred             hhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCc
Q 002214          305 ALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNN  384 (952)
Q Consensus       305 ~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N  384 (952)
                      .+.           +..+......                ......+|+.+.+..+ ++.+...+|..+..|+.+.+..+
T Consensus       212 ~i~-----------~~~~~~~i~~----------------~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~  263 (394)
T 4fs7_A          212 NME-----------FPNSLYYLGD----------------FALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNN  263 (394)
T ss_dssp             BCC-----------CCTTCCEECT----------------TTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCT
T ss_pred             eee-----------cCCCceEeeh----------------hhcccCCCceEEECCC-ceecccccccccccceeEEcCCC
Confidence            222           2221111000                0112234555555332 23244445555555555555554


Q ss_pred             cccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCch
Q 002214          385 KFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPL  464 (952)
Q Consensus       385 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  464 (952)
                      ... +....|..+..++.+....+.+.   ..+|..+.+|+.+.+..+ ++.+...+|.++.+|                
T Consensus       264 ~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L----------------  322 (394)
T 4fs7_A          264 KLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSL----------------  322 (394)
T ss_dssp             TCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTC----------------
T ss_pred             cce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCC----------------
Confidence            433 44455555555555554443322   234444555555555433 333444444444444                


Q ss_pred             hhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhccccc
Q 002214          465 EIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYL  544 (952)
Q Consensus       465 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  544 (952)
                              +.++|.++ ++.+...+|.++++|+.+++..| ++.+...+|.++++|+.+++..+ ++ .+...|.+.++|
T Consensus       323 --------~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L  390 (394)
T 4fs7_A          323 --------VSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKF  390 (394)
T ss_dssp             --------CEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEE
T ss_pred             --------CEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCC
Confidence                    44444322 33344445555555555555444 44344445555555555555433 22 223344445544


Q ss_pred             cc
Q 002214          545 KS  546 (952)
Q Consensus       545 ~~  546 (952)
                      +.
T Consensus       391 ~~  392 (394)
T 4fs7_A          391 KW  392 (394)
T ss_dssp             EE
T ss_pred             cE
Confidence            43

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.62  E-value=7.8e-15  Score=164.88  Aligned_cols=318  Identities=12%  Similarity=0.056  Sum_probs=220.9

Q ss_pred             ccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCcc
Q 002214          167 FKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDT  246 (952)
Q Consensus       167 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~  246 (952)
                      ++.+...+|.++.+|+.+.|..+ ++.+...+|.++++|+.++|.++ ++.+...+|..+.+|+.+.+.. ++..+...+
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~-~l~~i~~~a  135 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPL-MLKSIGVEA  135 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCT-TCCEECTTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccC-ceeeeccee
Confidence            44455677888888888888744 66667778888888888888755 5546667788888888877763 455555666


Q ss_pred             ccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceee
Q 002214          247 IFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTF  326 (952)
Q Consensus       247 ~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~  326 (952)
                      |.+...++.........-    ....|.++.+|+.+.+.++- ..+...+                              
T Consensus       136 F~~~~~~~~~~~~~~~~i----~~~aF~~c~~L~~i~l~~~~-~~I~~~~------------------------------  180 (394)
T 4fs7_A          136 FKGCDFKEITIPEGVTVI----GDEAFATCESLEYVSLPDSM-ETLHNGL------------------------------  180 (394)
T ss_dssp             TTTCCCSEEECCTTCCEE----CTTTTTTCTTCCEEECCTTC-CEECTTT------------------------------
T ss_pred             eecccccccccCcccccc----chhhhcccCCCcEEecCCcc-ceecccc------------------------------
Confidence            666554443333322221    12346666677777665432 2233333                              


Q ss_pred             chhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEec
Q 002214          327 STSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLN  406 (952)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  406 (952)
                                         |.++.+|+.+.+..| ++.+...+|.++..|+.+.+.++... + .+.+.....|+.+.+.
T Consensus       181 -------------------F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~-i-~~~~~~~~~l~~i~ip  238 (394)
T 4fs7_A          181 -------------------FSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY-L-GDFALSKTGVKNIIIP  238 (394)
T ss_dssp             -------------------TTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE-E-CTTTTTTCCCCEEEEC
T ss_pred             -------------------ccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE-e-ehhhcccCCCceEEEC
Confidence                               344555555555544 44455667777777777777665543 2 2333344677777775


Q ss_pred             cccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCC
Q 002214          407 RNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNI  486 (952)
Q Consensus       407 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  486 (952)
                      .+ ++.....+|.++..|+.+.+..+.. .+....|.....++.+....+.+.   ...|..+.+|+.+.+.++ ++.+.
T Consensus       239 ~~-~~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~  312 (394)
T 4fs7_A          239 DS-FTELGKSVFYGCTDLESISIQNNKL-RIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIG  312 (394)
T ss_dssp             TT-CCEECSSTTTTCSSCCEEEECCTTC-EECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEEC
T ss_pred             CC-ceecccccccccccceeEEcCCCcc-eeeccccccccccceeccCceeec---cccccccccccccccccc-cceec
Confidence            43 3335566778888888888877654 367778888888888888776543   346788889999999765 66677


Q ss_pred             cccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhccccccccccccc
Q 002214          487 PSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFN  552 (952)
Q Consensus       487 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  552 (952)
                      ..+|.++++|+.++|.++ ++.+...+|.++.+|+.+++..| ++.+....|.++++|+.+++..|
T Consensus       313 ~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          313 EEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             TTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             hhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence            889999999999999865 77677889999999999999887 77778889999999999999765

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.61  E-value=2.3e-15  Score=150.55  Aligned_cols=127  Identities=27%  Similarity=0.355  Sum_probs=92.5

Q ss_pred             EEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcc
Q 002214          402 VVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNN  481 (952)
Q Consensus       402 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  481 (952)
                      .+++++|.++ .+|..+.  ++|++|++++|+|+. +|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            4445555554 3333222  466777777777763 34667777777777777777776666777777888888888888


Q ss_pred             cCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccc
Q 002214          482 LSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSG  532 (952)
Q Consensus       482 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  532 (952)
                      |+++.+..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|++..
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            887777888888888888888888887666678888899999999998864

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.61  E-value=3.1e-15  Score=147.75  Aligned_cols=132  Identities=25%  Similarity=0.302  Sum_probs=99.6

Q ss_pred             eEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCc
Q 002214          401 YVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRN  480 (952)
Q Consensus       401 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  480 (952)
                      +.+++++|+++ .+|..+  .++|++|++++|+++++.+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|
T Consensus        10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A           10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            44555555555 233322  256777777777777766667777777777777777777666666778888888888888


Q ss_pred             ccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCc
Q 002214          481 NLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIP  535 (952)
Q Consensus       481 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  535 (952)
                      ++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            8887777778889999999999999987767678889999999999999986544

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.57  E-value=2.7e-15  Score=147.93  Aligned_cols=130  Identities=18%  Similarity=0.219  Sum_probs=69.9

Q ss_pred             CCCCCcEEeccccccCCcCCccccCC-CCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCce
Q 002214          420 DLNSLRILSLSSNELTSVIPSTFWNL-EDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQH  498 (952)
Q Consensus       420 ~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  498 (952)
                      ++++|++|++++|+++.+ +. +..+ ++|+.|++++|.+++.  ..+..+++|++|+|++|+|++..+..|..+++|++
T Consensus        17 ~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   92 (176)
T 1a9n_A           17 NAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   92 (176)
T ss_dssp             CTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             CcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence            334444444444444432 22 2222 2444444444444432  34455555555666666655444444466666666


Q ss_pred             EEccCccccCcccc--cccccccccEEeCCCCcccccCcc----chhcccccccccccccccc
Q 002214          499 LSLEHNKLQGPIPE--SFGELVSLEFLDLSNNDLSGVIPA----SLEKLLYLKSLNLSFNKLV  555 (952)
Q Consensus       499 L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~l~~N~l~  555 (952)
                      |+|++|+|+ .+|.  .+..+++|+.|++++|+++. .|.    .+..+++|+.||+++|+..
T Consensus        93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence            666666665 3333  56666666666666666663 343    3666677777777766654

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.55  E-value=9.1e-17  Score=161.93  Aligned_cols=162  Identities=20%  Similarity=0.269  Sum_probs=99.4

Q ss_pred             cccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCc
Q 002214          370 LGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDIL  449 (952)
Q Consensus       370 l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  449 (952)
                      +.....++.++++.|.+.+..|.                 ++ .+|..+..+++|++|++++|+++++ | .+..+++|+
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~-----------------l~-~l~~~~~~l~~L~~L~ls~n~l~~l-~-~~~~l~~L~   73 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPP-----------------IE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLR   73 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTT-----------------CC-CCHHHHHHTTTCSEEECSEEEESCC-C-CHHHHTTCC
T ss_pred             HHhcccccCcchheeEeccccCc-----------------Hh-hhhHHHhcCCCCCEEECCCCCCccc-c-ccccCCCCC
Confidence            44456666667777766655443                 11 1222455556666666666666552 3 556666666


Q ss_pred             eeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCccc-ccccccccccEEeCCCC
Q 002214          450 GFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIP-ESFGELVSLEFLDLSNN  528 (952)
Q Consensus       450 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N  528 (952)
                      .|++++|.++ .+|..+..+++|+.|+|++|++++ +| .+..+++|+.|+|++|+|++..+ ..+..+++|+.|++++|
T Consensus        74 ~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N  150 (198)
T 1ds9_A           74 ILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN  150 (198)
T ss_dssp             EEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSC
T ss_pred             EEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCC
Confidence            6666666666 455566666677777777777764 33 46666777777777777764332 35667777777777777


Q ss_pred             cccccCcc----------chhccccccccccccccccc
Q 002214          529 DLSGVIPA----------SLEKLLYLKSLNLSFNKLVG  556 (952)
Q Consensus       529 ~l~~~~~~----------~~~~l~~L~~L~l~~N~l~~  556 (952)
                      ++++..|.          .+..+++|+.||  +|+++.
T Consensus       151 ~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          151 PLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             HHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred             ccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence            77655443          267777787775  666653

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.54  E-value=8e-15  Score=144.54  Aligned_cols=105  Identities=17%  Similarity=0.219  Sum_probs=64.1

Q ss_pred             CCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcc--cccCCCCCceEE
Q 002214          423 SLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPS--TIIGLKNLQHLS  500 (952)
Q Consensus       423 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~  500 (952)
                      +|++|++++|+|+++  ..|..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+. +|.  .+..+++|+.|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCc-chhhHhhhcCCCCCEEE
Confidence            555555555555543  345555555555555555554433444666666666666666653 333  566777777777


Q ss_pred             ccCccccCcccc----cccccccccEEeCCCCccc
Q 002214          501 LEHNKLQGPIPE----SFGELVSLEFLDLSNNDLS  531 (952)
Q Consensus       501 L~~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~  531 (952)
                      +++|+++. .|.    .+..+++|+.||+++|.+.
T Consensus       120 l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A          120 ILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             ecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence            77777763 444    3777777788887777765

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.53  E-value=1.2e-14  Score=142.05  Aligned_cols=90  Identities=23%  Similarity=0.285  Sum_probs=54.2

Q ss_pred             cccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccc
Q 002214          470 KAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNL  549 (952)
Q Consensus       470 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  549 (952)
                      ++|+.|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  109 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL  109 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence            44555555555555555555666666666666666666555555566666666666666666555555666666666666


Q ss_pred             cccccccCCC
Q 002214          550 SFNKLVGEIP  559 (952)
Q Consensus       550 ~~N~l~~~~p  559 (952)
                      ++|+|+|.++
T Consensus       110 ~~N~~~c~c~  119 (170)
T 3g39_A          110 LNNPWDCACS  119 (170)
T ss_dssp             CSSCBCTTBG
T ss_pred             CCCCCCCCch
Confidence            6666666554

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.52  E-value=3e-16  Score=158.17  Aligned_cols=155  Identities=24%  Similarity=0.289  Sum_probs=101.8

Q ss_pred             cCCCcccEEEccCCCCCCCCCc------ccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCC
Q 002214          347 GNLINLTTLSLGDNNLSGSLPI------TLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGD  420 (952)
Q Consensus       347 ~~l~~L~~L~L~~n~l~~~~~~------~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  420 (952)
                      .....++.++++++.+++..|.      .+..+++|++|++++|.|++ .| .+..+++|+.|++++|+++ .+|..+..
T Consensus        15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~   91 (198)
T 1ds9_A           15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV   91 (198)
T ss_dssp             HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred             HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence            3455666666666666655554      67777777777777777765 34 5656666666666666655 33444444


Q ss_pred             CCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCc-ccccCCCCCceE
Q 002214          421 LNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIP-STIIGLKNLQHL  499 (952)
Q Consensus       421 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L  499 (952)
                                              +++|+.|++++|++++ +| .+..+++|+.|+|++|+++...+ ..+..+++|++|
T Consensus        92 ------------------------~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L  145 (198)
T 1ds9_A           92 ------------------------ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL  145 (198)
T ss_dssp             ------------------------HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEE
T ss_pred             ------------------------CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEE
Confidence                                    4445555555555543 33 46677778888888888775333 467788888888


Q ss_pred             EccCccccCccccc----------ccccccccEEeCCCCcccc
Q 002214          500 SLEHNKLQGPIPES----------FGELVSLEFLDLSNNDLSG  532 (952)
Q Consensus       500 ~L~~N~l~~~~~~~----------~~~l~~L~~L~Ls~N~l~~  532 (952)
                      ++++|++++..|..          +..+++|+.||  +|.++.
T Consensus       146 ~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          146 LLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             EECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred             EecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence            88888887665542          78888999887  777763

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.50  E-value=3.6e-14  Score=139.13  Aligned_cols=89  Identities=27%  Similarity=0.327  Sum_probs=43.4

Q ss_pred             cccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccc
Q 002214          470 KAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNL  549 (952)
Q Consensus       470 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  549 (952)
                      ++|+.|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++|+|+++++..|..+++|+.|+|
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            34444444444444444444455555555555555555433334445555555555555555444444555555555555


Q ss_pred             cccccccCC
Q 002214          550 SFNKLVGEI  558 (952)
Q Consensus       550 ~~N~l~~~~  558 (952)
                      ++|+|.|.+
T Consensus       113 ~~N~~~c~~  121 (174)
T 2r9u_A          113 YNNPWDCEC  121 (174)
T ss_dssp             CSSCBCTTB
T ss_pred             CCCCccccc
Confidence            555555443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.45  E-value=3.8e-13  Score=131.39  Aligned_cols=107  Identities=22%  Similarity=0.192  Sum_probs=83.1

Q ss_pred             CcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccC
Q 002214          424 LRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEH  503 (952)
Q Consensus       424 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  503 (952)
                      .+.+++++|+++.++. .+  .++|+.|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus        11 ~~~l~~s~n~l~~ip~-~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLASVPT-GI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCSSCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcCccCc-cC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            4567777777765433 22  26677777777777776777778888888888888888877777788889999999999


Q ss_pred             ccccCcccccccccccccEEeCCCCccccc
Q 002214          504 NKLQGPIPESFGELVSLEFLDLSNNDLSGV  533 (952)
Q Consensus       504 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  533 (952)
                      |+|++..+..|..+++|+.|+|++|+++..
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            999877777788899999999999988754

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.43  E-value=4.4e-13  Score=131.40  Aligned_cols=105  Identities=22%  Similarity=0.252  Sum_probs=79.6

Q ss_pred             cEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCc
Q 002214          425 RILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHN  504 (952)
Q Consensus       425 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  504 (952)
                      +.+++++|+++.++. .+.  ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+++.+..|..+++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~~iP~-~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLASVPA-GIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCSSCCS-CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCCccCC-CcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            566677777654433 222  66777777777777666777777888888888888888776677788888888889888


Q ss_pred             cccCcccccccccccccEEeCCCCcccc
Q 002214          505 KLQGPIPESFGELVSLEFLDLSNNDLSG  532 (952)
Q Consensus       505 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  532 (952)
                      +|++..+..|..+++|+.|+|++|++..
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCccc
Confidence            8887666668888999999999998874

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.43  E-value=1.2e-11  Score=138.95  Aligned_cols=167  Identities=13%  Similarity=0.085  Sum_probs=84.2

Q ss_pred             eEEEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcC-CCcEEeCcCCcccccCChhhcCCCCCCeEee
Q 002214           34 RVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLT-KLKELHLDYNKLQGEIPEELGNLAELEMLVL  112 (952)
Q Consensus        34 ~~~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  112 (952)
                      .++.....+..-.-.||+.+..-.       ....++..-..+|.+.+ .|+.+.+-.+ ++.+-..+|.++.+|+.+.+
T Consensus        23 ~~~i~~y~g~~~~v~IP~~i~~~~-------~~~~Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~   94 (394)
T 4gt6_A           23 TATITKYTGNEHRITIPAQVTHGA-------YIYPVSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTI   94 (394)
T ss_dssp             CEEEEEECCCCSEEECCSEEEETT-------EEEEEEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEE
T ss_pred             cEEEEEEeCCCceEEECCceeccc-------cceeeeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEee
Confidence            344444455444445776553210       00123422334566553 4777777654 55455677777777777777


Q ss_pred             cCccCccccCcccccccccccceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCccc
Q 002214          113 NNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFT  192 (952)
Q Consensus       113 ~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~  192 (952)
                      ..|.     |..+.                  .+....|.++.+|+.+.+..+ ++......|..+.+|+.+.+..+. +
T Consensus        95 ~~n~-----p~~l~------------------~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~~-~  149 (394)
T 4gt6_A           95 QDNK-----PSCVK------------------KIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEGV-T  149 (394)
T ss_dssp             GGGC-----CCCCC------------------EECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTTC-C
T ss_pred             cCCC-----CCeee------------------EechhhchhcccceeeccCCc-cceehhhhhhhhccccccccccee-e
Confidence            6653     11110                  334444555566666655443 333444556666666666665432 2


Q ss_pred             ccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeec
Q 002214          193 GRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGID  235 (952)
Q Consensus       193 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  235 (952)
                      .+...+|....+|+.+.+..+ ++.+...+|.. .+|+.+.+.
T Consensus       150 ~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip  190 (394)
T 4gt6_A          150 SVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIP  190 (394)
T ss_dssp             EECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEEC
T ss_pred             eecccceecccccccccccce-eeEeccccccc-cceeEEEEC
Confidence            244555566666666666543 22233333432 345555443

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.42  E-value=1.1e-11  Score=139.11  Aligned_cols=134  Identities=10%  Similarity=0.154  Sum_probs=68.7

Q ss_pred             cCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccC
Q 002214          413 SIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIG  492 (952)
Q Consensus       413 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  492 (952)
                      ....+|.++.+|+.+.+..+.. .+...+|.+++.|+.+.+. +.++.+....|.++.+|+.+.|..+ ++.+...+|.+
T Consensus       256 i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~  332 (394)
T 4gt6_A          256 IETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG  332 (394)
T ss_dssp             ECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred             cccceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence            3344555566666666554433 2455556666666666654 3344344455666666666666543 44455556666


Q ss_pred             CCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccc
Q 002214          493 LKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNK  553 (952)
Q Consensus       493 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  553 (952)
                      +.+|+.+.|..+ ++.+...+|.++.+|+.+++.+|....   ..+....+|+.+.+..|.
T Consensus       333 C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~  389 (394)
T 4gt6_A          333 CEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGS  389 (394)
T ss_dssp             CTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC---------
T ss_pred             CCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCC
Confidence            666666666543 444555566666666666666654321   234445556655555443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.33  E-value=3.3e-12  Score=140.87  Aligned_cols=132  Identities=17%  Similarity=0.096  Sum_probs=80.7

Q ss_pred             EEecccc-ccCCcCCccccCCCCCceeEecC-CccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccC
Q 002214          426 ILSLSSN-ELTSVIPSTFWNLEDILGFDFSS-NSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEH  503 (952)
Q Consensus       426 ~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  503 (952)
                      .++++++ +|+++ |. +..+++|+.|+|++ |+|++..+..|.++++|+.|+|++|+|+++.|..|.++++|+.|+|++
T Consensus        12 ~v~~~~~n~l~~i-p~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALDSL-HH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCTTT-TT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCCcc-CC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            3455555 55543 33 55556666666664 666655556666666666667777777666666777777777777777


Q ss_pred             ccccCcccccccccccccEEeCCCCcccccCc-cchhcccccccccccccccccCCCC
Q 002214          504 NKLQGPIPESFGELVSLEFLDLSNNDLSGVIP-ASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       504 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      |+|++..+..|..++ |+.|+|++|.|...-. ..|..+.......+..+.++|..|.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            777765555565554 7777777777764321 2333333344455566777776665

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.32  E-value=2.8e-14  Score=157.86  Aligned_cols=172  Identities=22%  Similarity=0.203  Sum_probs=90.7

Q ss_pred             CCcccEEEccCCCCCCCCCcccccC-----CCCcEEEccCccccCCCCcccc-CCCcceEEEeccccccccCCCcc----
Q 002214          349 LINLTTLSLGDNNLSGSLPITLGRL-----KKLQGLDLQNNKFEGPIPQEFC-HFSRLYVVYLNRNKLSGSIPSCL----  418 (952)
Q Consensus       349 l~~L~~L~L~~n~l~~~~~~~l~~l-----~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~----  418 (952)
                      +++|+.|+|++|.++......+...     ++|++|+|++|.|+......+. .+.+|+.|+|++|.|+......+    
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            4578888888888875433333332     5777777777777533222222 23455555555555542222221    


Q ss_pred             -CCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCC----CcccccCC
Q 002214          419 -GDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGN----IPSTIIGL  493 (952)
Q Consensus       419 -~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l  493 (952)
                       ...++|++|+|++|.|+.....                    .++..+..+++|++|+|++|.|+..    ++..+...
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~--------------------~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~  210 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVA--------------------VLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRN  210 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHH--------------------HHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGC
T ss_pred             HhcCCccceeeCCCCCCChHHHH--------------------HHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcC
Confidence             1233444444444444321111                    1223334455566666666655532    23445556


Q ss_pred             CCCceEEccCccccCc----ccccccccccccEEeCCCCcccccCccchhc
Q 002214          494 KNLQHLSLEHNKLQGP----IPESFGELVSLEFLDLSNNDLSGVIPASLEK  540 (952)
Q Consensus       494 ~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  540 (952)
                      ++|+.|+|++|.|++.    ++..+...++|++|||++|.|+......+..
T Consensus       211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~  261 (372)
T 3un9_A          211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRD  261 (372)
T ss_dssp             SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred             CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence            6777777777777642    2334445577777777777776544444443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.32  E-value=1.1e-12  Score=144.88  Aligned_cols=131  Identities=21%  Similarity=0.258  Sum_probs=108.1

Q ss_pred             ceeEecCC-ccCCCCchhhhcccccceeecCC-cccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCC
Q 002214          449 LGFDFSSN-SLNGSLPLEIENLKAVVDIYLSR-NNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLS  526 (952)
Q Consensus       449 ~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  526 (952)
                      ..++++++ +|+. +|. +..+++|+.|+|++ |+|+++.+..|.++++|+.|+|++|+|+++.|..|..+++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35789998 8985 777 99999999999996 99999888999999999999999999999889999999999999999


Q ss_pred             CCcccccCccchhcccccccccccccccccCCCCCCCcccc---cccccccCccCCCCCc
Q 002214          527 NNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANF---SAESFIGNDLLCGSPY  583 (952)
Q Consensus       527 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~---~~~~~~~n~~~c~~p~  583 (952)
                      +|+|+++++..|..++ |+.|+|++|+|.|.+... .|..+   ....+..+...|..|.
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~-~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCALR-WLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGH-HHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCCCccH-HHHHHHHhCcccccccCCCCCCCh
Confidence            9999987777777776 999999999999987632 11111   1122334566776664

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.28  E-value=5.5e-14  Score=155.52  Aligned_cols=192  Identities=17%  Similarity=0.157  Sum_probs=119.9

Q ss_pred             cCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCccc-ccCCCCcEEEccCccccCC
Q 002214          311 NSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITL-GRLKKLQGLDLQNNKFEGP  389 (952)
Q Consensus       311 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l-~~l~~L~~L~L~~N~i~~~  389 (952)
                      .+.++.|++++|.++......+.  ..+.       ...++|++|+|++|.++......+ ..+++|++|+|++|.|+..
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~--~~L~-------~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~  141 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVA--AVLG-------SGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPE  141 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHH--HHHS-------SCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHH--HHHh-------hCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHH
Confidence            46899999999998765544322  1111       234689999999999975433333 3467899999999999765


Q ss_pred             CCcccc-----CCCcceEEEeccccccc----cCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCC
Q 002214          390 IPQEFC-----HFSRLYVVYLNRNKLSG----SIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNG  460 (952)
Q Consensus       390 ~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  460 (952)
                      ....++     ..++|+.|+|++|.|+.    .++..+..+++|++|+|++|+|+.....                    
T Consensus       142 ~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~--------------------  201 (372)
T 3un9_A          142 ACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE--------------------  201 (372)
T ss_dssp             HHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH--------------------
T ss_pred             HHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH--------------------
Confidence            544543     46889999999999974    2344456778888888888888643211                    


Q ss_pred             CCchhhhcccccceeecCCcccCCC----CcccccCCCCCceEEccCccccCccccccccccc-----ccEEe--CCCCc
Q 002214          461 SLPLEIENLKAVVDIYLSRNNLSGN----IPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVS-----LEFLD--LSNND  529 (952)
Q Consensus       461 ~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-----L~~L~--Ls~N~  529 (952)
                      .++..+...++|+.|+|++|.|+..    ++..+...++|++|+|++|.|++.....+..+..     |+.+.  +..|.
T Consensus       202 ~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~  281 (372)
T 3un9_A          202 LLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTA  281 (372)
T ss_dssp             HHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----
T ss_pred             HHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCc
Confidence            1123334444555555555555432    2233445677888888888777544444433211     55555  55555


Q ss_pred             cc
Q 002214          530 LS  531 (952)
Q Consensus       530 l~  531 (952)
                      ++
T Consensus       282 ~~  283 (372)
T 3un9_A          282 VS  283 (372)
T ss_dssp             CH
T ss_pred             cC
Confidence            54

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.23  E-value=2e-11  Score=128.85  Aligned_cols=147  Identities=14%  Similarity=0.111  Sum_probs=115.5

Q ss_pred             HHHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEE
Q 002214          659 LLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       659 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  737 (952)
                      +....+.|++....+.|+.+.||++.. +++.+++|+...........+.+|+.+++.+. +..+.++++++...+..|+
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            344556788888899999999999986 47899999986532222356889999999984 6778889999988889999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG-------------------------------------  780 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-------------------------------------  780 (952)
                      ||||++|.++.+....      ......++.+++++++.||..                                     
T Consensus        88 v~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999998775321      123447888999999999751                                     


Q ss_pred             -------------------CCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          781 -------------------HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       781 -------------------h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                                         +...++|||++|.||+++.+..+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               11558999999999999876667799999775

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.13  E-value=1.3e-09  Score=121.46  Aligned_cols=146  Identities=11%  Similarity=0.134  Sum_probs=73.4

Q ss_pred             CccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhccc
Q 002214          391 PQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLK  470 (952)
Q Consensus       391 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  470 (952)
                      ...|....+|+.+.+..+ +......+|.++..|+.+.+..+ ++.+...+|.++.+|+.+.+..+ +.......|.++.
T Consensus       210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~  286 (379)
T 4h09_A          210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS  286 (379)
T ss_dssp             TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred             ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccc
Confidence            334444444444444332 22233444555555555555443 44444455555555555555432 3323344555555


Q ss_pred             ccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcc
Q 002214          471 AVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKL  541 (952)
Q Consensus       471 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  541 (952)
                      +|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.+.
T Consensus       287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c  355 (379)
T 4h09_A          287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS  355 (379)
T ss_dssp             TCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred             ccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence            5555555555555555556666666666666543 44344456666666666666543 443444445443

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.12  E-value=3.4e-09  Score=118.18  Aligned_cols=311  Identities=11%  Similarity=0.044  Sum_probs=172.5

Q ss_pred             CccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeee
Q 002214          155 PRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGI  234 (952)
Q Consensus       155 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  234 (952)
                      .+|+.+.+.. .++.+...+|.+|.+|+.+.|..+ ++.+...+|.+. +|+.+.+..+ ++.+...+|... +|+.+.+
T Consensus        46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~~i~l  120 (379)
T 4h09_A           46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLDDFEF  120 (379)
T ss_dssp             GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCSEEEC
T ss_pred             cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-CcccccC
Confidence            4555555543 344344555666666666666543 444555556554 4555555433 332333444433 5666665


Q ss_pred             ccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCcc
Q 002214          235 DQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNL  314 (952)
Q Consensus       235 ~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L  314 (952)
                      .. .+..+....|.+. +|+.+.+..+- +..  ....+..+.+++.+.+..+.........+ ......          
T Consensus       121 p~-~~~~i~~~~F~~~-~l~~~~~~~~v-~~i--~~~~f~~~~~l~~~~~~~~~~~~~~~~~~-~~~~~~----------  184 (379)
T 4h09_A          121 PG-ATTEIGNYIFYNS-SVKRIVIPKSV-TTI--KDGIGYKAENLEKIEVSSNNKNYVAENYV-LYNKNK----------  184 (379)
T ss_dssp             CT-TCCEECTTTTTTC-CCCEEEECTTC-CEE--CSCTTTTCTTCCEEEECTTCSSEEEETTE-EEETTS----------
T ss_pred             CC-ccccccccccccc-eeeeeecccee-ecc--ccchhcccccccccccccccceeecccce-eccccc----------
Confidence            43 2333333333332 34444443321 111  11224445555555544433321111000 000000          


Q ss_pred             ccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccc
Q 002214          315 KRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEF  394 (952)
Q Consensus       315 ~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~  394 (952)
                                                .....+.....+..+.+..+.. ......+....+|+.+.+..+ +..+...+|
T Consensus       185 --------------------------~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f  236 (379)
T 4h09_A          185 --------------------------TILESYPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAF  236 (379)
T ss_dssp             --------------------------SEEEECCTTCCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTT
T ss_pred             --------------------------ceecccccccccccccccccee-EEeecccccccccceeeeccc-eeEEccccc
Confidence                                      0000122334455555544332 245556666777777777554 344666677


Q ss_pred             cCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccce
Q 002214          395 CHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVD  474 (952)
Q Consensus       395 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  474 (952)
                      .++..|+.+.+..+ ++.....+|.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+.++.++.+....|.++.+|+.
T Consensus       237 ~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~  314 (379)
T 4h09_A          237 YGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSS  314 (379)
T ss_dssp             TTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCE
T ss_pred             cCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCE
Confidence            77777777777655 55456667777778888877643 55566777888888888888877777666777888888888


Q ss_pred             eecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccc
Q 002214          475 IYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELV  518 (952)
Q Consensus       475 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  518 (952)
                      +.|..+ ++.+...+|.++++|+.+.+..+ ++.+...+|.+..
T Consensus       315 i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~  356 (379)
T 4h09_A          315 VTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS  356 (379)
T ss_dssp             EECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred             EEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence            888654 66566778888888888888765 6555567777654

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.12  E-value=1e-10  Score=123.23  Aligned_cols=137  Identities=17%  Similarity=0.094  Sum_probs=100.8

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCc--cceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN--LVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..+.+....+.|..+.||++...+|+.+++|+....   ....+.+|+.+++.+++.+  +.+++++...++..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            344443333466679999998877889999997543   2255788999999986444  45688888887888999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH----------------------------------------  781 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h----------------------------------------  781 (952)
                      ++|.++.  ...    .+   ...++.++++.++.||...                                        
T Consensus        97 i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A           97 VPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             CSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             cCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            9998884  211    12   2356778888888885311                                        


Q ss_pred             ---------------CCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          782 ---------------SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       782 ---------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                                     ..+++|||++|.||+++.++.+.|+|||.|.
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                           1239999999999999887667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.88  E-value=3.3e-09  Score=117.23  Aligned_cols=142  Identities=14%  Similarity=0.220  Sum_probs=107.3

Q ss_pred             ccceecCccceEEEEEEeCCCcEEEEEEee--ccC-chhhHHHHHHHHHHHhCC--CCccceeeeEeecC---CeeEEEE
Q 002214          668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFH--LQR-EGALNSFDAECEILKTIR--HRNLVKIISSCTNH---NFKALVL  739 (952)
Q Consensus       668 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  739 (952)
                      ..+.++.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.++  +..+.++++++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4567999999999999875 4678888875  322 122356789999999997  45578888888766   4589999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH--------------------------------------  781 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h--------------------------------------  781 (952)
                      ||++|..+.+..   ...++..++..++.++++.|+.||...                                      
T Consensus       121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999998775421   124678888999999999999998520                                      


Q ss_pred             -----------------CCCeEeCCCCCCCeeeCCCCc--EEEeccccccc
Q 002214          782 -----------------SNPIVHCDIKPSNVLLDDSMV--AHLSDFGIAKL  813 (952)
Q Consensus       782 -----------------~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgla~~  813 (952)
                                       ...++|||+++.||+++.++.  +.|+||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             257999999999999997753  68999999875

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.87  E-value=7.6e-10  Score=121.13  Aligned_cols=159  Identities=13%  Similarity=0.150  Sum_probs=69.2

Q ss_pred             cccCCCCcEEEccCccccC---------CCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCc
Q 002214          370 LGRLKKLQGLDLQNNKFEG---------PIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPS  440 (952)
Q Consensus       370 l~~l~~L~~L~L~~N~i~~---------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  440 (952)
                      ...+++|+.|.+.++....         .....+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.+......
T Consensus       135 ~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~  211 (362)
T 2ra8_A          135 KEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVE  211 (362)
T ss_dssp             HHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHH
T ss_pred             hhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHH
Confidence            3445666666665443210         12223344555666666555211 1122 2 255566666655555432222


Q ss_pred             ccc--CCCCCceeEecC--CccCCC-----Cchhh--hcccccceeecCCcccCCCCcccc---cCCCCCceEEccCccc
Q 002214          441 TFW--NLEDILGFDFSS--NSLNGS-----LPLEI--ENLKAVVDIYLSRNNLSGNIPSTI---IGLKNLQHLSLEHNKL  506 (952)
Q Consensus       441 ~~~--~l~~L~~L~Ls~--N~l~~~-----~~~~~--~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~l  506 (952)
                      .+.  .+++|+.|+|+.  |...+.     +...+  ..+++|+.|+|++|.+....+..+   ..+++|++|+|+.|.|
T Consensus       212 ~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L  291 (362)
T 2ra8_A          212 DILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL  291 (362)
T ss_dssp             HHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCC
T ss_pred             HHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCC
Confidence            222  455555555542  111100     00111  124455555555555442211111   1345566666666655


Q ss_pred             cCc----ccccccccccccEEeCCCCccc
Q 002214          507 QGP----IPESFGELVSLEFLDLSNNDLS  531 (952)
Q Consensus       507 ~~~----~~~~~~~l~~L~~L~Ls~N~l~  531 (952)
                      ++.    ++..+..+++|+.|+|++|.|+
T Consensus       292 ~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          292 TDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             BHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             ChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            532    2222334555666666666554

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.84  E-value=1.9e-09  Score=118.00  Aligned_cols=161  Identities=18%  Similarity=0.217  Sum_probs=113.4

Q ss_pred             cccCCCcceEEEecccccc---------ccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCc
Q 002214          393 EFCHFSRLYVVYLNRNKLS---------GSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLP  463 (952)
Q Consensus       393 ~~~~l~~L~~L~L~~N~l~---------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  463 (952)
                      +...+++|+.|.+..+...         +.+...+..+|+|+.|+|++|.-....+  + .+++|+.|+|..|.+.....
T Consensus       134 s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~l~~--~-~~~~L~~L~L~~~~l~~~~l  210 (362)
T 2ra8_A          134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGK--K-PRPNLKSLEIISGGLPDSVV  210 (362)
T ss_dssp             THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCBCCS--C-BCTTCSEEEEECSBCCHHHH
T ss_pred             hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCceecc--c-cCCCCcEEEEecCCCChHHH
Confidence            3556789999999765432         1233455678999999999884222322  3 38899999999998875444


Q ss_pred             hhhh--cccccceeecCC--cccCCC-----Ccccc--cCCCCCceEEccCccccCcccccc---cccccccEEeCCCCc
Q 002214          464 LEIE--NLKAVVDIYLSR--NNLSGN-----IPSTI--IGLKNLQHLSLEHNKLQGPIPESF---GELVSLEFLDLSNND  529 (952)
Q Consensus       464 ~~~~--~l~~L~~L~Ls~--N~l~~~-----~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~Ls~N~  529 (952)
                      ..+.  .+++|+.|+|+.  |...+.     +...+  ..+++|+.|+|++|.+.+..+..+   ..+++|++|+|+.|.
T Consensus       211 ~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~  290 (362)
T 2ra8_A          211 EDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV  290 (362)
T ss_dssp             HHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSC
T ss_pred             HHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCC
Confidence            4444  689999999864  322111     11123  257999999999999975443333   257899999999999


Q ss_pred             cccc----Cccchhccccccccccccccccc
Q 002214          530 LSGV----IPASLEKLLYLKSLNLSFNKLVG  556 (952)
Q Consensus       530 l~~~----~~~~~~~l~~L~~L~l~~N~l~~  556 (952)
                      |++.    ++..+..+++|+.|+|++|.++.
T Consensus       291 L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          291 LTDEGARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             CBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             CChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence            9864    34445678999999999998763

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.84  E-value=2e-09  Score=115.90  Aligned_cols=186  Identities=15%  Similarity=0.149  Sum_probs=122.5

Q ss_pred             cceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCc--cceeeeEeecCC---eeEEEEEcc
Q 002214          669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRN--LVKIISSCTNHN---FKALVLEYM  742 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  742 (952)
                      .+.++.|....||+..    ..+++|+....  .....+.+|+.+++.+. +..  +.++++.....+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    56899986432  33467899999999884 332  344555443332   458999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG------------------------------------------  780 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~------------------------------------------  780 (952)
                      +|.++.+....   .++..++..++.++++.++.||..                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888754332   367777888888888888888741                                          


Q ss_pred             -------------CCCCeEeCCCCCCCeeeCC--CCcEEEeccccccccCCcCccccccc----cc---------ccccc
Q 002214          781 -------------HSNPIVHCDIKPSNVLLDD--SMVAHLSDFGIAKLLSEEDSMKQTQT----LA---------TIGYI  832 (952)
Q Consensus       781 -------------h~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~~----~~---------~~~y~  832 (952)
                                   ....++|+|++|.||++++  ...+.|+||+.+..-....+......    .+         ..++.
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                         1245899999999999998  56688999999875322111100000    00         00111


Q ss_pred             c-ccccCcCCcCcccchHhHHHHHHHHHhCCCCC
Q 002214          833 A-PEYGREGQVSIKGDVYNYGIMLMEVFTGMKPT  865 (952)
Q Consensus       833 a-PE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~  865 (952)
                      . |+...  ......+.|++|.++|.+.+|..+|
T Consensus       256 ~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          256 DIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1 22111  1122258999999999999998875

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.73  E-value=2.7e-10  Score=118.00  Aligned_cols=98  Identities=14%  Similarity=0.078  Sum_probs=52.7

Q ss_pred             CCCCCceEEEeCCCCeEEEEEecC---CCCcccCC-ccccCCcccCeeeccccccccccCC-CcCCcCCCcE--EeCcCC
Q 002214           19 SVCSWMGITCDVYGNRVTSLTISD---LGLAGTIP-SHLGNLSSLQTLVLSRNWFSGTIPK-EIGNLTKLKE--LHLDYN   91 (952)
Q Consensus        19 ~~c~w~~v~c~~~~~~~~~l~l~~---~~~~~~~p-~~l~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~--L~L~~n   91 (952)
                      ..|.|.|++|+..+.+++.+...+   ..+.+.++ +.+..++.  +|...+|.-++.++- .+...+.|+.  ++++.|
T Consensus        76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N  153 (267)
T 3rw6_A           76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN  153 (267)
T ss_dssp             HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred             HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence            479999999998777887665544   12222332 23333333  344444544433332 2455555655  666666


Q ss_pred             ccc---ccCChhhcCCCCCCeEeecCccCc
Q 002214           92 KLQ---GEIPEELGNLAELEMLVLNNNLLT  118 (952)
Q Consensus        92 ~l~---~~~p~~l~~l~~L~~L~L~~n~l~  118 (952)
                      +..   ..++....++++|+.|+|++|+|+
T Consensus       154 ~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~  183 (267)
T 3rw6_A          154 RRSCMAATLRIIEENIPELLSLNLSNNRLY  183 (267)
T ss_dssp             SHHHHHHHHHHHHHHCTTCCEEECTTSCCC
T ss_pred             HHHHHHHHHHHHHhhCCCCCEEECCCCCCC
Confidence            443   111222245666666666666665

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.45  E-value=1.6e-08  Score=99.79  Aligned_cols=44  Identities=14%  Similarity=0.191  Sum_probs=25.3

Q ss_pred             ccccCCCCCcEEEc--cCCccccc----CCccccccCCccEEEeeCCcCC
Q 002214          173 NNLWHCKELSSVSL--SYNQFTGR----LPRDLGNSTKLKSLDLGFNNLN  216 (952)
Q Consensus       173 ~~l~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~  216 (952)
                      ..+...++|++|+|  ++|.|+..    +...+...++|++|+|++|.+.
T Consensus       115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            34444455666666  55665532    2334445567777777777764

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.44  E-value=3.5e-08  Score=102.08  Aligned_cols=80  Identities=29%  Similarity=0.348  Sum_probs=54.0

Q ss_pred             hcccccceeecCCcccCCC--CcccccCCCCCceEEccCccccCcccccccccc--cccEEeCCCCcccccCc-------
Q 002214          467 ENLKAVVDIYLSRNNLSGN--IPSTIIGLKNLQHLSLEHNKLQGPIPESFGELV--SLEFLDLSNNDLSGVIP-------  535 (952)
Q Consensus       467 ~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~-------  535 (952)
                      .++++|+.|+|++|+|+++  +|..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|++.+..|       
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            4567777777777777763  345566778888888888888754  2334444  78888888888876444       


Q ss_pred             cchhccccccccc
Q 002214          536 ASLEKLLYLKSLN  548 (952)
Q Consensus       536 ~~~~~l~~L~~L~  548 (952)
                      ..+..+|+|+.||
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence            2356677777664

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.38  E-value=1.6e-06  Score=91.33  Aligned_cols=135  Identities=17%  Similarity=0.119  Sum_probs=96.5

Q ss_pred             eecCccce-EEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEEEEccCCCCh
Q 002214          671 LIGIGSYG-SVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALVLEYMPKGSL  747 (952)
Q Consensus       671 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  747 (952)
                      .+..|..| .||+.... ++..+++|+....   ....+.+|+..++.+. +-.|.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            44555555 68988764 4678999986533   3467889999999884 33467788899888999999999999887


Q ss_pred             hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 002214          748 EDCMYASNFNLDIFQRLGIMIDVASALEYLHF------------------------------------------------  779 (952)
Q Consensus       748 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~------------------------------------------------  779 (952)
                      .+.....     ......+..++++.++.||.                                                
T Consensus       108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            7654321     12233455566666666652                                                


Q ss_pred             -------cCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          780 -------GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       780 -------~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                             .+...++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                   1122378999999999999887778999998863

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.37  E-value=2.2e-06  Score=91.88  Aligned_cols=136  Identities=13%  Similarity=0.099  Sum_probs=95.7

Q ss_pred             cceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCC---ccceeeeEee-cCCeeEEEEEccCC
Q 002214          669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHR---NLVKIISSCT-NHNFKALVLEYMPK  744 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  744 (952)
                      .+.++.|....||+.    |..+++|+..  .......+.+|+++++.+++.   .+.+++.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888888899987    5678899853  223346789999999999642   3556666664 45667899999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG--------------------------------------------  780 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~--------------------------------------------  780 (952)
                      .++.+....   .++..++..++.++++.++.||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            888763211   234455555555555555555521                                            


Q ss_pred             -------------CCCCeEeCCCCCCCeeeCC---CCc-EEEeccccccc
Q 002214          781 -------------HSNPIVHCDIKPSNVLLDD---SMV-AHLSDFGIAKL  813 (952)
Q Consensus       781 -------------h~~~ivH~Dlk~~Nill~~---~~~-~kl~Dfgla~~  813 (952)
                                   ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         3345799999999999987   455 58999998864

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.36  E-value=7.6e-08  Score=94.89  Aligned_cols=114  Identities=11%  Similarity=0.122  Sum_probs=54.9

Q ss_pred             cCCCCCCcEEecccc-ccCCc----CCccccCCCCCceeEecCCccCCC----CchhhhcccccceeecCCcccCCC---
Q 002214          418 LGDLNSLRILSLSSN-ELTSV----IPSTFWNLEDILGFDFSSNSLNGS----LPLEIENLKAVVDIYLSRNNLSGN---  485 (952)
Q Consensus       418 ~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~---  485 (952)
                      +...++|++|+|++| .|...    +...+...++|+.|+|++|.|...    +...+...+.|++|+|++|.|...   
T Consensus        32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~  111 (185)
T 1io0_A           32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL  111 (185)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence            344455555555555 44421    112233344555555555554421    222333445556666666655532   


Q ss_pred             -CcccccCCCCCceEEc--cCccccCc----ccccccccccccEEeCCCCccc
Q 002214          486 -IPSTIIGLKNLQHLSL--EHNKLQGP----IPESFGELVSLEFLDLSNNDLS  531 (952)
Q Consensus       486 -~~~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~  531 (952)
                       +...+...++|++|+|  ++|.|+..    +...+...++|+.|+|++|.+.
T Consensus       112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence             2334444556666666  55666532    2233344456666666666654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.16  E-value=2.8e-06  Score=93.48  Aligned_cols=81  Identities=10%  Similarity=0.026  Sum_probs=57.4

Q ss_pred             ccee-cCccceEEEEEEeC-------CCcEEEEEEeeccC---chhhHHHHHHHHHHHhCC-C--CccceeeeEeecC--
Q 002214          669 ENLI-GIGSYGSVYKGRFP-------DGIEVAIKVFHLQR---EGALNSFDAECEILKTIR-H--RNLVKIISSCTNH--  732 (952)
Q Consensus       669 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  732 (952)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+.+|+.+++.++ +  -.+.++++++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88989999998764       26789999875432   101245788999998884 2  3567788877655  


Q ss_pred             -CeeEEEEEccCCCChhH
Q 002214          733 -NFKALVLEYMPKGSLED  749 (952)
Q Consensus       733 -~~~~lv~e~~~~g~L~~  749 (952)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             45789999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.98  E-value=3.2e-05  Score=86.34  Aligned_cols=75  Identities=16%  Similarity=0.074  Sum_probs=50.1

Q ss_pred             cceecCccceEEEEEEeC-CCcEEEEEEeeccCc-------hhhHHHHHHHHHHHhCCC--Ccc-ceeeeEeecCCeeEE
Q 002214          669 ENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQRE-------GALNSFDAECEILKTIRH--RNL-VKIISSCTNHNFKAL  737 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~ni-v~l~~~~~~~~~~~l  737 (952)
                      .+.+|.|..+.||++... +++.|+||.......       ....++..|+++++.+..  |.. .+++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            568999999999999764 468899997643211       123567889999988742  433 3555443  344689


Q ss_pred             EEEccCCC
Q 002214          738 VLEYMPKG  745 (952)
Q Consensus       738 v~e~~~~g  745 (952)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.94  E-value=5.1e-06  Score=79.43  Aligned_cols=82  Identities=9%  Similarity=0.056  Sum_probs=37.7

Q ss_pred             CCcEEEccCCcccccCCccccccCCccEEEeeCCc-CCccCchhhhcc----CCCcEeeecccc-ccccCCccccCCCCc
Q 002214          180 ELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNN-LNGEIPQEIGNL----RNLEILGIDQSN-LVGFVPDTIFNISTL  253 (952)
Q Consensus       180 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~n~-~~~~~~~~~~~l~~L  253 (952)
                      +|+.||++++.|+..--..+.++++|++|+|++|. +++..-..+..+    ++|+.|+|++|. ++...-..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            45555555555544333444555555555555553 443333334432    245555555542 333322333344444


Q ss_pred             cEEEeeCc
Q 002214          254 KILSLFNN  261 (952)
Q Consensus       254 ~~L~Ls~N  261 (952)
                      +.|+|++|
T Consensus       142 ~~L~L~~c  149 (176)
T 3e4g_A          142 KYLFLSDL  149 (176)
T ss_dssp             CEEEEESC
T ss_pred             CEEECCCC
Confidence            44444444

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.86  E-value=6.6e-06  Score=78.70  Aligned_cols=85  Identities=7%  Similarity=0.013  Sum_probs=69.3

Q ss_pred             CccceEEcccCcccccCCccccCCCCCcEEEccCCc-ccccCCcccccc----CCccEEEeeCCc-CCccCchhhhccCC
Q 002214          155 PRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQ-FTGRLPRDLGNS----TKLKSLDLGFNN-LNGEIPQEIGNLRN  228 (952)
Q Consensus       155 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~  228 (952)
                      .+|++|||++|.++...-..+..+++|+.|+|++|. |++.--..++.+    ++|++|+|++|. +++..-..+.++++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            379999999999887666778889999999999995 775544555554    379999999985 88766778899999


Q ss_pred             CcEeeeccccc
Q 002214          229 LEILGIDQSNL  239 (952)
Q Consensus       229 L~~L~L~~n~~  239 (952)
                      |+.|+|++|.-
T Consensus       141 L~~L~L~~c~~  151 (176)
T 3e4g_A          141 LKYLFLSDLPG  151 (176)
T ss_dssp             CCEEEEESCTT
T ss_pred             CCEEECCCCCC
Confidence            99999998853

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.84  E-value=7.9e-05  Score=81.23  Aligned_cols=138  Identities=17%  Similarity=0.169  Sum_probs=80.1

Q ss_pred             ceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCC--Cccceeee------EeecCCeeEEEEEc
Q 002214          670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRH--RNLVKIIS------SCTNHNFKALVLEY  741 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~  741 (952)
                      +.|+.|..+.||+....+| .+++|+.... .   ..+..|+.+++.+..  -.+.+++.      +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999987555 5999988642 1   334456666665531  12333333      12345678899999


Q ss_pred             cCCCChh-----H---------Hhhh--cCC-----------CCCHHHHH------------------------------
Q 002214          742 MPKGSLE-----D---------CMYA--SNF-----------NLDIFQRL------------------------------  764 (952)
Q Consensus       742 ~~~g~L~-----~---------~l~~--~~~-----------~l~~~~~~------------------------------  764 (952)
                      ++|..+.     .         .++.  ...           ...|....                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542     0         0111  000           01222110                              


Q ss_pred             -HHHHHHHHHHHHHHh----------cCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          765 -GIMIDVASALEYLHF----------GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       765 -~i~~~ia~~l~~Lh~----------~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                       .+...+.+++++|+.          .....++|||+.+.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             111123345666642          135789999999999999888899999999775

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.78  E-value=3.4e-05  Score=86.71  Aligned_cols=81  Identities=9%  Similarity=0.059  Sum_probs=51.4

Q ss_pred             CCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccccccccccccccccCcC---CcCcccchHhHHHHHHH
Q 002214          781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG---QVSIKGDVYNYGIMLME  857 (952)
Q Consensus       781 h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~e  857 (952)
                      +...++|||++|.||+++.++ ++++||+.+..-...-+.......-...|.+|+.....   ......++......+|+
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            577899999999999999876 99999999975422111111000012346676654321   12233556688888888


Q ss_pred             HHhCC
Q 002214          858 VFTGM  862 (952)
Q Consensus       858 l~tg~  862 (952)
                      .+++.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.76  E-value=0.00014  Score=77.48  Aligned_cols=137  Identities=13%  Similarity=0.076  Sum_probs=92.8

Q ss_pred             ccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC---CCccceeeeEeecCCeeEEEEEccCC
Q 002214          668 EENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIR---HRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       668 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      ..+.|+.|....+|+... ++..+++|+....   ....+.+|+..++.+.   ...+.++++++...+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346789999999999986 5778999987543   2467889999999884   35688888888888889999999998


Q ss_pred             CChhH-----------HhhhcCC---------------------CCCHHHHH---HHHH----------------HHHHH
Q 002214          745 GSLED-----------CMYASNF---------------------NLDIFQRL---GIMI----------------DVASA  773 (952)
Q Consensus       745 g~L~~-----------~l~~~~~---------------------~l~~~~~~---~i~~----------------~ia~~  773 (952)
                      ..+..           .++....                     .-+|....   ++..                .+.+.
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            86521           1222110                     12454321   1111                11111


Q ss_pred             -HHHHHh-cCCCCeEeCCCCCCCeeeCCCCcEEEeccc
Q 002214          774 -LEYLHF-GHSNPIVHCDIKPSNVLLDDSMVAHLSDFG  809 (952)
Q Consensus       774 -l~~Lh~-~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  809 (952)
                       .+.|.. .....++|+|+.+.|++++.++ +.|.||+
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             223311 1246799999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.68  E-value=0.00015  Score=76.75  Aligned_cols=79  Identities=14%  Similarity=0.132  Sum_probs=59.2

Q ss_pred             cCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCC---CccceeeeEeecCCeeEEEEEc
Q 002214          665 QFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRH---RNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      +...++.+|.|..+.||+.+..+|+.|+||+...........|.+|+..|+.+.-   -.+.+++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            4555678999999999999999999999998765544444678899999998842   2344555442    24799999


Q ss_pred             cCCCCh
Q 002214          742 MPKGSL  747 (952)
Q Consensus       742 ~~~g~L  747 (952)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987754

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.33  E-value=0.0002  Score=65.35  Aligned_cols=60  Identities=23%  Similarity=0.322  Sum_probs=37.0

Q ss_pred             eEEccCcccc-CcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCC
Q 002214          498 HLSLEHNKLQ-GPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIP  559 (952)
Q Consensus       498 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  559 (952)
                      .++.+++.++ ..+|..+.  ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|+|.|.+-
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~   72 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR   72 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence            4556666654 12332221  356777777777776666667777777777777777776554

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.33  E-value=0.0005  Score=74.05  Aligned_cols=156  Identities=15%  Similarity=0.178  Sum_probs=89.2

Q ss_pred             cCHHHHHHHhccCCc-----cceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCc--cceee
Q 002214          654 YSHDELLRATDQFSE-----ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN--LVKII  726 (952)
Q Consensus       654 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~  726 (952)
                      .+.+++.....+|..     .+.|+.|....+|+....+| .+++|+.....  ....+..|+.+++.++..+  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            455666666666655     24567788899999987655 68899886421  1245667888887774222  23333


Q ss_pred             eE------eecCCeeEEEEEccCCCChhH-----H---------hhhc--C--CC----C---CHHHHHH----------
Q 002214          727 SS------CTNHNFKALVLEYMPKGSLED-----C---------MYAS--N--FN----L---DIFQRLG----------  765 (952)
Q Consensus       727 ~~------~~~~~~~~lv~e~~~~g~L~~-----~---------l~~~--~--~~----l---~~~~~~~----------  765 (952)
                      ..      ....+..+++|+|++|..+..     +         ++..  .  ..    .   .|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      122356789999998865421     0         1111  0  00    1   1221110          


Q ss_pred             --HHHHHHHHHHHHHh----cCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          766 --IMIDVASALEYLHF----GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       766 --i~~~ia~~l~~Lh~----~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                        +...+.+.++++..    ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              00113344555532    124579999999999999987667899999875

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.20  E-value=0.0001  Score=71.83  Aligned_cols=38  Identities=24%  Similarity=0.365  Sum_probs=17.9

Q ss_pred             CCCcEEeCcCC-cccc----cCChhhcCCCCCCeEeecCccCc
Q 002214           81 TKLKELHLDYN-KLQG----EIPEELGNLAELEMLVLNNNLLT  118 (952)
Q Consensus        81 ~~L~~L~L~~n-~l~~----~~p~~l~~l~~L~~L~L~~n~l~  118 (952)
                      +.|++|+|++| .|..    .+.+++..-+.|++|+|++|++.
T Consensus        41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~ig   83 (197)
T 1pgv_A           41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS   83 (197)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred             CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCC
Confidence            44555555543 4431    23344444555555555555554

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.20  E-value=8.2e-05  Score=72.53  Aligned_cols=64  Identities=16%  Similarity=0.168  Sum_probs=34.3

Q ss_pred             CCccceEEcccC-cccc----cCCccccCCCCCcEEEccCCcccccCC----ccccccCCccEEEeeCCcCCc
Q 002214          154 LPRLKGLYVSYN-QFKG----PIPNNLWHCKELSSVSLSYNQFTGRLP----RDLGNSTKLKSLDLGFNNLNG  217 (952)
Q Consensus       154 l~~L~~L~L~~n-~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~  217 (952)
                      -+.|++|+|++| +|..    .+.+.+..-..|+.|+|++|+|.....    +.+..-+.|++|+|++|.|.+
T Consensus        40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~  112 (197)
T 1pgv_A           40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP  112 (197)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence            346667777664 5542    123344445566666666666653322    223344566666666666653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.19  E-value=0.0022  Score=69.18  Aligned_cols=158  Identities=13%  Similarity=0.106  Sum_probs=92.1

Q ss_pred             cccCHHHHHHHhccCCc-----cceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCc--cce
Q 002214          652 RRYSHDELLRATDQFSE-----ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN--LVK  724 (952)
Q Consensus       652 ~~~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~  724 (952)
                      ...+.+.+......|.+     .+.++ |....||+....+|+.+++|+...... ....+..|..+++.++...  +.+
T Consensus         9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~   86 (328)
T 1zyl_A            9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAA   86 (328)
T ss_dssp             CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecc
Confidence            34556666666555533     24566 888899998877788899999864321 2356677888888774222  344


Q ss_pred             eeeE-----eecCCeeEEEEEccCCCChh-----HH---------hhh----c----CCCCCHHHH--------------
Q 002214          725 IISS-----CTNHNFKALVLEYMPKGSLE-----DC---------MYA----S----NFNLDIFQR--------------  763 (952)
Q Consensus       725 l~~~-----~~~~~~~~lv~e~~~~g~L~-----~~---------l~~----~----~~~l~~~~~--------------  763 (952)
                      ++..     ....+..++||||++|..+.     ..         ++.    .    ....++...              
T Consensus        87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  166 (328)
T 1zyl_A           87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI  166 (328)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred             eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence            4443     12245668899999875432     11         111    0    011222211              


Q ss_pred             --------HHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          764 --------LGIMIDVASALEYLHF-GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       764 --------~~i~~~ia~~l~~Lh~-~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                              ...+..+...++.... .....++|||+++.||+++ + .+.++||+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                    0111112222222210 1345689999999999999 4 899999998763

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.18  E-value=0.0014  Score=63.90  Aligned_cols=103  Identities=13%  Similarity=0.030  Sum_probs=69.2

Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccccc
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQ  824 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  824 (952)
                      -+|.+++...+.++++.++|.+..|.+.+|.-.-.  ++.-..+=+.|..|++..+|.+...+ +.+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            37999999999999999999999999999877631  11111233456889999999988753 1110            


Q ss_pred             cccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCC
Q 002214          825 TLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP  864 (952)
Q Consensus       825 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p  864 (952)
                       .....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence             0223466888764 3556788999999999999885444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.13  E-value=0.0024  Score=68.98  Aligned_cols=139  Identities=14%  Similarity=0.111  Sum_probs=74.7

Q ss_pred             ceecCccceE-EEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCC--CccceeeeEeecCCeeEEEEEccCCCC
Q 002214          670 NLIGIGSYGS-VYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRH--RNLVKIISSCTNHNFKALVLEYMPKGS  746 (952)
Q Consensus       670 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  746 (952)
                      +.++.|+... +|+....+|+.+++|.......   ..+..|+.+++.+..  -.+.+++.+..+.+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3465555444 6777664477788886543321   234567777777642  23456666644444  78999997766


Q ss_pred             hhHHhhhc---------------------C----CCCCHHHHH---------H-----------HHHHHHHHHHHHH---
Q 002214          747 LEDCMYAS---------------------N----FNLDIFQRL---------G-----------IMIDVASALEYLH---  778 (952)
Q Consensus       747 L~~~l~~~---------------------~----~~l~~~~~~---------~-----------i~~~ia~~l~~Lh---  778 (952)
                      +.+.+...                     .    ..++.....         .           ....+...++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            64332210                     0    012211100         0           0001111222221   


Q ss_pred             hcCCCCeEeCCCCCCCeeeCCC----CcEEEeccccccc
Q 002214          779 FGHSNPIVHCDIKPSNVLLDDS----MVAHLSDFGIAKL  813 (952)
Q Consensus       779 ~~h~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgla~~  813 (952)
                      ..+...++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1245679999999999999875    6899999998874

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.01  E-value=0.0018  Score=70.77  Aligned_cols=140  Identities=14%  Similarity=0.165  Sum_probs=82.8

Q ss_pred             cceecCccceEEEEEEeC--------CCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEEE
Q 002214          669 ENLIGIGSYGSVYKGRFP--------DGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .+.+..|-...+|+....        +++.|++|+..... .......+|.++++.+. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            356777888889999874        35789999873322 22455678999998884 3333566666543    2999


Q ss_pred             EccCCCChhHH-----------------hhhcC----CCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 002214          740 EYMPKGSLEDC-----------------MYASN----FNLD--IFQRLGIMIDVAS-------------------ALEYL  777 (952)
Q Consensus       740 e~~~~g~L~~~-----------------l~~~~----~~l~--~~~~~~i~~~ia~-------------------~l~~L  777 (952)
                      ||++|.++...                 ++...    ....  +.+..++..++..                   .++.|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998665311                 11111    1122  3344444433321                   12233


Q ss_pred             H-----hcCCCCeEeCCCCCCCeeeCCC----CcEEEeccccccc
Q 002214          778 H-----FGHSNPIVHCDIKPSNVLLDDS----MVAHLSDFGIAKL  813 (952)
Q Consensus       778 h-----~~h~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgla~~  813 (952)
                      .     ......++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2     1234568999999999999876    7899999998863

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.95  E-value=0.00071  Score=72.05  Aligned_cols=136  Identities=12%  Similarity=0.108  Sum_probs=76.2

Q ss_pred             cceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCcc-ceeeeEeecCCeeEEEEEcc-CCCC
Q 002214          669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL-VKIISSCTNHNFKALVLEYM-PKGS  746 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~  746 (952)
                      .+.|+.|....+|+.     ..+++|+....... .....+|+.+++.+...++ .++++++.  +.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence            678999999999998     56889987643222 1223568888887743233 45555443  3346899999 6655


Q ss_pred             hhHH------------------hhhcCCC----CCHHHH-HHH------------------HHHHHHHHHHHH-hcCCCC
Q 002214          747 LEDC------------------MYASNFN----LDIFQR-LGI------------------MIDVASALEYLH-FGHSNP  784 (952)
Q Consensus       747 L~~~------------------l~~~~~~----l~~~~~-~~i------------------~~~ia~~l~~Lh-~~h~~~  784 (952)
                      +...                  ++.....    .+.... ...                  ...+....+.+. ......
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            4321                  0111100    111110 000                  000111111111 113345


Q ss_pred             eEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          785 IVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       785 ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ++|+|+.+.||+ ..++.+.++||..|..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5667789999998874

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.95  E-value=0.0015  Score=73.19  Aligned_cols=73  Identities=21%  Similarity=0.292  Sum_probs=50.2

Q ss_pred             cceecCccceEEEEEEeCC--------CcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCcc-ceeeeEeecCCeeEEEE
Q 002214          669 ENLIGIGSYGSVYKGRFPD--------GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL-VKIISSCTNHNFKALVL  739 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  739 (952)
                      .+.|+.|....||+....+        ++.|++|+......  ...+.+|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4578888889999998753        57899999843211  1445579999988853333 566666542    3899


Q ss_pred             EccCCCCh
Q 002214          740 EYMPKGSL  747 (952)
Q Consensus       740 e~~~~g~L  747 (952)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.80  E-value=0.0043  Score=69.70  Aligned_cols=74  Identities=18%  Similarity=0.144  Sum_probs=48.9

Q ss_pred             cceecCccceEEEEEEeCC-CcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCcc-ceeeeEeecCCeeEEEEEccCCCC
Q 002214          669 ENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL-VKIISSCTNHNFKALVLEYMPKGS  746 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  746 (952)
                      .+.|+.|-...+|+....+ +..+++|+........ ..-.+|..+++.+...++ .++++++. .   ..||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCcc
Confidence            4578888889999998865 5789999875432221 112589999999865444 46676663 2   35999998755


Q ss_pred             h
Q 002214          747 L  747 (952)
Q Consensus       747 L  747 (952)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.78  E-value=0.0017  Score=59.06  Aligned_cols=56  Identities=21%  Similarity=0.272  Sum_probs=42.0

Q ss_pred             eeecCCcccC-CCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCccc
Q 002214          474 DIYLSRNNLS-GNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLS  531 (952)
Q Consensus       474 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  531 (952)
                      .++.+++.++ ..+|..+.  ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5677777776 23444333  46888888888888777778888888999999999875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.59  E-value=0.0031  Score=69.20  Aligned_cols=74  Identities=14%  Similarity=0.216  Sum_probs=45.4

Q ss_pred             cceecCccceEEEEEEeCC---------CcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCc-cceeeeEeecCCeeEEE
Q 002214          669 ENLIGIGSYGSVYKGRFPD---------GIEVAIKVFHLQREGALNSFDAECEILKTIRHRN-LVKIISSCTNHNFKALV  738 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  738 (952)
                      .+.++.|....+|+....+         ++.+++|+....... ......|..+++.+...+ +.++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3567788888999998754         268999987543221 122467888888885333 34666544  2  2689


Q ss_pred             EEccCCCCh
Q 002214          739 LEYMPKGSL  747 (952)
Q Consensus       739 ~e~~~~g~L  747 (952)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.51  E-value=0.0068  Score=65.50  Aligned_cols=67  Identities=10%  Similarity=0.148  Sum_probs=43.6

Q ss_pred             CccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC---CCccceeeeE------eecCCeeEEEEEccCC
Q 002214          674 IGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIR---HRNLVKIISS------CTNHNFKALVLEYMPK  744 (952)
Q Consensus       674 ~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~~  744 (952)
                      .|....||+....+| .+++|+......      ..|+.+++.+.   -|.+.+++..      ....+..++||+|++|
T Consensus        33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            333679999987777 899998765432      34666666552   2224454432      2335678999999998


Q ss_pred             CCh
Q 002214          745 GSL  747 (952)
Q Consensus       745 g~L  747 (952)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.50  E-value=0.024  Score=62.77  Aligned_cols=74  Identities=9%  Similarity=0.144  Sum_probs=48.9

Q ss_pred             cceecCccceEEEEEEeCC--------CcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEEE
Q 002214          669 ENLIGIGSYGSVYKGRFPD--------GIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  739 (952)
                      .+.+..|--..+|+....+        ++.|++|+....... ...-.+|.++++.+. +.-..++++.+.    -+.||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3567778888999998753        688999987543222 223367888888884 332445555432    26899


Q ss_pred             EccCCCCh
Q 002214          740 EYMPKGSL  747 (952)
Q Consensus       740 e~~~~g~L  747 (952)
                      ||++|.++
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.29  E-value=0.29  Score=53.91  Aligned_cols=30  Identities=27%  Similarity=0.390  Sum_probs=25.5

Q ss_pred             CeEeCCCCCCCeee------CCCCcEEEeccccccc
Q 002214          784 PIVHCDIKPSNVLL------DDSMVAHLSDFGIAKL  813 (952)
Q Consensus       784 ~ivH~Dlk~~Nill------~~~~~~kl~Dfgla~~  813 (952)
                      .++|+|+.+.||++      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567899999998863

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	952
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-60
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-57
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-54
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-52
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-51
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-49
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-49
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-48
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-48
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-48
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-47
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-46
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-46
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-43
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-40
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-40
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-39
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-38
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-36
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-32
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-28
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-10
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-22
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-21
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.004
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.004
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-07
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	7e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	7e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	7e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.004
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.001
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	5e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 3e-60
 Identities = 67/285 (23%), Positives = 131/285 (45%), Gaps = 27/285 (9%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRN 721
            Q +    IG GS+G+VYKG++    +VA+K+ ++       L +F  E  +L+  RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           ++  +   T     A+V ++    SL   ++      ++ + + I    A  ++YLH   
Sbjct: 66  ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPEY---G 837
              I+H D+K +N+ L + +   + DFG+A + S      Q + L+ +I ++APE     
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 838 REGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE 897
            +   S + DVY +GI+L E+ TG  P    ++          ++   ++ ++    LS 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP----YSNI--------NNRDQIIFMVGRGYLSP 229

Query: 898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR 942
           D         +C  ++  L  EC  +  + R    +I++ +  + 
Sbjct: 230 DLSKVR---SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 3e-58
 Identities = 65/276 (23%), Positives = 126/276 (45%), Gaps = 25/276 (9%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLV 723
           +       +G G +G V+ G +    +VA+K    Q   + ++F AE  ++K ++H+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYA-SNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           ++ +  T      ++ EYM  GSL D +   S   L I + L +   +A  + ++     
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV 842
              +H D++ +N+L+ D++   ++DFG+A+L+ + +   +      I + APE    G  
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187

Query: 843 SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA 902
           +IK DV+++GI+L E+ T  +     + G          + P V+  ++        ++ 
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRI---PYPGM---------TNPEVIQNLERGYRMVRPDN- 234

Query: 903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                 C   +  L   C  E PE+R     + S L
Sbjct: 235 ------CPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 2e-57
 Identities = 64/280 (22%), Positives = 116/280 (41%), Gaps = 23/280 (8%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLV 723
            + +    IG G +G V+ G + +  +VAIK            F  E E++  + H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++   C       LV E+M  G L D +            LG+ +DV   + YL      
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EA 120

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
            ++H D+   N L+ ++ V  +SDFG+ + + ++     T T   + + +PE     + S
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN 903
            K DV+++G+++ EVF+  K              + N S   V+  + T           
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIP------------YENRSNSEVVEDISTGFRLYKPRL-- 226

Query: 904 VAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
                 ++ V  +   C  E PE+R     ++ +L +I +
Sbjct: 227 -----ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 8e-57
 Identities = 54/278 (19%), Positives = 111/278 (39%), Gaps = 23/278 (8%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLV 723
              +    +G G +G V  G++    +VAIK+         + F  E +++  + H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
           ++   CT      ++ EYM  G L + +          Q L +  DV  A+EYL      
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---K 119

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVS 843
             +H D+   N L++D  V  +SDFG+++ + +++      +   + +  PE     + S
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 844 IKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN 903
            K D++ +G+++ E+++  K              +   +       +   L         
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMP------------YERFTNSETAEHIAQGLRLYRPHL-- 225

Query: 904 VAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                 +  V ++   C  E  + R   K ++S ++ +
Sbjct: 226 -----ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  194 bits (493), Expect = 3e-56
 Identities = 64/306 (20%), Positives = 133/306 (43%), Gaps = 40/306 (13%)

Query: 654 YSHDELLRATDQFSEE---------NLIGIGSYGSVYKGRFP----DGIEVAIKVFHLQR 700
           ++ ++   A  +F++E          +IG G +G V  G         I VAIK      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 701 -EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLD 759
            E     F +E  I+    H N++ +    T      ++ E+M  GSL+  +  ++    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 760 IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS 819
           + Q +G++  +A+ ++YL        VH D+   N+L++ ++V  +SDFG+++ L ++ S
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 820 MKQTQT----LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI 875
                +       I + APE  +  + +   DV++YGI++ EV +  +            
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---------- 233

Query: 876 KRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII 935
             + + +   V+N ++ +               C S++  L ++C  +   +R    +I+
Sbjct: 234 --YWDMTNQDVINAIEQDYRLPPPMD-------CPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 936 SRLIKI 941
           + L K+
Sbjct: 285 NTLDKM 290

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 3e-54
 Identities = 66/285 (23%), Positives = 124/285 (43%), Gaps = 25/285 (8%)

Query: 655 SHDELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEIL 714
           + D      +    E  +G G +G V+ G +     VAIK           +F  E +++
Sbjct: 8   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVM 66

Query: 715 KTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIF-QRLGIMIDVASA 773
           K +RH  LV++ +  +      +V EYM KGSL D +           Q + +   +AS 
Sbjct: 67  KKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
           + Y+        VH D++ +N+L+ +++V  ++DFG+A+L+ + +   +      I + A
Sbjct: 126 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182

Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           PE    G+ +IK DV+++GI+L E+ T  +     + G              V++ ++  
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRV---PYPGM---------VNREVLDQVERG 230

Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                          C  S+  L  +C  + PE R   + + + L
Sbjct: 231 YRMPCPPE-------CPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-53
 Identities = 64/300 (21%), Positives = 120/300 (40%), Gaps = 30/300 (10%)

Query: 658 ELLRATDQFSEENL-IGIGSYGSVYKGRF---PDGIEVAIKVFHLQ-REGALNSFDAECE 712
           +L    D     ++ +G G++GSV +G +      I+VAIKV      +        E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 713 ILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           I+  + +  +V++I  C       LV+E    G L   +      + +     ++  V+ 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA--TIG 830
            ++YL        VH D+   NVLL +   A +SDFG++K L  +DS    ++     + 
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM 890
           + APE     + S + DV++YG+ + E  +  +              +     P VM  +
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP------------YKKMKGPEVMAFI 225

Query: 891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIE 950
           +     E           C   + +L  +C     E+R +   +  R+      L + +E
Sbjct: 226 EQGKRMECPPE-------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-53
 Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 8/205 (3%)

Query: 662 ATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ-REGALNSFDAECEILKTIRH 719
             D F + + +G G+ G V+K    P G+ +A K+ HL+ +    N    E ++L     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             +V    +  +    ++ +E+M  GSL+  +  +   +       + I V   L YL  
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR- 121

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
              + I+H D+KPSN+L++      L DFG++  L +  +      + T  Y++PE  + 
Sbjct: 122 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQG 177

Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKP 864
              S++ D+++ G+ L+E+  G  P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  186 bits (473), Expect = 1e-53
 Identities = 69/300 (23%), Positives = 127/300 (42%), Gaps = 29/300 (9%)

Query: 644 GMSPQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREG 702
            M P       ++D+        + ++ +G G YG VY+G +    + VA+K        
Sbjct: 1   AMDPS----SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM- 55

Query: 703 ALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASN-FNLDIF 761
            +  F  E  ++K I+H NLV+++  CT      ++ E+M  G+L D +   N   +   
Sbjct: 56  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV 115

Query: 762 QRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK 821
             L +   ++SA+EYL        +H D+   N L+ ++ +  ++DFG+++L++ +    
Sbjct: 116 VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172

Query: 822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND 881
                  I + APE     + SIK DV+ +G++L E+ T        + G          
Sbjct: 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGI--------- 220

Query: 882 SLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
            L  V  +++ +   E  E        C   V  L   C   +P +R +  EI      +
Sbjct: 221 DLSQVYELLEKDYRMERPEG-------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 3e-52
 Identities = 62/286 (21%), Positives = 122/286 (42%), Gaps = 30/286 (10%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDG-----IEVAIKVFHLQR-EGALNSFDAECEILKTI 717
              + + +IG G +G VYKG          + VAIK       E     F  E  I+   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 718 RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYL 777
            H N++++    + +    ++ EYM  G+L+  +   +    + Q +G++  +A+ +   
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM--- 123

Query: 778 HFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA--TIGYIAPE 835
            +  +   VH D+   N+L++ ++V  +SDFG++++L ++     T +     I + APE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL 895
                + +   DV+++GI++ EV T  +              +   S   VM  ++    
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGER------------PYWELSNHEVMKAINDGFR 231

Query: 896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
                        C S++  L M+C  +    R    +I+S L K+
Sbjct: 232 LPTPMD-------CPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 1e-51
 Identities = 72/281 (25%), Positives = 122/281 (43%), Gaps = 31/281 (11%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLV 723
            +      IG G +G V  G +  G +VA+K   ++ +    +F AE  ++  +RH NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63

Query: 724 KIISSCTNHNFK-ALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGH 781
           +++           +V EYM KGSL D + +   + L     L   +DV  A+EYL    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQ 841
            N  VH D+   NVL+ +  VA +SDFG+ K  S      Q      + + APE  RE +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALREKK 176

Query: 842 VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH 901
            S K DV+++GI+L E+++  +              +    L  V+  ++     +  + 
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVP------------YPRIPLKDVVPRVEKGYKMDAPDG 224

Query: 902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR 942
                  C  +V  +   C       R +  ++  +L  I+
Sbjct: 225 -------CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 4e-50
 Identities = 62/283 (21%), Positives = 119/283 (42%), Gaps = 31/283 (10%)

Query: 669 ENLIGIGSYGSVYKGRFPD----GIEVAIKVFH-LQREGALNSFDAECEILKTIRHRNLV 723
             +IG G +G VY G   D     I  A+K  + +   G ++ F  E  I+K   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 724 KIISSCTNHNFKA-LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
            ++  C        +VL YM  G L + +     N  +   +G  + VA  +    F  S
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK---QTQTLATIGYIAPEYGRE 839
              VH D+   N +LD+     ++DFG+A+ + +++      +T     + ++A E  + 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
            + + K DV+++G++L E+ T   P       +++              ++    L + E
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITV-------YLLQGRRLLQPE 257

Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR 942
                    C   +  + ++C     E R +  E++SR+  I 
Sbjct: 258 Y--------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 1e-49
 Identities = 59/278 (21%), Positives = 116/278 (41%), Gaps = 31/278 (11%)

Query: 668 EENLIGIGSYGSVYKGRFPD---GIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNL 722
           E+  +G G++G+V KG +        VA+K+   +       +   AE  +++ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           V++I  C   ++  LV+E    G L   +   N ++     + ++  V+  ++YL     
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE--- 125

Query: 783 NPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA--TIGYIAPEYGREG 840
           +  VH D+   NVLL     A +SDFG++K L  +++  + QT     + + APE     
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
           + S K DV+++G+++ E F+  +              +       V  +++         
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP------------YRGMKGSEVTAMLEKGERMGCPA 233

Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
                   C   +  L   C +   ENR     +  RL
Sbjct: 234 G-------CPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (444), Expect = 2e-49
 Identities = 62/281 (22%), Positives = 109/281 (38%), Gaps = 35/281 (12%)

Query: 663 TDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHL---QREGALNSFDAECEILKTIR 718
              FS+   IG GS+G+VY  R   +   VAIK       Q          E   L+ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           H N ++        +   LV+EY    + +         L   +   +       L YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 132

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY-- 836
              S+ ++H D+K  N+LL +  +  L DFG A +++  +S      + T  ++APE   
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-----VGTPYWMAPEVIL 184

Query: 837 -GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL 895
              EGQ   K DV++ GI  +E+     P                +++ A+ +I      
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPP----LFNM--------NAMSALYHIAQNESP 232

Query: 896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
           +    H        +    +    C  + P++R  ++ ++ 
Sbjct: 233 ALQSGH-------WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 3e-49
 Identities = 59/285 (20%), Positives = 113/285 (39%), Gaps = 28/285 (9%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPD----GIEVAIKVFH-LQREGALNSFDAECEILKTIR 718
           ++      IG G +G V++G +       + VAIK       +     F  E   ++   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           H ++VK+I   T +    +++E    G L   +    ++LD+   +     +++AL YL 
Sbjct: 67  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR 838
              S   VH DI   NVL+  +    L DFG+++ + +    K ++    I ++APE   
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED 898
             + +   DV+ +G+ + E+        +       I R  N     +            
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------------ 230

Query: 899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
                    +C  ++ SL  +C +  P  R    E+ ++L  I +
Sbjct: 231 -------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 6e-49
 Identities = 61/282 (21%), Positives = 107/282 (37%), Gaps = 31/282 (10%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHR 720
           + +     IG GSYG   K R   DG  +  K        E       +E  +L+ ++H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 721 NLVKIISSCTNHNFKAL--VLEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALE 775
           N+V+      +     L  V+EY   G L   +         LD    L +M  +  AL+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 776 YLHFGH--SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
             H      + ++H D+KP+NV LD      L DFG+A++L+ + S  +     T  Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMS 182

Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
           PE       + K D+++ G +L E+   M P   F   E+   +        +       
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFRRI------- 234

Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEII 935
                           +  +  +     +    +R + +EI+
Sbjct: 235 ------------PYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 7e-49
 Identities = 58/294 (19%), Positives = 110/294 (37%), Gaps = 23/294 (7%)

Query: 669 ENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISS 728
           +  IG G +G V++G++  G EVA+K+F  + E +    +AE      +RH N++  I++
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAA 65

Query: 729 CTNHNFKA----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH-----F 779
               N       LV +Y   GSL D  Y + + + +   + + +  AS L +LH      
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED---SMKQTQTLATIGYIAPEY 836
                I H D+K  N+L+  +    ++D G+A           +     + T  Y+APE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 837 ------GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN-DSLPAVMNI 889
                  +  +   + D+Y  G++  E+             ++     +  D     M  
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
           +                      +  +  EC   +   R+    I   L ++  
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 9e-49
 Identities = 58/280 (20%), Positives = 114/280 (40%), Gaps = 28/280 (10%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
            D +     +G G++G VYK +  +  +  A KV   + E  L  +  E +IL +  H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +VK++ +    N   +++E+   G+++  M      L   Q   +      AL YL   H
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---H 127

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY----- 836
            N I+H D+K  N+L        L+DFG++   +     + +    T  ++APE      
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCET 186

Query: 837 GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
            ++     K DV++ GI L+E+     P                + +  ++ I  +   +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPP----HHEL--------NPMRVLLKIAKSEPPT 234

Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
             +          +S+      +C  ++ + R  T +++ 
Sbjct: 235 LAQP------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-48
 Identities = 61/291 (20%), Positives = 119/291 (40%), Gaps = 31/291 (10%)

Query: 658 ELLRATDQFSEENLIGIGSYGSVYKGRFPD-----GIEVAIKVFHL-QREGALNSFDAEC 711
            +L+ T+ F +  ++G G++G+VYKG +        I VAIK         A      E 
Sbjct: 4   RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62

Query: 712 EILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVA 771
            ++ ++ + ++ +++  C     + L+ + MP G L D +     N+     L   + +A
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121

Query: 772 SALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIG 830
             + YL       +VH D+   NVL+       ++DFG+AKLL  E+     +     I 
Sbjct: 122 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM 890
           ++A E       + + DV++YG+ + E+ T        + G              + +I+
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGI---------PASEISSIL 226

Query: 891 DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
           +                 C   V  + ++C     ++R   +E+I    K+
Sbjct: 227 EKGERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 6e-48
 Identities = 56/306 (18%), Positives = 108/306 (35%), Gaps = 52/306 (16%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPD------GIEVAIKVFHLQ-REGALNSFDAECEILKT 716
           +      ++G G++G V              I+VA+K+   +       +  +E +++  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 717 I-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFN------------------ 757
           +  H N+V ++ +CT      L+ EY   G L + + +                      
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 758 ----LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL 813
               L     L     VA  +E+L        VH D+   NVL+    V  + DFG+A+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 814 LSEEDSMKQTQTLA-TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           +  + +          + ++APE   EG  +IK DV++YGI+L E+F+        + G 
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGI 270

Query: 873 MSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTK 932
                           ++      +   +           +  +   C +     R +  
Sbjct: 271 --------PVDANFYKLIQNGFKMDQPFY-------ATEEIYIIMQSCWAFDSRKRPSFP 315

Query: 933 EIISRL 938
            + S L
Sbjct: 316 NLTSFL 321

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 7e-48
 Identities = 60/276 (21%), Positives = 112/276 (40%), Gaps = 32/276 (11%)

Query: 669 ENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKI 725
           +  IG GS+ +VYKG   +  +EVA      ++  +     F  E E+LK ++H N+V+ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 726 ISSC----TNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
             S            LV E M  G+L+  +      + I         +   L++LH   
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHT-R 131

Query: 782 SNPIVHCDIKPSNVLLDD-SMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           + PI+H D+K  N+ +   +    + D G+A L     +      + T  ++APE   E 
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEM-YEE 187

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
           +     DVY +G+ ++E+ T   P +E        +R  +   PA  +            
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD------------ 235

Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                 +     V  +   C  ++ + R + K++++
Sbjct: 236 ------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (431), Expect = 8e-48
 Identities = 65/309 (21%), Positives = 122/309 (39%), Gaps = 53/309 (17%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQ-REGALNSFDAECEILKT 716
           +       IG G++G V++ R P          VA+K+   +        F  E  ++  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFN------------------- 757
             + N+VK++  C       L+ EYM  G L + + + + +                   
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 758 ----LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL 813
               L   ++L I   VA+ + YL        VH D+   N L+ ++MV  ++DFG+++ 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 814 LSEEDSMKQTQTLA-TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
           +   D  K     A  I ++ PE     + + + DV+ YG++L E+F+        + G 
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ---PYYGM 246

Query: 873 MSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTK 932
              +         +  + D N+L+  E         C   + +L   C S+ P +R +  
Sbjct: 247 AHEE--------VIYYVRDGNILACPEN--------CPLELYNLMRLCWSKLPADRPSFC 290

Query: 933 EIISRLIKI 941
            I   L ++
Sbjct: 291 SIHRILQRM 299

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  171 bits (434), Expect = 1e-47
 Identities = 58/285 (20%), Positives = 111/285 (38%), Gaps = 28/285 (9%)

Query: 655 SHDELLRATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEI 713
            HD +L   D +     +G G++G V++      G   A K      E    +   E + 
Sbjct: 20  KHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76

Query: 714 LKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASA 773
           +  +RH  LV +  +  + N   ++ E+M  G L + +   +  +   + +  M  V   
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 774 LEYLHFGHSNPIVHCDIKPSNVLL--DDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGY 831
           L ++   H N  VH D+KP N++     S    L DFG+   L  + S+K T    T  +
Sbjct: 137 LCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEF 191

Query: 832 IAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD 891
            APE      V    D+++ G++   + +G+ P    F GE        +    + N+  
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP----FGGE--------NDDETLRNVKS 239

Query: 892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
            +   +D   + +++            +     P  R+   + + 
Sbjct: 240 CDWNMDDSAFSGISED-----GKDFIRKLLLADPNTRMTIHQALE 279

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-47
 Identities = 60/288 (20%), Positives = 111/288 (38%), Gaps = 31/288 (10%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFP----DGIEVAIKVFH---LQREGALNSFDAECEILKT 716
                   +G GS+G V +G +       + VA+K      L +  A++ F  E   + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
           + HRNL+++         K +V E  P GSL D +     +  +       + VA  + Y
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA--TIGYIAP 834
           L    S   +H D+   N+LL    +  + DFG+ + L + D     Q        + AP
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
           E  +    S   D + +G+ L E+FT  +       G   + +   +             
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---------- 233

Query: 895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR 942
           L   E+        C   + ++ ++C +  PE+R     +   L++ +
Sbjct: 234 LPRPED--------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 5e-47
 Identities = 66/275 (24%), Positives = 117/275 (42%), Gaps = 25/275 (9%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN 721
             +++    IG G+ G+VY       G EVAI+  +LQ++        E  +++  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +V  + S    +   +V+EY+  GSL D +  +  +    Q   +  +   ALE+L   H
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFL---H 133

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQ 841
           SN ++H DIK  N+LL       L+DFG    ++ E S K++  + T  ++APE      
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKA 192

Query: 842 VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH 901
              K D+++ GIM +E+  G  P    +  E  ++     +      + +   LS     
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP----YLNENPLRALYLIATNGTPELQNPEKLSAI--- 245

Query: 902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                             C     E R + KE++ 
Sbjct: 246 -----------FRDFLNRCLDMDVEKRGSAKELLQ 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 1e-46
 Identities = 60/277 (21%), Positives = 103/277 (37%), Gaps = 32/277 (11%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFH---LQREGALNSFDAECEILKTIRH 719
           + F     +G G +G+VY  R       +A+KV     L++ G  +    E EI   +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
            N++++     +     L+LEY P G++   +   +   D  +    + ++A+AL Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH- 123

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
             S  ++H DIKP N+LL  +    ++DFG +                T+ Y+ PE    
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG---TLDYLPPEMIEG 178

Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
                K D+++ G++  E   G  P    F          N        I        D 
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPP----FEA--------NTYQETYKRISRVEFTFPD- 225

Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                           L       +P  R   +E++ 
Sbjct: 226 --------FVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 2e-46
 Identities = 63/300 (21%), Positives = 122/300 (40%), Gaps = 44/300 (14%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDG---IEVAIKVFH-LQREGALNSFDAECEILKTI-R 718
           +    +++IG G++G V K R       ++ AIK       +     F  E E+L  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFN---------------LDIFQR 763
           H N++ ++ +C +  +  L +EY P G+L D +  S                  L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 764 LGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT 823
           L    DVA  ++YL        +H D+   N+L+ ++ VA ++DFG+++   +E  +K+T
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 184

Query: 824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSL 883
                + ++A E       +   DV++YG++L E+ +                 +   + 
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT------------PYCGMTC 232

Query: 884 PAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD 943
             +   +      E   +       C   V  L  +C  E P  R +  +I+  L ++ +
Sbjct: 233 AELYEKLPQGYRLEKPLN-------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 2e-46
 Identities = 53/304 (17%), Positives = 110/304 (36%), Gaps = 47/304 (15%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHL-QREGALNSFDAECEILKT 716
           ++ S    +G G++G V +            + VA+K+           +  +E ++L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 717 I-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY-----------------ASNFNL 758
           +  H N+V ++ +CT      ++ EY   G L + +                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
           D+   L     VA  + +L    S   +H D+   N+LL    +  + DFG+A+ +  + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 819 S-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
           + + +      + ++APE       + + DV++YGI L E+F+           +    +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 878 WINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR 937
            I +    +                    +   + +  +   C    P  R   K+I+  
Sbjct: 260 MIKEGFRMLSP------------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 938 LIKI 941
           + K 
Sbjct: 302 IEKQ 305

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 4e-46
 Identities = 62/277 (22%), Positives = 106/277 (38%), Gaps = 26/277 (9%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRN 721
           + +     +G G+YG V           VA+K+  ++R      +   E  I K + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +VK        N + L LEY   G L D +   +  +           + + + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPEYGREG 840
              I H DIKP N+LLD+     +SDFG+A +    +  +    +  T+ Y+APE  +  
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 841 QV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE 899
           +  +   DV++ GI+L  +  G  P ++          W                     
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW----------- 229

Query: 900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                  +   S+ L+L  +   E+P  R+   +I  
Sbjct: 230 -------KKIDSAPLALLHKILVENPSARITIPDIKK 259

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 7e-46
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 9/209 (4%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVF---HLQREGALNSFDAECEILKT 716
           +  + F    ++G GS+ +V   R      E AIK+    H+ +E  +     E +++  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
           + H   VK+  +  +       L Y   G L   +     + D         ++ SALEY
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEY 123

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLA-TIGYIAPE 835
           LH      I+H D+KP N+LL++ M   ++DFG AK+LS E    +  +   T  Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 836 YGREGQVSIKGDVYNYGIMLMEVFTGMKP 864
              E       D++  G ++ ++  G+ P
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  164 bits (417), Expect = 3e-45
 Identities = 54/276 (19%), Positives = 113/276 (40%), Gaps = 25/276 (9%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL 722
           D +     +G G++G V++      G     K  +        +   E  I+  + H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           + +  +  +     L+LE++  G L D + A ++ +   + +  M      L+++   H 
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HE 145

Query: 783 NPIVHCDIKPSNVLLD--DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           + IVH DIKP N++ +   +    + DFG+A  L+ ++ +K T    T  + APE     
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA--TAEFAAPEIVDRE 203

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            V    D++  G++   + +G+ P    F GE        D L  + N+   +   +++ 
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSP----FAGE--------DDLETLQNVKRCDWEFDEDA 251

Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
            ++V+ +               + P  R+   + + 
Sbjct: 252 FSSVSPE-----AKDFIKNLLQKEPRKRLTVHDALE 282

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 9e-45
 Identities = 59/302 (19%), Positives = 126/302 (41%), Gaps = 39/302 (12%)

Query: 654 YSHDELLRATDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQR-EGALNS 706
           Y  DE   A ++ +    +G GS+G VY+G             VAIK  +          
Sbjct: 10  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69

Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMY---------ASNFN 757
           F  E  ++K     ++V+++   +      +++E M +G L+  +               
Sbjct: 70  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129

Query: 758 LDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE 817
             + + + +  ++A  + YL+   +N  VH D+   N ++ +     + DFG+ + + E 
Sbjct: 130 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186

Query: 818 DSMKQTQT-LATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK 876
           D  ++    L  + +++PE  ++G  +   DV+++G++L E+ T  +   +  + E  ++
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246

Query: 877 RWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
                       +M+  LL + +         C   +  L   C   +P+ R +  EIIS
Sbjct: 247 F-----------VMEGGLLDKPDN--------CPDMLFELMRMCWQYNPKMRPSFLEIIS 287

Query: 937 RL 938
            +
Sbjct: 288 SI 289

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  157 bits (397), Expect = 2e-43
 Identities = 61/292 (20%), Positives = 128/292 (43%), Gaps = 32/292 (10%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFH---LQREGALNSFDAECEILKTIR 718
           +D++    ++G G    V+  R      +VA+KV      +       F  E +    + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 719 HRNLVKIISSCTNHNFKA----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
           H  +V +  +            +V+EY+   +L D ++     +   + + ++ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQAL 124

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS--MKQTQTLATIGYI 832
            + H    N I+H D+KP+N+++  +    + DFGIA+ +++  +   +    + T  Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           +PE  R   V  + DVY+ G +L EV TG  P    FTG+          +      +  
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD--------SPVSVAYQHVRE 229

Query: 893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNT-KEIISRLIKIRD 943
           + +     H  ++       + ++ ++  +++PENR  T  E+ + L+++ +
Sbjct: 230 DPIPPSARHEGLSAD-----LDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 1e-42
 Identities = 61/304 (20%), Positives = 125/304 (41%), Gaps = 48/304 (15%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFP--------DGIEVAIKVFHLQR-EGALNSFDAECEIL 714
           D+      +G G++G V                 +VA+K+      E  L+   +E E++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 715 KTI-RHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCM---------------YASNFNL 758
           K I +H+N++ ++ +CT      +++EY  KG+L + +               +     L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 759 DIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED 818
                +     VA  +EYL    S   +H D+   NVL+ +  V  ++DFG+A+ +   D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 819 SMKQTQTLA-TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKR 877
             K+T      + ++APE   +   + + DV+++G++L E+FT        + G      
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGV----- 241

Query: 878 WINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR 937
                +  +  ++      +   +       C + +  +  +C    P  R   K+++  
Sbjct: 242 ----PVEELFKLLKEGHRMDKPSN-------CTNELYMMMRDCWHAVPSQRPTFKQLVED 290

Query: 938 LIKI 941
           L +I
Sbjct: 291 LDRI 294

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-40
 Identities = 53/274 (19%), Positives = 113/274 (41%), Gaps = 26/274 (9%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL 722
           +++     +G G +G V++            K   ++    +     E  IL   RHRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNI 63

Query: 723 VKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHS 782
           + +  S  +     ++ E++    + + +  S F L+  + +  +  V  AL++L   HS
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HS 120

Query: 783 NPIVHCDIKPSNVLLDDSMVAH--LSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
           + I H DI+P N++      +   + +FG A+ L   D+ +   T     Y APE  +  
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHD 178

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
            VS   D+++ G ++  + +G+ P    F  E + +         + NIM+     ++E 
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP----FLAETNQQ--------IIENIMNAEYTFDEEA 226

Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
              ++ +      +        +  ++R+   E 
Sbjct: 227 FKEISIE-----AMDFVDRLLVKERKSRMTASEA 255

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  148 bits (375), Expect = 4e-40
 Identities = 54/265 (20%), Positives = 108/265 (40%), Gaps = 25/265 (9%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFH---LQREGALNSFDAECEILKTIRH 719
             F     +G GS+G V+  R   +G   A+KV     + R   +   + E  +L  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             ++++  +  +     ++++Y+  G L   +  S    +   +     +V      L +
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVC---LALEY 119

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
            HS  I++ D+KP N+LLD +    ++DFG AK + +           T  YIAPE    
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVST 175

Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKPTNE---------FFTGEMSIKRWINDSLPAVMNIM 890
              +   D +++GI++ E+  G  P  +             E+    + N+ +  +++  
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS-- 233

Query: 891 DTNLLSEDEEHANVAKQSCASSVLS 915
              L++ D        Q+    V +
Sbjct: 234 --RLITRDLSQRLGNLQNGTEDVKN 256

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  146 bits (370), Expect = 6e-40
 Identities = 61/290 (21%), Positives = 111/290 (38%), Gaps = 40/290 (13%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHL---------QREGALNSFDAECEI 713
           + +  + ++G G    V +    P   E A+K+  +         + +    +   E +I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 714 LKTIR-HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
           L+ +  H N++++  +   + F  LV + M KG L D +      L   +   IM  +  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLE 121

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYI 832
            +  LH      IVH D+KP N+LLDD M   L+DFG +  L   + +   +   T  Y+
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYL 176

Query: 833 APEYGREGQV------SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV 886
           APE               + D+++ G+++  +  G  P    F             +  +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHR--------KQMLML 224

Query: 887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
             IM  N      E  + +       V  L        P+ R   +E ++
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDT-----VKDLVSRFLVVQPQKRYTAEEALA 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (369), Expect = 2e-39
 Identities = 51/276 (18%), Positives = 97/276 (35%), Gaps = 22/276 (7%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHR 720
            D +   +++G G++  V           VAIK    +  EG   S + E  +L  I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
           N+V +     +     L+++ +  G L D +    F         ++  V  A++YLH  
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
                           LD+     +SDFG++K+      +  +    T GY+APE   + 
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGTPGYVAPEVLAQK 184

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE 900
             S   D ++ G++   +  G  P    F  E        +       I+      +   
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPP----FYDE--------NDAKLFEQILKAEYEFDSPY 232

Query: 901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
             +++                 + PE R   ++ + 
Sbjct: 233 WDDISDS-----AKDFIRHLMEKDPEKRFTCEQALQ 263

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (367), Expect = 2e-39
 Identities = 53/283 (18%), Positives = 106/283 (37%), Gaps = 14/283 (4%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRN 721
           +++     IG G+YG VYK +   G   A+K   L++  EG  ++   E  ILK ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 722 LVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGH 781
           +VK+           LV E++    L+  +      L+       ++ + + + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 782 SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQ 841
              ++H D+KP N+L++      ++DFG+A+           + +              +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 842 VSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIKRWINDSLPAVMNI-----MDTN 893
            S   D+++ G +  E+  G       +E        +     +     N+      D N
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
               +        +    S + L  +     P  R+  K+ + 
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 9e-39
 Identities = 55/310 (17%), Positives = 111/310 (35%), Gaps = 49/310 (15%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQR-EGALNSFDAECEILKT 716
           D+      +G G++G V +              VA+K+           +  +E +IL  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 717 IRHRNLVKII--SSCTNHNFKALVLEYMPKGSLEDCMYASNFN---------------LD 759
           I H   V  +  +         +++E+   G+L   + +                   L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 760 IFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS 819
           +   +     VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ + ++  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 820 MKQTQTLA-TIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW 878
             +       + ++APE   +   +I+ DV+++G++L E+F+           +    R 
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 879 INDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           + +     M   D                     +    ++C    P  R    E++  L
Sbjct: 250 LKEGTR--MRAPD----------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 939 IKIRDLLFAN 948
               +LL AN
Sbjct: 292 ---GNLLQAN 298

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  144 bits (364), Expect = 4e-38
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 15/209 (7%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHL------QREGALNSFDAECEILKT 716
           + FS   +IG G +G VY  R  D G   A+K          Q E    +      ++ T
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
                +V +  +    +  + +L+ M  G L   +       +         ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEY 836
           +H   +  +V+ D+KP+N+LLD+     +SD G+A   S++   K   ++ T GY+APE 
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEV 176

Query: 837 GREGQ-VSIKGDVYNYGIMLMEVFTGMKP 864
            ++G       D ++ G ML ++  G  P
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 205

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 7e-38
 Identities = 57/284 (20%), Positives = 110/284 (38%), Gaps = 14/284 (4%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHL--QREGALNSFDAECEILKTIRHR 720
           + F +   IG G+YG VYK R    G  VA+K   L  + EG  ++   E  +LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
           N+VK++      N   LV E++ +   +    ++   + +      +  +   L + H  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
            S+ ++H D+KP N+L++      L+DFG+A+           + +              
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKP------TNEFFTGEMSIKRWINDSLPAVMNIMDTNL 894
             S   D+++ G +  E+ T           ++ F    ++        P V ++ D   
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 895 LSEDEEHANVAK--QSCASSVLSLAMECTSESPENRVNTKEIIS 936
                   + +K          SL  +     P  R++ K  ++
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 9e-38
 Identities = 55/289 (19%), Positives = 105/289 (36%), Gaps = 28/289 (9%)

Query: 660 LRATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIR 718
           LR  +++     IG GS+G +Y G     G EVAIK+  ++ +        E +I K ++
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQ 60

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
               +  I  C       +++  +   SLED     +    +   L +   + S +EY+ 
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI- 119

Query: 779 FGHSNPIVHCDIKPSNVL---LDDSMVAHLSDFGIAKLLSEEDS------MKQTQTLATI 829
             HS   +H D+KP N L        + ++ DFG+AK   +  +       +      T 
Sbjct: 120 --HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 830 GYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNI 889
            Y +       + S + D+ + G +LM           F  G +  +     +       
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLM----------YFNLGSLPWQGLKAATKRQKYER 227

Query: 890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRL 938
           +    +S   E      +   S   +    C S   +++ +   +    
Sbjct: 228 ISEKKMSTPIEVLC---KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 3e-37
 Identities = 58/284 (20%), Positives = 111/284 (39%), Gaps = 34/284 (11%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHL------QREGALNSFDAECEILKT 716
           D +     +G G +  V K R    G++ A K          +R  +    + E  ILK 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 717 IRHRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEY 776
           I+H N++ +     N     L+LE +  G L D +     +L   +    +  + +    
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNG--- 125

Query: 777 LHFGHSNPIVHCDIKPSNVLLDDSMVA----HLSDFGIAKLLSEEDSMKQTQTLATIGYI 832
           +++ HS  I H D+KP N++L D  V      + DFG+A  +   +         T  ++
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 183

Query: 833 APEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT 892
           APE      + ++ D+++ G++   + +G  P    F G+   +           N+   
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETL--------ANVSAV 231

Query: 893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
           N   EDE  +N +                 + P+ R+  ++ + 
Sbjct: 232 NYEFEDEYFSNTSAL-----AKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 4e-37
 Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 10/206 (4%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFH---LQREGALNSFDAECEIL-KTIR 718
           + F    ++G GS+G V+   F       AIK      +  +  +     E  +L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 719 HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLH 778
           H  L  +  +         V+EY+  G L   +  S    D+ +      ++   L++LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLH 120

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR 838
              S  IV+ D+K  N+LLD      ++DFG+ K     D+ K      T  YIAPE   
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILL 176

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKP 864
             + +   D +++G++L E+  G  P
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSP 202

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 5e-37
 Identities = 66/294 (22%), Positives = 120/294 (40%), Gaps = 23/294 (7%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGRF--PDGIEVAIKVFHLQ--REGALNSFDAECEILKT 716
           RA  Q+     IG G+YG V+K R     G  VA+K   +Q   EG   S   E  +L+ 
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 717 I---RHRNLVKIISSCTNHNFKA-----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMI 768
           +    H N+V++   CT           LV E++ +             +       +M 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 769 DVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLAT 828
            +   L++LH   S+ +VH D+KP N+L+  S    L+DFG+A++ S + ++  T  + T
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178

Query: 829 IGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP------TNEFFTGEMSIKRWINDS 882
           + Y APE   +   +   D+++ G +  E+F            ++       I     + 
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
            P  + +      S+  +               L ++C + +P  R++    +S
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 9e-37
 Identities = 54/278 (19%), Positives = 102/278 (36%), Gaps = 33/278 (11%)

Query: 669 ENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEIL-KTIRHRNLVKII 726
             ++G+G  G V +        + A+K+     +        E E+  +  +  ++V+I+
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71

Query: 727 SSC----TNHNFKALVLEYMPKGSLEDCMYASNFN-LDIFQRLGIMIDVASALEYLHFGH 781
                         +V+E +  G L   +           +   IM  +  A++YLH   
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 128

Query: 782 SNPIVHCDIKPSNVLLDDSM---VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGR 838
           S  I H D+KP N+L        +  L+DFG AK  +  +S+       T  Y+APE   
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLG 186

Query: 839 EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED 898
             +     D+++ G+++  +  G  P             + ++   A+   M T +    
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPP-------------FYSNHGLAISPGMKTRIRMGQ 233

Query: 899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS 936
            E  N      +  V  L        P  R+   E ++
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 3e-36
 Identities = 62/291 (21%), Positives = 110/291 (37%), Gaps = 26/291 (8%)

Query: 664 DQFSEENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL 722
             +++  +IG GS+G VY+ +  D G  VAIK     +       + E +I++ + H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNI 75

Query: 723 VKIISSCT------NHNFKALVLEYMPKGSLEDCMYASNFN--LDIFQRLGIMIDVASAL 774
           V++           +  +  LVL+Y+P+       + S     L +      M  +  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
            Y+   HS  I H DIKP N+LLD D+ V  L DFG AK L   +    +   +      
Sbjct: 136 AYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAP 191

Query: 834 PEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN 893
                    +   DV++ G +L E+  G          +  ++       P    I + N
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 894 LLSEDEEHANVAKQSCASSV--------LSLAMECTSESPENRVNTKEIIS 936
               + +   +                 ++L       +P  R+   E  +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 4e-36
 Identities = 55/291 (18%), Positives = 113/291 (38%), Gaps = 20/291 (6%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFH-LQREGALNSFDAECEILKTIRHR 720
             +++  + IG G+YG V       + + VAIK     + +        E +IL   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYA--SNFNLDIFQRLGIMIDVASALEYLH 778
           N++ I         + +   Y+    +   +Y      +L        +  +   L+Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 779 FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQT--LATIGYIAPEY 836
              S  ++H D+KPSN+LL+ +    + DFG+A++   +       T  +AT  Y APE 
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 837 GREGQVSI-KGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIKRWINDSLPAVMNIMDT 892
               +      D+++ G +L E+ +        +        +    + S   +  I++ 
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 893 NLLSEDEEHANVAKQ-------SCASSVLSLAMECTSESPENRVNTKEIIS 936
              +      +  K        +  S  L L  +  + +P  R+  ++ ++
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 5e-36
 Identities = 49/288 (17%), Positives = 106/288 (36%), Gaps = 22/288 (7%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHR 720
            ++ +   IG G+YG+V+K +       VA+K   L    EG  +S   E  +LK ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 721 NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG 780
           N+V++     +     LV E+  +   +     +    D       +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS- 119

Query: 781 HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREG 840
               ++H D+KP N+L++ +    L++FG+A+           + +              
Sbjct: 120 --RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 841 QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE----------MSIKRWINDSLPAVMNIM 890
             S   D+++ G +  E+    +P    F G             +     +  P++  + 
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 891 DTNLLSEDEEHANVAK--QSCASSVLSLAMECTSESPENRVNTKEIIS 936
           D           ++        ++   L       +P  R++ +E + 
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-35
 Identities = 62/280 (22%), Positives = 119/280 (42%), Gaps = 19/280 (6%)

Query: 670 NLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ-----REGALNSFDAECEILKTIRHRNLV 723
           + +G G + +VYK R       VAIK   L      ++G   +   E ++L+ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 724 KIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSN 783
            ++ +  + +  +LV ++M    LE  +  ++  L        M+     LEYLH    +
Sbjct: 64  GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 784 PIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQV- 842
            I+H D+KP+N+LLD++ V  L+DFG+AK      +   T  + T  Y APE     ++ 
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 843 SIKGDVYNYGIMLMEVFTGMKP------TNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
            +  D++  G +L E+   +         ++      ++     +  P + ++ D     
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 897 EDEEHANVAKQSCASS-VLSLAMECTSESPENRVNTKEII 935
                      S A   +L L       +P  R+   + +
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 3e-35
 Identities = 52/241 (21%), Positives = 89/241 (36%), Gaps = 20/241 (8%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNS------FDAECEILKT 716
            Q+    L+G G +GSVY G    D + VAIK     R               E  +LK 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 717 IR--HRNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
           +      +++++      +   L+LE                 L           V  A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIA 833
            +    H+  ++H DIK  N+L+D +     L DFG   LL +      T    T  Y  
Sbjct: 124 RHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 177

Query: 834 PEYGREGQV-SIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIKRWINDSLPAVMNI 889
           PE+ R  +       V++ GI+L ++  G  P     E   G++  ++ ++     ++  
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 237

Query: 890 M 890
            
Sbjct: 238 C 238

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  129 bits (325), Expect = 1e-33
 Identities = 39/285 (13%), Positives = 89/285 (31%), Gaps = 30/285 (10%)

Query: 669 ENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIIS 727
              IG GS+G +++G    +  +VAIK    + +        E    K +     +  + 
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVY 67

Query: 728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVH 787
                    +++  +   SLED +        +         + + ++ +   H   +V+
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVY 124

Query: 788 CDIKPSNVLLDDSMVAH-----LSDFGIAKLLSEEDS------MKQTQTLATIGYIAPEY 836
            DIKP N L+      +     + DFG+ K   +  +       ++     T  Y++   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 837 GREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS 896
               + S + D+   G + M    G    +  + G  +       +      I +    +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRG----SLPWQGLKA-----ATNKQKYERIGEKKQST 235

Query: 897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI 941
              E                     + + +   +   +     K+
Sbjct: 236 PLRELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 8e-33
 Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 9/205 (4%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFH---LQREGALNSFDAECEILKTIRH 719
           + F    L+G G++G V   R    G   A+K+     +  +  +     E  +L+  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             L  +  +   H+    V+EY   G L   +          +      ++ SAL    +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSAL---EY 120

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
            HS  +V+ DIK  N++LD      ++DFG+ K    + +  +T    T  Y+APE   +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLED 179

Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKP 864
                  D +  G+++ E+  G  P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (321), Expect = 1e-32
 Identities = 50/227 (22%), Positives = 88/227 (38%), Gaps = 18/227 (7%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFH---LQREGALNSFDAECEILKTIRH 719
           DQF     +G GS+G V   +    G   A+K+     + +   +     E  IL+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 720 RNLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF 779
             LVK+  S  +++   +V+EY+  G +   +                  +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 158

Query: 780 GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGRE 839
             S  +++ D+KP N+L+D      ++DFG AK        +      T   +APE    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILS 212

Query: 840 GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE--MSIKRWINDSLP 884
              +   D +  G+++ E+  G  P    F  +  + I   I     
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVSGKV 255

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 2e-32
 Identities = 58/302 (19%), Positives = 118/302 (39%), Gaps = 30/302 (9%)

Query: 661 RATDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTI 717
               ++ +   IG G++G V+K R    G +VA+K   ++  +EG   +   E +IL+ +
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66

Query: 718 RHRNLVKIISSCTNHNFKA--------LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMID 769
           +H N+V +I  C               LV ++                  + +   +M  
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQM 125

Query: 770 VASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS---MKQTQTL 826
           +   L  L++ H N I+H D+K +NVL+    V  L+DFG+A+  S   +    + T  +
Sbjct: 126 L---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 827 ATIGYIAPEYGREGQ-VSIKGDVYNYGIMLMEVFTGMKPTN-----------EFFTGEMS 874
            T+ Y  PE     +      D++  G ++ E++T                     G ++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEI 934
            + W N     +   ++     + +    +         L L  +     P  R+++ + 
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

Query: 935 IS 936
           ++
Sbjct: 303 LN 304

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 6e-31
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 15/212 (7%)

Query: 664 DQFSEENLIGIGSYGSVYKGR----FPDGIEVAIKVFH----LQREGALNSFDAECEILK 715
           + F    ++G G+YG V+  R       G   A+KV      +Q+         E ++L+
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 716 TIRHR-NLVKIISSCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
            IR    LV +  +        L+L+Y+  G L   +       + F    + I V   +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIV 139

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
             L   H   I++ DIK  N+LLD +    L+DFG++K    +++ +      TI Y+AP
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 835 EYGREGQVSI--KGDVYNYGIMLMEVFTGMKP 864
           +  R G        D ++ G+++ E+ TG  P
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  115 bits (289), Expect = 1e-28
 Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 21/232 (9%)

Query: 647 PQVMWRRYSHDELLRATDQFSEENLIGIGSYGSVYKGR-FPDGIEVAIKVFHLQREGALN 705
           P+  W   SH       D +     +G G Y  V++     +  +V +K+    ++    
Sbjct: 18  PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---K 74

Query: 706 SFDAECEILKTIR-HRNLVKIISSCTNHNFK--ALVLEYMPKGSLEDCMYASNFNLDIFQ 762
               E +IL+ +R   N++ +     +   +  ALV E++     +         L  + 
Sbjct: 75  KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYD 130

Query: 763 RLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMK 821
               M ++  AL+Y H   S  I+H D+KP NV++D +     L D+G+A+         
Sbjct: 131 IRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186

Query: 822 QTQTLATIGYIAPEYGREGQ-VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGE 872
               +A+  +  PE   + Q      D+++ G ML  +    +P   FF G 
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGH 234

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-28
 Identities = 56/306 (18%), Positives = 111/306 (36%), Gaps = 32/306 (10%)

Query: 654 YSHDELLRAT----DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFH--LQREGALNS 706
           +   E+ +        + +   +G G+YG+V        G +VAIK  +   Q E     
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 707 FDAECEILKTIRHRNLVKIISSCTNHNFKA------LVLEYMPKGSLEDCMYASNFNLDI 760
              E  +LK +RH N++ ++   T            LV+ +M     +      +  L  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGE 120

Query: 761 FQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM 820
            +   ++  +   L Y+H   +  I+H D+KP N+ +++     + DFG+A+   + DS 
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSE 174

Query: 821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKP---------TNEFFTG 871
                +              + +   D+++ G ++ E+ TG              E    
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234

Query: 872 EMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASS-VLSLAMECTSESPENRVN 930
             +        L +         L E E+    +  + AS   ++L  +      E RV 
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294

Query: 931 TKEIIS 936
             E ++
Sbjct: 295 AGEALA 300

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 1e-27
 Identities = 45/292 (15%), Positives = 105/292 (35%), Gaps = 26/292 (8%)

Query: 663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFH--LQREGALNSFDAECEILKTIRH 719
            +++   + +G G+YGSV        G+ VA+K      Q          E  +LK ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 720 RNLVKIISSCTNHNFKA-----LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
            N++ ++   T            ++ ++    L + +              ++  +   L
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHVQFLIYQILRGL 134

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           +Y+H   S  I+H D+KPSN+ +++     + DFG+A+     D                
Sbjct: 135 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPE 188

Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTGMKP---TNEFFTGEMSIKRWINDSLPAVMNIMD 891
                   +   D+++ G ++ E+ TG      T+     ++ ++         +  I  
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248

Query: 892 TNLLSEDEEHANVAKQSCA-------SSVLSLAMECTSESPENRVNTKEIIS 936
            +  +  +    + K + A          + L  +      + R+   + ++
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 1e-26
 Identities = 56/303 (18%), Positives = 104/303 (34%), Gaps = 39/303 (12%)

Query: 664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFH--LQREGALNSFDAECEILKTIRHR 720
            ++     IG G+ G V           VAIK      Q +        E  ++K + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 721 NLVKIISSCTNHNFK------ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASAL 774
           N++ +++  T            LV+E M     +         LD  +   ++  +   +
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGI 132

Query: 775 EYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAP 834
           ++LH   S  I+H D+KPSN+++       + DFG+A+       M  T  + T  Y AP
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAP 187

Query: 835 EYGREGQVSIKGDVYNYGIMLMEVFTG--------------------MKPTNEFFTGEMS 874
           E           D+++ G ++ E+                         P  EF      
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247

Query: 875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASS-VLSLAMECTSESPENRVNTKE 933
             R   ++ P    +    L  +    A+       +S    L  +     P  R++  +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307

Query: 934 IIS 936
            + 
Sbjct: 308 ALQ 310

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  108 bits (270), Expect = 6e-26
 Identities = 43/242 (17%), Positives = 87/242 (35%), Gaps = 24/242 (9%)

Query: 669 ENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIIS 727
              +G G + +V+  +   +   VA+K+     +    + + E ++L+ +   +  K  S
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 728 SCTNHNFK---------------ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVAS 772
              NH  K                +V E + +  L       +  + +     I   +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 773 ALEYLHFGHSNPIVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLSEEDSMKQTQTLATI-G 830
            L+Y+H      I+H DIKP NVL++      +L    IA L +     +          
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 831 YIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIM 890
           Y +PE           D+++   ++ E+ TG      F   E       +D +  ++ ++
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL---FEPDEGHSYTKDDDHIAQIIELL 251

Query: 891 DT 892
             
Sbjct: 252 GE 253

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 96.4 bits (239), Expect = 3e-23
 Identities = 25/164 (15%), Positives = 50/164 (30%), Gaps = 26/164 (15%)

Query: 670 NLIGIGSYGSVYKGRFPDGIEVAIKVFHL----------QREGALNSFDAECEILKTIRH 719
            L+G G   +V+        E  +K   +          +R+     F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 720 RNLVKIISSCTNHNF----KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALE 775
           R L K+        +     A+++E +    L                  ++  +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRV--------ENPDEVLDMILEEVA 117

Query: 776 YLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS 819
                +   IVH D+   NVL+ +  +  + DF  +  + EE  
Sbjct: 118 KF---YHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGW 157

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  100 bits (248), Expect = 5e-23
 Identities = 72/401 (17%), Positives = 130/401 (32%), Gaps = 36/401 (8%)

Query: 152 PGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLG 211
             L       +        +        +++++              +     L  ++  
Sbjct: 19  TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 74

Query: 212 FNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSK 271
            N L    P  + NL  L  + ++ + +    P       T   L     T    L +  
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 272 NLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSEL 331
           NL  L          N +S         + +  +                  L   T+  
Sbjct: 133 NLNRLELSS------NTISDISALSGLTSLQQLSFGNQVTDLK--------PLANLTTLE 178

Query: 332 MSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIP 391
               S+        +  L NL +L   +N +S   P+ +     L  L L  N+ +    
Sbjct: 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDI-- 234

Query: 392 QEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGF 451
                 + L  + L  N++S   P  L  L  L  L L +N+++++ P     L  +   
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 290

Query: 452 DFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIP 511
           + + N L       I NLK +  + L  NN+S   P  +  L  LQ L   +NK+     
Sbjct: 291 ELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-- 344

Query: 512 ESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFN 552
            S   L ++ +L   +N +S + P  L  L  +  L L+  
Sbjct: 345 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 97.4 bits (241), Expect = 4e-22
 Identities = 82/387 (21%), Positives = 133/387 (34%), Gaps = 32/387 (8%)

Query: 55  NLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNN 114
            L+     VL +   + T+ +   +L ++  L  D   ++    + +  L  L  +  +N
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75

Query: 115 NLLTGTIPAS--------IFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQ 166
           N LT   P          + N + I+     ++ +                    ++   
Sbjct: 76  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135

Query: 167 FKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLN-GEIPQEIGN 225
                 N +     LS ++       G    DL     L +L+    + N       +  
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195

Query: 226 LRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLG 285
           L NLE L    + +    P  I   + L  LSL  N L         L  L NL  L+L 
Sbjct: 196 LTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD----IGTLASLTNLTDLDLA 249

Query: 286 LNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLK 345
            N +S   P      +KL  L+LG N          + L   T+      +         
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQI-----SNISPLAGLTALTNLELNENQLEDISP 302

Query: 346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYL 405
           I NL NLT L+L  NN+S   P+    L KLQ L   NNK          + + +  +  
Sbjct: 303 ISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358

Query: 406 NRNKLSGSIPSCLGDLNSLRILSLSSN 432
             N++S   P  L +L  +  L L+  
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 83.5 bits (205), Expect = 2e-17
 Identities = 75/368 (20%), Positives = 135/368 (36%), Gaps = 28/368 (7%)

Query: 201 NSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFN 260
              +     LG  N+   + Q   +L  +  L  D+  +     D +  ++ L  ++  N
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 261 NTLSGNLPSSKNLIGLPNLEG---------LNLGLNNLSGSIPSFFFNASKLYALELGYN 311
           N L+  +   KNL  L ++               L NL+G                L   
Sbjct: 76  NQLTD-ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134

Query: 312 SNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLG 371
           + L+      + ++  +        +  N  +         T   L  ++   S    L 
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194

Query: 372 RLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSS 431
           +L  L+ L   NN+     P      + L  + LN N+L       L  L +L  L L++
Sbjct: 195 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250

Query: 432 NELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTII 491
           N+++++ P     L  +      +N ++   PL    L A+ ++ L+ N       S I 
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLA--GLTALTNLELNENQ--LEDISPIS 304

Query: 492 GLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSF 551
            LKNL +L+L  N +    P     L  L+ L  +NN +S    +SL  L  +  L+   
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360

Query: 552 NKLVGEIP 559
           N++    P
Sbjct: 361 NQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 61.9 bits (149), Expect = 1e-10
 Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 6/115 (5%)

Query: 1   MINDNPNNILAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQ 60
           + N +P   L        +      I+       +T LT+    ++   P  + +L+ LQ
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 332

Query: 61  TLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNN 115
            L  + N  S      + NLT +  L   +N++    P  L NL  +  L LN+ 
Sbjct: 333 RLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 97.4 bits (241), Expect = 1e-22
 Identities = 61/307 (19%), Positives = 99/307 (32%), Gaps = 31/307 (10%)

Query: 21  CSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNL 80
           C    + C            SDLGL   +P  L        L L  N  +     +  NL
Sbjct: 10  CHLRVVQC------------SDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNL 54

Query: 81  TKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDN 140
             L  L L  NK+    P     L +LE L L+ N L   +P  +         L   +N
Sbjct: 55  KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP---KTLQELRVHEN 110

Query: 141 SLTGSFPYD-MCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDL 199
            +T              +  L  +  +  G         K+LS + ++    T       
Sbjct: 111 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ--- 167

Query: 200 GNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLF 259
           G    L  L L  N +       +  L NL  LG+  +++      ++ N   L+ L L 
Sbjct: 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227

Query: 260 NNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGL 319
           NN L        +      ++ + L  NN+S    + F              ++   + L
Sbjct: 228 NNKLVKVPGGLAD---HKYIQVVYLHNNNISAIGSNDFCPPGYNTKK-----ASYSGVSL 279

Query: 320 ERNYLTF 326
             N + +
Sbjct: 280 FSNPVQY 286

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 93.6 bits (231), Expect = 2e-21
 Identities = 65/324 (20%), Positives = 107/324 (33%), Gaps = 31/324 (9%)

Query: 180 ELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNL 239
            L  V  S      ++P+DL        LDL  N +      +  NL+NL  L +  + +
Sbjct: 11  HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 240 VGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFN 299
               P     +  L+ L L  N L   LP       +P          N    +    FN
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLK-ELPEK-----MPKTLQELRVHENEITKVRKSVFN 121

Query: 300 ASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGD 359
                 +     + LK  G+E          L  +  A  N  ++  G   +LT L L  
Sbjct: 122 GLNQMIVVELGTNPLKSSGIENGAFQGMKK-LSYIRIADTNITTIPQGLPPSLTELHLDG 180

Query: 360 NNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLG 419
           N ++     +L  L  L  L L  N           +   L  ++LN NKL   +P  L 
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 239

Query: 420 DLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSR 479
           D   ++++ L +N ++++  + F                    P       +   + L  
Sbjct: 240 DHKYIQVVYLHNNNISAIGSNDF------------------CPPGYNTKKASYSGVSLFS 281

Query: 480 NNLSGN--IPSTIIGLKNLQHLSL 501
           N +      PST   +     + L
Sbjct: 282 NPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 86.6 bits (213), Expect = 5e-19
 Identities = 59/240 (24%), Positives = 90/240 (37%), Gaps = 7/240 (2%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
           +L  +   D  L   +P  L        LDLQNNK       +F +   L+ + L  NK+
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 411 SGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLK 470
           S   P     L  L  L LS N+L  +       L+++   +     +  S+     N  
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQM 126

Query: 471 AVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDL 530
            VV++  +    SG       G+K L ++ +    +   IP+      SL  L L  N +
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI 183

Query: 531 SGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCK 590
           + V  ASL+ L  L  L LSFN +        A      E  + N+ L   P        
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 82.0 bits (201), Expect = 2e-17
 Identities = 49/297 (16%), Positives = 98/297 (32%), Gaps = 41/297 (13%)

Query: 269 SSKNLIGLP-----NLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNY 323
           S   L  +P     +   L+L  N ++      F N   L+ L L  N            
Sbjct: 18  SDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK----------- 66

Query: 324 LTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQN 383
                         +          L+ L  L L  N L          L++L+  + + 
Sbjct: 67  --------------ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEI 112

Query: 384 NKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFW 443
            K    +         + +   N  K SG        +  L  + ++   +T++      
Sbjct: 113 TKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPP 171

Query: 444 NLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEH 503
           +L ++       N +       ++ L  +  + LS N++S     ++    +L+ L L +
Sbjct: 172 SLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228

Query: 504 NKLQGPIPESFGELVSLEFLDLSNNDLSGV------IPASLEKLLYLKSLNLSFNKL 554
           NKL   +P    +   ++ + L NN++S +       P    K      ++L  N +
Sbjct: 229 NKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 80.9 bits (198), Expect = 5e-17
 Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 8/229 (3%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
           +   L L +N ++         LK L  L L NNK     P  F    +L  +YL++N+L
Sbjct: 32  DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91

Query: 411 SGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLED--ILGFDFSSNSLNGSLPLEIEN 468
              +P  +        L +  NE+T V  S F  L    ++    +    +G      + 
Sbjct: 92  K-ELPEKMPKTLQE--LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 148

Query: 469 LKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN 528
           +K +  I ++  N++  IP  +    +L  L L+ NK+      S   L +L  L LS N
Sbjct: 149 MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205

Query: 529 DLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDL 577
            +S V   SL    +L+ L+L+ NKLV                   N++
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI 254

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 53.1 bits (126), Expect = 7e-08
 Identities = 27/126 (21%), Positives = 41/126 (32%)

Query: 475 IYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVI 534
           + L  N ++         LKNL  L L +NK+    P +F  LV LE L LS N L  + 
Sbjct: 36  LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELP 95

Query: 535 PASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLCKSSPH 594
               + L  L+       K+   +  G                          + K S  
Sbjct: 96  EKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI 155

Query: 595 KKSRKQ 600
           + +   
Sbjct: 156 RIADTN 161

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 95.6 bits (236), Expect = 5e-22
 Identities = 72/281 (25%), Positives = 105/281 (37%), Gaps = 55/281 (19%)

Query: 4   DNPNNILAQNWTSNASVC--SWMGITCDVYGN--RVTSLTISDLGLAG--TIPSHLGNLS 57
            NP  +   +W      C  +W+G+ CD      RV +L +S L L     IPS L NL 
Sbjct: 19  GNPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP 76

Query: 58  SLQTLVLSRNW-FSGTIPKEIGNLTKLKELHL------------------------DYNK 92
            L  L +       G IP  I  LT+L  L++                         YN 
Sbjct: 77  YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136

Query: 93  LQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCP 152
           L G +P  + +L  L  +  + N ++G IP S  + S + T++  S N LTG  P     
Sbjct: 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196

Query: 153 GLPRLK---------------------GLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQF 191
                                                      +   K L+ + L  N+ 
Sbjct: 197 LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRI 256

Query: 192 TGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEIL 232
            G LP+ L     L SL++ FNNL GEIP + GNL+  ++ 
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVS 296

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 94.8 bits (234), Expect = 1e-21
 Identities = 72/277 (25%), Positives = 109/277 (39%), Gaps = 31/277 (11%)

Query: 339 VNCKSLKIGNLINLTTLSLGDNNLSGSLPI--TLGRLKKLQGLDLQNN-KFEGPIPQEFC 395
           V C +        +  L L   NL    PI  +L  L  L  L +       GPIP    
Sbjct: 41  VLCDT--DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98

Query: 396 HFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSS 455
             ++L+ +Y+    +SG+IP  L  + +L  L  S N L+  +P +  +L +++G  F  
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158

Query: 456 NSLNGSLPLEIENLKAVVDIYLSRNN-----------------------LSGNIPSTIIG 492
           N ++G++P    +   +        N                       +     S + G
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218

Query: 493 LKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFN 552
                                 G   +L  LDL NN + G +P  L +L +L SLN+SFN
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278

Query: 553 KLVGEIPRGGAFANFSAESFIGNDLLCGSPYLHVPLC 589
            L GEIP+GG    F   ++  N  LCGSP    P C
Sbjct: 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGSPL---PAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 63.2 bits (152), Expect = 3e-11
 Identities = 21/57 (36%), Positives = 30/57 (52%), Gaps = 2/57 (3%)

Query: 64  LSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVL-NNNLLTG 119
           L  N   GT+P+ +  L  L  L++ +N L GEIP + GNL   ++    NN  L G
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG 306

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.7 bits (231), Expect = 1e-21
 Identities = 57/269 (21%), Positives = 96/269 (35%), Gaps = 9/269 (3%)

Query: 269 SSKNLIGLP-----NLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNY 323
             + L  +P       + + L  N +S    + F     L  L L  N   +        
Sbjct: 19  PQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTG 78

Query: 324 LTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQN 383
           L       +S  + L +        L  L TL L    L    P     L  LQ L LQ+
Sbjct: 79  LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138

Query: 384 NKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFW 443
           N  +      F     L  ++L+ N++S         L+SL  L L  N +  V P  F 
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198

Query: 444 NLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEH 503
           +L  ++     +N+L+      +  L+A+  + L+ N    +  +       LQ      
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSS 257

Query: 504 NKLQGPIPESFGELVSLEFLDLSNNDLSG 532
           +++   +P+    L   +   L+ NDL G
Sbjct: 258 SEVPCSLPQR---LAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.0 bits (198), Expect = 3e-17
 Identities = 50/270 (18%), Positives = 86/270 (31%), Gaps = 7/270 (2%)

Query: 28  CDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELH 87
           C  Y     + +    GL   +P  +   ++ Q + L  N  S            L  L 
Sbjct: 6   CVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILW 62

Query: 88  LDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFP 147
           L  N L          LA LE L L++N    ++  + F+       L            
Sbjct: 63  LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD-RCGLQELG 121

Query: 148 YDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKS 207
             +  GL  L+ LY+  N  +    +       L+ + L  N+ +    R       L  
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181

Query: 208 LDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNL 267
           L L  N +    P    +L  L  L +  +NL     + +  +  L+ L L +N    + 
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241

Query: 268 PSSKNLIGLPNLEGLNLGLNNLSGSIPSFF 297
                      L+      + +  S+P   
Sbjct: 242 R---ARPLWAWLQKFRGSSSEVPCSLPQRL 268

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (194), Expect = 1e-16
 Identities = 52/233 (22%), Positives = 85/233 (36%), Gaps = 1/233 (0%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKL 410
               + L  N +S     +    + L  L L +N         F   + L  + L+ N  
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 411 SGSI-PSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENL 469
             S+ P+    L  L  L L    L  + P  F  L  +       N+L         +L
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152

Query: 470 KAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNND 529
             +  ++L  N +S        GL +L  L L  N++    P +F +L  L  L L  N+
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212

Query: 530 LSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSP 582
           LS +   +L  L  L+ L L+ N  V +      +A         +++ C  P
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.4 bits (160), Expect = 2e-12
 Identities = 44/232 (18%), Positives = 73/232 (31%), Gaps = 6/232 (2%)

Query: 10  LAQNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWF 69
           L   W  +  +                     +  L    P+    L  L TL L R   
Sbjct: 58  LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117

Query: 70  SGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLS 129
               P     L  L+ L+L  N LQ    +   +L  L  L L+ N ++     +   L 
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177

Query: 130 FISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYN 189
            +   L    N +    P+     L RL  LY+  N         L   + L  + L+ N
Sbjct: 178 SL-DRLLLHQNRVAHVHPHAFRD-LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

Query: 190 QFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVG 241
            +     R       L+      + +   +PQ    L   ++  +  ++L G
Sbjct: 236 PWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.7 bits (156), Expect = 7e-12
 Identities = 46/197 (23%), Positives = 69/197 (35%), Gaps = 9/197 (4%)

Query: 339 VNCKSLKIGNL-----INLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE 393
           VNC    +  L      + T L L +N L      TL    +L  L+L   +        
Sbjct: 15  VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG 74

Query: 394 FCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDF 453
                    +  N+ +    +   L  L  L +   S N LTS+       L ++     
Sbjct: 75  TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV---SFNRLTSLPLGALRGLGELQELYL 131

Query: 454 SSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPES 513
             N L    P  +     +  + L+ NNL+      + GL+NL  L L+ N L   IP+ 
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190

Query: 514 FGELVSLEFLDLSNNDL 530
           F     L F  L  N  
Sbjct: 191 FFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.4 bits (155), Expect = 9e-12
 Identities = 49/210 (23%), Positives = 74/210 (35%), Gaps = 7/210 (3%)

Query: 345 KIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVY 404
           ++  + +   ++    NL+ +LP  L   K    L L  N            ++RL  + 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 405 LNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPL 464
           L+R +L+         L  L  L LS N+L S+              D S N L      
Sbjct: 62  LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALT-VLDVSFNRLTSLPLG 118

Query: 465 EIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLD 524
            +  L  + ++YL  N L    P  +     L+ LSL +N L          L +L+ L 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 525 LSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
           L  N L   IP        L    L  N  
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.9 bits (146), Expect = 1e-10
 Identities = 43/208 (20%), Positives = 65/208 (31%), Gaps = 9/208 (4%)

Query: 54  GNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLN 113
             ++S   +   +   +  +P ++        LHL  N L       L     L  L L+
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 114 NNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPN 173
              LT         +            SL           +       VS+N+       
Sbjct: 64  RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-----DVSFNRLTSLPLG 118

Query: 174 NLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILG 233
            L    EL  + L  N+     P  L  + KL+ L L  NNL       +  L NL+ L 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 234 IDQSNLVGFVPDTIFNISTLKILSLFNN 261
           + Q N +  +P   F    L    L  N
Sbjct: 179 L-QENSLYTIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.8 bits (138), Expect = 1e-09
 Identities = 40/195 (20%), Positives = 64/195 (32%), Gaps = 9/195 (4%)

Query: 41  SDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEE 100
               L   +P  L        L LS N         +   T+L +L+LD  +L     + 
Sbjct: 18  DKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG 74

Query: 101 LGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGL 160
                 L +L   +          +   +  +  +     +   S P     GL  L+ L
Sbjct: 75  -----TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129

Query: 161 YVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIP 220
           Y+  N+ K   P  L    +L  +SL+ N  T      L     L +L L  N+L   IP
Sbjct: 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188

Query: 221 QEIGNLRNLEILGID 235
           +       L    + 
Sbjct: 189 KGFFGSHLLPFAFLH 203

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 4e-07
 Identities = 44/196 (22%), Positives = 66/196 (33%), Gaps = 10/196 (5%)

Query: 269 SSKNLIGLP-----NLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNY 323
             +NL  LP     +   L+L  N L     +     ++L  L L      K     +  
Sbjct: 18  DKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL----QVD 73

Query: 324 LTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQN 383
            T      + L    +    L    L  LT L +  N L+      L  L +LQ L L+ 
Sbjct: 74  GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133

Query: 384 NKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFW 443
           N+ +   P       +L  + L  N L+      L  L +L  L L  N L + IP  F+
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFF 192

Query: 444 NLEDILGFDFSSNSLN 459
               +       N   
Sbjct: 193 GSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.004
 Identities = 14/48 (29%), Positives = 16/48 (33%), Gaps = 1/48 (2%)

Query: 47  GTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQ 94
                 L  L +L TL+L  N    TIPK       L    L  N   
Sbjct: 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.8 bits (135), Expect = 5e-09
 Identities = 62/330 (18%), Positives = 106/330 (32%), Gaps = 22/330 (6%)

Query: 176 WHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGID 235
              ++   + L+    +  LP    +   L+SL    N+L  E+P+   +L++L +   +
Sbjct: 35  CLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNN 89

Query: 236 QSNLVGFVP----DTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSG 291
              L    P      + N    K+  L N++    +    N +        +L       
Sbjct: 90  LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGN 149

Query: 292 SIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSEL----MSLFSALVNCKSLKIG 347
           +          L  L   Y  N     L    L+  +       +     L N   L   
Sbjct: 150 NQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTI 209

Query: 348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNR 407
              N    +L D   S                  Q+  F       F   S L       
Sbjct: 210 YADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYL 269

Query: 408 NKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIE 467
           N  S  I S      SL  L++S+N+L   +P+    LE +     S N L   +P   +
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLA-EVPELPQ 324

Query: 468 NLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ 497
           NLK    +++  N L    P     +++L+
Sbjct: 325 NLK---QLHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.2 bits (118), Expect = 7e-07
 Identities = 22/79 (27%), Positives = 34/79 (43%), Gaps = 8/79 (10%)

Query: 476 YLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIP 535
               N  S  I S      +L+ L++ +NKL   +P        LE L  S N L+  +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLAE-VP 320

Query: 536 ASLEKLLYLKSLNLSFNKL 554
              +    LK L++ +N L
Sbjct: 321 ELPQN---LKQLHVEYNPL 336

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.3 bits (113), Expect = 3e-06
 Identities = 21/95 (22%), Positives = 38/95 (40%), Gaps = 9/95 (9%)

Query: 161 YVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIP 220
               N     I +       L  +++S N+    LP        L+ L   FN+L  E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320

Query: 221 QEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKI 255
           +   NL+ L +    + N +   PD   ++  L++
Sbjct: 321 ELPQNLKQLHV----EYNPLREFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.5 bits (111), Expect = 5e-06
 Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 9/89 (10%)

Query: 338 LVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHF 397
             N          +L  L++ +N L   LP    RL++   L    N     +P+     
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLAE-VPEL---P 323

Query: 398 SRLYVVYLNRNKLSGSIPSCLGDLNSLRI 426
             L  +++  N L    P     +  LR+
Sbjct: 324 QNLKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.5 bits (111), Expect = 5e-06
 Identities = 26/95 (27%), Positives = 36/95 (37%), Gaps = 11/95 (11%)

Query: 64  LSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPA 123
              N  S  I         L+EL++  NKL  E+P     L   E L+ + N L   +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPE 321

Query: 124 SIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLK 158
              NL      L    N L   FP D+   +  L+
Sbjct: 322 LPQNL----KQLHVEYNPLR-EFP-DIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 2e-05
 Identities = 57/357 (15%), Positives = 103/357 (28%), Gaps = 46/357 (12%)

Query: 28  CDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLT------ 81
            D    +   L +++LGL+ ++P    +L   ++LV S N  +  +P+   +L       
Sbjct: 33  RDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDN 87

Query: 82  -KLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDN 140
             LK L      L+             E+   +   +      S+  L  +  +L+F   
Sbjct: 88  NNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAA 147

Query: 141 SLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLG 200
                        LP L  +Y   N  K      L     ++  ++       +    L 
Sbjct: 148 GNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT 207

Query: 201 NSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFN 260
                 +L     +L   +         L  L     +L              ++     
Sbjct: 208 TIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLY 267

Query: 261 NTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLE 320
              + +          P+LE LN+  N L   +P+                  L+RL   
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP--------------PRLERLIAS 312

Query: 321 RNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQ 377
            N+L     EL                   NL  L +  N L    P     ++ L+
Sbjct: 313 FNHLA-EVPELPQ-----------------NLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.4 bits (103), Expect = 4e-05
 Identities = 22/98 (22%), Positives = 42/98 (42%), Gaps = 9/98 (9%)

Query: 12  QNWTSNASVCSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSG 71
                  +  S    +       +  L +S+  L   +P+    L   + L+ S N  + 
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA- 317

Query: 72  TIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEM 109
            +P+   NL   K+LH++YN L+ E P+   ++ +L M
Sbjct: 318 EVPELPQNL---KQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.0 bits (94), Expect = 5e-04
 Identities = 26/126 (20%), Positives = 40/126 (31%), Gaps = 16/126 (12%)

Query: 163 SYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQE 222
               F     N      EL       N  +  +         L+ L++  N L  E+P  
Sbjct: 244 QSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL 302

Query: 223 IGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGL 282
              L  L        N +  VP+   N   LK L +  N L    P         ++E  
Sbjct: 303 PPRLERLIA----SFNHLAEVPELPQN---LKQLHVEYNPLRE-FPDI-----PESVE-- 347

Query: 283 NLGLNN 288
           +L +N+
Sbjct: 348 DLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.001
 Identities = 21/99 (21%), Positives = 32/99 (32%), Gaps = 34/99 (34%)

Query: 133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFT 192
             L+ S+N L    P       PRL+ L  S+N                           
Sbjct: 287 EELNVSNNKLI-ELP----ALPPRLERLIASFNHLA------------------------ 317

Query: 193 GRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEI 231
             +P    N   LK L + +N L  E P    ++ +L +
Sbjct: 318 -EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.3 bits (124), Expect = 6e-08
 Identities = 38/217 (17%), Positives = 72/217 (33%), Gaps = 22/217 (10%)

Query: 348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNR 407
            L N   ++ G +N++    +T   L  +  L            +   + + L  + L  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 408 NKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIE 467
           N+++   P       +   LS +  +  S I          L     ++    +    ++
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 468 NLKAVVDI--------------YLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPES 513
            L   ++               YLS  N   +  + +  L  L  L  + NK+    P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 514 FGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLS 550
              L +L  + L NN +S V P  L     L  + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.0 bits (118), Expect = 3e-07
 Identities = 34/194 (17%), Positives = 66/194 (34%), Gaps = 20/194 (10%)

Query: 348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNR 407
           +L  +TTLS     ++ ++   +  L  L GL+L++N+     P +         +  N 
Sbjct: 39  DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNP 96

Query: 408 NKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSL--------- 458
            K   +I             +  ++       S    L   L    + + L         
Sbjct: 97  LKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYL 156

Query: 459 -----NGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPES 513
                  S    + NL  +  +    N +S   P  +  L NL  + L++N++    P  
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-- 212

Query: 514 FGELVSLEFLDLSN 527
                +L  + L+N
Sbjct: 213 LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 1e-06
 Identities = 35/218 (16%), Positives = 66/218 (30%), Gaps = 20/218 (9%)

Query: 55  NLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNN 114
            L++   +   ++  + T+ +   +L  +  L      +     E +  L  L  L L +
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 115 NLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGP---- 170
           N +T   P                  +++          L              G     
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 171 --------IPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQE 222
                   I N        +   LS           L N +KL +L    N ++   P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 223 IGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFN 260
           + +L NL  + +  + +    P  + N S L I++L N
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 2e-05
 Identities = 22/67 (32%), Positives = 32/67 (47%), Gaps = 4/67 (5%)

Query: 48  TIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAEL 107
           +  + L NLS L TL    N  S   P  + +L  L E+HL  N++    P  L N + L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219

Query: 108 EMLVLNN 114
            ++ L N
Sbjct: 220 FIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 43/217 (19%), Positives = 75/217 (34%), Gaps = 19/217 (8%)

Query: 201 NSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFN 260
                  +  G +N+   + Q   +L  +  L    + +     + +  ++ L  L L +
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 261 NTL-----SGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLK 315
           N +       NL     L    N       +  L         +        L   SNL+
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 316 RLGLERNYLTFSTSELMSLFSALVNCKSLK------IGNLINLTTLSLGDNNLSGSLPIT 369
            L L+ N +T  +          ++  + +      + NL  LTTL   DN +S   P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 370 LGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLN 406
           L  L  L  + L+NN+     P    + S L++V L 
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 12/64 (18%), Positives = 24/64 (37%), Gaps = 4/64 (6%)

Query: 467 ENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLS 526
             L   + I   ++N++  +      L  +  LS     +     E    L +L  L+L 
Sbjct: 16  PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELK 71

Query: 527 NNDL 530
           +N +
Sbjct: 72  DNQI 75

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 40/230 (17%), Positives = 75/230 (32%), Gaps = 21/230 (9%)

Query: 225 NLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNL 284
            L N   +   +SN+   V     ++  +  LS F       + + + +  L NL GL L
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGT----GVTTIEGVQYLNNLIGLEL 70

Query: 285 GLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSL 344
             N ++   P           L              +N    +  + +          + 
Sbjct: 71  KDNQITDLAPLKNLTKITELELSGNPL---------KNVSAIAGLQSIKTLDLTSTQITD 121

Query: 345 KIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVY 404
                       L  +    +    L  L  LQ L + N +     P    + S+L  + 
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLK 179

Query: 405 LNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFS 454
            + NK+S   P  L  L +L  + L +N+++ V P    N  ++     +
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.004
 Identities = 37/232 (15%), Positives = 70/232 (30%), Gaps = 26/232 (11%)

Query: 79  NLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIS--TALD 136
            L    ++    + +   + +   +L  +  L      +T     +I  + +++    L+
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-----TIEGVQYLNNLIGLE 69

Query: 137 FSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLP 196
             DN +T   P      +  L+                     +L+S  ++       L 
Sbjct: 70  LKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129

Query: 197 RDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKIL 256
                   L  +            Q +              N        + N+S L  L
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYL-----------SIGNAQVSDLTPLANLSKLTTL 178

Query: 257 SLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALEL 308
              +N +S   P    L  LPNL  ++L  N +S   P    N S L+ + L
Sbjct: 179 KADDNKISDISP----LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 8e-08
 Identities = 35/267 (13%), Positives = 82/267 (30%), Gaps = 12/267 (4%)

Query: 172 PNNLWHCKELSSVSLSYNQ-FTGRLPRDLGNSTKLKSLDLGFNNLNGE-IPQEIGNLRNL 229
           P+          ++    + F  +   +  +  +++ +DL  + +    +   +     L
Sbjct: 14  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73

Query: 230 EILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNL 289
           + L ++   L   + +T+   S L  L+L   +          L     L+ LNL     
Sbjct: 74  QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133

Query: 290 SGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKS------ 343
                     A     +     S  ++   + +  T        +   L +         
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193

Query: 344 LKIGNLINLTTLSLGD-NNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYV 402
            +   L  L  LSL    ++     + LG +  L+ L +     +G +         L +
Sbjct: 194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 253

Query: 403 VYLNRNKLSGSIPSCLGDLNSLRILSL 429
              N +  +      +G+  +  I  +
Sbjct: 254 ---NCSHFTTIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (122), Expect = 2e-07
 Identities = 45/269 (16%), Positives = 91/269 (33%), Gaps = 17/269 (6%)

Query: 42  DLGLAGTIPSHLGNLSSLQTLVL--SRNWFSGTIPKEIGNLTKLKELHLDYNKLQGE-IP 98
           DL      P   G L S   +     R++    +  E  +  +++ + L  + ++   + 
Sbjct: 6   DLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLH 64

Query: 99  EELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLK 158
             L   ++L+ L L    L+  I  ++   S +        +  +      +     RL 
Sbjct: 65  GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124

Query: 159 GLYV------SYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGF 212
            L +      +    +  + +      +L+      N     L   +     L  LDL  
Sbjct: 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 184

Query: 213 N-NLNGEIPQEIGNLRNLEILGIDQ-SNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSS 270
           +  L  +  QE   L  L+ L + +  +++      +  I TLK L +F     G L   
Sbjct: 185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL 244

Query: 271 KNLIGLPNLEGLNLGLNNLSGSIPSFFFN 299
           K    LP+   L +  ++ +        N
Sbjct: 245 KE--ALPH---LQINCSHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (121), Expect = 2e-07
 Identities = 37/267 (13%), Positives = 73/267 (27%), Gaps = 37/267 (13%)

Query: 25  GITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSG-TIPKEIGNLTKL 83
            +T  +    V +       +   +  H      +Q + LS +     T+   +   +KL
Sbjct: 15  DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKL 73

Query: 84  KELHLDYNKLQGEIPEELGNLAELEML--VLNNNLLTGTIPASIFNLSFISTA------- 134
           + L L+  +L   I   L   + L  L     +      +   + + S +          
Sbjct: 74  QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133

Query: 135 ----------------------LDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIP 172
                                   +  N         +      +          K    
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193

Query: 173 NNLWHCKELSSVSLSY-NQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEI 231
              +    L  +SLS           +LG    LK+L +     +G +      L +L+ 
Sbjct: 194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ- 252

Query: 232 LGIDQSNLVGFVPDTIFNISTLKILSL 258
             I+ S+       TI N    +I  +
Sbjct: 253 --INCSHFTTIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 1e-06
 Identities = 46/293 (15%), Positives = 96/293 (32%), Gaps = 23/293 (7%)

Query: 206 KSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSG 265
           ++LDL   NL+ ++   + + + +      +S +   + +  F+   ++ + L N+ +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEV 60

Query: 266 NLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLT 325
           +      L     L+ L+L    LS  I +     S L  L L   S      L+     
Sbjct: 61  STLHGI-LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL-- 117

Query: 326 FSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNK 385
                         +C  L   NL      +     ++ +          L G   +N +
Sbjct: 118 -------------SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR-KNLQ 163

Query: 386 FEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSS-NELTSVIPSTFWN 444
                       + +++   +   L          LN L+ LSLS   ++          
Sbjct: 164 KSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 223

Query: 445 LEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ 497
           +  +          +G+L L  E L     + ++ ++ +     TI   KN +
Sbjct: 224 IPTLKTLQVFGIVPDGTLQLLKEALP---HLQINCSHFTTIARPTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (108), Expect = 1e-05
 Identities = 44/293 (15%), Positives = 78/293 (26%), Gaps = 39/293 (13%)

Query: 263 LSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERN 322
           L+G          L +   +           P            E      ++ + L  +
Sbjct: 7   LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLA----------EHFSPFRVQHMDLSNS 56

Query: 323 YLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQ 382
            +  S     +L   L  C          L  LSL    LS  +  TL +   L  L+L 
Sbjct: 57  VIEVS-----TLHGILSQCS--------KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103

Query: 383 NNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTF 442
                     +    S   +  LN +         +    +    +++   L+    +  
Sbjct: 104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQ 163

Query: 443 WNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLE 502
            +    L     +                V         L  +       L  LQHLSL 
Sbjct: 164 KSDLSTLVRRCPNL---------------VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 208

Query: 503 H-NKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKL 554
               +        GE+ +L+ L +      G +    E L +L+     F  +
Sbjct: 209 RCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTI 261

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (121), Expect = 3e-07
 Identities = 15/80 (18%), Positives = 31/80 (38%), Gaps = 5/80 (6%)

Query: 475 IYLSRNNLSGNIPSTII-GLKNLQHLSLEHNKLQG----PIPESFGELVSLEFLDLSNND 529
           + +    LS    + ++  L+  Q + L+   L       I  +     +L  L+L +N+
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 530 LSGVIPASLEKLLYLKSLNL 549
           L  V    + + L   S  +
Sbjct: 67  LGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 1e-06
 Identities = 14/101 (13%), Positives = 28/101 (27%), Gaps = 13/101 (12%)

Query: 145 SFPYDMCPGLPRLKGLYVSYNQFKG----PIPNNLWHCKELSSVSLSYNQFTGRLPRDLG 200
                +      L+ L+++           +   L     L  + LS N         L 
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418

Query: 201 -----NSTKLKSLDLGFNNLNGEIPQEIGNLR----NLEIL 232
                    L+ L L     + E+   +  L     +L ++
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 24/94 (25%), Positives = 32/94 (34%), Gaps = 13/94 (13%)

Query: 348 NLINLTTLSLGDNNLSG----SLPITLGRLKKLQGLDLQNNKFEGPIPQEFC-----HFS 398
               L  L L D ++S     SL  TL     L+ LDL NN        +          
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 399 RLYVVYLNRNKLSGSIPSCLGDL----NSLRILS 428
            L  + L     S  +   L  L     SLR++S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 2e-06
 Identities = 18/80 (22%), Positives = 34/80 (42%), Gaps = 9/80 (11%)

Query: 475 IYLSRNNLSGN----IPSTIIGLKNLQHLSLEHNKLQGPIPESFGELV-----SLEFLDL 525
           ++L+  ++S +    + +T++   +L+ L L +N L         E V      LE L L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433

Query: 526 SNNDLSGVIPASLEKLLYLK 545
            +   S  +   L+ L   K
Sbjct: 434 YDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 5e-06
 Identities = 15/71 (21%), Positives = 27/71 (38%), Gaps = 5/71 (7%)

Query: 495 NLQHLSLEHNKLQ-GPIPESFGELVSLEFLDLSNNDLSGV----IPASLEKLLYLKSLNL 549
           ++Q L ++  +L      E    L   + + L +  L+      I ++L     L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 550 SFNKLVGEIPR 560
             N+L      
Sbjct: 63  RSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 6e-06
 Identities = 14/91 (15%), Positives = 31/91 (34%), Gaps = 9/91 (9%)

Query: 133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG----PIPNNLWHCKELSSVSLSY 188
            +LD     L+ +   ++ P L + + + +            I + L     L+ ++L  
Sbjct: 5   QSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRS 64

Query: 189 NQFTGRLPRDLG-----NSTKLKSLDLGFNN 214
           N+        +       S K++ L L    
Sbjct: 65  NELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 15/72 (20%), Positives = 27/72 (37%), Gaps = 6/72 (8%)

Query: 40  ISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIG-----NLTKLKELHLDYNKLQ 94
           +SD     ++ + L    SL+ L LS N        ++          L++L L      
Sbjct: 381 VSDSS-CSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439

Query: 95  GEIPEELGNLAE 106
            E+ + L  L +
Sbjct: 440 EEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 17/76 (22%), Positives = 25/76 (32%), Gaps = 9/76 (11%)

Query: 494 KNLQHLSLEHNKLQG----PIPESFGELVSLEFLDLSNNDLSGVIPASLEKLL-----YL 544
             L+ L L    +       +  +     SL  LDLSNN L       L + +      L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 545 KSLNLSFNKLVGEIPR 560
           + L L       E+  
Sbjct: 429 EQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 4e-05
 Identities = 16/104 (15%), Positives = 32/104 (30%), Gaps = 13/104 (12%)

Query: 167 FKGPIPNNLWHCKELSSVSLSYNQFTGR----LPRDLGNSTKLKSLDLGFNNLNGEIPQE 222
            +            L  + L+    +      L   L  +  L+ LDL  N L      +
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416

Query: 223 IG-----NLRNLEILGIDQSNLVGFVPDTI----FNISTLKILS 257
           +          LE L +        + D +     +  +L+++S
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 15/111 (13%), Positives = 34/111 (30%), Gaps = 17/111 (15%)

Query: 311 NSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSG----SL 366
           + +++ L ++   L  S +    L   L  C+            + L D  L+      +
Sbjct: 1   SLDIQSLDIQCEEL--SDARWAELLPLLQQCQ-----------VVRLDDCGLTEARCKDI 47

Query: 367 PITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSC 417
              L     L  L+L++N+             +     + +  L     + 
Sbjct: 48  SSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 11/75 (14%), Positives = 21/75 (28%), Gaps = 5/75 (6%)

Query: 157 LKGLYVSYNQFKGPIPNNLW-HCKELSSVSLSYNQFTGR----LPRDLGNSTKLKSLDLG 211
           ++ L +   +        L    ++   V L     T      +   L  +  L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 212 FNNLNGEIPQEIGNL 226
            N L       +   
Sbjct: 64  SNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 16/91 (17%), Positives = 29/91 (31%), Gaps = 5/91 (5%)

Query: 447 DILGFDFSSNSLNGSLPLEI-ENLKAVVDIYLSRNNLSG----NIPSTIIGLKNLQHLSL 501
           DI   D     L+ +   E+   L+    + L    L+     +I S +     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 502 EHNKLQGPIPESFGELVSLEFLDLSNNDLSG 532
             N+L         + +      +    L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 4e-04
 Identities = 17/105 (16%), Positives = 39/105 (37%), Gaps = 10/105 (9%)

Query: 83  LKELHLDYNKLQGE-IPEELGNLAELEMLVLNNNLLTG----TIPASIFNLSFISTALDF 137
           ++ L +   +L      E L  L + +++ L++  LT      I +++     ++  L+ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE-LNL 62

Query: 138 SDNSLTGSFPYDMCPGL----PRLKGLYVSYNQFKGPIPNNLWHC 178
             N L     + +  GL     +++ L +      G     L   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 4e-04
 Identities = 18/94 (19%), Positives = 30/94 (31%), Gaps = 21/94 (22%)

Query: 350 INLTTLSLGDNNLSGS-LPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRN 408
           +++ +L +    LS +     L  L++ Q + L +                         
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL--------------------TE 41

Query: 409 KLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTF 442
                I S L    +L  L+L SNEL  V     
Sbjct: 42  ARCKDISSALRVNPALAELNLRSNELGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 6e-04
 Identities = 20/100 (20%), Positives = 39/100 (39%), Gaps = 10/100 (10%)

Query: 249 NISTLKILSLFNNTLSGNLPSS--KNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYAL 306
             S L++L L +  +S +  SS    L+   +L  L+L  N L  +       + +    
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ--- 423

Query: 307 ELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKI 346
                  L++L L   Y +    +   L +   +  SL++
Sbjct: 424 ---PGCLLEQLVLYDIYWSEEMEDR--LQALEKDKPSLRV 458

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 7e-04
 Identities = 14/80 (17%), Positives = 25/80 (31%), Gaps = 13/80 (16%)

Query: 29  DVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIG----NLTKLK 84
           D+    ++    ++L         L  L   Q + L     +    K+I         L 
Sbjct: 8   DIQCEELSDARWAEL---------LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 58

Query: 85  ELHLDYNKLQGEIPEELGNL 104
           EL+L  N+L       +   
Sbjct: 59  ELNLRSNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 8e-04
 Identities = 22/127 (17%), Positives = 39/127 (30%), Gaps = 25/127 (19%)

Query: 278 NLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSA 337
           +++ L++    LS +  +      +            + + L+   LT   +    + SA
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQ----------QCQVVRLDDCGLT--EARCKDISSA 50

Query: 338 LVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRL-----KKLQGLDLQNNKFEGPIPQ 392
           L             L  L+L  N L       + +       K+Q L LQN    G    
Sbjct: 51  LRVNP--------ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 102

Query: 393 EFCHFSR 399
                 R
Sbjct: 103 VLSSTLR 109

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.3 bits (118), Expect = 3e-07
 Identities = 31/224 (13%), Positives = 68/224 (30%), Gaps = 9/224 (4%)

Query: 339 VNCKSLKIGNL-----INLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQE 393
             C+  K+  +      N   L      L             L+ +++  N     I  +
Sbjct: 13  FLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72

Query: 394 FCHFSRLYVVYLNR--NKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGF 451
                           N L    P    +L +L+ L +S+  +  +      +    +  
Sbjct: 73  VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132

Query: 452 DFSSNSLNGSLPLEIENLKAVV--DIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGP 509
           D   N    ++        +     ++L++N +         G +  +    ++N L+  
Sbjct: 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEEL 192

Query: 510 IPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNK 553
             + F        LD+S   +  +    LE L  L++ +    K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.8 bits (109), Expect = 5e-06
 Identities = 32/251 (12%), Positives = 64/251 (25%), Gaps = 20/251 (7%)

Query: 21  CSWMGITCDVYGNRVTSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNL 80
           CS     C    ++VT            IPS L    +   L                  
Sbjct: 8   CSNRVFLCQ--ESKVTE-----------IPSDL--PRNAIELRFVLTKLRVIQKGAFSGF 52

Query: 81  TKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDN 140
             L+++ +  N +   I  ++ +       +                 +  +       N
Sbjct: 53  GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112

Query: 141 SLTGSFPYD--MCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRD 198
           +     P    +      L  +  + N       + +    E   + L+ N         
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172

Query: 199 LGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSL 258
              +   +      NNL               IL I ++ +       + N+  L+  S 
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232

Query: 259 FNNTLSGNLPS 269
           +N      LP+
Sbjct: 233 YNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.1 bits (102), Expect = 4e-05
 Identities = 44/240 (18%), Positives = 79/240 (32%), Gaps = 10/240 (4%)

Query: 58  SLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLL 117
           S +  +   +  +  IP ++       EL     KL+           +LE + ++ N +
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 118 TGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWH 177
              I A +F+       +     +       +    LP L+ L +S    K     +  H
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 178 CKELSSVSLSY--NQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGID 235
             +   + +    N  T      +G S +   L L  N +           +  E+   D
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 236 QSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPS 295
            +NL     D     S   IL +    +  +LPS   L  L  L   +    NL   +P+
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIH-SLPSY-GLENLKKLRARS--TYNLK-KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 6e-04
 Identities = 15/85 (17%), Positives = 24/85 (28%), Gaps = 3/85 (3%)

Query: 379 LDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVI 438
           L L  N  +      F       +   + N L           +   IL +S   + S+ 
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217

Query: 439 PSTFWNLEDILGFDFSSNSLNGSLP 463
                NL+ +      S      LP
Sbjct: 218 SYGLENLKKL---RARSTYNLKKLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 0.001
 Identities = 35/236 (14%), Positives = 70/236 (29%), Gaps = 7/236 (2%)

Query: 182 SSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVG 241
                  ++ T  +P DL        L      L            +LE + I Q++++ 
Sbjct: 11  RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67

Query: 242 FVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNAS 301
            +   +F+              +    + +    LPNL+ L +    +         ++ 
Sbjct: 68  VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127

Query: 302 KLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNN 361
           +   L++  N N+  +           S ++ L    +        N   L  L+L DNN
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187

Query: 362 LSGSLPI-TLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPS 416
               LP            LD+   +          +  +L        K    +P+
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.003
 Identities = 29/234 (12%), Positives = 57/234 (24%), Gaps = 6/234 (2%)

Query: 84  KELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLT 143
           +      +K+  EIP +L        L      L      +      +       ++ L 
Sbjct: 11  RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67

Query: 144 GSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNST 203
                         +      N      P    +   L  + +S             +S 
Sbjct: 68  VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127

Query: 204 KLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTL 263
           +   LD+  N     I +      + E + +  +              T       ++  
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187

Query: 264 SGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRL 317
           +     +    G      L++    +         N  KL A       NLK+L
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST---YNLKKL 238

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.9 bits (115), Expect = 7e-07
 Identities = 29/195 (14%), Positives = 61/195 (31%), Gaps = 22/195 (11%)

Query: 348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNR 407
                   +L   +++    +T   L  +  +   N+  +        +   +  ++LN 
Sbjct: 22  AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 408 NKLSG---------------SIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFD 452
           NKL+                         +   +  L S  L     S    L  +   +
Sbjct: 78  NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137

Query: 453 FSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPE 512
                 N    + + +    +D     +N   +I   + GL  LQ+L L  N +      
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD--LR 194

Query: 513 SFGELVSLEFLDLSN 527
           +   L +L+ L+L +
Sbjct: 195 ALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 1e-06
 Identities = 27/191 (14%), Positives = 56/191 (29%), Gaps = 20/191 (10%)

Query: 55  NLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNN 114
             +      L +   +  + +    L  + ++  + + ++      +  L  +  L LN 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 115 NLLTGTIPAS-------------IFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLY 161
           N LT   P +                       L    +            GL  L  L 
Sbjct: 78  NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137

Query: 162 VSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQ 221
             Y          +             +     +   L   TKL++L L  N+++    +
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISD--LR 194

Query: 222 EIGNLRNLEIL 232
            +  L+NL++L
Sbjct: 195 ALAGLKNLDVL 205

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 7e-04
 Identities = 14/71 (19%), Positives = 30/71 (42%), Gaps = 4/71 (5%)

Query: 492 GLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSF 551
                   +L+   +   + ++  EL S++ +  +N+D+  V    ++ L  +  L L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 552 NKLVGEIPRGG 562
           NKL    P   
Sbjct: 78  NKLTDIKPLAN 88

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.2 bits (109), Expect = 1e-06
 Identities = 30/107 (28%), Positives = 44/107 (41%), Gaps = 6/107 (5%)

Query: 185 SLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVP 244
            L++   T      L     +  LDL  N L    P  +  LR LE+  +  S+      
Sbjct: 4   HLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEV--LQASDNALENV 58

Query: 245 DTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSG 291
           D + N+  L+ L L NN L     + + L+  P L  LNL  N+L  
Sbjct: 59  DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.5 bits (107), Expect = 2e-06
 Identities = 29/125 (23%), Positives = 44/125 (35%), Gaps = 6/125 (4%)

Query: 425 RILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSG 484
           R+L L+  +LT         L  +   D S N L    P  +  L+ +  +  S N    
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--L 55

Query: 485 NIPSTIIGLKNLQHLSLEHNKLQG-PIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLY 543
                +  L  LQ L L +N+LQ     +       L  L+L  N L             
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 544 LKSLN 548
           L S++
Sbjct: 116 LPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.1 bits (106), Expect = 3e-06
 Identities = 24/111 (21%), Positives = 39/111 (35%), Gaps = 10/111 (9%)

Query: 346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYL 405
           +  L+ +T L L  N L    P  L  L+ L+ L   +N  E           +   + L
Sbjct: 16  LEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLPRLQ--ELLL 72

Query: 406 NRNKL-SGSIPSCLGDLNSLRILSLSSNELTSV------IPSTFWNLEDIL 449
             N+L   +    L     L +L+L  N L         +     ++  IL
Sbjct: 73  CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.1 bits (106), Expect = 4e-06
 Identities = 26/120 (21%), Positives = 45/120 (37%), Gaps = 7/120 (5%)

Query: 402 VVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGS 461
           V++L    L+  +   L  L  +  L LS N L ++ P+    L  +     S N+L   
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN- 57

Query: 462 LPLEIENLKAVVDIYLSRNNL-SGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSL 520
               + NL  + ++ L  N L        ++    L  L+L+ N L          L  +
Sbjct: 58  -VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.7 bits (105), Expect = 4e-06
 Identities = 22/110 (20%), Positives = 33/110 (30%), Gaps = 6/110 (5%)

Query: 60  QTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTG 119
           + L L+      T+   +  L  +  L L +N+L+   P     LA L  L +       
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNA 54

Query: 120 TIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKG 169
                          L   +N L  S         PRL  L +  N    
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.7 bits (105), Expect = 5e-06
 Identities = 26/111 (23%), Positives = 41/111 (36%), Gaps = 8/111 (7%)

Query: 84  KELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLT 143
           + LHL +  L   +   L  L  +  L L++N L    P ++  L      L+    S  
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAAL----RCLEVLQASDN 53

Query: 144 GSFPYDMCPGLPRLKGLYVSYNQFKG-PIPNNLWHCKELSSVSLSYNQFTG 193
                D    LPRL+ L +  N+ +       L  C  L  ++L  N    
Sbjct: 54  ALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.0 bits (98), Expect = 4e-05
 Identities = 24/115 (20%), Positives = 38/115 (33%), Gaps = 5/115 (4%)

Query: 48  TIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAEL 107
           T+  HL  L  +  L LS N      P  +  L  L+ L    N     +          
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA-LENVDGVANLPRLQ 68

Query: 108 EMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTG--SFPYDMCPGLPRLKGL 160
           E+L+ NN L        + +   +   L+   NSL         +   LP +  +
Sbjct: 69  ELLLCNNRLQQSAAIQPLVSCPRLVL-LNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.0 bits (98), Expect = 4e-05
 Identities = 28/107 (26%), Positives = 39/107 (36%), Gaps = 6/107 (5%)

Query: 452 DFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIP 511
             +   L  ++   +E L  V  + LS N L    P+ +  L+ L+ L    N       
Sbjct: 4   HLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDN--ALENV 58

Query: 512 ESFGELVSLEFLDLSNNDLSGV-IPASLEKLLYLKSLNLSFNKLVGE 557
           +    L  L+ L L NN L        L     L  LNL  N L  E
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.1 bits (93), Expect = 2e-04
 Identities = 26/123 (21%), Positives = 46/123 (37%), Gaps = 11/123 (8%)

Query: 109 MLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYV-SYNQF 167
           +L L +  LT  +   +  L  + T LD S N L       + P L  L+ L V   +  
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLV-THLDLSHNRLRA-----LPPALAALRCLEVLQASDN 53

Query: 168 KGPIPNNLWHCKELSSVSLSYNQFTG-RLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNL 226
                + + +   L  + L  N+       + L +  +L  L+L  N+L  +       L
Sbjct: 54  ALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERL 112

Query: 227 RNL 229
             +
Sbjct: 113 AEM 115

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.8 bits (109), Expect = 8e-06
 Identities = 38/317 (11%), Positives = 82/317 (25%), Gaps = 20/317 (6%)

Query: 254 KILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSN 313
           K L L   T          L+   +++ + L  N +      +           +    +
Sbjct: 8   KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN-------IASKKD 60

Query: 314 LKRLGLERNYLTFSTSELMSLFSAL--VNCKSLKIGNLINLTTLSLGDNNLSGSLPITLG 371
           L+       +      E+      L     K  K+  +                  ++  
Sbjct: 61  LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120

Query: 372 RLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSS 431
              +   L       +                         SI      L +  +   + 
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180

Query: 432 NELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTII 491
              +  +  T   +++ +  +   + L   L    E     +      +  S  +   + 
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240

Query: 492 GLKNLQHLSLEHNKLQGPIPESFGE------LVSLEFLDLSNNDLSGVIPASL-----EK 540
              NL+ L L    L      +  +       + L+ L L  N++      +L     EK
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300

Query: 541 LLYLKSLNLSFNKLVGE 557
           +  L  L L+ N+   E
Sbjct: 301 MPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.8 bits (96), Expect = 3e-04
 Identities = 37/337 (10%), Positives = 75/337 (22%), Gaps = 30/337 (8%)

Query: 37  SLTISDLGLAG--TIPSHLGNLSSLQTLVLSRNWFSG----TIPKEIGNLTKLKELHLDY 90
           SL +  +      ++ + L    S++ +VLS N         + + I +   L+      
Sbjct: 9   SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 91  NKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDM 150
                   E    L  L   +L    L     +           L    +  T      +
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 151 CPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDL 210
                  +         +    N            +                T      L
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 211 GFNNLNGEIPQEIGNLRNLEILGIDQSNL--------------VGFVPDTIFNISTLKIL 256
               +     +  G    L         L                 +   + +   L+ L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 257 SLFNNTLSGN----LPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNS 312
            L +  LS      +  + + +    L+ L L  N +                       
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID------EKMP 302

Query: 313 NLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNL 349
           +L  L L  N  +     +  +          ++  L
Sbjct: 303 DLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDEL 339

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.0 bits (94), Expect = 5e-04
 Identities = 51/339 (15%), Positives = 108/339 (31%), Gaps = 35/339 (10%)

Query: 58  SLQTLVLSRNWFSG----TIPKEIGNLTKLKELHLDYNKLQGE----IPEELGNLAELEM 109
           S++   L  +  +     ++   +     +KE+ L  N +  E    + E + +  +LE+
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 110 LVLNNNLLTGTIPASIFNLSFISTALDFSDNSLT-GSFPYDMCPGLPRLKGLYVSYNQFK 168
              ++             L  +  AL       T         P        ++S +   
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123

Query: 169 GPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGN--- 225
             +  +       +   ++       + +   N+  L+S+  G N L     +E      
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183

Query: 226 ------LRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPS--SKNLIGLP 277
                    +   GI    +   + + +     LK+L L +NT +    S  +  L   P
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243

Query: 278 NLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSA 337
           NL  L L    LS    +   +     A     N  L+ L L+ N +      + +L + 
Sbjct: 244 NLRELGLNDCLLSARGAAAVVD-----AFSKLENIGLQTLRLQYNEIE--LDAVRTLKTV 296

Query: 338 LVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKL 376
           +          + +L  L L  N         +  ++++
Sbjct: 297 IDE-------KMPDLLFLELNGNRF-SEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.003
 Identities = 38/339 (11%), Positives = 93/339 (27%), Gaps = 29/339 (8%)

Query: 227 RNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPS--SKNLIGLPNLEGLNL 284
           ++L++  I   +        +    ++K + L  NT+        S+N+    +LE    
Sbjct: 8   KSLKLDAITTEDEKSV-FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 285 GLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKS- 343
                             L    L           +  +   +   L+   S     +  
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 344 -LKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYV 402
            L    L       +       ++         L+ +    N+       +    +    
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL-ENGSMKEWAKTFQSH 185

Query: 403 VYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSL 462
             L+  K+  +     G  + L        EL  +                 +       
Sbjct: 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL------ 239

Query: 463 PLEIENLKAVVDIYLSRNNLSGNIPSTII------GLKNLQHLSLEHNKLQGPIPESFGE 516
               ++   + ++ L+   LS    + ++          LQ L L++N+++     +   
Sbjct: 240 ----KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 295

Query: 517 -----LVSLEFLDLSNNDLS--GVIPASLEKLLYLKSLN 548
                +  L FL+L+ N  S    +   + ++   +   
Sbjct: 296 VIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 2e-05
 Identities = 32/190 (16%), Positives = 58/190 (30%), Gaps = 18/190 (9%)

Query: 55  NLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNN 114
            L+     VL +   + T+ +   +L ++  L  D   ++    + +  L  L  +  +N
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71

Query: 115 NLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSY---------- 164
           N LT   P             +     +T         GL                    
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 165 --NQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQE 222
                   I +        S   L+++       + L N T L+ LD+  N ++      
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189

Query: 223 IGNLRNLEIL 232
           +  L NLE L
Sbjct: 190 LAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 38/200 (19%), Positives = 72/200 (36%), Gaps = 16/200 (8%)

Query: 348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNR 407
            L       LG  N++    ++   L ++  L       +        + + L  +  + 
Sbjct: 16  ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71

Query: 408 NKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIE 467
           N+L+   P        L+ L+   + L +            L         N  +     
Sbjct: 72  NQLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123

Query: 468 NLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSN 527
                    L  ++ + +  S + GL +LQ L+   N++    P     L +LE LD+S+
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181

Query: 528 NDLSGVIPASLEKLLYLKSL 547
           N +S +  + L KL  L+SL
Sbjct: 182 NKVSDI--SVLAKLTNLESL 199

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (102), Expect = 2e-05
 Identities = 28/145 (19%), Positives = 56/145 (38%), Gaps = 6/145 (4%)

Query: 405 LNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPL 464
           L   ++   +   +         +L    L S       N++ +L      +S+  +L +
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVL---NRRSSMAATLRI 59

Query: 465 EIENLKAVVDIYLSRNNLSG--NIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEF 522
             EN+  ++ + LS N L    ++ S +    NL+ L+L  N+L+        + + LE 
Sbjct: 60  IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119

Query: 523 LDLSNNDLSGVIPASLEKLLYLKSL 547
           L L  N LS         +  ++  
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRER 144

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 7e-04
 Identities = 32/149 (21%), Positives = 47/149 (31%), Gaps = 4/149 (2%)

Query: 186 LSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPD 245
           L   Q   +L   +          L    L      ++       +L   +S++   +  
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRI 59

Query: 246 TIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYA 305
              NI  L  L+L NN L      S  +   PNL+ LNL  N L            KL  
Sbjct: 60  IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119

Query: 306 LELGYNSNLKRLGLERNYLTFSTSELMSL 334
           L L  NS       +  Y++        L
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERFPKL 148

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.9 bits (87), Expect = 0.002
 Identities = 23/147 (15%), Positives = 48/147 (32%), Gaps = 5/147 (3%)

Query: 73  IPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFIS 132
           +   +       +  LD   L+     +L       +L   +++   T+     N+  + 
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68

Query: 133 TALDFSDNSLTGSFPYDMCPG-LPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQF 191
           + L+ S+N L             P LK L +S N+ K     +     +L  + L  N  
Sbjct: 69  S-LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 192 TGRLPRDLGNSTKLKSLDLGFNNLNGE 218
           +          + ++        L+G 
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLDGH 154

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (85), Expect = 0.004
 Identities = 22/128 (17%), Positives = 53/128 (41%), Gaps = 7/128 (5%)

Query: 305 ALELGYNSNLKRLGLERNYLT---FSTSELMSLFSALVNCKSLKI--GNLINLTTLSLGD 359
            +   Y+ + + L L+         + +  + L        +L+I   N+  L +L+L +
Sbjct: 15  IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSN 74

Query: 360 NNLSG--SLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSC 417
           N L     +   + +   L+ L+L  N+ +     +     +L  ++L+ N LS +    
Sbjct: 75  NRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134

Query: 418 LGDLNSLR 425
              ++++R
Sbjct: 135 STYISAIR 142

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 43.6 bits (101), Expect = 3e-05
 Identities = 30/179 (16%), Positives = 63/179 (35%), Gaps = 8/179 (4%)

Query: 353 TTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFC-HFSRLYVVYLNRNKLS 411
           TT+      L   +P  +        L L +N+               L  + L RN+L+
Sbjct: 11  TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 412 GSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKA 471
           G  P+     + ++ L L  N++  +    F  L  +   +   N ++  +P   E+L +
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 472 VVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDL 530
           +       +N            + L+  SL     +   P     +  ++  DL +++ 
Sbjct: 128 L-TSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.6 bits (93), Expect = 3e-04
 Identities = 40/161 (24%), Positives = 65/161 (40%), Gaps = 4/161 (2%)

Query: 423 SLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIE-NLKAVVDIYLSRNN 481
               +  +   L  +      +  ++     + N L       +   L  +V + L RN 
Sbjct: 9   EGTTVDCTGRGLKEIPRDIPLHTTEL---LLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65

Query: 482 LSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKL 541
           L+G  P+   G  ++Q L L  NK++    + F  L  L+ L+L +N +S V+P S E L
Sbjct: 66  LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125

Query: 542 LYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSP 582
             L SLNL+ N                 +S  G    CG+P
Sbjct: 126 NSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.0 bits (89), Expect = 0.001
 Identities = 19/107 (17%), Positives = 36/107 (33%), Gaps = 6/107 (5%)

Query: 67  NWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIF 126
           N       K    L +LK L+L  N++   +P    +L  L  L L +N        + F
Sbjct: 88  NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF 147

Query: 127 NLSFISTALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPN 173
                      +  +     P      +  ++   + +++FK    N
Sbjct: 148 AEWLRK--KSLNGGAARCGAP----SKVRDVQIKDLPHSEFKCSSEN 188

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.5 bits (85), Expect = 0.003
 Identities = 35/182 (19%), Positives = 62/182 (34%), Gaps = 11/182 (6%)

Query: 182 SSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEI-GNLRNLEILGIDQSNLV 240
           ++V  +       +PRD+   T    L L  N L       + G L +L  L + ++ L 
Sbjct: 11  TTVDCTGRGLK-EIPRDIPLHTT--ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 241 GFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNA 300
           G  P+     S ++ L L  N +          +GL  L+ LNL  N +S  +P  F + 
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKM--FLGLHQLKTLNLYDNQISCVMPGSFEHL 125

Query: 301 SKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDN 360
           + L        ++                   SL      C +     + ++    L  +
Sbjct: 126 NSLT---SLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHS 180

Query: 361 NL 362
             
Sbjct: 181 EF 182

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (92), Expect = 3e-04
 Identities = 27/158 (17%), Positives = 46/158 (29%), Gaps = 33/158 (20%)

Query: 79  NLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFS 138
           N  + +EL L   K+   I      L + + +  ++N +                     
Sbjct: 16  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--------------------- 53

Query: 139 DNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTG----R 194
                     D  P L RLK L V+ N+             +L+ + L+ N         
Sbjct: 54  -------RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLD 106

Query: 195 LPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEIL 232
               L + T L  L     N        I  +  + +L
Sbjct: 107 PLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (91), Expect = 5e-04
 Identities = 16/102 (15%), Positives = 33/102 (32%), Gaps = 3/102 (2%)

Query: 342 KSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLY 401
           ++ +  N +    L L    +   +      L +   +D  +N+             RL 
Sbjct: 10  QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLK 66

Query: 402 VVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFW 443
            + +N N++          L  L  L L++N L  +      
Sbjct: 67  TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPL 108

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 7e-04
 Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 4/105 (3%)

Query: 481 NLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEK 540
            L              + L L   K+   I      L   + +D S+N++  +       
Sbjct: 6   ELIEQAAQ-YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP--L 61

Query: 541 LLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPYLH 585
           L  LK+L ++ N++               E  + N+ L     L 
Sbjct: 62  LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLD 106

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (84), Expect = 0.003
 Identities = 23/149 (15%), Positives = 45/149 (30%), Gaps = 4/149 (2%)

Query: 351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFC-HFSRLYVVYLNRNK 409
             + L    +         L   + L  L ++N +    +          L  + + ++ 
Sbjct: 9   GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 410 LSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLE-IEN 468
           L    P        L  L+LS N L S+   T      +     S N L+ S  L  ++ 
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG-LSLQELVLSGNPLHCSCALRWLQR 126

Query: 469 LKAVVDIYLSRNNLSGNIPSTIIGLKNLQ 497
            +      +    L  +    +  + N  
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (84), Expect = 0.003
 Identities = 26/106 (24%), Positives = 40/106 (37%), Gaps = 2/106 (1%)

Query: 475 IYLSRNNLSGNIPSTIIGLKNLQHLSLEHNK-LQGPIPESFGELVSLEFLDLSNNDLSGV 533
           +  +R+    +    + G +NL  L +E+ + LQ         L  L  L +  + L  V
Sbjct: 13  LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71

Query: 534 IPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLC 579
            P +      L  LNLSFN L     +     +       GN L C
Sbjct: 72  APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	952
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.79
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.78
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.78
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.77
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.76
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.75
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.74
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.72
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.55
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.53
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.52
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.49
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.48
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.48
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.48
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.47
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.39
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.37
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.34
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.33
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.58
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.52
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.48
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.06
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.62
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.58
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.56
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.96
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.94
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.85
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.55
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.05

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-51  Score=428.62  Aligned_cols=258  Identities=24%  Similarity=0.397  Sum_probs=205.3

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      ++|++.+.||+|+||+||+|++.+++.||||+++.... ..++|.+|++++++++|||||+++|++.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            47889999999999999999998899999999875433 34679999999999999999999999999999999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +|+|.+++......+++..+..++.|||+||+||   |+++|+||||||+||++++++.+||+|||+|+...........
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~l---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhh---hccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence            9999999987777899999999999999999999   7899999999999999999999999999999877655444444


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHAN  903 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (952)
                      ...||+.|+|||++.+..++.++|||||||++|||+||..|+......    .+..        ..+....       ..
T Consensus       161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~----~~~~--------~~i~~~~-------~~  221 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVV--------EDISTGF-------RL  221 (263)
T ss_dssp             ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH----HHHH--------HHHHHTC-------CC
T ss_pred             ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH----HHHH--------HHHHhcC-------CC
Confidence            567899999999999999999999999999999999965554321111    1111        0011110       01


Q ss_pred             HhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          904 VAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       904 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      ..+..+++++.+++.+||+.||++||||+||+++|++|.+.
T Consensus       222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            12345678899999999999999999999999999999764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=427.65  Aligned_cols=262  Identities=26%  Similarity=0.456  Sum_probs=208.7

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ..++|.+.+.||+|+||+||+|+.+  ..||||+++..  .....+.|.+|++++++++|||||++++++.+ +..++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            3568999999999999999999874  36999998644  34456789999999999999999999998765 4579999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++...+..+++..+..++.|||+||+||   |+++||||||||+|||++.++.+||+|||+|+.......
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---hcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            99999999999987777899999999999999999999   789999999999999999999999999999987654322


Q ss_pred             -ccccccccccccccccccCc---CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          820 -MKQTQTLATIGYIAPEYGRE---GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       820 -~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                       .......||+.|+|||++.+   +.++.++|||||||++|||+||+.||............            +.....
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~------------~~~~~~  227 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM------------VGRGYL  227 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------------HHHTSC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH------------HhcCCC
Confidence             22334579999999998864   35789999999999999999999999753221111111            111100


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      ...   ....+..+++++.+++.+||+.||++||||+||+++|+.+.+.
T Consensus       228 ~p~---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         228 SPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             CCC---GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCc---chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            000   0112345788999999999999999999999999999988764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-50  Score=423.27  Aligned_cols=258  Identities=24%  Similarity=0.447  Sum_probs=212.4

Q ss_pred             HhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ..++|++.+.||+|+||+||+|++++++.||||+++.... ..+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            4568999999999999999999998889999999975433 34679999999999999999999998865 457999999


Q ss_pred             cCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++|+|.+++.... ..+++..+..++.||++||+||   |+++|+||||||+|||+++++.+||+|||+|+........
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~l---H~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            99999998775433 3589999999999999999999   6899999999999999999999999999999987655544


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhH
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEE  900 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  900 (952)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..|+............            +....      
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~------------i~~~~------  227 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN------------LERGY------  227 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH------------HHTTC------
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH------------HHhcC------
Confidence            445567999999999999899999999999999999999976665332111111111            10000      


Q ss_pred             HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          901 HANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       901 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                       ....+..+++++.+++.+||+.||++||||+||++.|+++..
T Consensus       228 -~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         228 -RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence             011234567889999999999999999999999999988754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=414.59  Aligned_cols=253  Identities=23%  Similarity=0.434  Sum_probs=216.7

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccC
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMP  743 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  743 (952)
                      ++|++.++||+|+||+||+|++++++.||||+++.... ..+.|.+|+.++++++||||++++|++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57899999999999999999998899999999975543 34789999999999999999999999999999999999999


Q ss_pred             CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccccc
Q 002214          744 KGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQT  823 (952)
Q Consensus       744 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  823 (952)
                      +|+|.+++......+++..+.+++.|+++||+||   |++||+||||||+||++++++.+||+|||+|+...........
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~L---H~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHH---hhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence            9999999887777899999999999999999999   6889999999999999999999999999999877665555555


Q ss_pred             ccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          824 QTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       824 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ .....            .....       
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-~~~~i------------~~~~~-------  219 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TAEHI------------AQGLR-------  219 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-HHHHH------------HTTCC-------
T ss_pred             ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-HHHHH------------HhCCC-------
Confidence            5679999999999999999999999999999999998 899986532211 11111            11100       


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIK  940 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  940 (952)
                      ...+..+++++.+++.+||+.||++|||++||+++|.+
T Consensus       220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            11234567889999999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9e-50  Score=424.82  Aligned_cols=259  Identities=24%  Similarity=0.409  Sum_probs=216.4

Q ss_pred             HHhccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ...++|++.+.||+|+||+||+|++. +|+.||||+++.... ..++|.+|++++++++|||||++++++.+++..++||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            34568999999999999999999885 589999999865433 4578999999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          740 EYMPKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       740 e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      ||+++|+|.+++... ...+++..+..++.||++||+||   |++||+||||||+|||+++++.+||+|||+|+......
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yL---H~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHH---HHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999998754 44789999999999999999999   68899999999999999999999999999999876555


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      ........|++.|+|||++.++.++.++|||||||++|||++|..||.......            ...+.+......  
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------------~~~~~i~~~~~~--  235 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------QVYELLEKDYRM--  235 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------------HHHHHHHTTCCC--
T ss_pred             ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH------------HHHHHHhcCCCC--
Confidence            444445668999999999999999999999999999999999877754321111            111111111111  


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                           ..+..+++++.+++.+||+.||++|||++||++.|+.+.
T Consensus       236 -----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         236 -----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                 123456888999999999999999999999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-49  Score=417.27  Aligned_cols=264  Identities=23%  Similarity=0.402  Sum_probs=217.4

Q ss_pred             hccCCccce-ecCccceEEEEEEeC---CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENL-IGIGSYGSVYKGRFP---DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|.+.+. ||+|+||+||+|.+.   ++..||||+++... ....++|.+|++++++++|||||+++|++..+ ..|+
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEE
Confidence            346667774 999999999999763   45689999987543 33457899999999999999999999998754 5799


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|+|.+++...+..+++.++..++.|||+||+||   |+++|+||||||+||+++.++.+||+|||+|+.+...
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yl---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            9999999999999877777899999999999999999999   7899999999999999999999999999999987654


Q ss_pred             Cccc--ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          818 DSMK--QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       818 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ....  .....||+.|+|||++.++.++.++|||||||++|||+| |+.||......  ....           .+....
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~-----------~i~~~~  229 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMA-----------FIEQGK  229 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHH-----------HHHTTC
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHH-----------HHHcCC
Confidence            3322  223568999999999999999999999999999999998 89998753211  1111           111110


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhhcc
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANIE  950 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~  950 (952)
                             ....+..+++++.+++.+||+.||++||||.+|.+.|+.+...+..+++
T Consensus       230 -------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~  278 (285)
T d1u59a_         230 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  278 (285)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred             -------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence                   0112356788999999999999999999999999999999887776654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-49  Score=418.06  Aligned_cols=250  Identities=26%  Similarity=0.365  Sum_probs=210.3

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999987 579999999997666555678999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      ++|+|.+++...  .+++.++..++.|++.||+||   |++||+||||||+|||++.++.+||+|||+|+.+.... ...
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  173 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR  173 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence            999999987654  599999999999999999999   78999999999999999999999999999999775433 233


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHA  902 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  902 (952)
                      ...+||+.|+|||++.+..++.++||||+||++|||+||+.||......+ ..........        ...        
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~--------~~~--------  236 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGT--------PEL--------  236 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCS--------CCC--------
T ss_pred             cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCC--------CCC--------
Confidence            45679999999999999999999999999999999999999986522111 0111000000        000        


Q ss_pred             HHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          903 NVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       903 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       ..+..+++++.+++.+||+.||++|||++|+++|
T Consensus       237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             1134567889999999999999999999999864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=416.42  Aligned_cols=253  Identities=25%  Similarity=0.354  Sum_probs=206.2

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            35799999999999999999998 4699999999865432 334678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc-
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS-  819 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-  819 (952)
                      |+++|+|.+++.... .+++.++..++.|+++||+||   |++||+||||||+|||+++++.+||+|||+|+....... 
T Consensus        84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~yl---H~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999999986543 799999999999999999999   789999999999999999999999999999987644332 


Q ss_pred             ccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      ......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||.........+..+.....           .   
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-----------~---  225 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-----------Y---  225 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-----------T---
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----------C---
Confidence            22334679999999999887765 67899999999999999999999764332222221111100           0   


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ......+++++.+++.+||+.||++|||++|++++
T Consensus       226 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         226 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                00123456788999999999999999999999763

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.4e-49  Score=421.43  Aligned_cols=257  Identities=25%  Similarity=0.458  Sum_probs=202.4

Q ss_pred             ccCCccceecCccceEEEEEEeC-CC---cEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DG---IEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ++|++.+.||+|+||+||+|++. ++   ..||||.+... .....+.|.+|++++++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            46777899999999999999874 23   36899988654 334456899999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++|+|.+++......+++.++..++.|||+||+||   |+++|+||||||+|||+++++.+||+|||+|+......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHH---hhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            999999999999887777899999999999999999999   78999999999999999999999999999998765432


Q ss_pred             ccc----ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          819 SMK----QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       819 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      ...    .....+|+.|+|||++.++.++.++|||||||++|||+| |+.||......  ..           ...+...
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~-----------~~~i~~~  249 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DV-----------INAIEQD  249 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH-----------HHHHHTT
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HH-----------HHHHHcC
Confidence            211    122457999999999999999999999999999999998 89998653211  11           1111111


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                      ..       ...+..+++++.+++.+||+.||++||||.||++.|+++.+
T Consensus       250 ~~-------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         250 YR-------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CC-------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CC-------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            10       11234578889999999999999999999999999998865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-49  Score=418.60  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=210.4

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      +.|++.+.||+|+||+||+|++ .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4689999999999999999997 468999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      ++|+|.+++......+++.++..++.||++||+||   |++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~yl---H~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~  167 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR  167 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEEeecChhheeECCCCCEEEEechhhhccCCC-cccc
Confidence            99999999877666799999999999999999999   7899999999999999999999999999999865332 1223


Q ss_pred             cccccccccccccccC-----cCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          823 TQTLATIGYIAPEYGR-----EGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      ....||+.|+|||++.     +..++.++|||||||++|||+||+.||......+ .+.+......+        ..   
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~~--------~~---  235 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEPP--------TL---  235 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCCC--------CC---
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCC--------CC---
Confidence            3467999999999873     4568899999999999999999999986532211 11111111000        00   


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                            ..+..+++++.+++.+||+.||++|||++|++++
T Consensus       236 ------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         236 ------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             ------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  1124467889999999999999999999999874

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=412.21  Aligned_cols=246  Identities=24%  Similarity=0.386  Sum_probs=207.6

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||+||+|+++ +|+.||+|++...   .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999984 6899999998643   2334567899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++.... .+++..+..++.||++||+||   |++||+||||||+|||++.++.+||+|||+|+...... 
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            9999999999987654 699999999999999999999   78999999999999999999999999999998664322 


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..           +.....     
T Consensus       161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~-----------i~~~~~-----  221 (263)
T d2j4za1         161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKR-----------ISRVEF-----  221 (263)
T ss_dssp             --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHH-----------HHTTCC-----
T ss_pred             --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-HHHHH-----------HHcCCC-----
Confidence              23457999999999999999999999999999999999999998652110 00111           000000     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                          ..+..+++++.+++.+||+.||++|||++|++++
T Consensus       222 ----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         222 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                1123467889999999999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=412.63  Aligned_cols=259  Identities=24%  Similarity=0.438  Sum_probs=205.7

Q ss_pred             ccCCccceecCccceEEEEEEeCCC-----cEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDG-----IEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      +.|+..+.||+|+||+||+|.+++.     ..||||+++... +.....|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4688899999999999999987432     479999986543 3345678999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|++.+.+......+++.++..++.||+.|++||   |+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~l---H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhc---cccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            9999999999998887777899999999999999999999   7899999999999999999999999999999876543


Q ss_pred             Cc--ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          818 DS--MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       818 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ..  .......||+.|+|||++.++.++.++|||||||++|||++|..|+.......    +        ....+.....
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~----~--------~~~~i~~~~~  231 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----E--------VMKAINDGFR  231 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----H--------HHHHHHTTCC
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH----H--------HHHHHhccCC
Confidence            22  12233568999999999999999999999999999999999766654321111    1        1111111111


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      .       ..+..++.++.+++.+||+.||++||||.||++.|+++.+.
T Consensus       232 ~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         232 L-------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             C-------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             C-------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            1       12345678899999999999999999999999999988753

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=406.26  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=203.2

Q ss_pred             ceecCccceEEEEEEeC---CCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEccCC
Q 002214          670 NLIGIGSYGSVYKGRFP---DGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYMPK  744 (952)
Q Consensus       670 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  744 (952)
                      ++||+|+||+||+|.+.   .++.||||+++..  .....++|.+|++++++++|||||+++++|..+ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999999863   3578999998643  233456899999999999999999999998654 57899999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc--c
Q 002214          745 GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK--Q  822 (952)
Q Consensus       745 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~  822 (952)
                      |+|.+++.... .+++.++..++.||+.||+||   |+++|+||||||+|||++.++.+||+|||+|+.........  .
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~yl---H~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhH---HhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999987654 699999999999999999999   78999999999999999999999999999998765443322  2


Q ss_pred             cccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          823 TQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......  ..           ...+....       
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~-----------~~~i~~~~-------  227 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV-----------TAMLEKGE-------  227 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH-----------HHHHHTTC-------
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HH-----------HHHHHcCC-------
Confidence            23568999999999999999999999999999999998 89998653211  11           11111110       


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                      ....+..+++++.+++.+||+.||++|||++||.+.|+....+.
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence            01123457889999999999999999999999999998876554

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=408.87  Aligned_cols=253  Identities=24%  Similarity=0.345  Sum_probs=194.1

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeec--CCeeEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTN--HNFKALV  738 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  738 (952)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....  +...+.+.+|++++++++|||||++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6799999999999999999987 469999999986543  3345678999999999999999999998865  4568999


Q ss_pred             EEccCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          739 LEYMPKGSLEDCMYA---SNFNLDIFQRLGIMIDVASALEYLHFGH--SNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~Lh~~h--~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      |||+++|+|.+++..   .+..+++..++.++.|++.||+|||...  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999998864   3457999999999999999999996322  23599999999999999999999999999997


Q ss_pred             cCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ ....+           ....
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-~~~~i-----------~~~~  230 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-LAGKI-----------REGK  230 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH-----------HHTC
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-HHHHH-----------HcCC
Confidence            754332 2334679999999999999999999999999999999999999986532110 01110           0000


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .        ...+..+++++.+++.+||+.||++|||++|++++
T Consensus       231 ~--------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         231 F--------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             C--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             C--------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            0        01123467889999999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=406.26  Aligned_cols=261  Identities=25%  Similarity=0.394  Sum_probs=205.1

Q ss_pred             hccCCccceecCccceEEEEEEeCC----CcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPD----GIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      .++|++.+.||+|+||+||+|++..    +..||||.++... ....+.+.+|+.++++++|||||++++++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            4689999999999999999998742    4578999886443 3345679999999999999999999999964 56899


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ||||+++|++.+++......+++..++.++.||++||+||   |+++|+||||||+||++++++.+||+|||+|+.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhh---cccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            9999999999998887777899999999999999999999   7899999999999999999999999999999977655


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                      .........||+.|+|||++.+..++.++|||||||++|||+| |..||......+ .......           ...  
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-~~~~i~~-----------~~~--  227 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIEN-----------GER--  227 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHHT-----------TCC--
T ss_pred             cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-HHHHHHc-----------CCC--
Confidence            4444455678999999999999999999999999999999998 888886532211 1111110           000  


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFA  947 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~  947 (952)
                            ...+..+++++.+++.+||+.||++|||+.||+++|+++.++-.+
T Consensus       228 ------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~  272 (273)
T d1mp8a_         228 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA  272 (273)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhC
Confidence                  012345788999999999999999999999999999999877654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=400.16  Aligned_cols=246  Identities=23%  Similarity=0.373  Sum_probs=198.0

Q ss_pred             CCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeec----CCeeEEE
Q 002214          666 FSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTN----HNFKALV  738 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  738 (952)
                      |+..+.||+|+||+||+|++. +++.||+|++....  ....+.+.+|++++++++|||||++++++.+    ....|+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            366778999999999999984 68899999986542  3345678999999999999999999999864    3467999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCeeeC-CCCcEEEeccccccccC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNP--IVHCDIKPSNVLLD-DSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~--ivH~Dlk~~Nill~-~~~~~kl~Dfgla~~~~  815 (952)
                      |||+++|+|.+++.... .+++..+..++.||++||+||   |+++  |+||||||+|||++ +++.+||+|||+|+...
T Consensus        91 mE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yL---H~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHH---HHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999997654 689999999999999999999   6666  99999999999996 57899999999998643


Q ss_pred             CcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      ..   .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||...............            ...
T Consensus       167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~------------~~~  230 (270)
T d1t4ha_         167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS------------GVK  230 (270)
T ss_dssp             TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT------------TCC
T ss_pred             CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc------------CCC
Confidence            32   2234679999999998875 5999999999999999999999999653221111111111            000


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .      ...+..+++++.+++.+||+.||++|||++|+++|
T Consensus       231 ~------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         231 P------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             C------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             C------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            0      01123456779999999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-48  Score=407.41  Aligned_cols=256  Identities=25%  Similarity=0.426  Sum_probs=203.9

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .++|++.+.||+|+||+||+|++++++.||||+++.... ..+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            468999999999999999999998888999999965433 34789999999999999999999999865 5578999999


Q ss_pred             CCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          743 PKGSLEDCMYAS-NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       743 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      ++|+|..++... ...+++.+++.++.||++||+||   |+++|+||||||+|||++.++.+||+|||+|+.........
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~L---H~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHH---hhhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            999999887653 34689999999999999999999   78899999999999999999999999999998775544444


Q ss_pred             ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhhHH
Q 002214          822 QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEH  901 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  901 (952)
                      .....||+.|+|||++..+.++.++|||||||++|||+||..|+.........+            ..+.....      
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~------------~~i~~~~~------  232 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------------DQVERGYR------  232 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------------HHHHTTCC------
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH------------HHHHhcCC------
Confidence            445679999999999999999999999999999999999777654422111111            11111110      


Q ss_pred             HHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          902 ANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       902 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                       ...+..+++++.+++.+||+.||++||+|++|++.|+++.
T Consensus       233 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         233 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             -CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence             0123456788999999999999999999999999887654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=414.75  Aligned_cols=256  Identities=23%  Similarity=0.384  Sum_probs=207.5

Q ss_pred             HhccCCccceecCccceEEEEEEeCC------CcEEEEEEeecc-CchhhHHHHHHHHHHHhC-CCCccceeeeEeecCC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFPD------GIEVAIKVFHLQ-REGALNSFDAECEILKTI-RHRNLVKIISSCTNHN  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  733 (952)
                      ..++|++.+.||+|+||+||+|++..      +..||||++... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34689999999999999999998632      236999988543 333456789999999998 8999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 002214          734 FKALVLEYMPKGSLEDCMYASN----------------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIK  791 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~----------------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk  791 (952)
                      ..++||||+++|+|.+++....                      ..+++..++.++.||++||+||   |+++|+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yL---H~~~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH---HHTTEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCc
Confidence            9999999999999999997543                      2488999999999999999999   78999999999


Q ss_pred             CCCeeeCCCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccc
Q 002214          792 PSNVLLDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFF  869 (952)
Q Consensus       792 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~  869 (952)
                      |+||+++.++.+||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||....
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999876543322 2234568999999999999999999999999999999998 899986532


Q ss_pred             cCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 002214          870 TGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLI  939 (952)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  939 (952)
                      ... .+.+.+           .....       ...+..+++++.+||.+||+.||++|||++||+++|.
T Consensus       272 ~~~-~~~~~~-----------~~~~~-------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VDA-NFYKLI-----------QNGFK-------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CSH-HHHHHH-----------HTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH-HHHHHH-----------hcCCC-------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            221 111111           11110       1123457888999999999999999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-48  Score=409.53  Aligned_cols=249  Identities=23%  Similarity=0.363  Sum_probs=205.4

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++..   .+...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999998 47999999998643   2334567899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhh---ccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999887654 699999999999999999999   789999999999999999999999999999997754332


Q ss_pred             -ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          820 -MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       820 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                       ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+.+           +.....    
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~-----------i~~~~~----  227 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-LIFQK-----------IIKLEY----  227 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH-----------HHTTCC----
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-HHHHH-----------HHcCCC----
Confidence             2233467999999999999999999999999999999999999999652110 00111           110000    


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                           ..+..+++++.+++.+||+.||++|||++|+.++
T Consensus       228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                 0123457789999999999999999999997654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=415.88  Aligned_cols=269  Identities=22%  Similarity=0.321  Sum_probs=206.7

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|++.+.||+|+||+||+|++ .+|+.||+|+++... ....+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            57899999999999999999997 478999999987553 3345678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+++|+|.+++...+ .+++..+..++.|+++||+|||  +++||+||||||+|||+++++.+||+|||+|+.....   
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH--~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH--HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH--HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence            999999999997654 6999999999999999999994  2358999999999999999999999999999866332   


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh--ccchhh------------h
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI--NDSLPA------------V  886 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~------------~  886 (952)
                      .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+.......  ......            .
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            22346799999999999999999999999999999999999999965322111000000  000000            0


Q ss_pred             hhhccccccchhhHHHHH---------hhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 MNIMDTNLLSEDEEHANV---------AKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....+.............         .....+.++.+++.+||..||++|||++|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            000000000000000000         001246789999999999999999999999985

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.5e-47  Score=412.17  Aligned_cols=253  Identities=20%  Similarity=0.322  Sum_probs=211.7

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++........+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46899999999999999999997 47999999999766666667899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC--CCCcEEEeccccccccCCcCc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD--DSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~--~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      +++|+|.+++......+++..+..++.||+.||+||   |++||+||||||+|||++  .++.+||+|||+|+.......
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            999999999976666799999999999999999999   789999999999999996  467899999999997754332


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+..           +........  
T Consensus       182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~-----------i~~~~~~~~--  245 (350)
T d1koaa2         182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRN-----------VKSCDWNMD--  245 (350)
T ss_dssp             --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH-----------HHHTCCCSC--
T ss_pred             --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHHH-----------HHhCCCCCC--
Confidence              2346799999999999999999999999999999999999999864211 111111           110000000  


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ......+++++.+++.+||+.||++|||++|+++|
T Consensus       246 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         246 ---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ---CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               01123457789999999999999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-47  Score=408.91  Aligned_cols=252  Identities=22%  Similarity=0.331  Sum_probs=192.3

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .+.|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467999999999999999999984 68999999986543 2334568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC---CCCcEEEeccccccccCCc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD---DSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgla~~~~~~  817 (952)
                      |++||+|.+++...+ .+++.++..++.|++.||+||   |++||+||||||+||++.   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhh---hhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999997643 799999999999999999999   789999999999999995   5789999999999866433


Q ss_pred             CcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccch
Q 002214          818 DSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSE  897 (952)
Q Consensus       818 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  897 (952)
                      ..  ....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....           +........
T Consensus       164 ~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~-----------i~~~~~~~~  229 (307)
T d1a06a_         164 SV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQ-----------ILKAEYEFD  229 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH-----------HHTTCCCCC
T ss_pred             Ce--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHH-----------HhccCCCCC
Confidence            22  234679999999999999999999999999999999999999996522111 0111           111111000


Q ss_pred             hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          898 DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       898 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .     ..+..+++++.+++.+||+.||++|||++|++++
T Consensus       230 ~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         230 S-----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             T-----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             C-----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            0     0123467789999999999999999999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-46  Score=410.39  Aligned_cols=253  Identities=20%  Similarity=0.317  Sum_probs=211.7

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|++.+.||+|+||+||+|++ .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            45799999999999999999997 57999999999766655567889999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeC--CCCcEEEeccccccccCCcCc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLD--DSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~--~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      +++|+|.+.+......+++.++..++.||+.||+||   |++||+||||||+|||++  .++.+||+|||+|+.+.....
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            999999998877776899999999999999999999   789999999999999998  678999999999998754332


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        .....||+.|+|||++.+..++.++||||+||++|||+||+.||......+ .+.....           ......  
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~-----------~~~~~~--  248 (352)
T d1koba_         185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKR-----------CDWEFD--  248 (352)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHH-----------CCCCCC--
T ss_pred             --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh-----------CCCCCC--
Confidence              334579999999999999999999999999999999999999986521111 1111100           000000  


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ...+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       249 ---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         249 ---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               00123457789999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-47  Score=406.47  Aligned_cols=245  Identities=23%  Similarity=0.329  Sum_probs=201.5

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ..|+..+.||+|+||+||+|++ .+|+.||||+++...   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4599999999999999999987 578999999986543   233467899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+++|++..++... ..+++.++..++.||++||+||   |++||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            999999987665543 4799999999999999999999   7899999999999999999999999999999865432  


Q ss_pred             ccccccccccccccccccCc---CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccc
Q 002214          820 MKQTQTLATIGYIAPEYGRE---GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLS  896 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  896 (952)
                         ....||+.|+|||++.+   +.++.++|||||||++|||++|+.||......+ .+..           ........
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~-----------i~~~~~~~  233 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYH-----------IAQNESPA  233 (309)
T ss_dssp             ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHH-----------HHHSCCCC
T ss_pred             ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHH-----------HHhCCCCC
Confidence               33569999999998753   468999999999999999999999986521111 0111           11000000


Q ss_pred             hhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHH
Q 002214          897 EDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIIS  936 (952)
Q Consensus       897 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~  936 (952)
                             ..+..+++++.+++.+||+.||++|||++|+++
T Consensus       234 -------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 -------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                   012345778999999999999999999999976

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-46  Score=399.63  Aligned_cols=252  Identities=21%  Similarity=0.337  Sum_probs=208.3

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC------chhhHHHHHHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR------EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      .++|++.+.||+|+||+||+|++ .+|+.||||+++...      ....+.+.+|++++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            36799999999999999999998 579999999986432      12356799999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC----cEEEeccccc
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM----VAHLSDFGIA  811 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgla  811 (952)
                      |+||||+++|+|.+++...+ .+++..+..++.|++.||+||   |+++|+||||||+||+++.++    .+|++|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yL---H~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhh---hhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999987654 699999999999999999999   789999999999999998776    5999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      +.......  .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+..           +..
T Consensus       165 ~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~-----------i~~  230 (293)
T d1jksa_         165 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLAN-----------VSA  230 (293)
T ss_dssp             EECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH-----------HHT
T ss_pred             hhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHHH-----------HHh
Confidence            87654332  234568999999999999999999999999999999999999986521110 0111           110


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .....     ....+..+++++.+++.+||+.||++|||++|++++
T Consensus       231 ~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         231 VNYEF-----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             TCCCC-----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCCC-----CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000     111234567889999999999999999999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-47  Score=395.31  Aligned_cols=251  Identities=29%  Similarity=0.439  Sum_probs=200.4

Q ss_pred             hccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeec-CCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTN-HNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  741 (952)
                      .++|++.+.||+|+||.||+|++ .|+.||||+++.+.  ..+.+.+|++++++++||||++++|++.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            45788999999999999999998 57899999986443  34789999999999999999999999865 4568999999


Q ss_pred             cCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          742 MPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       742 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      +++|+|.+++.... ..+++..++.++.||+.||+||   |+++|+||||||+||+++.++.+|++|||+++......  
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~yl---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--  157 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  157 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccc---ccCceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence            99999999987543 3589999999999999999999   78999999999999999999999999999998654322  


Q ss_pred             cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          821 KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        ....+|+.|+|||++.++.++.++|||||||++|||+| |+.||......  +....+.           ...     
T Consensus       158 --~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~-----------~~~-----  217 (262)
T d1byga_         158 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVE-----------KGY-----  217 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHT-----------TTC-----
T ss_pred             --ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH-----------cCC-----
Confidence              23457899999999999999999999999999999998 67776543211  1111111           000     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                        ....+..+++++.+++.+||+.||++||||.|++++|++++.
T Consensus       218 --~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         218 --KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence              111234567889999999999999999999999999999864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-46  Score=404.30  Aligned_cols=259  Identities=24%  Similarity=0.410  Sum_probs=211.5

Q ss_pred             HHhccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhCCCCccceeeeEeecCC
Q 002214          661 RATDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQRE-GALNSFDAECEILKTIRHRNLVKIISSCTNHN  733 (952)
Q Consensus       661 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  733 (952)
                      ...++|++.+.||+|+||+||+|+++      +++.||||+++.... ...++|.+|++++++++||||+++++++...+
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            34678999999999999999999863      467899999875543 33567999999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 002214          734 FKALVLEYMPKGSLEDCMYASN-----------------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI  790 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dl  790 (952)
                      ..++||||+++|+|.+++....                       ..+++.+++.++.|++.||+||   |+++||||||
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl---H~~~ivHrDl  166 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDL  166 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhc---ccCCeEeeEE
Confidence            9999999999999999986432                       2488999999999999999999   7999999999


Q ss_pred             CCCCeeeCCCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCC-CCCCcc
Q 002214          791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGM-KPTNEF  868 (952)
Q Consensus       791 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~-~p~~~~  868 (952)
                      ||+|||++.++.+||+|||+|+........ ..+...+++.|+|||++.+..++.++|||||||++|||++|. .||...
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            999999999999999999999876543322 233456899999999999999999999999999999999986 466442


Q ss_pred             ccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 002214          869 FTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIR  942 (952)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~  942 (952)
                      ...+ ....           +.+...        ...+..+++++.+|+.+||+.||++||||.||+++|++|.
T Consensus       247 ~~~e-~~~~-----------v~~~~~--------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         247 AHEE-VIYY-----------VRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CHHH-HHHH-----------HHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CHHH-HHHH-----------HHcCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            1111 1111           111111        0123456788999999999999999999999999999874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=396.58  Aligned_cols=276  Identities=21%  Similarity=0.302  Sum_probs=206.6

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCC----eeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHN----FKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  739 (952)
                      ++|.+.+.||+|+||+||+|++ +|+.||||+++..... ......|+..+.+++|||||++++++.+++    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4677889999999999999997 7899999998644321 122334555556789999999999997653    578999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFG-----HSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~-----h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      ||+++|+|.+++...  .+++.++..++.|+|.||+|+|..     |++||+||||||+|||++.++.+||+|||+++..
T Consensus        81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999999865  599999999999999999999842     4689999999999999999999999999999876


Q ss_pred             CCcCcc---cccccccccccccccccCcC------CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhcc--ch
Q 002214          815 SEEDSM---KQTQTLATIGYIAPEYGREG------QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIND--SL  883 (952)
Q Consensus       815 ~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--~~  883 (952)
                      ......   ......||+.|+|||++.+.      .++.++|||||||++|||+||..||................  ..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            543322   22346799999999987654      36778999999999999999998876543332222221111  11


Q ss_pred             hhhhh-hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          884 PAVMN-IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       884 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                      ..... ..+.......+.  ......++.++.+++.+||+.||++|||+.||+++|+++.++-
T Consensus       239 ~~~~~~~~~~~~~p~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPN--RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCG--GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccccCCCCCc--ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            11111 111111111111  1112345677999999999999999999999999999998773

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-46  Score=400.60  Aligned_cols=256  Identities=24%  Similarity=0.440  Sum_probs=208.7

Q ss_pred             cceecCccceEEEEEEeCC----CcEEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeec-CCeeEEEEEcc
Q 002214          669 ENLIGIGSYGSVYKGRFPD----GIEVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTN-HNFKALVLEYM  742 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  742 (952)
                      .++||+|+||+||+|++.+    ...||||+++.. .....++|.+|++++++++||||++++|++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            5789999999999998743    236899998643 44456789999999999999999999999865 56889999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc--
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM--  820 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--  820 (952)
                      ++|+|.+++.......++..++.++.|+++||+||   |+++|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~l---H~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhh---cccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            99999999988777889999999999999999999   7899999999999999999999999999999976543322  


Q ss_pred             -cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          821 -KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       821 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                       ......||+.|+|||.+.++.++.++||||||+++|||+||+.||....... +...++..           +.     
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~-----------g~-----  251 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQ-----------GR-----  251 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHT-----------TC-----
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHc-----------CC-----
Confidence             2223568999999999999999999999999999999999888875432221 11111100           00     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHh
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~  946 (952)
                        ....+..+++++.++|.+||+.||++||+|.||+++|+++..+..
T Consensus       252 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             --CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence              001234567889999999999999999999999999999987643

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-46  Score=401.41  Aligned_cols=268  Identities=21%  Similarity=0.345  Sum_probs=205.1

Q ss_pred             CHHHHHHHhccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhC-CCCccceee
Q 002214          655 SHDELLRATDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQR-EGALNSFDAECEILKTI-RHRNLVKII  726 (952)
Q Consensus       655 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~  726 (952)
                      +.+++....++|++.+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|..++.++ +|+||+.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            34455555678999999999999999999862      35789999986543 33456778888888877 689999999


Q ss_pred             eEeecC-CeeEEEEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 002214          727 SSCTNH-NFKALVLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDI  790 (952)
Q Consensus       727 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dl  790 (952)
                      +++.++ ...++||||+++|+|.+++....               ..+++.++..++.||++||+||   |+++|+||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH---HhCCCcCCcC
Confidence            987654 56899999999999999986532               2489999999999999999999   7899999999


Q ss_pred             CCCCeeeCCCCcEEEeccccccccCCcCc-ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCC-CCCCcc
Q 002214          791 KPSNVLLDDSMVAHLSDFGIAKLLSEEDS-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGM-KPTNEF  868 (952)
Q Consensus       791 k~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~-~p~~~~  868 (952)
                      ||+|||+++++.+||+|||+|+....... .......||+.|+|||++.++.++.++|||||||++|||+||. .||...
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987654333 2333467999999999999999999999999999999999975 566542


Q ss_pred             ccCccchhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          869 FTGEMSIKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      ...+ .+.+.+           .....       ...+..+++++.+++.+||+.||++|||++||+++|+++.+.
T Consensus       241 ~~~~-~~~~~~-----------~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         241 KIDE-EFCRRL-----------KEGTR-------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             CCSH-HHHHHH-----------HHTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHH-HHHHHH-----------hcCCC-------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            2111 111111           11100       012344678899999999999999999999999999998754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-46  Score=402.87  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=206.7

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCc----EEEEEEeecc-CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGI----EVAIKVFHLQ-REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKAL  737 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  737 (952)
                      ++|++.+.||+|+||+||+|++. +|+    +||+|+++.. .....+.|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999873 444    6889887543 334567899999999999999999999999875 4678


Q ss_pred             EEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCc
Q 002214          738 VLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       738 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  817 (952)
                      ++||+.+|+|.+.+......+++..++.++.|||+||+||   |+++|+||||||+||++++++.+||+|||+|+.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHH---HHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            8999999999999888877899999999999999999999   6889999999999999999999999999999977544


Q ss_pred             Cccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccccc
Q 002214          818 DSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLL  895 (952)
Q Consensus       818 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  895 (952)
                      .... .....||+.|+|||++.++.++.++|||||||++|||+| |..||......+  +..           .+.....
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~-----------~i~~~~~  231 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS-----------ILEKGER  231 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHH-----------HHHHTCC
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHH-----------HHHcCCC
Confidence            3322 223468999999999999999999999999999999999 788876532111  111           1111110


Q ss_pred             chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          896 SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       896 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                             ...+..+++++.+++.+||+.||++|||+.||+++|+++.+.
T Consensus       232 -------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         232 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             -------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                   112345788899999999999999999999999999988654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=395.24  Aligned_cols=255  Identities=23%  Similarity=0.390  Sum_probs=199.4

Q ss_pred             ccCCccceecCccceEEEEEEeC--C--CcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP--D--GIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  736 (952)
                      ++|++.+.||+|+||+||+|++.  +  +..||||++...   .+...++|.+|++++++++|||||+++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            57999999999999999999862  2  347899988643   334457899999999999999999999999764 678


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      +||||+++|++.+.+......+++..++.++.|+|+||+||   |+++|+||||||+||+++.++.+||+|||+|+....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHh---hhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            99999999999998887766799999999999999999999   689999999999999999999999999999998754


Q ss_pred             cCcc--cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccchhhhhccchhhhhhhcccc
Q 002214          817 EDSM--KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTN  893 (952)
Q Consensus       817 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (952)
                      ....  ......++..|+|||.+.+..++.++|||||||++|||+| |+.||......+ ...           .+....
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-~~~-----------~i~~~~  231 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILH-----------KIDKEG  231 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHH-----------HHHTSC
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-HHH-----------HHHhCC
Confidence            4322  2223457889999999999999999999999999999998 899986532111 011           111111


Q ss_pred             ccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 002214          894 LLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKI  941 (952)
Q Consensus       894 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i  941 (952)
                      ..       ...+..+++++.+++.+||+.||++||||+||.+.|++.
T Consensus       232 ~~-------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 ER-------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            10       011345678899999999999999999999999988764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=399.63  Aligned_cols=249  Identities=22%  Similarity=0.296  Sum_probs=208.8

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      .++|.+.+.||+|+||+||+|+. .+|+.||||+++..   .....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            46799999999999999999997 57999999999643   233457789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++|+|.+++...+ .+++..+..++.|++.||+||   |++||+||||||+|||++++|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhh---hhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999887755 689999999999999999999   79999999999999999999999999999998764332


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                      . .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+...           ....     
T Consensus       160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~i-----------~~~~-----  221 (337)
T d1o6la_         160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELI-----------LMEE-----  221 (337)
T ss_dssp             C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH-----------HHCC-----
T ss_pred             c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-HHHHH-----------hcCC-----
Confidence            2 2334679999999999999999999999999999999999999986521100 01110           0000     


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVN-----TKEIISR  937 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~  937 (952)
                          ...|..+++++.+|+.+||+.||++||+     ++|+++|
T Consensus       222 ----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                0123446788999999999999999995     8888774

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-46  Score=399.67  Aligned_cols=261  Identities=25%  Similarity=0.422  Sum_probs=208.1

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCc--EEEEEEeecc-CchhhHHHHHHHHHHHhC-CCCccceeeeEeecCCeeEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGI--EVAIKVFHLQ-REGALNSFDAECEILKTI-RHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ++|++.++||+|+||+||+|+++ +|.  .||||.++.. .....+.+.+|+++++++ +|||||++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            67899999999999999999874 444  4778877543 333456899999999999 799999999999999999999


Q ss_pred             EEccCCCChhHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcE
Q 002214          739 LEYMPKGSLEDCMYAS---------------NFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVA  803 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~  803 (952)
                      |||+++|+|.++++..               ...+++..+.+++.|||+|++|+   |+++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l---H~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh---hcCCccccccccceEEEcCCCce
Confidence            9999999999998643               24799999999999999999999   78999999999999999999999


Q ss_pred             EEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCC-CCCccccCccchhhhhccc
Q 002214          804 HLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMK-PTNEFFTGEMSIKRWINDS  882 (952)
Q Consensus       804 kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~-p~~~~~~~~~~~~~~~~~~  882 (952)
                      ||+|||+|+......  ......||..|+|||.+.++.++.++|||||||++|||++|.. ||....  .   .      
T Consensus       167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~---~------  233 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--C---A------  233 (309)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--H---H------
T ss_pred             EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--H---H------
Confidence            999999998654322  2233568999999999999999999999999999999999765 554321  1   1      


Q ss_pred             hhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHhhhc
Q 002214          883 LPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLFANI  949 (952)
Q Consensus       883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~  949 (952)
                        ++...+....       ....+..+++++.+++.+||+.||++||||.||+++|+++.++....+
T Consensus       234 --~~~~~i~~~~-------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~  291 (309)
T d1fvra_         234 --ELYEKLPQGY-------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV  291 (309)
T ss_dssp             --HHHHHGGGTC-------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred             --HHHHHHHhcC-------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCC
Confidence              1111111110       011234567889999999999999999999999999999987655443

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-45  Score=391.79  Aligned_cols=260  Identities=22%  Similarity=0.412  Sum_probs=204.5

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC---chhhHHHHHHHHHHHhCCCCccceeeeEeecCC----e
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR---EGALNSFDAECEILKTIRHRNLVKIISSCTNHN----F  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  734 (952)
                      .++|++.+.||+|+||+||+|++ .+|+.||||+++...   ....+.+.+|++++++++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999987 579999999996542   334567899999999999999999999987643    4


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .|+||||++||+|.+++...+ .+++.++..++.||+.||+||   |++||+||||||+||+++.++..+++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHH---HhCCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999887654 699999999999999999999   7899999999999999999999999999999765


Q ss_pred             CCcCc--ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          815 SEEDS--MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       815 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                      .....  ......+||+.|+|||++.+..++.++||||+||++|||+||+.||......+. ..+           .+..
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~-----------~~~~  229 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQ-----------HVRE  229 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH-----------HHHC
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHH-----------HHhc
Confidence            43322  223346799999999999999999999999999999999999999965221110 001           0100


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRV-NTKEIISRLIKIRD  943 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~~i~~  943 (952)
                      ....     .......+++++.+++.+||+.||++|| |++|+.+.|.++++
T Consensus       230 ~~~~-----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         230 DPIP-----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             CCCC-----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             CCCC-----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            0000     0011234678899999999999999999 89999999988753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-45  Score=396.41  Aligned_cols=245  Identities=24%  Similarity=0.350  Sum_probs=206.4

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++..   .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999998 56999999998643   2334577899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||++||++...+.... .+++..+..++.||+.||+||   |++||+||||||+|||+++++.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhh---ccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            9999999998887654 688999999999999999999   7999999999999999999999999999999876432  


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        ....+||+.|+|||++.+..++.++||||+||++|||+||+.||......+ ...           .+.....     
T Consensus       158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~-----------~i~~~~~-----  218 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYE-----------KILNAEL-----  218 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHH-----------HHHHCCC-----
T ss_pred             --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-HHH-----------HHHcCCC-----
Confidence              234679999999999999999999999999999999999999986521110 011           1111100     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                          ..+..+++++.+++.+||..||.+||     |++|+++|
T Consensus       219 ----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                11234577899999999999999996     89999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=396.44  Aligned_cols=252  Identities=20%  Similarity=0.321  Sum_probs=209.1

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||+++.... ....+.+|++++++++|||||++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            468999999999999999999984 689999999976543 335688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC--CcEEEeccccccccCCcCc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS--MVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~--~~~kl~Dfgla~~~~~~~~  819 (952)
                      ++||+|.+++...+..+++.++..++.||++||+||   |++||+||||||+|||++.+  ..+||+|||+++.......
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yL---H~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            999999999987766799999999999999999999   78999999999999999854  5899999999987644322


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        .....+|+.|+|||...+..++.++||||+||++|||++|+.||...... ..+.           .+........  
T Consensus       160 --~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~~~-----------~i~~~~~~~~--  223 (321)
T d1tkia_         160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIE-----------NIMNAEYTFD--  223 (321)
T ss_dssp             --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHH-----------HHHHTCCCCC--
T ss_pred             --ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-HHHH-----------HHHhCCCCCC--
Confidence              23456899999999999999999999999999999999999998652111 0011           1111111000  


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ...+..+++++.+++.+||..||++|||++|+++|
T Consensus       224 ---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         224 ---EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               11223467889999999999999999999999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.4e-45  Score=387.68  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=206.0

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc---------hhhHHHHHHHHHHHhCC-CCccceeeeEeecC
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE---------GALNSFDAECEILKTIR-HRNLVKIISSCTNH  732 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  732 (952)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++....         ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999997 5799999999865431         12346889999999997 99999999999999


Q ss_pred             CeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          733 NFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       733 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                      +..|+||||+++|+|.+++.... .+++.++..++.||++||+||   |++||+||||||+||+++.++.+||+|||+|+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999997654 799999999999999999999   78999999999999999999999999999999


Q ss_pred             ccCCcCcccccccccccccccccccCc------CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhh
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGRE------GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAV  886 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  886 (952)
                      ......  ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||......+ .....        
T Consensus       159 ~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i--------  227 (277)
T d1phka_         159 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMI--------  227 (277)
T ss_dssp             ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH--------
T ss_pred             EccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHH--------
Confidence            775432  2344679999999998753      356889999999999999999999996532111 11111        


Q ss_pred             hhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         .......     .......+++++.+++.+||++||++|||++||+++
T Consensus       228 ---~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 ---MSGNYQF-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ---HHTCCCC-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ---HhCCCCC-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               1111000     001123567889999999999999999999999865

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-45  Score=393.53  Aligned_cols=262  Identities=20%  Similarity=0.356  Sum_probs=213.7

Q ss_pred             HhccCCccceecCccceEEEEEEe------CCCcEEEEEEeeccCc-hhhHHHHHHHHHHHhC-CCCccceeeeEeecCC
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRF------PDGIEVAIKVFHLQRE-GALNSFDAECEILKTI-RHRNLVKIISSCTNHN  733 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  733 (952)
                      ..++|++.++||+|+||.||+|++      .+++.||||+++.... .....+.+|+.+++++ +|||||++++++.+++
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            346899999999999999999975      3567899999975443 3456789999999999 6999999999999999


Q ss_pred             eeEEEEEccCCCChhHHhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCee
Q 002214          734 FKALVLEYMPKGSLEDCMYASN-----------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVL  796 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nil  796 (952)
                      ..++||||+++|+|.+++....                 ..+++..+..++.||++|++||   |+++|+||||||+||+
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L---H~~~ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccccccccc
Confidence            9999999999999999987543                 2589999999999999999999   7899999999999999


Q ss_pred             eCCCCcEEEeccccccccCCcCc-ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccch
Q 002214          797 LDDSMVAHLSDFGIAKLLSEEDS-MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSI  875 (952)
Q Consensus       797 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  875 (952)
                      ++.++.+|++|||.++....... ...+...||+.|+|||++.++.++.++|||||||++|||+|++.|+.........+
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999997754433 23344678999999999999999999999999999999999555543322222222


Q ss_pred             hhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 002214          876 KRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDL  944 (952)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~  944 (952)
                      .+.+           .......       .+..+++++.+|+.+||+.||++||||+||++.|+++...
T Consensus       258 ~~~i-----------~~~~~~~-------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         258 YKMI-----------KEGFRML-------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHH-----------HHTCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHH-----------hcCCCCC-------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            2221           1111111       1234577899999999999999999999999999887654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-46  Score=398.46  Aligned_cols=266  Identities=22%  Similarity=0.388  Sum_probs=214.3

Q ss_pred             HHHHHHhccCCccceecCccceEEEEEEeC------CCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEe
Q 002214          657 DELLRATDQFSEENLIGIGSYGSVYKGRFP------DGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSC  729 (952)
Q Consensus       657 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~  729 (952)
                      +++....++|.+.+.||+|+||+||+|.+.      +++.||||+++... ......|.+|++++++++|||||++++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            334445678999999999999999999863      35789999996543 33445789999999999999999999999


Q ss_pred             ecCCeeEEEEEccCCCChhHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCC
Q 002214          730 TNHNFKALVLEYMPKGSLEDCMYASN---------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDS  800 (952)
Q Consensus       730 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~  800 (952)
                      ..++..++||||+++|+|.+++....         ..+++..+..++.|+|+||+||   |+++|+||||||+|||++++
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L---H~~~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAED  169 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSGGGEEECTT
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeeceEcCCceeecCC
Confidence            99999999999999999999886432         2578999999999999999999   68899999999999999999


Q ss_pred             CcEEEeccccccccCCcCccc-ccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCC-CCCCccccCccchhhh
Q 002214          801 MVAHLSDFGIAKLLSEEDSMK-QTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGM-KPTNEFFTGEMSIKRW  878 (952)
Q Consensus       801 ~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~-~p~~~~~~~~~~~~~~  878 (952)
                      +.+||+|||+|+......... .....+|+.|+|||.+.++.++.++|||||||++|||+||. .||..... ...+   
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-~~~~---  245 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVL---  245 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-HHHH---
T ss_pred             ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-HHHH---
Confidence            999999999998765433322 23346899999999999999999999999999999999985 56543211 1111   


Q ss_pred             hccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          879 INDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       879 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                              ..+.+....        ..+..+++++.+++.+||+.||++||||.||+++|++..+..
T Consensus       246 --------~~i~~~~~~--------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         246 --------RFVMEGGLL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             --------HHHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             --------HHHHhCCCC--------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence                    111111111        123456788999999999999999999999999998765443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.2e-45  Score=397.26  Aligned_cols=245  Identities=22%  Similarity=0.282  Sum_probs=206.6

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc---CchhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ---REGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++...   .....+.+.+|++++++++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999998 47999999998643   2334567899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCc
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDS  819 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  819 (952)
                      ||+.+|+|.+++...+ .+++..+..++.||+.||+||   |++|||||||||+|||++.++.+||+|||+|+.....  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yL---H~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999987655 699999999999999999999   7899999999999999999999999999999976432  


Q ss_pred             ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchhh
Q 002214          820 MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSEDE  899 (952)
Q Consensus       820 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  899 (952)
                        .....||+.|+|||++.+..++.++|||||||++|||+||+.||....  ....          ...+.....     
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~----------~~~i~~~~~-----  255 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQI----------YEKIVSGKV-----  255 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHH----------HHHHHHCCC-----
T ss_pred             --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHH----------HHHHhcCCC-----
Confidence              233569999999999999999999999999999999999999986421  1000          001111100     


Q ss_pred             HHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          900 EHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       900 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                          ..+..+++++.+++.+||..||.+|+     |++|+++|
T Consensus       256 ----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         256 ----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                11234677899999999999999994     89999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=389.01  Aligned_cols=259  Identities=24%  Similarity=0.428  Sum_probs=207.6

Q ss_pred             HhccCCccceecCccceEEEEEEeC--------CCcEEEEEEeeccCc-hhhHHHHHHHHHHHhC-CCCccceeeeEeec
Q 002214          662 ATDQFSEENLIGIGSYGSVYKGRFP--------DGIEVAIKVFHLQRE-GALNSFDAECEILKTI-RHRNLVKIISSCTN  731 (952)
Q Consensus       662 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  731 (952)
                      ..++|.+.+.||+|+||.||+|+..        ++..||||+++.+.. .....+.+|...+.++ +|||||+++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            3568999999999999999999752        235799999976543 3457788999999888 89999999999999


Q ss_pred             CCeeEEEEEccCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCee
Q 002214          732 HNFKALVLEYMPKGSLEDCMYASN---------------FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVL  796 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nil  796 (952)
                      ++..++||||+++|+|.+++....               ..+++.+++.++.|++.||+||   |+++||||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl---H~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh---hhCCEEeeeeccccee
Confidence            999999999999999999997543               3589999999999999999999   7999999999999999


Q ss_pred             eCCCCcEEEeccccccccCCcCcc-cccccccccccccccccCcCCcCcccchHhHHHHHHHHHh-CCCCCCccccCccc
Q 002214          797 LDDSMVAHLSDFGIAKLLSEEDSM-KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFT-GMKPTNEFFTGEMS  874 (952)
Q Consensus       797 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~  874 (952)
                      ++.++.+||+|||+++........ ......+|+.|+|||.+.++.++.++|||||||++|||++ |..||......  .
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~  245 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--E  245 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--H
Confidence            999999999999999876543322 2234568999999999999999999999999999999998 67787542211  1


Q ss_pred             hhhhhccchhhhhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 002214          875 IKRWINDSLPAVMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRD  943 (952)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~  943 (952)
                      .           ...+.....       ...+..+++++.+++.+||+.||++|||+.||++.|+++..
T Consensus       246 ~-----------~~~i~~~~~-------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         246 L-----------FKLLKEGHR-------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             H-----------HHHHHTTCC-------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H-----------HHHHHcCCC-------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            1           111111110       01234567889999999999999999999999999998865

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-45  Score=393.82  Aligned_cols=247  Identities=23%  Similarity=0.326  Sum_probs=203.5

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHHHHHHHHH-hCCCCccceeeeEeecCCeeEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFDAECEILK-TIRHRNLVKIISSCTNHNFKALV  738 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  738 (952)
                      ++|.+.+.||+|+||+||+|++. +|+.||||+++...   ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999984 79999999996432   233456677777665 68999999999999999999999


Q ss_pred             EEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcC
Q 002214          739 LEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEED  818 (952)
Q Consensus       739 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  818 (952)
                      |||+++|+|.+++.... .+++.++..++.||+.||+||   |+++|+||||||+|||+++++.+||+|||+|+......
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~yl---H~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999997654 689999999999999999999   78999999999999999999999999999998664332


Q ss_pred             cccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccccchh
Q 002214          819 SMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNLLSED  898 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (952)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....  .....          .+...      
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~----------~i~~~------  218 (320)
T d1xjda_         158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFH----------SIRMD------  218 (320)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----------HHHHC------
T ss_pred             -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHH----------HHHcC------
Confidence             223346799999999999999999999999999999999999999965211  11100          00000      


Q ss_pred             hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 002214          899 EEHANVAKQSCASSVLSLAMECTSESPENRVNTK-EIIS  936 (952)
Q Consensus       899 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~~  936 (952)
                         ....+..+++++.+++.+||..||++||++. |+.+
T Consensus       219 ---~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 ---NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               0012344678899999999999999999995 7764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=392.00  Aligned_cols=252  Identities=21%  Similarity=0.282  Sum_probs=199.7

Q ss_pred             hccCCccc-eecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhC-CCCccceeeeEeec----CCee
Q 002214          663 TDQFSEEN-LIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTI-RHRNLVKIISSCTN----HNFK  735 (952)
Q Consensus       663 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  735 (952)
                      .++|.+.. .||+|+||+||+|++ .+|+.||||+++.     ...+.+|+.++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            45788765 699999999999987 5799999999853     24577899987655 89999999999865    4678


Q ss_pred             EEEEEccCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC---CCcEEEeccccc
Q 002214          736 ALVLEYMPKGSLEDCMYASN-FNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD---SMVAHLSDFGIA  811 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgla  811 (952)
                      |+|||||+||+|.+++...+ ..+++.++..++.|++.||+||   |++||+||||||+|||++.   ++.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~yl---H~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHH---HHcCCcccccccccccccccccccccccccccee
Confidence            99999999999999997643 4699999999999999999999   7999999999999999985   567999999999


Q ss_pred             cccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          812 KLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       812 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      +.......  .....||+.|+|||++.+..++.++||||+||++|||+||+.||........ ...... .      ...
T Consensus       162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~~~-~------i~~  231 (335)
T d2ozaa1         162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKT-R------IRM  231 (335)
T ss_dssp             EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------C------CCS
T ss_pred             eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHHHH-H------Hhc
Confidence            87654332  3346799999999999999999999999999999999999999965322111 000000 0      000


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .....     .......+++++.+|+.+||+.||++|||+.|++++
T Consensus       232 ~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         232 GQYEF-----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CSSSC-----CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCC-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00000     001123467889999999999999999999999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.5e-44  Score=395.17  Aligned_cols=250  Identities=21%  Similarity=0.274  Sum_probs=200.7

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC---chhhHHHH---HHHHHHHhCCCCccceeeeEeecCCee
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR---EGALNSFD---AECEILKTIRHRNLVKIISSCTNHNFK  735 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~  735 (952)
                      .++|++.+.||+|+||.||+|++. +|+.||||++....   ......+.   +|+++++.++|||||++++++.+++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            367999999999999999999974 69999999986432   11122333   446777778899999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccC
Q 002214          736 ALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLS  815 (952)
Q Consensus       736 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  815 (952)
                      |+||||+++|+|.+++.... .+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|||+|+...
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~yl---H~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHH---HHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999999997654 689999999999999999999   79999999999999999999999999999999765


Q ss_pred             CcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccccc
Q 002214          816 EEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDTNL  894 (952)
Q Consensus       816 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  894 (952)
                      ...   .....||+.|+|||++.. ..++.++||||+||++|||+||+.||......+  .......       ..... 
T Consensus       159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~-------~~~~~-  225 (364)
T d1omwa3         159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRM-------TLTMA-  225 (364)
T ss_dssp             SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHHH-------SSSCC-
T ss_pred             CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh-------cccCC-
Confidence            432   234579999999998864 568999999999999999999999997532221  1110000       00000 


Q ss_pred             cchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 002214          895 LSEDEEHANVAKQSCASSVLSLAMECTSESPENRVN-----TKEIISR  937 (952)
Q Consensus       895 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~  937 (952)
                              ...+..+++++.+++.+||+.||++|||     ++|+++|
T Consensus       226 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         226 --------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             --------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             --------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                    0012346778999999999999999999     6888764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-44  Score=385.72  Aligned_cols=269  Identities=23%  Similarity=0.313  Sum_probs=202.8

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++...  +...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5899999999999999999997 579999999986543  2235788999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      |+.++.+..........+++..+..++.|++.||+||   |++|||||||||+|||++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yL---H~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHh---hcCCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence            9976544444444455799999999999999999999   789999999999999999999999999999987654332 


Q ss_pred             cccccccccccccccccCcCC-cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cch----hhhhhhcc-
Q 002214          821 KQTQTLATIGYIAPEYGREGQ-VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSL----PAVMNIMD-  891 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~----~~~~~~~~-  891 (952)
                      ......||+.|+|||...... ++.++||||+||++|||++|+.||......+ .+.....   ...    +......+ 
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhcccccccccc
Confidence            233457999999999866654 5789999999999999999999996532111 1111000   000    00000000 


Q ss_pred             -ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 -TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 -~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                       .................+++++.+++.+||..||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             0000000000111223456789999999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=380.49  Aligned_cols=240  Identities=25%  Similarity=0.317  Sum_probs=197.5

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCc------hhhHHHHHHHHHHHhCC--CCccceeeeEeecCCe
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE------GALNSFDAECEILKTIR--HRNLVKIISSCTNHNF  734 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  734 (952)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++.....      ....++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999997 5799999999864321      11234678999999996  8999999999999999


Q ss_pred             eEEEEEccCC-CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-CCcEEEecccccc
Q 002214          735 KALVLEYMPK-GSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-SMVAHLSDFGIAK  812 (952)
Q Consensus       735 ~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgla~  812 (952)
                      .++||||+.+ +++.+++.... .+++.++..++.|+++||+||   |++||+||||||+|||++. ++.+||+|||+|+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccccCcccceEEecCCCeEEECccccce
Confidence            9999999976 57777776543 699999999999999999999   7999999999999999985 5799999999998


Q ss_pred             ccCCcCcccccccccccccccccccCcCCc-CcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          813 LLSEEDSMKQTQTLATIGYIAPEYGREGQV-SIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      .....   ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||....       ....           
T Consensus       160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~-----------  218 (273)
T d1xwsa_         160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIR-----------  218 (273)
T ss_dssp             ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH-----------
T ss_pred             ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhh-----------
Confidence            65432   2334679999999999887665 677899999999999999999985421       0000           


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...         ..+..+++++.+++.+||+.||++|||++|++++
T Consensus       219 ~~~---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         219 GQV---------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             CCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccc---------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            000         0123357789999999999999999999999874

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-44  Score=383.08  Aligned_cols=263  Identities=22%  Similarity=0.293  Sum_probs=196.1

Q ss_pred             cceecCccceEEEEEEe-CCCcEEEEEEeeccCc-----hhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEcc
Q 002214          669 ENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQRE-----GALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEYM  742 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  742 (952)
                      .++||+|+||+||+|++ .+|+.||||+++....     ...+.+.+|+.++++++|||||++++++.+++..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            57899999999999998 4699999999864422     22357889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcccc
Q 002214          743 PKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMKQ  822 (952)
Q Consensus       743 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  822 (952)
                      +++++.... .....+++..+..++.||+.||+||   |++||+||||||+|||+++++.+||+|||+|+....... ..
T Consensus        83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~  157 (299)
T d1ua2a_          83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AY  157 (299)
T ss_dssp             SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CC
T ss_pred             cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHh---hccceecccCCcceEEecCCCccccccCccccccCCCcc-cc
Confidence            887766554 4445789999999999999999999   789999999999999999999999999999987654332 23


Q ss_pred             cccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cch----hhhhhhccccc
Q 002214          823 TQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSL----PAVMNIMDTNL  894 (952)
Q Consensus       823 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~----~~~~~~~~~~~  894 (952)
                      ...+||+.|+|||++.. ..++.++||||+||++|||+||..||......+ .+....+   ...    +..........
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccchhhh
Confidence            34579999999998764 467999999999999999999999986422111 1111110   000    00000000000


Q ss_pred             cchhh-HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          895 LSEDE-EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       895 ~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..... ..........++++.+|+.+||..||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            00000 00011123456789999999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.9e-44  Score=380.37  Aligned_cols=268  Identities=22%  Similarity=0.339  Sum_probs=202.7

Q ss_pred             ccCCccceecCccceEEEEEEeCCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEEc
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLEY  741 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  741 (952)
                      ++|++.++||+|+||+||+|++++|+.||||+++...  +...+.+.+|+.++++++|||||++++++..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999999999999986543  23357899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCccc
Q 002214          742 MPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSMK  821 (952)
Q Consensus       742 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  821 (952)
                      +.++.+..+. .....+++..+..++.||+.||+||   |+++||||||||+|||++.++.+|++|||.|........ .
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~  156 (286)
T d1ob3a_          82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K  156 (286)
T ss_dssp             CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHh---ccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence            9776665554 4455799999999999999999999   689999999999999999999999999999987654322 2


Q ss_pred             ccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cc----hhhhhhh--cc
Q 002214          822 QTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DS----LPAVMNI--MD  891 (952)
Q Consensus       822 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~----~~~~~~~--~~  891 (952)
                      .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ..+...   ..    .+.....  .+
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhcc
Confidence            334568999999998765 4578999999999999999999999965322111 111100   00    0000000  00


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ..................++++.+++++||..||++|||+.|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000000001111223457789999999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-43  Score=380.84  Aligned_cols=269  Identities=23%  Similarity=0.317  Sum_probs=201.9

Q ss_pred             hccCCccceecCccceEEEEEEe-CC-CcEEEEEEeeccC--chhhHHHHHHHHHHHhC---CCCccceeeeEeec----
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PD-GIEVAIKVFHLQR--EGALNSFDAECEILKTI---RHRNLVKIISSCTN----  731 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  731 (952)
                      .++|++.+.||+|+||+||+|++ ++ ++.||||+++...  +.....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999997 34 6779999986543  22234567788887766   79999999998853    


Q ss_pred             -CCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccc
Q 002214          732 -HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGI  810 (952)
Q Consensus       732 -~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  810 (952)
                       ....+++|||++++.+..........+++..+..++.|++.||+||   |+++|+||||||+|||+++++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yL---H~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             3467999999998877666666666799999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhh-h
Q 002214          811 AKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPA-V  886 (952)
Q Consensus       811 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~-~  886 (952)
                      ++......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+.....   ...+. .
T Consensus       163 ~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         163 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGGGS
T ss_pred             hhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCchhcc
Confidence            98654332  3345679999999999999999999999999999999999999996532111 1111100   00000 0


Q ss_pred             ---hhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          887 ---MNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       887 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         .......................++++.+|+.+||..||++|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence               000000000000000111223456789999999999999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-42  Score=369.22  Aligned_cols=264  Identities=21%  Similarity=0.253  Sum_probs=205.5

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccce-eeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVK-IISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e  740 (952)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++.....  .+++..|++++++++|++++. +.+++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            35799999999999999999987 5689999999865433  246789999999998776555 4555677888999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC---CCcEEEeccccccccCCc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD---SMVAHLSDFGIAKLLSEE  817 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgla~~~~~~  817 (952)
                      |+ ++++.+.+......+++..+..++.|++.||+||   |++||+||||||+||+++.   +..+|++|||+|+.+...
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            99 5677777776667899999999999999999999   7899999999999999864   557999999999977543


Q ss_pred             Ccc------cccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhcc
Q 002214          818 DSM------KQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMD  891 (952)
Q Consensus       818 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (952)
                      ...      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........... ........      
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-~~~~~~~~------  232 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKK------  232 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHH------
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-HHHhhccc------
Confidence            221      22335799999999999999999999999999999999999999976432221110 00000000      


Q ss_pred             ccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 002214          892 TNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLL  945 (952)
Q Consensus       892 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~  945 (952)
                            ...........+|+++.+++..||+.+|++||+++++.+.|+++..+.
T Consensus       233 ------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         233 ------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                  000011123457889999999999999999999999999999886543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.6e-42  Score=365.45  Aligned_cols=265  Identities=15%  Similarity=0.191  Sum_probs=213.3

Q ss_pred             hccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccCchhhHHHHHHHHHHHhCCC-CccceeeeEeecCCeeEEEEE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQREGALNSFDAECEILKTIRH-RNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  740 (952)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++....  ...+.+|+++++.++| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            368999999999999999999974 689999998864432  2457889999999965 899999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCC-----CCcEEEeccccccccC
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDD-----SMVAHLSDFGIAKLLS  815 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfgla~~~~  815 (952)
                      |+ +++|.+++......+++.++..++.|++.||+||   |++||+||||||+||+++.     ++.+||+|||+|+...
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~l---H~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHH---HHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99 7899999887777899999999999999999999   7999999999999999974     5789999999998765


Q ss_pred             CcCc------ccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhh
Q 002214          816 EEDS------MKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNI  889 (952)
Q Consensus       816 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  889 (952)
                      ....      .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......... .. ..    ....
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-~~-~~----i~~~  231 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KY-ER----IGEK  231 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HH-HH----HHHH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-HH-HH----HHhc
Confidence            3321      11223579999999999999999999999999999999999999997533221110 00 00    0000


Q ss_pred             ccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHHh
Q 002214          890 MDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISRLIKIRDLLF  946 (952)
Q Consensus       890 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~i~~~~~  946 (952)
                         .    ...........+|+++.+++..|+..+|++||+++.+.+.|+++.++..
T Consensus       232 ---~----~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         232 ---K----QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             ---H----HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ---c----CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence               0    0000111234577889999999999999999999999999999877654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-41  Score=368.17  Aligned_cols=271  Identities=21%  Similarity=0.306  Sum_probs=198.1

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeec--------
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTN--------  731 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  731 (952)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++....  +...+++.+|+.++++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999997 579999999985442  3345678999999999999999999998855        


Q ss_pred             CCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccc
Q 002214          732 HNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIA  811 (952)
Q Consensus       732 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  811 (952)
                      .+..++||||++++.+... ......++...+..++.|++.||+||   |++||+||||||+|||+++++.+|++|||+|
T Consensus        89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~l---H~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHh---ccCCEEecCcCchheeecCCCcEEeeeccee
Confidence            3467899999987766543 34445789999999999999999999   7999999999999999999999999999999


Q ss_pred             cccCCcCcc---cccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCcc--chhhhhccchhh
Q 002214          812 KLLSEEDSM---KQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM--SIKRWINDSLPA  885 (952)
Q Consensus       812 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~  885 (952)
                      +........   .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||......+.  ...+......++
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            876543221   22235699999999987654 689999999999999999999999865321110  001111111111


Q ss_pred             hhhhc---------cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 VMNIM---------DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      .....         ...................++++.+|+.+||+.||++|||+.|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00000         00000000001111122345678899999999999999999999865

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-41  Score=370.45  Aligned_cols=269  Identities=20%  Similarity=0.223  Sum_probs=198.2

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC-chhhHHHHHHHHHHHhCCCCccceeeeEeecCC----eeE
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR-EGALNSFDAECEILKTIRHRNLVKIISSCTNHN----FKA  736 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  736 (952)
                      +++|++.+.||+|+||+||+|++ .+|+.||||+++... ....+.+.+|+.+|++++|||++++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            45799999999999999999987 579999999986543 344567899999999999999999999986543    234


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCC
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSE  816 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  816 (952)
                      ++++|+.+|+|.+++...  .+++..+..++.|+++||+||   |++||+||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yL---H~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            455566799999998754  599999999999999999999   789999999999999999999999999999987654


Q ss_pred             cCcc--cccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh--ccchhh------
Q 002214          817 EDSM--KQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI--NDSLPA------  885 (952)
Q Consensus       817 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~------  885 (952)
                      ....  .....+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.......  ......      
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            3322  2234679999999998754 4678999999999999999999999965322111000000  000000      


Q ss_pred             ---hhhhccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          886 ---VMNIMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       886 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ........... ............+.++.+++.+||..||++|||++|++++
T Consensus       242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         242 NLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               00000000000 0000011123456789999999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=373.44  Aligned_cols=268  Identities=21%  Similarity=0.275  Sum_probs=197.3

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeecc--CchhhHHHHHHHHHHHhCCCCccceeeeEeecCC------
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQ--REGALNSFDAECEILKTIRHRNLVKIISSCTNHN------  733 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  733 (952)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||+++..  .+...+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999997 46999999998643  2334567899999999999999999999997654      


Q ss_pred             eeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          734 FKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       734 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      ..|+||||+ +++|..+....  .+++..+..++.|++.||+||   |++||+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~L---H~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHH---HhCCCcccccCcchhhcccccccccccccceec
Confidence            469999999 66787776543  599999999999999999999   789999999999999999999999999999987


Q ss_pred             cCCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhhhhhh
Q 002214          814 LSEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPAVMNI  889 (952)
Q Consensus       814 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~  889 (952)
                      ....    .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+.....   ....+....
T Consensus       171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHT
T ss_pred             cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhccCCCcHHHHhh
Confidence            6432    234679999999998765 457899999999999999999999986532111 1111100   000000000


Q ss_pred             c--------cccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHH
Q 002214          890 M--------DTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR--LIKI  941 (952)
Q Consensus       890 ~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~i  941 (952)
                      .        ..................+++++.+|+.+||..||++|||++|+++|  |+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            0        00000000000011123456788999999999999999999999986  5443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-42  Score=369.08  Aligned_cols=253  Identities=24%  Similarity=0.325  Sum_probs=205.0

Q ss_pred             ccCCccceecCccceEEEEEEe----CCCcEEEEEEeecc----CchhhHHHHHHHHHHHhCCC-CccceeeeEeecCCe
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF----PDGIEVAIKVFHLQ----REGALNSFDAECEILKTIRH-RNLVKIISSCTNHNF  734 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  734 (952)
                      ++|++.+.||+|+||+||+|+.    .+|+.||||+++..    .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999986    25899999998543    22335678899999999966 899999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .++||||+.+|+|.+++...+ .+.+..+..++.|++.|++|+   |+++|+||||||+||+++.++.+||+|||+|+.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHh---hcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999987665 578899999999999999999   7899999999999999999999999999999887


Q ss_pred             CCcCcccccccccccccccccccCcC--CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhccchhhhhhhccc
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREG--QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWINDSLPAVMNIMDT  892 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  892 (952)
                      ............|++.|+|||.+.+.  .++.++||||+||++|||++|+.||......+. .........       ..
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~-------~~  251 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRIL-------KS  251 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHH-------HC
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcc-------cC
Confidence            65555445557799999999988654  467899999999999999999999976432221 111111000       00


Q ss_pred             cccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 002214          893 NLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRV-----NTKEIISR  937 (952)
Q Consensus       893 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~  937 (952)
                      .         ...+..+++++.+++.+||++||++||     |++|+++|
T Consensus       252 ~---------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         252 E---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             C---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             C---------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            0         011234678899999999999999999     47888864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-41  Score=369.34  Aligned_cols=267  Identities=23%  Similarity=0.327  Sum_probs=196.9

Q ss_pred             cCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCccceeeeEeecC------CeeEE
Q 002214          665 QFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNLVKIISSCTNH------NFKAL  737 (952)
Q Consensus       665 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  737 (952)
                      +|+..++||+|+||+||+|++ .+|+.||||++.....    ...+|++++++++||||+++++++...      .+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            688899999999999999998 4699999999865433    234799999999999999999998542      35789


Q ss_pred             EEEccCCCChhHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC-cEEEecccccccc
Q 002214          738 VLEYMPKGSLEDCMY--ASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-VAHLSDFGIAKLL  814 (952)
Q Consensus       738 v~e~~~~g~L~~~l~--~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~  814 (952)
                      ||||++++.+.....  .....+++.++..++.||+.||+||   |++||+||||||+|||++.++ .+||+|||+|+..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL---H~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH---HhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998764444332  3445799999999999999999999   799999999999999999775 8999999999876


Q ss_pred             CCcCcccccccccccccccccccCc-CCcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhh---ccchhh-hhhh
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGRE-GQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWI---NDSLPA-VMNI  889 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~-~~~~  889 (952)
                      .....  .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+....   .....+ ....
T Consensus       174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHH
T ss_pred             cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhhhh
Confidence            54332  233579999999997664 578999999999999999999999986532111 111111   111111 0000


Q ss_pred             c----cccccch-hhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHH
Q 002214          890 M----DTNLLSE-DEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR--LIKI  941 (952)
Q Consensus       890 ~----~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~i  941 (952)
                      .    +...... ............++++.+|+.+||..||++|||+.|+++|  ++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            0    0000000 0000111123457789999999999999999999999975  4444

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-41  Score=361.05  Aligned_cols=269  Identities=20%  Similarity=0.275  Sum_probs=205.9

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecCCeeEEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNHNFKALVLE  740 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  740 (952)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++...  +....++.+|+.++++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5899999999999999999998 578999999986543  3346788999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEeccccccccCCcCcc
Q 002214          741 YMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLLSEEDSM  820 (952)
Q Consensus       741 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  820 (952)
                      ++.++++..++... ..+++..+..++.|+++||+||   |++||+||||||+|||++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~l---H~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHh---hcCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            99998888776544 4789999999999999999999   789999999999999999999999999999987654332 


Q ss_pred             cccccccccccccccccCcCC-cCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cch----hhhhhhccc
Q 002214          821 KQTQTLATIGYIAPEYGREGQ-VSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSL----PAVMNIMDT  892 (952)
Q Consensus       821 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~----~~~~~~~~~  892 (952)
                      ......+++.|+|||.+.... ++.++||||+||++|||++|+.||...............   ...    +......+.
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            233356788999999877654 689999999999999999999997432211111111100   000    000000000


Q ss_pred             ccc--chhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          893 NLL--SEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       893 ~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ...  ..............++++.+|+.+||+.||.+||||+|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000  000001111223456789999999999999999999999864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-40  Score=363.53  Aligned_cols=262  Identities=19%  Similarity=0.265  Sum_probs=198.7

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCccceeeeEeec--CCeeEEEE
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIISSCTN--HNFKALVL  739 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  739 (952)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++...   .+++.+|++++++++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            6899999999999999999998 579999999986433   367889999999995 9999999999874  35689999


Q ss_pred             EccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC-cEEEeccccccccCCcC
Q 002214          740 EYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM-VAHLSDFGIAKLLSEED  818 (952)
Q Consensus       740 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~  818 (952)
                      ||+++++|....    ..+++..+..++.||+.||+||   |++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~L---H~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHH---hhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999987754    3589999999999999999999   799999999999999998655 69999999998765433


Q ss_pred             cccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhh---hccchh----------
Q 002214          819 SMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRW---INDSLP----------  884 (952)
Q Consensus       819 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~~~----------  884 (952)
                      .  .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.............   ......          
T Consensus       185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             c--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            2  3346789999999987664 57999999999999999999999986532211111110   000000          


Q ss_pred             ---hhhhhccccccchhh-HHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          885 ---AVMNIMDTNLLSEDE-EHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       885 ---~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                         ............... .........+++++.+|+.+||..||++|||++|+++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               000000000000000 00011223467789999999999999999999999863

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-40  Score=365.01  Aligned_cols=264  Identities=19%  Similarity=0.209  Sum_probs=191.4

Q ss_pred             ccCCccceecCccceEEEEEEeC-CCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeec------CCe
Q 002214          664 DQFSEENLIGIGSYGSVYKGRFP-DGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTN------HNF  734 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  734 (952)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...  ....+++.+|+.++++++|||||++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999984 69999999997543  3345678999999999999999999999864      367


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .|+||||+.++.+.. +.   ..+++..+..++.|++.||+||   |++||+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~l~~~-~~---~~~~~~~i~~~~~qil~gl~~L---H~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLCQV-IQ---MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHHHH-HT---SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHHHh-hh---cCCCHHHHHHHHHHHHHHHHHh---hhcccccccCCccccccccccceeeechhhhhcc
Confidence            899999997655543 32   3589999999999999999999   7899999999999999999999999999999865


Q ss_pred             CCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCccchh-----------hhhccch
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIK-----------RWINDSL  883 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~-----------~~~~~~~  883 (952)
                      ....  ......+|+.|+|||++.+..++.++||||+||++|||++|+.||....... ...           .+.....
T Consensus       170 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         170 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHTTSC
T ss_pred             cccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHHHHHHhh
Confidence            4332  3344579999999999999999999999999999999999999986422110 000           0111111


Q ss_pred             hhhhhhccccccchh-----------hHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          884 PAVMNIMDTNLLSED-----------EEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       884 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                      ....+..........           ...........++++.+|+++|+..||++|||++|+++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            111111111100000           000011223457889999999999999999999999865

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-40  Score=362.61  Aligned_cols=265  Identities=19%  Similarity=0.250  Sum_probs=196.2

Q ss_pred             hccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccC--chhhHHHHHHHHHHHhCCCCccceeeeEeecC-----Ce
Q 002214          663 TDQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQR--EGALNSFDAECEILKTIRHRNLVKIISSCTNH-----NF  734 (952)
Q Consensus       663 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  734 (952)
                      .++|++.+.||+|+||+||+|++ .+|+.||||+++...  ....+++.+|++++++++|||+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            56899999999999999999987 579999999986543  23456788999999999999999999998632     34


Q ss_pred             eEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEecccccccc
Q 002214          735 KALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAKLL  814 (952)
Q Consensus       735 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  814 (952)
                      .+++++|+.+|+|.+++...  .+++.++..++.||+.||+||   |++||+||||||+|||++.++.+|++|||.|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~L---H~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHH---HhCCCcccccCCccccccccccccccccchhccc
Confidence            46677788899999988654  599999999999999999999   7899999999999999999999999999999765


Q ss_pred             CCcCcccccccccccccccccccCcC-CcCcccchHhHHHHHHHHHhCCCCCCccccCccchhhhhc---cchhhhhh--
Q 002214          815 SEEDSMKQTQTLATIGYIAPEYGREG-QVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEMSIKRWIN---DSLPAVMN--  888 (952)
Q Consensus       815 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~--  888 (952)
                      ...    .....|++.|+|||...+. .++.++||||+||++|+|++|+.||....... .......   ....+...  
T Consensus       172 ~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         172 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             TGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHTTC
T ss_pred             Ccc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChHHhhhc
Confidence            332    2345689999999976654 56889999999999999999999986421110 0000000   00000000  


Q ss_pred             ------hccccccchhhHHHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 002214          889 ------IMDTNLLSEDEEHANVAKQSCASSVLSLAMECTSESPENRVNTKEIISR  937 (952)
Q Consensus       889 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  937 (952)
                            ....................+++++.+|+.+||..||++|||++|+++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                  0000000000000111123457789999999999999999999999874

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.3e-35  Score=321.90  Aligned_cols=279  Identities=29%  Similarity=0.479  Sum_probs=237.3

Q ss_pred             CCCCccccccCCCCCCCC--CceEEEeCCC--CeEEEEEecCCCCcc--cCCccccCCcccCeeeccc-cccccccCCCc
Q 002214            5 NPNNILAQNWTSNASVCS--WMGITCDVYG--NRVTSLTISDLGLAG--TIPSHLGNLSSLQTLVLSR-NWFSGTIPKEI   77 (952)
Q Consensus         5 ~~~~~~~~~~~~~~~~c~--w~~v~c~~~~--~~~~~l~l~~~~~~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~l   77 (952)
                      ||+ .++ +|..++|||.  |+||+|+..+  .+|++|||+++++.|  .+|+.|+++++|++|+|++ |+++|.+|++|
T Consensus        20 ~~~-~l~-sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i   97 (313)
T d1ogqa_          20 NPT-TLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI   97 (313)
T ss_dssp             CCG-GGT-TCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGG
T ss_pred             CCC-cCC-CCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccccccccccccccccccc
Confidence            454 566 6666789995  9999998644  389999999999987  5899999999999999997 89999999999


Q ss_pred             CCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeeccccccccCCCCCCCCCCcc
Q 002214           78 GNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNSLTGSFPYDMCPGLPRL  157 (952)
Q Consensus        78 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~~~~~~~~l~~L  157 (952)
                      ++|++|++|+|++|++.+..|..+.++.+|+++++++|.+.+.+|..+.++..+ +.+++++|.+++.+|..+......+
T Consensus        98 ~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L-~~l~l~~n~l~~~ip~~~~~l~~l~  176 (313)
T d1ogqa_          98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL-VGITFDGNRISGAIPDSYGSFSKLF  176 (313)
T ss_dssp             GGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTC-CEEECCSSCCEEECCGGGGCCCTTC
T ss_pred             ccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccc-ceeeccccccccccccccccccccc
Confidence            999999999999999999999999999999999999999999999999988776 7888999998888887765444445


Q ss_pred             ceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccc
Q 002214          158 KGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQS  237 (952)
Q Consensus       158 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n  237 (952)
                      +.+++++|++++..|..+..+..+ .++++.|.+.+.+|..+..+++|+.|++++|.+.+.+ ..++.+++|+.|+|++|
T Consensus       177 ~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N  254 (313)
T d1ogqa_         177 TSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNN  254 (313)
T ss_dssp             CEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSS
T ss_pred             cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc-cccccccccccccCccC
Confidence            888888898888888888776554 6888888888888888888888999999988887554 46888888899999888


Q ss_pred             cccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCc-CCC
Q 002214          238 NLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNN-LSG  291 (952)
Q Consensus       238 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~-l~~  291 (952)
                      ++.+.+|+.+.++++|++|+|++|+|+|.+|.   +..+++|+.+++++|+ +.|
T Consensus       255 ~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~---~~~L~~L~~l~l~~N~~l~g  306 (313)
T d1ogqa_         255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ---GGNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             CCEECCCGGGGGCTTCCEEECCSSEEEEECCC---STTGGGSCGGGTCSSSEEES
T ss_pred             eecccCChHHhCCCCCCEEECcCCcccccCCC---cccCCCCCHHHhCCCccccC
Confidence            88888888888888899999999988887775   4567788888888887 444

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.6e-36  Score=330.78  Aligned_cols=267  Identities=18%  Similarity=0.254  Sum_probs=189.9

Q ss_pred             ccCCccceecCccceEEEEEEe-CCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-----------CCccceeeeEeec
Q 002214          664 DQFSEENLIGIGSYGSVYKGRF-PDGIEVAIKVFHLQREGALNSFDAECEILKTIR-----------HRNLVKIISSCTN  731 (952)
Q Consensus       664 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  731 (952)
                      ++|+++++||+|+||+||+|++ .+|+.||||+++.+. ...+.+.+|++++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3599999999999999999997 579999999986543 23467788999998875           5789999988764


Q ss_pred             C--CeeEEEEEccCCCChhHH--hhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCC------
Q 002214          732 H--NFKALVLEYMPKGSLEDC--MYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSM------  801 (952)
Q Consensus       732 ~--~~~~lv~e~~~~g~L~~~--l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~------  801 (952)
                      .  ...+++|+++..+.....  .......+++..+..++.||+.|++|||  +..||+||||||+|||++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh--~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh--hhcCcccccCChhHeeeeccCcccccc
Confidence            3  456667776655443222  2334457899999999999999999996  468999999999999998665      


Q ss_pred             cEEEeccccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHHHHHHhCCCCCCccccCcc-----chh
Q 002214          802 VAHLSDFGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIMLMEVFTGMKPTNEFFTGEM-----SIK  876 (952)
Q Consensus       802 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-----~~~  876 (952)
                      .++++|||.|......    ....+||+.|+|||++....++.++||||+||+++||++|+.||........     ...
T Consensus       170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            4999999999865432    2345699999999999988999999999999999999999999865322110     000


Q ss_pred             hhhc--cchh-hh-------hhhccc-----cc----cchhhH---HHHHhhhhhHHHHHHHHhhccccCCCCCCCHHHH
Q 002214          877 RWIN--DSLP-AV-------MNIMDT-----NL----LSEDEE---HANVAKQSCASSVLSLAMECTSESPENRVNTKEI  934 (952)
Q Consensus       877 ~~~~--~~~~-~~-------~~~~~~-----~~----~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  934 (952)
                      +...  +..+ ..       ....+.     ..    ......   .........++++.+|+.+|+..||++|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            0000  0000 00       000000     00    000000   0111224567889999999999999999999999


Q ss_pred             HHH
Q 002214          935 ISR  937 (952)
Q Consensus       935 ~~~  937 (952)
                      ++|
T Consensus       326 L~H  328 (362)
T d1q8ya_         326 VNH  328 (362)
T ss_dssp             HTC
T ss_pred             hcC
Confidence            875

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=1.6e-30  Score=281.48  Aligned_cols=240  Identities=33%  Similarity=0.581  Sum_probs=224.1

Q ss_pred             ccCCCcccEEEccC-CCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCC
Q 002214          346 IGNLINLTTLSLGD-NNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSL  424 (952)
Q Consensus       346 ~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  424 (952)
                      ++++++|++|+|++ |++++.+|..|.++++|++|+|++|+|.+..+..+..+.+|+.+++++|++.+.+|..+..+++|
T Consensus        72 l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L  151 (313)
T d1ogqa_          72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL  151 (313)
T ss_dssp             GGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTC
T ss_pred             HhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccc
Confidence            56788999999987 89998999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cEEeccccccCCcCCccccCCCCC-ceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccC
Q 002214          425 RILSLSSNELTSVIPSTFWNLEDI-LGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEH  503 (952)
Q Consensus       425 ~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  503 (952)
                      +.+++++|++++.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|...+.+|..+..+++|+.|++++
T Consensus       152 ~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~  230 (313)
T d1ogqa_         152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAK  230 (313)
T ss_dssp             CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCS
T ss_pred             ceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccc
Confidence            999999999999999999988876 889999999999999988887655 799999999999999999999999999999


Q ss_pred             ccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCCCcccccccccccCccCCCCCc
Q 002214          504 NKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSPY  583 (952)
Q Consensus       504 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p~  583 (952)
                      |.+.+.+| .+..+++|+.|+|++|+|++.+|..|.++++|++|+|++|+|+|.+|..+.+.++....+.+|+.+||.| 
T Consensus       231 ~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p-  308 (313)
T d1ogqa_         231 NSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP-  308 (313)
T ss_dssp             SEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT-
T ss_pred             cccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC-
Confidence            99997554 6889999999999999999999999999999999999999999999998888999999999999999999 


Q ss_pred             cCCCCCC
Q 002214          584 LHVPLCK  590 (952)
Q Consensus       584 ~~lp~c~  590 (952)
                        +|.|.
T Consensus       309 --lp~c~  313 (313)
T d1ogqa_         309 --LPACT  313 (313)
T ss_dssp             --SSCCC
T ss_pred             --CCCCC
Confidence              56673

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=1.5e-28  Score=274.29  Aligned_cols=356  Identities=24%  Similarity=0.328  Sum_probs=257.4

Q ss_pred             eeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcC
Q 002214          136 DFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNL  215 (952)
Q Consensus       136 ~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  215 (952)
                      .++.+.+++.++.+   .+.+|++|++++|+|+. + +++..+++|++|+|++|+|++..  .|+++++|++|++++|++
T Consensus        28 ~l~~~~~~~~~~~~---~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i  100 (384)
T d2omza2          28 VLGKTNVTDTVSQT---DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQI  100 (384)
T ss_dssp             HTTCSSTTSEECHH---HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             HhCCCCCCCccCHH---HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccc
Confidence            45555666544432   35678888888888874 3 46778888888888888888543  378888888888888888


Q ss_pred             CccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCc
Q 002214          216 NGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPS  295 (952)
Q Consensus       216 ~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  295 (952)
                      .+..  .++.+++|+.|+++++.+.+..+  ......+..+....|.+.......  ................+.     
T Consensus       101 ~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~-----  169 (384)
T d2omza2         101 ADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS--GLTSLQQLSFGNQVTDLK-----  169 (384)
T ss_dssp             CCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGT--TCTTCSEEEEEESCCCCG-----
T ss_pred             cccc--ccccccccccccccccccccccc--cccccccccccccccccccccccc--ccccccccccccccchhh-----
Confidence            7543  37888888888888777766533  344566777777777765321111  111111111111111111     


Q ss_pred             ccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCC
Q 002214          296 FFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKK  375 (952)
Q Consensus       296 ~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~  375 (952)
                      .+           .............|....                ...+..+++++.+++++|.+++..|  +...++
T Consensus       170 ~~-----------~~~~~~~~~~~~~~~~~~----------------~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~  220 (384)
T d2omza2         170 PL-----------ANLTTLERLDISSNKVSD----------------ISVLAKLTNLESLIATNNQISDITP--LGILTN  220 (384)
T ss_dssp             GG-----------TTCTTCCEEECCSSCCCC----------------CGGGGGCTTCSEEECCSSCCCCCGG--GGGCTT
T ss_pred             hh-----------cccccccccccccccccc----------------ccccccccccceeeccCCccCCCCc--ccccCC
Confidence            11           111111112222222111                1135678899999999999996654  566789


Q ss_pred             CcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecC
Q 002214          376 LQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSS  455 (952)
Q Consensus       376 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  455 (952)
                      |++|++++|.++.  ...+..+++|+.|++++|++++..+  +..+++|++|++++|++++..  .+..++.++.+++++
T Consensus       221 L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~  294 (384)
T d2omza2         221 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNE  294 (384)
T ss_dssp             CCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCS
T ss_pred             CCEEECCCCCCCC--cchhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccccc
Confidence            9999999999974  3468889999999999999986543  788999999999999998764  478899999999999


Q ss_pred             CccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCc
Q 002214          456 NSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIP  535 (952)
Q Consensus       456 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  535 (952)
                      |++++  ...+..+++++.|++++|++++..  .+..+++|+.|+|++|+|++ ++ .+..+++|++|+|++|+|++..|
T Consensus       295 n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~  368 (384)
T d2omza2         295 NQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP  368 (384)
T ss_dssp             SCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred             ccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence            99985  345889999999999999999754  38899999999999999985 44 68999999999999999997765


Q ss_pred             cchhccccccccccccc
Q 002214          536 ASLEKLLYLKSLNLSFN  552 (952)
Q Consensus       536 ~~~~~l~~L~~L~l~~N  552 (952)
                        +.++++|+.|+|++|
T Consensus       369 --l~~l~~L~~L~L~~N  383 (384)
T d2omza2         369 --LANLTRITQLGLNDQ  383 (384)
T ss_dssp             --GTTCTTCSEEECCCE
T ss_pred             --hccCCCCCEeeCCCC
Confidence              889999999999998

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=3.4e-28  Score=271.40  Aligned_cols=358  Identities=26%  Similarity=0.347  Sum_probs=236.5

Q ss_pred             eeccccccccccCCCcCCcCCCcEEeCcCCcccccCChhhcCCCCCCeEeecCccCccccCcccccccccccceeecccc
Q 002214           62 LVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGEIPEELGNLAELEMLVLNNNLLTGTIPASIFNLSFISTALDFSDNS  141 (952)
Q Consensus        62 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~l~~~L~l~~n~  141 (952)
                      ..++.+.+++.+.  ...+.+|++|++++|.|+ .+ +.++.+++|++|+|++|+++ .+|.                  
T Consensus        27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~-~l~~------------------   83 (384)
T d2omza2          27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLT-DITP------------------   83 (384)
T ss_dssp             HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCC-CCGG------------------
T ss_pred             HHhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCC-CCcc------------------
Confidence            3555566665443  245666777777777776 33 34667777777777777766 2221                  


Q ss_pred             ccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCch
Q 002214          142 LTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQ  221 (952)
Q Consensus       142 l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  221 (952)
                               +.++++|++|++++|++++..  .++.+++|+.|++++|.+++..+  ......+..+....|.+....+.
T Consensus        84 ---------l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~  150 (384)
T d2omza2          84 ---------LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISAL  150 (384)
T ss_dssp             ---------GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGG
T ss_pred             ---------ccCCccccccccccccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccc
Confidence                     124556677777777666422  26666777777777776664322  33445666666666666533332


Q ss_pred             hhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccch
Q 002214          222 EIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNAS  301 (952)
Q Consensus       222 ~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~  301 (952)
                      ................     ....+...+.........|....    ......+++++.+++++|.+++..|       
T Consensus       151 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~~~l~l~~n~i~~~~~-------  214 (384)
T d2omza2         151 SGLTSLQQLSFGNQVT-----DLKPLANLTTLERLDISSNKVSD----ISVLAKLTNLESLIATNNQISDITP-------  214 (384)
T ss_dssp             TTCTTCSEEEEEESCC-----CCGGGTTCTTCCEEECCSSCCCC----CGGGGGCTTCSEEECCSSCCCCCGG-------
T ss_pred             cccccccccccccccc-----hhhhhcccccccccccccccccc----ccccccccccceeeccCCccCCCCc-------
Confidence            2222222222222111     11223334444555555554431    2234556677777777776664322       


Q ss_pred             hhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEc
Q 002214          302 KLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDL  381 (952)
Q Consensus       302 ~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L  381 (952)
                                                                  ++..++|++|++++|+++..  +.+..+++|+.|++
T Consensus       215 --------------------------------------------~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l  248 (384)
T d2omza2         215 --------------------------------------------LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDL  248 (384)
T ss_dssp             --------------------------------------------GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred             --------------------------------------------ccccCCCCEEECCCCCCCCc--chhhcccccchhcc
Confidence                                                        23456778888888888742  35777888888888


Q ss_pred             cCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCC
Q 002214          382 QNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGS  461 (952)
Q Consensus       382 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  461 (952)
                      ++|.+++..  .+..+++|+.|++++|++++..  .+..++.++.+.++.|++++.  ..+..+++++.|++++|++++.
T Consensus       249 ~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l  322 (384)
T d2omza2         249 ANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDI  322 (384)
T ss_dssp             CSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCC
T ss_pred             ccCccCCCC--cccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCC
Confidence            888887543  3777888888888888887443  367788899999999998864  3578888999999999999865


Q ss_pred             CchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCc
Q 002214          462 LPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNND  529 (952)
Q Consensus       462 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  529 (952)
                      .  .+..+++|++|++++|+|++ ++ .|.++++|++|+|++|+|++..|  +.++++|++|+|++|.
T Consensus       323 ~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         323 S--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             G--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             c--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            3  37889999999999999985 33 68899999999999999997655  8899999999999983

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=9.2e-26  Score=242.70  Aligned_cols=245  Identities=22%  Similarity=0.298  Sum_probs=123.9

Q ss_pred             cceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeC
Q 002214          133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGF  212 (952)
Q Consensus       133 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  212 (952)
                      +.+|.++++++ ++|..+.   +++++|+|++|+|+...+..|.++++|+.|++++|.+....|.+|.++++|++|++++
T Consensus        13 ~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~   88 (305)
T d1xkua_          13 RVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK   88 (305)
T ss_dssp             TEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence            34555555555 5555442   3566666666666644344566666666666666666655566666666666666666


Q ss_pred             CcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCC
Q 002214          213 NNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGS  292 (952)
Q Consensus       213 N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~  292 (952)
                      |+++ .+|..  ....|+.|.+..|.+..+.+..+.....+..++...|...........+..+++|+.+++++|++...
T Consensus        89 n~l~-~l~~~--~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l  165 (305)
T d1xkua_          89 NQLK-ELPEK--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI  165 (305)
T ss_dssp             SCCS-BCCSS--CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC
T ss_pred             CccC-cCccc--hhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcccc
Confidence            6665 33332  22345555555555555544444444555555555544332211222233344444444444443311


Q ss_pred             CCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCccccc
Q 002214          293 IPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGR  372 (952)
Q Consensus       293 ~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~  372 (952)
                       |.                                                   ..+++|+.|++++|.++...+..|..
T Consensus       166 -~~---------------------------------------------------~~~~~L~~L~l~~n~~~~~~~~~~~~  193 (305)
T d1xkua_         166 -PQ---------------------------------------------------GLPPSLTELHLDGNKITKVDAASLKG  193 (305)
T ss_dssp             -CS---------------------------------------------------SCCTTCSEEECTTSCCCEECTGGGTT
T ss_pred             -Cc---------------------------------------------------ccCCccCEEECCCCcCCCCChhHhhc
Confidence             10                                                   11234445555555555444455555


Q ss_pred             CCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCc
Q 002214          373 LKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSV  437 (952)
Q Consensus       373 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  437 (952)
                      ++.+++|++++|.+++..+..|.++++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+.+
T Consensus       194 ~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i  257 (305)
T d1xkua_         194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI  257 (305)
T ss_dssp             CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred             cccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCcc
Confidence            555555555555555444445555555555555555544 3344444455555555555554443

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=1.8e-25  Score=240.35  Aligned_cols=267  Identities=23%  Similarity=0.282  Sum_probs=151.1

Q ss_pred             CCcEEEccCCcccccCCccccccCCccEEEeeCCcCCccCchhhhccCCCcEeeeccccccccCCccccCCCCccEEEee
Q 002214          180 ELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGEIPQEIGNLRNLEILGIDQSNLVGFVPDTIFNISTLKILSLF  259 (952)
Q Consensus       180 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls  259 (952)
                      .++.++-+++.++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|.+..+.|..|.++++|++|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            4567888888888 5566664  578888888888885555678888888888888888888888888888888888888


Q ss_pred             CccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhh
Q 002214          260 NNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALV  339 (952)
Q Consensus       260 ~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~  339 (952)
                      +|+++.. |.    ...+.++.|++.+|.+.+..+..+                                          
T Consensus        88 ~n~l~~l-~~----~~~~~l~~L~~~~n~l~~l~~~~~------------------------------------------  120 (305)
T d1xkua_          88 KNQLKEL-PE----KMPKTLQELRVHENEITKVRKSVF------------------------------------------  120 (305)
T ss_dssp             SSCCSBC-CS----SCCTTCCEEECCSSCCCBBCHHHH------------------------------------------
T ss_pred             CCccCcC-cc----chhhhhhhhhccccchhhhhhhhh------------------------------------------
Confidence            8887643 22    123455666666665553222111                                          


Q ss_pred             ccccccccCCCcccEEEccCCCCC--CCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCc
Q 002214          340 NCKSLKIGNLINLTTLSLGDNNLS--GSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSC  417 (952)
Q Consensus       340 ~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  417 (952)
                             .....+..++...|...  ...+..+..+++|+.+++++|.+..                         +|..
T Consensus       121 -------~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-------------------------l~~~  168 (305)
T d1xkua_         121 -------NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-------------------------IPQG  168 (305)
T ss_dssp             -------TTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-------------------------CCSS
T ss_pred             -------hccccccccccccccccccCCCccccccccccCccccccCCccc-------------------------cCcc
Confidence                   12223334444444332  1223344445555555555555442                         2221


Q ss_pred             cCCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCc
Q 002214          418 LGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQ  497 (952)
Q Consensus       418 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  497 (952)
                        .+++|+.|++++|.++...+..|..++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|.+|..+++|+
T Consensus       169 --~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~  245 (305)
T d1xkua_         169 --LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ  245 (305)
T ss_dssp             --CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCC
T ss_pred             --cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCC
Confidence              1344555555555555444445555555555555555554444444555555555555555555 3344555555555


Q ss_pred             eEEccCccccCcccccc------cccccccEEeCCCCccc
Q 002214          498 HLSLEHNKLQGPIPESF------GELVSLEFLDLSNNDLS  531 (952)
Q Consensus       498 ~L~L~~N~l~~~~~~~~------~~l~~L~~L~Ls~N~l~  531 (952)
                      .|+|++|+|+.+....|      ..+++|+.|+|++|+++
T Consensus       246 ~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         246 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             EEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             EEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence            55555555553322222      33455556666666553

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.4e-26  Score=243.15  Aligned_cols=233  Identities=22%  Similarity=0.242  Sum_probs=209.0

Q ss_pred             CcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEec-cccccccCCCccCCCCCCcEEe
Q 002214          350 INLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLN-RNKLSGSIPSCLGDLNSLRILS  428 (952)
Q Consensus       350 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~  428 (952)
                      +++++|+|++|+|+++.+.+|.++++|++|++++|+|..+.+..+..+..++.+... .|.++...+..|.++++|++|+
T Consensus        32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~  111 (284)
T d1ozna_          32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (284)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence            478999999999998888899999999999999999999999999999999998765 6778877788999999999999


Q ss_pred             ccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccC
Q 002214          429 LSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQG  508 (952)
Q Consensus       429 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  508 (952)
                      +++|.+..+.+..+....+|+.+++++|+|+++.+..|..+++|+.|++++|+++++.+..|.++++|+.+++++|++++
T Consensus       112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~  191 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence            99999998888899999999999999999998888899999999999999999999999999999999999999999999


Q ss_pred             cccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCCCCCcccccccccccCccCCCCC
Q 002214          509 PIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPRGGAFANFSAESFIGNDLLCGSP  582 (952)
Q Consensus       509 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~p  582 (952)
                      +.|..|..+++|++||+++|++.+..+..|..+++|+.|++++|+|.|.++......++.......+...|..|
T Consensus       192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p  265 (284)
T d1ozna_         192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP  265 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred             cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCc
Confidence            88999999999999999999999999999999999999999999999998753333344444444455566544

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.2e-24  Score=230.98  Aligned_cols=193  Identities=24%  Similarity=0.268  Sum_probs=109.2

Q ss_pred             CCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcC
Q 002214          359 DNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVI  438 (952)
Q Consensus       359 ~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  438 (952)
                      .|.++.+.+..|.++++|++|++++|.+....+..+....+|+.+++++|+|++..+..|..+++|+.|++++|+++++.
T Consensus        90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~  169 (284)
T d1ozna_          90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (284)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence            34444445555666666666666666665555555555566666666666665555555666666666666666666666


Q ss_pred             CccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccc
Q 002214          439 PSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELV  518 (952)
Q Consensus       439 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  518 (952)
                      +.+|.++++|+.+++++|++++..|..|.++++|++|++++|++.+..+..|..+++|++|+|++|++...-+ .-+-..
T Consensus       170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~  248 (284)
T d1ozna_         170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWA  248 (284)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHH
T ss_pred             hhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHH
Confidence            6666666666666666666665555556666666666666666665555566666666666666666653222 111112


Q ss_pred             cccEEeCCCCcccccCccchhcccccccccccccccc
Q 002214          519 SLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLV  555 (952)
Q Consensus       519 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  555 (952)
                      .++.+....++++...|..+.+   ....+++.+.|+
T Consensus       249 ~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~  282 (284)
T d1ozna_         249 WLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQ  282 (284)
T ss_dssp             HHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSC
T ss_pred             HHHhCcCCCCceEeCCchHHcC---CccccCCHHHCC
Confidence            3444555555555555555443   233444444443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.5e-24  Score=227.74  Aligned_cols=206  Identities=25%  Similarity=0.250  Sum_probs=184.3

Q ss_pred             cCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcE
Q 002214          347 GNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRI  426 (952)
Q Consensus       347 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  426 (952)
                      .....+.+++.++++++. +|..+.  +++++|+|++|+|+++.+..|.++++|++|+|++|+|+.. + .++.+++|++
T Consensus         7 ~~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~   81 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGT   81 (266)
T ss_dssp             ECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCE
T ss_pred             cccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccc
Confidence            455677788999999994 565553  5799999999999988888999999999999999999843 3 3578999999


Q ss_pred             EeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccc
Q 002214          427 LSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKL  506 (952)
Q Consensus       427 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  506 (952)
                      |+|++|+++. .+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.++.+.+..+..+++|+.|++++|+|
T Consensus        82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l  160 (266)
T d1p9ag_          82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL  160 (266)
T ss_dssp             EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred             cccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence            9999999985 466889999999999999999988888999999999999999999988888899999999999999999


Q ss_pred             cCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCC
Q 002214          507 QGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIP  559 (952)
Q Consensus       507 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  559 (952)
                      ++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|||.|.|.
T Consensus       161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence            9888889999999999999999999 678888889999999999999998764

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2.4e-23  Score=218.29  Aligned_cols=207  Identities=26%  Similarity=0.268  Sum_probs=183.7

Q ss_pred             cccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCc
Q 002214          370 LGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDIL  449 (952)
Q Consensus       370 l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  449 (952)
                      ......+.+.+.+++.++. +|..+.  +++++|+|++|+|++..+..|.++++|++|+|++|+|+.+.  .++.+++|+
T Consensus         6 ~~~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~   80 (266)
T d1p9ag_           6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLG   80 (266)
T ss_dssp             EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCC
T ss_pred             EcccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccc
Confidence            3456677888999999995 565553  57999999999999887889999999999999999998654  467899999


Q ss_pred             eeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCc
Q 002214          450 GFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNND  529 (952)
Q Consensus       450 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  529 (952)
                      .|+|++|+++. .+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+
T Consensus        81 ~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~  159 (266)
T d1p9ag_          81 TLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (266)
T ss_dssp             EEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             ccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence            99999999984 67789999999999999999998889999999999999999999998888889999999999999999


Q ss_pred             ccccCccchhcccccccccccccccccCCCC-CCCcccccccccccCccCCCCCc
Q 002214          530 LSGVIPASLEKLLYLKSLNLSFNKLVGEIPR-GGAFANFSAESFIGNDLLCGSPY  583 (952)
Q Consensus       530 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~~p~  583 (952)
                      |++..+..|..+++|+.|+|++|+|+ .+|. ......+....+.||||.|+|..
T Consensus       160 l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~  213 (266)
T d1p9ag_         160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI  213 (266)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred             ccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcch
Confidence            99888899999999999999999999 6665 34456677788999999999874

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=8.2e-23  Score=202.39  Aligned_cols=170  Identities=16%  Similarity=0.130  Sum_probs=121.7

Q ss_pred             CCccceecCccceEEEEEEeCCCcEEEEEEeeccCc------------------hhhHHHHHHHHHHHhCCCCccceeee
Q 002214          666 FSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQRE------------------GALNSFDAECEILKTIRHRNLVKIIS  727 (952)
Q Consensus       666 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~  727 (952)
                      +.++++||+|+||+||+|++.+|+.||||+++....                  .......+|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            356789999999999999998999999998753210                  01234567889999999999998876


Q ss_pred             EeecCCeeEEEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCeeeCCCCcEEEec
Q 002214          728 SCTNHNFKALVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHFGHSNPIVHCDIKPSNVLLDDSMVAHLSD  807 (952)
Q Consensus       728 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~~h~~~ivH~Dlk~~Nill~~~~~~kl~D  807 (952)
                      +..    .+++|||++++.+.+        ++......++.|++++++||   |++||+||||||+|||++++ .++++|
T Consensus        82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~l---H~~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEETT-EEEECC
T ss_pred             ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHH---hhCCEEEccCChhheeeeCC-CEEEEE
Confidence            542    379999998866543        33445678999999999999   78999999999999999965 589999


Q ss_pred             cccccccCCcCcccccccccccccccccccCcCCcCcccchHhHHHHH
Q 002214          808 FGIAKLLSEEDSMKQTQTLATIGYIAPEYGREGQVSIKGDVYNYGIML  855 (952)
Q Consensus       808 fgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l  855 (952)
                      ||.|+....+.....-.  ..... -.+.+ .+.|+.++|+||..--+
T Consensus       146 FG~a~~~~~~~~~~~l~--rd~~~-~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWREILE--RDVRN-IITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHHHHHH--HHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcHHHHH--HHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence            99998654322110000  00000 01111 35678899999965433

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=3.9e-19  Score=194.51  Aligned_cols=59  Identities=25%  Similarity=0.363  Sum_probs=33.6

Q ss_pred             ccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCcc
Q 002214          469 LKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPA  536 (952)
Q Consensus       469 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  536 (952)
                      +++|++|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|.
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~  341 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD  341 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred             CCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence            345566666666665 2332   2456666666666666 34432   346667777777766 3443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=7.6e-19  Score=192.18  Aligned_cols=69  Identities=22%  Similarity=0.273  Sum_probs=34.1

Q ss_pred             CCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEE
Q 002214          421 LNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLS  500 (952)
Q Consensus       421 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  500 (952)
                      +++|++|++++|+|+.+ |.   .+++|+.|+|++|+|+ .+|..   +++|++|+|++|+|+ .+|..   ..+|+.|.
T Consensus       283 ~~~L~~L~Ls~N~l~~l-p~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~---~~~L~~L~  350 (353)
T d1jl5a_         283 PPSLEELNVSNNKLIEL-PA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDI---PESVEDLR  350 (353)
T ss_dssp             CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEE
T ss_pred             CCCCCEEECCCCccCcc-cc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcc---ccccCeeE
Confidence            34555555555555532 21   2345555555555555 23322   345666666666666 33432   12455554


Q ss_pred             c
Q 002214          501 L  501 (952)
Q Consensus       501 L  501 (952)
                      +
T Consensus       351 ~  351 (353)
T d1jl5a_         351 M  351 (353)
T ss_dssp             C
T ss_pred             C
Confidence            4

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=1.1e-21  Score=223.45  Aligned_cols=386  Identities=20%  Similarity=0.155  Sum_probs=207.8

Q ss_pred             ccceEEcccCcccccC-CccccCCCCCcEEEccCCcccc----cCCccccccCCccEEEeeCCcCCccCchhhh-----c
Q 002214          156 RLKGLYVSYNQFKGPI-PNNLWHCKELSSVSLSYNQFTG----RLPRDLGNSTKLKSLDLGFNNLNGEIPQEIG-----N  225 (952)
Q Consensus       156 ~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~  225 (952)
                      +|++||+++|++++.. .+-+..+++++.|+|++|.++.    .+...+..+++|++|||++|+|+......+.     .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            4566666666665321 2234445666666666666652    2234445566666666666666432111221     1


Q ss_pred             cCCCcEeeecccccccc----CCccccCCCCccEEEeeCccccccCCCC--ccc-CCCCCcceEEcccCcCCCCCCcccc
Q 002214          226 LRNLEILGIDQSNLVGF----VPDTIFNISTLKILSLFNNTLSGNLPSS--KNL-IGLPNLEGLNLGLNNLSGSIPSFFF  298 (952)
Q Consensus       226 l~~L~~L~L~~n~~~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~--~~l-~~l~~L~~L~L~~N~l~~~~~~~~~  298 (952)
                      ..+|+.|+|++|+++..    ++..+..+++|++|++++|.|.......  ..+ ...............+..      .
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~------~  156 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA------A  156 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBG------G
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccch------h
Confidence            23566666666666543    2344555666777777777664210000  000 011122233333322221      0


Q ss_pred             cchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCC----CCcccccCC
Q 002214          299 NASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGS----LPITLGRLK  374 (952)
Q Consensus       299 ~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~  374 (952)
                      .. ......+..+..++.+.++.+.+.........  ..+.       ........+++..+.+...    ....+...+
T Consensus       157 ~~-~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~--~~l~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~  226 (460)
T d1z7xw1         157 SC-EPLASVLRAKPDFKELTVSNNDINEAGVRVLC--QGLK-------DSPCQLEALKLESCGVTSDNCRDLCGIVASKA  226 (460)
T ss_dssp             GH-HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH--HHHH-------HSCCCCCEEECTTSCCBTTHHHHHHHHHHHCT
T ss_pred             hh-cccccccccccccccccccccccccccccccc--cccc-------cccccccccccccccccchhhhcccccccccc
Confidence            00 01112234455666666666554322221111  1111       1123455677777766522    122345567


Q ss_pred             CCcEEEccCccccC-----CCCccccCCCcceEEEecccccccc----CCCccCCCCCCcEEeccccccCCcCCccc---
Q 002214          375 KLQGLDLQNNKFEG-----PIPQEFCHFSRLYVVYLNRNKLSGS----IPSCLGDLNSLRILSLSSNELTSVIPSTF---  442 (952)
Q Consensus       375 ~L~~L~L~~N~i~~-----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---  442 (952)
                      .++.+++++|.+..     ..+..+.....++.+++++|.+...    ....+...+.++.+++++|.++......+   
T Consensus       227 ~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~  306 (460)
T d1z7xw1         227 SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET  306 (460)
T ss_dssp             TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH
T ss_pred             cccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcc
Confidence            78888888877632     1223344456788888888877632    22334556778888888888764222211   


Q ss_pred             --cCCCCCceeEecCCccCCCCchh----hhcccccceeecCCcccCCC----Cccccc-CCCCCceEEccCccccCc--
Q 002214          443 --WNLEDILGFDFSSNSLNGSLPLE----IENLKAVVDIYLSRNNLSGN----IPSTII-GLKNLQHLSLEHNKLQGP--  509 (952)
Q Consensus       443 --~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~~----~~~~~~-~l~~L~~L~L~~N~l~~~--  509 (952)
                        .....|+.+++++|.++......    +...++|++|+|++|+|+..    ++..+. ..+.|++|+|++|+|+..  
T Consensus       307 l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~  386 (460)
T d1z7xw1         307 LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSC  386 (460)
T ss_dssp             HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHH
T ss_pred             ccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHH
Confidence              23457888888888877543333    34455788888888887632    222332 356788888888888742  


Q ss_pred             --ccccccccccccEEeCCCCcccccCccchh-----cccccccccccccccccC
Q 002214          510 --IPESFGELVSLEFLDLSNNDLSGVIPASLE-----KLLYLKSLNLSFNKLVGE  557 (952)
Q Consensus       510 --~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~~  557 (952)
                        ++..+...++|++|||++|+|+......+.     .-..|+.|++.+|.+..+
T Consensus       387 ~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~  441 (460)
T d1z7xw1         387 SSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE  441 (460)
T ss_dssp             HHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred             HHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence              344566678888888888888754333331     223688888888877643

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.78  E-value=4.5e-19  Score=175.27  Aligned_cols=175  Identities=22%  Similarity=0.274  Sum_probs=116.7

Q ss_pred             EEEeccccccccCCCccCCCCCCcEEeccccccCC-cCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCc
Q 002214          402 VVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTS-VIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRN  480 (952)
Q Consensus       402 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  480 (952)
                      .++.++++++ .+|..+.  +++++|+|++|+|++ ..+..|.++++|+.|+|++|.+....+..|..+++|++|+|++|
T Consensus        12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            4555555555 3444332  466777777777764 34556677777777777777777667777777777777777777


Q ss_pred             ccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          481 NLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       481 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      +|+.+.+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.+....+ ...-...++.+.+..|.++|..|.
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~  167 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSST
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCCh
Confidence            7777777777888888888888888877777777788888888888887764322 222223466677777777777664


Q ss_pred             CCCcccccccccccCccCCCCC
Q 002214          561 GGAFANFSAESFIGNDLLCGSP  582 (952)
Q Consensus       561 ~~~~~~~~~~~~~~n~~~c~~p  582 (952)
                        .++...-..+..|...|.++
T Consensus       168 --~l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         168 --KVRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             --TTTTSBGGGSCTTTCCCCCC
T ss_pred             --hhcCCEeeecCHhhCcCCCC
Confidence              34444445566666667555

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=8.9e-19  Score=180.61  Aligned_cols=202  Identities=15%  Similarity=0.141  Sum_probs=147.9

Q ss_pred             cccEEEccCCCCCCCCCcccccCCCCcEEEccCccccC-CCCccccCCCcceEEEecc-ccccccCCCccCCCCCCcEEe
Q 002214          351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEG-PIPQEFCHFSRLYVVYLNR-NKLSGSIPSCLGDLNSLRILS  428 (952)
Q Consensus       351 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~  428 (952)
                      ++++|+|++|+|+.+.+.+|.++++|++|++++|.+.. +.+..|.++++++.+.+.. |.+....+..|.++++|++|+
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence            57788888888886666778888888888888888764 4566788888888887764 667767777788888888888


Q ss_pred             ccccccCCcCCc-cccCCCCCceeEecCCccCCCCchhhhccc-ccceeecCCcccCCCCcccccCCCCCceEEccCccc
Q 002214          429 LSSNELTSVIPS-TFWNLEDILGFDFSSNSLNGSLPLEIENLK-AVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKL  506 (952)
Q Consensus       429 L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  506 (952)
                      +++|++....+. .+..+..+..+..+++.+....+..|.+++ .++.|++++|+++.+.+..|.....++.+++++|+|
T Consensus       110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l  189 (242)
T d1xwdc1         110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL  189 (242)
T ss_dssp             EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTC
T ss_pred             cchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhcccccccccc
Confidence            888888755433 234456666666777777766666676654 677888888888865555554433334445777888


Q ss_pred             cCcccccccccccccEEeCCCCcccccCccchhccccccccccccc
Q 002214          507 QGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFN  552 (952)
Q Consensus       507 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  552 (952)
                      +.+.+..|.++++|+.|+|++|+|+.+.+..|.++++|+.+++.+.
T Consensus       190 ~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~l  235 (242)
T d1xwdc1         190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL  235 (242)
T ss_dssp             CCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEESS
T ss_pred             ccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCCC
Confidence            8665667888888888888888888766777888888888777543

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=1.8e-18  Score=176.09  Aligned_cols=190  Identities=22%  Similarity=0.330  Sum_probs=160.9

Q ss_pred             ccCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCc
Q 002214          346 IGNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLR  425 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  425 (952)
                      +.++.+|+.|++.+|+|+.. + .+..+++|++|++++|+|.+..+  +..+++|+.+++++|.++. ++ .+..+++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~  110 (227)
T d1h6ua2          37 QADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIK  110 (227)
T ss_dssp             HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCC
T ss_pred             HHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-cc-ccccccccc
Confidence            35677899999999999954 3 58999999999999999986543  8899999999999999984 33 578899999


Q ss_pred             EEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcc
Q 002214          426 ILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNK  505 (952)
Q Consensus       426 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  505 (952)
                      .+++++|...+.  ..+...+.+..+.++.+.+...  ..+..+++|+.|++++|.+...  ..+.++++|+.|+|++|+
T Consensus       111 ~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~  184 (227)
T d1h6ua2         111 TLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNK  184 (227)
T ss_dssp             EEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred             cccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCc
Confidence            999999998754  3467788999999999998743  3478889999999999999843  348899999999999999


Q ss_pred             ccCcccccccccccccEEeCCCCcccccCccchhcccccccccccc
Q 002214          506 LQGPIPESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSF  551 (952)
Q Consensus       506 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~  551 (952)
                      +++. + .++.+++|+.|+|++|+|+++.|  +.++++|+.|++++
T Consensus       185 l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         185 ISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN  226 (227)
T ss_dssp             CCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred             cCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence            9864 3 38999999999999999996543  88999999999873

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=3.6e-18  Score=175.93  Aligned_cols=219  Identities=15%  Similarity=0.130  Sum_probs=112.6

Q ss_pred             ceEEcccCcccccCCccccCCCCCcEEEccCCcccccCCccccccCCccEEEeeCCcCCcc-CchhhhccCCCcEeeecc
Q 002214          158 KGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGRLPRDLGNSTKLKSLDLGFNNLNGE-IPQEIGNLRNLEILGIDQ  236 (952)
Q Consensus       158 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~  236 (952)
                      +.++.+++.++ .+|..+.  ++++.|+|++|+|+.+.+.+|.++++|++|+|++|.+... .+..|..+++++.|.+..
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            45666666666 4554442  3566666666666655455566666666666666665532 233455566666665543


Q ss_pred             -ccccccCCccccCCCCccEEEeeCccccccCCCCcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccc
Q 002214          237 -SNLVGFVPDTIFNISTLKILSLFNNTLSGNLPSSKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLK  315 (952)
Q Consensus       237 -n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~  315 (952)
                       |++....+..|.++++|+.|++++|.+... +....+                                          
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~-~~~~~~------------------------------------------  124 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHL-PDVHKI------------------------------------------  124 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSC-CCCTTT------------------------------------------
T ss_pred             cccccccccccccccccccccccchhhhccc-cccccc------------------------------------------
Confidence             344455555555555555555555554321 111111                                          


Q ss_pred             cccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCCCCcccccCC-CCcEEEccCccccCCCCccc
Q 002214          316 RLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGSLPITLGRLK-KLQGLDLQNNKFEGPIPQEF  394 (952)
Q Consensus       316 ~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~N~i~~~~~~~~  394 (952)
                                                     ..+..+..+...++.+..+.+..|.+++ .++.|++++|+++.+.+..|
T Consensus       125 -------------------------------~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~  173 (242)
T d1xwdc1         125 -------------------------------HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF  173 (242)
T ss_dssp             -------------------------------CBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT
T ss_pred             -------------------------------ccccccccccccccccccccccccccccccceeeecccccccccccccc
Confidence                                           1223344444444455444444444442 55566666666654444444


Q ss_pred             cCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCceeEe
Q 002214          395 CHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDF  453 (952)
Q Consensus       395 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  453 (952)
                      .....++.+++++|+++...+..|.++++|++|++++|+|+.+++..|.++++|+.+++
T Consensus       174 ~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         174 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST  232 (242)
T ss_dssp             TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred             cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence            33222233344555555444445556666666666666666555555555555555444

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=4.9e-19  Score=175.03  Aligned_cols=178  Identities=17%  Similarity=0.172  Sum_probs=106.1

Q ss_pred             ccEEEccCCCCCCCCCcccccCCCCcEEEccCccccC-CCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEecc
Q 002214          352 LTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEG-PIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLS  430 (952)
Q Consensus       352 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  430 (952)
                      .++++.++++++. +|..+.  +++++|+|++|+|+. ..+..|.++++|+.|+|++|++.                   
T Consensus        10 ~~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~-------------------   67 (192)
T d1w8aa_          10 GTTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-------------------   67 (192)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC-------------------
T ss_pred             CCEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccc-------------------
Confidence            3466677777663 333332  456666666666653 33444445555555555555554                   


Q ss_pred             ccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcc
Q 002214          431 SNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPI  510 (952)
Q Consensus       431 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  510 (952)
                           .+.+..|..+++|+.|+|++|+|+...+..|.++++|++|+|++|+|+++.++.|..+++|++|+|++|.+....
T Consensus        68 -----~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~  142 (192)
T d1w8aa_          68 -----GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             -----CBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             -----cccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence                 444444444444555555555554444455555666666666666666666677777777777888877776432


Q ss_pred             cccccccccccEEeCCCCcccccCccchhcccccccccccccccccCCCC
Q 002214          511 PESFGELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       511 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      . ...-...++.+.+..|.++...|..+   ..++.++|+.|.+.|..+.
T Consensus       143 ~-~~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C~~~~  188 (192)
T d1w8aa_         143 H-LAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCSSEN  188 (192)
T ss_dssp             G-GHHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCCCCC-
T ss_pred             c-hHHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcCCCCC
Confidence            2 22222346677788888887667654   4567889999999987664

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=2.2e-21  Score=220.87  Aligned_cols=369  Identities=20%  Similarity=0.164  Sum_probs=201.7

Q ss_pred             CCccceEEcccCcccc----cCCccccCCCCCcEEEccCCccccc----CCcccc-ccCCccEEEeeCCcCCcc----Cc
Q 002214          154 LPRLKGLYVSYNQFKG----PIPNNLWHCKELSSVSLSYNQFTGR----LPRDLG-NSTKLKSLDLGFNNLNGE----IP  220 (952)
Q Consensus       154 l~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~----~~~~~~-~l~~L~~L~L~~N~l~~~----~p  220 (952)
                      +++++.|+|++|+++.    .++..+..+++|+.|+|++|+|+..    +...+. ..++|++|+|++|++++.    ++
T Consensus        26 l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~  105 (460)
T d1z7xw1          26 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS  105 (460)
T ss_dssp             HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCcccccccccc
Confidence            4566666666666552    2234455666677777777666521    111221 123567777777766532    34


Q ss_pred             hhhhccCCCcEeeeccccccccCCcccc-----CCCCccEEEeeCccccccC--CCCcccCCCCCcceEEcccCcCCCCC
Q 002214          221 QEIGNLRNLEILGIDQSNLVGFVPDTIF-----NISTLKILSLFNNTLSGNL--PSSKNLIGLPNLEGLNLGLNNLSGSI  293 (952)
Q Consensus       221 ~~~~~l~~L~~L~L~~n~~~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~--~~~~~l~~l~~L~~L~L~~N~l~~~~  293 (952)
                      ..+..+++|++|++++|.+.......+.     ..............+....  .....+.....++.++++++......
T Consensus       106 ~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~  185 (460)
T d1z7xw1         106 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAG  185 (460)
T ss_dssp             HHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred             chhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccccccccccccccccccc
Confidence            4555666677777776665543211111     1112223333322221100  00011223455666666666543211


Q ss_pred             CcccccchhhhhhhccccCccccccccCcceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCC-----CCCc
Q 002214          294 PSFFFNASKLYALELGYNSNLKRLGLERNYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSG-----SLPI  368 (952)
Q Consensus       294 ~~~~~~~~~L~~l~l~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~-----~~~~  368 (952)
                      ...+     ...+. ........+.+..+.+.......  ...        .+...+.++.+++.+|.+..     ..+.
T Consensus       186 ~~~~-----~~~l~-~~~~~~~~l~~~~~~~~~~~~~~--~~~--------~l~~~~~~~~l~~~~n~~~~~~~~~~~~~  249 (460)
T d1z7xw1         186 VRVL-----CQGLK-DSPCQLEALKLESCGVTSDNCRD--LCG--------IVASKASLRELALGSNKLGDVGMAELCPG  249 (460)
T ss_dssp             HHHH-----HHHHH-HSCCCCCEEECTTSCCBTTHHHH--HHH--------HHHHCTTCCEEECCSSBCHHHHHHHHHHH
T ss_pred             cccc-----ccccc-cccccccccccccccccchhhhc--ccc--------cccccccccccchhhccccccccchhhcc
Confidence            0000     00000 11112334444444333222111  111        12345667788888887642     1233


Q ss_pred             ccccCCCCcEEEccCccccCCC----CccccCCCcceEEEeccccccccCCC----c-cCCCCCCcEEeccccccCCcCC
Q 002214          369 TLGRLKKLQGLDLQNNKFEGPI----PQEFCHFSRLYVVYLNRNKLSGSIPS----C-LGDLNSLRILSLSSNELTSVIP  439 (952)
Q Consensus       369 ~l~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~----~-~~~l~~L~~L~L~~N~l~~~~~  439 (952)
                      .......++.|++++|.+....    ...+...+.++.+++++|.++.....    . ......|+.+++++|.++....
T Consensus       250 ~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~  329 (460)
T d1z7xw1         250 LLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACC  329 (460)
T ss_dssp             HTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhh
Confidence            3445677888888888775322    22345567888888888887632211    1 1234578999999998875433


Q ss_pred             cc----ccCCCCCceeEecCCccCCC----Cchhhh-cccccceeecCCcccCCC----CcccccCCCCCceEEccCccc
Q 002214          440 ST----FWNLEDILGFDFSSNSLNGS----LPLEIE-NLKAVVDIYLSRNNLSGN----IPSTIIGLKNLQHLSLEHNKL  506 (952)
Q Consensus       440 ~~----~~~l~~L~~L~Ls~N~l~~~----~~~~~~-~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l  506 (952)
                      ..    +...++|+.|+|++|+++..    ++..+. ..+.|++|+|++|+|+..    ++..+..+++|++|+|++|+|
T Consensus       330 ~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i  409 (460)
T d1z7xw1         330 SHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL  409 (460)
T ss_dssp             HHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSC
T ss_pred             hhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcC
Confidence            33    34556899999999998643    223332 456799999999999742    345566789999999999999


Q ss_pred             cCcccccc----c-ccccccEEeCCCCcccccCccch
Q 002214          507 QGPIPESF----G-ELVSLEFLDLSNNDLSGVIPASL  538 (952)
Q Consensus       507 ~~~~~~~~----~-~l~~L~~L~Ls~N~l~~~~~~~~  538 (952)
                      +......+    . ...+|+.|++++|.+....+..+
T Consensus       410 ~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l  446 (460)
T d1z7xw1         410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL  446 (460)
T ss_dssp             CHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred             CHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHH
Confidence            75433332    2 33479999999999985444433

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=6.9e-18  Score=171.75  Aligned_cols=96  Identities=25%  Similarity=0.340  Sum_probs=39.7

Q ss_pred             cccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEecc
Q 002214          351 NLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLS  430 (952)
Q Consensus       351 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  430 (952)
                      .++.+.++++.+...  ..+...++|+.|++++|.+...  ..|.++++|+.|+|++|++++. + .+.++++|++|+|+
T Consensus       130 ~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls  203 (227)
T d1h6ua2         130 NLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLK  203 (227)
T ss_dssp             TCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECT
T ss_pred             chhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECc
Confidence            334444444444321  1234444455555555444321  1233444444444444444321 1 13444444444444


Q ss_pred             ccccCCcCCccccCCCCCceeEec
Q 002214          431 SNELTSVIPSTFWNLEDILGFDFS  454 (952)
Q Consensus       431 ~N~l~~~~~~~~~~l~~L~~L~Ls  454 (952)
                      +|+++++.+  +.++++|+.|+++
T Consensus       204 ~N~lt~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         204 NNQISDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             TSCCCBCGG--GTTCTTCCEEEEE
T ss_pred             CCcCCCCcc--cccCCCCCEEEee
Confidence            444443322  3444444444443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=7.4e-18  Score=168.92  Aligned_cols=180  Identities=22%  Similarity=0.336  Sum_probs=127.8

Q ss_pred             EccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccC
Q 002214          356 SLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELT  435 (952)
Q Consensus       356 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  435 (952)
                      .+..+.+++.++  ...+.+|+.|++++|.++...  .+..+++|++|+|++|+|++..  .++.+++|++|++++|+|+
T Consensus        30 ~l~~~~~~~~~~--~~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~  103 (210)
T d1h6ta2          30 NLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK  103 (210)
T ss_dssp             HTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             HhCcCccCCccC--HHHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccc
Confidence            344555553332  234567777777777776432  3666777777777777777433  2567778888888888877


Q ss_pred             CcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCccccccc
Q 002214          436 SVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFG  515 (952)
Q Consensus       436 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  515 (952)
                      ++.  .+..+++|+.|++++|.+..  ...+..++.++.+++++|.++.  +..+..+++|+.+++++|++++..  .+.
T Consensus       104 ~l~--~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~  175 (210)
T d1h6ta2         104 DLS--SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLA  175 (210)
T ss_dssp             CGG--GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGT
T ss_pred             ccc--cccccccccccccccccccc--cccccccccccccccccccccc--cccccccccccccccccccccccc--ccc
Confidence            543  47777888888888887763  3357778888888888888874  345677888888888888888543  378


Q ss_pred             ccccccEEeCCCCcccccCccchhcccccccccccc
Q 002214          516 ELVSLEFLDLSNNDLSGVIPASLEKLLYLKSLNLSF  551 (952)
Q Consensus       516 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~  551 (952)
                      .+++|+.|+|++|+|+. +| .+.++++|+.|+|++
T Consensus       176 ~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         176 GLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             TCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             CCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            88888888888888874 34 588888888888864

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=2.3e-17  Score=163.86  Aligned_cols=176  Identities=26%  Similarity=0.407  Sum_probs=121.2

Q ss_pred             EccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccC
Q 002214          356 SLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELT  435 (952)
Q Consensus       356 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  435 (952)
                      .++.+.+++..  ....++++++|++++|.|+..  +.+..+++|++|++++|++++..+  ++++++|++|++++|.+.
T Consensus        24 ~l~~~~~~~~~--~~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~   97 (199)
T d2omxa2          24 VLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA   97 (199)
T ss_dssp             HTTCSSTTSEE--CHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             HhCCCCCCCcc--CHHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc
Confidence            34555555332  234566777777777777643  246667777777777777764432  677777777777777776


Q ss_pred             CcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCccccccc
Q 002214          436 SVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFG  515 (952)
Q Consensus       436 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  515 (952)
                      .+.  .+.+++.|+.|++++|.+...  ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|++++..  .++
T Consensus        98 ~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~  169 (199)
T d2omxa2          98 DIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLA  169 (199)
T ss_dssp             CCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGT
T ss_pred             ccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--ccc
Confidence            543  367777777888877777642  346777888888888888763 2 35777888888888888887543  378


Q ss_pred             ccccccEEeCCCCcccccCccchhcccccccc
Q 002214          516 ELVSLEFLDLSNNDLSGVIPASLEKLLYLKSL  547 (952)
Q Consensus       516 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  547 (952)
                      ++++|+.|++++|+|+++ + .+.++++|++|
T Consensus       170 ~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         170 NLTTLERLDISSNKVSDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             TCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred             CCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence            888888888888888753 3 46777777764

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=2.7e-17  Score=164.82  Aligned_cols=166  Identities=21%  Similarity=0.365  Sum_probs=142.9

Q ss_pred             CCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEE
Q 002214          348 NLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRIL  427 (952)
Q Consensus       348 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  427 (952)
                      .+.+|+.|++++|.+++..  .+..+++|++|++++|+|++..  .++.+++|+.|++++|+|++ ++ .+..+++|+.|
T Consensus        44 ~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L  117 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL  117 (210)
T ss_dssp             HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred             HhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccc
Confidence            4568999999999998543  4788999999999999998644  46889999999999999984 44 58899999999


Q ss_pred             eccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCcccc
Q 002214          428 SLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQ  507 (952)
Q Consensus       428 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  507 (952)
                      ++++|.+...  ..+..++.++.+++++|.+++  +..+..+++|+.+++++|+++++.  .+.++++|+.|+|++|+|+
T Consensus       118 ~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~  191 (210)
T d1h6ta2         118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHIS  191 (210)
T ss_dssp             ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccc--ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCC
Confidence            9999998754  468899999999999999984  446788999999999999998643  3899999999999999998


Q ss_pred             CcccccccccccccEEeCCC
Q 002214          508 GPIPESFGELVSLEFLDLSN  527 (952)
Q Consensus       508 ~~~~~~~~~l~~L~~L~Ls~  527 (952)
                      + ++ .+..+++|+.|+|++
T Consensus       192 ~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         192 D-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             B-CG-GGTTCTTCSEEEEEE
T ss_pred             C-Ch-hhcCCCCCCEEEccC
Confidence            5 44 599999999999874

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=7e-17  Score=160.25  Aligned_cols=163  Identities=22%  Similarity=0.372  Sum_probs=139.6

Q ss_pred             cCCCcccEEEccCCCCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcE
Q 002214          347 GNLINLTTLSLGDNNLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRI  426 (952)
Q Consensus       347 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  426 (952)
                      ..+.++++|++++|.++..  +.+..+++|++|++++|+|++..+  +.++++|+.|++++|.+... + .+.++++|+.
T Consensus        37 ~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~  110 (199)
T d2omxa2          37 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTG  110 (199)
T ss_dssp             HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSE
T ss_pred             HHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccc-c-cccccccccc
Confidence            3567899999999999854  358889999999999999986543  89999999999999999843 3 4889999999


Q ss_pred             EeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccc
Q 002214          427 LSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKL  506 (952)
Q Consensus       427 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  506 (952)
                      |++++|.+...  ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|++++..  .+.++++|++|++++|+|
T Consensus       111 L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i  184 (199)
T d2omxa2         111 LTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKV  184 (199)
T ss_dssp             EECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             ccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCC
Confidence            99999999864  358889999999999999984 3 46889999999999999999643  489999999999999999


Q ss_pred             cCcccccccccccccEE
Q 002214          507 QGPIPESFGELVSLEFL  523 (952)
Q Consensus       507 ~~~~~~~~~~l~~L~~L  523 (952)
                      +++ + .++.+++|++|
T Consensus       185 ~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         185 SDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             CCC-G-GGGGCTTCSEE
T ss_pred             CCC-c-cccCCCCCCcC
Confidence            963 3 58889999876

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=2.6e-15  Score=142.59  Aligned_cols=127  Identities=18%  Similarity=0.175  Sum_probs=70.9

Q ss_pred             CCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCce
Q 002214          419 GDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQH  498 (952)
Q Consensus       419 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  498 (952)
                      .++.+|++|+|++|+|+.+ +..+..+++|+.|+|++|+|+..  +.|..+++|++|++++|+++.+.+..+..+++|+.
T Consensus        15 ~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~   91 (162)
T d1a9na_          15 TNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   91 (162)
T ss_dssp             ECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             cCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccccc
Confidence            3444555555555555533 33444455555555555555522  23555566666666666666544445556666666


Q ss_pred             EEccCccccCccc-ccccccccccEEeCCCCcccccC---ccchhccccccccc
Q 002214          499 LSLEHNKLQGPIP-ESFGELVSLEFLDLSNNDLSGVI---PASLEKLLYLKSLN  548 (952)
Q Consensus       499 L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~  548 (952)
                      |+|++|+|+.... ..+..+++|+.|++++|+++...   +..+..+|+|+.||
T Consensus        92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             ceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            6666666663221 34666677777777777765332   12456667777665

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=6.7e-15  Score=139.66  Aligned_cols=128  Identities=16%  Similarity=0.153  Sum_probs=70.3

Q ss_pred             cccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEeccccccCCcCCccccCCCCCc
Q 002214          370 LGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILSLSSNELTSVIPSTFWNLEDIL  449 (952)
Q Consensus       370 l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  449 (952)
                      |.+..++++|+|++|+|+.+ +..+..+++|+.|+|++|+|+.. + .|..+++|++|++++|+++++.+..        
T Consensus        14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~--------   82 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGL--------   82 (162)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCH--------
T ss_pred             ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCccc--------
Confidence            44555666666666666633 44445555555555555555522 2 2455555555555555555444433        


Q ss_pred             eeEecCCccCCCCchhhhcccccceeecCCcccCCCCc-ccccCCCCCceEEccCccccCcc---cccccccccccEEe
Q 002214          450 GFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIP-STIIGLKNLQHLSLEHNKLQGPI---PESFGELVSLEFLD  524 (952)
Q Consensus       450 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~  524 (952)
                                      +..+++|+.|++++|+|+.... ..+..+++|++|++++|.++...   +..+..+++|+.||
T Consensus        83 ----------------~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          83 ----------------DQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             ----------------HHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             ----------------cccccccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence                            4445555555555555543211 34566667777777777665322   12466677777766

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.52  E-value=2.3e-14  Score=129.05  Aligned_cols=102  Identities=28%  Similarity=0.364  Sum_probs=58.2

Q ss_pred             cEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCc
Q 002214          425 RILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHN  504 (952)
Q Consensus       425 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  504 (952)
                      +.|+|++|+|+.+.  .+..+++|++|++++|+|+ .+|..+..+++|+.|++++|+|+.. | .+..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~~l~--~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLTVLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCSSCC--CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCCCCc--ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence            34566666665332  2555555666666666555 3444555666666666666666532 2 3566666666666666


Q ss_pred             cccCcc-cccccccccccEEeCCCCccc
Q 002214          505 KLQGPI-PESFGELVSLEFLDLSNNDLS  531 (952)
Q Consensus       505 ~l~~~~-~~~~~~l~~L~~L~Ls~N~l~  531 (952)
                      +|++.. ...+..+++|+.|++++|+++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            665432 234566666666666666665

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.49  E-value=6.1e-16  Score=168.07  Aligned_cols=201  Identities=17%  Similarity=0.181  Sum_probs=94.5

Q ss_pred             CccccCCCCccEEEeeCccccccCCC--CcccCCCCCcceEEcccCcCCCCCCcccccchhhhhhhccccCccccccccC
Q 002214          244 PDTIFNISTLKILSLFNNTLSGNLPS--SKNLIGLPNLEGLNLGLNNLSGSIPSFFFNASKLYALELGYNSNLKRLGLER  321 (952)
Q Consensus       244 ~~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~l~l~~~~~L~~L~L~~  321 (952)
                      ...+.+..+|+.|+|++|.|......  ...+...++|+.|+++++.........                         
T Consensus        24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~-------------------------   78 (344)
T d2ca6a1          24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEI-------------------------   78 (344)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGS-------------------------
T ss_pred             HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCccccccccc-------------------------
Confidence            34455677788888888877422100  112455677777777766554211111                         


Q ss_pred             cceeechhhHHHHHHHhhccccccccCCCcccEEEccCCCCCCC----CCcccccCCCCcEEEccCccccCCCCccc---
Q 002214          322 NYLTFSTSELMSLFSALVNCKSLKIGNLINLTTLSLGDNNLSGS----LPITLGRLKKLQGLDLQNNKFEGPIPQEF---  394 (952)
Q Consensus       322 n~l~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~i~~~~~~~~---  394 (952)
                            +.....+...        +...++|+.|+|++|.++..    +...+...++|+.|++++|.+.......+   
T Consensus        79 ------~~~~~~l~~~--------l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~  144 (344)
T d2ca6a1          79 ------PEALRLLLQA--------LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA  144 (344)
T ss_dssp             ------HHHHHHHHHH--------HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred             ------chHHHHHHHH--------HhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccccccccc
Confidence                  0011111111        23455677777777777643    22334456777777777776642111111   


Q ss_pred             ----------cCCCcceEEEecccccccc----CCCccCCCCCCcEEeccccccCCc-----CCccccCCCCCceeEecC
Q 002214          395 ----------CHFSRLYVVYLNRNKLSGS----IPSCLGDLNSLRILSLSSNELTSV-----IPSTFWNLEDILGFDFSS  455 (952)
Q Consensus       395 ----------~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~  455 (952)
                                ...+.|+.+.+++|+++..    +...+...+.|+.|+|++|+|+..     ....+...++|+.|+|++
T Consensus       145 l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~  224 (344)
T d2ca6a1         145 LQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD  224 (344)
T ss_dssp             HHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCS
T ss_pred             ccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccc
Confidence                      1234455555555554411    122233445555555555555421     122233444455555555


Q ss_pred             CccCCC----CchhhhcccccceeecCCcccC
Q 002214          456 NSLNGS----LPLEIENLKAVVDIYLSRNNLS  483 (952)
Q Consensus       456 N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~  483 (952)
                      |.++..    +...+..+++|++|+|++|.|+
T Consensus       225 N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~  256 (344)
T d2ca6a1         225 NTFTHLGSSALAIALKSWPNLRELGLNDCLLS  256 (344)
T ss_dssp             SCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred             ccccccccccccccccccccchhhhhhcCccC
Confidence            544321    1222334444444444444443

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.48  E-value=4.9e-14  Score=126.87  Aligned_cols=104  Identities=29%  Similarity=0.324  Sum_probs=91.9

Q ss_pred             ceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCCC
Q 002214          449 LGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSNN  528 (952)
Q Consensus       449 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  528 (952)
                      +.|+|++|+|+. ++ .+..+++|++|++++|+|+ .+|..|..+++|+.|++++|+|++ +| .+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            579999999994 44 4899999999999999999 467789999999999999999995 44 5999999999999999


Q ss_pred             cccccCc-cchhcccccccccccccccccC
Q 002214          529 DLSGVIP-ASLEKLLYLKSLNLSFNKLVGE  557 (952)
Q Consensus       529 ~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~  557 (952)
                      +|+...+ ..+..+++|+.|++++|+++..
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence            9986643 6789999999999999999854

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=2e-15  Score=158.57  Aligned_cols=223  Identities=18%  Similarity=0.208  Sum_probs=121.6

Q ss_pred             EEEEecCCCCcccCCccccCCcccCeeeccccccccccCCCcCCcCCCcEEeCcCCccccc-CChhhcCCCCCCeEeecC
Q 002214           36 TSLTISDLGLAGTIPSHLGNLSSLQTLVLSRNWFSGTIPKEIGNLTKLKELHLDYNKLQGE-IPEELGNLAELEMLVLNN  114 (952)
Q Consensus        36 ~~l~l~~~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~  114 (952)
                      +.+|+++..+.......+.. ..+..+.++++.+. ..........+|++|+|++|.+... ++..+.++++|++|+|++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccc-cchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence            36777777664222222211 13445556665554 2223344556778888887777633 344567778888888888


Q ss_pred             ccCccccCcccccccccccceeeccc-cccccCCCCCCCCCCccceEEcccCc-cccc-CCccccC-CCCCcEEEccCCc
Q 002214          115 NLLTGTIPASIFNLSFISTALDFSDN-SLTGSFPYDMCPGLPRLKGLYVSYNQ-FKGP-IPNNLWH-CKELSSVSLSYNQ  190 (952)
Q Consensus       115 n~l~~~~p~~~~~l~~l~~~L~l~~n-~l~~~~~~~~~~~l~~L~~L~L~~n~-l~~~-~~~~l~~-l~~L~~L~L~~N~  190 (952)
                      |.+++..+..+++++.+ +.|++++| .++...-..+..++++|++|++++|. ++.. +...+.. .++|+.|+++++.
T Consensus        81 ~~l~~~~~~~l~~~~~L-~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~  159 (284)
T d2astb2          81 LRLSDPIVNTLAKNSNL-VRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR  159 (284)
T ss_dssp             CBCCHHHHHHHTTCTTC-SEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred             cCCCcHHHHHHhcCCCC-cCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccc
Confidence            77765555555554432 55555553 23311111122345677777777653 3211 1122222 3567777776542


Q ss_pred             --cccc-CCccccccCCccEEEeeCC-cCCccCchhhhccCCCcEeeeccc-cccccCCccccCCCCccEEEeeCc
Q 002214          191 --FTGR-LPRDLGNSTKLKSLDLGFN-NLNGEIPQEIGNLRNLEILGIDQS-NLVGFVPDTIFNISTLKILSLFNN  261 (952)
Q Consensus       191 --l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~n-~~~~~~~~~~~~l~~L~~L~Ls~N  261 (952)
                        ++.. +...+.++++|++|++++| .+++.....+.++++|++|+|++| ++.......+.++++|+.|+++++
T Consensus       160 ~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         160 KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             GGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence              3321 2222345567777777665 355555666667777777777764 454444455666677777777665

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=1.1e-14  Score=152.92  Aligned_cols=102  Identities=17%  Similarity=0.187  Sum_probs=50.4

Q ss_pred             cceeeccccccccCCCCCCCCCCccceEEcccCcccccCCccccCCCCCcEEEccCCccccc-CCccccccCCccEEEee
Q 002214          133 TALDFSDNSLTGSFPYDMCPGLPRLKGLYVSYNQFKGPIPNNLWHCKELSSVSLSYNQFTGR-LPRDLGNSTKLKSLDLG  211 (952)
Q Consensus       133 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~  211 (952)
                      +.+|++++.+.......+..  ..+..+.++...+.... .......+|++|++++|.++.. ++..+..+++|++|+|+
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~   79 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE   79 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred             CEEECCCCCCCchHHHHHHh--ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence            35677766654322222211  12334444444443211 2222344566666666655422 23334555666666666


Q ss_pred             CCcCCccCchhhhccCCCcEeeeccc
Q 002214          212 FNNLNGEIPQEIGNLRNLEILGIDQS  237 (952)
Q Consensus       212 ~N~l~~~~p~~~~~l~~L~~L~L~~n  237 (952)
                      +|.+++..+..++.+++|+.|++++|
T Consensus        80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c  105 (284)
T d2astb2          80 GLRLSDPIVNTLAKNSNLVRLNLSGC  105 (284)
T ss_dssp             TCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred             ccCCCcHHHHHHhcCCCCcCcccccc
Confidence            66665555555666666666666554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.47  E-value=3.6e-15  Score=161.80  Aligned_cols=212  Identities=19%  Similarity=0.197  Sum_probs=154.8

Q ss_pred             ccCCCcccEEEccCCCCCCC----------CCcccccCCCCcEEEccCccccCCCC----ccccCCCcceEEEecccccc
Q 002214          346 IGNLINLTTLSLGDNNLSGS----------LPITLGRLKKLQGLDLQNNKFEGPIP----QEFCHFSRLYVVYLNRNKLS  411 (952)
Q Consensus       346 ~~~l~~L~~L~L~~n~l~~~----------~~~~l~~l~~L~~L~L~~N~i~~~~~----~~~~~l~~L~~L~L~~N~l~  411 (952)
                      +...++|+.|+++++.....          +...+...++|+.|+|++|.+.....    ..+...++|+.|++++|.+.
T Consensus        55 l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~  134 (344)
T d2ca6a1          55 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG  134 (344)
T ss_dssp             TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred             HHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccccc
Confidence            45678899999988765422          12345667899999999999875432    34456789999999999876


Q ss_pred             ccCCC-------------ccCCCCCCcEEeccccccCCcCC----ccccCCCCCceeEecCCccCCC-----Cchhhhcc
Q 002214          412 GSIPS-------------CLGDLNSLRILSLSSNELTSVIP----STFWNLEDILGFDFSSNSLNGS-----LPLEIENL  469 (952)
Q Consensus       412 ~~~~~-------------~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l  469 (952)
                      .....             .....+.|+.+.+++|+++....    ..+...+.|+.|++++|++...     +...+..+
T Consensus       135 ~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~  214 (344)
T d2ca6a1         135 PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC  214 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGC
T ss_pred             ccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcch
Confidence            21111             11356789999999999874322    2345678999999999998742     23446778


Q ss_pred             cccceeecCCcccCCC----CcccccCCCCCceEEccCccccCccccc----ccc--cccccEEeCCCCccccc----Cc
Q 002214          470 KAVVDIYLSRNNLSGN----IPSTIIGLKNLQHLSLEHNKLQGPIPES----FGE--LVSLEFLDLSNNDLSGV----IP  535 (952)
Q Consensus       470 ~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~----~~~--l~~L~~L~Ls~N~l~~~----~~  535 (952)
                      ++|+.|+|++|.++..    +...+..+++|++|+|++|.|++.....    +..  .+.|++|++++|+|+..    +.
T Consensus       215 ~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~  294 (344)
T d2ca6a1         215 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK  294 (344)
T ss_dssp             TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred             hhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHH
Confidence            8999999999998632    3456778899999999999998543322    322  36799999999999743    23


Q ss_pred             cchh-cccccccccccccccccC
Q 002214          536 ASLE-KLLYLKSLNLSFNKLVGE  557 (952)
Q Consensus       536 ~~~~-~l~~L~~L~l~~N~l~~~  557 (952)
                      ..+. ++++|+.|++++|++..+
T Consensus       295 ~~l~~~~~~L~~L~l~~N~~~~~  317 (344)
T d2ca6a1         295 TVIDEKMPDLLFLELNGNRFSEE  317 (344)
T ss_dssp             HHHHHHCTTCCEEECTTSBSCTT
T ss_pred             HHHHccCCCCCEEECCCCcCCCc
Confidence            3342 578899999999999643

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.39  E-value=7.1e-15  Score=144.69  Aligned_cols=125  Identities=22%  Similarity=0.278  Sum_probs=61.2

Q ss_pred             CCCCCCcEEeccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCce
Q 002214          419 GDLNSLRILSLSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQH  498 (952)
Q Consensus       419 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  498 (952)
                      ..+++|++|+|++|+|+.+.  .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+.+  ..+..+++|+.
T Consensus        45 ~~L~~L~~L~Ls~n~I~~i~--~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~~  119 (198)
T d1m9la_          45 STLKACKHLALSTNNIEKIS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRV  119 (198)
T ss_dssp             HHTTTCCEEECSEEEESCCC--CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSSE
T ss_pred             hcccccceeECcccCCCCcc--cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccccccc
Confidence            33444444444444444321  2444444444444444444 2333334444555555555555532  23455555666


Q ss_pred             EEccCccccCccc-ccccccccccEEeCCCCcccccCcc----------chhccccccccc
Q 002214          499 LSLEHNKLQGPIP-ESFGELVSLEFLDLSNNDLSGVIPA----------SLEKLLYLKSLN  548 (952)
Q Consensus       499 L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~----------~~~~l~~L~~L~  548 (952)
                      |+|++|+|+.... ..+..+++|+.|+|++|++....+.          .+..+|+|+.||
T Consensus       120 L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             EEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             cccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            6666666553221 3455566666666666665433222          145667777654

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=4.6e-13  Score=125.90  Aligned_cols=108  Identities=21%  Similarity=0.244  Sum_probs=78.3

Q ss_pred             ceeEecCCccCCCCchhhhcccccceeecCCc-ccCCCCcccccCCCCCceEEccCccccCcccccccccccccEEeCCC
Q 002214          449 LGFDFSSNSLNGSLPLEIENLKAVVDIYLSRN-NLSGNIPSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLDLSN  527 (952)
Q Consensus       449 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  527 (952)
                      ..++.+++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++
T Consensus        11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~   89 (156)
T d2ifga3          11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (156)
T ss_dssp             SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence            34555555555 34555666777777777655 47766777788888888888888888877777888888888888888


Q ss_pred             CcccccCccchhcccccccccccccccccCC
Q 002214          528 NDLSGVIPASLEKLLYLKSLNLSFNKLVGEI  558 (952)
Q Consensus       528 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  558 (952)
                      |+|+.+.+..|.. .+|+.|+|++|+|.|.+
T Consensus        90 N~l~~l~~~~~~~-~~l~~L~L~~Np~~C~C  119 (156)
T d2ifga3          90 NALESLSWKTVQG-LSLQELVLSGNPLHCSC  119 (156)
T ss_dssp             SCCSCCCSTTTCS-CCCCEEECCSSCCCCCG
T ss_pred             CCCcccChhhhcc-ccccccccCCCcccCCc
Confidence            8888555555544 36888888888887665

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.34  E-value=4.5e-14  Score=138.86  Aligned_cols=149  Identities=23%  Similarity=0.265  Sum_probs=85.5

Q ss_pred             cccEEEccCC--CCCCCCCcccccCCCCcEEEccCccccCCCCccccCCCcceEEEeccccccccCCCccCCCCCCcEEe
Q 002214          351 NLTTLSLGDN--NLSGSLPITLGRLKKLQGLDLQNNKFEGPIPQEFCHFSRLYVVYLNRNKLSGSIPSCLGDLNSLRILS  428 (952)
Q Consensus       351 ~L~~L~L~~n--~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  428 (952)
                      .++.+++.++  .++ .++..+..+++|++|+|++|.|+.+ + .+.++++|+.|+|++|+|+ .+|.            
T Consensus        24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~------------   87 (198)
T d1m9la_          24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIEN------------   87 (198)
T ss_dssp             TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSS------------
T ss_pred             ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-cccc------------
Confidence            3455555443  232 3344566666666666666666532 1 3445555555555555544 2232            


Q ss_pred             ccccccCCcCCccccCCCCCceeEecCCccCCCCchhhhcccccceeecCCcccCCCCc-ccccCCCCCceEEccCcccc
Q 002214          429 LSSNELTSVIPSTFWNLEDILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNIP-STIIGLKNLQHLSLEHNKLQ  507 (952)
Q Consensus       429 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  507 (952)
                                  .+..+++|+.|++++|+++. + ..+..+++|+.|++++|+|+.... ..+..+++|+.|+|++|++.
T Consensus        88 ------------~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_          88 ------------LDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             ------------HHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             ------------cccccccccccccccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence                        23333445555555555553 2 346677777777777777774322 45777888888888888876


Q ss_pred             Cccccc----------ccccccccEEeCCCCccc
Q 002214          508 GPIPES----------FGELVSLEFLDLSNNDLS  531 (952)
Q Consensus       508 ~~~~~~----------~~~l~~L~~L~Ls~N~l~  531 (952)
                      ...+..          +..+|+|+.||  +..++
T Consensus       154 ~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~  185 (198)
T d1m9la_         154 NDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred             cCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence            443322          56688888876  55554

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=1.1e-12  Score=123.15  Aligned_cols=133  Identities=16%  Similarity=0.059  Sum_probs=71.6

Q ss_pred             EEeccccccCCcCCccccCCCCCceeEecCC-ccCCCCchhhhcccccceeecCCcccCCCCcccccCCCCCceEEccCc
Q 002214          426 ILSLSSNELTSVIPSTFWNLEDILGFDFSSN-SLNGSLPLEIENLKAVVDIYLSRNNLSGNIPSTIIGLKNLQHLSLEHN  504 (952)
Q Consensus       426 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  504 (952)
                      .++.+++.++. .|..+..+++|+.|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|.++++|++|+|++|
T Consensus        12 ~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             eEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            34444444442 2333444445555555433 244444455566666666666666666666666777777777777777


Q ss_pred             cccCcccccccccccccEEeCCCCcccc-cCccchhcccccccccccccccccCCCC
Q 002214          505 KLQGPIPESFGELVSLEFLDLSNNDLSG-VIPASLEKLLYLKSLNLSFNKLVGEIPR  560 (952)
Q Consensus       505 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~  560 (952)
                      +|+...+..|.. .+|+.|+|++|++.- -.-.+|..+.......+..+.+.|.-|.
T Consensus        91 ~l~~l~~~~~~~-~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~  146 (156)
T d2ifga3          91 ALESLSWKTVQG-LSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (156)
T ss_dssp             CCSCCCSTTTCS-CCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CCcccChhhhcc-ccccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcCh
Confidence            777444444444 357777777777742 1112233333333444455666665553

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.58  E-value=2.9e-09  Score=100.15  Aligned_cols=105  Identities=25%  Similarity=0.167  Sum_probs=63.5

Q ss_pred             CCceeEecCCccCCCCchhhhcccccceeecCCcccCCCC--cccccCCCCCceEEccCccccCcccccccccccccEEe
Q 002214          447 DILGFDFSSNSLNGSLPLEIENLKAVVDIYLSRNNLSGNI--PSTIIGLKNLQHLSLEHNKLQGPIPESFGELVSLEFLD  524 (952)
Q Consensus       447 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  524 (952)
                      .+..++...|... .++..+..++.|++|+|++|+|+.+.  +..+..+++|+.|+|++|+|+...+-.+....+|+.|+
T Consensus        43 ~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~  121 (162)
T d1koha1          43 IDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELW  121 (162)
T ss_dssp             CCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCC
T ss_pred             chhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceee
Confidence            3333444443333 33444556777777777777777543  34456677788888888887754443444455678888


Q ss_pred             CCCCcccccCcc-------chhccccccccccccccc
Q 002214          525 LSNNDLSGVIPA-------SLEKLLYLKSLNLSFNKL  554 (952)
Q Consensus       525 Ls~N~l~~~~~~-------~~~~l~~L~~L~l~~N~l  554 (952)
                      +++|++......       .+..+|+|+.||  |+++
T Consensus       122 L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1         122 LDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             CTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred             cCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence            888887654332       245677777664  5544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.52  E-value=3e-07  Score=93.90  Aligned_cols=148  Identities=15%  Similarity=0.140  Sum_probs=103.5

Q ss_pred             HHHHHhccCCccceecCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeE
Q 002214          658 ELLRATDQFSEENLIGIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKA  736 (952)
Q Consensus       658 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  736 (952)
                      ++....+.|+..+..+-++.+.||+... +++.+++|+...........+.+|..+++.++ +--+.+++++...++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4566667787776655555678999875 56678889876555444556788999988874 333667788888888999


Q ss_pred             EEEEccCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 002214          737 LVLEYMPKGSLEDCMYASNFNLDIFQRLGIMIDVASALEYLHF-------------------------------------  779 (952)
Q Consensus       737 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh~-------------------------------------  779 (952)
                      +||++++|.++.+......      ....++.++++.++.||.                                     
T Consensus        87 lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            9999999988765432111      122234445555555542                                     


Q ss_pred             -------------------cCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          780 -------------------GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       780 -------------------~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                                         .....++|+|+.|.||++++++.+-|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                               012237899999999999987777899999886

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.48  E-value=5.2e-09  Score=98.36  Aligned_cols=41  Identities=24%  Similarity=0.270  Sum_probs=19.2

Q ss_pred             CCCCCCcEEeccccccCCcCC--ccccCCCCCceeEecCCccC
Q 002214          419 GDLNSLRILSLSSNELTSVIP--STFWNLEDILGFDFSSNSLN  459 (952)
Q Consensus       419 ~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~  459 (952)
                      ..+++|++|+|++|+|+.+.+  ..+..+++|+.|+|++|+|+
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~  104 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK  104 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence            345555555555555554321  22333444444444444444

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.06  E-value=2.2e-06  Score=86.83  Aligned_cols=130  Identities=18%  Similarity=0.168  Sum_probs=85.9

Q ss_pred             eecCcc-ceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCC--CccceeeeEeecCCeeEEEEEccCCCCh
Q 002214          671 LIGIGS-YGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRH--RNLVKIISSCTNHNFKALVLEYMPKGSL  747 (952)
Q Consensus       671 ~lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L  747 (952)
                      .+..|. .+.||+...+++..+++|......   ...+..|+..++.+..  -.+.+++++..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            445555 368999998888889999865433   2456788888887743  3356778888888889999999988765


Q ss_pred             hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q 002214          748 EDCMYASNFNLDIFQRLGIMIDVASALEYLH-------------------------------------------------  778 (952)
Q Consensus       748 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~Lh-------------------------------------------------  778 (952)
                      .+..      ...   ...+.++++.++.||                                                 
T Consensus        94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            3310      000   011112222222222                                                 


Q ss_pred             --h----cCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          779 --F----GHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       779 --~----~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                        .    .....++|+|+.|.||+++.+..+.|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence              1    122348999999999999988778899999775

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.62  E-value=1.1e-05  Score=75.40  Aligned_cols=65  Identities=15%  Similarity=0.201  Sum_probs=33.0

Q ss_pred             CCCCCCcEEecccc-ccCCc----CCccccCCCCCceeEecCCccCC----CCchhhhcccccceeecCCcccC
Q 002214          419 GDLNSLRILSLSSN-ELTSV----IPSTFWNLEDILGFDFSSNSLNG----SLPLEIENLKAVVDIYLSRNNLS  483 (952)
Q Consensus       419 ~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~  483 (952)
                      .+.++|++|+|+++ .++..    ....+...+.|+.|+|++|.+..    .+...+...+.|++|+|++|.|+
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~   85 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT   85 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence            34567778888764 35421    11234445566666666666542    12223333444555555555554

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.58  E-value=1.1e-05  Score=75.48  Aligned_cols=85  Identities=14%  Similarity=0.126  Sum_probs=46.2

Q ss_pred             CCCccceEEcccC-ccccc----CCccccCCCCCcEEEccCCcccccC----CccccccCCccEEEeeCCcCCccC----
Q 002214          153 GLPRLKGLYVSYN-QFKGP----IPNNLWHCKELSSVSLSYNQFTGRL----PRDLGNSTKLKSLDLGFNNLNGEI----  219 (952)
Q Consensus       153 ~l~~L~~L~L~~n-~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~----  219 (952)
                      +.++|++|+|+++ .++..    +...+...++|+.|+|++|.++...    ...+...+.|++|+|++|.++...    
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l   92 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL   92 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence            3467888888764 35421    2334555666777777777766322    223344566777777777666322    


Q ss_pred             chhhhccCCCcEeeeccc
Q 002214          220 PQEIGNLRNLEILGIDQS  237 (952)
Q Consensus       220 p~~~~~l~~L~~L~L~~n  237 (952)
                      -.++...+.|++|+|++|
T Consensus        93 ~~aL~~n~sL~~L~l~~n  110 (167)
T d1pgva_          93 LRSTLVTQSIVEFKADNQ  110 (167)
T ss_dssp             HHHTTTTCCCSEEECCCC
T ss_pred             HHHHHhCCcCCEEECCCC
Confidence            122333344444444444

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.56  E-value=0.00016  Score=77.58  Aligned_cols=77  Identities=16%  Similarity=0.084  Sum_probs=49.6

Q ss_pred             cceecCccceEEEEEEeCC-CcEEEEEEeeccC-------chhhHHHHHHHHHHHhCC-C-C-ccceeeeEeecCCeeEE
Q 002214          669 ENLIGIGSYGSVYKGRFPD-GIEVAIKVFHLQR-------EGALNSFDAECEILKTIR-H-R-NLVKIISSCTNHNFKAL  737 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~l  737 (952)
                      .+.||.|....||+....+ ++.|+||.-.+..       +....+...|++.++.+. + | .+.+++.+.  ++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            4578999999999998754 6789999653211       112345667888888763 3 3 344555543  344579


Q ss_pred             EEEccCCCCh
Q 002214          738 VLEYMPKGSL  747 (952)
Q Consensus       738 v~e~~~~g~L  747 (952)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.96  E-value=9e-05  Score=68.86  Aligned_cols=82  Identities=20%  Similarity=0.194  Sum_probs=46.6

Q ss_pred             CCCccceEEccc-Cccccc----CCccccCCCCCcEEEccCCccccc----CCccccccCCccEEEeeCCcCCcc----C
Q 002214          153 GLPRLKGLYVSY-NQFKGP----IPNNLWHCKELSSVSLSYNQFTGR----LPRDLGNSTKLKSLDLGFNNLNGE----I  219 (952)
Q Consensus       153 ~l~~L~~L~L~~-n~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~  219 (952)
                      +.++|++|+|++ +.++..    +...+...++|++|+|++|.++..    +-..+...++++.|++++|.+...    +
T Consensus        15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l   94 (166)
T d1io0a_          15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL   94 (166)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred             cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence            456788888876 445421    233444567777777777776532    223344556777777777776532    2


Q ss_pred             chhhhccCCCcEeee
Q 002214          220 PQEIGNLRNLEILGI  234 (952)
Q Consensus       220 p~~~~~l~~L~~L~L  234 (952)
                      .+.+...++|+.++|
T Consensus        95 ~~~l~~~~~L~~l~L  109 (166)
T d1io0a_          95 VEALQSNTSLIELRI  109 (166)
T ss_dssp             HHGGGGCSSCCEEEC
T ss_pred             HHHHHhCccccEEee
Confidence            233444555555444

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.94  E-value=0.00094  Score=69.32  Aligned_cols=133  Identities=14%  Similarity=0.132  Sum_probs=78.5

Q ss_pred             eEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCcc--ceeee-----EeecCCeeEEEEEccCCCChh--
Q 002214          678 GSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRNL--VKIIS-----SCTNHNFKALVLEYMPKGSLE--  748 (952)
Q Consensus       678 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~g~L~--  748 (952)
                      -.||++..++|+.|++|+.+.... ..+++..|...+..|....+  +..+.     .....+..+.++++++|..+.  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            489999999999999999875532 23667889988888742222  22211     223456778999999765431  


Q ss_pred             ---HH------h---hh----c----CCCCCHH----------------------HHHHHHHHHHHHHHHHH-hcCCCCe
Q 002214          749 ---DC------M---YA----S----NFNLDIF----------------------QRLGIMIDVASALEYLH-FGHSNPI  785 (952)
Q Consensus       749 ---~~------l---~~----~----~~~l~~~----------------------~~~~i~~~ia~~l~~Lh-~~h~~~i  785 (952)
                         .+      +   +.    .    +...++.                      .....+.++...++-.- ..-..++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               11      0   00    0    0111111                      11222233333332221 1124579


Q ss_pred             EeCCCCCCCeeeCCCCcEEEeccccccc
Q 002214          786 VHCDIKPSNVLLDDSMVAHLSDFGIAKL  813 (952)
Q Consensus       786 vH~Dlk~~Nill~~~~~~kl~Dfgla~~  813 (952)
                      +|+|+.+.|||++.+  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999743  45899998863

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.85  E-value=0.00013  Score=67.85  Aligned_cols=40  Identities=15%  Similarity=0.138  Sum_probs=18.2

Q ss_pred             CcCCCcEEeCcC-Ccccc----cCChhhcCCCCCCeEeecCccCc
Q 002214           79 NLTKLKELHLDY-NKLQG----EIPEELGNLAELEMLVLNNNLLT  118 (952)
Q Consensus        79 ~l~~L~~L~L~~-n~l~~----~~p~~l~~l~~L~~L~L~~n~l~  118 (952)
                      +.++|++|+|++ +.++.    .+-.++...++|++|+|++|.++
T Consensus        15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN   59 (166)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred             cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence            334555555554 23331    12233444555555555555544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.55  E-value=0.0035  Score=64.56  Aligned_cols=156  Identities=14%  Similarity=0.078  Sum_probs=86.3

Q ss_pred             cCHHHHHHHhccCCcccee-----cCccceEEEEEEeCCCcEEEEEEeeccCchhhHHHHHHHHHHHhCCCCc--cceee
Q 002214          654 YSHDELLRATDQFSEENLI-----GIGSYGSVYKGRFPDGIEVAIKVFHLQREGALNSFDAECEILKTIRHRN--LVKII  726 (952)
Q Consensus       654 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~  726 (952)
                      .+.+++.....+|.+++..     ..|---+.|+.+.++|+ +++|++....+  .+.+..|++++..+...+  +...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            4567788888888776543     45555778999886654 89999854322  245566777777774322  22221


Q ss_pred             e------EeecCCeeEEEEEccCCCChhHH--------------hhhc--C------CCCC------------------H
Q 002214          727 S------SCTNHNFKALVLEYMPKGSLEDC--------------MYAS--N------FNLD------------------I  760 (952)
Q Consensus       727 ~------~~~~~~~~~lv~e~~~~g~L~~~--------------l~~~--~------~~l~------------------~  760 (952)
                      .      +....+..+.++.++.+......              ++..  .      ....                  .
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      11223455667777665433110              0000  0      0000                  0


Q ss_pred             HHHHHHHHHHHHHHHHHH-hcCCCCeEeCCCCCCCeeeCCCCcEEEecccccc
Q 002214          761 FQRLGIMIDVASALEYLH-FGHSNPIVHCDIKPSNVLLDDSMVAHLSDFGIAK  812 (952)
Q Consensus       761 ~~~~~i~~~ia~~l~~Lh-~~h~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  812 (952)
                      ......+......++... ..-..|+||+|+.+.||+++.+...-|+||+.|.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            011122222222333322 1245789999999999999998888899999886

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.05  E-value=0.0089  Score=63.51  Aligned_cols=73  Identities=19%  Similarity=0.241  Sum_probs=49.8

Q ss_pred             cceecCccceEEEEEEeCC--------CcEEEEEEeeccCchhhHHHHHHHHHHHhCC-CCccceeeeEeecCCeeEEEE
Q 002214          669 ENLIGIGSYGSVYKGRFPD--------GIEVAIKVFHLQREGALNSFDAECEILKTIR-HRNLVKIISSCTNHNFKALVL  739 (952)
Q Consensus       669 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  739 (952)
                      ++.|+.|---.+|+...++        .+.|.+++.- .... .....+|..+++.+. +.-..++++++.+    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3578888888999998753        3567777764 2222 244568999999885 4334467777653    5899


Q ss_pred             EccCCCCh
Q 002214          740 EYMPKGSL  747 (952)
Q Consensus       740 e~~~~g~L  747 (952)
                      ||++|.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987554